Citrus Sinensis ID: 007498
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 601 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZUZ2 | 595 | CDPK-related kinase 3 OS= | yes | no | 0.985 | 0.994 | 0.801 | 0.0 | |
| Q9FIM9 | 594 | CDPK-related kinase 4 OS= | no | no | 0.968 | 0.979 | 0.645 | 0.0 | |
| P53681 | 602 | CDPK-related protein kina | N/A | no | 0.973 | 0.971 | 0.622 | 0.0 | |
| Q9SCS2 | 601 | CDPK-related kinase 5 OS= | no | no | 0.905 | 0.905 | 0.661 | 0.0 | |
| Q9SG12 | 594 | CDPK-related kinase 6 OS= | no | no | 0.973 | 0.984 | 0.639 | 0.0 | |
| O80673 | 576 | CDPK-related kinase 1 OS= | no | no | 0.946 | 0.987 | 0.586 | 0.0 | |
| Q9FX86 | 606 | CDPK-related kinase 8 OS= | no | no | 0.926 | 0.919 | 0.596 | 0.0 | |
| Q9LET1 | 577 | CDPK-related kinase 7 OS= | no | no | 0.948 | 0.987 | 0.580 | 0.0 | |
| Q9LJL9 | 599 | CDPK-related kinase 2 OS= | no | no | 0.933 | 0.936 | 0.611 | 0.0 | |
| Q10KY3 | 600 | Calcium/calmodulin-depend | no | no | 0.896 | 0.898 | 0.621 | 0.0 |
| >sp|Q9ZUZ2|CAMK3_ARATH CDPK-related kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 915 bits (2365), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/600 (80%), Positives = 536/600 (89%), Gaps = 8/600 (1%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQT-PLPPSTPGNGSMPVKNTPGRSSHPS 59
MGQCYGK + +N A TTT VVS + NQ PL P G KNTP RSS+PS
Sbjct: 1 MGQCYGKVNQSKQN-GEEEANTTTYVVSGDGNQIQPLTPVNYGRA----KNTPARSSNPS 55
Query: 60 PWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPK 119
PWPSP+PHG SASPLP+GVSPSPAR STPRRFFRRPFPPPSPAKHIKASL KRLG KPK
Sbjct: 56 PWPSPFPHG-SASPLPSGVSPSPARTSTPRRFFRRPFPPPSPAKHIKASLIKRLGV-KPK 113
Query: 120 ESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVA 179
E IPEERGTEPEQSLDKSFGY KNFGAKYELGKEVGRGHFGHTCS RGKKG++KD +A
Sbjct: 114 EGPIPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSGRGKKGDIKDHPIA 173
Query: 180 VKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELL 239
VKIISKAKMTTAI+IEDVRREVK+LK+LSGHK+L+K+ DACED NNVYIVMELC+GGELL
Sbjct: 174 VKIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACEDANNVYIVMELCDGGELL 233
Query: 240 DRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299
DRILARGG+Y E+DAKAIVVQIL+VV+FCHLQGVVHRDLKPENFLFTS R+D+D++LIDF
Sbjct: 234 DRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPENFLFTSSREDSDLKLIDF 293
Query: 300 GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTES 359
GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI+YILLCGSRPFWARTES
Sbjct: 294 GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILLCGSRPFWARTES 353
Query: 360 GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419
GIFR VLR++PN+DD+PWPS S E KDFVKRLLNKDYRKRM+AVQALTHPWLRDDSR +P
Sbjct: 354 GIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSAVQALTHPWLRDDSRVIP 413
Query: 420 LDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRM 479
LDILI+KLVK+YLHATP +RAALKAL+KALTE+ELVYLRAQF LL PNKDGSVSLENF+
Sbjct: 414 LDILIYKLVKAYLHATPLRRAALKALAKALTENELVYLRAQFMLLGPNKDGSVSLENFKT 473
Query: 480 VLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFE 539
L +NATDAMRESRVP++L +MESLAYRKMYFEEFCAAAIS HQLEA++ WE+IA+ F+
Sbjct: 474 ALMQNATDAMRESRVPEILHTMESLAYRKMYFEEFCAAAISIHQLEAVDAWEEIATAGFQ 533
Query: 540 YFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRSSNTR 599
+FE EGNRVI+IEELARELNVG SAY L+DW+R+SDGKLS G+TKFLHGVTLR+++ R
Sbjct: 534 HFETEGNRVITIEELARELNVGASAYGHLRDWVRSSDGKLSYLGFTKFLHGVTLRAAHAR 593
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3 an GLN1-1. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FIM9|CAMK4_ARATH CDPK-related kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 759 bits (1960), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/609 (64%), Positives = 477/609 (78%), Gaps = 27/609 (4%)
Query: 1 MGQCYGKTIPTTENDAT-TSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPS 59
MG CY + I E+D T + S N +P S +G+ V S + S
Sbjct: 1 MGHCYSRNISAVEDDEIPTGNGEVSNQPSQNHRHASIPQSPVASGTPEVN-----SYNIS 55
Query: 60 PWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGG-KP 118
P+ SPLPAGV+PSPAR TP R F+ PFPPPSPAK I A+L +R G +P
Sbjct: 56 PF---------QSPLPAGVAPSPAR--TPGRKFKWPFPPPSPAKPIMAALRRRRGAPPQP 104
Query: 119 KESTIPEER--------GTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKK 170
++ IPE+ + + LDK+FG+ KNF KYELGKEVGRGHFGHTC A+ KK
Sbjct: 105 RDEPIPEDSEDVVDHGGDSGGGERLDKNFGFGKNFEGKYELGKEVGRGHFGHTCWAKAKK 164
Query: 171 GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVM 230
G++K+Q VAVKIISKAKMT+ +SIEDVRREVK+LKALSGH+H+VKF D ED +NV++VM
Sbjct: 165 GKMKNQTVAVKIISKAKMTSTLSIEDVRREVKLLKALSGHRHMVKFYDVYEDADNVFVVM 224
Query: 231 ELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290
ELCEGGELLDRILARGGRY E DAK I+VQILS AF HLQGVVHRDLKPENFLFTS +
Sbjct: 225 ELCEGGELLDRILARGGRYPEVDAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSRNE 284
Query: 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGS 350
DA +++IDFGLSDFIR D+RLND+VGSAYYVAPEVLHRSYS EAD+WSIGVISYILLCGS
Sbjct: 285 DAILKVIDFGLSDFIRYDQRLNDVVGSAYYVAPEVLHRSYSTEADMWSIGVISYILLCGS 344
Query: 351 RPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
RPF+ RTES IFR VLR++PNF+D+PWPS+SP AKDFVKRLLNKD+RKRMTA QAL HPW
Sbjct: 345 RPFYGRTESAIFRCVLRANPNFEDMPWPSISPTAKDFVKRLLNKDHRKRMTAAQALAHPW 404
Query: 411 LRDDSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDG 470
LRD++ + LD ++KLVKSY+ A+PF+R+ALKALSKA+ ++ELV+L+AQF LL+P KDG
Sbjct: 405 LRDENPGLLLDFSVYKLVKSYIRASPFRRSALKALSKAIPDEELVFLKAQFMLLDP-KDG 463
Query: 471 SVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGW 530
+SL F M L R ATDAM ESR+PD+L++M+ LA +K+ FEEFCAAA+S +QLEALE W
Sbjct: 464 GLSLNCFTMALTRYATDAMMESRLPDILNTMQPLAQKKLDFEEFCAAAVSVYQLEALEEW 523
Query: 531 EQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHG 590
EQIA++AFE+FE EGNR+IS++ELA E++VGPSAY LKDWIR+SDGKLS GY KFLHG
Sbjct: 524 EQIATSAFEHFEHEGNRIISVQELAGEMSVGPSAYPLLKDWIRSSDGKLSFLGYAKFLHG 583
Query: 591 VTLRSSNTR 599
VT+RSS++R
Sbjct: 584 VTVRSSSSR 592
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53681|CRK_DAUCA CDPK-related protein kinase OS=Daucus carota GN=CRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 751 bits (1940), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/607 (62%), Positives = 469/607 (77%), Gaps = 22/607 (3%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPST----PGNGSMPVKNT---PG 53
MG C K P+ E D T+ + N T LPP P + ++P ++ PG
Sbjct: 1 MGICVSK--PSPEPDLHNHHTSIPV------NDTSLPPQDNSIPPKDIAIPAQDNNKPPG 52
Query: 54 RSSHPSPWPSPYP-HGVSASPLPAGVSPSPARA-STPRRFFRRPFPPPSPAKHIKASLAK 111
+ S P+ SP P H + + PA SP+ + STP+R F PFPPPSPAKHIKA+ A+
Sbjct: 53 KKSPFLPFYSPSPAHFLFSKKSPAVGSPAAGSSNSTPKRLF--PFPPPSPAKHIKAAWAR 110
Query: 112 RLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKG 171
R G KP E+ IPE + LDKSFG++K FG+K+E+G+EVGRGHFG+TC A+ KKG
Sbjct: 111 RHGSVKPNEAAIPENNEVDGGAGLDKSFGFSKKFGSKFEVGEEVGRGHFGYTCRAKFKKG 170
Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
E K Q VAVK+I KAKMTTAI+IEDVRREVKIL+AL+GH +LV+F DA ED NVY+VME
Sbjct: 171 EFKGQDVAVKVIPKAKMTTAIAIEDVRREVKILRALTGHNNLVQFYDAFEDHTNVYVVME 230
Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
LCEGGELLDRIL+RGG+YTE+DAKA+++QIL+VVAFCHLQGVVHRDLKPENFLF S +D
Sbjct: 231 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFKSKDED 290
Query: 292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSR 351
+ ++ IDFGLSD+++PDERLNDIVGSAYYVAPEVLHRSYS EAD+WSIGVISYILLCGSR
Sbjct: 291 SQLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVISYILLCGSR 350
Query: 352 PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
PFWARTESGIFRAVL+++ +FD+ PWPSVS EAKDFVKRLLNKD RKRMTA QAL H W+
Sbjct: 351 PFWARTESGIFRAVLKANLSFDEPPWPSVSSEAKDFVKRLLNKDPRKRMTAAQALCHSWI 410
Query: 412 RDDSR-PVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDG 470
++ + PLDIL+FKL+K Y+ ++P ++AAL+ALSK LT DEL YL+ QF LLEP K+G
Sbjct: 411 KNSNDIKFPLDILVFKLMKVYMRSSPLRKAALRALSKTLTVDELFYLKEQFVLLEPTKNG 470
Query: 471 SVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGW 530
++SLEN + L RN+TDAM++SRV D+L S+ +L YR+M FEEFCAAA+S HQLEAL+ W
Sbjct: 471 TISLENIKQALMRNSTDAMKDSRVLDLLVSLNALQYRRMDFEEFCAAALSVHQLEALDRW 530
Query: 531 EQIASTAFEYFEEEGNRVISIEELARELNVGPS--AYSFLKDWIRNSDGKLSLHGYTKFL 588
EQ A A++ FE++GNR I IEELA EL +GPS ++ L DWIR++DGKLS GY K L
Sbjct: 531 EQHARCAYDLFEKDGNRAIMIEELASELGLGPSIPVHAVLHDWIRHTDGKLSFLGYVKLL 590
Query: 589 HGVTLRS 595
HGV+ R+
Sbjct: 591 HGVSTRA 597
|
Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SCS2|CAMK5_ARATH CDPK-related kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 750 bits (1936), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/553 (66%), Positives = 448/553 (81%), Gaps = 9/553 (1%)
Query: 50 NTPGRSSHPSPWPSPYP-HGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKAS 108
N G+ S P+ SP P H + PA + + STP+RFF+RPFPPPSPAKHI+A
Sbjct: 47 NNEGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAV 106
Query: 109 LAKRLGGGKPKESTIPEERGTEPEQS---LDKSFGYNKNFGAKYELGKEVGRGHFGHTCS 165
LA+R G KP S IPE G+E E LDKSFG++K+F +KYELG EVGRGHFG+TC+
Sbjct: 107 LARRHGSVKPNSSAIPE--GSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCA 164
Query: 166 ARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225
A+ KKG+ K QQVAVK+I KAKMTTAI+IEDVRREVKIL+ALSGH +L F DA ED +N
Sbjct: 165 AKFKKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDN 224
Query: 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLF 285
VYIVMELCEGGELLDRIL+RGG+YTEEDAK +++QIL+VVAFCHLQGVVHRDLKPENFLF
Sbjct: 225 VYIVMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLF 284
Query: 286 TSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYI 345
TS D + ++ IDFGLSD++RPDERLNDIVGSAYYVAPEVLHRSYS EADIWS+GVI YI
Sbjct: 285 TSKEDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYI 344
Query: 346 LLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
LLCGSRPFWARTESGIFRAVL++DP+FDD PWP +S EA+DFVKRLLNKD RKR+TA QA
Sbjct: 345 LLCGSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQA 404
Query: 406 LTHPWLRD-DSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLL 464
L+HPW++D + VP+DIL+FKL+++YL ++ ++AAL+ALSK LT DEL YLR QF LL
Sbjct: 405 LSHPWIKDSNDAKVPMDILVFKLMRAYLRSSSLRKAALRALSKTLTVDELFYLREQFALL 464
Query: 465 EPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL 524
EP+K+G++SLEN + L + ATDAM++SR+P+ L + +L YR+M FEEFCAAA+S HQL
Sbjct: 465 EPSKNGTISLENIKSALMKMATDAMKDSRIPEFLGQLSALQYRRMDFEEFCAAALSVHQL 524
Query: 525 EALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPS--AYSFLKDWIRNSDGKLSLH 582
EAL+ WEQ A A+E FE+EGNR I I+ELA EL +GPS ++ L DW+R++DGKLS
Sbjct: 525 EALDRWEQHARCAYELFEKEGNRPIMIDELASELGLGPSVPVHAVLHDWLRHTDGKLSFL 584
Query: 583 GYTKFLHGVTLRS 595
G+ K LHGV+ R+
Sbjct: 585 GFVKLLHGVSSRT 597
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SG12|CAMK6_ARATH CDPK-related kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 729 bits (1883), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/605 (63%), Positives = 472/605 (78%), Gaps = 20/605 (3%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSP 60
MG CY + I T ++D + T + ++QN T + S+P +P S
Sbjct: 1 MGHCYSRNISTVDDDDEIPSATAQLPHRSHQNHH----QTSSSSSIP--QSPATSE---- 50
Query: 61 WPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGG-KPK 119
+PY SPLPAGV+PSPAR TP R F+ PFPPPSPAK I A+L +R G P+
Sbjct: 51 -VNPYNISPFQSPLPAGVAPSPAR--TPGRKFKWPFPPPSPAKPIMAALRRRRGTAPHPR 107
Query: 120 ESTIPEE-----RGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELK 174
+ IPE+ G + LDK+FG+ KNF KYELG+EVGRGHFGHTC A+ KKG++K
Sbjct: 108 DGPIPEDSEAGGSGGGIGERLDKNFGFAKNFEGKYELGREVGRGHFGHTCWAKAKKGKIK 167
Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234
Q VAVKIISK+KMT+A+SIEDVRREVK+LKALSGH H+VKF D ED +NV++VMELCE
Sbjct: 168 GQTVAVKIISKSKMTSALSIEDVRREVKLLKALSGHSHMVKFYDVFEDSDNVFVVMELCE 227
Query: 235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294
GGELLD ILARGGRY E +AK I+VQILS AF HLQGVVHRDLKPENFLFTS +DA +
Sbjct: 228 GGELLDSILARGGRYPEAEAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSKNEDAVL 287
Query: 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFW 354
++IDFGLSD+ R D+RLND+VGSAYYVAPEVLHRSYS EADIWSIGVISYILLCGSRPF+
Sbjct: 288 KVIDFGLSDYARFDQRLNDVVGSAYYVAPEVLHRSYSTEADIWSIGVISYILLCGSRPFY 347
Query: 355 ARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414
RTES IFR VLR++PNFDDLPWPS+SP AKDFVKRLLNKD+RKRMTA QAL HPWLRD+
Sbjct: 348 GRTESAIFRCVLRANPNFDDLPWPSISPIAKDFVKRLLNKDHRKRMTAAQALAHPWLRDE 407
Query: 415 SRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSL 474
+ + LD I+KLVKSY+ A+PF+RAALK+LSKA+ E+ELV+L+AQF LLEP +DG + L
Sbjct: 408 NPGLLLDFSIYKLVKSYIRASPFRRAALKSLSKAIPEEELVFLKAQFMLLEP-EDGGLHL 466
Query: 475 ENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534
NF L R ATDAM ESR+PD+L+ M+ LA++K+ FEEFCAA++S +QLEALE WEQIA
Sbjct: 467 HNFTTALTRYATDAMIESRLPDILNMMQPLAHKKLDFEEFCAASVSVYQLEALEEWEQIA 526
Query: 535 STAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVTLR 594
+ AFE+FE EG+R IS++ELA E+++GP+AY LKDWIR+ DGKL+ GY KFLHGVT+R
Sbjct: 527 TVAFEHFESEGSRAISVQELAEEMSLGPNAYPLLKDWIRSLDGKLNFLGYAKFLHGVTVR 586
Query: 595 SSNTR 599
SS++R
Sbjct: 587 SSSSR 591
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80673|CAMK1_ARATH CDPK-related kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 708 bits (1827), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/598 (58%), Positives = 451/598 (75%), Gaps = 29/598 (4%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSP 60
MG C+GK + + ++ VS N+ P N P K++ PSP
Sbjct: 1 MGICHGKPV---------EQQSKSLPVSGETNEAPT------NSQPPAKSSGFPFYSPSP 45
Query: 61 WPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKE 120
PS + S S + +STP R F+RPFPPPSPAKHI+A LA+R G KP E
Sbjct: 46 VPSLFKSSPSVSS---------SVSSTPLRIFKRPFPPPSPAKHIRAFLARRYGSVKPNE 96
Query: 121 STIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAV 180
+IPE G E E LDKSFG++K F + YE+ EVGRGHFG+TCSA+GKKG LK Q+VAV
Sbjct: 97 VSIPE--GKECEIGLDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAV 154
Query: 181 KIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
K+I K+KMTTAI+IEDV REVK+L+AL+GHK+LV+F DA ED NVYIVMELC+GGELLD
Sbjct: 155 KVIPKSKMTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGELLD 214
Query: 241 RILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
+IL RGG+Y+E+DAK ++VQILSVVA+CHLQGVVHRDLKPENFLF++ + + ++ IDFG
Sbjct: 215 KILQRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAIDFG 274
Query: 301 LSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESG 360
LSD+++PDERLNDIVGSAYYVAPEVLHR+Y EAD+WSIGVI+YILLCGSRPFWARTESG
Sbjct: 275 LSDYVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTESG 334
Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR-PVP 419
IFRAVL+++PNF++ PWPS+SPEA DFVKRLLNKDYRKR+TA QAL HPWL +P
Sbjct: 335 IFRAVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHELKIP 394
Query: 420 LDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRM 479
D++I+KLVK Y+ +T +++AL AL+K LT +L YLR QF LL P+K+G +S++N++
Sbjct: 395 SDMIIYKLVKVYIMSTSLRKSALAALAKTLTVPQLAYLREQFTLLGPSKNGYISMQNYKT 454
Query: 480 VLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFE 539
+ +++TDAM++SRV D + + L Y+K+ FEEFCA+A+S +QLEA+E WEQ A A+E
Sbjct: 455 AILKSSTDAMKDSRVFDFVHMISCLQYKKLDFEEFCASALSVYQLEAMETWEQHARRAYE 514
Query: 540 YFEEEGNRVISIEELARELNVGPS--AYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRS 595
FE++GNR I IEELA EL +GPS + L+DWIR+SDGKLS G+ + LHGV+ R+
Sbjct: 515 LFEKDGNRPIMIEELASELGLGPSVPVHVVLQDWIRHSDGKLSFLGFVRLLHGVSSRT 572
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3. Confers thermotolerance; involved in the heat-shock-mediated calmodulin-dependent signal transduction leading to the activation of heat-shock transcription factors (HSFs); phosphorylates HSFA1A. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FX86|CAMK8_ARATH CDPK-related kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 706 bits (1823), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/587 (59%), Positives = 436/587 (74%), Gaps = 30/587 (5%)
Query: 38 PSTPGNGSMPVKNTPGRSSHPSPWPSPYPHGVSASPLPAGVSPSPAR------------- 84
P PGN + + HP P P P ASP +PSPAR
Sbjct: 17 PFAPGNDYPQIDDFA--PDHPGKSPIPTPSAAKASPFFPFYTPSPARHRRNKSRDVGGGG 74
Query: 85 -----ASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQ------ 133
STP R RR F PPSPAKHI+A+L +R G + S + + P++
Sbjct: 75 ESKSLTSTPLRQLRRAFHPPSPAKHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEV 134
Query: 134 SLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS 193
LDK FG++K F ++ ELG+E+GRGHFG+TCSA+ KKGELK Q VAVKII K+KMTTAI+
Sbjct: 135 GLDKRFGFSKEFHSRVELGEEIGRGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIA 194
Query: 194 IEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED 253
IEDVRREVKIL+ALSGHK+LV+F DA ED NVYI MELCEGGELLDRILARGG+Y+E D
Sbjct: 195 IEDVRREVKILQALSGHKNLVQFYDAFEDNANVYIAMELCEGGELLDRILARGGKYSEND 254
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
AK +++QIL+VVAFCH QGVVHRDLKPENFL+TS +++ ++ IDFGLSDF+RPDERLND
Sbjct: 255 AKPVIIQILNVVAFCHFQGVVHRDLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLND 314
Query: 314 IVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373
IVGSAYYVAPEVLHRSY+ EAD+WSIGVI+YILLCGSRPFWARTESGIFRAVL++DP+FD
Sbjct: 315 IVGSAYYVAPEVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 374
Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR--DDSRPVPLDILIFKLVKSY 431
+ PWP +S +AKDFVKRLL KD R+RM+A QAL HPW+R + +P DILIF+ +K+Y
Sbjct: 375 EPPWPFLSSDAKDFVKRLLFKDPRRRMSASQALMHPWIRAYNTDMNIPFDILIFRQMKAY 434
Query: 432 LHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRE 491
L ++ ++AAL+ALSK L +DE++YL+ QF LL PNKDG ++++ RM L NAT+AM+E
Sbjct: 435 LRSSSLRKAALRALSKTLIKDEILYLKTQFSLLAPNKDGLITMDTIRMALASNATEAMKE 494
Query: 492 SRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISI 551
SR+P+ L+ + L YR M FEEFCAAAI+ HQ E+L+ WEQ A+E F++ GNR I I
Sbjct: 495 SRIPEFLALLNGLQYRGMDFEEFCAAAINVHQHESLDCWEQSIRHAYELFDKNGNRAIVI 554
Query: 552 EELARELNVGPS--AYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRSS 596
EELA EL VGPS +S L DWIR++DGKLS G+ K LHGV++R+S
Sbjct: 555 EELASELGVGPSIPVHSVLHDWIRHTDGKLSFFGFVKLLHGVSVRAS 601
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LET1|CAMK7_ARATH CDPK-related kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 699 bits (1804), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/598 (58%), Positives = 448/598 (74%), Gaps = 28/598 (4%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSP 60
MG C+GK I + S TP N S K++ PSP
Sbjct: 1 MGLCHGKPIEQQSKNLPISNEIE---------------ETPKNSSQKAKSSGFPFYSPSP 45
Query: 61 WPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKE 120
PS + + S S + +STP R F+RPFPPPSPAKHI+A LA+R G KP E
Sbjct: 46 LPSLFKTSPAVS--------SSSVSSTPLRIFKRPFPPPSPAKHIRALLARRHGSVKPNE 97
Query: 121 STIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAV 180
++IPE G+E E LDK FG++K F + YE+ EVGRGHFG+TCSA+GKKG LK Q VAV
Sbjct: 98 ASIPE--GSECEVGLDKKFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQDVAV 155
Query: 181 KIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
K+I K+KMTTAI+IEDVRREVKIL+AL+GHK+LV+F DA ED NVYIVMELC+GGELLD
Sbjct: 156 KVIPKSKMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFEDDENVYIVMELCQGGELLD 215
Query: 241 RILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
+IL RGG+Y+E DAK +++QILSVVA+CHLQGVVHRDLKPENFLFT+ + + ++ IDFG
Sbjct: 216 KILQRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDESSPLKAIDFG 275
Query: 301 LSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESG 360
LSD++RPDERLNDIVGSAYYVAPEVLHR+Y EAD+WSIGVI+YILLCGSRPFWAR+ESG
Sbjct: 276 LSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARSESG 335
Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR-PVP 419
IFRAVL+++PNF++ PWPS+SP+A DFVKRLLNKDYRKR+TA QAL HPWL +P
Sbjct: 336 IFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHELKIP 395
Query: 420 LDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRM 479
D++I+KLVK Y+ ++ +++AL AL+K LT +L YL+ QF LL P+K+G +S++N++
Sbjct: 396 SDMIIYKLVKVYIMSSSLRKSALAALAKTLTVPQLTYLQEQFNLLGPSKNGYISMQNYKT 455
Query: 480 VLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFE 539
+ +++T+A ++SRV D + + L Y+K+ FEEFCA+A+S +QLEA+E WEQ A A+E
Sbjct: 456 AILKSSTEATKDSRVLDFVHMISCLQYKKLDFEEFCASALSVYQLEAMETWEQHARRAYE 515
Query: 540 YFEEEGNRVISIEELARELNVGPS--AYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRS 595
+E++GNRVI IEELA EL +GPS + L+DWIR+SDGKLS G+ + LHGV+ R+
Sbjct: 516 LYEKDGNRVIMIEELATELGLGPSVPVHVVLQDWIRHSDGKLSFLGFVRLLHGVSSRT 573
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJL9|CAMK2_ARATH CDPK-related kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 699 bits (1804), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/581 (61%), Positives = 443/581 (76%), Gaps = 20/581 (3%)
Query: 27 VSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPS-PW--PSPYPHGVSASPLPAGVSPSPA 83
V N + TP P G PV+++P + P P+ PSP H + S G S +
Sbjct: 23 VLQNDDSTPAHP-----GKSPVRSSPAVKASPFFPFYTPSPARHRRNKSR-DGGGGESKS 76
Query: 84 RASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQ-----SLDKS 138
STP R R F PPSPA+HI+ L +R + KE+ +P R + E+ LDK
Sbjct: 77 VTSTPLRQLARAFHPPSPARHIRDVLRRR---KEKKEAALPAARQQKEEEEREEVGLDKR 133
Query: 139 FGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR 198
FG++K ++ ELG+E+GRGHFG+TCSA+ KKGELKDQ+VAVK+I K+KMT+AISIEDVR
Sbjct: 134 FGFSKELQSRIELGEEIGRGHFGYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVR 193
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
REVKIL+ALSGH++LV+F DA ED NVYIVMELC GGELLDRILARGG+Y+E+DAKA++
Sbjct: 194 REVKILRALSGHQNLVQFYDAFEDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVL 253
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
+QIL+VVAFCHLQGVVHRDLKPENFL+TS +++ +++IDFGLSDF+RPDERLNDIVGSA
Sbjct: 254 IQILNVVAFCHLQGVVHRDLKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSA 313
Query: 319 YYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
YYVAPEVLHRSY+ EAD+WSIGVI+YILLCGSRPFWARTESGIFRAVL++DP+FD+ PWP
Sbjct: 314 YYVAPEVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWP 373
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR-PVPLDILIFKLVKSYLHATPF 437
S+S EAKDFVKRLL KD RKRMTA QAL HPW+ + +P DILIFK +K+YL ++
Sbjct: 374 SLSFEAKDFVKRLLYKDPRKRMTASQALMHPWIAGYKKIDIPFDILIFKQIKAYLRSSSL 433
Query: 438 KRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDV 497
++AAL ALSK LT DEL+YL+AQF L PNK+G ++L++ R+ L NAT+AM+ESR+PD
Sbjct: 434 RKAALMALSKTLTTDELLYLKAQFAHLAPNKNGLITLDSIRLALATNATEAMKESRIPDF 493
Query: 498 LSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARE 557
L+ + L Y+ M FEEFCAA+IS HQ E+L+ WEQ A+E FE GNRVI IEELA E
Sbjct: 494 LALLNGLQYKGMDFEEFCAASISVHQHESLDCWEQSIRHAYELFEMNGNRVIVIEELASE 553
Query: 558 LNVGPS--AYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRSS 596
L VG S ++ L DWIR++DGKLS G+ K LHGV+ R S
Sbjct: 554 LGVGSSIPVHTILNDWIRHTDGKLSFLGFVKLLHGVSTRQS 594
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10KY3|CAMK1_ORYSJ Calcium/calmodulin-dependent serine/threonine-protein kinase 1 OS=Oryza sativa subsp. japonica GN=CAMK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 697 bits (1799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/550 (62%), Positives = 438/550 (79%), Gaps = 11/550 (2%)
Query: 50 NTPGRSSHPSPWPSPYP-HGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKAS 108
TP + P PSP P SP + V+ +PAR F+RPFPPPSPAKHI+A
Sbjct: 54 GTPKQHKFPFYLPSPLPASSYKGSPANSSVASTPARGG-----FKRPFPPPSPAKHIRAL 108
Query: 109 LAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARG 168
LA+R G KP E++IPE EP +LDK FG++++F AKYELG+EVGRGHFG+TC+A
Sbjct: 109 LARRHGSVKPNEASIPES--GEPGVALDKGFGFSRHFAAKYELGREVGRGHFGYTCAATC 166
Query: 169 KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228
KKGELK VAVK+I KAKMTTAI+IEDVRREV+IL +L+GH +LV+F DA ED NVYI
Sbjct: 167 KKGELKGDDVAVKVIPKAKMTTAIAIEDVRREVRILSSLAGHSNLVQFYDAYEDEENVYI 226
Query: 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288
VMELC+GGELLDRILARGG+Y+EEDAK ++ QILSV +FCHLQGVVHRDLKPENFLF+S
Sbjct: 227 VMELCKGGELLDRILARGGKYSEEDAKVVMRQILSVASFCHLQGVVHRDLKPENFLFSSK 286
Query: 289 RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLC 348
+++ M++IDFGLSDF++PDERLNDIVGSAYYVAPEVLHRSY EAD+WSIGVI YILLC
Sbjct: 287 DENSAMKVIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIVYILLC 346
Query: 349 GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
GSRPFWARTESGIFRAVL++DP+F++ PWP++S EAKDFV+RLLNKDYRKRMTA QAL H
Sbjct: 347 GSRPFWARTESGIFRAVLKADPSFEEAPWPTLSAEAKDFVRRLLNKDYRKRMTAAQALCH 406
Query: 409 PWLR-DDSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPN 467
PW+R + +PLD++I++L+++Y+ ++ +RAAL+AL+K LT D++ YLR QF L+ PN
Sbjct: 407 PWIRGTEEVKLPLDMIIYRLMRAYISSSSLRRAALRALAKTLTTDQIYYLREQFELIGPN 466
Query: 468 KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEAL 527
K ++L+N + L +N+T+AM++SRV D ++++ ++ YRK+ FEEF AAAIS +Q+E L
Sbjct: 467 KSDLITLQNLKTALMKNSTNAMKDSRVVDFVNTISNIQYRKLDFEEFSAAAISVYQMEGL 526
Query: 528 EGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSA--YSFLKDWIRNSDGKLSLHGYT 585
E WEQ A A+E+F++EGNR I I+ELA EL +GPS + L+DWIR+ DGKLS G+
Sbjct: 527 ETWEQHARQAYEFFDKEGNRPIVIDELASELGLGPSVPLHVVLQDWIRHPDGKLSFLGFM 586
Query: 586 KFLHGVTLRS 595
K LHGV+ R+
Sbjct: 587 KLLHGVSSRT 596
|
Possesses kinase activity in vitro. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 601 | ||||||
| 255578190 | 602 | calcium-dependent protein kinase, putati | 0.991 | 0.990 | 0.887 | 0.0 | |
| 224130636 | 608 | predicted protein [Populus trichocarpa] | 0.991 | 0.980 | 0.857 | 0.0 | |
| 224068086 | 604 | cpk-related protein kinase 3 [Populus tr | 0.991 | 0.986 | 0.835 | 0.0 | |
| 225453579 | 591 | PREDICTED: CDPK-related protein kinase [ | 0.983 | 1.0 | 0.826 | 0.0 | |
| 449445491 | 609 | PREDICTED: CDPK-related protein kinase-l | 0.998 | 0.985 | 0.804 | 0.0 | |
| 449519762 | 609 | PREDICTED: LOW QUALITY PROTEIN: CDPK-rel | 0.998 | 0.985 | 0.803 | 0.0 | |
| 357512599 | 596 | Calcium dependent protein kinase-like pr | 0.981 | 0.989 | 0.809 | 0.0 | |
| 15226426 | 595 | CDPK-related kinase 3 [Arabidopsis thali | 0.985 | 0.994 | 0.801 | 0.0 | |
| 356520241 | 592 | PREDICTED: CDPK-related protein kinase-l | 0.970 | 0.984 | 0.784 | 0.0 | |
| 18087555 | 595 | At2g46700/T3A4.8 [Arabidopsis thaliana] | 0.985 | 0.994 | 0.8 | 0.0 |
| >gi|255578190|ref|XP_002529963.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223530525|gb|EEF32406.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1057 bits (2734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 539/607 (88%), Positives = 564/607 (92%), Gaps = 11/607 (1%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRS-SHPS 59
MGQCYGKT PT END TT+ TT A+ NQTPL PSTP NG VKNTP RS +HPS
Sbjct: 1 MGQCYGKTNPTNENDTTTTIVTT-----ADPNQTPLRPSTPRNGVPSVKNTPARSFNHPS 55
Query: 60 PWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGG-KP 118
PWPSPYPHGVSASPLP GVSPSPARASTPRRFFRRPFPPPSPAKHI ASLAKRLGGG KP
Sbjct: 56 PWPSPYPHGVSASPLPGGVSPSPARASTPRRFFRRPFPPPSPAKHIAASLAKRLGGGAKP 115
Query: 119 KESTIPEERGTEP----EQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELK 174
KE IPE G EP +QSLDKSFGY+KNFGAKYELGKEVGRGHFGHTCSAR KKGELK
Sbjct: 116 KEGPIPEHGGAEPDQQQQQSLDKSFGYSKNFGAKYELGKEVGRGHFGHTCSARVKKGELK 175
Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234
DQ VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKF DACED NNVYIVMELCE
Sbjct: 176 DQPVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFYDACEDANNVYIVMELCE 235
Query: 235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294
GGELLDRILARGGRYTEEDAKAIVVQILSVV+FCHLQGVVHRDLKPENFLFTSG +DADM
Sbjct: 236 GGELLDRILARGGRYTEEDAKAIVVQILSVVSFCHLQGVVHRDLKPENFLFTSGGEDADM 295
Query: 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFW 354
RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFW
Sbjct: 296 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFW 355
Query: 355 ARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414
ARTESGIFR+VLRSDPNFDDLPWPSV+PE KDFVKRLLNKDYRKRMTAVQALTHPWLRDD
Sbjct: 356 ARTESGIFRSVLRSDPNFDDLPWPSVTPEGKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 415
Query: 415 SRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSL 474
SR +PLD+LI+KLVK YLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPN+DGSVSL
Sbjct: 416 SRSIPLDVLIYKLVKIYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNRDGSVSL 475
Query: 475 ENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534
+NF+M L R+ATDAMRESRVP++L++ME+LAYRKMYFEEFCAAAIST+QLEALEGWEQIA
Sbjct: 476 DNFKMALVRHATDAMRESRVPEILNAMEALAYRKMYFEEFCAAAISTYQLEALEGWEQIA 535
Query: 535 STAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVTLR 594
STAFE+FE EGNRVIS+EELARELNVGPSAYSF+KDWIRNSDGKLSL GYTKFLHGVTLR
Sbjct: 536 STAFEHFEREGNRVISVEELARELNVGPSAYSFIKDWIRNSDGKLSLLGYTKFLHGVTLR 595
Query: 595 SSNTRHH 601
SSNTRH
Sbjct: 596 SSNTRHQ 602
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130636|ref|XP_002320890.1| predicted protein [Populus trichocarpa] gi|222861663|gb|EEE99205.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1023 bits (2644), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/609 (85%), Positives = 551/609 (90%), Gaps = 13/609 (2%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQ-TPLPPSTPGNGSMPVKNTPGRSS--H 57
MGQCYGKT P ENDATT T + S + NQ T LP ST NG + VKNTP RSS H
Sbjct: 1 MGQCYGKTSPANENDATT---VTIVASSTDHNQPTSLPSSTSRNGVLSVKNTPARSSSTH 57
Query: 58 PSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGK 117
PSPWPS YPHGV+ASPLP GVSPSPARASTPRRFFRRPFPPPSPAKHI ASL KRLGGG
Sbjct: 58 PSPWPSTYPHGVAASPLPGGVSPSPARASTPRRFFRRPFPPPSPAKHIAASLVKRLGGGG 117
Query: 118 PKEST-IPEERGTEPEQ------SLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKK 170
+ IPE G E EQ SLDKSFGY+KNFGAKYELGKE+GRGHFGHTCSA KK
Sbjct: 118 KPKEGPIPEHGGVEAEQQQQQQQSLDKSFGYSKNFGAKYELGKEIGRGHFGHTCSATVKK 177
Query: 171 GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVM 230
GELKDQ VAVKIISKAKMTTAISIEDVRREVKILK LSGH+HLVKF DACED NNVYIVM
Sbjct: 178 GELKDQTVAVKIISKAKMTTAISIEDVRREVKILKGLSGHRHLVKFYDACEDANNVYIVM 237
Query: 231 ELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290
ELCEGGELLDRILARGGRYTEEDAKAI+VQIL VVAFCHLQGVVHRDLKPENFLFTSG +
Sbjct: 238 ELCEGGELLDRILARGGRYTEEDAKAIIVQILCVVAFCHLQGVVHRDLKPENFLFTSGSE 297
Query: 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGS 350
DADM+LIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI+YIL+CGS
Sbjct: 298 DADMKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILICGS 357
Query: 351 RPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
RPFWARTESGIFRAVLRSDPNF+DLPWPSV+PEAKDFVKRLLNKDYRKRMTAVQALTHPW
Sbjct: 358 RPFWARTESGIFRAVLRSDPNFEDLPWPSVTPEAKDFVKRLLNKDYRKRMTAVQALTHPW 417
Query: 411 LRDDSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDG 470
LRDDSRP+ LDILI+KLVK+YLHATPFKRAALKALSKALTEDELVYLRAQF LLEPN DG
Sbjct: 418 LRDDSRPINLDILIYKLVKAYLHATPFKRAALKALSKALTEDELVYLRAQFSLLEPNGDG 477
Query: 471 SVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGW 530
SVSL+NFRM L RNATDAMRESR P++L++MESLAYRKMYFEEFCAAAIST+QLEALEGW
Sbjct: 478 SVSLDNFRMALVRNATDAMRESRAPEILNAMESLAYRKMYFEEFCAAAISTYQLEALEGW 537
Query: 531 EQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHG 590
EQIA TAFE+FE+EGNRVIS+EELARELNVGPSAY+F+KDWIRNSDGKLSL GYTKFLHG
Sbjct: 538 EQIAFTAFEHFEQEGNRVISVEELARELNVGPSAYTFIKDWIRNSDGKLSLIGYTKFLHG 597
Query: 591 VTLRSSNTR 599
VTLRSSNTR
Sbjct: 598 VTLRSSNTR 606
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224068086|ref|XP_002302662.1| cpk-related protein kinase 3 [Populus trichocarpa] gi|222844388|gb|EEE81935.1| cpk-related protein kinase 3 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1009 bits (2608), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/607 (83%), Positives = 547/607 (90%), Gaps = 11/607 (1%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQ-TPLPPSTPGNGSMPVK-NTPGRSSHP 58
MGQCYGKT T NDATT T + S +QNQ TPLP STP NG +K + S+HP
Sbjct: 1 MGQCYGKTNSTNINDATT---VTIVASSTDQNQQTPLPSSTPRNGVRSLKYSASSSSTHP 57
Query: 59 SPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGG-GK 117
SPWPSPYP GV+ASPL GVSPSPAR+STPRRFF+RPFPPPSPA+HI ASL KRLGG GK
Sbjct: 58 SPWPSPYPQGVAASPL-QGVSPSPARSSTPRRFFKRPFPPPSPARHIAASLVKRLGGRGK 116
Query: 118 PKESTIPE----ERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGEL 173
PKE IPE E + EQSLDKSFGY+KNFGAKYELGKE+GRGHFGHTCSAR KKGEL
Sbjct: 117 PKEGPIPEHGSVEAEQQQEQSLDKSFGYSKNFGAKYELGKEIGRGHFGHTCSARVKKGEL 176
Query: 174 KDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELC 233
KD+ VAVKIISKAKMT+ ISIEDVRREVKILKALSGH+HLVKF DA ED NNVYIVMELC
Sbjct: 177 KDEAVAVKIISKAKMTSTISIEDVRREVKILKALSGHRHLVKFYDAFEDANNVYIVMELC 236
Query: 234 EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD 293
EGGELLDRILARGGRYTEEDAKAI+VQIL VVAFCHLQGVVHRDLKPENFLFTSG +DAD
Sbjct: 237 EGGELLDRILARGGRYTEEDAKAIIVQILCVVAFCHLQGVVHRDLKPENFLFTSGSEDAD 296
Query: 294 MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPF 353
M+LIDFGLSDF RPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIG+I+YILLCGSRPF
Sbjct: 297 MKLIDFGLSDFFRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGIITYILLCGSRPF 356
Query: 354 WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
WARTESGIFRAVLRSDPNF+DLPWPSV+PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD
Sbjct: 357 WARTESGIFRAVLRSDPNFEDLPWPSVTPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 416
Query: 414 DSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVS 473
DSRP+ +DILI+KLVK YLHATPFKRAALKALSKALTEDEL YLRAQF LL PN DGSVS
Sbjct: 417 DSRPIHVDILIYKLVKVYLHATPFKRAALKALSKALTEDELFYLRAQFNLLGPNGDGSVS 476
Query: 474 LENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533
L+NFRM L NATDAMRESRVP++L++MESL+YRKMYFEEFCAAAIST+QLEALEGWEQI
Sbjct: 477 LDNFRMALVHNATDAMRESRVPEILNAMESLSYRKMYFEEFCAAAISTYQLEALEGWEQI 536
Query: 534 ASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVTL 593
ASTAFE+FE+EGNRVIS+EELARELNVGPSAY+ +KDWIR+SDGKLS+ GY KFLHGVTL
Sbjct: 537 ASTAFEHFEQEGNRVISVEELARELNVGPSAYTIIKDWIRSSDGKLSVLGYAKFLHGVTL 596
Query: 594 RSSNTRH 600
RS+NTRH
Sbjct: 597 RSTNTRH 603
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225453579|ref|XP_002266654.1| PREDICTED: CDPK-related protein kinase [Vitis vinifera] gi|296088985|emb|CBI38688.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 988 bits (2553), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/601 (82%), Positives = 534/601 (88%), Gaps = 10/601 (1%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSP 60
MGQCYGK + V Q+PLP G S+ TP RSS SP
Sbjct: 1 MGQCYGKPVVNGNGKGG---------VVEEYPQSPLPSVGNGAASVQSVKTPARSSSTSP 51
Query: 61 WPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKE 120
W SP+PHG ++SPLPAGV+PSPAR+STPRRFFRRPFPPPSPAKHIKASLAKRLG KPKE
Sbjct: 52 WRSPFPHGSASSPLPAGVAPSPARSSTPRRFFRRPFPPPSPAKHIKASLAKRLGPAKPKE 111
Query: 121 STIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAV 180
IPEE GTEPEQ LDKSFGY KNFGAKYELGKEVGRGHFGHTCSARGKKGEL+DQ +AV
Sbjct: 112 GPIPEE-GTEPEQLLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSARGKKGELRDQPLAV 170
Query: 181 KIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
KIISKAKMTTAI+IEDVRREVKILKALSGH HLVKF DACED NNVYI+MELCEGGELLD
Sbjct: 171 KIISKAKMTTAIAIEDVRREVKILKALSGHAHLVKFYDACEDANNVYIIMELCEGGELLD 230
Query: 241 RILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
RIL+RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS +DADM+LIDFG
Sbjct: 231 RILSRGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSRSEDADMKLIDFG 290
Query: 301 LSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESG 360
LSDFIRPDERLNDIVGSAYYVAPEVLHRSY LEADIWS+GVI+YILLCGSRPFWARTESG
Sbjct: 291 LSDFIRPDERLNDIVGSAYYVAPEVLHRSYYLEADIWSVGVITYILLCGSRPFWARTESG 350
Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPL 420
IFRAVLR+DPNFDDLPWP+VS EAKDFVKRLLNKDYRKRMTAVQALTHPWLRD S P+PL
Sbjct: 351 IFRAVLRADPNFDDLPWPTVSAEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDGSHPIPL 410
Query: 421 DILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMV 480
DILI+KLVKSYL ATPFKRAALKALSKALTEDELVYLR+QF+LLEP +DGSVSL++F+M
Sbjct: 411 DILIYKLVKSYLLATPFKRAALKALSKALTEDELVYLRSQFKLLEPGRDGSVSLDSFKMA 470
Query: 481 LGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEY 540
L RNATDAM+ESRVPD+L+++E L YR+M FEEFCAAAISTHQLEALEGWEQIASTAFE
Sbjct: 471 LARNATDAMKESRVPDILNALEPLCYRRMDFEEFCAAAISTHQLEALEGWEQIASTAFEI 530
Query: 541 FEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRSSNTRH 600
FE+EGNRVIS+EELARELN+GPSAYS LK+WIRNSDGKLSL GYTKFLHGVT RSSNTR
Sbjct: 531 FEQEGNRVISVEELARELNLGPSAYSVLKEWIRNSDGKLSLLGYTKFLHGVTHRSSNTRQ 590
Query: 601 H 601
H
Sbjct: 591 H 591
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445491|ref|XP_004140506.1| PREDICTED: CDPK-related protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 972 bits (2513), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/610 (80%), Positives = 532/610 (87%), Gaps = 10/610 (1%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTP-----GNGSMPVKNTPGRS 55
MGQCYGKTIPTT+ND T + TTT+ + P P GNG + +K T +
Sbjct: 1 MGQCYGKTIPTTDNDVTPTTITTTVSPPSTTGYGVDPSHFPSGSGAGNGVVNLKTTTATT 60
Query: 56 SHPSPWPS----PYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAK 111
+ +PS PYPHGV ASPLP GVSPSPARASTP RFF+R F PPSPAKHIKASLAK
Sbjct: 61 PARTSYPSPWPSPYPHGVGASPLPVGVSPSPARASTPGRFFKRRFAPPSPAKHIKASLAK 120
Query: 112 RLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKG 171
R G KPKE IPEERG EPEQ LDKSFGY KNFGAKYELGKEVGRGHFGHTCSA+GKKG
Sbjct: 121 RFGYTKPKEGPIPEERGAEPEQLLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSAKGKKG 180
Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
EL+DQ VAVKIISKAKMTTAISIEDVRREVKILK+LSGHKHLVKF DACED NNVYIVME
Sbjct: 181 ELRDQPVAVKIISKAKMTTAISIEDVRREVKILKSLSGHKHLVKFHDACEDANNVYIVME 240
Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
LCEGGELLDRIL+RGGRYTEEDAK IVVQILSVVAFCHLQGVVHRDLKPENFLFTS +D
Sbjct: 241 LCEGGELLDRILSRGGRYTEEDAKNIVVQILSVVAFCHLQGVVHRDLKPENFLFTSRSED 300
Query: 292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSR 351
ADM+LIDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSY+LEADIWSIGVI+YILLCGSR
Sbjct: 301 ADMKLIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTLEADIWSIGVITYILLCGSR 360
Query: 352 PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
PFWARTESGIFRAVLR+DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL
Sbjct: 361 PFWARTESGIFRAVLRADPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 420
Query: 412 RDDSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGS 471
+DDSR +PLDILI+KLVKSYL ATPFKRAA+KALSKAL+E EL YLRAQF LLEPN DG
Sbjct: 421 QDDSRRIPLDILIYKLVKSYLQATPFKRAAMKALSKALSETELFYLRAQFALLEPNHDGR 480
Query: 472 VSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWE 531
V L+NF+M L RNATDAMRESRV ++++S+E LAYR+M FEEFCAA+ISTHQLEAL+ WE
Sbjct: 481 VGLDNFKMALMRNATDAMRESRVHEIVNSLEPLAYRRMDFEEFCAASISTHQLEALDRWE 540
Query: 532 QIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591
QIA AFE+FE EGNRVIS+EELA+ELN+G SA+S LK+WIR DGKLS GYTKFLHGV
Sbjct: 541 QIACVAFEHFEREGNRVISVEELAKELNLGSSAHSILKEWIRG-DGKLSFLGYTKFLHGV 599
Query: 592 TLRSSNTRHH 601
TLRSSNTRHH
Sbjct: 600 TLRSSNTRHH 609
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449519762|ref|XP_004166903.1| PREDICTED: LOW QUALITY PROTEIN: CDPK-related protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 969 bits (2505), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 490/610 (80%), Positives = 531/610 (87%), Gaps = 10/610 (1%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTP-----GNGSMPVKNTPGRS 55
MGQCYGKTIPTT+ND T + TTT+ + P P GNG + +K T +
Sbjct: 1 MGQCYGKTIPTTDNDVTPTTITTTVSPPSTTGYGVDPSHFPSGSGAGNGVVNLKTTTATT 60
Query: 56 SHPSPWPS----PYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAK 111
+ +PS PYPHGV ASPLP GVSPSPARASTP R F+R F PPSPAKHIKASLAK
Sbjct: 61 PARTSYPSPWPSPYPHGVGASPLPVGVSPSPARASTPGRXFKRRFAPPSPAKHIKASLAK 120
Query: 112 RLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKG 171
R G KPKE IPEERG EPEQ LDKSFGY KNFGAKYELGKEVGRGHFGHTCSA+GKKG
Sbjct: 121 RFGYTKPKEGPIPEERGAEPEQLLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSAKGKKG 180
Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
EL+DQ VAVKIISKAKMTTAISIEDVRREVKILK+LSGHKHLVKF DACED NNVYIVME
Sbjct: 181 ELRDQPVAVKIISKAKMTTAISIEDVRREVKILKSLSGHKHLVKFHDACEDANNVYIVME 240
Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
LCEGGELLDRIL+RGGRYTEEDAK IVVQILSVVAFCHLQGVVHRDLKPENFLFTS +D
Sbjct: 241 LCEGGELLDRILSRGGRYTEEDAKNIVVQILSVVAFCHLQGVVHRDLKPENFLFTSRSED 300
Query: 292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSR 351
ADM+LIDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSY+LEADIWSIGVI+YILLCGSR
Sbjct: 301 ADMKLIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTLEADIWSIGVITYILLCGSR 360
Query: 352 PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
PFWARTESGIFRAVLR+DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL
Sbjct: 361 PFWARTESGIFRAVLRADPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 420
Query: 412 RDDSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGS 471
+DDSR +PLDILI+KLVKSYL ATPFKRAA+KALSKAL+E EL YLRAQF LLEPN DG
Sbjct: 421 QDDSRRIPLDILIYKLVKSYLQATPFKRAAMKALSKALSETELFYLRAQFALLEPNHDGR 480
Query: 472 VSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWE 531
V L+NF+M L RNATDAMRESRV ++++S+E LAYR+M FEEFCAA+ISTHQLEAL+ WE
Sbjct: 481 VGLDNFKMALMRNATDAMRESRVHEIVNSLEPLAYRRMDFEEFCAASISTHQLEALDRWE 540
Query: 532 QIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591
QIA AFE+FE EGNRVIS+EELA+ELN+G SA+S LK+WIR DGKLS GYTKFLHGV
Sbjct: 541 QIACVAFEHFEREGNRVISVEELAKELNLGSSAHSILKEWIRG-DGKLSFLGYTKFLHGV 599
Query: 592 TLRSSNTRHH 601
TLRSSNTRHH
Sbjct: 600 TLRSSNTRHH 609
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357512599|ref|XP_003626588.1| Calcium dependent protein kinase-like protein [Medicago truncatula] gi|355501603|gb|AES82806.1| Calcium dependent protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 960 bits (2481), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/603 (80%), Positives = 533/603 (88%), Gaps = 13/603 (2%)
Query: 1 MGQCYGKTIPTTENDATTSATTT--TMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSS-H 57
MGQCYGKT+P + + TT T + ++TPLP + NG VKNTP RSS H
Sbjct: 1 MGQCYGKTVPGAGSHRQQNTTTIIDTSAGDGDGSRTPLP--SFANGIPSVKNTPARSSSH 58
Query: 58 PSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGK 117
SPWPSPYPHGV+ SP SPARASTP+RFFRRPFPPPSPAKHI+ SLAKRLG K
Sbjct: 59 ASPWPSPYPHGVNPSP-------SPARASTPKRFFRRPFPPPSPAKHIRESLAKRLGKAK 111
Query: 118 PKESTIPEERGTEPE-QSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQ 176
PKE IPEE G E + QSLDKSFGY+KNFGAKYELGKEVGRGHFGHTCSAR KKG+LKDQ
Sbjct: 112 PKEGPIPEEHGVETDSQSLDKSFGYSKNFGAKYELGKEVGRGHFGHTCSARAKKGDLKDQ 171
Query: 177 QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG 236
VAVKIISK+KMT+AI+IEDVRREVK+LKALSGHKHL+KF DACED NNVYIVMELCEGG
Sbjct: 172 PVAVKIISKSKMTSAIAIEDVRREVKLLKALSGHKHLIKFHDACEDANNVYIVMELCEGG 231
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
ELLDRIL+RGGRYTEEDAKAIV+QILSV AFCHLQGVVHRDLKPENFLFTS +DADM+L
Sbjct: 232 ELLDRILSRGGRYTEEDAKAIVLQILSVAAFCHLQGVVHRDLKPENFLFTSRSEDADMKL 291
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWAR 356
IDFGLSDFIRP+ERLNDIVGSAYYVAPEVLHRSYS+EADIWSIGVI+YILLCGSRPFWAR
Sbjct: 292 IDFGLSDFIRPEERLNDIVGSAYYVAPEVLHRSYSVEADIWSIGVITYILLCGSRPFWAR 351
Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416
TESGIFR VLR+DPNFDDLPWPSVSPE KDFVKRLLNKDYRKRMTA QALTHPWLRD+SR
Sbjct: 352 TESGIFRTVLRADPNFDDLPWPSVSPEGKDFVKRLLNKDYRKRMTAAQALTHPWLRDESR 411
Query: 417 PVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLEN 476
P+PLDILI+KLVKSYLHATPFKRAA+KALSKALT+D+LVYLRAQFRLLEPN+DG VSL+N
Sbjct: 412 PIPLDILIYKLVKSYLHATPFKRAAVKALSKALTDDQLVYLRAQFRLLEPNRDGHVSLDN 471
Query: 477 FRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIAST 536
F+M L R+ATDAMRESRV D++ +ME LAYRKM FEEFCAAA ST+QLEAL+GWE IA
Sbjct: 472 FKMALARHATDAMRESRVLDIIHTMEPLAYRKMDFEEFCAAATSTYQLEALDGWEDIACA 531
Query: 537 AFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRSS 596
AFE+FE EGNRVISIEELARELN+GPSAYS L+DWIRN+DGKLSL GYTKFLHGVTLRSS
Sbjct: 532 AFEHFESEGNRVISIEELARELNLGPSAYSVLRDWIRNTDGKLSLLGYTKFLHGVTLRSS 591
Query: 597 NTR 599
R
Sbjct: 592 LPR 594
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15226426|ref|NP_182193.1| CDPK-related kinase 3 [Arabidopsis thaliana] gi|75339064|sp|Q9ZUZ2.1|CAMK3_ARATH RecName: Full=CDPK-related kinase 3; Short=AtCRK3; AltName: Full=Calcium/calmodulin-dependent protein kinase 4; Short=AtCK gi|3831444|gb|AAC69927.1| putative calcium-dependent protein kinase [Arabidopsis thaliana] gi|330255648|gb|AEC10742.1| CDPK-related kinase 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 915 bits (2365), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/600 (80%), Positives = 536/600 (89%), Gaps = 8/600 (1%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQT-PLPPSTPGNGSMPVKNTPGRSSHPS 59
MGQCYGK + +N A TTT VVS + NQ PL P G KNTP RSS+PS
Sbjct: 1 MGQCYGKVNQSKQN-GEEEANTTTYVVSGDGNQIQPLTPVNYGRA----KNTPARSSNPS 55
Query: 60 PWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPK 119
PWPSP+PHG SASPLP+GVSPSPAR STPRRFFRRPFPPPSPAKHIKASL KRLG KPK
Sbjct: 56 PWPSPFPHG-SASPLPSGVSPSPARTSTPRRFFRRPFPPPSPAKHIKASLIKRLGV-KPK 113
Query: 120 ESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVA 179
E IPEERGTEPEQSLDKSFGY KNFGAKYELGKEVGRGHFGHTCS RGKKG++KD +A
Sbjct: 114 EGPIPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSGRGKKGDIKDHPIA 173
Query: 180 VKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELL 239
VKIISKAKMTTAI+IEDVRREVK+LK+LSGHK+L+K+ DACED NNVYIVMELC+GGELL
Sbjct: 174 VKIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACEDANNVYIVMELCDGGELL 233
Query: 240 DRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299
DRILARGG+Y E+DAKAIVVQIL+VV+FCHLQGVVHRDLKPENFLFTS R+D+D++LIDF
Sbjct: 234 DRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPENFLFTSSREDSDLKLIDF 293
Query: 300 GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTES 359
GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI+YILLCGSRPFWARTES
Sbjct: 294 GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILLCGSRPFWARTES 353
Query: 360 GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419
GIFR VLR++PN+DD+PWPS S E KDFVKRLLNKDYRKRM+AVQALTHPWLRDDSR +P
Sbjct: 354 GIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSAVQALTHPWLRDDSRVIP 413
Query: 420 LDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRM 479
LDILI+KLVK+YLHATP +RAALKAL+KALTE+ELVYLRAQF LL PNKDGSVSLENF+
Sbjct: 414 LDILIYKLVKAYLHATPLRRAALKALAKALTENELVYLRAQFMLLGPNKDGSVSLENFKT 473
Query: 480 VLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFE 539
L +NATDAMRESRVP++L +MESLAYRKMYFEEFCAAAIS HQLEA++ WE+IA+ F+
Sbjct: 474 ALMQNATDAMRESRVPEILHTMESLAYRKMYFEEFCAAAISIHQLEAVDAWEEIATAGFQ 533
Query: 540 YFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRSSNTR 599
+FE EGNRVI+IEELARELNVG SAY L+DW+R+SDGKLS G+TKFLHGVTLR+++ R
Sbjct: 534 HFETEGNRVITIEELARELNVGASAYGHLRDWVRSSDGKLSYLGFTKFLHGVTLRAAHAR 593
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520241|ref|XP_003528772.1| PREDICTED: CDPK-related protein kinase-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2363), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/609 (78%), Positives = 525/609 (86%), Gaps = 26/609 (4%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTM--VVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHP 58
MGQCYGKT ENDAT + T T VV+ + + P P +P K+TP R+S
Sbjct: 1 MGQCYGKTNLAPENDATAATTNTETTAVVAGSGDVPPSP--------LPAKDTPARAS-- 50
Query: 59 SPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGK- 117
PWPSP+PHG GV+PSPAR TPRRFFRRPFPPPSPAKHI+ASLAKRLG K
Sbjct: 51 -PWPSPFPHG------GGGVTPSPARG-TPRRFFRRPFPPPSPAKHIRASLAKRLGHAKA 102
Query: 118 -PKESTIPEERGTEPE----QSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGE 172
PKE IPEE Q+LDKSFGY KNFGAK+E+GKEVGRGHFGHTC A+GKKGE
Sbjct: 103 APKEGPIPEEEAAAAAAAAEQTLDKSFGYGKNFGAKFEIGKEVGRGHFGHTCYAKGKKGE 162
Query: 173 LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232
LKDQ VA+KIISKAKMTTAI+IEDVRREVKILKALSGHKHLVKF DA ED NNVYIVMEL
Sbjct: 163 LKDQPVAIKIISKAKMTTAIAIEDVRREVKILKALSGHKHLVKFHDAFEDANNVYIVMEL 222
Query: 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292
CEGGELLDRIL+RGG+Y+EEDAK IV+QILSVVAFCHLQGVVHRDLKPENFL+TS +DA
Sbjct: 223 CEGGELLDRILSRGGKYSEEDAKVIVLQILSVVAFCHLQGVVHRDLKPENFLYTSRSEDA 282
Query: 293 DMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRP 352
DM+LIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI+YILLCGSRP
Sbjct: 283 DMKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILLCGSRP 342
Query: 353 FWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
F+ARTESGIFRAVLR+DPNFDDLPWP+ S EAKDFVKRLLNKDYRKRMTAVQALTHPWLR
Sbjct: 343 FYARTESGIFRAVLRADPNFDDLPWPTASAEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 402
Query: 413 DDSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSV 472
DDSRP+PLDIL+FKLVK+YLHATPFKRAA+KALSKAL ED+L YL AQFRLLEPN+DG +
Sbjct: 403 DDSRPIPLDILVFKLVKAYLHATPFKRAAVKALSKALPEDQLPYLSAQFRLLEPNRDGHI 462
Query: 473 SLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQ 532
SL+NF+M L RNATDAMRESRV +++++ME LAYRKM FEEFCAA ISTHQLEA + WE
Sbjct: 463 SLDNFKMALVRNATDAMRESRVLEIINAMEPLAYRKMDFEEFCAATISTHQLEAHDRWED 522
Query: 533 IASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592
IASTAFE+FE EGNR+IS+EELARELN+GPSAYS LKDWIRN+DGKLSL GYTKFLHGVT
Sbjct: 523 IASTAFEHFEREGNRLISVEELARELNLGPSAYSVLKDWIRNTDGKLSLLGYTKFLHGVT 582
Query: 593 LRSSNTRHH 601
LRSSN R H
Sbjct: 583 LRSSNPRQH 591
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18087555|gb|AAL58909.1|AF462819_1 At2g46700/T3A4.8 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 913 bits (2360), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/600 (80%), Positives = 535/600 (89%), Gaps = 8/600 (1%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQT-PLPPSTPGNGSMPVKNTPGRSSHPS 59
MGQCYGK + +N A T T VVS + NQ PL P G KNTP RSS+PS
Sbjct: 1 MGQCYGKVNQSKQN-GEEEANTATYVVSGDGNQIQPLTPVNYGRA----KNTPARSSNPS 55
Query: 60 PWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPK 119
PWPSP+PHG SASPLP+GVSPSPAR STPRRFFRRPFPPPSPAKHIKASL KRLG KPK
Sbjct: 56 PWPSPFPHG-SASPLPSGVSPSPARTSTPRRFFRRPFPPPSPAKHIKASLIKRLGV-KPK 113
Query: 120 ESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVA 179
E IPEERGTEPEQSLDKSFGY KNFGAKYELGKEVGRGHFGHTCS RGKKG++KD +A
Sbjct: 114 EGPIPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSGRGKKGDIKDHPIA 173
Query: 180 VKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELL 239
VKIISKAKMTTAI+IEDVRREVK+LK+LSGHK+L+K+ DACED NNVYIVMELC+GGELL
Sbjct: 174 VKIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACEDANNVYIVMELCDGGELL 233
Query: 240 DRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299
DRILARGG+Y E+DAKAIVVQIL+VV+FCHLQGVVHRDLKPENFLFTS R+D+D++LIDF
Sbjct: 234 DRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPENFLFTSSREDSDLKLIDF 293
Query: 300 GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTES 359
GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI+YILLCGSRPFWARTES
Sbjct: 294 GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILLCGSRPFWARTES 353
Query: 360 GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419
GIFR VLR++PN+DD+PWPS S E KDFVKRLLNKDYRKRM+AVQALTHPWLRDDSR +P
Sbjct: 354 GIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSAVQALTHPWLRDDSRVIP 413
Query: 420 LDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRM 479
LDILI+KLVK+YLHATP +RAALKAL+KALTE+ELVYLRAQF LL PNKDGSVSLENF+
Sbjct: 414 LDILIYKLVKAYLHATPLRRAALKALAKALTENELVYLRAQFMLLGPNKDGSVSLENFKT 473
Query: 480 VLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFE 539
L +NATDAMRESRVP++L +MESLAYRKMYFEEFCAAAIS HQLEA++ WE+IA+ F+
Sbjct: 474 ALMQNATDAMRESRVPEILHTMESLAYRKMYFEEFCAAAISIHQLEAVDAWEEIATAGFQ 533
Query: 540 YFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRSSNTR 599
+FE EGNRVI+IEELARELNVG SAY L+DW+R+SDGKLS G+TKFLHGVTLR+++ R
Sbjct: 534 HFETEGNRVITIEELARELNVGASAYGHLRDWVRSSDGKLSYLGFTKFLHGVTLRAAHAR 593
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 601 | ||||||
| TAIR|locus:2062764 | 595 | CRK3 "AT2G46700" [Arabidopsis | 0.986 | 0.996 | 0.724 | 1.1e-229 | |
| TAIR|locus:2152876 | 594 | AT5G24430 [Arabidopsis thalian | 0.873 | 0.883 | 0.657 | 2.8e-185 | |
| TAIR|locus:2082931 | 594 | AT3G49370 [Arabidopsis thalian | 0.873 | 0.883 | 0.647 | 7.8e-181 | |
| TAIR|locus:2063197 | 576 | CRK1 "AT2G41140" [Arabidopsis | 0.816 | 0.852 | 0.629 | 2.8e-169 | |
| TAIR|locus:2012232 | 606 | AT1G49580 [Arabidopsis thalian | 0.821 | 0.815 | 0.626 | 1.2e-168 | |
| TAIR|locus:2103655 | 577 | AT3G56760 [Arabidopsis thalian | 0.816 | 0.850 | 0.620 | 2.5e-168 | |
| TAIR|locus:2094053 | 599 | AT3G19100 [Arabidopsis thalian | 0.816 | 0.819 | 0.633 | 4.1e-168 | |
| TAIR|locus:2827826 | 571 | CPK16 "AT2G17890" [Arabidopsis | 0.762 | 0.802 | 0.480 | 7.6e-112 | |
| TAIR|locus:2156947 | 523 | CPK28 "calcium-dependent prote | 0.755 | 0.868 | 0.461 | 1.4e-103 | |
| TAIR|locus:2177023 | 528 | CPK17 "calcium-dependent prote | 0.698 | 0.795 | 0.410 | 3.8e-85 |
| TAIR|locus:2062764 CRK3 "AT2G46700" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2216 (785.1 bits), Expect = 1.1e-229, P = 1.1e-229
Identities = 434/599 (72%), Positives = 485/599 (80%)
Query: 1 MGQCYGKTIPXXXXXXXXXXXXXXMVVSANQNQTPLPPSTPGNGSMPVKNTXXXXXXXXX 60
MGQCYGK + VVS + NQ + P TP N KNT
Sbjct: 1 MGQCYGK-VNQSKQNGEEEANTTTYVVSGDGNQ--IQPLTPVNYGR-AKNTPARSSNPSP 56
Query: 61 XXXXXXHGVSASPLPAGVSPSXXXXXXXXXXXXXXXXXXXXXKHIKASLAKRLGGGKPKE 120
HG SASPLP+GVSPS KHIKASL KRLG KPKE
Sbjct: 57 WPSPFPHG-SASPLPSGVSPSPARTSTPRRFFRRPFPPPSPAKHIKASLIKRLGV-KPKE 114
Query: 121 STIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAV 180
IPEERGTEPEQSLDKSFGY KNFGAKYELGKEVGRGHFGHTCS RGKKG++KD +AV
Sbjct: 115 GPIPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSGRGKKGDIKDHPIAV 174
Query: 181 KIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
KIISKAKMTTAI+IEDVRREVK+LK+LSGHK+L+K+ DACED NNVYIVMELC+GGELLD
Sbjct: 175 KIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACEDANNVYIVMELCDGGELLD 234
Query: 241 RILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
RILARGG+Y E+DAKAIVVQIL+VV+FCHLQGVVHRDLKPENFLFTS R+D+D++LIDFG
Sbjct: 235 RILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPENFLFTSSREDSDLKLIDFG 294
Query: 301 LSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESG 360
LSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI+YILLCGSRPFWARTESG
Sbjct: 295 LSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILLCGSRPFWARTESG 354
Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPL 420
IFR VLR++PN+DD+PWPS S E KDFVKRLLNKDYRKRM+AVQALTHPWLRDDSR +PL
Sbjct: 355 IFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSAVQALTHPWLRDDSRVIPL 414
Query: 421 DILIFKLVKSYLHATPFXXXXXXXXXXXXTEDELVYLRAQFRLLEPNKDGSVSLENFRMV 480
DILI+KLVK+YLHATP TE+ELVYLRAQF LL PNKDGSVSLENF+
Sbjct: 415 DILIYKLVKAYLHATPLRRAALKALAKALTENELVYLRAQFMLLGPNKDGSVSLENFKTA 474
Query: 481 LGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEY 540
L +NATDAMRESRVP++L +MESLAYRKMYFEEFCAAAIS HQLEA++ WE+IA+ F++
Sbjct: 475 LMQNATDAMRESRVPEILHTMESLAYRKMYFEEFCAAAISIHQLEAVDAWEEIATAGFQH 534
Query: 541 FEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRSSNTR 599
FE EGNRVI+IEELARELNVG SAY L+DW+R+SDGKLS G+TKFLHGVTLR+++ R
Sbjct: 535 FETEGNRVITIEELARELNVGASAYGHLRDWVRSSDGKLSYLGFTKFLHGVTLRAAHAR 593
|
|
| TAIR|locus:2152876 AT5G24430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1797 (637.6 bits), Expect = 2.8e-185, P = 2.8e-185
Identities = 353/537 (65%), Positives = 425/537 (79%)
Query: 72 SPLPAGVSPSXXXXXXXXXXXXXXXXXXXXXKHIKASLAKRLGGG-KPKESTIPEE---- 126
SPLPAGV+PS K I A+L +R G +P++ IPE+
Sbjct: 59 SPLPAGVAPSPARTPGRKFKWPFPPPSPA--KPIMAALRRRRGAPPQPRDEPIPEDSEDV 116
Query: 127 --RGTEPE--QSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI 182
G + + LDK+FG+ KNF KYELGKEVGRGHFGHTC A+ KKG++K+Q VAVKI
Sbjct: 117 VDHGGDSGGGERLDKNFGFGKNFEGKYELGKEVGRGHFGHTCWAKAKKGKMKNQTVAVKI 176
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI 242
ISKAKMT+ +SIEDVRREVK+LKALSGH+H+VKF D ED +NV++VMELCEGGELLDRI
Sbjct: 177 ISKAKMTSTLSIEDVRREVKLLKALSGHRHMVKFYDVYEDADNVFVVMELCEGGELLDRI 236
Query: 243 LARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302
LARGGRY E DAK I+VQILS AF HLQGVVHRDLKPENFLFTS +DA +++IDFGLS
Sbjct: 237 LARGGRYPEVDAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSRNEDAILKVIDFGLS 296
Query: 303 DFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIF 362
DFIR D+RLND+VGSAYYVAPEVLHRSYS EAD+WSIGVISYILLCGSRPF+ RTES IF
Sbjct: 297 DFIRYDQRLNDVVGSAYYVAPEVLHRSYSTEADMWSIGVISYILLCGSRPFYGRTESAIF 356
Query: 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDI 422
R VLR++PNF+D+PWPS+SP AKDFVKRLLNKD+RKRMTA QAL HPWLRD++ + LD
Sbjct: 357 RCVLRANPNFEDMPWPSISPTAKDFVKRLLNKDHRKRMTAAQALAHPWLRDENPGLLLDF 416
Query: 423 LIFKLVKSYLHATPFXXXXXXXXXXXXTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLG 482
++KLVKSY+ A+PF ++ELV+L+AQF LL+P KDG +SL F M L
Sbjct: 417 SVYKLVKSYIRASPFRRSALKALSKAIPDEELVFLKAQFMLLDP-KDGGLSLNCFTMALT 475
Query: 483 RNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFE 542
R ATDAM ESR+PD+L++M+ LA +K+ FEEFCAAA+S +QLEALE WEQIA++AFE+FE
Sbjct: 476 RYATDAMMESRLPDILNTMQPLAQKKLDFEEFCAAAVSVYQLEALEEWEQIATSAFEHFE 535
Query: 543 EEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRSSNTR 599
EGNR+IS++ELA E++VGPSAY LKDWIR+SDGKLS GY KFLHGVT+RSS++R
Sbjct: 536 HEGNRIISVQELAGEMSVGPSAYPLLKDWIRSSDGKLSFLGYAKFLHGVTVRSSSSR 592
|
|
| TAIR|locus:2082931 AT3G49370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1755 (622.8 bits), Expect = 7.8e-181, P = 7.8e-181
Identities = 346/534 (64%), Positives = 416/534 (77%)
Query: 72 SPLPAGVSPSXXXXXXXXXXXXXXXXXXXXXKHIKASLAKRLGGGK-PKESTIPEER--- 127
SPLPAGV+PS K I A+L +R G P++ IPE+
Sbjct: 61 SPLPAGVAPSPARTPGRKFKWPFPPPSPA--KPIMAALRRRRGTAPHPRDGPIPEDSEAG 118
Query: 128 --GTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISK 185
G + LDK+FG+ KNF KYELG+EVGRGHFGHTC A+ KKG++K Q VAVKIISK
Sbjct: 119 GSGGGIGERLDKNFGFAKNFEGKYELGREVGRGHFGHTCWAKAKKGKIKGQTVAVKIISK 178
Query: 186 AKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR 245
+KMT+A+SIEDVRREVK+LKALSGH H+VKF D ED +NV++VMELCEGGELLD ILAR
Sbjct: 179 SKMTSALSIEDVRREVKLLKALSGHSHMVKFYDVFEDSDNVFVVMELCEGGELLDSILAR 238
Query: 246 GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305
GGRY E +AK I+VQILS AF HLQGVVHRDLKPENFLFTS +DA +++IDFGLSD+
Sbjct: 239 GGRYPEAEAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSKNEDAVLKVIDFGLSDYA 298
Query: 306 RPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV 365
R D+RLND+VGSAYYVAPEVLHRSYS EADIWSIGVISYILLCGSRPF+ RTES IFR V
Sbjct: 299 RFDQRLNDVVGSAYYVAPEVLHRSYSTEADIWSIGVISYILLCGSRPFYGRTESAIFRCV 358
Query: 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIF 425
LR++PNFDDLPWPS+SP AKDFVKRLLNKD+RKRMTA QAL HPWLRD++ + LD I+
Sbjct: 359 LRANPNFDDLPWPSISPIAKDFVKRLLNKDHRKRMTAAQALAHPWLRDENPGLLLDFSIY 418
Query: 426 KLVKSYLHATPFXXXXXXXXXXXXTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNA 485
KLVKSY+ A+PF E+ELV+L+AQF LLEP +DG + L NF L R A
Sbjct: 419 KLVKSYIRASPFRRAALKSLSKAIPEEELVFLKAQFMLLEP-EDGGLHLHNFTTALTRYA 477
Query: 486 TDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEG 545
TDAM ESR+PD+L+ M+ LA++K+ FEEFCAA++S +QLEALE WEQIA+ AFE+FE EG
Sbjct: 478 TDAMIESRLPDILNMMQPLAHKKLDFEEFCAASVSVYQLEALEEWEQIATVAFEHFESEG 537
Query: 546 NRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRSSNTR 599
+R IS++ELA E+++GP+AY LKDWIR+ DGKL+ GY KFLHGVT+RSS++R
Sbjct: 538 SRAISVQELAEEMSLGPNAYPLLKDWIRSLDGKLNFLGYAKFLHGVTVRSSSSR 591
|
|
| TAIR|locus:2063197 CRK1 "AT2G41140" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1646 (584.5 bits), Expect = 2.8e-169, P = 2.8e-169
Identities = 312/496 (62%), Positives = 396/496 (79%)
Query: 103 KHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGH 162
KHI+A LA+R G KP E +IPE G E E LDKSFG++K F + YE+ EVGRGHFG+
Sbjct: 79 KHIRAFLARRYGSVKPNEVSIPE--GKECEIGLDKSFGFSKQFASHYEIDGEVGRGHFGY 136
Query: 163 TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222
TCSA+GKKG LK Q+VAVK+I K+KMTTAI+IEDV REVK+L+AL+GHK+LV+F DA ED
Sbjct: 137 TCSAKGKKGSLKGQEVAVKVIPKSKMTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFED 196
Query: 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPEN 282
NVYIVMELC+GGELLD+IL RGG+Y+E+DAK ++VQILSVVA+CHLQGVVHRDLKPEN
Sbjct: 197 DENVYIVMELCKGGELLDKILQRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPEN 256
Query: 283 FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI 342
FLF++ + + ++ IDFGLSD+++PDERLNDIVGSAYYVAPEVLHR+Y EAD+WSIGVI
Sbjct: 257 FLFSTKDETSPLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVI 316
Query: 343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
+YILLCGSRPFWARTESGIFRAVL+++PNF++ PWPS+SPEA DFVKRLLNKDYRKR+TA
Sbjct: 317 AYILLCGSRPFWARTESGIFRAVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTA 376
Query: 403 VQALTHPWLRDDSR-PVPLDILIFKLVKSYLHATPFXXXXXXXXXXXXTEDELVYLRAQF 461
QAL HPWL +P D++I+KLVK Y+ +T T +L YLR QF
Sbjct: 377 AQALCHPWLVGSHELKIPSDMIIYKLVKVYIMSTSLRKSALAALAKTLTVPQLAYLREQF 436
Query: 462 RLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521
LL P+K+G +S++N++ + +++TDAM++SRV D + + L Y+K+ FEEFCA+A+S
Sbjct: 437 TLLGPSKNGYISMQNYKTAILKSSTDAMKDSRVFDFVHMISCLQYKKLDFEEFCASALSV 496
Query: 522 HQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSA--YSFLKDWIRNSDGKL 579
+QLEA+E WEQ A A+E FE++GNR I IEELA EL +GPS + L+DWIR+SDGKL
Sbjct: 497 YQLEAMETWEQHARRAYELFEKDGNRPIMIEELASELGLGPSVPVHVVLQDWIRHSDGKL 556
Query: 580 SLHGYTKFLHGVTLRS 595
S G+ + LHGV+ R+
Sbjct: 557 SFLGFVRLLHGVSSRT 572
|
|
| TAIR|locus:2012232 AT1G49580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1640 (582.4 bits), Expect = 1.2e-168, P = 1.2e-168
Identities = 316/504 (62%), Positives = 394/504 (78%)
Query: 103 KHIKASLAKRLG------GGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVG 156
KHI+A+L +R G G + +T +R E E LDK FG++K F ++ ELG+E+G
Sbjct: 98 KHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEVGLDKRFGFSKEFHSRVELGEEIG 157
Query: 157 RGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKF 216
RGHFG+TCSA+ KKGELK Q VAVKII K+KMTTAI+IEDVRREVKIL+ALSGHK+LV+F
Sbjct: 158 RGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVRREVKILQALSGHKNLVQF 217
Query: 217 CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHR 276
DA ED NVYI MELCEGGELLDRILARGG+Y+E DAK +++QIL+VVAFCH QGVVHR
Sbjct: 218 YDAFEDNANVYIAMELCEGGELLDRILARGGKYSENDAKPVIIQILNVVAFCHFQGVVHR 277
Query: 277 DLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADI 336
DLKPENFL+TS +++ ++ IDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSY+ EAD+
Sbjct: 278 DLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADV 337
Query: 337 WSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDY 396
WSIGVI+YILLCGSRPFWARTESGIFRAVL++DP+FD+ PWP +S +AKDFVKRLL KD
Sbjct: 338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSDAKDFVKRLLFKDP 397
Query: 397 RKRMTAVQALTHPWLR--DDSRPVPLDILIFKLVKSYLHATPFXXXXXXXXXXXXTEDEL 454
R+RM+A QAL HPW+R + +P DILIF+ +K+YL ++ +DE+
Sbjct: 398 RRRMSASQALMHPWIRAYNTDMNIPFDILIFRQMKAYLRSSSLRKAALRALSKTLIKDEI 457
Query: 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEF 514
+YL+ QF LL PNKDG ++++ RM L NAT+AM+ESR+P+ L+ + L YR M FEEF
Sbjct: 458 LYLKTQFSLLAPNKDGLITMDTIRMALASNATEAMKESRIPEFLALLNGLQYRGMDFEEF 517
Query: 515 CAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPS--AYSFLKDWI 572
CAAAI+ HQ E+L+ WEQ A+E F++ GNR I IEELA EL VGPS +S L DWI
Sbjct: 518 CAAAINVHQHESLDCWEQSIRHAYELFDKNGNRAIVIEELASELGVGPSIPVHSVLHDWI 577
Query: 573 RNSDGKLSLHGYTKFLHGVTLRSS 596
R++DGKLS G+ K LHGV++R+S
Sbjct: 578 RHTDGKLSFFGFVKLLHGVSVRAS 601
|
|
| TAIR|locus:2103655 AT3G56760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1637 (581.3 bits), Expect = 2.5e-168, P = 2.5e-168
Identities = 308/496 (62%), Positives = 396/496 (79%)
Query: 103 KHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGH 162
KHI+A LA+R G KP E++IPE G+E E LDK FG++K F + YE+ EVGRGHFG+
Sbjct: 80 KHIRALLARRHGSVKPNEASIPE--GSECEVGLDKKFGFSKQFASHYEIDGEVGRGHFGY 137
Query: 163 TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222
TCSA+GKKG LK Q VAVK+I K+KMTTAI+IEDVRREVKIL+AL+GHK+LV+F DA ED
Sbjct: 138 TCSAKGKKGSLKGQDVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFED 197
Query: 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPEN 282
NVYIVMELC+GGELLD+IL RGG+Y+E DAK +++QILSVVA+CHLQGVVHRDLKPEN
Sbjct: 198 DENVYIVMELCQGGELLDKILQRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPEN 257
Query: 283 FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI 342
FLFT+ + + ++ IDFGLSD++RPDERLNDIVGSAYYVAPEVLHR+Y EAD+WSIGVI
Sbjct: 258 FLFTTKDESSPLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVI 317
Query: 343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
+YILLCGSRPFWAR+ESGIFRAVL+++PNF++ PWPS+SP+A DFVKRLLNKDYRKR+TA
Sbjct: 318 AYILLCGSRPFWARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTA 377
Query: 403 VQALTHPWLRDDSR-PVPLDILIFKLVKSYLHATPFXXXXXXXXXXXXTEDELVYLRAQF 461
QAL HPWL +P D++I+KLVK Y+ ++ T +L YL+ QF
Sbjct: 378 AQALCHPWLVGSHELKIPSDMIIYKLVKVYIMSSSLRKSALAALAKTLTVPQLTYLQEQF 437
Query: 462 RLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521
LL P+K+G +S++N++ + +++T+A ++SRV D + + L Y+K+ FEEFCA+A+S
Sbjct: 438 NLLGPSKNGYISMQNYKTAILKSSTEATKDSRVLDFVHMISCLQYKKLDFEEFCASALSV 497
Query: 522 HQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSA--YSFLKDWIRNSDGKL 579
+QLEA+E WEQ A A+E +E++GNRVI IEELA EL +GPS + L+DWIR+SDGKL
Sbjct: 498 YQLEAMETWEQHARRAYELYEKDGNRVIMIEELATELGLGPSVPVHVVLQDWIRHSDGKL 557
Query: 580 SLHGYTKFLHGVTLRS 595
S G+ + LHGV+ R+
Sbjct: 558 SFLGFVRLLHGVSSRT 573
|
|
| TAIR|locus:2094053 AT3G19100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1635 (580.6 bits), Expect = 4.1e-168, P = 4.1e-168
Identities = 318/502 (63%), Positives = 396/502 (78%)
Query: 103 KHIKASLAKRLGGGKPKESTIPEERGTEPEQS-----LDKSFGYNKNFGAKYELGKEVGR 157
+HI+ L +R + KE+ +P R + E+ LDK FG++K ++ ELG+E+GR
Sbjct: 96 RHIRDVLRRRK---EKKEAALPAARQQKEEEEREEVGLDKRFGFSKELQSRIELGEEIGR 152
Query: 158 GHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFC 217
GHFG+TCSA+ KKGELKDQ+VAVK+I K+KMT+AISIEDVRREVKIL+ALSGH++LV+F
Sbjct: 153 GHFGYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVRREVKILRALSGHQNLVQFY 212
Query: 218 DACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRD 277
DA ED NVYIVMELC GGELLDRILARGG+Y+E+DAKA+++QIL+VVAFCHLQGVVHRD
Sbjct: 213 DAFEDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVLIQILNVVAFCHLQGVVHRD 272
Query: 278 LKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIW 337
LKPENFL+TS +++ +++IDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSY+ EAD+W
Sbjct: 273 LKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADVW 332
Query: 338 SIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYR 397
SIGVI+YILLCGSRPFWARTESGIFRAVL++DP+FD+ PWPS+S EAKDFVKRLL KD R
Sbjct: 333 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVKRLLYKDPR 392
Query: 398 KRMTAVQALTHPWLRDDSR-PVPLDILIFKLVKSYLHATPFXXXXXXXXXXXXTEDELVY 456
KRMTA QAL HPW+ + +P DILIFK +K+YL ++ T DEL+Y
Sbjct: 393 KRMTASQALMHPWIAGYKKIDIPFDILIFKQIKAYLRSSSLRKAALMALSKTLTTDELLY 452
Query: 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCA 516
L+AQF L PNK+G ++L++ R+ L NAT+AM+ESR+PD L+ + L Y+ M FEEFCA
Sbjct: 453 LKAQFAHLAPNKNGLITLDSIRLALATNATEAMKESRIPDFLALLNGLQYKGMDFEEFCA 512
Query: 517 AAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPS--AYSFLKDWIRN 574
A+IS HQ E+L+ WEQ A+E FE GNRVI IEELA EL VG S ++ L DWIR+
Sbjct: 513 ASISVHQHESLDCWEQSIRHAYELFEMNGNRVIVIEELASELGVGSSIPVHTILNDWIRH 572
Query: 575 SDGKLSLHGYTKFLHGVTLRSS 596
+DGKLS G+ K LHGV+ R S
Sbjct: 573 TDGKLSFLGFVKLLHGVSTRQS 594
|
|
| TAIR|locus:2827826 CPK16 "AT2G17890" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1104 (393.7 bits), Expect = 7.6e-112, P = 7.6e-112
Identities = 224/466 (48%), Positives = 315/466 (67%)
Query: 139 FGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR 198
FGY K+F +Y +GK +G G FG+T A KK +VAVK I KAKMT I++EDV+
Sbjct: 98 FGYAKDFDHRYTIGKLLGHGQFGYTYVATDKK---TGDRVAVKKIDKAKMTIPIAVEDVK 154
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAI 257
REVKIL+AL+GH+++V+F +A ED N+VYIVMELCEGGELLDRILAR RY+E DA +
Sbjct: 155 REVKILQALTGHENVVRFYNAFEDKNSVYIVMELCEGGELLDRILARKDSRYSERDAAVV 214
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
V Q+L V A CHL+G+VHRD+KPENFLF S +D+ ++ DFGLSDFI+P ++ +DIVGS
Sbjct: 215 VRQMLKVAAECHLRGLVHRDMKPENFLFKSTEEDSPLKATDFGLSDFIKPGKKFHDIVGS 274
Query: 318 AYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
AYYVAPEVL R E+D+WSIGVISYILLCG RPFW +TE GIF+ VL++ P+F PW
Sbjct: 275 AYYVAPEVLKRRSGPESDVWSIGVISYILLCGRRPFWDKTEDGIFKEVLKNKPDFRRKPW 334
Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD--DSRPVPLDILIFKLVKSYLHAT 435
P++S AKDFVK+LL KD R R+TA QAL+HPW+R+ D+ +P+DI + ++ ++ +
Sbjct: 335 PTISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKFS 394
Query: 436 PFXXXXXXXXXXXXTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVP 495
E+EL LR QF ++ +K+G +SLE R L ++ ++++RV
Sbjct: 395 RLKQFALRALATTLDEEELADLRDQFDAIDVDKNGVISLEEMRQALAKDHPWKLKDARVA 454
Query: 496 DVLSSMESLAYRKMYFEEFCAAAISTHQLEA--LEGWEQIASTAFEYFEEEGNRVISIEE 553
++L +++S + F EF AAA+ +QLE E W+Q + AFE F+ +G+ I+ EE
Sbjct: 455 EILQAIDSNTDGFVDFGEFVAAALHVNQLEEHDSEKWQQRSRAAFEKFDIDGDGFITAEE 514
Query: 554 LARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRSSNTR 599
L + S L++ ++DGK+SL + + L +++S N R
Sbjct: 515 LRMHTGLKGSIEPLLEEADIDNDGKISLQEFRRLLRTASIKSRNVR 560
|
|
| TAIR|locus:2156947 CPK28 "calcium-dependent protein kinase 28" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1026 (366.2 bits), Expect = 1.4e-103, P = 1.4e-103
Identities = 213/462 (46%), Positives = 302/462 (65%)
Query: 139 FGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR 198
FGY+K+F Y +GK +G G FG+T A + +VAVK + K+KM I++EDV+
Sbjct: 52 FGYSKDFHDHYTIGKLLGHGQFGYTYVAIHRPN---GDRVAVKRLDKSKMVLPIAVEDVK 108
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAI 257
REV+IL ALSGH+++V+F +A ED + VYIVMELCEGGELLDRIL++ G RY+E+DA +
Sbjct: 109 REVQILIALSGHENVVQFHNAFEDDDYVYIVMELCEGGELLDRILSKKGNRYSEKDAAVV 168
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
V Q+L V CHL G+VHRD+KPENFLF S + D+ ++ DFGLSDFI+P +R +DIVGS
Sbjct: 169 VRQMLKVAGECHLHGLVHRDMKPENFLFKSAQLDSPLKATDFGLSDFIKPGKRFHDIVGS 228
Query: 318 AYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
AYYVAPEVL R E+D+WSIGVI+YILLCG RPFW RTE GIF+ VLR+ P+F PW
Sbjct: 229 AYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPFWDRTEDGIFKEVLRNKPDFSRKPW 288
Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD--DSRPVPLDILIFKLVKSYLHAT 435
++S AKDFVK+LL KD R R+TA QAL+H W+R+ ++ +P+DI + ++ ++ +
Sbjct: 289 ATISDSAKDFVKKLLVKDPRARLTAAQALSHAWVREGGNATDIPVDISVLNNLRQFVRYS 348
Query: 436 PFXXXXXXXXXXXXTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVP 495
E E+ LR QF ++ +K+G +SLE R L ++ +++SRV
Sbjct: 349 RLKQFALRALASTLDEAEISDLRDQFDAIDVDKNGVISLEEMRQALAKDLPWKLKDSRVA 408
Query: 496 DVLSSMESLAYRKMYFEEFCAAAISTHQLEA--LEGWEQIASTAFEYFEEEGNRVISIEE 553
++L +++S + F EF AAA+ HQLE E W+ + AFE F+ + + I+ EE
Sbjct: 409 EILEAIDSNTDGLVDFTEFVAAALHVHQLEEHDSEKWQLRSRAAFEKFDLDKDGYITPEE 468
Query: 554 LARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRS 595
L + S L + + DGK+SLH + + L ++ S
Sbjct: 469 LRMHTGLRGSIDPLLDEADIDRDGKISLHEFRRLLRTASISS 510
|
|
| TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 852 (305.0 bits), Expect = 3.8e-85, P = 3.8e-85
Identities = 179/436 (41%), Positives = 268/436 (61%)
Query: 147 AKYELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
A Y LGKE+GRG FG H C+ + Q A K I+K K+ IEDVRREV+I+
Sbjct: 71 ASYSLGKELGRGQFGVTHLCTQKAT-----GHQFACKTIAKRKLVNKEDIEDVRREVQIM 125
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
L+G ++V+ A ED ++V++VMELC GGEL DRI+A+G Y+E A +++ I+ +
Sbjct: 126 HHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKG-HYSERAAASLLRTIVQI 184
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
V CH GV+HRDLKPENFL + +++ ++ DFGLS F +P E DIVGSAYY+APE
Sbjct: 185 VHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPE 244
Query: 325 VLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
VL R Y EADIWSIGV+ YILLCG PFWA +E+GIF A+LR +F PWPS+SP+A
Sbjct: 245 VLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSISPQA 304
Query: 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR-P-VPLDILIFKLVKSYLHATPFXXXXX 442
KD VK++LN D ++R+TA Q L HPW+++D P VPLD + +K + F
Sbjct: 305 KDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFKKVAL 364
Query: 443 XXXXXXXTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSME 502
+E+E++ L+ F+ ++ + G+++LE R L + T + E V ++ + +
Sbjct: 365 RVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQGT-RLSEYEVQQLMEAAD 423
Query: 503 SLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-VG 561
+ + + EF AA + ++L+ E+ +AF++F+++ + I++EEL + L G
Sbjct: 424 ADGNGTIDYGEFIAATMHINRLDR----EEHLYSAFQHFDKDNSGYITMEELEQALREFG 479
Query: 562 PSAYSFLKDWIRNSDG 577
+ +K+ I DG
Sbjct: 480 MNDGRDIKEIISEVDG 495
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9ZUZ2 | CAMK3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8016 | 0.9850 | 0.9949 | yes | no |
| P53681 | CRK_DAUCA | 2, ., 7, ., 1, 1, ., 1 | 0.6227 | 0.9733 | 0.9717 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00140489 | hypothetical protein (608 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 601 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-98 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-80 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-60 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-56 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-55 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-51 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-50 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-49 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-47 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-46 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-42 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-41 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-39 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-39 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-38 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-38 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-36 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-36 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-35 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-35 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-35 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-35 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-33 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-33 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-32 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-32 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-32 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-32 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-32 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-32 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-32 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-31 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-31 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-31 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-31 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-31 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-30 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-30 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-29 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-28 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-28 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-28 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-27 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-27 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-27 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-27 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-27 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-27 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-26 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-26 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-26 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-26 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-25 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-25 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-25 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-25 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-25 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-24 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-24 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-24 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-24 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-24 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-24 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-24 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-24 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-24 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-24 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-23 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-23 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-23 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-23 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-23 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-22 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-22 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-22 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-22 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-22 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-22 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-22 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-21 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-21 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-21 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-21 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-21 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-21 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-21 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-20 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-20 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-19 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-19 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-19 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-19 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-18 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-16 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-12 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-07 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 5e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-06 | |
| pfam06293 | 206 | pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/Waa | 8e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-05 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 1e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 | |
| COG5126 | 160 | COG5126, FRQ1, Ca2+-binding protein (EF-Hand super | 0.004 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.004 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 299 bits (769), Expect = 2e-98
Identities = 113/265 (42%), Positives = 161/265 (60%), Gaps = 13/265 (4%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
YE+ +++G G FG AR KK + VA+K+I K K+ E + RE+KILK L
Sbjct: 1 YEILEKLGEGSFGKVYLARDKK---TGKLVAIKVIKKKKIKK--DRERILREIKILKKL- 54
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H ++V+ D ED + +Y+VME CEGG+L D + RG R +E++A+ + QILS + +
Sbjct: 55 KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYL 113
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-H 327
H +G+VHRDLKPEN L D ++L DFGL+ + P E+L VG+ Y+APEVL
Sbjct: 114 HSKGIVHRDLKPENILLDE---DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
+ Y DIWS+GVI Y LL G PF + +F+ + + P F P +SPEAKD
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWDISPEAKD 229
Query: 387 FVKRLLNKDYRKRMTAVQALTHPWL 411
+++LL KD KR+TA +AL HP+
Sbjct: 230 LIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 252 bits (647), Expect = 4e-80
Identities = 110/269 (40%), Positives = 156/269 (57%), Gaps = 15/269 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
YEL +++G G FG A+ K + VAVKI+ K + RRE++IL+ LS
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTG---KIVAVKILKKRSEKSKKDQTA-RREIRILRRLS 56
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H ++V+ DA ED +++Y+VME CEGG+L D L+RGG +E++AK I +QIL + +
Sbjct: 57 -HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFD-YLSRGGPLSEDEAKKIALQILRGLEYL 114
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL- 326
H G++HRDLKPEN L + +++ DFGL+ ++ L VG+ +Y+APEVL
Sbjct: 115 HSNGIIHRDLKPENILLDE---NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171
Query: 327 -HRSYSLEADIWSIGVISYILLCGSRPFWARTESG---IFRAVLRSDPNFDDLPWPSVSP 382
Y + D+WS+GVI Y LL G PF + R +L FD+ W S S
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
EAKD +K+ LNKD KR TA + L HPW
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 7e-60
Identities = 96/258 (37%), Positives = 140/258 (54%), Gaps = 46/258 (17%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G G FG AR KK ++VA+KII K ++ +E++ RE++ILK L+ H ++V
Sbjct: 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIV 54
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
K ED N++Y+VME CEGG L D + G+ +E++ I++QIL + + H G++
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVAPEVLH--RSYS 331
HRDLKPEN L S D+ ++L DFGLS + D+ L IVG+ Y+APEVL YS
Sbjct: 115 HRDLKPENILLDS--DNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
++DIWS+GVI Y L PE KD ++++
Sbjct: 173 EKSDIWSLGVILYEL-----------------------------------PELKDLIRKM 197
Query: 392 LNKDYRKRMTAVQALTHP 409
L KD KR +A + L H
Sbjct: 198 LQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 1e-56
Identities = 85/262 (32%), Positives = 132/262 (50%), Gaps = 19/262 (7%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
+G+G FG R K ++ A+K++ K K+ +E E IL ++ H +
Sbjct: 1 LGKGSFGKVLLVRKKD----TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFI 55
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
VK A + +Y+V+E GGEL + G R++EE A+ +I+ + + H G+
Sbjct: 56 VKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGI 114
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHRS-YS 331
++RDLKPEN L D ++L DFGL+ + R N G+ Y+APEVL Y
Sbjct: 115 IYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
D WS+GV+ Y +L G PF+A I+ +L+ F + +SPEA+D + L
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGL 227
Query: 392 LNKDYRKRMTAVQALT---HPW 410
L KD KR+ + A HP+
Sbjct: 228 LQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 1e-55
Identities = 83/268 (30%), Positives = 140/268 (52%), Gaps = 18/268 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
KYE+ K++G+G FG R K + +K I + M+ ED EVKILK L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNMS-EKEREDALNEVKILKKL 56
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSV 264
+ H +++K+ ++ E+ + IVME +GG+L +I + G + EE VQ+
Sbjct: 57 N-HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 265 VAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIVGSAYYVA 322
+ + H + ++HRD+KP+N FL ++G ++L DFG+S + L +VG+ YY++
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNG----LVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171
Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
PE+ ++ Y+ ++DIWS+G + Y L PF + +L+ + +P S
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--YPPIP-SQYS 228
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALTHP 409
E ++ V LL KD +R + Q L P
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 181 bits (458), Expect = 3e-51
Identities = 93/331 (28%), Positives = 149/331 (45%), Gaps = 30/331 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
Y + +++G G FG AR +K VA+K+++K + + +E RE++IL +L
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------LVALKVLAKKLESKSKEVERFLREIQILASL 54
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVV 265
+ ++VK D +D ++Y+VME +GG L D + G G +E +A I+ QILS +
Sbjct: 55 NHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-------PDERLNDIVGSA 318
+ H +G++HRD+KPEN L D ++LIDFGL+ + + VG+
Sbjct: 115 EYLHSKGIIHRDIKPENILLDR--DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 319 YYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR------- 367
Y+APEVL S +DIWS+G+ Y LL G PF S L+
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 368 --SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIF 425
+S A D +K+LL KD + R+++ L+H L +
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
Query: 426 KLVKSYLHATPFKRAALKALSKALTEDELVY 456
K S + +S +
Sbjct: 293 KPDDSAPLRLSLPPSLEALISSLNSLAISGS 323
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 9e-51
Identities = 90/268 (33%), Positives = 147/268 (54%), Gaps = 20/268 (7%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+E+ +++G+G FG AR K+ ++VA+K+I K+ + E + E++ILK
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVI---KLESKEKKEKIINEIQILKKC 54
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H ++VK+ + + ++IVME C GG L D + + TE + ++L + +
Sbjct: 55 K-HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 327
H G++HRD+K N L TS D +++LIDFGLS + + N +VG+ Y++APEV++
Sbjct: 114 LHSNGIIHRDIKAANILLTS---DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN 170
Query: 328 R-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA---VLRSDPNFDDLPWPS-VSP 382
Y +ADIWS+G+ + L G P+ +E +A + + P L P S
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPG--LRNPEKWSD 225
Query: 383 EAKDFVKRLLNKDYRKRMTAVQALTHPW 410
E KDF+K+ L K+ KR TA Q L HP+
Sbjct: 226 EFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 1e-50
Identities = 93/270 (34%), Positives = 144/270 (53%), Gaps = 22/270 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
Y+LG +GRG FG + VA+K IS K+ +++ + +E+ +LK L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNL 56
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H ++VK+ + E +++YI++E E G L +I+ + G + E V Q+L +A+
Sbjct: 57 K-HPNIVKYIGSIETSDSLYIILEYAENGSLR-QIIKKFGPFPESLVAVYVYQVLQGLAY 114
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL 326
H QGV+HRD+K N L T D ++L DFG++ + +VG+ Y++APEV+
Sbjct: 115 LHEQGVIHRDIKAANILTTK---DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 327 HRS-YSLEADIWSIG--VISYILLCGSRPFWARTE-SGIFRAVLRSDPNFDDLPWPS-VS 381
S S +DIWS+G VI LL G+ P++ + +FR V P P P +S
Sbjct: 172 EMSGASTASDIWSLGCTVIE--LLTGNPPYYDLNPMAALFRIVQDDHP-----PLPEGIS 224
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
PE KDF+ + KD R TA Q L HPW+
Sbjct: 225 PELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 5e-49
Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 41/290 (14%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
++ GK +G G F A+ K+ +++ A+KI+ K ++ ++ V+ E ++L L+
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKET---NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN 59
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
GH ++K +D N+Y V+E GELL I G E+ + +IL + +
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSL-DEKCTRFYAAEILLALEYL 118
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMR--LIDFGLSDFIRPDE----------------- 309
H +G++HRDLKPEN L D DM + DFG + + P+
Sbjct: 119 HSKGIIHRDLKPENILL-----DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 310 ----RLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA 364
R VG+A YV+PE+L + +D+W++G I Y +L G PF E F+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233
Query: 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT----HPW 410
+L+ + +F P+ P+AKD +++LL D + R+ + HP+
Sbjct: 234 ILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 82/258 (31%), Positives = 123/258 (47%), Gaps = 21/258 (8%)
Query: 169 KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228
KK D A+K+I KA M ++ V E IL ++VK + + N+Y+
Sbjct: 13 KKKSTGDI-YAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYL 70
Query: 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288
VME GG+L +L G E+ A+ + +I+ + + H G++HRDLKP+N L S
Sbjct: 71 VMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS- 128
Query: 289 RDDADMRLIDFGLSDF---------IRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWS 338
+ ++L DFGLS ++ IVG+ Y+APEV L + +S D WS
Sbjct: 129 --NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWS 186
Query: 339 IGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRK 398
+G I Y L G PF T IF+ +L + + VS EA D + +LL D K
Sbjct: 187 LGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLISKLLVPDPEK 244
Query: 399 RMTAVQA---LTHPWLRD 413
R+ A HP+ +
Sbjct: 245 RLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-47
Identities = 81/275 (29%), Positives = 139/275 (50%), Gaps = 26/275 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD--QQVAVKIISKAKMTTAISIEDVRREVKILK 205
++ G+ +GRG FG + KD + +AVK + + + +E + RE++IL
Sbjct: 1 EWTRGELLGRGSFG-SVYL----ALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILS 54
Query: 206 ALSGHKHLVKF--CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
+L H ++V++ + E+ N + I +E GG L +L + G+ E + QIL
Sbjct: 55 SLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILE 112
Query: 264 VVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLS---DFIRPDERLNDIVGSAY 319
+A+ H G+VHRD+K N + + G ++L DFG + I E + G+ Y
Sbjct: 113 GLAYLHSNGIVHRDIKGANILVDSDGV----VKLADFGCAKRLGDIETGEGTGSVRGTPY 168
Query: 320 YVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESG--IFRAVLRSDPNFDDLP 376
++APEV+ Y ADIWS+G + G P+ +++ +P ++P
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP--PEIP 226
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
+S EAKDF+++ L +D +KR TA + L HP+L
Sbjct: 227 -EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-46
Identities = 80/272 (29%), Positives = 140/272 (51%), Gaps = 24/272 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+EL + +G+G FG C + + + + A+K ++K K S+ +V E +IL+ L+
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTK---KMFAMKYMNKQKCVEKGSVRNVLNERRILQELN 58
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-LARGGRYTEEDAKAIVVQILSVVAF 267
H LV + +D N+Y+V++L GG+L R L++ +++EE K + +I+ + +
Sbjct: 59 -HPFLVNLWYSFQDEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
H +G++HRD+KP+N L D + + DF ++ + PD G+ Y+APEV
Sbjct: 116 LHSKGIIHRDIKPDNILL-----DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEV 170
Query: 326 L-HRSYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSDPNFDDLPWPSVS 381
L + YS+ D WS+GV +Y L G RP+ + I +D + + S
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY----PATWS 226
Query: 382 PEAKDFVKRLLNKDYRKRM--TAVQALTHPWL 411
EA D + +LL +D +KR+ HP+
Sbjct: 227 TEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 1e-45
Identities = 88/272 (32%), Positives = 137/272 (50%), Gaps = 22/272 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E K +G G FG R K + A+KI+SKAK+ +E V E +IL+++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSG---KYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H LV + +D +N+Y+VME GGEL L + GR+ E A+ Q++ + +
Sbjct: 60 -HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV-LH 327
H +V+RDLKPEN L S D +++ DFG + + R + G+ Y+APE+ L
Sbjct: 118 HSLDIVYRDLKPENLLLDS---DGYIKITDFGFAKRV--KGRTYTLCGTPEYLAPEIILS 172
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKD 386
+ Y D W++G++ Y +L G PF+ I+ +L F PS SP+AKD
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF-----PSFFSPDAKD 227
Query: 387 FVKRLLNKDYRKRMTAVQALT-----HPWLRD 413
++ LL D KR+ ++ HPW
Sbjct: 228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 89/294 (30%), Positives = 136/294 (46%), Gaps = 43/294 (14%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
YE +++G G +G AR KK + VA+K I I +R E+ +LK L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDNEEEGIPSTALR-EISLLKELK 56
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKAIVVQILSVVA 266
H ++VK D +Y+V E C+ + LD+ R G + K+I+ Q+L +A
Sbjct: 57 -HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDK---RPGPLSPNLIKSIMYQLLRGLA 112
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAPEV 325
+CH ++HRDLKP+N L D ++L DFGL+ P V + +Y APE+
Sbjct: 113 YCHSHRILHRDLKPQNILINR---DGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169
Query: 326 L--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVL-----RSDPNFDD 374
L + YS DIWS+G I ++ G F +E IF+ +L S P
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEESWPGVTK 228
Query: 375 LPW-----------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
LP P + PE D + ++L + KR++A +AL HP+
Sbjct: 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 103/301 (34%), Positives = 145/301 (48%), Gaps = 56/301 (18%)
Query: 149 YELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAI-SIEDVR--REVKIL 204
Y++ K++G G FG AR K GEL VA+K KM S E+ REVK L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGEL----VAIK-----KMKKKFYSWEECMNLREVKSL 51
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILS 263
+ L+ H ++VK + + + +Y V E EG L + R G+ +E ++I+ QIL
Sbjct: 52 RKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAP 323
+A H G HRDLKPEN L + +++ DFGL+ IR D V + +Y AP
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAP 167
Query: 324 EVL--HRSYSLEADIWSIGVIS---YILLCGSRP-FWARTESG-IFR--AVLRSDPNFDD 374
E+L SYS DIW++G I Y L RP F +E +++ +VL + P D
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTL----RPLFPGSSEIDQLYKICSVLGT-PTKQD 222
Query: 375 LP------------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
P P+ SPEA D +K +L D +KR TA QAL HP+
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
Query: 411 L 411
Sbjct: 283 F 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 2e-39
Identities = 100/308 (32%), Positives = 151/308 (49%), Gaps = 60/308 (19%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDV----R--REV 201
+YEL K +G G +G CSA K+ ++VA+K IS +D+ R RE+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNV-------FDDLIDAKRILREI 50
Query: 202 KILKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
K+L+ L H++++ D + ED N+VYIV EL E L +++ T++ +
Sbjct: 51 KLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDHIQY 107
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LN 312
+ QIL + + H V+HRDLKP N L S + D+++ DFGL+ + PDE L
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNS---NCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 313 DIVGSAYYVAPEVL--HRSYSLEADIWSIGVI--------------SYI----LLC---G 349
+ V + +Y APE+L Y+ DIWS+G I YI L+ G
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224
Query: 350 SRP--FWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAV 403
+ S R L+S P P P SPEA D ++++L D +KR+TA
Sbjct: 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD 284
Query: 404 QALTHPWL 411
+AL HP+L
Sbjct: 285 EALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 77/271 (28%), Positives = 136/271 (50%), Gaps = 26/271 (9%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQV--AVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
+G G FG R + ++K + A+K + K + E + E +IL+ + H
Sbjct: 1 LGVGGFG-----RVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPF 54
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+VK +D +Y++ME C GGEL IL G + E A+ + ++ + H +G
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWT-ILRDRGLFDEYTARFYIACVVLAFEYLHNRG 113
Query: 273 VVHRDLKPENFLF-TSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV-LHRSY 330
+++RDLKPEN L ++G ++L+DFG + ++ ++ G+ YVAPE+ L++ Y
Sbjct: 114 IIYRDLKPENLLLDSNGY----VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGY 169
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTES--GIFRAVLRSDPNFDDLPWPS-VSPEAKDF 387
D WS+G++ Y LL G PF E I+ +L+ + L +P+ + AKD
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---GKLEFPNYIDKAAKDL 226
Query: 388 VKRLLNKDYRKRMTAVQA-----LTHPWLRD 413
+K+LL ++ +R+ ++ H W
Sbjct: 227 IKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 92/299 (30%), Positives = 141/299 (47%), Gaps = 43/299 (14%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKAL 207
+E+ K +GRG FG R K QV A+K++ K+ M I VR E IL A
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKD----TGQVYAMKVLRKSDMIKRNQIAHVRAERDIL-AD 57
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ +VK + +D ++Y+VME GG+L+ +L R + EE A+ + +++ +
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEETARFYIAELVLALDS 116
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERL--------------- 311
H G +HRD+KP+N L + D ++L DFGL + +R
Sbjct: 117 VHKLGFIHRDIKPDNILIDA---DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 312 --------------NDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWAR 356
N VG+ Y+APEVL Y LE D WS+GVI Y +L G PF++
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAV-QALTHPWLRDD 414
T + ++ + P P VSPEA D + RLL D R+ + + +HP+ +
Sbjct: 234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 80/272 (29%), Positives = 130/272 (47%), Gaps = 24/272 (8%)
Query: 150 ELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
E K +G+G G R K G++ A+K I + + RE+K L++
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKI----YALKKI-HVDGDEEF-RKQLLRELKTLRS-C 56
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
++VK A + IV+E +GG L +L + G+ E I QIL + +
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILKGLDYL 115
Query: 269 HLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERLNDIVGSAYYVAPEVL 326
H + ++HRD+KP N L S ++++ DFG+S + ++ N VG+ Y++PE +
Sbjct: 116 HTKRHIIHRDIKPSNLLINS---KGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI 172
Query: 327 H-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIF---RAVLRSDPNFDDLPWPS--V 380
SYS ADIWS+G+ G PF + F +A+ P P+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----PSLPAEEF 228
Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
SPE +DF+ L KD +KR +A + L HP+++
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 3e-38
Identities = 84/296 (28%), Positives = 139/296 (46%), Gaps = 49/296 (16%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
+ +EL + +G G +G AR KK Q VA+KI+ E+++ E
Sbjct: 2 PDPTGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMD----IIEDEEEEIKEEYN 54
Query: 203 ILKALSGHKHLVKFCDA--------CEDVNNVYIVMELCEGG---ELLDRILARGGRYTE 251
IL+ S H ++ F A +D +++VMELC GG +L+ + +G R E
Sbjct: 55 ILRKYSNHPNIATFYGAFIKKNPPGNDD--QLWLVMELCGGGSVTDLVKGLRKKGKRLKE 112
Query: 252 EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDER 310
E I+ + L +A+ H V+HRD+K +N L T +A+++L+DFG+S R
Sbjct: 113 EWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGR 169
Query: 311 LNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA 364
N +G+ Y++APEV+ SY +D+WS+G+ + L G P + RA
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHPMRA 226
Query: 365 ---VLRSDPNFDDLPWPSVSPEAK------DFVKRLLNKDYRKRMTAVQALTHPWL 411
+ R+ P P++ DF+ L K+Y +R + L HP++
Sbjct: 227 LFKIPRNPP-------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 92/293 (31%), Positives = 136/293 (46%), Gaps = 40/293 (13%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
Y+ ++G G +G AR K L + VA+K I + I +R E+K+LK L+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDK---LTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELN 56
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H +++K D ++Y+V E + +L I R E K+ + Q+L +AFC
Sbjct: 57 -HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC 114
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVAPEVLH 327
H G++HRDLKPEN L + + ++L DFGL+ R V + +Y APE+L
Sbjct: 115 HSHGILHRDLKPENLLINT---EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL 171
Query: 328 RS--YSLEADIWSIGVISYILLCGSRPFWARTE-----SGIF------------------ 362
YS DIWS+G I LL RP + IF
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230
Query: 363 RAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
R S P +P P+ SP+A D + ++L+ D KR+TA QAL HP+
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 85/287 (29%), Positives = 145/287 (50%), Gaps = 31/287 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ L + +G+G FG A K+ +Q VA+K+I + IED+++E++ L
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQC 56
Query: 208 -SGH--KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
S + K+ F ++I+ME C GG LD L + G+ E I+ ++L
Sbjct: 57 RSPYITKYYGSFLKGS----KLWIIMEYCGGGSCLD--LLKPGKLDETYIAFILREVLLG 110
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAP 323
+ + H +G +HRD+K N L + + D++L DFG+S + + N VG+ +++AP
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSE---EGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAP 167
Query: 324 EVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGI--FRAVL---RSDPNFDDLPW 377
EV+ +S Y +ADIWS+G+ + L G P S + R + +++P L
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPL-----SDLHPMRVLFLIPKNNP--PSLEG 220
Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
S KDFV LNKD ++R +A + L H +++ + L +LI
Sbjct: 221 NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLI 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 88/280 (31%), Positives = 136/280 (48%), Gaps = 32/280 (11%)
Query: 148 KYELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
+++ G ++G G FG +T GEL +AVK I I+++ E+K+L+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNL-DTGEL----MAVKEIRIQDNDPKT-IKEIADEMKVLE 54
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA-KAIVVQILSV 264
L H +LVK+ VYI ME C GG L + L GR +E + +Q+L
Sbjct: 55 LLK-HPNLVKYYGVEVHREKVYIFMEYCSGGTLEE--LLEHGRILDEHVIRVYTLQLLEG 111
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-----RPDERLNDIVGSAY 319
+A+ H G+VHRD+KP N + ++L DFG + + E + + G+
Sbjct: 112 LAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168
Query: 320 YVAPEVLHRS----YSLEADIWSIGVISYILLCGSRPFWARTESG---IFRAVLRSDPNF 372
Y+APEV+ + ADIWS+G + + G RP W+ ++ +F P
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKPPI 227
Query: 373 -DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
D L +SPE KDF+ R L D +KR TA + L HP++
Sbjct: 228 PDSL---QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 78/277 (28%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVK--IISKAKMTTAISIEDVRREVKILK 205
Y+ +++G G G A + ++VA+K + K I E+ I+K
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQNKELII------NEILIMK 70
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
H ++V + D+ + +++VME +GG L D I R E + ++L +
Sbjct: 71 DCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERLNDIVGSAYYVAPE 324
+ H Q V+HRD+K +N L + D ++L DFG + + + + N +VG+ Y++APE
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSK---DGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186
Query: 325 VLHRS-YSLEADIWSIGVISYILLCGSRPF---------WARTESGIFRAVLRSDPNFDD 374
V+ R Y + DIWS+G++ + G P+ + T GI P +
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI--------PPLKN 238
Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
SPE KDF+ + L KD KR +A + L HP+L
Sbjct: 239 P--EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 94/315 (29%), Positives = 145/315 (46%), Gaps = 57/315 (18%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--------TAISIEDVRR 199
+YE GK++G G + AR K+ + VA+K I + TA+ R
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTAL------R 51
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG-ELL--DRILARGGRYTEEDAKA 256
E+K+L+ L H +++ D +N+ +V E E E + D+ + T D K+
Sbjct: 52 EIKLLQELK-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI----VLTPADIKS 106
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIV 315
++ L + + H ++HRDLKP N L S D ++L DFGL+ F P+ ++ V
Sbjct: 107 YMLMTLRGLEYLHSNWILHRDLKPNNLLIAS---DGVLKLADFGLARSFGSPNRKMTHQV 163
Query: 316 GSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTE-----SGIFRA---- 364
+ +Y APE+L R Y + D+WS+G I LL PF IF A
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQLGKIFEALGTP 222
Query: 365 ------VLRSDPN---FDDLP-------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
+ S P+ F P +P+ S +A D ++RLL + KR+TA QAL H
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282
Query: 409 PWLRDDSRPVPLDIL 423
P+ +D P P L
Sbjct: 283 PYFSNDPAPTPPSQL 297
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 14/265 (5%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K + +G FG A+ + A+K++ K+ M + +V+ E I+ +
Sbjct: 2 KPISKGAFGSVYLAKKR---STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+ K + + + +Y+VME GG+ I GG E+ AK + +++ V H +G
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSL 332
++HRD+KPEN L ++L DFGLS R VG+ Y+APE +
Sbjct: 118 IIHRDIKPENLLID---QTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDD 171
Query: 333 EA-DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
+ D WS+G + + L G PF A T +F +L N+ + SPEA D + RL
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231
Query: 392 LNKDYRKRMTA--VQAL-THPWLRD 413
L D KR+ A Q + +HP+ +
Sbjct: 232 LCMDPAKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 89/302 (29%), Positives = 138/302 (45%), Gaps = 53/302 (17%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVR----REVK 202
KYE+ VG G +G R K GE+ VA+K K + EDV+ REVK
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEI----VAIK-----KFKESEDDEDVKKTALREVK 52
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
+L+ L H+++V +A +Y+V E E LL+ + A G + ++ + Q+L
Sbjct: 53 VLRQLR-HENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLL 110
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI--RPDERLNDIVGSAYY 320
+A+CH ++HRD+KPEN L + ++L DFG + + RP L D V + +Y
Sbjct: 111 QAIAYCHSHNIIHRDIKPENILVSE---SGVLKLCDFGFARALRARPASPLTDYVATRWY 167
Query: 321 VAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES-----GIFRA--------- 364
APE+L +Y D+W+IG I LL G P + I +
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226
Query: 365 -VLRSDPNFDDLPWPSVSPE--------------AKDFVKRLLNKDYRKRMTAVQALTHP 409
+ S+P F + +P S A DF+K L D ++R+T + L HP
Sbjct: 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP 286
Query: 410 WL 411
+
Sbjct: 287 YF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 95/278 (34%), Positives = 140/278 (50%), Gaps = 31/278 (11%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAV-KIISKAKMTTAISIEDVRREVKILKA 206
YE+ + +G+G FG R K D ++ V K I MT + V EV IL+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKS----DGKILVWKEIDYGNMTEKEKQQLVS-EVNILRE 55
Query: 207 LSGHKHLVKFCDACEDVNN--VYIVMELCEGGEL--LDRILARGGRYTEEDAK-AIVVQI 261
L H ++V++ D D +N +YIVME CEGG+L L + + +Y EE+ I+ Q+
Sbjct: 56 LK-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 262 LSVVAFCHLQG-----VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIV 315
L + CH + V+HRDLKP N +F ++ +L DFGL+ + D V
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPAN-IFLDANNNV--KLGDFGLAKILGHDSSFAKTYV 171
Query: 316 GSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS---DPN 371
G+ YY++PE L H SY ++DIWS+G + Y L S PF AR + L S +
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----LQLASKIKEGK 226
Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
F +P S E + +K +LN D KR + + L P
Sbjct: 227 FRRIP-YRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 82/294 (27%), Positives = 134/294 (45%), Gaps = 39/294 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+Y++ +G G G A+ ++ + VA+K ++ ++ I RE+K L+A
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEGGIP-NQALREIKALQAC 56
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H ++VK D + +VME +L + + E K+ + +L VA+
Sbjct: 57 Q-HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL--NDIVGSAYYVAPEV 325
H G++HRDLKP N L D +++ DFGL+ +E + V + +Y APE+
Sbjct: 115 MHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171
Query: 326 LH--RSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAV----LRSDPNFDDL 375
L+ R Y D+W++G I LL GS F + + +FR + + P L
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 376 P------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
P +P SPEA D +K LL D KR++A +AL HP+
Sbjct: 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 87/277 (31%), Positives = 133/277 (48%), Gaps = 23/277 (8%)
Query: 154 EVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
+VG+G +G A+ K GE+ VA+K + K+ + + V E IL + +
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEI----VALKRMKKSLLFKLNEVRHVLTERDIL-TTTKSEW 62
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
LVK A +D +Y+ ME GG+ +L G +E+ A+ + ++ V H G
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYS 331
+HRDLKPENFL + ++L DFGLS I N +VGS Y+APEVL + Y
Sbjct: 122 YIHRDLKPENFLIDA---SGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYD 176
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR-----SDPNFDDLPWPSVSPEAKD 386
D WS+G + Y LCG PF T + + + P +DD P ++S EA D
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD-PRFNLSDEAWD 235
Query: 387 FVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDIL 423
+ +L+N R+ + HP+ + V + L
Sbjct: 236 LITKLINDPSRRFGSLEDIKNHPFF----KEVDWNEL 268
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 79/270 (29%), Positives = 137/270 (50%), Gaps = 18/270 (6%)
Query: 148 KYELGKEVGRGHFGHTCSA-RGKKGELKDQQVAVKIISKAK--MTTAISIEDVRREVKIL 204
++ G+ +G G FG G+ AVK +S A T +++ + +E+ +L
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDF----FAVKEVSLADDGQTGQEAVKQLEQEIALL 56
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
L H ++V++ + +N+YI +EL GG L ++L + G + E + QIL
Sbjct: 57 SKLQ-HPNIVQYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILLG 114
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
+ + H + VHRD+K N L + + ++L DFG++ + GS Y++APE
Sbjct: 115 LEYLHDRNTVHRDIKGANILVDT---NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171
Query: 325 VLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVS 381
V+ + Y L ADIWS+G + + + +P W++ E AV + + + P P +S
Sbjct: 172 VIAQQGGYGLAADIWSLGC-TVLEMATGKPPWSQLEG--VAAVFKIGRSKELPPIPDHLS 228
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
EAKDF+ + L +D R TA + L HP++
Sbjct: 229 DEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 79/276 (28%), Positives = 140/276 (50%), Gaps = 37/276 (13%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+++ +++G G +G A K+ Q VA+K++ + ++++ +E+ ILK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKET---GQVVAIKVVP---VEE--DLQEIIKEISILKQ-C 55
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
++VK+ + +++IVME C G + D + TEE+ AI+ Q L + +
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND-------IVGSAYYV 321
H +HRD+K N L ++ +L DFG+S +L D ++G+ +++
Sbjct: 116 HSNKKIHRDIKAGNILLN---EEGQAKLADFGVS------GQLTDTMAKRNTVIGTPFWM 166
Query: 322 APEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL----RSDPNFDDLP 376
APEV+ Y+ +ADIWS+G I+ I + +P ++ RA+ + P D
Sbjct: 167 APEVIQEIGYNNKADIWSLG-ITAIEMAEGKPPYSDIHP--MRAIFMIPNKPPPTLSD-- 221
Query: 377 WPS-VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
P SPE DFVK+ L KD +R +A+Q L HP++
Sbjct: 222 -PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-33
Identities = 74/267 (27%), Positives = 133/267 (49%), Gaps = 16/267 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKAL 207
+E+ ++G+G FG K D++V A+K I +KM E + E ++L L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKA----DKRVYAMKQIDLSKMNRREREEAID-EARVLAKL 56
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVA 266
+++++ ++ D + IVME E G+L + RG E+ +QIL +A
Sbjct: 57 D-SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA 115
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIVGSAYYVAPEV 325
H + ++HRD+K N LF D ++++ D G++ + + N IVG+ YY++PE+
Sbjct: 116 HLHSKKILHRDIKSLN-LFLDAYD--NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
Query: 326 LH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
+ Y+ ++D+W++GV+ Y G PF A + + ++R F + S +
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG--VFPPVSQM-YSQQL 229
Query: 385 KDFVKRLLNKDYRKRMTAVQALTHPWL 411
+ + L KDYR+R Q L +P L
Sbjct: 230 AQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 86/298 (28%), Positives = 130/298 (43%), Gaps = 48/298 (16%)
Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
YE ++G G +G AR KK GEL VA+K I I +R E+K+L+ L
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGEL----VALKKIRMENEKEGFPITAIR-EIKLLQKL 55
Query: 208 SGHKHLVKFCDAC--EDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSV 264
H ++V+ + + ++Y+V E + L +L ++TE K + Q+L
Sbjct: 56 R-HPNIVRLKEIVTSKGKGSIYMVFEYMDHD--LTGLLDSPEVKFTESQIKCYMKQLLEG 112
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI--RPDERLNDIVGSAYYVA 322
+ + H G++HRD+K N L +D ++L DFGL+ R + V + +Y
Sbjct: 113 LQYLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169
Query: 323 PEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSD-----PN 371
PE+L Y E D+WS+G I L G F TE IF + S P
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE-LCGSPTDENWPG 228
Query: 372 FDDLPW----------PSV---------SPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
LPW P A D + +LL D +KR++A QAL H +
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 85/297 (28%), Positives = 131/297 (44%), Gaps = 47/297 (15%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G+G G R K A+K++ K +M ++ V E +IL A H
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKL---FALKVLDKKEMIKRNKVKRVLTEQEIL-ATLDHPF 62
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHL 270
L + + + +VM+ C GGEL R+L R G +EE A+ ++L + + HL
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELF-RLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS---------------------------- 302
G+V+RDLKPEN L + + L DF LS
Sbjct: 122 LGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 303 DFIR--PDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTES 359
+ P R N VG+ Y+APEV+ + D W++G++ Y +L G+ PF
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238
Query: 360 GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRM----TAVQALTHPWLR 412
F +L+ + F P VS A+D +++LL KD KR+ A + HP+ R
Sbjct: 239 ETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 87/276 (31%), Positives = 132/276 (47%), Gaps = 32/276 (11%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
YEL + +G G +G AR GEL VA+K+I K+ E +++E+ +LK
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGEL----VAIKVI---KLEPGDDFEIIQQEISMLKE 56
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV-VQILSVV 265
H ++V + + + ++IVME C GG L D I E A V + L +
Sbjct: 57 CR-HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGL 114
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERLNDIVGSAYYVAPE 324
A+ H G +HRD+K N L T +D D++L DFG+S + + +G+ Y++APE
Sbjct: 115 AYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPE 171
Query: 325 VL----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP---- 376
V Y + DIW++G I+ I L +P + RA+ + P
Sbjct: 172 VAAVERKGGYDGKCDIWALG-ITAIELAELQP--PMFDLHPMRALFLISKSNFPPPKLKD 228
Query: 377 ---WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
W SP DF+K+ L KD +KR TA + L HP
Sbjct: 229 KEKW---SPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 78/282 (27%), Positives = 129/282 (45%), Gaps = 40/282 (14%)
Query: 149 YELGKEVGRGH----FGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
YEL + +G G + C +K VA+K I K T S++++R+EV+ +
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEK-------VAIKRIDLEKCQT--SVDELRKEVQAM 53
Query: 205 KALSGHKHLVK-FCDACEDVNNVYIVMELCEGGELLD---RILARGGRYTEEDAKAIVV- 259
+ H ++VK + + +++VM GG LLD RGG +E A V+
Sbjct: 54 -SQCNHPNVVKYYTSFVVG-DELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLK 109
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-----RPDERLNDI 314
++L + + H G +HRD+K N L +D +++ DFG+S + R +
Sbjct: 110 EVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTRKVRKTF 166
Query: 315 VGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-- 370
VG+ ++APEV+ Y +ADIWS G+ + L G+ P+ + L++DP
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPS 226
Query: 371 ---NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
D + S + + L KD KR TA + L H
Sbjct: 227 LETGADYKKY---SKSFRKMISLCLQKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 76/268 (28%), Positives = 130/268 (48%), Gaps = 20/268 (7%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G+G FG A K D+ AVK++ K + +E E ++L H
Sbjct: 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
L + + + ++ VME GG+L+ I R GR+ E A+ +I+ + F H +G
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERG 116
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL-HRSY 330
+++RDLK +N L S + +++ DFG+ + I + G+ Y+APE+L ++ Y
Sbjct: 117 IIYRDLKLDNVLLDS---EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEAKDFVK 389
D W++GV+ Y +L G PF E +F+++L + + P +S EAK +K
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY-----PRWLSKEAKSILK 228
Query: 390 RLLNKDYRKRMTAVQA-----LTHPWLR 412
L K+ KR+ + HP+ R
Sbjct: 229 SFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 83/266 (31%), Positives = 139/266 (52%), Gaps = 22/266 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-AISIEDVRREVKILKAL 207
+EL + +G G +G R G + A+K++ KA + A + E R E ++L+A+
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
LV A + ++++++ GGEL + R +TE + + + +I V+A
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEI--VLAL 118
Query: 268 CHLQ--GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAP 323
HL G+++RD+K EN L S + + L DFGLS +E R G+ Y+AP
Sbjct: 119 DHLHQLGIIYRDIKLENILLDS---EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 324 EVLHR---SYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSDPNFDDLP 376
EV+ + D WS+GV+++ LL G+ PF ++S I R +L+S P F
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP--- 232
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTA 402
++S EA+DF+++LL KD +KR+ A
Sbjct: 233 -KTMSAEARDFIQKLLEKDPKKRLGA 257
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 91/288 (31%), Positives = 138/288 (47%), Gaps = 28/288 (9%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E+ E+G G FG A+ K+ A KII ++ + +ED E+ IL
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKE---TGLFAAAKII---QIESEEELEDFMVEIDILSECK 60
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H ++V +A N ++I++E C+GG L +L TE + + Q+L + F
Sbjct: 61 -HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL- 326
H V+HRDLK N L T D D++L DFG+S ++ + +G+ Y++APEV+
Sbjct: 120 HSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176
Query: 327 -----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA---VLRSDPNFDDLP-- 376
Y +ADIWS+G I+ I L P E R +L+S+P D P
Sbjct: 177 CETFKDNPYDYKADIWSLG-ITLIELAQMEP--PHHELNPMRVLLKILKSEPPTLDQPSK 233
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
W S DF+K L KD R TA + L HP++ D S + L+
Sbjct: 234 W---SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLL 278
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
LGK++G G FG + KG K +VAVK + + I E+ RE +I++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLD 59
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H ++VK C + +YIVME EGG+LL + + + D + +QI + +
Sbjct: 60 -HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
+ +HRDL N L +++ DFGLS + D+ YY
Sbjct: 119 ESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLYDDD---------YYRKRGGKLP 166
Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFW 354
APE L ++ ++D+WS GV+ + I G +P+
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP 205
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 90/287 (31%), Positives = 141/287 (49%), Gaps = 27/287 (9%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS---IEDVRREVKILK 205
+E+ E+G G FG A+ K+ +++ AK+ S +ED E+ IL
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDIL- 56
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
A H ++VK DA NN++I++E C GG + +L TE + + Q L +
Sbjct: 57 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEAL 116
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPE 324
+ H ++HRDLK N LFT D D++L DFG+S R +R + +G+ Y++APE
Sbjct: 117 NYLHENKIIHRDLKAGNILFTL---DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 173
Query: 325 VL------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
V+ R Y +AD+WS+G+ + P + + +S+P L P
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--PTLAQP 231
Query: 379 SV-SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
S S E KDF+K+ L K+ R T Q L HP++ +S P+ LI
Sbjct: 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK-PIRELI 277
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 89/302 (29%), Positives = 148/302 (49%), Gaps = 47/302 (15%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
YEL KE+G+G +G CSAR +++ VA+K I+ + I + RE+K+L+
Sbjct: 2 YELIKELGQGAYGIVCSAR-NAETSEEETVAIKKITNV-FSKKILAKRALRELKLLRHFR 59
Query: 209 GHKHLVKFCDA----CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
GHK++ D + N +Y+ EL E L +I+ G T+ ++ + QIL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQILCG 117
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-----DFIRPDERLNDIVGSAY 319
+ + H V+HRDLKP N L + D ++++ DFGL+ + + + V + +
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 320 YVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW----------------------- 354
Y APE++ +SY+ D+WS+G I LL G +P +
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVLGTPDEET 233
Query: 355 -ARTESGIFRAVLRSDPNFDDLPWPSV----SPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
+R S + +RS PN P+ S+ +P A D +++LL D KR++ +AL HP
Sbjct: 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293
Query: 410 WL 411
+L
Sbjct: 294 YL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 150 ELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
LGK++G G FG K KG+ K+ +VAVK + + I E+ RE +I++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLD 59
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAF 267
H ++VK C + + IVME GG+LLD + + + D + +QI + +
Sbjct: 60 -HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------ 321
+ +HRDL N L +++ DFGLS + D+ YY
Sbjct: 119 LESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLYDDD---------YYKVKGGKL 166
Query: 322 -----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFW 354
APE L ++ ++D+WS GV+ + I G P+
Sbjct: 167 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP 206
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 85/303 (28%), Positives = 146/303 (48%), Gaps = 52/303 (17%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
+Y+ VG G +G CSA K K VA+K +S+ +AI + RE+++LK
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRK---VAIKKLSRP-FQSAIHAKRTYRELRLLKH 70
Query: 207 LSGHKHLVKFCDA------CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
+ H++++ D ED +VY+V L G L+ I+ + + +++ + +V Q
Sbjct: 71 MD-HENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIV-KCQKLSDDHIQFLVYQ 126
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERLNDIVGSAY 319
IL + + H G++HRDLKP N +D +++++DFGL+ R D+ + V + +
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFGLA---RHTDDEMTGYVATRW 180
Query: 320 YVAPEVLH--RSYSLEADIWSIGVISYILLCG-----------------------SRPFW 354
Y APE++ Y+ DIWS+G I LL G
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240
Query: 355 ARTESGIFRAVLRSDP-----NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
+ S R ++S P +F ++ + +P A D ++++L D KR+TA +AL HP
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299
Query: 410 WLR 412
+L
Sbjct: 300 YLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 80/262 (30%), Positives = 131/262 (50%), Gaps = 15/262 (5%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
++G G G C A K +QVAVK K + E + EV I++ H +
Sbjct: 25 VKIGEGSTGIVCIATDKS---TGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQ-HPN 77
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+V+ + + +++VME EGG L D + R EE + + +L ++F H QG
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG 135
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHRS-Y 330
V+HRD+K ++ L TS D ++L DFG + + R +VG+ Y++APEV+ R Y
Sbjct: 136 VIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
E DIWS+G++ ++ G P++ + + + P VSP + F+ R
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-HKVSPRLRSFLDR 251
Query: 391 LLNKDYRKRMTAVQALTHPWLR 412
+L +D +R TA + L HP+L
Sbjct: 252 MLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 88/306 (28%), Positives = 140/306 (45%), Gaps = 50/306 (16%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
G++Y+ + +G G +G CSA + ++VA+K I A + RE+KIL
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHA-FDVPTLAKRTLRELKIL 58
Query: 205 KALSGHKHLVKFCD----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
+ H +++ D D +VY+VM+L E L I+ TEE + + Q
Sbjct: 59 RHFK-HDNIIAIRDILRPPGADFKDVYVVMDLMESD--LHHIIHSDQPLTEEHIRYFLYQ 115
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI--RPDER---LNDIV 315
+L + + H V+HRDLKP N L D ++R+ DFG++ + P E + + V
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNE---DCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 316 GSAYYVAPE---VLHRSYSLEADIWSIGVI--------------SY-------ILLCGSR 351
+ +Y APE L Y+ D+WS+G I +Y + + GS
Sbjct: 173 ATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231
Query: 352 P--FWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
R S R +++ P +PW P SPEA D + ++L D +R+T QA
Sbjct: 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA 291
Query: 406 LTHPWL 411
L HP+L
Sbjct: 292 LQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 74/274 (27%), Positives = 128/274 (46%), Gaps = 22/274 (8%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
E K VG G FG R + E A+K+++ ++ + V E ++LK
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISE---HYYALKVMAIPEVIRLKQEQHVHNEKRVLKE 57
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
+S H +++ D +Y++ME GGEL + G R++ +I+ +
Sbjct: 58 VS-HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALE 115
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
+ H + +V+RDLKPEN L + ++L DFG + +R +R + G+ Y+APEV+
Sbjct: 116 YLHSKEIVYRDLKPENILLDK---EGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVI 170
Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEA 384
++ D W++G++ Y +L G PF+ GI+ +L L +P + A
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-----KLEFPRHLDLYA 225
Query: 385 KDFVKRLLNKDYRKRM-----TAVQALTHPWLRD 413
KD +K+LL D +R+ A H W +
Sbjct: 226 KDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-31
Identities = 89/290 (30%), Positives = 141/290 (48%), Gaps = 45/290 (15%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
+ VG G FG CSAR +L Q VA+K I K T ++ + RE+K+LK L H++
Sbjct: 16 QPVGMGAFGLVCSARD---QLTGQNVAIKKIMKPFSTPVLA-KRTYRELKLLKHLR-HEN 70
Query: 213 LVKFCDA-CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
++ D + ++Y V EL G L R+L ++ + + QIL + + H
Sbjct: 71 IISLSDIFISPLEDIYFVTELL--GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERLNDIVGSAYYVAPEVL--HR 328
GVVHRDLKP N L ++ D+++ DFGL+ R D ++ V + YY APE++ +
Sbjct: 128 GVVHRDLKPSNILIN---ENCDLKICDFGLA---RIQDPQMTGYVSTRYYRAPEIMLTWQ 181
Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL---------------------- 366
Y +E DIWS G I +L G F + F +
Sbjct: 182 KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241
Query: 367 -RSDPNFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
+S P + +P + + P A D ++++L D +KR++A +AL HP+L
Sbjct: 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 85/285 (29%), Positives = 150/285 (52%), Gaps = 29/285 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ EL +GRG +G RGK + VA+KII+ T + D++REV +L L
Sbjct: 5 RLEL---IGRGAYGAV--YRGKHVPTG-RVVALKIINLD--TPDDDVSDIQREVALLSQL 56
Query: 208 --SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
S ++ K+ + ++I+ME EGG + R L + G E+ I+ ++L +
Sbjct: 57 RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVAL 114
Query: 266 AFCHLQGVVHRDLKPENFLFT-SGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAP 323
+ H GV+HRD+K N L T +G ++L DFG++ + + + VG+ Y++AP
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGN----VKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170
Query: 324 EVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL---RSDPNFDDLPWP 378
EV+ + Y +ADIWS+G+ Y + G+ P+ ++ FRA++ +S P L
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKP--PRLEDN 225
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDIL 423
S ++FV L+++ ++R++A + L W++ S+ P+ IL
Sbjct: 226 GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK-TPVSIL 269
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 150 ELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
ELGK++G G FG K GE + +VAVK + + + E+ E I+K LS
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASIMKKLS 59
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H ++V+ C +YIV E GG+LLD + G + T +D + +QI + +
Sbjct: 60 -HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
+ VHRDL N L T +++ DFGLS I D+ YY
Sbjct: 119 ESKNFVHRDLAARNCLVTENL---VVKISDFGLSRDIYEDD---------YYRKRGGGKL 166
Query: 322 -----APEVL-HRSYSLEADIWSIGV 341
APE L ++ ++D+WS GV
Sbjct: 167 PIKWMAPESLKDGKFTSKSDVWSFGV 192
|
Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 83/269 (30%), Positives = 132/269 (49%), Gaps = 25/269 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
E+G G+ G + ++ AVK I + ++ AI + + RE+ IL
Sbjct: 7 GELGAGNSGVVSKVLHRP----TGKIMAVKTI-RLEINEAI-QKQILRELDILHK-CNSP 59
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHL 270
++V F A + ++ I ME +GG L D+IL GR E I V +L + + H
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 271 Q-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-R 328
+ ++HRD+KP N L S ++L DFG+S + + VG++ Y+APE +
Sbjct: 119 KHKIIHRDVKPSNILVNS---RGQIKLCDFGVSGQL-VNSLAKTFVGTSSYMAPERIQGN 174
Query: 329 SYSLEADIWSIGVISYILLCGSR---PFWARTESGIF---RAVLRSDPNFDDLPWPSVSP 382
YS+++DIWS+G +S I L R P GIF + ++ P LP SP
Sbjct: 175 DYSVKSDIWSLG-LSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--PRLPSGKFSP 231
Query: 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
+ +DFV L KD R+R + + L HP++
Sbjct: 232 DFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 83/272 (30%), Positives = 140/272 (51%), Gaps = 18/272 (6%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
++G G G C AR K +QVAVK++ K E + EV I++ H+++
Sbjct: 28 KIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ-HQNV 80
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
V+ + ++++ME +GG L D + R EE + +L + + H QGV
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTD--IVSQTRLNEEQIATVCESVLQALCYLHSQGV 138
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHRS-YS 331
+HRD+K ++ L T D ++L DFG I D + +VG+ Y++APEV+ R+ Y
Sbjct: 139 IHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
E DIWS+G++ ++ G P+++ + + LR P +SP +DF++R+
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNAHKISPVLRDFLERM 254
Query: 392 LNKDYRKRMTAVQALTHPWLRDDSRP---VPL 420
L ++ ++R TA + L HP+L P VPL
Sbjct: 255 LTREPQERATAQELLDHPFLLQTGLPECLVPL 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 79/263 (30%), Positives = 134/263 (50%), Gaps = 20/263 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKAL 207
+EL K +G G +G R G + A+K++ KA + A + E R E ++L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
LV A + ++++++ GGEL + R R+ E++ + +I+ +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEH 120
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD--ERLNDIVGSAYYVAPEV 325
H G+++RD+K EN L S + + L DFGLS D ER G+ Y+AP++
Sbjct: 121 LHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 326 LH---RSYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSDPNFDDLPWP 378
+ + D WS+GV+ Y LL G+ PF +++ I R +L+S+P P+P
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-----PYP 232
Query: 379 S-VSPEAKDFVKRLLNKDYRKRM 400
+S AKD ++RLL KD +KR+
Sbjct: 233 QEMSALAKDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 28/272 (10%)
Query: 148 KYELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR----EV 201
KYE + VGRG FG H C + + + V +K I +MT +D R E
Sbjct: 1 KYEKIRVVGRGAFGIVHLC-----RRKADQKLVIIKQIPVEQMT-----KDERLAAQNEC 50
Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA-KAIVVQ 260
++LK LS H +++++ + + + IVME GG L + I R +ED VQ
Sbjct: 51 QVLKLLS-HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQ 109
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
IL + H + ++HRDLK +N L + +++ DFG+S + + +VG+ Y
Sbjct: 110 ILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPCY 167
Query: 321 VAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS--DPNFDDLPW 377
++PE+ + Y+ ++DIW++G + Y L R F A + ++ P D
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---- 223
Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
SP+ + + +LN D KR Q + P
Sbjct: 224 -RYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 90/289 (31%), Positives = 142/289 (49%), Gaps = 30/289 (10%)
Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+E+ E+G G FG A+ K+ G L A K+I + + +ED E++IL A
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGAL----AAAKVI---ETKSEEELEDYMVEIEIL-AT 65
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H ++VK A ++I++E C GG + +L TE + I Q+L + +
Sbjct: 66 CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL 326
H ++HRDLK N L T D D++L DFG+S ++ +R + +G+ Y++APEV+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTL---DGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 327 ------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL---RSDPNFDDLP- 376
Y +ADIWS+G I+ I + P E R +L +S+P P
Sbjct: 183 MCETMKDTPYDYKADIWSLG-ITLIEMAQIEP--PHHELNPMRVLLKIAKSEPPTLSQPS 239
Query: 377 -WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
W S E +DF+K L+K R +A Q L HP++ + PL L+
Sbjct: 240 KW---SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELV 285
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 85/306 (27%), Positives = 135/306 (44%), Gaps = 62/306 (20%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQ-VAVKIISKAKMTTAISIED------VRREV 201
YE E+G G +G AR +L + VA+K + + + + RE+
Sbjct: 1 YEELAEIGEGAYGTVYKAR----DLNTGRFVALKKVR-------VPLSEEGIPLSTLREI 49
Query: 202 KILKAL--SGHKHLVKFCDACEDVNN-----VYIVMELCEG--GELLDRILARGGRYTEE 252
+LK L H ++V+ D C + +V E + L + G E
Sbjct: 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPE 107
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
K ++ Q+L V F H +VHRDLKP+N L TS D +++ DFGL+ + L
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS---DGQVKIADFGLARIYSFEMALT 164
Query: 313 DIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRP-FWARTESG----IFRAVL 366
+V + +Y APEVL +S Y+ D+WS+G I L RP F +E+ IF +
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEADQLDKIFDVIG 223
Query: 367 RSDPNFDD------LPW---------------PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
P+ ++ LP P + E D +K++L + KR++A +A
Sbjct: 224 L--PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281
Query: 406 LTHPWL 411
L HP+
Sbjct: 282 LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 71/240 (29%), Positives = 119/240 (49%), Gaps = 35/240 (14%)
Query: 199 REVKILKALSGHKHLVKFCDAC--EDVNNVYIVMELCEGGEL---LDRILARGGRYTEED 253
RE++I K+ ++VK+ A E +++ I ME CEGG L ++ RGGR E+
Sbjct: 48 RELEINKSCK-SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
I +L +++ H + ++HRD+KP N L T ++L DFG+S E +N
Sbjct: 107 LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR---KGQVKLCDFGVS-----GELVNS 158
Query: 314 I----VGSAYYVAPE-VLHRSYSLEADIWSIGVISYILLCGSRPFWARTE---------- 358
+ G+++Y+APE + + YS+ +D+WS+G+ + PF E
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218
Query: 359 --SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416
+ L+ +P + + W S E KDF+K+ L KD +R T L HPW++ +
Sbjct: 219 YIVNMPNPELKDEPG-NGIKW---SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 76/268 (28%), Positives = 132/268 (49%), Gaps = 21/268 (7%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G+G FG AR K+ + AVK++ K + +E E +IL H L
Sbjct: 3 LGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
+ + + ++ VME GG+L+ I + R+ E A+ +I S + F H +G++
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFLHDKGII 118
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS-YSL 332
+RDLK +N L + +L DFG+ + I + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLLDH---EGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKRL 391
D W++GV+ Y +LCG PF A E +F A+L D++ +P+ +S +A D +K
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVYPTWLSQDAVDILKAF 230
Query: 392 LNKDYRKRMTAVQ------ALTHPWLRD 413
+ K+ R+ ++ L HP+ ++
Sbjct: 231 MTKNPTMRLGSLTLGGEEAILRHPFFKE 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 76/266 (28%), Positives = 131/266 (49%), Gaps = 14/266 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
Y + +G+G FG R + D V K ++ +++ D E+ IL L
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTE---DDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQ 57
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAF 267
H +++ + + D N + I ME GG L D+I+ + G+ + EE + QI+S V++
Sbjct: 58 -HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND-IVGSAYYVAPEVL 326
H G++HRD+K N T + ++L DFG+S + + + + +VG+ YY++PE+
Sbjct: 117 IHKAGILHRDIKTLNIFLT--KAGL-IKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173
Query: 327 H-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
Y+ ++DIW++G + Y LL R F A + +++ N+ + S E
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYTPVVSV-YSSELI 230
Query: 386 DFVKRLLNKDYRKRMTAVQALTHPWL 411
V LL +D KR TA + L P L
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 73/267 (27%), Positives = 138/267 (51%), Gaps = 14/267 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
KY K++G G FG + K+ +Q +K I+ +KM+ E+ R+EV +L +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMSPK-EREESRKEVAVLSNM 56
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVA 266
H ++V++ ++ E+ N+YIVM+ CEGG+L +I A RG + E+ VQI +
Sbjct: 57 K-HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIVGSAYYVAPEV 325
H + ++HRD+K +N T D ++L DFG++ + L +G+ YY++PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTK---DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172
Query: 326 L-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
+R Y+ ++DIW++G + Y + F A + ++R ++ + S +
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYPPVS-SHYSYDL 229
Query: 385 KDFVKRLLNKDYRKRMTAVQALTHPWL 411
++ V +L ++ R R + L ++
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 22/271 (8%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G+G FG A KG D+ A+K++ K + ++ E +IL + H
Sbjct: 1 KVLGKGSFGKVMLAE-LKG--TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
L + + ++ VME GG+L+ +I R ++ E ++ ++ + F H G
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQI-QRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHR-SY 330
V++RDLK +N L + + +L DFG+ + I G+ Y+APE+L Y
Sbjct: 117 VIYRDLKLDNILLDA---EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVK 389
D W++GV+ Y ++ G PF A E +F ++L DD+ +P +S EA +K
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-----DDVLYPVWLSKEAVSILK 228
Query: 390 RLLNKDYRKRMTAVQA-------LTHPWLRD 413
+ K+ KR+ V + HP+ ++
Sbjct: 229 AFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 84/293 (28%), Positives = 140/293 (47%), Gaps = 28/293 (9%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL--KALSGHKH 212
+G+G FG R K + A+K++SK ++ + E IL L
Sbjct: 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPF 57
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+V + + +++Y+V + GGEL L + GR++E+ AK + +++ + H
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWH-LQKEGRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDF-IRPDERLNDIVGSAYYVAPEVL--HRS 329
+V+RDLKPEN L + + L DFGLS + ++ N G+ Y+APEVL +
Sbjct: 117 IVYRDLKPENILLDA---TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 330 YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389
Y+ D WS+GV+ + + CG PF+A ++R + F P +S E + FVK
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVK 230
Query: 390 RLLNKDYRKRMTAVQALT----HPWLRDDSRPVPLDILIFKLVKSYLHATPFK 438
LLN++ + R+ A + HP+ D + D+L K + PFK
Sbjct: 231 GLLNRNPQHRLGAHRDAVELKEHPFFAD----IDWDLLSKKQITP-----PFK 274
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 82/270 (30%), Positives = 132/270 (48%), Gaps = 21/270 (7%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-TTAISIEDVRREVKILKALSGHK 211
K +G+G +G R G + A+K++ KA + + E IL+A+ H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
+V A + +Y+++E GGEL L R G + E+ A + +I + H Q
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMH-LEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS- 329
G+++RDLKPEN L + ++L DFGL + I + G+ Y+APE+L RS
Sbjct: 120 GIIYRDLKPENILLDA---QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG 176
Query: 330 YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389
+ D WS+G + Y +L G+ PF A +L+ N LP P ++PEA+D +K
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN---LP-PYLTPEARDLLK 232
Query: 390 RLLNKDYRKRM-------TAVQALTHPWLR 412
+LL ++ R+ VQ+ HP+ R
Sbjct: 233 KLLKRNPSSRLGAGPGDAAEVQS--HPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 87/309 (28%), Positives = 143/309 (46%), Gaps = 56/309 (18%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR--REV 201
+ G +Y+ +G G +G CSA K +VA+K IS + T R RE+
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHK---PTGVKVAIKKISPFEHQTFC----QRTLREI 54
Query: 202 KILKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
KIL+ H++++ D + E N+VYIV EL E L +++ + + + +
Sbjct: 55 KILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLI-KTQHLSNDHIQY 110
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LN 312
+ QIL + + H V+HRDLKP N L + + D+++ DFGL+ P+ L
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFGLARIADPEHDHTGFLT 167
Query: 313 DIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW---------------- 354
+ V + +Y APE++ + Y+ DIWS+G I +L RP +
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGKDYLHQLNLILGVL 226
Query: 355 --------ARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTA 402
S R ++S P +PW P+ P+A D + ++L + KR+T
Sbjct: 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV 286
Query: 403 VQALTHPWL 411
+AL HP+L
Sbjct: 287 EEALAHPYL 295
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 74/259 (28%), Positives = 130/259 (50%), Gaps = 15/259 (5%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
+ +E+G+ +G G FG A+ K + A+K + K ++ ++ V +E IL
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTG---EYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
LS H +V + +D N VY ++E GGEL L + GR+ + AK +++
Sbjct: 75 LS-HPFIVNMMCSFQDENRVYFLLEFVVGGELFTH-LRKAGRFPNDVAKFYHAELVLAFE 132
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
+ H + +++RDLKPEN L + +++ DFG + + +R + G+ Y+APEV+
Sbjct: 133 YLHSKDIIYRDLKPENLLLDN---KGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI 187
Query: 327 H-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
+ + D W++GV+ Y + G PF+ T I+ +L F + W A+
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRAR 243
Query: 386 DFVKRLLNKDYRKRMTAVQ 404
D VK LL D+ KR+ ++
Sbjct: 244 DLVKGLLQTDHTKRLGTLK 262
|
Length = 329 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 80/275 (29%), Positives = 134/275 (48%), Gaps = 25/275 (9%)
Query: 152 GKEVGRGHFGHTCSA-RGKKGEL---KDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
G+ +G+G +G A GE+ K ++ I + ++ +R E++ LK L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 208 SGHKHLVKFCDACEDVNNVY-IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
H ++V+ E I +E GG + L GR+ E+ + Q+L +A
Sbjct: 66 D-HLNIVQ-YLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEGLA 122
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGL---SDFIRPDERLNDIVGSAYYV 321
+ H +G++HRDLK +N L DAD ++ DFG+ SD I +++ + GS +++
Sbjct: 123 YLHSKGILHRDLKADNLLV-----DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 322 APEVLH---RSYSLEADIWSIGVISYILLCGSRPFWARTES--GIFR-AVLRSDPNFDDL 375
APEV+H + YS + DIWS+G + + G RP W+ E+ +F+ RS P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPPIPPD 236
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
++SP A DF+ + R TA + L HP+
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 84/278 (30%), Positives = 133/278 (47%), Gaps = 35/278 (12%)
Query: 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKII---SKAKMTTAISIEDVRREVKILKALS 208
G+ +G+G +G +G+L +AVK + + + E ++ EV +LK+L
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQL----IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H ++V++ C D N + I ME GG + IL R G E QIL VA+
Sbjct: 61 -HVNIVQYLGTCLDDNTISIFMEFVPGGSI-SSILNRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-------RPDERLNDIVGSAYYV 321
H VVHRD+K N + + ++LIDFG + + L + G+ Y++
Sbjct: 119 HNNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 322 APEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTE--SGIF-----RAVLRSDPNFD 373
APEV++ S Y ++DIWSIG + + G +P A + + +F R ++ P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATG-KPPLASMDRLAAMFYIGAHRGLM---PRLP 231
Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
D S S A DFV L +D +R +A+Q L H +L
Sbjct: 232 D----SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 58/237 (24%), Positives = 106/237 (44%), Gaps = 41/237 (17%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K++G G FG + K + K +VAVK + + + +D +E +++K L GH +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKL-GHPN 57
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC---- 268
+V+ C + +Y+V+E EGG+LLD + + + + ++ L ++F
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL--LSFAIQIA 115
Query: 269 ----HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV- 321
+L + VHRDL N L +++ DFGLS + D+ YY
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDL---VVKISDFGLSRDVYDDD---------YYRK 163
Query: 322 -----------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
APE L ++ ++D+WS GV+ + I G+ P+ + + +
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 83/264 (31%), Positives = 134/264 (50%), Gaps = 17/264 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+Y + + VG G FG A + DQ+ A+K I K ++A+ ED R+E +L +
Sbjct: 1 QYNVLRVVGEGSFGR---ALLVQHVNSDQKYAMKEIRLPKSSSAV--EDSRKEAVLLAKM 55
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-LARGGRYTEEDAKAIVVQILSVVA 266
H ++V F ++ E ++YIVME C+GG+L+ +I L RG + E+ VQ+ V
Sbjct: 56 K-HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERLNDIVGSAYYVAPEV 325
H + V+HRD+K +N T + ++L DFG + + P VG+ YYV PE+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQ---NGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
Query: 326 LHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPE 383
Y+ ++DIWS+G I Y L PF A + + V + P PS S E
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----PLPSHYSYE 227
Query: 384 AKDFVKRLLNKDYRKRMTAVQALT 407
+ +K++ ++ R R +A L+
Sbjct: 228 LRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 73/260 (28%), Positives = 131/260 (50%), Gaps = 20/260 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+++ K++G+G F A L + VA+K + +M A + +D +E+ +LK L
Sbjct: 4 FKIEKKIGKGQFSVVYKAICL---LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI--LARGGRYTEEDAKAI---VVQILS 263
H +++K+ + + N + IV+EL + G+L I + R E + I VQ+ S
Sbjct: 61 -HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE--RTIWKYFVQLCS 117
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVA 322
+ H + ++HRD+KP N T+ ++L D GL F + +VG+ YY++
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
Query: 323 PEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTES--GIFRAVLRSDPNFDDLPWPS 379
PE +H + Y+ ++DIWS+G + Y + PF+ + + + + + D + LP
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPLPADH 232
Query: 380 VSPEAKDFVKRLLNKDYRKR 399
S E +D V R +N D KR
Sbjct: 233 YSEELRDLVSRCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 35/277 (12%)
Query: 149 YELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
+ GK +G+G FG + C EL +QV S T + + E+++LK
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP---ETKKEVNALECEIQLLKN 60
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
L H+ +V++ D + I ME GG + D++ A G TE + QIL V
Sbjct: 61 LQ-HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVE 118
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFIRPDERLNDI----------V 315
+ H +VHRD+K N L RD A +++L DFG S +RL I
Sbjct: 119 YLHSNMIVHRDIKGANIL----RDSAGNVKLGDFGAS------KRLQTICSSGTGMKSVT 168
Query: 316 GSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNF 372
G+ Y+++PEV+ Y +AD+WS+G +L +P WA E + IF+ + + P
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIFK--IATQPTN 225
Query: 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
LP VSP+A++F++R ++ +KR +A + L H
Sbjct: 226 PQLP-SHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 81/277 (29%), Positives = 139/277 (50%), Gaps = 31/277 (11%)
Query: 152 GKEVGRGHFGHT-CSARGKKGELKD-QQVAVKIIS-KAKMTTAISIEDVRREVKILKALS 208
G +G G FG GEL +QV + +S +K ++ + RE+ +LK L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H+++V++ + D +++ I +E GG + +L G + E + V QIL + +
Sbjct: 65 -HENIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQILKGLNYL 122
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI------------RPDERLNDIVG 316
H +G++HRD+K N L + +++ DFG+S + RP + G
Sbjct: 123 HNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP-----SLQG 174
Query: 317 SAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSDPNFDD 374
S +++APEV+ + SY+ +ADIWS+G + +L G PF T+ IF+ + P
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPS 234
Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
++S EA DF+++ D+ KR TA + L HP+L
Sbjct: 235 ----NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 79/279 (28%), Positives = 140/279 (50%), Gaps = 22/279 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-AISIEDVRREVKILKAL 207
+EL K +G G +G R G + A+K++ KA + A ++E R E +L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
LV A + ++++++ GGE+ + R ++E++ + +I+ +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEH 120
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPD-ERLNDIVGSAYYVAPEV 325
H G+V+RD+K EN L S + + L DFGLS +F+ + ER G+ Y+APE+
Sbjct: 121 LHKLGIVYRDIKLENILLDS---EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 326 LH--RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLRSDPNFDDLPWPS 379
+ + D WS+G++ + LL G+ PF T+S + R +L+ DP F
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----SF 233
Query: 380 VSPEAKDFVKRLLNKDYRKRM-----TAVQALTHPWLRD 413
+ PEA+D + +LL KD +KR+ A + HP+ +
Sbjct: 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 87/284 (30%), Positives = 136/284 (47%), Gaps = 38/284 (13%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E+ + +G+G +G KK + AVKI+ E++ E ILKALS
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIHDID----EEIEAEYNILKALS 72
Query: 209 GHKHLVKFCDAC--EDVNN---VYIVMELCEGGELLDRI---LARGGRYTEEDAKAIVVQ 260
H ++VKF +DV N +++V+ELC GG + D + L RG R E I+ +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAY 319
L + H+ +HRD+K N L T+ ++L+DFG+S R N VG+ +
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189
Query: 320 YVAPEV------LHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373
++APEV L +Y D+WS+G+ + L G P + RA+ + N
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRN-- 244
Query: 374 DLPWPSV------SPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
P P++ S E DF+++ L KDY KR T L H ++
Sbjct: 245 --PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 13/217 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKG-----ELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
Y + + +G G FG R K LK+ V K K SI D+ EV I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEG---GELLDRILARGGRYTEEDAKAIVVQ 260
+K H ++V++ + + +YIVM+L EG GE + + + R+TEE I VQ
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 261 ILSVVAFCHLQG-VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
++ + + H + +VHRDL P N + +D + + DFGL+ +P+ +L +VG+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQKQPESKLTSVVGTIL 178
Query: 320 YVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWA 355
Y PE++ + Y +AD+W+ G I Y + PF++
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 88/307 (28%), Positives = 141/307 (45%), Gaps = 55/307 (17%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKILK 205
KYE+ +++G+G +G A ++ + VA+K I A T A + RE+ L+
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAFRNATDA---QRTFREIMFLQ 61
Query: 206 ALSGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
L H ++VK + + N+ +Y+V E E L ++ R + + I+ Q+L
Sbjct: 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD--LHAVI-RANILEDVHKRYIMYQLLK 118
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER------LNDIVGS 317
+ + H V+HRDLKP N L S D ++L DFGL+ + E L D V +
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNS---DCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 318 AYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWART------------------ 357
+Y APE+L Y+ D+WS+G I +L G +P + T
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQLEKIIEVIGPPSA 234
Query: 358 ------ESGIFRAVLRSDP-----NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
+S +L S P D+L P S +A D +K+LL + KR+TA +AL
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKPLDEL-LPKASDDALDLLKKLLVFNPNKRLTAEEAL 293
Query: 407 THPWLRD 413
HP++
Sbjct: 294 EHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 76/252 (30%), Positives = 128/252 (50%), Gaps = 26/252 (10%)
Query: 155 VGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
VGRGHFG R K G++ A+K++ K+ + ++ E IL ++S +
Sbjct: 9 VGRGHFGEVQVVREKATGDI----YAMKVMKKSVLLAQETVSFFEEERDIL-SISNSPWI 63
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
+ A +D +N+Y+VME GG+LL + ++ E+ A+ + +++ + H G
Sbjct: 64 PQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY 123
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--VGSAYYVAPEVLHR--- 328
VHRD+KPEN L ++L DFG + + ++ +N VG+ Y+APEVL
Sbjct: 124 VHRDIKPENVLIDR---TGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 329 ----SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD-LPWPS---V 380
+Y +E D WS+GVI+Y ++ G PF T + + ++ NF L +P V
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM----NFQRFLKFPEDPKV 236
Query: 381 SPEAKDFVKRLL 392
S + D ++ LL
Sbjct: 237 SSDFLDLIQSLL 248
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 87/278 (31%), Positives = 139/278 (50%), Gaps = 30/278 (10%)
Query: 154 EVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
++G G G C A K G+L VAVK K + E + EV I++ H++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKL----VAVK---KMDLRKQQRRELLFNEVVIMRDYQ-HEN 78
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+V+ ++ + +++VME EGG L D + R EE A+ + +L ++ H QG
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTD--IVTHTRMNEEQIAAVCLAVLKALSVLHAQG 136
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHR-SY 330
V+HRD+K ++ L T D ++L DFG + + R +VG+ Y++APE++ R Y
Sbjct: 137 VIHRDIKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY 193
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP-----WPSVSPEAK 385
E DIWS+G++ ++ G P++ + + D+LP VSP K
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR------DNLPPKLKNLHKVSPSLK 247
Query: 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP---VPL 420
F+ RLL +D +R TA + L HP+L P VPL
Sbjct: 248 GFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 83/293 (28%), Positives = 130/293 (44%), Gaps = 50/293 (17%)
Query: 153 KEVGRGHFGHTCSARGK-KGELKDQQVAVKII----SKAKMTTAISIEDVRREVKILKAL 207
+++G G + R + GE+ VA+K I + +TAI RE+ ++K L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEI----VALKEIHLDAEEGTPSTAI------REISLMKEL 55
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEE--DAKAIVVQILSVV 265
H+++V+ D N + +V E + +L + G R + K+ Q+L +
Sbjct: 56 K-HENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPE 324
AFCH V+HRDLKP+N L +++L DFGL+ F P ++ V + +Y AP+
Sbjct: 114 AFCHENRVLHRDLKPQNLLINK---RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPD 170
Query: 325 VL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS- 381
VL R+YS DIWS+G I ++ G F + R + WP +S
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230
Query: 382 -PEAK-----------------------DFVKRLLNKDYRKRMTAVQALTHPW 410
PE K D + RLL + R++A AL HPW
Sbjct: 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 82/300 (27%), Positives = 144/300 (48%), Gaps = 50/300 (16%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+Y+ VG G +G C+A K L+ VAVK +S+ + I + RE+++LK +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLSRP-FQSIIHAKRTYRELRLLKHM 73
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
H++++ D + E+ N+VY+V L G L+ I+ + + T++ + ++ QI
Sbjct: 74 K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV-KCQKLTDDHVQFLIYQI 129
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
L + + H ++HRDLKP N +D +++++DFGL+ D+ + V + +Y
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLAR--HTDDEMTGYVATRWYR 184
Query: 322 APEVLHR--SYSLEADIWSIGVISYILLCGSRPF-----------------------WAR 356
APE++ Y+ DIWS+G I LL G F +
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244
Query: 357 TESGIFRAVLRSDP-----NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
S R ++S NF ++ + +P A D ++++L D KR+TA QAL H +
Sbjct: 245 ISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 78/258 (30%), Positives = 131/258 (50%), Gaps = 24/258 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKILKALSG 209
K +G+G FG R G Q A+K++ KA + + D R E IL A
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA----TLKVRDRVRTKMERDIL-AEVN 56
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H +VK A + +Y++++ GG+L R L++ +TEED K + ++ + H
Sbjct: 57 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHR 328
G+++RDLKPEN L ++ ++L DFGLS + I +++ G+ Y+APEV++R
Sbjct: 116 SLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 329 -SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---PNFDDLPWPSVSPEA 384
++ AD WS GV+ + +L GS PF + +L++ P F +SPEA
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF-------LSPEA 225
Query: 385 KDFVKRLLNKDYRKRMTA 402
+ ++ L ++ R+ A
Sbjct: 226 QSLLRALFKRNPANRLGA 243
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 81/274 (29%), Positives = 130/274 (47%), Gaps = 20/274 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E+ K +GRG FG + K Q A+KI++K +M R E +L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVL-VNG 58
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
+ + A +D NN+Y+VM+ GG+LL + R E+ A+ + +++ +
Sbjct: 59 DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPEVL 326
H G VHRD+KP+N L + +RL DFG + D + N VG+ Y++PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLLDK---NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175
Query: 327 HR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW--P 378
Y E D WS+GV Y +L G PF+A + + ++ +F P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF-QFPPDVT 234
Query: 379 SVSPEAKDFVKRLL-NKDYRKRMTAVQAL-THPW 410
VS EAKD ++RL+ + + R +Q HP+
Sbjct: 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 75/252 (29%), Positives = 120/252 (47%), Gaps = 13/252 (5%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G+G FG AR K E + AVK++ K + + + E +L H
Sbjct: 1 KVIGKGSFGKVLLARHKAEE---KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 57
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
LV + + + +Y V++ GGEL L R + E A+ +I S + + H
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLN 116
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS-Y 330
+V+RDLKPEN L S + L DFGL + I + + G+ Y+APEVLH+ Y
Sbjct: 117 IVYRDLKPENILLDS---QGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
D W +G + Y +L G PF++R + ++ +L P+++ A+ ++
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEG 229
Query: 391 LLNKDYRKRMTA 402
LL KD KR+ A
Sbjct: 230 LLQKDRTKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 76/268 (28%), Positives = 127/268 (47%), Gaps = 21/268 (7%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G+G FG R K + A+KI+ K + + E ++L+ + H
Sbjct: 1 KLLGKGTFGKVILVREKATG---KYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPF 56
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
L + + + + VME GGEL L+R ++E+ A+ +I+S + + H
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS-Y 330
VV+RDLK EN + D +++ DFGL + I + G+ Y+APEVL + Y
Sbjct: 116 VVYRDLKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVK 389
D W +GV+ Y ++CG PF+ + +F +L + F P +SPEAK +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF-----PRTLSPEAKSLLA 227
Query: 390 RLLNKDYRKRM-----TAVQALTHPWLR 412
LL KD ++R+ A + + H +
Sbjct: 228 GLLKKDPKQRLGGGPEDAKEIMEHRFFA 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+YE+ K++G G FG A+ K + +K I KM E ++EV IL A
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKMPVK-EKEASKKEV-ILLAK 55
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-LARGGRYTEEDAKAIVVQILSVVA 266
H ++V F + ++ ++IVME C+GG+L+ RI RG ++E+ + VQI +
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND-------IVGSAY 319
H + ++HRD+K +N + A +L DFG++ +LND VG+ Y
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVA--KLGDFGIA------RQLNDSMELAYTCVGTPY 167
Query: 320 YVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPF 353
Y++PE+ +R Y+ + DIWS+G + Y L PF
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 80/282 (28%), Positives = 126/282 (44%), Gaps = 28/282 (9%)
Query: 142 NKNFGAKYE---LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR 198
+ KYE + +G G FG A K + VA+K K+K+ ++ V
Sbjct: 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFP--PVAIKRFEKSKIIKQKQVDHVF 79
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
E KIL ++ H V + +D + +Y+V+E GGE L R R+ +
Sbjct: 80 SERKILNYIN-HPFCVNLYGSFKDESYLYLVLEFVIGGEFFT-FLRRNKRFPNDVGCFYA 137
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
QI+ + + +V+RDLKPEN L D +++ DFG + + D R + G+
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDK---DGFIKMTDFGFAKVV--DTRTYTLCGTP 192
Query: 319 YYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---PNFDD 374
Y+APE+L + + AD W++G+ Y +L G PF+A I++ +L P F D
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD 252
Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRM-----TAVQALTHPWL 411
K +K+LL+ D KR A HPW
Sbjct: 253 -------NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 53/304 (17%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
KY K +GRG +G CSA K +++VA+K I+ A I + RE+K+L+
Sbjct: 5 TKYVPIKPIGRGAYGIVCSA---KNSETNEKVAIKKIANA-FDNRIDAKRTLREIKLLRH 60
Query: 207 LSGHKHLVKFCDAC-----EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
L H++++ D E N+VYIV EL + L +I+ +++ + + Q+
Sbjct: 61 LD-HENVIAIKDIMPPPHREAFNDVYIVYELMDTD--LHQIIRSSQTLSDDHCQYFLYQL 117
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP----DERLNDIVGS 317
L + + H V+HRDLKP N L + + D+++ DFGL+ R + + + V +
Sbjct: 118 LRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLA---RTTSEKGDFMTEYVVT 171
Query: 318 AYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTE----------------- 358
+Y APE+L Y+ D+WS+G I LL G +P + +
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLITELLGSPSE 230
Query: 359 -------SGIFRAVLRSDPNFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407
+ R +RS P +P +P A D ++++L D KR+T +AL
Sbjct: 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290
Query: 408 HPWL 411
HP+L
Sbjct: 291 HPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 5e-24
Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 20/273 (7%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
++G G G C A K +QVAVK K + E + EV I++ H+++
Sbjct: 29 KIGEGSTGIVCIATEKH---TGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYH-HENV 81
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
V ++ + +++VME EGG L D + R EE + + +L +++ H QGV
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTD--IVTHTRMNEEQIATVCLSVLRALSYLHNQGV 139
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLHR-SYS 331
+HRD+K ++ L TS D ++L DFG + + + +VG+ Y++APEV+ R Y
Sbjct: 140 IHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-DPNFDDLPWPSVSPEAKDFVKR 390
E DIWS+G++ ++ G P++ R + + P D VS + F+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS--HKVSSVLRGFLDL 254
Query: 391 LLNKDYRKRMTAVQALTHPWLRDDSRP---VPL 420
+L ++ +R TA + L HP+L+ P VPL
Sbjct: 255 MLVREPSQRATAQELLQHPFLKLAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 82/304 (26%), Positives = 131/304 (43%), Gaps = 61/304 (20%)
Query: 148 KYE-LGKEVGRGHFGHTCSARGKKGELKDQQVAVK---------IISKAKMTTAISIEDV 197
KYE L K +G G +G R ++ Q VA+K +I K +
Sbjct: 2 KYEKLSK-IGEGSYGVVFKCRNRE---TGQIVAIKKFVESEDDPVIKKIAL--------- 48
Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
RE+++LK L H +LV + +++V E C+ +L+ + E K I
Sbjct: 49 -REIRMLKQLK-HPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKI 105
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERLNDIVG 316
+ Q L V FCH +HRD+KPEN L T ++L DFG + + P + D V
Sbjct: 106 IWQTLQAVNFCHKHNCIHRDVKPENILITK---QGQIKLCDFGFARILTGPGDDYTDYVA 162
Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWA------------RT----- 357
+ +Y APE+L Y D+W+IG + LL G +P W +T
Sbjct: 163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDLI 221
Query: 358 --------ESGIFRAVLRSDP-NFDDLP--WPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
+ F+ + +P + L +P++S A F+K L D +R++ + L
Sbjct: 222 PRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281
Query: 407 THPW 410
HP+
Sbjct: 282 EHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 75/250 (30%), Positives = 122/250 (48%), Gaps = 14/250 (5%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G+G FG R K + A+KI+ K + + E ++L+ + H
Sbjct: 1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPF 56
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
L A + + + VME GGEL L+R +TEE A+ +I+S + + H +
Sbjct: 57 LTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RSY 330
VV+RD+K EN + D +++ DFGL + I + G+ Y+APEVL Y
Sbjct: 116 VVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
D W +GV+ Y ++CG PF+ + +F +L + F ++SPEAK +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAG 228
Query: 391 LLNKDYRKRM 400
LL KD ++R+
Sbjct: 229 LLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 87/310 (28%), Positives = 144/310 (46%), Gaps = 58/310 (18%)
Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+E K +GRG FG + K G + A+K + K++M + VR E IL A
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHI----YAMKKLRKSEMLEKEQVAHVRAERDIL-AE 57
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ + +VK + +D N +Y++ME GG+++ +L + +TEE+ + + + + +
Sbjct: 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMT-LLMKKDTFTEEETRFYIAETILAIDS 116
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL---------SDFIR------PDERLN 312
H G +HRD+KP+N L + ++L DFGL ++F R P L+
Sbjct: 117 IHKLGYIHRDIKPDNLLLDA---KGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 313 DI------------------------VGSAYYVAPEVLHRS-YSLEADIWSIGVISYILL 347
I VG+ Y+APEV ++ Y+ E D WS+GVI Y +L
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 348 CGSRPFWARTESGIFRAVLRSDPNFDDLPWPS---VSPEAKDFVKRLL-NKDYRKRMTAV 403
G PF + +R ++ L +P +SPEAKD +KRL + R V
Sbjct: 234 VGYPPFCSDNPQETYRKIINWKET---LQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGV 290
Query: 404 QAL-THPWLR 412
+ +HP+ +
Sbjct: 291 NEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 72/266 (27%), Positives = 131/266 (49%), Gaps = 18/266 (6%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKAL 207
+++ K++G+G +G + L D Q A+K + M+ ED E++IL ++
Sbjct: 2 FKVLKKLGKGSYGSVYKVK----RLSDNQFYALKEVDLGSMSQK-EREDAVNEIRILASV 56
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSV 264
+ H +++ + +A D N + IVME G+L I R E++ I +Q+L
Sbjct: 57 N-HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
+ H Q ++HRDLK N L + +++ D G+S ++ +G+ +Y+APE
Sbjct: 116 LQALHEQKILHRDLKSANILLVAN---DLVKIGDLGISKVLK-KNMAKTQIGTPHYMAPE 171
Query: 325 VLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
V R YS ++DIWS+G + Y + + PF AR+ + V R + +P P S +
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYPPIP-PIYSQD 228
Query: 384 AKDFVKRLLNKDYRKRMTAVQALTHP 409
++F++ +L + R + L P
Sbjct: 229 LQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 76/278 (27%), Positives = 135/278 (48%), Gaps = 28/278 (10%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+EL + VG G +G R K Q A+K++ T E++++E+ +LK S
Sbjct: 8 FELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTGDEEEEIKQEINMLKKYS 60
Query: 209 GHKHLVKFCDACEDVN------NVYIVMELCEGGELLDRIL-ARGGRYTEEDAKAIVVQI 261
H+++ + A N +++VME C G + D I +G EE I +I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYY 320
L ++ H V+HRD+K +N L T ++A+++L+DFG+S R R N +G+ Y+
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 177
Query: 321 VAPEVL------HRSYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNFD 373
+APEV+ +Y ++D+WS+G+ + + G+ P +F P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237
Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
W S + + F++ L K++ +R T Q + HP++
Sbjct: 238 SKKW---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 87/317 (27%), Positives = 149/317 (47%), Gaps = 59/317 (18%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+Y K+VG G +G CSA K+ ++VA+K +S+ + I + RE+ +LK +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKHM 71
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
H++++ D + ++ + Y+VM + D G +E+ + +V Q+
Sbjct: 72 Q-HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQM 126
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
L + + H G++HRDLKP N +D +++++DFGL+ D + V + +Y
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLAR--HADAEMTGYVVTRWYR 181
Query: 322 APEV----LHRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNF- 372
APEV +H Y+ DIWS+G I +L G F + + I + P F
Sbjct: 182 APEVILNWMH--YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239
Query: 373 ---DD---------LP----------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
+D LP +P SP+A D ++++L D KR+TA +AL HP+
Sbjct: 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299
Query: 411 ---LRD---DSRPVPLD 421
RD ++ P D
Sbjct: 300 FDSFRDADEETEQQPYD 316
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 74/251 (29%), Positives = 124/251 (49%), Gaps = 15/251 (5%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G+G FG A K ++ A+K + K + +E E ++L H
Sbjct: 1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF 57
Query: 213 LVK-FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
L FC + +++ VME GG+L+ I GR+ E A+ +I+ + F H +
Sbjct: 58 LTHLFC-TFQTKEHLFFVMEYLNGGDLMFHI-QSSGRFDEARARFYAAEIICGLQFLHKK 115
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF-IRPDERLNDIVGSAYYVAPEVLH-RS 329
G+++RDLK +N L D +++ DFG+ + + + + G+ Y+APE+L +
Sbjct: 116 GIIYRDLKLDNVLLDK---DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK 172
Query: 330 YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389
Y+ D WS GV+ Y +L G PF E +F ++L P+F W +S EAKD +
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLS 228
Query: 390 RLLNKDYRKRM 400
+L +D KR+
Sbjct: 229 KLFERDPTKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-23
Identities = 81/299 (27%), Positives = 143/299 (47%), Gaps = 48/299 (16%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+Y+ VG G +G CSA + Q+VAVK +S+ + I RE+++LK +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLR---QKVAVKKLSRP-FQSLIHARRTYRELRLLKHM 71
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
H++++ D + E+ N VY+V L G L+ I+ + + ++E + ++ Q+
Sbjct: 72 K-HENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIV-KCQKLSDEHVQFLIYQL 127
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
L + + H G++HRDLKP N +D ++R++DFGL+ + D+ + V + +Y
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLAR--QADDEMTGYVATRWYR 182
Query: 322 APEVLHR--SYSLEADIWSIGVISYILLCG-----------------------SRPFWAR 356
APE++ Y+ DIWS+G I LL G S +
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242
Query: 357 TESGIFRAVLRSDPNFDDLPWPSV----SPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
S R ++S P+ + +P A D ++++L D KR++A +AL HP+
Sbjct: 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 72/252 (28%), Positives = 118/252 (46%), Gaps = 13/252 (5%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G+G FG A+ K + AVK++ K + + + E +L H
Sbjct: 1 KVIGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
LV + + + +Y V++ GGEL L R + E A+ +I S + + H
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSLN 116
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS-Y 330
+++RDLKPEN L S + L DFGL + I + + G+ Y+APEVL + Y
Sbjct: 117 IIYRDLKPENILLDS---QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
D W +G + Y +L G PF++R + ++ +L P++S A+ ++
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEG 229
Query: 391 LLNKDYRKRMTA 402
LL KD KR+ A
Sbjct: 230 LLQKDRTKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 80/279 (28%), Positives = 134/279 (48%), Gaps = 30/279 (10%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+EL + VG G +G R K Q A+K++ T E+++ E+ +LK S
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTEDEEEEIKLEINMLKKYS 70
Query: 209 GHKHL-------VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA-IVVQ 260
H+++ +K D + +++VME C G + D + G +ED A I +
Sbjct: 71 HHRNIATYYGAFIKKSPPGHD-DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAY 319
IL +A H V+HRD+K +N L T ++A+++L+DFG+S R R N +G+ Y
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186
Query: 320 YVAPEVL------HRSYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNF 372
++APEV+ +Y +DIWS+G+ + + G+ P +F P
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246
Query: 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
W S + DF++ L K+Y R + Q L HP++
Sbjct: 247 KSKKW---SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-23
Identities = 87/294 (29%), Positives = 137/294 (46%), Gaps = 52/294 (17%)
Query: 153 KEVGRGHFGHTCSARGKK-GELKDQQVAVKII-----SKAKMTTAISIEDVRREVKILKA 206
+++G G +G AR K GE+ VA+K I ++ +TAI RE+ +LK
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEV----VALKKIRLDTETEGVPSTAI------REISLLKE 55
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRIL--ARGGRYTEEDAKAIVVQILSV 264
L+ H ++VK D N +Y+V E + L + + + K+ + Q+L
Sbjct: 56 LN-HPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVGSAYYVAP 323
+AFCH V+HRDLKP+N L + + ++L DFGL+ F P V + +Y AP
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169
Query: 324 EVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSD----PNFD 373
E+L + YS DIWS+G I ++ F +E IFR + D P
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229
Query: 374 DLP--------W---------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
LP W P + + +D + ++L+ D KR++A AL HP+
Sbjct: 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 84/307 (27%), Positives = 134/307 (43%), Gaps = 55/307 (17%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G G FG C R K + A+K + KA + V+ E IL A + ++
Sbjct: 7 KTIGIGAFGEVCLVR--KVDTN-ALYAMKTLRKADVLMRNQAAHVKAERDIL-AEADNEW 62
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+VK + +D +N+Y VM+ GG+++ +L R G + E+ A+ + ++ + H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRLGIFEEDLARFYIAELTCAIESVHKMG 121
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL--------------------SDFIRPDERLN 312
+HRD+KP+N L D ++L DFGL D + P E +
Sbjct: 122 FIHRDIKPDNILIDR---DGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 313 DI------------------------VGSAYYVAPEVLHRS-YSLEADIWSIGVISYILL 347
+I VG+ Y+APEVL R+ Y+ D WS+GVI Y +L
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 348 CGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL-NKDYR-KRMTAVQA 405
G PF A T + V+ + +S EA D + RL + R + A +
Sbjct: 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEI 298
Query: 406 LTHPWLR 412
HP+ +
Sbjct: 299 KAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 4e-23
Identities = 87/301 (28%), Positives = 146/301 (48%), Gaps = 31/301 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
KY +++G+G G +A Q+VA+K I+ K E + E+ ++K L
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQKQPKK---ELIINEILVMKEL 73
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ ++V F D+ + +++VME GG L D + E A+ + L + F
Sbjct: 74 K-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEF 130
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
H V+HRD+K +N L D ++L DFG I P++ + + +VG+ Y++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 327 HR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEA 384
R +Y + DIWS+G+++ ++ G P+ E+ + L + +L P +SP
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSPIF 245
Query: 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHATPFKRAALKA 444
+DF+ R L D KR +A + L HP+L KL K TP AA +A
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFL--------------KLAKPLSSLTPLILAAKEA 291
Query: 445 L 445
+
Sbjct: 292 M 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 7e-23
Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 23/271 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS---KAKMTTAISIEDVRREVKIL 204
KY +++G+G G +A Q+VA+K ++ + K I+ V RE K
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATG---QEVAIKQMNLQQQPKKELIINEILVMRENK-- 74
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
H ++V + D+ + +++VME GG L D + E A+ + L
Sbjct: 75 -----HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQA 127
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVAP 323
+ F H V+HRD+K +N L D ++L DFG I P++ + +VG+ Y++AP
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 324 EVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVS 381
EV+ R +Y + DIWS+G+++ ++ G P+ E+ + L + +L P +S
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPEKLS 242
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
+DF+ R L D KR +A + L HP+L+
Sbjct: 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 8e-23
Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 55/289 (19%)
Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED------------ 222
D++VAVK I +T S++ RE+KI++ L H ++VK +
Sbjct: 30 DKRVAVKKIV---LTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSL 85
Query: 223 --VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKP 280
+N+VYIV E E L +L +G +EE A+ + Q+L + + H V+HRDLKP
Sbjct: 86 TELNSVYIVQEYMETD--LANVLEQG-PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKP 142
Query: 281 ENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDIVGSAYYVAPEVL--HRSYSLEA 334
N + +D +++ DFGL+ + P L++ + + +Y +P +L +Y+
Sbjct: 143 ANVFINT--EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200
Query: 335 DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD---------LPW-------- 377
D+W+ G I +L G F E + +L S P + +P
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGE 260
Query: 378 ---------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417
P V+PEA DF++++L + R+TA +AL HP++ S P
Sbjct: 261 PRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 8e-23
Identities = 77/265 (29%), Positives = 122/265 (46%), Gaps = 40/265 (15%)
Query: 176 QQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG 235
Q+ A+K I+K + I+ V E IL + + +V + E ++ +VME EG
Sbjct: 27 QRFAMKKINKQNLILRNQIQQVFVERDIL-TFAENPFVVSMFCSFETKRHLCMVMEYVEG 85
Query: 236 GE---LLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292
G+ LL I G + A+ + + + + H G+VHRDLKP+N L TS
Sbjct: 86 GDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM---G 138
Query: 293 DMRLIDFGLSD-------------FIRPDERL---NDIVGSAYYVAPEV-LHRSYSLEAD 335
++L DFGLS I D R + G+ Y+APEV L + Y D
Sbjct: 139 HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVD 198
Query: 336 IWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP----SVSPEAKDFVKRL 391
W++G+I Y L G PF+ T +F V+ DD+ WP ++ +A+D + RL
Sbjct: 199 WWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-----DDIEWPEGDEALPADAQDLISRL 253
Query: 392 LNKDYRKRM---TAVQALTHPWLRD 413
L ++ +R+ A + H +
Sbjct: 254 LRQNPLERLGTGGAFEVKQHRFFLG 278
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 9e-23
Identities = 86/307 (28%), Positives = 129/307 (42%), Gaps = 59/307 (19%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIED------VRRE 200
YE +++G G +G AR K G+L VA+K T + +++ RE
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKL----VALK-------KTRLEMDEEGIPPTALRE 50
Query: 201 VKILKALSGHKHLVKFCDACEDVNN-----VYIVMELCEGGELLDRILARGGRYTEEDAK 255
+ +L+ LS ++V+ D +Y+V E + G AK
Sbjct: 51 ISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAK 110
Query: 256 AI---VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERL 311
I + Q+L VA CH GV+HRDLKP+N L + +++ D GL F P +
Sbjct: 111 TIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSY 168
Query: 312 NDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTES----GIFRAV 365
+ + +Y APEVL YS DIWS+G I + F +E IF+
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK-- 226
Query: 366 LRSDPNFDDLP-------W---------------PSVSPEAKDFVKRLLNKDYRKRMTAV 403
L P P W P +SPE D ++++L D KR++A
Sbjct: 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK 286
Query: 404 QALTHPW 410
ALTHP+
Sbjct: 287 AALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 76/269 (28%), Positives = 130/269 (48%), Gaps = 25/269 (9%)
Query: 156 GRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-- 212
GRGHFG A KK GEL A+K + K + +E + E +I + + +H
Sbjct: 8 GRGHFGKVLLAEYKKTGEL----YAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
LV + ++V VME GG+L+ I ++E A ++ + + H
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK 121
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVL-HRSY 330
+V+RDLK +N L + + +++ DFGL + + +R + G+ ++APEVL SY
Sbjct: 122 IVYRDLKLDNLLLDT---EGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY 178
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEAKDFVK 389
+ D W +GV+ Y +L G PF E +F +++ D++ +P +S EA ++
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRFLSREAISIMR 233
Query: 390 RLLNKDYRKRM-----TAVQALTHPWLRD 413
RLL ++ +R+ A P+ RD
Sbjct: 234 RLLRRNPERRLGSGEKDAEDVKKQPFFRD 262
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 72/264 (27%), Positives = 133/264 (50%), Gaps = 24/264 (9%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
A +++ K++GRG F A L + VA+K + +M A + +D +E+ +LK
Sbjct: 2 ANFQIEKKIGRGQFSEVYRA---TCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQ 58
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI--------V 258
L+ H +++K+ D+ + N + IV+EL + G+L I +Y ++ + I
Sbjct: 59 LN-HPNVIKYLDSFIEDNELNIVLELADAGDLSQMI-----KYFKKQKRLIPERTVWKYF 112
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGS 317
VQ+ S V H + V+HRD+KP N T+ ++L D GL F + +VG+
Sbjct: 113 VQLCSAVEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 318 AYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-NFDDL 375
YY++PE +H + Y+ ++DIWS+G + Y + PF+ + +F + + ++ L
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLFSLCQKIEQCDYPPL 228
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKR 399
P S + ++ V + D +R
Sbjct: 229 PTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 40/246 (16%)
Query: 199 REVKILKALSGHKHLVKFCDAC--EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
RE+ IL L H ++V + +++ +Y+VME E +L + + + + K
Sbjct: 53 REINILLKLQ-HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC 110
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFT-SGRDDADMRLIDFGLS-DFIRPDERLNDI 314
+++Q+LS VA H ++HRDLK N L G +++ DFGL+ ++ P + +
Sbjct: 111 LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI----LKICDFGLAREYGSPLKPYTQL 166
Query: 315 VGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAV--- 365
V + +Y APE+L + YS D+WS+G I LL F ++E + IF+ +
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP 226
Query: 366 -LRSDPNFDDLPW--------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
+ P F +LP S+S D + RLL D KR++A
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED 286
Query: 405 ALTHPW 410
AL HP+
Sbjct: 287 ALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 78/278 (28%), Positives = 136/278 (48%), Gaps = 26/278 (9%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E+ K +GRG FG + K D+ A+KI++K +M R E +L ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVL--VN 57
Query: 209 G-HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
G ++ + A +D NN+Y+VM+ GG+LL + R E+ A+ + +++ +
Sbjct: 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND--IVGSAYYVAPEV 325
H VHRD+KP+N L + +RL DFG + D + VG+ Y++PE+
Sbjct: 118 VHQLHYVHRDIKPDNILMDM---NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 326 LHR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
L Y E D WS+GV Y +L G PF+A + + ++ F +P+
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPA 231
Query: 380 ----VSPEAKDFVKRLL-NKDYRKRMTAVQAL-THPWL 411
VS +AKD ++RL+ ++++R ++ HP+
Sbjct: 232 QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 73/280 (26%), Positives = 130/280 (46%), Gaps = 28/280 (10%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
+E+G G FG AR + + VA+K +S + + +D+ +EV+ L+ L H +
Sbjct: 21 REIGHGSFGAVYFARDVRTN---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPN 76
Query: 213 LVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
+++ + ++VME C G ++L+ + + + E + AI L +A+ H
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILE-VHKKPLQ--EVEIAAICHGALQGLAYLHS 133
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL---- 326
+HRD+K N L T + ++L DFG + + P N VG+ Y++APEV+
Sbjct: 134 HERIHRDIKAGNILLT---EPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMD 187
Query: 327 HRSYSLEADIWSIGVISYILLCGSRP--FWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
Y + D+WS+G I+ I L +P F S ++ P W S
Sbjct: 188 EGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW---SDYF 243
Query: 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
++FV L K + R ++ + L H ++ R P ++I
Sbjct: 244 RNFVDSCLQKIPQDRPSSEELLKHRFVL---RERPPTVII 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 24/263 (9%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E+ K +GRG FG + K E + A+KI++K +M R E +L ++
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTE---RIYAMKILNKWEMLKRAETACFREERNVL--VN 57
Query: 209 GH-KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
G + + A +D N +Y+VM+ GG+LL + R E+ A+ + +++ +
Sbjct: 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND--IVGSAYYVAPEV 325
H VHRD+KP+N L + +RL DFG + D + VG+ Y++PE+
Sbjct: 118 IHQLHYVHRDIKPDNVLLDM---NGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 326 LHR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
L Y E D WS+GV Y +L G PF+A + + ++ + F +PS
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPS 231
Query: 380 ----VSPEAKDFVKRLLNKDYRK 398
VS EAKD ++RL+ R+
Sbjct: 232 HITDVSEEAKDLIQRLICSRERR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 90/305 (29%), Positives = 148/305 (48%), Gaps = 47/305 (15%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS----KAKMTTAISIE-DVRREVK 202
+YE+ K++G G FG + K+ + + K IS K + + + IE +V RE+K
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQ---EFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 203 ILKALSGHKHLVKFCDACEDVNN--VYIVMELCEGGEL---LDRILARGGRYTEEDAKAI 257
HK++V++ D + N +YI+ME C+ G+L + + G+ E I
Sbjct: 71 -------HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123
Query: 258 VVQILSVVAFCHL-------QGVVHRDLKPENFLFTSG----------RDDADMRLI--- 297
Q+L +A+CH + V+HRDLKP+N ++G ++ + R I
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 298 -DFGLSDFIRPDERLNDIVGSAYYVAPEVL---HRSYSLEADIWSIGVISYILLCGSRPF 353
DFGLS I + + VG+ YY +PE+L +SY ++D+W++G I Y L G PF
Sbjct: 184 GDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
Query: 354 WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
+ L+ P DLP S E +K LLN ++R +A+Q L + +++
Sbjct: 244 HKANNFSQLISELKRGP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300
Query: 414 DSRPV 418
PV
Sbjct: 301 VGPPV 305
|
Length = 1021 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-22
Identities = 73/251 (29%), Positives = 123/251 (49%), Gaps = 15/251 (5%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G+G FG + K + A+KI+ K + + E ++L+ S H
Sbjct: 1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPF 56
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ- 271
L + + + + VME GGEL L+R ++E+ A+ +I+S + + H +
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RS 329
VV+RDLK EN + D +++ DFGL + I+ + G+ Y+APEVL
Sbjct: 116 NVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 330 YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389
Y D W +GV+ Y ++CG PF+ + +F +L + F ++SPEAK +
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLS 228
Query: 390 RLLNKDYRKRM 400
LL KD ++R+
Sbjct: 229 GLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 70/249 (28%), Positives = 124/249 (49%), Gaps = 15/249 (6%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-L 213
+G+G FG A +KG D+ A+KI+ K + +E E ++L AL G L
Sbjct: 8 LGKGSFGKVMLAE-RKG--TDELYAIKILKKDVIIQDDDVECTMVEKRVL-ALPGKPPFL 63
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
+ + ++ +Y VME GG+L+ I + G++ E A +I + F H +G+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPE-VLHRSYS 331
++RDLK +N + + + +++ DFG+ + I + G+ Y+APE + ++ Y
Sbjct: 123 IYRDLKLDNVMLDA---EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
D W+ GV+ Y +L G PF E +F++++ + ++ S+S EA K L
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGL 235
Query: 392 LNKDYRKRM 400
L K KR+
Sbjct: 236 LTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 80/271 (29%), Positives = 128/271 (47%), Gaps = 24/271 (8%)
Query: 155 VGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
+G+G FG C+ + K G++ A K + K ++ + E KIL+ +S + +
Sbjct: 1 LGKGGFGEVCACQVKATGKM----YACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFI 55
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQG 272
V A E +++ +VM L GG+L I G + E A QI+ + H +
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS-YS 331
+V+RDLKPEN L D ++R+ D GL+ ++ +++ G+ Y+APEVL Y
Sbjct: 116 IVYRDLKPENVLLD---DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172
Query: 332 LEADIWSIGVISYILLCGSRPFWARTES----GIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
D +++G Y ++ G PF R E + R L + D SPEAKD
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD----KFSPEAKDL 228
Query: 388 VKRLLNKDYRKRM-----TAVQALTHPWLRD 413
+ LL KD KR+ +A + HP +D
Sbjct: 229 CEALLQKDPEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 77/286 (26%), Positives = 129/286 (45%), Gaps = 40/286 (13%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E+ + +G+G +G KK AVKI+ E++ E IL++L
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPISDVD----EEIEAEYNILQSLP 76
Query: 209 GHKHLVKF------CDACEDVNNVYIVMELCEGG---ELLDRILARGGRYTEEDAKAIVV 259
H ++VKF D +++V+ELC GG EL+ +L G R E I+
Sbjct: 77 NHPNVVKFYGMFYKADKLVG-GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSA 318
L + H ++HRD+K N L T+ + ++L+DFG+S + R N VG+
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSVGTP 192
Query: 319 YYVAPEVL------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF 372
+++APEV+ SY D+WS+G+ + L G P + + R+ P
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP-- 250
Query: 373 DDLPWPSV-SPEA-----KDFVKRLLNKDYRKRMTAVQALTHPWLR 412
P++ PE F+ + L KD+ R + L HP+++
Sbjct: 251 -----PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 76/308 (24%), Positives = 141/308 (45%), Gaps = 46/308 (14%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
++E +G G +G AR + VA+K + I I +R E+ +L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDGIPISSLR-EITLLLN 62
Query: 207 LSGHKHLVKFCD--ACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKAIVVQIL 262
L H ++V+ + + ++++++VME CE LLD + ++E K +++Q+L
Sbjct: 63 LR-HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLL 118
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYV 321
+ + H ++HRDLK N L T D +++ DFGL+ + P + + V + +Y
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYR 175
Query: 322 APEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR-----SD---PN 371
APE+L +Y+ D+W++G I LL ++E +++ ++ P
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235
Query: 372 FDDLP------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
F DLP +P +S + LL D +KR TA +AL + ++
Sbjct: 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295
Query: 414 DSRPVPLD 421
+P+P +
Sbjct: 296 --KPLPCE 301
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 6e-22
Identities = 69/276 (25%), Positives = 127/276 (46%), Gaps = 27/276 (9%)
Query: 152 GKEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAIS---IEDVRREVKILKAL 207
G+++G G F AR K G L +AVK ++ + T++ +E +R+E++++ L
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTL----MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ H H+++ A + ++ + +E GG + +L++ G + E Q+L +++
Sbjct: 61 N-HPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSY 118
Query: 268 CHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFGL-----SDFIRPDERLNDIVGSAYYV 321
H ++HRD+K N L S G+ +R+ DFG + E ++G+ ++
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQ---RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 322 APEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSDPNFDDLP 376
APEVL Y D+WS+G + + P+ A S IF+ + +P
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA--PSIP 233
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
+SP +D R L R + + L HP R
Sbjct: 234 -EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 7e-22
Identities = 70/276 (25%), Positives = 129/276 (46%), Gaps = 28/276 (10%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+GRG + R KK ++ A+K++ K + I+ V+ E + + S H LV
Sbjct: 3 IGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
+ + ++ V+E GG+L+ + R + EE A+ +I + + H +G++
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 118
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RSYSL 332
+RDLK +N L S + ++L D+G+ + +RP + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 333 EADIWSIGVISYILLCGSRPF---------WARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
D W++GV+ + ++ G PF TE +F+ +L S+S +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 231
Query: 384 AKDFVKRLLNKDYRKRMTAVQAL------THPWLRD 413
A +K LNKD ++R+ HP+ R+
Sbjct: 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 8e-22
Identities = 88/315 (27%), Positives = 129/315 (40%), Gaps = 70/315 (22%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
KYE ++G+G FG AR KK Q VA+K + I +R E+KIL+ L
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKEGFPITALR-EIKILQLL 68
Query: 208 SGHKHLVKFCDACED----VNN----VYIVMELCEG--GELLDRILARGGRYTEEDAKAI 257
H+++V + C N Y+V E CE LL + +T + K +
Sbjct: 69 K-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIKKV 124
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDE----RLN 312
+ +L+ + + H ++HRD+K N L T D ++L DFGL+ F R
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITK---DGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 313 DIVGSAYYVAPEVL--HRSYSLEADIWSIGVI-------SYIL--------------LCG 349
+ V + +Y PE+L R Y D+W G I S I+ LCG
Sbjct: 182 NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241
Query: 350 S-----------RPFWARTE--SGIFRAVLRSDPNFDDLPWPSVS-PEAKDFVKRLLNKD 395
S + + E G R V + L P V P A D + +LL D
Sbjct: 242 SITPEVWPGVDKLELFKKMELPQGQKRKVK------ERL-KPYVKDPHALDLIDKLLVLD 294
Query: 396 YRKRMTAVQALTHPW 410
KR+ A AL H +
Sbjct: 295 PAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 8e-22
Identities = 74/264 (28%), Positives = 123/264 (46%), Gaps = 17/264 (6%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G+G FG R K+ + A+K I KA + + + E +L A +V
Sbjct: 1 IGKGSFGKVMQVR-KRDTQR--IYALKTIRKAHIVSRSEVTHTLAERTVL-AQVNCPFIV 56
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
+ + +Y+V+ GGEL L R GR+ A+ ++L + H V+
Sbjct: 57 PLKFSFQSPEKLYLVLAFINGGELFHH-LQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDF-IRPDERLNDIVGSAYYVAPEVLH-RSYSL 332
+RDLKPEN L + L DFGL ++ D++ N G+ Y+APE+L Y+
Sbjct: 116 YRDLKPENILLDYQ---GHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392
D W++GV+ Y +L G PF+ + ++R +L+ F D +AKD + LL
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLL 228
Query: 393 NKDYRKRM---TAVQALTHPWLRD 413
++D +R+ A + HP+
Sbjct: 229 SRDPTRRLGYNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 67/255 (26%), Positives = 123/255 (48%), Gaps = 20/255 (7%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+GRG + R KK DQ A+K++ K + I+ V+ E + + S + LV
Sbjct: 3 IGRGSYAKVLLVRLKK---NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
+ + +++V+E GG+L+ + R + EE A+ +I + F H +G++
Sbjct: 60 GLHSCFQTTSRLFLVIEYVNGGDLMFH-MQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RSYSL 332
+RDLK +N L + D ++L D+G+ + + P + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLLDA---DGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 333 EADIWSIGVISYILLCGSRPF-------WARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
D W++GV+ + ++ G PF TE +F+ +L +S +A
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKAS 231
Query: 386 DFVKRLLNKDYRKRM 400
+K LNKD ++R+
Sbjct: 232 HVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 74/252 (29%), Positives = 117/252 (46%), Gaps = 13/252 (5%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G+G FG A+ K AVK++ K + + E +L H
Sbjct: 1 KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPF 57
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
LV + + +Y V++ GGEL L R + E A+ ++ S + + H
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGELFFH-LQRERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS-Y 330
+++RDLKPEN L S + L DFGL + + P+E + G+ Y+APEVL + Y
Sbjct: 117 IIYRDLKPENILLDS---QGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
D W +G + Y +L G PF++R S ++ +L LP + A D +
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ---LP-GGKTVAACDLLVG 229
Query: 391 LLNKDYRKRMTA 402
LL+KD R+R+ A
Sbjct: 230 LLHKDQRRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-21
Identities = 84/311 (27%), Positives = 136/311 (43%), Gaps = 59/311 (18%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G G FG C AR A+K + K + + V+ E IL A + ++
Sbjct: 7 KTLGIGAFGEVCLARKVD---TKALYAMKTLRKKDVLLRNQVAHVKAERDIL-AEADNEW 62
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+V+ + +D +N+Y VM+ GG+++ +L R G + E+ A+ + ++ V H G
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMGIFPEDLARFYIAELTCAVESVHKMG 121
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL------------------------------- 301
+HRD+KP+N L D ++L DFGL
Sbjct: 122 FIHRDIKPDNILIDR---DGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 302 -------SDFIRPDER----------LNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVIS 343
D ++P ER + +VG+ Y+APEVL R+ Y+ D WS+GVI
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 344 YILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLN--KDYRKRMT 401
Y +L G PF A+T V+ + P +SPEA D + +L +D +
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNG 298
Query: 402 AVQALTHPWLR 412
A + HP+ +
Sbjct: 299 ADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 77/266 (28%), Positives = 125/266 (46%), Gaps = 14/266 (5%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G+G FG C+ + + + A K + K ++ E +IL+ ++ + +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS-QFVV 63
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQGV 273
A E + + +V+ + GG+L I G + EE A +IL + H +
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYSL 332
V+RDLKPEN L D +R+ D GL+ I E + VG+ Y+APEVL ++ Y+L
Sbjct: 124 VYRDLKPENILLD---DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180
Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392
D W +G + Y ++ G PF R E V R +++ S EAK K LL
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 393 NKDYRKRM-----TAVQALTHPWLRD 413
KD ++R+ A + HP+ R+
Sbjct: 241 TKDPKQRLGCQEEGAGEVKRHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 71/264 (26%), Positives = 127/264 (48%), Gaps = 14/264 (5%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G+G FG A K +Q A+K + K + +E E ++L H
Sbjct: 1 KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 57
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
L + N++ VME GG+L+ I + ++ A +I+ + F H +G
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKG 116
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVL-HRSY 330
+V+RDLK +N L + D +++ DFG+ + + D + G+ Y+APE+L + Y
Sbjct: 117 IVYRDLKLDNILLDT---DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
+ D WS GV+ Y +L G PF E +F+++ +P + W ++ EAKD + +
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTREAKDILVK 229
Query: 391 LLNKDYRKRMTAVQAL-THPWLRD 413
L ++ +R+ + HP+ R+
Sbjct: 230 LFVREPERRLGVKGDIRQHPFFRE 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 75/263 (28%), Positives = 132/263 (50%), Gaps = 24/263 (9%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G+G FG +G K + VA+KII + IED+++E+ +L ++
Sbjct: 12 IGKGSFGEV--YKGIDNRTK-EVVAIKIIDLEEAED--EIEDIQQEITVLSQCDS-PYIT 65
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
++ + ++I+ME GG LD L + G E I+ +IL + + H + +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALD--LLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS-YSL 332
HRD+K N L + + D++L DFG++ + + + N VG+ +++APEV+ +S Y
Sbjct: 124 HRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV----SPEAKDFV 388
+ADIWS+G+ + L G P + + ++ P P++ S K+FV
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------PTLEGQYSKPFKEFV 233
Query: 389 KRLLNKDYRKRMTAVQALTHPWL 411
+ LNKD R R TA + L H ++
Sbjct: 234 EACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 79/297 (26%), Positives = 127/297 (42%), Gaps = 47/297 (15%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA---KMTTAISIEDVRREVKIL 204
KYE VG G +G + K+ Q VA+K ++ KM I++ RE+++L
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDKMVKKIAM----REIRML 54
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
K L H++LV + +Y+V E + +LD + E + + QIL
Sbjct: 55 KQLR-HENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRG 112
Query: 265 VAFCHLQGVVHRDLKPENFLFT-SGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVA 322
+ FCH ++HRD+KPEN L + SG ++L DFG + + P E D V + +Y A
Sbjct: 113 IEFCHSHNIIHRDIKPENILVSQSGV----VKLCDFGFARTLAAPGEVYTDYVATRWYRA 168
Query: 323 PEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN--------F 372
PE+L Y DIW++G + +L G F ++ +++ N F
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228
Query: 373 DDLP-------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
P +P +S D K+ L D R ++ Q L H +
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 72/250 (28%), Positives = 118/250 (47%), Gaps = 14/250 (5%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G+G FG R K + A+KI+ K + + E ++LK + H
Sbjct: 1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPF 56
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
L + + + + VME GGEL L+R ++E+ + +I+S + + H
Sbjct: 57 LTSLKYSFQTKDRLCFVMEYVNGGELFFH-LSRERVFSEDRTRFYGAEIVSALDYLHSGK 115
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RSY 330
+V+RDLK EN + D +++ DFGL + I + G+ Y+APEVL Y
Sbjct: 116 IVYRDLKLENLMLDK---DGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
D W +GV+ Y ++CG PF+ + +F +L D F ++S +AK +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSG 228
Query: 391 LLNKDYRKRM 400
LL KD KR+
Sbjct: 229 LLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 3e-21
Identities = 73/264 (27%), Positives = 128/264 (48%), Gaps = 16/264 (6%)
Query: 153 KEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
K +G+G FG A K KGE AVK + K + +E E ++L +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEY----FAVKALKKDVVLIDDDVECTMVEKRVLALAWENP 56
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
L + +++ VME GG+L+ I +G R+ A +I+ + F H +
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSK 115
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RS 329
G+++RDLK +N + D +++ DFG+ + + D R + G+ Y+APE+L
Sbjct: 116 GIIYRDLKLDNVMLDR---DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 330 YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389
Y+ D WS GV+ Y +L G PF E +F ++ P++ W ++ E+KD ++
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILE 228
Query: 390 RLLNKDYRKRMTAVQALT-HPWLR 412
+L +D +R+ V + HP+ +
Sbjct: 229 KLFERDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 89/306 (29%), Positives = 141/306 (46%), Gaps = 59/306 (19%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-----SKAKMTTAISIEDVRREVK 202
+YE +++G G +G AR + + ++ +A+K I + +TAI RE+
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDR---VTNETIALKKIRLEQEDEGVPSTAI------REIS 53
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA------KA 256
+LK + H ++V+ D +Y+V E LD L + + + A K
Sbjct: 54 LLKEMQ-HGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKT 106
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIV 315
+ QIL +A+CH V+HRDLKP+N L R ++L DFGL+ F P V
Sbjct: 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVRTFTHEV 164
Query: 316 GSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRP-FWARTE----SGIFRAV--- 365
+ +Y APE+L R YS DIWS+G I + + +P F +E IFR +
Sbjct: 165 VTLWYRAPEILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGTP 223
Query: 366 -------LRSDPNFDD-LP-W---------PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407
+ S P++ P W P++ P D + ++L D KR+TA AL
Sbjct: 224 NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283
Query: 408 HPWLRD 413
H + +D
Sbjct: 284 HEYFKD 289
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 79/293 (26%), Positives = 135/293 (46%), Gaps = 40/293 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
KYE +++G G +G A+ ++ E+ VA+K + + +R E+ +LK
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEI----VALKRVRLDDDDEGVPSSALR-EICLLKE 55
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
L HK++V+ D + +V E C+ +L + G E K+ + Q+L +A
Sbjct: 56 LK-HKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEV 325
FCH V+HRDLKP+N L + +++L DFGL+ F P + V + +Y P+V
Sbjct: 114 FCHSHNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 170
Query: 326 L--HRSYSLEADIWSIGVISYILLCGSRPFWARTE-----SGIFRAV----------LRS 368
L + YS D+WS G I L RP + + IFR + +
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230
Query: 369 DPNFDDLP-------W----PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
P++ P P ++ +D ++ LL + +R++A +AL HP+
Sbjct: 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
KE+G G FG G+ + + VA+K+I + M S +D E K++ LS
Sbjct: 8 FLKELGSGQFG-----VVHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS- 57
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H +LV+ C ++IV E G LL+ + R G+ E + + + +
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV---APEVL 326
G +HRDL N L D +++ DFGL+ ++ D+ + G+ + V PEV
Sbjct: 118 SNGFIHRDLAARNCLVGE---DNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVF 173
Query: 327 HRS-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
S +S ++D+WS GV+ + + G P+ + S + +V
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 86/279 (30%), Positives = 133/279 (47%), Gaps = 31/279 (11%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
+N YEL + VG G +G AR GEL AVKII K+ +++E+
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGEL----AAVKII---KLEPGDDFSLIQQEI 57
Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
++K H ++V + + ++I ME C GG L D I G +E + +
Sbjct: 58 FMVKECK-HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRET 115
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYY 320
L +A+ H +G +HRD+K N L T D+ D++L DFG++ I + +G+ Y+
Sbjct: 116 LQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFIGTPYW 172
Query: 321 VAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV-LRSDPNF--- 372
+APEV + Y+ DIW++G+ + L P + + RA+ L S NF
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF---DLHPMRALFLMSKSNFQPP 229
Query: 373 ---DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
D W S +FVK L K+ +KR TA + LTH
Sbjct: 230 KLKDKTKW---SSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 70/270 (25%), Positives = 132/270 (48%), Gaps = 16/270 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+Y L + +G+G FG + KK +++ +K I ++ +++ +E ++L L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ-ANQEAQLLSKL 59
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSV 264
H +VKF + + + I+ E CEG +L ++ G +E +Q+L
Sbjct: 60 D-HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIVGSAYYVAP 323
V + H + ++HRDLK +N + +++ DFG+S + L G+ YY++P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL----LKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 324 EVL-HRSYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRSDPNFDDLPWPSVS 381
E L H+ Y ++DIWS+G I Y + C + F + S + R V P+ + + S
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPE----TYS 230
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
+ ++ +LNKD R +A + L +P++
Sbjct: 231 RQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 8e-21
Identities = 77/278 (27%), Positives = 133/278 (47%), Gaps = 24/278 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKAL 207
+++ K +GRG FG R K +QV A+K++SK +M E I+ A
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKS----SKQVYAMKLLSKFEMIKRSDSAFFWEERDIM-AH 99
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ + +V+ A +D +Y+VME GG+L++ L E+ A+ +++ +
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN--LMSNYDIPEKWARFYTAEVVLALDA 157
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE----RLNDIVGSAYYVAP 323
H G +HRD+KP+N L ++L DFG ++ D R + VG+ Y++P
Sbjct: 158 IHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISP 212
Query: 324 EVL-----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
EVL Y E D WS+GV Y +L G PF+A + G + ++ +
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272
Query: 379 SVSPEAKDFVKRLL-NKDYRKRMTAVQAL-THPWLRDD 414
+S +AKD + L +++ R V + +HP+ ++D
Sbjct: 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 8e-21
Identities = 69/257 (26%), Positives = 124/257 (48%), Gaps = 22/257 (8%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+GRG + KK + A+K+I K + I+ V+ E + + S H LV
Sbjct: 3 IGRGSYAKVLLVELKK---TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
+ + ++ V+E GG+L+ + R + EE A+ +I + F H +G++
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDLMFH-MQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLH-RSYSL 332
+RDLK +N L + + ++L D+G+ + IRP + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLLDA---EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 333 EADIWSIGVISYILLCGSRPF---------WARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
D W++GV+ + ++ G PF TE +F+ +L +P S+S +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR---IP-RSLSVK 231
Query: 384 AKDFVKRLLNKDYRKRM 400
A +K LNKD ++R+
Sbjct: 232 ASSVLKGFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 90/303 (29%), Positives = 136/303 (44%), Gaps = 60/303 (19%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-----SKAKMTTAISIEDVRREVKI 203
Y+ +++G G +G AR K + VA+K I + +TAI RE+ +
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLT---GEIVALKKIRLETEDEGVPSTAI------REISL 51
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA------KAI 257
LK L+ H ++V+ D N +Y+V E LD L + + K+
Sbjct: 52 LKELN-HPNIVRLLDVVHSENKLYLVFEF------LDLDLKKYMDSSPLTGLDPPLIKSY 104
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-FIRPDERLNDIVG 316
+ Q+L +A+CH V+HRDLKP+N L + ++L DFGL+ F P V
Sbjct: 105 LYQLLQGIAYCHSHRVLHRDLKPQNLLIDR---EGALKLADFGLARAFGVPVRTYTHEVV 161
Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRP-FWARTESG----IFRAVLRSD 369
+ +Y APE+L R YS DIWSIG I + + RP F +E IFR + D
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPD 220
Query: 370 ----PNFDDLP--------W---------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
P LP W P++ + D + ++L D KR++A AL H
Sbjct: 221 EDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280
Query: 409 PWL 411
P+
Sbjct: 281 PYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 44/286 (15%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKI-ISKAKMTTAISIEDVRREVKIL-KALSGHK 211
E+G+G++G + + +++ + ++K I E+ IL KA+S
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQII------MELDILHKAVS--P 59
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
++V F A VY+ ME + G L D++ A GG TE I +L + + ++
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYA-GGVATE----GIPEDVLRRITYAVVK 113
Query: 272 G---------VVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYV 321
G ++HRD+KP N L + ++L DFG+S + + + N +G Y+
Sbjct: 114 GLKFLKEEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLVASLAKTN--IGCQSYM 168
Query: 322 APEVLHR-------SYSLEADIWSIGVISYILLCGSRPFWARTESGIF---RAVLRSDPN 371
APE + +Y++++D+WS+G+ + G P+ T + IF A++ DP
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP- 227
Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417
LP S +A+DFV + LNK +R T Q L HPWL
Sbjct: 228 -PTLP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 76/268 (28%), Positives = 135/268 (50%), Gaps = 24/268 (8%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G+G FG + + Q VA+KII + IED+++E+ +L ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQ---QVVAIKIIDLEEAED--EIEDIQQEITVLSQCDS-PYVT 65
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
K+ + ++I+ME GG LD L R G + E ++ +IL + + H + +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALD--LLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS-YSL 332
HRD+K N L + + D++L DFG++ + + + N VG+ +++APEV+ +S Y
Sbjct: 124 HRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180
Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE----AKDFV 388
+ADIWS+G+ + L G P ++ R VL P P+++ E K+F+
Sbjct: 181 KADIWSLGITAIELAKGEPP---NSDMHPMR-VLFLIPKN---NPPTLTGEFSKPFKEFI 233
Query: 389 KRLLNKDYRKRMTAVQALTHPWLRDDSR 416
LNKD R TA + L H ++ +++
Sbjct: 234 DACLNKDPSFRPTAKELLKHKFIVKNAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 64/240 (26%), Positives = 110/240 (45%), Gaps = 19/240 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ L +++G G+FG K +VA+KI+ + +D ++EV+ LK L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKN----RVRVAIKILKSDDLLKQ---QDFQKEVQALKRLR 60
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAF 267
HKHL+ C VYI+ EL E G LL + + G+ + Q+ +A+
Sbjct: 61 -HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY-YVAPEVL 326
Q +HRDL N L +D ++ DFGL+ I+ D L+ Y + APE
Sbjct: 120 LEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
H ++S ++D+WS G++ Y + G P+ ++ + + +P P+ P+
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA---GY-RMPCPAKCPQE 232
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 72/252 (28%), Positives = 114/252 (45%), Gaps = 13/252 (5%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G+G FG A+ K L + AVK++ K + + + E +L H
Sbjct: 1 KVIGKGSFGKVLLAKRK---LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPF 57
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
LV + + +Y V++ GGEL L R + E A+ +I S + + H
Sbjct: 58 LVGLHYSFQTTEKLYFVLDFVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSIN 116
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVLHRS-Y 330
+V+RDLKPEN L S + L DFGL + I + G+ Y+APEV+ + Y
Sbjct: 117 IVYRDLKPENILLDS---QGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390
D W +G + Y +L G PF+ R + ++ +L P S A ++
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEE 229
Query: 391 LLNKDYRKRMTA 402
LL KD ++R+ A
Sbjct: 230 LLEKDRQRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 93/305 (30%), Positives = 140/305 (45%), Gaps = 61/305 (20%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-----SKAKMTTAISIEDVRREVK 202
Y +++G G +G R KK Q VA+K I + +TAI RE+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEEEGVPSTAI------REIS 51
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMEL--CEGGELLDRILARGGRYTE-EDAKAIVV 259
+LK L H ++V D + +Y++ E + + LD + G+Y + E K+ +
Sbjct: 52 LLKELQ-HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVKSYLY 108
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSA 318
QIL + FCH + V+HRDLKP+N L + ++L DFGL+ F P V +
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDN---KGVIKLADFGLARAFGIPVRVYTHEVVTL 165
Query: 319 YYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRP-FWARTESG----IFRAVLRSDPN 371
+Y APEVL S YS DIWSIG I + + +P F +E IFR + P
Sbjct: 166 WYRAPEVLLGSPRYSTPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRIL--GTPT 222
Query: 372 FDDLPWPSVS--PEAK-----------------------DFVKRLLNKDYRKRMTAVQAL 406
D WP V+ P+ K D ++++L D KR++A +AL
Sbjct: 223 EDV--WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280
Query: 407 THPWL 411
HP+
Sbjct: 281 NHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 84/320 (26%), Positives = 138/320 (43%), Gaps = 62/320 (19%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKA 206
KYE+ +GRG +G A+ K G+ ++ A+K K T IS R E+ +L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDG-KEYAIKKFKGDKEQYTGISQSACR-EIALLRE 58
Query: 207 LSGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRI----LARGGRYTEEDAKAIVVQ 260
L H+++V + + + VY++ + E +L I A+ K+++ Q
Sbjct: 59 LK-HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFGLSDF----IRPDERLNDIV 315
IL+ V + H V+HRDLKP N L G + +++ D GL+ ++P L+ +V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 316 GSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRP-FWARTES------------- 359
+ +Y APE+L R Y+ DIW+IG I + L P F R
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCI-FAELLTLEPIFKGREAKIKKSNPFQRDQLE 235
Query: 360 GIFRAV----------LRSDPNFDDLP-------------------WPSVSPEAKDFVKR 390
IF + ++ P +D L + D +++
Sbjct: 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295
Query: 391 LLNKDYRKRMTAVQALTHPW 410
LL D KR+TA +AL HP+
Sbjct: 296 LLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 75/300 (25%), Positives = 145/300 (48%), Gaps = 48/300 (16%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
+Y K+VG G +G CSA ++ K VA+K + + + + + RE+++LK
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAK---VAIKKLYRP-FQSELFAKRAYRELRLLKH 70
Query: 207 LSGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
+ H++++ D + + ++ Y+VM G L +++ + + +E+ + +V Q
Sbjct: 71 MK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLM-KHEKLSEDRIQFLVYQ 126
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
+L + + H G++HRDLKP N +D +++++DFGL+ + D + V + +Y
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLAR--QTDSEMTGYVVTRWY 181
Query: 321 VAPEVLHR--SYSLEADIWSIGVISYILLCG-----------------------SRPFWA 355
APEV+ Y+ DIWS+G I +L G S+ F
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241
Query: 356 RTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
+ +S + ++ P F + P+ +P A + ++++L D R+TA +AL HP+
Sbjct: 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 79/271 (29%), Positives = 134/271 (49%), Gaps = 26/271 (9%)
Query: 152 GKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
GK +G+G FG + C EL +QV S T+ + + E+++LK L
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE---TSKEVSALECEIQLLKNLQ- 62
Query: 210 HKHLVKFCDACED--VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H+ +V++ D + I ME GG + D++ A G TE + QIL +++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSY 121
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFIR----PDERLNDIVGSAYYVA 322
H +VHRD+K N L RD A +++L DFG S ++ + + G+ Y+++
Sbjct: 122 LHSNMIVHRDIKGANIL----RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 323 PEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLPWPS 379
PEV+ Y +AD+WS+G + + + +P WA E + IF+ + + P LP
Sbjct: 178 PEVISGEGYGRKADVWSLGC-TVVEMLTEKPPWAEYEAMAAIFK--IATQPTNPQLP-SH 233
Query: 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
+S A+DF+ + + R R +A + L HP+
Sbjct: 234 ISEHARDFLGCIF-VEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 81/272 (29%), Positives = 135/272 (49%), Gaps = 26/272 (9%)
Query: 149 YELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
+ LGK +G+G FG + C EL +QV S T+ + + E+++LK
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPE---TSKEVNALECEIQLLKN 60
Query: 207 LSGHKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
L H+ +V++ D + I ME GG + D++ + G TE + QIL
Sbjct: 61 LL-HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEG 118
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFIR----PDERLNDIVGSAY 319
V++ H +VHRD+K N L RD +++L DFG S ++ + + G+ Y
Sbjct: 119 VSYLHSNMIVHRDIKGANIL----RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 320 YVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLP 376
+++PEV+ Y +ADIWS+G + + + +P WA E + IF+ + + P LP
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGC-TVVEMLTEKPPWAEFEAMAAIFK--IATQPTNPVLP 231
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
P VS +DF+KR+ + + R +A + L H
Sbjct: 232 -PHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 72/250 (28%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G+G FG A +KG D+ A+KI+ K + +E E ++L ALSG +
Sbjct: 8 LGKGSFGKVMLAE-RKG--TDELYAIKILKKDVVIQDDDVECTMVEKRVL-ALSGKPPFL 63
Query: 215 KFCDAC-EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
+C + ++ +Y VME GG+L+ +I + GR+ E A +I + F H +G+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGL-SDFIRPDERLNDIVGSAYYVAPEVL-HRSYS 331
++RDLK +N + S + +++ DFG+ + + G+ Y+APE++ ++ Y
Sbjct: 123 IYRDLKLDNVMLDS---EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEAKDFVKR 390
D W+ GV+ Y +L G PF E +F++++ ++ +P S+S EA K
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-----NVAYPKSMSKEAVAICKG 234
Query: 391 LLNKDYRKRM 400
L+ K KR+
Sbjct: 235 LMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 82/327 (25%), Positives = 136/327 (41%), Gaps = 91/327 (27%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVK--IISKAK---MTTAISIEDVRREVK 202
YE+ ++G G FG AR ++K VA+K ++ K TA+ RE+K
Sbjct: 10 YEILGKLGEGTFGEVYKAR----QIKTGRVVALKKILMHNEKDGFPITAL------REIK 59
Query: 203 ILKALSGHKHLVKFCD--------ACEDVNNVYIVM-----ELCEGGELLD--RILARGG 247
ILK L H ++V D + +VY+V +L LL+ +
Sbjct: 60 ILKKLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG---LLENPSV----- 110
Query: 248 RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
+ TE K ++Q+L + + H ++HRD+K N L + +++ DFGL+ RP
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLA---RP 164
Query: 308 ---------------DERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGS 350
+ ++V + +Y PE+L R Y+ DIW IG + +
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR- 223
Query: 351 RP-FWARTE----SGIFRAV----LRSDPNFDDLP------------------WPSVSPE 383
RP +++ IF+ + P + LP + + PE
Sbjct: 224 RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283
Query: 384 AKDFVKRLLNKDYRKRMTAVQALTHPW 410
D + +LL+ D KR+TA AL HP+
Sbjct: 284 GLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 76/277 (27%), Positives = 133/277 (48%), Gaps = 22/277 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
Y++ K +GRG FG R K + + A+K++SK +M E I+ A +
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQ---KVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFA 100
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
+V+ A +D +Y+VME GG+L++ L E+ AK +++ +
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN--LMSNYDVPEKWAKFYTAEVVLALDAI 158
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE----RLNDIVGSAYYVAPE 324
H G++HRD+KP+N L ++L DFG ++ DE R + VG+ Y++PE
Sbjct: 159 HSMGLIHRDVKPDNMLLDK---HGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPE 213
Query: 325 VLHRS-----YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
VL Y E D WS+GV + +L G PF+A + G + ++ + +
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273
Query: 380 VSPEAKDFVKRLL-NKDYRKRMTAVQALT-HPWLRDD 414
+S AK+ + L +++ R V+ + HP+ ++D
Sbjct: 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 98/369 (26%), Positives = 154/369 (41%), Gaps = 69/369 (18%)
Query: 71 ASPLPAGVSPSPARASTPRRFFRRP---FPPPSPAKHIKASLAKRLGGGKPKESTIPEER 127
P P PS AR +T R RRP P P + L S+
Sbjct: 4 IQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSAS 63
Query: 128 GTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFG------HTCSARGKKGELKDQQVAVK 181
G+ P + S + E +G G G H + R A+K
Sbjct: 64 GSAPSAAKSLS---------ELERVNRIGSGAGGTVYKVIHRPTGR---------LYALK 105
Query: 182 IISKAKMTTAISIEDVR----REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGE 237
+I + VR RE++IL+ ++ H ++VK D + + +++E +GG
Sbjct: 106 VIYGNHE------DTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDGGS 158
Query: 238 LLDRILARGGRYTEEDAKAIVV-QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
L G +E A V QILS +A+ H + +VHRD+KP N L S + ++++
Sbjct: 159 L------EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK---NVKI 209
Query: 297 IDFGLSDFI-RPDERLNDIVGSAYYVAPEVL-----HRSYSLEA-DIWSIGVISYILLCG 349
DFG+S + + + N VG+ Y++PE + H +Y A DIWS+GV G
Sbjct: 210 ADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
Query: 350 SRPF-------WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA 402
PF WA + A+ S P + S E + F+ L ++ KR +A
Sbjct: 270 RFPFGVGRQGDWA----SLMCAICMSQP---PEAPATASREFRHFISCCLQREPAKRWSA 322
Query: 403 VQALTHPWL 411
+Q L HP++
Sbjct: 323 MQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-20
Identities = 83/321 (25%), Positives = 136/321 (42%), Gaps = 55/321 (17%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E K +GRG FG + K A+KI+ KA M + +R E IL
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKD---TGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD 59
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
G +VK + +D N+Y++ME GG+++ +L + +EE + + + + +
Sbjct: 60 G-AWVVKMFYSFQDKRNLYLIMEFLPGGDMMT-LLMKKDTLSEEATQFYIAETVLAIDAI 117
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN---------------- 312
H G +HRD+KP+N L + ++L DFGL ++ R
Sbjct: 118 HQLGFIHRDIKPDNLLLDA---KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 313 --------------------DIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSR 351
VG+ Y+APEV ++ Y+ D WS+GVI Y +L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 352 PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL-LNKDYRKRMTAVQAL-THP 409
PF + T +R V+ P +S +AKD + R + + R V+ + +HP
Sbjct: 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHP 294
Query: 410 ------WLRDDSRP--VPLDI 422
W RP +P++I
Sbjct: 295 FFEGVDWGHIRERPAAIPIEI 315
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-20
Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 24/278 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
YE+ K +GRG FG R K + A+K++SK +M E I+ A +
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFA 100
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
+V+ A +D +Y+VME GG+L++ L E+ A+ +++ +
Sbjct: 101 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKWARFYTAEVVLALDAI 158
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPEVL 326
H G +HRD+KP+N L ++L DFG + + R + VG+ Y++PEVL
Sbjct: 159 HSMGFIHRDVKPDNMLLDK---SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 327 HRS-----YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP--- 378
Y E D WS+GV Y +L G PF+A + G + ++ + L +P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK---NSLTFPDDN 272
Query: 379 SVSPEAKDFVKRLL-NKDYRKRMTAVQALT-HPWLRDD 414
+S EAK+ + L +++ R V+ + H + ++D
Sbjct: 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 225 NVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHL---QGVVHRDLKP 280
+V+I MEL LD++L R G E+ + V I+ A +L GV+HRD+KP
Sbjct: 88 DVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVK--ALHYLKEKHGVIHRDVKP 143
Query: 281 ENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-----HRSYSLEAD 335
N L +++L DFG+S + + G A Y+APE + + Y + AD
Sbjct: 144 SNILLD---ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRAD 200
Query: 336 IWSIGVISYILLCGSRPF-WARTESGIFRAVLRSDPNFDDLPWP----SVSPEAKDFVKR 390
+WS+G+ L G P+ +TE + +L+ +P P SP+ FV
Sbjct: 201 VWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-----PSLPPNEGFSPDFCSFVDL 255
Query: 391 LLNKDYRKRMTAVQALTHPWLRD 413
L KD+RKR + L HP++R
Sbjct: 256 CLTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 71/260 (27%), Positives = 127/260 (48%), Gaps = 16/260 (6%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
A + + K++GRG F A L VA+K + + A + D +E+ +LK
Sbjct: 2 ANFRIEKKIGRGQFSEVYRA---TCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 58
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGEL--LDRILARGGRYT-EEDAKAIVVQILS 263
L+ H +++K+ + + N + IV+EL + G+L + + + R E+ VQ+ S
Sbjct: 59 LN-HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVA 322
+ H + V+HRD+KP N T+ ++L D GL F + +VG+ YY++
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
Query: 323 PEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTES--GIFRAVLRSDPNFDDLPWPS 379
PE +H + Y+ ++DIWS+G + Y + PF+ + + + + + D + LP
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDH 232
Query: 380 VSPEAKDFVKRLLNKDYRKR 399
S E + V +N D KR
Sbjct: 233 YSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 71/268 (26%), Positives = 135/268 (50%), Gaps = 17/268 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
KY +++G+G G +A Q+VA++ + + E + E+ +++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIR---QMNLQQQPKKELIINEILVMRE- 73
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ + ++V + D+ + +++VME GG L D + E A+ + L + F
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEF 131
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
H V+HRD+K +N L D ++L DFG I P++ + + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 327 HR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEA 384
R +Y + DIWS+G+++ ++ G P+ E+ + L + +L P +S
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 385 KDFVKRLLNKDYRKRMTAVQALTHPWLR 412
+DF+ R L+ D KR +A + L H +L+
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 72/268 (26%), Positives = 135/268 (50%), Gaps = 17/268 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
KY +++G+G G +A Q+VA+K + + E + E+ +++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIA---TGQEVAIK---QMNLQQQPKKELIINEILVMRE- 72
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ + ++V + D+ + +++VME GG L D + E A+ + L + F
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALDF 130
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
H V+HRD+K +N L D ++L DFG I P++ + + +VG+ Y++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 327 HR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEA 384
R +Y + DIWS+G+++ ++ G P+ E+ + L + +L P +S
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPERLSAVF 245
Query: 385 KDFVKRLLNKDYRKRMTAVQALTHPWLR 412
+DF+ R L D +R +A + L HP+L+
Sbjct: 246 RDFLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 81/281 (28%), Positives = 130/281 (46%), Gaps = 24/281 (8%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
K KY + + +G G G A+ + AVK++ M+ A + EV
Sbjct: 28 KEQAKKYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDMEGMSEA-DKNRAQAEVC 83
Query: 203 IL------KALSGHKHLVKFCDAC-EDVNNVYIVMELCEGGELLDRI--LARGGR-YTEE 252
L + H+ K E+V + +V++ G+L I A+ R + E
Sbjct: 84 CLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH 143
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR---PDE 309
+A + +Q+L V H + ++HRD+K N L S + ++L DFG S D+
Sbjct: 144 EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVSDD 200
Query: 310 RLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS 368
G+ YYVAPE+ R YS +AD++S+GV+ Y LL RPF + L
Sbjct: 201 VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260
Query: 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
+D LP PS+SPE ++ V LL+ D ++R ++ + L P
Sbjct: 261 --RYDPLP-PSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 76/280 (27%), Positives = 121/280 (43%), Gaps = 45/280 (16%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E K +GRG FG + K A+KI+ KA M + +R E IL +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKADMLEKEQVGHIRAERDIL-VEA 58
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
+VK + +D N+Y++ME GG+++ +L + TEE+ + + + + +
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMT-LLMKKDTLTEEETQFYIAETVLAIDSI 117
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER------LN---------- 312
H G +HRD+KP+N L S ++L DFGL ++ R LN
Sbjct: 118 HQLGFIHRDIKPDNLLLDS---KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 313 --------------------DIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSR 351
VG+ Y+APEV + Y+ D WS+GVI Y +L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 352 PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
PF + T ++ V+ P +S +AKD + R
Sbjct: 235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRF 274
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 82/318 (25%), Positives = 139/318 (43%), Gaps = 72/318 (22%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA-KMTTAISIEDVRREVKILKA 206
+Y+ K +G G G C+A + Q VA+K +S+ + T + RE+ ++K
Sbjct: 17 RYQNLKPIGSGAQGIVCAA---YDTVTGQNVAIKKLSRPFQNVT--HAKRAYRELVLMKL 71
Query: 207 LSGHKHLVKFCDA------CEDVNNVYIVME-----LCEGGEL-LDRILARGGRYTEEDA 254
++ HK+++ + E+ +VY+VME LC+ ++ LD E
Sbjct: 72 VN-HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD----------HERM 120
Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI 314
++ Q+L + H G++HRDLKP N + + D ++++DFGL+ +
Sbjct: 121 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY 177
Query: 315 VGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPF--------WAR------TES 359
V + YY APEV L Y DIWS+G I ++ G+ F W + T S
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237
Query: 360 GIF--------RAVLRSDPN---------FDDLPWPSVSPE--------AKDFVKRLLNK 394
F R + + P F D+ +P S A+D + ++L
Sbjct: 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI 297
Query: 395 DYRKRMTAVQALTHPWLR 412
D KR++ AL HP++
Sbjct: 298 DPEKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 69/253 (27%), Positives = 121/253 (47%), Gaps = 23/253 (9%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G+G FG A K D+ A+KI+ K + +E E ++L L
Sbjct: 8 LGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
+ + V+ +Y VME GG+L+ I + G++ E A +I + F H +G++
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123
Query: 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV------GSAYYVAPEVL-H 327
+RDLK +N + S + +++ DFG+ E + D V G+ Y+APE++ +
Sbjct: 124 YRDLKLDNVMLDS---EGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAPEIIAY 175
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
+ Y D W+ GV+ Y +L G PF E +F++++ + ++ S+S EA
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSI 231
Query: 388 VKRLLNKDYRKRM 400
K L+ K KR+
Sbjct: 232 CKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 86/301 (28%), Positives = 125/301 (41%), Gaps = 50/301 (16%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+YE E+G G +G AR VA+K + + + VR EV +LK L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRL 56
Query: 208 SG--HKHLVKFCDACEDVNN-----VYIVMELCEGG--ELLDRILARGGRYTEEDAKAIV 258
H ++V+ D C V +V E + LD++ G E K ++
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLM 114
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
Q L + F H +VHRDLKPEN L TSG ++L DFGL+ L +V +
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIYSCQMALTPVVVTL 171
Query: 319 YYVAPEVLHRS-YSLEADIWSIGVI------SYILLCGSRPFWARTESGIFRAVLRSDPN 371
+Y APEVL +S Y+ D+WS+G I L CG+ A IF + P
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLI--GLPP 227
Query: 372 FDDLPW---------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
DD P P + + +L + KR++A +AL HP+
Sbjct: 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287
Query: 411 L 411
Sbjct: 288 F 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 26/273 (9%)
Query: 149 YELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
+ LGK +GRG FG + C EL +QV S+ T+ + + E+++LK
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE---TSKEVNALECEIQLLKN 60
Query: 207 LSGHKHLVKF--CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
L H +V++ C + + I +E GG + D++ A G TE + QIL
Sbjct: 61 LR-HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQG 118
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFIR----PDERLNDIVGSAY 319
V++ H +VHRD+K N L RD A +++L DFG S I+ + + G+ Y
Sbjct: 119 VSYLHSNMIVHRDIKGANIL----RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 320 YVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLP 376
+++PEV+ Y +AD+WS+ + + + +P WA E + IF+ + + P LP
Sbjct: 175 WMSPEVISGEGYGRKADVWSVAC-TVVEMLTEKPPWAEYEAMAAIFK--IATQPTKPMLP 231
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
VS +DF+K++ ++ R R TA L HP
Sbjct: 232 -DGVSDACRDFLKQIFVEEKR-RPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 71/270 (26%), Positives = 134/270 (49%), Gaps = 24/270 (8%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
+++G+G FG + + + VA+KII + IED+++E+ +L +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQ---KVVAIKIIDLEEAED--EIEDIQQEITVLSQCDS-PY 63
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+ K+ + ++I+ME GG LD L G E I+ +IL + + H +
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS-Y 330
+HRD+K N L + + +++L DFG++ + + + N VG+ +++APEV+ +S Y
Sbjct: 122 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 331 SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV----SPEAKD 386
+ADIWS+G+ + L G P + + +++P P++ S K+
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------PTLEGNYSKPLKE 231
Query: 387 FVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416
FV+ LNK+ R TA + L H ++ ++
Sbjct: 232 FVEACLNKEPSFRPTAKELLKHKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 80/319 (25%), Positives = 130/319 (40%), Gaps = 79/319 (24%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
K+++ ++G G +G AR K + VA+K + I +R E+KIL+ L
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDK---DTGELVALKKVRLDNEKEGFPITAIR-EIKILRQL 63
Query: 208 SGHKHLVKFCDAC----------EDVNNVYIVME--------LCEGGELLDRILARGGRY 249
+ H+++V + +D Y+V E L E G L+ +
Sbjct: 64 N-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVH--------F 113
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
+E+ K+ + Q+L + +CH + +HRD+K N L + ++L DFGL+ +E
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEE 170
Query: 310 R--LNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYIL------------------- 346
+ V + +Y PE+L Y D+WS G I L
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
Query: 347 --LCGSR-----------PFWARTE-SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392
LCGS P++ + +R LR + F +P A D + +L
Sbjct: 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE--FSFIP-----TPALDLLDHML 283
Query: 393 NKDYRKRMTAVQALTHPWL 411
D KR TA +AL PWL
Sbjct: 284 TLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-18
Identities = 77/289 (26%), Positives = 123/289 (42%), Gaps = 59/289 (20%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
K +G G FG C A L A+K + K + + V+ E IL A + ++
Sbjct: 7 KTLGIGAFGEVCLACKVDTHAL----YAMKTLRKKDVLNRNQVAHVKAERDIL-AEADNE 61
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
+VK + +D +N+Y VM+ GG+++ +L R + E A+ + ++ + H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGL--------------------SDFIRPDERL 311
G +HRD+KP+N L D ++L DFGL D + P +
Sbjct: 121 GFIHRDIKPDNILIDL---DGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 312 NDI----------------------------VGSAYYVAPEVLHRS-YSLEADIWSIGVI 342
+D+ VG+ Y+APEVL R Y+ D WS+GVI
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
+ +L G PF A T + V+ + P +SPEA D + +L
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 83/286 (29%), Positives = 135/286 (47%), Gaps = 41/286 (14%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
+N +EL + +G G +G AR GEL A+K+I K+ V++E+
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGEL----AAIKVI---KLEPGEDFAVVQQEI 57
Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
++K H ++V + + + ++I ME C GG L D I G +E + +
Sbjct: 58 IMMKDCK-HSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRET 115
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYY 320
L + + H +G +HRD+K N L T D+ ++L DFG+S I + +G+ Y+
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYW 172
Query: 321 VAPEV--LHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIF-----RAV-LRSDP 370
+APEV + R Y+ DIW++G+ + L A + +F RA+ L +
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIEL--------AELQPPMFDLHPMRALFLMTKS 224
Query: 371 NF------DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
NF D + W S FVK L K+ +KR TA + L HP+
Sbjct: 225 NFQPPKLKDKMKW---SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 78/326 (23%), Positives = 137/326 (42%), Gaps = 67/326 (20%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED-----------VRR 199
G +G G +G A L + VA+K + +++ ++ + R
Sbjct: 13 KGAHLGEGTYGKVEKAYDT---LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
E+KI+ + H++++ D + + + +VM++ L +++ R R TE K I++
Sbjct: 70 ELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILL 126
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS---------------DF 304
QIL+ + H +HRDL P N ++ DFGL+ +
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFIN---SKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 305 IRPDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTE---- 358
++ E + V + +Y APE+L + Y D+WS+G I LL G F E
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243
Query: 359 SGIFRAVLRSDPNFDDLP----------------------WPSVSPEAKDFVKRLLNKDY 396
IF L PN D+ P +P+ S +A D ++ LL +
Sbjct: 244 GRIFE--LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP 301
Query: 397 RKRMTAVQALTHPWLRDDSRPVPLDI 422
+R++A +AL H + + D P+P D
Sbjct: 302 LERISAKEALKHEYFKSD--PLPCDP 325
|
Length = 335 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 44/233 (18%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ--QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
L +E+G G FG E ++ VAVK + + + + +D RE ++L
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKE--TASNDARKDFEREAELLTNF- 65
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-------------GRYTEEDAK 255
H+++VKF C + + +V E E G+L + + G G T
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
I VQI S + + Q VHRDL N L D +++ DFG+S D+
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMS---------RDVY 173
Query: 316 GSAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFW 354
+ YY + PE +++R ++ E+D+WS GV+ + I G +P++
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 153 KEVGRGHFGHTCSAR-----GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
K++G GHFG R GE QVAVK ++ D RE++IL+ L
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGE----QVAVKSLNH--SGEEQHRSDFEREIEILRTL 63
Query: 208 SGHKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQIL 262
H+++VK+ CE ++ ++ME G L R + R + + K ++ QI
Sbjct: 64 D-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHR-DQINLKRLLLFSSQIC 119
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGS-A 318
+ + Q +HRDL N L S + +++ DFGL+ + D+ + + S
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVES---EDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 319 YYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPF 353
++ APE L +S +D+WS GV Y L P
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 84/309 (27%), Positives = 129/309 (41%), Gaps = 63/309 (20%)
Query: 150 ELGKEVGRGHFGHTCSAR----GKKGELKDQQVAVKIISKAKMTTA----ISIEDVRREV 201
E + +G G FG S GK+ LK KM +S + V RE+
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALK------------KMPNVFQNLVSCKRVFREL 50
Query: 202 KILKALSGHKHLVKFCDACEDVN-----NVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
K+L H +++ D + + +Y+V EL + L +I+ + + K
Sbjct: 51 KMLCFFK-HDNVLSALDILQPPHIDPFEEIYVVTELMQSD--LHKIIVSPQPLSSDHVKV 107
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI-- 314
+ QIL + + H G++HRD+KP N L S + +++ DFGL+ PDE +
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQE 164
Query: 315 VGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE-------------- 358
V + YY APE+L R Y+ DIWS+G I LL F A++
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224
Query: 359 ---------SGIFRAVLRSDPNFDDLPW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
G +LR LP + EA + R+L D KR++A
Sbjct: 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD 284
Query: 405 ALTHPWLRD 413
AL HP+L +
Sbjct: 285 ALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 64/254 (25%), Positives = 114/254 (44%), Gaps = 45/254 (17%)
Query: 175 DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234
Q++ V+ I KAK AI E + + + + + +K + + ++M+ +
Sbjct: 40 TQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK 92
Query: 235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294
G+L D +L + G+ +E + K I+ Q++ + H ++H D+K EN L+ +D +
Sbjct: 93 DGDLFD-LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDR--I 149
Query: 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISYILLCGSRPF 353
L D+GL I D G+ Y +PE + +Y + D W++GV++Y LL G PF
Sbjct: 150 YLCDYGLCK-IIGTPSCYD--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206
Query: 354 WARTESGIFRAVLRSDPNFD--------------DLPWPS-VSPEAKDFVKRLLNKDYRK 398
+ D LP+ VS A DFV+ +L +
Sbjct: 207 ---------------KEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINY 251
Query: 399 RMTAV-QALTHPWL 411
R+T + + HP+L
Sbjct: 252 RLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 78/270 (28%), Positives = 123/270 (45%), Gaps = 22/270 (8%)
Query: 155 VGRGHFGHTCS----ARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
+G+G FG C+ A GK K ++ K I K K A+++ E +IL+ ++
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRK-GEAMALN----EKQILEKVNS- 59
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCH 269
+ +V A E + + +V+ L GG+L I G + EE A +I + H
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HR 328
+ +V+RDLKPEN L D +R+ D GL+ I E + VG+ Y+APEV+ +
Sbjct: 120 RERIVYRDLKPENILLD---DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE 176
Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFV 388
Y+ D W +G + Y ++ G PF R E V R + S A+
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236
Query: 389 KRLLNKDYRKRM-----TAVQALTHPWLRD 413
++LL KD R+ A + HP+ R
Sbjct: 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-18
Identities = 73/223 (32%), Positives = 109/223 (48%), Gaps = 16/223 (7%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR---YTEEDA 254
R E+ L A H +VK D + + + ++ME GG+L +I R + E +
Sbjct: 113 RSELHCLAACD-HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171
Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPEN-FLFTSGRDDADMRLIDFGLSDFIRPDERLN- 312
+ QI+ + H + ++HRDLK N FL +G ++L DFG S L+
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI----IKLGDFGFSKQYSDSVSLDV 227
Query: 313 --DIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
G+ YY+APE+ R YS +AD+WS+GVI Y LL RPF ++ I + VL
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG- 286
Query: 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
+D P P VS K + LL+K+ R T Q L +L+
Sbjct: 287 -KYDPFPCP-VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 66/269 (24%), Positives = 110/269 (40%), Gaps = 68/269 (25%)
Query: 199 REVKILKALSGHK----HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA 254
RE+K+L H+ ++V F A + I ME +GG L D++L + GR E
Sbjct: 48 RELKVL-----HECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPE--- 98
Query: 255 KAIVVQILSVVAFCHLQG---------VVHRDLKPENFLFTSGRDDADMRLIDFGLS-DF 304
IL ++ L+G ++HRD+KP N L S +++L DFG+S
Sbjct: 99 -----NILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQL 150
Query: 305 IRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGI-- 361
I D N VG+ Y++PE L + Y++++DIWS+G+ + G P +
Sbjct: 151 I--DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208
Query: 362 -----------FRAVLRSDPNFDD---------------------LPWPSVSPEAKDFVK 389
+ + D LP + S E +DFV
Sbjct: 209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVD 268
Query: 390 RLLNKDYRKRMTAVQALTHPWLRDDSRPV 418
+ L K+ ++R + HP+++
Sbjct: 269 KCLKKNPKERADLKELTKHPFIKRAELEE 297
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 76/277 (27%), Positives = 123/277 (44%), Gaps = 24/277 (8%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
E+G G FG A ++ VAVK +S + T +D+ +EVK L+ L H +
Sbjct: 28 EIGHGSFGAVYFATNSH---TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNT 83
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
+++ + ++VME C G D + E + AI L +A+ H +
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL----HRS 329
+HRD+K N L T + ++L DFG + P N VG+ Y++APEV+
Sbjct: 143 IHRDIKAGNILLT---EPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQ 196
Query: 330 YSLEADIWSIGVISYILLCGSRP--FWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
Y + D+WS+G I+ I L +P F S ++ P W + + F
Sbjct: 197 YDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRGF 252
Query: 388 VKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
V L K ++R + + L H ++R D P +LI
Sbjct: 253 VDYCLQKIPQERPASAELLRHDFVRRDR---PARVLI 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 8e-18
Identities = 68/242 (28%), Positives = 109/242 (45%), Gaps = 31/242 (12%)
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
RE++I+ ++V F A + NN+ + ME + G L DRI +GG E I
Sbjct: 52 RELQIMHECRS-PYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIA 109
Query: 259 VQILSVVAFCH-LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--- 314
V ++ + + + + ++HRD+KP N L S ++L DFG+S E +N I
Sbjct: 110 VAVVEGLTYLYNVHRIMHRDIKPSNILVNS---RGQIKLCDFGVSG-----ELINSIADT 161
Query: 315 -VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES--------GIF-- 362
VG++ Y++PE + Y++++D+WS+G+ L G PF GI
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL 221
Query: 363 --RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPL 420
+ V P LP + +DFV L KD +R T Q P R +
Sbjct: 222 LQQIVQEPPPR---LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
Query: 421 DI 422
D+
Sbjct: 279 DL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 81/307 (26%), Positives = 136/307 (44%), Gaps = 55/307 (17%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKILK 205
+Y++ + +G+G +G CSA ++VA+K I+ ++ A I RE+K+L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSA---IDTHTGEKVAIKKINDVFEHVSDATRI---LREIKLLR 54
Query: 206 ALSGHKHLVK-----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
L H +V+ + + ++Y+V EL E L +++ T E + + Q
Sbjct: 55 LLR-HPDIVEIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHHQFFLYQ 111
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDIVG 316
+L + + H V HRDLKP+N L + D +++ DFGL+ D D V
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 317 SAYYVAPEV---LHRSYSLEADIWSIGVISYILLCGSRPFW------------------- 354
+ +Y APE+ Y+ DIWSIG I +L G +P +
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLITDLLGTP 227
Query: 355 -----ARTESGIFRAVLRSDPNFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
+R + R L S +P +P+ P A ++RLL D + R TA +A
Sbjct: 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA 287
Query: 406 LTHPWLR 412
L P+ +
Sbjct: 288 LADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 38/274 (13%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G+G +G +AR ++ ++A+K I + ++ + E+ + L H+++V
Sbjct: 16 LGKGTYGIVYAARDLSTQV---RIAIKEIPERDSR---YVQPLHEEIALHSYLK-HRNIV 68
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV--QILSVVAFCHLQG 272
++ + + I ME GG L + ++ G + + I QIL + + H
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 273 VVHRDLKPENFLFT--SGRDDADMRLIDFGLSDFIRPDERLNDI-------VGSAYYVAP 323
+VHRD+K +N L SG +++ DFG S +RL I G+ Y+AP
Sbjct: 129 IVHRDIKGDNVLVNTYSGV----VKISDFGTS------KRLAGINPCTETFTGTLQYMAP 178
Query: 324 EVLH---RSYSLEADIWSIGVISYILLCGSRPFW--ARTESGIFR-AVLRSDPNFDDLPW 377
EV+ R Y ADIWS+G + G PF ++ +F+ + + P +
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE--- 235
Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
S+S EAK+F+ R D KR +A L P+L
Sbjct: 236 -SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 71/274 (25%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED--VRREVKILKA 206
Y + VG+G +G R + Q V I K + A E +E ++L
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRT--DGKQYV----IKKLNLRNASRRERKAAEQEAQLLSQ 55
Query: 207 LSGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSV 264
L H ++V + ++ E + +YIVM CEGG+L ++ + G+ E VQI
Sbjct: 56 LK-HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA 114
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND----IVGSAYY 320
+ + H + ++HRDLK +N T +I G R E D ++G+ YY
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTR------TNIIKVGDLGIARVLENQCDMASTLIGTPYY 168
Query: 321 VAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWAR-TESGIFRAVLRSDPNFDDLPWP 378
++PE+ ++ Y+ ++D+W++G Y + F A+ S ++R + P P P
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-----PMP 223
Query: 379 S-VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
SPE + + +L+K KR + L P++
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 74/291 (25%), Positives = 130/291 (44%), Gaps = 23/291 (7%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G+G FG C+ + + + A K + K ++ E +IL+ ++ + +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS-RFVV 63
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGV 273
A E + + +V+ L GG+L I G + E A +I + H + +
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYSL 332
V+RDLKPEN L D +R+ D GL+ + + + VG+ Y+APEV+ + Y+
Sbjct: 124 VYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392
D W++G + Y ++ G PF R + V R + SP+A+ K LL
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240
Query: 393 NKDYRKRM-----TAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHATPFK 438
KD ++R+ A + HP + + FK +++ + PFK
Sbjct: 241 CKDPKERLGCQGGGAREVKEHPLFKQ---------INFKRLEAGMLEPPFK 282
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 75/278 (26%), Positives = 128/278 (46%), Gaps = 22/278 (7%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
+E+G G FG AR + ++ VA+K +S + + +D+ +EVK L+ + H +
Sbjct: 31 REIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPN 86
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+++ + ++VME C G D + E + AI L +A+ H
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL----HR 328
++HRD+K N L T + ++L DFG + P N VG+ Y++APEV+
Sbjct: 146 MIHRDIKAGNILLT---EPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEG 199
Query: 329 SYSLEADIWSIGVISYILLCGSRP--FWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
Y + D+WS+G I+ I L +P F S ++ P W S ++
Sbjct: 200 QYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRN 255
Query: 387 FVKRLLNKDYRKRMTAVQALTHPW-LRDDSRPVPLDIL 423
FV L K + R T+ + L H + LR+ V +D++
Sbjct: 256 FVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLI 293
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
KE+G G FG G+ + Q +VA+K I++ M S ED E K++ LS H
Sbjct: 10 KELGSGQFGVV-----HLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HP 59
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
LV+ C +YIV E E G LL+ + R G+ +++ ++ + + +
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV---APEVLHR 328
+HRDL N L + +++ DFG++ ++ DE + G+ + V PEV +
Sbjct: 120 SFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNF 175
Query: 329 S-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSD 369
S YS ++D+WS GV+ + + G PF ++ + + R
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 71/278 (25%), Positives = 126/278 (45%), Gaps = 22/278 (7%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
+E+G G FG AR + + VA+K +S + + +D+ +EV+ L+ L H +
Sbjct: 21 REIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPN 76
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+++ + ++VME C G D + E + A+ L +A+ H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL----HR 328
++HRD+K N L + + ++L DFG + + P N VG+ Y++APEV+
Sbjct: 136 MIHRDVKAGNILLS---EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEG 189
Query: 329 SYSLEADIWSIGVISYILLCGSRP--FWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
Y + D+WS+G+ I L +P F S ++ P W S ++
Sbjct: 190 QYDGKVDVWSLGITC-IELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRN 245
Query: 387 FVKRLLNKDYRKRMTAVQALTHPWL-RDDSRPVPLDIL 423
FV L K + R T+ L H ++ R+ V +D++
Sbjct: 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 79/286 (27%), Positives = 122/286 (42%), Gaps = 52/286 (18%)
Query: 168 GKKGE-----------LKDQQ-VAVKIISKAKMTTAISIEDVR--REVKILKALSGHKHL 213
GK GE K + A+K + K S+E V RE++ L+ LS H ++
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 214 VKFCDACED--VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
++ + D + +V EL + L + I R E+ K+ + Q+L + H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS-- 329
G+ HRD+KPEN L D ++L DFG I + + + +Y APE L
Sbjct: 120 GIFHRDIKPENILI----KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGY 175
Query: 330 YSLEADIWSIGVISYILLCGSRPFWARTE----SGI--------------FRAVLRSDPN 371
Y + DIW++G + + +L F E + I FR + N
Sbjct: 176 YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235
Query: 372 FDD-----LPW--PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
F L P+ S E D +K+LL D +R+TA QAL HP+
Sbjct: 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 5e-17
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
KE+G G FG K G+ + Q VA+K+I + M S ++ E K++ LS H+
Sbjct: 10 KELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HE 59
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
LV+ C +YIV E G LL+ + G R+ + + +A+ +
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV---APEVLHR 328
+HRDL N L D +++ DFGLS ++ DE + VGS + V PEVL
Sbjct: 120 QFIHRDLAARNCLVD---DQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLY 175
Query: 329 S-YSLEADIWSIGVISY-ILLCGSRPF 353
S +S ++D+W+ GV+ + + G P+
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-17
Identities = 84/309 (27%), Positives = 139/309 (44%), Gaps = 57/309 (18%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+Y+ K +G G G C+A + VAVK +S+ + RE+ +LK +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDT---VLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCV 77
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
+ HK+++ + + E+ +VY+VMEL + L +++ E ++ Q+
Sbjct: 78 N-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHM--ELDHERMSYLLYQM 132
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
L + H G++HRDLKP N + S D ++++DFGL+ + + V + YY
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRYYR 189
Query: 322 APEV-LHRSYSLEADIWSIGVISYILLCGSRPF--------WAR------TESGIFRAVL 366
APEV L Y DIWS+G I L+ GS F W + T S F L
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249
Query: 367 R--------SDPN---------FDDLPWPSVS-------PEAKDFVKRLLNKDYRKRMTA 402
+ + P F D +PS S +A+D + ++L D KR++
Sbjct: 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV 309
Query: 403 VQALTHPWL 411
+AL HP++
Sbjct: 310 DEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 7e-17
Identities = 77/309 (24%), Positives = 136/309 (44%), Gaps = 57/309 (18%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+Y+ K +G G G C+A + D+ VA+K +S+ + RE+ ++K +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 73
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
+ HK+++ + + E+ +VY+VMEL + L +++ E ++ Q+
Sbjct: 74 N-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 128
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
L + H G++HRDLKP N + S D ++++DFGL+ + V + YY
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 322 APEV-LHRSYSLEADIWSIGVI------SYILLCGSR----------------PFWARTE 358
APEV L Y DIWS+G I IL G P + +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 359 SGIFRAVLRSDPNFDDLPWPSVSP----------------EAKDFVKRLLNKDYRKRMTA 402
R + + P + L +P + P +A+D + ++L D KR++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 403 VQALTHPWL 411
+AL HP++
Sbjct: 306 DEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-17
Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 21/260 (8%)
Query: 176 QQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDA--CEDVNNVYIVMELC 233
+VA+K++ RRE + L H ++V D+ ++ V E
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPP-GLLFAVFEYV 61
Query: 234 EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD 293
G L + LA G + +++Q+L +A H QG+VHRDLKP+N + +
Sbjct: 62 PGRTLREV-LAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 294 MRLIDFG----LSDFIRPDE----RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISY 344
+++DFG L D R +++G+ Y APE L + +D+++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 345 ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
L G R + + I L PW + P +++ LNKD R+R +
Sbjct: 181 ECLTGQRVVQGASVAEILYQQLSPVD-VSLPPWIAGHPLG-QVLRKALNKDPRQRAASAP 238
Query: 405 ALTHPWLRDDSRPVPLDILI 424
AL R R + L L+
Sbjct: 239 AL---AER--FRALELCALV 253
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 21/271 (7%)
Query: 155 VGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
+G+G FG + + + G+L A K ++K ++ E E +IL + + +
Sbjct: 1 LGKGGFGEVSACQMRATGKL----YACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFI 55
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRIL---ARGGRYTEEDAKAIVVQILSVVAFCHL 270
V A + ++ +VM + GG+L I + E A QI+S + H
Sbjct: 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH-R 328
+ +++RDLKPEN L +D ++R+ D GL+ + + G+ ++APE+L
Sbjct: 116 RRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEAKDF 387
Y D +++GV Y ++ PF AR E + + + N D + +P SP +K F
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-DSVTYPDKFSPASKSF 231
Query: 388 VKRLLNKDYRKRM-----TAVQALTHPWLRD 413
+ LL KD KR+ THP RD
Sbjct: 232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 67/266 (25%), Positives = 118/266 (44%), Gaps = 14/266 (5%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G+G FG C+ + + + A K + K ++ E +IL+ ++ + +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RFVV 63
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQGV 273
A E + + +V+ + GG+L I G + E+ A ++ + + +
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYSL 332
V+RDLKPEN L D +R+ D GL+ I E + VG+ Y+APEV+ + Y+
Sbjct: 124 VYRDLKPENILLD---DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180
Query: 333 EADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392
D W +G + Y ++ G PF R E V R + S +AK + LL
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240
Query: 393 NKDYRKRM-----TAVQALTHPWLRD 413
K+ ++R+ A HP ++
Sbjct: 241 TKNPKERLGCRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 150 ELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRREVKILKA 206
GK +G G FG +A G +VAVK++ A + E + E+KI+
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER---EALMSELKIMSH 94
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVV 265
L H+++V AC + ++ E C G+LL+ + + + T ED + Q+ +
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV-GSAY----Y 320
AF + +HRDL N L T G+ +++ DFGL+ I D N +V G+A +
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLARDIMNDS--NYVVKGNARLPVKW 209
Query: 321 VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
+APE + + Y+ E+D+WS G++ + I GS P+
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 57/296 (19%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKII----SKAKMTTAISIEDVRREVKILKALSG 209
++G G + R K L D VA+K I + TAI REV +LK L
Sbjct: 13 KLGEGTYATVYKGRSK---LTDNLVALKEIRLEHEEGAPCTAI------REVSLLKDLK- 62
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR-----GGRYTEEDAKAIVVQILSV 264
H ++V D ++ +V E LD+ L + G + K + Q+L
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEY------LDKDLKQYLDDCGNSINMHNVKLFLFQLLRG 116
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAP 323
+ +CH + V+HRDLKP+N L + +++L DFGL+ P + ++ V + +Y P
Sbjct: 117 LNYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173
Query: 324 EVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAV----------LR 367
++L S YS + D+W +G I Y + G F T IFR + +
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233
Query: 368 SDPNFDDLPWPSVSPEA------------KDFVKRLLNKDYRKRMTAVQALTHPWL 411
S+ F +P + + + +LL + RKR++A +A+ HP+
Sbjct: 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 77/309 (24%), Positives = 138/309 (44%), Gaps = 57/309 (18%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+Y+ K +G G G C+A + ++ VA+K +S+ + RE+ ++K +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 80
Query: 208 SGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
+ HK+++ + + E+ +VYIVMEL + L +++ E ++ Q+
Sbjct: 81 N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLYQM 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
L + H G++HRDLKP N + S D ++++DFGL+ + V + YY
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 322 APEV-LHRSYSLEADIWSIGVISYILLCGSRPF--------WARTESGI----------- 361
APEV L Y DIWS+G I ++ G F W + +
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252
Query: 362 ---FRAVLRSDPN---------FDDLPWPSVS-------PEAKDFVKRLLNKDYRKRMTA 402
R + + P F D+ +P+ S +A+D + ++L D KR++
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 403 VQALTHPWL 411
+AL HP++
Sbjct: 313 DEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 61/214 (28%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
L +E+G G FG L+ ++VA+K I + M S ED E +++ LS H
Sbjct: 8 LVQEIGSGQFGLV----WLGYWLEKRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-H 58
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
LV+ C + + + +V E E G L D + A+ G++++E + + + +A+
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV---APEVLH 327
V+HRDL N L ++ +++ DFG++ F+ D++ G+ + V +PEV
Sbjct: 119 SNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFS 174
Query: 328 RS-YSLEADIWSIGVISYILLC-GSRPFWARTES 359
S YS ++D+WS GV+ + + G P+ R+ S
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 23/198 (11%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+LG +G+G FG G+ + Q+VAVK + K T A + E ++ L
Sbjct: 9 KLGATIGKGEFGDV-----MLGDYRGQKVAVKCL-KDDSTAAQAFLA---EASVMTTLR- 58
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H +LV+ N +YIV E G L+D + +R GR A+ + + +
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEY 117
Query: 270 LQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AYYVAPEV 325
L+ VHRDL N L + +D ++ DFGL+ + G + APE
Sbjct: 118 LEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEA 170
Query: 326 L-HRSYSLEADIWSIGVI 342
L + +S ++D+WS G++
Sbjct: 171 LREKKFSTKSDVWSFGIL 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 75/295 (25%), Positives = 131/295 (44%), Gaps = 44/295 (14%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
K+E+ VG G +G R K+ + VA+K ++ + E RE+K+L+ L
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSEENEEVK-ETTLRELKMLRTL 57
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVV 265
+++V+ +A +Y+V E E ELL+ + G E ++ + Q++ +
Sbjct: 58 K-QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE-MPNGV--PPEKVRSYIYQLIKAI 113
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP--DERLNDIVGSAYYVAP 323
+CH +VHRD+KPEN L + + ++L DFG + + + + V + +Y +P
Sbjct: 114 HWCHKNDIVHRDIKPENLLISH---NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170
Query: 324 EVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR--------------S 368
E+L + Y D+WS+G I L G F +E + + S
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230
Query: 369 DPNFDDLPWPSVS-PEA-------------KDFVKRLLNKDYRKRMTAVQALTHP 409
+P F L +P+V+ P++ D +K LL + R Q L HP
Sbjct: 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 84/316 (26%), Positives = 139/316 (43%), Gaps = 60/316 (18%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKII----SKAKMTTAISIEDVRREVKILKALS 208
+++G G + R K L + VA+K I + TAI REV +LK L
Sbjct: 12 EKLGEGTYATVFKGRSK---LTENLVALKEIRLEHEEGAPCTAI------REVSLLKDLK 62
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR-----GGRYTEEDAKAIVVQILS 263
H ++V D ++ +V E LD+ L + G + + K + QIL
Sbjct: 63 -HANIVTLHDIVHTDKSLTLVFEY------LDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVA 322
+A+CH + V+HRDLKP+N L + +++L DFGL+ P + ++ V + +Y
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172
Query: 323 PEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAV----------L 366
P+VL S YS + D+W +G I + + G F T IFR + +
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232
Query: 367 RSDPNFDDLPWPSVSP------------EAKDFVKRLLNKDYRKRMTAVQALTHPWLRD- 413
S+ F + +P P E + + + L + +KR++A +A+ H + R
Sbjct: 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292
Query: 414 --DSRPVPLDILIFKL 427
+P I IF L
Sbjct: 293 GTRIHSLPESISIFSL 308
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 53/281 (18%)
Query: 170 KGELKDQQVAVKIIS----KAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225
+ +L Q VA+K I + TAI RE +LK L H ++V D
Sbjct: 25 RSKLTGQLVALKEIRLEHEEGAPFTAI------REASLLKDLK-HANIVTLHDIIHTKKT 77
Query: 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLF 285
+ +V E + +L + GG + + + + Q+L +A+CH + V+HRDLKP+N L
Sbjct: 78 LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI 136
Query: 286 TSGRDDADMRLIDFGLSDFIR----PDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSI 339
+ + +++L DFGL+ R P + ++ V + +Y P+VL S YS D+W +
Sbjct: 137 S---ERGELKLADFGLA---RAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGV 190
Query: 340 GVISYILLCGSRPFWARTESG-----IFRAV----------LRSDPNFDDLP-------- 376
G I Y + G F T+ IFR + + S+P F
Sbjct: 191 GCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRP 250
Query: 377 ----WPSVS--PEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
P + P ++ + L + +KR++A +A+ HP+
Sbjct: 251 LINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 67/263 (25%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-----QVAVKIISKAKMTTAISIEDVRREVKILKAL 207
K++G G FG ++GE VAVK + K++ + D +E I+ +L
Sbjct: 1 KKLGDGSFGVV-----RRGEWSTSGGKVIPVAVKCLKSDKLSDIMD--DFLKEAAIMHSL 53
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV--------- 258
H++L++ + + +V EL G LLDR+ +DA
Sbjct: 54 D-HENLIRLYGVVLT-HPLMMVTELAPLGSLLDRL--------RKDALGHFLISTLCDYA 103
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
VQI + + + + +HRDL N L S +++ DFGL L
Sbjct: 104 VQIANGMRYLESKRFIHRDLAARNILLASDD---KVKIGDFGLM------RALPQ--NED 152
Query: 319 YYV------------APEVL-HRSYSLEADIWSIGV-----ISYILLCGSRPFWARTESG 360
+YV APE L R++S +D+W GV +Y G P+ + S
Sbjct: 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTY----GEEPWAGLSGSQ 208
Query: 361 IFRAVLRSDPNFDDLPWPSVSPE 383
I + + D + L P P+
Sbjct: 209 ILKKI---DKEGERLERPEACPQ 228
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 19/223 (8%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
L +++G G FG +VAVK + M S E +E +I+K L H
Sbjct: 10 LERKLGAGQFGEVWMGTW----NGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-H 60
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAFCH 269
LV+ C + +YIV E G LLD + + G+ + QI +A+
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-V 325
+ +HRDL N L ++ DFGL+ I DE G+ + + APE
Sbjct: 121 SRNYIHRDLAARNILVGENL---VCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAA 176
Query: 326 LHRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
+ +++++D+WS G++ I+ G P+ T + V R
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+YE E+G G +G AR K + VA+K + + + +R EV +L+ L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHL 58
Query: 208 SG--HKHLVKFCDAC-----EDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIV 258
H ++V+ D C + + +V E + LD++ G E K ++
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMM 116
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
Q+L + F H VVHRDLKP+N L TS ++L DFGL+ L +V +
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQMALTSVVVTL 173
Query: 319 YYVAPEV-LHRSYSLEADIWSIGVI 342
+Y APEV L SY+ D+WS+G I
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCI 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 21/196 (10%)
Query: 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288
+++L GG+L L++ G ++E + + +I+ + H + VV+RDLKP N L
Sbjct: 75 ILDLMNGGDL-HYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-- 131
Query: 289 RDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYI 345
+ +R+ D GL+ DF + ++ + VG+ Y+APEVL + +Y AD +S+G + +
Sbjct: 132 -EHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 188
Query: 346 LLCGSRPF---WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRM-- 400
LL G PF + + I R L D S SPE + ++ LL +D +R+
Sbjct: 189 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELRSLLEGLLQRDVNRRLGC 244
Query: 401 ---TAVQALTHPWLRD 413
A + HP+ R
Sbjct: 245 LGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 153 KEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
+++G GHFG R +G+ +QVAVK S + I D+++E++IL+ L H+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLY-HE 66
Query: 212 HLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
++VK+ C + N + ++ME G L + + + + VQI + +
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL----NDIVGSAYYVAPEV 325
+ VHRDL N L S + +++ DFGL+ I D+ +D+ ++ APE
Sbjct: 127 SRQYVHRDLAARNVLVES---EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 326 L-HRSYSLEADIWSIGVISYILL 347
L + + +D+WS GV Y LL
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 67/252 (26%), Positives = 111/252 (44%), Gaps = 16/252 (6%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G+G FG C+ + K + A K + K ++ + E +IL+ ++ +V
Sbjct: 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIV 56
Query: 215 KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQGV 273
A E ++ +VM L GG+L I G R E E QI + H +
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYSL 332
V+RD+KPEN L D + RL D GL+ ++ + + G+ Y+APE+L YS
Sbjct: 117 VYRDMKPENVLLD---DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 333 EADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPWPSVSPEAKDFV 388
D +++G Y ++ G PF E + R L + F+ + + E+KD
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEH---QNFTEESKDIC 230
Query: 389 KRLLNKDYRKRM 400
+ L K R+
Sbjct: 231 RLFLAKKPEDRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 33/204 (16%)
Query: 153 KEVGRGHFGHTCSA--RGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
KE+G G+FG K G K+ +VAVK + + + ++ RE ++ L H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSG--KEVEVAVKTLKQEHIAA--GKKEFLREASVMAQLD-H 55
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
+V+ C+ + +VMEL G LL + R D K + Q+ +A+
Sbjct: 56 PCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLES 113
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY---------- 320
+ VHRDL N L + R A ++ DFG+S + GS YY
Sbjct: 114 KHFVHRDLAARNVLLVN-RHQA--KISDFGMSRALGA--------GSDYYRATTAGRWPL 162
Query: 321 --VAPEVLH-RSYSLEADIWSIGV 341
APE ++ +S ++D+WS GV
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGV 186
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 78/299 (26%), Positives = 125/299 (41%), Gaps = 56/299 (18%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII----SKAKMTTAISIEDVRREVKILK 205
+L K +G G + R K L + VA+K I + TAI REV +LK
Sbjct: 9 KLDK-LGEGTYATVFKGRSK---LTENLVALKEIRLEHEEGAPCTAI------REVSLLK 58
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILS 263
L H ++V D + +V E + + LD G + + K + Q+L
Sbjct: 59 NLK-HANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLR 114
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVA 322
+++CH + ++HRDLKP+N L + +++L DFGL+ P + ++ V + +Y
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 171
Query: 323 PEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSDPNFDDLP 376
P+VL S YS D+W +G I Y + G F T IFR L P + P
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR--LLGTPTEETWP 229
Query: 377 W------------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
P + + D + LL + + R++A AL H +
Sbjct: 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 225 NVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPE 281
+V+I ME+ + + ++ +G E+ I V I+ + + H + V+HRD+KP
Sbjct: 74 DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS 133
Query: 282 NFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-----HRSYSLEADI 336
N L + ++L DFG+S ++ G Y+APE + + Y +++D+
Sbjct: 134 NVLINR---NGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDV 190
Query: 337 WSIGVISYILLCGSRPF--WARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNK 394
WS+G+ L G P+ W + + V P LP SPE +DFV + L K
Sbjct: 191 WSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ---LPAEKFSPEFQDFVNKCLKK 247
Query: 395 DYRKRMTAVQALTHP 409
+Y++R + L HP
Sbjct: 248 NYKERPNYPELLQHP 262
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 67/255 (26%), Positives = 115/255 (45%), Gaps = 38/255 (14%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRR----EVKILKAL 207
+++G+G+FG KG LK +VAVK + T D++R E +ILK
Sbjct: 1 EKIGKGNFGDV-----YKGVLKGNTEVAVK---TCRSTL---PPDLKRKFLQEAEILKQY 49
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H ++VK C +YIVMEL GG LL + + R T + + + + + +
Sbjct: 50 D-HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY 108
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY------YV 321
+ +HRDL N L ++ +++ DFG+S R +E V +
Sbjct: 109 LESKNCIHRDLAARNCLVG---ENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWT 162
Query: 322 APEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
APE L+ Y+ E+D+WS G++ + G P+ + + R + + +P P
Sbjct: 163 APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRERIESGY-RMPAPQ 218
Query: 380 VSPEAKDFVKRLLNK 394
+ PE + RL+ +
Sbjct: 219 LCPEE---IYRLMLQ 230
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 71/254 (27%), Positives = 121/254 (47%), Gaps = 21/254 (8%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKILKALSGHKH 212
+GRG FG R + A+K + K KM ++ R + L +
Sbjct: 2 IGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+V A + + +++L GG+L L++ G ++E++ + +I+ + H +
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDL-HYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHR--S 329
VV+RDLKP N L + +R+ D GL+ DF + ++ + VG+ Y+APEVL + +
Sbjct: 118 VVYRDLKPANILLD---EHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTA 172
Query: 330 YSLEADIWSIGVISYILLCGSRPFW---ARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
Y AD +S+G + + LL G PF + + I R L + D S SPE K
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD----SFSPELKS 228
Query: 387 FVKRLLNKDYRKRM 400
++ LL +D KR+
Sbjct: 229 LLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 63/241 (26%), Positives = 108/241 (44%), Gaps = 23/241 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+L +++G G FG VAVK + M +D E +I+K L
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNN----TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR- 59
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFC 268
H L++ C +YIV EL + G LL+ + GR + + Q+ S +A+
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE- 324
Q +HRDL N L ++ ++ DFGL+ I+ D G+ + + APE
Sbjct: 120 EAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEA 175
Query: 325 VLHRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
L+ +S+++D+WS G++ I+ G P+ T + + + V D + +P P P+
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV---DQGY-RMPCPPGCPK 231
Query: 384 A 384
Sbjct: 232 E 232
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-14
Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 11/173 (6%)
Query: 153 KEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
K + RG FG R +L AVK++ KA M + V+ E L ALS
Sbjct: 10 KPISRGAFGKVYLGRKKNNSKL----YAVKVVKKADMINKNMVHQVQAERDAL-ALSKSP 64
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
+V + + NNVY+VME GG++ +L G + EE A + ++ + + H
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF-IRPDERLNDIVGSAYYVAP 323
G++HRDLKP+N L ++ + ++L DFGLS + + + DI+ + P
Sbjct: 124 GIIHRDLKPDNMLISN---EGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 85/322 (26%), Positives = 142/322 (44%), Gaps = 49/322 (15%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR-----REVK 202
+YE G +VGRG +GH A+ K G+ +++ A+K I T IS+ R RE+K
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEG----TGISMSACREIALLRELK 56
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED-------AK 255
++ K + D V+++ + E R + ++ K
Sbjct: 57 HPNVIALQKVFLSHSD-----RKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK 111
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFT-SGRDDADMRLIDFGLSDF----IRPDER 310
+++ QIL + + H V+HRDLKP N L G + +++ D G + ++P
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 311 LNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS 368
L+ +V + +Y APE+L R Y+ DIW+IG I LL F R E + S
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----IKTS 226
Query: 369 DP----NFDDLPWPSVSPEAKDF--VKRL-----LNKDYRKRMTAVQALTHPWLRDDSRP 417
+P D + P KD+ ++++ L KD+R+ A +L + +P
Sbjct: 227 NPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKP 286
Query: 418 VPLDILIFKLVKSYLHATPFKR 439
D +F L++ L P KR
Sbjct: 287 ---DSKVFLLLQKLLTMDPTKR 305
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
LG+ +G G FG E + VAVK K + ++ E +E I++
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKT-CKNCTSPSVR-EKFLQEAYIMRQFD- 65
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H H+VK + N V+IVMEL GEL + Q+ + +A+
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS--AYYVAPEVLH 327
+ VHRD+ N L +S ++L DFGLS ++ + G ++APE ++
Sbjct: 125 SKRFVHRDIAARNVLVSS---PDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 328 -RSYSLEADIWSIGVISY-ILLCGSRPF 353
R ++ +D+W GV + IL+ G +PF
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 86/326 (26%), Positives = 139/326 (42%), Gaps = 73/326 (22%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR-----REVK 202
+YE G +VGRG +GH A+ K G+ D+ A+K I T IS+ R RE+K
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEG----TGISMSACREIALLRELK 56
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA-------K 255
+S K + D V+++ + E R + ++ K
Sbjct: 57 HPNVISLQKVFLSHAD-----RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 111
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFT-SGRDDADMRLIDFGLSDF----IRPDER 310
+++ QIL + + H V+HRDLKP N L G + +++ D G + ++P
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 311 LNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE---------- 358
L+ +V + +Y APE+L R Y+ DIW+IG I LL F R E
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 231
Query: 359 ---SGIFRAV-LRSDPNFDD---LPWPS------------------------VSPEAKDF 387
IF + +D +++D +P S V P++K F
Sbjct: 232 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 291
Query: 388 --VKRLLNKDYRKRMTAVQALTHPWL 411
+++LL D KR+T+ QA+ P+
Sbjct: 292 HLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G G FG C R K K+ VA+K + KA + + D E I+ H +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRL-DFLTEASIMGQFD-HPN 66
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+++ V I+ E E G LD+ L E D K V Q++ + L+G
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGS-LDKFL------RENDGKFTVGQLVGM-----LRG 114
Query: 273 V------------VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG---S 317
+ VHRDL N L S + ++ DFGLS + E G
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
+ APE + +R ++ +D+WS G++ + ++ G RP+W + + +AV
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 25/228 (10%)
Query: 148 KYELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
K LGK +G G FG A G + + V V + T + D+ E++++K
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 75
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY------------T 250
+ HK+++ AC +Y+++E G L + + AR G Y T
Sbjct: 76 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
+D + Q+ + + Q +HRDL N L T ++ M++ DFGL+ + +
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNIDY 192
Query: 311 LNDIVGS---AYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
++APE L R Y+ ++D+WS GV+ + I G P+
Sbjct: 193 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 24/225 (10%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G G FG CS R K ++ VA+K + KA T D E I+ H +
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEK-QRRDFLSEASIMGQFD-HPN 66
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
++ V IV E E G L + G++T ++ I S + + G
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY----------YVA 322
VHRDL N L S + ++ DFGLS + D +AY + A
Sbjct: 127 YVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPE------AAYTTRGGKIPIRWTA 177
Query: 323 PEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
PE + +R ++ +D+WS G++ + ++ G RP+W + + +A+
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 59/194 (30%), Positives = 93/194 (47%), Gaps = 19/194 (9%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQ-VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
+G+G+FG KG LKD+ VAVK K + + I+ + E +ILK H ++
Sbjct: 3 LGKGNFGEV-----FKGTLKDKTPVAVKT-CKEDLPQELKIKFLS-EARILKQYD-HPNI 54
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV 273
VK C +YIVMEL GG+ L + + + + + +A+ +
Sbjct: 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114
Query: 274 VHRDLKPENFLFTSGRDDADMRLIDFGLS----DFIRPDERLNDIVGSAYYVAPEVL-HR 328
+HRDL N L G ++ +++ DFG+S D I L I + APE L +
Sbjct: 115 IHRDLAARNCLV--GENNV-LKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYG 169
Query: 329 SYSLEADIWSIGVI 342
YS E+D+WS G++
Sbjct: 170 RYSSESDVWSYGIL 183
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 29/231 (12%)
Query: 147 AKYELGKEVGRGHFGHTCSARG----KKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
+ LGK +G G FG A K K VAVK++ T + D+ E++
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEME 69
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY---------- 249
++K + HK+++ AC +Y+++E G L + + AR G Y
Sbjct: 70 MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE 129
Query: 250 --TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
T +D + Q+ + + Q +HRDL N L T +D M++ DFGL+ +
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHN 186
Query: 308 DERLNDIVGS---AYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
+ ++APE L R Y+ ++D+WS GV+ + I G P+
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 70/274 (25%), Positives = 116/274 (42%), Gaps = 51/274 (18%)
Query: 176 QQVAVKIIS----KAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
Q VA+K+IS + TAI RE +LK L H ++V D + V E
Sbjct: 31 QLVALKVISMKTEEGVPFTAI------REASLLKGLK-HANIVLLHDIIHTKETLTFVFE 83
Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
+L ++ G + + + Q+L +A+ H Q ++HRDLKP+N L +
Sbjct: 84 YMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY---L 139
Query: 292 ADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLC 348
+++L DFGL+ P + + V + +Y P+VL + YS DIW G I +I +
Sbjct: 140 GELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCI-FIEML 198
Query: 349 GSRPFWARTESGIFRAVLR-----------SDPNFDDLP--------WP----------- 378
+P + S +F + + + P LP
Sbjct: 199 QGQPAFPGV-SDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKR 257
Query: 379 -SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
S P+A+D ++L + R++A AL HP+
Sbjct: 258 LSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 71/263 (26%), Positives = 121/263 (46%), Gaps = 39/263 (14%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED-VRREVKILKALSGHK 211
+ +GRG+FG S R + + VAVK + T ++ +E +ILK S H
Sbjct: 1 ERIGRGNFGEVFSGRLRA---DNTPVAVK---SCRETLPPDLKAKFLQEARILKQYS-HP 53
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
++V+ C +YIVMEL +GG+ L + G R ++ +V + + + +
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK 113
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---------YVA 322
+HRDL N L T + +++ DFG+S R +E D V ++ + A
Sbjct: 114 HCIHRDLAARNCLVT---EKNVLKISDFGMS---REEE---DGVYASTGGMKQIPVKWTA 164
Query: 323 PEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
PE L + YS E+D+WS G++ + G+ P+ + A+ + LP P +
Sbjct: 165 PEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG----VRLPCPEL 220
Query: 381 SPEAKDFVKRLLNK----DYRKR 399
P+A V RL+ + D +R
Sbjct: 221 CPDA---VYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 67/237 (28%), Positives = 101/237 (42%), Gaps = 55/237 (23%)
Query: 155 VGRGHFGHTCSARGKKGELKD--------QQVAVKIISKAKMTTAISIEDVR--REVKIL 204
+G G FG +G D +VAVK + K A E +E ++
Sbjct: 3 LGSGAFGEV-----YEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLM 53
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI----VVQ 260
+ H ++VK C YI+MEL EGG+LL + R R + ++
Sbjct: 54 SNFN-HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLD 110
Query: 261 I-LSVVAFCH-LQGV--VHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDERLNDI 314
I L V C L+ + +HRDL N L + DAD +++ DFGL+ DI
Sbjct: 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDI 161
Query: 315 VGSAYY------------VAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWART 357
S YY +APE L ++ ++D+WS GV+ + IL G +P+ A
Sbjct: 162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 41/235 (17%)
Query: 148 KYELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
+ LGK +G G FG A G + VAVK++ +S D+ E++++K
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS--DLVSEMEMMK 70
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS-- 263
+ HK+++ C +Y+V+E G L D + AR R E A +
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR--RPPGEYASPDDPRPPEET 128
Query: 264 -----VVAFCHL----------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------ 302
+V+F + + +HRDL N L T +D M++ DFGL+
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLARDIHHI 185
Query: 303 DFIRP--DERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
D+ R + RL ++APE L R Y+ ++D+WS GV+ + I G P+
Sbjct: 186 DYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 45/217 (20%)
Query: 153 KEVGRGHFGHTCSAR-----GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+++G+G+FG R GE+ VAVK K + +TA + D RE++ILK+L
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEV----VAVK---KLQHSTAEHLRDFEREIEILKSL 62
Query: 208 SGHKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV---QIL 262
H ++VK+ C N+ +VME G L D + R D + +++ QI
Sbjct: 63 Q-HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQIC 118
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV- 321
+ + + VHRDL N L S + +++ DFGL+ + D+ YY
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVES---ENRVKIGDFGLTKVLPQDKE--------YYKV 167
Query: 322 -----------APEVLHRS-YSLEADIWSIGVISYIL 346
APE L S +S+ +D+WS GV+ Y L
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 47/246 (19%)
Query: 151 LGKEVGRGHFGHTCSARGKK-GELKDQQ-VAVKIISKAKMTTAISIEDVRREVKILKALS 208
L +E+G G FG A KD+ VAVK + + +D +RE ++L L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---KDFQREAELLTNLQ 65
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG---------------GRYTEED 253
H+H+VKF C D + + +V E + G+L + A G G
Sbjct: 66 -HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
I QI S + + Q VHRDL N L + +++ DFG+S D
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN---LLVKIGDFGMS---------RD 172
Query: 314 IVGSAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFWARTES 359
+ + YY + PE +++R ++ E+D+WS GVI + I G +P++ + +
Sbjct: 173 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 360 GIFRAV 365
+ +
Sbjct: 233 EVIECI 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 59/227 (25%), Positives = 103/227 (45%), Gaps = 29/227 (12%)
Query: 151 LGKEVGRGHFGHTCSARG----KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
LGK +G G FG A K+ + +VAVK++ T + D+ E++++K
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKM 79
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRY------------TE 251
+ HK+++ AC +Y+++E G L + + AR G Y +
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 252 EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL 311
+D + Q+ + + + +HRDL N L T +D M++ DFGL+ I +
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 196
Query: 312 NDIVGS---AYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
++APE L R Y+ ++D+WS GV+ + I G P+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+L K++G G FG +VAVK + M S++ E ++K L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNN----STKVAVKTLKPGTM----SVQAFLEEANLMKTLQ- 59
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFC 268
H LV+ +YI+ E G LLD + + GG+ QI +A+
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
+ +HRDL+ N L + + ++ DFGL+ I +E G+ + + APE
Sbjct: 120 ERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEA 175
Query: 326 LHR-SYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
++ S+++++D+WS G++ Y I+ G P+ + S + A+ R
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 153 KEVGRGHFGHTCSARGKKGELK----DQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
E+G G+FG KKG K ++ VAVKI+ A+ +++ RE +++ L
Sbjct: 1 GELGSGNFGTV-----KKGMYKMKKSEKTVAVKILKNDNNDPALK-DELLREANVMQQLD 54
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
+ ++V+ CE + +VMEL E G L ++ L + TE++ +V Q+ + +
Sbjct: 55 -NPYIVRMIGICE-AESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKYL 111
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA----YYVAPE 324
VHRDL N L + ++ DFGLS + DE + APE
Sbjct: 112 EETNFVHRDLAARNVLLVT---QHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
Query: 325 VL-HRSYSLEADIWSIGVI-----SYILLCGSRPF 353
+ + +S ++D+WS GV+ SY G +P+
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSY----GQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 51/183 (27%), Positives = 92/183 (50%), Gaps = 11/183 (6%)
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
RE+++L + ++V F A + I ME +GG L D++L + GR E+ +
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 109
Query: 259 VQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
+ ++ + + + ++HRD+KP N L S +++L DFG+S + D N VG+
Sbjct: 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQL-IDSMANSFVGT 165
Query: 318 AYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFW---ARTESGIFRAVLRSDPNFD 373
Y++PE L + YS+++DIWS+G+ + G P A+ +F + DP
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225
Query: 374 DLP 376
+
Sbjct: 226 ETS 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 78/312 (25%), Positives = 140/312 (44%), Gaps = 61/312 (19%)
Query: 153 KEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
K +G+G FG + K G++ A+K + K++M + V+ E +L A S
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKI----YAMKTLLKSEMFKKDQLAHVKAERDVL-AESDSP 61
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
+V + +D +Y++ME GG+L+ +L + ++E+ + + + + + H
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMT-MLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 272 GVVHRD-------------LKPENFLFTSG---RDDAD--MRL----------------- 296
G +HRD +K +F ++G + D+ +L
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 297 ---IDFGLS--DFI---RPDERL--NDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYI 345
I+ +S D I + + RL VG+ Y+APE+ L + Y E D WS+G I +
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
Query: 346 LLCGSRPFWARTESGIFRAVL--RSDPNF-DDLPWPSVSPEAKDFVKRLL-NKDYR-KRM 400
L G PF + +R ++ R F DD+ +S EA+D ++RL+ N + R R
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDI---HLSVEAEDLIRRLITNAENRLGRG 297
Query: 401 TAVQALTHPWLR 412
A + +HP+ R
Sbjct: 298 GAHEIKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 77/303 (25%), Positives = 128/303 (42%), Gaps = 54/303 (17%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII----SKAKMTTAISIEDVRREVKIL 204
YE +++G G + + K + + VA+K+I + TAI RE +L
Sbjct: 7 YEKLEKLGEGSYATVYKGKSK---VNGKLVALKVIRLQEEEGTPFTAI------REASLL 57
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
K L H ++V D + +V E +L + G E+ K + Q+L
Sbjct: 58 KGLK-HANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRG 115
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAP 323
+++ H + ++HRDLKP+N L + D +++L DFGL+ P ++ V + +Y P
Sbjct: 116 LSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPP 172
Query: 324 EVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTE-----SGIFRAVLRSDPNFDDLP 376
+VL S YS D+W +G I ++ G F + IF ++ PN D P
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF--LVLGTPNEDTWP 230
Query: 377 ----WPSVSPE----------------------AKDFVKRLLNKDYRKRMTAVQALTHPW 410
P PE A+D +LL + R++A AL+H +
Sbjct: 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290
Query: 411 LRD 413
D
Sbjct: 291 FSD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 20/227 (8%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
+L K++G G FG A K +VAVK + M S+E E ++K
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNK----HTKVAVKTMKPGSM----SVEAFLAEANVMKT 57
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVV 265
L H LVK A +YI+ E G LLD + + G + QI +
Sbjct: 58 LQ-HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 115
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVA 322
AF + +HRDL+ N L ++ ++ DFGL+ I +E G+ + + A
Sbjct: 116 AFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTA 171
Query: 323 PEVL-HRSYSLEADIWSIGV-ISYILLCGSRPFWARTESGIFRAVLR 367
PE + S+++++D+WS G+ + I+ G P+ + + RA+ R
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 8/156 (5%)
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
RE+++L + ++V F A + I ME +GG L D++L R EE +
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVS 109
Query: 259 VQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
+ +L +A+ + ++HRD+KP N L S +++L DFG+S + D N VG+
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNS---RGEIKLCDFGVSGQL-IDSMANSFVGT 165
Query: 318 AYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRP 352
Y++PE L + YS+++DIWS+G+ L G P
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 78/298 (26%), Positives = 130/298 (43%), Gaps = 54/298 (18%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIE----DVRREVKILK 205
+LG E+GRG FG K +AVK I + E + ++ ++
Sbjct: 8 DLG-EIGRGAFGTVNKMLHKP---SGTIMAVKRIR------STVDEKEQKRLLMDLDVVM 57
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA-IVVQILSV 264
S ++VKF A + +I MEL +D L + +Y E K+ I +IL
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMEL------MDISLDKFYKYVYEVLKSVIPEEILGK 111
Query: 265 VAFC------HLQ---GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI- 314
+A +L+ ++HRD+KP N L +++L DFG+S + ++ I
Sbjct: 112 IAVATVKALNYLKEELKIIHRDVKPSNILLDRN---GNIKLCDFGISGQL-----VDSIA 163
Query: 315 ----VGSAYYVAPEVLHRS----YSLEADIWSIGVISYILLCGSRPFWARTESGIF---R 363
G Y+APE + S Y + +D+WS+G+ Y + G P+ + +F
Sbjct: 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLT 221
Query: 364 AVLRSD-PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD-DSRPVP 419
V++ D P + SP +F+ L KD KR + L HP+++D + R V
Sbjct: 222 QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVD 279
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 48/235 (20%)
Query: 148 KYELGKEVGRGHFGHT---CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR---REV 201
K L +E+G+G FG + KGE + +VA+K +++ S+ + E
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGE-PETRVAIKTVNENA-----SMRERIEFLNEA 60
Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---------GGRYTEE 252
++K + H H+V+ +VMEL G+L + +R G T +
Sbjct: 61 SVMKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
+ +I +A+ + VHRDL N + D +++ DFG++
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE---DLTVKIGDFGMT---------R 167
Query: 313 DIVGSAYY------------VAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPF 353
DI + YY +APE L ++ ++D+WS GV+ + + +P+
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
Q+ +A+ H + + HRDLKP+N L + ++L DFG + + +R + S +
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDP--NTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 320 YVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR---------- 367
Y APE++ +Y+ D+WS+G I ++ G F ++ +++
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 368 --SDPNFDDLPWPSVSP-------------EAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
+PN+ D+ +P V P +A +F+ + L + KR+ ++AL P+
Sbjct: 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355
Query: 413 DDSRPVPLDILIFKLVKSYLHATP----FKRAALKALSKA 448
D P KL K Y+ P F A +K +S A
Sbjct: 356 DLRDPC------IKLPK-YIDKLPDLFNFCDAEIKEMSDA 388
|
Length = 440 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 67/232 (28%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQ---VAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
E+G G FG A L +Q VAVK + +A + +D +RE ++L L H
Sbjct: 12 ELGEGAFGKVFLAECHN-LLPEQDKMLVAVKALKEASESAR---QDFQREAELLTVLQ-H 66
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLD---------RILARG-----GRYTEEDAKA 256
+H+V+F C + + +V E G+L +ILA G G+ T A
Sbjct: 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
I QI S + + VHRDL N L +++ DFG+S DI
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVG---QGLVVKIGDFGMS---------RDIYS 174
Query: 317 SAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFW 354
+ YY + PE +L+R ++ E+DIWS GV+ + I G +P++
Sbjct: 175 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 35/230 (15%)
Query: 151 LGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
LGK +G G FG A G DQ V V + T + D+ E++++K +
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR----------GGRYTEE-----D 253
HK+++ C +Y+++E G L + + AR + EE D
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------DFIR- 306
+ Q+ + + + +HRDL N L T +D M++ DFGL+ D+ +
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDYYKK 192
Query: 307 -PDERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
+ RL ++APE L R Y+ ++D+WS G++ + I G P+
Sbjct: 193 TSNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 17/215 (7%)
Query: 147 AKYELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
+ E K +G G FG +GE VA+K++ + T+ + +++ E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYVMA 64
Query: 206 ALSGHKHLVKFCDAC--EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
++ H H+V+ C V + +M L G LLD + + VQI
Sbjct: 65 SV-DHPHVVRLLGICLSSQVQLITQLMPL---GCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---Y 320
+++ + +VHRDL N L + +++ DFGL+ + DE+ G +
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 321 VAPE-VLHRSYSLEADIWSIGV-ISYILLCGSRPF 353
+A E +LHR Y+ ++D+WS GV + ++ G++P+
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
K LG+ +G G FG +GE Q+VAVK I K +T +E+ K+
Sbjct: 7 KLTLGEIIGEGEFGAVL-----QGEYTGQKVAVKNI-KCDVTAQAFLEETAVMTKL---- 56
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
HK+LV+ N +YIVMEL G L++ + R GR + + +
Sbjct: 57 -HHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGM 113
Query: 268 CHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
+L+ +VHRDL N L + +D ++ DFGL+ +++ + APE
Sbjct: 114 EYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGS--MGVDNSKLPVKWTAPEA 168
Query: 326 L-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
L H+ +S ++D+WS GV+ + + G P+
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 61/243 (25%), Positives = 106/243 (43%), Gaps = 44/243 (18%)
Query: 151 LGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
L +E+G G FG A E VAVK + A +D RE ++L L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQ 65
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG------------GRYTEEDAKA 256
H+H+VKF C + + + +V E + G+L + A G T+
Sbjct: 66 -HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
I QI + + + Q VHRDL N L ++ +++ DFG+S D+
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---------RDVYS 172
Query: 317 SAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIF 362
+ YY + PE +++R ++ E+D+WS+GV+ + I G +P++ + + +
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
Query: 363 RAV 365
+
Sbjct: 233 ECI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG---HK 211
+G G FG C R K ++ VA+K + K+ T E RR+ ++ G H
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYT-----EKQRRDFLSEASIMGQFDHP 65
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
+++ V I+ E E G L + G++T ++ I + + +
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY-------YVAPE 324
VHRDL N L S + ++ DFGLS F+ D+ + S+ + APE
Sbjct: 126 NYVHRDLAARNILVNS---NLVCKVSDFGLSRFLE-DDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 325 -VLHRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
+ +R ++ +D+WS G++ + ++ G RP+W + + A+
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 40/238 (16%)
Query: 148 KYELGKEVGRGHFGHTCSARGK--KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
LGK +G G FG A KG VAVK++ + ++ + D+ E +LK
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLK 58
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-------------- 251
++ H H++K AC + +++E + G L R R R
Sbjct: 59 QVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSL--RSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 252 ---EDAKAIVVQILSVVAFCHLQG--------VVHRDLKPENFLFTSGRDDADMRLIDFG 300
D +A+ + L A+ +G +VHRDL N L GR M++ DFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR---KMKISDFG 172
Query: 301 LS-DFIRPDERLNDIVGS--AYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
LS D D + G ++A E L Y+ ++D+WS GV+ + I+ G P+
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 21/196 (10%)
Query: 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213
++G G +G KK VAVK + + M +E+ +E ++K + H +L
Sbjct: 13 KLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNL 64
Query: 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV---VQILSVVAFCHL 270
V+ C YI+ E G LLD L R E +A ++ QI S + +
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNR-QEVNAVVLLYMATQISSAMEYLEK 122
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVL- 326
+ +HRDL N L ++ +++ DFGLS + + G+ + + APE L
Sbjct: 123 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 178
Query: 327 HRSYSLEADIWSIGVI 342
+ +S+++D+W+ GV+
Sbjct: 179 YNKFSIKSDVWAFGVL 194
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 153 KEVGRGHFGHTC-----SARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ +G GHFG A GE+ VAVK + + + ++E+ ILK L
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEM----VAVKTLKRE--CGQQNTSGWKKEINILKTL 63
Query: 208 SGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRILARGGRYTEEDAKAIVV--QILS 263
H+++VK+ C + + ++ME G L D + ++ A+ ++ QI
Sbjct: 64 Y-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICE 118
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL----NDIVGSAY 319
+A+ H Q +HRDL N L +D +++ DFGL+ + D +
Sbjct: 119 GMAYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175
Query: 320 YVAPEVLHR-SYSLEADIWSIGVISYILL 347
+ A E L +S +D+WS GV Y LL
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 79/317 (24%), Positives = 130/317 (41%), Gaps = 57/317 (17%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+Y++ + +G+G G A + VA+K I + + + RE KI L
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRR---VALKKIREDLSENPLLKKRFLREAKIAADL 59
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK------------ 255
H +V C D + VY M EG L + L + E +K
Sbjct: 60 I-HPGIVPVYSICSDGDPVYYTMPYIEGYTL--KSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFL---FTSGRDDADMRLIDFGLSDFIRPDE--- 309
+I +I + + + H +GV+HRDLKP+N L F ++ ++D+G + F + +E
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLF------GEVVILDWGAAIFKKLEEEDL 170
Query: 310 ----------------RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISYILLCGSRP 352
IVG+ Y+APE +L S DI+++GVI Y +L S P
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
Query: 353 FWARTESG---IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT-- 407
+ R + G +R V+ P + P+ + P + L D +R ++VQ L
Sbjct: 231 Y--RRKKGRKISYRDVI-LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD 286
Query: 408 -HPWLRDDSRPVPLDIL 423
P L+ L
Sbjct: 287 LEPHLQGSPEWTVKATL 303
|
Length = 932 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 38/232 (16%)
Query: 150 ELGKEVGRGHFGHTCSA--RGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
L + +G G FG RG+ G+ + QVAVK + + + D E I+
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVK--TLPESCSEQDESDFLMEALIMSKF 66
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ H+++V+ + +I++EL GG+L R R E ++ ++ L A
Sbjct: 67 N-HQNIVRLIGVSFERLPRFILLELMAGGDLKS--FLRENRPRPERPSSLTMKDLLFCAR 123
Query: 268 -----CHL---QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
C +HRD+ N L T ++ DFG++ DI ++Y
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASY 174
Query: 320 Y------------VAPEV-LHRSYSLEADIWSIGVISY-ILLCGSRPFWART 357
Y + PE L ++ + D+WS GV+ + I G P+ RT
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 41/214 (19%)
Query: 153 KEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
+GRG FG A+G + E + V VK + K K S + RRE+ + + LS H
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLS-H 67
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH- 269
K++V+ C + Y+++E + G+L + A + +E K + VA C
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSK--DEKLKPPPLSTKQKVALCTQ 125
Query: 270 -LQGV--------VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
G+ VHRDL N L +S R ++++ LS D+ S YY
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQR---EVKVSLLSLS---------KDVYNSEYY 173
Query: 321 -----------VAPE-VLHRSYSLEADIWSIGVI 342
+APE V +S ++D+WS GV+
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVL 207
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 24/241 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+L K++G G FG +VA+K + + M S E E ++K L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNG----HTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ- 59
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRI-LARGGRYTEEDAKAIVVQILSVVAFC 268
H LV+ A +YI+ E E G L+D + G + T + QI +AF
Sbjct: 60 HPRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEV 325
+ +HRDL+ N L + + ++ DFGL+ I +E G+ + + APE
Sbjct: 119 ERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEA 174
Query: 326 L-HRSYSLEADIWSIGV-ISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
+ + ++++++D+WS G+ ++ I+ G P+ T + + + R +P P PE
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG----YRMPRPDNCPE 230
Query: 384 A 384
Sbjct: 231 E 231
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
+++ F A N + I E +GG L + E I V ++ + +
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-----DVYRKIPEHVLGRIAVAVVKGLTYLWSL 114
Query: 272 GVVHRDLKPENFLF-TSGRDDADMRLIDFGLSDFIRPDERLNDI----VGSAYYVAPE-V 325
++HRD+KP N L T G+ ++L DFG+S + +N I VG+ Y+APE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQ----VKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERI 165
Query: 326 LHRSYSLEADIWSIGVISYILLCGSRPFWARTES-------GIFRAVLRSDPNFDDLPWP 378
Y + +D+WS+G+ L G P+ ++ + + ++ DP LP
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV--LPVG 223
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
S + F+ + + K ++R + HP++
Sbjct: 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 36/149 (24%), Positives = 72/149 (48%), Gaps = 9/149 (6%)
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H ++V+ C + + +V +L G LLD + + VQI + +
Sbjct: 68 HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVL 326
+VHR+L N L S D+ +++ DFG++D + PD++ ++ ++A E +
Sbjct: 127 EHRMVHRNLAARNILLKS---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 327 H-RSYSLEADIWSIGVISYILLC-GSRPF 353
Y+ ++D+WS GV + ++ G+ P+
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 29/223 (13%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G G+FG A KK LK A+K++ + + D E+++L L H +++
Sbjct: 10 IGEGNFGQVIRAMIKKDGLK-MNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNII 66
Query: 215 KFCDACEDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKA----------IVV 259
ACE+ +YI +E G LLD R+L + +E A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGS- 317
+ + + + + +HRDL N L ++ ++ DFGLS R +E + +G
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS---RGEEVYVKKTMGRL 180
Query: 318 -AYYVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWART 357
++A E L+ S Y+ ++D+WS GV+ + I+ G P+ T
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 34/216 (15%)
Query: 154 EVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIED-VRREVKILKALSGHK 211
E+G G+FG C +G K K VA+K++ K S+ D + RE +I+ L +
Sbjct: 2 ELGSGNFG--CVKKGVYKMRKKQIDVAIKVL---KNENEKSVRDEMMREAEIMHQLD-NP 55
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
++V+ CE + +VME+ GG L + + T + ++ Q+ + + +
Sbjct: 56 YIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY----------- 320
VHRDL N L + ++ DFGLS + D+ +YY
Sbjct: 115 NFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADD--------SYYKARSAGKWPLK 163
Query: 321 -VAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPF 353
APE ++ R +S +D+WS G+ + G +P+
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 177 QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG 236
+VA+K + M S E +E +++K L H+ LV+ + +YIV E G
Sbjct: 32 RVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKG 85
Query: 237 ELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295
LLD + G+Y + QI S +A+ VHRDL+ N L ++ +
Sbjct: 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCK 142
Query: 296 LIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLHRSYSLEADIWSIGVISYILLCGSR 351
+ DFGL+ I D G+ + + APE L+ +++++D+WS G++ L R
Sbjct: 143 VADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201
Query: 352 -PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
P+ + V R +P P PE+
Sbjct: 202 VPYPGMVNREVLDQVERG----YRMPCPPECPES 231
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 29/223 (13%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
+G G+FG AR KK L+ A+K + + + D E+++L L H +++
Sbjct: 3 IGEGNFGQVLKARIKKDGLR-MDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 215 KFCDACEDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKAIVV---QILSVVA 266
ACE +Y+ +E G LLD R+L + ++ A + Q+L A
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 267 -------FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGS- 317
+ + +HRDL N L G + ++ DFGLS R E + +G
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILV--GENYVA-KIADFGLS---RGQEVYVKKTMGRL 173
Query: 318 -AYYVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWART 357
++A E L+ S Y+ +D+WS GV+ + I+ G P+ T
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 23/228 (10%)
Query: 177 QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG 236
+VA+K + M E +E +I+K L K + + E+ +YIV E G
Sbjct: 32 KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSEE--PIYIVTEFMGKG 85
Query: 237 ELLDRILARGGRYTE-EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295
LLD + G+Y + + QI +A+ +HRDL+ N L D+ +
Sbjct: 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCK 142
Query: 296 LIDFGLSDFIRPDERLNDIVGSAY---YVAPEV-LHRSYSLEADIWSIGVISYILLCGSR 351
+ DFGL+ I D G+ + + APE L+ +++++D+WS G++ L+ R
Sbjct: 143 IADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
Query: 352 -PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRK 398
P+ + V R +P P PE+ + L+ ++K
Sbjct: 202 VPYPGMVNREVLEQVERG----YRMPCPQGCPES---LHELMKLCWKK 242
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 16/238 (6%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
K +G G FG K K+ VA+K + T +D E I+ S H +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFS-HHN 67
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+++ I+ E E G L + G ++ ++ I + + +
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAY---YVAPEVL-H 327
VHRDL N L S + + ++ DFGLS + D E G + APE + +
Sbjct: 128 YVHRDLAARNILVNS---NLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 328 RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
R ++ +D+WS G++ + ++ G RP+W + + +A+ + F LP P P A
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---NDGF-RLPAPMDCPSA 238
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 19/198 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+L K++G G FG + +VAVK + M S E E +I+K L
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNG----NTKVAVKTLKPGTM----SPESFLEEAQIMKKLR- 59
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQILSVVAFC 268
H LV+ A +YIV E G LLD + GR + + + Q+ + +A+
Sbjct: 60 HDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE- 324
+HRDL+ N L G ++ DFGL+ I D G+ + + APE
Sbjct: 119 ERMNYIHRDLRSANILVGDG---LVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEA 174
Query: 325 VLHRSYSLEADIWSIGVI 342
L+ +++++D+WS G++
Sbjct: 175 ALYGRFTIKSDVWSFGIL 192
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 39/228 (17%)
Query: 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKILKALSGHK 211
+G G+FG AR KK L+ A+K +M S +D R E+++L L H
Sbjct: 15 IGEGNFGQVLKARIKKDGLR-MDAAIK-----RMKEYASKDDHRDFAGELEVLCKLGHHP 68
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED-AKAIVVQILSVVAFCHL 270
+++ ACE +Y+ +E G LLD R R E D A AI S ++ L
Sbjct: 69 NIINLLGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 271 ----------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLND 313
+ +HRDL N L ++ ++ DFGLS R E +
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKK 180
Query: 314 IVGS--AYYVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWART 357
+G ++A E L+ S Y+ +D+WS GV+ + I+ G P+ T
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 35/105 (33%), Positives = 51/105 (48%), Gaps = 6/105 (5%)
Query: 245 RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI-DFGLSD 303
R + A I QIL + + H Q ++HRD+K EN +D D I D G +
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI----NDVDQVCIGDLGAAQ 205
Query: 304 FIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILL 347
F + G+ APEVL R Y+ +ADIWS G++ + +L
Sbjct: 206 FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 58/233 (24%), Positives = 106/233 (45%), Gaps = 34/233 (14%)
Query: 148 KYELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
+Y + + G G C+ K G+ + ++V VK ++ K RE+ ILK
Sbjct: 93 QYNILSSLTPGSEGEVFVCT---KHGDEQRKKVIVKAVTGGK--------TPGREIDILK 141
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMEL--CEGGELLDRILARGGRYTEEDAKAIVVQILS 263
+S H+ ++ A + V +VM C+ +DR G E A I ++L
Sbjct: 142 TIS-HRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS----GPLPLEQAITIQRRLLE 196
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND-----IVGSA 318
+A+ H +G++HRD+K EN +F ++A L DFG + + D + G+
Sbjct: 197 ALAYLHGRGIIHRDVKTEN-IFLDEPENA--VLGDFGAA--CKLDAHPDTPQCYGWSGTL 251
Query: 319 YYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR---TESGIFRAVLR 367
+PE+L Y + DIWS G++ + + + + + + S R+++R
Sbjct: 252 ETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
|
Length = 392 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
K +G G FG +GE VA+K + +A T+ + +++ E ++ ++ +
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NP 69
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
H+ + C + V ++ +L G LLD + + VQI + + +
Sbjct: 70 HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER 128
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPE-VLH 327
+VHRDL N L + +++ DFGL+ + DE+ G ++A E +LH
Sbjct: 129 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
R Y+ ++D+WS GV + L+ GS+P+
Sbjct: 186 RIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 8/135 (5%)
Query: 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF 283
+ V +V +L G LLD + R +D VQI +++ +VHRDL N
Sbjct: 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNV 140
Query: 284 LFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS----AYYVAPEVLHRSYSLEADIWSI 339
L S +++ DFGL+ + DE G + +LHR ++ ++D+WS
Sbjct: 141 LVKS---PNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSY 197
Query: 340 GVISYILLC-GSRPF 353
GV + L+ G++P+
Sbjct: 198 GVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+L + +G+G FG G+ + +VAVK I A E ++ L
Sbjct: 9 KLLQTIGKGEFGDVML-----GDYRGNKVAVKCIKNDATAQAFLAE-----ASVMTQLR- 57
Query: 210 HKHLVKFCDA-CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK-AIVVQILSVVAF 267
H +LV+ E+ +YIV E G L+D + +RG D + + + +
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
VHRDL N L + +D ++ DFGL+ + + + APE L
Sbjct: 118 LEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALR 172
Query: 327 HRSYSLEADIWSIGVI 342
+ +S ++D+WS G++
Sbjct: 173 EKKFSTKSDVWSFGIL 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 153 KEVGRGHFGHTCSARG-KKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK 211
K +G G FG +GE VA+KI+++ TT + ++ A H
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE---TTGPKANVEFMDEALIMASMDHP 69
Query: 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ 271
HLV+ C + +V +L G LLD + + VQI + + +
Sbjct: 70 HLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 128
Query: 272 GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY---YVAPEVLH- 327
+VHRDL N L S +++ DFGL+ + DE+ + G ++A E +H
Sbjct: 129 RLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPF 353
R ++ ++D+WS GV + L+ G +P+
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR---EVKILKALSG 209
KE+G G FG G QV VK ++ + S+++ + E + ++L
Sbjct: 1 KEIGNGWFGKVILGEVNSG-YTPAQVVVK-----ELRVSASVQEQMKFLEEAQPYRSLQ- 53
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA------KAIVVQILS 263
H +L++ C +V +VME C G+ L L R R E + + +I
Sbjct: 54 HSNLLQCLGQCTEVTPYLLVMEFCPLGD-LKGYL-RSCRKAELMTPDPTTLQRMACEIAL 111
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD-------FIRPDERLNDIVG 316
+ H +H DL N L T+ D +++ D+GLS ++ PD+ +
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL-- 166
Query: 317 SAYYVAPEVLHRSY--------SLEADIWSIGVISYILL-CGSRPF 353
++APE++ + + E+++WS+GV + L GS+P+
Sbjct: 167 --RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 53/236 (22%), Positives = 99/236 (41%), Gaps = 40/236 (16%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQ---VAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+++G+G FG AR G L + VAVK++ + +A D +RE ++
Sbjct: 11 RDIGQGAFGRVFQARAP-GLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD- 66
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK-------------- 255
H ++VK C + ++ E G+L + + R R +
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 256 -------AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------ 302
I Q+ + +A+ + VHRDL N L ++ +++ DFGLS
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNIYSA 183
Query: 303 DFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISY-ILLCGSRPFWART 357
D+ + E ND + + + + Y+ E+D+W+ GV+ + I G +P++
Sbjct: 184 DYYKASE--NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 29/137 (21%)
Query: 241 RILARGGRYTEEDAKAIVV-----------------QILSVVAFCHLQGVVHRDLKPENF 283
R R G Y ++D + ++ Q+ ++F + +HRDL N
Sbjct: 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI 245
Query: 284 LFTSGRDDADMRLIDFGLSDFIRPDERLNDIV-GSAY----YVAPE-VLHRSYSLEADIW 337
L T GR ++ DFGL+ IR D N +V G+A ++APE + + Y+ E+D+W
Sbjct: 246 LLTHGR---ITKICDFGLARDIRNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVW 300
Query: 338 SIGVISY-ILLCGSRPF 353
S G++ + I GS P+
Sbjct: 301 SYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 28/83 (33%), Positives = 40/83 (48%), Gaps = 9/83 (10%)
Query: 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE 281
D N IVME EG L D ++ G E ++ I V H G++H DL
Sbjct: 70 DPENFIIVMEYIEGEPLKD-LINSNGMEELELSREIGRL----VGKLHSAGIIHGDLTTS 124
Query: 282 NFLFTSGRDDADMRLIDFGLSDF 304
N + + G+ + LIDFGL++F
Sbjct: 125 NMILSGGK----IYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 25/185 (13%)
Query: 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF 283
++V++V++ EGG+L I EE K +++ + H +G+V RDL P N
Sbjct: 58 DSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 284 LFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEA-DIWSIGVI 342
L D ++L F + ++ + Y APEV S EA D WS+G I
Sbjct: 117 LLD---DRGHIQLTYFS--RWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAI 171
Query: 343 SYILLCG-----SRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYR 397
+ LL G P SGI + P + VS EA+ +++LL +
Sbjct: 172 LFELLTGKTLVECHP------SGINTHTTLNIPEW-------VSEEARSLLQQLLQFNPT 218
Query: 398 KRMTA 402
+R+ A
Sbjct: 219 ERLGA 223
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 50/248 (20%), Positives = 104/248 (41%), Gaps = 33/248 (13%)
Query: 170 KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVK----FCDACEDVNN 225
KG +++V ++ K + I+ E+K L+ + + +++K D +D+
Sbjct: 38 KGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSN-NILKIYGFIIDIVDDLPR 96
Query: 226 VYIVMELCEGGELLDRILARGGRYTEED------AKAIVVQILSVVAFCHLQGVVHRDLK 279
+ +++E C G L R E+D + + +++L
Sbjct: 97 LSLILEYCTRGYL------REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150
Query: 280 PENFLFTSGRDDADMRLIDFGLSDFIR--PDERLNDIVGSAYYVAPEVLH---RSYSLEA 334
+FL T ++ +++I GL + P + +N +V Y + ++L+ Y+++
Sbjct: 151 SVSFLVT---ENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKD 203
Query: 335 DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP-EAKDFVKRLLN 393
DI+S+GV+ + + G PF T I+ ++ + L P P E K V+ +
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN---KNNSLKLPLDCPLEIKCIVEACTS 260
Query: 394 KDYRKRMT 401
D KR
Sbjct: 261 HDSIKRPN 268
|
Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 56/236 (23%), Positives = 96/236 (40%), Gaps = 46/236 (19%)
Query: 150 ELGKEVGRGHFGHTCSAR--GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+E+G G FG G L VA+K + K + ++ R+E +++ L
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQ-QEFRQEAELMSDL 65
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR------GGRYTEEDAKA----- 256
H ++V C ++ E G+L + ++ G +E K+
Sbjct: 66 Q-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 257 ----IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
I +QI + + + VHRDL N L G +++ DFGLS
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT---VKISDFGLS---------R 172
Query: 313 DIVGSAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFW 354
DI + YY + PE +L+ ++ E+DIWS GV+ + I G +P++
Sbjct: 173 DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 64/315 (20%), Positives = 119/315 (37%), Gaps = 70/315 (22%)
Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRR---EVKIL 204
+GK H A+ K L VAVK I+ + ED++ E+
Sbjct: 4 TLIGKCFEDLMIVHL--AKHKPTNTL----VAVKKINLDSCSK----EDLKLLQQEIITS 53
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGG---ELLDRILARGGRYTEEDAKAIVVQ- 260
+ L H +++ + + + +Y+V L G +LL G E A A +++
Sbjct: 54 RQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKD 109
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSA- 318
+L+ + + H +G +HR +K + L + D + L S I+ +R +
Sbjct: 110 VLNALDYIHSKGFIHRSVKASHILLSG---DGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166
Query: 319 ------YYVAPEVLHRS---YSLEADIWSIGVISYILLCGSRPFW--------------- 354
+++PEVL ++ Y+ ++DI+S+G+ + L G PF
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGT 226
Query: 355 -----------------ARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYR 397
+++ S R + D + S FV+ L +D
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRD--SVDHPYTRTFSEHFHQFVELCLQRDPE 284
Query: 398 KRMTAVQALTHPWLR 412
R +A Q L H + +
Sbjct: 285 SRPSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 53/231 (22%), Positives = 90/231 (38%), Gaps = 45/231 (19%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
LGK +G G FG + + + +VAVK + K + T IE+ E +K H
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD-H 60
Query: 211 KHLVKFCDAC---EDVNNV---YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
+++K C + + +++ + G+L +L + + +Q L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY---SRLGGLPEKLPLQTLLK 117
Query: 265 VAFCHLQGV--------VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
G+ +HRDL N + R+D + + DFGLS I
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLS---------KKIYS 165
Query: 317 SAYY------------VAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPF 353
YY +A E L R Y+ ++D+W+ GV + I G P+
Sbjct: 166 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 7/91 (7%)
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN--- 312
A+ Q+LS + + H +G++HRD+K EN L D+ L DFG + F R
Sbjct: 264 AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE---DICLGDFGAACFARGSWSTPFHY 320
Query: 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVI 342
I G+ APEVL Y+ DIWS G++
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLV 351
|
Length = 461 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 36/135 (26%), Positives = 55/135 (40%), Gaps = 20/135 (14%)
Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV-KFCDACEDVNNVYIVM 230
KD+ +KI + D REV IL+ L+ V K + E Y++M
Sbjct: 18 GTKDEDYVLKIN-----PSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72
Query: 231 ELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH---LQGVVHRDLKPENFLFTS 287
E EG L +EE+ + I Q+ ++A H L + H DL P N L
Sbjct: 73 EWIEGETL--------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD 124
Query: 288 GRDDADMRLIDFGLS 302
G+ +ID+ +
Sbjct: 125 GKILG---IIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 56/239 (23%), Positives = 103/239 (43%), Gaps = 30/239 (12%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ---QVAVKIISK-AKMTTAISIEDVRREVKI 203
K + +E+G+G FG K G +KD+ +VA+K +++ A M I + E +
Sbjct: 7 KITMSRELGQGSFGMVYEGIAK-GVVKDEPETRVAIKTVNEAASMRERIEFLN---EASV 62
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV---- 259
+K + H H+V+ ++MEL G+L + R R E+
Sbjct: 63 MKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLK 119
Query: 260 -------QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERL 311
+I +A+ + VHRDL N + +D +++ DFG++ D D
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 176
Query: 312 NDIVG--SAYYVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVL 366
G +++PE L ++ +D+WS GV+ + I +P+ + + R V+
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|218977 pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/WaaP) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 23/72 (31%), Positives = 34/72 (47%)
Query: 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS 287
++ E EG + L LA+ EE +A+ + ++A H GV H DL N L +
Sbjct: 94 LLTERLEGAQDLVTWLAQWADPAEELRRALWRAVGRLIARMHRAGVNHTDLNAHNILLDT 153
Query: 288 GRDDADMRLIDF 299
G + LIDF
Sbjct: 154 GEGGFKVWLIDF 165
|
These lipopolysaccharide kinases are related to protein kinases pfam00069. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of S. enterica. Length = 206 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 41/152 (26%), Positives = 59/152 (38%), Gaps = 24/152 (15%)
Query: 166 ARGKKGELKDQQVAVKI-ISKA----KMTTAISIEDVRREVKIL---KALSGHKHLVKFC 217
A + VK I K ++ + E RRE +IL + +V
Sbjct: 10 AIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV 69
Query: 218 DACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRD 277
D +N IVME EG L D EE ++ ++ +V H G+VH D
Sbjct: 70 D----PDNGLIVMEYIEGELLKD--------ALEEARPDLLREVGRLVGKLHKAGIVHGD 117
Query: 278 LKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
L N + + GR + IDFGL +F E
Sbjct: 118 LTTSNIILSGGR----IYFIDFGLGEFSDEVE 145
|
Length = 204 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 69/289 (23%), Positives = 116/289 (40%), Gaps = 71/289 (24%)
Query: 243 LARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302
L +G + + I+ QIL + H G+VHRD+KP+N +F+ G ++ID G +
Sbjct: 246 LPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG--SGSFKIIDLGAA 303
Query: 303 DFIR------PDERLNDIVGSAYYVAPE-VLHRSYSLEA--------------------- 334
+R P E L D Y APE + + + A
Sbjct: 304 ADLRVGINYIPKEFLLD----PRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359
Query: 335 -DIWSIGVISYILLCGSRPFWARTESGI--FRAVLRSDPNFDDLPW-----PSVSPEAK- 385
DI+S G+I ++ + R++S + F L+ ++D + W P SP+ +
Sbjct: 360 FDIYSAGLI-FLQMAFPN---LRSDSNLIQFNRQLK-RNDYDLVAWRKLVEPRASPDLRR 414
Query: 386 -------------DFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYL 432
+ +K ++ R+R++A AL HP+ + + L ++ L
Sbjct: 415 GFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG-LLGLSVMQ-NLRLQLF 472
Query: 433 HATPFKRAALKA-----LSKALTEDELVYLRAQ---FRLLEPNKDGSVS 473
AT A ++K+ TE E + AQ R EP K GS
Sbjct: 473 RATQQDYGEAAAWVVFLMAKSGTEKEGGFTEAQLQELREKEPKKKGSAQ 521
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 314 IVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF 372
I+G+ Y+APE+L + + D W++GV + L G PF T +F+ +L
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNR---- 595
Query: 373 DDLPWP----SVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
D+PWP +S A++ ++ LL D KR + HP
Sbjct: 596 -DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 36/203 (17%)
Query: 178 VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGE 237
VAVKI+ A + D +EVKIL L ++++ C D + + ++ E E G+
Sbjct: 49 VAVKILRPDANKNARN--DFLKEVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 238 L--------LDRILARGGRYTEEDAKAIVV----------QILSVVAFCHLQGVVHRDLK 279
L LD G + QI S + + VHRDL
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165
Query: 280 PENFLFTSGRDDADMRLIDFGLS------DFIRPDERLNDIVGSAYYVAPE-VLHRSYSL 332
N L +++ DFG+S D+ R R V ++A E +L ++
Sbjct: 166 TRNCLVGENL---TIKIADFGMSRNLYAGDYYRIQGR---AVLPIRWMAWECILMGKFTT 219
Query: 333 EADIWSIGVISY--ILLCGSRPF 353
+D+W+ GV + ++LC +P+
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG-LSDFIRPDE-RLN 312
+AI+ Q+L V + H + ++HRD+K EN +F + D + L DFG F + E
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLEN-IFLNC--DGKIVLGDFGTAMPFEKEREAFDY 326
Query: 313 DIVGSAYYVAPEVLHR-SYSLEADIWSIGVI 342
VG+ +PE+L Y DIWS G+I
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLI 357
|
Length = 501 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 52/238 (21%), Positives = 98/238 (41%), Gaps = 51/238 (21%)
Query: 153 KEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISI----------EDVRRE 200
+++G G FG H C A G + + D+ ++ + + A+ + D +E
Sbjct: 11 EKLGEGQFGEVHLCEAEGME-KFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL---LDRILARGGRYTEE----- 252
+KI+ L ++++ C + + ++ E E G+L L R + +
Sbjct: 70 IKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 253 --DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------DF 304
+ QI S + + VHRDL N L G++ +++ DFG+S D+
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV--GKNYT-IKIADFGMSRNLYSGDY 185
Query: 305 IRPDERLNDIVGSAYYVAP-------EVLHRSYSLEADIWSIGVISY--ILLCGSRPF 353
R I G A V P +L ++ +D+W+ GV + + LC +P+
Sbjct: 186 YR-------IQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 61/293 (20%), Positives = 120/293 (40%), Gaps = 53/293 (18%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR--REVKILKALSGH 210
E+G G FG GE +++ K +A E + +EV+ + L+ H
Sbjct: 1 DEIGNGWFGKVL-----LGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN-H 54
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE-EDAKAIVVQ-----ILSV 264
++++ C + +V+E C G+L + + R R + A+ V+Q + S
Sbjct: 55 PNVLQCLGQCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------DFIRPDERLNDIVGSA 318
+ + H +H DL N T+ D +++ D+GL+ D+ +
Sbjct: 113 LLWLHQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITKDCH---AVPL 166
Query: 319 YYVAPEV--------LHRSYSLEADIWSIGVISYILL-CGSRPFWARTESGIFRAVLRSD 369
++APE+ L + + +++IWS+GV + L +P+ ++ + + V+R
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE- 225
Query: 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDI 422
D+ P K L+ Y R V + WL ++RP ++
Sbjct: 226 ---QDIKLP----------KPQLDLKYSDRWYEV--MQFCWLDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED--VRREVKILKALS 208
LG+ +G G FG A L Q +K+ K +TA S E + E+KI+ L
Sbjct: 41 LGRTLGSGAFGRVVEATAHG--LSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG 98
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
H ++V AC +YI+ E C G+L+D
Sbjct: 99 PHLNIVNLLGACTKGGPIYIITEYCRYGDLVD 130
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 25/232 (10%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ LG+ +G+G FG A+ K + Q+VAVK++ KA + ++ IE+ RE +K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 209 GHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA------ 256
H +++K A + +++ + G+L +L R EE
Sbjct: 60 -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM--SRIGEEPFTLPLQTLV 116
Query: 257 -IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
++ I S + + + +HRDL N + ++ + + DFGLS I +
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGDYYRQGC 173
Query: 316 GSAY---YVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWARTESGIF 362
S ++A E L + Y+ +D+W+ GV + I+ G P+ S I+
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 32/108 (29%), Positives = 46/108 (42%), Gaps = 12/108 (11%)
Query: 192 ISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE 251
+S RE + L+ L V N +VME EG EL R
Sbjct: 151 VSRLAAEREFEALQRLYPEGVKVP---KPIAWNRHAVVMEYIEGVEL------YRLRLDV 201
Query: 252 EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299
E+ I+ +IL V + +G+VH DL N L T +D D+ +ID+
Sbjct: 202 ENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---EDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 27/88 (30%), Positives = 34/88 (38%), Gaps = 12/88 (13%)
Query: 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE 281
D +N IVME EG L D I E + V H G+VH DL
Sbjct: 68 DPDNKTIVMEYIEGKPLKDVIEEGNDELLREIGRL--------VGKLHKAGIVHGDLTTS 119
Query: 282 NFLFTSGRDDADMRLIDFGLSDFIRPDE 309
N + + + LIDFGL + E
Sbjct: 120 NIIVRDDK----LYLIDFGLGKYSDEIE 143
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 8/109 (7%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
T ED Q+ + F + +HRDL N L + ++ +++ DFGL+ I D
Sbjct: 177 TLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDP 233
Query: 310 ---RLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
R D ++APE + R Y++++D+WS GV+ + I G+ P+
Sbjct: 234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 48/233 (20%), Positives = 93/233 (39%), Gaps = 30/233 (12%)
Query: 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
++ + +G G FG C K ++ VA+ + D +R + +A
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA-------GCSDKQRRGFLAEA 57
Query: 207 LS----GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQI 261
L+ H ++V+ N + IV E G LD L + G+ ++ +
Sbjct: 58 LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNG-ALDSFLRKHEGQLVAGQLMGMLPGL 116
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGS--- 317
S + + G VH+ L L S + +S F R +++ I +
Sbjct: 117 ASGMKYLSEMGYVHKGLAAHKVLVNSD--------LVCKISGFRRLQEDKSEAIYTTMSG 168
Query: 318 ---AYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
+ APE + + +S +D+WS G++ + ++ G RP+W + + +AV
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 60/244 (24%), Positives = 97/244 (39%), Gaps = 57/244 (23%)
Query: 150 ELGKEVGRGHFG--HTCSARG---------KKGELKDQ--QVAVKIISKAKMTTAISIED 196
+++G G FG H C A G + + D VAVK++ A ED
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR--ED 65
Query: 197 VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGE----LLDRILARGGRYTEE 252
+EVKIL LS ++ + C + ++ME E G+ L + G
Sbjct: 66 FLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG--LAC 122
Query: 253 DAKAI--------VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304
++K++ QI S + + VHRDL N L +++ DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN---YTIKIADFGMS-- 177
Query: 305 IRPDERLNDIVGSAYY------VAP-------EVLHRSYSLEADIWSIGVISY-IL-LCG 349
++ S YY P VL ++ ++D+W+ GV + IL LC
Sbjct: 178 -------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR 230
Query: 350 SRPF 353
+P+
Sbjct: 231 EQPY 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 26/210 (12%)
Query: 155 VGRGHFGHTCSARGKKGELKD------QQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+G+G F +G + E+ D +V +K++ K+ + E ++ LS
Sbjct: 3 LGQGTFTKI--FKGIRREVGDYGELHKTEVLLKVLDKSHRNYS---ESFFEAASMMSQLS 57
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
HKHLV C + +V E + G L D L + K V + L+ A
Sbjct: 58 -HKHLVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAW-ALH 114
Query: 269 HLQ--GVVHRDLKPENFLFTSGRDDAD-----MRLIDFGLSDFIRPDERLNDIVGSAYYV 321
L+ G+ H ++ +N L D ++L D G+S + P E L + + +V
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP---WV 171
Query: 322 APEVLH--RSYSLEADIWSIGVISYILLCG 349
PE + ++ SL AD WS G + + G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 148 KYELGKEVGRGHFGHT--CSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
+ GK +G G FG +A G E +VAVK++ + T E + E+KIL
Sbjct: 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD--EREALMSELKILS 96
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
L HK++V AC V ++ E C G+LL+
Sbjct: 97 HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLN 131
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 57/235 (24%), Positives = 105/235 (44%), Gaps = 36/235 (15%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ----QVAVKIISKAKMTTAISIEDVRREVKILKA 206
LGK +G G FG +G+L +VAVK + K + T +ED E +K
Sbjct: 3 LGKTLGEGEFGSV-----MEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKE 56
Query: 207 LSGHKHLVKFCDAC------EDVNNVYIVMELCEGGELLDRIL-ARGGRYTEEDAKAIVV 259
H ++++ C E + +++ + G+L +L +R G + ++V
Sbjct: 57 FD-HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLV 115
Query: 260 QILSVVA----FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------DFIRPDE 309
+ ++ +A + + +HRDL N + ++ ++ + DFGLS D+ R
Sbjct: 116 KFMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVADFGLSKKIYNGDYYR-QG 171
Query: 310 RLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIF 362
R+ + ++A E L R Y+ ++D+WS GV + I G P+ S I+
Sbjct: 172 RIAKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 52/210 (24%), Positives = 82/210 (39%), Gaps = 38/210 (18%)
Query: 253 DAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
D AI +L + + H ++HRD+K EN D+ L DFG + F
Sbjct: 183 DILAIERSVLRAIQYLHENRIIHRDIKAENIFINH---PGDVCLGDFGAACFPV------ 233
Query: 313 DIVGSAYY--------VAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWAR------- 356
DI + YY APE+L R Y DIWS G++ + + + +
Sbjct: 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC 293
Query: 357 -TESGIFRAVLRSDPNFDDLPWPSVSPEA--KDFVKRLLNKDYRKRMTAVQALTHP-WLR 412
++ I + RS + ++ P + +A + L K RK + P W
Sbjct: 294 DSDRQIKLIIRRSGTHPNEFP---IDAQANLDEIYIGLAKKSSRK------PGSRPLWTN 344
Query: 413 DDSRPVPLDILIFKLVKSYLHATPFKRAAL 442
P+ L+ LI K++ H P A L
Sbjct: 345 LYELPIDLEYLICKMLAFDAHHRPSAEALL 374
|
Length = 391 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 77/294 (26%)
Query: 150 ELGKE----VGRGH-FGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
ELG++ V +GH FG GE + Q VA+K + K K + E+ + E ++
Sbjct: 12 ELGEDRFGKVYKGHLFGTA------PGE-QTQAVAIKTL-KDKAEGPLR-EEFKHEA-MM 61
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY----TEEDAKA---- 256
++ H ++V + ++ C +L + ++ R T++D
Sbjct: 62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTL 121
Query: 257 -------IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
IV QI + + F VVH+DL N L D ++++ D GL
Sbjct: 122 EPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---DKLNVKISDLGL-------- 170
Query: 310 RLNDIVGSAYY------------VAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFWA 355
++ + YY ++PE +++ +S+++DIWS GV+ + + G +P+
Sbjct: 171 -FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229
Query: 356 RTESGIF-----RAVLRSDPNFDDLP-------------WPSVSPEAKDFVKRL 391
+ + R VL P DD P +PS P KD RL
Sbjct: 230 YSNQDVIEMIRNRQVL---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 20/46 (43%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
K ++ Q+L+ + H G+VHRD+KPEN L T D +++IDFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV-GSA 318
Q+ + F + +HRD+ N L T GR ++ DFGL+ I D N +V G+A
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGR---VAKICDFGLARDIMNDS--NYVVKGNA 274
Query: 319 Y----YVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
++APE + Y++++D+WS G++ + I G P+
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 39/181 (21%), Positives = 49/181 (27%), Gaps = 16/181 (8%)
Query: 17 TTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSPWPSPYPHGVSASPLPA 76
T +T+ S + + P T G + T + P P P LPA
Sbjct: 37 LTPLGSTSEATSEDDDDLYPPRETGSGGGVA---TSTIYTVPRPPRGPEQTLDKPDSLPA 93
Query: 77 GVSPSPARASTPRRFFRRPFPPPSPAKHI----------KASLAKRLGGGKPKESTIPEE 126
P P FR P A LA E EE
Sbjct: 94 SRELPPGPTPVPPGGFRGASSPRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELSEEE 153
Query: 127 RGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA 186
+ P S KN G Y G + H S KK K + V S+
Sbjct: 154 EHSRPPPS---ESLKVKNGGKVYPKGFSKHKTHKRSEFSGLTKKAARKRKGSFVFKPSQL 210
Query: 187 K 187
K
Sbjct: 211 K 211
|
Length = 580 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 22/129 (17%)
Query: 238 LLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDAD--- 293
LLD I+ + G ++ I+ Q + + H + ++H DLKPEN L + D
Sbjct: 218 LLDWIM-KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276
Query: 294 ----------MRLIDFGLSDFIRPDERLND--IVGSAYYVAPEV-LHRSYSLEADIWSIG 340
+R+ D G DER + IV + +Y +PEV L + D+WS+G
Sbjct: 277 NRALPPDPCRVRICDLGGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMG 332
Query: 341 VISYILLCG 349
I Y L G
Sbjct: 333 CIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 29/101 (28%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSA 318
Q+ + + F + VHRDL N L G+ +++ DFGL+ D +R ++ GS
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGK---LVKICDFGLARDIMRDSNYISK--GST 301
Query: 319 Y----YVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
+ ++APE + + Y+ +D+WS G++ + I G P+
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 34/112 (30%), Positives = 57/112 (50%), Gaps = 14/112 (12%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
T ED Q+ + F + +HRDL N L + ++ +++ DFGL+ I D
Sbjct: 172 TMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDP 228
Query: 310 RLNDIV--GSAY----YVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
D V GSA ++APE + + Y+ ++D+WS GV+ + I G+ P+
Sbjct: 229 ---DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 23/90 (25%), Positives = 34/90 (37%), Gaps = 3/90 (3%)
Query: 16 ATTSATTTTMVV--SANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSPWPSPYPHGVSASP 73
A A+ + + +AN + P PP + P P P+ P+P P +A+P
Sbjct: 22 AVAGASAVAIALPATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAP 81
Query: 74 LPAGVSPSPARASTPRRFFRRPFPPPSPAK 103
P P A P P P P P +
Sbjct: 82 PPPPADP-NAPPPPPVDPNAPPPPAPEPGR 110
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 32/114 (28%), Positives = 58/114 (50%), Gaps = 18/114 (15%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------- 302
T ED + Q+ + F + +HRDL N L + ++ +++ DFGL+
Sbjct: 171 TLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDP 227
Query: 303 DFIRP-DERLNDIVGSAYYVAPE-VLHRSYSLEADIWSIGVISY-ILLCGSRPF 353
D++R D RL ++APE + + Y+ ++D+WS GV+ + I G+ P+
Sbjct: 228 DYVRKGDARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 32/149 (21%), Positives = 65/149 (43%), Gaps = 19/149 (12%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVL---GRNATDAMRESRVPDVLSSMESLA 505
LTE+++ L+ F+L + + DG + +L G N ++A + + +++
Sbjct: 14 LTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAE----INKLFEEIDA-G 68
Query: 506 YRKMYFEEF-CAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSA 564
+ F EF ++ + + E + AF+ F+++ + ISI EL R L
Sbjct: 69 NETVDFPEFLTVMSVKLKRGDKEEELRE----AFKLFDKDHDGYISIGELRRVLKSLGER 124
Query: 565 YS------FLKDWIRNSDGKLSLHGYTKF 587
S LK++ + DG++ + K
Sbjct: 125 LSDEEVEKLLKEYDEDGDGEIDYEEFKKL 153
|
Length = 160 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED--VRREVKILKALS 208
LG+ +G G FG G L Q +K+ K TA S E + E+KI+ L
Sbjct: 41 LGRILGSGAFGKV--VEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG 98
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLD 240
H ++V AC +YI+ E C G+L++
Sbjct: 99 PHLNIVNLLGACTKSGPIYIITEYCFYGDLVN 130
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 41/178 (23%), Positives = 73/178 (41%), Gaps = 27/178 (15%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI------SIEDVR 198
G ++++ K +G G FG + + Q KI + T + +I D+
Sbjct: 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDID 69
Query: 199 REVKILKALSGHKHL-VKFCDACEDV--NNVYIVMELCE-----GGELLDRILARGGRYT 250
+ + + K + HL + C +Y L E E+ RI
Sbjct: 70 K-IALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKC----KN 124
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR--LIDFGL-SDFI 305
++ K I+ +L+ + + H G+ H D+KPEN + D + R +ID+G+ S FI
Sbjct: 125 KKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV-----DGNNRGYIIDYGIASHFI 177
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 601 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.74 | |
| PTZ00184 | 149 | calmodulin; Provisional | 99.74 | |
| PTZ00183 | 158 | centrin; Provisional | 99.73 | |
| KOG0034 | 187 | consensus Ca2+/calmodulin-dependent protein phosph | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 99.71 | |
| KOG0044 | 193 | consensus Ca2+ sensor (EF-Hand superfamily) [Signa | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| KOG0037 | 221 | consensus Ca2+-binding protein, EF-Hand protein su | 99.64 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| KOG4223 | 325 | consensus Reticulocalbin, calumenin, DNA supercoil | 99.45 | |
| KOG0036 | 463 | consensus Predicted mitochondrial carrier protein | 99.45 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.38 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.34 | |
| KOG4223 | 325 | consensus Reticulocalbin, calumenin, DNA supercoil | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| KOG0038 | 189 | consensus Ca2+-binding kinase interacting protein | 99.25 | |
| KOG0044 | 193 | consensus Ca2+ sensor (EF-Hand superfamily) [Signa | 99.24 | |
| PLN02964 | 644 | phosphatidylserine decarboxylase | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 99.15 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 99.06 | |
| KOG0037 | 221 | consensus Ca2+-binding protein, EF-Hand protein su | 99.05 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 99.05 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.03 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.03 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 99.01 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| PTZ00183 | 158 | centrin; Provisional | 98.95 | |
| KOG0034 | 187 | consensus Ca2+/calmodulin-dependent protein phosph | 98.93 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 98.93 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 98.91 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 98.85 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 98.83 | |
| PTZ00184 | 149 | calmodulin; Provisional | 98.83 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 98.83 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.79 | |
| smart00027 | 96 | EH Eps15 homology domain. Pair of EF hand motifs t | 98.77 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.76 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 98.75 | |
| cd05023 | 89 | S-100A11 S-100A11: S-100A11 domain found in protei | 98.7 | |
| cd00252 | 116 | SPARC_EC SPARC_EC; extracellular Ca2+ binding doma | 98.69 | |
| KOG0040 | 2399 | consensus Ca2+-binding actin-bundling protein (spe | 98.69 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 98.69 | |
| cd05031 | 94 | S-100A10_like S-100A10_like: S-100A10 domain found | 98.68 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 98.66 | |
| cd00213 | 88 | S-100 S-100: S-100 domain, which represents the la | 98.62 | |
| cd00052 | 67 | EH Eps15 homology domain; found in proteins implic | 98.61 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 98.61 | |
| smart00027 | 96 | EH Eps15 homology domain. Pair of EF hand motifs t | 98.59 | |
| cd05031 | 94 | S-100A10_like S-100A10_like: S-100A10 domain found | 98.59 | |
| KOG4251 | 362 | consensus Calcium binding protein [General functio | 98.58 | |
| KOG0377 | 631 | consensus Protein serine/threonine phosphatase RDG | 98.58 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.57 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-63 Score=486.76 Aligned_cols=275 Identities=36% Similarity=0.610 Sum_probs=248.8
Q ss_pred ccCcCcccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch----hhHHHHHHHHHHHHHhcCCCCe
Q 007498 138 SFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA----ISIEDVRREVKILKALSGHKHL 213 (601)
Q Consensus 138 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~ni 213 (601)
...+.+.+...|.+.+.||+|+||.|-+|..++ +++.||||++.+.+.... .....+++|++||++|+ ||||
T Consensus 163 ~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~---tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~I 238 (475)
T KOG0615|consen 163 SKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKK---TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNI 238 (475)
T ss_pred ccCccchhcceeEeeeeecCCceeEEEEEEEcc---cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCE
Confidence 344455677889999999999999999999987 899999999988665542 23345789999999996 9999
Q ss_pred eEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCC
Q 007498 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD 293 (601)
Q Consensus 214 v~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~ 293 (601)
|+++++|...+..||||||++||+|++.+... +.+.+...+.+++|++.||.|||++||+||||||+|||+..++++..
T Consensus 239 V~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~l 317 (475)
T KOG0615|consen 239 VRIKDFFEVPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCL 317 (475)
T ss_pred EEEeeeeecCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceE
Confidence 99999999999999999999999999998765 68999999999999999999999999999999999999998667889
Q ss_pred eEEeecccccccCCCCCccccccccccccchhccC----CCCChhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHcc
Q 007498 294 MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR----SYSLEADIWSIGVISYILLCGSRPFWARTESG-IFRAVLRS 368 (601)
Q Consensus 294 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~ 368 (601)
+||+|||+|+.......+.++|||+.|.|||++.. .++.++|+||||||||-+|+|.+||.+..... +.++|.++
T Consensus 318 lKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G 397 (475)
T KOG0615|consen 318 LKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG 397 (475)
T ss_pred EEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC
Confidence 99999999999988888999999999999999863 25669999999999999999999998776555 88999999
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 369 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
...|....|..+|.++++||.+||..||++|||++|+|+||||+..+..
T Consensus 398 ~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~ 446 (475)
T KOG0615|consen 398 RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL 446 (475)
T ss_pred cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence 9999999999999999999999999999999999999999999987643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-59 Score=475.48 Aligned_cols=265 Identities=33% Similarity=0.601 Sum_probs=245.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|..++.||+|||+.||.+++.. +|+.||+|++.+..+......+.+.+||+|.++|. |||||+++++|++.+++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCce
Confidence 579999999999999999999976 89999999999988888888999999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||+|+|+.++|..++. +.+.++|.+++.+++||+.||.|||+++|||||||..||||+ ++.+|||+|||+|..+.
T Consensus 94 YivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~---~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN---ENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec---CcCcEEecccceeeeec
Confidence 99999999999988765 567899999999999999999999999999999999999995 58899999999999987
Q ss_pred CC-CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
.. ++..+.||||.|+|||++. ..++..+||||+|||||-||+|++||...+-.+.+..|......+|. .+|.++
T Consensus 170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A 245 (592)
T KOG0575|consen 170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEA 245 (592)
T ss_pred CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHH
Confidence 44 7888999999999999987 57999999999999999999999999999999999999999888875 799999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCCCCCCChhHH
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDIL 423 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~ 423 (601)
++||.+||++||.+|||++++|.|+||+...-|..+...
T Consensus 246 ~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~ 284 (592)
T KOG0575|consen 246 KDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSS 284 (592)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCcc
Confidence 999999999999999999999999999776655555443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-58 Score=444.67 Aligned_cols=257 Identities=29% Similarity=0.599 Sum_probs=235.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||+||+|+.+. +++.||+|+++|.........+...+|..||.+++ ||.||+++..|++.+++
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~d---t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKD---TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKL 100 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcc---cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeE
Confidence 479999999999999999999885 89999999999988888778899999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc-
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI- 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~- 305 (601)
|||+||+.||.|..+|.+ .+.|++..++.|+.+|+.||.|||++|||||||||+||||+ .+|+|+|+|||+++..
T Consensus 101 ylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd---~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD---EQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec---CCCcEEEeccccchhcc
Confidence 999999999999988765 47899999999999999999999999999999999999994 6999999999999854
Q ss_pred CCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
..+....++|||+.|||||++. ..|+..+|+|||||++|||++|.+||.+.+...+++.|.+.....+. ..++.++
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~a 253 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEA 253 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHH
Confidence 4455677899999999999876 68999999999999999999999999999999999999988743332 2489999
Q ss_pred HHHHHHcccccccCCC----CHHHHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRM----TAVQALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~----s~~ell~hp~f~~~ 414 (601)
++||+++|++||++|. ++.++.+||||+..
T Consensus 254 rdll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 254 RDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 9999999999999996 68999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-57 Score=421.81 Aligned_cols=253 Identities=32% Similarity=0.619 Sum_probs=237.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||.|+||.|.+++.+. ++..||+|++++.++......+...+|..+|+.+. ||++++|++.|.+.+.+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~---~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKH---SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNL 119 (355)
T ss_pred hhhhheeeeccCccceEEEEEEcc---CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeE
Confidence 469999999999999999999987 78899999999988888888899999999999997 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
||||||++||.|..++.+. ++|++..++.|+.||+.||+|||+++|++|||||+||||+ .+|.+||+|||+|+.+.
T Consensus 120 ymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD---~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD---QNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec---cCCcEEEEeccceEEec
Confidence 9999999999999987654 7899999999999999999999999999999999999994 59999999999999875
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.. ..+.|||+.|+|||++. ++|+.++|+|||||++|||+.|.+||...+...++.+|+.++..||. .++++++
T Consensus 196 ~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~k 269 (355)
T KOG0616|consen 196 GR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAK 269 (355)
T ss_pred Cc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHH
Confidence 43 77899999999999876 78999999999999999999999999999999999999999999985 7899999
Q ss_pred HHHHHcccccccCCC-----CHHHHHcCcccCC
Q 007498 386 DFVKRLLNKDYRKRM-----TAVQALTHPWLRD 413 (601)
Q Consensus 386 ~li~~~L~~dP~~R~-----s~~ell~hp~f~~ 413 (601)
|||+++|+.|-++|. ...++.+||||++
T Consensus 270 dLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 270 DLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 999999999999994 5789999999985
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-58 Score=417.01 Aligned_cols=297 Identities=34% Similarity=0.646 Sum_probs=268.0
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.|.+.|++.+.||+|.|+.|+.+.++. +|+.+|+|++...++... ..+.+.+|++|.+.|+ |||||+|.+.+...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~---tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ-HPNIVRLHDSIQEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhcc---chHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcC-CCcEeehhhhhccc
Confidence 456789999999999999999887765 899999999987776654 6788999999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+..|||+|+|.|++|..-|-++ -.++|..+..+++||++||.|||.+||||||+||+|+|+.+.++..-+||+|||+|.
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999999999998777665 468999999999999999999999999999999999999987777789999999999
Q ss_pred ccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
.+..+....+++|||.|||||++. .+|+..+|||+.|||||-|+.|.+|||+.+...+++.|..+...++...|+++++
T Consensus 162 ~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 162 EVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred EeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence 998777778899999999999997 4799999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC--hhHHHHHHHHhhhccCchhHHHHHHhh
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP--LDILIFKLVKSYLHATPFKRAALKALS 446 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~--~~~~~~~~~k~~~~~~~l~~~~~~~~~ 446 (601)
++++||++||..||.+|+|+.|+|+|||+++...-.. -......-+++|+...++.-+.+..+.
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~ 307 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVI 307 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999987643211 122467788999988888888877764
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-55 Score=448.63 Aligned_cols=320 Identities=50% Similarity=0.872 Sum_probs=291.4
Q ss_pred CcccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 142 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
...+...|++.+.||+|.||.||.++.+. +++.||+|++.+.........+.+.+|+.||++|.+|||||.++++|+
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e 106 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE 106 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34566789999999999999999999987 799999999999887766667889999999999977999999999999
Q ss_pred cCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC-CCCeEEeecc
Q 007498 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD-DADMRLIDFG 300 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~-~~~vkl~DFG 300 (601)
+...+|+|||+|.||.|++.+... .+++.++..++.|++.|+.|||+.||+||||||+|+|+...+. ++.+|++|||
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999999999877 3999999999999999999999999999999999999987433 4589999999
Q ss_pred cccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 301 LSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
+|.....+......|||+.|+|||++. ..|+..+||||+||++|.|++|..||++.+.......+..+...|...+|+.
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 999988877888999999999999998 6899999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC--CCChhHHHHHHHHhhhccCchhHHHHHHhhhhcchHHHHHH
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR--PVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYL 457 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~--~~~~~~~~~~~~k~~~~~~~l~~~~~~~~~~~l~~~~~~~l 457 (601)
++..+++||++||..||.+|+++.++|+|||+++... ..+.+...+..++.+.+.+++.+.+.......++ +..+
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 341 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISGL 341 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHHH
Confidence 9999999999999999999999999999999998633 3355666777778888888888887777777776 8889
Q ss_pred HHHHHhhCCCCC
Q 007498 458 RAQFRLLEPNKD 469 (601)
Q Consensus 458 ~~~F~~~D~d~~ 469 (601)
+.+|..+|.+++
T Consensus 342 ~~~~~~~~~~~~ 353 (382)
T KOG0032|consen 342 KEMFKLMDTDNN 353 (382)
T ss_pred HHHHHhhccccc
Confidence 999999999877
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=431.99 Aligned_cols=262 Identities=35% Similarity=0.642 Sum_probs=237.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|.+.++||+|+||+||+++++. ++..||||.+.+... ....++.+..||+||+.|+ |||||.|++++..++.+
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~---~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKK---SGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccceehhhccCcceEEEEEeEecc---CCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeE
Confidence 579999999999999999999997 779999999988765 4456788999999999997 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCC---CCeEEeeccccc
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD---ADMRLIDFGLSD 303 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~---~~vkl~DFG~a~ 303 (601)
|||||||+||+|.++|.++ +.+++..++.++.||+.||++||+++||||||||+||||+....+ -.+||+|||+|+
T Consensus 85 ~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999998876 589999999999999999999999999999999999999874233 579999999999
Q ss_pred ccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
.+.++....+.||++.|||||++. +.|+.|+|+||+|+|+|+|++|+.||...+..+++..+.++....+..+ ..+++
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~ 242 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSN 242 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccC
Confidence 999888889999999999999985 7899999999999999999999999999999998887776655444333 35777
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
...+|+..+|..|+..|.+..+-+.|+++...+
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 888999999999999999999999999998765
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-56 Score=429.54 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=225.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc-
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN- 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~- 225 (601)
...+.++.||+|+.|+||+|+++. +++.+|+|++... .+....+++.+|++|++.. +||+||.+|++|..++.
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~---t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKP---TGKIYALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcC---CCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCce
Confidence 356778899999999999999997 8999999999433 2344678899999999999 59999999999999995
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
++|+||||+||+|.+.+... ++++|..+..|+.+|++||.|||. ++||||||||+|||++. .|.|||||||.++.
T Consensus 153 isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs---kGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS---KGEVKICDFGVSGI 228 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc---CCCEEeccccccHH
Confidence 99999999999998876544 789999999999999999999996 89999999999999964 89999999999988
Q ss_pred cCCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC-----ChhHHHHHHHccCC-CCCCCCC
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWAR-----TESGIFRAVLRSDP-NFDDLPW 377 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~-~~~~~~~ 377 (601)
+... ...+++||..|||||.+.+ .|+.++||||||++++||++|+.||... ...+++..|+...+ .++.
T Consensus 229 lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--- 304 (364)
T KOG0581|consen 229 LVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--- 304 (364)
T ss_pred hhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc---
Confidence 7655 6788999999999999885 7999999999999999999999999774 55677778877543 3332
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
..+|+++++||..||++||.+|+++.|+|+|||++....
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 248999999999999999999999999999999997654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=444.70 Aligned_cols=257 Identities=33% Similarity=0.617 Sum_probs=237.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|.+++.||+|+|++|++|+.+. +++.||||++.+..+.....+.-+.+|-.+|.+|.+||.|++||..|++...+
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~---t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKA---TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred hhcchhheeccccceeEEEeeecC---CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 369999999999999999999987 89999999999887777777788899999999998899999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|+||+++|+|+++|.+. +.|++..++.|+.||+.||+|||++|||||||||+|||| ++++++||+|||.|+.+.
T Consensus 150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCC
Confidence 9999999999999998766 789999999999999999999999999999999999999 569999999999998764
Q ss_pred CCC--------------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC
Q 007498 307 PDE--------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 307 ~~~--------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
+.. ...+++||..|.+||+|. +..++.+|||+||||||.|+.|.+||.+.++-.+++.|+.....
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE 305 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence 321 124589999999999997 56789999999999999999999999999999999999999988
Q ss_pred CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 372 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
|+. .++++++|||+++|..||+.|+|+.+|.+||||.+.
T Consensus 306 fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 306 FPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred CCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 885 789999999999999999999999999999999753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-56 Score=418.60 Aligned_cols=257 Identities=30% Similarity=0.544 Sum_probs=225.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|+.+.++|+|+||.||+++++. +|+.||||++.... .+....+-..|||++|++|+ |+|+|.|+++|.....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~---TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD---TGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC---cccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhccee
Confidence 368999999999999999999987 99999999986654 23334556789999999997 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+||+|||+. ++++-+......++.+.++.|+.|++.|+.|||++++|||||||+|||++. ++.+||||||+|+.+.
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~---~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ---NGVVKLCDFGFARTLS 152 (396)
T ss_pred EEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec---CCcEEeccchhhHhhc
Confidence 999999988 667777776667999999999999999999999999999999999999975 8999999999999887
Q ss_pred -CCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHc--------------cC
Q 007498 307 -PDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR--------------SD 369 (601)
Q Consensus 307 -~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~--------------~~ 369 (601)
++...+..+.|.||+|||++-+ .|+..+||||+||++.||++|.+.|.+.++-+++-.|.+ ..
T Consensus 153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 6777888999999999998865 699999999999999999999999999998887766543 23
Q ss_pred CCCCCC-------------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 370 PNFDDL-------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 370 ~~~~~~-------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
+.|... .++.++.-+.||+++||+.||.+|++.+|+|.|+||.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 322222 1456788999999999999999999999999999993
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-55 Score=403.65 Aligned_cols=264 Identities=30% Similarity=0.526 Sum_probs=234.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|...++||+|.||.||+|++.. +|+.||||.++..+..+... ....|||+.|+.++ |+||+.|+++|...+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~-h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---TGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELK-HPNIIELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---CCcEEEEEEeeccccccCcc-HHHHHHHHHHHHcc-CcchhhhhhhccCCCce
Confidence 368899999999999999999987 89999999998876665544 34678999999997 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
.||+||++. +|...|......++..+++.|+.++++||+|||++.|+||||||+|+|++. +|.+||+|||+|+.+.
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~---~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS---DGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC---CCcEEeecccchhccC
Confidence 999999986 899999888888999999999999999999999999999999999999964 8999999999999886
Q ss_pred CCCC-ccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC-----
Q 007498 307 PDER-LNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP----- 378 (601)
Q Consensus 307 ~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----- 378 (601)
+... ....+-|.||+|||++.| .|+..+||||.|||+.||+.|.+.|.+.++-+++..|++.........|+
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 5544 334589999999999874 69999999999999999999999999999999999998765544444444
Q ss_pred -------------------CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 379 -------------------SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 379 -------------------~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
..+.++.||+.+||..||.+|+++.|+|+|+||+..+.|.+
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP 292 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence 34678999999999999999999999999999998766554
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-53 Score=440.75 Aligned_cols=256 Identities=28% Similarity=0.519 Sum_probs=238.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|.+++.||+|+||+|++|..+. +++.||||+++|..+.....++.+..|-+|+....+||.+++|+.+|+...++
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~---~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKG---TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcC---CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 479999999999999999999987 88999999999999888889999999999999998899999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+.||++..+ .+.+.|++..++.|+.+|+.||.|||++||||||||.+||||+ .+|++||+|||+++...
T Consensus 445 ~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD---~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD---TEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc---ccCcEEecccccccccC
Confidence 999999999995433 3446899999999999999999999999999999999999994 59999999999998754
Q ss_pred -CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 -PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 -~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
.+....++|||+.|||||++. ..|+.++|+|||||+|||||.|..||.+.++++++..|+...+.+|. .+|.++
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea 595 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEA 595 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHH
Confidence 666788999999999999997 57999999999999999999999999999999999999999988885 699999
Q ss_pred HHHHHHcccccccCCCC-----HHHHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRMT-----AVQALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~ 414 (601)
.++++++|++||++|.. +.+|..||||+..
T Consensus 596 ~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 596 IAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 99999999999999996 4899999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-54 Score=430.43 Aligned_cols=265 Identities=28% Similarity=0.490 Sum_probs=232.9
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.....|+.+++||+|+||.||+|++.. +++.||+|.+........ ...-..|||.||++|. ||||++|.+...+.
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~---tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~-HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLE---TGKIVALKKVRFDNEKEG-FPITAIREIKILRRLD-HPNIIKLEEIVTSK 188 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecc---cCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcC-CCcccceeeEEEec
Confidence 344579999999999999999999987 899999999987664443 3445678999999995 99999999988766
Q ss_pred --CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 224 --NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 224 --~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
+.+|||+|||++ +|..++...+-.|++.+|+.|++||+.||+|||.+||+|||||.+||||+ .+|.+||+||||
T Consensus 189 ~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid---n~G~LKiaDFGL 264 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID---NNGVLKIADFGL 264 (560)
T ss_pred CCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc---CCCCEEeccccc
Confidence 789999999998 88888877777899999999999999999999999999999999999995 599999999999
Q ss_pred ccccCCCC--CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCC
Q 007498 302 SDFIRPDE--RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 302 a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 377 (601)
|+++.... .++..+.|.||+|||+|.| .|+.++|+||.||||.||++|++.|.+.++.+++..|.+.+.......|
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 99876554 4677899999999999875 6999999999999999999999999999999999999876655444444
Q ss_pred C-------------------------CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 378 P-------------------------SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 378 ~-------------------------~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
+ .++..+.+|+..||..||.+|.||.++|+|+||...+.+
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~ 409 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLP 409 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCC
Confidence 3 357889999999999999999999999999999666543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-54 Score=432.33 Aligned_cols=260 Identities=32% Similarity=0.536 Sum_probs=231.6
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|+++..||+|+||.||+|+-+. +|..||+|++++..+.....++.++.|-.||... ++|+||+||..|++..+
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~---Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKD---TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEY 215 (550)
T ss_pred cccchhheeeccccceeEEEEEEcc---CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCe
Confidence 3579999999999999999999887 8999999999999988888899999999999996 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+||||||++||++..+|.+. +.|++..++.|+.+++.|++.||+.|+|||||||+|+|| |..|++||+||||+.-+
T Consensus 216 LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGL 291 (550)
T ss_pred eEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchh
Confidence 99999999999999877654 689999999999999999999999999999999999999 46999999999998422
Q ss_pred CC----------------------C--C-----C-------------------ccccccccccccchhcc-CCCCChhhH
Q 007498 306 RP----------------------D--E-----R-------------------LNDIVGSAYYVAPEVLH-RSYSLEADI 336 (601)
Q Consensus 306 ~~----------------------~--~-----~-------------------~~~~~gt~~y~aPE~~~-~~~~~~~Dv 336 (601)
.. . . . ....+|||.|||||++. ..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 10 0 0 0 01358999999999986 579999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCC---HHHHHcCcccCC
Q 007498 337 WSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT---AVQALTHPWLRD 413 (601)
Q Consensus 337 wSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~ell~hp~f~~ 413 (601)
|||||||||||.|.+||.+.+..+.+++|.+....+....-..++++++|||.+||+ ||.+|.. ++||..||||+.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 999999999999999999999999999999877544443335789999999999999 9999985 899999999986
Q ss_pred C
Q 007498 414 D 414 (601)
Q Consensus 414 ~ 414 (601)
.
T Consensus 451 v 451 (550)
T KOG0605|consen 451 V 451 (550)
T ss_pred C
Confidence 4
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-53 Score=428.32 Aligned_cols=267 Identities=31% Similarity=0.544 Sum_probs=230.7
Q ss_pred CcccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 142 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
..+....|....+||+|+.|.||.|+... +++.||||++...... ..+-+.+|+.+|+.++ |+|||++++.|.
T Consensus 268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~---~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~-H~NiVnfl~Syl 340 (550)
T KOG0578|consen 268 QGDPRSKYTDFKKIGQGATGGVYVARKIS---TKQEVAIKRMDLRKQP---KKELLLNEILVMRDLH-HPNIVNFLDSYL 340 (550)
T ss_pred CCChhhhhcchhhhccccccceeeeeecc---CCceEEEEEEEeccCC---chhhhHHHHHHHHhcc-chHHHHHHHHhc
Confidence 34455679999999999999999999887 7889999999776543 3467899999999997 999999999999
Q ss_pred cCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
.++.+|+|||||+||+|.+.+... .++|.+|..|+++++.||+|||.+||||||||.+|||++. +|.+||+|||+
T Consensus 341 v~deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~---~g~vKltDFGF 415 (550)
T KOG0578|consen 341 VGDELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTM---DGSVKLTDFGF 415 (550)
T ss_pred ccceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEecc---CCcEEEeeeee
Confidence 999999999999999999987654 5999999999999999999999999999999999999964 88899999999
Q ss_pred ccccCCCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH-ccCCCCCCCCCC
Q 007498 302 SDFIRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL-RSDPNFDDLPWP 378 (601)
Q Consensus 302 a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~ 378 (601)
+..+.... ...+.+||++|||||++. +.|++|+||||||++++||+.|++||...+....+..|. ++.+.+.. +.
T Consensus 416 caqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~--~~ 493 (550)
T KOG0578|consen 416 CAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN--PE 493 (550)
T ss_pred eeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC--cc
Confidence 98876554 667899999999999987 589999999999999999999999998766655444443 44444433 35
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCChhH
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDI 422 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~ 422 (601)
.+|++++|||.+||+.|+.+|++|.|||+||||+....+..+..
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~p 537 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPESSLNP 537 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCHHHhHH
Confidence 79999999999999999999999999999999976654444333
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-54 Score=430.41 Aligned_cols=262 Identities=32% Similarity=0.473 Sum_probs=230.1
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+..+|.++++||.|+||.||+|+.+. +++.||||.+++..... ... .-+||++.|++|..|||||+|.+++.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~---~~~~VAIK~MK~Kf~s~-ee~-~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE---TGELVAIKKMKKKFYSW-EEC-MNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC---CCceeeHHHHHhhhccH-HHH-HHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 44689999999999999999999876 88999999997654332 222 23579999999976999999999999887
Q ss_pred -cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 225 -NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 225 -~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
.+|+|||||+. +|++++..++..|++..++.|+.||+.||+|+|.+|+.||||||+|||+.. ...|||+|||+|+
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---NDVIKIADFGLAR 158 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc---cceeEeccccccc
Confidence 99999999975 999999999889999999999999999999999999999999999999963 6789999999999
Q ss_pred ccCCCCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC-----
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP----- 376 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----- 376 (601)
.+......+..+.|.||+|||++. +.|+.++||||+|||++|+++-++.|.|.++.+++-.|+.-........
T Consensus 159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 999888999999999999999874 5799999999999999999999999999999888877765322211111
Q ss_pred ---------------------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 377 ---------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 377 ---------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
.+..+.++.+||.+||..||.+||||.|+|+||||+...
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 245789999999999999999999999999999998653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=404.52 Aligned_cols=264 Identities=28% Similarity=0.463 Sum_probs=230.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--CC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--VN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~ 224 (601)
..|+.+.+|++|+||.||.|+++. +++.||+|+++..+......... .|||.+|.+++ |||||.+-++... -+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~---t~eIVALKr~kmekek~GFPIts-LREIniLl~~~-H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKK---TDEIVALKRLKMEKEKEGFPITS-LREINILLKAR-HPNIVEVKEVVVGSNMD 150 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCC---cceeEEeeecccccccCCCcchh-HHHHHHHHhcC-CCCeeeeEEEEeccccc
Confidence 469999999999999999999987 89999999998877555555444 57999999997 9999999987653 46
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|||||||+. +|..++.....+|...+++.++.|+++||+|||.+.|+|||||++|+|++ ..|.+||+|||+|+.
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIADFGLARE 226 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEecccchhhh
Confidence 79999999998 89888888778999999999999999999999999999999999999996 489999999999998
Q ss_pred cCCC-CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC---
Q 007498 305 IRPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP--- 378 (601)
Q Consensus 305 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--- 378 (601)
+... ...+..+-|.||+|||++.+ .|+.++|+||+|||+.||+++++.|.+..+.+++..|++.........|+
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 8655 44677899999999998864 69999999999999999999999999999999999887643332222222
Q ss_pred -------------------------CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 379 -------------------------SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 379 -------------------------~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
.++....+|+..+|..||.+|.||+|.|+|.||++.+.|.+
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~ 372 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPID 372 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCC
Confidence 24588999999999999999999999999999999877665
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=431.47 Aligned_cols=257 Identities=39% Similarity=0.748 Sum_probs=233.1
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch--hhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA--ISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
...|.+++.||+|+||.|+++++.. +++.||+|++.+...... ...+.+.+|+.+++.+..||||+++++++...
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 4589999999999999999999886 779999998877533211 24566789999999997699999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCC-CCeEEeecccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD-ADMRLIDFGLS 302 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~-~~vkl~DFG~a 302 (601)
..+|||||||.||+|++++.+ .+++.|.+++.+++||+.|++|||++||+||||||+|||++. + +++||+|||++
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~---~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDG---NEGNLKLSDFGLS 168 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecC---CCCCEEEeccccc
Confidence 999999999999999999988 689999999999999999999999999999999999999964 5 99999999999
Q ss_pred ccc-CCCCCccccccccccccchhccC-C-C-CChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 303 DFI-RPDERLNDIVGSAYYVAPEVLHR-S-Y-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 303 ~~~-~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
... .......+.|||+.|+|||++.+ . | +.++||||+||+||.|++|+.||...+...++..|.+....++.
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~---- 244 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS---- 244 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----
Confidence 988 56678899999999999999974 4 6 58999999999999999999999998888899998888877775
Q ss_pred CC-CHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 379 SV-SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 379 ~~-s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
.+ |+++++||.+||..||.+|+++.++++||||+.
T Consensus 245 ~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 245 YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 35 999999999999999999999999999999997
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-54 Score=390.27 Aligned_cols=256 Identities=30% Similarity=0.609 Sum_probs=238.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++++.||+|.||.||+|+.++ ++-.||+|++.+.++.......++.+|++|-..|+ ||||+++|++|.+...+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekk---s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKK---SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRI 97 (281)
T ss_pred hhccccccccCCccccEeEeeecc---CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheecccee
Confidence 469999999999999999999987 77899999999998887777889999999999997 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~-~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
||++||...|+|+..+.. ...++++..++.|+.|++.||.|||.++||||||||+|+|++. .+.+||+|||++...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~---~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGS---AGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCC---CCCeeccCCCceeec
Confidence 999999999999998874 3467999999999999999999999999999999999999975 889999999999654
Q ss_pred CCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 306 RPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
. ..+..+.|||..|.+||+..+ .++..+|+|++|++.||++.|.+||...+..+.++.|.+.+..++ ..++.++
T Consensus 175 p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a 249 (281)
T KOG0580|consen 175 P-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGA 249 (281)
T ss_pred C-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhH
Confidence 4 667788999999999999874 799999999999999999999999999999999999999988887 4799999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+|||.+||.++|.+|.+..|++.|||+...
T Consensus 250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 250 ADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999999999754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-52 Score=424.72 Aligned_cols=256 Identities=33% Similarity=0.596 Sum_probs=236.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
+-|++++.||.|+-|.|-+|++.. +|+.+|||++.+...........+.+||-||+.|. ||||+++|++|++..++
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~---TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAE---TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHL 87 (786)
T ss_pred cceeccccccCCCCceehhhhccc---ccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceE
Confidence 469999999999999999999876 99999999998875444445677899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|.||++||.|++++..+ |++++.+++.++.||+.|+.|||..+|+||||||+|+||+ ..++|||+|||+|..-.
T Consensus 88 ylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd---~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD---VKNNIKIADFGMASLEV 163 (786)
T ss_pred EEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh---cccCEeeeccceeeccc
Confidence 9999999999999998876 6899999999999999999999999999999999999995 56779999999998877
Q ss_pred CCCCccccccccccccchhccC-CC-CChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLHR-SY-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
++....+.||++.|.|||++.| .| +.++||||.|||||.||+|++||.+.+-..++.++.++.+..+. .+++++
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~ea 239 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSEA 239 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHHH
Confidence 7888899999999999999985 45 78999999999999999999999999999999999999888774 799999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
++||++||++||++|+|.+||++|||+...
T Consensus 240 QdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 240 QDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred HHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 999999999999999999999999999754
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-53 Score=391.62 Aligned_cols=262 Identities=35% Similarity=0.628 Sum_probs=239.1
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHHhcCCCCeeEEee
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-----TAISIEDVRREVKILKALSGHKHLVKFCD 218 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~l~~ 218 (601)
.+..+|.-.+.||.|..+.|-.+..+. +++.+|+|++...... .....+.-.+|+.||+++.+||+|+++.+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~---t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKE---TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcc---cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 455678888999999999998887776 7889999998653221 11234556789999999999999999999
Q ss_pred eEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 219 ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 219 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
+|+.+..+++|+|+|+.|.|+|++... -.+++...+.|++||+.|+.|||.++|+||||||+|||+ +++.+|||+|
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isD 166 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISD 166 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEec
Confidence 999999999999999999999998765 579999999999999999999999999999999999999 4689999999
Q ss_pred cccccccCCCCCccccccccccccchhcc-------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
||+|+.+.++++....|||++|+|||.+. .+|+..+|+||+|||||-|+.|.+|||.....-+++.|.+++..
T Consensus 167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 99999999999999999999999999873 36999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 372 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
|....|.++|.+.+|||.+||+.||.+|+|++|+|.||||.
T Consensus 247 F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 247 FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 99999999999999999999999999999999999999993
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-53 Score=393.42 Aligned_cols=246 Identities=29% Similarity=0.546 Sum_probs=214.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEee-eEecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD-ACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~-~~~~~~~ 225 (601)
..|++.++||+|.||.||+|++.. +++.||.|.+.-.. -+....+.+..|+.+|++|+ |||||++|+ .|.++..
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~---~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLL---DGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNE 93 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeecc---Ccchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccch
Confidence 469999999999999999999986 89999999987433 34556788999999999996 999999999 4554444
Q ss_pred -EEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHH--cC--CeeccCCCCceEeecCCCCCCeEEe
Q 007498 226 -VYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHL--QG--VVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 226 -~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~--~~--iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
++||||||.+|+|...|.. ....++|..+|+++.|++.||..||. .+ |+||||||.||+|+ .+|.|||+
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~---~~gvvKLG 170 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT---ANGVVKLG 170 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc---CCCceeec
Confidence 9999999999999887753 45679999999999999999999999 45 99999999999996 48999999
Q ss_pred ecccccccCCCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCC
Q 007498 298 DFGLSDFIRPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375 (601)
Q Consensus 298 DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 375 (601)
|||+++.+..... ..+.+|||+||+||+++ .+|+.++||||+||++|||+.-+.||.+.+-..+-++|.++. ++..
T Consensus 171 DfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd--~~~~ 248 (375)
T KOG0591|consen 171 DFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD--YPPL 248 (375)
T ss_pred cchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC--CCCC
Confidence 9999999876544 45689999999999987 589999999999999999999999999998888888888774 4433
Q ss_pred CCCCCCHHHHHHHHHcccccccCCCCH
Q 007498 376 PWPSVSPEAKDFVKRLLNKDYRKRMTA 402 (601)
Q Consensus 376 ~~~~~s~~~~~li~~~L~~dP~~R~s~ 402 (601)
+-..+|.++..||..|+..||+.||+.
T Consensus 249 p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 249 PDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred cHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 334689999999999999999999986
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-52 Score=402.51 Aligned_cols=258 Identities=33% Similarity=0.618 Sum_probs=239.1
Q ss_pred CcccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 142 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
..+...+|++.+.||+|+||.|-+|+... .|+.||||.|++.++.+..+.-.+++||+||..|+ ||||+.+|++|+
T Consensus 48 khnlkHRyE~~etLGkGTYGKVk~A~e~~---sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFE 123 (668)
T KOG0611|consen 48 KHNLKHRYEITETLGKGTYGKVKLAYEHK---SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFE 123 (668)
T ss_pred ccchhhHHHHHHHhcCCcccceeehhhcc---CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhc
Confidence 34566789999999999999999999876 78999999999999999889999999999999996 999999999999
Q ss_pred cCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
..+.+.|||||..+|.|++++..+ +.|++.+++.+++||+.|+.|||.++|+|||||.+|||| |.++++||+|||+
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGL 199 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGL 199 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccch
Confidence 999999999999999999998776 689999999999999999999999999999999999999 4689999999999
Q ss_pred ccccCCCCCccccccccccccchhccC-CC-CChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 302 SDFIRPDERLNDIVGSAYYVAPEVLHR-SY-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 302 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
+..+.......++||++.|.+||++++ +| ++.+|-|||||+||-|..|..||.+.+...++++|.++...-+ .
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-----~ 274 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-----E 274 (668)
T ss_pred hhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-----C
Confidence 999988888999999999999999986 45 7899999999999999999999999999999999988765444 3
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
-+.++.-||++||..||++|.|++++-+|-|+.
T Consensus 275 ~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 275 TPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred CCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 567899999999999999999999999998874
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=399.32 Aligned_cols=259 Identities=31% Similarity=0.525 Sum_probs=234.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|+++++||+|.-|+||+|+.+. ++..+|+|++.+..+.......+++.|-+||+.+ +||.++.||..|+.++..
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~---t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRG---TNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYS 152 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecC---CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeecccee
Confidence 368999999999999999999987 6789999999998888777888899999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|||||||+||+|....+++ ++.|++..++.|+.+|+.||+|||-.|||+|||||+|||| .++|+|.|+||.++...
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccC
Confidence 9999999999999877654 5679999999999999999999999999999999999999 56999999999987432
Q ss_pred CC---------------------------------C------------------------CCccccccccccccchhccC
Q 007498 306 RP---------------------------------D------------------------ERLNDIVGSAYYVAPEVLHR 328 (601)
Q Consensus 306 ~~---------------------------------~------------------------~~~~~~~gt~~y~aPE~~~~ 328 (601)
.. . .+...++||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 0 01124689999999999986
Q ss_pred -CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCC----HH
Q 007498 329 -SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT----AV 403 (601)
Q Consensus 329 -~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~ 403 (601)
..+.++|||+|||++||||.|..||.+.+..+.+.+|+.....|+..+ .++..++|||+++|.+||++|.. |.
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~ 387 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAA 387 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchH
Confidence 689999999999999999999999999999999999999999998865 78999999999999999999998 99
Q ss_pred HHHcCcccCCC
Q 007498 404 QALTHPWLRDD 414 (601)
Q Consensus 404 ell~hp~f~~~ 414 (601)
||.+||||+..
T Consensus 388 eIK~HpFF~gV 398 (459)
T KOG0610|consen 388 EIKRHPFFEGV 398 (459)
T ss_pred HhhcCccccCC
Confidence 99999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-51 Score=403.71 Aligned_cols=259 Identities=34% Similarity=0.627 Sum_probs=225.0
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchh-----------hHHHHHHHHHHHHHhcCCCCe
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI-----------SIEDVRREVKILKALSGHKHL 213 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~h~ni 213 (601)
.-.+|++++.||+|.||.|-+|++.. +++.||||++.+....... ..+++++||.||++|. ||||
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~---~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nV 170 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEV---DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNV 170 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecC---CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCe
Confidence 34589999999999999999999876 8899999999875443321 2468899999999997 9999
Q ss_pred eEEeeeEecC--CcEEEEEeecCCCchHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC
Q 007498 214 VKFCDACEDV--NNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 214 v~l~~~~~~~--~~~~lv~e~~~~g~L~~~~~~~~~~-l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~ 290 (601)
|+|+++..+. +.+|||+|||..|.+.. ....+. +++.+++.|++.++.||+|||.+|||||||||+|+||+.
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w--~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~--- 245 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKW--CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS--- 245 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCcccc--CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC---
Confidence 9999998764 67999999999998653 223344 999999999999999999999999999999999999964
Q ss_pred CCCeEEeecccccccCCC------CCccccccccccccchhccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCChh
Q 007498 291 DADMRLIDFGLSDFIRPD------ERLNDIVGSAYYVAPEVLHR-----SYSLEADIWSIGVISYILLCGSRPFWARTES 359 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlG~il~ell~g~~pf~~~~~~ 359 (601)
+|.|||+|||.+.....+ ......+||+.|+|||++.+ ..+.+.||||+||+||+|+.|+.||.+....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 799999999999766322 22345789999999998764 1478899999999999999999999999999
Q ss_pred HHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 360 GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 360 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+++..|.+....|+.. +.+..+++|||.+||++||.+|++..++..|||....
T Consensus 326 ~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 326 ELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9999999988888775 3689999999999999999999999999999999766
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-51 Score=412.41 Aligned_cols=254 Identities=30% Similarity=0.601 Sum_probs=229.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|.+.+.||+|+||.||+++.+. +.+.||+|.+.|.... ......+++|++|++.|+ |||||.+++.|+...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~---t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY---TIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc---ceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceE
Confidence 368899999999999999999886 8899999999886643 346788999999999997 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|+|||.| +|..++. .++.++|+.++.++.+++.||.|||+++|+|||+||.|||+. +.+.+|+||||+|+.+.
T Consensus 77 ~vVte~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~---~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE---KGGTLKLCDFGLARAMS 151 (808)
T ss_pred EEEehhhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec---CCCceeechhhhhhhcc
Confidence 999999977 8887654 567899999999999999999999999999999999999995 58999999999998876
Q ss_pred CCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
.+.. .....||+.|||||++. +.|+..+|+||||||+|||++|++||....-..+.+.|......++. ..+.++
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f 227 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSF 227 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHH
Confidence 5543 45578999999999987 57999999999999999999999999999888888999887766553 789999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
..||+.+|.+||.+|.+..+++.|||++..
T Consensus 228 ~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 228 VNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 999999999999999999999999999754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=401.13 Aligned_cols=259 Identities=34% Similarity=0.576 Sum_probs=215.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC--
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-- 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-- 224 (601)
..|..++.||+|+||.||++.+.+ +++.+|||.+...... ..+.+.+|+.+|++|+ |||||++++......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~---~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~ 89 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK---TGELMAVKSVELEDSP---TSESLEREIRILSRLN-HPNIVQYYGSSSSREND 89 (313)
T ss_pred chhhhhccccCccceEEEEEEecC---CCcceeeeeeecccch---hHHHHHHHHHHHHhCC-CCCEEeeCCccccccCe
Confidence 358889999999999999999986 6889999998765211 2577899999999997 999999999855444
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.++|+|||+++|+|.+.+.+.++.|++..++.+.+||++||.|||++|||||||||+|||++. .++.+||+|||+++.
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~--~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDP--SNGDVKLADFGLAKK 167 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeC--CCCeEEeccCccccc
Confidence 699999999999999999887668999999999999999999999999999999999999953 158999999999987
Q ss_pred cCC----CCCccccccccccccchhccCCC--CChhhHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHccCCCCCCCCC
Q 007498 305 IRP----DERLNDIVGSAYYVAPEVLHRSY--SLEADIWSIGVISYILLCGSRPFWAR-TESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 305 ~~~----~~~~~~~~gt~~y~aPE~~~~~~--~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~ 377 (601)
... ........||+.|||||++.... .+++|||||||++.||+||..||... .....+-.+.... ..+..+
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P~ip- 245 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLPEIP- 245 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCCCCC-
Confidence 663 12234578999999999988433 34999999999999999999999763 3333333343333 222222
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
..+|+++++||.+||.+||++||||.++|+|||.+....
T Consensus 246 ~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 246 DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 469999999999999999999999999999999987644
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=392.25 Aligned_cols=262 Identities=34% Similarity=0.594 Sum_probs=221.9
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-- 222 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-- 222 (601)
....|..++.||+|+||.|+.|.++. +++.||||.+... +......++..||+++|+.++ |+||+.+++.+..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~---t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKR---TGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPS 94 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcC---CCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccccc
Confidence 44567778999999999999999987 7899999998642 445556788899999999997 9999999998865
Q ss_pred ---CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 223 ---VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 223 ---~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
-+.+|+|+|+|+. +|...+ +.+..+++.+++.++.||++||.|+|+.+|+||||||.|+|++ .+..+|||||
T Consensus 95 ~~~f~DvYiV~elMet-DL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n---~~c~lKI~DF 169 (359)
T KOG0660|consen 95 RDKFNDVYLVFELMET-DLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN---ADCDLKICDF 169 (359)
T ss_pred ccccceeEEehhHHhh-HHHHHH-HcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec---cCCCEEeccc
Confidence 3569999999954 777655 4445699999999999999999999999999999999999996 4888999999
Q ss_pred ccccccCC---CCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHc-------
Q 007498 300 GLSDFIRP---DERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR------- 367 (601)
Q Consensus 300 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~------- 367 (601)
|+|+.... ....+..+.|.||+|||++. ..|+.++||||+||||.||++|++.|.+.+.-.++..|+.
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 99998764 44457789999999999864 5799999999999999999999999998877666665543
Q ss_pred ----------------cCCCCCCCC----CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 368 ----------------SDPNFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 368 ----------------~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
..+..+..+ +++.++++.||+.+||..||.+|+|++|+|.||||.....
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 223333333 4678999999999999999999999999999999976544
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-50 Score=398.63 Aligned_cols=326 Identities=30% Similarity=0.546 Sum_probs=274.7
Q ss_pred cCcccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeE
Q 007498 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC 220 (601)
Q Consensus 141 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~ 220 (601)
+...+..-|.+.+.||+|.|+.|-+|++.- +|+.||||++.+.++... ....+.+|++.|+.+. |||||+||++.
T Consensus 12 ~DgkIAGLYDLekTlG~GHFAVVKLArHVF---TGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQ-HpNiVRLYEVi 86 (864)
T KOG4717|consen 12 YDGKIAGLYDLEKTLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQ-HPNIVRLYEVI 86 (864)
T ss_pred cccceeeeehhhhhhcCCceehhhhhhhhc---ccceeEEEEecccccchh-hhhHHHHHHHHHHHhc-CcCeeeeeehh
Confidence 344566789999999999999999999875 999999999999887654 4466788999999996 99999999999
Q ss_pred ecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecc
Q 007498 221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300 (601)
Q Consensus 221 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG 300 (601)
.....+|||+|+-++|+|+++|.++...+.|..+++|+.||+.|+.|||+..||||||||+||.+- .+-|.|||+|||
T Consensus 87 DTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFG 164 (864)
T KOG4717|consen 87 DTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFG 164 (864)
T ss_pred cccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeecc
Confidence 999999999999999999999999988899999999999999999999999999999999999886 368999999999
Q ss_pred cccccCCCCCccccccccccccchhccC-CC-CChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 301 LSDFIRPDERLNDIVGSAYYVAPEVLHR-SY-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
++..+.++.+..+.||+..|-|||++.+ .| .+++||||||||||.|.||++||...++.+.+-.|+..+...+.
T Consensus 165 FSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs---- 240 (864)
T KOG4717|consen 165 FSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS---- 240 (864)
T ss_pred ccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----
Confidence 9999999999999999999999999875 56 47899999999999999999999999999999999988877764
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCChhHHHHHHHHhhhccCchhHHHHHHhhhhcchHHHHHHH
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLR 458 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~k~~~~~~~l~~~~~~~~~~~l~~~~~~~l~ 458 (601)
.++.++++||..||..||.+|.+.++|..|+|++....+..-.+ -+.+...+.......+.+.+-...|.-=.
T Consensus 241 hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~i-------PLvsr~~L~ee~Ha~IIq~Mv~G~IAs~e 313 (864)
T KOG4717|consen 241 HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAI-------PLVSRHHLPEEAHATIIQQMVAGAIASEE 313 (864)
T ss_pred hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccC-------ceeehhhCChHHHHHHHHHHhcccccCHH
Confidence 79999999999999999999999999999999997655332211 12233344444444444433333333334
Q ss_pred HHHHhhCCCCCCcccHHHHHHHHhhc
Q 007498 459 AQFRLLEPNKDGSVSLENFRMVLGRN 484 (601)
Q Consensus 459 ~~F~~~D~d~~G~I~~~el~~~l~~~ 484 (601)
++.+.+|.|.-..|+..=|..+=+.+
T Consensus 314 ~Il~aLe~n~YNhiTATYfLLAEr~L 339 (864)
T KOG4717|consen 314 DILRALENNEYNHITATYFLLAERVL 339 (864)
T ss_pred HHHHHHhccccchhhhHHHHHHHHHH
Confidence 56677788887888877665544433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=388.86 Aligned_cols=261 Identities=29% Similarity=0.473 Sum_probs=229.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++...||.|.-++||+|+... +++.||||++..++... ..+.+++|+..|+.+. ||||++++..|..+..+
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p---~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIP---TNEVVAIKIINLEKCNN--DLDALRKEVQTMSLID-HPNIVTYHCSFVVDSEL 99 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecc---cCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcC-CCCcceEEEEEEeccee
Confidence 479999999999999999999987 78999999998876554 3788999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||.||.+|++++.+... ...|+|..|..|++++++||.|||.+|.||||||+.||||+ .+|.|||+|||.+..+
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~---~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID---SDGTVKLADFGVSASL 176 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc---CCCcEEEcCceeeeee
Confidence 9999999999999988753 23499999999999999999999999999999999999995 5999999999987655
Q ss_pred CCC-CC----ccccccccccccchhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC---
Q 007498 306 RPD-ER----LNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD--- 374 (601)
Q Consensus 306 ~~~-~~----~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--- 374 (601)
... .+ ..+++||++|||||++. .+|+.|+|||||||+..||.+|..||......+++...+++.+....
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 332 22 25679999999999964 47999999999999999999999999998888888888887775332
Q ss_pred ---CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 375 ---LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 375 ---~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
.....++..++.+|..||.+||++|||++++|+|+||+....
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 223356788999999999999999999999999999997754
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=383.33 Aligned_cols=264 Identities=30% Similarity=0.485 Sum_probs=226.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCC-eeEEeeeEecCC-
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-LVKFCDACEDVN- 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~- 224 (601)
..|..+++||+|+||+||+|+.+. +|+.||+|++........ .-....+|+.+|+.|+ |+| ||+|++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~---~g~~VALKkirl~~~~EG-~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKR---TGKFVALKKIRLEFEEEG-VPSTAIREISLLKRLS-HANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEec---CCCEEEEEEEeccccccC-CCchhhHHHHHHHHhC-CCcceEEEEeeeeeccc
Confidence 358888999999999999999987 889999999976543222 3345678999999997 999 999999998877
Q ss_pred -----cEEEEEeecCCCchHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEE
Q 007498 225 -----NVYIVMELCEGGELLDRILARG---GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296 (601)
Q Consensus 225 -----~~~lv~e~~~~g~L~~~~~~~~---~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl 296 (601)
.++|||||++. +|..++.... ..++...++.++.||+.||+|||+++|+||||||.|||++ ++|.+||
T Consensus 86 ~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~---~~G~lKl 161 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS---SSGVLKL 161 (323)
T ss_pred ccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC---CCCcEee
Confidence 89999999975 8998887765 3588899999999999999999999999999999999996 4899999
Q ss_pred eecccccccC-CCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCC
Q 007498 297 IDFGLSDFIR-PDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373 (601)
Q Consensus 297 ~DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 373 (601)
+|||+|+.+. +.......++|.+|+|||++.+ .|+..+||||+|||++||+++++.|.+.++.+++..|.+......
T Consensus 162 aDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 162 ADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred eccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 9999998776 3344677899999999999864 599999999999999999999999999999999888876444333
Q ss_pred CCCCC--------------------------CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 374 DLPWP--------------------------SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 374 ~~~~~--------------------------~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
...|+ ..+++..+++.+||+.+|.+|.|+..+|.||||.+.+.+.+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~ 313 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS 313 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence 33333 23468999999999999999999999999999998866544
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=372.74 Aligned_cols=260 Identities=36% Similarity=0.654 Sum_probs=232.6
Q ss_pred cCCCeEEc-ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-
Q 007498 145 FGAKYELG-KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED- 222 (601)
Q Consensus 145 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~- 222 (601)
+.++|.+. ++||-|-.|.|..+.++. +++.+|+|++... ...++|+++.-...+|||||+++++|++
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~---T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKR---TQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred chhhheehhhhhccccCCceEEEEecc---chhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 34567663 579999999999999887 8899999998543 4567899998888899999999998764
Q ss_pred ---CCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 223 ---VNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 223 ---~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
...+.+|||.|+||.|+.+|..++ ..|+|.++..|++||..|+.|||+.+|.||||||+|+|++....+..+||+|
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence 367889999999999999998764 4699999999999999999999999999999999999999877888999999
Q ss_pred cccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHccCCCCC
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAVLRSDPNFD 373 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~ 373 (601)
||+|+.........+.|.|++|.|||++. ..|+...|+||+||++|-||||.+||+... ..++...|..+...|+
T Consensus 208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred cccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 99999887777788899999999999997 579999999999999999999999998653 3456778888999999
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
...|..+|.+++|+|+++|..+|++|.|+.++++|||+....
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 999999999999999999999999999999999999997653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=397.82 Aligned_cols=254 Identities=29% Similarity=0.560 Sum_probs=224.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++.+.||+|+||.||+|+++. +++.||||++.+.........+.+.+|+.+++++. ||||+++++++.+++.+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRV 93 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEE
Confidence 479999999999999999999876 78899999997755444345577899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|||||.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD---NKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC---CCCCEEEeeccCceEcC
Confidence 9999999999999987654 5799999999999999999999999999999999999995 48899999999997664
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.. ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+..+......++. .++..++
T Consensus 170 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~ 243 (329)
T PTZ00263 170 DR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRAR 243 (329)
T ss_pred CC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHH
Confidence 32 33568999999999886 46899999999999999999999999988888888888776655442 4789999
Q ss_pred HHHHHcccccccCCCC-----HHHHHcCcccCCC
Q 007498 386 DFVKRLLNKDYRKRMT-----AVQALTHPWLRDD 414 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s-----~~ell~hp~f~~~ 414 (601)
+||++||..||.+|++ +.++++||||++.
T Consensus 244 ~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 244 DLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 9999999999999997 7999999999863
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=391.05 Aligned_cols=252 Identities=28% Similarity=0.546 Sum_probs=222.9
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+|+++. +++.||||++...........+.+.+|+.+++++. ||||+++++++.+...+|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~ 77 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRI---SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLY 77 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEE
Confidence 68999999999999999999876 78899999997654433334567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~---~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 78 MLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred EEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEEecCcchhccC
Confidence 999999999999987654 5799999999999999999999999999999999999995 478999999999976643
Q ss_pred CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHH
Q 007498 308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386 (601)
Q Consensus 308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 386 (601)
. ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+......++. .+++.+++
T Consensus 154 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~ 227 (291)
T cd05612 154 R--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKD 227 (291)
T ss_pred C--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHH
Confidence 2 33468999999999886 46899999999999999999999999998888888888877665543 57899999
Q ss_pred HHHHcccccccCCCC-----HHHHHcCcccCC
Q 007498 387 FVKRLLNKDYRKRMT-----AVQALTHPWLRD 413 (601)
Q Consensus 387 li~~~L~~dP~~R~s-----~~ell~hp~f~~ 413 (601)
||++||..||.+|++ ++++++||||+.
T Consensus 228 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-49 Score=379.70 Aligned_cols=257 Identities=28% Similarity=0.504 Sum_probs=220.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--C
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--N 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~ 224 (601)
-.|.-.+.+|.|+||.||.+.... +++.||||.+....... .+|++||+.+. |||||+|..+|... .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e---~~~~vAIKKv~~d~r~k-------nrEl~im~~l~-HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRE---TEEEVAIKKVLQDKRYK-------NRELQIMRKLD-HPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcC---CCceeEEEEecCCCCcC-------cHHHHHHHhcC-CcCeeeEEEEEEecCCC
Confidence 368889999999999999999886 67899999987654433 37999999995 99999999988643 2
Q ss_pred ---cEEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 225 ---NVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 225 ---~~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
.+.||||||+. +|.+.+.. .+..++.-.++-|..||++||.|||+.||+||||||.|||++. +.|.+||||
T Consensus 93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~--~tg~LKicD 169 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP--DTGVLKICD 169 (364)
T ss_pred chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC--CCCeEEecc
Confidence 45689999986 89888764 2567999999999999999999999999999999999999974 579999999
Q ss_pred cccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC-------
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD------- 369 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------- 369 (601)
||.|+.+..++...+...|..|+|||++.+ .|+.++||||.|||+.||+-|++.|.+.+..+++..|++..
T Consensus 170 FGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 170 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred CCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999999998888888999999999998864 69999999999999999999999999998888887776421
Q ss_pred -----CC--------CCCCCC-----CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 370 -----PN--------FDDLPW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 370 -----~~--------~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
+. +...+| ..+++++.+|+.++|..+|.+|.++.|+|.||||.+...+
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 11 111122 3578999999999999999999999999999999866443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=396.34 Aligned_cols=250 Identities=29% Similarity=0.528 Sum_probs=218.8
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+++++. ||||+++++++...+.+||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeC
Confidence 469999999999999876 78899999998755444445567889999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC-CCCCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~ 311 (601)
+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++... .....
T Consensus 77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 77 ANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD---KDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEeeCCCCcccccCCCcc
Confidence 9999998887654 6799999999999999999999999999999999999995 47899999999987542 22334
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHH
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 390 (601)
...+||+.|+|||++. ..++.++|||||||++|||++|..||........+..+......++ ..+++++.+||++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAG 228 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 5578999999999986 5689999999999999999999999998888777777776665554 3689999999999
Q ss_pred cccccccCCC-----CHHHHHcCcccCCC
Q 007498 391 LLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 391 ~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
||..||++|+ ++.++++||||+..
T Consensus 229 ~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 229 LLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=387.52 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=216.8
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
|++.+.||+|+||.||++.+.. +++.||+|++.+...........+.+|+.+++++. |+||+++++++.+.+.+|+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~l 77 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCL 77 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEec---CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEE
Confidence 7889999999999999999876 78899999997655443334456789999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 229 VMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
|||||++|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++ +++.+||+|||++.....
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~---~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD---DRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeCCCcEEcCC
Confidence 99999999998877643 34699999999999999999999999999999999999995 478899999999987655
Q ss_pred CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHH
Q 007498 308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386 (601)
Q Consensus 308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 386 (601)
.......+||..|+|||++. ..++.++|||||||++|+|++|+.||...........+..............++.++.+
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 234 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS 234 (285)
T ss_pred CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHH
Confidence 44455678999999999886 57999999999999999999999999876543322222221111111122468999999
Q ss_pred HHHHcccccccCCCC-----HHHHHcCcccCCC
Q 007498 387 FVKRLLNKDYRKRMT-----AVQALTHPWLRDD 414 (601)
Q Consensus 387 li~~~L~~dP~~R~s-----~~ell~hp~f~~~ 414 (601)
||++||..||.+|++ ++++++||||++.
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 999999999999997 8999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=399.97 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=219.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+.++..+. |+||+++++.+.+...+|
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~ 77 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLY 77 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEE
Confidence 68999999999999999999876 78899999998755444445567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+..
T Consensus 78 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~---~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCCEEEeeccCcccccc
Confidence 999999999999987654 6799999999999999999999999999999999999995 478999999999875432
Q ss_pred CC------------------------------------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCC
Q 007498 308 DE------------------------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGS 350 (601)
Q Consensus 308 ~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~ 350 (601)
.. .....+||+.|+|||++. ..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 11 012458999999999976 56899999999999999999999
Q ss_pred CCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHccccccc---CCCCHHHHHcCcccCCC
Q 007498 351 RPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYR---KRMTAVQALTHPWLRDD 414 (601)
Q Consensus 351 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~---~R~s~~ell~hp~f~~~ 414 (601)
.||.+....+.+..+..........+...+++++++||.+|+. +|. .||+++|+++||||++.
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 9999888888888887644333222234589999999999875 444 45899999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=374.32 Aligned_cols=257 Identities=29% Similarity=0.545 Sum_probs=236.5
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
-..|..++.||+|.||+|.+++.+. +++.||||++++..+.....+..-..|-++|+..+ ||.+..|-..|+..++
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKa---t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKA---TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDR 242 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecc---cCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCce
Confidence 3568899999999999999999886 89999999999988777777788889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc-
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF- 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~- 304 (601)
+|+||||..||.|+-++.+ ...|++..++.|..+|+.||.|||+++||+||||.+|+|+ |++|+|||+|||+++.
T Consensus 243 lCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhc
Confidence 9999999999999987654 4679999999999999999999999999999999999999 5699999999999975
Q ss_pred cCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
+..+....++|||+.|+|||++. ..|+.++|+|.+||++|||+||+.||+......++..|+.....|+. .++++
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~e 394 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPE 394 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHH
Confidence 34556678899999999999997 57999999999999999999999999999999999999999988885 79999
Q ss_pred HHHHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 384 AKDFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
++.|+..+|.+||.+|. .+.|+..|+||...
T Consensus 395 AktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 395 AKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 99999999999999998 47999999999763
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=393.57 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=206.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|+++++||+|+||.||++++.. +++.||||++.... .......+.+|+++++.+. |+||+++++++...+.+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEI 147 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECC---CCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeE
Confidence 358888999999999999999875 77899999986542 2234567899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|||||++|+|.+. ....+..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+.
T Consensus 148 ~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 148 QVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN---SAKNVKIADFGVSRILA 219 (353)
T ss_pred EEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEcccccceecc
Confidence 999999999988642 2467888999999999999999999999999999999995 47899999999998764
Q ss_pred CCC-CccccccccccccchhccC------CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLHR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
... .....+||..|+|||++.. .++.++|||||||++|||++|+.||......+....+..............
T Consensus 220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (353)
T PLN00034 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT 299 (353)
T ss_pred cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence 332 2345689999999998742 245789999999999999999999974333222221111111111112246
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
++.++++||.+||..||++||++.|+|+||||....
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 889999999999999999999999999999998764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=389.97 Aligned_cols=262 Identities=28% Similarity=0.516 Sum_probs=225.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|...+.||+|+||.||++.+.. +++.||+|++....... ..+.+++|+.+|.+++ ++||.++|+.|..+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~---t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~-~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK---TKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccchhccccccceeeeeeecc---ccceEEEEEechhhcch--hhHHHHHHHHHHHhcC-cchHHhhhhheeecccH
Confidence 358888999999999999999987 88999999998765433 5688999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|++||||.||++.+.+. .+..+.+..+..++++++.||.|||..+.+|||||+.|||+.. +|.+||+|||.+..+.
T Consensus 87 wiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~---~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE---SGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEec---cCcEEEEecceeeeee
Confidence 99999999999999764 4455699999999999999999999999999999999999974 6999999999998776
Q ss_pred CCC-CccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
... +..+++||+.|||||++.+ .|+.|+||||||++.+||++|.+||........+-.|-+..+.. .. ..+|+.+
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~--L~-~~~S~~~ 239 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPR--LD-GDFSPPF 239 (467)
T ss_pred chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCc--cc-cccCHHH
Confidence 543 3478999999999999885 79999999999999999999999997766544333343333322 22 3689999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCCCCCCChh
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLD 421 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~ 421 (601)
++||..||++||+.||+|.+||+|+|++...+...+.
T Consensus 240 kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L~ 276 (467)
T KOG0201|consen 240 KEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSELK 276 (467)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchHHH
Confidence 9999999999999999999999999999865544443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=398.92 Aligned_cols=258 Identities=29% Similarity=0.538 Sum_probs=221.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++++.||+|+||.||+|++.. +++.||||++.+...........+.+|+.+++.+. ||||+++++++.++..+|
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~ 77 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLY 77 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEE
Confidence 69999999999999999999876 78899999998754444445567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||||+||+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+..
T Consensus 78 lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD---AKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred EEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEeecccceeccc
Confidence 999999999999987654 5799999999999999999999999999999999999995 588999999999865432
Q ss_pred CC---------------------------------------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHH
Q 007498 308 DE---------------------------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILL 347 (601)
Q Consensus 308 ~~---------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell 347 (601)
.. .....+||+.|+|||++. ..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11 011347999999999876 56899999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCC---HHHHHcCcccCCC
Q 007498 348 CGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT---AVQALTHPWLRDD 414 (601)
Q Consensus 348 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~ell~hp~f~~~ 414 (601)
+|..||......+.+..+......+.......+++++++||++||. +|.+|++ +.|+|.||||+..
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999999888877777777655443333334689999999999997 9999998 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=398.33 Aligned_cols=259 Identities=29% Similarity=0.475 Sum_probs=217.9
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+++.+. |+||+++++++.+.+.+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~ 77 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---THALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLY 77 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEE
Confidence 58999999999999999999876 78899999998765555455677899999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+..
T Consensus 78 lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~---~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID---LDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC---CCCCEEEeeCcCCccccc
Confidence 999999999999887654 5799999999999999999999999999999999999995 478999999999753310
Q ss_pred C------------------------------------------------CCccccccccccccchhcc-CCCCChhhHHH
Q 007498 308 D------------------------------------------------ERLNDIVGSAYYVAPEVLH-RSYSLEADIWS 338 (601)
Q Consensus 308 ~------------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwS 338 (601)
. ......+||+.|+|||++. ..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 0 0012357999999999876 56899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHccc--ccccCCCCHHHHHcCcccCCC
Q 007498 339 IGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLN--KDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 339 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~--~dP~~R~s~~ell~hp~f~~~ 414 (601)
|||++|||++|..||......+....+......+....+..+++++.+||.+||. .++..|+++.++++||||++.
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999999999998877766666666443333333344689999999999664 455569999999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=392.22 Aligned_cols=255 Identities=28% Similarity=0.511 Sum_probs=223.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++.+.||+|+||.||+|+++.. .+..||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYL 106 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECC--CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEE
Confidence 4699999999999999999987641 34689999997655444445677889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEecCCCCeecC
Confidence 9999999999999887654 5799999999999999999999999999999999999995 48899999999997664
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
. .....+||+.|+|||++. ..++.++|||||||++|||++|..||.+.+....+..+......++ ..+++++.
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 256 (340)
T PTZ00426 183 T--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCK 256 (340)
T ss_pred C--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence 3 234568999999999986 4689999999999999999999999998888888888877665554 35789999
Q ss_pred HHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 386 DFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 386 ~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
++|++||..||.+|+ +++++++||||++.
T Consensus 257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999996 89999999999863
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=399.00 Aligned_cols=258 Identities=26% Similarity=0.469 Sum_probs=217.7
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+++++.+. |||||+++++|.+...+|
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~ 77 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLY 77 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeE
Confidence 68999999999999999999876 78899999997654444445677889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||||+||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+++.+..
T Consensus 78 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~---~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEEeeccccccccc
Confidence 999999999999987654 6799999999999999999999999999999999999995 478999999999863321
Q ss_pred CC------------------------------------------------Cccccccccccccchhcc-CCCCChhhHHH
Q 007498 308 DE------------------------------------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWS 338 (601)
Q Consensus 308 ~~------------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwS 338 (601)
.. .....+||+.|+|||++. ..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 00 001247999999999876 56999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCC---CCHHHHHcCcccCCC
Q 007498 339 IGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR---MTAVQALTHPWLRDD 414 (601)
Q Consensus 339 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---~s~~ell~hp~f~~~ 414 (601)
|||++|||++|..||.+....+.+..+......+.......++.++++||.+||. +|.+| +++.|++.||||++.
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999999999999998888777777776543333222233689999999999998 77765 599999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=391.07 Aligned_cols=257 Identities=30% Similarity=0.514 Sum_probs=222.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++++.||+|+||.||+|++.. +++.||||++.+...........+.+|+.++..+. ||||+++++++...+.+|
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~ 77 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLY 77 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEE
Confidence 69999999999999999999876 67899999998765443345567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEEEeCcCCccccc
Confidence 999999999999987654 5799999999999999999999999999999999999995 478999999999976543
Q ss_pred CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCC----CCCCH
Q 007498 308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW----PSVSP 382 (601)
Q Consensus 308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~ 382 (601)
.....+||+.|+|||++. ..++.++|||||||++|||++|..||...+..+.+..+......+....+ ..++.
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~ 231 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD 231 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCH
Confidence 345568999999999886 46899999999999999999999999988877777666553322222111 25799
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
++.+||.+||..+|.+|+++.++++||||++.
T Consensus 232 ~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 232 EAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=398.66 Aligned_cols=258 Identities=30% Similarity=0.518 Sum_probs=220.1
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+++++. |+|||++++.|.+++.+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~ 77 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD---TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLY 77 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEE
Confidence 58999999999999999999876 78899999997755444445677899999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||||++|+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+..
T Consensus 78 lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~---~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEeECCCCccccc
Confidence 999999999999987654 5799999999999999999999999999999999999995 488999999999753210
Q ss_pred C------------------------------------------------CCccccccccccccchhcc-CCCCChhhHHH
Q 007498 308 D------------------------------------------------ERLNDIVGSAYYVAPEVLH-RSYSLEADIWS 338 (601)
Q Consensus 308 ~------------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwS 338 (601)
. ......+||+.|+|||++. ..|+.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 0 0012357999999999876 57999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCC---HHHHHcCcccCCC
Q 007498 339 IGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT---AVQALTHPWLRDD 414 (601)
Q Consensus 339 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~ell~hp~f~~~ 414 (601)
|||++|||++|+.||.+....+....+..............+++++.+||.+|+ .||.+|++ +.++++||||+..
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999999999999988877777777665444443344578999999999987 59999997 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=380.54 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=212.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.++||+|+||.||+++++. ++..||+|+++..... .....+.+|+.+++++. ||||+++++++.....+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEE--GAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCL 78 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC---CCCEEEEEEecccccC--CcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeE
Confidence 369999999999999999999876 7889999998654322 12346778999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++ +|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAKS 154 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEECcCcceeecc
Confidence 999999975 89988877666789999999999999999999999999999999999995 47899999999997653
Q ss_pred CC-CCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCC--------
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL-------- 375 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------- 375 (601)
.. .......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......+..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 32 2234567899999999875 358999999999999999999999998877666555543321110000
Q ss_pred ------------------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 376 ------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 376 ------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
..+.++.++++||++||+.||.+|+|++|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 013568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=365.22 Aligned_cols=264 Identities=35% Similarity=0.614 Sum_probs=231.2
Q ss_pred cCCCeEE-cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 145 FGAKYEL-GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 145 ~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
|.+-|++ .+.||+|+|+.|-.+.... ++..||||++.+. ....+.++.+|++++.+..+|+||++|+++|+++
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~---t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQ---TGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeec---cchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3445665 5689999999999888776 8899999999875 3346788999999999999999999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
.+.|||||-|.||.|+.+|.++ ..|++.++.++.++|+.||.|||.+||.||||||+|||-...+.-.-||||||.+..
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence 9999999999999999999876 579999999999999999999999999999999999999765555679999998864
Q ss_pred ccCC--------CCCccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-----------
Q 007498 304 FIRP--------DERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTE----------- 358 (601)
Q Consensus 304 ~~~~--------~~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~----------- 358 (601)
-+.- .....+.+|+..|||||++. ..|+.+.|.||||||||-||+|.+||.+...
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 3321 12345679999999999752 2589999999999999999999999965422
Q ss_pred ----hHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 359 ----SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 359 ----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
..++..|..+...|+...|..+|.+++|||+.+|..|+.+|.++.++++|||++...
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 457888999999999999999999999999999999999999999999999998653
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=395.27 Aligned_cols=259 Identities=28% Similarity=0.480 Sum_probs=223.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+.+++.++ ||||+++++++.++..+
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKYL 118 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEE
Confidence 479999999999999999999876 78899999997654444344566789999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc---CCCCEEEEeccceeecc
Confidence 999999999999987754 3689999999999999999999999999999999999995 58899999999997764
Q ss_pred CCC--CccccccccccccchhccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 307 PDE--RLNDIVGSAYYVAPEVLHR-----SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 307 ~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+......+..+......+.......
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence 332 2345689999999998752 378999999999999999999999999888888888876554433333346
Q ss_pred CCHHHHHHHHHcccccccC--CCCHHHHHcCcccCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRK--RMTAVQALTHPWLRDD 414 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~--R~s~~ell~hp~f~~~ 414 (601)
++.++.+||++||..+|.+ |++++++++||||++.
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 8999999999999999988 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=386.22 Aligned_cols=248 Identities=28% Similarity=0.538 Sum_probs=217.3
Q ss_pred eccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeecC
Q 007498 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234 (601)
Q Consensus 155 lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 234 (601)
||+|+||.||+|++.. +++.||+|++.+...........+.+|+.+++++. ||||+++++++...+.+|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCC
Confidence 7999999999999876 77899999997654444445677889999999996 9999999999999999999999999
Q ss_pred CCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC-CCCccc
Q 007498 235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERLND 313 (601)
Q Consensus 235 ~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~~~ 313 (601)
+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.... ......
T Consensus 77 ~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~ 152 (312)
T cd05585 77 GGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD---YQGHIALCDFGLCKLNMKDDDKTNT 152 (312)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC---CCCcEEEEECcccccCccCCCcccc
Confidence 99999887654 6799999999999999999999999999999999999995 478999999999975432 223445
Q ss_pred cccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcc
Q 007498 314 IVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392 (601)
Q Consensus 314 ~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 392 (601)
.+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......++ ..+++++.+||.+||
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L 228 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLL 228 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHc
Confidence 68999999999886 4689999999999999999999999998888888888877665554 368999999999999
Q ss_pred cccccCCC---CHHHHHcCcccCCC
Q 007498 393 NKDYRKRM---TAVQALTHPWLRDD 414 (601)
Q Consensus 393 ~~dP~~R~---s~~ell~hp~f~~~ 414 (601)
..||.+|+ ++.++|+||||.+.
T Consensus 229 ~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 229 SRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=388.39 Aligned_cols=249 Identities=29% Similarity=0.522 Sum_probs=217.1
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+++++. +++.||||++.+...........+.+|+.+++.+. ||||+++++++...+.+||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeC
Confidence 469999999999999876 78899999998755444445667889999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC-CCCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~ 311 (601)
+++|+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.... ....
T Consensus 77 ~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 77 VNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD---KDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC---CCCcEEEecCcCCccCCCccccc
Confidence 999999887754 45799999999999999999999999999999999999995 478999999999876432 2233
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHH
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 390 (601)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+......++ ..+++++.+||++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSG 228 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHH
Confidence 4568999999999986 5689999999999999999999999988887777777766555544 3689999999999
Q ss_pred cccccccCCC-----CHHHHHcCcccCC
Q 007498 391 LLNKDYRKRM-----TAVQALTHPWLRD 413 (601)
Q Consensus 391 ~L~~dP~~R~-----s~~ell~hp~f~~ 413 (601)
||.+||.+|+ ++.++++||||..
T Consensus 229 ~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 229 LLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred HcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=386.88 Aligned_cols=250 Identities=30% Similarity=0.536 Sum_probs=217.5
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+++++. +++.||+|++.+...........+.+|+++++.+. ||||++++++|...+.+||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeC
Confidence 469999999999999876 78899999998754434445567788999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC-CCCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~ 311 (601)
+++|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ....
T Consensus 77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 77 ANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc---CCCCEEecccHHhccccCCCCcc
Confidence 9999998876543 5799999999999999999999999999999999999995 478999999999875422 2333
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHH
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 390 (601)
...+||+.|+|||++. +.++.++|||||||++|||++|+.||...+.......+......++ ..+++++.+||.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAG 228 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHH
Confidence 4568999999999886 5789999999999999999999999998888777777776655544 3689999999999
Q ss_pred cccccccCCC-----CHHHHHcCcccCCC
Q 007498 391 LLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 391 ~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
||..||.+|+ ++.++++|+||.+.
T Consensus 229 ~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 229 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred HccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9999999998 89999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=397.86 Aligned_cols=258 Identities=29% Similarity=0.497 Sum_probs=219.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+|+.+. |+||+++++.+.+++.+|
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~ 77 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVD---TNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLY 77 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEE
Confidence 69999999999999999999876 78899999997654433344567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|..+..
T Consensus 78 lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC---CCCCEEEEeCCCCccccc
Confidence 999999999999987654 5799999999999999999999999999999999999995 478999999999753210
Q ss_pred C--------------------------------------------CCccccccccccccchhcc-CCCCChhhHHHHHHH
Q 007498 308 D--------------------------------------------ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVI 342 (601)
Q Consensus 308 ~--------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~i 342 (601)
. ......+||+.|+|||++. ..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0 0012357999999999986 468999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCC---CHHHHHcCcccCCC
Q 007498 343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRM---TAVQALTHPWLRDD 414 (601)
Q Consensus 343 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~ell~hp~f~~~ 414 (601)
+|||++|+.||.+....+....+......+....+..+++++.+||.+|+ .+|.+|+ ++.++++||||+..
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 99999999999988877766666654444433334578999999999987 5999999 99999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=383.17 Aligned_cols=247 Identities=27% Similarity=0.444 Sum_probs=210.8
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcE-EEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC-cE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQ-VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-NV 226 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-~~ 226 (601)
..+.+.||+|+||+||++.++ |+. ||||++......... .+.|.+|+.+|.+|+ |||||+|+|++.+.. .+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~-----g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR-----GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSL 115 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC-----CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCce
Confidence 455567999999999999885 345 999999876554443 778999999999997 999999999999887 79
Q ss_pred EEEEeecCCCchHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcC-CeeccCCCCceEeecCCCCC-CeEEeeccccc
Q 007498 227 YIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFCHLQG-VVHRDLKPENFLFTSGRDDA-DMRLIDFGLSD 303 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~-~~~~l~~~~~~~i~~ql~~~L~~LH~~~-iiHrDikp~NIll~~~~~~~-~vkl~DFG~a~ 303 (601)
+|||||+++|+|.+++.. ....++...+..++.||++||+|||+++ |||||||++|||++ .++ ++||+|||+++
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~---~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD---LKGKTLKIADFGLSR 192 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc---CCCCEEEECCCccce
Confidence 999999999999999887 4678999999999999999999999999 99999999999995 465 99999999998
Q ss_pred ccCCC-CCccccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 304 FIRPD-ERLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 304 ~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
..... .......||..|||||++.+ .|+.|+|||||||+||||+||+.||...........+......... + ..
T Consensus 193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~-p-~~ 270 (362)
T KOG0192|consen 193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI-P-KE 270 (362)
T ss_pred eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC-C-cc
Confidence 76644 33444789999999999984 4999999999999999999999999988876655555543332221 1 23
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+++.+..|+.+||..||.+||+..+++.
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 8999999999999999999999988764
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=394.67 Aligned_cols=263 Identities=31% Similarity=0.458 Sum_probs=220.4
Q ss_pred CcccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCC-----CCeeEE
Q 007498 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-----KHLVKF 216 (601)
Q Consensus 142 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-----~niv~l 216 (601)
++.+..+|.+.+.||+|+||.|.+|.+.+ +++.||||+++.... ...+...|+.||..|+.| -|||++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~---T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm 253 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHK---TGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRM 253 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecC---CCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence 34556689999999999999999999987 899999999976543 345667899999999744 389999
Q ss_pred eeeEecCCcEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeE
Q 007498 217 CDACEDVNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295 (601)
Q Consensus 217 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vk 295 (601)
+++|...+++|||+|+++. +|++++... ...|+...++.++.||+.||.+||+.||||+||||+||||.. .....||
T Consensus 254 ~d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~-~~r~~vK 331 (586)
T KOG0667|consen 254 LDYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD-PKRSRIK 331 (586)
T ss_pred eeccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc-CCcCcee
Confidence 9999999999999999965 999998754 345999999999999999999999999999999999999976 3456899
Q ss_pred EeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC---
Q 007498 296 LIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN--- 371 (601)
Q Consensus 296 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--- 371 (601)
|+|||.|++.... ..+.+.+..|+|||++. .+|+.+.||||||||++||++|.+.|.+.++.+++..|++....
T Consensus 332 VIDFGSSc~~~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 332 VIDFGSSCFESQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred EEecccccccCCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 9999999876433 33788999999999876 58999999999999999999999999999999888877531110
Q ss_pred ------------CCC-C-------------------------------CCC------------CCCHHHHHHHHHccccc
Q 007498 372 ------------FDD-L-------------------------------PWP------------SVSPEAKDFVKRLLNKD 395 (601)
Q Consensus 372 ------------~~~-~-------------------------------~~~------------~~s~~~~~li~~~L~~d 395 (601)
|.. . ..+ .-...+.|||++||+.|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 000 0 001 01246899999999999
Q ss_pred ccCCCCHHHHHcCcccCCCC
Q 007498 396 YRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 396 P~~R~s~~ell~hp~f~~~~ 415 (601)
|.+|+|+.++|+||||....
T Consensus 490 P~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 490 PAERITPAQALNHPFLTGTS 509 (586)
T ss_pred chhcCCHHHHhcCccccccc
Confidence 99999999999999998543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=387.57 Aligned_cols=256 Identities=33% Similarity=0.522 Sum_probs=230.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc-
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN- 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~- 225 (601)
..|..++.+|+|+||.+++++++. .++.||+|.+........ .+....+|+.+++++. |||||.+++.|..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~---~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKS---DDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhcc---CCceEEEEEEeccccCch-hhHHHHHHHHHHHhcc-CCCeeeeccchhcCCce
Confidence 479999999999999999999886 778999999988766554 3457889999999997 9999999999999988
Q ss_pred EEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+||||+||+||+|.+.|.+.. ..|+++.+..|+.|++.||.|||+++|+|||||+.||+++. ++.|||+|||+|+.
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk---~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTK---DKKVKLGDFGLAKI 155 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccc---cCceeecchhhhhh
Confidence 999999999999999998765 67999999999999999999999999999999999999974 77889999999999
Q ss_pred cCCCC-CccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 305 IRPDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 305 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
+.+.. ...+.+||+.||.||++.+ +|+.|+|||||||++|||++-+++|.+.+...+...|.+....... ...+.
T Consensus 156 l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~ 232 (426)
T KOG0589|consen 156 LNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSS 232 (426)
T ss_pred cCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccH
Confidence 98776 6778999999999999985 7999999999999999999999999999999999999887732211 36899
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
+++.||+.||..+|..||++.++|.+|.+..
T Consensus 233 el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 233 ELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999999999999987753
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=386.26 Aligned_cols=251 Identities=29% Similarity=0.528 Sum_probs=218.3
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+|+++. +++.||||++.+...........+.+|+.++..+.+||||+++++++...+.+||||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 469999999999999876 78899999997654433344567788999998876799999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC-CCCCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~ 311 (601)
|++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~---~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 78 VNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeeCCCCeecCcCCCcc
Confidence 9999999877654 5799999999999999999999999999999999999995 47899999999987543 22334
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHH
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 390 (601)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+++..+......++ ..++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~ 229 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKA 229 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHH
Confidence 4568999999999986 4689999999999999999999999999888888888887665544 2589999999999
Q ss_pred cccccccCCCCH------HHHHcCcccCCC
Q 007498 391 LLNKDYRKRMTA------VQALTHPWLRDD 414 (601)
Q Consensus 391 ~L~~dP~~R~s~------~ell~hp~f~~~ 414 (601)
||+.||.+|+++ +++++||||+..
T Consensus 230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 999999999998 999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=384.42 Aligned_cols=256 Identities=26% Similarity=0.479 Sum_probs=221.7
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++++.||+|+||.||+|+++. +++.||||++.+.........+.+..|++++..+..|++|+++++++...+.+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence 48899999999999999999876 678999999987554444456678889999999974567899999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC-
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR- 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~- 306 (601)
+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 78 lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---AEGHIKIADFGMCKENIF 153 (324)
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc---CCCCEEEeecCcceecCC
Confidence 999999999999887654 5799999999999999999999999999999999999995 47899999999986532
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
........+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+......++ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~ 229 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAV 229 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 222344568999999999886 4689999999999999999999999998888888888877665554 36899999
Q ss_pred HHHHHcccccccCCCCH-----HHHHcCcccCCC
Q 007498 386 DFVKRLLNKDYRKRMTA-----VQALTHPWLRDD 414 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~-----~ell~hp~f~~~ 414 (601)
+||++||.+||.+|+++ .++++||||+..
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 230 SICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999999999986 899999999763
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=392.60 Aligned_cols=258 Identities=34% Similarity=0.602 Sum_probs=223.7
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++++.||+|+||.||+|++.. +++.||||++.+...........+.+|+.++..+. |+||+++++++.+++.+|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 77 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLY 77 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEE
Confidence 69999999999999999999876 78899999998765444345677889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEeecCCCCccCcc
Confidence 999999999999988765 6799999999999999999999999999999999999995 588999999999976644
Q ss_pred CC------------------------------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 007498 308 DE------------------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR 356 (601)
Q Consensus 308 ~~------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~ 356 (601)
.. .....+||+.|+|||++. ..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 33 233467999999999986 46899999999999999999999999988
Q ss_pred ChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCC-HHHHHcCcccCCC
Q 007498 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT-AVQALTHPWLRDD 414 (601)
Q Consensus 357 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-~~ell~hp~f~~~ 414 (601)
.....+..+......+.......+++++.+||.+||. ||.+|++ +.++|+||||++.
T Consensus 234 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred CHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 8777777777633322222234579999999999997 9999999 9999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=392.64 Aligned_cols=259 Identities=27% Similarity=0.472 Sum_probs=221.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||+++++. +++.||+|++.+...........+.+|+.+++.+. ||||+++++++.++..+
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDKYL 118 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEE
Confidence 579999999999999999999876 78899999997654444444566889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|..+.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~---~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD---KHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEEecccceecc
Confidence 999999999999998754 3689999999999999999999999999999999999995 57899999999998764
Q ss_pred CCC--CccccccccccccchhccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 307 PDE--RLNDIVGSAYYVAPEVLHR-----SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 307 ~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
... ...+.+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......+.......
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence 332 2345789999999998753 378999999999999999999999998888888888876543333222346
Q ss_pred CCHHHHHHHHHcccccccC--CCCHHHHHcCcccCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRK--RMTAVQALTHPWLRDD 414 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~--R~s~~ell~hp~f~~~ 414 (601)
++..++++|.+||..++.+ |+++.|+++||||+..
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 7999999999999865544 8999999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=379.40 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=210.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++.+.||+|+||.||+|+++. +++.||||++....... ....+.+|+.+++.+. ||||+++++++.+...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKV---NGKLVALKVIRLQEEEG--TPFTAIREASLLKGLK-HANIVLLHDIIHTKETL 78 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECC---CCCEEEEEEeccccccc--cchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeE
Confidence 479999999999999999999876 78899999987543221 2345678999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+. ++|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKS 154 (303)
T ss_pred EEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECCCCcceecc
Confidence 99999996 588888877667899999999999999999999999999999999999995 47899999999987543
Q ss_pred CC-CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHccCC------------
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSDP------------ 370 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~------------ 370 (601)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..+ ...+..+.....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 22 23345678999999998753 589999999999999999999999987543 222322221100
Q ss_pred --CCCCCC------------C--CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 371 --NFDDLP------------W--PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 371 --~~~~~~------------~--~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.+.... | ..+++++.+||.+||+.||++|+|+.|+|+||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000000 0 1245789999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=395.55 Aligned_cols=258 Identities=25% Similarity=0.390 Sum_probs=202.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc-----CCCCeeEEeeeE
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-----GHKHLVKFCDAC 220 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~l~~~~ 220 (601)
..+|+++++||+|+||.||+|.+.. +++.||||+++... .....+..|+.+++.+. +|.+|++++++|
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcC---CCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 4689999999999999999999876 67899999986432 12344567888888875 234589999988
Q ss_pred ecC-CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecCC---------
Q 007498 221 EDV-NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGR--------- 289 (601)
Q Consensus 221 ~~~-~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~~--------- 289 (601)
... .++|||||++ |++|++++.+. +.+++..++.|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 764 5799999998 67899887654 579999999999999999999998 5999999999999996421
Q ss_pred ----CCCCeEEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007498 290 ----DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA 364 (601)
Q Consensus 290 ----~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~ 364 (601)
+...+||+|||++.... ......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+....+.+..
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred ccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 11259999999885432 2334578999999999876 4699999999999999999999999987776555444
Q ss_pred HHccCCCCCCC------------------------------------CCC--CCCHHHHHHHHHcccccccCCCCHHHHH
Q 007498 365 VLRSDPNFDDL------------------------------------PWP--SVSPEAKDFVKRLLNKDYRKRMTAVQAL 406 (601)
Q Consensus 365 i~~~~~~~~~~------------------------------------~~~--~~s~~~~~li~~~L~~dP~~R~s~~ell 406 (601)
+......++.. .+. ..++.+.|||.+||++||.+|+|++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 33221111100 000 1145678999999999999999999999
Q ss_pred cCcccCCC
Q 007498 407 THPWLRDD 414 (601)
Q Consensus 407 ~hp~f~~~ 414 (601)
+||||+..
T Consensus 437 ~Hp~~~~~ 444 (467)
T PTZ00284 437 THPYVLKY 444 (467)
T ss_pred cCcccccc
Confidence 99999864
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=391.50 Aligned_cols=269 Identities=30% Similarity=0.499 Sum_probs=233.1
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
..+.|+|+..||.|+||.||+|..+. ++-..|-|+|.. ......+.+.-||+||..+. ||+||+|++.|...+
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nke---t~~lAAaKvIet---kseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKE---TKLLAAAKVIET---KSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhccc---chhhhhhhhhcc---cchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccC
Confidence 34579999999999999999999875 667788888844 33446788899999999985 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+||+.|||.||-+...+..-+..|++.+|+.+++|++.||.|||+++|||||||..|||++. +|.|+|+|||.+..
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl---dGdirLADFGVSAK 179 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL---DGDIRLADFGVSAK 179 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe---cCcEeeeccccccc
Confidence 999999999999999888888889999999999999999999999999999999999999986 89999999999754
Q ss_pred cC-CCCCccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCC
Q 007498 305 IR-PDERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 305 ~~-~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 377 (601)
.. .-....+++||++|||||++. .+|+.++|||||||+|.||..+.+|-...+...++..|.+..+..-..+
T Consensus 180 n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP- 258 (1187)
T KOG0579|consen 180 NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP- 258 (1187)
T ss_pred chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc-
Confidence 32 334567899999999999863 4699999999999999999999999988888777777777665433222
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCChhHHH
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~ 424 (601)
..++..+.||+++||.+||..||++.+||.||||.+.+...++..++
T Consensus 259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ireLl 305 (1187)
T KOG0579|consen 259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIRELL 305 (1187)
T ss_pred chhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHHHHH
Confidence 47899999999999999999999999999999999877665555443
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=388.09 Aligned_cols=259 Identities=28% Similarity=0.491 Sum_probs=223.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++.+.||+|+||.||+|+++. +++.||||++++...........+.+|+.+++.+. |+||+++++++.+...+|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~ 77 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLY 77 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEE
Confidence 58999999999999999999876 78899999998765434445567889999999985 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
|||||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++..+..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~---~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID---RTGHIKLADFGSAARLTA 154 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC---CCCCEEeccCCCCeECCC
Confidence 99999999999998877667899999999999999999999999999999999999995 488999999999987654
Q ss_pred CCCc--cccccccccccchhcc-------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 308 DERL--NDIVGSAYYVAPEVLH-------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 308 ~~~~--~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
.... ...+||+.|+|||++. ..++.++|||||||++|+|++|..||........+..+............+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP 234 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCC
Confidence 3322 3357999999999874 347899999999999999999999998888777777776654322222234
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.+++++.+||.+||. ||.+|+++.++++||||+..
T Consensus 235 ~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 235 KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 689999999999998 99999999999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=383.52 Aligned_cols=250 Identities=27% Similarity=0.484 Sum_probs=218.4
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+|+++. +++.||||++.+...........+..|++++..+.+||||+++++++...+.+||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 469999999999999875 77899999998755444445567788999998876799999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC-CCCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~ 311 (601)
|++|+|...+... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~---~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 78 VNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD---AEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeecccceecccCCccc
Confidence 9999999887654 5799999999999999999999999999999999999995 478999999999875432 2334
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHH
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 390 (601)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||...+..+.+..+......++. .++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~ 229 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKA 229 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence 4568999999999886 46899999999999999999999999999888888888876654442 478999999999
Q ss_pred cccccccCCC-------CHHHHHcCcccCC
Q 007498 391 LLNKDYRKRM-------TAVQALTHPWLRD 413 (601)
Q Consensus 391 ~L~~dP~~R~-------s~~ell~hp~f~~ 413 (601)
||..||++|+ ++.++++||||..
T Consensus 230 ~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred HhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 9999999999 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=382.88 Aligned_cols=255 Identities=26% Similarity=0.477 Sum_probs=222.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+|+++. +++.||||++.+...........+..|..++..+..|++|+++++++...+.+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence 48899999999999999999876 778999999987554444445667788999988866899999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
|||||+++|+|.+.+... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 78 lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENMW 153 (323)
T ss_pred EEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC---CCCcEEEccCCCceecCC
Confidence 999999999999887654 5799999999999999999999999999999999999995 578999999999975432
Q ss_pred -CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 308 -DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 308 -~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.......+||+.|+|||++. +.++.++|||||||++|||++|+.||.+.....++..+......++. .++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~ 229 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAV 229 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHH
Confidence 22344578999999999886 56999999999999999999999999998888888888876655543 6899999
Q ss_pred HHHHHcccccccCCCC-----HHHHHcCcccCC
Q 007498 386 DFVKRLLNKDYRKRMT-----AVQALTHPWLRD 413 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s-----~~ell~hp~f~~ 413 (601)
+||.+||..||.+|++ ..++++||||+.
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999999998 489999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=385.95 Aligned_cols=259 Identities=30% Similarity=0.549 Sum_probs=217.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc-chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.|++++.||+|+||.||+|+...+..+++.||+|++.+.... .....+.+.+|+.+++.+++|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 489999999999999999988655457899999999764332 2234566889999999997799999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~---~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC---CCCCEEEeeCcCCcccc
Confidence 9999999999999987654 5699999999999999999999999999999999999995 47899999999997654
Q ss_pred CCC--CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCC----ChhHHHHHHHccCCCCCCCCCC
Q 007498 307 PDE--RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 307 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||... ........+....+.++ .
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~ 232 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----S 232 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC----C
Confidence 332 2335689999999999864 4789999999999999999999999643 22334444554444333 3
Q ss_pred CCCHHHHHHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
.+++.+.+||.+||..||++|+ +++++++||||++.
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 6899999999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=382.57 Aligned_cols=254 Identities=28% Similarity=0.490 Sum_probs=218.2
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc--CCCCeeEEeeeEecCCcE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~ 226 (601)
|++.+.||+|+||.||+|+++. +++.||||++++.........+.+.+|++++..++ +||||+++++++...+.+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEE
Confidence 7889999999999999999876 78899999998654433334567778877765332 499999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 78 ~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~---~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD---TEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCcEEeCcccCCccCC
Confidence 999999999999877643 5799999999999999999999999999999999999995 47899999999987543
Q ss_pred C-CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 P-DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
. .......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+......++ ..+++++
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 228 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREA 228 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHH
Confidence 2 23345578999999999886 4689999999999999999999999998888888888877665544 3689999
Q ss_pred HHHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
.+||.+||..||.+|| ++.++++||||++.
T Consensus 229 ~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 229 ISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999999999999 69999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=390.31 Aligned_cols=258 Identities=29% Similarity=0.511 Sum_probs=219.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+.++..+. |+||+++++.+.+.+.+|
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~ 77 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKD---TGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLY 77 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEE
Confidence 58999999999999999999876 78899999997654444445677889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||||+||+|.+++.+. +.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++..+..
T Consensus 78 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~---~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD---AKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred EEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEeeccCCccccc
Confidence 999999999999987654 5799999999999999999999999999999999999995 488999999999865421
Q ss_pred CC------------------------------------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCC
Q 007498 308 DE------------------------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGS 350 (601)
Q Consensus 308 ~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~ 350 (601)
.. .....+||+.|+|||++. ..++.++|||||||++|||++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 10 012457999999999876 56999999999999999999999
Q ss_pred CCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCC---CHHHHHcCcccCCC
Q 007498 351 RPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRM---TAVQALTHPWLRDD 414 (601)
Q Consensus 351 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~ell~hp~f~~~ 414 (601)
.||.+......+..+......+...+...++.++++||.+|+ .||.+|+ ++.++++||||++.
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 234 PPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 999988888887777754332222222357999999999987 4999998 48999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=383.20 Aligned_cols=250 Identities=28% Similarity=0.526 Sum_probs=211.8
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+|+++. +++.||||++++...........+.+|+.+++.+.+||||+++++++.+...+||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 469999999999999876 78899999998765444445667889999999996799999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc-CCCCCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~-~~~~~~ 311 (601)
|+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.. ......
T Consensus 78 ~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 78 VSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD---AEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEECcCccccccccCCCcc
Confidence 9999998877544 6799999999999999999999999999999999999995 4789999999998753 233344
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC---------ChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR---------TESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
...+||..|+|||++. ..++.++|||||||++|+|++|+.||... ........+......++ ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~ 229 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCC
Confidence 5678999999999986 46899999999999999999999999531 11223444554444433 3589
Q ss_pred HHHHHHHHHcccccccCCCC------HHHHHcCcccCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMT------AVQALTHPWLRD 413 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s------~~ell~hp~f~~ 413 (601)
.++.+||++||..||.+|++ ++++++||||..
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999999999999987 799999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=385.39 Aligned_cols=250 Identities=28% Similarity=0.529 Sum_probs=217.1
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+|++.. +++.||+|++.+...........+.+|+++++.+. ||||+++++++...+.+||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeC
Confidence 469999999999999876 78899999998765444445567788999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecCCCCCCeEEeecccccccC-CCCC
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDER 310 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~ 310 (601)
+++|+|..++... ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.... ....
T Consensus 77 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 77 ANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC---CCCCEEEecCCCCeecCCCCcc
Confidence 9999998876543 579999999999999999999997 7999999999999995 47899999999987543 2233
Q ss_pred ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHH
Q 007498 311 LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389 (601)
Q Consensus 311 ~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 389 (601)
....+||+.|+|||++. +.++.++|||||||++|+|++|..||.+.........+......++ ..+++++.+||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 228 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLS 228 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence 44568999999999886 5789999999999999999999999998888777777776655554 368999999999
Q ss_pred HcccccccCCC-----CHHHHHcCcccCCC
Q 007498 390 RLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 390 ~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
+||..||++|+ ++.++++||||...
T Consensus 229 ~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 229 GLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 99999999997 89999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=380.18 Aligned_cols=251 Identities=27% Similarity=0.506 Sum_probs=215.2
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+|+++. +++.||||++++...........+..|..++..+.+||||+++++++.+.+.+||||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 469999999999999876 78899999997654332234556778888888765699999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC-CCCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~ 311 (601)
|.+|+|..++... +.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.... ....
T Consensus 78 ~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 78 LNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEeCccCCCeecccCCCce
Confidence 9999999887654 5799999999999999999999999999999999999995 478999999999875322 2234
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHH
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 390 (601)
...+||..|+|||++. ..++.++|||||||++|||++|..||.+......+..+....+.++. .++.++++||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~ 229 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEK 229 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHH
Confidence 5578999999999986 56899999999999999999999999988888877777665554443 489999999999
Q ss_pred cccccccCCCCH-HHHHcCcccCCC
Q 007498 391 LLNKDYRKRMTA-VQALTHPWLRDD 414 (601)
Q Consensus 391 ~L~~dP~~R~s~-~ell~hp~f~~~ 414 (601)
||..||++|+++ +++++||||+..
T Consensus 230 ~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 230 LFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HccCCHHHcCCChHHHHcCCCcCCC
Confidence 999999999998 589999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=381.17 Aligned_cols=254 Identities=29% Similarity=0.525 Sum_probs=218.1
Q ss_pred cceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc-chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEE
Q 007498 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVM 230 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 230 (601)
++.||+|+||.||+|+...+..+++.||||++.+.... .......+.+|+.+|+.+. ||||++++++|..++.+|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEE
Confidence 36799999999999987654457889999999765432 2223456789999999996 999999999999999999999
Q ss_pred eecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC-CC
Q 007498 231 ELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DE 309 (601)
Q Consensus 231 e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~ 309 (601)
||+++++|.+++... +.+.+..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.... ..
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEeeCcCCeecccCCC
Confidence 999999999887654 5789999999999999999999999999999999999995 478999999999875432 23
Q ss_pred Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHH
Q 007498 310 RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFV 388 (601)
Q Consensus 310 ~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 388 (601)
.....+||+.|+|||++. ..++.++|||||||++|||++|+.||........+..+......++ +.+++++.+||
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li 231 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 334568999999999986 4688999999999999999999999998888777777777655443 36899999999
Q ss_pred HHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 389 KRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 389 ~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
++||.+||++|+ ++.++++||||+..
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=379.75 Aligned_cols=251 Identities=29% Similarity=0.532 Sum_probs=215.1
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+|++.. +++.||||++++.........+.+..|..++..+.+||||+++++++..++.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 469999999999999876 78899999998754433334556677888887765699999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC-CCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~-~~~ 311 (601)
++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...... ...
T Consensus 78 ~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 78 LNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC---CCCCEEEccCcCCeECCCCCCcc
Confidence 9999999887654 5799999999999999999999999999999999999995 4789999999999764322 334
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHH
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 390 (601)
...+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.+..+++..+....+.++ ..++.++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~ 229 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSK 229 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 4568999999999886 4689999999999999999999999998888888877776555444 3588999999999
Q ss_pred cccccccCCCCH-HHHHcCcccCCC
Q 007498 391 LLNKDYRKRMTA-VQALTHPWLRDD 414 (601)
Q Consensus 391 ~L~~dP~~R~s~-~ell~hp~f~~~ 414 (601)
||..||.+|+++ .++++||||+..
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 230 LFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HccCCHHHcCCChHHHHcCcccCCC
Confidence 999999999986 589999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=382.32 Aligned_cols=266 Identities=35% Similarity=0.634 Sum_probs=240.1
Q ss_pred cccCCCeEE--cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeE
Q 007498 143 KNFGAKYEL--GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC 220 (601)
Q Consensus 143 ~~~~~~y~~--~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~ 220 (601)
.++..-|+| .+.||.|-||+||-+.+++ +|+.||||+|.+.++... ...++++|+.||+.++ ||.||.|...|
T Consensus 558 vd~stvYQif~devLGSGQFG~VYgg~hRk---tGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~-HPGiV~le~M~ 632 (888)
T KOG4236|consen 558 VDISTVYQIFADEVLGSGQFGTVYGGKHRK---TGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLH-HPGIVNLECMF 632 (888)
T ss_pred hhHHHHHHhhhHhhccCCcceeeecceecc---cCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcC-CCCeeEEEEee
Confidence 344555766 4689999999999999987 899999999999887765 3488999999999997 99999999999
Q ss_pred ecCCcEEEEEeecCCCchHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 221 EDVNNVYIVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 221 ~~~~~~~lv~e~~~~g~L~~~~~~-~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
+..+++++|||-+.| +.++.|+. ..+++++...+.++.||+.||.|||-++|+|+||||+|||+.+.+.--.+|||||
T Consensus 633 ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 633 ETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred cCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccc
Confidence 999999999999965 66666664 5688999999999999999999999999999999999999987666678999999
Q ss_pred ccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
|+|+++.......+.+||+.|+|||++. +.|+..-|+||+|||+|--+.|..||. .++++-.+|.+....++..+|.
T Consensus 712 GfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMyPp~PW~ 789 (888)
T KOG4236|consen 712 GFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMYPPNPWS 789 (888)
T ss_pred cceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccccCCCchh
Confidence 9999998887788899999999999986 789999999999999999999999994 4566778888899999999999
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
.+++++.|||..+|+..-++|.|++..|.|||+++..-
T Consensus 790 eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 790 EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQT 827 (888)
T ss_pred hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchH
Confidence 99999999999999999999999999999999998643
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=395.41 Aligned_cols=257 Identities=24% Similarity=0.394 Sum_probs=209.1
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-- 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-- 223 (601)
..+|++++.||+|+||.||+|++.. +++.||||++.... ....+|+.+|+.++ |||||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECF 133 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeeccc
Confidence 3579999999999999999999875 77899999885432 22457999999996 99999999876432
Q ss_pred ------CcEEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCe
Q 007498 224 ------NNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294 (601)
Q Consensus 224 ------~~~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~v 294 (601)
..+|+|||||++ +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++. ..+.+
T Consensus 134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--~~~~v 210 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTHTL 210 (440)
T ss_pred ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC--CCCce
Confidence 247899999975 67666543 3567999999999999999999999999999999999999953 34579
Q ss_pred EEeecccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC--
Q 007498 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-- 370 (601)
Q Consensus 295 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-- 370 (601)
||+|||+|+.+.........+||+.|+|||++.+ .|+.++|||||||++|||++|.+||.+....+.+..+.....
T Consensus 211 kL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred eeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999999987765555566789999999998753 689999999999999999999999988877666555543211
Q ss_pred ---------------CCCCCC--------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 371 ---------------NFDDLP--------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 371 ---------------~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
.++... ....++++++||.+||++||.+|+|+.|+|+||||++...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 111110 0136789999999999999999999999999999976543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=379.49 Aligned_cols=251 Identities=29% Similarity=0.521 Sum_probs=218.2
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+|+++. +++.||||++++...........+.+|+.++..+.+||||+++++++...+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 469999999999999876 67899999998765444445567788999999886799999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC-CCCCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~ 311 (601)
++||+|..++... +.+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 78 VNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC---CCCcEEecccCCCeecCcCCCcc
Confidence 9999998877654 5799999999999999999999999999999999999995 47899999999986532 22233
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHH
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 390 (601)
...+||..|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+......++ ..++.++.+||++
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~ 229 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKS 229 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHH
Confidence 4568999999999986 4689999999999999999999999998888887777776655544 3589999999999
Q ss_pred cccccccCCCCH-----HHHHcCcccCCC
Q 007498 391 LLNKDYRKRMTA-----VQALTHPWLRDD 414 (601)
Q Consensus 391 ~L~~dP~~R~s~-----~ell~hp~f~~~ 414 (601)
||..||.+||++ .+++.||||+..
T Consensus 230 ~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 230 FLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=386.95 Aligned_cols=259 Identities=28% Similarity=0.467 Sum_probs=221.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+.+++.++ ||||+++++++.++..+
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYL 118 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECC---CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEE
Confidence 579999999999999999999876 78899999997654444444566789999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~---~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC---CCCCEEEEeCCceeEcC
Confidence 999999999999988754 3589999999999999999999999999999999999995 47899999999998764
Q ss_pred CCC--CccccccccccccchhccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 307 PDE--RLNDIVGSAYYVAPEVLHR-----SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 307 ~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+....+..+......+.......
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence 332 2345689999999998752 378999999999999999999999999888888888876554333333457
Q ss_pred CCHHHHHHHHHcccccccC--CCCHHHHHcCcccCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRK--RMTAVQALTHPWLRDD 414 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~--R~s~~ell~hp~f~~~ 414 (601)
++.++++||.+||..++.+ |++++++++|+||++.
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 8999999999999854443 7899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=373.05 Aligned_cols=255 Identities=27% Similarity=0.453 Sum_probs=210.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+++++. +++.||||++...... ....+.+.+|+.+++.+. ||||+++++++...+.+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 76 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLY 76 (287)
T ss_pred CceEEEEecccCCEEEEEEEECC---CCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEE
Confidence 69999999999999999999876 7789999998764332 223567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||++++.+. .+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 77 lv~e~~~~~~l~-~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 77 LVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS---HNDVLKLCDFGFARNLSE 152 (287)
T ss_pred EEEecCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccCcccccc
Confidence 999999986554 4555556799999999999999999999999999999999999995 478999999999987643
Q ss_pred CC--Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC--------------C
Q 007498 308 DE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--------------P 370 (601)
Q Consensus 308 ~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------------~ 370 (601)
.. ......||..|+|||++. ..++.++|||||||++|||++|+.||.+.+..+....+.... +
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 32 233467999999999876 468999999999999999999999998766544433332211 1
Q ss_pred CCCCC--------------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 371 NFDDL--------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 371 ~~~~~--------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.+... .+..++.++.+||++||++||++|||++|+|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 11000 012378899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=372.09 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=217.0
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++.+.||+|+||.||++.+.. +++.||||++.............+.+|+.+++.+. ||||+++++.+..+..+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 76 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEE
Confidence 38899999999999999999875 78899999997654443334456788999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++ +++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---DYGHIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC---CCCCEEEeeCCCceecC
Confidence 999999999998877654 34699999999999999999999999999999999999995 47899999999998765
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
........+|+..|+|||++. ..++.++||||+||++|+|++|+.||.+.........+..............++..+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05605 154 EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233 (285)
T ss_pred CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence 544445568999999999876 5689999999999999999999999987655433333322111111112246899999
Q ss_pred HHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 386 DFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 386 ~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
+||.+||..||.+|| +++++++||||...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 999999999999999 99999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=379.74 Aligned_cols=260 Identities=30% Similarity=0.502 Sum_probs=219.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++++.||+|+||.||+++++. +++.||||++.+...........+.+|+.+++.+. |+||+++++++.+++.+|
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 77 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLY 77 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEE
Confidence 69999999999999999999876 78899999997654444445566889999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||++||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+..
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC---CCCCEEEEECCceeecCC
Confidence 99999999999998876667899999999999999999999999999999999999995 478999999999876644
Q ss_pred CCC--ccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC-CCCC
Q 007498 308 DER--LNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD-LPWP 378 (601)
Q Consensus 308 ~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~ 378 (601)
... ....+||+.|+|||++. +.++.++|||||||++|+|++|+.||......+.+..+......+.. ....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 234 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccC
Confidence 332 22357999999999875 34788999999999999999999999888777777777654332221 1124
Q ss_pred CCCHHHHHHHHHcccccccC--CCCHHHHHcCcccCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRK--RMTAVQALTHPWLRDD 414 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~--R~s~~ell~hp~f~~~ 414 (601)
.++.++++||++||..++.+ |+++.++++||||...
T Consensus 235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 58999999999999765444 7899999999999763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=371.23 Aligned_cols=257 Identities=28% Similarity=0.428 Sum_probs=210.7
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc--CCCCeeEEeeeEe----
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACE---- 221 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~---- 221 (601)
+|++.+.||+|+||.||+|++.. .+++.||||++........ ....+.+|+.+++.+. +||||+++++++.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcC--CCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 69999999999999999998754 1467899999875433222 2345667888887764 4999999999885
Q ss_pred -cCCcEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 222 -DVNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 222 -~~~~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
....+|+||||+. ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~---~~~~~kl~Df 154 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADF 154 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc---CCCCEEEccc
Confidence 3456999999996 5888887653 34589999999999999999999999999999999999995 4789999999
Q ss_pred ccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCC---
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL--- 375 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--- 375 (601)
|++.............||+.|+|||++. ..++.++|||||||++|||++|.+||.+....+.+..+..........
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9998766554455678999999999875 578999999999999999999999999888877776665432111000
Q ss_pred --------------------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 376 --------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 376 --------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
..+.++..+++||.+||..||++|||+.|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 013578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=379.65 Aligned_cols=251 Identities=27% Similarity=0.515 Sum_probs=211.4
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+.++.++.+||||+++++++...+.+||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 469999999999999876 78899999998765444445667889999998886799999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC-CCCCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~ 311 (601)
|++|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++... .....
T Consensus 78 ~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~---~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 78 VNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCCEEEeeCCccccccCCCCcc
Confidence 9999998876543 6799999999999999999999999999999999999995 47899999999987542 23334
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC---------ChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR---------TESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
...+||..|+|||++. ..++.++|||||||++|+|++|+.||... ........+......++ ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~ 229 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCC
Confidence 5578999999999886 56899999999999999999999999521 11223444555444443 3688
Q ss_pred HHHHHHHHHcccccccCCCC------HHHHHcCcccCCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMT------AVQALTHPWLRDD 414 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s------~~ell~hp~f~~~ 414 (601)
.++.+||++||..||.+|++ +.++++||||++.
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999999999998 5899999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=355.18 Aligned_cols=268 Identities=30% Similarity=0.486 Sum_probs=217.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCc-cCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-CC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-VN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~ 224 (601)
..|++++.||+|+||.||+|..+++.. ..+.+|||.++..+..+..+ ...-||+.+++.|+ ||||+.|..+|.. +.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELK-HPNVISLVKVFLSHDK 101 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhc-CCcchhHHHHHhccCc
Confidence 369999999999999999996654321 24589999997665444433 45668999999997 9999999999877 78
Q ss_pred cEEEEEeecCCCchHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec-CCCCCCeEEeec
Q 007498 225 NVYIVMELCEGGELLDRILAR----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDF 299 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~-~~~~~~vkl~DF 299 (601)
.+||++||.+. +|+..|..+ ...++...++.|+.||+.|+.|||++-|+||||||.|||+.. +.+.|.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 89999999988 898887643 345899999999999999999999999999999999999975 235699999999
Q ss_pred ccccccCCC----CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCh---------hHHHHH
Q 007498 300 GLSDFIRPD----ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTE---------SGIFRA 364 (601)
Q Consensus 300 G~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~---------~~~~~~ 364 (601)
|+++.+... .....++-|.||+|||++.| .|++++||||+|||+.||++-++.|.+... .+++..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999987543 23355788999999998864 699999999999999999999999965422 345566
Q ss_pred HHccCCCCCCCCCCC---------------------------------CCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 365 VLRSDPNFDDLPWPS---------------------------------VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 365 i~~~~~~~~~~~~~~---------------------------------~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
|++.........|+. -++.+.+|+.+||+.||.+|+|++++|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 655443333333332 14558999999999999999999999999999
Q ss_pred CCCCCC
Q 007498 412 RDDSRP 417 (601)
Q Consensus 412 ~~~~~~ 417 (601)
++++.|
T Consensus 341 ~~d~lp 346 (438)
T KOG0666|consen 341 TEDPLP 346 (438)
T ss_pred ccCCCC
Confidence 999765
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=376.19 Aligned_cols=251 Identities=28% Similarity=0.494 Sum_probs=214.3
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+|++.. +++.||||++.+..............|..+++.+.+||||+++++++.+.+.+||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 469999999999999876 77899999997754322233456677888888765699999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC-CCCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~ 311 (601)
++||+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 78 LNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEccCCcceECCCCCCce
Confidence 9999999887654 5799999999999999999999999999999999999995 478999999999875432 2234
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHH
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 390 (601)
...+||..|+|||++. ..++.++|||||||++|||++|..||.+....+.+..+....+.++ ..++.++++||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~ 229 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVK 229 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHH
Confidence 4568999999999886 4689999999999999999999999998887777777765554443 2488999999999
Q ss_pred cccccccCCCCHH-HHHcCcccCCC
Q 007498 391 LLNKDYRKRMTAV-QALTHPWLRDD 414 (601)
Q Consensus 391 ~L~~dP~~R~s~~-ell~hp~f~~~ 414 (601)
||..||++|+++. ++++||||+..
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 230 LFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred HhccCHhhcCCChHHHHcCcccCCC
Confidence 9999999999996 99999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=409.63 Aligned_cols=258 Identities=31% Similarity=0.504 Sum_probs=229.6
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|.+++.||+|+||.|.+|+.+. +++.||+|++.+..+.......-|..|-.||..- +.+-|++|..+|.++.+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~---t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKS---TEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeec---cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccc
Confidence 3579999999999999999999987 8899999999886666555667788899999765 58999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||+||+|+.++.+.. ++++.-++.|+.+|+.||.-||+.|+|||||||+|||| |..|+|||+|||.+-.+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKM 225 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhc
Confidence 999999999999999887665 89999999999999999999999999999999999999 46999999999998777
Q ss_pred CCCCC--ccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc--CCCCCCC
Q 007498 306 RPDER--LNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS--DPNFDDL 375 (601)
Q Consensus 306 ~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~ 375 (601)
..+.. ....+|||.|++||++. +.|+..+|+||+||++|||++|..||+..+-.+.|..|++. ...||.
T Consensus 226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~- 304 (1317)
T KOG0612|consen 226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD- 304 (1317)
T ss_pred CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc-
Confidence 64433 45679999999999983 45999999999999999999999999999999999999876 445553
Q ss_pred CCCCCCHHHHHHHHHcccccccCCCC---HHHHHcCcccCCC
Q 007498 376 PWPSVSPEAKDFVKRLLNKDYRKRMT---AVQALTHPWLRDD 414 (601)
Q Consensus 376 ~~~~~s~~~~~li~~~L~~dP~~R~s---~~ell~hp~f~~~ 414 (601)
-..+|.++++||.++|+ +|..|.. ++++.+||||.+.
T Consensus 305 -~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 305 -ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred -ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 24699999999999996 6889998 9999999999754
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=376.71 Aligned_cols=256 Identities=27% Similarity=0.482 Sum_probs=221.1
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++.+.||+|+||.||+|+++. +++.||||++.+.........+.+..|+.++..+.+|++|+++++++...+.+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEE
Confidence 37788999999999999999876 788999999987544333445677889999998875788899999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
|||||++||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 78 lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~---~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD---SEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeccccccccCC
Confidence 999999999999887554 5799999999999999999999999999999999999995 478999999999875432
Q ss_pred C-CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 308 D-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 308 ~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
. ......+||+.|+|||++. +.++.++|||||||++|+|++|+.||.+......+..+......++ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 229 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAV 229 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Confidence 2 2334567999999999876 5689999999999999999999999998888888888877665544 36899999
Q ss_pred HHHHHcccccccCCCC-----HHHHHcCcccCCC
Q 007498 386 DFVKRLLNKDYRKRMT-----AVQALTHPWLRDD 414 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s-----~~ell~hp~f~~~ 414 (601)
+|+.+||.+||.+|++ ..++++||||+..
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 9999999999999997 5899999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=361.98 Aligned_cols=265 Identities=25% Similarity=0.481 Sum_probs=224.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.-|.++.+||+|+||.||+|.++. +|..+|||.+.... +.+.+..||.||+++. .|+||++|+.|.....+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~E---sG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRE---SGHVLAIKKVPVDT-----DLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDL 103 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhc---cCcEEEEEecCccc-----hHHHHHHHHHHHHHcC-CchhhhhhhhhccCCce
Confidence 458899999999999999999987 89999999886542 5678899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||..|++.+.+..+++.|++.++..+++..++||+|||...-||||||..||||+. +|..||+|||.|..+.
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT---~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT---DGIAKLADFGVAGQLT 180 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc---cchhhhhhccccchhh
Confidence 9999999999999999999999999999999999999999999999999999999999964 8999999999998765
Q ss_pred CC-CCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC----CCCCCCCCCCC
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD----PNFDDLPWPSV 380 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~ 380 (601)
.. .+.++++||+.|||||++.. .|+.++||||||++..||..|++||...-. ++.|+... +.|.. ...+
T Consensus 181 DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PPPTF~K--PE~W 255 (502)
T KOG0574|consen 181 DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPPPTFKK--PEEW 255 (502)
T ss_pred hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCCCCCCC--hHhh
Confidence 33 34577899999999999875 799999999999999999999999965443 23333211 11211 1247
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCChhHHHHHHH
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLV 428 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~ 428 (601)
|.++.|||++||.++|++|.|+-++++|||+++.+.-.-+...+...+
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~~A~ 303 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQDAQ 303 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHHHHH
Confidence 899999999999999999999999999999998764333333333333
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=371.30 Aligned_cols=256 Identities=29% Similarity=0.511 Sum_probs=230.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|+.-+.||+||||.||-++.+. +|+.||+|.+.+..+.........++|-.||++++ .+.||.|-.+|+..+.+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvra---TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRA---TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDAL 260 (591)
T ss_pred cceeeeEEEecccccceeEEEEec---chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCce
Confidence 357788899999999999999886 89999999999888877777788899999999996 89999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
||||..|.||+|.-+|.+.+ ..|++..++.|+.+|+.||++||..+||+|||||+|||| |+.|+|+|+|+|+|..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEec
Confidence 99999999999988887654 469999999999999999999999999999999999999 57999999999999999
Q ss_pred CCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHccCCCCCCCCCCCC
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
..+......+||.+|||||+++ +.|+...|+|||||+||||+.|+.||....+ .++-+.++.....++ ..+
T Consensus 338 ~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~kF 413 (591)
T KOG0986|consen 338 PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----DKF 413 (591)
T ss_pred CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----ccc
Confidence 9888888889999999999987 5699999999999999999999999976533 355555666555555 378
Q ss_pred CHHHHHHHHHcccccccCCCC-----HHHHHcCcccCC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMT-----AVQALTHPWLRD 413 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s-----~~ell~hp~f~~ 413 (601)
|+++++|++.+|++||.+|.. +.++.+||||++
T Consensus 414 S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 414 SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 999999999999999999985 679999999987
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=367.54 Aligned_cols=249 Identities=28% Similarity=0.486 Sum_probs=208.0
Q ss_pred eccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeecC
Q 007498 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234 (601)
Q Consensus 155 lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 234 (601)
||+|+||+||++.++. +++.||+|++.+.........+.+..|+.+++.++ |+||+++++++.....+|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEcc---CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCC
Confidence 7999999999999876 78899999997655444444567788999999996 9999999999999999999999999
Q ss_pred CCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCC-C
Q 007498 235 GGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-R 310 (601)
Q Consensus 235 ~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-~ 310 (601)
+|+|...+.. ....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+.... .
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCccceecCCCCcc
Confidence 9999877643 345699999999999999999999999999999999999995 47889999999997664432 2
Q ss_pred ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 311 LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES----GIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 311 ~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.....||+.|+|||++. +.++.++|||||||++|+|++|+.||...... .....+......+ ...++.++.
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 229 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTY----PDKFSPASK 229 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCC----cccCCHHHH
Confidence 34568999999999886 57899999999999999999999999765432 2222222222111 246899999
Q ss_pred HHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 386 DFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 386 ~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
+|+.+||..||++|+ +++++++||||+..
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 999999999999999 88999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=366.24 Aligned_cols=257 Identities=29% Similarity=0.492 Sum_probs=210.6
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
+..|+++++||+||.+.||+|... +...||+|.+.... .+......+.+||.+|.+|.+|.+||+||+|-..++.
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s----~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS----DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC----CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 457999999999999999999875 44678888765433 3445678899999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+||||||-+. +|..+|.++..-++...++.|..|++.|+.++|..||||.||||.|+|+. .|.+||+|||+|..+
T Consensus 435 lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 435 LYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAI 509 (677)
T ss_pred EEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhccc
Confidence 9999999754 88888777666666679999999999999999999999999999999996 789999999999888
Q ss_pred CCCCC---ccccccccccccchhccC------------CCCChhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHccC
Q 007498 306 RPDER---LNDIVGSAYYVAPEVLHR------------SYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRSD 369 (601)
Q Consensus 306 ~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~ 369 (601)
..+.. ..+.+||+.||+||.+.. ..++++||||||||||+|+.|++||.... ...-+..|....
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN 589 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence 76543 356799999999998731 15789999999999999999999995432 222233333322
Q ss_pred C--CCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 370 P--NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 370 ~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
. .|+..+ -..++.++++.||..||.+||++.+||+|||++..+
T Consensus 590 ~~Iefp~~~---~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 590 HEIEFPDIP---ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred ccccccCCC---CchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 2 333322 123499999999999999999999999999997643
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=378.49 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=225.4
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
...|.-++.||.|+||.||.|++.. +.+.||||.+.-........+.++..|++.|++|. |||+|.+-++|.....
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~---n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHT 100 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccC---ccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccch
Confidence 3457888999999999999999987 78999999997766555567788999999999997 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.|||||||-| +-.|++.-..+++-+-+|..|+.+.+.||.|||+.+.||||||..||||+ +.|.|||+|||.|...
T Consensus 101 aWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 101 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhc
Confidence 9999999965 77777777778899999999999999999999999999999999999996 5899999999999765
Q ss_pred CCCCCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
.+ .++++|||+|||||++. |.|+-++|||||||++.||...++|+...+-...+..|..+... .+.-+.+|
T Consensus 177 ~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesP--tLqs~eWS 251 (948)
T KOG0577|consen 177 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--TLQSNEWS 251 (948)
T ss_pred Cc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCC--CCCCchhH
Confidence 43 46789999999999862 78999999999999999999999999887766656666655432 22236789
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
..++.|+..||++-|..|||++++|.|+|+.-..
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 9999999999999999999999999999987543
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=376.45 Aligned_cols=250 Identities=28% Similarity=0.519 Sum_probs=212.8
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHH-HHHhcCCCCeeEEeeeEecCCcEEEEEe
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI-LKALSGHKHLVKFCDACEDVNNVYIVME 231 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~e 231 (601)
+.||+|+||.||+|+++. +++.||||++.+...........+.+|..+ ++.++ ||||+++++.+...+.+|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEc
Confidence 469999999999999876 788999999976544333334555666654 56675 9999999999999999999999
Q ss_pred ecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC-CCC
Q 007498 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DER 310 (601)
Q Consensus 232 ~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~ 310 (601)
|+++|+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ...
T Consensus 77 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~---~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 77 YVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred CCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeccCCCcccccCCCc
Confidence 9999999887765 46799999999999999999999999999999999999995 478999999999875432 233
Q ss_pred ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHH
Q 007498 311 LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389 (601)
Q Consensus 311 ~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 389 (601)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+.+..+......+. +.+++++.+||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 228 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLE 228 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 44568999999999876 4689999999999999999999999998888888888876654433 468999999999
Q ss_pred HcccccccCCCCH----HHHHcCcccCCC
Q 007498 390 RLLNKDYRKRMTA----VQALTHPWLRDD 414 (601)
Q Consensus 390 ~~L~~dP~~R~s~----~ell~hp~f~~~ 414 (601)
+||..||.+|+++ .++++||||...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 229 GLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred HHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999987 699999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=374.44 Aligned_cols=249 Identities=26% Similarity=0.450 Sum_probs=209.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
....++.+||+|.||+||++++.. .||||++........ ..+.|++|+.+|++-+ |.||+-+.|+|.....
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG------dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG------DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTR-HENILLFMGACMNPPL- 462 (678)
T ss_pred HHhhccceeccccccceeeccccc------ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-
Confidence 456788999999999999999865 699999988765544 7889999999999997 9999999999998877
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc-
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI- 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~- 305 (601)
.||+.+|+|.+|+.+++....+|...+++.|++||+.|+.|||.++|||||||..||+|. +++.|||+|||++..-
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~---~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH---EDLKVKIGDFGLATVKT 539 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc---cCCcEEEecccceeeee
Confidence 899999999999999988777899999999999999999999999999999999999995 4699999999998542
Q ss_pred --CCCCCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCC-CCCCC
Q 007498 306 --RPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD-DLPWP 378 (601)
Q Consensus 306 --~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~ 378 (601)
..........|...|||||++. .+|++.+||||||||+|||++|..||...+...++-.+-++..... .....
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 3334455567899999999985 3699999999999999999999999986555554433333311111 11123
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.++++++|+..||+.++++||...+||.
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 56779999999999999999999999886
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=376.78 Aligned_cols=259 Identities=30% Similarity=0.493 Sum_probs=208.1
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC----
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV---- 223 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---- 223 (601)
+|++.+.||+|+||.||+++++. +++.||||++..... .......+.+|+.+++.++ ||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---CCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCC
Confidence 58999999999999999999876 788999999864322 2223456889999999996 99999999987543
Q ss_pred -CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 224 -NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 224 -~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
..+|+|||||. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 76 ~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kL~Dfg~~ 150 (338)
T cd07859 76 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLA 150 (338)
T ss_pred CceEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEccCccc
Confidence 35899999995 5888877543 5799999999999999999999999999999999999995 4889999999999
Q ss_pred cccCCCC----Cccccccccccccchhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHc--------
Q 007498 303 DFIRPDE----RLNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR-------- 367 (601)
Q Consensus 303 ~~~~~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-------- 367 (601)
+...... .....+||..|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 7643221 123467999999999875 4689999999999999999999999977654332222111
Q ss_pred -------------------cCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 368 -------------------SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 368 -------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
..+......++.+++++.+||.+||..||++||+++|+|+||||+....
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0011011123467889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=377.90 Aligned_cols=252 Identities=29% Similarity=0.519 Sum_probs=217.7
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||++++..+..+++.||+|++.+..... .....+.+|+++++++. ||||+++++++..++.+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence 67999999999999876544578999999997654322 23456778999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC-CCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~-~~~ 311 (601)
+++|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...... ...
T Consensus 80 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 80 LRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC---CCCcEEEeeccCCcccCCCCCce
Confidence 9999999887554 5799999999999999999999999999999999999995 4789999999999765443 234
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHH
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 390 (601)
...+||+.|+|||++. ..++.++|||||||++|||++|+.||........+..+......++ ..+++++.+||++
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~ 231 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRA 231 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 4578999999999986 4689999999999999999999999998888888887776655444 3589999999999
Q ss_pred cccccccCCCC-----HHHHHcCcccCCC
Q 007498 391 LLNKDYRKRMT-----AVQALTHPWLRDD 414 (601)
Q Consensus 391 ~L~~dP~~R~s-----~~ell~hp~f~~~ 414 (601)
||..||.+||+ +.+++.||||+..
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999999999 7889999999863
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=375.68 Aligned_cols=260 Identities=29% Similarity=0.483 Sum_probs=219.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.++||+|+||.||+++++. +++.||+|++.+...........+.+|+.++..+. |+||+++++++.+...+|
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 77 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLY 77 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEE
Confidence 69999999999999999999876 67899999997644333334456888999999985 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
|||||+++|+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+..
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~---~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLME 154 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEeecchheeccc
Confidence 99999999999999877667899999999999999999999999999999999999995 478999999999876543
Q ss_pred CCC--ccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC-CCCC
Q 007498 308 DER--LNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD-LPWP 378 (601)
Q Consensus 308 ~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~ 378 (601)
... ....+||+.|+|||++. +.++.++|||||||++|||++|+.||......+.+..+......+.. ....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 234 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT 234 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccc
Confidence 322 23467999999999874 35889999999999999999999999988887878777765433221 1124
Q ss_pred CCCHHHHHHHHHcccccccC--CCCHHHHHcCcccCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRK--RMTAVQALTHPWLRDD 414 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~--R~s~~ell~hp~f~~~ 414 (601)
.+++++++||++||..++.+ |++++|+++||||...
T Consensus 235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred cCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 68999999999999765544 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=374.49 Aligned_cols=251 Identities=27% Similarity=0.503 Sum_probs=211.6
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+.++.++.+||||+++++++...+.+||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 479999999999999876 77899999998765544445677889999999997799999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC-CCCCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~ 311 (601)
|++|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 78 VNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD---ADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe---CCCCEEEeccccceeccCCCCce
Confidence 9999998877544 5799999999999999999999999999999999999995 47899999999987532 23334
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-------hhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART-------ESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
...+||+.|+|||++. ..++.++|||||||++|+|++|..||.... .......+......++ ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~ 229 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVK 229 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHH
Confidence 5678999999999876 578999999999999999999999995321 2233444444333333 358899
Q ss_pred HHHHHHHcccccccCCCC------HHHHHcCcccCCC
Q 007498 384 AKDFVKRLLNKDYRKRMT------AVQALTHPWLRDD 414 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s------~~ell~hp~f~~~ 414 (601)
+.++|++||..||.+|++ ..++++||||+..
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 999999999999999998 5799999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=375.87 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=219.4
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+++++. +++.||+|++.+...........+.+|+.++..+. |+||+++++++.+.+.+|
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~ 77 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKH---TERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLY 77 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEE
Confidence 69999999999999999999876 77899999997644333334566888999999986 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
|||||++||+|.+++......+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||++..+..
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~---~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD---MNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc---CCCCEEEEeccceeeccC
Confidence 99999999999999877667899999999999999999999999999999999999995 478899999999977654
Q ss_pred CCCc--cccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC-CCCC
Q 007498 308 DERL--NDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD-LPWP 378 (601)
Q Consensus 308 ~~~~--~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~ 378 (601)
.... ...+||+.|+|||++. +.++.++|||||||++|+|++|+.||......+.+..+......+.. ..+.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 234 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHIT 234 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccc
Confidence 3322 3357999999999875 35789999999999999999999999988777777777654432221 1234
Q ss_pred CCCHHHHHHHHHcccccccC--CCCHHHHHcCcccCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRK--RMTAVQALTHPWLRD 413 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~--R~s~~ell~hp~f~~ 413 (601)
.++.++++||.+||..++.+ |++++++++||||+.
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 67999999999999876654 568999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=379.57 Aligned_cols=250 Identities=30% Similarity=0.550 Sum_probs=214.0
Q ss_pred eccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc--CCCCeeEEeeeEecCCcEEEEEee
Q 007498 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 155 lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
||+|+||.||+|+++. +++.||||++.+..............|..++..+. +||||+++++.+.....+||||||
T Consensus 1 lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 7999999999999876 78899999997654443334455667777877664 699999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC-CCCc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERL 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~ 311 (601)
+++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 78 MSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD---ATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred CCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEecCCcCcCCCCCCCCc
Confidence 999999988765 46799999999999999999999999999999999999995 478999999999875432 2334
Q ss_pred cccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHH
Q 007498 312 NDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 389 (601)
...+||..|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......++. ..+++++.+||+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~ 230 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVK 230 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHH
Confidence 56789999999998753 4899999999999999999999999988888888887766655543 357999999999
Q ss_pred HcccccccCCC----CHHHHHcCcccCCC
Q 007498 390 RLLNKDYRKRM----TAVQALTHPWLRDD 414 (601)
Q Consensus 390 ~~L~~dP~~R~----s~~ell~hp~f~~~ 414 (601)
+||..||.+|+ ++.++++||||++.
T Consensus 231 ~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 231 GLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99999999998 79999999999863
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=361.93 Aligned_cols=256 Identities=27% Similarity=0.493 Sum_probs=231.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|..+..||+|+||.|.++..+. +.+.||||++++..+-...+++--..|-++|......|.+++|..+|+.-+++
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkg---tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred cccceEEEeccCccceeeeecccC---cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 478899999999999999999876 77899999999887766666666677888887766678999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc-
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI- 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~- 305 (601)
|+||||+.||+|.-+|..- ++|.+..+..|+.+|+-||-+||++|||+||||.+||||+ .+|+|||+|||+++.-
T Consensus 426 yFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd---~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENI 501 (683)
T ss_pred eeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec---cCCceEeeecccccccc
Confidence 9999999999999887654 7899999999999999999999999999999999999995 5999999999999753
Q ss_pred CCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
-.+....++|||+.|+|||++. .+|+..+|+||+||+||||+.|++||.+..+.++++.|...+..++. .+|.++
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEA 577 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEA 577 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHH
Confidence 3445567899999999999875 78999999999999999999999999999999999999999888875 799999
Q ss_pred HHHHHHcccccccCCCCH-----HHHHcCcccCC
Q 007498 385 KDFVKRLLNKDYRKRMTA-----VQALTHPWLRD 413 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~-----~ell~hp~f~~ 413 (601)
.++++.+|.+.|.+|..+ .++..||||+.
T Consensus 578 v~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 578 VAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 999999999999999865 68999999985
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=381.59 Aligned_cols=254 Identities=20% Similarity=0.317 Sum_probs=206.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++++.||+|+||.||+|++.. +++.||||.... ..+.+|++++++|+ |||||+++++|..+...
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~---~~~~vaiK~~~~---------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNK---TCEHVVIKAGQR---------GGTATEAHILRAIN-HPSIIQLKGTFTYNKFT 158 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECC---CCCEEEEechhh---------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCee
Confidence 479999999999999999999986 788999996432 34678999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|||++. ++|..++... ..+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|....
T Consensus 159 ~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~---~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc---CCCCEEEEeCCcccccc
Confidence 99999995 5888877654 5799999999999999999999999999999999999995 47889999999997543
Q ss_pred CC--CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-------hhHHHHHHHccCCC-----
Q 007498 307 PD--ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART-------ESGIFRAVLRSDPN----- 371 (601)
Q Consensus 307 ~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~----- 371 (601)
.. ......+||+.|+|||++. ..|+.++|||||||++|||++|..||.... ....+..++.....
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 22 2334568999999999886 569999999999999999999998875432 11122222211100
Q ss_pred ---------------------CC--CCCC---CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCC
Q 007498 372 ---------------------FD--DLPW---PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPV 418 (601)
Q Consensus 372 ---------------------~~--~~~~---~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 418 (601)
.+ ...| ..++.++.+||.+||..||.+|||+.|+|+||||++.+.+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~ 386 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPY 386 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCC
Confidence 00 0001 13567899999999999999999999999999999876543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=320.95 Aligned_cols=260 Identities=29% Similarity=0.512 Sum_probs=224.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|...++||+|+||+||+++++. +++.||+|.++....... ......+||-+|+.|. |.|||++++....++.+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~---t~eivalkrvrlddddeg-vpssalreicllkelk-hknivrl~dvlhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE---THEIVALKRVRLDDDDEG-VPSSALREICLLKELK-HKNIVRLHDVLHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC---ccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhh-hcceeehhhhhccCceeE
Confidence 57778899999999999999886 889999999987654333 3456789999999997 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+|+|||.. +|..++...++.++.+.++.++.|+++||.|||+++++|||+||.|+|++ .+|.+|++|||+++-+.-
T Consensus 78 lvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin---~ngelkladfglarafgi 153 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN---RNGELKLADFGLARAFGI 153 (292)
T ss_pred EeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec---cCCcEEecccchhhhcCC
Confidence 99999965 89988888899999999999999999999999999999999999999995 599999999999987654
Q ss_pred CCC-ccccccccccccchhccC--CCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCC----
Q 007498 308 DER-LNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS---- 379 (601)
Q Consensus 308 ~~~-~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---- 379 (601)
.-+ ...-+-|.||++|.++.+ -|+...|+||.|||+.|+.. |++.|.+..-.++++.|........+..|+.
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 432 344578999999999864 59999999999999999986 7778888888888999887555444444443
Q ss_pred ---------------------CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 380 ---------------------VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 380 ---------------------~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
++...+||++++|.-+|.+|++++++|+||||.+.+.
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s~ 291 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFSP 291 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccCC
Confidence 3456799999999999999999999999999987643
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=335.45 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=220.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
..+.+..||.|+-|.||+++.+. ++...|||.+.+... ....+++++.+.++..-.+.|+||+.+|+|..+..++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs---~~~iiAVK~M~rt~N--kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRS---TGHIIAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcc---cceEEEEEeecccCC--HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 35667889999999999999987 889999999987643 3456788899999888777899999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|.||.|.. -+..++..-.++++|.-+-++...+++||.||.++ +|||||+||+|||+ |+.|+|||||||++.++.
T Consensus 168 IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 168 ICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceee
Confidence 99999954 34444444567899999999999999999999876 89999999999999 569999999999999887
Q ss_pred CCCCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 307 PDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWAR-TESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
.........|.+.|||||.+. ..|+.++|||||||.++||.||+.||.+. .+.+++-.+++..+..-.. -..+|
T Consensus 244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~-~~gFS 322 (391)
T KOG0983|consen 244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG-HMGFS 322 (391)
T ss_pred cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc-ccCcC
Confidence 776667778999999999885 35999999999999999999999999874 5778888888765522111 12489
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+++++|+..||++|+.+||...++|+|||++..
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 999999999999999999999999999999865
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=369.65 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=214.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|.+.+.||+|+||.||+++++. +++.||+|+++...... ....+.+|+.++++++ ||||+++++++..++.+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEEG--APCTAIREVSLLKDLK-HANIVTLHDIVHTDKSL 79 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC---CCCeEEEEEeeccccCC--cchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeE
Confidence 469999999999999999999876 67899999987543222 2345678999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKS 155 (309)
T ss_pred EEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECccccceecC
Confidence 999999975 88888877666799999999999999999999999999999999999995 47899999999997653
Q ss_pred CCC-Cccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC-------------
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP------------- 370 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------- 370 (601)
... ......+|..|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 322 233457899999999875 3589999999999999999999999987766555444432111
Q ss_pred ------CCCC-------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 371 ------NFDD-------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 371 ------~~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
.++. ...+.+++++++||.+||..||.+|+|+.|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0010 01235789999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=371.00 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=213.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||++++.. ++..||+|++.... .......+.+|++++++++ ||||+++++++..++.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 78 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKP---SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEI 78 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECC---CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 579999999999999999999876 78899999987542 2234567899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN---SRGEIKLCDFGVSGQL 154 (331)
T ss_pred EEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc---CCCcEEEccCcccccc
Confidence 9999999999999887654 5699999999999999999999986 699999999999995 4788999999999765
Q ss_pred CCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC---------------
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--------------- 369 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------------- 369 (601)
... .....+||..|+|||++. ..++.++|||||||++|||++|+.||......++...+....
T Consensus 155 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 155 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence 432 334567999999999886 468999999999999999999999997655433322111000
Q ss_pred -----------------------------CCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 370 -----------------------------PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 370 -----------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
...+..+...+++++++||.+||..||++|||+.|+|+||||+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 00011112347889999999999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=376.73 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=204.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
...|.+.+.||+|+||.||++++.. .++.||||.... ..+.+|+++|++|. |+|||++++++..++.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---YPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---CCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCE
Confidence 4479999999999999999999876 678999996321 23568999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.|||||++. ++|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~---~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN---GPEDICLGDFGAACFA 310 (461)
T ss_pred EEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC---CCCCEEEcccCCceec
Confidence 999999995 689988877666799999999999999999999999999999999999995 4788999999999765
Q ss_pred CCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC--------hhHHHHHHHccCC---
Q 007498 306 RPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART--------ESGIFRAVLRSDP--- 370 (601)
Q Consensus 306 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~--- 370 (601)
..... ....+||..|+|||++. ..++.++|||||||+||||++|..++.... ...+.+.+.....
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 43221 23467999999999886 468999999999999999999887664322 1222222222111
Q ss_pred CC------------------------CCCCCC---CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 371 NF------------------------DDLPWP---SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 371 ~~------------------------~~~~~~---~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
.+ ....|. .++.++.+||.+||..||.+|||+.|+|+||||++
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11 111122 45678999999999999999999999999999975
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=364.10 Aligned_cols=256 Identities=29% Similarity=0.445 Sum_probs=208.6
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc--CCCCeeEEeeeEec---
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACED--- 222 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~--- 222 (601)
+|++.+.||+|+||.||+|+++. +++.||+|++....... .....+.+|+.+++.+. +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 48999999999999999999886 78899999987643222 12234567888887764 49999999998864
Q ss_pred --CCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 223 --VNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 223 --~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
...+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 77 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~kl~df 152 (288)
T cd07863 77 DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGQVKLADF 152 (288)
T ss_pred CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECcc
Confidence 3458999999975 8888776542 3589999999999999999999999999999999999995 4788999999
Q ss_pred ccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC-------
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN------- 371 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------- 371 (601)
|++.............||..|+|||++. ..++.++|||||||++|+|++|.+||.+....+.+..+......
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 153 GLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred CccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 9998776544445568899999999875 56899999999999999999999999887766655555431100
Q ss_pred ---------CCC-------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 372 ---------FDD-------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 372 ---------~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+.. ...+.++.++.+||.+||..||.+|||+.|++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 0123578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=363.70 Aligned_cols=255 Identities=26% Similarity=0.467 Sum_probs=213.4
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
|++.+.||+|+||.||++.+.. +++.||||.+.+...........+.+|+.+++.++ |+||+.+++.+.+.+.+|+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~l 77 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCL 77 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcC---CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEE
Confidence 7788899999999999999886 78899999987655444334456788999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 229 VMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||+.|++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++ .++.++|+|||++.....
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~---~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPE 154 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeccceeecCC
Confidence 99999999998887543 23599999999999999999999999999999999999995 478899999999977654
Q ss_pred CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHHHHccCCCCCCCCCCCCCHH
Q 007498 308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES---GIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.......+||..|+|||++. +.++.++|||||||++|+|++|+.||...... .....+..... ......++++
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 231 (285)
T cd05630 155 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---EEYSEKFSPD 231 (285)
T ss_pred CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh---hhcCccCCHH
Confidence 44445568999999999886 56899999999999999999999999765432 12222222111 1122468899
Q ss_pred HHHHHHHcccccccCCCC-----HHHHHcCcccCC
Q 007498 384 AKDFVKRLLNKDYRKRMT-----AVQALTHPWLRD 413 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s-----~~ell~hp~f~~ 413 (601)
+.+||.+||..||.+|+| ++|+++||||+.
T Consensus 232 ~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 999999999999999999 999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=373.58 Aligned_cols=250 Identities=28% Similarity=0.510 Sum_probs=212.0
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHH-HHHhcCCCCeeEEeeeEecCCcEEEEEe
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI-LKALSGHKHLVKFCDACEDVNNVYIVME 231 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~e 231 (601)
+.||+|+||.||+|+++. +++.||||++.+...........+.+|..+ ++.+. ||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEc
Confidence 469999999999999876 788999999976544333344556666654 56675 9999999999999999999999
Q ss_pred ecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC-CCC
Q 007498 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DER 310 (601)
Q Consensus 232 ~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~ 310 (601)
|+.+|+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ...
T Consensus 77 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~---~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 77 FVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD---SQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEeecCCcccCCCCCCC
Confidence 9999999887754 46799999999999999999999999999999999999995 478999999999875422 233
Q ss_pred ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHH
Q 007498 311 LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389 (601)
Q Consensus 311 ~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 389 (601)
....+||..|+|||++. ..++.++|||||||++|+|++|..||...+..+++..+......+. +.++..+.++|+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~ 228 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILE 228 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHH
Confidence 44568999999999886 4689999999999999999999999998888888887776544332 468999999999
Q ss_pred HcccccccCCCCH----HHHHcCcccCCC
Q 007498 390 RLLNKDYRKRMTA----VQALTHPWLRDD 414 (601)
Q Consensus 390 ~~L~~dP~~R~s~----~ell~hp~f~~~ 414 (601)
+||..||.+||++ .++++||||...
T Consensus 229 ~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred HHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 9999999999976 599999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=372.21 Aligned_cols=249 Identities=29% Similarity=0.531 Sum_probs=210.2
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHH-HHHHhcCCCCeeEEeeeEecCCcEEEEEe
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK-ILKALSGHKHLVKFCDACEDVNNVYIVME 231 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~lv~e 231 (601)
+.||+|+||.||+|+++. +++.||+|++.+...........+.+|.. +++.+. ||||+++++++...+.+|+|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEe
Confidence 469999999999999876 67899999997654333223344555554 456675 9999999999999999999999
Q ss_pred ecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC-CCCC
Q 007498 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDER 310 (601)
Q Consensus 232 ~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~ 310 (601)
|+++|+|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++... ....
T Consensus 77 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~---~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 77 YINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEEccCCCCcccccCCCC
Confidence 9999999988765 45799999999999999999999999999999999999995 47899999999997543 2233
Q ss_pred ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHH
Q 007498 311 LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389 (601)
Q Consensus 311 ~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 389 (601)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......+. +.+++.+.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 228 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLE 228 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCCHHHHHHHH
Confidence 45578999999999886 4689999999999999999999999998888888877776544332 478999999999
Q ss_pred HcccccccCCCCHH----HHHcCcccCC
Q 007498 390 RLLNKDYRKRMTAV----QALTHPWLRD 413 (601)
Q Consensus 390 ~~L~~dP~~R~s~~----ell~hp~f~~ 413 (601)
+||.+||.+|+++. ++++|+||..
T Consensus 229 ~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 229 GLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 99999999999875 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=361.06 Aligned_cols=260 Identities=29% Similarity=0.463 Sum_probs=218.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|+..+.||+|+||+||++.+.. +++.||+|++.............+.+|+++++.++ |+||+.+++++..++.+|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC---CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEE
Confidence 37788899999999999999876 78899999997655444444556788999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+||||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~---~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC---CCCCEEEecCCcceecC
Confidence 999999999998877653 34699999999999999999999999999999999999995 47889999999997665
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.........|+..|+|||++. ..++.++|+|||||++|+|++|..||...........+..............++.++.
T Consensus 154 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05632 154 EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAK 233 (285)
T ss_pred CCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHH
Confidence 444445568999999999875 5689999999999999999999999987665444333333222222222346889999
Q ss_pred HHHHHcccccccCCCC-----HHHHHcCcccCCC
Q 007498 386 DFVKRLLNKDYRKRMT-----AVQALTHPWLRDD 414 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s-----~~ell~hp~f~~~ 414 (601)
+|+.+||..||.+||+ +.++++|+||++.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=360.72 Aligned_cols=250 Identities=26% Similarity=0.444 Sum_probs=208.0
Q ss_pred eccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeecC
Q 007498 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234 (601)
Q Consensus 155 lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 234 (601)
||+|+||.||+++++. +++.||+|++.+...........+..|+++++++. ||||+++++++..+..+|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEcc---CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCC
Confidence 7999999999999876 78899999997654433333445667999999995 9999999999999999999999999
Q ss_pred CCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCccc
Q 007498 235 GGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313 (601)
Q Consensus 235 ~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 313 (601)
|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.++|+|||++...........
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD---DQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc---CCCCEEEeeceeeeecCCCceeec
Confidence 999988776532 3589999999999999999999999999999999999995 478899999999987655444445
Q ss_pred cccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHccCCCCCCCCCCCCCHHHHHHH
Q 007498 314 IVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPWPSVSPEAKDFV 388 (601)
Q Consensus 314 ~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 388 (601)
..||..|+|||++. ..++.++|||||||++|||++|..||..... ..+..........+ ....++.++++||
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li 230 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF---EHQNFTEESKDIC 230 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc---ccccCCHHHHHHH
Confidence 67999999999875 5689999999999999999999999975432 23333333332222 2246899999999
Q ss_pred HHcccccccCCCCH----HHHHcCcccCCC
Q 007498 389 KRLLNKDYRKRMTA----VQALTHPWLRDD 414 (601)
Q Consensus 389 ~~~L~~dP~~R~s~----~ell~hp~f~~~ 414 (601)
++||..||.+||++ ++++.||||+..
T Consensus 231 ~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 231 RLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 99999999999999 778899999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=370.77 Aligned_cols=249 Identities=29% Similarity=0.516 Sum_probs=210.8
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHH-HHHHhcCCCCeeEEeeeEecCCcEEEEEe
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK-ILKALSGHKHLVKFCDACEDVNNVYIVME 231 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~lv~e 231 (601)
+.||+|+||.||+|++.. +++.||+|++.+...........+.+|+. +++.++ ||||+++++++.+.+.+|||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEc
Confidence 469999999999999876 78899999997654433333445566655 567775 9999999999999999999999
Q ss_pred ecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC-CCCC
Q 007498 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDER 310 (601)
Q Consensus 232 ~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~ 310 (601)
||++|+|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.... ....
T Consensus 77 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 77 YVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEccCCCCccCCCCCCc
Confidence 9999999887754 46799999999999999999999999999999999999995 47899999999987532 2233
Q ss_pred ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHH
Q 007498 311 LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVK 389 (601)
Q Consensus 311 ~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 389 (601)
....+||+.|+|||++. ..++.++|||||||++|||++|..||.+.+....+..+......++ +..+.++.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 228 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLV 228 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence 44568999999999986 4689999999999999999999999998887777777776554433 357899999999
Q ss_pred HcccccccCCCCH----HHHHcCcccCC
Q 007498 390 RLLNKDYRKRMTA----VQALTHPWLRD 413 (601)
Q Consensus 390 ~~L~~dP~~R~s~----~ell~hp~f~~ 413 (601)
+||+.||.+|+++ .++++|+||..
T Consensus 229 ~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 229 GLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred HHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 9999999999975 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=344.67 Aligned_cols=263 Identities=30% Similarity=0.507 Sum_probs=224.5
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec---
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--- 222 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--- 222 (601)
...|+...+||+|.||.||+|+.++ +++.||+|++-......... ....+|+++|..|. |+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n---~~kkvalkkvlmeneKeGfp-italreikiL~~lk-Henv~nliEic~tk~T 90 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKN---TGKKVALKKVLMENEKEGFP-ITALREIKILQLLK-HENVVNLIEICRTKAT 90 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcC---ccchhHHHHHHHhccccCCc-HHHHHHHHHHHHhc-chhHHHHHHHHhhccC
Confidence 3578889999999999999999987 78889999875433233322 34567999999997 9999999998753
Q ss_pred -----CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 223 -----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 223 -----~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
...+||||.+|+. +|...+.....+|+..+|+.++.+++.||.|+|++.|+|||+|++|+||+ .++.+||+
T Consensus 91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt---~dgilklA 166 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT---KDGILKLA 166 (376)
T ss_pred CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc---CCceEEee
Confidence 2459999999987 88888877777899999999999999999999999999999999999995 58999999
Q ss_pred ecccccccCCC-----CCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC
Q 007498 298 DFGLSDFIRPD-----ERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP 370 (601)
Q Consensus 298 DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 370 (601)
|||+++.+... ...+..+.|.+|++||.+. +.|+++.|||..|||+.||.++.+.|.+.++..++..|...+.
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 99999765422 2355678899999999876 4699999999999999999999999999999998888877666
Q ss_pred CCCCCCCCCC-------------------------------CHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 371 NFDDLPWPSV-------------------------------SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 371 ~~~~~~~~~~-------------------------------s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
.+....||++ ++++.||+.+||..||.+|+.++++|+|.||+.++.|
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 6666666543 3579999999999999999999999999999988776
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=374.72 Aligned_cols=255 Identities=35% Similarity=0.580 Sum_probs=232.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|.+.+.||+|.|+.|.++++.. ++..||||++++...... ....+.+|+++|+.|. |||||+++.+......+
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLN-HPNIVKLFSVIETEATL 130 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcccChH-HHHHHHHHHHHHHhcC-Ccceeeeeeeeeeccee
Confidence 469999999999999999999986 789999999999876554 4455899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+.+|.+++++.+. +++.+..++.++.|++.|++|||+++|+|||||.+||||+ .+.++||+|||++..+.
T Consensus 131 ylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~---~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD---ENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc---cccceeeeccccceeec
Confidence 9999999999999998766 6788899999999999999999999999999999999995 57889999999999999
Q ss_pred CCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
.+....++||++.|.|||++.+ .-++.+|+||+|++||-|++|.+||.+.+-.+....++.++...+. .++.++
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dc 282 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDC 282 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechh
Confidence 8888999999999999999985 3478999999999999999999999998887777777777766654 589999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.++|+++|.++|.+|++.++++.|.|....
T Consensus 283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred HHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 999999999999999999999999998643
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=395.76 Aligned_cols=266 Identities=30% Similarity=0.536 Sum_probs=219.3
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED- 222 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~- 222 (601)
.+..+|++++.||+|+||.||+|+++. ++..||+|++....... .....+.+|+.+|+.|. |||||+++++|..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~---tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de 84 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKR---TQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELK-HKNIVRYIDRFLNK 84 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECC---CCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcC-CCCcCeEEEEEEec
Confidence 344689999999999999999999876 77899999987654332 34567889999999996 9999999998854
Q ss_pred -CCcEEEEEeecCCCchHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHc-------CCeeccCCCCceEeecC---
Q 007498 223 -VNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQ-------GVVHRDLKPENFLFTSG--- 288 (601)
Q Consensus 223 -~~~~~lv~e~~~~g~L~~~~~~~---~~~l~~~~~~~i~~ql~~~L~~LH~~-------~iiHrDikp~NIll~~~--- 288 (601)
...+|||||||++|+|.++|... .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 45699999999999999988652 35799999999999999999999984 49999999999999641
Q ss_pred -----------CCCCCeEEeecccccccCCCCCccccccccccccchhcc---CCCCChhhHHHHHHHHHHHHhCCCCCC
Q 007498 289 -----------RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFW 354 (601)
Q Consensus 289 -----------~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~ 354 (601)
+....+||+|||++..+.........+||+.|+|||++. ..++.++||||||||||+|++|..||.
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 123458999999998765554455678999999999874 358999999999999999999999997
Q ss_pred CCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 355 ARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 355 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
.......+...+...+.+ +....+.++.+||.+||..+|.+||++.|+|.|+||+....+
T Consensus 245 ~~~~~~qli~~lk~~p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 245 KANNFSQLISELKRGPDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred cCCcHHHHHHHHhcCCCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 665544444444433332 234678999999999999999999999999999999865443
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=373.66 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=208.1
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+..+|++.+.||+|+||.||++++.. +++.||||++..... .......+.+|+.+++.++ ||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 93 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV---LGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQK 93 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC---CCceeEEEEeccccc-chhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCC
Confidence 34689999999999999999999876 788999999865432 2234567789999999996 999999999986543
Q ss_pred ------cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 225 ------NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 225 ------~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~---~~~~~kl~D 166 (359)
T cd07876 94 SLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 166 (359)
T ss_pred CccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEec
Confidence 57999999976 6666553 2589999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHc----------
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR---------- 367 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---------- 367 (601)
||++.............||..|+|||++. ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 167 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 167 FGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 99997665444455678999999999886 4689999999999999999999999987655433322221
Q ss_pred ------------cCCCCCCCC----------------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 368 ------------SDPNFDDLP----------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 368 ------------~~~~~~~~~----------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
..+.++... ....++++++||.+||..||++|||+.|+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 111111110 0124678999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=382.93 Aligned_cols=255 Identities=28% Similarity=0.380 Sum_probs=217.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|.+.+.||+|+||.||+|.... ..++.||+|.+... .......+.+|+.+|+.+. |||||+++++|...+.+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~--~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGS--DPKEKVVAKFVMLN---DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKL 140 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcC--CCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEE
Confidence 359999999999999999998765 12678999976433 2233456788999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 227 YIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
||||||++||+|.+++.. ....+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~~kL~DFgla~ 217 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC---CCCcEEEEeCcCce
Confidence 999999999999987754 245689999999999999999999999999999999999995 47899999999998
Q ss_pred ccCCCC---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 304 FIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 304 ~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
.+.... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+++..+........ ...
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~ 294 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCP 294 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---Ccc
Confidence 765332 234567999999999886 5689999999999999999999999988888777777766543211 136
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
++.++.+||.+||..||++||++.++|.|+|++.
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 8899999999999999999999999999999864
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=379.60 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=219.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC-
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN- 224 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~- 224 (601)
..+|++.+.||+|+||.||+|++.. +++.||||++...... ......+.+|+.++..+. |+||+++++.+....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDP 105 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcC---CCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCC-CCcEEEeecceecccc
Confidence 4589999999999999999999876 7889999999765433 334567889999999996 999999988775432
Q ss_pred -------cEEEEEeecCCCchHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCe
Q 007498 225 -------NVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294 (601)
Q Consensus 225 -------~~~lv~e~~~~g~L~~~~~~~---~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~v 294 (601)
.+++||||+++|+|.+++..+ ...+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~---~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC---SNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe---CCCCE
Confidence 378999999999999988653 34699999999999999999999999999999999999995 47899
Q ss_pred EEeecccccccCCC---CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC
Q 007498 295 RLIDFGLSDFIRPD---ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP 370 (601)
Q Consensus 295 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 370 (601)
||+|||+++.+... ......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+....+.+..+.....
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999999765432 2234568999999999986 4699999999999999999999999998887777777765543
Q ss_pred CCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
... .+.+++++.+||.+||..||.+||++.++++|||++..
T Consensus 263 ~~~---~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 263 DPL---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 211 14689999999999999999999999999999998753
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=364.46 Aligned_cols=252 Identities=27% Similarity=0.442 Sum_probs=195.5
Q ss_pred cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--CCcEEEE
Q 007498 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--VNNVYIV 229 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~lv 229 (601)
+++||+|+||.||+|+++.+. +++.||+|.+..... ...+.+|+.+++++. ||||+++++++.. +..+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~-~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCC-CCceEEEEEECCCCC-----cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEE
Confidence 468999999999999976422 567899999865432 245678999999996 9999999998854 4568999
Q ss_pred EeecCCCchHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC-CCCCCeEEeecc
Q 007498 230 MELCEGGELLDRILAR--------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG-RDDADMRLIDFG 300 (601)
Q Consensus 230 ~e~~~~g~L~~~~~~~--------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~-~~~~~vkl~DFG 300 (601)
|||+.+ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 999965 787776432 1258999999999999999999999999999999999999542 346789999999
Q ss_pred cccccCCCC----CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCh---------hHHHHHH
Q 007498 301 LSDFIRPDE----RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTE---------SGIFRAV 365 (601)
Q Consensus 301 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~---------~~~~~~i 365 (601)
+++.+.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|++||..... ...+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 998764322 2345688999999998753 589999999999999999999999965432 1222222
Q ss_pred HccCCCC-----------C-----------------------CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 366 LRSDPNF-----------D-----------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 366 ~~~~~~~-----------~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
....... + .......+.++.+||++||+.||.+|+|++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 2110000 0 00001235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=369.15 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=202.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++++.||+|+||.||+|++.. +++.||+|+..+. ....|+.++++++ |+||+++++++......
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPG---QPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAIT 132 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECC---CCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCee
Confidence 469999999999999999999876 6789999985432 2346999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+. ++|.+++......+++..+..|+.||+.||.|||++||+||||||+|||+. .++.+||+|||++....
T Consensus 133 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---DVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEecCccccccc
Confidence 99999995 589988877777899999999999999999999999999999999999995 47889999999997654
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh----------HHHHHHHccC----CC
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES----------GIFRAVLRSD----PN 371 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----------~~~~~i~~~~----~~ 371 (601)
.........||..|+|||++. ..++.++|||||||++|||+++..++...... ..+..++... ..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 444445678999999999876 56899999999999999999866555332111 1111111110 01
Q ss_pred CC--------------------------CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 372 FD--------------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 372 ~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
++ ......++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 11 0001245778899999999999999999999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=364.32 Aligned_cols=243 Identities=29% Similarity=0.445 Sum_probs=210.1
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.+++++.||+|.||.||++++.. ...||+|.++...+ ..+.+.+|+++|++|+ |+|||+|+++|...+.+|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~----~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG----STKVAVKTIKEGSM----SPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC----CCcccceEEecccc----ChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceE
Confidence 46778999999999999999863 44799999977544 3367889999999997 999999999999988999
Q ss_pred EEEeecCCCchHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~-~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
||||||+.|+|++++.. .+..+...+...++.||++|++||+++++|||||-..||||+ ++..+||+|||+|+.+.
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~---~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD---EDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec---cCceEEEcccccccccC
Confidence 99999999999999987 567799999999999999999999999999999999999995 58899999999999554
Q ss_pred CCCCccccc---cccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 307 PDERLNDIV---GSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 307 ~~~~~~~~~---gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
++. ..... -...|.|||.+. +.++.|||||||||+|+||+| |+.||.+.+..+.++.+.++-.-... ..++
T Consensus 355 d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P---~~CP 430 (468)
T KOG0197|consen 355 DDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP---EGCP 430 (468)
T ss_pred CCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---CCCC
Confidence 333 22222 245699999986 789999999999999999998 89999999999998888776543222 4799
Q ss_pred HHHHHHHHHcccccccCCCCHHHHH
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQAL 406 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell 406 (601)
+++.+++..||..+|++|||.+.+.
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999999999999998554
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=368.99 Aligned_cols=257 Identities=27% Similarity=0.462 Sum_probs=209.8
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-- 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-- 223 (601)
..+|++.+.||+|+||.||++++.. .++.||||++..... .......+.+|+.+++.+. ||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKS 97 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECC---CCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcC-CCCccccceeeccccc
Confidence 4689999999999999999999876 678999999875432 2234466789999999996 99999999987543
Q ss_pred ----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 224 ----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 224 ----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 98 ~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~Df 170 (364)
T cd07875 98 LEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDF 170 (364)
T ss_pred ccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC---CCCcEEEEeC
Confidence 358999999975 67776643 489999999999999999999999999999999999995 4789999999
Q ss_pred ccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC---------
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--------- 369 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------- 369 (601)
|+++............||..|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..++...
T Consensus 171 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 171 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred CCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9998765544455678999999999886 468999999999999999999999998877666555544311
Q ss_pred -------------CCCCCC----------------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 370 -------------PNFDDL----------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 370 -------------~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+.+... .....+.++++||.+||..||.+|||+.|+|+||||...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 111100 001235678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=358.62 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=213.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|.+.++||+|+||.||+++++. +++.||+|.+....... ....+.+|+.+++.|. ||||+++++++.....+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKL---TDNLVALKEIRLEHEEG--APCTAIREVSLLKDLK-HANIVTLHDIIHTEKSL 79 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcC---CCcEEEEEEEecccccC--chhHHHHHHHHHHhcC-CCCcceEEEEEecCCeE
Confidence 469999999999999999999875 77899999986543222 2345778999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+. ++|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKS 155 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC---CCCcEEECcCcchhccC
Confidence 99999997 489888877667799999999999999999999999999999999999995 47899999999987643
Q ss_pred CCC-CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC------------
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN------------ 371 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------ 371 (601)
... ......+++.|+|||++.+ .++.++|||||||++|+|++|++||...+..+.+..+......
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 222 2334567899999998753 5789999999999999999999999877665554443321110
Q ss_pred -------CCC-------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 372 -------FDD-------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 372 -------~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
++. ...+.+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 01135788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=363.87 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=211.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.++||+|+||.||++++.. ++..||+|++.... .......+.+|+++++.++ |+||++++++|..++.+
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 78 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKP---SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEI 78 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECC---CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEE
Confidence 579999999999999999999876 77899999986542 2234567899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
||||||+.+|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||++..+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc---CCCCEEEeeCCcchhh
Confidence 9999999999999987654 5699999999999999999999985 799999999999995 4788999999998765
Q ss_pred CCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH-------------------
Q 007498 306 RPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV------------------- 365 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i------------------- 365 (601)
... .....+||..|+|||++.+ .++.++|||||||++|+|++|+.||...........+
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 155 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 322 2344679999999998864 6899999999999999999999999765443322111
Q ss_pred -------------------------HccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 366 -------------------------LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 366 -------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
.... .+......++.++++||.+||++||++|||+.|++.||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEP--PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCC--CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0000 00111123678999999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=370.57 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=211.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC---
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN--- 224 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--- 224 (601)
+|++++.||+|+||.||++++.. +++.||||++.... ........+.+|+.+++.++ |+||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---CCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccc
Confidence 37889999999999999999865 78899999986532 22234567889999999996 999999999998776
Q ss_pred --cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 225 --NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 225 --~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
.+|+||||+. ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~a 150 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN---SNCVLKICDFGLA 150 (372)
T ss_pred cceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC---CCCCEEeccccce
Confidence 7999999996 478877654 46799999999999999999999999999999999999995 4789999999999
Q ss_pred cccCCCC--CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC---------
Q 007498 303 DFIRPDE--RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--------- 369 (601)
Q Consensus 303 ~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------- 369 (601)
....... ......+|..|+|||++.+ .++.++|||||||++|||++|+.||.+.+....+..+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 7654322 2334578999999998864 48999999999999999999999998877665555443211
Q ss_pred --------------CCCCC-----CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 370 --------------PNFDD-----LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 370 --------------~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
...+. ......++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00000 01134688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=367.56 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=208.2
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV- 223 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~- 223 (601)
+..+|++.+.||+|+||.||++++.. +++.||||++..... .......+.+|+.+++.++ ||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---CCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccc
Confidence 34589999999999999999999875 778999999865432 2234466788999999996 99999999988643
Q ss_pred -----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 224 -----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~---~~~~~kl~D 162 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 162 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC---CCCCEEEee
Confidence 357999999976 67666543 589999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHc----------
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR---------- 367 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---------- 367 (601)
||+++...........+||..|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..++.
T Consensus 163 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred CcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99998765554455678999999999886 4689999999999999999999999987665443332221
Q ss_pred ------------cCCCCCCC----------------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 368 ------------SDPNFDDL----------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 368 ------------~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
..+.+... .....+.++++||.+||..||++|||+.|+|+||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 11111000 011245788999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=353.77 Aligned_cols=254 Identities=40% Similarity=0.694 Sum_probs=210.3
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
|++++.||+|+||+||++++.. +++.||+|++........ ......+|+.+++++. ||||+++++++.+...+|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---NGQKVAVKIIDKSEIEEE-EREENIREIKILRRLR-HPNIVQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---TTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC---CCeEEEEEEecccccccc-ccchhhhhhhcccccc-ccccccccccccccccccc
Confidence 8899999999999999999986 778999999987654332 2334456999999995 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc-CC
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RP 307 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~-~~ 307 (601)
||||+.+++|.+++. ..+.+++..+..++.||+.||.|||++||+|+||||+||+++ .++.++|+|||.+... ..
T Consensus 76 v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~---~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD---ENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES---TTSEEEESSGTTTEESTST
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 999999999998887 335799999999999999999999999999999999999995 5889999999999764 23
Q ss_pred CCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 308 DERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 308 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
........++..|+|||++. ..++.++||||||+++|+|++|..||.... ....+..............+...+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE 231 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence 33455678999999999986 568999999999999999999999998763 2223333322111111111112348
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
++.++|.+||..||++||++.++++||||
T Consensus 232 ~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 232 ELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=368.94 Aligned_cols=256 Identities=22% Similarity=0.388 Sum_probs=206.7
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
...+|++++.||+|+||.||++.... ...++.||+|.+... ....+|+++|++|+ |||||++++++....
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~-~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHG-DEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWKS 159 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcC-CccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeCC
Confidence 34579999999999999999997643 225678999987543 23458999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|+|||++. ++|.+++ ...+.+++.++..|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 160 ~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~---~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLGDFGAACK 234 (392)
T ss_pred EEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEccCccccc
Confidence 9999999996 5888887 4446799999999999999999999999999999999999995 478999999999976
Q ss_pred cCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHccCC----CCC
Q 007498 305 IRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE---SGIFRAVLRSDP----NFD 373 (601)
Q Consensus 305 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~----~~~ 373 (601)
+..... ....+||..|+|||++. ..|+.++|||||||++|||++|+.||.+... ...+..+.+... .++
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 643322 23468999999999986 5689999999999999999999999976532 222222222100 000
Q ss_pred C--------------------CCC------CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 374 D--------------------LPW------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 374 ~--------------------~~~------~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
. ..+ ..++.++++||++||..||.+||++.|+|+||||+..+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 0 000 13567899999999999999999999999999998754
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=353.08 Aligned_cols=253 Identities=32% Similarity=0.620 Sum_probs=221.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||++.+.. +++.||+|++.+...........+.+|+++++++. ||||+++++++.+...+|
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 77 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLY 77 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEE
Confidence 69999999999999999999876 67899999997655444445677899999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||+|.|||++ .++.+||+|||++.....
T Consensus 78 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 78 LVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD---SDGYIKITDFGFAKRVKG 153 (290)
T ss_pred EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEeeCCCccccCC
Confidence 999999999999887655 6799999999999999999999999999999999999995 478899999999977654
Q ss_pred CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHH
Q 007498 308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386 (601)
Q Consensus 308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 386 (601)
. ....+|++.|+|||.+. ..++.++|||||||++|+|++|..||...........+......++. .++..+++
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~ 227 (290)
T cd05580 154 R--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKD 227 (290)
T ss_pred C--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----cCCHHHHH
Confidence 3 34567999999999875 56889999999999999999999999887766667777665544442 57899999
Q ss_pred HHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 387 FVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 387 li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
+|.+||..||.+|+ +++|+++||||+..
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 99999999999999 99999999999763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=366.12 Aligned_cols=259 Identities=29% Similarity=0.538 Sum_probs=209.5
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV- 223 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~- 223 (601)
+..+|++++.||+|+||.||+|++.. +++.||||++..... .......+.+|+.+++++. ||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 87 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTR---LRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECC---CCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccc
Confidence 34579999999999999999999876 778999999865432 2223456778999999996 99999999987543
Q ss_pred -----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 224 -----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..+|++||++ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~---~~~~~kl~D 161 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILD 161 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC---CCCCEEEcC
Confidence 4579999998 678877654 34799999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC-------
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD------- 369 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------- 369 (601)
||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+....
T Consensus 162 fg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 162 FGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred CccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999986543 2345689999999998764 58999999999999999999999998766544444332211
Q ss_pred ----------------CCCCCC----CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 370 ----------------PNFDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 370 ----------------~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+..+.. .+...++.+.+||.+||..||.+|||+.|+|+||||.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 011110 01246778999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=368.86 Aligned_cols=248 Identities=27% Similarity=0.481 Sum_probs=213.3
Q ss_pred eeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeec
Q 007498 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELC 233 (601)
Q Consensus 154 ~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 233 (601)
.||+|+||+||.++++. +...+|||-+.... ....+-+..||.+.++|+ |.|||+++|.+..++.+-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~---tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---TQVRIAIKEIPEKD---SREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeecccc---ceeEEEeeeccccc---chhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecC
Confidence 69999999999999987 77889999986543 224466889999999998 999999999999999999999999
Q ss_pred CCCchHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC-CC
Q 007498 234 EGGELLDRILARGGRY--TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ER 310 (601)
Q Consensus 234 ~~g~L~~~~~~~~~~l--~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~-~~ 310 (601)
+||+|.+.+...=|++ .+..+..|.+||++||.|||++.|||||||-+|||++. -.|.+||.|||.++++..- ..
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT--ySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT--YSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee--ccceEEecccccchhhccCCcc
Confidence 9999999988777788 88999999999999999999999999999999999975 5789999999999887543 34
Q ss_pred ccccccccccccchhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCC--hhHHHHH-HHccCCCCCCCCCCCCCHHH
Q 007498 311 LNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWART--ESGIFRA-VLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 311 ~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~--~~~~~~~-i~~~~~~~~~~~~~~~s~~~ 384 (601)
..++.||..|||||++. .+|+.++|||||||++.||.||++||..-. ...+++. +.+..+..+ ..+|.++
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP----eelsaea 808 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP----EELSAEA 808 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc----HHHHHHH
Confidence 56789999999999985 369999999999999999999999996432 2333322 122233333 3689999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+.||.+|+.+||..||+|.++|.+||++..
T Consensus 809 k~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 809 KNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999999999877
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=361.65 Aligned_cols=254 Identities=24% Similarity=0.405 Sum_probs=202.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeec--CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV- 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~- 223 (601)
++|+++++||+|+||.||+|++.. ...+++.||||++.... .......+.+|+.++..+.+||||++++++|...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 479999999999999999998632 11245789999986532 2223467889999999995599999999988764
Q ss_pred CcEEEEEeecCCCchHHHHHHcC---------------------------------------------------------
Q 007498 224 NNVYIVMELCEGGELLDRILARG--------------------------------------------------------- 246 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~--------------------------------------------------------- 246 (601)
..+|+|||||++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46899999999999998886431
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCC---ccccccccc
Q 007498 247 ----GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAY 319 (601)
Q Consensus 247 ----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~ 319 (601)
..+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+..... .....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~---~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---CCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 2478889999999999999999999999999999999995 478999999999976533221 123456778
Q ss_pred cccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHccccccc
Q 007498 320 YVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYR 397 (601)
Q Consensus 320 y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 397 (601)
|+|||++. ..++.++|||||||++|||++ |..||.+......+...+....... ....+++++.+||.+||..||.
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~ 319 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR--APENATPEIYRIMLACWQGDPK 319 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHccCChh
Confidence 99999875 568999999999999999997 9999987554433333333222111 1246789999999999999999
Q ss_pred CCCCHHHHHc
Q 007498 398 KRMTAVQALT 407 (601)
Q Consensus 398 ~R~s~~ell~ 407 (601)
+|||+.|+++
T Consensus 320 ~RPs~~el~~ 329 (338)
T cd05102 320 ERPTFSALVE 329 (338)
T ss_pred hCcCHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=350.84 Aligned_cols=259 Identities=32% Similarity=0.512 Sum_probs=219.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
+.|++.+.||.|+||.||++.+.. ++..||+|++... .....+.+.+|+++++++. |+||+++++++..+..+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKE---TGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKL 77 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcC---CCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeE
Confidence 469999999999999999999875 6789999998643 2334567889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++......+++..++.++.|++.||.|||++||+|+||||+||+++ .++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~---~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 78 WILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT---LDGDVKLADFGVSAKNK 154 (280)
T ss_pred EEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC---CCCCEEEccCccchhhc
Confidence 999999999999998877667799999999999999999999999999999999999995 47899999999986653
Q ss_pred CC-CCccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
.. .......|+..|+|||++. ..++.++|||||||++|+|++|+.||........+..+.......... ...
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 233 (280)
T cd06611 155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ-PSK 233 (280)
T ss_pred ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCC-ccc
Confidence 32 2234467899999999863 246789999999999999999999998776666665555443221111 135
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
++.++.+||.+||..||.+||++.++|+||||.+...
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (280)
T cd06611 234 WSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270 (280)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence 7899999999999999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=349.29 Aligned_cols=263 Identities=30% Similarity=0.474 Sum_probs=219.3
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+.|+++++||+|+||.||++++.. +++.||+|++... .....+.+.+|+.+++.+. |+||+++++.+..++.
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKE---TGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGK 83 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECC---CCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCe
Confidence 3579999999999999999999876 6789999998653 2334567889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+||||+++++|..++.+....+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT---LDGDIKLADFGVSAKN 160 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc---CCCCEEEccCccceec
Confidence 9999999999999888776666799999999999999999999999999999999999995 4788999999998654
Q ss_pred CCC-CCccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 306 RPD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 306 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
... .......++..|+|||++. ..++.++|||||||++|+|++|..||........+..+......... ...
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 239 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS-QPS 239 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCC-CCc
Confidence 322 2234567889999999873 24788999999999999999999999877665555555443321111 123
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
.++.++.+||.+||..||++||++.++++||||.......+
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchh
Confidence 67889999999999999999999999999999987554444
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=353.77 Aligned_cols=258 Identities=31% Similarity=0.554 Sum_probs=221.9
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+|.+.. +++.||||.+.+...........+.+|+++++.+. |+||+++++.+......|
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 77 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLC 77 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcC---CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEE
Confidence 69999999999999999999876 68899999998765544345677899999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+||||+.+++|.+++... ...+++..+..++.|++.||.|||++||+|+||||+||+++ .++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc---CCCCEEEeecchhhccc
Confidence 999999999999987653 35699999999999999999999999999999999999995 47899999999986543
Q ss_pred CCC------------------------------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 007498 307 PDE------------------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWA 355 (601)
Q Consensus 307 ~~~------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~ 355 (601)
... ......||..|+|||++. ..++.++|||||||++|+|++|..||.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 211 112347899999999876 4689999999999999999999999988
Q ss_pred CChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCC----HHHHHcCcccCCC
Q 007498 356 RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT----AVQALTHPWLRDD 414 (601)
Q Consensus 356 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~ell~hp~f~~~ 414 (601)
......+..+......++.. ..++.++.++|.+||..||++||+ ++++|+||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 235 SNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred CchHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 88777777776655544432 237999999999999999999999 9999999999875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=348.73 Aligned_cols=255 Identities=30% Similarity=0.437 Sum_probs=207.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+|++.. +++.||||++...... ......+.+|+.+++++. ||||+++++++.++..+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---CCcEEEEEEecccccc-CCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEE
Confidence 48899999999999999999875 6789999998654322 223456788999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 228 IVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~--~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+||||++ ++|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAF 151 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc---CCCcEEECcccceeec
Confidence 9999997 5888877543 25699999999999999999999999999999999999995 4789999999998765
Q ss_pred CCCCC-ccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC-----------
Q 007498 306 RPDER-LNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN----------- 371 (601)
Q Consensus 306 ~~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------- 371 (601)
..... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+......
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 152 GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred CCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 43222 233467899999998753 4789999999999999999999999876554333322211100
Q ss_pred --------------CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 372 --------------FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 372 --------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.....+..+++++.+||++||..||.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0001124578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=351.46 Aligned_cols=255 Identities=29% Similarity=0.505 Sum_probs=207.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+|+++. +++.||+|++....... .....+.+|+.+++++. |+||+++++++.+...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDE-GVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---CCcEEEEEEeecccccc-cCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceE
Confidence 48899999999999999999876 78899999987543222 23356778999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+|+||+++ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++.....
T Consensus 76 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 76 LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGI 151 (284)
T ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc---CCCcEEECccchhhccCC
Confidence 99999975 88888776667899999999999999999999999999999999999995 478999999999976543
Q ss_pred CC-CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHccC--------------
Q 007498 308 DE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSD-------------- 369 (601)
Q Consensus 308 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~-------------- 369 (601)
.. ......++..|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+.+..+....
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 32 2234567899999998754 478999999999999999999988644 33333333332211
Q ss_pred CC---CCC--------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 370 PN---FDD--------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 370 ~~---~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+. ++. ...+.+++++.+||.+||..||.+|||+++++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 000 0123578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=376.18 Aligned_cols=248 Identities=29% Similarity=0.475 Sum_probs=207.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeee-Eec---
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDA-CED--- 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~-~~~--- 222 (601)
.+++|.+.|.+|||+.||+|++.. .+..||+|++... +....+.+.+||++|++|.+|+|||.+++. ...
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~---~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVK---GGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecC---CCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 368899999999999999999986 4489999998554 455778899999999999999999999993 211
Q ss_pred ---CCcEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCceEeecCCCCCCeEE
Q 007498 223 ---VNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRL 296 (601)
Q Consensus 223 ---~~~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDikp~NIll~~~~~~~~vkl 296 (601)
.-.++|.||||.||.|.|++..+ ..+|++.+|.+|+.++++|+.+||... |||||||-+||||+ .++..||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KL 187 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKL 187 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEe
Confidence 13588999999999999999854 345999999999999999999999998 99999999999996 4889999
Q ss_pred eecccccccCCCC-Ccc---------ccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 007498 297 IDFGLSDFIRPDE-RLN---------DIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIF 362 (601)
Q Consensus 297 ~DFG~a~~~~~~~-~~~---------~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~ 362 (601)
||||.|.-..... ... ...-|+.|+|||++. ...+.|+|||+|||+||-|+....||......
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--- 264 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--- 264 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence 9999986432211 110 134689999999874 36899999999999999999999999765442
Q ss_pred HHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCc
Q 007498 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409 (601)
Q Consensus 363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp 409 (601)
.|+.+...|+.. +.++..+++||+.||+.||.+||++-+++.+-
T Consensus 265 -aIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 265 -AILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred -eEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 466777777654 68999999999999999999999999988753
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=341.82 Aligned_cols=254 Identities=27% Similarity=0.459 Sum_probs=212.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc--hhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT--AISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.|++.+.||+|+||.||.+.+.. +++.||+|.+....... ......+.+|+++++++. ||||+++++++.....
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 78 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVD---TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDET 78 (263)
T ss_pred cccccceecCCCceEEEEEEEcC---CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCe
Confidence 58999999999999999998875 67899999987543222 223457889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+||||+++++|.+.+... +.+++..+..++.|++.||.|||++||+||||+|+||+++ .++.++|+|||++...
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~---~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccceec
Confidence 99999999999999887654 5699999999999999999999999999999999999995 4788999999998765
Q ss_pred CCCCCc----cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 306 RPDERL----NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 306 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
...... ....|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+....... .. ...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~-~~~~ 232 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP-QL-PSHV 232 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC-CC-CccC
Confidence 432211 3356889999999886 458999999999999999999999997765554444443332221 11 1368
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+.++.+||++||..||.+||++.++++|+||
T Consensus 233 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 233 SPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 8999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=344.90 Aligned_cols=254 Identities=28% Similarity=0.518 Sum_probs=210.4
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-- 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-- 223 (601)
...|++.+.||+|+||.||++++.. +++.||+|++..... ....+.+|+.+++++.+|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcC---CCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 3579999999999999999999876 778999999865421 2356789999999996699999999998753
Q ss_pred ----CcEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 224 ----NNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 224 ----~~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..+|+||||+.+++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++ +++.+||+|
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~---~~~~~~l~D 154 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVD 154 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC---CCCCEEEcc
Confidence 4689999999999999988763 35689999999999999999999999999999999999995 478899999
Q ss_pred cccccccCCC-CCccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC
Q 007498 299 FGLSDFIRPD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 299 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
||++...... .......|+..|+|||++. ..++.++|||||||++|||++|..||...........+....
T Consensus 155 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~-- 232 (272)
T cd06637 155 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-- 232 (272)
T ss_pred CCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--
Confidence 9999765432 2334567999999999874 248889999999999999999999997655544443333221
Q ss_pred CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 372 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
........++.++.+||.+||..||.+|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 1222234678999999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=351.05 Aligned_cols=265 Identities=29% Similarity=0.475 Sum_probs=217.9
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc--chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
+|++.+.||+|+||.||++.+.. +++.||||.+...... .......+.+|++++++++ |+||+++++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCE
Confidence 48889999999999999999876 6789999999765433 1223355778999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+||||+ +++|.+++......+++..+..++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++...
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSF 152 (298)
T ss_pred EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc---CCCCEEEccceeeeec
Confidence 99999999 8899988765544799999999999999999999999999999999999995 4789999999999776
Q ss_pred CCCC-Cccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC--------
Q 007498 306 RPDE-RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD-------- 374 (601)
Q Consensus 306 ~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-------- 374 (601)
.... ......++..|+|||++. ..++.++|||||||++|+|++|.++|.+..+.+.+..+.........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 153 GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred cCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 5432 233446788999999875 35789999999999999999998888777665555554332110000
Q ss_pred ----------------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCCh
Q 007498 375 ----------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPL 420 (601)
Q Consensus 375 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 420 (601)
..+...+.++.+||.+||..||++|||+.|+|.|+||++.+.+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~ 294 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP 294 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence 0123457899999999999999999999999999999998877653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=347.91 Aligned_cols=256 Identities=31% Similarity=0.510 Sum_probs=214.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+|++.. +++.||+|++....... .....+.+|+.+++++. ||||+++++++.....+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEG-GIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---CCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeE
Confidence 48999999999999999999876 68899999987654322 23467889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+ +++|.+++......+++.+++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++.....
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSE 151 (286)
T ss_pred EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---CCCcEEEeeeeecccccC
Confidence 999999 9999998877667899999999999999999999999999999999999995 478899999999977654
Q ss_pred CC--Cccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC------------
Q 007498 308 DE--RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN------------ 371 (601)
Q Consensus 308 ~~--~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------ 371 (601)
.. ......|+..|+|||++. ..++.++|||||||++|+|++|.++|.+......+..+......
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 33 234467899999999875 34789999999999999999999888777665555554432110
Q ss_pred -------CCCC-------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 372 -------FDDL-------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 372 -------~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
++.. .++..+.++.+||.+||..||++||+++++|+||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 1235678999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=345.65 Aligned_cols=258 Identities=32% Similarity=0.516 Sum_probs=217.0
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++.+.||+|+||.||++++.. ++..+|+|.+.... ....+.+.+|+++++.+. |+||+++++++......|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~ 78 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLW 78 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECC---CCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEE
Confidence 47889999999999999999875 67889999985432 234567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++++|...+......+++..+..++.|++.||.|||+.||+||||||+|||++ .++.+||+|||++.....
T Consensus 79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTR 155 (282)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---cCCCEEEccccccccccc
Confidence 99999999999887776566799999999999999999999999999999999999995 478899999999876532
Q ss_pred C-CCccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 308 D-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 308 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
. .......|+..|+|||++. ..++.++|||||||++|+|++|+.||...+..+....+.......... ...+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 234 (282)
T cd06643 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQ-PSRW 234 (282)
T ss_pred cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCC-cccc
Confidence 2 2234467899999999873 247889999999999999999999998877666666655443221111 1357
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+.++.+||.+||..||.+||++.++++||||+....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 899999999999999999999999999999987644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=352.72 Aligned_cols=252 Identities=27% Similarity=0.463 Sum_probs=194.2
Q ss_pred cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe--cCCcEEEE
Q 007498 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE--DVNNVYIV 229 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--~~~~~~lv 229 (601)
+.+||+|+||.||+|+.+.+. ++..||+|.+..... ...+.+|+.+++++. ||||+++++++. .+..+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~-~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGTGI-----SMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCC-ccceEEEEEecCCCC-----cHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEE
Confidence 468999999999999875432 567899999865432 245778999999996 999999999885 35678999
Q ss_pred EeecCCCchHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC-CCCCCeEEeecc
Q 007498 230 MELCEGGELLDRILAR--------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG-RDDADMRLIDFG 300 (601)
Q Consensus 230 ~e~~~~g~L~~~~~~~--------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~-~~~~~vkl~DFG 300 (601)
|||+.+ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+..+ +.++.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 999965 777776421 2248899999999999999999999999999999999999532 346789999999
Q ss_pred cccccCCCC----CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChh---------HHHHHH
Q 007498 301 LSDFIRPDE----RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTES---------GIFRAV 365 (601)
Q Consensus 301 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~---------~~~~~i 365 (601)
+++...... .....+||..|+|||++.+ .++.++|||||||++|||++|++||....+. ..+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 998764332 2344678999999998753 5899999999999999999999999654321 111111
Q ss_pred HccC--------------CCCCC--------------------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 366 LRSD--------------PNFDD--------------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 366 ~~~~--------------~~~~~--------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.... +.+.. ......+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 1100 00000 0011245678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=349.91 Aligned_cols=264 Identities=25% Similarity=0.427 Sum_probs=215.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--C
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--N 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~ 224 (601)
.+|++.+.||+|+||.||++.++. +++.||+|++........ ....+.+|+.++++++ |+||+++++++... +
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDG-IPISSLREITLLLNLR-HPNIVELKEVVVGKHLD 81 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECC---CCcEEEEEEEEeccCCCC-CcchhhHHHHHHHhCC-CCCCcceEEEEecCCCC
Confidence 479999999999999999999876 788999999875432221 2234567999999996 99999999998755 5
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|+||||+.+ +|.+.+......+++.++..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++..
T Consensus 82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~kL~dfg~~~~ 157 (309)
T cd07845 82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLART 157 (309)
T ss_pred eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccceeee
Confidence 68999999975 78888776556799999999999999999999999999999999999995 478999999999987
Q ss_pred cCCCC-Cccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC----------
Q 007498 305 IRPDE-RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN---------- 371 (601)
Q Consensus 305 ~~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------- 371 (601)
..... ......++..|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 65432 223345688899999875 35899999999999999999999999888877776666542211
Q ss_pred ---------CCCCC-------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 372 ---------FDDLP-------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 372 ---------~~~~~-------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
..... ...+++++.+||.+||..||++|||+.|+|.||||++.+.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~ 301 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence 01000 1235889999999999999999999999999999997766543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=348.82 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=210.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||++++.. ++..||+|.+.... .......+.+|++++++++ ||||+++++++..++.+|
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 75 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRP---SGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEIS 75 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcC---CCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEE
Confidence 58999999999999999999876 67889999986432 2234567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+||||+++++|.+++... +.+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||++....
T Consensus 76 lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLI 151 (308)
T ss_pred EEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---cCCcEEEccCCCccccc
Confidence 999999999999987654 679999999999999999999998 5899999999999995 47889999999987653
Q ss_pred CCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC--------------
Q 007498 307 PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN-------------- 371 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------------- 371 (601)
.. .....+|+..|+|||++.+ .++.++|||||||++|+|++|+.||...........+......
T Consensus 152 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 152 DS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred cc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 32 2345688999999998764 5889999999999999999999999755433322211110000
Q ss_pred --------------------CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 372 --------------------FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 372 --------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
.+..+...++.++++||.+||..||++||++.++++||||....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 01111224688999999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.85 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=219.0
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++.+.||+|+||.||++++.. +++.||+|.+.+...........+.+|+.+++.+. ||||+++++.+..++.+|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 77 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKE---TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLC 77 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECC---CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEE
Confidence 58999999999999999999876 77899999987654433344567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||++|++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+|||+++....
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~---~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 78 MVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC---CCCCEEEeeCCCccccCc
Confidence 999999999999887654 5799999999999999999999999999999999999995 478999999999864211
Q ss_pred CC----------------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC
Q 007498 308 DE----------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP 370 (601)
Q Consensus 308 ~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 370 (601)
.. ......|+..|+|||.+. ..++.++|+|||||++|||++|..||.+....+.+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~ 233 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 233 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence 00 011246788999999875 5789999999999999999999999998877777777766554
Q ss_pred CCCCCCCCCCCHHHHHHHHHcccccccCCCC---HHHHHcCcccCCC
Q 007498 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT---AVQALTHPWLRDD 414 (601)
Q Consensus 371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~ell~hp~f~~~ 414 (601)
..+... ..++.++.++|.+||..||++||+ +.++|+||||...
T Consensus 234 ~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 234 EWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred CCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 444332 268899999999999999999998 7999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=341.71 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=208.1
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||++++.. +++.||+|++.... .......+.+|+++++++. ||||+++++++...+..+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 75 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLL---TRRILAVKVIPLDI--TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRIS 75 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcC---CCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEE
Confidence 57888999999999999999876 77899999986542 2223467889999999995 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++++|... ..+++..+..++.|++.||.|||++||+|+||||+|||++ .++.+||+|||++..+..
T Consensus 76 lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~---~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 76 ICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN---TRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC---CCCCEEEeeCCcceeccc
Confidence 99999999988543 3589999999999999999999999999999999999995 488999999999976543
Q ss_pred CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-------hHHHHHHHccCCCCCCCCCCC
Q 007498 308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE-------SGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~ 379 (601)
. .....+||..|+|||++. ..++.++|||||||++|+|++|+.||..... ......+.... ....+...
T Consensus 148 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 224 (279)
T cd06619 148 S-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQ 224 (279)
T ss_pred c-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCc
Confidence 2 334568999999999876 5689999999999999999999999964321 12222222221 12222345
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
+++++.+||.+||..||.+||+++|++.||||+...
T Consensus 225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 225 FSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred CCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 789999999999999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.61 Aligned_cols=257 Identities=29% Similarity=0.533 Sum_probs=218.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||.|+||.||++++.. +++.||+|++..... ......+.+|+++++.+. |+||+++++++.++..+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLW 75 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECC---CCeEEEEEEeecccc--chHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEE
Confidence 68899999999999999999875 788999999865431 223466889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+|+||+++++|.+++... .+++..+..++.|++.||.|||+++|+||||+|+||+++ .++.++|+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEcccccceeecc
Confidence 999999999999987653 799999999999999999999999999999999999995 488999999999987654
Q ss_pred C-CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 308 D-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 308 ~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
. .......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+...... ......++.++.
T Consensus 151 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 228 (274)
T cd06609 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--SLEGNKFSKPFK 228 (274)
T ss_pred cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC--CCcccccCHHHH
Confidence 3 2334567899999999876 46899999999999999999999999876655555444443221 111123789999
Q ss_pred HHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
++|.+||..||++||+++++++||||+.....
T Consensus 229 ~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 229 DFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=336.99 Aligned_cols=253 Identities=23% Similarity=0.489 Sum_probs=212.9
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-CCcE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-VNNV 226 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~~~ 226 (601)
.|++.+.||+|+||.||++.++. +++.||+|.+...... ....+.+.+|++++++++ |+||+++++.+.. ...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---DGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---CCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEE
Confidence 38999999999999999999876 6789999998654332 224566889999999996 9999999998764 4568
Q ss_pred EEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+++++|.+++... ...+++.+++.++.|++.||.|||++||+||||||+||+++ .++.++|+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~---~~~~~~l~df~~~~~~ 152 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVL 152 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe---cCCcEEEecccceEEe
Confidence 9999999999999888763 44689999999999999999999999999999999999995 4789999999999766
Q ss_pred CCCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.... ......|++.|+|||++. ..++.++|||||||++|+|++|+.||...........+...... .. ...++++
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~ 229 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP--PM-PKDYSPE 229 (257)
T ss_pred cccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CC-ccccCHH
Confidence 4322 234467899999999876 56889999999999999999999999877766655555544321 11 1468899
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+.+||.+||..||.+||++.+++.||||
T Consensus 230 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 230 LGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=353.51 Aligned_cols=256 Identities=22% Similarity=0.292 Sum_probs=204.3
Q ss_pred EcceeccC--CCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 151 LGKEVGRG--HFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 151 ~~~~lG~G--~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
++++||+| +||+||+++++. +++.||+|++...... ......+.+|+.+++.+. ||||++++++|..++.+|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---TGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecc---cCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEE
Confidence 56789999 678999999886 8899999998765332 224567888999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 229 VMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+++|+||||||+|||++ .++.++++|||.+.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhcccc
Confidence 99999999999988653 34599999999999999999999999999999999999995 478899999987543321
Q ss_pred CCC--------ccccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCC-C--
Q 007498 308 DER--------LNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF-D-- 373 (601)
Q Consensus 308 ~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~-- 373 (601)
... .....++..|+|||++.+ .|+.++|||||||++|||++|+.||................... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence 110 122357788999999853 58999999999999999999999997655444333322211100 0
Q ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 374 ---------------------------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 374 ---------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
......+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00011357889999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=340.23 Aligned_cols=255 Identities=28% Similarity=0.483 Sum_probs=216.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++++.||.|+||.||++.... ++..||+|++....... ....+.+|+.+++.+. |+||+++++.+.....+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELW 75 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcC---CCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEE
Confidence 69999999999999999999765 67899999987544332 4577899999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 228 IVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~--~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+||||+++++|.+.+... ...+++..+..++.|++.||.|||++||+||||||+||+++ +++.+||+|||++..+
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~---~~~~~~l~df~~~~~~ 152 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASL 152 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccchHHHh
Confidence 999999999999988654 24689999999999999999999999999999999999995 4788999999998766
Q ss_pred CCCCCc-----cccccccccccchhcc-C-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCC--C
Q 007498 306 RPDERL-----NDIVGSAYYVAPEVLH-R-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL--P 376 (601)
Q Consensus 306 ~~~~~~-----~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--~ 376 (601)
...... ...+|+..|+|||++. . .++.++|+|||||++|+|++|+.||........+..+.......... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD 232 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccc
Confidence 543222 3457899999999876 3 58999999999999999999999998776666555555543321111 1
Q ss_pred CCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+..+++++.+||.+||..||++||++.+++.||||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 24678999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=357.39 Aligned_cols=257 Identities=26% Similarity=0.487 Sum_probs=233.1
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.++++..||-||||.|-+++.+. ....+|+|++++..+.+....+.+..|-.||..++ .|.||+||..|.+.+.+|
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~---~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNS---QKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred hhhhhhhcccCccceEEEEEecc---cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhh
Confidence 45677789999999999998765 33359999999988887778889999999999997 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
|.||-|-||.|+..+..+ +.|++..++.|+..+++|++|||++|||+|||||+|++|+ .+|.+||.|||+|+.+..
T Consensus 497 mLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd---~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD---NRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec---cCCceEEeehhhHHHhcc
Confidence 999999999999877655 7899999999999999999999999999999999999994 599999999999999999
Q ss_pred CCCccccccccccccchh-ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHH
Q 007498 308 DERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386 (601)
Q Consensus 308 ~~~~~~~~gt~~y~aPE~-~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 386 (601)
+.+..++|||+.|.|||+ +++..+.++|.||||+++|||++|.+||.+.+....+..|+++...+.-. ..++..+.+
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~ 650 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATD 650 (732)
T ss_pred CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHH
Confidence 999999999999999997 56889999999999999999999999999999999999999876543321 368999999
Q ss_pred HHHHcccccccCCCC-----HHHHHcCcccCCC
Q 007498 387 FVKRLLNKDYRKRMT-----AVQALTHPWLRDD 414 (601)
Q Consensus 387 li~~~L~~dP~~R~s-----~~ell~hp~f~~~ 414 (601)
||+++...+|.+|.. +.|+..|-||...
T Consensus 651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 999999999999996 7899999999653
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=342.43 Aligned_cols=253 Identities=28% Similarity=0.468 Sum_probs=209.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||+|++.. +++.||+|+++... ......+.+|+.+++.+. ||||+++++.+...+.+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVN---TGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcC---CCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEE
Confidence 479999999999999999999876 77899999986542 223456788999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++... +.+++.++..++.|++.||.|||++||+|+||||+||+++ .++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQIT 157 (267)
T ss_pred EEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECcceeeeEcc
Confidence 9999999999999987554 5799999999999999999999999999999999999995 47889999999987654
Q ss_pred CCC-Cccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCC-CCCCC
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL-PWPSV 380 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~ 380 (601)
... ......|+..|+|||++. +.++.++|||||||++|+|++|..||...................+.. ....+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06645 158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237 (267)
T ss_pred CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence 322 234457999999999863 458899999999999999999999997655443333332222221111 11246
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCcc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~ 410 (601)
+..+.+||.+||..||++||+++++++|||
T Consensus 238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=343.77 Aligned_cols=253 Identities=29% Similarity=0.458 Sum_probs=208.3
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--CcE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--NNV 226 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~ 226 (601)
|++.++||+|+||.||++.+.. +++.||+|++++..... ......+|+.++.++.+|+||+++++++.+. +.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---TGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcC---CCcEEEEEEehhccCCc--hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 6788999999999999999875 77899999986543221 1223457999999997799999999999987 899
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+.+ +|++.+......+++..+..++.|++.||.|||++||+||||||+||+++ . +.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 76 ALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIY 150 (282)
T ss_pred EEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccc
Confidence 999999974 88888876656799999999999999999999999999999999999995 3 899999999998775
Q ss_pred CCCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC--------------
Q 007498 307 PDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-------------- 370 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------- 370 (601)
.........++..|+|||++. +.++.++|||||||++|||++|..||.+.+..+.+..+.....
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred cCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 554445567899999999764 4578999999999999999999999987766554444432110
Q ss_pred ----CCCCCC-------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 371 ----NFDDLP-------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 371 ----~~~~~~-------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.++... .+.++.++.+||.+||.+||++||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 011000 12568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=336.43 Aligned_cols=253 Identities=26% Similarity=0.499 Sum_probs=217.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|.+.+.||+|+||.||++.++. +++.|++|.+...... ......+.+|+++++.++ ||||+++++++...+.+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---CCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEE
Confidence 37888999999999999999876 7889999998764433 335677899999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+||||+++++|.+++... ...+++..+..++.|++.||.|||++||+|+||||+||+++ .++.+||+|||++..+.
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceecc
Confidence 999999999999988764 46799999999999999999999999999999999999996 47899999999988765
Q ss_pred CCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
.... .....|+..|+|||++. +.++.++|+|||||++|+|++|+.||...........+...... ... ..++.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~ 229 (256)
T cd08529 153 DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP--PVS-QMYSQQL 229 (256)
T ss_pred CccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCc-cccCHHH
Confidence 4332 33457899999999876 56899999999999999999999999888776666666654322 111 2578999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCccc
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.++|.+||+.+|++||++.+++.|||+
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 230 AQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=344.87 Aligned_cols=261 Identities=29% Similarity=0.481 Sum_probs=217.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||.|+||.||++.+.. +++.||||.+..... ...+.+.+|+.+++.++ ||||+++++++.....+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQKQ---PKKELIINEILVMKELK-NPNIVNFLDSFLVGDEL 91 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC---CCcEEEEEEEecccC---chHHHHHHHHHHHHhcC-CCceeeeeeeEecCceE
Confidence 469999999999999999998865 788999999865432 23467889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 92 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~---~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG---MDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccchhcc
Confidence 999999999999987754 3699999999999999999999999999999999999995 47899999999987654
Q ss_pred CCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
.... .....|+..|+|||.+. +.++.++|||||||++|+|++|..||...........+........ .....+++.+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 245 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSPIF 245 (296)
T ss_pred cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCccc-CCcccCCHHH
Confidence 3322 23457899999999876 4689999999999999999999999987766554444433221111 1224688999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCCCCCCCh
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPL 420 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 420 (601)
.+||++||..||.+||++.+++.||||+....-..+
T Consensus 246 ~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~ 281 (296)
T cd06655 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSL 281 (296)
T ss_pred HHHHHHHhhcChhhCCCHHHHhhChHhhhccccccC
Confidence 999999999999999999999999999876543333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=356.65 Aligned_cols=236 Identities=27% Similarity=0.403 Sum_probs=201.6
Q ss_pred cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEe
Q 007498 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 231 (601)
++-||.|+.|.||+++. .++.||||+++.- -..+|+.|++|+ ||||+.|.++|.....+|||||
T Consensus 129 LeWlGSGaQGAVF~Grl-----~netVAVKKV~el----------kETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-----HNETVAVKKVREL----------KETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeeec-----cCceehhHHHhhh----------hhhhHHHHHhcc-CcceeeEeeeecCCceeEEeee
Confidence 45699999999999987 4578999976432 135899999997 9999999999999999999999
Q ss_pred ecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCc
Q 007498 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL 311 (601)
Q Consensus 232 ~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~ 311 (601)
||..|.|...+.. +..+.......|..+|+.|++|||.+.|||||||.-||||+. +..|||+|||.++........
T Consensus 193 fCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~---~d~VKIsDFGTS~e~~~~STk 268 (904)
T KOG4721|consen 193 FCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY---DDVVKISDFGTSKELSDKSTK 268 (904)
T ss_pred ccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec---cceEEeccccchHhhhhhhhh
Confidence 9999999998755 467999999999999999999999999999999999999976 678999999999888766667
Q ss_pred cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHH
Q 007498 312 NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 390 (601)
-.++||..|||||++. .+++.|+|||||||||||||||..||.......++--+-.+...++. ...++..++-||+.
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv--PstcP~GfklL~Kq 346 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV--PSTCPDGFKLLLKQ 346 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC--cccCchHHHHHHHH
Confidence 7799999999999987 57899999999999999999999999766655443322222222222 13577889999999
Q ss_pred cccccccCCCCHHHHHcCc
Q 007498 391 LLNKDYRKRMTAVQALTHP 409 (601)
Q Consensus 391 ~L~~dP~~R~s~~ell~hp 409 (601)
||.-.|..||++.++|.|-
T Consensus 347 cw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 347 CWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHhcCCCCCccHHHHHHHH
Confidence 9999999999999999983
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.87 Aligned_cols=254 Identities=28% Similarity=0.471 Sum_probs=217.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+|.+.. +++.||||.+....... .....+.+|+.+++.++ ||||+++++.+..++.++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---DQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---CCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEE
Confidence 58999999999999999999876 78899999997654433 24577899999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+||||+++++|.+++... ...+++..+..++.|++.||.|||++||+|+||||+||+++. .++.+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK--HKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEccCCCceecC
Confidence 999999999999998764 345899999999999999999999999999999999999963 35568999999998776
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.........|+..|+|||++. ..++.++|||||||++|+|++|..||...+.......+...... .. ...++.++.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~l~ 230 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA--PI-SDRYSPDLR 230 (256)
T ss_pred CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC--CC-CCCcCHHHH
Confidence 555455567899999999886 45789999999999999999999999877666666555543322 11 135789999
Q ss_pred HHHHHcccccccCCCCHHHHHcCccc
Q 007498 386 DFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
++|.+||..||.+|||+.|+++||||
T Consensus 231 ~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 231 QLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=341.57 Aligned_cols=252 Identities=31% Similarity=0.594 Sum_probs=216.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++.+.||.|+||.||+|++.. +++.||+|++.+.........+.+.+|+++++++. ||||+++++++.....+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEE
Confidence 48999999999999999999875 68899999998765544445678999999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+.|++|.+++... ..+++..+..++.||+.||.|||+++|+|+||+|+||+++ +++.++|+|||++.....
T Consensus 77 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD---EQGHVHITDFNIATKVTP 152 (258)
T ss_pred EEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc---CCCCEEEeecccccccCC
Confidence 999999999999887655 6799999999999999999999999999999999999995 478999999999987665
Q ss_pred CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHc-cCCCCCCCCCCCCCHH
Q 007498 308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLR-SDPNFDDLPWPSVSPE 383 (601)
Q Consensus 308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~-~~~~~~~~~~~~~s~~ 383 (601)
........|+..|+|||++. ..++.++|+|||||++|+|++|..||..... ...+..... ....++ ..++.+
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 228 (258)
T cd05578 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP----ATWSTE 228 (258)
T ss_pred CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc----ccCcHH
Confidence 54455677899999999876 4579999999999999999999999987663 222222222 222222 367899
Q ss_pred HHHHHHHcccccccCCCCH--HHHHcCccc
Q 007498 384 AKDFVKRLLNKDYRKRMTA--VQALTHPWL 411 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~--~ell~hp~f 411 (601)
+.++|.+||..||.+|+++ .|+++||||
T Consensus 229 ~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 229 AIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 9999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=343.12 Aligned_cols=253 Identities=30% Similarity=0.485 Sum_probs=208.2
Q ss_pred eccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeecC
Q 007498 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234 (601)
Q Consensus 155 lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 234 (601)
||+|+||.||+|.+.. +++.||+|++.+...........+.+|+++++.++ ||||+++++.+...+.+|+||||++
T Consensus 1 lg~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcC---CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCC
Confidence 6999999999998875 78899999997654443334556778999999996 9999999999999999999999999
Q ss_pred CCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCccc
Q 007498 235 GGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313 (601)
Q Consensus 235 ~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 313 (601)
+++|.+++.... ..+++.++..++.|++.||.|||++||+||||+|+||+++ .++.+||+|||++...........
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD---DHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEccCcchhhhccCCcccc
Confidence 999998887643 3699999999999999999999999999999999999995 478999999999977654444445
Q ss_pred cccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcc
Q 007498 314 IVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392 (601)
Q Consensus 314 ~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 392 (601)
..++..|+|||++. +.++.++|||||||++|+|++|+.||...........+..............+++++.++|.+||
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence 67888999999875 46899999999999999999999999765432112222221111111122457999999999999
Q ss_pred cccccCCC-----CHHHHHcCcccCCC
Q 007498 393 NKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 393 ~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
..||.+|| ++.++++||||++.
T Consensus 234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 234 QKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred cCChhHccCCCcccHHHHHhChhhhcC
Confidence 99999999 89999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=355.44 Aligned_cols=258 Identities=29% Similarity=0.495 Sum_probs=221.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
-|..++.||-|+||+|++|+... +...||+|.+++..+...+.+..+..|..||..- +.+-||+||..|.+++.+|
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvD---T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVD---TRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ceEEEeeecccccceeEEEeecc---hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceE
Confidence 47788999999999999998776 6789999999998888888888999999999998 5999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc--
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-- 305 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~-- 305 (601)
+||+|++||++..+|.+. +-|.|..++.|+.+|..|+++.|..|+|||||||+|||| |.+|+|||+||||+.-+
T Consensus 706 FVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeecccccccee
Confidence 999999999999988765 689999999999999999999999999999999999999 46999999999998421
Q ss_pred -------CCCC----------------------------------Cccccccccccccchhcc-CCCCChhhHHHHHHHH
Q 007498 306 -------RPDE----------------------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVIS 343 (601)
Q Consensus 306 -------~~~~----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il 343 (601)
..+. .....+||+.|+|||++. ..|+..+|+||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 1100 012368999999999876 5799999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCC---HHHHHcCcccCCC
Q 007498 344 YILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT---AVQALTHPWLRDD 414 (601)
Q Consensus 344 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~ell~hp~f~~~ 414 (601)
|||+.|+.||...+..+....+++....+....-.++|+++.+||.++.. +++.|.. ++|+..||||+..
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence 99999999999888777666665554443333345799999999999764 6788874 6789999999874
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=338.52 Aligned_cols=254 Identities=30% Similarity=0.480 Sum_probs=210.4
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc---chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT---TAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+|++++.||+|+||.||++... +++.+|+|.+...... .......+.+|++++++++ |+||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCC
Confidence 4888999999999999999763 5778999998654221 1223466889999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|+||||+++++|.+++.+. +.+++..+..++.|++.||.|||+.+|+|+||+|+||+++ .++.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~ 151 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARR 151 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC---CCCeEEeccchhhHh
Confidence 999999999999999887654 5789999999999999999999999999999999999995 478999999999875
Q ss_pred cCCC-------CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC
Q 007498 305 IRPD-------ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376 (601)
Q Consensus 305 ~~~~-------~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 376 (601)
.... .......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+.......+..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP 231 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCC
Confidence 4211 1123457899999999986 4688999999999999999999999987655444444433322222222
Q ss_pred CCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
..++.++.+||++||..+|.+||++.++|+||||
T Consensus 232 -~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 232 -DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -CCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 4688999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=342.81 Aligned_cols=255 Identities=28% Similarity=0.496 Sum_probs=209.1
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+++++. +++.||+|++....... ...+.+.+|+.+++++. |+||+++++++.....+|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~ 76 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRE---TGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLH 76 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECC---CCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEE
Confidence 69999999999999999999875 68899999986543221 23356789999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||++++.|..++ .....+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++.....
T Consensus 77 ~v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 77 LVFEYCDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTG 152 (286)
T ss_pred EEEeccCccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc---CCCcEEECccccceecCC
Confidence 999999987666544 4445799999999999999999999999999999999999995 478899999999987654
Q ss_pred CC-CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC--------------
Q 007498 308 DE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-------------- 370 (601)
Q Consensus 308 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------- 370 (601)
.. ......++..|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 43 2344568899999998753 578999999999999999999999987665544433321100
Q ss_pred -----CCCC--------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 371 -----NFDD--------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 371 -----~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
..+. ..++.++..+.+||.+||..||++||++.|++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 0124578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=342.15 Aligned_cols=256 Identities=26% Similarity=0.466 Sum_probs=214.1
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++.+.||+|+||.||++++.. +++.||+|.+...... ..+.+.+|+.+++.+. |+||+++++.+.....
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGDE 91 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECC---CCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCE
Confidence 3589999999999999999999765 7789999998764432 3466889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.|+||||+++++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 92 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~---~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQI 166 (296)
T ss_pred EEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEECccccchhc
Confidence 9999999999999998754 4689999999999999999999999999999999999995 4789999999998765
Q ss_pred CCCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
..... .....|++.|+|||++. ..++.++|||||||++|+|++|+.||...........+...... .......++..
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 245 (296)
T cd06654 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAI 245 (296)
T ss_pred cccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC-CCCCccccCHH
Confidence 43322 23457899999999876 45889999999999999999999999876654443333322211 11112358899
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+.+||.+||..||.+||++.++++||||...
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=344.10 Aligned_cols=260 Identities=26% Similarity=0.454 Sum_probs=215.1
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
...+|.+++.||+|+||.||++.+.. +++.||+|.+...... ..+.+.+|+.+++.+. |+||+++++++...+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~ 89 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIA---TGQEVAIKQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGD 89 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECC---CCCEEEEEEEecCccc---hHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 34689999999999999999999865 7889999998654322 3466889999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|+||||+++++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+|||++ .++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~---~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQ 164 (297)
T ss_pred EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEECcCccceE
Confidence 99999999999999998754 4689999999999999999999999999999999999995 478999999999876
Q ss_pred cCCCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 305 IRPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 305 ~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
...... .....|++.|+|||.+. ..++.++|+|||||++|+|++|..||...........+...... .......++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 243 (297)
T cd06656 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPERLSA 243 (297)
T ss_pred ccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC-CCCCccccCH
Confidence 543322 23457899999999876 46889999999999999999999999776543332222221111 1111235788
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
.+.+||.+||..||.+||++.++++||||+.....
T Consensus 244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 99999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=344.41 Aligned_cols=258 Identities=29% Similarity=0.437 Sum_probs=209.0
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc--
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN-- 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-- 225 (601)
+|++.+.||+|+||.||++++.. +++.||||++...... ......+.+|+.+++.+.+|+||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKN---TGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CceEeeEecccCCeEEEEEEECC---CCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 69999999999999999999876 7889999998654322 22335678899999999767999999999887665
Q ss_pred ---EEEEEeecCCCchHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 226 ---VYIVMELCEGGELLDRILAR----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 226 ---~~lv~e~~~~g~L~~~~~~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++. .++.+||+|
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~--~~~~~kl~d 154 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK--QKGLLKIAD 154 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec--CCCeEEEee
Confidence 8999999986 788877653 235899999999999999999999999999999999999953 378899999
Q ss_pred cccccccCCC-CCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCC--
Q 007498 299 FGLSDFIRPD-ERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD-- 373 (601)
Q Consensus 299 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-- 373 (601)
||++..+... .......+++.|+|||++. ..++.++|||||||++|+|++|..||.+.+....+..+........
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9998765332 2223346788999999875 3579999999999999999999999988766555544433111000
Q ss_pred ----------------------CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 374 ----------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 374 ----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
....+.++.++.+||.+||..||.+||++.|+|.||||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 001245789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.92 Aligned_cols=252 Identities=29% Similarity=0.519 Sum_probs=213.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
+.|++.+.||+|+||.||+++++. +++.||+|.+.... ..+.+.+|+++++++. |+||+++++++.....+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---TGQVVAIKVVPVEE-----DLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---CCcEEEEEEeecHH-----HHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcE
Confidence 469999999999999999999875 57899999986542 1578899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|+||+.+++|.+++......+++..+..++.|++.||.|||+++|+||||+|+||+++ .++.+||+|||++....
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~---~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---EEGQAKLADFGVSGQLT 150 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC---CCCcEEEcccccchhcc
Confidence 999999999999998876667899999999999999999999999999999999999995 47889999999998765
Q ss_pred CCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+......... ....++.++
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 229 (256)
T cd06612 151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS-DPEKWSPEF 229 (256)
T ss_pred cCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCC-chhhcCHHH
Confidence 443 233456889999999876 46899999999999999999999999766554443333222111111 113577899
Q ss_pred HHHHHHcccccccCCCCHHHHHcCccc
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.+||.+||..||.+||++.|+|.||||
T Consensus 230 ~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 230 NDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=344.72 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=212.1
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++++.||+|+||.||++++.. +++.||+|.+.... .......+.+|+.+++++. |+||+++++++...+.+|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRP---TGVTMAMKEIRLEL--DESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVY 75 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcC---CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEE
Confidence 68999999999999999999875 67899999886532 2234567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 228 IVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~--~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+||||+++++|..++... ...+++..+..++.||+.||.|||+ .+|+||||||+||+++ .++.+||+|||++..
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~ 152 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGN 152 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCccc
Confidence 999999999998876553 2379999999999999999999997 5999999999999995 478899999999876
Q ss_pred cCCCCCccccccccccccchhccC-------CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCC
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLHR-------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 377 (601)
+... ......|+..|+|||++.+ .++.++|||||||++|+|++|..||...........+............
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd06622 153 LVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLP 231 (286)
T ss_pred ccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC
Confidence 5322 2344578899999998742 3588999999999999999999999765544433332221111111112
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
+.++.++.+||.+||..+|.+||++.++++||||......
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 3589999999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.80 Aligned_cols=252 Identities=29% Similarity=0.481 Sum_probs=210.4
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+|.+.. +++.||||++.+...........+..|..++....+|+||+++++++..++.+|+||||
T Consensus 2 ~~l~~g~~~~v~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecC---CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 579999999999999875 67899999987654333333344566766665554699999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCcc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~ 312 (601)
+++++|.+++... +.+++..+..++.||+.||.|||+++|+||||+|+||+++ .++.+||+|||++..... ..
T Consensus 79 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~---~~ 151 (260)
T cd05611 79 LNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRNGLE---NK 151 (260)
T ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEeecccceeccc---cc
Confidence 9999999877554 5799999999999999999999999999999999999995 478899999999875432 23
Q ss_pred ccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHc
Q 007498 313 DIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391 (601)
Q Consensus 313 ~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 391 (601)
...|+..|+|||.+.+ .++.++|||||||++|+|++|..||........+..+......++......+++++.++|.+|
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 4568899999998764 579999999999999999999999988877777777666555444433346899999999999
Q ss_pred ccccccCCCC---HHHHHcCcccCCC
Q 007498 392 LNKDYRKRMT---AVQALTHPWLRDD 414 (601)
Q Consensus 392 L~~dP~~R~s---~~ell~hp~f~~~ 414 (601)
|..||++||+ ++|+|+||||++.
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcC
Confidence 9999999994 5899999999763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=340.15 Aligned_cols=270 Identities=26% Similarity=0.463 Sum_probs=221.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|+..++||.|+||.||++.+.. ++..||||++..... ......+.+|+.+++++. |+||+++++++.++..+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---CCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEE
Confidence 358889999999999999999875 678999999875432 234567899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||++|++|.+++.. +.+++.++..++.|++.||.|||+++++|+||+|+||+++ .++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEcccccceecc
Confidence 999999999999998753 4699999999999999999999999999999999999995 47889999999997664
Q ss_pred CCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
... ......++..|+|||++. ..++.++|+|||||++|||++|..||...........+...... .....++..+
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 229 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP---TLTGEFSKPF 229 (277)
T ss_pred CCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC---CCchhhhHHH
Confidence 332 223456889999999876 46899999999999999999999999877665555444332221 1123578899
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCCCCCCChhHHHHHHHHh
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKS 430 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~k~ 430 (601)
.+||.+||..+|.+||++.+++.|+||.........-..+.+.+++
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~~ 275 (277)
T cd06640 230 KEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDRFKR 275 (277)
T ss_pred HHHHHHHcccCcccCcCHHHHHhChHhhhcchhhhHHHHHHHHHHh
Confidence 9999999999999999999999999998876544433334444443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=337.67 Aligned_cols=252 Identities=17% Similarity=0.295 Sum_probs=209.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||++.++.....+..||+|.++... .......+.+|+.+++++. ||||+++++++..++.+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCCc
Confidence 36999999999999999999876433356799999986542 2233467889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
||||||+++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~---~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc---CCCcEEECCCccccccc
Confidence 999999999999988877666899999999999999999999999999999999999995 47899999999876543
Q ss_pred CCCCcc--ccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 307 PDERLN--DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 307 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
...... ...++..|+|||++. +.++.++|||||||++|||++ |..||+.....+.+..+..... .+ ....++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 235 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-LP--APRNCPN 235 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CC--CCCCCCH
Confidence 222111 234567899999875 678999999999999999775 9999998887777776654422 12 1246889
Q ss_pred HHHHHHHHcccccccCCCCHHHHHc
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.+.+++.+||..+|.+||++.++++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=339.67 Aligned_cols=253 Identities=29% Similarity=0.455 Sum_probs=208.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||++++.. +++.||+|++..... .....+.+|+.+++++. ||||+++++++.....+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLH---TGELAAVKIIKLEPG---DDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKL 81 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECC---CCeEEEEEEEecCcc---chHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEE
Confidence 479999999999999999999875 778999999865422 23456789999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++..+.
T Consensus 82 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKIT 157 (267)
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEECcCccceeec
Confidence 9999999999999887654 5799999999999999999999999999999999999995 47889999999997664
Q ss_pred CCC-Cccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC-CCCC
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP-WPSV 380 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~ 380 (601)
... ......|+..|+|||.+. ..++.++|||||||++|||++|+.||...........+.......+... ...+
T Consensus 158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06646 158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW 237 (267)
T ss_pred ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccccc
Confidence 322 234467899999999873 3478899999999999999999999965543332222222221111111 1247
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCcc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~ 410 (601)
+..+.+||++||..||++||+++++|+|+|
T Consensus 238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 238 SSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 899999999999999999999999999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=342.48 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=215.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
...|++.+.||+|+||.||++.+.. +++.||+|++.............+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~ 89 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHT 89 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCe
Confidence 3469999999999999999999875 67899999986554444444567889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.|+||||+.| +|.+.+......+++..+..++.||+.||.|||++||+||||+|+||+++ .++.+||+|||++...
T Consensus 90 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~---~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 90 AWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLV 165 (307)
T ss_pred EEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC---CCCCEEEeecCcceec
Confidence 9999999974 77777766566799999999999999999999999999999999999995 4789999999998765
Q ss_pred CCCCCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
... ....|+..|+|||++. +.++.++|||||||++|||++|..||...........+..... +......++
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 240 (307)
T cd06607 166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDWS 240 (307)
T ss_pred CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCchhhC
Confidence 432 3457888999999863 4588999999999999999999999987766555444443221 111123468
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
.++.+||.+||..||.+||++.+++.||||.....
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 275 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP 275 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence 89999999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=358.09 Aligned_cols=254 Identities=23% Similarity=0.445 Sum_probs=217.2
Q ss_pred EEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc-chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc--E
Q 007498 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN--V 226 (601)
Q Consensus 150 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--~ 226 (601)
+...+||+|+|-+||+|.+.. +|..||--.++...+. .....++|..|+.+|+.|. |||||++|++|.+... +
T Consensus 43 k~~evLGrGafKtVYka~De~---~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE---EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccc---cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCcee
Confidence 456789999999999999865 7778886555443332 3345688999999999996 9999999999987655 8
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|+|++..|+|..++.+. ++++...++.|++||++||.|||++. |||||||.+||+|+. ..|.|||+|+|+|..
T Consensus 119 n~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG--~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG--NLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC--CcCceeecchhHHHH
Confidence 8999999999999987665 67999999999999999999999995 999999999999974 589999999999988
Q ss_pred cCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.+... ....+|||.|||||+....|+..+||||||+.|+||+|+..||.. .+...+|+.+..+...-.-. .--.++
T Consensus 196 ~r~s~-aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~--kV~dPe 272 (632)
T KOG0584|consen 196 LRKSH-AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS--KVKDPE 272 (632)
T ss_pred hhccc-cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh--ccCCHH
Confidence 76543 344899999999999999999999999999999999999999964 56788899988775432111 112689
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+++||.+||.. .+.|+|+.|||+||||..+
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999999998 9999999999999999986
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=336.42 Aligned_cols=254 Identities=30% Similarity=0.505 Sum_probs=214.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||.|+||.||+|.+.. +++.+|+|++...... ....+.+|+.++++++ ||||+++++++.+...+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~ 75 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLEPGD---DFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKL 75 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecC---CCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEE
Confidence 479999999999999999999876 6788999999754322 4577899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+.+++|.+++......+++.++..++.|++.||.|||+++|+|+||||+||+++ .++.+||+|||++....
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLT 152 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC---CCCCEEECccccchhhh
Confidence 999999999999988776656899999999999999999999999999999999999995 47889999999997665
Q ss_pred CCC-Cccccccccccccchhcc-C---CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC-CCCCCC
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLH-R---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD-LPWPSV 380 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~-~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~ 380 (601)
... ......++..|+|||++. . .++.++|||||||++|+|++|..||...........+......... .....+
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (262)
T cd06613 153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW 232 (262)
T ss_pred hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhh
Confidence 332 334567899999999875 3 6889999999999999999999999877655554444433211111 111346
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCcc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~ 410 (601)
+.++.+||.+||..||..||++.+++.|+|
T Consensus 233 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 233 SPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=333.52 Aligned_cols=253 Identities=30% Similarity=0.496 Sum_probs=218.4
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||.|+||.||.+++.. +++.|++|.+....... .....+.+|+.++++++ |+||+++++++.+.+.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---DDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---CCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEE
Confidence 48999999999999999999876 78899999987654332 34567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+|||||++++|.+.+... ...+++.++..++.|++.||.|||++|++|+||+|+||+++ .++.+||+|||++....
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEEcc
Confidence 999999999999988764 45689999999999999999999999999999999999995 47889999999997664
Q ss_pred CCC-CccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
... ......|+..|+|||++.+ .++.++|||||||++|+|++|..||......+....+......... ..++.++
T Consensus 153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (256)
T cd08221 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSEL 229 (256)
T ss_pred cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHH
Confidence 433 2345678999999998764 5789999999999999999999999887777777777655433221 4678999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCccc
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.++|.+||..||.+||++.++|+|+|+
T Consensus 230 ~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 230 ISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=337.11 Aligned_cols=248 Identities=29% Similarity=0.571 Sum_probs=212.7
Q ss_pred eccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeecC
Q 007498 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234 (601)
Q Consensus 155 lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 234 (601)
||.|+||.||++++.. +++.||+|++.+.........+.+.+|+.+++.+. ||||+++++.+.++..+|+||||++
T Consensus 1 lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKS---KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCC
Confidence 7999999999999875 68899999998765444445577999999999996 9999999999999999999999999
Q ss_pred CCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCcccc
Q 007498 235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI 314 (601)
Q Consensus 235 ~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~ 314 (601)
+++|.+++... ..+++..+..++.||+.||.|||+++++|+||+|+||+++ .++.++|+|||++............
T Consensus 77 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~---~~~~~~l~df~~~~~~~~~~~~~~~ 152 (262)
T cd05572 77 GGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKLKSGQKTWTF 152 (262)
T ss_pred CCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc---CCCCEEEeeCCcccccCcccccccc
Confidence 99999987654 5689999999999999999999999999999999999995 4789999999999877554434456
Q ss_pred ccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC--hhHHHHHHHc--cCCCCCCCCCCCCCHHHHHHHH
Q 007498 315 VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART--ESGIFRAVLR--SDPNFDDLPWPSVSPEAKDFVK 389 (601)
Q Consensus 315 ~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~ 389 (601)
.|+..|+|||++. ..++.++|+|||||++|+|++|..||.... ....+..+.. ....++ ...+.++.++|.
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~ 228 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP----NYIDKAAKDLIK 228 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC----cccCHHHHHHHH
Confidence 7899999999875 468999999999999999999999998766 5555555553 222222 245899999999
Q ss_pred HcccccccCCCC-----HHHHHcCcccCCC
Q 007498 390 RLLNKDYRKRMT-----AVQALTHPWLRDD 414 (601)
Q Consensus 390 ~~L~~dP~~R~s-----~~ell~hp~f~~~ 414 (601)
+||..||++|++ +.|+++||||++.
T Consensus 229 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 229 QLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred HHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=341.08 Aligned_cols=241 Identities=17% Similarity=0.247 Sum_probs=204.8
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec----CCcEEE
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED----VNNVYI 228 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~~~~l 228 (601)
..||+|++|.||++.. +++.||||++.+.........+.+.+|+.+|++++ |||||++++++.+ ...+++
T Consensus 26 ~~i~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~l 99 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSL 99 (283)
T ss_pred eEEeeCCceEEEEEEE-----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEE
Confidence 4699999999999976 56799999997654444334577889999999996 9999999999876 357899
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
|||||++|+|.+++... +.+++.....++.|++.||.|||+. +++||||||+|||++ +++.+||+|||+++.+..
T Consensus 100 v~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~---~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 100 ILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT---ENYKLKIICHGLEKILSS 175 (283)
T ss_pred EEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC---CCCcEEEcccchHhhhcc
Confidence 99999999999987654 5799999999999999999999985 999999999999995 478999999999976543
Q ss_pred CCCccccccccccccchhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 308 DERLNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 308 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
. ....+||..|+|||++. +.++.++|||||||++|||++|+.||.+.+..+++..+......+... ..+++++
T Consensus 176 ~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l 251 (283)
T PHA02988 176 P--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEI 251 (283)
T ss_pred c--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHH
Confidence 2 23457899999999985 468999999999999999999999999888777777776554433221 2578999
Q ss_pred HHHHHHcccccccCCCCHHHHHc
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++||.+||+.||++|||+.++++
T Consensus 252 ~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 252 KCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999999999999999985
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=336.36 Aligned_cols=253 Identities=28% Similarity=0.522 Sum_probs=211.0
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch------hhHHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA------ISIEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
+|.++..||+|+||.||+|.+.. +++.||+|.+........ ...+.+.+|+.+++++. ||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSL 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Confidence 47888999999999999999865 678999998865433221 22356889999999996 999999999999
Q ss_pred cCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
.....++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||+|+||+++ .++.+||+|||+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~---~~~~~~l~dfg~ 152 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGI 152 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc---CCCCEEecccCC
Confidence 999999999999999999887654 6799999999999999999999999999999999999995 478899999999
Q ss_pred ccccCCCC-------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCC
Q 007498 302 SDFIRPDE-------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373 (601)
Q Consensus 302 a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 373 (601)
++.+.... ......|+..|+|||++. +.++.++|||||||++|+|++|..||........+..+.... .+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~ 230 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--SP 230 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC--CC
Confidence 87664221 112346889999999876 468899999999999999999999998766555444443321 11
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.. ...++.++.++|++||+.||.+||++.++++||||
T Consensus 231 ~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 231 EI-PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cC-CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 11 13578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=356.12 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=204.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|++++.||+|+||.||+|++... ..++..||||++...... .....+.+|+.+++.+.+|+|||+++++|...+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 4799999999999999999986531 224568999999754322 235678899999999955999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC----------------------------------------------------------
Q 007498 225 NVYIVMELCEGGELLDRILARG---------------------------------------------------------- 246 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~---------------------------------------------------------- 246 (601)
.+|||||||++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999875421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCC---cc
Q 007498 247 -----------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LN 312 (601)
Q Consensus 247 -----------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~---~~ 312 (601)
..+++.+++.|+.||+.||.|||++||+||||||+|||++ +++.+||+|||+++.+..... ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---CCCeEEEeeceeeeeccCCcceeecc
Confidence 2478889999999999999999999999999999999995 478899999999976543321 11
Q ss_pred ccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHH
Q 007498 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKR 390 (601)
Q Consensus 313 ~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 390 (601)
...++..|+|||++. ..++.++|||||||++|+|++ |+.||........+..+......... ...+++++.++|.+
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~ 350 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--PDFAPPEIYSIMKM 350 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--CCCCCHHHHHHHHH
Confidence 233566799999875 579999999999999999997 99999876554444444433322221 12468999999999
Q ss_pred cccccccCCCCHHHHHc
Q 007498 391 LLNKDYRKRMTAVQALT 407 (601)
Q Consensus 391 ~L~~dP~~R~s~~ell~ 407 (601)
||..||.+||++.++++
T Consensus 351 cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 351 CWNLEPTERPTFSQISQ 367 (374)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=340.15 Aligned_cols=256 Identities=27% Similarity=0.492 Sum_probs=210.7
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-- 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-- 223 (601)
..+|.+.+.||+|+||.||++.... +++.||+|++..... ....+.+|+.+++++.+||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~---~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 4679999999999999999999876 788999999865321 2356788999999996699999999998653
Q ss_pred ---CcEEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 224 ---NNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 224 ---~~~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
..+|+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++|+||||||+||+++ .++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~---~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT---TEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEe
Confidence 468999999999999887753 346799999999999999999999999999999999999995 47889999
Q ss_pred ecccccccCCCC-CccccccccccccchhccC------CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC
Q 007498 298 DFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP 370 (601)
Q Consensus 298 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 370 (601)
|||++....... ......|+..|+|||++.. .++.++|||||||++|+|++|+.||........+..+.+...
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 250 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP 250 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence 999987654332 2234578999999998742 268999999999999999999999987766555555444322
Q ss_pred CCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
.... ....++.++.+||.+||..||++||++.++++||||+
T Consensus 251 ~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 PTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 1111 1134678899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=340.80 Aligned_cols=253 Identities=30% Similarity=0.537 Sum_probs=208.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec----
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED---- 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---- 222 (601)
..|++.+.||+|+||.||++++.. +++.||+|++.... .....+.+|+.+++++.+|+||+++++++..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcC---CCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 479999999999999999999876 77899999986542 2345688899999999679999999999853
Q ss_pred --CCcEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 223 --VNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 223 --~~~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
...+|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++ +++.++|+||
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~---~~~~~~l~df 165 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDF 165 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeC
Confidence 46789999999999999887653 35689999999999999999999999999999999999995 4788999999
Q ss_pred ccccccCCC-CCccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCC
Q 007498 300 GLSDFIRPD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF 372 (601)
Q Consensus 300 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 372 (601)
|++...... .......|+..|+|||++. ..++.++|||||||++|+|++|..||........+..+.....
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-- 243 (282)
T cd06636 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP-- 243 (282)
T ss_pred cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--
Confidence 998765422 2234567999999999874 3578899999999999999999999976655444433333221
Q ss_pred CCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 373 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.......++.++.+||.+||..||.+||++.|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 112223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=340.47 Aligned_cols=256 Identities=31% Similarity=0.517 Sum_probs=207.5
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe---
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE--- 221 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--- 221 (601)
...+|++.+.||+|+||.||+|++.. +++.||+|++..... ....+.+|+.+++.+.+|+||+++++++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECC---CCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 45689999999999999999999876 678999998754321 23567889999999966999999999874
Q ss_pred --cCCcEEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEE
Q 007498 222 --DVNNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296 (601)
Q Consensus 222 --~~~~~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl 296 (601)
.+..+|+||||+++++|.+.+.. ....+++..++.++.|++.||.|||+++|+||||||+||+++ .++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEEE
Confidence 34679999999999999887653 345689999999999999999999999999999999999995 4778999
Q ss_pred eecccccccCCCC-Cccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC
Q 007498 297 IDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369 (601)
Q Consensus 297 ~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 369 (601)
+|||++..+.... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||........+..+....
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 9999997664332 234457999999999874 347899999999999999999999997765544333332221
Q ss_pred CCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
... ......++.++.+||.+||..||.+||++.|+++|+||
T Consensus 246 ~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 PPT-LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCc-ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 111 10112367899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=339.94 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=207.6
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+++++. +++.||||+++...... ....+..|+.++.+..+||||+++++++..++.+|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVP---TGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcC---CCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 68999999999999999999876 78999999987643222 23456667776545446999999999999999999
Q ss_pred EEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 228 IVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+||||++ |+|.+.+.. ....+++..++.++.||+.||.|||++ +++||||||+|||++ .++.+||+|||++.
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~---~~~~~kl~dfg~~~ 152 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN---RNGQVKLCDFGISG 152 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeeccccc
Confidence 9999997 477776654 235699999999999999999999998 999999999999995 47899999999998
Q ss_pred ccCCCCCccccccccccccchhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHccCCCCCCCCC
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH-----RSYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 377 (601)
.+..........|+..|+|||++. ..++.++|+|||||++|+|++|+.||.... ..+.+..+..... +..+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~ 230 (283)
T cd06617 153 YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLPA 230 (283)
T ss_pred ccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCCc
Confidence 764433334467899999999874 347889999999999999999999996432 2233333333211 11122
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
..++.++.+||.+||..+|.+||++.++++||||+....
T Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 357899999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=339.49 Aligned_cols=249 Identities=26% Similarity=0.422 Sum_probs=199.5
Q ss_pred eeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHh--cCCCCeeEEeeeEecCCcEEEEEe
Q 007498 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL--SGHKHLVKFCDACEDVNNVYIVME 231 (601)
Q Consensus 154 ~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~lv~e 231 (601)
.||+|+||.||++++.. +++.||+|++.+.............+|..+++.+ .+|+||+.+++++...+..|+|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECC---CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 48999999999999875 7889999999765543332233345555444443 259999999999999999999999
Q ss_pred ecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCc
Q 007498 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL 311 (601)
Q Consensus 232 ~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~ 311 (601)
|+++++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+|||++ .++.++|+|||++...... ..
T Consensus 78 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~---~~~~~~l~dfg~~~~~~~~-~~ 152 (279)
T cd05633 78 LMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK-KP 152 (279)
T ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC---CCCCEEEccCCcceecccc-Cc
Confidence 99999998877654 5799999999999999999999999999999999999995 4789999999998755432 22
Q ss_pred cccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh--HHHHHH-HccCCCCCCCCCCCCCHHHHH
Q 007498 312 NDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTES--GIFRAV-LRSDPNFDDLPWPSVSPEAKD 386 (601)
Q Consensus 312 ~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--~~~~~i-~~~~~~~~~~~~~~~s~~~~~ 386 (601)
....||..|+|||++. ..++.++||||+||++|+|++|..||...... ...... ......+ ...+++++.+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 228 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL----PDSFSPELKS 228 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCC----ccccCHHHHH
Confidence 3457999999999875 35899999999999999999999999754321 112111 1111111 2468999999
Q ss_pred HHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 387 FVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 387 li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
+|++||..||++|+ ++.++++||||+..
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 229 LLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred HHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 99999999999999 69999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=333.71 Aligned_cols=253 Identities=28% Similarity=0.540 Sum_probs=216.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||++++.. +++.||+|.+....... .....+.+|+.+++++. |+||+++++++...+..|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMSP-KEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---CCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEE
Confidence 58999999999999999999876 67899999987644322 24467899999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+||||+.+++|.+.+... ...+++.++..++.|++.||.|||+++++|+||+|+|||++ .++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~---~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEEeeccceeecC
Confidence 999999999999988664 34689999999999999999999999999999999999995 47889999999997654
Q ss_pred CCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
.... .....|+..|+|||++. +.++.++|+|||||++|+|++|..||......+....+........ + ..++.++
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~ 229 (256)
T cd08218 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV--S-SHYSYDL 229 (256)
T ss_pred cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC--c-ccCCHHH
Confidence 3322 23356889999999876 5688999999999999999999999988777777766665443211 1 3678999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCccc
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.++|.+||..+|.+||++.++++||||
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=340.43 Aligned_cols=255 Identities=27% Similarity=0.475 Sum_probs=205.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++.+.||+|+||.||++.++. +++.||||.+....... ....+.+|+++++.++ |+||+++++++......
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKL---TGQLVALKEIRLEHEEG--APFTAIREASLLKDLK-HANIVTLHDIIHTKKTL 78 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcC---CCcEEEEEEEecccccC--CchhHHHHHHHHhhCC-CcceeeEEEEEecCCeE
Confidence 469999999999999999999875 67899999987543221 2234678999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+.+ +|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKLADFGLARAKS 154 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc---CCCCEEECccccccccC
Confidence 999999975 89988877666799999999999999999999999999999999999995 47889999999986543
Q ss_pred CCC-Cccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHccCCC-----------
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRSDPN----------- 371 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~----------- 371 (601)
... ......++..|+|||++. ..++.++||||+||++|+|++|..||.... ..+.+..+......
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 221 122345788999999875 358999999999999999999999997654 22222222211000
Q ss_pred --------CCC-------CCCCCCC--HHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 372 --------FDD-------LPWPSVS--PEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 372 --------~~~-------~~~~~~s--~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+.. ..++.++ .++.++|.+||..||.+|||+.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0012344 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=318.66 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=204.3
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-- 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-- 223 (601)
..+|++.+.||+|||+.||+++... ++..||+|++.... ....+...+|++..+++. ||||++++++...+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s---~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLS---TGHLYALKKILCHS---QEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEK 92 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccC---cccchhhheeeccc---hHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhc
Confidence 3589999999999999999998665 78899999996654 345678899999999996 99999999987544
Q ss_pred ---CcEEEEEeecCCCchHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCceEeecCCCCCCeE
Q 007498 224 ---NNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMR 295 (601)
Q Consensus 224 ---~~~~lv~e~~~~g~L~~~~~~~---~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDikp~NIll~~~~~~~~vk 295 (601)
...||++.|...|+|.+.+... +..+++.++..|+.+|++||++||+.. +.||||||.|||++. .+.++
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~---~~~~v 169 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD---SGLPV 169 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC---CCceE
Confidence 3499999999999999988753 446999999999999999999999998 999999999999963 78999
Q ss_pred EeecccccccCCC----CC------ccccccccccccchhcc-C---CCCChhhHHHHHHHHHHHHhCCCCCCCCChh--
Q 007498 296 LIDFGLSDFIRPD----ER------LNDIVGSAYYVAPEVLH-R---SYSLEADIWSIGVISYILLCGSRPFWARTES-- 359 (601)
Q Consensus 296 l~DFG~a~~~~~~----~~------~~~~~gt~~y~aPE~~~-~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-- 359 (601)
|.|||.+....-. .. ...-..|..|+|||++. + ..+.++|||||||+||.|+.|..||......
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 9999998754311 10 11235789999999986 2 3689999999999999999999999532111
Q ss_pred HHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 360 GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 360 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.+...+.+....++... .+|..+.+||++||+.||.+||++.+++.+
T Consensus 250 SlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eEEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11112333344555443 489999999999999999999999999874
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=337.42 Aligned_cols=254 Identities=32% Similarity=0.549 Sum_probs=210.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC--
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-- 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-- 224 (601)
++|++.+.||+|+||.||+|.++. +++.||+|++..... ..+.+.+|+.+++++.+|+||+++++++....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECC---CCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 579999999999999999999875 678999999865432 34678899999999966999999999997644
Q ss_pred ----cEEEEEeecCCCchHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 225 ----NVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 225 ----~~~lv~e~~~~g~L~~~~~~~---~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
.+|+||||+++++|.+++... ...+++..++.++.|++.||.|||+++|+|+||+|+||+++ .++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~---~~~~~~l~ 155 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLV 155 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc---cCCeEEEC
Confidence 489999999999998877542 46799999999999999999999999999999999999995 47889999
Q ss_pred ecccccccCCCC-Cccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC
Q 007498 298 DFGLSDFIRPDE-RLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP 370 (601)
Q Consensus 298 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 370 (601)
|||++....... ......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+.....
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 235 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP 235 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence 999987654322 234467899999999874 2478899999999999999999999986655555555544322
Q ss_pred CCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.... ....++.++++||.+||..||++|||+.+++.|||+
T Consensus 236 ~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 PTLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 1111 112378899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=337.08 Aligned_cols=249 Identities=24% Similarity=0.435 Sum_probs=199.2
Q ss_pred CCeEEccee--ccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEV--GRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~l--G~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
..|++.+.+ |+|+||.||+++.+. ++..+|+|++....... .|+.+...+.+|+||+++++.|...+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKP---TQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcC---CCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 456666665 999999999999876 78899999986543221 13333333446999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCC-CeEEeeccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSD 303 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~-~vkl~DFG~a~ 303 (601)
.+|+||||+++++|.+++... ..+++.++..++.||+.||.|||++||+||||||+||++.. ++ .++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~---~~~~~~l~dfg~~~ 158 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR---AKDRIYLCDYGLCK 158 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC---CCCeEEEecCccce
Confidence 999999999999999987654 48999999999999999999999999999999999999964 45 89999999987
Q ss_pred ccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
..... ....|+..|+|||++. ..++.++|||||||++|+|++|..||.......................++.+++
T Consensus 159 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T PHA03390 159 IIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSK 235 (267)
T ss_pred ecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCH
Confidence 65432 2346899999999886 4689999999999999999999999975544332111111111111122346899
Q ss_pred HHHHHHHHcccccccCCCC-HHHHHcCcccCC
Q 007498 383 EAKDFVKRLLNKDYRKRMT-AVQALTHPWLRD 413 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s-~~ell~hp~f~~ 413 (601)
.+.+||.+||+.||.+|++ ++++|+||||++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 9999999999999999996 599999999974
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=363.41 Aligned_cols=265 Identities=21% Similarity=0.307 Sum_probs=198.2
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEE--------------EeecccccchhhHHHHHHHHHHHHHhcC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVK--------------IISKAKMTTAISIEDVRREVKILKALSG 209 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 209 (601)
.+..+|++++.||+|+||+||++..+.. .+..+++| ++.+...........+.+|+.+|++|.
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~- 221 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRAS--TEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN- 221 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEecc--chhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-
Confidence 3456899999999999999999876531 12222222 111111112223456889999999996
Q ss_pred CCCeeEEeeeEecCCcEEEEEeecCCCchHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEe
Q 007498 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLF 285 (601)
Q Consensus 210 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll 285 (601)
|||||++++++...+..|+|||++. ++|++++... .......+++.|+.||+.||.|||++|||||||||+|||+
T Consensus 222 HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl 300 (501)
T PHA03210 222 HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300 (501)
T ss_pred CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 9999999999999999999999995 4787776542 1234567788999999999999999999999999999999
Q ss_pred ecCCCCCCeEEeecccccccCCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hh
Q 007498 286 TSGRDDADMRLIDFGLSDFIRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART---ES 359 (601)
Q Consensus 286 ~~~~~~~~vkl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~ 359 (601)
+ .++.+||+|||++..+..... ....+||..|+|||++. ..|+.++|||||||++|||++|..+++... ..
T Consensus 301 ~---~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 301 N---CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred C---CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 5 478999999999987654322 23468999999999986 469999999999999999999987654322 22
Q ss_pred HHHHHHHccCC----CCCCC------------------------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 360 GIFRAVLRSDP----NFDDL------------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 360 ~~~~~i~~~~~----~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
..+..++.... .++.. ....++.++.++|.+||..||.+|||+.|+|.||||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 22222222110 01100 011356788899999999999999999999999999
Q ss_pred CCCC
Q 007498 412 RDDS 415 (601)
Q Consensus 412 ~~~~ 415 (601)
....
T Consensus 458 ~~~~ 461 (501)
T PHA03210 458 SAEE 461 (501)
T ss_pred hcCC
Confidence 8753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=353.87 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=203.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|++++.||+|+||.||+|++... ..++..||||+++.... ....+.+.+|+.+++.+.+|||||+++++|...+
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 3699999999999999999975421 22567899999865432 2234678899999999955999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC----------------------------------------------------------
Q 007498 225 NVYIVMELCEGGELLDRILARG---------------------------------------------------------- 246 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~---------------------------------------------------------- 246 (601)
..|+|||||++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999886432
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCC
Q 007498 247 ----------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310 (601)
Q Consensus 247 ----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~ 310 (601)
..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCccc
Confidence 2478889999999999999999999999999999999995 477899999999976643322
Q ss_pred c---cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 311 L---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 311 ~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
. ....++..|+|||++. ..++.++|||||||++|||++ |..||........+...+....... .....+.++.
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 347 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEMY 347 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHHH
Confidence 1 1234566799999876 578999999999999999997 8999977654433333333222111 1134688999
Q ss_pred HHHHHcccccccCCCCHHHHHcC
Q 007498 386 DFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~h 408 (601)
+||.+||..||++||++.|+++.
T Consensus 348 ~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 348 DIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=341.05 Aligned_cols=254 Identities=20% Similarity=0.314 Sum_probs=202.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC-------------ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCe
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE-------------LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~-------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni 213 (601)
.+|++.++||+|+||.||+|++.... .++..||+|++.... .......+.+|+.++.+++ ||||
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~ni 81 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPNI 81 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCCe
Confidence 57999999999999999999864311 134579999986542 2334567899999999996 9999
Q ss_pred eEEeeeEecCCcEEEEEeecCCCchHHHHHHcC------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 007498 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARG------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVH 275 (601)
Q Consensus 214 v~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~------------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiH 275 (601)
+++++++.+.+.+||||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999875431 24678889999999999999999999999
Q ss_pred ccCCCCceEeecCCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh--C
Q 007498 276 RDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC--G 349 (601)
Q Consensus 276 rDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~--g 349 (601)
|||||+|||++ .++.+||+|||++..+..... .....++..|+|||++. +.++.++|||||||++|||++ +
T Consensus 162 ~dlkp~Nill~---~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 162 RDLATRNCLVG---ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cCcchhheEEc---CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 99999999995 478999999999976543321 12345678899999865 679999999999999999986 6
Q ss_pred CCCCCCCChhHHHHHHHcc---C-CCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHH
Q 007498 350 SRPFWARTESGIFRAVLRS---D-PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406 (601)
Q Consensus 350 ~~pf~~~~~~~~~~~i~~~---~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell 406 (601)
..||......+.+..+... . ........+.++..+.+||.+||..||.+|||+.++.
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 6788776665555443221 1 1111111245789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=342.95 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=204.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC--
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-- 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-- 224 (601)
.+|++.+.||+|+||.||+|++.. +++.||||++....... .....+.+|+++++++. ||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKATP 86 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECC---CCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCC-CCCccceEEEEeccccc
Confidence 469999999999999999999875 78899999986543222 12345568999999996 999999999886543
Q ss_pred ------cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 225 ------NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 225 ------~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..|+||||+.+ +|.+.+......+++.+++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~d 162 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLAD 162 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC---CCCcEEECc
Confidence 45999999965 88888776666799999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCCC-----ccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC
Q 007498 299 FGLSDFIRPDER-----LNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 299 FG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
||++..+..... .....++..|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999976543221 234567889999998754 4789999999999999999999999876655444333322111
Q ss_pred CCCCC----------------------------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 372 FDDLP----------------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 372 ~~~~~----------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
++... ....+..+.+||.+||..||.+|||++++|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 11100 01135778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=342.61 Aligned_cols=256 Identities=29% Similarity=0.440 Sum_probs=210.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--C
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--N 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~ 224 (601)
..|++.+.||+|+||.||+|.+.. +++.||+|.++...... .....+.+|+.+++++. ||||+++++++... .
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---TGEIVALKKLKMEKEKE-GFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---CCcEEEEEEEeeccccc-cchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCC
Confidence 369999999999999999999875 67899999997654332 22345678999999996 99999999998877 8
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+||||||+.+ +|.+.+......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++..
T Consensus 80 ~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~~l~d~g~~~~ 155 (293)
T cd07843 80 KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN---NRGILKICDFGLARE 155 (293)
T ss_pred cEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCcEEEeecCceee
Confidence 89999999975 88888776656799999999999999999999999999999999999995 478999999999987
Q ss_pred cCCC-CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCC---------
Q 007498 305 IRPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF--------- 372 (601)
Q Consensus 305 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------- 372 (601)
.... .......++..|+|||++.+ .++.++|+|||||++|+|++|..||........+..+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 6543 23344568899999998753 46899999999999999999999998776655544443211100
Q ss_pred -----C------------CCCCCC--CCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 373 -----D------------DLPWPS--VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 373 -----~------------~~~~~~--~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
. ...++. +++.+.+||++||..||++|||+.|+|.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0 001122 58899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=328.11 Aligned_cols=256 Identities=27% Similarity=0.521 Sum_probs=228.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|.+++.||+|+|++|.+++.++ +.+.||+|++++.-+....+..-++.|-.+..+-++||.+|-|..+|+...++
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~---t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKK---TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred ccceeeeeecCcchhhhhheehcc---cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 479999999999999999999987 88999999999988888778888999999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc-c
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF-I 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~-~ 305 (601)
++|.||++||+|.-++.+. .+++++.++.|..+|+.||.|||++|||+||||.+|+|++ ..|++||+|+|+++. +
T Consensus 327 ffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld---aeghikltdygmcke~l 402 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD---AEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc---cCCceeecccchhhcCC
Confidence 9999999999998776554 6799999999999999999999999999999999999995 589999999999976 4
Q ss_pred CCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCC--------CChhHHHHHHHccCCCCCCCC
Q 007498 306 RPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWA--------RTESGIFRAVLRSDPNFDDLP 376 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~--------~~~~~~~~~i~~~~~~~~~~~ 376 (601)
.++....++|||+.|+|||++.+ .|+..+|+|+|||+++||+.|+.||.- +++.-+++.|+.....++.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr-- 480 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR-- 480 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--
Confidence 56677889999999999999986 699999999999999999999999941 2333456666766666654
Q ss_pred CCCCCHHHHHHHHHcccccccCCCC------HHHHHcCcccCC
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMT------AVQALTHPWLRD 413 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s------~~ell~hp~f~~ 413 (601)
.+|-.+..+++..|++||.+|.. ..++..|+||+.
T Consensus 481 --slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 481 --SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred --eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 67888999999999999999974 689999999984
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=336.51 Aligned_cols=258 Identities=24% Similarity=0.429 Sum_probs=209.1
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc---hhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT---AISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.|+.++.||+|+||.||++.+.. +++.||+|++....... ......+.+|++++++++ |+||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCC
Confidence 37888999999999999998865 78899999987543221 123567899999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+|+||||+||+++. ....+||+|||++..
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~ 153 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAAR 153 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccc
Confidence 999999999999999887654 57999999999999999999999999999999999999953 234699999999876
Q ss_pred cCCCCC-----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC-CCCCCCC
Q 007498 305 IRPDER-----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-NFDDLPW 377 (601)
Q Consensus 305 ~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~ 377 (601)
+..... .....|+..|+|||++. ..++.++|||||||++|+|++|..||...........+..... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCc
Confidence 643211 22356889999999876 4688999999999999999999999965443322222222111 0111111
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
..+++++.++|.+||..||.+||++.++++||||+
T Consensus 234 ~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 234 EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred hhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 35789999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=343.10 Aligned_cols=260 Identities=29% Similarity=0.506 Sum_probs=215.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|.....||+|+||.||++.+.. ++..||||.+.... ....+.+.+|+.+++.+. |+||+++++.+...+..
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKH---TGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDEL 94 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECC---CCCEEEEEEEecch---HHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeE
Confidence 346666789999999999998865 67899999985532 224566889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVS 169 (292)
T ss_pred EEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEccCcchhhcc
Confidence 999999999999887643 4699999999999999999999999999999999999995 47899999999987553
Q ss_pred CCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
... ......|+..|+|||++. ..++.++|||||||++|||++|..||........+..+......... ....++..+
T Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 248 (292)
T cd06658 170 KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK-DSHKVSSVL 248 (292)
T ss_pred cccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc-cccccCHHH
Confidence 222 234467899999999876 46899999999999999999999999877666555554433221111 123578899
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
.+||.+||..||.+|||+.++++||||+....|..
T Consensus 249 ~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 249 RGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred HHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 99999999999999999999999999998776654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=340.56 Aligned_cols=255 Identities=27% Similarity=0.465 Sum_probs=209.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||++.+.. +++.||+|++.+..... ...+.+.+|+++++.+. ||||+++++++..++..|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 76 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLY 76 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECC---CCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEE
Confidence 68999999999999999999875 67899999986543322 23466889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++++|..+. .....+++..+..++.||+.||.|||++||+|+||+|+||+++ +++.++|+|||++..+..
T Consensus 77 lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~---~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 77 LVFEFVDHTVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAA 152 (286)
T ss_pred EEEecCCccHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCcEEEEeeeeeeeccC
Confidence 999999988776654 3445699999999999999999999999999999999999995 478999999999876643
Q ss_pred CC-CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC-------------
Q 007498 308 DE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN------------- 371 (601)
Q Consensus 308 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------- 371 (601)
.. ......++..|+|||++.+ .++.++|||||||++|+|++|.+||......+....+......
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 32 2344578999999998763 4788999999999999999999999766554433333221110
Q ss_pred ------CCC--------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 372 ------FDD--------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 372 ------~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.+. ..++.++..+.+|+.+||..||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 0134678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=339.05 Aligned_cols=255 Identities=30% Similarity=0.470 Sum_probs=208.1
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++++.||.|+||.||+|+++. +++.||||++...... ......+.+|++++++++ ||||+++++++.+.+..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTET-EGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---CCCEEEEEEccccccc-cccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEE
Confidence 38899999999999999999875 7889999998654322 223456889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+||||+. ++|.+++... ...+++..+..++.|++.||.|||+++++||||+|+||+++ .++.+||+|||++....
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~---~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEeeccchhhcc
Confidence 9999996 5888877653 35689999999999999999999999999999999999995 47899999999987654
Q ss_pred CCC-CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC------------
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN------------ 371 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------ 371 (601)
... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||.+..+......+.+....
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 322 2233467889999998753 3688999999999999999999999877655444333321110
Q ss_pred ------CCC-------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 372 ------FDD-------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 372 ------~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
++. ...+.++++++++|.+||..||++||++.++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000 0023578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=331.80 Aligned_cols=253 Identities=34% Similarity=0.547 Sum_probs=214.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--CCc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--VNN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~ 225 (601)
+|++.+.||.|+||.||+|.+.. +++.||+|++...... ....+.+.+|++++++++ |+||+++++++.. +..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---CCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCE
Confidence 48899999999999999999876 7789999998765432 334567889999999996 9999999998754 456
Q ss_pred EEEEEeecCCCchHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-----HcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 226 VYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCH-----LQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~---~~~l~~~~~~~i~~ql~~~L~~LH-----~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
+|+||||+++++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||+++ .++.+||+
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~kl~ 152 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVKLG 152 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEEEe
Confidence 89999999999999888653 467999999999999999999999 89999999999999996 47899999
Q ss_pred ecccccccCCCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCC
Q 007498 298 DFGLSDFIRPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375 (601)
Q Consensus 298 DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 375 (601)
|||++........ .....|+..|+|||++. ..++.++|+|||||++|+|++|..||...........+...... ..
T Consensus 153 d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~ 230 (265)
T cd08217 153 DFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR--RI 230 (265)
T ss_pred cccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC--CC
Confidence 9999987654443 34567899999999876 46889999999999999999999999887766666555544321 11
Q ss_pred CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 376 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+ ..++.++.+++.+||..+|++||++.++++|||+
T Consensus 231 ~-~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 231 P-YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred c-cccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 1 3678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.49 Aligned_cols=261 Identities=28% Similarity=0.440 Sum_probs=210.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|++|.||+++++. +++.||+|.+....... .....+.+|+++++++. |+||+++++++.....+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---TNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---CCcEEEEEehhhccccc-cchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeE
Confidence 369999999999999999999875 78899999986543222 23456788999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+++ +|.+.+..... .+++..++.++.||+.||+|||+++|+||||+|+||+++. .++.+||+|||++...
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAF 153 (294)
T ss_pred EEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEccccccccc
Confidence 999999964 78887755432 3688999999999999999999999999999999999963 3567999999999765
Q ss_pred CCCC-CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCC----------
Q 007498 306 RPDE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF---------- 372 (601)
Q Consensus 306 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------- 372 (601)
.... ......++..|+|||++.+ .++.++|||||||++|+|++|..||......+.+..+.......
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 3322 2234567899999998753 57899999999999999999999998776655554443211100
Q ss_pred --------CC-------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 373 --------DD-------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 373 --------~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
+. ...+.+++++.++|.+||+.||++||++.++++||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 00 01245789999999999999999999999999999998643
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.72 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=199.9
Q ss_pred eeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHH---HHhcCCCCeeEEeeeEecCCcEEEEE
Q 007498 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL---KALSGHKHLVKFCDACEDVNNVYIVM 230 (601)
Q Consensus 154 ~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~~h~niv~l~~~~~~~~~~~lv~ 230 (601)
.||+|+||.||+|++.. +++.||+|++.+..............|..++ +.. +||||+.+++++...+.+|+||
T Consensus 1 ~ig~g~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEec---CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEE
Confidence 48999999999999875 6889999999775443322222334444443 334 4999999999999999999999
Q ss_pred eecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCC
Q 007498 231 ELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310 (601)
Q Consensus 231 e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~ 310 (601)
||+.|++|.+++.. .+.+++..++.++.|++.||.|||+++|+||||||+||+++ .++.+||+|||++...... .
T Consensus 77 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~---~~~~~kl~dfg~~~~~~~~-~ 151 (278)
T cd05606 77 DLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK-K 151 (278)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC---CCCCEEEccCcCccccCcc-C
Confidence 99999999887754 46799999999999999999999999999999999999995 4788999999998765432 2
Q ss_pred ccccccccccccchhcc-C-CCCChhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 311 LNDIVGSAYYVAPEVLH-R-SYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 311 ~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
....+|+..|+|||++. + .++.++||||+||++|+|++|+.||.... .......+......++ ..++.++.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~ 227 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELR 227 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCC----CcCCHHHH
Confidence 33457999999999986 3 58999999999999999999999997652 2222222222222222 35789999
Q ss_pred HHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 386 DFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 386 ~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
++|.+||..||.+|+ ++.++++||||+..
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 228 SLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 999999999999999 99999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.79 Aligned_cols=261 Identities=26% Similarity=0.471 Sum_probs=216.7
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
-|++.+.||+|+||.||++.+.. +++.||||++..... ......+.+|+.+++++. ||||+++++++..+..+|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~---~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC---CCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEE
Confidence 48888999999999999998765 678999999865432 223467889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||||+||+++ .++.++|+|||++..+..
T Consensus 79 lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~---~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 79 IIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTD 153 (277)
T ss_pred EEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC---CCCCEEEeecccceeccc
Confidence 99999999999987753 4699999999999999999999999999999999999995 478899999999876543
Q ss_pred CC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 308 DE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 308 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.. ......|+..|+|||++. ..++.++|+|||||++|+|++|..||...........+...... .. ...++.++.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~ 230 (277)
T cd06641 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP--TL-EGNYSKPLK 230 (277)
T ss_pred chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC--CC-CcccCHHHH
Confidence 32 223457889999999876 46788999999999999999999999876665555554333221 11 135789999
Q ss_pred HHHHHcccccccCCCCHHHHHcCcccCCCCCCCChhH
Q 007498 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDI 422 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~ 422 (601)
++|.+||..+|.+||++.++++||||...........
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~~~~~~ 267 (277)
T cd06641 231 EFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLT 267 (277)
T ss_pred HHHHHHccCChhhCcCHHHHHhCHHHhhhhhccchHH
Confidence 9999999999999999999999999988655443333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=349.37 Aligned_cols=257 Identities=27% Similarity=0.466 Sum_probs=207.4
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV- 223 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~- 223 (601)
+..+|++.+.||+|+||.||+|++.. +++.||||++.+... .......+.+|+.+++++. |+||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 88 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---TGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQK 88 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---CCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCC
Confidence 34689999999999999999999876 788999999865322 2223456778999999996 99999999988643
Q ss_pred -----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 224 -----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~---~~~~~kL~D 161 (353)
T cd07850 89 SLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 161 (353)
T ss_pred CccccCcEEEEEeccCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEcc
Confidence 357999999965 88877653 299999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC--------
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD-------- 369 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------- 369 (601)
||++.............|+..|+|||++. ..++.++|||||||++|+|++|+.||...+....+..+....
T Consensus 162 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 162 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred CccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99998765544445567899999999876 568999999999999999999999998765544433332210
Q ss_pred --------------CCCCCC---------C--------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 370 --------------PNFDDL---------P--------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 370 --------------~~~~~~---------~--------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
+..... . ....+..+++||.+||..||++|||+.|+|.||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 000000 0 1134667899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.87 Aligned_cols=245 Identities=25% Similarity=0.429 Sum_probs=207.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+++.+ .+..+|+|.+..... ....+.+|+.+++++. ||||+++++++.....+|
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~----~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWR----AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLY 75 (256)
T ss_pred HcEEeeEecCCcCceEEEEEec----cCceEEEEecccCCc----cHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEE
Confidence 5889999999999999999875 345799998764432 2356889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++|+|.+++....+.+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++.....
T Consensus 76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc---CCCeEEECCCCCccccCC
Confidence 99999999999998876556799999999999999999999999999999999999995 478899999999876543
Q ss_pred CCCc--cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 308 DERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 308 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.... ....++..|+|||++. ..++.++|||||||++|+|++ |+.||...+..+.+..+......... ...+.+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~ 229 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMT 229 (256)
T ss_pred CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHH
Confidence 2221 2234566899999876 568999999999999999999 99999888877777777665432211 246789
Q ss_pred HHHHHHHcccccccCCCCHHHHHc
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.+++.+||..||.+||++.++++
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=336.98 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=204.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++.+.||+|+||.||++.++. +++.||+|++....... ....+.+|+.+++.+. |+||+++++++..+...
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRI---NGQLVALKVISMKTEEG--VPFTAIREASLLKGLK-HANIVLLHDIIHTKETL 78 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcC---CCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeE
Confidence 479999999999999999999876 67899999986543221 2345678999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+. ++|++.+......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS---YLGELKLADFGLARAKS 154 (291)
T ss_pred EEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc---CCCcEEEeccccccccC
Confidence 99999996 688877766556789999999999999999999999999999999999995 47899999999987643
Q ss_pred CC-CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHccC-------------
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSD------------- 369 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~------------- 369 (601)
.. .......++..|+|||++.+ .++.++|||||||++|+|++|..||.+.... +.+..+....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 22 22334567899999998753 5789999999999999999999999765432 2222221100
Q ss_pred -CCCCCC------------CCC--CCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 370 -PNFDDL------------PWP--SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 370 -~~~~~~------------~~~--~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+.+... .|. ..+.++.+||.+||..||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000000 011 136789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=350.33 Aligned_cols=248 Identities=36% Similarity=0.543 Sum_probs=212.7
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+...|.+...+|.|+||.|-.+.+.. +++..++|++.+... +..+|+.++....+||||+++.+.+.++
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~---t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSP---TDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccc---cccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCC
Confidence 456789999999999999998888876 788999999977622 2346888888888899999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
.+.|+|||++.|+-|++.+... +....++..|+.||+.|+.|||++|||||||||+|||+. +..++++|+|||.++
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~--~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSK--PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWS 464 (612)
T ss_pred ceeeeeehhccccHHHHHHHhc--chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhh
Confidence 9999999999999999887654 333378889999999999999999999999999999995 247899999999998
Q ss_pred ccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHccCCCCCCCCCCCCC
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s 381 (601)
..... +.+.|-|..|.|||++. ..|+.++||||||++||+||+|+.||...... +++..+...... ..+|
T Consensus 465 ~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS 536 (612)
T KOG0603|consen 465 ELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVS 536 (612)
T ss_pred hCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccC
Confidence 77655 55667899999999987 57999999999999999999999999876655 444444433222 3699
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
.++++||.+||+.||.+|+++.+++.||||-+
T Consensus 537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 537 DEAKDLLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred HHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence 99999999999999999999999999999933
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=333.23 Aligned_cols=256 Identities=27% Similarity=0.456 Sum_probs=210.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc-------hhhHHHHHHHHHHHHHhcCCCCeeEEeeeE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-------AISIEDVRREVKILKALSGHKHLVKFCDAC 220 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~l~~~~ 220 (601)
+|.+.+.||+|+||.||++.+.. +++.||+|.+....... ....+.+.+|+.+++.+. |+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFE 77 (272)
T ss_pred ceeecceecccCceEEEEEeecC---CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEe
Confidence 58999999999999999998865 68899999886422111 112456889999999996 99999999999
Q ss_pred ecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecc
Q 007498 221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300 (601)
Q Consensus 221 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG 300 (601)
.....+++||||+++++|.+++... +.+++..+..++.||+.||.|||+++++||||+|+||+++ .++.++|+|||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~---~~~~~~l~d~~ 153 (272)
T cd06629 78 TTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD---ADGICKISDFG 153 (272)
T ss_pred ccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc---CCCeEEEeecc
Confidence 9999999999999999999987655 6799999999999999999999999999999999999995 47899999999
Q ss_pred cccccCCCC---CccccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc--CCCC
Q 007498 301 LSDFIRPDE---RLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS--DPNF 372 (601)
Q Consensus 301 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~ 372 (601)
++....... ......|+..|+|||++.. .++.++|+|||||++|+|++|..||........+..+... ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence 987643221 1234568899999998752 3789999999999999999999999655444333333222 2223
Q ss_pred CCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 373 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+....+.++.++.+||.+||.++|.+||++.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 332335678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=346.98 Aligned_cols=260 Identities=31% Similarity=0.552 Sum_probs=207.4
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV- 223 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~- 223 (601)
++.+|++.+.||+|+||.||++++.. +++.||||++.... .......+.+|+.++++++ |+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 76 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKP---TGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPS 76 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcC---CCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeeccc
Confidence 45689999999999999999999876 78899999986422 2223456788999999996 99999999986544
Q ss_pred ----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 224 ----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 224 ----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
..+|+||||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 77 ~~~~~~~~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~---~~~~~kl~df 150 (336)
T cd07849 77 FESFNDVYIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TNCDLKICDF 150 (336)
T ss_pred ccccceEEEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEECcc
Confidence 358999999965 88776643 4799999999999999999999999999999999999995 4789999999
Q ss_pred ccccccCCCCC----ccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC----
Q 007498 300 GLSDFIRPDER----LNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---- 369 (601)
Q Consensus 300 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---- 369 (601)
|++........ ....+||..|+|||++. ..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99876543221 23357899999999764 468999999999999999999999997655433322221100
Q ss_pred -------------------CCCCCCC----CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 370 -------------------PNFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 370 -------------------~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+.....+ .+.++.++.+||.+||..||++||++.|+++||||+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000111 2356889999999999999999999999999999986644
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=331.63 Aligned_cols=254 Identities=26% Similarity=0.469 Sum_probs=206.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc--chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--C
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--TAISIEDVRREVKILKALSGHKHLVKFCDACED--V 223 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~ 223 (601)
.|++.+.||+|+||.||++.+.. ++..||+|++...... .......+.+|+.+++.++ ||||+++++++.. .
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVD---TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAE 78 (266)
T ss_pred CccccceecCCCCEEEEEEEEcC---CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCC
Confidence 58899999999999999999875 6889999998654322 2223467889999999996 9999999998875 3
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
..+++||||+++++|.+++... +.+++..++.++.|++.||.|||+++|+||||||+||+++ .++.+||+|||++.
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~---~~~~~~l~dfg~~~ 154 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASK 154 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEccCCCcc
Confidence 6789999999999999887654 4689999999999999999999999999999999999995 47889999999987
Q ss_pred ccCCC----CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 304 FIRPD----ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 304 ~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
.+... .......++..|+|||++. ..++.++|||||||++|+|++|+.||...........+..... .+..+ .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~-~ 232 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT-NPQLP-S 232 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-CCCCc-h
Confidence 65321 1123356889999999876 4689999999999999999999999977655444443332211 11111 2
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
.+++.+++|| +||..+|++||+++|+++||||+
T Consensus 233 ~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 233 HISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 4688899999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.88 Aligned_cols=254 Identities=28% Similarity=0.515 Sum_probs=209.1
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||.|++|.||++++.. +++.||||++...... .....+.+|+.+++++. |+||+++++++...+.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---TGEIVALKEIHLDAEE--GTPSTAIREISLMKELK-HENIVRLHDVIHTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---CCeEEEEEEecccccc--cchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEE
Confidence 48999999999999999999875 7889999998764322 23456778999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 228 IVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|||||+++ +|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++ .++.++|+|||++...
T Consensus 75 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~---~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAF 150 (284)
T ss_pred EEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCcEEEeecchhhhh
Confidence 99999985 8888876543 4689999999999999999999999999999999999995 4789999999999765
Q ss_pred CCCC-CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC------------
Q 007498 306 RPDE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP------------ 370 (601)
Q Consensus 306 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------ 370 (601)
.... ......++..|++||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 151 GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred cCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 4322 2234567899999998753 478999999999999999999999987766655554432210
Q ss_pred --C----CCCC-------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 371 --N----FDDL-------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 371 --~----~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
. ++.. ..+.++.++.++|.+||+.||.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 0000 012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=339.95 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=208.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|...+.||+|+||.||++++.. +++.||+|.+...... .....+.+|+.++.++.+|+||+++++++......+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKP---SGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECC---CCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 46778899999999999999876 7889999998754332 345678899999999967999999999999999999
Q ss_pred EEEeecCCCchHHHH---HH-cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 228 IVMELCEGGELLDRI---LA-RGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 228 lv~e~~~~g~L~~~~---~~-~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
+||||+.. +|.+.. .. ....+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||++
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~ 155 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGIS 155 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc---cCCcEEEeecchh
Confidence 99999964 554432 22 246799999999999999999999985 999999999999995 4788999999999
Q ss_pred cccCCCCCccccccccccccchhccC----CCCChhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHccC-CCCCCCC
Q 007498 303 DFIRPDERLNDIVGSAYYVAPEVLHR----SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSD-PNFDDLP 376 (601)
Q Consensus 303 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~-~~~~~~~ 376 (601)
..+..........|+..|+|||++.+ .++.++|||||||++|+|++|+.||..... .+.+..+.... +......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd06616 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE 235 (288)
T ss_pred HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence 77654444445578999999998863 489999999999999999999999965442 12222222221 2222222
Q ss_pred CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
+..++.++.+||.+||..||++||++.+++.||||+...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 235889999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=335.27 Aligned_cols=255 Identities=29% Similarity=0.456 Sum_probs=212.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++.+.||+|+||.||++.++. +++.||+|++...... .....+.+|+++++++. ||||+++++.+.....+|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEINE--AIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDIS 75 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcC---CCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEE
Confidence 57888999999999999999876 7889999998765322 34567889999999997 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+||||+.+++|.+++......+++..+..++.|++.||.|||+ .|++|+||||+||+++ .++.++|+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhhH
Confidence 9999999999999887655789999999999999999999999 9999999999999995 47889999999987654
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-----hhHHHHHHHccCCCCCCCCCCCC
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART-----ESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
.... ....|+..|+|||++. ..++.++|||||||++|+|++|..||.... .......+..... +..+...+
T Consensus 153 ~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 229 (265)
T cd06605 153 NSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--PRLPSGKF 229 (265)
T ss_pred HHHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--CCCChhhc
Confidence 3222 2267899999999876 468999999999999999999999996542 2233333333221 11111237
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+.++.+||.+||..||.+||++.+++.||||+..
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 8999999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=336.96 Aligned_cols=261 Identities=25% Similarity=0.420 Sum_probs=218.7
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
...|...+.||+|+||.||++++.. ++..||+|++.............+.+|+++++.+. |+||+++++++.....
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcC---CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCe
Confidence 3458889999999999999999875 67899999987654444444567889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.||||||+.| +|.+.+......+++.++..++.|++.||.|||+++|+||||+|+||+++ .++.+||+|||++...
T Consensus 100 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~---~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 100 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIA 175 (317)
T ss_pred EEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC---CCCCEEEecCCCcccc
Confidence 9999999975 78887766667799999999999999999999999999999999999995 4789999999998654
Q ss_pred CCCCCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
.. .....|+..|+|||++. +.++.++|||||||++|+|++|..||...........+....... .....++
T Consensus 176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 250 (317)
T cd06635 176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWS 250 (317)
T ss_pred CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--CCCcccc
Confidence 32 23457889999999863 458899999999999999999999998776666555555443221 1223578
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
+.+.+||.+||..+|.+||++.++++|+|+........
T Consensus 251 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 288 (317)
T cd06635 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV 288 (317)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence 89999999999999999999999999999977654443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.54 Aligned_cols=252 Identities=19% Similarity=0.329 Sum_probs=210.4
Q ss_pred CeEEcceeccCCCeEEEEEEeecCC--ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
+|++.+.||+|+||.||++...... .....||+|.+.... .......+.+|+.++..+. ||||+++++++...+.
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQP 82 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCCc
Confidence 6899999999999999999876421 234689999986442 2234567899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC
Q 007498 226 VYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~ 290 (601)
.|++|||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++ +
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~---~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---E 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc---C
Confidence 999999999999999886532 4588899999999999999999999999999999999995 4
Q ss_pred CCCeEEeecccccccCCCC---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007498 291 DADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAV 365 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i 365 (601)
++.+||+|||++....... ......+++.|+|||++. +.++.++|||||||++|||++ |..||.+....+....+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 7889999999997654322 123346788999999875 678999999999999999998 99999988877777666
Q ss_pred HccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
........ ...+++++.+|+.+||..||.+||++.|++++
T Consensus 240 ~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 65433221 14689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=329.81 Aligned_cols=255 Identities=30% Similarity=0.503 Sum_probs=211.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||++.+.. +++.||+|++...... ......+.+|+.+++.++ |+||+++++.+.....++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---TGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---CCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEE
Confidence 58999999999999999998865 6789999998765433 345678999999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++ .++.+||+|||++.....
T Consensus 76 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 76 IFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred EEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccccCC
Confidence 999999999999987654 5689999999999999999999999999999999999995 478999999999877643
Q ss_pred CCC-----ccccccccccccchhccC-C---CCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 308 DER-----LNDIVGSAYYVAPEVLHR-S---YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 308 ~~~-----~~~~~gt~~y~aPE~~~~-~---~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
... .....++..|+|||++.+ . ++.++|||||||++|+|++|..||.......................+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSL 231 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccc
Confidence 322 223578899999998863 3 7899999999999999999999997653332222222222111112233
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.+++.+.+||.+||..||.+||++.+++.|||+
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 568999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=329.86 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=207.9
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccc--cchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM--TTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-- 223 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-- 223 (601)
.|++.+.||+|+||.||.+++.. +++.||||++..... ......+.+.+|+.+++++. ||||+++++++.+.
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDAD---TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPME 78 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcC---CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCC
Confidence 68999999999999999999875 788999999864321 12234567889999999996 99999999998763
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
..+|+||||+++++|.+++... +.+++..+..++.|++.||.|||+++|+|+||||+||+++ .++.++|+|||++.
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~Dfg~~~ 154 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASK 154 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec---CCCCEEECcCcccc
Confidence 5688999999999999987654 5689999999999999999999999999999999999995 47899999999987
Q ss_pred ccCCC----CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 304 FIRPD----ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 304 ~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
..... .......|+..|+|||++. ..++.++|||||||++|+|++|+.||........+..+.... ..+.. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-~~ 232 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-TNPVL-PP 232 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCC-CCCCC-ch
Confidence 65321 1223456899999999875 468899999999999999999999997665444444433221 11211 23
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
.++..+.++|++||. +|.+||+++|++.|||++
T Consensus 233 ~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 233 HVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 578899999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.82 Aligned_cols=259 Identities=31% Similarity=0.536 Sum_probs=216.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|.....||+|+||.||++.+.. +++.||+|++..... ...+.+.+|+.+++.+. ||||+++++++..++.+|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~ 94 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELW 94 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcC---CCCEEEEEEEEeccc---chHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEE
Confidence 35566789999999999999875 678999999865432 23466889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++++|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++.....
T Consensus 95 iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~---~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISK 169 (297)
T ss_pred EEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc---cCCcEEEeechhHhhccc
Confidence 99999999999886643 4699999999999999999999999999999999999995 478999999999875543
Q ss_pred CC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 308 DE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 308 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.. .....+|+..|+|||++. ..++.++|||||||++|||++|+.||........+..+....... ...+..++.++.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 248 (297)
T cd06659 170 DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNAHKISPVLR 248 (297)
T ss_pred ccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC-ccccCCCCHHHH
Confidence 32 234467999999999886 468999999999999999999999998776666655554332221 122346789999
Q ss_pred HHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
++|.+||..+|.+||++.++++||||.+...+.-
T Consensus 249 ~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 249 DFLERMLTREPQERATAQELLDHPFLLQTGLPEC 282 (297)
T ss_pred HHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence 9999999999999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=333.00 Aligned_cols=257 Identities=27% Similarity=0.514 Sum_probs=213.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc--CCCCeeEEeeeEecCCc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACEDVNN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~ 225 (601)
.|++.+.||+|+||.||++.+.. +++.||+|++..... ......+.+|+.+++.+. .||||+++++++..+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---TGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---CCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 48889999999999999999875 778999999865422 224567889999999995 49999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+|+||+|+||+++ .++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeec
Confidence 9999999999999987644 4799999999999999999999999999999999999995 4789999999999876
Q ss_pred CCCC-CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 306 RPDE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 306 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
.... ......|+..|+|||++.+ .++.++|+|||||++|+|++|..||...........+... ..+......++.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 229 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSK 229 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCH
Confidence 5433 2344578999999998753 4789999999999999999999999766554433332222 122222234788
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
++.++|.+||..||.+||++.+++.|+||++...
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 9999999999999999999999999999987653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=329.03 Aligned_cols=249 Identities=31% Similarity=0.533 Sum_probs=211.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||++++.. +++.||+|.++.... ....+.+.+|+.+++.+. |+||+++++.+...+.+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---SDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---CCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence 48899999999999999999876 788999999865432 224567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~-~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++....
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC---CCCcEEEcccCcceeec
Confidence 99999999999988765 345689999999999999999999999999999999999995 47889999999997664
Q ss_pred CCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
... ......|+..|+|||++. ..++.++|+|||||++|+|++|..||...+.......+........ + ..++..+
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~ 228 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL--P-SHYSYEL 228 (255)
T ss_pred ccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC--C-cccCHHH
Confidence 332 233467899999999986 4689999999999999999999999988776666666655433221 1 3578999
Q ss_pred HHHHHHcccccccCCCCHHHHHcC
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.+||.+||..||.+||++.++++-
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=327.71 Aligned_cols=254 Identities=29% Similarity=0.479 Sum_probs=212.7
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc--chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
+|+..+.||+|+||.||+|.+.. +++.||+|.+...... .....+.+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCe
Confidence 47788999999999999999875 6789999998654322 1234567899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+|+||+|+||+++ .++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~---~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD---TNGVVKLADFGMAKQV 152 (258)
T ss_pred EEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccceec
Confidence 99999999999999887654 5699999999999999999999999999999999999995 4789999999998776
Q ss_pred CCCCCccccccccccccchhcc-CC-CCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH-RS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
..........|+..|+|||.+. .. ++.++|+|||||++|+|++|+.||...........+.... ..+.. ...++++
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~ 230 (258)
T cd06632 153 VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELPPI-PDHLSDE 230 (258)
T ss_pred cccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cCCCc-CCCcCHH
Confidence 5444445567899999999875 34 8999999999999999999999997665444443333211 12221 2467899
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+.+||.+||..||.+||++.+++.|||+
T Consensus 231 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 231 AKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.38 Aligned_cols=255 Identities=31% Similarity=0.543 Sum_probs=208.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+|.+.. +++.||||++..... .......+.+|+++++++. |+||+++++++..++.+|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 76 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKA---TGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLY 76 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCC---CCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEE
Confidence 69999999999999999999876 678999999865432 2223467899999999997 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||++++.+ +.+......+++.++..++.||+.||.|||+++|+||||+|+||+++ +++.+||+|||++.....
T Consensus 77 iv~e~~~~~~l-~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~---~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 77 LVFEYVERTLL-ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRA 152 (288)
T ss_pred EEEecCCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEEeeecccccCC
Confidence 99999987554 44455556799999999999999999999999999999999999995 488999999999987654
Q ss_pred CC--Cccccccccccccchhcc-C-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC--------------
Q 007498 308 DE--RLNDIVGSAYYVAPEVLH-R-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD-------------- 369 (601)
Q Consensus 308 ~~--~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------------- 369 (601)
.. ......++..|+|||++. . .++.++|||||||++|+|++|..||.+....+.+..+....
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 43 334567899999999875 4 68899999999999999999999998765544433322110
Q ss_pred CCCC-----CC--------CC-CCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 370 PNFD-----DL--------PW-PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 370 ~~~~-----~~--------~~-~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
..+. .. .+ ..++.++.+||++||..||++||++++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 00 01 1248899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=334.89 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=215.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|...+.||+|+||.||++++.. +++.||+|++.............+.+|+.+++.++ ||||+++++++.+....
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSH---TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTA 96 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECC---CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEE
Confidence 347777889999999999998865 78899999997654444445567889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+. |+|.+.+......+++.++..++.||+.||.|||++||+||||+|+||++. .++.+||+|||++....
T Consensus 97 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~---~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSS 172 (313)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC---CCCCEEEeecCCCcccC
Confidence 99999996 578888776667799999999999999999999999999999999999995 47889999999986432
Q ss_pred CCCCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 307 PDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
......|+..|+|||++. +.++.++|||||||++|+|++|..||...........+..... +......++.
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 247 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTD 247 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccCH
Confidence 233567899999999873 4588999999999999999999999987766555555443322 2222345788
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
.+++||.+||..+|.+||++.+++.||||+....
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 9999999999999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=338.23 Aligned_cols=255 Identities=28% Similarity=0.487 Sum_probs=211.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++.+.||+|+||.||++.+.. +++.||+|++..... ....+.+.+|+.+++++. |+||+++++++..+..+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR---TKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC---CCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCce
Confidence 357888999999999999998865 678999999865432 224567899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+|+||+|+||+++ .++.++|+|||++..+.
T Consensus 78 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEcccccccccc
Confidence 999999999999987643 5799999999999999999999999999999999999995 47889999999997665
Q ss_pred CCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
.... .....|+..|+|||++. ..++.++|||||||++|||++|..||...........+...... .. ...++.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~ 229 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP--TL-EGQYSKPF 229 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC--CC-CcccCHHH
Confidence 3322 23356889999999886 46889999999999999999999999765554444333322211 11 12478899
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
.++|.+||..+|.+||++.++++||||+...
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 230 KEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 9999999999999999999999999997643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=335.70 Aligned_cols=260 Identities=31% Similarity=0.533 Sum_probs=214.7
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc-chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.|++.+.||+|+||.||+|++..+..+++.||+|++...... .....+.+.+|+.+++++.+|+||+.+++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 388999999999999999998655457889999998764322 2223466789999999997799999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC---CCCCEEEeeCccceecc
Confidence 9999999999999988654 5699999999999999999999999999999999999995 47899999999997654
Q ss_pred CCC--CccccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHccCCCCCCCCC
Q 007498 307 PDE--RLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 307 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~ 377 (601)
... ......|+..|+|||++.. .++.++|||||||++|+|++|..||..... ..+...+....+.++
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 232 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---- 232 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC----
Confidence 332 2234678999999998753 478899999999999999999999964322 333333333333332
Q ss_pred CCCCHHHHHHHHHcccccccCCC-----CHHHHHcCcccCCCC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRM-----TAVQALTHPWLRDDS 415 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 415 (601)
..+++.+.+|+.+||..||.+|+ ++.+++.||||+...
T Consensus 233 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 35789999999999999999997 899999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=329.95 Aligned_cols=246 Identities=28% Similarity=0.450 Sum_probs=202.1
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
..||+|+||.||++++.. ++..||+|.+.... ....+.+.+|+.+++.++ |+||+++++++..++.+|+||||
T Consensus 14 ~~lg~g~~g~v~~~~~~~---~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 14 VVLGKGTYGIVYAARDLS---TQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred EEEecCCceEEEEeEecC---CCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEec
Confidence 479999999999999875 67889999886542 224567889999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCC-
Q 007498 233 CEGGELLDRILARGGRY--TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE- 309 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l--~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~- 309 (601)
+++++|.+++......+ ++..+..++.||+.||.|||++||+||||||+||+++. ..+.++|+|||++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~--~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCeEEEecchhheecccCCC
Confidence 99999999887654556 88999999999999999999999999999999999953 35689999999987654322
Q ss_pred CccccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHH-HH--HccCCCCCCCCCCCCCHH
Q 007498 310 RLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFR-AV--LRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 310 ~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~-~i--~~~~~~~~~~~~~~~s~~ 383 (601)
......|+..|+|||++.+ .++.++|||||||++|+|++|..||.......... .. ....+.++ ..++++
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 240 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP----ESLSAE 240 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCC----cccCHH
Confidence 2234568999999998753 37899999999999999999999997543322111 11 11111111 357899
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+.+|+.+||..+|.+||++.|++.||||
T Consensus 241 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 241 AKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=329.96 Aligned_cols=252 Identities=27% Similarity=0.486 Sum_probs=208.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||++++.. +++.||||.+.............+.+|+++++.++ ||||+++++++...+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeE
Confidence 469999999999999999999876 77899999987654444445567889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 227 YIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
|+||||+++++|.+++.. ....+++..+..++.||+.||.|||+++|+|+||||+|||++ .++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~---~~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc---CCCCEEECccccce
Confidence 999999999999887753 234589999999999999999999999999999999999995 47889999999987
Q ss_pred ccCCCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHccCCCCCCCCCCC
Q 007498 304 FIRPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 304 ~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 379 (601)
....... .....|+..|+|||.+. ..++.++|+|||||++|+|++|+.||..... ......+... .++......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEH 232 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhh
Confidence 7643322 23457889999999876 4688999999999999999999999965432 2333333221 222223345
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++..+.++|.+||..+|++||++.++++
T Consensus 233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 233 YSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred cCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 7889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=367.49 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=204.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|+++++||+|+||.||+|++.. +++.||||++...........+++.+|+++++++. ||||+++++++.+++..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~l 77 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---CSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPV 77 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEE
Confidence 479999999999999999999876 78899999997654333444567899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHc----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEE
Q 007498 227 YIVMELCEGGELLDRILAR----------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~----------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl 296 (601)
|+||||++||+|.+++... ...++...+..++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd---~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG---LFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc---CCCCEEE
Confidence 9999999999999887542 12356678899999999999999999999999999999995 4788999
Q ss_pred eecccccccCCCC-------------------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 007498 297 IDFGLSDFIRPDE-------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR 356 (601)
Q Consensus 297 ~DFG~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~ 356 (601)
+|||++....... .....+||+.|+|||++. ..++.++|||||||++|||++|+.||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999997652110 012357999999999876 46899999999999999999999999775
Q ss_pred ChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 357 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.............+ ....++..+++.+.+++.+||..||++|++..+.+.+
T Consensus 235 ~~~ki~~~~~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYRDVILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhhhhccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 54333222111111 1112234688999999999999999999887665543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=333.63 Aligned_cols=252 Identities=24% Similarity=0.397 Sum_probs=211.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|.+.+.||+|+||.||++++... ..+++.||||++..... ......+.+|+++++.+. |+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQ-HENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcC-CCCchheeeEEecCC
Confidence 4689999999999999999987643 12467899999865422 224578899999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCC
Q 007498 225 NVYIVMELCEGGELLDRILARG-------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~-------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~ 291 (601)
..|+||||+++++|.+++...+ ..+++.++..++.|++.||.|||++||+||||||+||+++ .+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc---CC
Confidence 9999999999999999886542 3478999999999999999999999999999999999995 47
Q ss_pred CCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 007498 292 ADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVL 366 (601)
Q Consensus 292 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 366 (601)
+.+||+|||++..+..... .....++..|+|||++. +.++.++|||||||++|||++ |..||......+....+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 8999999999976533221 12345678899999876 578999999999999999998 999998888777777776
Q ss_pred ccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 367 RSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 367 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
........ ..++..+.+||.+||..||.+||++.|+++
T Consensus 239 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 QGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54433222 368899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=332.95 Aligned_cols=258 Identities=31% Similarity=0.544 Sum_probs=215.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|...+.||+|++|.||++.+.. +++.||+|++.... ....+.+.+|+.+++.+. ||||+++++++...+..|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~ 92 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS---TGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELW 92 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC---CCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEE
Confidence 45556799999999999999875 67899999885432 223456889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+|+||+.+++|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++ .++.++|+|||++.....
T Consensus 93 ~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 93 VVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred EEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc---CCCcEEEcccccchhhcc
Confidence 99999999999988765 5799999999999999999999999999999999999995 478999999998875543
Q ss_pred CC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 308 DE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 308 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.. ......|+..|+|||++. ..++.++|||||||++|+|++|..||........+..+......... ....++..+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~ 246 (285)
T cd06648 168 EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRLR 246 (285)
T ss_pred CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHHH
Confidence 22 223457899999999876 46899999999999999999999999877766666655544322221 1134789999
Q ss_pred HHHHHcccccccCCCCHHHHHcCcccCCCCCCC
Q 007498 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPV 418 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 418 (601)
+||.+||..||++||++.++++||||+....+.
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 279 (285)
T cd06648 247 SFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279 (285)
T ss_pred HHHHHHcccChhhCcCHHHHccCcccccCCCcc
Confidence 999999999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=328.44 Aligned_cols=254 Identities=27% Similarity=0.505 Sum_probs=213.6
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|.+.+.||+|+||.||++.++. ++..||+|.+....... ...+.+.+|+.+++.++ |+||+++++.+.....+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---CCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEE
Confidence 48899999999999999999876 67889999987643322 23467889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+|+||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||+++. +...+||+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhcc
Confidence 9999999999999886543 35899999999999999999999999999999999999963 23457999999997765
Q ss_pred CCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
.... .....|+..|+|||++. ..++.++|+|||||++|+|++|..||...+.......+....... ..+.++.++
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 230 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSRDL 230 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---CCCCCCHHH
Confidence 4332 23356899999999875 568999999999999999999999998777666665555433221 124678999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCccc
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.++|.+||..+|++|||+.|++.||||
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=334.35 Aligned_cols=263 Identities=29% Similarity=0.468 Sum_probs=212.7
Q ss_pred CcccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCC-C----CeeEE
Q 007498 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-K----HLVKF 216 (601)
Q Consensus 142 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~----niv~l 216 (601)
.+.+..+|.++..||+|+||.|..+.+.. ++..||||+++.-. ...+..+-|+++|++|..+ | -+|++
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRE---TKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecC---CCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 45668899999999999999999999886 57899999986432 2345667899999999523 2 38889
Q ss_pred eeeEecCCcEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC------
Q 007498 217 CDACEDVNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR------ 289 (601)
Q Consensus 217 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~------ 289 (601)
.++|...++.|||+|.+ |-++++.+... ..+|+..+++.|..||+.++.|||+++++|-||||+|||+.+++
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 99999999999999999 66899988653 35699999999999999999999999999999999999997421
Q ss_pred -----------CCCCeEEeecccccccCCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 007498 290 -----------DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWART 357 (601)
Q Consensus 290 -----------~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~ 357 (601)
++..|||+|||.|.+.... ..+.+.|..|+|||++.+ +++..+||||+||||+|+++|...|+...
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 2456999999999875433 367899999999998775 89999999999999999999999998877
Q ss_pred hhH---HHHHHHccCCC-------------CCCCCCCCC--------------------------CHHHHHHHHHccccc
Q 007498 358 ESG---IFRAVLRSDPN-------------FDDLPWPSV--------------------------SPEAKDFVKRLLNKD 395 (601)
Q Consensus 358 ~~~---~~~~i~~~~~~-------------~~~~~~~~~--------------------------s~~~~~li~~~L~~d 395 (601)
..+ +++.|+...+. -....|++. -..+.|||++||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 655 33333321110 001122221 135899999999999
Q ss_pred ccCCCCHHHHHcCcccCCC
Q 007498 396 YRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 396 P~~R~s~~ell~hp~f~~~ 414 (601)
|.+|+|+.|+|.||||+..
T Consensus 394 P~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 394 PARRITLREALSHPFFARL 412 (415)
T ss_pred ccccccHHHHhcCHHhhcC
Confidence 9999999999999999754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=310.11 Aligned_cols=252 Identities=29% Similarity=0.611 Sum_probs=212.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--C
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--N 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~ 224 (601)
++|++++++|+|.|+.||.++... +++.++||+++.-+ .+.+.+|++||+.|++||||++|++...+. .
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~---~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINIT---NNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccC---CCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 479999999999999999998775 77899999986532 367899999999999999999999998765 5
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
...||+||+++.+..... ..|+..+++.++.||++||.|||+.||+|||+||.|++++. +.-.++|+|+|+|.+
T Consensus 109 tpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh--~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEF 182 (338)
T ss_pred CchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech--hhceeeeeecchHhh
Confidence 688999999987654432 36899999999999999999999999999999999999974 567899999999999
Q ss_pred cCCCCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCC-CCChhHHHHHHHc--------------
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLR-------------- 367 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~-~~~~~~~~~~i~~-------------- 367 (601)
+.++...+-.+.+.+|--||++- ..|+..-|+|||||+|..|+..+.||. +.+..+++..|.+
T Consensus 183 YHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 183 YHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred cCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 99998888889999999999875 579999999999999999999999985 4444444444321
Q ss_pred ---cCCC-------CCCCCCC---------CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 368 ---SDPN-------FDDLPWP---------SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 368 ---~~~~-------~~~~~~~---------~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
..+. ....+|. -+++++.|||.++|..|-.+|+||.|++.||||..
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 1111 1112222 24799999999999999999999999999999964
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=337.40 Aligned_cols=250 Identities=21% Similarity=0.342 Sum_probs=202.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCc--EEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQ--QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.|++.+.||+|+||.||+|+++. ++. .+|+|.+... ........+.+|+.++.++.+|+||+++++++...+.
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~---~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred hceeeeeecCCCCceEEEEEEcc---CCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 68999999999999999999865 343 4677766432 2233456788999999999559999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC
Q 007498 226 VYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~ 290 (601)
+|+||||+++++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++ .
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~---~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---E 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec---C
Confidence 999999999999999886532 3588999999999999999999999999999999999995 4
Q ss_pred CCCeEEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHcc
Q 007498 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRS 368 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~ 368 (601)
++.+||+|||++.............++..|+|||++. ..++.++|||||||++|||++ |..||......+....+...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 7889999999986432211112223466799999876 458899999999999999998 99999877766666555432
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 369 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
. .. .....+++++.+||.+||..||++||++.++|.+
T Consensus 240 ~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 Y-RL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred C-cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 11 1123578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=333.90 Aligned_cols=253 Identities=32% Similarity=0.642 Sum_probs=218.4
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|.+.+.||+|+||.||++.++. +++.||+|++.+...........+.+|+.+++++.+|+||+++++++...+.+|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKE---TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcC---CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 69999999999999999999876 788999999977555444455778899999999966999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++++|.+.+.+. +.+++..+..++.|++.||.|||++|++|+||+|+||+++ .++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~---~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 79 FVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEecCCccccccCC
Confidence 999999999999987654 5799999999999999999999999999999999999995 478999999999876543
Q ss_pred CC---------------------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 007498 308 DE---------------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV 365 (601)
Q Consensus 308 ~~---------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i 365 (601)
.. ......|+..|+|||++. ..++.++|||||||++++|++|..||........+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 21 122356789999999875 56889999999999999999999999887776666666
Q ss_pred HccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCH----HHHHcCccc
Q 007498 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTA----VQALTHPWL 411 (601)
Q Consensus 366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~----~ell~hp~f 411 (601)
......++ ..+++.+.+||.+||+.||.+||++ .++|+||||
T Consensus 235 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 235 LKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 64444333 3578999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=381.01 Aligned_cols=263 Identities=30% Similarity=0.496 Sum_probs=222.3
Q ss_pred cccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 143 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
.+..-+|+.+..||.|.||.||.|.+.. +|+..|+|-+...... ......+.+|..++..|. |||+|++||+-.+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~---tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLD---TGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVH 1305 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCC---ccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeec
Confidence 4555688889999999999999999876 8999999998764433 445677889999999996 9999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
.+.+||.||||++|+|.+.+ ..++-.++...+.|..|++.||.|||++|||||||||+||||+ .+|.+|++|||.|
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld---~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD---FNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee---cCCcEEeecccce
Confidence 99999999999999999865 4556688888999999999999999999999999999999995 4889999999999
Q ss_pred cccCCCC-----CccccccccccccchhccC----CCCChhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHH-HccCCC
Q 007498 303 DFIRPDE-----RLNDIVGSAYYVAPEVLHR----SYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAV-LRSDPN 371 (601)
Q Consensus 303 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i-~~~~~~ 371 (601)
..+.... .....+||+.|||||++.+ +...+.||||||||+.||+||+.||...+ +-.++..+ ....|.
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC
Confidence 8876543 2356789999999999863 46789999999999999999999996533 33333333 334455
Q ss_pred CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCC
Q 007498 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPV 418 (601)
Q Consensus 372 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 418 (601)
+|. .+|++.+|||.+||..||++|.++.|||+|.|-+......
T Consensus 1462 ~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1462 IPE----RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred Cch----hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence 554 4999999999999999999999999999999987765543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.73 Aligned_cols=265 Identities=26% Similarity=0.421 Sum_probs=212.8
Q ss_pred cCCCeEE-cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchh-----------hHHHHHHHHHHHHHhcCCCC
Q 007498 145 FGAKYEL-GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI-----------SIEDVRREVKILKALSGHKH 212 (601)
Q Consensus 145 ~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~h~n 212 (601)
+..+|.. .+.||.|+||.||+|+++. +++.||||++......... ....+.+|+++++.+. |+|
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 81 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTL---TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HEN 81 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECC---CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccc
Confidence 4457765 5779999999999999875 7889999998654322200 0124678999999996 999
Q ss_pred eeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCC
Q 007498 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292 (601)
Q Consensus 213 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~ 292 (601)
|+++++++.....+|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++ .++
T Consensus 82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~---~~~ 156 (335)
T PTZ00024 82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---SKG 156 (335)
T ss_pred eeeeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC---CCC
Confidence 9999999999999999999997 588887754 35799999999999999999999999999999999999995 478
Q ss_pred CeEEeecccccccCCC---------------CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 007498 293 DMRLIDFGLSDFIRPD---------------ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWA 355 (601)
Q Consensus 293 ~vkl~DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~ 355 (601)
.+||+|||++...... .......++..|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998765411 11223457889999998764 478999999999999999999999988
Q ss_pred CChhHHHHHHHccCCCCCCC------------------------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 356 RTESGIFRAVLRSDPNFDDL------------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 356 ~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
....+.+..+.......... ..+..+.++.+||.+||..||++||+++|+|.||||
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 77766665554321111000 013457889999999999999999999999999999
Q ss_pred CCCCCCC
Q 007498 412 RDDSRPV 418 (601)
Q Consensus 412 ~~~~~~~ 418 (601)
+....+.
T Consensus 317 ~~~~~~~ 323 (335)
T PTZ00024 317 KSDPLPC 323 (335)
T ss_pred CCCCCCC
Confidence 9876543
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=333.87 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=212.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++.+.||+|+||+||++++.. +++.||+|++.... .......+.+|+++++.++ ||||+++++++.....+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIP---TGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcC---CCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEE
Confidence 469999999999999999999875 67899999986542 2234577899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
||||||+++++|.+++.. .+.+++..+..++.|++.||.|||+ .+++||||||+||+++ +++.++|+|||++...
T Consensus 79 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN---SRGQIKLCDFGVSGEL 154 (284)
T ss_pred EEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC---CCCcEEEccCCcccch
Confidence 999999999999887655 3579999999999999999999997 5899999999999995 4788999999998654
Q ss_pred CCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh-----------HHHHHHHccCCCCC
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES-----------GIFRAVLRSDPNFD 373 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-----------~~~~~i~~~~~~~~ 373 (601)
... .....+|+..|+|||++. +.++.++|||||||++|+|++|..||...... +.+..+..... +
T Consensus 155 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 231 (284)
T cd06620 155 INS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--P 231 (284)
T ss_pred hhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--C
Confidence 322 223467999999999875 57889999999999999999999999764431 22223332211 1
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
..+...++.++.+||.+||.+||.+||++.|+++|+||......
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~ 275 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA 275 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 11223478899999999999999999999999999999776543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=333.01 Aligned_cols=254 Identities=30% Similarity=0.488 Sum_probs=210.7
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--CcE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--NNV 226 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~ 226 (601)
|++.+.||.|+||.||++.+.. +++.||+|++.... ........+.+|+.+++.+. |+||+++++++... +.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---TGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---CCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcE
Confidence 6788999999999999999876 67899999997654 22223456788999999996 99999999999988 899
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++ +|.+.+......+++..+..++.||+.||.|||++|++|+||||+||+++ +++.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~---~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 76 YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPYT 151 (287)
T ss_pred EEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc---CCCCEEEccccceeecc
Confidence 999999975 88888766556799999999999999999999999999999999999995 48899999999998765
Q ss_pred CCC--CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCC-----
Q 007498 307 PDE--RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW----- 377 (601)
Q Consensus 307 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----- 377 (601)
... ......++..|+|||.+.+ .++.++|||||||++|+|++|..||........+..+...........|
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 433 2334567889999997653 5789999999999999999999999887766655555432211111111
Q ss_pred ---------------------CC-CCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 378 ---------------------PS-VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 378 ---------------------~~-~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.. ++.++.++|++||..||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 12 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=346.38 Aligned_cols=254 Identities=23% Similarity=0.372 Sum_probs=203.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC--ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|++++.||+|+||.||++.+.... .....||||++.... .....+.+.+|+++|+++..|||||+++++|....
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 47999999999999999999875311 134579999986542 22345678999999999956999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC----------------------------------------------------------
Q 007498 225 NVYIVMELCEGGELLDRILARG---------------------------------------------------------- 246 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~---------------------------------------------------------- 246 (601)
.+|||||||++|+|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999998876421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC
Q 007498 247 -------------------------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289 (601)
Q Consensus 247 -------------------------------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~ 289 (601)
..+++.++..++.||+.||.|||+++|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~--- 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA--- 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe---
Confidence 2478888999999999999999999999999999999995
Q ss_pred CCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 007498 290 DDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRA 364 (601)
Q Consensus 290 ~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~ 364 (601)
.++.+||+|||+++.+..... .....++..|+|||++. ..++.++|||||||++|||++ |..||........+..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 477899999999976543222 22345678899999875 568999999999999999997 9999977544333333
Q ss_pred HHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.......... ...++.++.++|.+||..||++||++.++.+
T Consensus 352 ~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRMAK--PDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCCCC--CccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3333222221 2467899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.88 Aligned_cols=260 Identities=30% Similarity=0.479 Sum_probs=209.9
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--Cc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--NN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~ 225 (601)
.|+..++||.|++|.||++.+.. +++.||+|++...... .....+.+|+++++.++ ||||++++++|... +.
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 75 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKN---TGMIFALKTITTDPNP--DLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSS 75 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECC---CCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCe
Confidence 58899999999999999999876 6789999998754322 34567899999999996 99999999988653 47
Q ss_pred EEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 226 VYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
+|+||||+++++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++ .++.++|+|||++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~ 152 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT---RKGQVKLCDFGVS 152 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---cCCeEEEeecccc
Confidence 8999999999999876543 345689999999999999999999999999999999999995 4778999999998
Q ss_pred cccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC-----ChhHHHHHHHccC-CCCCCC
Q 007498 303 DFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR-----TESGIFRAVLRSD-PNFDDL 375 (601)
Q Consensus 303 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~-~~~~~~ 375 (601)
....... .....++..|+|||.+. ..++.++|||||||++|+|++|..||... ...+....+.... +.+...
T Consensus 153 ~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd06621 153 GELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231 (287)
T ss_pred ccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccC
Confidence 7654322 23456888999999876 57899999999999999999999999765 2233333333311 111111
Q ss_pred CC--CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 376 PW--PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 376 ~~--~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
.. ..+++.+.+||.+||..||++|||+.|++.||||+.....
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 10 1356789999999999999999999999999999876554
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=343.54 Aligned_cols=259 Identities=32% Similarity=0.510 Sum_probs=209.1
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV- 223 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~- 223 (601)
++.+|.+.+.||.|+||.||+++++. +++.||+|++..... ...+.+.+|++++++++ ||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~---~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~ 75 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSD---CDKRVAVKKIVLTDP---QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSG 75 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECC---CCcEEEEEEEecCCC---chHHHHHHHHHHHHhcC-CCcchhhHhhhcccc
Confidence 45789999999999999999999876 788999999865433 24567889999999996 99999999876543
Q ss_pred -------------CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC
Q 007498 224 -------------NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 224 -------------~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~ 290 (601)
..+|+||||++ ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++. .
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--~ 150 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--E 150 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--C
Confidence 35899999997 488876643 47999999999999999999999999999999999999963 4
Q ss_pred CCCeEEeecccccccCCCCC----ccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007498 291 DADMRLIDFGLSDFIRPDER----LNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA 364 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~ 364 (601)
++.+||+|||++........ .....|+..|+|||++. ..++.++|||||||++|+|++|+.||.+....+....
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 230 (342)
T cd07854 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230 (342)
T ss_pred CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 56799999999976533211 12346788999999764 3588999999999999999999999987766555544
Q ss_pred HHccCCCC----------------------CCC----CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 365 VLRSDPNF----------------------DDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 365 i~~~~~~~----------------------~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
+....+.. ... ..+.++.++.+||.+||..||.+||++.++|.||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 43321100 000 0235788999999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.95 Aligned_cols=262 Identities=30% Similarity=0.506 Sum_probs=210.2
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV- 223 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~- 223 (601)
+..+|.+.+.||+|+||.||++++.. +++.||||.+..... .......+.+|+.+++.+. |+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~ 77 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSE---TNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPH 77 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecC---CCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCccchHHheeccc
Confidence 34579999999999999999999875 788999999865422 2223456778999999996 99999999987654
Q ss_pred ----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 224 ----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 224 ----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
..+||||||+. ++|.+++.. .+.+++..+..++.||+.||.|||+++++||||||+||+++ .++.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~---~~~~~kL~Df 152 (337)
T cd07858 78 REAFNDVYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICDF 152 (337)
T ss_pred ccccCcEEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECcC
Confidence 35899999996 588887654 46799999999999999999999999999999999999995 4788999999
Q ss_pred ccccccCCC-CCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc--------
Q 007498 300 GLSDFIRPD-ERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-------- 368 (601)
Q Consensus 300 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-------- 368 (601)
|++...... .......++..|+|||++. ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 999766443 2234457899999999875 35899999999999999999999999765443332222210
Q ss_pred ---------------CCCCCC----CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 369 ---------------DPNFDD----LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 369 ---------------~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
.+.... ..++.+++++.+||++||+.||++|||+.++|+||||.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 000000 113468899999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=326.97 Aligned_cols=246 Identities=25% Similarity=0.405 Sum_probs=207.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||++++.. +..||||.+..... ..+.+.+|+.+++++. ||||+++++++.....+|
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~----~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIY 75 (256)
T ss_pred HeEEeeEecCcccceEEEEEecC----CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcE
Confidence 58999999999999999998753 34699999865432 2356889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+.+|+|.+++......+++..+..++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++.....
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD---DQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCCEEECCCccceecCC
Confidence 99999999999998876555799999999999999999999999999999999999995 478899999999876543
Q ss_pred CCCc--cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 308 DERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 308 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.... ....++..|+|||++. ..++.++|||||||++|+|++ |..||...........+......... ...+..
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 229 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEK 229 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHH
Confidence 3211 1234567899999886 568999999999999999998 99999877777777777665433222 246889
Q ss_pred HHHHHHHcccccccCCCCHHHHHcC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+.+++.+||..||.+||++.+++.+
T Consensus 230 ~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 230 VYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=326.93 Aligned_cols=255 Identities=31% Similarity=0.480 Sum_probs=215.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++.+.||+|++|.||+|++.. +++.||||++...... .....+.+|+.++.++. |+||+++++++.....+|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEIS 75 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEE
Confidence 58999999999999999999876 7889999998765322 34577899999999997 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++ .++.++|+|||++....
T Consensus 76 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~---~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLE 151 (264)
T ss_pred EEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC---CCCCEEEccCccceecc
Confidence 999999999999988655 679999999999999999999999 9999999999999995 48899999999998765
Q ss_pred CCCCc-cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHccCCCCCCCCCCCCC
Q 007498 307 PDERL-NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 307 ~~~~~-~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
..... ....++..|+|||.+. +.++.++|+||||+++|+|++|..||.... ..+....+..... .......++
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 229 (264)
T cd06623 152 NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP--PSLPAEEFS 229 (264)
T ss_pred cCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC--CCCCcccCC
Confidence 43332 2567899999999876 568899999999999999999999997663 3444444443222 111212278
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
..+.++|.+||..+|++||++.++++||||+..
T Consensus 230 ~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 230 PEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=327.96 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=211.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||+|+++....+...||||+++... .......+.+|+.+++.++ ||||+++++++...+.+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence 36899999999999999999986533345689999986543 2334567889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++....+.+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCCEEECccchhhccc
Confidence 999999999999999877667899999999999999999999999999999999999995 47889999999998764
Q ss_pred CCC-Cc--cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 307 PDE-RL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 307 ~~~-~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
... .. ....++..|+|||.+. ..++.++|||||||++|+|++ |..||...........+...... +. ...++
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~ 234 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-PP--PMDCP 234 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-CC--CCCCC
Confidence 211 11 1234567899999876 568999999999999999998 99999887777666666543221 11 13578
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..+.+|+.+||..+|++||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=339.56 Aligned_cols=261 Identities=29% Similarity=0.486 Sum_probs=204.7
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--Cc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--NN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~ 225 (601)
+|++.+.||+|+||.||+|.+... ..++.||||++...........+.+.+|+.+++.+. ||||+++++++.+. ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCce
Confidence 488999999999999999998642 147899999997744222333466788999999996 99999999999988 88
Q ss_pred EEEEEeecCCCchHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec-CCCCCCeEEeecc
Q 007498 226 VYIVMELCEGGELLDRILAR----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFG 300 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~-~~~~~~vkl~DFG 300 (601)
+|+||||+++ +|.+.+... ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.++.+||+|||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999999975 677766432 236899999999999999999999999999999999999963 2237889999999
Q ss_pred cccccCCCCC----ccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhH---------HHHHH
Q 007498 301 LSDFIRPDER----LNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESG---------IFRAV 365 (601)
Q Consensus 301 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~---------~~~~i 365 (601)
++........ ....+++..|+|||++.+ .++.++|||||||++|+|++|+.||.+..... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9986543221 234578999999998753 58999999999999999999999997554321 11111
Q ss_pred HccC--------------C-------CCCCCCCC------------CCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 366 LRSD--------------P-------NFDDLPWP------------SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 366 ~~~~--------------~-------~~~~~~~~------------~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+... + ......++ ..+.++.++|.+||..||++|||+.|+++||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 1100 0 00000111 467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=329.41 Aligned_cols=249 Identities=32% Similarity=0.546 Sum_probs=213.4
Q ss_pred eccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeecC
Q 007498 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234 (601)
Q Consensus 155 lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 234 (601)
||.|+||.||++++.. +++.||+|++...........+.+.+|+++++++. |+||+++++.+..+...|+||||++
T Consensus 1 lg~g~~~~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCC
Confidence 6899999999999875 68899999997665444445678899999999996 9999999999999999999999999
Q ss_pred CCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCC-----
Q 007498 235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE----- 309 (601)
Q Consensus 235 ~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~----- 309 (601)
+++|.+++.+. +.+++..+..++.||+.||.|||+++|+|+||+|+||+++ .++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 77 GGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc---CCCCEEEEecccchhcccCcccccc
Confidence 99999887654 4799999999999999999999999999999999999995 47899999999987653321
Q ss_pred ----Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 310 ----RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 310 ----~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
......++..|+|||++. ..++.++|||||||++|+|++|..||...........+......++.. ..++..+
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 230 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEA 230 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHH
Confidence 223457889999999875 458899999999999999999999998888777777776644443321 2358999
Q ss_pred HHHHHHcccccccCCCCH---HHHHcCcccCC
Q 007498 385 KDFVKRLLNKDYRKRMTA---VQALTHPWLRD 413 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~---~ell~hp~f~~ 413 (601)
.+||.+||..+|.+||++ .++|+||||++
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 999999999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=324.50 Aligned_cols=243 Identities=24% Similarity=0.371 Sum_probs=200.0
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+++++. +++.||+|.+.... .......+.+|+++++.+. ||||+++++++.....+||||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---DNTPVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEec---CCceEEEEecCccC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEee
Confidence 469999999999999876 67899999875432 2234567899999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCcc
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~ 312 (601)
+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++..........
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~~ 151 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYAS 151 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc---CCCcEEECccccCcccccccccc
Confidence 999999998876666799999999999999999999999999999999999995 47889999999987644321111
Q ss_pred ---ccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHH
Q 007498 313 ---DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387 (601)
Q Consensus 313 ---~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 387 (601)
...++..|+|||.+. +.++.++|||||||++|+|++ |..||...........+...... . ....++..+.+|
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l 228 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL-P--CPELCPDAVYRL 228 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC-C--CcccCCHHHHHH
Confidence 112345699999876 568999999999999999997 89999776665555555443221 1 123578999999
Q ss_pred HHHcccccccCCCCHHHHHc
Q 007498 388 VKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 388 i~~~L~~dP~~R~s~~ell~ 407 (601)
+.+||..||++||++.++++
T Consensus 229 i~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 229 MERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=332.35 Aligned_cols=254 Identities=29% Similarity=0.464 Sum_probs=207.6
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
|++.+.||.|++|.||++.+.. +++.||+|++....... .....+.+|+++++.++ |+||+++++++.+.+..|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---TGEIVALKKIRLETEDE-GVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---CCCEEEEEEeecccccc-cchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEE
Confidence 6778899999999999999876 78899999987653322 23356788999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 229 VMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||++ ++|.+++.... ..+++..+..++.|++.||.|||+++++||||+|+||+++ .++.++|+|||++.....
T Consensus 76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCC
Confidence 999995 58888876543 3689999999999999999999999999999999999995 488999999999976542
Q ss_pred CC-CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC-------------
Q 007498 308 DE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN------------- 371 (601)
Q Consensus 308 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------- 371 (601)
.. ......++..|+|||++.+ .++.++|||||||++|+|++|..||........+..+.+....
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 22 2233467889999998753 4789999999999999999999999877665444443321100
Q ss_pred -----CC-------CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 372 -----FD-------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 372 -----~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
++ ....+.++.++.++|.+||+.||.+||++.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00 01124678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=337.37 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=205.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC-ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+|++.+.||+|+||.||++++.... .....||+|++.... .......+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence 36999999999999999999876421 123459999986432 2234567889999999996 99999999998764 5
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.++|+||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~---~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec---CCCcEEEccccccccc
Confidence 7899999999999999887666799999999999999999999999999999999999995 4788999999999876
Q ss_pred CCCCCc---cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 306 RPDERL---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 306 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
...... ....++..|+|||++. ..++.++|||||||++|||++ |..||.+....++. .+......++.. +.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~--~~~ 236 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQP--PIC 236 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCCC--CCC
Confidence 543322 2233467899999876 578999999999999999997 99999876665544 333333333322 357
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+.++.+++.+||..||.+||++.+++.+
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=329.75 Aligned_cols=259 Identities=20% Similarity=0.347 Sum_probs=209.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|++.+.||+|+||.||++.++.. ...+..||+|.+..... ......+.+|+.+++.+. |+||+++++++....
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 82 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFT-CHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCC
Confidence 4799999999999999999976521 12356899998764432 223345788999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeE
Q 007498 225 NVYIVMELCEGGELLDRILARG---------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~---------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vk 295 (601)
..|+||||+++|+|.+++.... ..++...+..++.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~---~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---CCCcEE
Confidence 9999999999999999986532 2356778999999999999999999999999999999995 478899
Q ss_pred EeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCC
Q 007498 296 LIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDP 370 (601)
Q Consensus 296 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~ 370 (601)
|+|||+++.+..... .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+....+....+.....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999876533221 12234567899999875 578999999999999999998 7889988777776666554322
Q ss_pred CCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc------CcccCCC
Q 007498 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT------HPWLRDD 414 (601)
Q Consensus 371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~------hp~f~~~ 414 (601)
. ..+ ..+++.+.+++.+||..||++||++.++++ ||||++.
T Consensus 240 ~--~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 240 L--DQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred C--CCC-CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 1 111 256789999999999999999999999987 9999764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=341.61 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=203.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeec--CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-C
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-V 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~ 223 (601)
++|++.+.||+|+||.||+|++.. ...+++.||+|++.... .......+.+|+.+++++.+|+||++++++|.. +
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 479999999999999999997643 12356789999986432 222345678899999999559999999998764 4
Q ss_pred CcEEEEEeecCCCchHHHHHHcC---------------------------------------------------------
Q 007498 224 NNVYIVMELCEGGELLDRILARG--------------------------------------------------------- 246 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~--------------------------------------------------------- 246 (601)
..+++||||+++++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 67899999999999998875421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCC---cccccccccc
Q 007498 247 ---GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYY 320 (601)
Q Consensus 247 ---~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y 320 (601)
..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+..... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 2588999999999999999999999999999999999995 478899999999987643221 2234567789
Q ss_pred ccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccC
Q 007498 321 VAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRK 398 (601)
Q Consensus 321 ~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 398 (601)
+|||++. ..++.++|||||||++|||++ |..||.+....+.+...+....... .+ ...++++.+++.+||+.+|++
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~l~~~cl~~~p~~ 319 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR-AP-EYATPEIYSIMLDCWHNNPED 319 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC-CC-ccCCHHHHHHHHHHccCChhh
Confidence 9999875 579999999999999999997 9999987554444444433322111 11 357899999999999999999
Q ss_pred CCCHHHHHcC
Q 007498 399 RMTAVQALTH 408 (601)
Q Consensus 399 R~s~~ell~h 408 (601)
||++.|+++|
T Consensus 320 RPs~~ell~~ 329 (337)
T cd05054 320 RPTFSELVEI 329 (337)
T ss_pred CcCHHHHHHH
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=329.15 Aligned_cols=252 Identities=27% Similarity=0.494 Sum_probs=209.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||++++.. +++.||||.+.............+.+|+.+++.+. |+||+++++++..++.+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeE
Confidence 368899999999999999999876 77899999887655444445677889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 227 YIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~ 154 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEECcchhhh
Confidence 999999999999987753 245689999999999999999999999999999999999995 47889999999987
Q ss_pred ccCCCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHccCCCCCCCCCCC
Q 007498 304 FIRPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES--GIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 304 ~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 379 (601)
....... .....|+..|+|||++. ..++.++|+|||||++|+|++|..||.+.... .....+... .++..++..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDH 232 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCccc
Confidence 6643322 33457899999999886 46889999999999999999999999765432 222333222 223333346
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++.++.+||.+||..||.+|||+.++++
T Consensus 233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 233 YSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 8899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.50 Aligned_cols=262 Identities=31% Similarity=0.554 Sum_probs=210.6
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec---
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--- 222 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--- 222 (601)
+.+|++.+.||+|+||.||++.++. +++.||+|++..... .......+.+|+.+++++. ||||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGA 78 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC---CCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCC
Confidence 4579999999999999999999876 788999999875432 2224566788999999996 9999999998753
Q ss_pred -CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 223 -VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 223 -~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
...+|+||||+. ++|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~ 153 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGDFGM 153 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEeccccc
Confidence 356899999996 588877654 45699999999999999999999999999999999999995 488999999999
Q ss_pred ccccCCCCC-----ccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc------
Q 007498 302 SDFIRPDER-----LNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS------ 368 (601)
Q Consensus 302 a~~~~~~~~-----~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~------ 368 (601)
+........ ....+|+..|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 976543221 23457899999999875 35899999999999999999999999776544333222211
Q ss_pred -----------------CCCCCCCC----CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 369 -----------------DPNFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 369 -----------------~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
........ ++.++.++.++|++||+.||.+||++.+++.||||.....+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 11111111 24578999999999999999999999999999999866554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=332.33 Aligned_cols=253 Identities=20% Similarity=0.331 Sum_probs=204.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++.+.||+|+||.||+|+.+... ....+++|.++.. ......+.+.+|+.++.++.+||||+++++++...+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-LKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-CcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 36899999999999999999886521 1235788887532 22234567889999999995599999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCC
Q 007498 227 YIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~ 291 (601)
|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---EN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC---CC
Confidence 99999999999999886532 3588999999999999999999999999999999999995 47
Q ss_pred CCeEEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccC
Q 007498 292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSD 369 (601)
Q Consensus 292 ~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 369 (601)
+.+||+|||++..............+..|+|||++. ..++.++|||||||++|||++ |..||...........+....
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 889999999986432211112223355799999875 568999999999999999997 999998877777666665432
Q ss_pred CCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.. . ....++.++.+||.+||..||.+||+++++++.
T Consensus 236 ~~-~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RM-E--KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC-C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 1 113588999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=333.05 Aligned_cols=261 Identities=27% Similarity=0.489 Sum_probs=214.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++.+.||+|+||.||++.+.. ++..||+|.+..... ...+.+.+|+.+++.+. ||||+++++++.....
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA---TGQEVAIKQMNLQQQ---PKKELIINEILVMRENK-HPNIVNYLDSYLVGDE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC---CCCEEEEEEeccccc---hHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCc
Confidence 3589999999999999999998765 678899999854322 23467889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.|+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++ .++.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~---~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc---CCCCEEEccCcceecc
Confidence 9999999999999988754 3689999999999999999999999999999999999995 4788999999998765
Q ss_pred CCCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc-CCCCCCCCCCCCCH
Q 007498 306 RPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-DPNFDDLPWPSVSP 382 (601)
Q Consensus 306 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~ 382 (601)
.... ......|+..|+|||++. +.++.++|||||||++|+|++|..||........+..+... .+.+. .+..++.
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 243 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ--NPEKLSA 243 (293)
T ss_pred cccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCC--CccccCH
Confidence 4332 233457899999999875 56899999999999999999999999766554433322221 11111 2235788
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCCh
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPL 420 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 420 (601)
.+.+||.+||..+|.+||++.+++.|+||+....-..+
T Consensus 244 ~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~ 281 (293)
T cd06647 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSL 281 (293)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccc
Confidence 99999999999999999999999999999876543333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.47 Aligned_cols=285 Identities=27% Similarity=0.465 Sum_probs=232.5
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec---
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--- 222 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--- 222 (601)
...|++...||+|.+|.||+++.++ +++..|+|++....- ..+++..|.+||+.+.+|||++.+|++|..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~---~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVK---TGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeee---cCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 4579999999999999999999987 888999999865432 236678899999999999999999999853
Q ss_pred --CCcEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 223 --VNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 223 --~~~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
++.+|||||||.||+..|++..- +.++.|..|..|++.++.||.+||.+.+||||||-.|||++. ++.|||+||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~---e~~VKLvDF 167 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTE---NAEVKLVDF 167 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEec---cCcEEEeee
Confidence 46799999999999999988653 667999999999999999999999999999999999999975 899999999
Q ss_pred ccccccCCC-CCccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCC
Q 007498 300 GLSDFIRPD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF 372 (601)
Q Consensus 300 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 372 (601)
|.+..+... .+..+.+||++|||||++. ..|+..+|+||||++..||.-|.+|+...-....+-.|.++. ..
T Consensus 168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PP 246 (953)
T KOG0587|consen 168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PP 246 (953)
T ss_pred eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-Cc
Confidence 999877543 4467789999999999874 247889999999999999999999997655443333333222 22
Q ss_pred CCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCChhHHHHHHHHhhhccCchhHHHHHHh
Q 007498 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHATPFKRAALKAL 445 (601)
Q Consensus 373 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~k~~~~~~~l~~~~~~~~ 445 (601)
.-..|..++.++.+||..||.+|..+||+..++|.|||+++.+ +...+...+++-...++..+......
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~----~e~qir~~ik~~~~~~r~~k~~~e~~ 315 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP----NERQVRIQIKDHIDRSRKKRGEKEET 315 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc----cHHHHHHHHHHHHhhccchhhhccCc
Confidence 2223567899999999999999999999999999999999443 55555555565555555444444333
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.99 Aligned_cols=256 Identities=19% Similarity=0.290 Sum_probs=207.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
..|.+.+.||+|+||.||+|.+... ......||+|.+.... .......+.+|+.+++.+. |+||+++++++.+..
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 82 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFERL 82 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence 4699999999999999999988641 1145789999875432 2223456889999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 225 NVYIVMELCEGGELLDRILARG------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..|+||||++|++|.+++.... ..+++..+..++.||+.||.|||+++++||||||+|||++.+.....+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999886643 2589999999999999999999999999999999999997533345799999
Q ss_pred cccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCC
Q 007498 299 FGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFD 373 (601)
Q Consensus 299 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~ 373 (601)
||+++.+..... ......+..|+|||++. +.++.++|||||||++|+|++ |..||......+....+...... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL-D 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-C
Confidence 999976632211 11223356799999875 579999999999999999997 99999887776666555443221 1
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
....++..+.+++.+||..||++||++.++++|
T Consensus 242 --~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 --PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 114678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.02 Aligned_cols=254 Identities=18% Similarity=0.325 Sum_probs=206.8
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
..+|++.+.||+|+||.||+++++.. ...+..||||++.... .......+.+|+.+++.+. |+||+++++++..+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~ 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC
Confidence 35799999999999999999987531 1245789999885432 2223456889999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCe
Q 007498 224 NNVYIVMELCEGGELLDRILARG---------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~---------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~v 294 (601)
...++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||++ .++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~---~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---CCCCE
Confidence 99999999999999999886532 2357788999999999999999999999999999999995 47899
Q ss_pred EEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccC
Q 007498 295 RLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSD 369 (601)
Q Consensus 295 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 369 (601)
||+|||++..+..... .....++..|+|||++. +.++.++|||||||++|||++ |..||.+......+..+....
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876533221 11235578899999876 568999999999999999999 789998877777766665543
Q ss_pred CCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.... + ..++..+.++|.+||..||++||++.|++++
T Consensus 239 ~~~~--~-~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LLDK--P-DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cCCC--C-CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2111 1 3578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=325.14 Aligned_cols=246 Identities=24% Similarity=0.401 Sum_probs=205.6
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+++++ .+..+|+|++.+... ....+.+|+.+++.+. |+||+++++++...+..|
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR----GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIF 75 (256)
T ss_pred HcchhhhhccCCCceEEEeEec----CCccEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceE
Confidence 5889999999999999999875 346799999865432 2356788999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++++|.+++....+.+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLD 152 (256)
T ss_pred EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC---CCCcEEECCcccceeccc
Confidence 99999999999999877666799999999999999999999999999999999999995 478899999999876543
Q ss_pred CCCc--cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 308 DERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 308 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.... ....++..|+|||++. ..++.++|||||||++|+|++ |..||......+....+...... . ....++.+
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~ 229 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL-Y--RPKLAPTE 229 (256)
T ss_pred ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC-C--CCCCCCHH
Confidence 2211 1122345799999876 578999999999999999999 89999877777766666543221 1 11357999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+.+++.+||..+|++||++.|+++.
T Consensus 230 ~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 230 VYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=329.37 Aligned_cols=251 Identities=24% Similarity=0.400 Sum_probs=208.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
..|.+.+.||+|+||.||++.+... ..++..||+|.+.... ......+.+|+.+++++. ||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence 4699999999999999999986432 1245679999886532 234567899999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCC
Q 007498 225 NVYIVMELCEGGELLDRILARG------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~ 292 (601)
.+|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ +++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~---~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---cCC
Confidence 9999999999999999886542 2489999999999999999999999999999999999995 478
Q ss_pred CeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHc
Q 007498 293 DMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLR 367 (601)
Q Consensus 293 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~ 367 (601)
.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||...........+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999976543221 12334577899999886 568999999999999999998 9999988877777777766
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 368 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
...... ...++.++.+|+.+||..||.+|||+.+++.
T Consensus 238 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 GRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 543211 1357899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=322.60 Aligned_cols=253 Identities=32% Similarity=0.582 Sum_probs=217.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||.|+||.||++.+.. ++..||+|++...... ......+.+|+++++.++ |+|++++++.+......+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---CCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEE
Confidence 48899999999999999999876 6789999998765432 234567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 228 IVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~---~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+||||+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++ .++.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~---~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT---SNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc---CCCcEEECCccceee
Confidence 999999999999988765 37799999999999999999999999999999999999995 478999999999976
Q ss_pred cCCCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 305 IRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 305 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
..... ......|++.|+|||.+. ..++.++|+||+|+++++|++|..||................. ...+ ..++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~-~~~~~ 229 (258)
T cd08215 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY--PPIP-SQYSS 229 (258)
T ss_pred cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC--CCCC-CCCCH
Confidence 64433 234467899999999875 5688999999999999999999999987776666666655432 2222 26789
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
++.++|.+||..+|++||++.++|+||||
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=332.24 Aligned_cols=259 Identities=27% Similarity=0.405 Sum_probs=210.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++.+.||+|+||.||++.+.. +++.||||++.+.... .....+.+|+.++.++.+|+||+++++++.....+
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECC---CCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 469999999999999999999875 6789999999764322 23455677888887776799999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+.+ +|.+.+......+++..+..++.||+.||.|||+ .||+||||+|+||+++ .++.+||+|||++..+
T Consensus 90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~---~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD---ASGNVKLCDFGISGRL 165 (296)
T ss_pred EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc---CCCCEEECccccchhc
Confidence 999999954 7777666655689999999999999999999997 5999999999999995 4789999999999776
Q ss_pred CCCCCccccccccccccchhccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHccCCCCCCCCCCC
Q 007498 306 RPDERLNDIVGSAYYVAPEVLHR-----SYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
..........++..|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+.+..+......... ....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 244 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP-PNEG 244 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC-CCCC
Confidence 54443444568889999998753 37899999999999999999999997532 23444444443321111 1124
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
++.++.+||.+||..||.+||++.+++.||||+...
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 789999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=329.21 Aligned_cols=255 Identities=30% Similarity=0.473 Sum_probs=209.1
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc--CCCCeeEEeeeEecCCc-
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACEDVNN- 225 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~- 225 (601)
|++.+.||+|+||.||+++++. +++.||+|++....... .....+.+|+.+++++. +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---CCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 6788999999999999999875 67899999997543322 22345678888888774 49999999999988776
Q ss_pred ----EEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecc
Q 007498 226 ----VYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300 (601)
Q Consensus 226 ----~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG 300 (601)
+|++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||+++|+|+||+|+||+++ .++.+||+|||
T Consensus 77 ~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~---~~~~~~l~dfg 152 (287)
T cd07838 77 RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFG 152 (287)
T ss_pred CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc---cCCCEEEeccC
Confidence 9999999975 7888776543 3599999999999999999999999999999999999995 46899999999
Q ss_pred cccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC--------
Q 007498 301 LSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN-------- 371 (601)
Q Consensus 301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------- 371 (601)
++..+..........++..|+|||++. ..++.++|||||||++|+|++|.+||......+.+..+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 153 LARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred cceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 998765554445567889999999876 56899999999999999999999999887777666655432110
Q ss_pred --------CCCC-------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 372 --------FDDL-------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 372 --------~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+... ..+.++..+.+||.+||..||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0000 012456888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=324.17 Aligned_cols=246 Identities=25% Similarity=0.422 Sum_probs=206.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|+++++||+|+||.||++... .+..||+|.+..... ..+.+.+|+.+++.++ |+||+++++++......
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN----NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPI 76 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec----CCceEEEEEccCCch----hHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCc
Confidence 47999999999999999999865 456799998764322 3467889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+++++|.+++... ...+++..+..++.|++.||.|||+++++||||||+||+++ .++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVI 153 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec---CCCcEEECCCccceec
Confidence 9999999999999988653 45689999999999999999999999999999999999995 4788999999999776
Q ss_pred CCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
..... .....++..|+|||++. +.++.++|||||||++|+|++ |..||...........+..... .+ ....++
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~ 230 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-MP--RMENCP 230 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-CC--CCCCCC
Confidence 43321 12234567899999876 568999999999999999998 9999988777776666654422 22 224688
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.++.+++.+||..||++||+++++++
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 231 DELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=335.38 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=206.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC---
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--- 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--- 223 (601)
.+|++.+.||+|+||.||+|+++. +++.||||++........ ....+.+|+++++.++ |+||+++++++...
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKDG-FPITALREIKILKKLK-HPNVVPLIDMAVERPDK 82 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcC-CCCccchhhheeccccc
Confidence 579999999999999999999876 778999999865432221 2245678999999996 99999999987543
Q ss_pred -----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 224 -----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..+|+||||+.+ +|...+......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 83 ~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~---~~~~~~l~d 158 (311)
T cd07866 83 SKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID---NQGILKIAD 158 (311)
T ss_pred ccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECc
Confidence 357999999965 77777766566899999999999999999999999999999999999995 488999999
Q ss_pred cccccccCCCCC------------ccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007498 299 FGLSDFIRPDER------------LNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA 364 (601)
Q Consensus 299 FG~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~ 364 (601)
||++........ .....|++.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999976532211 123467889999998753 589999999999999999999999988777665555
Q ss_pred HHccCCCCCC--------------------------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 365 VLRSDPNFDD--------------------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 365 i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+......... ..+..+++++.+||.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 4432111000 0012456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=338.88 Aligned_cols=260 Identities=27% Similarity=0.519 Sum_probs=211.5
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++++.||+|+||.||++.+.. +++.||||++.... ........+.+|+.+++.+. |+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 86 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPD 86 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECC---CCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCC
Confidence 356789999999999999999999876 78899999986532 22223456889999999996 99999999998765
Q ss_pred C------cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 224 N------NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 224 ~------~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
. .+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~ 160 (343)
T cd07880 87 LSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKIL 160 (343)
T ss_pred ccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEe
Confidence 3 468999999 6788876643 4799999999999999999999999999999999999995 47889999
Q ss_pred ecccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC----
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN---- 371 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---- 371 (601)
|||++..... ......++..|+|||++.+ .++.++|+|||||++|+|++|..||.+......+..+......
T Consensus 161 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 161 DFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred eccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999976543 2334578899999998763 5889999999999999999999999876655544444332111
Q ss_pred -------------------CCC----CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 372 -------------------FDD----LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 372 -------------------~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+.. ..++.+++++.++|.+||..||.+|||+.+++.||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 000 012467889999999999999999999999999999986533
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=332.26 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=215.7
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
....|...+.||+|+||.||+++++. +++.||+|.+.............+.+|+++++.+. |+|++++++++....
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 88 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH 88 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcC---CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCC
Confidence 34468888999999999999999876 67899999987543333334567889999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
..|+||||+. |+|.+.+......+++..+..++.|++.||.|||+++++||||||+|||++ .++.+||+|||++..
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~ 164 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASI 164 (308)
T ss_pred eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC---CCCcEEECCccccee
Confidence 9999999996 588887766666799999999999999999999999999999999999995 478999999999876
Q ss_pred cCCCCCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
.... ....|+..|+|||++. +.++.++|||||||++|+|++|..||...........+..... +......+
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~ 239 (308)
T cd06634 165 MAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHW 239 (308)
T ss_pred ecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--CCcCcccc
Confidence 5432 3456889999999863 4578899999999999999999999987655544444443322 11112357
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
+..+.+||++||..+|.+||++.++++|||+.....+
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred cHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 8899999999999999999999999999999886443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=364.20 Aligned_cols=149 Identities=31% Similarity=0.546 Sum_probs=134.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|.++++||+|+||.||+|++.. +++.||||++.+...........+.+|+.+++.+. |+||+++++++.....+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~ 79 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNV 79 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEE
Confidence 479999999999999999999876 78899999998765555555678899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
||||||+.|++|.+++... +.+++..++.|+.||+.||.|||.++||||||||+|||++ .++.+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~---~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc---CCCCEEEEeCCCCc
Confidence 9999999999999887654 5799999999999999999999999999999999999995 47899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.53 Aligned_cols=257 Identities=27% Similarity=0.456 Sum_probs=209.2
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC-
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN- 224 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~- 224 (601)
..+|++.+.||+|+||.||++.++. +++.||+|++....... .....+.+|+.+++.++ ||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKD---TGELVALKKVRLDNEKE-GFPITAIREIKILRQLN-HRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECC---CCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCC-CCCeeeeeheecCcch
Confidence 3579999999999999999999875 67899999987543222 23356778999999996 999999999987654
Q ss_pred ---------cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeE
Q 007498 225 ---------NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295 (601)
Q Consensus 225 ---------~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vk 295 (601)
.+||||||+++ +|.+.+......+++..+..++.||+.||.|||++||+||||||+||+++ .++.+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~k 156 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIK 156 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCcEE
Confidence 79999999976 77777766556799999999999999999999999999999999999995 478999
Q ss_pred EeecccccccCCCC--CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC
Q 007498 296 LIDFGLSDFIRPDE--RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 296 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
|+|||++....... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999997764332 1223456888999998753 4789999999999999999999999876665555444332110
Q ss_pred CCC--------------------------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 372 FDD--------------------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 372 ~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
... ..+..++..+.+||.+||..||++||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 000 0123578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.56 Aligned_cols=251 Identities=34% Similarity=0.595 Sum_probs=212.6
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|.+.+.||+|++|.||++.+.. +++.|++|++..... .....+.+|+.+++.+. |+||+++++++......+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---CCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEE
Confidence 37888999999999999999875 678999999866433 24577899999999997 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+|+||+++++|.+++......+++..+..++.|++.||.|||.+|++||||+|+||+++ .++.++|+|||++.....
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeeccccccccc
Confidence 99999999999998876656899999999999999999999999999999999999995 478999999999987765
Q ss_pred CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC-CCCHHHH
Q 007498 308 DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-SVSPEAK 385 (601)
Q Consensus 308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~s~~~~ 385 (601)
........|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+.... ....... .++..+.
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 228 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG--PPGLRNPEKWSDEFK 228 (253)
T ss_pred cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC--CCCcCcccccCHHHH
Confidence 44345567899999999876 457899999999999999999999997765444443333321 1111212 2489999
Q ss_pred HHHHHcccccccCCCCHHHHHcCcc
Q 007498 386 DFVKRLLNKDYRKRMTAVQALTHPW 410 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~hp~ 410 (601)
++|.+||..||++|||+.|+|.|||
T Consensus 229 ~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 229 DFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHccCChhhCCCHHHHhcCCC
Confidence 9999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=325.95 Aligned_cols=252 Identities=21% Similarity=0.342 Sum_probs=205.5
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc---
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN--- 225 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--- 225 (601)
|++++.||+|+||.||.|........+..||||++..... .......+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence 5788999999999999998765333457899999875432 2334567899999999996 9999999998866544
Q ss_pred ---EEEEEeecCCCchHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 226 ---VYIVMELCEGGELLDRILAR-----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 226 ---~~lv~e~~~~g~L~~~~~~~-----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
.++||||+++|+|..++... ...+++..+..++.|++.||.|||+++|+||||||+||+++ +++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR---EDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC---CCCeEEEC
Confidence 89999999999998887542 23589999999999999999999999999999999999995 47899999
Q ss_pred ecccccccCCCCCc---cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCC
Q 007498 298 DFGLSDFIRPDERL---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNF 372 (601)
Q Consensus 298 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 372 (601)
|||+++........ ....++..|+|||++. ..++.++|||||||++|||++ |..||.+....+.+..+......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 234 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL- 234 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence 99999866433221 1234567899999876 568999999999999999999 89999887777777666554321
Q ss_pred CCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 373 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..+ ..++.++.++|.+||..||.+||++.|++.+
T Consensus 235 -~~~-~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 -KQP-EDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -CCC-cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 3678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=342.20 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=212.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCc-cCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGEL-KDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
+-.+.++||+|+||.||+++.+.... ....||||..+............+.+|.++|++|. |||||+|||+......+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEEPL 236 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCcc
Confidence 34456899999999999999876322 12238999987644455667888999999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||+|.||+|.+++.+..+.++..+...++.+.+.||+|||++++|||||-..|+|++. ++.+||+|||+++...
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~---~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK---KGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC---CCeEEeCccccccCCc
Confidence 9999999999999999887767999999999999999999999999999999999999963 5668999999987643
Q ss_pred CCCCcccc-ccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 307 PDERLNDI-VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 307 ~~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.-...... .-...|+|||.+. +.|+.++|||||||++||+++ |..||.+....++...|.......+.. ...+.+
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p~~ 391 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTPKE 391 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCHHH
Confidence 11111212 2456899999987 679999999999999999999 788999999998888886544433322 367888
Q ss_pred HHHHHHHcccccccCCCCHHHHHc
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+..++.+|+..||+.|+++.++.+
T Consensus 392 ~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 392 LAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHhccCChhhccCHHHHHH
Confidence 999999999999999999988765
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=323.67 Aligned_cols=247 Identities=21% Similarity=0.367 Sum_probs=207.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|.+.++||+|+||.||++.++. +++.||+|++.... .....+.+|+++++.+. |+||+++++++.....+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPF 77 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---CCceEEEEEecCCc----hHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCc
Confidence 358999999999999999999876 67899999986432 23467889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
++||||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++ +++.+||+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~df~~~~~~ 154 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM 154 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCcEEeCCCcccccc
Confidence 9999999999999988654 34589999999999999999999999999999999999995 4788999999999776
Q ss_pred CCCCCc--cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
...... ....++..|+|||++. ..++.++|||||||++|||++ |..||.+....+....+..... . .....++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 231 (263)
T cd05052 155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR-M--ERPEGCP 231 (263)
T ss_pred ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-C--CCCCCCC
Confidence 543221 1223456799999876 568999999999999999998 9999988777666666554321 1 1124688
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.++.++|.+||..||++||++.++++
T Consensus 232 ~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 232 PKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=322.42 Aligned_cols=247 Identities=24% Similarity=0.412 Sum_probs=209.5
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+|.+......+..||+|++....... ....+.+|+++++.++ |+||+++++++.....+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence 46999999999999987532247899999987654322 4678899999999997 99999999999999999999999
Q ss_pred cCCCchHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 233 CEGGELLDRILAR--------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 233 ~~~g~L~~~~~~~--------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||++..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC---CCCcEEEcccccccc
Confidence 9999999988765 47799999999999999999999999999999999999995 478999999999987
Q ss_pred cCCCC---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 305 IRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 305 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
..... ......++..|+|||.+. ..++.++|||||||++|+|++ |..||...........+..... ... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR-LPK--PEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCC--Ccc
Confidence 65432 233456788999999876 478999999999999999999 6999988877777766665321 111 135
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
++.++.+++.+||..||.+||++.|++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 78999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=329.35 Aligned_cols=254 Identities=33% Similarity=0.538 Sum_probs=211.3
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
|++.+.||+|++|.||++.+.. +++.+|+|.+...... ......+.+|+.+++++. |+||+++++++..+..+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---TGEIVAIKKIKLRFES-EGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---CCcEEEEEEecccccc-chhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEE
Confidence 6678899999999999999865 7889999998765432 223467888999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~ 308 (601)
||||+++ +|.+.+......+++..+..++.||+.||.|||+++|+|+||||+||+++ .++.+||+|||.+......
T Consensus 76 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN---TEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC---CCCcEEEeeeeeeEecCCC
Confidence 9999975 88888877667899999999999999999999999999999999999995 4789999999999776544
Q ss_pred C-Cccccccccccccchhcc-C-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC--------------
Q 007498 309 E-RLNDIVGSAYYVAPEVLH-R-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN-------------- 371 (601)
Q Consensus 309 ~-~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------------- 371 (601)
. ......++..|+|||++. . .++.++|+|||||++|+|++|+.||...+..+.+..+......
T Consensus 152 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 152 VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 3 233456888999999875 3 6899999999999999999999999877765554444321110
Q ss_pred -----CCC-------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 372 -----FDD-------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 372 -----~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
++. ..++.++.++.+||.+||.+||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 000 0123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=323.66 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=209.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||+|+++.....+..||+|.++... .......+.+|+.+++++. ||||+++++++..++.+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence 46899999999999999999886533244579999986532 2234567899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++....+.+++.++..++.|++.||.|||+++|+||||||+|||++ .++.++|+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN---SNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC---CCCeEEeCCCCcccccc
Confidence 999999999999999877667799999999999999999999999999999999999995 47889999999997664
Q ss_pred CCCCc----cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 307 PDERL----NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 307 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
..... ....++..|+|||++. +.++.++|+|||||++|++++ |..||......+....+.... ..+. ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RLPA--PMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cCCC--CCCC
Confidence 33211 1123356899999886 578999999999999999886 999998877766666665442 2221 2357
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+..+.+++.+||..+|.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=339.93 Aligned_cols=261 Identities=30% Similarity=0.555 Sum_probs=213.4
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++.+.||+|+||.||++++.. +++.||||++..... .......+.+|+.+++++. |+||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 86 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPA 86 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECC---CCcEEEEEecccccc-hhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcc
Confidence 356689999999999999999999876 678999999865422 2223466788999999996 99999999987665
Q ss_pred Cc------EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 224 NN------VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 224 ~~------~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
+. +|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~---~~~~~kL~ 160 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKIL 160 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEc
Confidence 54 89999999 5689887654 4799999999999999999999999999999999999995 47889999
Q ss_pred ecccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCC--
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD-- 373 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-- 373 (601)
|||++...... .....++..|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+.......+
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99999765432 345578999999998753 578999999999999999999999987766655555443221100
Q ss_pred ---------------------C----CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 374 ---------------------D----LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 374 ---------------------~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
. ..+..+++++.+||.+||..||.+|||+.++++||||++...+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 0 0013468999999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=319.33 Aligned_cols=253 Identities=31% Similarity=0.527 Sum_probs=212.6
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--Cc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--NN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~ 225 (601)
+|++.+.||+|++|.||++.+.. +++.|++|++...... ....+.+.+|+.+++++. |+||+++++.+... ..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---TGELMAVKSVELSGDS-EEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---CCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCe
Confidence 47888999999999999999875 6789999998765432 335678899999999996 99999999999988 88
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||+++ .++.++|+|||.+...
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEec
Confidence 999999999999999877653 899999999999999999999999999999999999996 3789999999999877
Q ss_pred CCCCC---ccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHccCCCCCCCCCCCC
Q 007498 306 RPDER---LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 306 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
..... .....++..|+|||.+.+ .++.++|||||||++|+|++|..||..... ......+.. .......+ ..+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~-~~~ 229 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-SGEPPEIP-EHL 229 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-cCCCcCCC-ccc
Confidence 65543 445678999999998864 589999999999999999999999976652 222222221 11112211 356
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+.++.+||.+||..||.+||++.+++.||||
T Consensus 230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=325.84 Aligned_cols=252 Identities=19% Similarity=0.326 Sum_probs=206.6
Q ss_pred CeEEcceeccCCCeEEEEEEeec-CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.|++.+.||+|+||.||++.... +...+..||+|.+.... .......+.+|+.+++.+. ||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCce
Confidence 58999999999999999998642 12256789999986432 2334567889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC
Q 007498 227 YIVMELCEGGELLDRILARG----------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~ 290 (601)
|+||||+.+++|.+++.... ..+++.++..++.|++.||.|||++||+||||||+|||++ .
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~---~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---E 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc---C
Confidence 99999999999999875321 2478899999999999999999999999999999999995 4
Q ss_pred CCCeEEeecccccccCCCC---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007498 291 DADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAV 365 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i 365 (601)
++.+||+|||++....... ......++..|+|||++. +.++.++|||||||++|||++ |..||.+.....+...+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 7889999999997654322 123345677899999876 568999999999999999998 99999887766665555
Q ss_pred HccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..... .+ ....+++.+.+++.+||+.||.+||++.+++++
T Consensus 240 ~~~~~-~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQL-LP--CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCc-CC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 44332 21 123678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.16 Aligned_cols=259 Identities=31% Similarity=0.553 Sum_probs=211.6
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc-chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.|++.+.||+|+||.||++++.....+++.||||++.+.... .......+.+|+.+++++.+||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 388999999999999999987654446789999998754322 1223456889999999997799999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+.+++|.+.+... ..+++..++.++.|++.||.|||+++++||||||+||+++ .++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD---SEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEEECccccccc
Confidence 9999999999999887654 5799999999999999999999999999999999999995 47889999999987654
Q ss_pred CCCC--ccccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHccCCCCCCCCC
Q 007498 307 PDER--LNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 307 ~~~~--~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~ 377 (601)
.... ....+|+..|+|||.+.+ .++.++||||||+++|+|++|..||.... ..+....+.......+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 232 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP---- 232 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCC----
Confidence 3322 223568999999998753 26889999999999999999999995432 2233333333333222
Q ss_pred CCCCHHHHHHHHHcccccccCCCC---HHHHHcCcccCCC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMT---AVQALTHPWLRDD 414 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s---~~ell~hp~f~~~ 414 (601)
..++.++.++|.+||..||++||| +.++|+||||+..
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 357899999999999999999998 5788999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=337.81 Aligned_cols=255 Identities=19% Similarity=0.300 Sum_probs=201.8
Q ss_pred ceeccC--CCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEE
Q 007498 153 KEVGRG--HFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVM 230 (601)
Q Consensus 153 ~~lG~G--~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 230 (601)
..||+| +||+||+|++.. +++.||+|++....... ...+.+.+|+.+++.+. ||||++++++|..++.+|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~---~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP---TGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcC---CCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEE
Confidence 456766 999999999876 78999999987644322 34578899999999996 999999999999999999999
Q ss_pred eecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCC
Q 007498 231 ELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309 (601)
Q Consensus 231 e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~ 309 (601)
||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+. .++.+|++|||.+.......
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccC
Confidence 999999999887653 23589999999999999999999999999999999999996 47889999998654332111
Q ss_pred C-c-------cccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCC-----
Q 007498 310 R-L-------NDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD----- 373 (601)
Q Consensus 310 ~-~-------~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----- 373 (601)
. . ....++..|+|||++.+ .++.++|||||||++|+|++|..||........+..........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 1 0 11235667999999863 478999999999999999999999977655444443332211100
Q ss_pred --------------------------------------CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 374 --------------------------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 374 --------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
......+++.+.+||++||..||++|||+.|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 000123567899999999999999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=327.16 Aligned_cols=261 Identities=28% Similarity=0.479 Sum_probs=218.4
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.....|++.+.||+|+||.||++.+.. ++..||+|++..... ..+.+.+|+++++.+. |+||+++++++...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 87 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVG 87 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEcc---CCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEEC
Confidence 345579999999999999999999875 678999999865432 3567889999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
...|+|+||+++++|.+++......+++..+..++.|++.||.|||++||+|+||+|+||+++ .++.++|+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~---~~~~~~l~d~~~~~ 164 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS---KDGSVKLADFGFAA 164 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc---CCCCEEECccchhh
Confidence 999999999999999999877644799999999999999999999999999999999999995 47889999999986
Q ss_pred ccCCCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 304 FIRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 304 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
...... ......++..|+|||++. ..++.++|+|||||++|+|++|..||...........+...... .......++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 243 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWS 243 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCC
Confidence 654322 223456888999999876 46899999999999999999999999876665544444332221 111123478
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
.++.+||.+||..+|.+||++.++++|+||+....
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 99999999999999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=322.05 Aligned_cols=252 Identities=28% Similarity=0.501 Sum_probs=209.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++.+.||+|+||.||+|.+.. +++.||+|.++............+.+|+++++++. |+||+++++++...+..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeE
Confidence 469999999999999999999875 78899999987654444445678899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 227 YIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
++||||+++++|.+++.. ....+++.++..++.|++.||.|||+.||+||||||+||+++ .++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~---~~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT---ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC---CCCcEEEeccceee
Confidence 999999999999988754 234589999999999999999999999999999999999995 47889999999987
Q ss_pred ccCCCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHccCCCCCCCCCCC
Q 007498 304 FIRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 304 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 379 (601)
...... ......|+..|+|||++. ..++.++|||||||++|+|++|..||..... ......+... .++..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADH 232 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--CCCCCChhh
Confidence 654332 233457899999999876 4689999999999999999999999965432 2233333322 222233346
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++.++.++|.+||..+|++||++.++++
T Consensus 233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=328.74 Aligned_cols=257 Identities=31% Similarity=0.532 Sum_probs=213.4
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
|....+||+|+||.||++..+. +++.||||++.... ......+.+|+.+++.+. |+||+++++.+...+..|+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 94 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKS---SGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWV 94 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcC---CCeEEEEEEecccc---hhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEE
Confidence 4445789999999999998875 78899999875432 224567889999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~ 308 (601)
||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+|+||+|+||+++ .++.++|+|||++......
T Consensus 95 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~---~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 95 VMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred EEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEcccccceecccc
Confidence 9999999999886543 4689999999999999999999999999999999999995 4788999999998765433
Q ss_pred C-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHH
Q 007498 309 E-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386 (601)
Q Consensus 309 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 386 (601)
. ......|+..|+|||++. ..++.++|+||+||++|+|++|..||.+.........+....+.... ....++.++.+
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ 248 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLK-NLHKVSPSLKG 248 (292)
T ss_pred cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccC-CcccCCHHHHH
Confidence 2 223457899999999875 46899999999999999999999999876665555544433221111 12467899999
Q ss_pred HHHHcccccccCCCCHHHHHcCcccCCCCCCC
Q 007498 387 FVKRLLNKDYRKRMTAVQALTHPWLRDDSRPV 418 (601)
Q Consensus 387 li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 418 (601)
+|.+||..||.+||++.++|.||||.....|.
T Consensus 249 li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 249 FLDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred HHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 99999999999999999999999999887544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=330.07 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=206.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC----ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
.+|.+++.||+|+||.||+|++.... .+...||+|++.... .......+.+|+.+++.+.+|+||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 57999999999999999999875311 133579999987542 222456788899999999669999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec
Q 007498 223 VNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS 287 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~ 287 (601)
.+.+|+||||+.+|+|.+++.... ..+++.++..++.|++.||+|||++||+||||||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~- 174 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT- 174 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc-
Confidence 999999999999999999987542 2488899999999999999999999999999999999995
Q ss_pred CCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 007498 288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF 362 (601)
Q Consensus 288 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~ 362 (601)
.++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 175 --~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 175 --EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred --CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 478999999999876543221 11223456899999876 568999999999999999998 88999877766666
Q ss_pred HHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..+..... .. ....++.++.+||.+||..+|.+||++.+++++
T Consensus 253 ~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 253 KLLKEGHR-MD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHcCCC-CC--CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 55544322 11 123678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=328.76 Aligned_cols=254 Identities=24% Similarity=0.419 Sum_probs=208.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC--ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|++.+.||+|+||.||++..+... .....||+|++..... ......+.+|+.+++++.+|+||+++++++..++
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 47999999999999999999876422 2447899999865422 2234668899999999955999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC
Q 007498 225 NVYIVMELCEGGELLDRILAR---------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~---------------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~ 289 (601)
.+|+||||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~--- 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT--- 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc---
Confidence 999999999999999988642 34689999999999999999999999999999999999995
Q ss_pred CCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 007498 290 DDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRA 364 (601)
Q Consensus 290 ~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~ 364 (601)
.++.+||+|||++..+..... .....++..|+|||++. ..++.++|||||||++|||++ |..||.+....+....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 478999999999987643321 12233567899999865 568999999999999999997 9999988777666666
Q ss_pred HHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+..... .. .....+.++.+|+.+||..||.+|||+.+++++
T Consensus 247 ~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYR-ME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCc-CC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 554321 11 113578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=327.99 Aligned_cols=254 Identities=34% Similarity=0.500 Sum_probs=209.5
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
|++.+.||+|+||.||+|+... +++.||||++...... .......+|+..++++.+|+||+++++++.+++..|+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---CCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 6788999999999999999875 6789999998654322 1223456799999999669999999999999999999
Q ss_pred EEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 229 VMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||+ +|+|.+.+.... ..+++..+..++.|++.+|.|||++||+|+||+|+||+++ .++.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~---~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS---GPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCCEEEeecccceeccC
Confidence 99999 779998877653 4789999999999999999999999999999999999995 488999999999987765
Q ss_pred CCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC-----------
Q 007498 308 DERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD----------- 374 (601)
Q Consensus 308 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----------- 374 (601)
........|+..|+|||++. ..++.++|+|||||++++|++|..||......+.+..+.........
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 54555667899999999874 35789999999999999999999999877665555444321111000
Q ss_pred ---------------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 375 ---------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 375 ---------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
...+..+.++.+||.+||..||++||++.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0012346889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=338.63 Aligned_cols=259 Identities=35% Similarity=0.550 Sum_probs=214.6
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC---
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN--- 224 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--- 224 (601)
+|++.+.||+|+||.||+|++.. +++.||||++..... .....+.+.+|+.+++.+. |+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---CCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCccc
Confidence 58999999999999999999875 688999999875431 2234567889999999996 999999999988775
Q ss_pred --cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 225 --NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 225 --~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
.+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.++|+|||++
T Consensus 76 ~~~~~lv~e~~~~-~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~---~~~~~~L~dfg~~ 150 (330)
T cd07834 76 FNDVYIVTELMET-DLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN---SNCDLKICDFGLA 150 (330)
T ss_pred ccceEEEecchhh-hHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccCce
Confidence 79999999974 78877654 35899999999999999999999999999999999999995 4789999999999
Q ss_pred cccCCCC----Cccccccccccccchhcc-C-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCC-
Q 007498 303 DFIRPDE----RLNDIVGSAYYVAPEVLH-R-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL- 375 (601)
Q Consensus 303 ~~~~~~~----~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~- 375 (601)
....... ......++..|+|||++. . .++.++|||||||++|+|++|..||.+.+..+.+..+..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 8765443 234567899999999876 3 58999999999999999999999998887766665554422111100
Q ss_pred --------------------------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 376 --------------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 376 --------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
..+.++.++.+||.+||..||.+||++++++.||||+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 01346889999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.71 Aligned_cols=262 Identities=32% Similarity=0.529 Sum_probs=207.0
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec----C
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED----V 223 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~ 223 (601)
+|++.+.||+|+||.||++++.... .+..||+|++.... ........+.+|+.+++++.+||||+++++++.. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~-~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC-cCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 4889999999999999999987521 27889999986432 2222345678899999999779999999987542 2
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
..+|++|||+. ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~---~~~~~kl~Dfg~a~ 153 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN---ADCELKICDFGLAR 153 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc---CCCCEEeCcCCCce
Confidence 46899999996 588887654 46799999999999999999999999999999999999995 47889999999997
Q ss_pred ccCCCC-----CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC------
Q 007498 304 FIRPDE-----RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP------ 370 (601)
Q Consensus 304 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------ 370 (601)
.+.... ......||..|+|||++.+ .++.++|||||||++|+|++|..||........+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 654322 1234578999999998653 589999999999999999999999977654443333222110
Q ss_pred -----------------CCC----CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 371 -----------------NFD----DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 371 -----------------~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
..+ ...++.++.++.+||.+||..||.+|||+.+++.||||+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 000 0113456889999999999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=322.59 Aligned_cols=251 Identities=22% Similarity=0.396 Sum_probs=207.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++.+.||+|+||.||+|+++.....+..||||++.... .......+.+|+.+++.+. ||||+++++++..+..++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCceE
Confidence 5899999999999999999987633234579999986542 2334567899999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++++|.+++....+.+++.++..++.|++.||.|||++|++||||||+||+++ .++.+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~---~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc---CCCcEEECCCcccccccc
Confidence 99999999999998877667799999999999999999999999999999999999995 478899999999876543
Q ss_pred CCCcc---ccc---cccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 308 DERLN---DIV---GSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 308 ~~~~~---~~~---gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
..... ... ++..|+|||++. +.++.++|||||||++|||++ |..||+..........+.... ..+ ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~~~--~~~~ 235 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-RLP--PPMD 235 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-cCC--Cccc
Confidence 22211 111 245799999876 578999999999999999886 999998887776666664332 111 1246
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++.++.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=324.25 Aligned_cols=249 Identities=29% Similarity=0.480 Sum_probs=202.1
Q ss_pred EEcceeccCCCeEEEEEEee-cCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 150 ELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 150 ~~~~~lG~G~~g~V~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
.+.+.||.|.||.||.|... .....+..|+||++... ......+.+.+|++++++++ ||||+++++++...+.+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccc-ccccccccccccccccccc
Confidence 46789999999999999998 34446789999999542 23334678999999999995 9999999999998888999
Q ss_pred EEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 229 VMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
|||||++|+|.+++... ...+++.++..|+.||+.||.|||+++|+|+||+++|||++. ++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~---~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDS---NGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEET---TTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc
Confidence 99999999999999876 567999999999999999999999999999999999999964 78999999999977632
Q ss_pred CCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 308 DER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 308 ~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
... .....+...|+|||++. ..++.++||||||+++|||++ |+.||......+....+...... .. ...++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL-PI--PDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET-TS--BTTSBH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ee--ccchhH
Confidence 221 23345778899999986 568999999999999999999 78999888777777777544331 11 136899
Q ss_pred HHHHHHHHcccccccCCCCHHHHHc
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.+.++|.+||..||.+||++.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=320.28 Aligned_cols=253 Identities=27% Similarity=0.474 Sum_probs=208.0
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccc--ccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAK--MTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-- 223 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-- 223 (601)
.|++.+.||+|+||.||++++.. +++.||+|++.... .........+.+|+.+++++. |+||+++++++.+.
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDAD---TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEE 78 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcC---CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCC
Confidence 69999999999999999999875 78899999875432 112234567899999999996 99999999998764
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
..+++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++.
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~ 154 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASK 154 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECcccccc
Confidence 5689999999999999887654 4689999999999999999999999999999999999995 47889999999997
Q ss_pred ccCCC----CCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 304 FIRPD----ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 304 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
..... .......|+..|+|||++.+ .++.++|+|||||++|+|++|+.||...........+...... + ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~-~~p~ 232 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK-P-MLPD 232 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC-C-CCCc
Confidence 65321 12234578999999998864 5889999999999999999999999876555544444322211 1 1124
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.+++++.++|.+||. +|..||++.+++.|||.
T Consensus 233 ~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 233 GVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 689999999999998 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.98 Aligned_cols=261 Identities=29% Similarity=0.538 Sum_probs=209.0
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV- 223 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~- 223 (601)
+..+|.+.+.||+|+||.||++.+.. +++.||+|++.+... .....+.+.+|+.++++++ |+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~ 89 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 89 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcC---CCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecc
Confidence 45689999999999999999998875 788999999865322 2223466788999999996 99999999987543
Q ss_pred -----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 224 -----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..+|++++++ +++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~d 163 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILD 163 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc---CCCCEEEec
Confidence 3578999988 6788776543 4699999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC-------
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD------- 369 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------- 369 (601)
||++..... ......|+..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+....
T Consensus 164 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T cd07877 164 FGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241 (345)
T ss_pred ccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999876432 2344678999999998753 57899999999999999999999997665544433332211
Q ss_pred ----------------CCCCCC----CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCC
Q 007498 370 ----------------PNFDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPV 418 (601)
Q Consensus 370 ----------------~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 418 (601)
...+.. .+...++++.+||.+||..||.+|+++.++|+||||++...+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 011110 0124688999999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=319.59 Aligned_cols=245 Identities=34% Similarity=0.648 Sum_probs=212.5
Q ss_pred eccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeecC
Q 007498 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234 (601)
Q Consensus 155 lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 234 (601)
||+|+||.||++.+.. +++.||+|++.+...........+.+|+.+++++. |+||+++++.+..+..+|+||||++
T Consensus 1 lg~G~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCC
Confidence 7999999999999865 67899999998766555445678899999999996 9999999999999999999999999
Q ss_pred CCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC-CCccc
Q 007498 235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLND 313 (601)
Q Consensus 235 ~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~-~~~~~ 313 (601)
+++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.++|+|||++...... .....
T Consensus 77 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (250)
T cd05123 77 GGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNT 152 (250)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCCcccC
Confidence 99999987654 4699999999999999999999999999999999999995 4788999999999776443 23445
Q ss_pred cccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcc
Q 007498 314 IVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392 (601)
Q Consensus 314 ~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 392 (601)
..++..|+|||.+. ..++.++|+|||||++|+|++|..||...........+......++ ..++.++.++|++||
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l 228 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLL 228 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHh
Confidence 67899999999876 4578899999999999999999999987776666666666443333 246899999999999
Q ss_pred cccccCCCCH---HHHHcCccc
Q 007498 393 NKDYRKRMTA---VQALTHPWL 411 (601)
Q Consensus 393 ~~dP~~R~s~---~ell~hp~f 411 (601)
..||++||++ +++++||||
T Consensus 229 ~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 229 QKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred cCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=326.05 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=206.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|.+.+.||+|+||.||++++... ..+...|++|.+.... ......+.+|+.+++++. |+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence 3689999999999999999986431 1245679999875432 223467889999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC
Q 007498 225 NVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~ 289 (601)
..++||||+++++|.+++.... +.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~--- 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG--- 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---
Confidence 9999999999999999886532 3489999999999999999999999999999999999995
Q ss_pred CCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 007498 290 DDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRA 364 (601)
Q Consensus 290 ~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~ 364 (601)
.++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|||++ |..||......+....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 478999999999976543221 23345688899999876 568999999999999999998 9999988777666666
Q ss_pred HHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+........ ...++..+.+++.+||..||++||++.++++
T Consensus 238 ~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 554432211 2357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=327.31 Aligned_cols=252 Identities=18% Similarity=0.301 Sum_probs=208.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCC--ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.|++.+.||+|+||.||++.+..+. ..++.||||++.... .....+.+.+|+.+++.+. ||||+++++++.....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCCc
Confidence 5888999999999999999875421 245789999986542 2223467889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC
Q 007498 226 VYIVMELCEGGELLDRILAR---------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~---------------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~ 290 (601)
+++++||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||+. +
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~---~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---D 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec---C
Confidence 99999999999999887532 23588899999999999999999999999999999999995 4
Q ss_pred CCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007498 291 DADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAV 365 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i 365 (601)
++.+||+|||+++....... .....+++.|+|||++. +.++.++|||||||++|||++ |..||.+....+.+..+
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 77899999999876543221 22345678899999875 678999999999999999998 88899888777777777
Q ss_pred HccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
......... ..++.++.+|+.+||+.+|.+||++.+++..
T Consensus 240 ~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 665432211 3688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=317.40 Aligned_cols=252 Identities=34% Similarity=0.581 Sum_probs=214.0
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|++|.||++++.. +++.||+|.+...... ....+.+.+|+++++++. |+||+++++++.+...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---CCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEE
Confidence 48899999999999999998875 6789999999776433 235578999999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++ .++.++|+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 76 IILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLND 151 (254)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCC
Confidence 999999999999887655 6799999999999999999999999999999999999995 378999999999987654
Q ss_pred CCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 308 DER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 308 ~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
... .....++..|+|||.+. ..++.++||||||+++|+|++|..||...........+.... ... ....++..+.
T Consensus 152 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~ 228 (254)
T cd06627 152 VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--HPP-LPEGISPELK 228 (254)
T ss_pred CcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC--CCC-CCCCCCHHHH
Confidence 432 23457899999999876 457899999999999999999999998766544444433221 111 1246789999
Q ss_pred HHHHHcccccccCCCCHHHHHcCccc
Q 007498 386 DFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
++|.+||..+|++||++.+++.||||
T Consensus 229 ~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=351.87 Aligned_cols=250 Identities=22% Similarity=0.388 Sum_probs=213.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCC--ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.-+..+.||+|+||+||+++...-. .....||||.++... ......+|+||+++|..|. |||||+|+|.|..++.
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVCREGDP 563 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCCe
Confidence 4567789999999999999875432 135689999987653 3346789999999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcC---------C----CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCC
Q 007498 226 VYIVMELCEGGELLDRILARG---------G----RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~---------~----~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~ 292 (601)
+|||+|||..|||.++|..+. . .|+..+...|+.||+.|++||-++.+|||||-..|+||+ ++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---ENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---cce
Confidence 999999999999999987642 1 288899999999999999999999999999999999996 488
Q ss_pred CeEEeecccccccCCCCCccc---cccccccccchhc-cCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHc
Q 007498 293 DMRLIDFGLSDFIRPDERLND---IVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLR 367 (601)
Q Consensus 293 ~vkl~DFG~a~~~~~~~~~~~---~~gt~~y~aPE~~-~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~ 367 (601)
.|||+|||+++.+...+.+.. ..-...|||||.+ .+.|+.+|||||+||+|||+++ |+.||++.+.++.++.|.+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 999999999987654433221 2235689999965 5899999999999999999997 8999999999999999988
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHH
Q 007498 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406 (601)
Q Consensus 368 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell 406 (601)
+.. ++.. .+++.++.+|+..||..+|++||++.||=
T Consensus 721 g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 721 GQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 765 3332 47999999999999999999999999863
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=336.59 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=196.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC-c
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-N 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-~ 225 (601)
..|.-...||+|+||.||++... ++..||||++....... ..+|.+|+.++.+++ |||+|+|+|||.+.+ .
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~----~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~ 146 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS----DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVKLLGYCLEGGEH 146 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC----CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCcccEEEEEecCCce
Confidence 35666778999999999999876 34789999876543221 345999999999997 999999999999998 5
Q ss_pred EEEEEeecCCCchHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcC---CeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 226 VYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQG---VVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~---iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
.+||+|||++|+|.+++..... .++|....+|+.++++||+|||+.. |||||||++|||| |++...||+|||+
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGL 223 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGL 223 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccC
Confidence 9999999999999999987766 8999999999999999999999964 9999999999999 4699999999999
Q ss_pred ccccCC-CCCcccc-ccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hhHHH---HHHHccC--C
Q 007498 302 SDFIRP-DERLNDI-VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART---ESGIF---RAVLRSD--P 370 (601)
Q Consensus 302 a~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~---~~i~~~~--~ 370 (601)
|+.... .....+. .||.+|+|||++. +..+.|+|||||||+|+||++|+.+..... ..... ...+... .
T Consensus 224 a~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ 303 (361)
T KOG1187|consen 224 AKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLR 303 (361)
T ss_pred cccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchh
Confidence 966554 3333333 8999999999986 789999999999999999999998886432 11111 1122111 0
Q ss_pred CCCCCCC--CCCC-----HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 371 NFDDLPW--PSVS-----PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 371 ~~~~~~~--~~~s-----~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.+..... .... ..+..+..+|+..+|..||+..|++.
T Consensus 304 eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 304 EIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred heeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111111 1222 22556778899999999999998643
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=323.43 Aligned_cols=252 Identities=21% Similarity=0.361 Sum_probs=208.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC--ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|.+.+.||+|+||.||++.++... ..+..||+|.+.... .......+.+|+.+++.+. |+||+++++++....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~ 82 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSTGQ 82 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcCCC
Confidence 47999999999999999999886422 245789999986442 2223456889999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeE
Q 007498 225 NVYIVMELCEGGELLDRILARG---------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~---------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vk 295 (601)
..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~---~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc---CCCCEE
Confidence 9999999999999999886431 2478889999999999999999999999999999999995 478999
Q ss_pred EeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCC
Q 007498 296 LIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDP 370 (601)
Q Consensus 296 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~ 370 (601)
|+|||+++.+..... .....++..|+|||.+. +.++.++|||||||++|||++ |..||...........+.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 999999876543321 23345788999999875 568999999999999999998 9999988777777666653321
Q ss_pred CCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
...+ ..++.++.+||.+||..+|++|||+.++++
T Consensus 240 --~~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 --LDLP-ENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred --CCCC-CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1112 356899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=327.16 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=206.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|.+.+.||+|+||.||++.+... ...+..||||+++.... ....+.+.+|+.+++++.+|+||+++++++...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 4699999999999999999986421 22456899999865432 2235678999999999955999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 225 NVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
.+|+||||+.+|+|.+++.... ..+++.++..++.|++.||.|||+++|+|+||||+|||++ .++.+||+|||++.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc---CCCeEEECCCcccc
Confidence 9999999999999999886543 3489999999999999999999999999999999999995 47789999999997
Q ss_pred ccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 304 FIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 304 ~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
....... .....++..|+|||++. +.++.++|||||||++|+|++ |..||........+........... ...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 267 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--QPE 267 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--CCC
Confidence 6543321 12234677899999875 568999999999999999998 9999987665544444433222211 123
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..++++.+|+.+||..+|++||++.|++.
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 57899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=328.17 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=208.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeec----CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKK----GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
..+|.+.+.||+|+||.||+|++.. ....+..||+|.+.... .......+.+|+.+++.+.+||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3579999999999999999998532 12245689999886432 22345678999999999955999999999999
Q ss_pred cCCcEEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEee
Q 007498 222 DVNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT 286 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~ 286 (601)
....+|+||||+.+|+|.+++.... ..++..++..++.||+.||.|||++||+||||||+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 9999999999999999999887532 3478889999999999999999999999999999999995
Q ss_pred cCCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 007498 287 SGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGI 361 (601)
Q Consensus 287 ~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~ 361 (601)
.++.+||+|||+++.+..... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....++
T Consensus 172 ---~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 172 ---ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred ---CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 478999999999986643221 22234667899999876 568999999999999999998 8899988877777
Q ss_pred HHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 362 FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 362 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
...+........ ...++.++.+||.+||..+|.+||++.++++.
T Consensus 249 ~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 766654432211 13678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=323.00 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=202.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC-ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+|++.+.||+|+||.||+|++.... .....||+|++.... .......+.+|+.+++.+. |+||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLT-ST 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-CC
Confidence 47999999999999999999876411 112358999986532 2234567889999999996 9999999999875 45
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.+++|||+++|+|.+.+....+.+++..+..++.||+.||.|||+++|+||||||+|||++ +++.+||+|||+++.+
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCceeec
Confidence 7899999999999999877667799999999999999999999999999999999999995 4778999999999876
Q ss_pred CCCCCc---cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 306 RPDERL---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 306 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
...... ....++..|+|||.+. ..++.++|||||||++|||++ |..||...........+.... ..+. ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~ 236 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RLPQ--PPIC 236 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCCC--CccC
Confidence 433221 1223467899999875 568999999999999999998 899997665555444443322 2221 2467
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.++.++|.+||..||++||++.+++.
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=319.97 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=205.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||++.+. .++.||||.+..... ..+.+.+|+.+++++. |+||+++++++...+.+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN----NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPI 76 (261)
T ss_pred hheeeEEEecccCCccEEEEEec----CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCCe
Confidence 46999999999999999999875 346799999865432 2456889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++..+
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVI 153 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc---CCCCEEECCcceEEEc
Confidence 99999999999999886543 4689999999999999999999999999999999999995 4788999999999876
Q ss_pred CCCCCc--cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
...... ....++..|+|||++. ..++.++|||||||++|+|++ |+.||.+......+..+..... .+. ...++
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~ 230 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-MPC--PPGCP 230 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCC--CCcCC
Confidence 532211 1122345799999876 568999999999999999999 9999988777666666654322 111 13578
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..+.+++.+||..||.+||++.+++.
T Consensus 231 ~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 231 KELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=328.74 Aligned_cols=253 Identities=23% Similarity=0.393 Sum_probs=206.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC----CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG----ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
.+|.+++.||+|+||.||+|++... ......||+|++.... .......+.+|+.+++++.+||||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4799999999999999999986421 1235679999986532 223456788999999999669999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec
Q 007498 223 VNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS 287 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~ 287 (601)
.+.+|+||||+++|+|.+++.... ..+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~- 168 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT- 168 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc-
Confidence 999999999999999999886532 3588999999999999999999999999999999999995
Q ss_pred CCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 007498 288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF 362 (601)
Q Consensus 288 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~ 362 (601)
.++.+||+|||+++....... .....++..|+|||++. +.++.++|||||||++|+|++ |..||.+....+.+
T Consensus 169 --~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 169 --EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred --CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 478899999999976543221 11223456799999876 568999999999999999999 89999887777766
Q ss_pred HHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..+...... .. ...++.++.+||.+||..||++||++.++++
T Consensus 247 ~~~~~~~~~--~~-~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGHRM--DK-PSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCCCC--CC-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 666544321 11 1367889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=338.71 Aligned_cols=255 Identities=22% Similarity=0.382 Sum_probs=205.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|.++++||+|+||.||+|++... ...++.||||++...... ...+.+.+|+++|.++..|||||++++++...+
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3688999999999999999987531 124578999999754322 234568899999999955999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC----------------------------------------------------------
Q 007498 225 NVYIVMELCEGGELLDRILARG---------------------------------------------------------- 246 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~---------------------------------------------------------- 246 (601)
.+|||||||++|+|.+++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999886431
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec
Q 007498 247 ---------------------------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS 287 (601)
Q Consensus 247 ---------------------------------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~ 287 (601)
..+++..+..|+.||+.||.|||+++|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~- 273 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC- 273 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe-
Confidence 1367778899999999999999999999999999999995
Q ss_pred CCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 007498 288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF 362 (601)
Q Consensus 288 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~ 362 (601)
+++.+||+|||+++.+..... .....++..|+|||++. ..++.++|||||||++|||++ |..||......+..
T Consensus 274 --~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 274 --EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred --CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 478899999999976532221 22346788899999876 568999999999999999998 89999766555544
Q ss_pred HHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
...+........ ...++.++.+||.+||..+|.+||++.+|++.
T Consensus 352 ~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRMAK--PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCCCC--CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 444333222211 23578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=320.45 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=202.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.++||+|+||.||+|++.. ...||+|++..... ..+.+.+|+++++.+. |+||+++++.+.. ...
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~----~~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~ 75 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPI 75 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecC----CceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCc
Confidence 469999999999999999998753 34699999875332 2356889999999996 9999999998754 568
Q ss_pred EEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+|||++..+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLI 152 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---CCCcEEeccCCceeec
Confidence 9999999999999988753 34589999999999999999999999999999999999995 4788999999999766
Q ss_pred CCCCCc--cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
...... ....++..|+|||++. +.++.++|||||||++|+|++ |..||.+......+..+...... +. ...++
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~ 229 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PC--PPECP 229 (262)
T ss_pred cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-CC--ccccC
Confidence 433221 2334667899999875 578999999999999999999 88899877776666665543221 11 13578
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..+.+||.+||.+||++||++.++++
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=318.52 Aligned_cols=243 Identities=24% Similarity=0.376 Sum_probs=198.7
Q ss_pred eeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeec
Q 007498 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELC 233 (601)
Q Consensus 154 ~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 233 (601)
+||+|+||.||++.++.. .++..||+|+++... ......+.+.+|+.+++.+. |+||+++++++. ....++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~-~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK-KSEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecC-CCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEecC
Confidence 699999999999976422 257889999986543 22334577899999999996 999999999886 45679999999
Q ss_pred CCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCC---
Q 007498 234 EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER--- 310 (601)
Q Consensus 234 ~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~--- 310 (601)
++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||.|||++ .++.+||+|||++..+.....
T Consensus 78 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~---~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 78 ELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc---CCCeEEECCCccccccCCCCCeee
Confidence 999999887654 5799999999999999999999999999999999999995 478899999999977643322
Q ss_pred -ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHH
Q 007498 311 -LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387 (601)
Q Consensus 311 -~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 387 (601)
.....++..|+|||.+. ..++.++|||||||++|||++ |..||......+....+.+... . .. ...+++++.+|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~-~~-~~~~~~~l~~l 230 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-M-EC-PQRCPPEMYDL 230 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-C-CC-CCCCCHHHHHH
Confidence 12233467899999876 568899999999999999997 9999988777776666654432 1 11 13689999999
Q ss_pred HHHcccccccCCCCHHHHHc
Q 007498 388 VKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 388 i~~~L~~dP~~R~s~~ell~ 407 (601)
|.+||..||++||++.+|..
T Consensus 231 i~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 231 MKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHhccCchhCcCHHHHHH
Confidence 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=356.60 Aligned_cols=257 Identities=31% Similarity=0.499 Sum_probs=199.5
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe--
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE-- 221 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-- 221 (601)
.+..+|+.++.||+||||.||+|+++- +|+.||||+|.... .......+.+|+.+|.+|. |||||++|..|.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKl---DGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKL---DGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVES 549 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecc---cchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-Ccceeeeehhhhcc
Confidence 345578889999999999999999986 99999999997654 3445677899999999996 999999842210
Q ss_pred ----------------------------------------------------------------------------c---
Q 007498 222 ----------------------------------------------------------------------------D--- 222 (601)
Q Consensus 222 ----------------------------------------------------------------------------~--- 222 (601)
+
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence 0
Q ss_pred ------------------------------C--------CcEEEEEeecCCCchHHHHHHcCCCC-CHHHHHHHHHHHHH
Q 007498 223 ------------------------------V--------NNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILS 263 (601)
Q Consensus 223 ------------------------------~--------~~~~lv~e~~~~g~L~~~~~~~~~~l-~~~~~~~i~~ql~~ 263 (601)
. ..+||-||||+. +|+..+..++... ....++++++||++
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~-~ll~~iI~~N~~~~~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEK-TLLRDIIRRNHFNSQRDEAWRLFREILE 708 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhh-hHHHHHHHhcccchhhHHHHHHHHHHHH
Confidence 0 137999999988 4555555554433 47889999999999
Q ss_pred HHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC-------------------CCCCccccccccccccch
Q 007498 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-------------------PDERLNDIVGSAYYVAPE 324 (601)
Q Consensus 264 ~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE 324 (601)
||.|+|+.|||||||||.||+|+ .++.|||+|||+|+... .....+..+||..|+|||
T Consensus 709 GLaYIH~~giIHRDLKP~NIFLd---~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 709 GLAYIHDQGIIHRDLKPRNIFLD---SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHhCceeeccCCcceeEEc---CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 99999999999999999999995 58899999999997621 011235679999999999
Q ss_pred hcc--C--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCC
Q 007498 325 VLH--R--SYSLEADIWSIGVISYILLCGSRPFWARTESG-IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399 (601)
Q Consensus 325 ~~~--~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 399 (601)
++. . .|+.|+|||||||||+||+. ||....+.. ++.++......++...+..--+.-..+|++||..||++|
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence 985 2 59999999999999999984 575444333 333333332222211233445667899999999999999
Q ss_pred CCHHHHHcCcccCC
Q 007498 400 MTAVQALTHPWLRD 413 (601)
Q Consensus 400 ~s~~ell~hp~f~~ 413 (601)
|||.|+|++.||..
T Consensus 863 PtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 863 PTATELLNSELLPP 876 (1351)
T ss_pred CCHHHHhhccCCCc
Confidence 99999999999974
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.14 Aligned_cols=260 Identities=23% Similarity=0.320 Sum_probs=216.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
..+-+..||.|+||+|++..++. +|+..|||+|+.... .....+++.|.+...+-.+.||||++||++..++..|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~---sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKP---SGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCc---cCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 34556789999999999999987 899999999987644 3456789999998888778999999999999999999
Q ss_pred EEEeecCCCchHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 228 IVMELCEGGELLDRIL----ARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~----~~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
|.||+|+- +|..+.. .....++|.-+-.|....+.||+||-+. +||||||||+|||++ ..|.|||||||++
T Consensus 140 iCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld---r~G~vKLCDFGIc 215 (361)
T KOG1006|consen 140 ICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD---RHGDVKLCDFGIC 215 (361)
T ss_pred eeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe---cCCCEeeecccch
Confidence 99999965 5543322 1345799999999999999999999876 899999999999994 5999999999999
Q ss_pred cccCCCCCccccccccccccchhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHccCCCCCCCCC-
Q 007498 303 DFIRPDERLNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRSDPNFDDLPW- 377 (601)
Q Consensus 303 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~- 377 (601)
..+...-..+.-+|...|||||.+. ..|+.++||||||++|||+.||..||.+.+ -.+++..+..+.+..-....
T Consensus 216 GqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 216 GQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKE 295 (361)
T ss_pred HhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccc
Confidence 8776554455568999999999885 359999999999999999999999997654 35566667766654332221
Q ss_pred -CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 378 -PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 378 -~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
-+++..+..||..||.+|-+.||...+++.+||++....
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 247899999999999999999999999999999987644
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=334.88 Aligned_cols=258 Identities=30% Similarity=0.581 Sum_probs=207.6
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV- 223 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~- 223 (601)
+..+|.+.+.||+|+||.||+|++.. +++.||||++.+.... ......+.+|+.+++.+. |+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 87 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAV 87 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCC---CCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcC-CCCccchhheecccc
Confidence 34689999999999999999999875 7889999998654322 223456789999999996 99999999998654
Q ss_pred -----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 224 -----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..+|+||||+.. +|...+ +..+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~---~~~~~kL~d 160 (342)
T cd07879 88 SGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILD 160 (342)
T ss_pred cCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEee
Confidence 346999999964 666543 34699999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC-------
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD------- 369 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------- 369 (601)
||++..... ......++..|+|||++.+ .++.++|||||||++|||++|+.||.+......+..+....
T Consensus 161 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 161 FGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999876532 2334578899999998753 58999999999999999999999998776544444333211
Q ss_pred ----------------CCCCCCC----CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 370 ----------------PNFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 370 ----------------~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+.++... ++.++.++.+||.+||+.||.+||++.++|.||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 1111111 2457889999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=320.15 Aligned_cols=251 Identities=21% Similarity=0.362 Sum_probs=208.0
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|+..+.||+|+||.||+|+.+........||+|.+.... .....+.+.+|+++++++. |+||+++++++...+..|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCcE
Confidence 5888899999999999999987532234579999986542 2224567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+++++|.+++....+.+++.++..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN---SNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc---CCCcEEECCCccceeccc
Confidence 99999999999998877667899999999999999999999999999999999999995 478899999999876543
Q ss_pred CCCc--c--ccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 308 DERL--N--DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 308 ~~~~--~--~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
.... . ....+..|+|||++. +.++.++|||||||++|||++ |..||+.....+....+..... .+. ...++
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~-~~~--~~~~~ 236 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR-LPA--PMDCP 236 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC-CCC--CCCCC
Confidence 2211 1 122345799999876 568999999999999999997 9999988887777777654322 111 13578
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.++.+++.+||..+|++||++.++++
T Consensus 237 ~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 237 SAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=322.62 Aligned_cols=248 Identities=19% Similarity=0.329 Sum_probs=200.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCc----EEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQ----QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
.+|++++.||+|+||.||++.+.. +++ .|++|.+... ........+..|+.+++++. ||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~---~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIP---EGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICPG 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcC---CCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCC-CCCcceEEEEECC
Confidence 368999999999999999998864 333 4777876432 12223466788998999996 9999999998764
Q ss_pred CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
...++|+||+++|+|.+++....+.+++..+..++.||+.||.|||+++++||||||+|||++ .++.+||+|||++
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~---~~~~~kl~Dfg~~ 156 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVA 156 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEEcCCccc
Confidence 567899999999999999887667899999999999999999999999999999999999995 4788999999999
Q ss_pred cccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCC
Q 007498 303 DFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 303 ~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 377 (601)
+....... .....++..|+|||++. +.++.++|||||||++|||++ |..||.+.........+.... .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~ 233 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE-RLAQ--P 233 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCCC--C
Confidence 86643322 23345778899999875 579999999999999999998 999998776655444443322 2221 1
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
...+.++.+++.+||..||++|||+.|+++
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 234 QICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 246778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=325.49 Aligned_cols=255 Identities=20% Similarity=0.271 Sum_probs=206.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC-------------ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCe
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE-------------LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~-------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni 213 (601)
.+|++++.||+|+||.||+|.+.... ..+..||+|++..... ....+.+.+|++++++++ ||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i 81 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLS-DPNI 81 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcC-CCCE
Confidence 47999999999999999999875411 1235689999875432 234577899999999996 9999
Q ss_pred eEEeeeEecCCcEEEEEeecCCCchHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCce
Q 007498 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARG----------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF 283 (601)
Q Consensus 214 v~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~----------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NI 283 (601)
+++++++..+..+++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999886543 2689999999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh--CCCCCCCCC
Q 007498 284 LFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC--GSRPFWART 357 (601)
Q Consensus 284 ll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~--g~~pf~~~~ 357 (601)
+++ .++.++|+|||++........ .....++..|+|||++. +.++.++|||||||++|||++ |..||....
T Consensus 162 li~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 162 LVG---KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eec---CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 996 468999999999876543321 22345678899999876 578999999999999999998 788887766
Q ss_pred hhHHHHHHHcc----CCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 358 ESGIFRAVLRS----DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 358 ~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
....+..+... ...........++.++.+||.+||..||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 66666655432 111111112356789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=321.39 Aligned_cols=251 Identities=20% Similarity=0.316 Sum_probs=201.5
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-----
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV----- 223 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----- 223 (601)
|.+++.||+|+||.||++++.... ....||+|.++.... .....+.+.+|+.+++.++ |+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~-~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD-SILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCC-CeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccC
Confidence 356789999999999999886521 123699998865432 3334677889999999996 99999999987432
Q ss_pred -CcEEEEEeecCCCchHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 224 -NNVYIVMELCEGGELLDRILAR-----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 224 -~~~~lv~e~~~~g~L~~~~~~~-----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
...++||||+.+|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~ 154 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVA 154 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc---CCCCEEEC
Confidence 3578999999999998877432 23489999999999999999999999999999999999995 47889999
Q ss_pred ecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCC
Q 007498 298 DFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNF 372 (601)
Q Consensus 298 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 372 (601)
|||++..+..... .....++..|+|||++. ..++.++|||||||++|||++ |+.||.+.........+......
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 233 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL- 233 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence 9999987643322 12234677899999876 568999999999999999999 89999887777766666554321
Q ss_pred CCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 373 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
. ..+.++..+.++|.+||..||.+|||+.+++++
T Consensus 234 ~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 K--QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 124678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=322.18 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=206.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeec--CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|.+.++||+|+||.||++.... ...++..+|+|.+.... ......+.+|+++++.+. |+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQ-HQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCC-CCCCceEEEEEecCC
Confidence 368889999999999999997542 12246689999876432 234567899999999995 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC
Q 007498 225 NVYIVMELCEGGELLDRILARG--------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~--------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~ 290 (601)
..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~---~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---Q 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc---C
Confidence 9999999999999999886542 2488999999999999999999999999999999999995 4
Q ss_pred CCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007498 291 DADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAV 365 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i 365 (601)
++.+||+|||++........ .....+++.|+|||++. ..++.++|||||||++|||++ |..||......+.+..+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 78999999999876543221 12234577899999876 568999999999999999998 99999877776666666
Q ss_pred HccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
....... ....+++.+.+||.+||..||.+||++.+++.
T Consensus 238 ~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5543321 11368899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=334.05 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=200.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeec--CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-C
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-V 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~ 223 (601)
++|++++.||+|+||.||+|++.. ...+++.||||+++.... ......+.+|+.++.++.+|+||+++++++.. +
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 479999999999999999998643 123578999999865432 22346688999999999668999999998765 4
Q ss_pred CcEEEEEeecCCCchHHHHHHcC---------------------------------------------------------
Q 007498 224 NNVYIVMELCEGGELLDRILARG--------------------------------------------------------- 246 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~--------------------------------------------------------- 246 (601)
..+|+|||||++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56899999999999999886432
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCC---cccc
Q 007498 247 ---------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDI 314 (601)
Q Consensus 247 ---------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~ 314 (601)
..+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++........ ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc---CCCcEEEEecccccccccCcchhhcCCC
Confidence 2367888899999999999999999999999999999995 478999999999976532221 1223
Q ss_pred ccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcc
Q 007498 315 VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392 (601)
Q Consensus 315 ~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 392 (601)
.++..|+|||++. ..++.++|||||||++|+|++ |..||........+............ + ..+++++.+++.+||
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~cl 319 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-P-DYTTPEMYQTMLDCW 319 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC-C-CCCCHHHHHHHHHHc
Confidence 4567899999875 568999999999999999996 99999765433333333322222211 1 246789999999999
Q ss_pred cccccCCCCHHHHHcC
Q 007498 393 NKDYRKRMTAVQALTH 408 (601)
Q Consensus 393 ~~dP~~R~s~~ell~h 408 (601)
..||.+||++.++++|
T Consensus 320 ~~~p~~Rps~~eil~~ 335 (343)
T cd05103 320 HGEPSQRPTFSELVEH 335 (343)
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=316.94 Aligned_cols=243 Identities=22% Similarity=0.370 Sum_probs=198.9
Q ss_pred eeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeec
Q 007498 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELC 233 (601)
Q Consensus 154 ~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 233 (601)
.||+|+||.||++.++... .+..||+|++.... .....+.+.+|+.+++++. |+||+++++++.. ...|+||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~-~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCEA-EALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCC-CceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEcC-CCeEEEEEeC
Confidence 4899999999999875321 45679999986542 2334567899999999996 9999999998864 5789999999
Q ss_pred CCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCc--
Q 007498 234 EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-- 311 (601)
Q Consensus 234 ~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~-- 311 (601)
++++|.+++......+++..+..++.||+.||.|||++|++||||||+|||++ .++.+||+|||++.........
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc---CCCcEEeccCCccccccCCcccee
Confidence 99999998876667899999999999999999999999999999999999995 4788999999999765433221
Q ss_pred --cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHH
Q 007498 312 --NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387 (601)
Q Consensus 312 --~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 387 (601)
....++..|+|||++. +.++.++|||||||++|+|++ |..||......+....+........ ....++++.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l 230 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC---PAECPPEMYAL 230 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---CCCCCHHHHHH
Confidence 1123357899999876 568999999999999999996 9999988777776666655432211 13578999999
Q ss_pred HHHcccccccCCCCHHHHHc
Q 007498 388 VKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 388 i~~~L~~dP~~R~s~~ell~ 407 (601)
|.+||..||++||++.++.+
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=330.48 Aligned_cols=260 Identities=33% Similarity=0.554 Sum_probs=208.4
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-C
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-V 223 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~ 223 (601)
+..+|++.+.||+|+||.||+|++.. +++.||||++.+.... ....+.+.+|+.+++.+. ||||++++++|.. .
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 82 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQL---TGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLR-HENIISLSDIFISPL 82 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECC---CCCEEEEEEecccccc-cchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCC
Confidence 45689999999999999999999876 7889999998654322 223467889999999996 9999999999865 5
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
...|+||||+ +++|...+.. ..+++..+..++.||+.||.|||+++|+||||+|+|||++ .++.+||+|||++.
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~---~~~~~~l~dfg~~~ 156 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGLAR 156 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC---CCCCEEeCcccccc
Confidence 6799999999 5588776543 4689999999999999999999999999999999999995 47899999999987
Q ss_pred ccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc-------------
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS------------- 368 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~------------- 368 (601)
.... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||...........+.+.
T Consensus 157 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 157 IQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5432 2344578899999998753 5899999999999999999999999766543222211110
Q ss_pred ----------CC---CCC-CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 369 ----------DP---NFD-DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 369 ----------~~---~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
.. ..+ ....+.++.++.++|++||..+|++||++.+++.||||.....+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00 000 00123578899999999999999999999999999999766443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=321.20 Aligned_cols=253 Identities=26% Similarity=0.493 Sum_probs=206.7
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc--chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
+|.+.+.||+|+||.||++++.. .+..+++|+++..... .......+.+|+.+++.++ ||||+++++++.+...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCc
Confidence 58899999999999999998875 4445666665432221 1122345678999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 226 VYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
.|+||||+++++|.+.+.. ....+++..++.++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~ 152 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVS 152 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCce
Confidence 9999999999999887753 345799999999999999999999999999999999999995 456999999998
Q ss_pred cccCCCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 303 DFIRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 303 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
....... ......|+..|+|||.+. ..++.++|+||||+++|+|++|..||...........+....... .+ ..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~ 229 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS--LP-ETY 229 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC--Cc-chh
Confidence 7664332 233456889999999875 468889999999999999999999997766655555554432211 11 357
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+.++.++|.+||..||++||++.+++.||||
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 8999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=320.19 Aligned_cols=246 Identities=21% Similarity=0.347 Sum_probs=197.2
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||+++++.+. ....+|+|.+... ......+.+.+|+.++.++.+||||+++++++...+.+|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-CeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 36999999999999987521 1235788887542 22234567889999999996699999999999999999999999
Q ss_pred cCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 233 CEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 233 ~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
+++|+|.+++.... ..+++.++..++.|++.||+|||++||+||||||+|||++ .++.+||+
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~---~~~~~kl~ 154 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIA 154 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc---CCCeEEEC
Confidence 99999999886532 2478999999999999999999999999999999999995 47899999
Q ss_pred ecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCC
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDL 375 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 375 (601)
|||++..............+..|+|||++. ..++.++|||||||++|||++ |..||.+....+.+..+..... ..
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~~-- 231 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-LE-- 231 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC-CC--
Confidence 999985332111112223456799999875 568999999999999999997 9999987776666665544321 11
Q ss_pred CCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 376 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
....++.++.+|+.+||..||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 11357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=317.72 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=205.5
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||++.+.........||||.+...... ...+.+.+|+.+++++. |+||+++++.+.. ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence 4689999999999998653223447999999775543 45678899999999996 9999999999988 889999999
Q ss_pred cCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCC-
Q 007498 233 CEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER- 310 (601)
Q Consensus 233 ~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~- 310 (601)
+++++|.+.+.... ..+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||++..+.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~---~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS---DDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEec---CCEEEeccccccccccccccc
Confidence 99999999987754 57899999999999999999999999999999999999964 68999999999987643221
Q ss_pred ---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 311 ---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 311 ---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.....++..|+|||++. ..++.++|||||||++|+|++ |..||......+....+......... ...++..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER--PEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC--CccCCHHHH
Confidence 12345778899999876 578999999999999999998 99999877777776666643322221 135789999
Q ss_pred HHHHHcccccccCCCCHHHHHc
Q 007498 386 DFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~ 407 (601)
+++.+||..+|++||++.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=317.42 Aligned_cols=252 Identities=28% Similarity=0.486 Sum_probs=214.4
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||+++++. +++.||+|.+....... .....+.+|+++++.+. |+||+++++++......|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---DNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---CCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEE
Confidence 48899999999999999998875 77899999987654332 34567788999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 228 IVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~---~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+||||+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++. ++.+||+|||++..
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~---~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA---NDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec---CCcEEEeeccchhh
Confidence 999999999999887652 356899999999999999999999999999999999999964 78899999999977
Q ss_pred cCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.... ......|+..|+|||.+. ..++.++|+||||+++|+|++|+.||...........+.... ++... ..++.+
T Consensus 153 ~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~ 228 (256)
T cd08530 153 LKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--YPPIP-PIYSQD 228 (256)
T ss_pred hccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCc-hhhCHH
Confidence 6544 334457899999999876 468899999999999999999999998877666555554432 22222 267899
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
++++|.+||..+|.+||++.++++||++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=318.60 Aligned_cols=246 Identities=23% Similarity=0.384 Sum_probs=204.2
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+.|+++++||+|+||.||+|..+ +++.||+|.+..... ....+.+|+.+++++. |+||+++++++. .+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~----~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN----GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QEP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC----CCceEEEEEecCCCC----cHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cCC
Confidence 357999999999999999999865 467899999875443 2357889999999996 999999999874 457
Q ss_pred EEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+|+||||+.+++|.+++... +..+++.++..++.|++.||.|||++|++||||||+||+++ .++.++|+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~ 151 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc---CCCCEEEccCcceee
Confidence 89999999999999987653 34689999999999999999999999999999999999995 478899999999976
Q ss_pred cCCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 305 IRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 305 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
...... .....++..|+|||++. ..++.++|||||||++|||++ |+.||.+.+..+....+..... .+ ....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 228 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR-MP--RPDNC 228 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-CC--CCCCC
Confidence 653221 12345667899999876 568999999999999999999 9999988777666665544321 11 12357
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.++.++|.+||..||++||+++++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=316.20 Aligned_cols=244 Identities=22% Similarity=0.341 Sum_probs=199.9
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
++||+|+||.||+|.+......+..||+|.+...... ...+.+.+|+.+++.+. |+||+++++++. ...+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEe
Confidence 4799999999999987653323478999998765433 24567889999999996 999999999876 4568999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCc-
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL- 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~- 311 (601)
+++++|.+++... ..+++..+..++.|++.||.|||.++|+||||||+|||++ .++.+||+|||+++........
T Consensus 77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~---~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 77 APLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc---CCCcEEeccccccceeecCCccc
Confidence 9999999988654 4799999999999999999999999999999999999995 4789999999999866433221
Q ss_pred ---cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHH
Q 007498 312 ---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386 (601)
Q Consensus 312 ---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 386 (601)
....++..|+|||.+. ..++.++|||||||++|+|++ |..||......+....+...... . ....++..+.+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~ 229 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-P--RPEECPQEIYS 229 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC-C--CCCCCCHHHHH
Confidence 1122356799999876 568999999999999999998 99999877766666665544321 1 12467899999
Q ss_pred HHHHcccccccCCCCHHHHHc
Q 007498 387 FVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 387 li~~~L~~dP~~R~s~~ell~ 407 (601)
+|.+||..||.+||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=324.55 Aligned_cols=254 Identities=32% Similarity=0.530 Sum_probs=210.0
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
|++.+.||+|+||.||+++... +++.||+|++..... .....+.+.+|+.+++++. |+||+++++++...+.+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDNE-EEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecC---CCcEEEEEEeccccc-cccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEE
Confidence 6678899999999999999876 688999999976542 2223456788999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~ 308 (601)
||||+++ +|.+++......+++..+..++.|++.||.|||++||+||||+|+||+++ +++.+||+|||++......
T Consensus 76 v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~---~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 76 VFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFGIP 151 (282)
T ss_pred EecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc---CCCCEEEecCCcccccCCC
Confidence 9999974 89998877656799999999999999999999999999999999999995 4789999999998766433
Q ss_pred C-Cccccccccccccchhcc-C-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC----------------
Q 007498 309 E-RLNDIVGSAYYVAPEVLH-R-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---------------- 369 (601)
Q Consensus 309 ~-~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------------- 369 (601)
. ......++..|+|||++. . .++.++|||||||++|||++|..||......+.+..+....
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 2 233456688899999875 3 68999999999999999999999998776655544443211
Q ss_pred --CCCCC-------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 370 --PNFDD-------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 370 --~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
..++. ..++.++.++.++|++||..||++||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00110 1123568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=333.85 Aligned_cols=262 Identities=31% Similarity=0.472 Sum_probs=209.4
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++.+.||+|+||.||++.+.. +++.||||++.+... .......+.+|+.+++++.+|+||+++++++...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcC---CCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 345689999999999999999999875 678999998865322 2223456778999999994499999999998653
Q ss_pred --CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 224 --NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 224 --~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
..+|+||||+.+ +|..++... .+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~---~~~~~kl~d~g~ 153 (337)
T cd07852 80 NDKDIYLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGL 153 (337)
T ss_pred CCceEEEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccc
Confidence 468999999974 888876543 789999999999999999999999999999999999995 588999999999
Q ss_pred ccccCCCC------Cccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC--
Q 007498 302 SDFIRPDE------RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN-- 371 (601)
Q Consensus 302 a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-- 371 (601)
+..+.... ......||..|+|||++. ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 97654322 223457899999999864 35789999999999999999999999776554443333221110
Q ss_pred -------------------------CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 372 -------------------------FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 372 -------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
......+.++.++.+||.+||..||++|||+.++++||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 00111234789999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=317.78 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=202.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++.++||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|+.+++++. |+||+++++++.. ...
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~----~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~ 75 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN----GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQLYAVVSE-EPI 75 (260)
T ss_pred HHhhhhheeccccCceEEEEEec----CCceeEEEEecCCCC----CHHHHHHHHHHHHhcC-CCceEEEEeEECC-CCc
Confidence 47999999999999999999875 455799999875433 2356889999999996 9999999998854 568
Q ss_pred EEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++ +++.++|+|||++..+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLI 152 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeec
Confidence 9999999999999988653 34589999999999999999999999999999999999996 4788999999999765
Q ss_pred CCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
..... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..... .+. ....+
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~ 229 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-MPC--PQDCP 229 (260)
T ss_pred cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCC--CCcCC
Confidence 43321 12234566899999875 568999999999999999999 8999988777666666654321 111 13578
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..+.+|+.+||.+||.+|||+.++++
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.32 Aligned_cols=251 Identities=23% Similarity=0.365 Sum_probs=203.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
+|++.+.||+|+||.||++++... ......+|+|.+.... .......+.+|+.+++.+. ||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence 478899999999999999987531 1134679999886542 2223567889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCc
Q 007498 226 VYIVMELCEGGELLDRILAR-----------------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPEN 282 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~-----------------------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~N 282 (601)
.|+||||+.+++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999887542 1347889999999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 007498 283 FLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWART 357 (601)
Q Consensus 283 Ill~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~ 357 (601)
||+. +++.+||+|||+++....... .....++..|+|||++. ..++.++|||||||++|||++ |..||.+..
T Consensus 158 ill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVA---EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEc---CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9995 478899999999976533221 22335677899999865 568999999999999999998 999998877
Q ss_pred hhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 358 ESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 358 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
...+...+.... ... ....++.++.+|+.+||..||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~-~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGY-RME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCC-CCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 766655544322 111 12357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=319.92 Aligned_cols=247 Identities=25% Similarity=0.411 Sum_probs=208.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|+++++||.|+||.||+|++. .++.||+|++..... .....+.+|+.+++.++ |+||+++++++.....+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~----~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWK----NRVRVAIKILKSDDL---LKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPV 77 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEec----CCCcEEEEeccccch---hhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCe
Confidence 36999999999999999999986 367899999865432 23457889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~---~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLI 154 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc---CCceEEEccccchhhc
Confidence 9999999999999988753 35689999999999999999999999999999999999995 4788999999999766
Q ss_pred CCCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 306 RPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 306 ~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
..... .....++..|+|||++. +.++.++|||||||++|+|++ |..||......+.+..+..... .+ ....+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 231 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-MP--CPAKCPQ 231 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-CC--CCCCCCH
Confidence 43321 12334567899999875 578999999999999999998 8999988777777776664322 11 1246889
Q ss_pred HHHHHHHHcccccccCCCCHHHHHc
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.+.++|.+||..||.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 232 EIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=315.48 Aligned_cols=246 Identities=24% Similarity=0.438 Sum_probs=206.4
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++.+.||+|+||.||++.+. .+..+|+|++..... ....+.+|+++++++. ||||+++++++......|
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~----~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL----EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPIC 75 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe----CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceE
Confidence 6899999999999999999875 356799999865433 2356889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+||||+.+++|.+++....+.+++..++.++.|++.||.|||+++++||||||+||+++ .++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---CCCeEEECCCcceeeccc
Confidence 99999999999998877666799999999999999999999999999999999999995 478899999999876533
Q ss_pred CCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 308 DER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 308 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
... .....++..|+|||++. +.++.++|||||||++|||++ |..||...........+......+.. ...+.+
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 229 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQS 229 (256)
T ss_pred CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHH
Confidence 221 12234567899999876 578999999999999999998 99999877777766666544222211 246899
Q ss_pred HHHHHHHcccccccCCCCHHHHHcC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+.+|+.+||..+|++||++.+++++
T Consensus 230 ~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 230 VYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHh
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.70 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=206.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC----ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
.+|++++.||+|+||.||+|++.... .....||+|++.... .......+.+|+.+++++.+||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 46999999999999999999865311 123479999876432 223456788999999999559999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec
Q 007498 223 VNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS 287 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~ 287 (601)
.+.+|+||||+++|+|.+++.... ..++..++..++.||+.||.|||++||+||||||+|||++
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~- 168 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT- 168 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc-
Confidence 999999999999999999886532 2478889999999999999999999999999999999995
Q ss_pred CCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 007498 288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF 362 (601)
Q Consensus 288 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~ 362 (601)
.++.+||+|||+++....... .....++..|+|||++. ..++.++|||||||++|||++ |..||.+....+.+
T Consensus 169 --~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 169 --EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred --CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 478899999999976543221 12233456799999875 568999999999999999998 89999887777776
Q ss_pred HHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..+...... . ....++.++.+||.+||..+|.+||++.+++++
T Consensus 247 ~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 247 KLLKEGHRM-D--KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHcCCCC-C--CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 666543221 1 113578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=329.25 Aligned_cols=256 Identities=21% Similarity=0.305 Sum_probs=199.6
Q ss_pred EEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEE
Q 007498 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV 229 (601)
Q Consensus 150 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv 229 (601)
.+++.+|. +|.||+++.+. +++.||||++..... .......+.+|+.+++.++ |+||+++++++...+..|++
T Consensus 5 ~i~~~~~~--~~~v~~~~~~~---~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 77 (314)
T cd08216 5 LIGKCFED--LMIVHLAKHKP---TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVV 77 (314)
T ss_pred hhhHhhcC--CceEEEEEecC---CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEE
Confidence 33444444 45566666654 788999999976532 2335678999999999996 99999999999999999999
Q ss_pred EeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC
Q 007498 230 MELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308 (601)
Q Consensus 230 ~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~ 308 (601)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||+++ .++.+||+|||.+..+...
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~ 154 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKH 154 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeeccc
Confidence 9999999999988753 34689999999999999999999999999999999999996 4789999999988655322
Q ss_pred CC--------ccccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC------
Q 007498 309 ER--------LNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN------ 371 (601)
Q Consensus 309 ~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------ 371 (601)
.. .....++..|+|||++.. .++.++|||||||++|||++|..||........+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (314)
T cd08216 155 GKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234 (314)
T ss_pred cccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccC
Confidence 11 123457888999999753 4889999999999999999999999765544333222211100
Q ss_pred -CCC-----------------------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 372 -FDD-----------------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 372 -~~~-----------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
.+. .....++.++.+||.+||..||++|||+.++|+||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000 00012356899999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=314.94 Aligned_cols=243 Identities=24% Similarity=0.389 Sum_probs=204.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++.+.||+|+||.||++.. .++.||||.+..... ...++.+|+.+++.+. |+||+++++++.+....
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 75 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-----RGQKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPL 75 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-----cCcEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCe
Confidence 4689999999999999999976 357899999865432 4567899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~---~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKEA 152 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe---CCCCEEEccccccccc
Confidence 99999999999999886653 2689999999999999999999999999999999999995 4788999999999776
Q ss_pred CCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.... ....++..|+|||++. +.++.++|||||||++|+|++ |..||...........+..... .. ....++++
T Consensus 153 ~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~ 227 (256)
T cd05039 153 SQGQ--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-ME--APEGCPPE 227 (256)
T ss_pred cccc--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CC--CccCCCHH
Confidence 3222 2334567799999875 578899999999999999997 9999987776666555544321 11 11357899
Q ss_pred HHHHHHHcccccccCCCCHHHHHc
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.++|.+||..+|++||++.++++
T Consensus 228 ~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 228 VYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=315.53 Aligned_cols=241 Identities=22% Similarity=0.367 Sum_probs=200.9
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe-cCCcE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE-DVNNV 226 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-~~~~~ 226 (601)
+|++.+.||+|+||.||++.. .+..||+|.+.... ..+.+.+|+.+++++. |+||+++++++. .+..+
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred hCeeeeeecccCCCeEEEEEE-----cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCce
Confidence 689999999999999999975 35679999885432 2456889999999996 999999999754 55679
Q ss_pred EEEEeecCCCchHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+++++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++ +++.+||+|||++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEA 152 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc---CCCcEEecCCccceec
Confidence 999999999999998876433 489999999999999999999999999999999999995 4789999999998765
Q ss_pred CCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.... ....++..|+|||++. ..++.++|||||||++|+|++ |+.||...........+.+.... ...+.+++.
T Consensus 153 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 227 (256)
T cd05082 153 SSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPV 227 (256)
T ss_pred cccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCHH
Confidence 3322 2334567899999876 468999999999999999997 99999877766666665543221 122468899
Q ss_pred HHHHHHHcccccccCCCCHHHHHc
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.++|.+||..||++|||+.++++
T Consensus 228 ~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 228 VYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=312.37 Aligned_cols=242 Identities=22% Similarity=0.324 Sum_probs=200.1
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||++... .+..||+|++.... .......+.+|+.+++++. ||||+++++++...+..|+||||
T Consensus 1 ~~ig~g~~g~vy~~~~~----~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec----CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEEC
Confidence 36999999999999854 46789999886532 2223456889999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCc-
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL- 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~- 311 (601)
+++++|.+++......+++..+..++.|++.||.|||++|++||||||+||+++ .++.+||+|||++.........
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc---CCCeEEECCCccceecccccccc
Confidence 999999998876666789999999999999999999999999999999999995 4788999999998754332211
Q ss_pred -cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHH
Q 007498 312 -NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFV 388 (601)
Q Consensus 312 -~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 388 (601)
....++..|+|||++. +.++.++|||||||++|+|++ |..||...........+...... .....++..+.+++
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li 227 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVM 227 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHH
Confidence 1223456799999876 568999999999999999998 99999877766665555443211 11246889999999
Q ss_pred HHcccccccCCCCHHHHHc
Q 007498 389 KRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 389 ~~~L~~dP~~R~s~~ell~ 407 (601)
.+||..+|++||++.++++
T Consensus 228 ~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 228 QRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHcccCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=319.19 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=195.5
Q ss_pred Ce-EEcceeccCCCeEEEEEEeec-CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--
Q 007498 148 KY-ELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-- 223 (601)
Q Consensus 148 ~y-~~~~~lG~G~~g~V~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-- 223 (601)
+| ++.+.||+|+||.||++.... ...++..||+|++..... ......+.+|+++++++. ||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLY-HENIVKYKGCCSEQGG 80 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCC
Confidence 45 999999999999999876432 122577899999865421 223467889999999996 99999999987653
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
..+|+||||+++++|.+++.. ..+++.+++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~ 155 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 155 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc---CCCcEEEeeccccc
Confidence 468999999999999998765 3699999999999999999999999999999999999995 47889999999998
Q ss_pred ccCCCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh--H------------HHHH
Q 007498 304 FIRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES--G------------IFRA 364 (601)
Q Consensus 304 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--~------------~~~~ 364 (601)
.+..... .....++..|+|||++. ..++.++|||||||++|+|++|..||...... + .+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 7653322 12234567799999876 56899999999999999999999998543211 0 0011
Q ss_pred HHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
........+. ...++.++.+++.+||..||++||++.++++
T Consensus 236 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 LLERGMRLPC--PKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111111111 1357899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=314.87 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=202.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||++.+.. +..||+|++..... ..+.+.+|+.+++.+. |+||+++++++.. +..
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~ 75 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG----TTKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVSE-EPI 75 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC----CceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEcC-CCc
Confidence 469999999999999999998753 34699998765432 2356889999999996 9999999998754 568
Q ss_pred EEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++ +++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~---~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLI 152 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCeEEECCCccceEc
Confidence 99999999999999886543 3589999999999999999999999999999999999995 4788999999999765
Q ss_pred CCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
..... .....++..|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+..... .+ ....++
T Consensus 153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~ 229 (260)
T cd05069 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-MP--CPQGCP 229 (260)
T ss_pred cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCcccC
Confidence 43321 12234667899999876 568999999999999999999 9999988777776666654321 11 123678
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..+.+++++||.+||.+||++.++++
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=314.58 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=206.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|.+.+.||+|+||.||+|.+. .+..||||.+..... ....+.+|+.+++++. |+||+++++++.....+
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~----~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWN----GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPI 76 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEc----CCceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCce
Confidence 57999999999999999999875 346799999875432 3467889999999996 99999999999998999
Q ss_pred EEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++ .++.+||+|||++..+
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLI 153 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc---CCCCEEECccccceec
Confidence 99999999999999886643 4689999999999999999999999999999999999995 4789999999998766
Q ss_pred CCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
..... .....++..|+|||.+. +.++.++|||||||++|+|++ |+.||.+......+..+...... +. ....+
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~ 230 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-PR--PPNCP 230 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CC--CCCCC
Confidence 43211 11233456899999876 568999999999999999998 99999887777777776554221 11 13568
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.++.+++.+||..||.+||++.+++.
T Consensus 231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 231 EELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHH
Confidence 89999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=320.51 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=206.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|++.+.||+|+||.||+|++... ..++..||+|++.... .......+.+|+.+++++. ||||+++++++..+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~~ 81 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVGK 81 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCC
Confidence 4699999999999999999987531 1256789999986532 2233467889999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCce
Q 007498 225 NVYIVMELCEGGELLDRILARG---------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF 283 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~---------------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NI 283 (601)
.+|+||||+++|+|.+++.... ..+++.++..++.||+.||.|||+++++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999886431 2478889999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 007498 284 LFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTE 358 (601)
Q Consensus 284 ll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~ 358 (601)
|++ .++.+||+|||++..+..... .....++..|+|||++. ..++.++|||||||++|||++ |..||.+...
T Consensus 162 l~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 162 LVG---ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred Eec---CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 995 478999999999876533221 12234566799999875 578999999999999999997 8899988777
Q ss_pred hHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 359 SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 359 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.+....+....... . ...++.++.+||.+||..||.+||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~--~-~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 239 EEVIYYVRDGNVLS--C-PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHhcCCCCC--C-CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77776665543221 1 1357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=317.84 Aligned_cols=251 Identities=21% Similarity=0.321 Sum_probs=206.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC-ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+|++++.||+|+||.||++.++... .....||+|.+..... ......+.+|+.+++++. |+||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVD-HPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-Cc
Confidence 47999999999999999999876421 1234699998865532 334567889999999996 9999999999987 78
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.++||||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||+. .++.+||+|||++...
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL 159 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc---CCCeEEECCCcccccc
Confidence 9999999999999999887666799999999999999999999999999999999999995 4788999999999876
Q ss_pred CCCCCcc---ccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 306 RPDERLN---DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 306 ~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
....... ...++..|+|||.+. ..++.++|+|||||++|||++ |+.||.+....++...+..... ++.. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~ 236 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LPQP--PIC 236 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CCCC--CCC
Confidence 5332211 122356799999875 578999999999999999998 9999988777666655554322 2211 246
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.++.+++.+||..||.+||++.++++
T Consensus 237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 237 TIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=322.22 Aligned_cols=254 Identities=19% Similarity=0.313 Sum_probs=202.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC-----------ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE-----------LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVK 215 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~ 215 (601)
.+|++.++||+|+||.||++++.... .....||+|++.... .......+.+|+++++++. |+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence 47999999999999999999875311 123469999986532 2234567899999999996 999999
Q ss_pred EeeeEecCCcEEEEEeecCCCchHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceE
Q 007498 216 FCDACEDVNNVYIVMELCEGGELLDRILARG-----------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFL 284 (601)
Q Consensus 216 l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-----------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIl 284 (601)
+++++.....+|+||||+.+++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999875432 23688899999999999999999999999999999999
Q ss_pred eecCCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh--CCCCCCCCCh
Q 007498 285 FTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC--GSRPFWARTE 358 (601)
Q Consensus 285 l~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~--g~~pf~~~~~ 358 (601)
++ .++.+||+|||++........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||.....
T Consensus 162 l~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 162 VG---NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred Ec---CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 95 477899999999976543321 12234567899999865 678999999999999999988 6788877666
Q ss_pred hHHHHHHHcc-----CCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 359 SGIFRAVLRS-----DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 359 ~~~~~~i~~~-----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.+....+... ...+.. ..+.+++.+.+||.+||..||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLS-QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHhhhhccccccCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5555444321 111111 12357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=314.74 Aligned_cols=246 Identities=20% Similarity=0.304 Sum_probs=196.6
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe-cCCcEEEEEe
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE-DVNNVYIVME 231 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-~~~~~~lv~e 231 (601)
+.||+|+||.||+|.+.........||||.+... ......+.+.+|+.+++.+. ||||+++++++. .++..|+|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence 4689999999999987643334568999987542 22234567889999999996 999999999765 4566899999
Q ss_pred ecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCC--
Q 007498 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-- 309 (601)
Q Consensus 232 ~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-- 309 (601)
|+.+|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++..+....
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~---~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD---ESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCccccccccCCcce
Confidence 9999999999876656678888999999999999999999999999999999995 47889999999997553221
Q ss_pred ---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 310 ---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCG-SRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 310 ---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
......++..|+|||++. ..++.++|||||||++|||++| .+||......+....+......... ..++..+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP---EYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCHHH
Confidence 112345677899999875 5789999999999999999995 6667666665655555443221111 2468899
Q ss_pred HHHHHHcccccccCCCCHHHHHc
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.+++.+||..+|++||++.+++.
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=313.82 Aligned_cols=249 Identities=26% Similarity=0.421 Sum_probs=207.0
Q ss_pred EEcceeccCCCeEEEEEEeecCC-ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 150 ELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 150 ~~~~~lG~G~~g~V~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
.+.+.||.|+||.||++++.... ..+..||+|++...... .....+.+|+.+++.+. |+||+++++++.+.+..|+
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeEE
Confidence 56789999999999999987521 12488999998654322 14578899999999995 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 229 VMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~-l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||+++++|.+++...... +++.++..++.|++.||.|||+++|+||||||+||+++ .++.++|+|||++.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~---~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc---cCCeEEEcccCCceeccc
Confidence 99999999999988765434 99999999999999999999999999999999999995 477899999999977654
Q ss_pred CCCcc--ccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 308 DERLN--DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 308 ~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
..... ...++..|+|||.+. ..++.++|||||||++|+|++ |..||...........+........ ...++.+
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPPE 232 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHH
Confidence 32222 133678999999875 568999999999999999998 8899988777777776665443221 1347899
Q ss_pred HHHHHHHcccccccCCCCHHHHHc
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.+++.+||..||++|||+.|+++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 233 IYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=320.71 Aligned_cols=254 Identities=16% Similarity=0.278 Sum_probs=201.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC-------------CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCe
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG-------------ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHL 213 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~-------------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni 213 (601)
.+|++.+.||+|+||.||++++... ..+...||+|++.... .......+.+|+.+++.++ |+||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~i 81 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPNI 81 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCc
Confidence 4699999999999999999875421 1134579999986542 2234567899999999996 9999
Q ss_pred eEEeeeEecCCcEEEEEeecCCCchHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCce
Q 007498 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARG----------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF 283 (601)
Q Consensus 214 v~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~----------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NI 283 (601)
+++++++...+.+|+||||+.+++|.+++.... ..+++.++..++.||+.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999886532 2477889999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh--CCCCCCCCC
Q 007498 284 LFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC--GSRPFWART 357 (601)
Q Consensus 284 ll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~--g~~pf~~~~ 357 (601)
|++ .++.++|+|||++..+..... .....++..|+|||+.. +.++.++|||||||++|||++ |..||....
T Consensus 162 li~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 162 LVG---KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred EEc---CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 995 478899999999976543321 12234467899999754 679999999999999999998 788997766
Q ss_pred hhHHHHHHHc---c--CCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 358 ESGIFRAVLR---S--DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 358 ~~~~~~~i~~---~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..+.+..... . ...... ....++..+.+|+.+||..||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLP-KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hHHHHHHHHHHHhhccccccCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6555443321 1 111111 11357789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=315.66 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=205.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|.+.+.||+|+||.||+|.+.........||||...... .....+.+.+|+.+++.+. ||||+++++++.+ ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CCc
Confidence 36889999999999999999876432234579999875432 1234567899999999996 9999999999876 457
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++|+|.+++......+++..+..++.|++.||.|||++|++||||||+|||++. ++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~---~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS---PDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEec---CCCeEEccCceeeecc
Confidence 8999999999999998766557999999999999999999999999999999999999964 7889999999997664
Q ss_pred CCCCc--cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 307 PDERL--NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 307 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
..... ....++..|+|||.+. ..++.++|||||||++|||++ |..||......+....+.+.... + ....++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 235 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-P--MPPNCPP 235 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-C--CCCCCCH
Confidence 43221 1223456799999876 568999999999999999986 99999887776666665544322 1 1246889
Q ss_pred HHHHHHHHcccccccCCCCHHHHHc
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.+.++|.+||..+|.+|||+.+++.
T Consensus 236 ~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 236 TLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=343.98 Aligned_cols=345 Identities=17% Similarity=0.217 Sum_probs=224.3
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecC-CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeee-----
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKG-ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDA----- 219 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~----- 219 (601)
..+|++.+.||+|+||.||+|++... ...+..||||++..... .+...+| .+.... +.+++.++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~-~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRAC-PNSCADFVYGFLEPV 202 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhc-hhhHHHHHHhhhccc
Confidence 35799999999999999999998751 01178999998754221 1111111 111221 2333332222
Q ss_pred -EecCCcEEEEEeecCCCchHHHHHHcCCC-------------------CCHHHHHHHHHHHHHHHHHHHHcCCeeccCC
Q 007498 220 -CEDVNNVYIVMELCEGGELLDRILARGGR-------------------YTEEDAKAIVVQILSVVAFCHLQGVVHRDLK 279 (601)
Q Consensus 220 -~~~~~~~~lv~e~~~~g~L~~~~~~~~~~-------------------l~~~~~~~i~~ql~~~L~~LH~~~iiHrDik 279 (601)
......+||||||+.+++|.+++...... ..+..+..++.||+.||.|||+++|+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 24556799999999999999887653211 1234577899999999999999999999999
Q ss_pred CCceEeecCCCCCCeEEeecccccccCCC--CCccccccccccccchhcc-C----------------------CCCChh
Q 007498 280 PENFLFTSGRDDADMRLIDFGLSDFIRPD--ERLNDIVGSAYYVAPEVLH-R----------------------SYSLEA 334 (601)
Q Consensus 280 p~NIll~~~~~~~~vkl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~----------------------~~~~~~ 334 (601)
|+|||++. +++.+||+|||+|+.+... ......+||+.|+|||.+. . .++.++
T Consensus 283 P~NILl~~--~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 283 PQNIIFSE--GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHHEEEeC--CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 99999963 3578999999999865433 2234578999999999652 1 234567
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc-CCCC-------CCCC----------CCCCCHHHHHHHHHcccccc
Q 007498 335 DIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-DPNF-------DDLP----------WPSVSPEAKDFVKRLLNKDY 396 (601)
Q Consensus 335 DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~-------~~~~----------~~~~s~~~~~li~~~L~~dP 396 (601)
|||||||+||||+++..++.. ....+..++.. ...+ .... +.....++.+||.+||.+||
T Consensus 361 DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999999997766532 22222222111 1000 0000 01123456699999999999
Q ss_pred cCCCCHHHHHcCcccCCCCCCCChhHHHHHHHHhhhccCchhHHHHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHH
Q 007498 397 RKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLEN 476 (601)
Q Consensus 397 ~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~k~~~~~~~l~~~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~e 476 (601)
++|||+.|+|+||||+....... .. +...... ....... --.+-.+++.....+-+.+.+|..+..|
T Consensus 439 ~kR~ta~e~L~Hpff~~~~~~~~-~~-----~~~~~~~--~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 505 (566)
T PLN03225 439 RQRISAKAALAHPYFDREGLLGL-SV-----MQNLRLQ--LFRATQQ-----DYGEAAAWVVFLMAKSGTEKEGGFTEAQ 505 (566)
T ss_pred ccCCCHHHHhCCcCcCCCCcccc-cc-----ccccccc--cchhhHH-----HHHHHHHHHHHHHHhcCCCCCCCccHHH
Confidence 99999999999999987543211 00 0000000 0001110 1112234566667777788899999999
Q ss_pred HHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHH
Q 007498 477 FRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCA 516 (601)
Q Consensus 477 l~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~ 516 (601)
+..+.+.-. .+.....=..+....+-+..|..++.+++.
T Consensus 506 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (566)
T PLN03225 506 LQELREKEP-KKKGSAQRNALASALRLQRKGVKTVARTVD 544 (566)
T ss_pred HHHhhhhcC-cchhhhhhhhHHHHHhhhhhhhhhhhhhhh
Confidence 999887642 222222222477778888889999998876
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=318.95 Aligned_cols=244 Identities=19% Similarity=0.276 Sum_probs=193.9
Q ss_pred ceeccCCCeEEEEEEeecCC----ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 153 KEVGRGHFGHTCSARGKKGE----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
+.||+|+||.||++.++... .....||+|.+.... ....+.+.+|+.+++.+. ||||+++++++..+...++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence 36999999999999875421 123458888875432 223467888999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC-----CCCeEEeeccccc
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD-----DADMRLIDFGLSD 303 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~-----~~~vkl~DFG~a~ 303 (601)
||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.+.. ...++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999988776667999999999999999999999999999999999999975211 1237999999986
Q ss_pred ccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCC-CCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGS-RPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
..... ....++..|+|||++.+ .++.++|||||||++|+|++|. .||........ ..+......++. ..
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~----~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPA----PK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCC----CC
Confidence 55332 33568889999999864 5799999999999999999995 55544443332 233333333332 45
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+.++.+||.+||+.||++|||++++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 6889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=314.77 Aligned_cols=247 Identities=20% Similarity=0.328 Sum_probs=194.6
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
++||+|+||.||++....+ .....+|+|.+.... .......+.+|+.+++.+. |+||+++++.+.....+||||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRASA--TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecC-CCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEe
Confidence 4699999999999976543 245678999875432 2223456789999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC
Q 007498 233 CEGGELLDRILARG----GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308 (601)
Q Consensus 233 ~~~g~L~~~~~~~~----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~ 308 (601)
+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT---ADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec---CCCcEEEeccccccccccc
Confidence 99999999886643 2346788899999999999999999999999999999995 4789999999998654322
Q ss_pred CC---ccccccccccccchhcc--------CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccC-CCCCCC
Q 007498 309 ER---LNDIVGSAYYVAPEVLH--------RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSD-PNFDDL 375 (601)
Q Consensus 309 ~~---~~~~~gt~~y~aPE~~~--------~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~ 375 (601)
.. .....++..|+|||++. ..++.++|||||||++|||++ |..||......+.+..+.... ..++..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 11 12335677899999863 246889999999999999999 788887776666555554432 222222
Q ss_pred C-CCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 376 P-WPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 376 ~-~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
. ...++..+.+++..|+ .||++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 1 1357888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=311.36 Aligned_cols=242 Identities=22% Similarity=0.339 Sum_probs=200.6
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
++||+|+||.||++.+. .++.||+|++...... .....+.+|+++++++. |+||+++++++......|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~----~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK----GNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEe----CCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEc
Confidence 47999999999999875 3678999998664332 34567899999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCc-
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL- 311 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~- 311 (601)
+.+++|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++.........
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc---CCCcEEEeeccccccccCCccee
Confidence 999999998876666789999999999999999999999999999999999995 4789999999999765422111
Q ss_pred --cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHH
Q 007498 312 --NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387 (601)
Q Consensus 312 --~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 387 (601)
....++..|+|||++. +.++.++|||||||++|+|++ |..||...........+.... ... ....++.++.++
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~l 227 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMP--APQLCPEEIYRL 227 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCC--CCccCCHHHHHH
Confidence 1223456799999876 568999999999999999998 889997776655555554321 111 123578999999
Q ss_pred HHHcccccccCCCCHHHHHc
Q 007498 388 VKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 388 i~~~L~~dP~~R~s~~ell~ 407 (601)
+.+||..+|.+||++.|+++
T Consensus 228 i~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 228 MLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=314.68 Aligned_cols=268 Identities=29% Similarity=0.497 Sum_probs=208.3
Q ss_pred CcccC-CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCC-------CCe
Q 007498 142 NKNFG-AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-------KHL 213 (601)
Q Consensus 142 ~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-------~ni 213 (601)
.+.|. .+|.+.++||.|.|++||+|.+.. ..+.||+|+.+..+.. .+....||++|++++.+ .+|
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq---~~r~VAlKVvKSAqhY----tEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ---NKRYVALKVVKSAQHY----TEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeecc---CCeEEEEEEEehhhHH----HHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 35565 899999999999999999999987 7789999999766543 35567899999999743 379
Q ss_pred eEEeeeEec----CCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeec
Q 007498 214 VKFCDACED----VNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTS 287 (601)
Q Consensus 214 v~l~~~~~~----~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~ 287 (601)
|+|++.|.. +.++|||+|++ |.+|+.+|...+ ..++...++.|++||+.||.|||.+ ||||-||||+|||+..
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCS 223 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeec
Confidence 999999964 56899999999 779999987653 4599999999999999999999987 9999999999999853
Q ss_pred CC------------------------------------------------------------------------------
Q 007498 288 GR------------------------------------------------------------------------------ 289 (601)
Q Consensus 288 ~~------------------------------------------------------------------------------ 289 (601)
++
T Consensus 224 ~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~ 303 (590)
T KOG1290|consen 224 TEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESY 303 (590)
T ss_pred cccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccc
Confidence 20
Q ss_pred ---------------------------------CC---------------------------------------------
Q 007498 290 ---------------------------------DD--------------------------------------------- 291 (601)
Q Consensus 290 ---------------------------------~~--------------------------------------------- 291 (601)
+.
T Consensus 304 n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~ 383 (590)
T KOG1290|consen 304 NNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPD 383 (590)
T ss_pred ccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCC
Confidence 00
Q ss_pred -------CCeEEeecccccccCCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC------
Q 007498 292 -------ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWART------ 357 (601)
Q Consensus 292 -------~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~------ 357 (601)
..|||+|||-|+++.. ..+.-+.|..|+|||++-+ .|+..+||||++|+++||+||...|....
T Consensus 384 ~~~~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~r 461 (590)
T KOG1290|consen 384 IPLPECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSR 461 (590)
T ss_pred CCCCccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCc
Confidence 0257777777766532 2344567899999998765 79999999999999999999999995331
Q ss_pred hhHHHHHHHccCCCCCC-------------------------CCCC---------CC----CHHHHHHHHHcccccccCC
Q 007498 358 ESGIFRAVLRSDPNFDD-------------------------LPWP---------SV----SPEAKDFVKRLLNKDYRKR 399 (601)
Q Consensus 358 ~~~~~~~i~~~~~~~~~-------------------------~~~~---------~~----s~~~~~li~~~L~~dP~~R 399 (601)
+++-+..|++....+|. .+|+ .+ ..++.+||.-||+.+|++|
T Consensus 462 DEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR 541 (590)
T KOG1290|consen 462 DEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR 541 (590)
T ss_pred cHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc
Confidence 22333333321111111 0122 12 3568899999999999999
Q ss_pred CCHHHHHcCcccCCCCCCCC
Q 007498 400 MTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 400 ~s~~ell~hp~f~~~~~~~~ 419 (601)
+||.++|+|||+.....+.+
T Consensus 542 ~tA~~cl~hPwLn~~~~~~~ 561 (590)
T KOG1290|consen 542 PTAAQCLKHPWLNPVAGPPP 561 (590)
T ss_pred ccHHHHhcCccccCCCCCcc
Confidence 99999999999998877633
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=312.31 Aligned_cols=246 Identities=25% Similarity=0.410 Sum_probs=203.4
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++.++||+|+||.||++.+. .+..||+|.+.... ...+.+.+|+.+++.+. |+||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~----~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~ 74 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EP 74 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec----CCccEEEEecCCCh----hHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CC
Confidence 457999999999999999999865 34579999876432 23467889999999996 9999999999887 78
Q ss_pred EEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.|+||||+++++|.+++... ...+++..+..++.||+.||.|||++|++||||||+||+++ .++.+||+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~ 151 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARV 151 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCCcceee
Confidence 89999999999999988763 34588899999999999999999999999999999999995 478999999999876
Q ss_pred cCCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 305 IRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 305 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
...... .....++..|+|||++. +.++.++|+|||||++|+|++ |..||.+.........+..... .+ .....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 228 (260)
T cd05073 152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MP--RPENC 228 (260)
T ss_pred ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-CC--CcccC
Confidence 543322 12234567799999876 568999999999999999998 9999988777666655544322 11 12468
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.++.+++.+||..||++||++.+++.
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=319.38 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=200.2
Q ss_pred CeEEcceeccCCCeEEEEEEeec-CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--C
Q 007498 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--N 224 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~ 224 (601)
.|++++.||+|+||.||+++... +..++..||+|.++... .......+.+|+.+++.+. ||||+++++++... .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence 47899999999999999997532 22367899999986442 2234567899999999996 99999999998775 5
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|+||||++|++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECCCccccc
Confidence 68999999999999998876555789999999999999999999999999999999999995 478899999999987
Q ss_pred cCCCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh--------------hHHHHHH
Q 007498 305 IRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--------------SGIFRAV 365 (601)
Q Consensus 305 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~--------------~~~~~~i 365 (601)
+..... .....|+..|+|||++. ..++.++|||||||++|+|+++..|+..... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 643322 12355777899999865 5689999999999999999998776532111 0011111
Q ss_pred HccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.......+ .+..++..+.+||.+||..||.+||++.+++++
T Consensus 239 ~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 LEEGKRLP--RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHcCccCC--CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 11111111 134688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=313.26 Aligned_cols=247 Identities=21% Similarity=0.323 Sum_probs=193.6
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
+.||+|+||.||++.+.. ..++..+|+|.++.... ......+.+|+.++++++ ||||+++++++.+...+|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-GYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcC-CCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEEC
Confidence 469999999999998753 22567899998865432 223456888999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC
Q 007498 233 CEGGELLDRILARG----GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308 (601)
Q Consensus 233 ~~~g~L~~~~~~~~----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~ 308 (601)
+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEECCccccccccCc
Confidence 99999999886532 2457778889999999999999999999999999999995 4788999999998654322
Q ss_pred CC---ccccccccccccchhccC--------CCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHc-cCCCCCCC
Q 007498 309 ER---LNDIVGSAYYVAPEVLHR--------SYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLR-SDPNFDDL 375 (601)
Q Consensus 309 ~~---~~~~~gt~~y~aPE~~~~--------~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~-~~~~~~~~ 375 (601)
.. .....|+..|+|||++.+ .++.++|||||||++|||++ |..||......+....... ....+...
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 21 123467888999998752 35789999999999999996 9999977665554433322 22222221
Q ss_pred CC-CCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 376 PW-PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 376 ~~-~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.. ...+..+.+++.+|+ .+|++|||+.||+.
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 11 246788999999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=316.23 Aligned_cols=243 Identities=20% Similarity=0.241 Sum_probs=192.8
Q ss_pred eeccCCCeEEEEEEeecC---------------------CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCC
Q 007498 154 EVGRGHFGHTCSARGKKG---------------------ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212 (601)
Q Consensus 154 ~lG~G~~g~V~~~~~~~~---------------------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n 212 (601)
+||+|+||.||++..... ......||+|++.... ......+.+|+.+++.+. |||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence 699999999999875321 1123468999885432 123456788999999996 999
Q ss_pred eeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC----
Q 007498 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG---- 288 (601)
Q Consensus 213 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~---- 288 (601)
|+++++++......||||||+++|+|..++....+.+++..+..++.||+.||.|||+++|+||||||+|||++..
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999988877666789999999999999999999999999999999999999641
Q ss_pred CCCCCeEEeecccccccCCCCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHH-hCCCCCCCCChhHHHHHH
Q 007498 289 RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILL-CGSRPFWARTESGIFRAV 365 (601)
Q Consensus 289 ~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell-~g~~pf~~~~~~~~~~~i 365 (601)
.....+|++|||++...... ....++..|+|||++. ..++.++|||||||++|||+ +|..||......+... .
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-F 233 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-H
Confidence 11234899999998544221 2346788899999875 35899999999999999984 7999998766554433 2
Q ss_pred HccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
......++. ..++++.++|.+||..+|++||++.++|++
T Consensus 234 ~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 234 YEKKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHhccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 222222222 356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=319.93 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=207.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.....++++||+|-||.|.++... .+..||||.++.... ......|.+||++|.+|+ |||||+|+++|..++.
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeve----g~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVE----GPLKVAVKILRPDAT--KNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDP 609 (807)
T ss_pred hhheehhhhhcCcccceeEEEEec----CceEEEEeecCcccc--hhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCc
Confidence 346788999999999999999864 357899999976533 334688999999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~-l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+|||||||++|+|.+++.++..+ +.......|+.||+.|++||.+.++|||||.+.|+|++ .++++||+|||+++.
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~---~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD---GEFTIKIADFGMSRN 686 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec---CcccEEecCcccccc
Confidence 99999999999999999876433 35566778999999999999999999999999999994 589999999999987
Q ss_pred cCCCCCcc---ccccccccccchh-ccCCCCChhhHHHHHHHHHHHH--hCCCCCCCCChhHHHHHHHccCCCCCC---C
Q 007498 305 IRPDERLN---DIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILL--CGSRPFWARTESGIFRAVLRSDPNFDD---L 375 (601)
Q Consensus 305 ~~~~~~~~---~~~gt~~y~aPE~-~~~~~~~~~DvwSlG~il~ell--~g~~pf~~~~~~~~~~~i~~~~~~~~~---~ 375 (601)
+..+.... ..+-...|||+|. +.++++.++|||+||+++||++ |...||....+++..++.......-+. .
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 65554332 2345678999995 6799999999999999999865 689999888887777665432221111 1
Q ss_pred -CCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 376 -PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 376 -~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..+-++..+.+|+.+||..|-.+||+.+++-.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 11357889999999999999999999999743
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=320.95 Aligned_cols=263 Identities=30% Similarity=0.507 Sum_probs=214.4
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc----hhhHHHHHHHHHHHHHhcCCCCeeEEeeeE
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT----AISIEDVRREVKILKALSGHKHLVKFCDAC 220 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~ 220 (601)
+..+|-++..||+|||+.||+|.+.. ..+.||||+-...+... .+..+..-+|.+|.+.| +||.||++|++|
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~---EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyf 536 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLT---EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYF 536 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccc---hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeee
Confidence 44579999999999999999999875 67899999864433221 12345577999999999 599999999998
Q ss_pred e-cCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCceEeecCCCCCCeEEe
Q 007498 221 E-DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 221 ~-~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
. +.+.+|-|+|||+|.+|.-++ +....+++.+++.|+.||+.||.||.+.. |||-||||.||||..+...|.|||+
T Consensus 537 slDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred eeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 6 557799999999998876555 45578999999999999999999999884 9999999999999887778999999
Q ss_pred ecccccccCCCCC--------ccccccccccccchhcc-C----CCCChhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHH
Q 007498 298 DFGLSDFIRPDER--------LNDIVGSAYYVAPEVLH-R----SYSLEADIWSIGVISYILLCGSRPFWART-ESGIFR 363 (601)
Q Consensus 298 DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~ 363 (601)
|||+++++..+.. .....||.||++||.+- + ..+.|+||||+|||+|..+.|+.||-... ..+++.
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 9999998864432 23468999999999763 2 47899999999999999999999995443 223322
Q ss_pred --HHHcc-CCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 364 --AVLRS-DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 364 --~i~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.|++. ...|+.. |-++.++++||++||..--+.|..+.++-+||||...
T Consensus 696 eNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 696 ENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 23332 2344443 5799999999999999999999999999999999753
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=313.46 Aligned_cols=244 Identities=18% Similarity=0.231 Sum_probs=191.6
Q ss_pred ceeccCCCeEEEEEEeecCC---------ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 153 KEVGRGHFGHTCSARGKKGE---------LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
+.||+|+||.||++...... .....||+|++.... ......+.+|+.+++.+. ||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVS-HKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 36999999999999753211 123468899875432 223456788999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC----CCCCeEEeec
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR----DDADMRLIDF 299 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~----~~~~vkl~DF 299 (601)
...++||||+++|+|..++......+++..+..++.||+.||.|||+++|+||||||+|||++.+. ....+|++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999998887766667799999999999999999999999999999999999996411 1123899999
Q ss_pred ccccccCCCCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHH-hCCCCCCCCChhHHHHHHHccCCCCCCCC
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILL-CGSRPFWARTESGIFRAVLRSDPNFDDLP 376 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 376 (601)
|++...... ....|+..|+|||++. ..++.++|||||||++|||+ .|..||......+.. .........
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~---- 228 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCML---- 228 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccC----
Confidence 998654322 3356888999999875 46899999999999999998 588888765443332 222222111
Q ss_pred CCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
....+.++.+||.+||..||.+||++.+|+++
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 12356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=313.92 Aligned_cols=254 Identities=22% Similarity=0.371 Sum_probs=208.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC--ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
..|++.+.||+|+||.||+|+.+... ...+.||+|.+.... .......+.+|++++++++ |+||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence 36899999999999999999976421 245689999875532 2224567899999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEE
Q 007498 225 NVYIVMELCEGGELLDRILARG--------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~--------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl 296 (601)
..|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---CCCcEEE
Confidence 9999999999999999886543 1589999999999999999999999999999999999995 4788999
Q ss_pred eecccccccCCCC--Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCC
Q 007498 297 IDFGLSDFIRPDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNF 372 (601)
Q Consensus 297 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 372 (601)
+|||++....... ......++..|+|||.+. +.++.++|||||||++|+|++ |..||........+..+......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999986543221 223446678899999875 568899999999999999998 888997776666666655444333
Q ss_pred CCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 373 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.. ...++..+.++|.+||..||.+||++.|++..
T Consensus 239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 22 23578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.53 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=197.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeec-CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--C
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--V 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~ 223 (601)
..|++.+.||+|+||.||+++... ...+++.||||.+.... ......+.+|+++++++. ||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence 368999999999999999997531 12267899999986432 234567889999999996 9999999998753 3
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
..+|+||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE---SENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC---CCCeEEECCCcccc
Confidence 568999999999999999876656799999999999999999999999999999999999995 47889999999998
Q ss_pred ccCCCCCc----cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhH---------------HHH
Q 007498 304 FIRPDERL----NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESG---------------IFR 363 (601)
Q Consensus 304 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~---------------~~~ 363 (601)
........ ....++..|+|||++. +.++.++|||||||++|||++|..++....... .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 76433221 1123445699999876 468999999999999999999877764322110 011
Q ss_pred HHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 364 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.++.....++. ...++.++.+||.+||..+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGRLPA--PPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCcCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 12222222221 2367899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.10 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=201.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC-ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+|++.+.||+|+||.||++.+.... .....||+|++..... ......+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~ 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMD-HPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-C
Confidence 36889999999999999999886511 1123579998765322 223346889999999996 99999999998754 5
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.++|+||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+|||+++.+
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~---~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK---SPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec---CCCceEEccccccccc
Confidence 7799999999999999877666799999999999999999999999999999999999995 4778999999999876
Q ss_pred CCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 306 RPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 306 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
..... .....++..|+|||++. ..++.++|||||||++|||++ |..||.+.........+ .....++. .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~--~~~~ 236 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLPQ--PPIC 236 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCC--CCCC
Confidence 43322 12334577899999876 568999999999999999997 99999776555444333 33322222 2357
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+..+.+++.+||..||++||++.+++..
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=308.18 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=199.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||++.. +++.||+|++.... ....+.+|+.+++.+. ||||+++++++..+ ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----CCCceEEEeecCcc-----hHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-Cc
Confidence 3699999999999999998753 56789999985432 2357889999999996 99999999998765 47
Q ss_pred EEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+.+++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++ .++.+||+|||++...
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~---~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVG 150 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCcEEECCCccceec
Confidence 99999999999999887643 3589999999999999999999999999999999999995 4788999999998754
Q ss_pred CCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
... ......+..|+|||++. +.++.++|+|||||++|+|++ |..||......+....+.+... . .....++..
T Consensus 151 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~ 225 (254)
T cd05083 151 SMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-M--EPPEGCPAD 225 (254)
T ss_pred ccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-C--CCCCcCCHH
Confidence 322 22234456899999876 578999999999999999997 9999987776666555544321 1 122468899
Q ss_pred HHHHHHHcccccccCCCCHHHHHc
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.+|+.+||..+|.+||++.+++.
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=311.97 Aligned_cols=252 Identities=18% Similarity=0.271 Sum_probs=204.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC-ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-CC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-VN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~ 224 (601)
.+|++.+.||+|+||.||++.+.... ..+..||+|++... ........+.+|+.+++++. |+||+++++++.. +.
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDGE 82 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCC
Confidence 47999999999999999999986421 13678999987643 23334677899999999995 9999999998765 57
Q ss_pred cEEEEEeecCCCchHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 225 NVYIVMELCEGGELLDRILARG-------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~-------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
..++++||+.+++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++ +++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCCcEEEC
Confidence 7899999999999999876532 4589999999999999999999999999999999999995 47899999
Q ss_pred ecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCC
Q 007498 298 DFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNF 372 (601)
Q Consensus 298 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 372 (601)
|||+++.+..... .....++..|+|||++. ..++.++|||||||++|||++ |+.||......+....+... ..+
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~ 238 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRL 238 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CCC
Confidence 9999976543321 12234677899999876 468999999999999999998 99999877665555444432 222
Q ss_pred CCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 373 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.. ...+++++.+++.+||..||++|||+.++++
T Consensus 239 ~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 AQ--PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 21 2357899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.70 Aligned_cols=253 Identities=28% Similarity=0.503 Sum_probs=207.6
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccc-------cchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-------TTAISIEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
|++.+.||+|+||.||++++... .++.+|+|.+..... ........+.+|+.++.+..+|+||+++++++.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNN--GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCC--CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 78889999999999999998641 467899998864321 222345567789998876435999999999999
Q ss_pred cCCcEEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 222 DVNNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
.++..|+||||++|++|.+.+.. ....+++..++.++.|++.||.|||+ .+|+|+||+|+|||++ .++.+||+
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~---~~~~~~l~ 156 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTIT 156 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC---CCCcEEEe
Confidence 99999999999999999887643 34579999999999999999999996 6899999999999995 47899999
Q ss_pred ecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 376 (601)
|||++.............|+..|+|||++. +.++.++|||||||++|+|++|..||...........+...... ...
T Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 234 (269)
T cd08528 157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE--PLP 234 (269)
T ss_pred cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC--cCC
Confidence 999998765544445667899999999876 46899999999999999999999999876665555555443322 112
Q ss_pred CCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
...+++++.+||.+||..||++||++.|+..+
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 23578999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.13 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=199.2
Q ss_pred ceeccCCCeEEEEEEeecCC---ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEE
Q 007498 153 KEVGRGHFGHTCSARGKKGE---LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV 229 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv 229 (601)
+.||+|+||.||++++.... ..++.||||.+.+... ......+.+|+.+++.+. ||||+++++++......|+|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence 46999999999999876411 1336899998865421 123467889999999996 99999999999999999999
Q ss_pred EeecCCCchHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC--CCCCeEEeeccc
Q 007498 230 MELCEGGELLDRILAR------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR--DDADMRLIDFGL 301 (601)
Q Consensus 230 ~e~~~~g~L~~~~~~~------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~--~~~~vkl~DFG~ 301 (601)
|||+++++|.+++... ...+++.++..++.||+.||.|||+++++|+||||+||+++.+. ....+||+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999988652 23478899999999999999999999999999999999997521 123799999999
Q ss_pred ccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCC
Q 007498 302 SDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLP 376 (601)
Q Consensus 302 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 376 (601)
+..+..... .....++..|+|||++. +.++.++|||||||++|+|++ |..||......+....+..... + ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~--~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR-L--QK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc-c--CC
Confidence 876543221 12335578899999876 578999999999999999998 9999987776665555543221 1 11
Q ss_pred CCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
...++..+.+||.+||..+|.+||++.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2467899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=307.37 Aligned_cols=228 Identities=23% Similarity=0.347 Sum_probs=186.8
Q ss_pred CCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeecCCCc
Q 007498 158 GHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGE 237 (601)
Q Consensus 158 G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 237 (601)
|.||.||+|+++. +++.||+|++.+.. ...+|...+.... ||||+++++++.....+|+||||++||+
T Consensus 4 g~~~~v~~~~~~~---~~~~~~~K~i~~~~--------~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTR---TQQTFILKGLRKSS--------EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEcc---CCcEEEEEeecchh--------hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCC
Confidence 8999999999986 78899999986642 1234555555554 9999999999999999999999999999
Q ss_pred hHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCccccccc
Q 007498 238 LLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317 (601)
Q Consensus 238 L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt 317 (601)
|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.++++|||++...... .....++
T Consensus 72 L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~df~~~~~~~~~--~~~~~~~ 145 (237)
T cd05576 72 LWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD---DRGHIQLTYFSRWSEVEDS--CDGEAVE 145 (237)
T ss_pred HHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEecccchhccccc--cccCCcC
Confidence 99988654 4699999999999999999999999999999999999995 4788999999987655432 2344567
Q ss_pred cccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccc
Q 007498 318 AYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDY 396 (601)
Q Consensus 318 ~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 396 (601)
..|+|||++. +.++.++||||+||++|||++|..||....... .....+. .+ +.+++.+++||.+||+.||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~-~~-~~~~~~~~~li~~~l~~dp 217 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLN-IP-EWVSEEARSLLQQLLQFNP 217 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccC-Cc-ccCCHHHHHHHHHHccCCH
Confidence 8899999876 568999999999999999999999885432210 0001111 11 3578999999999999999
Q ss_pred cCCCCH-----HHHHcCccc
Q 007498 397 RKRMTA-----VQALTHPWL 411 (601)
Q Consensus 397 ~~R~s~-----~ell~hp~f 411 (601)
++|+++ +++++||||
T Consensus 218 ~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 218 TERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHhcCCCccchHHHHcCCCC
Confidence 999985 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=333.22 Aligned_cols=247 Identities=29% Similarity=0.498 Sum_probs=197.6
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC----
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV---- 223 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---- 223 (601)
.|..-+.||+||||.||.++++. +|+.||||.+.+.. ....++..-+|+++|++|+ |+|||++++.-+..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnke---tG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKE---TGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGL 87 (732)
T ss_pred ceeehhhhcCCccceeeeecccc---cccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCc
Confidence 57788899999999999999887 89999999987654 2235677889999999997 99999999976544
Q ss_pred --CcEEEEEeecCCCchHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC-CCCCeEEee
Q 007498 224 --NNVYIVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR-DDADMRLID 298 (601)
Q Consensus 224 --~~~~lv~e~~~~g~L~~~~~~~--~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~-~~~~vkl~D 298 (601)
....+|||||.||||...+.+. ...|++.++..++..+..||.|||++||+||||||.||++-.+. ....-||+|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 3568999999999999988653 24599999999999999999999999999999999999996533 233469999
Q ss_pred cccccccCCCCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHccCCC-
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPN- 371 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~- 371 (601)
||.|+.+..+....+++||..|.+||++. +.|+..+|.|||||++|+.+||..||..... .++...+...++.
T Consensus 168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 168 FGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99999999999999999999999999986 6799999999999999999999999943221 1233333221111
Q ss_pred --------------CC-CCC-CCCCCHH----HHHHHHHcccccccCCC
Q 007498 372 --------------FD-DLP-WPSVSPE----AKDFVKRLLNKDYRKRM 400 (601)
Q Consensus 372 --------------~~-~~~-~~~~s~~----~~~li~~~L~~dP~~R~ 400 (601)
+. ..+ ..++++. +-.++..+|+.||++|-
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 00 000 1133443 45567789999999998
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=309.92 Aligned_cols=251 Identities=20% Similarity=0.337 Sum_probs=202.6
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC----
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN---- 224 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---- 224 (601)
|.+.+.||+|+||.||+|.++....+++.||||++..... .....+.+.+|+++++++. ||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 6778899999999999998765444678999999865432 3334567889999999996 999999999886432
Q ss_pred --cEEEEEeecCCCchHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 225 --NVYIVMELCEGGELLDRILAR-----GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 225 --~~~lv~e~~~~g~L~~~~~~~-----~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
..++++||+.+|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~---~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc---CCCCEEEC
Confidence 247899999999998776532 12478999999999999999999999999999999999995 47889999
Q ss_pred ecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCC
Q 007498 298 DFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNF 372 (601)
Q Consensus 298 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 372 (601)
|||+++....... .....++..|++||.+. +.++.++|||||||++|+|++ |..||.+....+....+.......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9999986643321 12334567899999876 568899999999999999999 899998777666666665443211
Q ss_pred CCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 373 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
. .+..+..+.+++.+||..+|++||++.+++.
T Consensus 236 ~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 236 Q---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 1357889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=307.94 Aligned_cols=247 Identities=17% Similarity=0.278 Sum_probs=193.2
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
++||+|+||.||+++...+. ....+++|.+.... .....+.+.+|+.+++.++ ||||+++++.+.....+|+||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDT-GVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred CcCCCCcCceEEEEEEEcCC-CcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEec
Confidence 36999999999999765321 33456777665432 1224567899999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCC
Q 007498 233 CEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309 (601)
Q Consensus 233 ~~~g~L~~~~~~~---~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~ 309 (601)
+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~---~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT---SDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc---CCccEEecccccccccCcch
Confidence 9999999988653 23467778899999999999999999999999999999995 47889999999986432211
Q ss_pred ---CccccccccccccchhccC--------CCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCC-CCCCCC
Q 007498 310 ---RLNDIVGSAYYVAPEVLHR--------SYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDP-NFDDLP 376 (601)
Q Consensus 310 ---~~~~~~gt~~y~aPE~~~~--------~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~ 376 (601)
.....+|+..|+|||++.. .++.++|||||||++|||++ |..||......+.+..++.... ......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 1234578899999998732 35789999999999999996 5778877777666666554432 211111
Q ss_pred -CCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 377 -WPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 377 -~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
...+++.+.+++..|| .+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 1347889999999999 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=308.19 Aligned_cols=241 Identities=19% Similarity=0.234 Sum_probs=189.8
Q ss_pred ceeccCCCeEEEEEEeecCC-------ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 153 KEVGRGHFGHTCSARGKKGE-------LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
+.||+|+||.||++.+.... .....|++|++..... ....+.+|+.+++.+. ||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence 46999999999999987521 0113578887654321 1467889999999996 9999999999988 77
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC----CCCCeEEeeccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR----DDADMRLIDFGL 301 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~----~~~~vkl~DFG~ 301 (601)
.|+||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.+. ....+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 8999999999999998876655799999999999999999999999999999999999997421 112699999999
Q ss_pred ccccCCCCCccccccccccccchhccC---CCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCC
Q 007498 302 SDFIRPDERLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 302 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 377 (601)
+..... .....++..|+|||++.+ .++.++|||||||++|+|++ |..||............. .....+.
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~--- 227 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPM--- 227 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCC---
Confidence 976543 233457788999999864 58999999999999999999 577886654333322222 2111111
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.....+.++|.+||..||.+||++.++++
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 -PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=344.03 Aligned_cols=252 Identities=21% Similarity=0.369 Sum_probs=213.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCcc--CcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELK--DQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
..-.+.+.||+|+||.||.+........ .-.||||.+.+. .+.....+|.+|..+|+.+. |||||+++|.+.+..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDSG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCCC
Confidence 3567788999999999999987653222 345888887654 44556788999999999995 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 225 NVYIVMELCEGGELLDRILAR------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..+|++|||+||+|+.+|.+. ...++..+...++.+|++|++||+++++|||||-..|+||+ ....|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCcEEEcc
Confidence 999999999999999999876 56799999999999999999999999999999999999996 468999999
Q ss_pred cccccccCCCCCc-ccc--ccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCC
Q 007498 299 FGLSDFIRPDERL-NDI--VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFD 373 (601)
Q Consensus 299 FG~a~~~~~~~~~-~~~--~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~ 373 (601)
||+|+.+...... ... .-...|||||.+. +.++.|+|||||||+|||+++ |..||.+....+++..+.++. .++
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccC
Confidence 9999954333221 111 2235799999987 789999999999999999998 899999988888887676665 333
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.. ..++..+.+++..||+.+|++||+...|++
T Consensus 925 ~P--~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PP--SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CC--CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 32 478999999999999999999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=322.70 Aligned_cols=261 Identities=26% Similarity=0.454 Sum_probs=218.1
Q ss_pred CcccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcC-----CCCeeEE
Q 007498 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG-----HKHLVKF 216 (601)
Q Consensus 142 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~niv~l 216 (601)
.+.+..+|.+....|+|-||+|..|++.. .+..||||+|.....-. ..=+.|++||++|.. --|+++|
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~---r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQA---RGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccC---CCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 34566789999999999999999999876 67799999998765422 333679999999972 3489999
Q ss_pred eeeEecCCcEEEEEeecCCCchHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCe
Q 007498 217 CDACEDVNNVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294 (601)
Q Consensus 217 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~v 294 (601)
+..|...+++|||+|-+. .+|.+++.+.+ -.|....++.|+.||+.||..|-..||+|.||||+|||++. ....+
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE--~k~iL 576 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE--SKNIL 576 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc--Cccee
Confidence 999999999999999985 48888887653 34788999999999999999999999999999999999974 56789
Q ss_pred EEeecccccccCCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCC
Q 007498 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373 (601)
Q Consensus 295 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 373 (601)
||||||.|.....++ .+.+..+..|+|||++.| .|+...|+||+||+||||+||+..|.+.+...+++..+.....|+
T Consensus 577 KLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 577 KLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred eeccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 999999997766443 444556788999998765 799999999999999999999999999999999888776665554
Q ss_pred CCCC---------------------------------C----------------CC-------CHHHHHHHHHccccccc
Q 007498 374 DLPW---------------------------------P----------------SV-------SPEAKDFVKRLLNKDYR 397 (601)
Q Consensus 374 ~~~~---------------------------------~----------------~~-------s~~~~~li~~~L~~dP~ 397 (601)
.... . .+ -..+++||.+||..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 4210 0 01 13589999999999999
Q ss_pred CCCCHHHHHcCcccCC
Q 007498 398 KRMTAVQALTHPWLRD 413 (601)
Q Consensus 398 ~R~s~~ell~hp~f~~ 413 (601)
+|.|+.++|.||||..
T Consensus 736 KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 736 KRITVNQALKHPFITE 751 (752)
T ss_pred hcCCHHHHhcCCcccC
Confidence 9999999999999974
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=310.77 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=202.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC-CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--C
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG-ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--V 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~ 223 (601)
..|++.+.||+|+||.||+++.... ..+++.||||++...... .....+.+|+++++.+. |+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence 3688889999999999999986531 225789999998765432 34577999999999996 9999999999877 5
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
...|+||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++ .++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE---SEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEccccccc
Confidence 679999999999999999877655799999999999999999999999999999999999995 47899999999998
Q ss_pred ccCCCCCc----cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhH--------------HHHH
Q 007498 304 FIRPDERL----NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESG--------------IFRA 364 (601)
Q Consensus 304 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~--------------~~~~ 364 (601)
........ ....++..|+|||.+. ..++.++|||||||++|||++|..||....... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76533221 1234556799999875 568899999999999999999999986432211 1122
Q ss_pred HHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.+.....++. ...++.++.+|+.+||..||.+||++.|+++
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222222222 1356789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=299.89 Aligned_cols=253 Identities=29% Similarity=0.506 Sum_probs=207.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC---
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--- 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--- 223 (601)
.+|.-++.+|.|+- .|..|.+.- .++.||+|.+... +.......+..+|..++..+. |+||++++.+|.-.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v---~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQV---LGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhh---ccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccH
Confidence 46888899999998 777777654 7889999998665 333445677889999999996 99999999998543
Q ss_pred ---CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecc
Q 007498 224 ---NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300 (601)
Q Consensus 224 ---~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG 300 (601)
..+|+|||||.. +|...++. .++...+..|+.|++.|++|||+.||+||||||+||++. .++.+||.|||
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~---~~~~lKi~dfg 163 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN---SDCTLKILDFG 163 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec---chhheeeccch
Confidence 458999999975 88887763 588999999999999999999999999999999999995 48899999999
Q ss_pred cccccCCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc-----------
Q 007498 301 LSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS----------- 368 (601)
Q Consensus 301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~----------- 368 (601)
+|+.-...-..+..+.|..|+|||++.+ .|...+||||+||++.||++|...|.+...-+++-++...
T Consensus 164 ~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 164 LARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred hhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 9987665556677899999999998753 5999999999999999999999999877665544443321
Q ss_pred -----------CC---------CCCCCCCC-------CCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 369 -----------DP---------NFDDLPWP-------SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 369 -----------~~---------~~~~~~~~-------~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
.+ .|+...|+ .-+..+++|+.+||..||++|.+++++|+||||+
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 11 11221222 1245689999999999999999999999999997
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.90 Aligned_cols=252 Identities=16% Similarity=0.216 Sum_probs=185.6
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhh--------HHHHHHHHHHHHHhcCCCCeeEE
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS--------IEDVRREVKILKALSGHKHLVKF 216 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l 216 (601)
...+|++.+.||+|+||.||+|++......+..+|+|+........... ......++..+..+ +|+||+++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~ 88 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKY 88 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcE
Confidence 3468999999999999999999987532225677877643322111000 01112233344555 49999999
Q ss_pred eeeEecCC----cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCC
Q 007498 217 CDACEDVN----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292 (601)
Q Consensus 217 ~~~~~~~~----~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~ 292 (601)
++++.... ..+++||++.. ++.+.+.. ...+++..+..++.|++.||.|||+++|+||||||+|||++ .++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~---~~~ 163 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD---GNN 163 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCC
Confidence 99766543 35788888744 56555433 34578999999999999999999999999999999999995 478
Q ss_pred CeEEeecccccccCCCC--------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh-HH-
Q 007498 293 DMRLIDFGLSDFIRPDE--------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES-GI- 361 (601)
Q Consensus 293 ~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~- 361 (601)
.+||+|||+|+.+.... ......||+.|+|||++. ..++.++|||||||++|||++|..||.+.... ..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 89999999997664221 122357999999999876 46899999999999999999999999776332 21
Q ss_pred -------HHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 362 -------FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 362 -------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+..+..... ..+..++++.++++.|+..+|.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 122222211 22457899999999999999999999999875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=321.80 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=219.1
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+..+.++||+|.||.|+.+.|.....+...||||+++...... ...+|++|+.+|.+|. |+|+|+|||...+ ..+.
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhcc-CcceeEEeeeecc-chhh
Confidence 4667889999999999999998754456789999998765543 5788999999999996 9999999999887 6788
Q ss_pred EEEeecCCCchHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 228 IVMELCEGGELLDRILA-RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~-~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
||||++++|+|++++.+ ....|.......|+.||+.|+.||.++++|||||-..||||.+ ...|||+|||+.+-+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas---prtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS---PRTVKICDFGLMRALG 263 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc---cceeeeecccceeccC
Confidence 99999999999999987 5567899999999999999999999999999999999999965 6689999999999887
Q ss_pred CCCCccccc----cccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 307 PDERLNDIV----GSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 307 ~~~~~~~~~----gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
.++...... -...|+|||.+. +.++.++|||++||+||||++ |+.||.+.....++++|-.. -.++.. +.+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-erLpRP--k~c 340 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-ERLPRP--KYC 340 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-ccCCCC--CCC
Confidence 665544332 245799999886 789999999999999999997 78999999999998888733 233332 468
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
+.++.++++.||..+|..||++..|.+.-+.++
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 999999999999999999999999876655544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=293.82 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=205.1
Q ss_pred cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-----CcE
Q 007498 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-----NNV 226 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-----~~~ 226 (601)
.+.||-|+||.||.+.+.. +++.||+|++..-. ..-...+.+.+|+++|..++ |.|++..++...-. ..+
T Consensus 58 DRPIGYGAFGVVWsVTDPR---dgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPR---SGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCcccccceeEEEeccCCC---CccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHH
Confidence 4679999999999999876 88999999886432 23334577889999999997 99999988876533 358
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|+|+|.. +|...|-.. ..++.+.++-++.||++||+|||+.+|+||||||.|+|+++ +..+||||||+|+...
T Consensus 133 YV~TELmQS-DLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS---NCvLKICDFGLARvee 207 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS---NCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHh-hhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc---CceEEecccccccccc
Confidence 999999965 777766543 67999999999999999999999999999999999999965 8899999999998765
Q ss_pred CCCC--ccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc--------------
Q 007498 307 PDER--LNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-------------- 368 (601)
Q Consensus 307 ~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-------------- 368 (601)
.... .+.-+-|.+|+|||++++ .|+.++||||+|||+.||+..+..|...+.-++++.|...
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 4433 334577999999999985 6999999999999999999999999888877766665421
Q ss_pred ---------CCCCCCCC-------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 369 ---------DPNFDDLP-------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 369 ---------~~~~~~~~-------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
....+..+ ...-..+..+++.+||..||.+|++..+++.|+|..+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 11111111 01224578899999999999999999999999998654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.68 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=188.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeec-------------CCccCcEEEEEEeecccccchh-----------hHHHHHHHH
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKK-------------GELKDQQVAVKIISKAKMTTAI-----------SIEDVRREV 201 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~-------------~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~ 201 (601)
.++|++.++||+|+||.||++.... ....++.||||.+......... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 3479999999999999999986521 1124568999998643211100 112234577
Q ss_pred HHHHHhcCCCC-----eeEEeeeEec--------CCcEEEEEeecCCCchHHHHHHcCC---------------------
Q 007498 202 KILKALSGHKH-----LVKFCDACED--------VNNVYIVMELCEGGELLDRILARGG--------------------- 247 (601)
Q Consensus 202 ~~l~~l~~h~n-----iv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~~~~~~~--------------------- 247 (601)
.++.+++ |.+ +++++++|.. .+..||||||+++++|.+++....+
T Consensus 224 ~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 224 YMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 7778886 544 4667777653 3568999999999999988764321
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCcccc--ccccccccc
Q 007498 248 --RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--VGSAYYVAP 323 (601)
Q Consensus 248 --~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~--~gt~~y~aP 323 (601)
.+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++............ .+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---CCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 235677899999999999999999999999999999995 4788999999999765443333332 347899999
Q ss_pred hhccC-C--------------------C--CChhhHHHHHHHHHHHHhCCC-CCCCCCh-----------hHHHHHHHcc
Q 007498 324 EVLHR-S--------------------Y--SLEADIWSIGVISYILLCGSR-PFWARTE-----------SGIFRAVLRS 368 (601)
Q Consensus 324 E~~~~-~--------------------~--~~~~DvwSlG~il~ell~g~~-pf~~~~~-----------~~~~~~i~~~ 368 (601)
|++.. . | ..+.||||+|||+|+|++|.. ||..... ....+.+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98642 1 1 134799999999999999986 6643211 1111112222
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHcccccc---cCCCCHHHHHcCcccCC
Q 007498 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDY---RKRMTAVQALTHPWLRD 413 (601)
Q Consensus 369 ~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~R~s~~ell~hp~f~~ 413 (601)
...+. .|+.+++.++|||.+||..+| .+|+|+.|+|+||||..
T Consensus 460 ~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 22332 466789999999999999866 78999999999999964
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=311.06 Aligned_cols=246 Identities=25% Similarity=0.420 Sum_probs=207.2
Q ss_pred EEcceeccCCCeEEEEEEeecCC-ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 150 ELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 150 ~~~~~lG~G~~g~V~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
.+.+.||.|-||.||++....-+ ...-.||||..+... +....+.|..|.-+|+.+. |||||+|+|.|.+. ..||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfd-HphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCC-Ccchhheeeeeecc-ceeE
Confidence 34568999999999999875421 123468999886643 3335788999999999995 99999999999874 6899
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~ 308 (601)
|||+++.|.|..++......++......|+.||+.||.|||++++|||||-..|||+.+ ...|||+|||+++.+...
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS---p~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS---PQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC---cceeeecccchhhhcccc
Confidence 99999999999999988888999999999999999999999999999999999999975 678999999999998877
Q ss_pred CCcccccc--ccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 309 ERLNDIVG--SAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 309 ~~~~~~~g--t~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
..+....| ..-|||||-++ ..++.++|||-|||.+||++. |..||.+....+.+-.+-++.. ++.. +++++.+
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-lP~P--~nCPp~L 621 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-LPCP--PNCPPAL 621 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-CCCC--CCCChHH
Confidence 66555455 45699999887 789999999999999999775 9999999888777666655543 2221 5899999
Q ss_pred HHHHHHcccccccCCCCHHHH
Q 007498 385 KDFVKRLLNKDYRKRMTAVQA 405 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~el 405 (601)
..|+.+||..+|.+||...++
T Consensus 622 YslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred HHHHHHHhccCcccCCcHHHH
Confidence 999999999999999987654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=325.51 Aligned_cols=251 Identities=30% Similarity=0.457 Sum_probs=200.1
Q ss_pred EcceeccCCCeE-EEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEE
Q 007498 151 LGKEVGRGHFGH-TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV 229 (601)
Q Consensus 151 ~~~~lG~G~~g~-V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv 229 (601)
-.+.+|.|+.|+ ||++.. .++.||||++-... ..-..+||..|+.-.+|||||++|+.-.+.+.+||.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-----e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-----EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred cHHHcccCCCCcEEEEEee-----CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 345789999985 676654 67899999874432 345689999999998999999999999999999999
Q ss_pred EeecCCCchHHHHHHcCCC--C-CHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC--CCCCeEEeecccccc
Q 007498 230 MELCEGGELLDRILARGGR--Y-TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR--DDADMRLIDFGLSDF 304 (601)
Q Consensus 230 ~e~~~~g~L~~~~~~~~~~--l-~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~--~~~~vkl~DFG~a~~ 304 (601)
.|+|.. +|.+++...... + .....+.++.|++.||++||+.+||||||||.||||...+ ....++|+|||+++.
T Consensus 582 lELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 999965 999998763111 1 1145678999999999999999999999999999998632 345789999999998
Q ss_pred cCCCC----CccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 305 IRPDE----RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCG-SRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 305 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
+..+. ...+..||.+|+|||++.. .-+.++||||||||+|+.++| ..||..... .-.+|+.+........ +
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~-~ 737 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLE-P 737 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeec-c
Confidence 86553 2456789999999999874 456799999999999988887 899954433 3456776665544432 1
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
....++.|||.+||.++|..||+|.++|+||+|.+..+
T Consensus 738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ek 775 (903)
T KOG1027|consen 738 LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEK 775 (903)
T ss_pred CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHH
Confidence 12228999999999999999999999999999987543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=321.15 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=218.0
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
-.|.+.||.|.||.||.++.+........||||.++... ....+.+|+.|..||-++. ||||++|.|+......+.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCceeEE
Confidence 467889999999999999998644456789999997653 3446788999999999995 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~ 308 (601)
|+|||++|+|..+|..+.+.|+.-++.-+++.|+.|+.||-+.|+|||||-..|||+++ +..+|++|||+++.+.++
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs---nLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc---ceEEEeccccceeecccC
Confidence 99999999999999999999999999999999999999999999999999999999964 888999999999988655
Q ss_pred CC--cccccc--ccccccchhcc-CCCCChhhHHHHHHHHHHHH-hCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 309 ER--LNDIVG--SAYYVAPEVLH-RSYSLEADIWSIGVISYILL-CGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 309 ~~--~~~~~g--t~~y~aPE~~~-~~~~~~~DvwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
.. ..+.-| ...|.|||.+. +.++.++||||+||||||.+ .|..|||..+..+.++.|.++-. ++. ...++.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR-LPp--PmDCP~ 861 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR-LPP--PMDCPA 861 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC-CCC--CCCCcH
Confidence 42 222223 36799999775 88999999999999999855 59999999999999988876543 222 247999
Q ss_pred HHHHHHHHcccccccCCCCHHHHHc
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.+..|+..||++|=.+||...||++
T Consensus 862 aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 862 ALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 9999999999999999999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=270.25 Aligned_cols=214 Identities=26% Similarity=0.405 Sum_probs=181.6
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
....+..||+|+||.|-+.++.. +|...|+|.+...-. .....++++|+.+..+..++|.+|.+|+.+...+.+|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~---sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQ---SGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred hhhhhhhhcCCccchhhheeecc---CCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 34556789999999999999887 899999999976432 3356778899999888878999999999999999999
Q ss_pred EEEeecCCCchHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 228 IVMELCEGGELLDRI---LARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 228 lv~e~~~~g~L~~~~---~~~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
|.||.|+. +|..+. .++++.++|..+-+|+..++.||+|||++ .|||||+||+|||++ .+|.|||||||.+.
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn---~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN---YDGQVKICDFGISG 197 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc---cCCcEEEcccccce
Confidence 99999975 654432 34678899999999999999999999998 899999999999995 59999999999998
Q ss_pred ccCCCCCccccccccccccchhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHccCC
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH-----RSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDP 370 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~ 370 (601)
.+.+.-..+-..|...|||||.+. ..|+.++||||||+.++||.+++.||.. .++.++++++....+
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 876554444467889999999874 3699999999999999999999999965 467778888876543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=286.70 Aligned_cols=242 Identities=43% Similarity=0.758 Sum_probs=204.0
Q ss_pred CCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeecCCCch
Q 007498 159 HFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL 238 (601)
Q Consensus 159 ~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 238 (601)
+||.||++.+.. +++.||+|++........ ...+.+|++++++++ |+||+++++++......++||||+.+++|
T Consensus 1 ~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKK---TGKLVAIKVIKKEKIKKK--RERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECC---CCcEEEEEEecccccccH--HHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 589999999875 678999999876543321 578899999999995 99999999999999999999999999999
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCcccccccc
Q 007498 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318 (601)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~ 318 (601)
.+++.... .+++..+..++.+++.+|.|||+.+|+|+||+|.||+++. ++.++|+|||++.............++.
T Consensus 75 ~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDE---DGHVKLADFGLARQLDPGGLLTTFVGTP 150 (244)
T ss_pred HHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECC---CCcEEEccccceeeeccccccccccCCc
Confidence 98876543 3899999999999999999999999999999999999964 6899999999998776554556678899
Q ss_pred ccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccc
Q 007498 319 YYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDY 396 (601)
Q Consensus 319 ~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 396 (601)
.|++||.+. ..++.++||||||+++++|++|..||.. .........+......... .+..++.++.+++.+||..||
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-ccccCCHHHHHHHHHHccCCc
Confidence 999999876 5688999999999999999999999977 4444444444433332221 122288999999999999999
Q ss_pred cCCCCHHHHHcCccc
Q 007498 397 RKRMTAVQALTHPWL 411 (601)
Q Consensus 397 ~~R~s~~ell~hp~f 411 (601)
++||++.++++||||
T Consensus 230 ~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 230 EKRLTAEEALQHPFF 244 (244)
T ss_pred hhccCHHHHhhCCCC
Confidence 999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.58 Aligned_cols=243 Identities=23% Similarity=0.411 Sum_probs=206.2
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
..+..+||-|.||.||.+.|++ -.-.||||.++...+ .+++|+.|..+|+.|+ |||+|+|+++|.....+||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKk---yslTvAVKtLKEDtM----eveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred eeeeeccCCCcccceeeeeeec---cceeeehhhhhhcch----hHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEE
Confidence 3445689999999999999997 456799999866543 5788999999999997 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 229 VMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~-l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
|+|||..|+|++++...+.. ++.-...+++.||..|++||..+++|||||-..|+|++ ++..|||+|||+++.+..
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcC
Confidence 99999999999999876543 56667788999999999999999999999999999996 588899999999988754
Q ss_pred CCCcccccc---ccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 308 DERLNDIVG---SAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 308 ~~~~~~~~g---t~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
+ .++...| ..-|.|||-+. ..++.|+|||+|||+|||+.| |..||.+.....++..+.++ ...... ..+++
T Consensus 418 D-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-yRM~~P--eGCPp 493 (1157)
T KOG4278|consen 418 D-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-YRMDGP--EGCPP 493 (1157)
T ss_pred C-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-ccccCC--CCCCH
Confidence 4 3333344 45699999775 679999999999999999987 89999999888877666544 222221 37999
Q ss_pred HHHHHHHHcccccccCCCCHHHHH
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQAL 406 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell 406 (601)
.+.+|++.||+.+|+.||+..|+-
T Consensus 494 kVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 494 KVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHHHHhcCCcccCccHHHHH
Confidence 999999999999999999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.73 Aligned_cols=277 Identities=28% Similarity=0.454 Sum_probs=227.2
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
+...+|+++.++|.|+||.||+||++. +++..|+|+++.. ......-++.|+-+++..+ |||||.+++.+...
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~---s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~-h~nivay~gsylr~ 84 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKR---SGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRR 84 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccc---cCchhhheeeecc---CCccccccccceeeeecCC-CcChHHHHhhhhhh
Confidence 345679999999999999999999997 8899999999653 3335567889999999986 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
..+||+||||.||+|.+.. .-.+.+++-++..++++.+.||+|||+.|-+|||||-.|||++ +.+.+|++|||.+.
T Consensus 85 dklwicMEycgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsa 160 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSA 160 (829)
T ss_pred cCcEEEEEecCCCccccee-eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchh
Confidence 9999999999999998854 3457899999999999999999999999999999999999996 48999999999987
Q ss_pred ccCCC-CCccccccccccccchhc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC-C
Q 007498 304 FIRPD-ERLNDIVGSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP-W 377 (601)
Q Consensus 304 ~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~ 377 (601)
.+... .+...+.||++|||||+. .+.|+..+|||++|+...|+-.-++|....-....+...-+..+..+... -
T Consensus 161 qitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk 240 (829)
T KOG0576|consen 161 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK 240 (829)
T ss_pred hhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence 66432 345678999999999985 36899999999999999999998988765544444444444433333222 2
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCChhHHHHHHHHhhhccC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHAT 435 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~k~~~~~~ 435 (601)
..+++.+.+|++.+|.+||.+||+++.+|.|||.... .. ......++.++++.+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-l~---~rl~~eLLdK~n~P~ 294 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-LS---RRLAIELLDKVNNPN 294 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-hh---hHHHHHHHHHccCCC
Confidence 3578999999999999999999999999999999754 11 223445555566555
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=293.21 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=206.7
Q ss_pred CcccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 142 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
...+...|.++.+||.|.|++||++.+.......+.||+|.+.... ...++.+|+++|..+.++.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence 3445567999999999999999999887644467899999986543 34568999999999999999999999999
Q ss_pred cCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
.++.+.+||||++..+..+++. .++..+++.|++.++.||.++|.+|||||||||.|+|++ ...+.-.|+|||+
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGL 179 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechh
Confidence 9999999999999988776553 478999999999999999999999999999999999997 4678889999999
Q ss_pred ccccC-----------------C--CC--------------------------Cccccccccccccchhcc--CCCCChh
Q 007498 302 SDFIR-----------------P--DE--------------------------RLNDIVGSAYYVAPEVLH--RSYSLEA 334 (601)
Q Consensus 302 a~~~~-----------------~--~~--------------------------~~~~~~gt~~y~aPE~~~--~~~~~~~ 334 (601)
|.... . +. ......||++|+|||++. +..+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 86210 0 00 001257999999999986 4679999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHH--------------ccC------CC----------------------
Q 007498 335 DIWSIGVISYILLCGSRPFWARTE-SGIFRAVL--------------RSD------PN---------------------- 371 (601)
Q Consensus 335 DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~--------------~~~------~~---------------------- 371 (601)
||||.|||++.+++++.||....+ .+.+..+. -+. ..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 999999999999999999954322 11111110 000 00
Q ss_pred ----CCCCCCC-CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 372 ----FDDLPWP-SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 372 ----~~~~~~~-~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.....|. ..+..+.||+.+||+.||.+|+|++++|.||||.+.
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0011111 234589999999999999999999999999999843
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=282.09 Aligned_cols=240 Identities=25% Similarity=0.370 Sum_probs=188.0
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc-CCCCeeEEeeeEecCC--
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-GHKHLVKFCDACEDVN-- 224 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~l~~~~~~~~-- 224 (601)
..++.+.||+|.||.||+|+. .++.||||++... ..+.+.+|-+|++... .|+||++|+++-....
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-----~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-----DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred chhhHHHhhcCccceeehhhc-----cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 467788999999999999976 5689999998654 3467888888887643 5999999999876555
Q ss_pred --cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeeccCCCCceEeecCCCCCC
Q 007498 225 --NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ---------GVVHRDLKPENFLFTSGRDDAD 293 (601)
Q Consensus 225 --~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~---------~iiHrDikp~NIll~~~~~~~~ 293 (601)
.++||+||.+.|+|.+++... .+++....+|+..+++||+|||+. .|+|||||..||||. .++.
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK---~DlT 354 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK---NDLT 354 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc---cCCc
Confidence 799999999999999998764 799999999999999999999974 499999999999995 5899
Q ss_pred eEEeecccccccCCCC---CccccccccccccchhccCCCC-------ChhhHHHHHHHHHHHHhCCC------------
Q 007498 294 MRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLHRSYS-------LEADIWSIGVISYILLCGSR------------ 351 (601)
Q Consensus 294 vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-------~~~DvwSlG~il~ell~g~~------------ 351 (601)
..|+|||+|.++.++. .....+||..|||||++.+..+ ...||||+|.|||||++.-.
T Consensus 355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql 434 (534)
T KOG3653|consen 355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL 434 (534)
T ss_pred EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence 9999999998886543 3345799999999999976432 34899999999999998632
Q ss_pred CCCC-----CChhHHHHHHHc--cCCCCCCCCCCC-CCHHHHHHHHHcccccccCCCCHH
Q 007498 352 PFWA-----RTESGIFRAVLR--SDPNFDDLPWPS-VSPEAKDFVKRLLNKDYRKRMTAV 403 (601)
Q Consensus 352 pf~~-----~~~~~~~~~i~~--~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~s~~ 403 (601)
||.. .+-.++...+.+ ..+.++.....+ --..+++.+..||+.|++-|.|+.
T Consensus 435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred chhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 3321 122233333332 334444322111 134578899999999999999984
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.49 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=205.6
Q ss_pred eEEcceeccCCCeEEEEEEeecCCc----cCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGEL----KDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
..+.+.||+|.||.|+++..+.... ....||||.++..... ...+.+..|+++|+.+..|+||+.++++|...+
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 3566799999999999998653221 2568999998765433 467889999999999988999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC
Q 007498 225 NVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~ 289 (601)
.+++|+|||..|+|.+++.... ..++..+...++.||+.|++||+++++|||||-..|||++.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~-- 453 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK-- 453 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC--
Confidence 9999999999999999988765 34899999999999999999999999999999999999964
Q ss_pred CCCCeEEeecccccccCCCCCcc--ccccc--cccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCC-hhHHH
Q 007498 290 DDADMRLIDFGLSDFIRPDERLN--DIVGS--AYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWART-ESGIF 362 (601)
Q Consensus 290 ~~~~vkl~DFG~a~~~~~~~~~~--~~~gt--~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~-~~~~~ 362 (601)
+..+||+|||+|+......... ...|+ ..|||||.+. ..|+.++||||+||+||||++ |..||.+.. ..+++
T Consensus 454 -~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 -NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred -CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 6789999999998654443322 22332 3499999887 579999999999999999998 789998755 55665
Q ss_pred HHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.+..+.. .... ..+++++.++++.||..+|++||+..++.+
T Consensus 533 ~~l~~G~r-~~~P--~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKEGNR-MEQP--EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhcCCC-CCCC--CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 54444332 2221 367999999999999999999999998774
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=273.63 Aligned_cols=246 Identities=26% Similarity=0.416 Sum_probs=188.2
Q ss_pred cccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc-CCCCeeEEeeeEe
Q 007498 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-GHKHLVKFCDACE 221 (601)
Q Consensus 143 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~l~~~~~ 221 (601)
..+..+..+.+.||+|.||+||.++++ |+.||||++.... .....||.+|++.+- +|+||+.|++.-.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-----Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-----GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-----CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 445678899999999999999999885 5789999986532 355678888888642 4999999998754
Q ss_pred cC----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeccCCCCceEeecCC
Q 007498 222 DV----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ--------GVVHRDLKPENFLFTSGR 289 (601)
Q Consensus 222 ~~----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~--------~iiHrDikp~NIll~~~~ 289 (601)
.+ .++|||++|.+.|||+|++.. ..++.+...+++..++.||.+||.. .|.|||||..|||+.
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK--- 350 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK--- 350 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc---
Confidence 33 359999999999999999876 4799999999999999999999964 499999999999995
Q ss_pred CCCCeEEeecccccccCCCC-----CccccccccccccchhccCCCC-------ChhhHHHHHHHHHHHHhC--------
Q 007498 290 DDADMRLIDFGLSDFIRPDE-----RLNDIVGSAYYVAPEVLHRSYS-------LEADIWSIGVISYILLCG-------- 349 (601)
Q Consensus 290 ~~~~vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-------~~~DvwSlG~il~ell~g-------- 349 (601)
+++...|+|+|+|....... ..+..+||..|||||++....+ ..+||||||.|+||++..
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e 430 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE 430 (513)
T ss_pred cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence 58999999999997765442 2356799999999999964322 358999999999999863
Q ss_pred --CCCCCCCCh----hHHHHHHHc---cCCCCCCCCCCCCC--HHHHHHHHHcccccccCCCCHHHH
Q 007498 350 --SRPFWARTE----SGIFRAVLR---SDPNFDDLPWPSVS--PEAKDFVKRLLNKDYRKRMTAVQA 405 (601)
Q Consensus 350 --~~pf~~~~~----~~~~~~i~~---~~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~R~s~~el 405 (601)
++||++..+ .+.++.++. ..+.++. .|...+ ..+..+++.||..||.-|.|+--+
T Consensus 431 ey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipn-rW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 431 EYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPN-RWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred hhcCCcccCCCCCCCHHHHhcceeecccCCCCCc-ccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 578865422 222233222 2222222 233221 235667888999999999887544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=327.20 Aligned_cols=239 Identities=23% Similarity=0.314 Sum_probs=182.4
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|...+.||+|+||.||+|+++. ++..||||++...... ...|++++++++ |||||+++++|.+....|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-------~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIK---NGMQFVVKEINDVNSI-------PSSEIADMGKLQ-HPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECC---CCcEEEEEEccCCccc-------cHHHHHHHhhCC-CCCcceEEEEEEcCCCCE
Confidence 46667889999999999999865 6789999998643221 135788999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH---LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH---~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+|||||++|+|.+++. .+++..+..|+.|++.||.||| +.+|+||||||+||+++. ++..++. ||.+..
T Consensus 760 lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~---~~~~~~~-~~~~~~ 831 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG---KDEPHLR-LSLPGL 831 (968)
T ss_pred EEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC---CCceEEE-eccccc
Confidence 9999999999999874 3899999999999999999999 669999999999999953 5556654 665543
Q ss_pred cCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHH---Hcc-------CCC
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAV---LRS-------DPN 371 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~--~~~~~~i---~~~-------~~~ 371 (601)
... .....||..|+|||++. +.|+.++|||||||++|||++|+.||..... ..+.... ... .+.
T Consensus 832 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 832 LCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred ccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 321 12347899999999876 5699999999999999999999999853211 1111110 000 000
Q ss_pred CCCC-CC-CCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 372 FDDL-PW-PSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 372 ~~~~-~~-~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.... .. .....++.+++.+||..||++||++.|+++.
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000 00 0112357789999999999999999998863
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=285.62 Aligned_cols=200 Identities=31% Similarity=0.558 Sum_probs=174.8
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHH-----HHHHHHHHHHHhc--CCCCeeEEeeeE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIE-----DVRREVKILKALS--GHKHLVKFCDAC 220 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~E~~~l~~l~--~h~niv~l~~~~ 220 (601)
.|..++.||.|+||.|++|.++. +...|+||.|.|.+......++ .+-.||+||..|+ .|+||++++++|
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~---n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKE---NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred cceeeeeccccccceEEEeeecc---cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 59999999999999999999987 6789999999887765433322 2567999999995 389999999999
Q ss_pred ecCCcEEEEEeec-CCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 221 EDVNNVYIVMELC-EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 221 ~~~~~~~lv~e~~-~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
++++++||+||-- +|-+|+++|..+ ..++|.++..|++||+.|+++||+.||||||||-+|+.++ .+|.+||+||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd---~~g~~klidf 714 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD---SNGFVKLIDF 714 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEe---cCCeEEEeec
Confidence 9999999999974 456889988654 6899999999999999999999999999999999999995 4899999999
Q ss_pred ccccccCCCCCccccccccccccchhccCC--CCChhhHHHHHHHHHHHHhCCCCCCC
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWA 355 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DvwSlG~il~ell~g~~pf~~ 355 (601)
|.|.... ......++||..|.|||++.|. .+..-|||+||++||-++....||+.
T Consensus 715 gsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9997655 4457889999999999999863 47888999999999999999999964
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=286.22 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=206.9
Q ss_pred CeEEcceeccCCCeEEEEEEeecC-CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKG-ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..+..++||+|+||+||++.+... +.-.-+||||++...... ....++++|.-+|.+|. |||+++|++++.... +
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLD-HPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-H
Confidence 355677899999999999988642 212457999998654332 34567899999999995 999999999998765 7
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
-||++|+++|.|++++......+..+....|+.||++||.|||+++++||||-..|||+.+ -..+||+|||+|+.+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVks---P~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKS---PNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecC---CCeEEEEecchhhccC
Confidence 8999999999999999988889999999999999999999999999999999999999964 7789999999998876
Q ss_pred CCCCcc-cc--ccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 307 PDERLN-DI--VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 307 ~~~~~~-~~--~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
...... .. .-.+-|||-|.+. ..|+.++|||||||++||++| |..||.+..-.++-..+..+.. ++.. +..+
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqP--piCt 926 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQP--PICT 926 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCC--CCcc
Confidence 554322 22 2245688888765 689999999999999999987 9999998877776555544433 4443 4688
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.++.-++.+||..|+..||+++++-.
T Consensus 927 iDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 927 IDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHHhccCcccCccHHHHHH
Confidence 99999999999999999999988654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=253.68 Aligned_cols=255 Identities=25% Similarity=0.443 Sum_probs=197.8
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeee-Eec
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDA-CED 222 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~-~~~ 222 (601)
.+.+.|.|.+.||+|.||.+-+|+++. +.+.+++|.+.+... ...+|.+|..---.|..|.||+.-|+. |+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~---s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQ---SKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccC---CceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 455689999999999999999999987 778999999876543 457889999877777779999998874 777
Q ss_pred CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
.+.+.++|||++.|+|...+.. ..+.|.-.+.++.|+++||.|+|++++||||||.+||||-.. +...|||||||+.
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t 170 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLT 170 (378)
T ss_pred CceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccc
Confidence 7888899999999999887654 358999999999999999999999999999999999999753 3558999999998
Q ss_pred cccCCCCCccccccccccccchhcc----CC--CCChhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHH---Hc-cCCC
Q 007498 303 DFIRPDERLNDIVGSAYYVAPEVLH----RS--YSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAV---LR-SDPN 371 (601)
Q Consensus 303 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~--~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i---~~-~~~~ 371 (601)
+.... .....--+..|.+||++. +. ..+.+|+|.||||+|.+++|.+||.... ....+.+. .. ..+.
T Consensus 171 ~k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 171 RKVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA 248 (378)
T ss_pred cccCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence 75432 222233456799999753 22 5788999999999999999999996432 12222222 22 2222
Q ss_pred CCCCCCCCCCHHHHHHHHHcccccccCC---CCHHHHHcCccc
Q 007498 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKR---MTAVQALTHPWL 411 (601)
Q Consensus 372 ~~~~~~~~~s~~~~~li~~~L~~dP~~R---~s~~ell~hp~f 411 (601)
.|. .+..+++.+..+.++-|.++++.| .++.......|.
T Consensus 249 ~P~-~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 249 LPK-KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred Cch-hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 232 245689999999999999999999 344444444443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=243.53 Aligned_cols=212 Identities=45% Similarity=0.781 Sum_probs=183.9
Q ss_pred eccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeecC
Q 007498 155 VGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCE 234 (601)
Q Consensus 155 lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 234 (601)
||+|++|.||+++... +++.+++|++....... ..+.+.+|+++++.+. |++|+++++++......++||||+.
T Consensus 1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecC---CCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCC
Confidence 6899999999999864 57899999987654321 3467899999999996 9999999999999999999999999
Q ss_pred CCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCC-Cccc
Q 007498 235 GGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLND 313 (601)
Q Consensus 235 ~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-~~~~ 313 (601)
+++|.+++......++...+..++.+++.+|.|||++|++|+||+|.||++.. .++.++|+|||.+....... ....
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~--~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS--DNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC--CCCcEEEecCCceEEccCCcchhhc
Confidence 89999987665456999999999999999999999999999999999999952 16789999999997664432 1334
Q ss_pred cccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHc
Q 007498 314 IVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391 (601)
Q Consensus 314 ~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 391 (601)
..+...|++||.+.. .++.+.|+|++|+++++| ..+.+++.+|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~ 197 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKM 197 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHH
Confidence 567889999998864 788999999999999999 5789999999
Q ss_pred ccccccCCCCHHHHHcCc
Q 007498 392 LNKDYRKRMTAVQALTHP 409 (601)
Q Consensus 392 L~~dP~~R~s~~ell~hp 409 (601)
|..||.+||++.++++|+
T Consensus 198 l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 198 LQKDPEKRPSAKEILEHL 215 (215)
T ss_pred hhCCcccCcCHHHHhhCC
Confidence 999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=306.03 Aligned_cols=198 Identities=16% Similarity=0.215 Sum_probs=149.5
Q ss_pred CCeeEEeeeE-------ecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCce
Q 007498 211 KHLVKFCDAC-------EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF 283 (601)
Q Consensus 211 ~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NI 283 (601)
.||++++++| .....++++|||+ +++|.+++......+++.+++.|+.||+.||.|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777888877 2334678889988 5599999876556799999999999999999999999999999999999
Q ss_pred Eeec----------------CCCCCCeEEeecccccccCCCC-----------------Cccccccccccccchhcc-CC
Q 007498 284 LFTS----------------GRDDADMRLIDFGLSDFIRPDE-----------------RLNDIVGSAYYVAPEVLH-RS 329 (601)
Q Consensus 284 ll~~----------------~~~~~~vkl~DFG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~~ 329 (601)
||+. .+.++.+||+|||+++...... .....+||++|||||++. ..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 9953 1235667888888876432100 011246899999999876 57
Q ss_pred CCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCc
Q 007498 330 YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409 (601)
Q Consensus 330 ~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp 409 (601)
|+.++|||||||+||||++|..|+.... ..+..+.... ++.. +....+...+++.+||.+||.+||++.|+|+||
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQ-ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChh-hhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 9999999999999999999998875322 1222221111 1111 112345678999999999999999999999999
Q ss_pred ccCCC
Q 007498 410 WLRDD 414 (601)
Q Consensus 410 ~f~~~ 414 (601)
||...
T Consensus 267 ~~~~~ 271 (793)
T PLN00181 267 FINEP 271 (793)
T ss_pred hhhhh
Confidence 99864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=243.14 Aligned_cols=212 Identities=43% Similarity=0.725 Sum_probs=179.1
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
|.+.+.||.|++|.||++.... +++.+|+|.+...... .....+.+|++.++.+. |+|++++++++......++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---TGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---CCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEE
Confidence 5678899999999999999875 5789999998765432 24578899999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~ 308 (601)
|+||+++++|.+++......+++..+..++.+++.+|.|||+++++|+||++.||+++. ++.++|+|||++......
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~---~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGM---DGLVKLADFGLARFIHRD 151 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEeeCceeeEecCc
Confidence 99999999999988765333899999999999999999999999999999999999953 689999999999877544
Q ss_pred C--Cccccccccccccchhc-c-CCCCChhhHHHHHHHHHHHHhCCCCCCC-CCh-hHHHHHHHccC
Q 007498 309 E--RLNDIVGSAYYVAPEVL-H-RSYSLEADIWSIGVISYILLCGSRPFWA-RTE-SGIFRAVLRSD 369 (601)
Q Consensus 309 ~--~~~~~~gt~~y~aPE~~-~-~~~~~~~DvwSlG~il~ell~g~~pf~~-~~~-~~~~~~i~~~~ 369 (601)
. ......++..|++||++ . ..++.++|+|+||+++++|++|+.||.. ... ..+.+.+....
T Consensus 152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 3 34556788999999987 3 4577899999999999999999999977 343 35555555544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-30 Score=264.60 Aligned_cols=244 Identities=25% Similarity=0.444 Sum_probs=213.1
Q ss_pred eeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeec
Q 007498 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELC 233 (601)
Q Consensus 154 ~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 233 (601)
.+|+|+||.|++++-..+...+..||+|+.++......... ....|..++..+++||.+|++...++.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 37999999999998877777889999999987655544332 56678889999888999999999999999999999999
Q ss_pred CCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCccc
Q 007498 234 EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313 (601)
Q Consensus 234 ~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 313 (601)
.||+|..++... ..+.+...+.+..+++.+++++|+.+|+|||+|++||++. .+|++|+.|||+++..-.....
T Consensus 80 rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld---~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL---LEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred ccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec---ccCccccCCchhhhHhHhhhhc--
Confidence 999998876544 5688999999999999999999999999999999999994 5999999999999876544333
Q ss_pred cccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHccc
Q 007498 314 IVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLN 393 (601)
Q Consensus 314 ~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 393 (601)
|||..|||||+++ .....+|+||+|++++||++|..||.+ ++...|++....++. .++.++++++..++.
T Consensus 154 -cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFK 223 (612)
T ss_pred -ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHh
Confidence 9999999999998 678889999999999999999999977 778888887777765 688999999999999
Q ss_pred ccccCCCCH-----HHHHcCcccCCC
Q 007498 394 KDYRKRMTA-----VQALTHPWLRDD 414 (601)
Q Consensus 394 ~dP~~R~s~-----~ell~hp~f~~~ 414 (601)
.+|.+|... .++++|+||+..
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheee
Confidence 999999854 799999999643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=219.34 Aligned_cols=240 Identities=24% Similarity=0.334 Sum_probs=194.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|+++++||.|+||.+|++.... +|+.||||+-.... ...++..|.++.+.|++...|..+..++.+...
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~---~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISIT---SGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred ccceEEEEeecCCchhheeeeeecc---CCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 4689999999999999999999886 89999999864432 124578899999999877899999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
-.|||+++ |.+|.+.+.-+...|+..++..++-|++.-++|+|.+++|||||||+|+|.+-+.....+.|+|||+|+.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999999 78999998888889999999999999999999999999999999999999988777788999999999877
Q ss_pred CCCC--------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHccCCCCC
Q 007498 306 RPDE--------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSDPNFD 373 (601)
Q Consensus 306 ~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~ 373 (601)
.+.. .-....||..|.+=.... -..+...|+-|+|.+|.++..|..||.+.. ...-++.|.+.+...+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 5332 124578999999876544 356788999999999999999999998753 3445566655443332
Q ss_pred CCC-CCCCCHHHHHHHHHcccc
Q 007498 374 DLP-WPSVSPEAKDFVKRLLNK 394 (601)
Q Consensus 374 ~~~-~~~~s~~~~~li~~~L~~ 394 (601)
... -..++.++.-.|.-|=..
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L 266 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGL 266 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhc
Confidence 211 124566666666666443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=227.43 Aligned_cols=204 Identities=25% Similarity=0.430 Sum_probs=177.2
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
..+..|+++++||+|+||..+.+.+.- +++.||||.-.... ...++..|.+.++.|.+.++|...|.+..++
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~---nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLY---NNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred EecccceeccccccCcceeeecccccc---cCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 345689999999999999999997654 89999999865432 2367889999999998889999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec--CCCCCCeEEeeccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS--GRDDADMRLIDFGL 301 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~--~~~~~~vkl~DFG~ 301 (601)
.+-.||||++ |.+|.|++.-++.+|+..++..++.|++.-++|+|++.+|+|||||+|+||+. ..+...|.|+|||+
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 9999999999 78999998888889999999999999999999999999999999999999975 23456789999999
Q ss_pred ccccCCCCC--------ccccccccccccchhc-cCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 007498 302 SDFIRPDER--------LNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWAR 356 (601)
Q Consensus 302 a~~~~~~~~--------~~~~~gt~~y~aPE~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~ 356 (601)
|+.+.+... .....||..||+=... .++.+.+.|+-|||-|+.++|.|.+||.+-
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 998865432 2457899999997754 356889999999999999999999999764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-27 Score=227.88 Aligned_cols=252 Identities=18% Similarity=0.240 Sum_probs=201.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCc--cCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-C
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGEL--KDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-V 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~ 223 (601)
.++++...+-+|+||.||.+.++.... +.+.|-+|.++.. .....+..++.|--++..+. |||+..+.+.+.. .
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIEDY 360 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCc-CCCccceeEEEeecc
Confidence 357778889999999999998764322 2356677766433 34556778899999999997 9999999998654 5
Q ss_pred CcEEEEEeecCCCchHHHHHHc-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEE
Q 007498 224 NNVYIVMELCEGGELLDRILAR-------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~-------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl 296 (601)
...+.++.++.-|+|..++... ...++..++..++.|++.|++|||.+||||.||-..|.+| ++...+||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEe
Confidence 6788889999889999888732 2347778899999999999999999999999999999999 45789999
Q ss_pred eecccccccCCCCCc---cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCC
Q 007498 297 IDFGLSDFIRPDERL---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 297 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
+|=.+++.+-+.... ..--....||+||.+. ..|+.++|||||||+||||++ |+.||...+..++..-+..+. .
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy-R 516 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY-R 516 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-e
Confidence 999999866443211 1112345799999875 689999999999999999987 899998888888766655543 3
Q ss_pred CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 372 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+... -++++++..++.-||..+|++||+.+|+..
T Consensus 517 laQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 LAQP--FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 3322 379999999999999999999999999764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=222.67 Aligned_cols=162 Identities=31% Similarity=0.385 Sum_probs=128.8
Q ss_pred CchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCccccc
Q 007498 236 GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315 (601)
Q Consensus 236 g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~ 315 (601)
|+|.+++..++..+++.+++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---WDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---Cccceee--ccceEeecccc----CC
Confidence 6899988776677999999999999999999999998 99999995 4788898 99987654322 36
Q ss_pred cccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHccCCCCCCC---CCCCCCH--HHHHHH
Q 007498 316 GSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSDPNFDDL---PWPSVSP--EAKDFV 388 (601)
Q Consensus 316 gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~---~~~~~s~--~~~~li 388 (601)
||+.|||||++. ..|+.++|||||||++|||++|+.||..... ...+..+.......... ....++. ++.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999886 5789999999999999999999999976543 23333333322211110 1112333 699999
Q ss_pred HHcccccccCCCCHHHHHcCcccC
Q 007498 389 KRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 389 ~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
.+||..||.+||++.|++.|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-26 Score=233.49 Aligned_cols=255 Identities=24% Similarity=0.304 Sum_probs=192.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcC---CCCeeEEeeeE-ecC
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG---HKHLVKFCDAC-EDV 223 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---h~niv~l~~~~-~~~ 223 (601)
+|.+.++||+|+||.||+|.+.... .+.+|+|+........ . ..+..|+.++..+.. -.++..+++.+ ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~--~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSK--P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCC--C-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 7999999999999999999987522 4689999876543221 1 257789999999962 36999999999 577
Q ss_pred CcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC--CCCCeEEeecc
Q 007498 224 NNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR--DDADMRLIDFG 300 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~--~~~~vkl~DFG 300 (601)
..-||||+++ |.+|.++..... +.|+..++..|+.|++.+|++||+.|+|||||||+|++++... ....+.|.|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 8899999999 789999775544 7899999999999999999999999999999999999998632 12569999999
Q ss_pred cccccC---CCC-------C-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc
Q 007498 301 LSDFIR---PDE-------R-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS 368 (601)
Q Consensus 301 ~a~~~~---~~~-------~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 368 (601)
+|+.+. ... . ...+.||..|+++.+.. ...+.+.|+||++.++.+|+.|..||...........+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998322 111 1 12356999999999876 46899999999999999999999999765543222222221
Q ss_pred CCCCCCC-CCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 369 DPNFDDL-PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 369 ~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
....... .....+.++..+...+-..+...+|....+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1111111 112345667777777766788888887665543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=267.70 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=194.9
Q ss_pred CCe-EEcceeccCCCeEEEEEEeecCCccCcEEEEEEeec---ccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 147 AKY-ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISK---AKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 147 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
..| ...+.+|.|++|.|+.+.... ..+.++.|.... ...........+..|+-+-..|. |+||+..+..+.+
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~---~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~ 392 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRS---DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQE 392 (601)
T ss_pred cccCCccceeeecccCceEEEEecC---CCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhh
Confidence 345 457789999999888777654 344455554331 11111112222667888888886 9999988888777
Q ss_pred CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
....+-+||||++ +|+..+... +.++..++..+++||+.||+|||+.||.|||||++|+++.. .+.+||+|||.+
T Consensus 393 ~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~---~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 393 IDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTE---NGILKIIDFGAA 467 (601)
T ss_pred cccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEec---CCceEEeecCcc
Confidence 7666667999999 999877653 57999999999999999999999999999999999999964 789999999998
Q ss_pred cccCCCC-----CccccccccccccchhccC-CCC-ChhhHHHHHHHHHHHHhCCCCCCCCChhHHH-HHHHc-cCCCC-
Q 007498 303 DFIRPDE-----RLNDIVGSAYYVAPEVLHR-SYS-LEADIWSIGVISYILLCGSRPFWARTESGIF-RAVLR-SDPNF- 372 (601)
Q Consensus 303 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~-~~~DvwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~-~~~~~- 372 (601)
....... .....+|+..|+|||++.+ .|. ..+||||.|++++.|++|+.||......+.. ..... .....
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF 547 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence 7654322 2456899999999999874 565 5689999999999999999999654332221 11111 11111
Q ss_pred --CCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 373 --DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 373 --~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+...|..++...+.+|.+||++||.+|.|+++|++.+||+..
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 111234578889999999999999999999999999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-25 Score=228.24 Aligned_cols=256 Identities=36% Similarity=0.599 Sum_probs=206.7
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCC-CeeEEeeeEecCCcEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK-HLVKFCDACEDVNNVY 227 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~ 227 (601)
|.+.+.||.|+||.||++.+. ..+|+|.+.............+.+|+.++..+. |+ +|+++++.+......+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEE
Confidence 788899999999999999875 579999998765544335678999999999997 66 8999999998777789
Q ss_pred EEEeecCCCchHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCC-CeEEeecccccc
Q 007498 228 IVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDF 304 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~-~vkl~DFG~a~~ 304 (601)
++++|+.++++.+.+.... ..+....+..++.|++.++.|+|+.+++||||||+||++.. .+ .++++|||++..
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~---~~~~~~l~dfg~~~~ 151 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR---DGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecC---CCCeEEEeccCccee
Confidence 9999999999996555433 27999999999999999999999999999999999999963 45 699999999975
Q ss_pred cCCCC-------CccccccccccccchhccC----CCCChhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHccC
Q 007498 305 IRPDE-------RLNDIVGSAYYVAPEVLHR----SYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSD 369 (601)
Q Consensus 305 ~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~ 369 (601)
..... .....+||..|+|||.+.+ .+....|+||+|++++++++|..||..... ......+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 54332 2466789999999998764 678899999999999999999999876653 34444444433
Q ss_pred CC-CCCCCCCCC----CHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 370 PN-FDDLPWPSV----SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 370 ~~-~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.. ......... ...+.+++.+++..+|..|.+..+...++|....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 32 221111111 2579999999999999999999999988766544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=234.26 Aligned_cols=166 Identities=20% Similarity=0.218 Sum_probs=128.6
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccc--cchhhHHHHHHHHHHHHHhcCCCCeeE-EeeeE
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM--TTAISIEDVRREVKILKALSGHKHLVK-FCDAC 220 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~-l~~~~ 220 (601)
.+...|.+.+.||+|+||+||+|+++. .+++.||||++..... ........+.+|+++|++|. |+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAG--DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcC--CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc-
Confidence 345679999999999999999998764 1456789998753211 12234567899999999996 999884 5542
Q ss_pred ecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccC-CCCceEeecCCCCCCeEEeec
Q 007498 221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDL-KPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 221 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDi-kp~NIll~~~~~~~~vkl~DF 299 (601)
+..|||||||+|++|.. + . ... ...++.|++.||.|||++||+|||| ||+|||++ .++.+||+||
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~-~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~---~~~~ikLiDF 156 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-A-R---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG---PDGEAAVIDF 156 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-h-C---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc---CCCCEEEEEC
Confidence 46899999999998862 2 1 111 2568899999999999999999999 99999995 3678999999
Q ss_pred ccccccCCCC---------Cccccccccccccchhcc
Q 007498 300 GLSDFIRPDE---------RLNDIVGSAYYVAPEVLH 327 (601)
Q Consensus 300 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~ 327 (601)
|+|+.+.... ...+.+++..|+|||++.
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 9998664332 124567899999999985
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-25 Score=238.86 Aligned_cols=220 Identities=30% Similarity=0.526 Sum_probs=172.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|+.++.|..|+||.||+++++. +.+.+|+|+ .+... +.|- |+... +.|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~---trqrfa~ki-Nkq~l--------ilRn--ilt~a-~npfvv------------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKE---TRQRFAMKI-NKQNL--------ILRN--ILTFA-GNPFVV------------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccc---cccchhhcc-cccch--------hhhc--ccccc-CCccee------------
Confidence 468999999999999999999986 678899954 33221 1111 22222 244444
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+-...+. .-+.++... +.+++|||+.||+|||+||+|+||+. -|++|++|||+++...
T Consensus 136 ---------gDc~tllk-~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~---mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 ---------GDCATLLK-NIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITS---MGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ---------chhhhhcc-cCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeee---cccccccchhhhhhhh
Confidence 33333332 224455443 78999999999999999999999975 8999999999986532
Q ss_pred CCC----------------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC
Q 007498 307 PDE----------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369 (601)
Q Consensus 307 ~~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 369 (601)
... .-...|||+.|+|||++. +.|+..+|||++|+|+||++.|..||.+.+.++++..++...
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 110 013469999999999865 789999999999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCHHHHHHHHHcccccccCCC---CHHHHHcCcccCCCC
Q 007498 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRM---TAVQALTHPWLRDDS 415 (601)
Q Consensus 370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~ell~hp~f~~~~ 415 (601)
..+++.. ..+.++++++|.++|+.+|..|. .+-++.+|+||+...
T Consensus 275 i~wpE~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 275 IEWPEED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred ccccccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 8888874 46889999999999999999996 577999999998653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=192.84 Aligned_cols=189 Identities=20% Similarity=0.240 Sum_probs=142.5
Q ss_pred EEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch-hhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-ISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 150 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
.+...|++|+||+||++.. .+..++.+.+........ .....+.+|+++|++|.+|++|++++++ ...|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~l 75 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHL 75 (218)
T ss_pred ccceeecCCCcceEEEeec-----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEE
Confidence 4567899999999997764 456788776654433211 1223578999999999767899999886 44799
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccC-CCCceEeecCCCCCCeEEeecccccccCC
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDL-KPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDi-kp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+|||+.|.+|...+. .. ...++.|++.+|.+||++||+|||| ||+|||++ .++.++|+|||+|.....
T Consensus 76 vmeyI~G~~L~~~~~-------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 76 DRSYLAGAAMYQRPP-------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred EEeeecCccHHhhhh-------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCC
Confidence 999999988764321 11 2357889999999999999999999 79999995 478899999999986554
Q ss_pred CCCc--------------cccccccccccchhcc--CCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 007498 308 DERL--------------NDIVGSAYYVAPEVLH--RSYS-LEADIWSIGVISYILLCGSRPFWARTE 358 (601)
Q Consensus 308 ~~~~--------------~~~~gt~~y~aPE~~~--~~~~-~~~DvwSlG~il~ell~g~~pf~~~~~ 358 (601)
.... .-...++.|++|+--. ...+ ...++++.|+.+|.++|++.++++..+
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 3321 0123677888887432 2333 667999999999999999999987654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=200.30 Aligned_cols=175 Identities=16% Similarity=0.169 Sum_probs=132.8
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHH------HHHHHHHHHHhcCCCCeeEEe
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED------VRREVKILKALSGHKHLVKFC 217 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~~h~niv~l~ 217 (601)
-+..+|++.+.||.|+||.||++.. ++..||||++............. +.+|+..+.+|. |++|..+.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~ 101 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLN 101 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcce
Confidence 3467899999999999999999754 34579999997654433333333 689999999996 99999999
Q ss_pred eeEecC--------CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC
Q 007498 218 DACEDV--------NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289 (601)
Q Consensus 218 ~~~~~~--------~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~ 289 (601)
+++... +..+|||||++|.+|.+.. .+++ ....+++.+|..||+.||+||||||.||+++.
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~-- 170 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK-- 170 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC--
Confidence 886533 3589999999999987652 2333 34669999999999999999999999999963
Q ss_pred CCCCeEEeecccccccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHH
Q 007498 290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILL 347 (601)
Q Consensus 290 ~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell 347 (601)
++ ++|+|||............. | ++...|+.++|+||||+++..+.
T Consensus 171 -~g-i~liDfg~~~~~~e~~a~d~------~----vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 -NG-LRIIDLSGKRCTAQRKAKDR------I----DLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -CC-EEEEECCCcccccchhhHHH------H----HHHhHhcccccccceeEeehHHH
Confidence 55 99999998865432211110 0 22356778999999999987554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=193.59 Aligned_cols=142 Identities=18% Similarity=0.186 Sum_probs=109.3
Q ss_pred cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchh-----------------------hHHHHHHHHHHHHHhc
Q 007498 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI-----------------------SIEDVRREVKILKALS 208 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~ 208 (601)
...||+|+||.||+|.+. +|+.||||+++........ ......+|++++.+|.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05147 2 NGCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV 77 (190)
T ss_pred CCccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 467999999999999874 6789999999764321110 0123346999999996
Q ss_pred CCCCeeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeccCCCCceEeec
Q 007498 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC-HLQGVVHRDLKPENFLFTS 287 (601)
Q Consensus 209 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~L-H~~~iiHrDikp~NIll~~ 287 (601)
++++.....+... ..+|||||++|+++...+.. .+.+++.++..++.|++.+|.|| |+.||+||||||+|||++
T Consensus 78 -~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 78 -TAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred -HCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 7776443332222 23899999998776654333 35799999999999999999999 799999999999999995
Q ss_pred CCCCCCeEEeeccccccc
Q 007498 288 GRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 288 ~~~~~~vkl~DFG~a~~~ 305 (601)
++.++|+|||+|...
T Consensus 153 ---~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 ---DGKLYIIDVSQSVEH 167 (190)
T ss_pred ---CCcEEEEEccccccC
Confidence 467999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=179.38 Aligned_cols=144 Identities=20% Similarity=0.344 Sum_probs=125.9
Q ss_pred HhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh
Q 007498 444 ALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ 523 (601)
Q Consensus 444 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~ 523 (601)
.....++++++++|+++|..||+|++|.|+..||..+++.++. .+++.++.+++..+|. +.+.|+|.+|+.++.....
T Consensus 9 ~~~~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~-~~s~~ei~~l~~~~d~-~~~~idf~~Fl~~ms~~~~ 86 (160)
T COG5126 9 LTFTQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGF-NPSEAEINKLFEEIDA-GNETVDFPEFLTVMSVKLK 86 (160)
T ss_pred hhcccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCC-CCcHHHHHHHHHhccC-CCCccCHHHHHHHHHHHhc
Confidence 3456789999999999999999999999999999999998886 6889999999999999 8999999999987654322
Q ss_pred hhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCcc------HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 524 LEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPS------AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 524 ~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~------~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
... .+++++++|++||+|++|+|+.+||+.+|...++ ++.+|+.+|.|+||.|+|+||++++...+
T Consensus 87 ~~~---~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~deev~~ll~~~d~d~dG~i~~~eF~~~~~~~~ 158 (160)
T COG5126 87 RGD---KEEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEYDEDGDGEIDYEEFKKLIKDSP 158 (160)
T ss_pred cCC---cHHHHHHHHHHhCCCCCceecHHHHHHHHHhhcccCCHHHHHHHHHhcCCCCCceEeHHHHHHHHhccC
Confidence 211 2788999999999999999999999999943332 99999999999999999999999887643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-23 Score=199.58 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=173.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC------------------------c--------cCcEEEEEEeecccccch--h
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE------------------------L--------KDQQVAVKIISKAKMTTA--I 192 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~------------------------~--------~~~~vavK~~~~~~~~~~--~ 192 (601)
++|+|+..||+|.-..||.|+..... . ..-+.|||.+-.-..... .
T Consensus 157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~ 236 (598)
T KOG4158|consen 157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAH 236 (598)
T ss_pred hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHH
Confidence 46999999999999999999865300 0 011456666543222211 1
Q ss_pred hHHHHHHHHH------HH--------H-------HhcCCCCeeEEeeeEec---------------------------CC
Q 007498 193 SIEDVRREVK------IL--------K-------ALSGHKHLVKFCDACED---------------------------VN 224 (601)
Q Consensus 193 ~~~~~~~E~~------~l--------~-------~l~~h~niv~l~~~~~~---------------------------~~ 224 (601)
....+.+|+- .+ + .|-.|||||++..+|.+ +.
T Consensus 237 iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~ 316 (598)
T KOG4158|consen 237 ILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPK 316 (598)
T ss_pred HHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCc
Confidence 1122222221 10 1 12359999999887643 23
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC-CCCCeEEeeccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR-DDADMRLIDFGLSD 303 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~-~~~~vkl~DFG~a~ 303 (601)
.+|+||..++. +|.+++..+ ..+....+-++.|+++|+.|||.+||.|||+|.+|||+..++ .--.+.|+|||++-
T Consensus 317 tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 317 TLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred eEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 58999999875 898887654 578899999999999999999999999999999999997643 23357899999873
Q ss_pred ccCCC-------CCccccccccccccchhcc---CC----CCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC
Q 007498 304 FIRPD-------ERLNDIVGSAYYVAPEVLH---RS----YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369 (601)
Q Consensus 304 ~~~~~-------~~~~~~~gt~~y~aPE~~~---~~----~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 369 (601)
-.... ...-..-|.-..||||+.. ++ --.|+|.|+.|.+.||++....||++..+..+-... ...
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yqe 472 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQE 472 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hhh
Confidence 22211 1112345778899999975 22 135789999999999999999999885432211111 111
Q ss_pred CCCCCCCCCCCCHHHHHHHHHcccccccCCCCHH
Q 007498 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAV 403 (601)
Q Consensus 370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 403 (601)
..++..+ ..+++.+++|+..+|+.||++|++..
T Consensus 473 ~qLPalp-~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 473 SQLPALP-SRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hhCCCCc-ccCChHHHHHHHHHhcCCccccCCcc
Confidence 1222222 46899999999999999999999853
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=198.49 Aligned_cols=236 Identities=24% Similarity=0.375 Sum_probs=152.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcC---------CCCeeEEe
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG---------HKHLVKFC 217 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---------h~niv~l~ 217 (601)
..+..++.||.|+++.||.|++.. +++.+|||+............+.+++|.-....+.+ |-.++-.+
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~---t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVE---TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred eEEEEccccccCCceEEEEEEEcc---CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 356788899999999999999986 899999999876665555567778877755544321 21222222
Q ss_pred eeE---------ecC---C-----cEEEEEeecCCCchHHHHH---HcCCC---CCHHHHHHHHHHHHHHHHHHHHcCCe
Q 007498 218 DAC---------EDV---N-----NVYIVMELCEGGELLDRIL---ARGGR---YTEEDAKAIVVQILSVVAFCHLQGVV 274 (601)
Q Consensus 218 ~~~---------~~~---~-----~~~lv~e~~~~g~L~~~~~---~~~~~---l~~~~~~~i~~ql~~~L~~LH~~~ii 274 (601)
+.. ... . +.+++|+-+.+ +|.+.+. ..... +.......+..|+++.+++||..||+
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 221 111 1 34778888854 8876643 22222 11222234558999999999999999
Q ss_pred eccCCCCceEeecCCCCCCeEEeecccccccCCCCCccccccccccccchhccC---------CCCChhhHHHHHHHHHH
Q 007498 275 HRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR---------SYSLEADIWSIGVISYI 345 (601)
Q Consensus 275 HrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DvwSlG~il~e 345 (601)
|+||||+|+|++ .+|.++|+||+....... .......+..|.+||.... .++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll~---~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLD---QDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE----TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEc---CCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999995 589999999988755432 2222345578999997631 37889999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCC
Q 007498 346 LLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399 (601)
Q Consensus 346 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 399 (601)
|.||..||........... .|..- .+++..+++||+.||++||.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~------~f~~C--~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW------DFSRC--RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG------GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc------cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence 9999999975533222111 12111 1578999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-23 Score=224.48 Aligned_cols=239 Identities=22% Similarity=0.301 Sum_probs=175.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccc-cchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-TTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.|...+.||.+.|=+|+++++.. | .|+||++-+..- ..-....+...|++ .... +|||++.+.-....+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHH
Confidence 68888999999999999998864 3 499999866431 12122333445555 3333 599999998888888889
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc-
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI- 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~- 305 (601)
|||-+|..+ +|+|++..+ .-+..-+.+.|+.||+.||.-||..||+|+|||.+|||+++ =+.+.|+||..-+..
T Consensus 97 ylvRqyvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS---WNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS---WNWLYLTDFASFKPTY 171 (1431)
T ss_pred HHHHHHHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee---echhhhhcccccCCcc
Confidence 999999976 899987544 45778888999999999999999999999999999999986 567899999876532
Q ss_pred -CCCC--Cc----cccccccccccchhccC-----------C-CCChhhHHHHHHHHHHHHh-CCCCCCC-------CCh
Q 007498 306 -RPDE--RL----NDIVGSAYYVAPEVLHR-----------S-YSLEADIWSIGVISYILLC-GSRPFWA-------RTE 358 (601)
Q Consensus 306 -~~~~--~~----~~~~gt~~y~aPE~~~~-----------~-~~~~~DvwSlG~il~ell~-g~~pf~~-------~~~ 358 (601)
..+. .. .+...-.+|+|||.+.. . .+++.||||+||+++||++ |++||.- ...
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~ 251 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN 251 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC
Confidence 1111 11 12222347999997631 1 5788999999999999987 5888830 000
Q ss_pred hHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 359 SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 359 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.......++. --+..++.||..|++.||++|.+|++.|+.
T Consensus 252 ~~~~e~~Le~----------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEK----------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHh----------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0111111111 013468999999999999999999999985
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=184.78 Aligned_cols=143 Identities=20% Similarity=0.205 Sum_probs=111.7
Q ss_pred cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch-----------------------hhHHHHHHHHHHHHHhc
Q 007498 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-----------------------ISIEDVRREVKILKALS 208 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~ 208 (601)
.+.||+|+||.||+|++. +|+.||||+++....... .....+.+|...+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 2 NGCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 568999999999999874 678999999976521100 01223468999999996
Q ss_pred CCCCeeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeec
Q 007498 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTS 287 (601)
Q Consensus 209 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~ 287 (601)
|++|.....+... ..||||||++|+++...+.. ...++..++..++.|++.+|.+||. +||+||||||+|||++
T Consensus 78 -~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~- 152 (190)
T cd05145 78 -EAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred -hCCCCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence 8887544443332 24899999998765544333 3568899999999999999999999 9999999999999995
Q ss_pred CCCCCCeEEeecccccccC
Q 007498 288 GRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 288 ~~~~~~vkl~DFG~a~~~~ 306 (601)
++.++|+|||+|....
T Consensus 153 ---~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 ---DGKPYIIDVSQAVELD 168 (190)
T ss_pred ---CCCEEEEEcccceecC
Confidence 5789999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=176.74 Aligned_cols=142 Identities=23% Similarity=0.398 Sum_probs=122.1
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALE 528 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~ 528 (601)
++..++.+++++|..||.|++|+|+..||..+++.++. .++..++..+++.+|.+++|.|+++||+.++.........+
T Consensus 2 ~~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~-~~t~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~ 80 (151)
T KOG0027|consen 2 LSEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQ-NPTEEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDE 80 (151)
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccc
Confidence 46778999999999999999999999999999999997 68899999999999999999999999998665332221111
Q ss_pred -hHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCc-cHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 529 -GWEQIASTAFEYFEEEGNRVISIEELARELN-----VGP-SAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 529 -~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
...++++.+|++||+||+|+||.+||+.+|. ... +++.+++.+|.|+||.|+|+||+++|...
T Consensus 81 ~~~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~~~~~~e~~~mi~~~d~d~dg~i~f~ef~~~m~~~ 150 (151)
T KOG0027|consen 81 EASSEELKEAFRVFDKDGDGFISASELKKVLTSLGEKLTDEECKEMIREVDVDGDGKVNFEEFVKMMSGK 150 (151)
T ss_pred cccHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCCcCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHhcC
Confidence 1245899999999999999999999999992 222 29999999999999999999999999763
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=179.78 Aligned_cols=138 Identities=20% Similarity=0.245 Sum_probs=106.3
Q ss_pred cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc----CCCCeeEEeeeEecCC---
Q 007498 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS----GHKHLVKFCDACEDVN--- 224 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~--- 224 (601)
.+.||+|+||.||. +.. +... +||++..... ...+.+.+|+.+++.|. +||||++++++++++.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~---~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPE---DAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cceecCCCceEEEE--CCC---CcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 35799999999995 443 3333 6898865422 23467899999999994 3799999999998873
Q ss_pred cEE-EEEee--cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHHcCCeeccCCCCceEeecCC-CCCCeEEeec
Q 007498 225 NVY-IVMEL--CEGGELLDRILARGGRYTEEDAKAIVVQILSVV-AFCHLQGVVHRDLKPENFLFTSGR-DDADMRLIDF 299 (601)
Q Consensus 225 ~~~-lv~e~--~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L-~~LH~~~iiHrDikp~NIll~~~~-~~~~vkl~DF 299 (601)
.++ +|||| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++... .+..++|+||
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 434 78999 557999998854 357666 36688888888 999999999999999999997522 3458999995
Q ss_pred ccc
Q 007498 300 GLS 302 (601)
Q Consensus 300 G~a 302 (601)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=209.18 Aligned_cols=194 Identities=23% Similarity=0.355 Sum_probs=156.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc--CCCCeeEEeeeEecC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACEDV 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~ 223 (601)
+.+|.|.+.||+|+||+||+|... +++.||||+-+...... |.-=.+++.+|+ --+.|..+..++...
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~----~~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHS----NGKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecC----CCcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 457999999999999999999876 47899999865543222 122223344442 124666666666666
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec----CCCCCCeEEeec
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS----GRDDADMRLIDF 299 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~----~~~~~~vkl~DF 299 (601)
+.-+||+||.+.|+|++++. ..+.+++..+..+..|++.-++.||..+|||+||||+|+||.. +.+...++|+||
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 77889999999999999876 5678999999999999999999999999999999999999974 223556999999
Q ss_pred cccccc---CCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCC
Q 007498 300 GLSDFI---RPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGS 350 (601)
Q Consensus 300 G~a~~~---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~ 350 (601)
|.|..+ .++......++|-.+-.+|+..| .++..+|.|.|+.+++.||.|+
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 998654 34556777899999999999875 7999999999999999999986
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-22 Score=217.14 Aligned_cols=260 Identities=27% Similarity=0.475 Sum_probs=211.9
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|.+.+.||+|+|+.|-++.... .....+|+|.+.... ........+..|..+-+.+..|.|++.+++...+....+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~--~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSR--DPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccchhhhhhhcC--CCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 58888999999999998776643 245567877775543 222344566678888888877999999999999999999
Q ss_pred EEEeecCCCchHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeeccCCCCceEeecCCCCC-CeEEeecccccc
Q 007498 228 IVMELCEGGELLDRI-LARGGRYTEEDAKAIVVQILSVVAFCH-LQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDF 304 (601)
Q Consensus 228 lv~e~~~~g~L~~~~-~~~~~~l~~~~~~~i~~ql~~~L~~LH-~~~iiHrDikp~NIll~~~~~~~-~vkl~DFG~a~~ 304 (601)
++++|..|+++.+.+ ......++...+..++.|+..+|.|+| ..++.||||||+|.+++. .+ .+|++|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~---s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE---SGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc---CCCcccCCCchhhcc
Confidence 999999999999877 433336888899999999999999999 999999999999999964 55 899999999987
Q ss_pred cCC-CC---Ccccccc-ccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHccCCCCCCCC
Q 007498 305 IRP-DE---RLNDIVG-SAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGI-FRAVLRSDPNFDDLP 376 (601)
Q Consensus 305 ~~~-~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~ 376 (601)
+.. .. .....+| ++.|+|||...+ ...+..|+||+|+++.-|++|..|+........ +.........+...+
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 765 22 2345688 999999998765 457889999999999999999999965443332 222333334556677
Q ss_pred CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
|..++....+++.++|..+|..|.+.+++..++|+..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccccccccc
Confidence 8899999999999999999999999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-20 Score=173.28 Aligned_cols=243 Identities=19% Similarity=0.241 Sum_probs=184.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
...+..+|.+...|+.|++++.+ ..+++|++......... ...|..|.-.|+-+. ||||+.+++.|....++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqg-----ndivakil~vr~~t~ri-srdfneefp~lrifs-hpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQG-----NDIVAKILNVREVTARI-SRDFNEEFPALRIFS-HPNILPVLGACNSPPNLV 263 (448)
T ss_pred hhhhhhhhccCCCcccccccccC-----cchhhhhhhhhhcchhh-cchhhhhCcceeeec-CCchhhhhhhccCCCCce
Confidence 45667789999999999999854 35777888765554443 356888988888886 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 228 IVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+|..||+.|+|+..++...+ ..+..++.+++.++++|+.|||+.. |.---|....++++. +-...+-++|--++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltarismad~kfsfq 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTARISMADTKFSFQ 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhheecccceeeee
Confidence 99999999999998876533 3688899999999999999999985 444568888899953 2233445555444421
Q ss_pred cCCCCCccccccccccccchhccCC----CCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLHRS----YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
.....-.+.||+||.+++. --.++|+|||++++|||.|...||..-...+.-..|.-..... .. .|.+
T Consensus 343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv-~i-ppgi 414 (448)
T KOG0195|consen 343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV-HI-PPGI 414 (448)
T ss_pred ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc-cC-CCCc
Confidence 1233457889999998743 2357899999999999999999998766655433332221111 11 2689
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHH
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQAL 406 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell 406 (601)
+..+..|+.-|+.-||.+||....++
T Consensus 415 s~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999999876543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=176.19 Aligned_cols=148 Identities=22% Similarity=0.195 Sum_probs=113.7
Q ss_pred CCCeEEcceeccCCCeEEEEEE-eecCCccCcEEEEEEeecccccch---------------------hhHHHHHHHHHH
Q 007498 146 GAKYELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTA---------------------ISIEDVRREVKI 203 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~~~~vavK~~~~~~~~~~---------------------~~~~~~~~E~~~ 203 (601)
+.-|.+.+.||+|+||.||+|. +.. +++.||||+++....... .....+.+|+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDG---SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCC---CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 3458899999999999999998 433 688999999975432100 011346789999
Q ss_pred HHHhcCCC--CeeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC-CeeccCCC
Q 007498 204 LKALSGHK--HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG-VVHRDLKP 280 (601)
Q Consensus 204 l~~l~~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~-iiHrDikp 280 (601)
++++. +. .+++++++ ...||||||+.|++|...... ...+....+..++.||+.+|.+||.+| |+||||||
T Consensus 104 L~~L~-~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp 177 (237)
T smart00090 104 LQRLY-EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSE 177 (237)
T ss_pred HHHHH-hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCCh
Confidence 99996 42 34444442 235899999999887665433 245677788899999999999999999 99999999
Q ss_pred CceEeecCCCCCCeEEeecccccccC
Q 007498 281 ENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 281 ~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~----~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH----DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE----CCCEEEEEChhhhccC
Confidence 999995 5789999999987543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-20 Score=190.49 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=168.3
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEee-------eE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD-------AC 220 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~-------~~ 220 (601)
.+.+.+-.+.+++|.++..+...+....+.++-+..+... ........+++-.+.-.. |.+..-+.+ .+
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~-~~~~s~~~d~~~s~~~~~ 320 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSS-HSNRSILEDLRPSLFESS 320 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccc-cCCcccccCCCCchhhhc
Confidence 4556667777777777655544321123344444432222 122334455666665554 444333333 11
Q ss_pred e-----cCCcEEEEEeecCCCchHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCC
Q 007498 221 E-----DVNNVYIVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD 293 (601)
Q Consensus 221 ~-----~~~~~~lv~e~~~~g~L~~~~~~~--~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~ 293 (601)
. ...++||.|++|.-.+|.+++..+ ....+......++.|+..|++| ++.+|||+||.||++. .+..
T Consensus 321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q 394 (516)
T KOG1033|consen 321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQ 394 (516)
T ss_pred cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchh
Confidence 1 123589999999999999998643 3346778899999999999999 9999999999999995 3668
Q ss_pred eEEeecccccccCCCC-------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 007498 294 MRLIDFGLSDFIRPDE-------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRA 364 (601)
Q Consensus 294 vkl~DFG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~ 364 (601)
+||.|||+........ .....+||.+||+||.+. ..|+.++||||||+||+|++. -...|.. ...+..
T Consensus 395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d 471 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTD 471 (516)
T ss_pred hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhh
Confidence 9999999987765544 445678999999999887 579999999999999999997 2333311 111111
Q ss_pred HHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
+-. ..++...+.. -++-.+|+.+||.+.|.+||++.+.--|+|.
T Consensus 472 ~r~--g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 472 IRD--GIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhc--CCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 211 2222222222 2456799999999999999988887777775
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.8e-18 Score=165.22 Aligned_cols=137 Identities=26% Similarity=0.324 Sum_probs=112.4
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc-----hhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-----AISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+.||+|++|.||++++ .+..|++|+........ ......+.+|+.++..+. |++|+....++.+....+
T Consensus 2 ~~l~~G~~~~vy~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFI 75 (211)
T ss_pred cccccCceEEEEEEee-----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCE
Confidence 5799999999999986 45679999865432211 112346789999999996 899887777777778899
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+||||++|++|.+.+... .. ....++.+++.+|.+||+.+++|||++|.|||++ ++.++|+|||++..
T Consensus 76 lv~e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 999999999999877543 12 8889999999999999999999999999999995 57899999999865
|
|
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=147.47 Aligned_cols=141 Identities=17% Similarity=0.328 Sum_probs=122.5
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
...+++++.++++..|..||.+++|+|+..||..+++.+|. .+..+++.+++..+|.++.|.|+|++|...+..+. ..
T Consensus 24 ~~~l~~~q~q~i~e~f~lfd~~~~g~iD~~EL~vAmralGF-E~~k~ei~kll~d~dk~~~g~i~fe~f~~~mt~k~-~e 101 (172)
T KOG0028|consen 24 KSELTEEQKQEIKEAFELFDPDMAGKIDVEELKVAMRALGF-EPKKEEILKLLADVDKEGSGKITFEDFRRVMTVKL-GE 101 (172)
T ss_pred CccccHHHHhhHHHHHHhhccCCCCcccHHHHHHHHHHcCC-CcchHHHHHHHHhhhhccCceechHHHHHHHHHHH-hc
Confidence 34578888899999999999999999999999999999997 57888899999999999999999999987644321 11
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCc-cHHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGP-SAYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~-~~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
.+ ..+++..+|+.||.|++|.|+..+|+.+.. +.+ +++.|++++|+|+||.|+-+||+.+|++
T Consensus 102 ~d--t~eEi~~afrl~D~D~~Gkis~~~lkrvakeLgenltD~El~eMIeEAd~d~dgevneeEF~~imk~ 170 (172)
T KOG0028|consen 102 RD--TKEEIKKAFRLFDDDKTGKISQRNLKRVAKELGENLTDEELMEMIEEADRDGDGEVNEEEFIRIMKK 170 (172)
T ss_pred cC--cHHHHHHHHHcccccCCCCcCHHHHHHHHHHhCccccHHHHHHHHHHhcccccccccHHHHHHHHhc
Confidence 11 277899999999999999999999999983 233 3999999999999999999999999976
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.8e-18 Score=176.47 Aligned_cols=228 Identities=25% Similarity=0.335 Sum_probs=171.6
Q ss_pred HHhcCCCCeeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCC-eeccCCCCce
Q 007498 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV-VHRDLKPENF 283 (601)
Q Consensus 205 ~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~i-iHrDikp~NI 283 (601)
+.+. |.|+.++++.+.++...++|.+||.-|+|.|.+......+++-....++++|+.||.|||...| .|+.++..|.
T Consensus 2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4565 9999999999999999999999999999999998877789999999999999999999999876 9999999999
Q ss_pred EeecCCCCCCeEEeecccccccCCC---CCccccccccccccchhccCC--------CCChhhHHHHHHHHHHHHhCCCC
Q 007498 284 LFTSGRDDADMRLIDFGLSDFIRPD---ERLNDIVGSAYYVAPEVLHRS--------YSLEADIWSIGVISYILLCGSRP 352 (601)
Q Consensus 284 ll~~~~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DvwSlG~il~ell~g~~p 352 (601)
+++ ....+||+|||+....... .......-..-|.|||++... .+.+.||||+|++++|+++.+.|
T Consensus 81 lvd---~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LVD---SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred eee---eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 995 4889999999998765321 111112234569999998642 46789999999999999999999
Q ss_pred CCCCC----hhHHHHHHHc-cCCCCCCCCC--CCCCHHHHHHHHHcccccccCCCCHHHHHcC--cccCCCCCCCChhHH
Q 007498 353 FWART----ESGIFRAVLR-SDPNFDDLPW--PSVSPEAKDFVKRLLNKDYRKRMTAVQALTH--PWLRDDSRPVPLDIL 423 (601)
Q Consensus 353 f~~~~----~~~~~~~i~~-~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s~~ell~h--p~f~~~~~~~~~~~~ 423 (601)
|.... ..+++..+.. ....+...-+ ..+.+++..+++.||..+|..||+++++-.. ..++.....-.+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~~~nl~D~ 237 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSSKGNLMDS 237 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccccchhHHH
Confidence 96532 2344444444 2211211111 1456689999999999999999999887542 222222112256667
Q ss_pred HHHHHHhhhccCc
Q 007498 424 IFKLVKSYLHATP 436 (601)
Q Consensus 424 ~~~~~k~~~~~~~ 436 (601)
.++.+..|.+...
T Consensus 238 m~~~le~Y~~nLe 250 (484)
T KOG1023|consen 238 LFRMLESYADNLE 250 (484)
T ss_pred HHHHHHHHHhhhH
Confidence 7888888866443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.4e-18 Score=183.83 Aligned_cols=141 Identities=23% Similarity=0.289 Sum_probs=112.4
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHHhcCCCCeeEEeeeE
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-----TAISIEDVRREVKILKALSGHKHLVKFCDAC 220 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~ 220 (601)
...|...+.||+|+||.||++.+.. ..+++|+....... .....+.+.+|+++++.++ |++|+..+.++
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~ 405 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG-----RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYD 405 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC-----ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEE
Confidence 3456778999999999999987643 33455543221111 1123456889999999996 99999888887
Q ss_pred ecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecc
Q 007498 221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300 (601)
Q Consensus 221 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG 300 (601)
.+....++||||++|++|.+.+. ....++.|++.+|.|||+.||+||||||+|||+. ++.++|+|||
T Consensus 406 ~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFG 472 (535)
T PRK09605 406 VDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFG 472 (535)
T ss_pred EeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCc
Confidence 77778899999999999988764 3577999999999999999999999999999993 6789999999
Q ss_pred ccccc
Q 007498 301 LSDFI 305 (601)
Q Consensus 301 ~a~~~ 305 (601)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 99653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.6e-18 Score=161.06 Aligned_cols=134 Identities=25% Similarity=0.278 Sum_probs=105.8
Q ss_pred eeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc-----hhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 154 EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-----AISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 154 ~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
.||+|+||.||+++. .+..|++|+........ .....++.+|++++..+. |+++.....++......+|
T Consensus 1 ~ig~G~~~~vy~~~~-----~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTI 74 (199)
T ss_pred CCCCCceEEEEEeec-----CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEE
Confidence 489999999999984 45689999865432211 122466789999999997 7766555555556667899
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
||||++|++|.+.+.... . .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus 75 v~e~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEEECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 999999999988764321 1 8899999999999999999999999999995 678999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.9e-18 Score=161.19 Aligned_cols=140 Identities=26% Similarity=0.312 Sum_probs=108.0
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch-------------------hhHHHHHHHHHHHHHhc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-------------------ISIEDVRREVKILKALS 208 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~ 208 (601)
.|.+.+.||+|+||.||++... +++.||||++........ .......+|+.++..+.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 4888899999999999999864 678999999765321000 01123678999999996
Q ss_pred CCC--CeeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEee
Q 007498 209 GHK--HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT 286 (601)
Q Consensus 209 ~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~ 286 (601)
|. .++..++ ....++||||++|++|..... ......++.+++.++.++|+.||+||||||+||+++
T Consensus 92 -~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 92 -EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred -HcCCCCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 76 4444444 234689999999988765321 145678899999999999999999999999999995
Q ss_pred cCCCCCCeEEeecccccccC
Q 007498 287 SGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 287 ~~~~~~~vkl~DFG~a~~~~ 306 (601)
+++.++|+|||++....
T Consensus 160 ---~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 ---DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ---CCCcEEEEECCccccCC
Confidence 47899999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.8e-18 Score=178.79 Aligned_cols=259 Identities=22% Similarity=0.262 Sum_probs=202.9
Q ss_pred ccCCCeEEcceecc--CCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 144 NFGAKYELGKEVGR--GHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 144 ~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
.+...+.+...+|. |.+|.||.++... ..++..+|+|.-+.. ........+=.+|+.-.+++..|+|.++.+..+.
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCc-ccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccc
Confidence 44556788889999 9999999998822 127788999974322 1211222334578888888888999999999999
Q ss_pred cCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHH----HHHHHHHcCCeeccCCCCceEeecCCCC-CCeEE
Q 007498 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS----VVAFCHLQGVVHRDLKPENFLFTSGRDD-ADMRL 296 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~----~L~~LH~~~iiHrDikp~NIll~~~~~~-~~vkl 296 (601)
..+.+|+-+|+|. .+|..+.......+++..++.++.+... ||.++|..+++|-|+||+||++.. + ...++
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~---~~~s~~~ 264 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTS---DWTSCKL 264 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccc---ccceeec
Confidence 9999999999995 6888888777777999999999999999 999999999999999999999964 4 78999
Q ss_pred eecccccccCCCCCcc------ccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC--ChhHHHHHHHcc
Q 007498 297 IDFGLSDFIRPDERLN------DIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWAR--TESGIFRAVLRS 368 (601)
Q Consensus 297 ~DFG~a~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~ 368 (601)
+|||+...+..+.... ...|...|++||++++-++...|+||||.++.+..++..+.... ..-..++...
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-- 342 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-- 342 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--
Confidence 9999988876554221 22577889999999999999999999999999999987776433 1111111111
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 369 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
.+.......+.++...+..|++.+|..|+++..+++|+++..
T Consensus 343 ---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 343 ---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 111112345677777999999999999999999999999874
|
|
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-17 Score=149.12 Aligned_cols=140 Identities=19% Similarity=0.366 Sum_probs=118.3
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
+..+++.+++++++.|..+|.+++|.|+.+||..++..++. ....+.+..+++.+|.+++|.|+++||+.++.......
T Consensus 2 ~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~l~~~~~~~ 80 (149)
T PTZ00184 2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLTLMARKMKDT 80 (149)
T ss_pred CCccCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHhcCcCCCCcCcHHHHHHHHHHhccCC
Confidence 34578889999999999999999999999999999988774 45567899999999999999999999987654322111
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
. .++.+..+|+.||.|++|+|+.+||+.++. +..+ +..++..+|.|++|.|+|+||+.+|.
T Consensus 81 ~---~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~ 147 (149)
T PTZ00184 81 D---SEEEIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLTDEEVDEMIREADVDGDGQINYEEFVKMMM 147 (149)
T ss_pred c---HHHHHHHHHHhhCCCCCCeEeHHHHHHHHHHHCCCCCHHHHHHHHHhcCCCCCCcCcHHHHHHHHh
Confidence 1 145688999999999999999999999882 2222 88999999999999999999999875
|
|
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.1e-17 Score=148.85 Aligned_cols=141 Identities=18% Similarity=0.323 Sum_probs=119.7
Q ss_pred hcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhh
Q 007498 448 ALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEAL 527 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~ 527 (601)
.+++.++++++.+|..+|.+++|.|+.+||..++..++. ......+..++..+|.+++|.|+++||..++........
T Consensus 10 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~g~-~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~- 87 (158)
T PTZ00183 10 GLTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGF-EPKKEEIKQMIADVDKDGSGKIDFEEFLDIMTKKLGERD- 87 (158)
T ss_pred CCCHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHhcCCC-
Confidence 478889999999999999999999999999999998875 355667999999999999999999999876543211111
Q ss_pred hhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 528 EGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 528 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.++.++.+|+.+|+|++|+|+.+||+.++. +..+ +..+|..+|.|++|.|+|+||+.+|.+.+
T Consensus 88 --~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~l~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 156 (158)
T PTZ00183 88 --PREEILKAFRLFDDDKTGKISLKNLKRVAKELGETITDEELQEMIDEADRNGDGEISEEEFYRIMKKTN 156 (158)
T ss_pred --cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhccc
Confidence 156789999999999999999999999983 3333 89999999999999999999999998754
|
|
| >KOG0034 consensus Ca2+/calmodulin-dependent protein phosphatase (calcineurin subunit B), EF-Hand superfamily protein [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.5e-17 Score=147.23 Aligned_cols=138 Identities=20% Similarity=0.285 Sum_probs=116.2
Q ss_pred hhcchHHHHHHHHHHHhhCCC-CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCc-ccHHHHHHHhhcchhh
Q 007498 447 KALTEDELVYLRAQFRLLEPN-KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRK-MYFEEFCAAAISTHQL 524 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d-~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~-i~~~ef~~~~~~~~~~ 524 (601)
..++.+|+..|+..|.++|.+ ++|+|+.+||..+..-. ......++++.+|.+.+|. |+|++|+..+......
T Consensus 25 ~~fs~~EI~~L~~rF~kl~~~~~~g~lt~eef~~i~~~~-----~Np~~~rI~~~f~~~~~~~~v~F~~Fv~~ls~f~~~ 99 (187)
T KOG0034|consen 25 TQFSANEIERLYERFKKLDRNNGDGYLTKEEFLSIPELA-----LNPLADRIIDRFDTDGNGDPVDFEEFVRLLSVFSPK 99 (187)
T ss_pred cccCHHHHHHHHHHHHHhccccccCccCHHHHHHHHHHh-----cCcHHHHHHHHHhccCCCCccCHHHHHHHHhhhcCC
Confidence 348899999999999999999 99999999999999322 2344778999999998888 9999999876544333
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh------cCC--cc-----HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELAREL------NVG--PS-----AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l------~~~--~~-----~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.. .+++++.+|++||.+++|+|+.+||.+++ +.. .+ ++.+|.++|.|+||+|+|+||.+++.+.
T Consensus 100 ~~---~~~Kl~faF~vYD~~~~G~I~reel~~iv~~~~~~~~~~~~e~~~~i~d~t~~e~D~d~DG~IsfeEf~~~v~~~ 176 (187)
T KOG0034|consen 100 AS---KREKLRFAFRVYDLDGDGFISREELKQILRMMVGENDDMSDEQLEDIVDKTFEEADTDGDGKISFEEFCKVVEKQ 176 (187)
T ss_pred cc---HHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHccCCcchHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcC
Confidence 22 14689999999999999999999999988 222 23 8999999999999999999999999886
Q ss_pred c
Q 007498 592 T 592 (601)
Q Consensus 592 ~ 592 (601)
+
T Consensus 177 P 177 (187)
T KOG0034|consen 177 P 177 (187)
T ss_pred c
Confidence 4
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.6e-17 Score=153.01 Aligned_cols=141 Identities=27% Similarity=0.272 Sum_probs=100.5
Q ss_pred cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHH---------------------HHHHHHHHHHHhcCC
Q 007498 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIE---------------------DVRREVKILKALSGH 210 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~~h 210 (601)
.+.||+|+||.||+|.+. +++.||||++............ ....|...+.++..+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECC----CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 568999999999999875 5789999998754322111111 114677777777522
Q ss_pred -CCeeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecC
Q 007498 211 -KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSG 288 (601)
Q Consensus 211 -~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~ 288 (601)
-.+.+.+++ ...+|||||++|+.+........ .. ...++.++.+++.++.++|. .+|+||||||+||+++
T Consensus 78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-- 149 (187)
T cd05119 78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-- 149 (187)
T ss_pred CCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE--
Confidence 234555543 24689999999864432211111 11 16788999999999999999 9999999999999995
Q ss_pred CCCCCeEEeecccccccC
Q 007498 289 RDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 289 ~~~~~vkl~DFG~a~~~~ 306 (601)
++.++|+|||.+....
T Consensus 150 --~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 --DGKVYIIDVPQAVEID 165 (187)
T ss_pred --CCcEEEEECccccccc
Confidence 6789999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-17 Score=135.45 Aligned_cols=139 Identities=21% Similarity=0.278 Sum_probs=117.3
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccC--CCCcccHHHHHHHhhcchhhhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESL--AYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~--~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
.+.+++.+++++|..||..+||+|+..+...+|+++|. +|++.++.+.+..++.+ +-.+|+|++|+.++..+.+...
T Consensus 5 ~~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~-nPT~aeV~k~l~~~~~~~~~~~rl~FE~fLpm~q~vaknk~ 83 (152)
T KOG0030|consen 5 FTPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQ-NPTNAEVLKVLGQPKRREMNVKRLDFEEFLPMYQQVAKNKD 83 (152)
T ss_pred cCcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcC-CCcHHHHHHHHcCcccchhhhhhhhHHHHHHHHHHHHhccc
Confidence 56778899999999999999999999999999999996 79999999999999877 4579999999987765544321
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHh-----cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELAREL-----NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l-----~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
. -..+.+...+++||++|+|+|...|||++| +++.+ ++.++... .|.||.|+|++|++.+..
T Consensus 84 q-~t~edfvegLrvFDkeg~G~i~~aeLRhvLttlGekl~eeEVe~Llag~-eD~nG~i~YE~fVk~i~~ 151 (152)
T KOG0030|consen 84 Q-GTYEDFVEGLRVFDKEGNGTIMGAELRHVLTTLGEKLTEEEVEELLAGQ-EDSNGCINYEAFVKHIMS 151 (152)
T ss_pred c-CcHHHHHHHHHhhcccCCcceeHHHHHHHHHHHHhhccHHHHHHHHccc-cccCCcCcHHHHHHHHhc
Confidence 1 126778889999999999999999999999 33333 88888776 699999999999997753
|
|
| >KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.1e-17 Score=147.20 Aligned_cols=150 Identities=19% Similarity=0.249 Sum_probs=122.0
Q ss_pred hhHHHHHHh--hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHH
Q 007498 437 FKRAALKAL--SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEF 514 (601)
Q Consensus 437 l~~~~~~~~--~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef 514 (601)
+....+.++ .+.+++.++.+|++-|..-+ .+|.++.++|+.++..+..........+.+|+.+|.|++|.|+|.||
T Consensus 9 ~~~~~~e~l~~~t~f~~~ei~~~Yr~Fk~~c--P~G~~~~~~F~~i~~~~fp~gd~~~y~~~vF~~fD~~~dg~i~F~Ef 86 (193)
T KOG0044|consen 9 LQPESLEQLVQQTKFSKKEIQQWYRGFKNEC--PSGRLTLEEFREIYASFFPDGDASKYAELVFRTFDKNKDGTIDFLEF 86 (193)
T ss_pred CCcHHHHHHHHhcCCCHHHHHHHHHHhcccC--CCCccCHHHHHHHHHHHCCCCCHHHHHHHHHHHhcccCCCCcCHHHH
Confidence 334444444 34689999999999997744 48999999999999998865556677899999999999999999999
Q ss_pred HHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh-------cC----Ccc------HHHHHHHHhcCCCC
Q 007498 515 CAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL-------NV----GPS------AYSFLKDWIRNSDG 577 (601)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l-------~~----~~~------~~~~~~~~d~~~dG 577 (601)
+.++........ ++.++++|++||.||||+|+.+|+..++ +. ..+ ++.+|..+|.|+||
T Consensus 87 i~als~~~rGt~----eekl~w~F~lyD~dgdG~It~~Eml~iv~~i~~m~~~~~~~~~~~~~~~~v~~if~k~D~n~Dg 162 (193)
T KOG0044|consen 87 ICALSLTSRGTL----EEKLKWAFRLYDLDGDGYITKEEMLKIVQAIYQMTGSKALPEDEETPEERVDKIFSKMDKNKDG 162 (193)
T ss_pred HHHHHHHcCCcH----HHHhhhhheeecCCCCceEcHHHHHHHHHHHHHHcccccCCcccccHHHHHHHHHHHcCCCCCC
Confidence 877654433333 7788999999999999999999999887 11 111 99999999999999
Q ss_pred ceeHHHHHHHHhhcc
Q 007498 578 KLSLHGYTKFLHGVT 592 (601)
Q Consensus 578 ~is~~EF~~~~~~~~ 592 (601)
.||++||+..+...+
T Consensus 163 ~lT~eef~~~~~~d~ 177 (193)
T KOG0044|consen 163 KLTLEEFIEGCKADP 177 (193)
T ss_pred cccHHHHHHHhhhCH
Confidence 999999999887654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.1e-16 Score=152.29 Aligned_cols=138 Identities=23% Similarity=0.261 Sum_probs=103.1
Q ss_pred ceec-cCCCeEEEEEEeecCCccCcEEEEEEeecccc----------cchhhHHHHHHHHHHHHHhcCCCCe--eEEeee
Q 007498 153 KEVG-RGHFGHTCSARGKKGELKDQQVAVKIISKAKM----------TTAISIEDVRREVKILKALSGHKHL--VKFCDA 219 (601)
Q Consensus 153 ~~lG-~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~ni--v~l~~~ 219 (601)
..|| .||.|+||.+.. .+..++||.+..... ........+.+|+.++..|. |++| +..+++
T Consensus 37 ~~lg~~~g~gtv~~v~~-----~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~ 110 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-----PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAA 110 (239)
T ss_pred ceeecCCCCccEEEEEe-----CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEee
Confidence 4577 888888988876 356799998854321 01123456789999999996 8774 677776
Q ss_pred EecC-Cc---EEEEEeecCC-CchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCe
Q 007498 220 CEDV-NN---VYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294 (601)
Q Consensus 220 ~~~~-~~---~~lv~e~~~~-g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~v 294 (601)
.... .. .+|||||++| .+|.+.+.. ..+++.. +.||+.+|.+||++||+||||||.|||++. ++.+
T Consensus 111 ~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~---~~~v 181 (239)
T PRK01723 111 RVVRHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDP---DGKF 181 (239)
T ss_pred eeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcC---CCCE
Confidence 4432 22 3599999997 588776643 3566543 578999999999999999999999999953 5689
Q ss_pred EEeeccccccc
Q 007498 295 RLIDFGLSDFI 305 (601)
Q Consensus 295 kl~DFG~a~~~ 305 (601)
+|+|||.+...
T Consensus 182 ~LIDfg~~~~~ 192 (239)
T PRK01723 182 WLIDFDRGELR 192 (239)
T ss_pred EEEECCCcccC
Confidence 99999998653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.4e-16 Score=141.64 Aligned_cols=133 Identities=26% Similarity=0.308 Sum_probs=110.7
Q ss_pred EcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCC-CCeeEEeeeEecCCcEEEE
Q 007498 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLVKFCDACEDVNNVYIV 229 (601)
Q Consensus 151 ~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~lv 229 (601)
+++.||+|.++.||++... +..+++|+...... ...+.+|+.+++.+..+ .++++++.++...+..|++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v 71 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL 71 (155)
T ss_pred cceecccccccceEEEEec-----CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence 3578999999999999874 25799998755432 35688999999999733 6899999988888889999
Q ss_pred EeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ---GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 230 ~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~---~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
|||++|+.+... +......++.+++.+|.+||.. +++|+||+|+||+++. .+.++++|||.+..
T Consensus 72 ~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~---~~~~~l~Df~~~~~ 138 (155)
T cd05120 72 MEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD---GKILGIIDWEYAGY 138 (155)
T ss_pred EEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC---CcEEEEEecccccC
Confidence 999998766532 5667788899999999999985 6999999999999963 67899999999854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.3e-16 Score=130.53 Aligned_cols=138 Identities=15% Similarity=0.254 Sum_probs=119.5
Q ss_pred hhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh
Q 007498 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL 524 (601)
Q Consensus 445 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~ 524 (601)
.-..+++.+|++++++|..+|+|+||.|+.++|...|..+|. ..++++++.|+++. .|.|+|--|+.+.......
T Consensus 22 vFamf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk-~~~d~elDaM~~Ea----~gPINft~FLTmfGekL~g 96 (171)
T KOG0031|consen 22 VFAMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGK-IASDEELDAMMKEA----PGPINFTVFLTMFGEKLNG 96 (171)
T ss_pred HHHHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHhC----CCCeeHHHHHHHHHHHhcC
Confidence 345689999999999999999999999999999999999996 58888999999885 6899999999876543221
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
.+ .++.+..+|+.||.+++|.|..+.|+++|. ...+ ++.|++.+-.|..|.|+|.+|+.+|..
T Consensus 97 -td--pe~~I~~AF~~FD~~~~G~I~~d~lre~Ltt~gDr~~~eEV~~m~r~~p~d~~G~~dy~~~~~~ith 165 (171)
T KOG0031|consen 97 -TD--PEEVILNAFKTFDDEGSGKIDEDYLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFDYKAFTYIITH 165 (171)
T ss_pred -CC--HHHHHHHHHHhcCccCCCccCHHHHHHHHHHhcccCCHHHHHHHHHhCCcccCCceeHHHHHHHHHc
Confidence 11 278899999999999999999999999993 3333 999999999999999999999999973
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.8e-17 Score=178.21 Aligned_cols=258 Identities=27% Similarity=0.389 Sum_probs=203.4
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.+.+.+-+-.|.+|.++.+.-.. .+...++|+..+.........+.++.+-.++-..+ +|-++...-.+......+
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~---sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAG---SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred cceecccccCCCCcccccCCccc---cccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCCCcc
Confidence 46777789999999999886554 45556666654433333333444555555554443 677887766677778899
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC-
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR- 306 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~- 306 (601)
|||+|+.+++|...+... +..+.+-++.++..+..+++|||...++|||++|.|+|.. .+++.+++|||......
T Consensus 881 L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCcccccccccc
Confidence 999999999998877654 4688888899999999999999999999999999999995 58999999998432210
Q ss_pred --------------------CC-----------CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCC
Q 007498 307 --------------------PD-----------ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFW 354 (601)
Q Consensus 307 --------------------~~-----------~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~ 354 (601)
.. .......||+.|.+||.+. ...+..+|+|++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 00 0012357899999999876 468889999999999999999999999
Q ss_pred CCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHH---HHHcCcccCCC
Q 007498 355 ARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAV---QALTHPWLRDD 414 (601)
Q Consensus 355 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~---ell~hp~f~~~ 414 (601)
......+++++.+....++.-+ -..+.++++++.++|..+|.+|..+. ++-.|+||++.
T Consensus 1037 a~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1037 AETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred CcchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 9999999999988877665543 35789999999999999999999987 99999999864
|
|
| >KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.4e-16 Score=140.83 Aligned_cols=137 Identities=13% Similarity=0.216 Sum_probs=120.6
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHH
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 533 (601)
...+...|...|+|+.|.|+.+|+..+|.....+..+.+.++.|+.++|.+.+|+|.++||..++-.+ ..
T Consensus 56 ~~~~~~~f~~vD~d~sg~i~~~eLq~aLsn~~~~~Fs~~TcrlmI~mfd~~~~G~i~f~EF~~Lw~~i----------~~ 125 (221)
T KOG0037|consen 56 FPQLAGWFQSVDRDRSGRILAKELQQALSNGTWSPFSIETCRLMISMFDRDNSGTIGFKEFKALWKYI----------NQ 125 (221)
T ss_pred cHHHHHHHHhhCccccccccHHHHHHHhhcCCCCCCCHHHHHHHHHHhcCCCCCccCHHHHHHHHHHH----------HH
Confidence 34677899999999999999999999999877777888889999999999999999999998866432 24
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHh-----cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcccCccCcCC
Q 007498 534 ASTAFEYFEEEGNRVISIEELAREL-----NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVTLRSSNTRH 600 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l-----~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~~~~~~~~~ 600 (601)
++.+|+.||+|++|.|+..||++.| .+... .+.+++.+|.-++|.|.|++|++++..+..-+++||.
T Consensus 126 Wr~vF~~~D~D~SG~I~~sEL~~Al~~~Gy~Lspq~~~~lv~kyd~~~~g~i~FD~FI~ccv~L~~lt~~Fr~ 198 (221)
T KOG0037|consen 126 WRNVFRTYDRDRSGTIDSSELRQALTQLGYRLSPQFYNLLVRKYDRFGGGRIDFDDFIQCCVVLQRLTEAFRR 198 (221)
T ss_pred HHHHHHhcccCCCCcccHHHHHHHHHHcCcCCCHHHHHHHHHHhccccCCceeHHHHHHHHHHHHHHHHHHHH
Confidence 6889999999999999999999999 34444 8899999998889999999999999998877777763
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.6e-13 Score=144.03 Aligned_cols=144 Identities=21% Similarity=0.235 Sum_probs=96.4
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch---------------------------hh----H------H
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---------------------------IS----I------E 195 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~---------------------------~~----~------~ 195 (601)
+.||.|++|.||+|+.+ +|+.||||+.+......- .. . -
T Consensus 123 ~plasaSigQVh~A~l~----~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~El 198 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV----DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRREL 198 (437)
T ss_pred cceeeeehhheEEEEec----CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHH
Confidence 57999999999999976 678999999864321000 00 0 0
Q ss_pred HHHHHHHHHHHhc----CCCCeeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHH-HHHHHHH
Q 007498 196 DVRREVKILKALS----GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS-VVAFCHL 270 (601)
Q Consensus 196 ~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~-~L~~LH~ 270 (601)
++.+|...+.++. ++++|.-..-++......+|||||++|++|.+........+. ...++.+++. .+..+|.
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh
Confidence 2445565555553 234433222222333457899999999998876543211222 3445556655 4788999
Q ss_pred cCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 271 ~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
.|++|+|+||.||++. .++.++++|||++..+.
T Consensus 276 ~g~~H~D~hPgNilv~---~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVL---KDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEEC---CCCcEEEEeCCCeeECC
Confidence 9999999999999995 47899999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.7e-13 Score=145.44 Aligned_cols=148 Identities=18% Similarity=0.312 Sum_probs=93.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc---------------------------h----hhHHH
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT---------------------------A----ISIED 196 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------~----~~~~~ 196 (601)
.|+. +.||.|++|+||.|+.+. +|+.||||+++...... . ...+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~---~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKD---NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECC---CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 4555 789999999999999874 58899999997542100 0 01122
Q ss_pred HHHHHHH------HHHhc---CCCCeeEEeeeE-ecCCcEEEEEeecCCCchHHH--HHHcCC---CCCHHHHHHHHHHH
Q 007498 197 VRREVKI------LKALS---GHKHLVKFCDAC-EDVNNVYIVMELCEGGELLDR--ILARGG---RYTEEDAKAIVVQI 261 (601)
Q Consensus 197 ~~~E~~~------l~~l~---~h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~--~~~~~~---~l~~~~~~~i~~ql 261 (601)
+.+|+.+ +.++. .+.+.+.+-..+ ......+||||||+|+.|.+. +...+. .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 3344443 33332 122222222222 123456799999999998764 222211 24555556666665
Q ss_pred HHHHHHHHHcCCeeccCCCCceEeecC-CCCCCeEEeecccccccC
Q 007498 262 LSVVAFCHLQGVVHRDLKPENFLFTSG-RDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 262 ~~~L~~LH~~~iiHrDikp~NIll~~~-~~~~~vkl~DFG~a~~~~ 306 (601)
+ ..|++|+|+||.||+++.+ ...+.++++|||++..+.
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4 5899999999999999641 112389999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.8e-14 Score=149.09 Aligned_cols=255 Identities=22% Similarity=0.224 Sum_probs=187.9
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
...+|..+..||.|.|+.|+.+..+ ..++..|++|.+.+.-...... ..-..|+-+...|.-|.+++.++..|....
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r--~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKR--PEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ecCCcceeEEccCCccccceeeeec--CCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3456888999999999999988732 2367889999876544332222 223567777777777999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+.||-.|||+++++...+ .....+.+...+.+..|++.++.++|++.++|+|+||+||++..+ .+..++.|||+...
T Consensus 340 ~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~--~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND--GFFSKLGDFGCWTR 416 (524)
T ss_pred cccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc--hhhhhccccccccc
Confidence 999999999999877655 223458899999999999999999999999999999999999741 27889999998864
Q ss_pred cCCCCCccccccccccc-cchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 305 IRPDERLNDIVGSAYYV-APEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~-aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
+.-. .....+.-++. ..|++. ..+..+.|++|||.-+.+.++|...-+..... ..+..+. .+. .+...
T Consensus 417 ~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~~--~p~--~~~~~ 487 (524)
T KOG0601|consen 417 LAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSGD--TPN--LPGLK 487 (524)
T ss_pred ccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeeccc--ccC--CCchH
Confidence 2211 11223344455 356554 35788999999999999999987654332221 1222221 111 12445
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.+++.+.+.++..++..|+.+.++..|.-|-.+
T Consensus 488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 488 LQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred HhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 788999999999999999999999988766543
|
|
| >KOG4223 consensus Reticulocalbin, calumenin, DNA supercoiling factor, and related Ca2+-binding proteins of the CREC family (EF-Hand protein superfamily) [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.3e-13 Score=127.51 Aligned_cols=152 Identities=14% Similarity=0.166 Sum_probs=119.6
Q ss_pred HHHHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHh
Q 007498 439 RAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAA 518 (601)
Q Consensus 439 ~~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 518 (601)
........+...++..+.+..+|.++|.++||.|+..|+..|...... +.-..+..+-+..+|.|+||.|+|+||....
T Consensus 61 ~e~~~~fd~l~~ee~~~rl~~l~~~iD~~~Dgfv~~~El~~wi~~s~k-~~v~~~~~~~~~~~d~~~Dg~i~~eey~~~~ 139 (325)
T KOG4223|consen 61 DEFADEFDQLTPEESQERLGKLVPKIDSDSDGFVTESELKAWIMQSQK-KYVVEEAARRWDEYDKNKDGFITWEEYLPQT 139 (325)
T ss_pred hhhhhhhhhhCcchhHHHHHHHHhhhcCCCCCceeHHHHHHHHHHHHH-HHHHHHHHHHHHHhccCccceeeHHHhhhhh
Confidence 344455555556667889999999999999999999999999987664 4456668889999999999999999998766
Q ss_pred hcch----------hhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCcc-------HHHHHHHHhcCCCCceeH
Q 007498 519 ISTH----------QLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPS-------AYSFLKDWIRNSDGKLSL 581 (601)
Q Consensus 519 ~~~~----------~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~-------~~~~~~~~d~~~dG~is~ 581 (601)
+... ......+.-..-+.-|++.|.|+||.+|.+||..+|..... +.+.++.+|+|+||+|++
T Consensus 140 ~~~~~~~~~~~d~e~~~~~~km~~rDe~rFk~AD~d~dg~lt~EEF~aFLHPEe~p~M~~iVi~Etl~d~Dkn~DG~I~~ 219 (325)
T KOG4223|consen 140 YGRVDLPDEFPDEEDNEEYKKMIARDEERFKAADQDGDGSLTLEEFTAFLHPEEHPHMKDIVIAETLEDIDKNGDGKISL 219 (325)
T ss_pred hhcccCccccccchhcHHHHHHHHHHHHHHhhcccCCCCcccHHHHHhccChhhcchHHHHHHHHHHhhcccCCCCceeH
Confidence 5311 00111122233466899999999999999999999965443 888999999999999999
Q ss_pred HHHHHHHhhc
Q 007498 582 HGYTKFLHGV 591 (601)
Q Consensus 582 ~EF~~~~~~~ 591 (601)
+||+.-|-..
T Consensus 220 eEfigd~~~~ 229 (325)
T KOG4223|consen 220 EEFIGDLYSH 229 (325)
T ss_pred HHHHhHHhhc
Confidence 9999977543
|
|
| >KOG0036 consensus Predicted mitochondrial carrier protein [Nucleotide transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.7e-13 Score=130.91 Aligned_cols=136 Identities=18% Similarity=0.221 Sum_probs=118.7
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALE 528 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~ 528 (601)
+.++--.+++.+|+.||.+++|.++..++.+.+.++...++.......++..+|.|.||.++|+||..-+...
T Consensus 8 ~~~er~~r~~~lf~~lD~~~~g~~d~~~l~k~~~~l~~~~~~~~~~~~l~~~~d~~~dg~vDy~eF~~Y~~~~------- 80 (463)
T KOG0036|consen 8 TDEERDIRIRCLFKELDSKNDGQVDLDQLEKGLEKLDHPKPNYEAAKMLFSAMDANRDGRVDYSEFKRYLDNK------- 80 (463)
T ss_pred CcHHHHHHHHHHHHHhccCCCCceeHHHHHHHHHhcCCCCCchHHHHHHHHhcccCcCCcccHHHHHHHHHHh-------
Confidence 4555566899999999999999999999999999988666778888999999999999999999998744321
Q ss_pred hHHHHHHHHHHHHcccCCCcccHHHHHHHh-----cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhccc
Q 007498 529 GWEQIASTAFEYFEEEGNRVISIEELAREL-----NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVTL 593 (601)
Q Consensus 529 ~~~~~~~~~F~~~D~d~~G~I~~~El~~~l-----~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~~ 593 (601)
|.++..+|...|.++||.|+.+|+.+.| .++.+ +..+++++|+++++.|+++||.+.+.-.+.
T Consensus 81 --E~~l~~~F~~iD~~hdG~i~~~Ei~~~l~~~gi~l~de~~~k~~e~~d~~g~~~I~~~e~rd~~ll~p~ 149 (463)
T KOG0036|consen 81 --ELELYRIFQSIDLEHDGKIDPNEIWRYLKDLGIQLSDEKAAKFFEHMDKDGKATIDLEEWRDHLLLYPE 149 (463)
T ss_pred --HHHHHHHHhhhccccCCccCHHHHHHHHHHhCCccCHHHHHHHHHHhccCCCeeeccHHHHhhhhcCCh
Confidence 6678899999999999999999999988 34444 888999999999999999999999887663
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.5e-12 Score=120.13 Aligned_cols=146 Identities=18% Similarity=0.197 Sum_probs=104.2
Q ss_pred cceeccCCCeEEEEEEeecC---CccCcEEEEEEeecccc--c-----------------chhhHHHH----HHHHHHHH
Q 007498 152 GKEVGRGHFGHTCSARGKKG---ELKDQQVAVKIISKAKM--T-----------------TAISIEDV----RREVKILK 205 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~---~~~~~~vavK~~~~~~~--~-----------------~~~~~~~~----~~E~~~l~ 205 (601)
...||.|.-+.||.|....+ ...+..+|||+.+.... . .......+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 35799999999999975421 01347899999752110 0 01112333 38999999
Q ss_pred HhcCC-CCeeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeccCCCCce
Q 007498 206 ALSGH-KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC-HLQGVVHRDLKPENF 283 (601)
Q Consensus 206 ~l~~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~L-H~~~iiHrDikp~NI 283 (601)
++... -++.+.+++ ..-+|||||+.++.+.....+ ...+++.++..+..+++.+|..| |..||||+||++.||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 99743 467777764 456799999976544322222 23466677888899999999999 899999999999999
Q ss_pred EeecCCCCCCeEEeecccccccC
Q 007498 284 LFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 284 ll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+. ++.+.|+|||.|....
T Consensus 157 L~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE----CCcEEEEECCCceeCC
Confidence 995 5679999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=1e-12 Score=121.77 Aligned_cols=129 Identities=19% Similarity=0.223 Sum_probs=95.5
Q ss_pred cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEe
Q 007498 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 231 (601)
++.|+.|.++.||.++. .+..|++|+...... ....+.+|+.+++.+.+...+.+++.+.. ...++|||
T Consensus 3 ~~~l~~G~~~~vy~~~~-----~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e 71 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-----ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITE 71 (170)
T ss_pred eeecCCcccCceEEEEE-----CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEE
Confidence 35789999999999986 356899998754321 11345789999999963333455665543 33579999
Q ss_pred ecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGV-----VHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 232 ~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~i-----iHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
|++|.++... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 72 ~i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 72 FIEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred ecCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 9999876542 01123467899999999999985 9999999999995 45799999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.9e-10 Score=114.36 Aligned_cols=211 Identities=17% Similarity=0.232 Sum_probs=150.2
Q ss_pred eEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec----CCcEEEEEeecCC-
Q 007498 161 GHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED----VNNVYIVMELCEG- 235 (601)
Q Consensus 161 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~~~- 235 (601)
.+.|++.... +|..|++|++...+.... .....-+++++++. |.|||.|.++|.. +..++||++|.++
T Consensus 290 ~Ttyk~~s~~---DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 290 ITTYKATSNV---DGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ceeEeeeecc---CCceeeeeeeccccccCc---ccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 4678888765 889999999943332221 12234578899997 9999999998873 3568999999987
Q ss_pred CchHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 236 GELLDRILAR--------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 236 g~L~~~~~~~--------------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
++|++..... +...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++. +.+|+|...|.
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G---~~RIriS~C~i 439 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTG---KMRIRISGCGI 439 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeC---cceEEEecccc
Confidence 4677654321 234688999999999999999999999999999999999963 44788877777
Q ss_pred ccccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hhHH-HHHHHccCCCCCCCCCCC
Q 007498 302 SDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWART-ESGI-FRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 302 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~-~~~i~~~~~~~~~~~~~~ 379 (601)
...+..+. . |.+.+ -.+-|.=.||.+++.|.||..-=+... .... ++.|. +.
T Consensus 440 ~Dvl~~d~-----------~--~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~ 493 (655)
T KOG3741|consen 440 MDVLQEDP-----------T--EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TT 493 (655)
T ss_pred eeeecCCC-----------C--cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hh
Confidence 65554332 0 11110 123488889999999999965422221 1111 11111 35
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
++.+++++|.-+...+++. -++.+++.+
T Consensus 494 yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 494 YSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 7899999999999888876 688888865
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.1e-12 Score=111.74 Aligned_cols=148 Identities=19% Similarity=0.210 Sum_probs=109.3
Q ss_pred EcceeccCCCeEEEEEEeecCCccCcEEEEEEee-----cccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS-----KAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 151 ~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
....|-+|+-+.|+.+.+ .|+.+.||.=. ...+.......+..+|.++|.++. --.|.--.-++.+...
T Consensus 11 ~l~likQGAEArv~~~~~-----~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYG 84 (229)
T ss_pred cceeeeccceeeEeeecc-----CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCC
Confidence 456788999999998876 56777777532 223333445677889999999986 4455544445566666
Q ss_pred EEEEEeecCC-CchHHHHHHcCCCCCHHH-HHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 226 VYIVMELCEG-GELLDRILARGGRYTEED-AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 226 ~~lv~e~~~~-g~L~~~~~~~~~~l~~~~-~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
-.|+|||++| .++.+++......-.++. ...++..|-..+.-||.++|||+||..+||++..+.....+.++|||++.
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 6799999987 466777766533333333 37889999999999999999999999999999865455566999999985
Q ss_pred c
Q 007498 304 F 304 (601)
Q Consensus 304 ~ 304 (601)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-12 Score=125.57 Aligned_cols=198 Identities=17% Similarity=0.187 Sum_probs=139.4
Q ss_pred HHHhcCCCCeeEEeeeEecC-----CcEEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcC--C
Q 007498 204 LKALSGHKHLVKFCDACEDV-----NNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQG--V 273 (601)
Q Consensus 204 l~~l~~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~--i 273 (601)
|-++- |.|||++..||.+. .++.++.|||..|+|..+|.+ ....+......+|+-||+.||.|||+.. |
T Consensus 121 llqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 121 LLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34454 99999999998654 358899999999999887764 3456888999999999999999999985 9
Q ss_pred eeccCCCCceEeecCCCCCCeEEeecccccccCCC------CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHH
Q 007498 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD------ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYIL 346 (601)
Q Consensus 274 iHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~el 346 (601)
+|+++..+-|++. .++-|||.---.. ..... .....-.|-++|.+||.=. ...+.++|||++|....+|
T Consensus 200 ihgnlTc~tifiq---~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQ---HNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred ccCCcchhheeec---CCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 9999999999995 3677776421111 11100 0111234678899998643 3567789999999999999
Q ss_pred HhCCCCCCC-CChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 347 LCGSRPFWA-RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 347 l~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
..+..--.. ......-..+.+..... -..--+++|.+||+..|..||++.++|-||-+-+
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~l-------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIGL-------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheeec-------cCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 988764221 11111111221111111 1223467899999999999999999999998654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.8e-11 Score=124.18 Aligned_cols=230 Identities=18% Similarity=0.247 Sum_probs=150.8
Q ss_pred cCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHH
Q 007498 174 KDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED 253 (601)
Q Consensus 174 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~ 253 (601)
++.+|.|...+.... ...+.+.+-++-|+.|+ ||||+++++.++..+.+|||+|-+. -|..++.+ +....
T Consensus 36 ~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~ 105 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEE 105 (690)
T ss_pred cCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHH
Confidence 677888888755432 23466788899999997 9999999999999999999999985 45555543 44778
Q ss_pred HHHHHHHHHHHHHHHH-HcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCC-ccccccccccccchhccCCCC
Q 007498 254 AKAIVVQILSVVAFCH-LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-LNDIVGSAYYVAPEVLHRSYS 331 (601)
Q Consensus 254 ~~~i~~ql~~~L~~LH-~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~ 331 (601)
+...+.||+.||.||| ..+++|++|.-+.|+++ ..|..||++|-++........ .....---.|..|+.+... +
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn---~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s-~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN---ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS-E 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc---CCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-c
Confidence 8889999999999998 56899999999999996 589999999988754432211 1111112235555543211 1
Q ss_pred ChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHH----H-HH
Q 007498 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAV----Q-AL 406 (601)
Q Consensus 332 ~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~----e-ll 406 (601)
-..|.|-|||+++|++.|. +....+... . ..++.....+..+-+.-.+..||... + .+
T Consensus 182 ~s~D~~~Lg~li~el~ng~--~~~~~~~~~-----------~----~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~ 244 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS--LLTKTDLSN-----------T----GKIPKALIELYCKKLGATELKRPNKLRFILECRL 244 (690)
T ss_pred cchhhhhHHHHHHHHhCcc--cCcchhhhc-----------c----CccchhHHHHHHHHhccccccccchhhHHHHHHh
Confidence 3469999999999999983 221111100 0 12333444454444445556666532 2 23
Q ss_pred cCcccCCCCCCCChhHHHHHHHHhhhccCchhHH
Q 007498 407 THPWLRDDSRPVPLDILIFKLVKSYLHATPFKRA 440 (601)
Q Consensus 407 ~hp~f~~~~~~~~~~~~~~~~~k~~~~~~~l~~~ 440 (601)
-|.||++. -..+...++.+..++...+.
T Consensus 245 ~~gff~n~------fvd~~~fLeel~lks~~eK~ 272 (690)
T KOG1243|consen 245 LGGFFRND------FVDTLLFLEELRLKSVEEKQ 272 (690)
T ss_pred ccccccch------HHHHHHHHHhcccCcHHHHH
Confidence 48898864 22334444555554444433
|
|
| >KOG4223 consensus Reticulocalbin, calumenin, DNA supercoiling factor, and related Ca2+-binding proteins of the CREC family (EF-Hand protein superfamily) [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.5e-12 Score=122.85 Aligned_cols=136 Identities=21% Similarity=0.291 Sum_probs=106.6
Q ss_pred hHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhH
Q 007498 451 EDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGW 530 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~ 530 (601)
...+.+-++.|..-|.|+||.+|.+||..+|.-=-...+....+..-+..+|+|+||.|+++||+.-++.......+..|
T Consensus 159 ~km~~rDe~rFk~AD~d~dg~lt~EEF~aFLHPEe~p~M~~iVi~Etl~d~Dkn~DG~I~~eEfigd~~~~~~~~~epeW 238 (325)
T KOG4223|consen 159 KKMIARDEERFKAADQDGDGSLTLEEFTAFLHPEEHPHMKDIVIAETLEDIDKNGDGKISLEEFIGDLYSHEGNEEEPEW 238 (325)
T ss_pred HHHHHHHHHHHhhcccCCCCcccHHHHHhccChhhcchHHHHHHHHHHhhcccCCCCceeHHHHHhHHhhccCCCCCccc
Confidence 34566678899999999999999999999995433445667778888999999999999999998665543321111100
Q ss_pred -HHHHHHHHHHHcccCCCcccHHHHHHHhcCCcc------HHHHHHHHhcCCCCceeHHHHHH
Q 007498 531 -EQIASTAFEYFEEEGNRVISIEELARELNVGPS------AYSFLKDWIRNSDGKLSLHGYTK 586 (601)
Q Consensus 531 -~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~------~~~~~~~~d~~~dG~is~~EF~~ 586 (601)
.-+-.+.|..+|+|+||+++.+|++.++-..+- +..++.+.|.|+||++|++|.+.
T Consensus 239 v~~Ere~F~~~~DknkDG~L~~dEl~~WI~P~~~d~A~~EA~hL~~eaD~dkD~kLs~eEIl~ 301 (325)
T KOG4223|consen 239 VLTEREQFFEFRDKNKDGKLDGDELLDWILPSEQDHAKAEARHLLHEADEDKDGKLSKEEILE 301 (325)
T ss_pred ccccHHHHHHHhhcCCCCccCHHHHhcccCCCCccHHHHHHHHHhhhhccCccccccHHHHhh
Confidence 112246888899999999999999999954432 88899999999999999999875
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2e-11 Score=109.87 Aligned_cols=135 Identities=24% Similarity=0.281 Sum_probs=97.3
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeec-----ccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISK-----AKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
..+++|+-+.+|.+.+. +..+++|.=.. ..+.......+..+|.+++.++. --.|..-+-+..+...-.
T Consensus 2 ~~i~~GAEa~i~~~~~~-----g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGL 75 (204)
T ss_pred chhhCCcceeEEeeecc-----CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCE
Confidence 35789999999988653 33466665322 12222233456789999999986 445554444555666678
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+|||++|-.|.+.+... ...++..+-.-+.-||..||+|+||.++||++. .+.+.++|||++.+.
T Consensus 76 I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~s 141 (204)
T COG3642 76 IVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEFS 141 (204)
T ss_pred EEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCccccc
Confidence 999999987777676543 245667777777889999999999999999996 445999999999653
|
|
| >KOG0038 consensus Ca2+-binding kinase interacting protein (KIP) (EF-Hand protein superfamily) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.2e-11 Score=104.30 Aligned_cols=138 Identities=16% Similarity=0.260 Sum_probs=101.7
Q ss_pred cchHHHHHHHHHHHhhCCCC-----CC------cccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHH
Q 007498 449 LTEDELVYLRAQFRLLEPNK-----DG------SVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAA 517 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~-----~G------~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~ 517 (601)
++..++-++...|..+-++. .| .+..+.+.+.-+ + .....-+++...+..|++|.++|++|+.+
T Consensus 22 FtrKdIlrl~~Rf~~L~P~lVP~~~~~~~~~~v~vp~e~i~kMPE-L----kenpfk~ri~e~FSeDG~GnlsfddFlDm 96 (189)
T KOG0038|consen 22 FTRKDILRLHKRFYELAPHLVPTDMTGNRPPIVKVPFELIEKMPE-L----KENPFKRRICEVFSEDGRGNLSFDDFLDM 96 (189)
T ss_pred ccHHHHHHHHHHHHHhCcccccccccCCCCCceeecHHHHhhChh-h----hcChHHHHHHHHhccCCCCcccHHHHHHH
Confidence 46666667777776665541 11 344444444322 1 12233467888899999999999999987
Q ss_pred hhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh------cCCcc-----HHHHHHHHhcCCCCceeHHHHHH
Q 007498 518 AISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL------NVGPS-----AYSFLKDWIRNSDGKLSLHGYTK 586 (601)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l------~~~~~-----~~~~~~~~d~~~dG~is~~EF~~ 586 (601)
..-.....+ ++-++..+|+.||.|+|++|..++|.+.+ .++.+ ++.+++++|.||||+|++.||.+
T Consensus 97 fSV~sE~AP---rdlK~~YAFkIYDfd~D~~i~~~DL~~~l~~lTr~eLs~eEv~~i~ekvieEAD~DgDgkl~~~eFe~ 173 (189)
T KOG0038|consen 97 FSVFSEMAP---RDLKAKYAFKIYDFDGDEFIGHDDLEKTLTSLTRDELSDEEVELICEKVIEEADLDGDGKLSFAEFEH 173 (189)
T ss_pred HHHHHhhCh---HHhhhhheeEEeecCCCCcccHHHHHHHHHHHhhccCCHHHHHHHHHHHHHHhcCCCCCcccHHHHHH
Confidence 654444433 25567889999999999999999999988 34443 88999999999999999999999
Q ss_pred HHhhcccC
Q 007498 587 FLHGVTLR 594 (601)
Q Consensus 587 ~~~~~~~~ 594 (601)
++.+.+..
T Consensus 174 ~i~raPDF 181 (189)
T KOG0038|consen 174 VILRAPDF 181 (189)
T ss_pred HHHhCcch
Confidence 99987643
|
|
| >KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.8e-11 Score=109.16 Aligned_cols=144 Identities=19% Similarity=0.247 Sum_probs=105.1
Q ss_pred HHHHHHhhhccCchhHHHHHHh----hhhc-chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHH
Q 007498 424 IFKLVKSYLHATPFKRAALKAL----SKAL-TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVL 498 (601)
Q Consensus 424 ~~~~~k~~~~~~~l~~~~~~~~----~~~l-~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~ 498 (601)
+...-+.|...++........+ +..+ ..+.-.....+|+.||.|+||.|++.||..+|..+.. ...++.+++.|
T Consensus 28 i~~~Yr~Fk~~cP~G~~~~~~F~~i~~~~fp~gd~~~y~~~vF~~fD~~~dg~i~F~Efi~als~~~r-Gt~eekl~w~F 106 (193)
T KOG0044|consen 28 IQQWYRGFKNECPSGRLTLEEFREIYASFFPDGDASKYAELVFRTFDKNKDGTIDFLEFICALSLTSR-GTLEEKLKWAF 106 (193)
T ss_pred HHHHHHHhcccCCCCccCHHHHHHHHHHHCCCCCHHHHHHHHHHHhcccCCCCcCHHHHHHHHHHHcC-CcHHHHhhhhh
Confidence 3344455555555444333332 2223 3556667788999999999999999999999987764 45567789999
Q ss_pred hhcccCCCCcccHHHHHHHhhcchhh-------hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHH
Q 007498 499 SSMESLAYRKMYFEEFCAAAISTHQL-------EALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFL 568 (601)
Q Consensus 499 ~~~D~~~~g~i~~~ef~~~~~~~~~~-------~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~ 568 (601)
+.+|.|++|.|+.+|++.++.....+ ...++.++.+.++|+.+|.|+||.||.+||.....-...+-.++
T Consensus 107 ~lyD~dgdG~It~~Eml~iv~~i~~m~~~~~~~~~~~~~~~~v~~if~k~D~n~Dg~lT~eef~~~~~~d~~i~~~l 183 (193)
T KOG0044|consen 107 RLYDLDGDGYITKEEMLKIVQAIYQMTGSKALPEDEETPEERVDKIFSKMDKNKDGKLTLEEFIEGCKADPSILRAL 183 (193)
T ss_pred eeecCCCCceEcHHHHHHHHHHHHHHcccccCCcccccHHHHHHHHHHHcCCCCCCcccHHHHHHHhhhCHHHHHHh
Confidence 99999999999999998665433222 12445688899999999999999999999999876555433333
|
|
| >PLN02964 phosphatidylserine decarboxylase | Back alignment and domain information |
|---|
Probab=99.21 E-value=4e-11 Score=129.64 Aligned_cols=106 Identities=20% Similarity=0.254 Sum_probs=88.9
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhcc---HHHHHhhcccCCCCcccHHHHHHHhhcchh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESR---VPDVLSSMESLAYRKMYFEEFCAAAISTHQ 523 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~---~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~ 523 (601)
..++..|+++++++|+.||+|++|.| +..+++.++...+++++ ++.+|+.+|.|++|.|+++||+.++.....
T Consensus 135 t~f~~kqi~elkeaF~lfD~dgdG~i----Lg~ilrslG~~~pte~e~~fi~~mf~~~D~DgdG~IdfdEFl~lL~~lg~ 210 (644)
T PLN02964 135 FDFVTQEPESACESFDLLDPSSSNKV----VGSIFVSCSIEDPVETERSFARRILAIVDYDEDGQLSFSEFSDLIKAFGN 210 (644)
T ss_pred hhccHHHHHHHHHHHHHHCCCCCCcC----HHHHHHHhCCCCCCHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcc
Confidence 35778899999999999999999997 88888888732355554 899999999999999999999987654332
Q ss_pred hhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcC
Q 007498 524 LEALEGWEQIASTAFEYFEEEGNRVISIEELARELNV 560 (601)
Q Consensus 524 ~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~ 560 (601)
... +++++.+|+.||+|++|+|+.+||+.+|..
T Consensus 211 ~~s----eEEL~eaFk~fDkDgdG~Is~dEL~~vL~~ 243 (644)
T PLN02964 211 LVA----ANKKEELFKAADLNGDGVVTIDELAALLAL 243 (644)
T ss_pred CCC----HHHHHHHHHHhCCCCCCcCCHHHHHHHHHh
Confidence 222 678999999999999999999999999843
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.8e-10 Score=111.42 Aligned_cols=143 Identities=25% Similarity=0.412 Sum_probs=104.9
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCC-CCeeEEeeeEecC---CcEEE
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLVKFCDACEDV---NNVYI 228 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~---~~~~l 228 (601)
+.||.|.++.||+++.. +++.+++|+....... .....+.+|+++++.+..+ .++.+++.+.... +..|+
T Consensus 4 ~~l~~G~~n~~~~v~~~----~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~ 77 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY 77 (223)
T ss_pred eecCCCccceEEEEEec----CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence 56899999999999864 3468999997654321 1235678999999999732 3467777776654 36789
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-------------------------------------- 270 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~-------------------------------------- 270 (601)
||||++|.++.+.+.. ..+++.+...++.+++.+|.+||+
T Consensus 78 v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 78 VMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 9999999877654321 346777777788888888888873
Q ss_pred ------------------cCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 271 ------------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 271 ------------------~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
..++|+|+++.|||++.+ .++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 236999999999999631 145689999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2e-10 Score=101.83 Aligned_cols=110 Identities=15% Similarity=0.238 Sum_probs=91.9
Q ss_pred HHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 441 ALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 441 ~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
++..++...++.+ +.++|..+|. ++|.|++.+|..++..........+++.+.|+.+|.|++|+|+..|+..++..
T Consensus 45 ilr~lg~~~s~~e---i~~l~~~~d~-~~~~idf~~Fl~~ms~~~~~~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~ 120 (160)
T COG5126 45 ILRSLGFNPSEAE---INKLFEEIDA-GNETVDFPEFLTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKS 120 (160)
T ss_pred HHHHcCCCCcHHH---HHHHHHhccC-CCCccCHHHHHHHHHHHhccCCcHHHHHHHHHHhCCCCCceecHHHHHHHHHh
Confidence 3445566677666 6667777888 99999999999999876654566888999999999999999999999887775
Q ss_pred chhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 521 THQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 521 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
...... ++++..+++.+|+|++|+|+.+||.+.+
T Consensus 121 lge~~~----deev~~ll~~~d~d~dG~i~~~eF~~~~ 154 (160)
T COG5126 121 LGERLS----DEEVEKLLKEYDEDGDGEIDYEEFKKLI 154 (160)
T ss_pred hcccCC----HHHHHHHHHhcCCCCCceEeHHHHHHHH
Confidence 555444 7789999999999999999999999865
|
|
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.3e-10 Score=99.92 Aligned_cols=114 Identities=14% Similarity=0.250 Sum_probs=92.3
Q ss_pred HHHHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhh----hccHHHHHhhcccCCCCcccHHHH
Q 007498 439 RAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMR----ESRVPDVLSSMESLAYRKMYFEEF 514 (601)
Q Consensus 439 ~~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~----~~~~~~~~~~~D~~~~g~i~~~ef 514 (601)
...+..++...++. ++..++..+|.|++|.|+++||..++......... .+++...|+.+|.|++|.|+..|+
T Consensus 31 ~~~lr~lg~~~t~~---el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~~~~~~el~eaF~~fD~d~~G~Is~~el 107 (151)
T KOG0027|consen 31 GAVLRSLGQNPTEE---ELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDEEASSEELKEAFRVFDKDGDGFISASEL 107 (151)
T ss_pred HHHHHHcCCCCCHH---HHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccccccHHHHHHHHHHHccCCCCcCcHHHH
Confidence 34455555555544 47788889999999999999999999877643222 338999999999999999999999
Q ss_pred HHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 515 CAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
..++.......+ .+++..+++.+|.|+||.|+.+||.+++.
T Consensus 108 ~~~l~~lg~~~~----~~e~~~mi~~~d~d~dg~i~f~ef~~~m~ 148 (151)
T KOG0027|consen 108 KKVLTSLGEKLT----DEECKEMIREVDVDGDGKVNFEEFVKMMS 148 (151)
T ss_pred HHHHHHhCCcCC----HHHHHHHHHhcCCCCCCeEeHHHHHHHHh
Confidence 988776655544 66889999999999999999999998763
|
|
| >KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.4e-09 Score=99.47 Aligned_cols=144 Identities=13% Similarity=0.192 Sum_probs=108.7
Q ss_pred cccccccCCCCHHHHHcCcccCCCCCCCChhHHHHHHHHhhhccCchhHHHHHHhhhhcchHHHHHHHHHHHhhCCCCCC
Q 007498 391 LLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDG 470 (601)
Q Consensus 391 ~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~k~~~~~~~l~~~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G 470 (601)
....|-..|++++|+.++.= +....+......++|-.+...+...+.-..++...- .-+..|+.+|..||+|++|
T Consensus 65 ~vD~d~sg~i~~~eLq~aLs---n~~~~~Fs~~TcrlmI~mfd~~~~G~i~f~EF~~Lw--~~i~~Wr~vF~~~D~D~SG 139 (221)
T KOG0037|consen 65 SVDRDRSGRILAKELQQALS---NGTWSPFSIETCRLMISMFDRDNSGTIGFKEFKALW--KYINQWRNVFRTYDRDRSG 139 (221)
T ss_pred hhCccccccccHHHHHHHhh---cCCCCCCCHHHHHHHHHHhcCCCCCccCHHHHHHHH--HHHHHHHHHHHhcccCCCC
Confidence 34567778888888887632 233445666667777777777766666555555444 4677899999999999999
Q ss_pred cccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCccc
Q 007498 471 SVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVIS 550 (601)
Q Consensus 471 ~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~ 550 (601)
.|+..||..+|..+|+ ..+.+.++.+++.+|....|.|.|++|+..|+.+. .+..+|+.+|++.+|.|+
T Consensus 140 ~I~~sEL~~Al~~~Gy-~Lspq~~~~lv~kyd~~~~g~i~FD~FI~ccv~L~----------~lt~~Fr~~D~~q~G~i~ 208 (221)
T KOG0037|consen 140 TIDSSELRQALTQLGY-RLSPQFYNLLVRKYDRFGGGRIDFDDFIQCCVVLQ----------RLTEAFRRRDTAQQGSIT 208 (221)
T ss_pred cccHHHHHHHHHHcCc-CCCHHHHHHHHHHhccccCCceeHHHHHHHHHHHH----------HHHHHHHHhccccceeEE
Confidence 9999999999999997 46777788899999977789999999988776432 345689999999888775
|
|
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.6e-10 Score=86.72 Aligned_cols=55 Identities=29% Similarity=0.618 Sum_probs=47.9
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhc-CC----cc-----HHHHHHHHhcCCCCceeHHHHHHHH
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELN-VG----PS-----AYSFLKDWIRNSDGKLSLHGYTKFL 588 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~-~~----~~-----~~~~~~~~d~~~dG~is~~EF~~~~ 588 (601)
++.+|+.||+|++|+|+.+||+.++. +. .. ++.+|+.+|.|+||.|+|+||+++|
T Consensus 2 l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~ 66 (66)
T PF13499_consen 2 LKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNFM 66 (66)
T ss_dssp HHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHHH
T ss_pred HHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhccC
Confidence 57899999999999999999999993 22 11 7777999999999999999999986
|
... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2e-10 Score=121.93 Aligned_cols=152 Identities=23% Similarity=0.325 Sum_probs=110.4
Q ss_pred HHHHHHHHHHHc-CCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCc-----c-----ccccccccccchhccC
Q 007498 260 QILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-----N-----DIVGSAYYVAPEVLHR 328 (601)
Q Consensus 260 ql~~~L~~LH~~-~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~-----~-----~~~gt~~y~aPE~~~~ 328 (601)
+++.||.|+|.. ++||+.|.|++|.++ ..+.+||+.|+++......... . -..-...|.|||++..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n---a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVN---ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeec---cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 444999999987 899999999999995 5889999999998654432211 1 1234567999998764
Q ss_pred -CCCChhhHHHHHHHHHHHH-hCCCCCCCCChhHHHHHHHccCCCCCCC-CCCCCCHHHHHHHHHcccccccCCCCHHHH
Q 007498 329 -SYSLEADIWSIGVISYILL-CGSRPFWARTESGIFRAVLRSDPNFDDL-PWPSVSPEAKDFVKRLLNKDYRKRMTAVQA 405 (601)
Q Consensus 329 -~~~~~~DvwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~el 405 (601)
..+.++|+||+||++|-+. .|+..+........+. ........... .-.++++++++=|.++|..+...||++.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 5789999999999999999 4555554433322221 11111111110 114789999999999999999999999999
Q ss_pred HcCcccCCCC
Q 007498 406 LTHPWLRDDS 415 (601)
Q Consensus 406 l~hp~f~~~~ 415 (601)
+..|||.+..
T Consensus 263 ~~~~ff~D~~ 272 (700)
T KOG2137|consen 263 LSIPFFSDPG 272 (700)
T ss_pred hcccccCCch
Confidence 9999998753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.8e-09 Score=105.14 Aligned_cols=240 Identities=17% Similarity=0.197 Sum_probs=158.3
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeee------Eec
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDA------CED 222 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~------~~~ 222 (601)
...++.||+|+-+.+|-+-... ..+-|+......... ..-+..|-..-+||-+-.-+.+ .-+
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~------d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~ 80 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVR------DQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGR 80 (637)
T ss_pred cCCCccccCCccceeeecchhh------chhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCC
Confidence 3456789999999999764332 245577755432211 1223334444345543321110 112
Q ss_pred C-CcEEEEEeecCCCchHHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeE
Q 007498 223 V-NNVYIVMELCEGGELLDRILA------RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295 (601)
Q Consensus 223 ~-~~~~lv~e~~~~g~L~~~~~~------~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vk 295 (601)
. ..+.+.|..+.|..=...+.+ ......+..+.++++.|+.+...||..|.+-+|+.++|+|++ +++.|.
T Consensus 81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~ 157 (637)
T COG4248 81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVV 157 (637)
T ss_pred ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEE
Confidence 2 237789999887522222221 123467888999999999999999999999999999999996 488899
Q ss_pred EeecccccccCCCCCccccccccccccchhcc-C-----CCCChhhHHHHHHHHHHHHhC-CCCCCCCCh----hHHHH-
Q 007498 296 LIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-R-----SYSLEADIWSIGVISYILLCG-SRPFWARTE----SGIFR- 363 (601)
Q Consensus 296 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~DvwSlG~il~ell~g-~~pf~~~~~----~~~~~- 363 (601)
|+|-..-.....+......+|...|.+||... + .-+...|.|.|||++++++.| +.||.+... ..-++
T Consensus 158 LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 158 LVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred EEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 99866544444555566678999999999764 2 246779999999999999987 999965311 11111
Q ss_pred HHHcc------------CCCCCCCCCCCCCHHHHHHHHHcccc--cccCCCCHH
Q 007498 364 AVLRS------------DPNFDDLPWPSVSPEAKDFVKRLLNK--DYRKRMTAV 403 (601)
Q Consensus 364 ~i~~~------------~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~R~s~~ 403 (601)
.|..+ .+.....+|.-++++++.|..+|+.. ++.-||+++
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 12111 11222334567899999999999974 467899874
|
|
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=99.01 E-value=7.7e-10 Score=89.26 Aligned_cols=61 Identities=16% Similarity=0.229 Sum_probs=53.8
Q ss_pred HHHHHHHHHHcc-cCCCcccHHHHHHHhc------CCc--cHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 532 QIASTAFEYFEE-EGNRVISIEELARELN------VGP--SAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 532 ~~~~~~F~~~D~-d~~G~I~~~El~~~l~------~~~--~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
..+..+|++||+ +++|+|+.+||+.+|. +.. +++.+|+.+|.|+||+|+|+||+.+|.++.
T Consensus 8 ~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~l~ 77 (89)
T cd05022 8 ETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGELA 77 (89)
T ss_pred HHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHH
Confidence 457889999999 9999999999999982 222 399999999999999999999999997763
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=3e-09 Score=99.17 Aligned_cols=130 Identities=28% Similarity=0.307 Sum_probs=83.2
Q ss_pred EEEEEEeecCCccCcEEEEEEeecccc-----------------------cchhhHHHHHHHHHHHHHhcCC-CCeeEEe
Q 007498 162 HTCSARGKKGELKDQQVAVKIISKAKM-----------------------TTAISIEDVRREVKILKALSGH-KHLVKFC 217 (601)
Q Consensus 162 ~V~~~~~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~~h-~niv~l~ 217 (601)
.||.|... .+..+|||+.+.... ..........+|.+.|+++... -++.+.+
T Consensus 1 ~Vy~~~~~----~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~ 76 (188)
T PF01163_consen 1 DVYHAIDP----DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPY 76 (188)
T ss_dssp EEEEEEEC----TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EE
T ss_pred CEEEEECC----CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEE
Confidence 38888765 567899999753110 0111234578999999999733 2577777
Q ss_pred eeEecCCcEEEEEeecC--CCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHHcCCeeccCCCCceEeecCCCCCCe
Q 007498 218 DACEDVNNVYIVMELCE--GGELLDRILARGGRYTEEDAKAIVVQILSVVAF-CHLQGVVHRDLKPENFLFTSGRDDADM 294 (601)
Q Consensus 218 ~~~~~~~~~~lv~e~~~--~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~-LH~~~iiHrDikp~NIll~~~~~~~~v 294 (601)
++. .-+|||||++ |..+. .+... .++......++.+++..+.. +|..||+|+||.+.|||++ ++.+
T Consensus 77 ~~~----~~~ivME~I~~~G~~~~-~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~ 145 (188)
T PF01163_consen 77 DYN----RNVIVMEYIGEDGVPLP-RLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKV 145 (188)
T ss_dssp EEE----TTEEEEE--EETTEEGG-CHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCE
T ss_pred EEe----CCEEEEEecCCCccchh-hHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceE
Confidence 553 2369999998 54443 33332 23356677888888886655 5799999999999999996 3489
Q ss_pred EEeecccccccC
Q 007498 295 RLIDFGLSDFIR 306 (601)
Q Consensus 295 kl~DFG~a~~~~ 306 (601)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=1e-08 Score=101.39 Aligned_cols=130 Identities=15% Similarity=0.159 Sum_probs=91.4
Q ss_pred cCcEEEEEEeecccccc--------hhhHHHHHHHHHHHHHhcCCCC--eeEEeeeEec-----CCcEEEEEeecCCC-c
Q 007498 174 KDQQVAVKIISKAKMTT--------AISIEDVRREVKILKALSGHKH--LVKFCDACED-----VNNVYIVMELCEGG-E 237 (601)
Q Consensus 174 ~~~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~n--iv~l~~~~~~-----~~~~~lv~e~~~~g-~ 237 (601)
.|+.|.||......... ......+.+|...+.+|. .-+ ++..+.++.. ...-+||||++++. +
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~s 122 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTIS 122 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCcc
Confidence 45678888663322100 011124778999998885 323 3344444432 23578999999885 7
Q ss_pred hHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec----CCCCCCeEEeecccccc
Q 007498 238 LLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS----GRDDADMRLIDFGLSDF 304 (601)
Q Consensus 238 L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~----~~~~~~vkl~DFG~a~~ 304 (601)
|.+++... ....+......++.+++..+.-||.+||+|+|+++.|||+.. +.++..+.|+||+.+..
T Consensus 123 L~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 123 LEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 87776432 245667788899999999999999999999999999999963 12357899999998853
|
|
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=3e-09 Score=97.16 Aligned_cols=100 Identities=11% Similarity=0.179 Sum_probs=82.6
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHH
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIAS 535 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~ 535 (601)
.+..+|..+|.+++|.|+.+||..++............++.+|+.+|.+++|.|+.+||..++........ ...+.
T Consensus 54 ~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~l~----~~~~~ 129 (158)
T PTZ00183 54 EIKQMIADVDKDGSGKIDFEEFLDIMTKKLGERDPREEILKAFRLFDDDKTGKISLKNLKRVAKELGETIT----DEELQ 129 (158)
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHHHHHHHhcCCCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCC----HHHHH
Confidence 47789999999999999999999988654322344567899999999999999999999887654332223 55688
Q ss_pred HHHHHHcccCCCcccHHHHHHHhc
Q 007498 536 TAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 536 ~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
.+|..+|.|++|.|+.+||..++.
T Consensus 130 ~~~~~~d~~~~g~i~~~ef~~~~~ 153 (158)
T PTZ00183 130 EMIDEADRNGDGEISEEEFYRIMK 153 (158)
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHh
Confidence 999999999999999999999874
|
|
| >KOG0034 consensus Ca2+/calmodulin-dependent protein phosphatase (calcineurin subunit B), EF-Hand superfamily protein [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.5e-09 Score=97.46 Aligned_cols=106 Identities=18% Similarity=0.203 Sum_probs=88.6
Q ss_pred HHHHHHhhCCCCCCc-ccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh-hhh--hhhHHH
Q 007498 457 LRAQFRLLEPNKDGS-VSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ-LEA--LEGWEQ 532 (601)
Q Consensus 457 l~~~F~~~D~d~~G~-I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~--~~~~~~ 532 (601)
..++++.||.+++|. |++++|...+..+.......+.++-.|+.+|.+++|.|+.+|+..++...-. ... ++.+++
T Consensus 68 ~~rI~~~f~~~~~~~~v~F~~Fv~~ls~f~~~~~~~~Kl~faF~vYD~~~~G~I~reel~~iv~~~~~~~~~~~~e~~~~ 147 (187)
T KOG0034|consen 68 ADRIIDRFDTDGNGDPVDFEEFVRLLSVFSPKASKREKLRFAFRVYDLDGDGFISREELKQILRMMVGENDDMSDEQLED 147 (187)
T ss_pred HHHHHHHHhccCCCCccCHHHHHHHHhhhcCCccHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHccCCcchHHHHHH
Confidence 357899999999998 9999999999988765555668999999999999999999999876543322 222 567788
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHhcCCc
Q 007498 533 IASTAFEYFEEEGNRVISIEELARELNVGP 562 (601)
Q Consensus 533 ~~~~~F~~~D~d~~G~I~~~El~~~l~~~~ 562 (601)
.+.+.|..+|.|+||+|+.+|+..++.-.+
T Consensus 148 i~d~t~~e~D~d~DG~IsfeEf~~~v~~~P 177 (187)
T KOG0034|consen 148 IVDKTFEEADTDGDGKISFEEFCKVVEKQP 177 (187)
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHcCc
Confidence 899999999999999999999999985543
|
|
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=98.93 E-value=2e-09 Score=82.58 Aligned_cols=62 Identities=19% Similarity=0.381 Sum_probs=48.1
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchh---hhhhccHHHHHhhcccCCCCcccHHHHHHH
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATD---AMRESRVPDVLSSMESLAYRKMYFEEFCAA 517 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~---~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~ 517 (601)
+|+++|..+|.|++|+|+.+||..++..++.. ....+.+..+++.+|.|++|.|+++||+.+
T Consensus 1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~ 65 (66)
T PF13499_consen 1 RLKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNF 65 (66)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHH
T ss_pred CHHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhcc
Confidence 47899999999999999999999999988742 223345566677777777777777777653
|
... |
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.9e-09 Score=85.88 Aligned_cols=69 Identities=16% Similarity=0.254 Sum_probs=61.2
Q ss_pred hHHHHHHHHHHHhhCC-CCCCcccHHHHHHHHhh-cchhhhhh-ccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLLEP-NKDGSVSLENFRMVLGR-NATDAMRE-SRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~-d~~G~I~~~el~~~l~~-~~~~~~~~-~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..+..|+++|..||. +++|+|+.+||+.++.. ++. ..++ .+++.+++.+|.|+||.|+|+||+.++..
T Consensus 4 E~ai~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~-~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~ 75 (89)
T cd05022 4 EKAIETLVSNFHKASVKGGKESLTASEFQELLTQQLPH-LLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGE 75 (89)
T ss_pred HHHHHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhh-hccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 4678899999999999 99999999999999998 763 4555 78999999999999999999999876543
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.1e-08 Score=93.82 Aligned_cols=131 Identities=18% Similarity=0.216 Sum_probs=92.5
Q ss_pred cCcEEEEEEeeccccc----chhhHHHHHHHHHHHHHhcC-CCCeeEEeeeEecC----CcEEEEEeecCCC-chHHHHH
Q 007498 174 KDQQVAVKIISKAKMT----TAISIEDVRREVKILKALSG-HKHLVKFCDACEDV----NNVYIVMELCEGG-ELLDRIL 243 (601)
Q Consensus 174 ~~~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~~~ 243 (601)
.++.|-+|.....-.. .........+|...+..|.. .=.++..+.+.... ...+||+|++++. +|.+.+.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 4556666654321111 11234567889998888862 12344555555542 2458999999884 6777765
Q ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 244 ARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 244 ~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
... .++......++.+++..+.-||.+||+|+|+++.|||+..++....+.++||+-++..
T Consensus 111 ~~~-~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWE-QLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhc-ccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 532 3777888999999999999999999999999999999975333457999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.5e-08 Score=87.69 Aligned_cols=114 Identities=13% Similarity=0.193 Sum_probs=93.0
Q ss_pred HHHHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHh
Q 007498 439 RAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAA 518 (601)
Q Consensus 439 ~~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 518 (601)
+.++..++...... ++.++..-+|+++.|+|++++|...+.......-+.+++...|+.+|.|++|+|++.+|..++
T Consensus 56 ~vAmralGFE~~k~---ei~kll~d~dk~~~g~i~fe~f~~~mt~k~~e~dt~eEi~~afrl~D~D~~Gkis~~~lkrva 132 (172)
T KOG0028|consen 56 KVAMRALGFEPKKE---EILKLLADVDKEGSGKITFEDFRRVMTVKLGERDTKEEIKKAFRLFDDDKTGKISQRNLKRVA 132 (172)
T ss_pred HHHHHHcCCCcchH---HHHHHHHhhhhccCceechHHHHHHHHHHHhccCcHHHHHHHHHcccccCCCCcCHHHHHHHH
Confidence 35556666555444 466677778999999999999999975543334588899999999999999999999999877
Q ss_pred hcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 519 ISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
..+....+ .++++.+.+-+|.|++|-|+.+||..++.
T Consensus 133 keLgenlt----D~El~eMIeEAd~d~dgevneeEF~~imk 169 (172)
T KOG0028|consen 133 KELGENLT----DEELMEMIEEADRDGDGEVNEEEFIRIMK 169 (172)
T ss_pred HHhCcccc----HHHHHHHHHHhcccccccccHHHHHHHHh
Confidence 77766665 66889999999999999999999998874
|
|
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=98.83 E-value=6.6e-09 Score=84.01 Aligned_cols=61 Identities=16% Similarity=0.266 Sum_probs=52.7
Q ss_pred HHHHHHHHHHHc-ccCCC-cccHHHHHHHhcC-----Cc-----c-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFE-EEGNR-VISIEELARELNV-----GP-----S-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D-~d~~G-~I~~~El~~~l~~-----~~-----~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
-..++.+|++|| +||+| +|+.+||+.+|.. .+ + ++.+++.+|.|+||+|+|+||+.++..+
T Consensus 7 ~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~~~ 80 (88)
T cd05027 7 MVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMV 80 (88)
T ss_pred HHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 346788999998 89999 5999999999943 22 1 9999999999999999999999998765
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.4e-08 Score=91.59 Aligned_cols=101 Identities=11% Similarity=0.206 Sum_probs=81.6
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
..+..+|..+|.+++|.|+.+||..++............+..+|+.+|.+++|.|+.+||..++........ .+.+
T Consensus 47 ~~~~~~~~~~d~~~~g~i~~~ef~~~l~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~----~~~~ 122 (149)
T PTZ00184 47 AELQDMINEVDADGNGTIDFPEFLTLMARKMKDTDSEEEIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLT----DEEV 122 (149)
T ss_pred HHHHHHHHhcCcCCCCcCcHHHHHHHHHHhccCCcHHHHHHHHHHhhCCCCCCeEeHHHHHHHHHHHCCCCC----HHHH
Confidence 467899999999999999999999998764322234456889999999999999999999876644322222 5678
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhc
Q 007498 535 STAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
..+|+.+|.+++|.|+.+||..++.
T Consensus 123 ~~~~~~~d~~~~g~i~~~ef~~~~~ 147 (149)
T PTZ00184 123 DEMIREADVDGDGQINYEEFVKMMM 147 (149)
T ss_pred HHHHHhcCCCCCCcCcHHHHHHHHh
Confidence 8899999999999999999998763
|
|
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=98.83 E-value=9.9e-09 Score=84.24 Aligned_cols=61 Identities=18% Similarity=0.308 Sum_probs=52.1
Q ss_pred HHHHHHHHHHHc-ccCCC-cccHHHHHHHhcC------Cc-----cHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFE-EEGNR-VISIEELARELNV------GP-----SAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D-~d~~G-~I~~~El~~~l~~------~~-----~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
-..+..+|..|| +||+| +|+.+||+.+|.- .. +++.+++.+|.|+||.|+|+||+.+|..+
T Consensus 9 ~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~l 82 (93)
T cd05026 9 MDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAAL 82 (93)
T ss_pred HHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 345778899999 89999 5999999999921 11 29999999999999999999999999876
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=98.81 E-value=1e-08 Score=82.92 Aligned_cols=69 Identities=17% Similarity=0.224 Sum_probs=60.5
Q ss_pred hHHHHHHHHHHHhhC-CCCCC-cccHHHHHHHHhh-----cchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLLE-PNKDG-SVSLENFRMVLGR-----NATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D-~d~~G-~I~~~el~~~l~~-----~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..+..|+++|..|| .|++| +|+.+||+.+|+. ++. ..+.++++.+++.+|.|++|.|+|+||+.++..
T Consensus 4 e~~~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~-~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~~ 79 (88)
T cd05027 4 EKAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEE-IKEQEVVDKVMETLDSDGDGECDFQEFMAFVAM 79 (88)
T ss_pred HHHHHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 467889999999998 79999 5999999999998 664 467778999999999999999999999876543
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.7e-08 Score=94.32 Aligned_cols=139 Identities=29% Similarity=0.329 Sum_probs=102.0
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccc-----------------cc--hhhHHHHHHHHHHHHHhcC
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-----------------TT--AISIEDVRREVKILKALSG 209 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-----------------~~--~~~~~~~~~E~~~l~~l~~ 209 (601)
+.++.+||-|.-|.||.+.+. .+..+|||.=+.... .. ...+...++|.++|.+|..
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred HhhccccccCccceEEEEECC----CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 567889999999999999886 578999997431100 00 1123456899999999963
Q ss_pred C-CCeeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC
Q 007498 210 H-KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288 (601)
Q Consensus 210 h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~ 288 (601)
+ -.|.+.+++ +.-.+||||++|-.|... +++......++..|+.-+.-+-..||||+|+.+-|||++
T Consensus 169 ~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~-- 236 (304)
T COG0478 169 EGVKVPKPIAW----NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT-- 236 (304)
T ss_pred cCCCCCCcccc----ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe--
Confidence 3 256666553 445799999998655432 235666677777777777777799999999999999996
Q ss_pred CCCCCeEEeecccccc
Q 007498 289 RDDADMRLIDFGLSDF 304 (601)
Q Consensus 289 ~~~~~vkl~DFG~a~~ 304 (601)
++|.+.++||--+..
T Consensus 237 -~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 -EDGDIVVIDWPQAVP 251 (304)
T ss_pred -cCCCEEEEeCccccc
Confidence 488999999976543
|
|
| >smart00027 EH Eps15 homology domain | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.7e-08 Score=83.64 Aligned_cols=70 Identities=16% Similarity=0.236 Sum_probs=62.4
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
++.+++.+++++|..||.|++|.|+.+|+..+++.++ .+.++++.+++.+|.+++|.|+|+||+.++..+
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~---~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~~~~ 73 (96)
T smart00027 4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG---LPQTLLAKIWNLADIDNDGELDKDEFALAMHLI 73 (96)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC---CCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHH
Confidence 5778999999999999999999999999999999865 356679999999999999999999999866543
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.5e-10 Score=117.24 Aligned_cols=245 Identities=17% Similarity=0.211 Sum_probs=172.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCC-eeEEeeeEecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-LVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~~ 225 (601)
..|.....+++|+++++++.|... + +....+.+... ....-++++|.+++ ||| .+..++-+..+..
T Consensus 242 kws~~fh~fvK~altknpKkRpta---e-klL~h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTA---E-KLLQHPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGEDY 308 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCCh---h-hheeceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCcccc
Confidence 346667789999999999887653 2 22335555332 33456899999996 999 7777777777788
Q ss_pred EEEEEeecCCC-chHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGG-ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g-~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+++|+++.++ +....+....-.+.+-+...+++.-+++|+|||+.-=+||| ||+.. ++..|..||+....
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQ 380 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcc
Confidence 99999999887 22221111222355566777888889999999999878999 88885 57899999999887
Q ss_pred cCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC--CCCCC-CCCCCC
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--PNFDD-LPWPSV 380 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~-~~~~~~ 380 (601)
+.......+..+|+.++|||+.. ..+....|+|++|+--.+|.-|.+|-.... .....+-... +.+.. .-|...
T Consensus 381 L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~ 458 (829)
T KOG0576|consen 381 LTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPV 458 (829)
T ss_pred cCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcc
Confidence 77665667789999999999765 678999999999988788888877753210 0000000000 00000 111111
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
.-.++...|+..-|..|+..-.++-|.+|...+.
T Consensus 459 --~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 459 --FHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred --cccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 1125788899999999999999999999876654
|
|
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.7e-08 Score=82.95 Aligned_cols=63 Identities=19% Similarity=0.344 Sum_probs=54.4
Q ss_pred HHHHHHHHHHHHc-ccCCCc-ccHHHHHHHhc--C--------Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 530 WEQIASTAFEYFE-EEGNRV-ISIEELARELN--V--------GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 530 ~~~~~~~~F~~~D-~d~~G~-I~~~El~~~l~--~--------~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
..+.++.+|.+|| +|++|+ |+.+||+.+|. + ..+ ++.+|..+|.|++|.|+|+||+.+|.++-
T Consensus 7 ~~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~~~~ 82 (92)
T cd05025 7 AMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALT 82 (92)
T ss_pred HHHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHH
Confidence 3677899999997 999995 99999999993 1 122 99999999999999999999999998753
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11 | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.6e-08 Score=80.72 Aligned_cols=61 Identities=20% Similarity=0.302 Sum_probs=52.1
Q ss_pred HHHHHHHHHH-HcccCCC-cccHHHHHHHhcCC-----------ccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEY-FEEEGNR-VISIEELARELNVG-----------PSAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~-~D~d~~G-~I~~~El~~~l~~~-----------~~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
-..+..+|.. +|+||+| +|+.+||+.+++-. .+++.+|+.+|.|+||+|+|+||+.+|.++
T Consensus 8 i~~l~~~F~~y~~~dg~~~~Ls~~Elk~ll~~e~~~~~~~~~~~~~~~~ll~~~D~d~DG~I~f~EF~~l~~~l 81 (89)
T cd05023 8 IESLIAVFQKYAGKDGDSYQLSKTEFLSFMNTELASFTKNQKDPGVLDRMMKKLDLNSDGQLDFQEFLNLIGGL 81 (89)
T ss_pred HHHHHHHHHHHhccCCCcCeECHHHHHHHHHHhhhHhhcCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHH
Confidence 3457889999 7898986 99999999999321 129999999999999999999999999875
|
S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S |
| >cd00252 SPARC_EC SPARC_EC; extracellular Ca2+ binding domain (containing 2 EF-hand motifs) of SPARC and related proteins (QR1, SC1/hevin, testican and tsc-36/FRP) | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.2e-08 Score=83.29 Aligned_cols=59 Identities=19% Similarity=0.238 Sum_probs=52.3
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhcCCc--c-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELNVGP--S-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~--~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
...+.++|..+|+|+||+|+.+||..+. +.. . +..+|..+|.|+||.||++||..++.+
T Consensus 47 ~~~l~w~F~~lD~d~DG~Ls~~EL~~~~-l~~~e~~~~~f~~~~D~n~Dg~IS~~Ef~~cl~~ 108 (116)
T cd00252 47 KDPVGWMFNQLDGNYDGKLSHHELAPIR-LDPNEHCIKPFFESCDLDKDGSISLDEWCYCFIK 108 (116)
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHH-ccchHHHHHHHHHHHCCCCCCCCCHHHHHHHHhC
Confidence 5678999999999999999999999986 222 2 899999999999999999999999844
|
SPARC (BM-40) is a multifunctional glycoprotein, a matricellular protein, that functions to regulate cell-matrix interactions; binds to such proteins as collagen and vitronectin and binds to endothelial cells thus inhibiting cellular proliferation. The EC domain interacts with a follistatin-like (FS) domain which appears to stabilize Ca2+ binding. The two EF-hands interact canonically but their conserved disulfide bonds confer a tight association between the EF-hand pair and an acid/amphiphilic N-terminal helix. Proposed active form involves a Ca2+ dependent symmetric homodimerization of EC-FS modules. |
| >KOG0040 consensus Ca2+-binding actin-bundling protein (spectrin), alpha chain (EF-Hand protein superfamily) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.6e-07 Score=105.41 Aligned_cols=139 Identities=17% Similarity=0.247 Sum_probs=108.9
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhh-hc-----cHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMR-ES-----RVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~-~~-----~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+.++++++.++..+|..||++.+|.++..+|..+|+.+|+..|. ++ +++.++..+|++.+|+|+..+|+..++.
T Consensus 2245 ~GVtEe~L~EFs~~fkhFDkek~G~Ldhq~F~sCLrslgY~lpmvEe~~~~p~fe~~ld~vDP~r~G~Vsl~dY~afmi~ 2324 (2399)
T KOG0040|consen 2245 NGVTEEQLKEFSMMFKHFDKEKNGRLDHQHFKSCLRSLGYDLPMVEEGEPEPEFEEILDLVDPNRDGYVSLQDYMAFMIS 2324 (2399)
T ss_pred CCCCHHHHHHHHHHHHHhchhhccCCcHHHHHHHHHhcCCCCcccccCCCChhHHHHHHhcCCCCcCcccHHHHHHHHHh
Confidence 35799999999999999999999999999999999999976533 33 6999999999999999999999998776
Q ss_pred chhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCc-c--HHHHHHHHhc----CCCCceeHHHHHHHH
Q 007498 521 THQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGP-S--AYSFLKDWIR----NSDGKLSLHGYTKFL 588 (601)
Q Consensus 521 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~-~--~~~~~~~~d~----~~dG~is~~EF~~~~ 588 (601)
....+-.. .+.++.+|+.+|. |.-||+.+|+..-|.-.. + +..|-..+|. .--+.+.|.+|++.+
T Consensus 2325 ~ETeNI~s--~~eIE~AfraL~a-~~~yvtke~~~~~ltreqaefc~s~m~~~~e~~~~~s~q~~l~y~dfv~sl 2396 (2399)
T KOG0040|consen 2325 KETENILS--SEEIEDAFRALDA-GKPYVTKEELYQNLTREQAEFCMSKMKPYAETSSGRSDQVALDYKDFVNSL 2396 (2399)
T ss_pred cccccccc--hHHHHHHHHHhhc-CCccccHHHHHhcCCHHHHHHHHHHhhhhcccccCCCccccccHHHHHHHH
Confidence 54333222 4588999999998 899999999988552221 1 3333334444 224668999998854
|
|
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.8e-08 Score=80.75 Aligned_cols=71 Identities=18% Similarity=0.229 Sum_probs=58.5
Q ss_pred hHHHHHHHHHHHhhC-CCCCC-cccHHHHHHHHhhcch----hhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 451 EDELVYLRAQFRLLE-PNKDG-SVSLENFRMVLGRNAT----DAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D-~d~~G-~I~~~el~~~l~~~~~----~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
+..+..++++|+.|| .|++| +|+.+||..++..... ......+++.+++.+|.|++|.|+|+||+.++..+
T Consensus 6 e~a~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~l 82 (93)
T cd05026 6 EGAMDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAAL 82 (93)
T ss_pred HHHHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 467888999999999 78998 5999999999976321 12345679999999999999999999998866543
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
| >cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.4e-08 Score=81.47 Aligned_cols=62 Identities=21% Similarity=0.446 Sum_probs=53.4
Q ss_pred HHHHHHHHHHHcc-cC-CCcccHHHHHHHhcC----------Cc-cHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEE-EG-NRVISIEELARELNV----------GP-SAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~-d~-~G~I~~~El~~~l~~----------~~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
...++.+|..||. || +|+|+.+||+.+|.- .. +++.+++.+|.|+||.|+|+||+.+|.+.+
T Consensus 7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I~f~eF~~l~~~~~ 81 (94)
T cd05031 7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKVNFEEFVSLVAGLS 81 (94)
T ss_pred HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 5568899999997 97 699999999998741 11 299999999999999999999999998765
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.5e-08 Score=78.23 Aligned_cols=61 Identities=23% Similarity=0.473 Sum_probs=52.2
Q ss_pred HHHHHHHHHHcc-cC-CCcccHHHHHHHhc----CCc----c-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 532 QIASTAFEYFEE-EG-NRVISIEELARELN----VGP----S-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 532 ~~~~~~F~~~D~-d~-~G~I~~~El~~~l~----~~~----~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
..+..+|.+||. || +|+|+.+||+++|. +.. + ++.+|+.+|.|+||+|+|+||+.+|.++-
T Consensus 10 ~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~l~ 81 (88)
T cd05029 10 GLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGALA 81 (88)
T ss_pred HHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHHH
Confidence 356779999998 77 89999999999993 221 1 99999999999999999999999998763
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif | Back alignment and domain information |
|---|
Probab=98.62 E-value=9.1e-08 Score=77.94 Aligned_cols=71 Identities=13% Similarity=0.143 Sum_probs=60.2
Q ss_pred hHHHHHHHHHHHhhCC--CCCCcccHHHHHHHHhh-cchh---hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 451 EDELVYLRAQFRLLEP--NKDGSVSLENFRMVLGR-NATD---AMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~--d~~G~I~~~el~~~l~~-~~~~---~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
+++++.++++|..||. |++|.|+.+||..+++. ++.. ..+..+++.+++.+|.+++|.|+|+||+.++...
T Consensus 4 ~~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~~~~g~I~f~eF~~~~~~~ 80 (88)
T cd00213 4 EKAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDVNKDGKVDFQEFLVLIGKL 80 (88)
T ss_pred HHHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHH
Confidence 5688899999999999 89999999999999986 4321 1247789999999999999999999998876543
|
Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th |
| >cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.8e-08 Score=73.81 Aligned_cols=58 Identities=21% Similarity=0.250 Sum_probs=50.6
Q ss_pred HHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 535 STAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
+.+|+.+|+|++|.|+.+||+.++ +...+ ++.++..+|.|++|.|+|+||+.+|....
T Consensus 2 ~~~F~~~D~~~~G~i~~~el~~~l~~~g~~~~~~~~i~~~~d~~~~g~i~~~ef~~~~~~~~ 63 (67)
T cd00052 2 DQIFRSLDPDGDGLISGDEARPFLGKSGLPRSVLAQIWDLADTDKDGKLDKEEFAIAMHLIA 63 (67)
T ss_pred hHHHHHhCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence 568999999999999999999988 44333 89999999999999999999999887543
|
The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. |
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=98.61 E-value=9.4e-08 Score=78.49 Aligned_cols=70 Identities=14% Similarity=0.180 Sum_probs=58.7
Q ss_pred hHHHHHHHHHHHhhC-CCCCCc-ccHHHHHHHHhh-cchh---hhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLLE-PNKDGS-VSLENFRMVLGR-NATD---AMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D-~d~~G~-I~~~el~~~l~~-~~~~---~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..++.++++|+.|| .|++|+ |+..||..+|+. ++.. .++..+++.+++.+|.+++|.|+|+||+.++..
T Consensus 5 e~~~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~~ 80 (92)
T cd05025 5 ETAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVAA 80 (92)
T ss_pred HHHHHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 355678999999997 999995 999999999986 5421 246778999999999999999999999876553
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >smart00027 EH Eps15 homology domain | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-07 Score=78.79 Aligned_cols=62 Identities=10% Similarity=0.108 Sum_probs=54.4
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
...++.+|+.||+|++|+|+.+||+.+| ++..+ ++.++..+|.+++|.|+|+||+.+|+.+.
T Consensus 9 ~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~~~~~ 74 (96)
T smart00027 9 KAKYEQIFRSLDKNQDGTVTGAQAKPILLKSGLPQTLLAKIWNLADIDNDGELDKDEFALAMHLIY 74 (96)
T ss_pred HHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcCCCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHH
Confidence 4568899999999999999999999998 33333 89999999999999999999999987654
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. |
| >cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-07 Score=78.45 Aligned_cols=67 Identities=13% Similarity=0.227 Sum_probs=57.5
Q ss_pred HHHHHHHHHHHhhCC-CC-CCcccHHHHHHHHhh-c----chhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 452 DELVYLRAQFRLLEP-NK-DGSVSLENFRMVLGR-N----ATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 452 ~~~~~l~~~F~~~D~-d~-~G~I~~~el~~~l~~-~----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
..+..++++|..||. |+ +|+|+.+||..+++. + +. ..+.++++.+++.+|.+++|.|+|+||+.++.
T Consensus 5 ~~~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~-~~s~~ei~~~~~~~D~~~dg~I~f~eF~~l~~ 78 (94)
T cd05031 5 HAMESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKN-QKDPMAVDKIMKDLDQNRDGKVNFEEFVSLVA 78 (94)
T ss_pred HHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhc-cccHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 456789999999997 97 799999999999986 2 32 45677899999999999999999999987654
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >KOG4251 consensus Calcium binding protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.8e-07 Score=86.30 Aligned_cols=139 Identities=13% Similarity=0.087 Sum_probs=97.6
Q ss_pred HHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhh--hhhccHHHHHhhcccCCCCcccHHHHHHHhh-cchhhhh--
Q 007498 452 DELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDA--MRESRVPDVLSSMESLAYRKMYFEEFCAAAI-STHQLEA-- 526 (601)
Q Consensus 452 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~--~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~-~~~~~~~-- 526 (601)
.-.+.|+.+|.+.|.|.||+|+..|+++++...-... ...++.+..|+..|.|+||.|+|+||..-.. .......
T Consensus 98 rsrrklmviFsKvDVNtDrkisAkEmqrwImektaEHfqeameeSkthFraVDpdgDGhvsWdEykvkFlaskghsekev 177 (362)
T KOG4251|consen 98 RSRRKLMVIFSKVDVNTDRKISAKEMQRWIMEKTAEHFQEAMEESKTHFRAVDPDGDGHVSWDEYKVKFLASKGHSEKEV 177 (362)
T ss_pred HHHHHHHHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHHhhhhhheeeeCCCCCCceehhhhhhHHHhhcCcchHHH
Confidence 3456889999999999999999999999985432111 2244567789999999999999999963322 1111100
Q ss_pred -------hhhHHHHHHHHHHHHcccCCCcccH---------HHHHHHhcCCcc-------HHHHHHHHhcCCCCceeHHH
Q 007498 527 -------LEGWEQIASTAFEYFEEEGNRVISI---------EELARELNVGPS-------AYSFLKDWIRNSDGKLSLHG 583 (601)
Q Consensus 527 -------~~~~~~~~~~~F~~~D~d~~G~I~~---------~El~~~l~~~~~-------~~~~~~~~d~~~dG~is~~E 583 (601)
++-.-++-.+.|..-+++..|..+. +|+-.+|...-. +.+++..+|+|+|..+|..|
T Consensus 178 adairlneelkVDeEtqevlenlkdRwyqaDsppadlllteeEflsFLHPEhSrgmLrfmVkeivrdlDqdgDkqlSvpe 257 (362)
T KOG4251|consen 178 ADAIRLNEELKVDEETQEVLENLKDRWYQADSPPADLLLTEEEFLSFLHPEHSRGMLRFMVKEIVRDLDQDGDKQLSVPE 257 (362)
T ss_pred HHHhhccCcccccHHHHHHHHhhhhhhccccCchhhhhhhHHHHHHHcChHhhhhhHHHHHHHHHHHhccCCCeeecchh
Confidence 0000011244566667777777665 899888843221 88899999999999999999
Q ss_pred HHHHHhh
Q 007498 584 YTKFLHG 590 (601)
Q Consensus 584 F~~~~~~ 590 (601)
|+....+
T Consensus 258 FislpvG 264 (362)
T KOG4251|consen 258 FISLPVG 264 (362)
T ss_pred hhcCCCc
Confidence 9987644
|
|
| >KOG0377 consensus Protein serine/threonine phosphatase RDGC/PPEF, contains STphosphatase and EF-hand domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.2e-07 Score=90.09 Aligned_cols=133 Identities=14% Similarity=0.196 Sum_probs=92.3
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHh-hcccCCCCcccHHHHHHHhhcc---h--hhhhhh
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLS-SMESLAYRKMYFEEFCAAAIST---H--QLEALE 528 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~-~~D~~~~g~i~~~ef~~~~~~~---~--~~~~~~ 528 (601)
.++.+-|+++|.++.|+|+..++..+++..-.-... +..+-. ....+.||.+.|.+.+..+... . ...-.+
T Consensus 464 sdL~~eF~~~D~~ksG~lsis~Wa~~mE~i~~L~LP---Wr~L~~kla~~s~d~~v~Y~~~~~~l~~e~~~~ea~~slve 540 (631)
T KOG0377|consen 464 SDLEDEFRKYDPKKSGKLSISHWAKCMENITGLNLP---WRLLRPKLANGSDDGKVEYKSTLDNLDTEVILEEAGSSLVE 540 (631)
T ss_pred hHHHHHHHhcChhhcCeeeHHHHHHHHHHHhcCCCc---HHHhhhhccCCCcCcceehHhHHHHhhhhhHHHHHHhHHHH
Confidence 356779999999999999999999999875421111 222222 2233467888888765432110 0 000111
Q ss_pred h---HHHHHHHHHHHHcccCCCcccHHHHHHHhc---------CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 529 G---WEQIASTAFEYFEEEGNRVISIEELARELN---------VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 529 ~---~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---------~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
+ -...++.+|+.+|.|++|.|+.+||+.... +... +-++-+.+|.|+||+|++.||+++..-
T Consensus 541 tLYr~ks~LetiF~~iD~D~SG~isldEF~~a~~l~~sh~~~~i~~~~i~~la~~mD~NkDG~IDlNEfLeAFrl 615 (631)
T KOG0377|consen 541 TLYRNKSSLETIFNIIDADNSGEISLDEFRTAWKLLSSHMNGAISDDEILELARSMDLNKDGKIDLNEFLEAFRL 615 (631)
T ss_pred HHHhchhhHHHHHHHhccCCCCceeHHHHHHHHHHHHhhcCCCcCHHHHHHHHHhhccCCCCcccHHHHHHHHhh
Confidence 1 134578899999999999999999999662 2222 778888999999999999999997643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.2e-06 Score=82.59 Aligned_cols=140 Identities=19% Similarity=0.215 Sum_probs=90.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhH------HHHHHHHHHHHHhc--CCCCeeEEe
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI------EDVRREVKILKALS--GHKHLVKFC 217 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~------~~~~~E~~~l~~l~--~h~niv~l~ 217 (601)
..+|.+.+.+-......|.+..- +++.+++|..+.......... ....+++..+.++. +--.++.++
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-----~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-----DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-----CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 35688888888877777777654 567899998754322211111 11345555555553 122333333
Q ss_pred eeEe-----cCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCC
Q 007498 218 DACE-----DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292 (601)
Q Consensus 218 ~~~~-----~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~ 292 (601)
-+.. .....+|||||++|..|.+.. .+++ .+...|..++.-||+.|+.|+|+.|.|++++ ++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~ 171 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIE-----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NN 171 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccch-----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CC
Confidence 3222 223456899999998776542 1333 2445677788999999999999999999996 45
Q ss_pred CeEEeeccccc
Q 007498 293 DMRLIDFGLSD 303 (601)
Q Consensus 293 ~vkl~DFG~a~ 303 (601)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 69999998764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 601 | ||||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-58 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-57 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-56 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-56 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-56 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-55 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-53 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-53 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-53 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-51 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-51 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-50 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-50 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-49 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-49 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-49 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-49 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-49 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-49 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-47 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-46 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-45 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-43 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-43 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-43 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-43 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-43 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-43 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-43 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-43 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-43 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-42 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-42 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-42 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-42 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-42 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-42 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-42 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-42 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-42 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-42 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-42 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-42 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-42 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-42 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-42 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-42 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-41 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-41 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-41 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-41 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-41 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-41 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-41 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-40 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-39 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-39 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-39 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-39 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-38 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-38 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-38 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-38 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-38 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-38 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-38 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-38 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-38 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-38 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-37 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-37 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-37 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-37 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-36 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-36 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-36 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-36 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-36 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-36 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-35 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-35 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-35 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-35 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-35 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-35 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-35 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-35 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-35 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-34 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-34 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-34 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-34 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-34 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-34 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-34 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-34 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-34 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-34 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-34 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-34 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-34 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-34 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-33 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-33 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-33 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-33 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-33 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-33 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-32 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-32 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-32 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-32 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-32 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-32 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-32 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-32 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-32 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-32 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-32 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-32 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-32 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-32 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-32 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-32 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-32 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-32 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-32 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-32 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-32 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-31 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-31 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-31 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-31 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-31 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-31 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-31 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-31 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-31 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-31 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-31 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-31 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-31 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-31 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-31 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-31 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-31 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-31 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-30 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-30 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-30 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-30 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-29 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-29 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-29 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-29 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-29 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-29 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-29 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-28 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-28 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-28 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-28 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-28 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-28 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-28 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-28 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-28 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-28 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-28 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-28 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-28 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-28 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-28 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-28 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-28 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-28 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-28 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-28 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-28 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-28 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-28 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-27 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-27 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-27 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-26 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-26 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-26 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-26 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-25 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-25 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-25 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-25 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-25 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-25 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-25 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-25 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-25 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-25 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-25 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-25 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-25 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-25 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-25 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-25 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-25 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-25 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-25 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-25 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-25 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-25 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-25 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-25 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-25 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-24 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-24 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-24 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-24 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-24 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-24 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-24 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-24 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-24 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-24 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-24 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-24 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-24 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-24 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-24 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-24 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-24 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-24 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-24 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-24 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-24 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-24 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-24 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-24 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-24 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-24 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-24 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-24 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-24 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-24 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-24 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-24 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-24 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-24 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-24 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-24 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-24 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-24 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-24 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-24 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-24 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-24 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-24 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-24 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-24 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-24 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-24 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-24 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-24 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-24 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-24 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-24 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-24 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-24 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-24 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-24 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-24 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-24 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-24 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-24 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-24 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-24 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-23 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-23 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-23 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-23 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-23 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-23 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-23 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-23 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-23 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-23 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-23 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-23 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-23 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-23 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-23 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-23 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-23 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-22 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-22 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-22 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-22 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-22 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-22 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-22 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-22 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-22 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-22 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-22 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-22 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-22 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-22 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-22 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-22 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-22 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-22 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-22 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-22 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-22 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-22 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-22 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-22 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-22 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-22 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-22 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-22 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-22 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-22 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-22 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-22 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-22 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-22 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-22 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-22 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-22 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-22 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-22 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-22 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-22 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-22 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-22 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-22 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-22 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-22 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-21 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-21 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-21 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-21 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-21 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-21 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-21 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-21 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-21 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-21 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-21 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-21 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-21 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-21 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-21 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-21 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-21 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-21 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-21 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-21 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-21 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-21 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-21 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-21 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-21 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-21 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-21 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-21 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-21 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-21 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-21 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-21 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-21 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-21 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-21 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-21 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-21 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-21 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-21 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-21 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-21 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-21 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-21 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-21 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-21 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-21 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-21 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-21 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-21 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-21 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-21 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-21 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-21 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-21 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-21 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-21 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-21 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-21 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-21 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-21 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-21 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-21 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-21 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-21 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-21 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-21 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-21 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-21 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-20 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-20 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-20 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-20 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-20 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-20 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 8e-20 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-19 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-19 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-19 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-19 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-19 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-19 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-19 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-19 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-19 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-19 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-19 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-19 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-19 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-19 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-19 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-19 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-19 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-19 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-19 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-19 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-19 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-19 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-19 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-19 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-19 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-19 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-19 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-19 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-19 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-18 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-18 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-18 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-18 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-18 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-18 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-18 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-18 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-18 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-18 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-18 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-17 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-16 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-16 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-15 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-15 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-15 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-15 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 3e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-12 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 3e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-11 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-10 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-10 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-10 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 7e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-10 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 7e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-10 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 8e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-09 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-08 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 7e-08 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 9e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-07 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 3e-07 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 3e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-07 |
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 576 bits (1487), Expect = 0.0
Identities = 136/507 (26%), Positives = 230/507 (45%), Gaps = 39/507 (7%)
Query: 117 KPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQ 176
+E+ + P + K G G Y +++G G +G + K G
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEG---KIGESYFKVRKLGSGAYGEVLLCKEKNG---HS 62
Query: 177 QVAVKIISKAKMTTAISI----------EDVRREVKILKALSGHKHLVKFCDACEDVNNV 226
+ A+K+I K++ E++ E+ +LK+L H +++K D ED
Sbjct: 63 EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLFDVFEDKKYF 121
Query: 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT 286
Y+V E EGGEL ++I+ R ++ E DA I+ QILS + + H +VHRD+KPEN L
Sbjct: 122 YLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLE 180
Query: 287 SGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYIL 346
+ +++++DFGLS F D +L D +G+AYY+APEVL + Y+ + D+WS GVI YIL
Sbjct: 181 NKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYIL 240
Query: 347 LCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
LCG PF + + I + V + FD W ++S EAK+ +K +L DY KR TA +AL
Sbjct: 241 LCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300
Query: 407 THPWLRDDSRPV-----PLDILIFKLVKSYLHATPFKRAALKALSKALTE-DELVYLRAQ 460
W++ + + ++ + + +AA+ + LT +E L
Sbjct: 301 NSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDI 360
Query: 461 FRLLEPNKDGSVSLENFRMVLGR-------NATDAMRESRVPDVLSSMESLAYRKMYFEE 513
F+ L+ N DG + + E V ++L ++ + + E
Sbjct: 361 FKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSE 420
Query: 514 FCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIR 573
F + + L E+ AF F+ + + I+ EELA + + D +
Sbjct: 421 FISVCMDKQILF----SEERLRRAFNLFDTDKSGKITKEELANLFGLTSISEKTWNDVLG 476
Query: 574 ----NSDGKLSLHGYTKFLHGVTLRSS 596
N D + + +H + +
Sbjct: 477 EADQNKDNMIDFDEFVSMMHKICDHKT 503
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 574 bits (1481), Expect = 0.0
Identities = 144/485 (29%), Positives = 238/485 (49%), Gaps = 36/485 (7%)
Query: 134 SLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS 193
S ++ + F +Y + +G+G FG + + Q+ AVK+I+KA
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNK-D 64
Query: 194 IEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED 253
+ REV++LK L H +++K + ED ++ YIV EL GGEL D I+ R R++E D
Sbjct: 65 TSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHD 122
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
A I+ Q+ S + + H +VHRDLKPEN L S D D+++IDFGLS + + ++ D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 314 IVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373
+G+AYY+APEVL +Y + D+WS GVI YILL G+ PF+ + E I + V FD
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR------PVPLDILIFKL 427
W ++S +AKD ++++L R+TA Q L HPW++ S +P
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTN 302
Query: 428 VKSYLHATPFKRAALKALSKALTE-DELVYLRAQFRLLEPNKDGSVSLENFRMVLGR--- 483
++ + +AAL ++ LT DE L FR L+ N DG + +
Sbjct: 303 IRQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMR 362
Query: 484 ----------NATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533
+ E ++ ++ ++ + + EF A+AI L + E E+
Sbjct: 363 LKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAIDRTILLSRERMER- 421
Query: 534 ASTAFEYFEEEGNRVISIEELARELNVGPSAYS------FLKDWIRNSDGKLSLHGYTKF 587
AF+ F+++G+ IS +EL + + S+ ++ N DG++ + + +
Sbjct: 422 ---AFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDNNKDGEVDFNEFVEM 478
Query: 588 LHGVT 592
L
Sbjct: 479 LQNFV 483
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 568 bits (1465), Expect = 0.0
Identities = 146/472 (30%), Positives = 242/472 (51%), Gaps = 28/472 (5%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
+ Y+ K++G G +G R K + A+KII K ++T+ S + EV
Sbjct: 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVT---HVERAIKIIRKTSVSTS-SNSKLLEEV 87
Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
+LK L H +++K D ED N Y+VME +GGEL D I+ R ++ E DA I+ Q+
Sbjct: 88 AVLKLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQV 145
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
LS V + H +VHRDLKPEN L S DA ++++DFGLS +++ + +G+AYY+
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 322 APEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
APEVL + Y + D+WSIGVI +ILL G PF +T+ I R V + FD W +VS
Sbjct: 206 APEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR------PVPLDILIFKLVKSYLHAT 435
AKD +K++L D ++R++A QAL HPW+++ +P + ++ + ++
Sbjct: 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQ 325
Query: 436 PFKRAALKALSKAL-TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMR---- 490
+AAL ++ L +++E L FR ++ N DG + + + + + +
Sbjct: 326 KLAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDL 385
Query: 491 ---ESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNR 547
ES V +L + + + + EF A+ L + + E AF+ F+++GN
Sbjct: 386 PQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLLSKDKLES----AFQKFDQDGNG 441
Query: 548 VISIEELARELNVGPSAYSFLKDWIR----NSDGKLSLHGYTKFLHGVTLRS 595
IS++ELA + K+ I N+DG + + K + + +
Sbjct: 442 KISVDELASVFGLDHLESKTWKEMISGIDSNNDGDVDFEEFCKMIQKLCSNN 493
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 565 bits (1458), Expect = 0.0
Identities = 145/471 (30%), Positives = 229/471 (48%), Gaps = 29/471 (6%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
F +Y+ + +G+G FG + K Q+ AVK+ISK ++ E + REV
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREV 77
Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
++LK L H +++K + ED Y+V E+ GGEL D I++R R++E DA I+ Q+
Sbjct: 78 QLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQV 135
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
LS + + H +VHRDLKPEN L S DA++R+IDFGLS +++ D +G+AYY+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195
Query: 322 APEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
APEVLH +Y + D+WS GVI YILL G PF E I + V + F+ W VS
Sbjct: 196 APEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR-----PVPLDILIFKLVKSYLHATP 436
AKD ++++L R++A AL H W++ ++ VP ++ +
Sbjct: 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQK 315
Query: 437 FKRAALKALSKAL-TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGR----------NA 485
+AAL + L ++DE L A F ++ N DG +
Sbjct: 316 LAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASML 375
Query: 486 TDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEG 545
+ E V VL +++ + + EF A+ L + E E+ AF F+ +
Sbjct: 376 DASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRERLER----AFRMFDSDN 431
Query: 546 NRVISIEELARELNVGP----SAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592
+ IS ELA V + S L + +N+DG++ + + L +
Sbjct: 432 SGKISSTELATIFGVSDVDSETWKSVLSEVDKNNDGEVDFDEFQQMLLKLC 482
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 452 bits (1164), Expect = e-156
Identities = 109/367 (29%), Positives = 165/367 (44%), Gaps = 22/367 (5%)
Query: 57 HPSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGG 116
H S + + + P RR F R + AK+L
Sbjct: 7 HSSGVDNKFNKERRRARREI--RHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA 64
Query: 117 KPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQ 176
+PK + + PE L + K F KY+ +GRG +
Sbjct: 65 QPKGTENLYFQSMGPEDEL-PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA---TGH 120
Query: 177 QVAVKIISKAKMTTAIS-----IEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
+ AVKI+ + E RRE IL+ ++GH H++ D+ E + +++V +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180
Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
L GEL D + + +E++ ++I+ +L V+F H +VHRDLKPEN L D+
Sbjct: 181 LMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDN 236
Query: 292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-------HRSYSLEADIWSIGVISY 344
+RL DFG S + P E+L ++ G+ Y+APE+L H Y E D+W+ GVI +
Sbjct: 237 MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296
Query: 345 ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
LL GS PFW R + + R ++ F W S KD + RLL D R+TA Q
Sbjct: 297 TLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356
Query: 405 ALTHPWL 411
AL HP+
Sbjct: 357 ALQHPFF 363
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 450 bits (1161), Expect = e-155
Identities = 107/418 (25%), Positives = 188/418 (44%), Gaps = 26/418 (6%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
F +Y+L +E+G+G F Q+ A II+ K++ + + RE +
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKLSA-RDHQKLEREAR 62
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
I + L H ++V+ D+ + + Y++ +L GGEL + I+AR Y+E DA + QIL
Sbjct: 63 ICRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQIL 120
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYV 321
V CH GVVHR+LKPEN L S A ++L DFGL+ + + G+ Y+
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180
Query: 322 APEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
+PEVL + Y D+W+ GVI YILL G PFW + +++ + +F W +V
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240
Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR--PVPLDILIFKLVKSYLHATPFK 438
+PEAKD + ++L + KR+TA +AL HPW+ S +K + K
Sbjct: 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLK 300
Query: 439 RAALK--ALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPD 496
A L ++ + + ++ +L+E +G + A + +
Sbjct: 301 GAILTVMLATRNFSVRKQEIIKVTEQLIEAISNGDFESY---TKMCDPGMTAFEPEALGN 357
Query: 497 VLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEEL 554
++ ++ F F + + + + I + + + + I+ +
Sbjct: 358 LVEGLD--------FHRFYFENLWSRNSKPVH--TTILN-PHIHLMGDESACIAYIRI 404
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 445 bits (1147), Expect = e-154
Identities = 83/327 (25%), Positives = 149/327 (45%), Gaps = 12/327 (3%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
K KY + +++GRG FG + K + V++E+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKGT----DQVLVKKEIS 53
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
IL H++++ ++ E + + ++ E G ++ +RI E + + V Q+
Sbjct: 54 ILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
+ F H + H D++PEN ++ + R + +++I+FG + ++P + + + Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
PEV H S D+WS+G + Y+LL G PF A T I ++ ++ FD+ + +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHATPFKRAA 441
EA DFV RLL K+ + RMTA +AL HPWL+ V ++ + Y H +
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT--LIKKD 289
Query: 442 LKALSKALTEDELVYLRAQFRLLEPNK 468
L + A +R+Q +
Sbjct: 290 LNMVVSAARISCGGAIRSQKGVSVAKV 316
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 443 bits (1141), Expect = e-154
Identities = 107/286 (37%), Positives = 163/286 (56%), Gaps = 6/286 (2%)
Query: 131 PEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT 190
S ++ + F +Y + +G+G FG + + Q+ AVK+I+KA
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKN 62
Query: 191 AISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYT 250
+ REV++LK L H +++K + ED ++ YIV EL GGEL D I+ R R++
Sbjct: 63 K-DTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFS 119
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
E DA I+ Q+ S + + H +VHRDLKPEN L S D D+++IDFGLS + + +
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
Query: 311 LNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP 370
+ D +G+AYY+APEVL +Y + D+WS GVI YILL G+ PF+ + E I + V
Sbjct: 180 MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
Query: 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416
FD W ++S +AKD ++++L R+TA Q L HPW++ S
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 442 bits (1139), Expect = e-154
Identities = 104/280 (37%), Positives = 162/280 (57%), Gaps = 8/280 (2%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
+ Y L +GRG +G A K + A K I K + ++ ++E++I
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGT---RIRRAAKKIPKYFVE---DVDRFKQEIEI 59
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
+K+L H ++++ + ED ++Y+VMELC GGEL +R++ + + E DA I+ +LS
Sbjct: 60 MKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLS 117
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAP 323
VA+CH V HRDLKPENFLF + D+ ++LIDFGL+ +P + + VG+ YYV+P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
Query: 324 EVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
+VL Y E D WS GV+ Y+LLCG PF A T+S + + F + W +VSP+
Sbjct: 178 QVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237
Query: 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDIL 423
A+ ++RLL K ++R+T++QAL H W P ++L
Sbjct: 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNLL 277
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 438 bits (1129), Expect = e-152
Identities = 92/286 (32%), Positives = 156/286 (54%), Gaps = 10/286 (3%)
Query: 131 PEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT 190
S ++ + + +++G G FG + + +K I+K +
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRS-- 60
Query: 191 AISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GG 247
+ +E + E+++LK+L H +++K + ED +N+YIVME CEGGELL+RI++ G
Sbjct: 61 QVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK 119
Query: 248 RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307
+E ++ Q+++ +A+ H Q VVH+DLKPEN LF + +++IDFGL++ +
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
Query: 308 DERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR 367
DE + G+A Y+APEV R + + DIWS GV+ Y LL G PF + + +
Sbjct: 180 DEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
+PN+ P ++P+A D +K++L KD +R +A Q L H W +
Sbjct: 240 KEPNYAVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 424 bits (1091), Expect = e-145
Identities = 96/332 (28%), Positives = 155/332 (46%), Gaps = 14/332 (4%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT--AISIEDVRR 199
+ F YEL + +G+G F ++ QQ AVKI+ AK T+ +S ED++R
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKR 75
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG---GRYTEEDAKA 256
E I L H H+V+ + +Y+V E +G +L I+ R Y+E A
Sbjct: 76 EASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIV 315
+ QIL + +CH ++HRD+KP L S + A ++L FG++ V
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 316 GSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374
G+ +++APEV+ R Y D+W GVI +ILL G PF+ T+ +F +++ +
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNP 253
Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR--PVPLDILIFKLVKSYL 432
W +S AKD V+R+L D +R+T +AL HPWL++ R + ++ +
Sbjct: 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFN 313
Query: 433 HATPFKRAALKALSKALTEDELVYLRAQFRLL 464
K A L A+S +
Sbjct: 314 ARRKLKGAVLAAVSSHKFNSFYGDPPEELPDF 345
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 419 bits (1080), Expect = e-144
Identities = 106/361 (29%), Positives = 172/361 (47%), Gaps = 14/361 (3%)
Query: 118 PKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQ 177
P +++ G + + + + F Y++ +E+G+G F K +
Sbjct: 2 PHMASMTG--GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTG---LE 56
Query: 178 VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGE 237
A KII+ K++ A + + RE +I + L H ++V+ D+ ++ + Y+V +L GGE
Sbjct: 57 FAAKIINTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGE 114
Query: 238 LLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297
L + I+AR Y+E DA + QIL +A+CH G+VHR+LKPEN L S A ++L
Sbjct: 115 LFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWAR 356
DFGL+ + E + G+ Y++PEVL + YS DIW+ GVI YILL G PFW
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233
Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416
+ ++ + ++ W +V+PEAK + +L + +KR+TA QAL PW+ + R
Sbjct: 234 DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293
Query: 417 --PVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSL 474
+K + K A L + L + S
Sbjct: 294 VASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSN---LGRNLLNKKEQGPPSTIK 350
Query: 475 E 475
E
Sbjct: 351 E 351
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 415 bits (1069), Expect = e-143
Identities = 97/278 (34%), Positives = 152/278 (54%), Gaps = 7/278 (2%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
F Y++ +E+G+G F K + A KII+ K++ A + + RE +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTT---GLEFAAKIINTKKLS-ARDFQKLEREAR 57
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
I + L H ++V+ D+ ++ + Y+V +L GGEL + I+AR Y+E DA + QIL
Sbjct: 58 ICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQIL 115
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
+A+CH G+VHR+LKPEN L S A ++L DFGL+ + E + G+ Y++
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLS 175
Query: 323 PEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
PEVL + YS DIW+ GVI YILL G PFW + ++ + ++ W +V+
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419
PEAK + +L + +KR+TA QAL PW+ + R
Sbjct: 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS 273
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 404 bits (1041), Expect = e-138
Identities = 82/307 (26%), Positives = 148/307 (48%), Gaps = 12/307 (3%)
Query: 142 NKNFGAKYEL-GKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRR 199
+NF Y L KE+GRG F K G Q+ A K + K + ++
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTG----QEYAAKFLKKRRRG-QDCRAEILH 77
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIV 258
E+ +L+ ++ + E+ + + +++E GGE+ L +E D ++
Sbjct: 78 EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLI 137
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
QIL V + H +VH DLKP+N L +S D++++DFG+S I L +I+G+
Sbjct: 138 KQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 319 YYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
Y+APE+L+ + D+W+IG+I+Y+LL + PF + + + + ++ + +
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF 257
Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD---DSRPVPLDILIFKLVKSYLHA 434
SVS A DF++ LL K+ KR TA L+H WL+ ++ P + + +
Sbjct: 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVR 317
Query: 435 TPFKRAA 441
+ + +
Sbjct: 318 SSEDKTS 324
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 403 bits (1037), Expect = e-138
Identities = 93/285 (32%), Positives = 141/285 (49%), Gaps = 20/285 (7%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISI------ED 196
F YE + +GRG K ++ AVKII + + E
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 197 VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA 256
+EV IL+ +SGH ++++ D E ++V +L + GEL D + + +E++ +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRK 128
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
I+ +L V+ H +VHRDLKPEN L DD +++L DFG S + P E+L ++ G
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCG 185
Query: 317 SAYYVAPEVL-------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
+ Y+APE++ H Y E D+WS GVI Y LL GS PFW R + + R ++ +
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245
Query: 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414
F W S KD V R L +KR TA +AL HP+ +
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 402 bits (1034), Expect = e-137
Identities = 111/349 (31%), Positives = 168/349 (48%), Gaps = 15/349 (4%)
Query: 97 PPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVG 156
S +L + S P P+ +D S +E+ E+G
Sbjct: 6 HHSSGVDLGTENLYFQ-SMSSVTASAAPGTASLVPDYWIDGS--NRDALSDFFEVESELG 62
Query: 157 RGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKF 216
RG + K + A+K++ K + VR E+ +L LS H +++K
Sbjct: 63 RGATSIVYRCKQKG---TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKL 113
Query: 217 CDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHR 276
+ E + +V+EL GGEL DRI+ +G Y+E DA V QIL VA+ H G+VHR
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 277 DLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEAD 335
DLKPEN L+ + DA +++ DFGLS + + + G+ Y APE+L +Y E D
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVD 232
Query: 336 IWSIGVISYILLCGSRPFWART-ESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNK 394
+WS+G+I+YILLCG PF+ + +FR +L + F W VS AKD V++L+
Sbjct: 233 MWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292
Query: 395 DYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHATPFKRAALK 443
D +KR+T QAL HPW+ + K ++ + K A
Sbjct: 293 DPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNARRKLKAAVKA 341
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 398 bits (1024), Expect = e-136
Identities = 96/278 (34%), Positives = 155/278 (55%), Gaps = 10/278 (3%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT---AISIEDVRRE 200
YE+G+E+G G F R K ++ A K I K ++++ +S E++ RE
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIERE 58
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
V IL+ + H +++ D E+ +V +++EL GGEL D + + TE++A + Q
Sbjct: 59 VNILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQ 116
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
IL V + H + + H DLKPEN + + ++LIDFG++ I +I G+
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE 176
Query: 320 YVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
+VAPE+++ LEAD+WSIGVI+YILL G+ PF T+ + + +FD+ +
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416
+ S AKDF++RLL KD ++RMT Q+L H W++ R
Sbjct: 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 408 bits (1049), Expect = e-136
Identities = 105/420 (25%), Positives = 174/420 (41%), Gaps = 26/420 (6%)
Query: 82 PARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGY 141
P + P P + ++ GK S+ + + +
Sbjct: 93 PCEPTAPVL---IPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 142 NK--NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR 199
K + Y++ +E+G G FG + A K + + E VR+
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHES---DKETVRK 203
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
E++ + L H LV DA ED N + ++ E GGEL +++ + +E++A +
Sbjct: 204 EIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR 262
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
Q+ + H VH DLKPEN +FT+ + +++LIDFGL+ + P + + G+A
Sbjct: 263 QVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 321
Query: 320 YVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
+ APEV + D+WS+GV+SYILL G PF + R V D N DD +
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 381
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP---VPLDILIFKLVKSYLH-- 433
+S + KDF+++LL D RMT QAL HPWL + P + + ++ +
Sbjct: 382 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTK 441
Query: 434 -------ATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNAT 486
P R + + + E A + E V + G++A
Sbjct: 442 YDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVGEGQSAN 501
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-134
Identities = 107/333 (32%), Positives = 162/333 (48%), Gaps = 20/333 (6%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTT---AISIEDV 197
+N Y+ G+E+G G F R K G Q A K I K + + +S ED+
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTG----LQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
REV ILK + H +++ + E+ +V +++EL GGEL D + + TEE+A
Sbjct: 62 EREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEF 119
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFGLSDFIRPDERLNDIVG 316
+ QIL+ V + H + H DLKPEN + +++IDFGL+ I +I G
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 317 SAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
+ +VAPE+++ LEAD+WSIGVI+YILL G+ PF T+ V + F+D
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 239
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHAT 435
+ + S AKDF++RLL KD +KRMT +L HPW++ L +
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKF--- 296
Query: 436 PFKRAALKALSKALTEDELVYLRAQFRLLEPNK 468
K+ A + S + L F +
Sbjct: 297 --KKFAARKKSNNGSGGG---LNDIFEAQKIEW 324
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 397 bits (1021), Expect = e-134
Identities = 106/403 (26%), Positives = 168/403 (41%), Gaps = 36/403 (8%)
Query: 81 SPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFG 140
S ++ +P F P PPP P P + P +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPH--------PPAQPPPPPPQQFPQFHVKSGLQI 54
Query: 141 YNKNFGAKYEL-GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR 199
Y++ + +G G G K+ ++ A+K++ RR
Sbjct: 55 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQD--------CPKARR 103
Query: 200 EVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGR-YTEEDA 254
EV++ S H+V+ D E++ + IVME +GGEL RI RG + +TE +A
Sbjct: 104 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 163
Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI 314
I+ I + + H + HRD+KPEN L+TS R +A ++L DFG + L
Sbjct: 164 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 223
Query: 315 VGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSD 369
+ YYVAPEVL Y D+WS+GVI YILLCG PF++ G+ +
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283
Query: 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR--PVPLDILIFKL 427
F + W VS E K ++ LL + +RMT + + HPW+ ++ PL L
Sbjct: 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR-VL 342
Query: 428 VKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDG 470
+ K AL+ + E + + ++ + +
Sbjct: 343 KEDKERWEDVKEEMTSALATMRVDYEQIKI---KKIEDASNPL 382
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 393 bits (1011), Expect = e-133
Identities = 97/368 (26%), Positives = 160/368 (43%), Gaps = 20/368 (5%)
Query: 117 KPKESTIPEERGTEPEQSLDKSFGY------NKNFGAKYELGKEVGRGHFGHTCSARGKK 170
+ K + + + K + + Y++ +E+G G FG K
Sbjct: 15 RGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKA 74
Query: 171 GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVM 230
+ K I+ + V+ E+ I+ L H L+ DA ED + +++
Sbjct: 75 TG---RVFVAKFINTPYP---LDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLIL 127
Query: 231 ELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290
E GGEL DRI A + +E + + Q + H +VH D+KPEN + + +
Sbjct: 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KK 186
Query: 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCG 349
+ +++IDFGL+ + PDE + +A + APE++ R D+W+IGV+ Y+LL G
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
Query: 350 SRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
PF + + V R D FD+ + SVSPEAKDF+K LL K+ RKR+T AL HP
Sbjct: 247 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306
Query: 410 WLRDDSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKD 469
WL+ D + I + K K + + + + ++
Sbjct: 307 WLKGDHSNLTSRIPSSRYNKIRQK---IKEKYADWPAPQPAIGRIANFSSLRKHR--PQE 361
Query: 470 GSVSLENF 477
+ F
Sbjct: 362 YQIYDSYF 369
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 388 bits (997), Expect = e-131
Identities = 94/344 (27%), Positives = 155/344 (45%), Gaps = 54/344 (15%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
+ ++L G KY L +G+G +G A + A+KI++
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTR---AIRAIKIMN 60
Query: 185 KAKM--TTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI 242
K K+ +E ++ EV+++K L H ++ + + ED + +VMELC GG LLD++
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKL 119
Query: 243 LARGGR---------------------------------------YTEEDAKAIVVQILS 263
E+ I+ QI S
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-----DERLNDIVGSA 318
+ + H QG+ HRD+KPENFLF++ +++L+DFGLS + G+
Sbjct: 180 ALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 319 YYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
Y+VAPEVL+ SY + D WS GV+ ++LL G+ PF ++ VL F++
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP 298
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419
+ +SP A+D + LLN++ +R A++AL HPW+ S +
Sbjct: 299 NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIY 342
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-130
Identities = 103/364 (28%), Positives = 166/364 (45%), Gaps = 13/364 (3%)
Query: 67 HGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEE 126
H S L + ++ + R A L +R+ + S + +
Sbjct: 7 HHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWS-NADLTERMPVKSKRTSALAVD 65
Query: 127 RGTEPEQSLDKSFGYNK-NFGAKYELGK--EVGRGHFGHTCSARGKKGELKDQQVAVKII 183
P + + + Y + K +G G FG ++A KII
Sbjct: 66 IPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETAT---GLKLAAKII 122
Query: 184 SKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRIL 243
M E+V+ E+ ++ L H +L++ DA E N++ +VME +GGEL DRI+
Sbjct: 123 KTRGMK---DKEEVKNEISVMNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178
Query: 244 ARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303
TE D + QI + H ++H DLKPEN L + RD +++IDFGL+
Sbjct: 179 DESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLAR 237
Query: 304 FIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIF 362
+P E+L G+ ++APEV++ S D+WS+GVI+Y+LL G PF ++
Sbjct: 238 RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL 297
Query: 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDI 422
+L + +D + +S EAK+F+ +LL K+ R++A +AL HPWL D L
Sbjct: 298 NNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSA 357
Query: 423 LIFK 426
K
Sbjct: 358 QKKK 361
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-129
Identities = 108/333 (32%), Positives = 167/333 (50%), Gaps = 36/333 (10%)
Query: 142 NKNFGAKYELG---KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR 198
+ F Y+L K +G G F KK +Q AVKIISK + +
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKRME------ANTQ 53
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
+E+ LK GH ++VK + D + ++VMEL GGEL +RI + ++E +A I+
Sbjct: 54 KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK-HFSETEASYIM 112
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGS 317
+++S V+ H GVVHRDLKPEN LFT D+ ++++IDFG + PD + L +
Sbjct: 113 RKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172
Query: 318 AYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTES-------GIFRAVLRSD 369
+Y APE+L+++ Y D+WS+GVI Y +L G PF + S I + + + D
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
Query: 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD----SRPVPLDILIF 425
+F+ W +VS EAKD ++ LL D KR+ + WL+D S P+ ++
Sbjct: 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILG 292
Query: 426 K---LVKSYLHAT-----PFKRAALK--ALSKA 448
V + + AT +KR + KA
Sbjct: 293 SSGAAVHTCVKATFHAFNKYKREGFCLQNVDKA 325
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 378 bits (972), Expect = e-128
Identities = 92/311 (29%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 141 YNKNFGAKYELGKEV-GRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR 199
++ F Y+L ++V G G + Q+ AVKII K V R
Sbjct: 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQPGH---IRSRVFR 59
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
EV++L GH+++++ + E+ + Y+V E GG +L I R + E +A +V
Sbjct: 60 EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQ 118
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI----- 314
+ S + F H +G+ HRDLKPEN L + +++ DF L I+ + + I
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 315 ---VGSAYYVAPEVL------HRSYSLEADIWSIGVISYILLCGSRPFWAR--------- 356
GSA Y+APEV+ Y D+WS+GVI YILL G PF R
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238
Query: 357 ------TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
++ +F ++ F D W +S AKD + +LL +D ++R++A Q L HPW
Sbjct: 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298
Query: 411 LRDDSRPVPLD 421
++ + L
Sbjct: 299 VQGCAPENTLP 309
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-128
Identities = 97/314 (30%), Positives = 156/314 (49%), Gaps = 16/314 (5%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTT---AISIEDV 197
+ Y++G+E+G G F R K G + A K I K + +S E++
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTG----LEYAAKFIKKRQSRASRRGVSREEI 62
Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
REV IL+ + H +++ D E+ +V +++EL GGEL D + + +EE+A +
Sbjct: 63 EREVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSF 120
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD-ADMRLIDFGLSDFIRPDERLNDIVG 316
+ QIL V + H + + H DLKPEN + ++LIDFGL+ I +I G
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180
Query: 317 SAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
+ +VAPE+++ LEAD+WSIGVI+YILL G+ PF T+ + +FD+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHAT 435
+ S AKDF+++LL K+ RKR+T +AL HPW+ + +
Sbjct: 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFR-- 298
Query: 436 PFKRAALKALSKAL 449
K+ + +
Sbjct: 299 --KQYVRRRWKLSF 310
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 375 bits (965), Expect = e-126
Identities = 101/343 (29%), Positives = 164/343 (47%), Gaps = 19/343 (5%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTT---AISIEDV 197
+ Y++G+E+G G F R K G + A K I K + + E++
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTG----LEYAAKFIKKRQSRASRRGVCREEI 62
Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
REV IL+ + H +++ D E+ +V +++EL GGEL D + + +EE+A +
Sbjct: 63 EREVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSF 120
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFGLSDFIRPDERLNDIVG 316
+ QIL V + H + + H DLKPEN + ++LIDFGL+ I +I G
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180
Query: 317 SAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
+ +VAPE+++ LEAD+WSIGVI+YILL G+ PF T+ + +FD+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHAT 435
+ S AKDF+++LL K+ RKR+T +AL HPW+ + +
Sbjct: 241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFK-- 298
Query: 436 PFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFR 478
K+ + + + +V L K + E+ R
Sbjct: 299 --KQYVRRRWKLSFS---IVSLCNHLTRSLMKKVHLRTSEDLR 336
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 372 bits (958), Expect = e-126
Identities = 105/323 (32%), Positives = 157/323 (48%), Gaps = 20/323 (6%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-----AISIE 195
Y K +Y + K +G G G A +K ++VA+KIISK K A
Sbjct: 4 YPKALRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIKIISKRKFAIGSAREADPAL 60
Query: 196 DVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK 255
+V E++ILK L+ H ++K + + + YIV+EL EGGEL D+++ R E K
Sbjct: 61 NVETEIEILKKLN-HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK-RLKEATCK 117
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
Q+L V + H G++HRDLKPEN L +S +D +++ DFG S + + +
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 316 GSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDP 370
G+ Y+APEVL Y+ D WS+GVI +I L G PF RT+ + +
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKS 430
NF W VS +A D VK+LL D + R T +AL HPWL+D+ + L+
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE----DMKRKFQDLLSE 293
Query: 431 YLHATPFKRAALKALSKALTEDE 453
+T + + + E
Sbjct: 294 ENESTALPQVLAQPSTSRKRPRE 316
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-125
Identities = 103/322 (31%), Positives = 156/322 (48%), Gaps = 25/322 (7%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
+ F YE+ +++G G + K + + AVKII K+K D E+
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSK-------RDPTEEI 66
Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
+IL H +++ D +D VY+V EL +GGELLD+IL + ++E +A A++ I
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTI 125
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM-RLIDFGLSDFIRPDER-LNDIVGSAY 319
V + H QGVVHRDLKP N L+ + + R+ DFG + +R + L +A
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 320 YVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWAR---TESGIFRAVLRSDPNFDDL 375
+VAPEVL R Y DIWS+GV+ Y +L G PF T I + +
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR--PVPLDILIFK-LVKSYL 432
W SVS AKD V ++L+ D +R+TA L HPW+ + L+ LVK +
Sbjct: 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAM 305
Query: 433 HAT-----PFKRAALKALSKAL 449
AT + L+ + ++
Sbjct: 306 AATYSALNRNQSPVLEPVGRST 327
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-125
Identities = 102/319 (31%), Positives = 150/319 (47%), Gaps = 28/319 (8%)
Query: 142 NKNFGAKYELGKEV-GRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
Y+L K+V G G G ++ Q+ A+K++ + R+E
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRR---TGQKCALKLLYDSP--------KARQE 71
Query: 201 VKILKALSGHKHLVKFCDACEDVNN----VYIVMELCEGGELLDRILARG-GRYTEEDAK 255
V SG H+V D E++++ + I+ME EGGEL RI RG +TE +A
Sbjct: 72 VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA 131
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
I+ I + + F H + HRD+KPEN L+TS DA ++L DFG + + L
Sbjct: 132 EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPC 190
Query: 316 GSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTES----GIFRAVLRSDP 370
+ YYVAPEVL Y D+WS+GVI YILLCG PF++ T G+ R +
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250
Query: 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP--VPLDIL-IFKL 427
F + W VS +AK ++ LL D +R+T Q + HPW+ PL + +
Sbjct: 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQE 310
Query: 428 VKSYLHATPFKRAALKALS 446
K + K AL+
Sbjct: 311 DKDHWDEV--KEEMTSALA 327
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 364 bits (937), Expect = e-123
Identities = 89/317 (28%), Positives = 134/317 (42%), Gaps = 45/317 (14%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
N + +G G G K+ ++ A+K++ RREV
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQD--------CPKARREV 61
Query: 202 KILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARG-GRYTEEDAKA 256
++ S H+V+ D E++ + IVME +GGEL RI RG +TE +A
Sbjct: 62 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 121
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
I+ I + + H + HRD+KPEN L+TS R +A ++L DFG
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------- 166
Query: 317 SAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSDPNF 372
A E Y D+WS+GVI YILLCG PF++ G+ + F
Sbjct: 167 -----AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221
Query: 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR--PVPLDIL-IFKLVK 429
+ W VS E K ++ LL + +RMT + + HPW+ ++ PL + K K
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK 281
Query: 430 SYLHATPFKRAALKALS 446
K AL+
Sbjct: 282 E--RWEDVKEEMTSALA 296
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 365 bits (939), Expect = e-122
Identities = 102/291 (35%), Positives = 151/291 (51%), Gaps = 16/291 (5%)
Query: 134 SLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT--- 190
++D Y K +Y + K +G G G A +K ++VA++IISK K
Sbjct: 122 TVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIRIISKRKFAIGSA 178
Query: 191 --AISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR 248
A +V E++ILK L+ H ++K + + + YIV+EL EGGEL D+++ R
Sbjct: 179 READPALNVETEIEILKKLN-HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK-R 235
Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
E K Q+L V + H G++HRDLKPEN L +S +D +++ DFG S +
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 309 ERLNDIVGSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFR 363
+ + G+ Y+APEVL Y+ D WS+GVI +I L G PF RT+ +
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 355
Query: 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414
+ NF W VS +A D VK+LL D + R T +AL HPWL+D+
Sbjct: 356 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-111
Identities = 87/385 (22%), Positives = 156/385 (40%), Gaps = 50/385 (12%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
+ ++ K +G G G +G + + VAVK + + E
Sbjct: 9 FEQSLKNLVVSEKILGYGSSGTVV----FQGSFQGRPVAVKRMLIDFC------DIALME 58
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG------GRYTEEDA 254
+K+L H +++++ + +YI +ELC L D + ++ E +
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS----------GRDDADMRLIDFGLSDF 304
+++ QI S VA H ++HRDLKP+N L ++ G ++ + + DFGL
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 305 IRPDE-----RLNDIVGSAYYVAPEVL--------HRSYSLEADIWSIGVISYILLC-GS 350
+ + LN+ G++ + APE+L R + DI+S+G + Y +L G
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 351 RPFWAR--TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
PF + ES I R + D L S+ EA D + ++++ D KR TA++ L H
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296
Query: 409 PWLRDDSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNK 468
P S+ + + + ++ P A L + V + + K
Sbjct: 297 PLFWPKSKKLEFLLKVSDRLEIENRDPP--SALLMKFDAG---SDFVIPSGDWTVKFD-K 350
Query: 469 DGSVSLENFRMVLGRNATDAMRESR 493
+LE +R D +R R
Sbjct: 351 TFMDNLERYRKYHSSKLMDLLRALR 375
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-109
Identities = 87/435 (20%), Positives = 165/435 (37%), Gaps = 55/435 (12%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ +G G G +G ++ VAVK I REV++L+
Sbjct: 25 SFCPKDVLGHGAEGTIV----YRGMFDNRDVAVKRILPECF------SFADREVQLLRES 74
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H +++++ +D YI +ELC L + + + + + ++ Q S +A
Sbjct: 75 DEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMR--LIDFGLSDFIRPDE----RLNDIVGSAYYV 321
H +VHRDLKP N L + ++ + DFGL + R + + G+ ++
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 322 APEVL----HRSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDL- 375
APE+L + + DI+S G + Y ++ GS PF + +L + D L
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGACSLDCLH 251
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHAT 435
P A++ +++++ D +KR +A L HP+ + + F+ V +
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK----QLQFFQDVSDRIEKE 307
Query: 436 PFKRAALKALSKA----LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRE 491
+K L + + D + L FR G + D +R
Sbjct: 308 SLDGPIVKQLERGGRAVVKMDWRENITVPL---------QTDLRKFRTYKGGSVRDLLRA 358
Query: 492 SR---------VPDVLSSMESL--AYRKMYFEE-FCAAAISTHQLEALEGWEQIASTAFE 539
R +V ++ +L + YF F T++ L E++ +
Sbjct: 359 MRNKKHHYRELPAEVRETLGTLPDDFVC-YFTSRFPHLLAHTYRAMELCSHERLFQPYYF 417
Query: 540 YFEEEGNRVISIEEL 554
+ E ++ + L
Sbjct: 418 HEPPEPQPPVTPDAL 432
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 1e-86
Identities = 71/312 (22%), Positives = 129/312 (41%), Gaps = 30/312 (9%)
Query: 125 EERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS 184
+ + F G Y + K++G G +K Q A+K ++
Sbjct: 6 HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKK----QIYAIKYVN 61
Query: 185 KAKMTTAISIEDVRREVKILKALSGH-KHLVKFCDACEDVNNVYIVMELCEGGELLDRIL 243
+ +++ R E+ L L H +++ D +Y+VME C +L L
Sbjct: 62 LEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNS-WL 118
Query: 244 ARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303
+ + K+ +L V H G+VH DLKP NFL G ++LIDFG+++
Sbjct: 119 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIAN 174
Query: 304 FIRPDER---LNDIVGSAYYVAPEVLHRS------------YSLEADIWSIGVISYILLC 348
++PD + VG+ Y+ PE + S ++D+WS+G I Y +
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
Query: 349 GSRPFWARTES-GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407
G PF A++ + + + +D +K L +D ++R++ + L
Sbjct: 235 GKTPFQQIINQISKLHAIIDPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
Query: 408 HPWLRDDSRPVP 419
HP+++ + PV
Sbjct: 293 HPYVQIQTHPVN 304
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 2e-86
Identities = 69/301 (22%), Positives = 126/301 (41%), Gaps = 43/301 (14%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
+ + + +E +G+G FG AR + A+K I + + + EV
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALD---SRYYAIKKIRHTEE----KLSTILSEV 53
Query: 202 KILKALSGHKHLVKFCDACEDVNN-------------VYIVMELCEGGELLDRILARGGR 248
+L +L+ H+++V++ A + N ++I ME CE G L D I +
Sbjct: 54 MLLASLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN 112
Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------ 302
++ + QIL +++ H QG++HRDLKP N ++++ DFGL+
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE---SRNVKIGDFGLAKNVHRS 169
Query: 303 ---------DFIRPDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSR 351
+ + L +G+A YVA EVL + Y+ + D++S+G+I + ++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-- 227
Query: 352 PFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
I + + F + K ++ L++ D KR A L WL
Sbjct: 228 FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
Query: 412 R 412
Sbjct: 288 P 288
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 4e-86
Identities = 69/291 (23%), Positives = 127/291 (43%), Gaps = 30/291 (10%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
G Y + K++G G +K ++ A+K ++ + +++ R E+ L
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQ-TLDSYRNEIAYLN 62
Query: 206 ALSGH-KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
L H +++ D +Y+VME C +L L + + K+ +L
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNS-WLKKKKSIDPWERKSYWKNMLEA 120
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYV 321
V H G+VH DLKP NFL G ++LIDFG+++ ++PD + VG+ Y+
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 322 APEVLHRS------------YSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRS 368
PE + S ++D+WS+G I Y + G PF A++
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236
Query: 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419
+ + + +D +K L +D ++R++ + L HP+++ + PV
Sbjct: 237 NHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 267 bits (683), Expect = 7e-85
Identities = 63/309 (20%), Positives = 112/309 (36%), Gaps = 45/309 (14%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ L +G+G + R KK A+K+ + ++ RE ++LK L+
Sbjct: 11 WLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLN 65
Query: 209 GHKHLVKFCDACEDVN--NVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSV 264
HK++VK E+ + ++ME C G L + E + ++ ++
Sbjct: 66 -HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRD-DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAP 323
+ G+VHR++KP N + G D + +L DFG + + DE+ + G+ Y+ P
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 324 EVL---------HRSYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSDP 370
++ + Y D+WSIGV Y GS PF R + ++ P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 371 N-----------------FDDLPWPSVSPEAKD----FVKRLLNKDYRKRMTAVQALTHP 409
+ D S+S + + +L D K Q
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 410 WLRDDSRPV 418
Sbjct: 305 SDILHRGNS 313
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 8e-85
Identities = 79/339 (23%), Positives = 144/339 (42%), Gaps = 34/339 (10%)
Query: 97 PPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVG 156
P S K A+ +R P T +++ + S ++ G Y + K++G
Sbjct: 12 PRGSGMKETAAAKFERQHMDSPDLGTDDDDKAS---SSANECISVK---GRIYSILKQIG 65
Query: 157 RGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLVK 215
G +K ++ A+K ++ + +++ R E+ L L H +++
Sbjct: 66 SGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 216 FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVH 275
D +Y+VME C +L + + + K+ +L V H G+VH
Sbjct: 121 LYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVH 178
Query: 276 RDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLHRS--- 329
DLKP NFL G ++LIDFG+++ ++PD + VG+ Y+ PE +
Sbjct: 179 SDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 330 ---------YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
S ++D+WS+G I Y + G PF I + DPN +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDIP 293
Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419
+ +D +K L +D ++R++ + L HP+++ + PV
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 2e-83
Identities = 81/301 (26%), Positives = 133/301 (44%), Gaps = 27/301 (8%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
+ +Y G+ +G+G F + A KI+ K+ + E + E
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADT---KEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
+ I ++L+ H+H+V F ED + V++V+ELC LL+ R TE +A+ + Q
Sbjct: 66 ISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQ 123
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL--IDFGLSDFI-RPDERLNDIVGS 317
I+ + H V+HRDLK N + D+ + DFGL+ + ER + G+
Sbjct: 124 IVLGCQYLHRNRVIHRDLKLGNLFL-----NEDLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
Y+APEVL + +S E D+WSIG I Y LL G PF + + ++ +
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-----EYS 233
Query: 377 WPS-VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHAT 435
P ++P A ++++L D R T + L + P L I + L
Sbjct: 234 IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPI-------TCLTIP 286
Query: 436 P 436
P
Sbjct: 287 P 287
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 1e-82
Identities = 86/329 (26%), Positives = 139/329 (42%), Gaps = 29/329 (8%)
Query: 99 PSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRG 158
P+PA KA + P P + +Y G+ +G+G
Sbjct: 2 PAPADPGKAGV---------PGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKG 52
Query: 159 HFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCD 218
F + A KI+ K+ + E + E+ I ++L+ H+H+V F
Sbjct: 53 GFAKCFEISDADT---KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHG 108
Query: 219 ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDL 278
ED + V++V+ELC LL+ R TE +A+ + QI+ + H V+HRDL
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 279 KPENFLFTSGRDDADMRL--IDFGLSDFI-RPDERLNDIVGSAYYVAPEVL-HRSYSLEA 334
K N + D+ + DFGL+ + ER + G+ Y+APEVL + +S E
Sbjct: 168 KLGNLFL-----NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222
Query: 335 DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAKDFVKRLLN 393
D+WSIG I Y LL G PF + + ++ + P ++P A ++++L
Sbjct: 223 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-----EYSIPKHINPVAASLIQKMLQ 277
Query: 394 KDYRKRMTAVQALTHPWLRDDSRPVPLDI 422
D R T + L + P L I
Sbjct: 278 TDPTARPTINELLNDEFFTSGYIPARLPI 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 2e-82
Identities = 82/276 (29%), Positives = 144/276 (52%), Gaps = 13/276 (4%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+++G +G+G F A +VA+K+I K M A ++ V+ EVKI L
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H +++ + ED N VY+V+E+C GE+ + R ++E +A+ + QI++ + +
Sbjct: 69 K-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERLNDIVGSAYYVAPEVL 326
H G++HRDL N L T + ++++ DFGL+ + P E+ + G+ Y++PE+
Sbjct: 128 LHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184
Query: 327 -HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
++ LE+D+WS+G + Y LL G PF T V+ +D P +S EAK
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEAK 240
Query: 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLD 421
D + +LL ++ R++ L HP++ +S D
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKD 276
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 3e-79
Identities = 70/363 (19%), Positives = 133/363 (36%), Gaps = 49/363 (13%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ L +G+G + R KK A+K+ + ++ RE ++LK L+
Sbjct: 11 WLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLN 65
Query: 209 GHKHLVKFCDACEDVN--NVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSV 264
HK++VK E+ + ++ME C G L + E + ++ ++
Sbjct: 66 -HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRD-DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAP 323
+ G+VHR++KP N + G D + +L DFG + + DE+ + G+ Y+ P
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 324 EVL---------HRSYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSDP 370
++ + Y D+WSIGV Y GS PF R + ++ P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 371 N-----------------FDDLPWPSVSPEAKD----FVKRLLNKDYRKRMTAVQALTHP 409
+ D S+S + + +L D K Q
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 410 WLRDDSRPV-PLDILIFKLVKSYLHATPFKRAALKALS---KALTEDELVYLRAQFRLLE 465
+ + K Y+H+ + + K ++ ++ + + +LE
Sbjct: 305 SDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLE 364
Query: 466 PNK 468
P +
Sbjct: 365 PGR 367
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 2e-77
Identities = 91/279 (32%), Positives = 149/279 (53%), Gaps = 15/279 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
Y L K +G+G+F AR L ++VA+KII K ++ S++ + REV+I+K L
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHI---LTGREVAIKIIDKTQLNPT-SLQKLFREVRIMKIL 71
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ H ++VK + E +Y++ME GGE+ D ++A G R E++A++ QI+S V +
Sbjct: 72 N-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQY 129
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 327
CH + +VHRDLK EN L + D ++++ DFG S+ +L+ G+ Y APE+
Sbjct: 130 CHQKRIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ 186
Query: 328 -RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
+ Y E D+WS+GVI Y L+ GS PF + + VLR + + +S + +
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFY--MSTDCE 242
Query: 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
+ +KR L + KR T Q + W+ L +
Sbjct: 243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFV 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 3e-77
Identities = 79/271 (29%), Positives = 142/271 (52%), Gaps = 14/271 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+E+G+ +G+G FG+ AR K+ +A+K++ KA++ A +RREV+I L
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H ++++ D VY+++E G + L + ++ E+ + ++ + +++
Sbjct: 67 R-HPNILRLYGYFHDATRVYLILEYAPLGTVYRE-LQKLSKFDEQRTATYITELANALSY 124
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
CH + V+HRD+KPEN L S ++++ DFG S P R D+ G+ Y+ PE++
Sbjct: 125 CHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIE 180
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
R + + D+WS+GV+ Y L G PF A T ++ + R + F P V+ A+D
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGARD 236
Query: 387 FVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417
+ RLL + +R + L HPW+ +S
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSK 267
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 257 bits (657), Expect = 4e-77
Identities = 77/349 (22%), Positives = 145/349 (41%), Gaps = 37/349 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+E+ + +G G FG+ + +QVA+K + + E E++I+K L
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQELSPK--NRERWCLEIQIMKKL 69
Query: 208 SGHKHLVKFCDACEDVNNV------YIVMELCEGGELLDRILARG--GRYTEEDAKAIVV 259
+ H ++V + + + + + ME CEGG+L + E + ++
Sbjct: 70 N-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
I S + + H ++HRDLKPEN + G ++ID G + + E + VG+
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 188
Query: 320 YVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD----- 373
Y+APE+L + Y++ D WS G +++ + G RPF + + +R N
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 374 ----------DLPWPS-----VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPV 418
LP P+ ++ + + +++ +L R+R T Q + +
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308
Query: 419 PLDIL-IFKLVKSYLHATPFKRA-ALKALSKALTEDELVYLRAQFRLLE 465
L +L + +V +H P L+ L L +D + Q L
Sbjct: 309 SLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQA 357
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 3e-76
Identities = 74/273 (27%), Positives = 143/273 (52%), Gaps = 14/273 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+++G+ +G+G FG+ AR K+ +A+K++ K+++ +RRE++I L
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H ++++ + D +Y+++E GEL L + GR+ E+ + + ++ + +
Sbjct: 72 R-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKE-LQKHGRFDEQRSATFMEELADALHY 129
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
CH + V+HRD+KPEN L ++++ DFG S P R + G+ Y+ PE++
Sbjct: 130 CHERKVIHRDIKPENLLMGY---KGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIE 185
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
+++ + D+W GV+ Y L G PF + + + R ++ D F P P +S +KD
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF---P-PFLSDGSKD 241
Query: 387 FVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419
+ +LL +R+ + HPW++ +SR V
Sbjct: 242 LISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 2e-74
Identities = 93/272 (34%), Positives = 133/272 (48%), Gaps = 14/272 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
Y LG +G G FG + L +VAVKI+++ K+ + + ++RE++ LK
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQ---LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H H++K + ++VME GGEL D I G R E +A+ + QILS V +
Sbjct: 69 R-HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDY 126
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
CH VVHRDLKPEN L + + ++ DFGLS+ + E L GS Y APEV+
Sbjct: 127 CHRHMVVHRDLKPENVLLDA---HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 183
Query: 327 HRSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
R Y+ E DIWS GVI Y LLCG+ PF +F+ + F + ++
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYIPEY--LNRSVA 239
Query: 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417
+ +L D KR T H W + D
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 7e-74
Identities = 55/359 (15%), Positives = 101/359 (28%), Gaps = 63/359 (17%)
Query: 92 FRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYEL 151
+ R PA ++A A T+ + +L
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAET--TVDSLLSQGERK---------------LKL 66
Query: 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL---- 207
+ + G R + + A+K+ + + +E + L
Sbjct: 67 VEPLRVGDRSVVFLVRDVER---LEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 208 -------------------SGHKHLVKFCDACED--VNNVYIVMELCEG-----GELLDR 241
+ +D V N ++M LD
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 242 ILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301
+ G + Q++ + A +G+VH P+N D + L D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGDVSA 240
Query: 302 SDFIRPDERLNDIVGSAYYVAPEVLHRS---YSLEADIWSIGVISYILLCGSRPFWARTE 358
+ R Y E L+ S ++ + W +G+ Y + C PF T
Sbjct: 241 L--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 359 S--GIFRAVLRSDPNFDDLP---WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
G ++ P D L + K + R LN D R+R+ ++A+ P
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-73
Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
++L + +G G +G A + + ++ VAVKI+ + E++++E+ I K L
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML 62
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ H+++VKF + N Y+ +E C GGEL DRI E DA+ Q+++ V +
Sbjct: 63 N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRL--IDFGLSDFIRP---DERLNDIVGSAYYVA 322
H G+ HRD+KPEN L D L DFGL+ R + LN + G+ YVA
Sbjct: 121 LHGIGITHRDIKPENLLL-----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 323 PEVL-HRSYS-LEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNFDDLPWPS 379
PE+L R + D+WS G++ +L G P+ ++S + PW
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKK 233
Query: 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414
+ + ++L ++ R+T W
Sbjct: 234 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-72
Identities = 76/295 (25%), Positives = 136/295 (46%), Gaps = 41/295 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS-------------- 193
+Y L E+G+G +G A + + A+K++SK K+
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNEND---NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 194 ---------IEDVRREVKILKALSGHKHLVKFCDACEDVN--NVYIVMELCEGGELLDRI 242
IE V +E+ ILK L H ++VK + +D N ++Y+V EL G +++
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP 129
Query: 243 LARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302
+E+ A+ ++ + + H Q ++HRD+KP N L D +++ DFG+S
Sbjct: 130 --TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE---DGHIKIADFGVS 184
Query: 303 -DFIRPDERLNDIVGSAYYVAPEVL---HRSYS-LEADIWSIGVISYILLCGSRPFWART 357
+F D L++ VG+ ++APE L + +S D+W++GV Y + G PF
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244
Query: 358 ESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
+ + F D P ++ + KD + R+L+K+ R+ + HPW+
Sbjct: 245 IMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-72
Identities = 85/313 (27%), Positives = 135/313 (43%), Gaps = 31/313 (9%)
Query: 118 PKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQ 177
+ P T P D+ + F A+Y LG +G+G FG + Q
Sbjct: 7 LQGPPAPPGTPTPPPGGKDR-----EAFEAEYRLGPLLGKGGFGTVFAGHRL---TDRLQ 58
Query: 178 VAVKIISKAKMTTAISIED---VRREVKILKALS---GHKHLVKFCDACEDVNNVYIVME 231
VA+K+I + ++ + D EV +L + GH +++ D E +V+E
Sbjct: 59 VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE 118
Query: 232 L-CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290
+L D I +G E ++ Q+++ + CH +GVVHRD+K EN L
Sbjct: 119 RPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--R 175
Query: 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYS-LEADIWSIGVISYILLC 348
+LIDFG + DE D G+ Y PE + Y L A +WS+G++ Y ++C
Sbjct: 176 RGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
Query: 349 GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
G PF + I A L P VSP+ ++R L R + + L
Sbjct: 235 GDIPF--ERDQEILEAELH-------FP-AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284
Query: 409 PWLRDDSRPVPLD 421
PW++ + VPL+
Sbjct: 285 PWMQTPAEDVPLN 297
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-72
Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
++L + +G G +G A + + ++ VAVKI+ + E++++E+ I K L
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVD--CPENIKKEICINKML 62
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ H+++VKF + N Y+ +E C GGEL DRI E DA+ Q+++ V +
Sbjct: 63 N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRL--IDFGLSDFIRP---DERLNDIVGSAYYVA 322
H G+ HRD+KPEN L D L DFGL+ R + LN + G+ YVA
Sbjct: 121 LHGIGITHRDIKPENLLL-----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 323 PEVL-HRSYS-LEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNFDDLPWPS 379
PE+L R + D+WS G++ +L G P+ ++S + PW
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKK 233
Query: 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414
+ + ++L ++ R+T W
Sbjct: 234 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 6e-72
Identities = 83/282 (29%), Positives = 121/282 (42%), Gaps = 26/282 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED-----VRREVK 202
KY +G G FG +A K K+++V VK I K K+ IED V E+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDK---EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIA 81
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMEL-CEGGELLDRILARGGRYTEEDAKAIVVQI 261
IL + H +++K D E+ +VME G +L I R E A I Q+
Sbjct: 82 ILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQL 139
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
+S V + L+ ++HRD+K EN + D ++LIDFG + ++ + G+ Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAE---DFTIKLIDFGSAAYLERGKLFYTFCGTIEYC 196
Query: 322 APEVLH-RSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
APEVL Y E ++WS+GV Y L+ PF E A + P
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--TVEAAIH-PPYL------- 246
Query: 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLD 421
VS E V LL +R T + +T PW+
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYT 288
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 7e-72
Identities = 78/286 (27%), Positives = 130/286 (45%), Gaps = 24/286 (8%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED---VR 198
+ ++Y++G +G G FG S + VA+K + K +++ + + V
Sbjct: 38 KEPLESQYQVGPLLGSGGFGSVYSGIRV---SDNLPVAIKHVEKDRISDWGELPNGTRVP 94
Query: 199 REVKILKALS-GHKHLVKFCDACEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKA 256
EV +LK +S G +++ D E ++ +++E E +L D I RG EE A++
Sbjct: 95 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARS 153
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVG 316
Q+L V CH GV+HRD+K EN L + +++LIDFG + D D G
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGALL-KDTVYTDFDG 210
Query: 317 SAYYVAPEVL-HRSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374
+ Y PE + + Y A +WS+G++ Y ++CG PF + I R +
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVF------- 261
Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPL 420
VS E + ++ L R T + HPW++D P
Sbjct: 262 FR-QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 306
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-71
Identities = 87/273 (31%), Positives = 137/273 (50%), Gaps = 18/273 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+Y+ K++G G+FG R K L + VAVK I + E+V+RE+ ++L
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDK---LTKELVAVKYIERGAAID----ENVQREIINHRSL 73
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H ++V+F + ++ I+ME GGEL +RI G R++E++A+ Q+LS V++
Sbjct: 74 R-HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSY 131
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
CH + HRDLK EN L G +++ DFG S + VG+ Y+APEVL
Sbjct: 132 CHSMQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190
Query: 327 HRSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFR----AVLRSDPNFDDLPWPSVS 381
+ Y AD+WS GV Y++L G+ PF E +R +L + D +S
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--IS 248
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414
PE + R+ D R++ + TH W +
Sbjct: 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-71
Identities = 71/304 (23%), Positives = 107/304 (35%), Gaps = 18/304 (5%)
Query: 113 LGGGKPKESTIPEERGTEPEQSLDKSFGYNKN---FGAKYELGKEVGRGHFGHTCSARGK 169
+ RG E + ++ F ++ +G G +G R K
Sbjct: 20 FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK 79
Query: 170 KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV 229
+ + AVK EV + + H V+ A E+ +Y+
Sbjct: 80 ED---GRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135
Query: 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289
ELC G L A G E + L +A H QG+VH D+KP N
Sbjct: 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP-- 192
Query: 290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCG 349
+L DFGL + G Y+APE+L SY AD++S+G+ + C
Sbjct: 193 -RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACN 251
Query: 350 -SRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
P + + L P F +S E + + +L D + R TA L
Sbjct: 252 MELPHGGEGWQQLRQGYLP--PEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305
Query: 409 PWLR 412
P LR
Sbjct: 306 PVLR 309
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 1e-71
Identities = 91/333 (27%), Positives = 155/333 (46%), Gaps = 31/333 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
Y + + +G G FG A Q+VA+K IS+ + + V RE+ LK L
Sbjct: 10 PYIIRETLGEGSFGKVKLATHY---KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL 66
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H H++K D ++ +V+E GGEL D I+ + R TE++ + QI+ + +
Sbjct: 67 R-HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEY 123
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
CH +VHRDLKPEN L + ++++ DFGLS+ + L GS Y APEV+
Sbjct: 124 CHRHKIVHRDLKPENLLLDD---NLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180
Query: 327 HRSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
+ Y+ E D+WS G++ Y++L G PF +F+ V + + +SP A+
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV--YVMPDF--LSPGAQ 236
Query: 386 DFVKRLLNKDYRKRMTAVQALTHPWLR----------DDSRPVPLDILIFKLVKSYLHAT 435
++R++ D +R+T + PW ++ + D I + + +
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFS 296
Query: 436 PFKRAALKALSKALTEDELVYLRAQFRLLEPNK 468
+ +AL DE ++ + LL N+
Sbjct: 297 EDY------IVEALRSDENNEVKEAYNLLHENQ 323
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-71
Identities = 98/277 (35%), Positives = 140/277 (50%), Gaps = 24/277 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
Y LG +G G FG + + L +VAVKI+++ K+ + + +RRE++ LK
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHE---LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF 73
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H H++K +++++VME GGEL D I G R E++++ + QILS V +
Sbjct: 74 R-HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDY 131
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADM--RLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
CH VVHRDLKPEN L DA M ++ DFGLS+ + E L GS Y APEV
Sbjct: 132 CHRHMVVHRDLKPENVLL-----DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186
Query: 326 L-HRSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD---PNFDDLPWPSV 380
+ R Y+ E DIWS GVI Y LLCG+ PF +F+ + P + +
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY-------L 239
Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417
+P +K +L D KR T H W + D
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPK 276
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 4e-71
Identities = 77/279 (27%), Positives = 124/279 (44%), Gaps = 25/279 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
YE+ +G G +G R K + + K + MT A + + EV +L+ L
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLREL 62
Query: 208 SGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRI---LARGGRYTEEDAKAIVVQIL 262
H ++V++ D D N +YIVME CEGG+L I EE ++ Q+
Sbjct: 63 K-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 263 SVVAFCH-----LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL-NDIVG 316
+ CH V+HRDLKP N +++L DFGL+ + D VG
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDG---KQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 317 SAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
+ YY++PE + SY+ ++DIWS+G + Y L PF A ++ + +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---- 234
Query: 376 PWPSV-SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
P S E + + R+LN R + + L +P + +
Sbjct: 235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 7e-71
Identities = 66/340 (19%), Positives = 127/340 (37%), Gaps = 55/340 (16%)
Query: 118 PKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQ 177
P S L+K + Y + + + +G F + E ++
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFN-----KIILCEKDNKF 56
Query: 178 VAVKIISKA--------------KMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223
A+K K+ K++ +D + E++I+ + +++ + +
Sbjct: 57 YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITNY 115
Query: 224 NNVYIVMELCEGGELLDRILARG-------GRYTEEDAKAIVVQILSVVAFCHLQ-GVVH 275
+ VYI+ E E +L + K I+ +L+ ++ H + + H
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175
Query: 276 RDLKPENFLFTSGRDDADMRL--IDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS---Y 330
RD+KP N L D + R+ DFG S+ D+++ G+ ++ PE
Sbjct: 176 RDVKPSNILM-----DKNGRVKLSDFGESE-YMVDKKIKGSRGTYEFMPPEFFSNESSYN 229
Query: 331 SLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDPNF---------------DD 374
+ DIWS+G+ Y++ PF + +F + + +
Sbjct: 230 GAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKST 289
Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414
+S E DF+K L K+ +R+T+ AL H WL D
Sbjct: 290 CSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 1e-69
Identities = 70/270 (25%), Positives = 134/270 (49%), Gaps = 16/270 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
KY +++G G FG + + +Q +K I+ ++M++ E+ RREV +L +
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTED---GRQYVIKEINISRMSSK-EREESRREVAVLANM 80
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVA 266
H ++V++ ++ E+ ++YIVM+ CEGG+L RI A+ G E+ VQI +
Sbjct: 81 K-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEV 325
H + ++HRD+K +N T D ++L DFG++ + E +G+ YY++PE+
Sbjct: 140 HVHDRKILHRDIKSQNIFLTK---DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196
Query: 326 L-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPE 383
++ Y+ ++DIW++G + Y L F A + + ++ P S +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP----PVSLHYSYD 252
Query: 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
+ V +L ++ R R + L ++
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 6e-69
Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 24/288 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED-VRREVKILKA 206
KY +G +G G +G + AVKI+ K K+ + E V++E+++L+
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDS---ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 207 LSGHKHLVKFCD--ACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQIL 262
L HK++++ D E+ +Y+VME C G E+LD + R+ A Q++
Sbjct: 63 LR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQLI 119
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS---DFIRPDERLNDIVGSAY 319
+ + H QG+VH+D+KP N L T+ +++ G++ D+ GS
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTT---GGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 320 YVAPEVL--HRSYS-LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
+ PE+ ++S + DIWS GV Y + G PF +F + + P
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI---P 233
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
P D +K +L + KR + Q H W R P + I
Sbjct: 234 -GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPI 280
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 2e-68
Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 40/290 (13%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
+K FG ++ + +G G FG A+ + + +K + E REV
Sbjct: 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN-------EKAEREV 55
Query: 202 KILKALSGHKHLVKFCDACEDV----------------NNVYIVMELCEGGELLDRILAR 245
K L L H ++V + + ++I ME C+ G L I R
Sbjct: 56 KALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
Query: 246 GGRY-TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304
G + A + QI V + H + +++RDLKP N D +++ DFGL
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTS 171
Query: 305 IRPDERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFR 363
++ D + G+ Y++PE + + Y E D++++G+I LL + ++
Sbjct: 172 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----- 226
Query: 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
+D + + K +++LL+K R + L +
Sbjct: 227 --FFTDLRDGIIS-DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 7e-68
Identities = 46/309 (14%), Positives = 95/309 (30%), Gaps = 60/309 (19%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
G +G+ A ++ + V + + + +I+ ++ EV L+ L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 208 SGHKHL--------------------------VKFCDACEDVNNVYIVMELCEG-----G 236
G K+ V+ + V + + + + G
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
E+L + + +Q++ ++A H G+VH L+P + + + L
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFL 247
Query: 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS------------YSLEADIWSIGVISY 344
F D S + PE+ R + D W++G++ Y
Sbjct: 248 TGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 345 ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
+ C P G + RS N + + ++ L R+ +Q
Sbjct: 305 WIWCADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQ 356
Query: 405 ALTHPWLRD 413
A+ P
Sbjct: 357 AMETPEYEQ 365
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 7e-64
Identities = 75/303 (24%), Positives = 133/303 (43%), Gaps = 18/303 (5%)
Query: 117 KPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQ 176
+ + P +P+++L GYN A + + K++GRG F A
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNT--LANFRIEKKIGRGQFSEVYRAACLLD---GV 58
Query: 177 QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG 236
VA+K + + A + D +E+ +LK L+ H +++K+ + + N + IV+EL + G
Sbjct: 59 PVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAG 117
Query: 237 ELLDRI---LARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD 293
+L I + E VQ+ S + H + V+HRD+KP N T+
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---TGV 174
Query: 294 MRLIDFGLSDFIR-PDERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSR 351
++L D GL F + +VG+ YY++PE + Y+ ++DIWS+G + Y +
Sbjct: 175 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
Query: 352 PFWARTES--GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
PF+ + + + + + D + LP S E + V +N D KR
Sbjct: 235 PFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292
Query: 410 WLR 412
Sbjct: 293 KRM 295
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 4e-63
Identities = 55/295 (18%), Positives = 102/295 (34%), Gaps = 36/295 (12%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
Y +++G G F + G A+K I + E+ +RE + +
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHD---GHFYALKRILCHEQQ---DREEAQREADMHR 81
Query: 206 ALSGHKHLVKFCDACED----VNNVYIVMELCEGGELLDRI---LARGGRYTEEDAKAIV 258
H ++++ C + ++++ + G L + I +G TE+ ++
Sbjct: 82 LF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD---------- 308
+ I + H +G HRDLKP N L D+ L+D G +
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 309 ERLNDIVGSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWARTESG--IF 362
+ + Y APE+ H D+WS+G + Y ++ G P+ + G +
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
Query: 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417
AV P S + ++ D +R L+ P
Sbjct: 258 LAVQN---QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 1e-62
Identities = 85/298 (28%), Positives = 126/298 (42%), Gaps = 42/298 (14%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+E + +GRG FG A+ K D A+K I A E V REVK L L
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVD---DCNYAIKRIRLPNRELAR--EKVMREVKALAKL 60
Query: 208 SGHKHLVKFCDACEDVNN------------VYIVMELCEGGELLDRILARGGRYTEEDAK 255
H +V++ +A + N +YI M+LC L D + R E +
Sbjct: 61 E-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 256 A--IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS----------- 302
I +QI V F H +G++HRDLKP N FT D +++ DFGL
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 303 --DFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES 359
+ R VG+ Y++PE +H SYS + DI+S+G+I + LL PF + E
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER 233
Query: 360 GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417
+R + F L P V+ +L+ +R A+ + + D P
Sbjct: 234 VRTLTDVR-NLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 6e-59
Identities = 62/313 (19%), Positives = 118/313 (37%), Gaps = 45/313 (14%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
+ + + + G F A+ ++ A+K + + + +EV +K
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGS---GREYALKRLLSNEEE---KNRAIIQEVCFMK 80
Query: 206 ALSGHKHLVKFCDACEDVNN--------VYIVMELCEGGELLDRILAR--GGRYTEEDAK 255
LSGH ++V+FC A ++ ELC+G L++ + G + +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ-LVEFLKKMESRGPLSCDTVL 139
Query: 256 AIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD----- 308
I Q V H Q ++HRDLK EN L + + ++L DFG + I
Sbjct: 140 KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSW 196
Query: 309 --------ERLNDIVGSAYYVAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWAR 356
E + Y PE++ + + DIW++G I Y+L PF
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--- 253
Query: 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416
E G ++ + P + ++ +L + +R++ + + +R
Sbjct: 254 -EDGAKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310
Query: 417 PVPLDILIFKLVK 429
V I +L++
Sbjct: 311 NVNPKSPITELLE 323
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-57
Identities = 57/295 (19%), Positives = 118/295 (40%), Gaps = 36/295 (12%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
+ ++ +++G G FG + G + A+K K + ++ REV
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCI----YAIKRSKKPLAGSV-DEQNALREVY 62
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVV 259
L H H+V++ A + +++ I E C GG L D I + E + K +++
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFT----------------SGRDDADMRLIDFGLSD 303
Q+ + + H +VH D+KP N + + ++ D G
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV- 181
Query: 304 FIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGI 361
G + ++A EVL ++ +ADI+++ ++ + G+ P +
Sbjct: 182 --TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGDQ-- 236
Query: 362 FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416
+ + + +P +S E + +K +++ D +R +A+ + H L SR
Sbjct: 237 WHEIRQG--RLPRIP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 7e-57
Identities = 47/281 (16%), Positives = 95/281 (33%), Gaps = 30/281 (10%)
Query: 148 KYELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
+ +G G F + + Q+ +K+ A + ++ LK
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLK 122
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRI----LARGGRYTEEDAKAIVVQI 261
+KF A N +V EL G LL+ I + + +++
Sbjct: 123 PSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM--------RLIDFGLSDFIR---PDER 310
L ++ H ++H D+KP+NF+ +G + D LID G S ++
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 311 LNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369
++ + E+L ++ ++ + D + + Y +L G+ L
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410
D+ W +F +LN + ++ L
Sbjct: 302 LPHLDM-W-------NEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-53
Identities = 54/388 (13%), Positives = 117/388 (30%), Gaps = 69/388 (17%)
Query: 81 SPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQS-----L 135
S R + + + F P + L R+ + ++ + + S
Sbjct: 8 SSGRENL----YFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNT 63
Query: 136 DKSFGYNKNFGAKYEL---GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI 192
+ F G + G +G+ A ++ + V + + +
Sbjct: 64 GQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFTERPPSN 120
Query: 193 SIEDVRREVKILKALSGHKHL--------------------------VKFCDACEDVNNV 226
+I+ ++ EV L+ L G K+ V+ + V +
Sbjct: 121 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 180
Query: 227 YIVMELCEG-----GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE 281
+ + + GE+L + + +Q++ ++A H G+VH L+P
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240
Query: 282 NFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY----YVAPEVLHRS------YS 331
+ + + L F +R +G + A +L +
Sbjct: 241 DIVLD---QRGGVFLTGFEHL--VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMT 295
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391
D W++G+ Y + C P G + RS N + + ++
Sbjct: 296 FAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKN--------IPQPVRALLEGF 347
Query: 392 LNKDYRKRMTAVQALTHPWLRDDSRPVP 419
L R+ +QA+ P +
Sbjct: 348 LRYPKEDRLLPLQAMETPEYEQLRTELS 375
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-53
Identities = 83/307 (27%), Positives = 138/307 (44%), Gaps = 27/307 (8%)
Query: 120 ESTIPEERGTEPEQSLDKSFGYNKNFGAK-YELGKEVGRGHFGHTCSARGKKGELKDQQV 178
+ T E R + + + ++ GK +G G F AR ++
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELAT---SREY 58
Query: 179 AVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL 238
A+KI+ K + + V RE ++ L H VK +D +Y + + GEL
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGEL 117
Query: 239 LDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM--RL 296
L + + G + E + +I+S + + H +G++HRDLKPEN L + DM ++
Sbjct: 118 LKY-IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL-----NEDMHIQI 171
Query: 297 IDFGLS---DFIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRP 352
DFG + R N VG+A YV+PE+L +D+W++G I Y L+ G P
Sbjct: 172 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
Query: 353 FWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQA------L 406
F A E IF+ +++ + +F P P+A+D V++LL D KR+ +
Sbjct: 232 FRAGNEYLIFQKIIKLEYDF---P-EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 407 THPWLRD 413
HP+
Sbjct: 288 AHPFFES 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-52
Identities = 79/329 (24%), Positives = 127/329 (38%), Gaps = 31/329 (9%)
Query: 97 PPPSPAKHIKASLAK--RLGGGKPKEST--IPEERGTEPEQSLDKSFGYNKNFGAKYELG 152
S H ASLAK G K + + G + L +
Sbjct: 4 SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ 63
Query: 153 KEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVR-REVKILKALSGH 210
VGRG FG + K+ G AVK + +E R E+ LS
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQ----CAVKKVR---------LEVFRVEELVACAGLS-S 109
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
+V A + V I MEL EGG L ++ + G E+ A + Q L + + H
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE------RLNDIVGSAYYVAPE 324
+ ++H D+K +N L +S D + L DFG + ++PD + I G+ ++APE
Sbjct: 169 RRILHGDVKADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 325 VLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
V+ + DIWS + +L G P+ + + P ++P PS +P
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PSCAPL 285
Query: 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
++ L K+ R +A++
Sbjct: 286 TAQAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-52
Identities = 75/312 (24%), Positives = 132/312 (42%), Gaps = 33/312 (10%)
Query: 121 STIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVA 179
S E G L+ + Y++N +G+G +G + R +A
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDEN-----GDRVVLGKGTYGIVYAGRDLSNQVR----IA 51
Query: 180 VKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELL 239
+K I + + + E+ + K L HK++V++ + + + I ME GG L
Sbjct: 52 IKEIPERDSR---YSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107
Query: 240 DRILARGGR--YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297
+ ++ G E+ QIL + + H +VHRD+K +N L + +++
Sbjct: 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKIS 165
Query: 298 DFGLSDFI-RPDERLNDIVGSAYYVAPEVLH---RSYSLEADIWSIG--VISYILLCGSR 351
DFG S + + G+ Y+APE++ R Y ADIWS+G +I + G
Sbjct: 166 DFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE--MATGKP 223
Query: 352 PFWARTE--SGIFR-AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
PF+ E + +F+ + + P + S+S EAK F+ + D KR A L
Sbjct: 224 PFYELGEPQAAMFKVGMFKVHPEIPE----SMSAEAKAFILKCFEPDPDKRACANDLLVD 279
Query: 409 PWLRDDSRPVPL 420
+L+ S+
Sbjct: 280 EFLKVSSKKKKT 291
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-50
Identities = 67/275 (24%), Positives = 135/275 (49%), Gaps = 26/275 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKALS 208
E+ + +G+G FG C + +++ A+K ++K K + +V +E++I++ L
Sbjct: 18 EILRAIGKGSFGKVCIVQKND----TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H LV + +D ++++V++L GG+L L + + EE K + +++ + +
Sbjct: 74 -HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYH-LQQNVHFKEETVKLFICELVMALDYL 131
Query: 269 HLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
Q ++HRD+KP+N L D + + DF ++ + + ++ + G+ Y+APE+
Sbjct: 132 QNQRIIHRDMKPDNILL-----DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF 186
Query: 327 HRS----YSLEADIWSIGVISYILLCGSRPFWARTESG---IFRAVLRSDPNFDDLPWPS 379
YS D WS+GV +Y LL G RP+ R+ + I + + P +
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---P-SA 242
Query: 380 VSPEAKDFVKRLLNKDYRKRMTAVQAL-THPWLRD 413
S E +K+LL + +R + + + P++ D
Sbjct: 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 61/297 (20%), Positives = 121/297 (40%), Gaps = 18/297 (6%)
Query: 126 ERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISK 185
+ + + L+ N G + E+GRG F + +VA +
Sbjct: 5 NQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQD 61
Query: 186 AKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDR 241
K+T + + + E ++LK L H ++V+F D+ E + +V EL G L
Sbjct: 62 RKLTKS-ERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT- 118
Query: 242 ILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDF 299
L R + ++ QIL + F H + ++HRDLK +N T +++ D
Sbjct: 119 YLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDL 176
Query: 300 GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTES 359
GL+ R ++G+ ++APE+ Y D+++ G+ + P+ +
Sbjct: 177 GLATLKRASFA-KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA 235
Query: 360 G-IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415
I+R V PE K+ ++ + ++ +R + L H + ++++
Sbjct: 236 AQIYRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET 290
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-47
Identities = 84/310 (27%), Positives = 139/310 (44%), Gaps = 27/310 (8%)
Query: 115 GGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAK---YELGKEVGRGHFGHTCSARGKKG 171
K E +E + ++ K + A+ ++ K +G G FG + K+
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE- 64
Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
A+KI+ K K+ IE E +IL+A++ LVK + +D +N+Y+VME
Sbjct: 65 --SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVME 121
Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
GGE+ L R GR++E A+ QI+ + H +++RDLKPEN L D
Sbjct: 122 YVAGGEMF-SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI-----D 175
Query: 292 AD--MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLC 348
+++ DFG + R R + G+ +APE++ Y+ D W++GV+ Y +
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 349 GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQA--- 405
G PF+A I+ ++ F P S + KD ++ LL D KR ++
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVN 289
Query: 406 --LTHPWLRD 413
H W
Sbjct: 290 DIKNHKWFAT 299
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-47
Identities = 72/305 (23%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
Y+L +++GRG + A +++V VKI+ K RE+KIL+ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKKKKIK------REIKILENL 87
Query: 208 SGHKHLVKFCDACEDVNN---VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
G +++ D +D + + + ++ T+ D + + +IL
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLY---QTLTDYDIRFYMYEILKA 142
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
+ +CH G++HRD+KP N + + +RLID+GL++F P + N V S Y+ PE
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 200
Query: 325 VL--HRSYSLEADIWSIGVISYILLCGSRPF-------------------------WART 357
+L ++ Y D+WS+G + ++ PF +
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260
Query: 358 ESGIFRAVLRSDPNFDDLPW---------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
+ W VSPEA DF+ +LL D++ R+TA +A+ H
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 409 PWLRD 413
P+
Sbjct: 321 PYFYT 325
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-46
Identities = 83/326 (25%), Positives = 149/326 (45%), Gaps = 39/326 (11%)
Query: 127 RGTEPEQSLDK-SFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISK 185
P +SLD+ ++ +EL + VG G +G R K Q A+K++
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD- 58
Query: 186 AKMTTAISIEDVRREVKILKALSGHKHLVKFCDA------CEDVNNVYIVMELCEGGELL 239
T E++++E+ +LK S H+++ + A + +++VME C G +
Sbjct: 59 ---VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115
Query: 240 DRI-LARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298
D I +G EE I +IL ++ H V+HRD+K +N L T ++A+++L+D
Sbjct: 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVD 172
Query: 299 FGLS-DFIRPDERLNDIVGSAYYVAPEVLHR------SYSLEADIWSIGVISYIL----- 346
FG+S R R N +G+ Y++APEV+ +Y ++D+WS+G+ + +
Sbjct: 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 347 -LCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
LC P A +F P W S + + F++ L K++ +R Q
Sbjct: 233 PLCDMHPMRA-----LFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQL 284
Query: 406 LTHPWLRDDSRPVPLDILIFKLVKSY 431
+ HP++RD + I + +
Sbjct: 285 MKHPFIRDQPNERQVRIQLKDHIDRT 310
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-46
Identities = 58/254 (22%), Positives = 102/254 (40%), Gaps = 25/254 (9%)
Query: 176 QQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG 235
+ + +++ ++ +++ + S K+ V +YI M+LC
Sbjct: 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQLQPSSPKVYLYIQMQLCRK 145
Query: 236 GELLDRILARGGRYTEEDAKA--IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD 293
L D + R E I +QI V F H +G++HRDLKP N FT D
Sbjct: 146 ENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM---DDV 202
Query: 294 MRLIDFGLS-------------DFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSI 339
+++ DFGL + VG+ Y++PE +H +YS + DI+S+
Sbjct: 203 VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSL 262
Query: 340 GVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKR 399
G+I + LL F + E +R + F L P+ V+ +L+ +R
Sbjct: 263 GLILFELLY---SFSTQMERVRIITDVR-NLKFPLLF-TQKYPQEHMMVQDMLSPSPTER 317
Query: 400 MTAVQALTHPWLRD 413
A + + +
Sbjct: 318 PEATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 24/89 (26%), Positives = 38/89 (42%), Gaps = 6/89 (6%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
+ +E + +GRG FG A+ K + D A+K I + E V REVK L
Sbjct: 4 YLTDFEPIQCMGRGGFGVVFEAKNK---VDDCNYAIKRIRLPNREL--AREKVMREVKAL 58
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELC 233
L H +V++ +A + E+
Sbjct: 59 AKLE-HPGIVRYFNAWLETPPEKWQEEMD 86
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 66/273 (24%), Positives = 129/273 (47%), Gaps = 24/273 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+++ + +G G FG R + + A+K++ K + +E E +L ++
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H +++ +D ++++M+ EGGEL L + R+ AK ++ + +
Sbjct: 65 -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 269 HLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
H + +++RDLKPEN L D + +++ DFG + + + G+ Y+APEV+
Sbjct: 123 HSKDIIYRDLKPENILL-----DKNGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVV 175
Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
Y+ D WS G++ Y +L G PF+ + +L ++ F P P + + K
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDVK 231
Query: 386 DFVKRLLNKDYRKRMTAVQA-----LTHPWLRD 413
D + RL+ +D +R+ +Q HPW ++
Sbjct: 232 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-45
Identities = 85/288 (29%), Positives = 136/288 (47%), Gaps = 26/288 (9%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+E+ E+G G FG A+ K+ A K+I + +ED E++IL
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIE---TKSEEELEDYIVEIEILATC 73
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H ++VK A ++I++E C GG + +L TE + + Q+L + F
Sbjct: 74 D-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVL 326
H + ++HRDLK N L T + D+RL DFG+S ++ + +G+ Y++APEV+
Sbjct: 133 LHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 327 HR------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL---RSDPNFDDLPW 377
Y +ADIWS+G+ + P E R +L +SDP L
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAKSDPP--TLLT 244
Query: 378 PS-VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
PS S E +DF+K L+K+ R +A Q L HP++ + L L+
Sbjct: 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELV 292
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 86/281 (30%), Positives = 137/281 (48%), Gaps = 19/281 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ ++G G G C AR K +QVAVK++ + E + EV I++
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMM---DLRKQQRRELLFNEVVIMRDY 99
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H ++V+ + ++++ME +GG L D + R EE + +L +A+
Sbjct: 100 Q-HFNVVEMYKSYLVGEELWVLMEFLQGGALTD--IVSQVRLNEEQIATVCEAVLQALAY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVL 326
H QGV+HRD+K ++ L T D ++L DFG I D + +VG+ Y++APEV+
Sbjct: 157 LHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLPWPSVSPE 383
RS Y+ E DIWS+G I I + P + + R P + VSP
Sbjct: 214 SRSLYATEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN--SHKVSPV 270
Query: 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
+DF++R+L +D ++R TA + L HP+L P L LI
Sbjct: 271 LRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLI 311
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 84/284 (29%), Positives = 131/284 (46%), Gaps = 32/284 (11%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E+ K +GRG F + K+ Q A+KI++K M + R E +L
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVL-VNG 118
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
+ + + A +D N +Y+VME GG+LL + G R E A+ + +I+ +
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 269 HLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPE 324
H G VHRD+KP+N L D +RL DFG +R D R VG+ Y++PE
Sbjct: 179 HRLGYVHRDIKPDNILL-----DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
Query: 325 VLHR--------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
+L SY E D W++GV +Y + G PF+A + + + ++ + L
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK---EHLS 290
Query: 377 WPS----VSPEAKDFVKRLLNKDYRKRMTAVQAL---THPWLRD 413
P V EA+DF++RLL R+ A THP+
Sbjct: 291 LPLVDEGVPEEARDFIQRLLCPP-ETRLGRGGAGDFRTHPFFFG 333
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-44
Identities = 72/281 (25%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
KY +++G+G G +A Q+VA++ + + E + E+ +++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQM---NLQQQPKKELIINEILVMREN 74
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ ++V + D+ + +++VME GG L D + E A+ + L + F
Sbjct: 75 K-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD--VVTETCMDEGQIAAVCRECLQALEF 131
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
H V+HRD+K +N L D ++L DFG I P++ + + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLPWPSVSPE 383
R Y + DIWS+G I I + P + ++ P + +S
Sbjct: 189 TRKAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN--PEKLSAI 245
Query: 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
+DF+ R L D KR +A + L H +L+ L LI
Sbjct: 246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-44
Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 55/311 (17%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMT-----TAISIEDVRREV 201
KYE ++G G +G R + G++ VA+K +++ A+ RE+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQI----VAIKKFLESEDDPVIKKIAL------REI 53
Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
++LK L H +LV + +++V E C+ +L + E K+I Q
Sbjct: 54 RMLKQLK-HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT 111
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYY 320
L V FCH +HRD+KPEN L T + ++L DFG + P + +D V + +Y
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITK---HSVIKLCDFGFARLLTGPSDYYDDEVATRWY 168
Query: 321 VAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW-ARTE----SGIFRAVL-----RS 368
+PE+L Y D+W+IG + LL G P W +++ I + L R
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRK-TLGDLIPRH 226
Query: 369 DPNFDDLPW-------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
F + P++S A +K L+ D +R+T Q L HP
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286
Query: 410 WLRDDSRPVPL 420
+ + L
Sbjct: 287 YFENIREIEDL 297
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 18/270 (6%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ L K +G+G FG A KK +Q A+K + K + +E E ++L
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H L + N++ VME GG+L+ I ++ A +I+ + F
Sbjct: 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFL 134
Query: 269 HLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEV 325
H +G+V+RDLK +N L D D +++ DFG+ + + D + N G+ Y+APE+
Sbjct: 135 HSKGIVYRDLKLDNILL-----DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 326 LHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
L Y+ D WS GV+ Y +L G PF + E +F ++ +P + P + EA
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEA 245
Query: 385 KDFVKRLLNKDYRKRMTAVQAL-THPWLRD 413
KD + +L ++ KR+ + HP R+
Sbjct: 246 KDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-44
Identities = 70/336 (20%), Positives = 135/336 (40%), Gaps = 24/336 (7%)
Query: 96 FPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEV 155
+ + + G G+ + + + F + + + +E+
Sbjct: 4 YHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELF-FKDDPEKLFSDLREI 62
Query: 156 GRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVK 215
G G FG AR + + VA+K +S + + +D+ +EV+ L+ L H + ++
Sbjct: 63 GHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 118
Query: 216 FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVH 275
+ + ++VME C G D + E + A+ L +A+ H ++H
Sbjct: 119 YRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 276 RDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS----YS 331
RD+K N L + + ++L DFG + + N VG+ Y++APEV+ Y
Sbjct: 178 RDVKAGNILLS---EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVILAMDEGQYD 231
Query: 332 LEADIWSIGVISYILLCGSRPFWARTESGIFRAVL---RSDPNFDDLPWPSVSPEAKDFV 388
+ D+WS+G+ L P + A+ +++ L S ++FV
Sbjct: 232 GKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNESP--ALQSGHWSEYFRNFV 286
Query: 389 KRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
L K + R T+ L H ++ + P + LI
Sbjct: 287 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 322
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 26/278 (9%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQV-AVKIISKAKMTTAISIEDVRREVKILKAL 207
YE+ K +GRG FG R K ++V A+K++SK +M E I+ A
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKS----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AF 125
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ +V+ A +D +Y+VME GG+L+ L E+ A+ +++ +
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV--NLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDE--RLNDIVGSAYYVAP 323
H G +HRD+KP+N L D ++L DFG + + R + VG+ Y++P
Sbjct: 184 IHSMGFIHRDVKPDNMLL-----DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 324 EVL-----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
EVL Y E D WS+GV Y +L G PF+A + G + ++ +
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQAL---THPWLRD 413
+S EAK+ + L D R+ H + ++
Sbjct: 299 DISKEAKNLICAFL-TDREVRLGRNGVEEIKRHLFFKN 335
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 78/296 (26%), Positives = 135/296 (45%), Gaps = 24/296 (8%)
Query: 131 PEQSLDKSFGYNKNFGAKY-----ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISK 185
P++S + G N + E + +G+G FG AR K+ AVK++ K
Sbjct: 2 PKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKK 58
Query: 186 AKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR 245
+ +E E +IL H L + + + ++ VME GG+L+ I +
Sbjct: 59 DVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI-QK 117
Query: 246 GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DF 304
R+ E A+ +I+S + F H +G+++RDLK +N L + +L DFG+ +
Sbjct: 118 SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH---EGHCKLADFGMCKEG 174
Query: 305 IRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFR 363
I G+ Y+APE+L Y D W++GV+ Y +LCG PF A E +F
Sbjct: 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
Query: 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQA------LTHPWLRD 413
A+L + + P + +A +K + K+ R+ ++ L HP+ ++
Sbjct: 235 AILNDEVVY---P-TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 79/279 (28%), Positives = 126/279 (45%), Gaps = 24/279 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E+ K +GRG FG + K D+ A+KI++K +M R E +L
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
K + A +D NN+Y+VM+ GG+LL + R EE A+ + +++ +
Sbjct: 133 -SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 269 HLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPE 324
H VHRD+KP+N L D + +RL DFG + D + + VG+ Y++PE
Sbjct: 192 HQLHYVHRDIKPDNILM-----DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 325 VL------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
+L Y E D WS+GV Y +L G PF+A + + ++ F
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306
Query: 379 S-VSPEAKDFVKRLLNKDYRKRMTAVQAL---THPWLRD 413
+ VS AKD ++RL+ R+ HP+
Sbjct: 307 TDVSENAKDLIRRLICSR-EHRLGQNGIEDFKKHPFFSG 344
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 77/281 (27%), Positives = 132/281 (46%), Gaps = 19/281 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+++ +++G G +G A K+ Q VA+K + ++++ +E+ I++
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES-----DLQEIIKEISIMQQC 81
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H+VK+ + +++IVME C G + D I R TE++ I+ L + +
Sbjct: 82 D-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD-ERLNDIVGSAYYVAPEVL 326
H +HRD+K N L + +L DFG++ + + N ++G+ +++APEV+
Sbjct: 141 LHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTE--SGIFRAVLRSDPNFDDLPWPSVSPE 383
Y+ ADIWS+G I+ I + +P +A IF P F S
Sbjct: 198 QEIGYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK--PELWSDN 254
Query: 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
DFVK+ L K +R TA Q L HP++R L LI
Sbjct: 255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLI 295
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-43
Identities = 85/423 (20%), Positives = 157/423 (37%), Gaps = 21/423 (4%)
Query: 1 MGQCYGKTIPTTENDATTSATTTTMVVSANQNQTPLPPSTPGNGSMPVKNTPGRSSHPSP 60
+ Y K + + + T T+ S N + +
Sbjct: 192 LSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLT 251
Query: 61 WPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPK- 119
+ + +S + + F P P + + + R + K
Sbjct: 252 SRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKI 311
Query: 120 --ESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQ 177
+ PEE+ D + ++ + +G+G FG + K D+
Sbjct: 312 GQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG---TDEL 368
Query: 178 VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGE 237
AVKI+ K + +E E ++L L + + ++ +Y VME GG+
Sbjct: 369 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 428
Query: 238 LLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297
L+ I + GR+ E A +I + F +G+++RDLK +N + S + +++
Sbjct: 429 LMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS---EGHIKIA 484
Query: 298 DFGLS-DFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWA 355
DFG+ + I G+ Y+APE++ Y D W+ GV+ Y +L G PF
Sbjct: 485 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544
Query: 356 RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQA-----LTHPW 410
E +F++++ + + P S+S EA K L+ K KR+ H +
Sbjct: 545 EDEDELFQSIMEHNVAY---P-KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600
Query: 411 LRD 413
R
Sbjct: 601 FRY 603
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 72/295 (24%), Positives = 138/295 (46%), Gaps = 22/295 (7%)
Query: 129 TEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM 188
+ + L + + +++G+G FG + + VA+KII +
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEA 60
Query: 189 TTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR 248
IED+++E+ +L ++ K+ + ++I+ME GG LD L G
Sbjct: 61 ED--EIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGP 115
Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
E I+ +IL + + H + +HRD+K N L + + +++L DFG++ +
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDT 172
Query: 309 -ERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL 366
+ N VG+ +++APEV+ +S Y +ADIWS+G+ + L G P E + +
Sbjct: 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS---ELHPMKVLF 229
Query: 367 ---RSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPV 418
+++P + + S K+FV+ LNK+ R TA + L H ++ +++
Sbjct: 230 LIPKNNPPTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 26/276 (9%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ +G+G FG + K D+ AVKI+ K + +E E ++L
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 209 GHKHLV--KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
L C D +Y VME GG+L+ I + GR+ E A +I +
Sbjct: 79 KPPFLTQLHSCFQTMD--RLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLF 135
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAP 323
F +G+++RDLK +N + D++ +++ DFG+ + I G+ Y+AP
Sbjct: 136 FLQSKGIIYRDLKLDNVML-----DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAP 190
Query: 324 EVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
E++ Y D W+ GV+ Y +L G PF E +F++++ + + P S+S
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSK 246
Query: 383 EAKDFVKRLLNKDYRKRMTAVQA-----LTHPWLRD 413
EA K L+ K KR+ H + R
Sbjct: 247 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-43
Identities = 76/274 (27%), Positives = 130/274 (47%), Gaps = 21/274 (7%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI-SIEDVRREVKILKALS 208
EL + +G+G +G R G + A+K++ KA + + E IL+ +
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H +V A + +Y+++E GGEL + L R G + E+ A + +I +
Sbjct: 80 -HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ-LEREGIFMEDTACFYLAEISMALGHL 137
Query: 269 HLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEV 325
H +G+++RDLKPEN + + ++L DFGL + I + G+ Y+APE+
Sbjct: 138 HQKGIIYRDLKPENIML-----NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 326 LHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
L RS ++ D WS+G + Y +L G+ PF +L+ N P P ++ EA
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEA 248
Query: 385 KDFVKRLLNKDYRKRMTAVQA-----LTHPWLRD 413
+D +K+LL ++ R+ A HP+ R
Sbjct: 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 76/273 (27%), Positives = 133/273 (48%), Gaps = 21/273 (7%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
EL K +G+G FG + G Q A+K++ KA + + E IL ++
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVEVN- 84
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H +VK A + +Y++++ GG+L R L++ +TEED K + ++ + H
Sbjct: 85 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 270 LQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL 326
G+++RDLKPEN L D + ++L DFGLS + I +++ G+ Y+APEV+
Sbjct: 144 SLGIIYRDLKPENILL-----DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
+R ++ AD WS GV+ + +L G+ PF + +L++ P +SPEA+
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQ 254
Query: 386 DFVKRLLNKDYRKRMTAVQA-----LTHPWLRD 413
++ L ++ R+ A H +
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 79/314 (25%), Positives = 125/314 (39%), Gaps = 61/314 (19%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMT--------TAISIEDVR 198
KYE VG G +G R K G + VA+K K + A+
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRI----VAIK---KFLESDDDKMVKKIAM------ 72
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
RE+K+LK L H++LV + C+ Y+V E + +LD + + + +
Sbjct: 73 REIKLLKQLR-HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYL 130
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGS 317
QI++ + FCH ++HRD+KPEN L + ++L DFG + P E +D V +
Sbjct: 131 FQIINGIGFCHSHNIIHRDIKPENILVSQ---SGVVKLCDFGFARTLAAPGEVYDDEVAT 187
Query: 318 AYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFW-ARTE----SGIFRAVL---- 366
+Y APE+L Y D+W+IG + + G P + ++ I L
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDSDIDQLYHIMM-CLGNLI 245
Query: 367 -RSDPNFDDLPW-------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
R F+ P P +S D K+ L+ D KR + L
Sbjct: 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305
Query: 407 THPWLRDDSRPVPL 420
H + + D
Sbjct: 306 HHDFFQMDGFAERF 319
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-42
Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 32/286 (11%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
YEL + +G G +A K ++VA+K I+ K T S++++ +E++ +
Sbjct: 17 YELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCH 71
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLD-------RILARGGRYTEEDAKAIVVQI 261
H ++V + + + +++VM+L GG +LD + + G E I+ ++
Sbjct: 72 -HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-------DFIRPDERLNDI 314
L + + H G +HRD+K N L +D +++ DFG+S D R R
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR-KTF 186
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-- 370
VG+ ++APEV+ + Y +ADIWS G+ + L G+ P+ + L++DP
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 371 ----NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
D + + L KD KR TA + L H + +
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 77/312 (24%), Positives = 130/312 (41%), Gaps = 26/312 (8%)
Query: 115 GGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKY-----ELGKEVGRGHFGHTCSARGK 169
G + P + + + K +G+G FG AR K
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 170 KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIV 229
++ AVK++ K + + + E +L H LV + + + +Y V
Sbjct: 61 A---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117
Query: 230 MELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289
++ GGEL L R + E A+ +I S + + H +V+RDLKPEN L
Sbjct: 118 LDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---- 172
Query: 290 DDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYI 345
D+ + L DFGL + I + + G+ Y+APEVLH+ Y D W +G + Y
Sbjct: 173 -DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 231
Query: 346 LLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
+L G PF++R + ++ +L P+++ A+ ++ LL KD KR+ A
Sbjct: 232 MLYGLPPFYSRNTAEMYDNILNKPLQL---K-PNITNSARHLLEGLLQKDRTKRLGAKDD 287
Query: 406 L----THPWLRD 413
+H +
Sbjct: 288 FMEIKSHVFFSL 299
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 63/314 (20%), Positives = 115/314 (36%), Gaps = 54/314 (17%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI-----SIEDVR 198
+ Y + + + G +G C+ +G VA+K + +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGI----PVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 199 ---REVKILKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRIL-ARGGRY 249
RE+++L H +++ D ++ +Y+V EL L +++ +
Sbjct: 75 RVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVI 131
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
+ + + + IL + H GVVHRDL P N L + D+ + DF L+ D
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD---NNDITICDFNLAREDTADA 188
Query: 310 RLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG------------------ 349
V +Y APE++ + ++ D+WS G + +
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248
Query: 350 -----SRPFWARTESGIFRAVLR-SDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKR 399
S R LR S N W P+ P A D + ++L + ++R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308
Query: 400 MTAVQALTHPWLRD 413
++ QAL HP+
Sbjct: 309 ISTEQALRHPYFES 322
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 78/274 (28%), Positives = 129/274 (47%), Gaps = 23/274 (8%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
++ K +G+G FG R K + A+KI+ K + + E ++L+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H L A + + + VME GGEL L+R +TEE A+ +I+S + +
Sbjct: 64 -HPFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYL 121
Query: 269 HLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEV 325
H + VV+RD+K EN + D D +++ DFGL + I + G+ Y+APEV
Sbjct: 122 HSRDVVYRDIKLENLML-----DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 326 LHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
L Y D W +GV+ Y ++CG PF+ + +F +L + F P ++SPEA
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---P-RTLSPEA 232
Query: 385 KDFVKRLLNKDYRKRMTAVQA-----LTHPWLRD 413
K + LL KD ++R+ + + H +
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-41
Identities = 85/356 (23%), Positives = 141/356 (39%), Gaps = 38/356 (10%)
Query: 83 ARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYN 142
A P+ F +A L +P + G P Q S +
Sbjct: 112 AAYLEPQAQLFCSFLDAETVARARAGAGDGLF--QPLLRAVLAHLGQAPFQEFLDSLYFL 169
Query: 143 KNFGAKY-----------ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA 191
+ K+ + +GRG FG + + K + A K ++K ++
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKR 226
Query: 192 ISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL---LDRILARGGR 248
+ E KIL + + +V A E ++ +VM + GG++ + +
Sbjct: 227 KGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRP 307
+ E A QI+S + H + +++RDLKPEN L DD ++R+ D GL+ +
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLAVELKAG 342
Query: 308 DERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESG----IF 362
+ G+ ++APE+L Y D +++GV Y ++ PF AR E +
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQA-----LTHPWLRD 413
+ VL + D SP +KDF + LL KD KR+ THP RD
Sbjct: 403 QRVLEQAVTYPD----KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 71/278 (25%), Positives = 120/278 (43%), Gaps = 27/278 (9%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS-IEDVRREVKILKAL 207
E E+GRG +G R Q +AVK I T + + ++ I
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPS---GQIMAVKRIR---ATVNSQEQKRLLMDLDISMRT 62
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEEDAKAIVVQILSVV 265
V F A +V+I MEL + + +++ +G E+ I V I+ +
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 266 AFCHLQG-VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
H + V+HRD+KP N L + +++ DFG+S ++ D + G Y+APE
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINA---LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179
Query: 325 VLH-----RSYSLEADIWSIGVISYI-LLCGSRPFWARTESGIFR---AVLRSDPNFDDL 375
++ + YS+++DIWS+G I+ I L P+ + F+ V+ L
Sbjct: 180 RINPELNQKGYSVKSDIWSLG-ITMIELAILRFPY--DSWGTPFQQLKQVVEEPSP--QL 234
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
P S E DF + L K+ ++R T + + HP+
Sbjct: 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 76/286 (26%), Positives = 137/286 (47%), Gaps = 36/286 (12%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
++L + +GRG + R KK D+ A+K++ K + I+ V+ E + + S
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 209 GHKHLV--KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
H LV C E ++ V+E GG+L+ + R + EE A+ +I +
Sbjct: 68 NHPFLVGLHSCFQTES--RLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALN 124
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLS-DFIRPDERLNDIVGSAYYVAP 323
+ H +G+++RDLK +N L D++ ++L D+G+ + +RP + + G+ Y+AP
Sbjct: 125 YLHERGIIYRDLKLDNVLL-----DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 179
Query: 324 EVLHR-SYSLEADIWSIGVISYILLCGSRPFW---------ARTESGIFRAVLRSDPNFD 373
E+L Y D W++GV+ + ++ G PF TE +F+ +L
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI- 238
Query: 374 DLPWPSVSPEAKDFVKRLLNKDYRKRM-----TAVQAL-THPWLRD 413
P S+S +A +K LNKD ++R+ T + HP+ R+
Sbjct: 239 --P-RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-41
Identities = 84/314 (26%), Positives = 147/314 (46%), Gaps = 28/314 (8%)
Query: 118 PKESTIPEERGTEPEQSLDKSFGYNKNFGAK-YELGKEVGRGHFGHTCSARGKKGELKDQ 176
+ + E G+ + G + +EL K +G G +G R G +
Sbjct: 24 DGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGK 83
Query: 177 QVAVKIISKAK-MTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG 235
A+K++ KA + A + E R E ++L+ + LV A + ++++++ G
Sbjct: 84 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 143
Query: 236 GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD-- 293
GEL L++ R+TE + + V +I+ + H G+++RD+K EN L D++
Sbjct: 144 GELFTH-LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL-----DSNGH 197
Query: 294 MRLIDFGLS--DFIRPDERLNDIVGSAYYVAPEVLHRS---YSLEADIWSIGVISYILLC 348
+ L DFGLS ER D G+ Y+AP+++ + D WS+GV+ Y LL
Sbjct: 198 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257
Query: 349 GSRPFWA----RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQ 404
G+ PF +++ I R +L+S+P + P +S AKD ++RLL KD +KR+
Sbjct: 258 GASPFTVDGEKNSQAEISRRILKSEPPY---P-QEMSALAKDLIQRLLMKDPKKRLGCGP 313
Query: 405 A-----LTHPWLRD 413
H + +
Sbjct: 314 RDADEIKEHLFFQK 327
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-41
Identities = 69/306 (22%), Positives = 123/306 (40%), Gaps = 31/306 (10%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS-IEDVRREVKILKAL 207
E E+G G G R +K +AVK + + + + + ++ ++
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKT---GHVIAVKQM---RRSGNKEENKRILMDLDVVLKS 80
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
++V+ +V+I MEL G E + V I+ + +
Sbjct: 81 HDCPYIVQCFGTFITNTDVFIAMELMGTC-AEKLKKRMQGPIPERILGKMTVAIVKALYY 139
Query: 268 CHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
+ GV+HRD+KP N L ++L DFG+S + D+ + G A Y+APE +
Sbjct: 140 LKEKHGVIHRDVKPSNILLDE---RGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERI 196
Query: 327 ------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFR---AVLRSDPNF--DDL 375
Y + AD+WS+G+ L G P+ + F VL+ +P +
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPPLLPGHM 254
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHAT 435
+ S + + FVK L KD+RKR + L H +++ ++ + K + T
Sbjct: 255 GF---SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETL---EVDVASWFKDVMAKT 308
Query: 436 PFKRAA 441
R+
Sbjct: 309 ESPRSG 314
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-41
Identities = 81/358 (22%), Positives = 137/358 (38%), Gaps = 39/358 (10%)
Query: 83 ARASTPRRFFRRPFPPPSPAKHIKASLAKRLGGG---KPKESTIPEERGTEPEQSLDKS- 138
S +H++ L K+ +P I + + Q +S
Sbjct: 110 DTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESD 169
Query: 139 ----FGYNKNFGAKYELGKE-------VGRGHFGHTCSARGKKGELKDQQVAVKIISKAK 187
F KN L +GRG FG R + A+K + K +
Sbjct: 170 KFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKR 226
Query: 188 MTTAISIEDVRREVKILKALSGHKH--LVKFCDACEDVNNVYIVMELCEGGELLDRILAR 245
+ E +L +S +V A + + +++L GG+L L++
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQ 285
Query: 246 GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305
G ++E D + +I+ + H + VV+RDLKP N L + +R+ D GL+
Sbjct: 286 HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF 342
Query: 306 RPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESG--- 360
++ + VG+ Y+APEVL + +Y AD +S+G + + LL G PF
Sbjct: 343 -SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401
Query: 361 IFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRM-----TAVQALTHPWLRD 413
I R L S SPE + ++ LL +D +R+ A + P+ R
Sbjct: 402 IDRMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-40
Identities = 85/307 (27%), Positives = 143/307 (46%), Gaps = 60/307 (19%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM--------TTAISIEDVRR 199
KY +++G G +G A+ GE A+K K ++ +T I R
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGET----FALK---KIRLEKEDEGIPSTTI------R 49
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKAI 257
E+ ILK L H ++VK D + +V E + +LLD G AK+
Sbjct: 50 EISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSF 105
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVG 316
++Q+L+ +A+CH + V+HRDLKP+N L + ++++ DFGL+ F P + +
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHEIV 162
Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVL---- 366
+ +Y AP+VL + YS DIWS+G I ++ G+ F +E IFR +L
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR-ILGTPN 221
Query: 367 -RSDPNFDDLPW-----------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
++ PN +LP + D + ++L D +R+TA QAL H
Sbjct: 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
Query: 409 PWLRDDS 415
+ ++++
Sbjct: 282 AYFKENN 288
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 77/306 (25%), Positives = 136/306 (44%), Gaps = 54/306 (17%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKI 203
+Y+ VG G +G C+A K +VAVK +S+ + A RE+++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRT---YRELRL 81
Query: 204 LKALSGHKHLVKFCD------ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
LK + H++++ D + E+ N+VY+V L L+ I+ + + T++ + +
Sbjct: 82 LKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--LNNIV-KCQKLTDDHVQFL 137
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERLNDIVG 316
+ QIL + + H ++HRDLKP N D +++++DFGL+ R + + V
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNE---DCELKILDFGLA---RHTADEMTGYVA 191
Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG-----------------------SR 351
+ +Y APE++ Y+ DIWS+G I LL G
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251
Query: 352 PFWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407
+ S R ++S + + +P A D ++++L D KR+TA QAL
Sbjct: 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311
Query: 408 HPWLRD 413
H +
Sbjct: 312 HAYFAQ 317
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 32/297 (10%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS-IEDVRREVKILKAL 207
+ E+GRG +G K Q +AVK I + T + + ++ ++
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPS---GQIMAVKRI---RSTVDEKEQKQLLMDLDVVMRS 77
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRIL-----ARGGRYTEEDAKAIVVQIL 262
S ++V+F A + +I MEL D+ EE I + +
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 263 SVVAFCHLQG-VVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYY 320
+ ++HRD+KP N L +++L DFG+S + + D G Y
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDR---SGNIKLCDFGISGQLVDSIAKTRD-AGCRPY 191
Query: 321 VAPEVLH-----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA---VLRSD-PN 371
+APE + + Y + +D+WS+G+ Y L G P+ + +F V++ D P
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQ 249
Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD-DSRPVPLDILIFKL 427
+ SP +FV L KD KR + L HP++ + R V + + K+
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKI 306
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-40
Identities = 83/341 (24%), Positives = 146/341 (42%), Gaps = 29/341 (8%)
Query: 90 RFFRRPFPPPSPA---------KHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFG 140
R F +P + + L K+ S P + E + +
Sbjct: 82 TVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKP 141
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
++ ++E K +G+G FG + K + A+KI+ K + + E
Sbjct: 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
++L S H L + + + + VME GGEL L+R ++E+ A+ +
Sbjct: 199 NRVL-QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAE 256
Query: 261 ILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSA 318
I+S + + H + VV+RDLK EN + D +++ DFGL + I+ + G+
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 319 YYVAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
Y+APEVL + Y D W +GV+ Y ++CG PF+ + +F +L + F P
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---P- 369
Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQA-----LTHPWLRD 413
++ PEAK + LL KD ++R+ + H +
Sbjct: 370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 75/284 (26%), Positives = 136/284 (47%), Gaps = 32/284 (11%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
++L + +GRG + R KK D+ A++++ K + I+ V+ E + + S
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 209 GHKHLV--KFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
H LV C E ++ V+E GG+L+ + R + EE A+ +I +
Sbjct: 111 NHPFLVGLHSCFQTES--RLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALN 167
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEV 325
+ H +G+++RDLK +N L S + ++L D+G+ + +RP + + G+ Y+APE+
Sbjct: 168 YLHERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 224
Query: 326 LHR-SYSLEADIWSIGVISYILLCGSRPFW---------ARTESGIFRAVLRSDPNFDDL 375
L Y D W++GV+ + ++ G PF TE +F+ +L
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI--- 281
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRM-----TAVQAL-THPWLRD 413
P S+S +A +K LNKD ++R+ T + HP+ R+
Sbjct: 282 P-RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-40
Identities = 83/311 (26%), Positives = 139/311 (44%), Gaps = 62/311 (19%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM--------TTAISIEDVR 198
KYE +++G G +G A+ ++ E+ VA+K + ++ ++A+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEI----VALK---RVRLDDDDEGVPSSAL------ 49
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKA 256
RE+ +LK L HK++V+ D + +V E C+ + D G E K+
Sbjct: 50 REICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKS 105
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIV 315
+ Q+L + FCH + V+HRDLKP+N L + +++L +FGL+ F P + V
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYSAEV 162
Query: 316 GSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRP-FWARTE----SGIFRAVL-- 366
+ +Y P+VL + YS D+WS G I L RP F IFR +L
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGT 221
Query: 367 ---RSDPNFDDLPW-----------------PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
P+ LP P ++ +D ++ LL + +R++A +AL
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
Query: 407 THPWLRDDSRP 417
HP+ D P
Sbjct: 282 QHPYFSDFCPP 292
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 8e-40
Identities = 78/343 (22%), Positives = 138/343 (40%), Gaps = 35/343 (10%)
Query: 95 PFPPPSPAKHIKASLAKRLGGGKPKEST--IPEERGTEPEQSLDKSFGYNKNFGAKY--- 149
P P + L + +E T E P S +N+ K+
Sbjct: 119 PEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLER 178
Query: 150 --------ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV 201
+ +G+G FG C+ + + + A K + K ++ E
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 202 KILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQ 260
+IL+ ++ + +V A E + + +V+ L GG+L I G + E A +
Sbjct: 236 QILEKVN-SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
I + H + +V+RDLKPEN L D +R+ D GL+ + + + VG+ Y
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 351
Query: 321 VAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSDPNFDDL 375
+APEV+ Y+ D W++G + Y ++ G PF R + + R V + +
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE- 410
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRM-----TAVQALTHPWLRD 413
SP+A+ +LL KD +R+ +A + HP +
Sbjct: 411 ---RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 83/306 (27%), Positives = 137/306 (44%), Gaps = 55/306 (17%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKI 203
Y VG G +G CSA K+ ++VA+K +S+ A RE+ +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPFQSEIFAKRA---YRELLL 76
Query: 204 LKALSGHKHLVKFCDA------CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
LK + H++++ D + + Y+VM + L +I+ +++EE + +
Sbjct: 77 LKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL--KFSEEKIQYL 131
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP-DERLNDIVG 316
V Q+L + + H GVVHRDLKP N D +++++DFGL+ R D + V
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNE---DCELKILDFGLA---RHADAEMTGYVV 185
Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG-----------------------SR 351
+ +Y APEV+ Y+ DIWS+G I +L G
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 245
Query: 352 PFWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407
F + ++ ++S P + P SP+A D ++++L D KR+TA QALT
Sbjct: 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305
Query: 408 HPWLRD 413
HP+
Sbjct: 306 HPFFEP 311
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 77/331 (23%), Positives = 142/331 (42%), Gaps = 58/331 (17%)
Query: 121 STIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAV 180
S P G ++ ++ A Y + VG G +G CSA + +VA+
Sbjct: 3 SPPPARSGFYRQEVTKTAW----EVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAI 55
Query: 181 KIISKA--KMTTAISIEDVRREVKILKALSGHKHLVKFCDA------CEDVNNVYIVMEL 232
K + + A RE+++LK + H++++ D +D + Y+VM
Sbjct: 56 KKLYRPFQSELFAKRA---YRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPF 111
Query: 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292
L +++ + + E+ + +V Q+L + + H G++HRDLKP N D
Sbjct: 112 MGTD--LGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE---DC 165
Query: 293 DMRLIDFGLSDFIRP-DERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG 349
+++++DFGL+ R D + V + +Y APEV+ Y+ DIWS+G I ++ G
Sbjct: 166 ELKILDFGLA---RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
Query: 350 -----------------------SRPFWARTESGIFRAVLRSDPNFDDLPW----PSVSP 382
F R +S + ++ P + + + SP
Sbjct: 223 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 282
Query: 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
A + ++++L D +R+TA +AL HP+
Sbjct: 283 LAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 79/313 (25%), Positives = 132/313 (42%), Gaps = 60/313 (19%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
G++Y K +G G G SA D++VA+K I + RE+KI++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLTDPQSVKHA---LREIKIIR 63
Query: 206 ALSGHKHLVKFCD--------------ACEDVNNVYIVMELCEGGELLDRILARGGRYTE 251
L H ++VK + + ++N+VYIV E E L +L G E
Sbjct: 64 RLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVL-EQGPLLE 119
Query: 252 EDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL 311
E A+ + Q+L + + H V+HRDLKP N + +D +++ DFGL+ + P
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPHYSH 177
Query: 312 NDI----VGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG---------------- 349
+ + +Y +P +L +Y+ D+W+ G I +L G
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
Query: 350 -------SRPFWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRK 398
S +R+D P P +S EA DF++++L
Sbjct: 238 LESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296
Query: 399 RMTAVQALTHPWL 411
R+TA +AL+HP++
Sbjct: 297 RLTAEEALSHPYM 309
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 87/306 (28%), Positives = 132/306 (43%), Gaps = 61/306 (19%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM--------TTAISIEDVRR 199
KY+ ++VG G +G A+ +G + VA+K + ++ +TAI R
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRI----VALK---RIRLDAEDEGIPSTAI------R 68
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKAI 257
E+ +LK L H ++V D + +V E E ++LD + K
Sbjct: 69 EISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIY 124
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVG 316
+ Q+L VA CH ++HRDLKP+N L D ++L DFGL+ F P V
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLARAFGIPVRSYTHEVV 181
Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVL---- 366
+ +Y AP+VL + YS DIWSIG I ++ G F T+ IF +L
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS-ILGTPN 240
Query: 367 -RSDPNFDDLPW------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407
R P +LP P E D + +L D KR++A A+
Sbjct: 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300
Query: 408 HPWLRD 413
HP+ +D
Sbjct: 301 HPYFKD 306
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-39
Identities = 75/311 (24%), Positives = 126/311 (40%), Gaps = 59/311 (18%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM-------TTAISIEDVRR 199
Y ++G G + + K L VA+K + ++ TAI R
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNL----VALK---EIRLEHEEGAPCTAI------R 49
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEEDAKAI 257
EV +LK L H ++V D ++ +V E + + LD G + K
Sbjct: 50 EVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD---CGNIINMHNVKLF 105
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVG 316
+ Q+L +A+CH Q V+HRDLKP+N L + +++L DFGL+ P + ++ V
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIPTKTYDNEVV 162
Query: 317 SAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAV----L 366
+ +Y P++L YS + D+W +G I Y + G F T IFR +
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE 222
Query: 367 RSDPNFDDLPW------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
+ P P + + D + +LL + R R++A A+ H
Sbjct: 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282
Query: 409 PWLRDDSRPVP 419
P+ +
Sbjct: 283 PFFLSLGERIH 293
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-39
Identities = 75/310 (24%), Positives = 125/310 (40%), Gaps = 56/310 (18%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM--------TTAISIEDVR 198
+Y ++G G +G A E VA+K + ++ TAI
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNET----VAIK---RIRLEHEEEGVPGTAI------ 81
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
REV +LK L H+++++ + ++++ E E L + + + + K+ +
Sbjct: 82 REVSLLKELQ-HRNIIELKSVIHHNHRLHLIFEYAEND--LKKYMDKNPDVSMRVIKSFL 138
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL--IDFGLS-DFIRPDERLNDIV 315
Q+++ V FCH + +HRDLKP+N L + L DFGL+ F P + +
Sbjct: 139 YQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI 198
Query: 316 GSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAV---- 365
+ +Y PE+L R YS DIWSI I +L + F +E IF +
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258
Query: 366 LRSDPNFDDLPW------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407
+ P LP + E D + +L D KR++A AL
Sbjct: 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318
Query: 408 HPWLRDDSRP 417
HP+ +
Sbjct: 319 HPYFSHNDFD 328
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 78/319 (24%), Positives = 128/319 (40%), Gaps = 64/319 (20%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM-------TTAISIEDVRR 199
+++ +++G G + K G VA+K + K+ +TAI R
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVY----VALK---EVKLDSEEGTPSTAI------R 52
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG--GELLD--RILARGGRYTEEDAK 255
E+ ++K L H+++V+ D N + +V E + + +D + K
Sbjct: 53 EISLMKELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDI 314
Q+L +AFCH ++HRDLKP+N L ++L DFGL+ F P +
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 315 VGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVL-- 366
V + +Y AP+VL R+YS DIWS G I ++ G F + IF ++
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD-IMGT 227
Query: 367 ---RSDPNFDDLPW----------------------PSVSPEAKDFVKRLLNKDYRKRMT 401
P+ LP + DF+ LL + R++
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287
Query: 402 AVQALTHPWLRDDSRPVPL 420
A QAL HPW + +
Sbjct: 288 AKQALHHPWFAEYYHHASM 306
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 82/312 (26%), Positives = 131/312 (41%), Gaps = 62/312 (19%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISK------AKMTTAISIEDVRR 199
G +Y +G G +G CSA +VA+K IS + T R
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFEHQTYCQRTL--------R 74
Query: 200 EVKILKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDA 254
E+KIL H++++ D E + +VYIV +L E L ++L + + +
Sbjct: 75 EIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHI 130
Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI 314
+ QIL + + H V+HRDLKP N L + D+++ DFGL+ PD
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGF 187
Query: 315 ----VGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG------------------- 349
V + +Y APE++ + Y+ DIWS+G I +L
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247
Query: 350 ----SRPFWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMT 401
S+ + R L S P+ + +PW P+ +A D + ++L + KR+
Sbjct: 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307
Query: 402 AVQALTHPWLRD 413
QAL HP+L
Sbjct: 308 VEQALAHPYLEQ 319
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 86/371 (23%), Positives = 139/371 (37%), Gaps = 77/371 (20%)
Query: 97 PPPSPAKHIKASLAKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVG 156
P P+ +++ G K +G + Q + Y K +G
Sbjct: 16 PVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEV------------SYTDTKVIG 63
Query: 157 RGHFGHTCSARGKK-GELKDQQVAVK-IISKAKMTTAISIEDVRREVKILKALSGHKHLV 214
G FG A+ GEL VA+K ++ + RE++I++ L H ++V
Sbjct: 64 NGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKN--------RELQIMRKLD-HCNIV 110
Query: 215 K----FCDACEDVNNVYI--VMELCEG--GELLDRILARGGRYTEEDAKAIVVQILSVVA 266
+ F + E + VY+ V++ + K + Q+ +A
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
+ H G+ HRD+KP+N L D A ++L DFG + + E + S YY APE++
Sbjct: 171 YIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 228
Query: 327 HRS--YSLEADIWSIGVISYILLCGSRPFWARTESG------IFR--------------- 363
+ Y+ D+WS G + LL G +P + +SG I +
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLG-QPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNP 286
Query: 364 -AVLRSDPNFDDLPW-----PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW---LRD- 413
P PW P PEA RLL R+T ++A H + LRD
Sbjct: 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346
Query: 414 -----DSRPVP 419
+ R P
Sbjct: 347 NVKLPNGRDTP 357
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 80/344 (23%), Positives = 134/344 (38%), Gaps = 66/344 (19%)
Query: 124 PEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVK-I 182
P + + + L + Y K +G G FG A+ ++ +VA+K +
Sbjct: 17 PLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK----LVESDEVAIKKV 72
Query: 183 ISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDA------CEDVNNVYIVMELCEG- 235
+ + RE++I++ + H ++V +D + +V+E
Sbjct: 73 LQDKRFKN--------RELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET 123
Query: 236 -GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294
K + Q+L +A+ H G+ HRD+KP+N L +
Sbjct: 124 VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVL 181
Query: 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRP 352
+LIDFG + + E + S YY APE++ + Y+ DIWS G + L+ G +P
Sbjct: 182 KLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QP 240
Query: 353 FWARTESG------IFRAVL-----------------RSDPNFDDLPW-----PSVSPEA 384
+ ESG I + VL P P+ P P+A
Sbjct: 241 LF-PGESGIDQLVEIIK-VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDA 298
Query: 385 KDFVKRLLNKDYRKRMTAVQALTHPW---LRD------DSRPVP 419
D + RLL R+TA++AL HP+ LR + R +P
Sbjct: 299 IDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELP 342
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALS 208
L + +G G FG + +VAVK + +IE+VR+E K+ L
Sbjct: 10 TLEEIIGIGGFGKVY-----RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H +++ C N+ +VME GG L + G R + VQI + +
Sbjct: 65 -HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYL 121
Query: 269 HLQG---VVHRDLKPENFLFTSGRDDADMR-----LIDFGLSDFIRPDERLNDIVGSAYY 320
H + ++HRDLK N L ++ D+ + DFGL+ +++ G+ +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAW 180
Query: 321 VAPEVL-HRSYSLEADIWSIGVISYILLCGSRPF 353
+APEV+ +S +D+WS GV+ + LL G PF
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 80/313 (25%), Positives = 127/313 (40%), Gaps = 57/313 (18%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM--------TTAISIEDVRR 199
+YE E+G G +G AR K + VA+K + ++ + I R
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLK--NGGRFVALK---RVRVQTGEEGMPLSTI------R 60
Query: 200 EVKILKALSG--HKHLVKFCDAC-----EDVNNVYIVMELCEG--GELLDRILARGGRYT 250
EV +L+ L H ++V+ D C + + +V E + LD++
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVP 118
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
E K ++ Q+L + F H VVHRDLKP+N L T ++L DFGL+
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMA 175
Query: 311 LNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAV 365
L +V + +Y APEVL SY+ D+WS+G I + F ++ I +
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 366 ----LRSDPNFDDLPW---------------PSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
P LP + KD + + L + KR++A AL
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295
Query: 407 THPWLRDDSRPVP 419
+HP+ +D R
Sbjct: 296 SHPYFQDLERCKE 308
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 79/318 (24%), Positives = 130/318 (40%), Gaps = 63/318 (19%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM-----------TTAISIE 195
+YE +G G F AR K ++ VA+K K K+ TA+
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQI----VAIK---KIKLGHRSEAKDGINRTAL--- 60
Query: 196 DVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEG--GELLDRILARGGRYTEED 253
RE+K+L+ LS H +++ DA +N+ +V + E ++ T
Sbjct: 61 ---REIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSH 113
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLN 312
KA ++ L + + H ++HRDLKP N L ++ ++L DFGL+ F P+
Sbjct: 114 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYT 170
Query: 313 DIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWA-RTE----SGIFRAV 365
V + +Y APE+L R Y + D+W++G I LL PF ++ + IF +
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLDQLTRIFETL 229
Query: 366 ----LRSDPNFDDLPW----------------PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
P+ LP + + D ++ L + R+TA QA
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 289
Query: 406 LTHPWLRDDSRPVPLDIL 423
L + + P P L
Sbjct: 290 LKMKYFSNRPGPTPGCQL 307
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-37
Identities = 77/333 (23%), Positives = 136/333 (40%), Gaps = 68/333 (20%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKI 203
+Y+ K +G G G C+A D+ VA+K +S+ T A RE+ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAKRA---YRELVL 114
Query: 204 LKALSGHKHLVKFCDA------CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
+K + HK+++ + E+ +VY+VMEL + L +++ E +
Sbjct: 115 MKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME--LDHERMSYL 169
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
+ Q+L + H G++HRDLKP N + S D ++++DFGL+ + V +
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVT 226
Query: 318 AYYVAPEV-LHRSYSLEADIWSIGVISYILLCG-----------------------SRPF 353
YY APEV L Y DIWS+G I ++ F
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286
Query: 354 WARTESGIFRAVLRSDPNFDDLPWPSV----------------SPEAKDFVKRLLNKDYR 397
+ + + R + + P + L +P + + +A+D + ++L D
Sbjct: 287 MKKLQPTV-RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345
Query: 398 KRMTAVQALTHPWLR-----DDSRPVPLDILIF 425
KR++ AL HP++ + P I
Sbjct: 346 KRISVDDALQHPYINVWYDPAEVEAPPPQIYDK 378
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
E+ + VGRG FG C K + + + VA+K I + E++ L ++
Sbjct: 11 EVEEVVGRGAFGVVC-----KAKWRAKDVAIKQIESESE-----RKAFIVELRQLSRVN- 59
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF-- 267
H ++VK AC +N V +VME EGG L +L A + +
Sbjct: 60 HPNIVKLYGAC--LNPVCLVMEYAEGGSL-YNVLHGAEPLPYYTAA-HAMSWCLQCSQGV 115
Query: 268 -----CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
+ ++HRDLKP N L + +++ DFG + I + + GSA ++A
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVA--GGTVLKICDFGTACDI--QTHMTNNKGSAAWMA 171
Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPF 353
PEV +YS + D++S G+I + ++ +PF
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 74/345 (21%), Positives = 135/345 (39%), Gaps = 63/345 (18%)
Query: 115 GGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELK 174
G K +E + E++ E L + + +E E+G G+ G K
Sbjct: 1 GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPS--- 57
Query: 175 DQQVAVKIISKAKMTTAIS-IEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELC 233
+A K+I + + + RE+++L + ++V F A + I ME
Sbjct: 58 GLVMARKLI---HLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHM 113
Query: 234 EGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG-VVHRDLKPENFLFTSGRDDA 292
+GG LD++L + GR E+ + + ++ + + + ++HRD+KP N L S
Sbjct: 114 DGG-SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RG 169
Query: 293 DMRLIDFG----LSDFIRPDERLNDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILL 347
+++L DFG L D + N VG+ Y++PE L + YS+++DIWS+G+ +
Sbjct: 170 EIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224
Query: 348 CGSRPF--------------------WARTESGIFRAVLRSDPNFDDLPWPSV------- 380
G P + D P ++
Sbjct: 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284
Query: 381 -------------SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
S E +DFV + L K+ +R Q + H +++
Sbjct: 285 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 88/319 (27%), Positives = 135/319 (42%), Gaps = 64/319 (20%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVR---RE 200
N + ++L +G G +G CSA K + VA+K K+ RE
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIK-----KIEPFDKPLFALRTLRE 59
Query: 201 VKILKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAK 255
+KILK H++++ + + E+ N VYI+ EL + L R++ +++ +
Sbjct: 60 IKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVI-STQMLSDDHIQ 115
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
+ Q L V H V+HRDLKP N L S + D+++ DFGL+ I N
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIIDESAADNSEP 172
Query: 316 GSA-----------YYVAPEVL--HRSYSLEADIWSIGVI--------------SY---- 344
+Y APEV+ YS D+WS G I Y
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232
Query: 345 --IL-LCG---SRPFWARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNK 394
I + G S ES R ++S P + P P V+P+ D ++R+L
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292
Query: 395 DYRKRMTAVQALTHPWLRD 413
D KR+TA +AL HP+L+
Sbjct: 293 DPAKRITAKEALEHPYLQT 311
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 150 ELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
E+G+ +G+G FG G+ GE VA+++I + ++ +REV +
Sbjct: 36 EIGELIGKGRFGQVY--HGRWHGE-----VAIRLIDIERDNED-QLKAFKREVMAYRQTR 87
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H+++V F AC ++ I+ LC+G L + + I +I+ + +
Sbjct: 88 -HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS------DFIRPDERLNDIVGSAYYVA 322
H +G++H+DLK +N + D+ + + DFGL R +++L G ++A
Sbjct: 147 HAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 323 PEVL----------HRSYSLEADIWSIGVISYILLCGSRPF 353
PE++ +S +D++++G I Y L PF
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 74/314 (23%), Positives = 132/314 (42%), Gaps = 63/314 (20%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKI 203
+Y+ K +G G G C+A ++ VA+K +S+ T A RE+ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAKRA---YRELVL 77
Query: 204 LKALSGHKHLVKFCDA------CEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
+K + HK+++ + E+ +VYIVMEL + L +++ E +
Sbjct: 78 MKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYL 132
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
+ Q+L + H G++HRDLKP N + S D ++++DFGL+ + V +
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVT 189
Query: 318 AYYVAPEV-LHRSYSLEADIWSIGVISYILLCG-----------------------SRPF 353
YY APEV L Y DIWS+G I ++ G F
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249
Query: 354 WARTESGIFRAVLRSDPNFDDLPW----------------PSVSPEAKDFVKRLLNKDYR 397
+ + + R + + P + + + +A+D + ++L D
Sbjct: 250 MKKLQPTV-RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308
Query: 398 KRMTAVQALTHPWL 411
KR++ +AL HP++
Sbjct: 309 KRISVDEALQHPYI 322
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 80/317 (25%), Positives = 122/317 (38%), Gaps = 64/317 (20%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM-----------TTAISIE 195
+YE E+G G +G AR G VA+K ++ + +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHF----VALK---SVRVPNGGGGGGGLPISTV--- 59
Query: 196 DVRREVKILKALSG--HKHLVKFCDAC-----EDVNNVYIVMELCEG--GELLDRILARG 246
REV +L+ L H ++V+ D C + V +V E + LD+
Sbjct: 60 ---REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA--PP 114
Query: 247 GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306
E K ++ Q L + F H +VHRDLKPEN L T ++L DFGL+
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIYS 171
Query: 307 PDERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGI 361
L +V + +Y APEVL +Y+ D+WS+G I + F +E I
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231
Query: 362 FRAV----LRSDPNFDDLPW---------------PSVSPEAKDFVKRLLNKDYRKRMTA 402
F + P LP P + + +L + KR++A
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291
Query: 403 VQALTHPWLRDDSRPVP 419
+AL H +L D P
Sbjct: 292 FRALQHSYLHKDE-GNP 307
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 6e-36
Identities = 67/362 (18%), Positives = 128/362 (35%), Gaps = 66/362 (18%)
Query: 148 KYELGKEVGRGH--FGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
YEL +G+G AR K + V V+ I+ + + ++ E+ + K
Sbjct: 26 CYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEACSNE-MVTFLQGELHVSK 81
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV-QILSV 264
+ H ++V + N +++V G D I E A A ++ +L
Sbjct: 82 LFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD--------ERLNDIVG 316
+ + H G VHR +K + L + D + L + + + V
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 317 SAYYVAPEVLHRS---YSLEADIWSIGVISYILLCGSRPF-------------------- 353
+++PEVL ++ Y ++DI+S+G+ + L G PF
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257
Query: 354 ----------------WARTESGIFRAVLRSDPNFDDLPWPSV------SPEAKDFVKRL 391
+ SG+ ++ S P + PS SP FV++
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317
Query: 392 LNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTE 451
L ++ R +A L H + + + + L +L++ T F+ + + S
Sbjct: 318 LQRNPDARPSASTLLNHSFFK-QIKRRASEALP-ELLRPVTPITNFEGSQSQDHSGIFGL 375
Query: 452 DE 453
Sbjct: 376 VT 377
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-36
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELK--DQQVAVKII----SKAKMTTAISIEDVRREVKI 203
E K++G+G FG KG L VA+K + S+ + ++ +REV I
Sbjct: 22 EYEKQIGKGGFGLVH-----KGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
+ L+ H ++VK N +VME G+L R+L + +++ I
Sbjct: 77 MSNLN-HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 264 VVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRL--IDFGLSDFIRPDERLNDIVGSAY 319
+ + Q +VHRDL+ N S ++A + DFGLS ++ ++G+
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQ 191
Query: 320 YVAPEVL---HRSYSLEADIWSIGVISYILLCGSRPF 353
++APE + SY+ +AD +S +I Y +L G PF
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 77/336 (22%), Positives = 128/336 (38%), Gaps = 77/336 (22%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRRE 200
+ + +YE+ K +G+G FG A K Q VA+K++ ++ + + E
Sbjct: 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNEKRFHRQAAEE----- 143
Query: 201 VKILKALSGH-----KHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEED 253
++IL+ L +++ + N++ + EL EL+ + +G ++
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG--FSLPL 201
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
+ IL + H ++H DLKPEN L + + +++IDFG S + +R+
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ-QGRSGIKVIDFGSSCYE--HQRVYT 258
Query: 314 IVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWARTE-------------- 358
+ S +Y APEV L Y + D+WS+G I LL G E
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318
Query: 359 -SGIFRAVLRSDPNFDDLPWPS------------VSPEAK-------------------- 385
+ A R+ +P V +
Sbjct: 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK 378
Query: 386 --------DFVKRLLNKDYRKRMTAVQALTHPWLRD 413
DF+K+ L D RMT QAL HPWLR
Sbjct: 379 GCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 20/212 (9%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+ +++G G FG + E VAVKI+ + + + REV I+K L
Sbjct: 40 NIKEKIGAGSFGTVH-----RAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLR- 92
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR--YTEEDAKAIVVQILSVVAF 267
H ++V F A N+ IV E G L + G R E ++ + + +
Sbjct: 93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 268 CHLQG--VVHRDLKPENFLFTSGRDDADMRL--IDFGLSDFIRPDER-LNDIVGSAYYVA 322
H + +VHR+LK N L D + DFGLS G+ ++A
Sbjct: 153 LHNRNPPIVHRNLKSPNLLV-----DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207
Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPF 353
PEVL + ++D++S GVI + L +P+
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 61/263 (23%), Positives = 109/263 (41%), Gaps = 29/263 (11%)
Query: 150 ELGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+G+ +G G FG +GK G+ VAVK+++ T ++ + EV +L+
Sbjct: 27 TVGQRIGSGSFGTVY--KGKWHGD-----VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTR 78
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H +++ F + IV + CEG L + A ++ + I Q + +
Sbjct: 79 -HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLI--DFGLS---DFIRPDERLNDIVGSAYYVAP 323
H + ++HRDLK N D + DFGL+ + + GS ++AP
Sbjct: 137 HAKSIIHRDLKSNNIFL-----HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 324 EVL----HRSYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRSD--PNFDDLP 376
EV+ YS ++D+++ G++ Y L+ G P+ I V R P+ +
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 377 WPSVSPEAKDFVKRLLNKDYRKR 399
+ K + L K +R
Sbjct: 252 -SNCPKRMKRLMAECLKKKRDER 273
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-35
Identities = 75/341 (21%), Positives = 131/341 (38%), Gaps = 87/341 (25%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKA--KMTTAISIEDVRREVKI 203
KYEL K++G+G +G + ++ + VAVK I A T A RE+ I
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDAFQNSTDAQRT---FREIMI 61
Query: 204 LKALSGHKHLVKFCDAC--EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
L LSGH+++V + ++ +VY+V + E L ++ R + +V Q+
Sbjct: 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVI-RANILEPVHKQYVVYQL 118
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA--- 318
+ V+ + H G++HRD+KP N L + + +++ DFGLS R+ + + +
Sbjct: 119 IKVIKYLHSGGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 319 -------------------YYVAPEVL--HRSYSLEADIWSIGVI--------------- 342
+Y APE+L Y+ D+WS+G I
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235
Query: 343 -----------------------------SYILLCGSRPFWARTESGIFRAVLRSDPNFD 373
+ I + +S +
Sbjct: 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKV--EIRQSNKRDIFTKWKNLLL 293
Query: 374 DL-PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
+ P + EA D + +LL + KR++A AL HP++
Sbjct: 294 KINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 8e-35
Identities = 81/399 (20%), Positives = 142/399 (35%), Gaps = 107/399 (26%)
Query: 110 AKRLGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGK 169
+ G +E ++ + + + +YE+ +G G +GH C A K
Sbjct: 16 TQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDK 75
Query: 170 KGELKDQQVAVKIISKA--KMTTAISIEDVRREVKILKALSGHKHLVKFCD-----ACED 222
+ + VA+K I + + I RE+ IL L+ H H+VK D E
Sbjct: 76 L---EKRVVAIKKILRVFEDLIDCKRI---LREIAILNRLN-HDHVVKVLDIVIPKDVEK 128
Query: 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPEN 282
+ +Y+V+E+ + ++ TE K ++ +L V + H G++HRDLKP N
Sbjct: 129 FDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186
Query: 283 FLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA------------------------ 318
L D +++ DFGL+ + E N + +
Sbjct: 187 CLVNQ---DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243
Query: 319 ----YYVAPEVL--HRSYSLEADIWSIGVI-------------------------SYILL 347
+Y APE++ +Y+ D+WSIG I S L
Sbjct: 244 VVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPL 303
Query: 348 CGSRPFWARTESG----------IF-------------------RAVLRSDPNFDDLPW- 377
+ + IF + +R P +
Sbjct: 304 SPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363
Query: 378 ---PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
P+ S +A +KR+L + KR+T + L HP+ ++
Sbjct: 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 78/331 (23%), Positives = 126/331 (38%), Gaps = 76/331 (22%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRREVKILKA 206
+Y L +++G GHF A+ + VA+KI+ T A E+K+L+
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDKVYTEA-----AEDEIKLLQR 71
Query: 207 LS----------GHKHLVKFCDA----CEDVNNVYIVMELCEGGELLDRILARGGR-YTE 251
++ G H++K D + +V +V E+ G LL I R
Sbjct: 72 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPL 130
Query: 252 EDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADM---RLIDFGLSDFIRP 307
K I Q+L + + H + G++H D+KPEN L ++ ++ D G + +
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-- 188
Query: 308 DERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFR--- 363
DE + + + Y +PEV L + ADIWS + + L+ G F +
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248
Query: 364 ------AVL------------RSDPNFDDL----------PWP----------SVSPEAK 385
+L + F+ WP EAK
Sbjct: 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 308
Query: 386 ---DFVKRLLNKDYRKRMTAVQALTHPWLRD 413
DF+ +L D RKR A + HPWL+D
Sbjct: 309 EISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 75/377 (19%), Positives = 133/377 (35%), Gaps = 99/377 (26%)
Query: 124 PEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII 183
+ ++L N + Y + +GRG +G+ A K ++ VA+K +
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKV 59
Query: 184 SKA--KMTTAISIEDVRREVKILKALSGHKHLVKFCD-----ACEDVNNVYIVMELCEGG 236
++ + I RE+ IL L ++++ D + +YIV+E+ +
Sbjct: 60 NRMFEDLIDCKRI---LREITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADSD 115
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
L ++ TEE K I+ +L F H G++HRDLKP N L D +++
Sbjct: 116 --LKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ---DCSVKV 170
Query: 297 IDFGLSDFIRPDERLNDIVGSA-----------------------YYVAPEVL--HRSYS 331
DFGL+ I ++ N + +Y APE++ +Y+
Sbjct: 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT 230
Query: 332 LEADIWSIGVI----------SYILLCGSRPFW--------------------------- 354
DIWS G I P +
Sbjct: 231 KSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLN 290
Query: 355 --------------ARTESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDY 396
++ P+ + PS+S + + ++ +L +
Sbjct: 291 IIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNP 350
Query: 397 RKRMTAVQALTHPWLRD 413
KR+T QAL HP+L+D
Sbjct: 351 NKRITIDQALDHPYLKD 367
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 76/346 (21%), Positives = 130/346 (37%), Gaps = 74/346 (21%)
Query: 137 KSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED 196
+ ++ ++++ + G+G FG + K VA+K + +
Sbjct: 13 AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDPRFR------ 63
Query: 197 VRREVKILKALSGHKH--LVKFCD-----ACEDVNNVY--IVMELCEGGELLDRILARGG 247
RE++I++ L+ H +V+ D ++Y +VME + L R
Sbjct: 64 -NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYY 120
Query: 248 RY----TEEDAKAIVVQILSVVAFCHLQ--GVVHRDLKPENFLFTSGRDDADMRLIDFGL 301
R K + Q++ + HL V HRD+KP N L D ++L DFG
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGS 178
Query: 302 SDFIRPDERLNDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCG---------- 349
+ + P E + S YY APE++ ++ Y+ DIWS+G I ++ G
Sbjct: 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 350 -------------SRPFWARTESGIFRAVLRSDPNFDDLPW--------PSVSPEAKDFV 388
SR + N +PW + EA D +
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTD---VDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295
Query: 389 KRLLNKDYRKRMTAVQALTHPW---LRD------DSRPVPLDILIF 425
LL +RM +AL HP+ L D +++ +P D+ F
Sbjct: 296 SALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRF 341
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 45/222 (20%), Positives = 92/222 (41%), Gaps = 30/222 (13%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
G+ +G+G FG K ++ + + + + +EVK+++ L
Sbjct: 13 IHGEVLGKGCFGQAI-----KVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKVMRCLE- 65
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H +++KF + + E +GG L I + +Y + I S +A+ H
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLI--DFGLSDFIRPDERLND-------------- 313
++HRDL N L + ++ DFGL+ + ++ +
Sbjct: 126 SMNIIHRDLNSHNCLV-----RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 314 -IVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPF 353
+VG+ Y++APE++ RSY + D++S G++ ++
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 81/334 (24%), Positives = 127/334 (38%), Gaps = 82/334 (24%)
Query: 148 KYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKM--------TTAISIEDVR 198
KYE ++G+G FG AR +K G+ VA+K K M TA+
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQK----VALK---KVLMENEKEGFPITAL------ 64
Query: 199 REVKILKALSGHKHLVKFCDAC--------EDVNNVYIVMELCEG--GELLDRILARGGR 248
RE+KIL+ L H+++V + C ++Y+V + CE LL +
Sbjct: 65 REIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVK 120
Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
+T + K ++ +L+ + + H ++HRD+K N L T D ++L DFGL+
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLA 177
Query: 309 ERLNDIVGSAY--------YVAPEVL--HRSYSLEADIWSIGVISYILLCGSRP-FWART 357
+ + Y Y PE+L R Y D+W G I + P T
Sbjct: 178 KNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNT 233
Query: 358 ESG----IFRAV----LRSDPNFDDLPW--------------------PSVSPEAKDFVK 389
E I + PN D+ P A D +
Sbjct: 234 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 293
Query: 390 RLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDIL 423
+LL D +R+ + AL H + D P L +
Sbjct: 294 KLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGM 327
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 78/341 (22%), Positives = 126/341 (36%), Gaps = 74/341 (21%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRRE 200
A+YE+ +G G FG K + VAVKI+ + + A E
Sbjct: 9 GDVLSARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNVDRYCEAARSE----- 61
Query: 201 VKILKAL-----SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDA 254
+++L+ L + V+ + E ++ IV EL G D I G + +
Sbjct: 62 IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHI 120
Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR----------------DDADMRLID 298
+ + QI V F H + H DLKPEN LF + D++++D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWART 357
FG + + DE + +V + +Y APEV L +S D+WSIG I G F
Sbjct: 181 FGSATYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238
Query: 358 ES----------GIF-RAVLRSDP---NFDD--LPWPSVSPEAK---------------- 385
G + +++ F L W S +
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298
Query: 386 --------DFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPV 418
D ++++L D KR+T +AL HP+ + +
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-33
Identities = 36/213 (16%), Positives = 72/213 (33%), Gaps = 23/213 (10%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
++ H G KG + + VK++ +T D E L+ S
Sbjct: 13 NFLTKLNENHSGELW-----KGRWQGNDIVVKVLKVRDWSTRK-SRDFNEECPRLRIFS- 65
Query: 210 HKHLVKFCDACED--VNNVYIVMELCEGGELLDRILARGGR-YTEEDAKAIVVQILSVVA 266
H +++ AC+ + ++ G L + + + A + + +A
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 267 FCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPE 324
F H + L + + +D R+ + + + + +VAPE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKFS----FQSPGRMYAPAWVAPE 178
Query: 325 VL-HRSYSLE---ADIWSIGVISYILLCGSRPF 353
L + AD+WS V+ + L+ PF
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-32
Identities = 61/284 (21%), Positives = 110/284 (38%), Gaps = 38/284 (13%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
YE+ + G G A + + + V +K + + A ++ E + L +
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRN--VNGRPVVLKGLVHSGDAEAQAM--AMAERQFLAEVV 137
Query: 209 GHKHLVKFCDACEDVNN-----VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
H +V+ + E + YIVME G L G + +A A +++IL
Sbjct: 138 -HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILP 193
Query: 264 VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAP 323
+++ H G+V+ DLKPEN + T + ++LID G + G+ + AP
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAV---SRINSFGYLYGTPGFQAP 246
Query: 324 EVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
E++ ++ DI+++G L +G + L D P
Sbjct: 247 EIVRTGPTVATDIYTVGRTLAALTLDLPTR-----NGRYVDGLPEDD-----PVLKTYDS 296
Query: 384 AKDFVKRLLNKDYRKR------MTA--VQALTHPWLRDDSRPVP 419
++R ++ D R+R M+A L +D P P
Sbjct: 297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRP 340
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 72/336 (21%), Positives = 113/336 (33%), Gaps = 74/336 (22%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRRE 200
+YE+ +G G FG QVA+KII + K A R E
Sbjct: 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARG--KSQVALKIIRNVGKYREA-----ARLE 66
Query: 201 VKILKAL-----SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDA 254
+ +LK + V D ++ I EL G + + + Y
Sbjct: 67 INVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHV 125
Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR----------------DDADMRLID 298
+ + Q+ + F H + H DLKPEN LF + + +R+ D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 299 FGLSDFIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWART 357
FG + F E IV + +Y PEV L ++ D+WSIG I + G F
Sbjct: 186 FGSATFD--HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243
Query: 358 E---------------SGIFRAVLRSDPNFDD-LPWPSVSPEAK---------------- 385
S + + + L W S + +
Sbjct: 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303
Query: 386 --------DFVKRLLNKDYRKRMTAVQALTHPWLRD 413
D ++R+L D +R+T +AL HP+
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 66/341 (19%), Positives = 114/341 (33%), Gaps = 82/341 (24%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRRE 200
+ + +++G G FG + + AVK++ + K T + IE
Sbjct: 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNIKKYTRSAKIE----- 81
Query: 201 VKILKALSGH----KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR-YTEEDAK 255
ILK + ++VK+ +++ ++ E G L + I + ED K
Sbjct: 82 ADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIK 140
Query: 256 AIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG----------------------RDDAD 293
++IL + + + H DLKPEN L
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 294 MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRP 352
++LIDFG + F + I+ + Y APEV L+ + + +D+WS G + L GS
Sbjct: 201 IKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258
Query: 353 FWARTES----------GIF------RAVLRSDPNFDD-----LPWPSVS---------- 381
F A + + + L WP +
Sbjct: 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318
Query: 382 -----------PEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
DF+ +L D R + + L H +L
Sbjct: 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 76/334 (22%), Positives = 129/334 (38%), Gaps = 71/334 (21%)
Query: 148 KYE-LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-TTAISIEDVRREVKILK 205
+E G +VGRG +GH A+ K G+ D+ A+K I + +A RE+ +L+
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGTGISMSAC------REIALLR 73
Query: 206 ALSGHKHLVKFCDACEDVNN--VYIVMELCEG--GELLDRILARGGRY-----TEEDAKA 256
L H +++ + V+++ + E ++ A K+
Sbjct: 74 ELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGL----SDFIRPDERL 311
++ QIL + + H V+HRDLKP N L + +++ D G + ++P L
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 312 NDIVGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRP-FWARTESGIFRAVLRS 368
+ +V + +Y APE+L R Y+ DIW+IG I LL P F R E
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPYHH 251
Query: 369 D-----------------PNFDDLPW--------------------------PSVSPEAK 385
D + +P +A
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311
Query: 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419
+++LL D KR+T+ QA+ P+ +D P
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTS 345
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 66/260 (25%), Positives = 113/260 (43%), Gaps = 14/260 (5%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
+Y++ ++G G A L + +VA+K I +++ REV
Sbjct: 9 INERYKIVDKLGGGGMSTVYLAEDTI--L-NIKVAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 205 KALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
LS H+++V D E+ + Y+VME EG L + + G + + A QIL
Sbjct: 66 SQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE-YIESHGPLSVDTAINFTNQILDG 123
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL---NDIVGSAYYV 321
+ H +VHRD+KP+N L + +++ DFG++ + + L N ++G+ Y
Sbjct: 124 IKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYF 179
Query: 322 APE-VLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD-PNFDDLPWPS 379
+PE + DI+SIG++ Y +L G PF T I ++ PN
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239
Query: 380 VSPEAKDFVKRLLNKDYRKR 399
+ + + R KD R
Sbjct: 240 IPQSLSNVILRATEKDKANR 259
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 81/297 (27%), Positives = 128/297 (43%), Gaps = 37/297 (12%)
Query: 117 KPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQ 176
S+ RG+ + + + G FG Y L + VGRG G A ++++
Sbjct: 7 HHHHSSGLVPRGSHMDGTAESREG--TQFG-PYRLRRLVGRGGMGDVYEAED---TVRER 60
Query: 177 QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGG 236
VA+K++S+ + + ++RE + L H+V D E +Y+ M L G
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYVDMRLINGV 119
Query: 237 ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296
+L +L R G A AIV QI S + H G HRD+KPEN L + D L
Sbjct: 120 DL-AAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYL 175
Query: 297 IDFGLSDFIRPDERL---NDIVGSAYYVAPE------VLHRSYSLEADIWSIGVISYILL 347
+DFG++ DE+L + VG+ YY+APE +R+ DI+++ + Y L
Sbjct: 176 VDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHATYRA-----DIYALTCVLYECL 229
Query: 348 CGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-----VSPEAKDFVKRLLNKDYRKR 399
GS P+ S + A + P PS + + R + K+ R
Sbjct: 230 TGSPPYQGDQLS-VMGAHINQAI-----PRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 68/338 (20%), Positives = 115/338 (34%), Gaps = 90/338 (26%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
KY LGK +G G FG C + ++ A+K + + RE+ I+K L
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRYK-------NRELDIMKVL 57
Query: 208 SGHKHLVKFCD--------------------------------------ACEDVNNVYIV 229
H +++K D + ++
Sbjct: 58 D-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 230 MELCEGGELLDRILARGGRY----TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLF 285
ME + L ++L R + Q+ V F H G+ HRD+KP+N L
Sbjct: 117 MEYVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 286 TSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVIS 343
S D ++L DFG + + P E + S +Y APE++ Y+ D+WSIG +
Sbjct: 175 NS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 344 YILLCG-----------------------SRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
L+ G ++ R P W +
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDWRKI 289
Query: 381 -----SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
A D ++++L + R+ +A+ HP+
Sbjct: 290 LPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 68/260 (26%), Positives = 113/260 (43%), Gaps = 17/260 (6%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
YELG+ +G G AR + + VAVK++ RRE + AL+
Sbjct: 14 YELGEILGFGGMSEVHLARDLR--D-HRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 209 GHKHLVKFCDACEDVNN----VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
H +V D E YIVME +G L D I+ G T + A ++
Sbjct: 71 -HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQA 128
Query: 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL----SDFIRPDERLNDIVGSAYY 320
+ F H G++HRD+KP N + + ++++DFG+ +D + ++G+A Y
Sbjct: 129 LNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 321 VAPE-VLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379
++PE S +D++S+G + Y +L G PF + + +R DP
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245
Query: 380 VSPEAKDFVKRLLNKDYRKR 399
+S + V + L K+ R
Sbjct: 246 LSADLDAVVLKALAKNPENR 265
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 53/232 (22%), Positives = 93/232 (40%), Gaps = 25/232 (10%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
L +++G G FG K VAVK + ++ +++D REV + +L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD- 79
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H++L++ + +V EL G LLDR+ G + VQ+ + +
Sbjct: 80 HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
+ +HRDL N L + +++ DFGL + ++ Y +
Sbjct: 139 SKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALPQND-------DHYVMQEHRKVPF 188
Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRS 368
APE L R++S +D W GV + + G P+ S I + +
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-SKAKMTTAISIEDVRRE 200
+ + +YE+ +G+G FG A + + + VA+KII +K + E
Sbjct: 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNKKAFLNQA-----QIE 100
Query: 201 VKILKALSGH-----KHLVKFCDACEDVNNVYIVMELCEGG--ELLDRILARGGRYTEED 253
V++L+ ++ H ++V N++ +V E+ +LL RG +
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG--VSLNL 158
Query: 254 AKAIVVQILSVVAFCHLQ--GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL 311
+ Q+ + + F ++H DLKPEN L + + ++++DFG S + +R+
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQL--GQRI 215
Query: 312 NDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFWARTE 358
+ S +Y +PEV L Y L D+WS+G I + G F E
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 9/28 (32%), Positives = 16/28 (57%)
Query: 385 KDFVKRLLNKDYRKRMTAVQALTHPWLR 412
KD + R+L+ D + R+ AL H + +
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 29/230 (12%)
Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ K +G G FG +GE VA+K + +A T+ + +++ E ++ ++
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD 75
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
+ H+ + C + V ++ +L G LLD + + VQI + +
Sbjct: 76 -NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
+ +VHRDL N L + + +++ DFGL+ + +E Y
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEE--------KEYHAEGGKVP 182
Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
A E + HR Y+ ++D+WS GV + ++ GS+P+ S I +
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 45/234 (19%), Positives = 80/234 (34%), Gaps = 31/234 (13%)
Query: 150 ELGKEVGRGHFGHTCSAR----GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
+ +G+G F G G+L + +V +K++ KA + E ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAASMMS 67
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
LS HKHLV C + +V E + G L + + Q+ + +
Sbjct: 68 KLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAM 126
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLI-----DFGLSDFIRPDERLNDIVGSAYY 320
F ++H ++ +N L D D G+S + P +
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---------IL 177
Query: 321 ------VAPEVLH--RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
V PE + ++ +L D WS G + I G +P A +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 39/278 (14%), Positives = 66/278 (23%), Gaps = 43/278 (15%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
Y L G A D+QVA+ + + +++ L +
Sbjct: 33 YRLLIFHGGVPPLQFWQALD---TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
+ + D +V E GG L + + A + + +
Sbjct: 90 -KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAA 145
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR 328
H GV P + D D+ L +
Sbjct: 146 HRAGVALSIDHPSRVRVS---IDGDVVLAYPA-------------------TMPDA---- 179
Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-----VSPE 383
+ + DI IG Y LL P R P+ + +
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA--GQPIEPADIDRDIPFQ 235
Query: 384 AKDFVKRLLNKDYRKRM-TAVQALTHPWLRDDSRPVPL 420
R + D R + + L R L
Sbjct: 236 ISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVL 273
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 75/407 (18%), Positives = 132/407 (32%), Gaps = 124/407 (30%)
Query: 118 PKESTIPEERGTEPEQSLD-KSFGY-----NKNFGAKYELGKEVGRGHFGHTCSARGKKG 171
+E I E E D GY F +Y + +++G GHF + +
Sbjct: 2 EQEEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ- 60
Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-------GHKHLVKFCDACEDVN 224
+ VA+K++ A+ T E E+++LK++ + +V+ D ++
Sbjct: 61 --GKKFVAMKVVKSAEHYT----ETALDEIRLLKSVRNSDPNDPNREMVVQLLD-DFKIS 113
Query: 225 NVY-----IVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHR 276
V +V E+ G L + + + K I+ Q+L + + H + ++H
Sbjct: 114 GVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHT 171
Query: 277 DLKPENFLFTSGR----------------------------------------------D 290
D+KPEN L + +
Sbjct: 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAE 231
Query: 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCG 349
+++ D G + + + + + Y + EV + Y+ ADIWS +++ L G
Sbjct: 232 KLKVKIADLGNA--CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATG 289
Query: 350 SRPFWARTESGIFR---------AVL------------RSDPNFDD----------LPWP 378
F + R +L S F PW
Sbjct: 290 DYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349
Query: 379 SVS----------PEAK---DFVKRLLNKDYRKRMTAVQALTHPWLR 412
EA DF+ +L KR TA + L HPWL
Sbjct: 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 59/232 (25%), Positives = 97/232 (41%), Gaps = 32/232 (13%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
LG+++GRG+FG S R + + VAVK + +E +ILK S
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRETLPPDLK--AKFLQEARILKQYS- 170
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H ++V+ C +YIVMEL +GG+ L + G R + +V + + +
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
+ +HRDL N L T + +++ DFG+S Y
Sbjct: 231 SKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGV---------YAASGGLRQVP 278
Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
APE L + YS E+D+WS G++ + G+ P+ + V +
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 36/231 (15%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
L KE+G G FG G+ K Q VAVK+I + M S ++ +E + + LS
Sbjct: 12 LLKELGSGQFGVVK-----LGKWKGQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLS- 61
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H LVKF C +YIV E G LL+ + + G + + +AF
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
+HRDL N L D +++ DFG++ ++ D+ Y
Sbjct: 122 SHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPV 169
Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
APEV + YS ++D+W+ G++ + + G P+ T S + V +
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E+G G FG G ++ +VA+K I + M S ED E +++ LS
Sbjct: 11 TFVQEIGSGQFGLVH-----LGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS 61
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H LV+ C + + +V E E G L D + + G + E + + + +A+
Sbjct: 62 -HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
V+HRDL N L + +++ DFG++ F+ D+ Y
Sbjct: 121 EEACVIHRDLAARNCLVGENQ---VIKVSDFGMTRFVLDDQ---------YTSSTGTKFP 168
Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
+PEV YS ++D+WS GV+ + + G P+ R+ S + +
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 56/251 (22%), Positives = 104/251 (41%), Gaps = 40/251 (15%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
L + +G+G FG +G+ + ++VAVKI S + + E+ L
Sbjct: 45 VLQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWFR----EAEIYQTVMLR- 94
Query: 210 HKHLVKFCDACEDVNNV----YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
H++++ F A N ++V + E G L D + T E + + S +
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGL 152
Query: 266 AFCHLQ--------GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--- 314
A H++ + HRDLK +N L + + + D GL+ DI
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 315 --VGSAYYVAPEVL-------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGI-FRA 364
VG+ Y+APEVL H ADI+++G++ + + + + +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 365 VLRSDPNFDDL 375
++ SDP+ +++
Sbjct: 270 LVPSDPSVEEM 280
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 36/232 (15%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
KE+G G FG G+ + Q VA+K+I + M S ++ E K++ LS
Sbjct: 27 TFLKELGTGQFGVVK-----YGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS 77
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H+ LV+ C ++I+ E G LL+ + R+ + + + + +
Sbjct: 78 -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
+ +HRDL N L D +++ DFGLS ++ DE Y
Sbjct: 137 ESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDE---------YTSSVGSKFP 184
Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
PEVL + +S ++DIW+ GV+ + I G P+ T S + +
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 61/243 (25%), Positives = 96/243 (39%), Gaps = 32/243 (13%)
Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ ++G+G+FG R G+ VAVK + + + D +RE++ILKAL
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALH 82
Query: 209 GHKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
+VK+ ++ +VME G L D + R QI +
Sbjct: 83 -SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV----- 321
+ + VHRDL N L S +A +++ DFGL+ + D+ YYV
Sbjct: 142 YLGSRRCVHRDLAARNILVES---EAHVKIADFGLAKLLPLDK--------DYYVVREPG 190
Query: 322 -------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNF 372
APE L +S ++D+WS GV+ Y + + E R P
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 373 DDL 375
L
Sbjct: 251 SRL 253
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 29/230 (12%)
Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ K +G G FG +GE VA+K + +A T+ + +++ E ++ ++
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD 75
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
+ H+ + C + V ++ +L G LLD + + VQI + +
Sbjct: 76 -NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
+ +VHRDL N L + + +++ DFGL+ + +E Y
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEE--------KEYHAEGGKVP 182
Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
A E + HR Y+ ++D+WS GV + ++ GS+P+ S I +
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 29/229 (12%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
ELG+ +G G FG E VA+K + E +E ++
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFD- 74
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H H+VK + N V+I+MELC GEL + R Q+ + +A+
Sbjct: 75 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
+ VHRD+ N L +S + ++L DFGLS ++ YY
Sbjct: 134 SKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDST---------YYKASKGKLPI 181
Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
APE + R ++ +D+W GV + IL+ G +PF + + +
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 55/254 (21%), Positives = 101/254 (39%), Gaps = 46/254 (18%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK-ALS 208
L + VG+G +G +G + + VAVKI S + RE ++ +
Sbjct: 11 TLLECVGKGRYGEVW-----RGSWQGENVAVKIFSSRDE------KSWFRETELYNTVML 59
Query: 209 GHKHLVKFCDACEDVNN----VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSV 264
H++++ F + + ++++ E G L D + + IV+ I S
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASG 117
Query: 265 VAFCHLQ--------GVVHRDLKPENFLFTSGRDDADMR--LIDFGLSDFIRPDERLNDI 314
+A H++ + HRDLK +N L + + + D GL+ D+
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNIL-----VKKNGQCCIADLGLAVMHSQSTNQLDV 172
Query: 315 -----VGSAYYVAPEVL-------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGI- 361
VG+ Y+APEVL DIW+ G++ + + +
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232
Query: 362 FRAVLRSDPNFDDL 375
F V+ +DP+F+D+
Sbjct: 233 FYDVVPNDPSFEDM 246
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/229 (24%), Positives = 90/229 (39%), Gaps = 26/229 (11%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+ K +G G G C R + +D VA+K + D E I+
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFD- 108
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H ++++ IV E E G L + G++T ++ + + + +
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
G VHRDL N L S ++ DFGLS + D A Y
Sbjct: 169 DLGYVHRDLAARNVLVDSNL---VCKVSDFGLSRVLEDDP-------DAAYTTTGGKIPI 218
Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
APE + R++S +D+WS GV+ + +L G RP+W T + +V
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 59/231 (25%), Positives = 88/231 (38%), Gaps = 29/231 (12%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
L + +G G FG + + VAVK K T + E E I+K L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLD- 71
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H H+VK E+ +I+MEL GEL + +QI +A+
Sbjct: 72 HPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
VHRD+ N L S ++L DFGLS R I YY
Sbjct: 131 SINCVHRDIAVRNILVASPE---CVKLGDFGLS---R------YIEDEDYYKASVTRLPI 178
Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
+PE + R ++ +D+W V + IL G +PF+ + + +
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 58/232 (25%), Positives = 92/232 (39%), Gaps = 34/232 (14%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
+ K VG G FG CS R K K+ VA+K + D E I+ H
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFD-H 105
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL 270
++++ V IV E E G L + ++T ++ I S + +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 271 QGVVHRDLKPENFLFTSGRDDADMRLI----DFGLSDFIRPDERLNDIVGSAYYV----- 321
G VHRDL N L S L+ DFGL + D A Y
Sbjct: 166 MGYVHRDLAARNILINSN-------LVCKVSDFGLGRVLEDDP-------EAAYTTRGGK 211
Query: 322 ------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
+PE + +R ++ +D+WS G++ + ++ G RP+W + + +AV
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 29/229 (12%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
ELG+ +G G FG E VA+K + E +E ++
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFD- 449
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H H+VK + N V+I+MELC GEL + R Q+ + +A+
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
+ VHRD+ N L +S + ++L DFGLS ++ YY
Sbjct: 509 SKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDST---------YYKASKGKLPI 556
Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
APE + R ++ +D+W GV + IL+ G +PF + + +
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 60/270 (22%), Positives = 102/270 (37%), Gaps = 54/270 (20%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ +++G+G+FG C + + VAVK + + + D RE++ILK+L
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEH---LRDFEREIEILKSL 99
Query: 208 SGHKHLVKFCDACED--VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
H ++VK+ C N+ ++ME G L D + R QI +
Sbjct: 100 Q-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV---- 321
+ + +HRDL N L + + +++ DFGL+ + D+ YY
Sbjct: 159 EYLGTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDK--------EYYKVKEP 207
Query: 322 --------APEVL-HRSYSLEADIWSIGV-----ISYILLCGSRPFWARTESGIFRAVLR 367
APE L +S+ +D+WS GV +YI S P G
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG------- 260
Query: 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYR 397
+ + + LL + R
Sbjct: 261 ------NDKQGQMIVFH---LIELLKNNGR 281
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 60/277 (21%), Positives = 105/277 (37%), Gaps = 44/277 (15%)
Query: 103 KHIKASLAKRLGGGKPKESTIPEERG-TEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFG 161
L RL K E T+ + +L+ + +L + +G+G FG
Sbjct: 157 TTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMK---------ELKLLQTIGKGEFG 207
Query: 162 HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC- 220
G+ + +VAVK I K T + E ++ L H +LV+
Sbjct: 208 DVM-----LGDYRGNKVAVKCI-KNDATA----QAFLAEASVMTQLR-HSNLVQLLGVIV 256
Query: 221 EDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAFCHLQGVVHRDLK 279
E+ +YIV E G L+D + +RG + + + + + VHRDL
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316
Query: 280 PENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------APEVL-HRSYS 331
N L + +D ++ DFGL+ + + APE L + +S
Sbjct: 317 ARNVLVS---EDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 332 LEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
++D+WS G++ + I G P+ + V +
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 34/232 (14%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+ ++G G +G KK L VAVK + + M +E+ +E ++K +
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTM----EVEEFLKEAAVMKEIK- 67
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAFC 268
H +LV+ C YI+ E G LLD + + + + QI S + +
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
+ +HRDL N L ++ +++ DFGLS + D Y
Sbjct: 128 EKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDT---------YTAHAGAKFP 175
Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
APE L + +S+++D+W+ GV+ + I G P+ S ++ + +
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 50/232 (21%), Positives = 94/232 (40%), Gaps = 29/232 (12%)
Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
K +G G FG +GE V +K+I + S + V + + +L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDHMLAIGSLD 73
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H H+V+ C +++ +V + G LLD + G + VQI + +
Sbjct: 74 -HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
G+VHR+L N L S +++ DFG++D + PD+ +
Sbjct: 132 EEHGMVHRNLAARNVLLKSPS---QVQVADFGVADLLPPDD--------KQLLYSEAKTP 180
Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
A E + Y+ ++D+WS GV + ++ G+ P+ + + + +
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 16/223 (7%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+ ++G G +G KK L VAVK + + M E+ +E ++K +
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTMEV----EEFLKEAAVMKEIK- 274
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAFC 268
H +LV+ C YI+ E G LLD + + + + QI S + +
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY--VAPEVL 326
+ +HR+L N L ++ +++ DFGLS + D APE L
Sbjct: 335 EKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
+ +S+++D+W+ GV+ + I G P+ S ++ + +
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 55/233 (23%), Positives = 96/233 (41%), Gaps = 38/233 (16%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ +++G+G+FG C + + VAVK + + +T + D RE++ILK+L
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKL---QHSTEEHLRDFEREIEILKSL 68
Query: 208 SGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
H ++VK+ C + ++ME G L D + R QI +
Sbjct: 69 Q-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV---- 321
+ + +HRDL N L + + +++ DFGL+ + D+ ++
Sbjct: 128 EYLGTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDK--------EFFKVKEP 176
Query: 322 --------APEVL-HRSYSLEADIWSIGV-----ISYILLCGSRPFWARTESG 360
APE L +S+ +D+WS GV +YI S P G
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 53/251 (21%), Positives = 104/251 (41%), Gaps = 40/251 (15%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
++ K++G+G +G G+ + ++VAVK+ TT + E+ +
Sbjct: 40 QMVKQIGKGRYGEVW-----MGKWRGEKVAVKVFF----TTEEASWFRETEIYQTVLMR- 89
Query: 210 HKHLVKFCDACEDVN----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
H++++ F A +Y++ + E G L D + + + + +S +
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGL 147
Query: 266 AFCHLQ--------GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI--- 314
H + + HRDLK +N L + + + D GL+ D DI
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 315 --VGSAYYVAPEVL-------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGI-FRA 364
VG+ Y+ PEVL H + AD++S G+I + + E + +
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 365 VLRSDPNFDDL 375
++ SDP+++D+
Sbjct: 265 LVPSDPSYEDM 275
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 49/233 (21%), Positives = 91/233 (39%), Gaps = 32/233 (13%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+ +GRGHFG + K AVK ++ ++T + E I+K S
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFS- 84
Query: 210 HKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H +++ C +V+ + G+L + I T +D +Q+ + +
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
+ VHRDL N + +++ DFGL+ R D+ YY
Sbjct: 145 ASKKFVHRDLAARNCMLDEKF---TVKVADFGLA---R------DMYDKEYYSVHNKTGA 192
Query: 322 -------APEVLH-RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
A E L + ++ ++D+WS GV+ + ++ G+ P+ I +
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 31/227 (13%)
Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ +++G GHFG R +G+ +QVAVK + K + I D+++E++IL+ L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGN-HIADLKKEIEILRNLY 81
Query: 209 GHKHLVKFCDAC--EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
H+++VK+ C + N + ++ME G L + + + + VQI +
Sbjct: 82 -HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV----- 321
+ + VHRDL N L + +++ DFGL+ I D+ YY
Sbjct: 141 YLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDK--------EYYTVKDDR 189
Query: 322 -------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTES 359
APE L + + +D+WS GV + +L
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 34/229 (14%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+L + +G+G FG G+ + +VAVK I + E ++ L
Sbjct: 24 KLLQTIGKGEFGDVM-----LGDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQLR- 72
Query: 210 HKHLVKFCDAC-EDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAF 267
H +LV+ E+ +YIV E G L+D + +RG + + + + +
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------ 321
VHRDL N L + +D ++ DFGL+ + + +
Sbjct: 133 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---K------EASSTQDTGKLPVKW 180
Query: 322 -APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
APE L + +S ++D+WS G++ + I G P+ + V +
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 38/233 (16%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+L + +G G FG G +VAVK + + M S + E ++K L
Sbjct: 16 KLVERLGAGQFGEVW-----MGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 66
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAF 267
H+ LV+ +YI+ E E G L+D + G T + QI +AF
Sbjct: 67 -HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------ 321
+ +HRDL+ N L + D ++ DFGL+ I +E Y
Sbjct: 125 IEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNE---------YTAREGAKF 172
Query: 322 -----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
APE + + ++++++D+WS G++ I+ G P+ T + + + R
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 53/255 (20%), Positives = 99/255 (38%), Gaps = 44/255 (17%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+L + RG FG K +L ++ VAVKI EV L +
Sbjct: 25 PLQLLEVKARGRFGCVW-----KAQLLNEYVAVKIFP----IQDKQSWQNEYEVYSLPGM 75
Query: 208 SGHKHLVKFCDACEDVNNV----YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
H+++++F A + +V +++ E G L D + + + + I +
Sbjct: 76 K-HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMAR 132
Query: 264 VVAFCHLQ----------GVVHRDLKPENFLFTSGRDDADMR--LIDFGLSDFIRPDERL 311
+A+ H + HRD+K +N L ++ + DFGL+ +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVL-----LKNNLTACIADFGLALKFEAGKSA 187
Query: 312 NDI---VGSAYYVAPEVL------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGI- 361
D VG+ Y+APEVL R L D++++G++ + L + +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 362 -FRAVLRSDPNFDDL 375
F + P+ +D+
Sbjct: 248 PFEEEIGQHPSLEDM 262
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 51/229 (22%), Positives = 90/229 (39%), Gaps = 27/229 (11%)
Query: 151 LGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
K +G G FG K K+ VA+K + D E I+ S
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFS- 104
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
H ++++ + I+ E E G L + + G ++ ++ I + + +
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
VHRDL N L S ++ DFGLS + D A Y
Sbjct: 165 NMNYVHRDLAARNILVNSNL---VCKVSDFGLSRVLEDDP-------EATYTTSGGKIPI 214
Query: 322 ---APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
APE + +R ++ +D+WS G++ + ++ G RP+W + + +A+
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 49/235 (20%), Positives = 95/235 (40%), Gaps = 32/235 (13%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+ +G+GHFG Q A+K +S+ T +E RE +++ L+
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN- 80
Query: 210 HKHLVKFCDACEDVNNV-YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H +++ + ++++ G+LL I + T +D + +Q+ + +
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
Q VHRDL N + +++ DFGL+ R DI+ YY
Sbjct: 141 AEQKFVHRDLAARNCMLDESF---TVKVADFGLA---R------DILDREYYSVQQHRHA 188
Query: 322 -------APEVLH-RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
A E L ++ ++D+WS GV+ + +L G+ P+ + + +
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 58/233 (24%), Positives = 93/233 (39%), Gaps = 38/233 (16%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+L K++G G FG +VAVK + M+ E E ++K L
Sbjct: 191 KLEKKLGAGQFGEVW-----MATYNKHTKVAVKTMKPGSMSV----EAFLAEANVMKTLQ 241
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAF 267
H LVK +YI+ E G LLD + + G QI +AF
Sbjct: 242 -HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------ 321
+ +HRDL+ N L + ++ DFGL+ I +E Y
Sbjct: 300 IEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE---------YTAREGAKF 347
Query: 322 -----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
APE + S+++++D+WS G++ I+ G P+ + + RA+ R
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 38/233 (16%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
L ++G+G FG G +VA+K + M+ E +E +++K L
Sbjct: 187 RLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR 237
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAF 267
H+ LV+ + +YIV E G LLD + G+Y + QI S +A+
Sbjct: 238 -HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------ 321
VHRDL+ N L ++ ++ DFGL+ I +E Y
Sbjct: 296 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE---------YTARQGAKF 343
Query: 322 -----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
APE + +++++D+WS G++ + G P+ + V R
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 32/227 (14%)
Query: 154 EVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
E+G G+FG +G + K VA+K++ + T E++ RE +I+ L + +
Sbjct: 17 ELGCGNFGSVR--QGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPY 71
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+V+ C+ + +VME+ GG L ++ + + ++ Q+ + + +
Sbjct: 72 IVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV----------- 321
VHRDL N L + ++ DFGLS + D+ +YY
Sbjct: 131 FVHRDLAARNVLLVNRH---YAKISDFGLSKALGADD--------SYYTARSAGKWPLKW 179
Query: 322 -APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
APE + R +S +D+WS GV + L G +P+ + +
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 51/238 (21%), Positives = 87/238 (36%), Gaps = 34/238 (14%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
L + +G G FG + G + QVAVK + + D E I+
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKF 90
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY------TEEDAKAIVVQI 261
+ H+++V+ +I+MEL GG+L + R D + I
Sbjct: 91 N-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
+ +HRD+ N L T ++ DFG++ R DI ++YY
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRASYYR 200
Query: 322 ------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
PE ++ + D WS GV+ + I G P+ +++ + V
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 54/243 (22%), Positives = 95/243 (39%), Gaps = 39/243 (16%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
LG+ +G+G FG A+ K+ + +VAVK++ KA + + IE+ RE +K
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFD- 83
Query: 210 HKHLVKFCDAC------EDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKAIV 258
H H+ K + +++ + G+L RI + +
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
V I + + + +HRDL N + + + DFGLS R I
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDM---TVCVADFGLS---R------KIYSGD 191
Query: 319 YYV------------APEVLH-RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRA 364
YY A E L Y++ +D+W+ GV + I+ G P+ + I+
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 365 VLR 367
++
Sbjct: 252 LIG 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 42/220 (19%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ GK +G G FG +A G E +VAVK++ A E + E+KI+ L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD-------------RILARGGRYTEEDA 254
H+++V AC V ++ E C G+LL+ + D
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 255 KAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDI 314
Q+ +AF + +HRD+ N L T + ++ DFGL+ R DI
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA---R------DI 214
Query: 315 VGSAYYV------------APEVL-HRSYSLEADIWSIGV 341
+ + Y+ APE + Y++++D+WS G+
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 32/230 (13%)
Query: 151 LGKEVGRGHFGHTCSARGK-KGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
KE+G G+FG +G + + + VAVKI+ K + +++ E +++ L
Sbjct: 21 EDKELGSGNFGTVK--KGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLD- 76
Query: 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH 269
+ ++V+ CE + +VME+ E G L L + +++ +V Q+ + +
Sbjct: 77 NPYIVRMIGICEA-ESWMLVMEMAELGPLNKY-LQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 270 LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV-------- 321
VHRDL N L + ++ DFGLS +R DE YY
Sbjct: 135 ESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADE--------NYYKAQTHGKWP 183
Query: 322 ----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
APE + + +S ++D+WS GV+ + G +P+ S + +
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 48/233 (20%), Positives = 90/233 (38%), Gaps = 32/233 (13%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
+ +GRGHFG + K AVK ++ ++T + E I+K S
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFS- 148
Query: 210 HKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H +++ C +V+ + G+L + I T +D +Q+ + F
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------- 321
+ VHRDL N + +++ DFGL+ R D+ +
Sbjct: 209 ASKKFVHRDLAARNCMLDEKF---TVKVADFGLA---R------DMYDKEFDSVHNKTGA 256
Query: 322 -------APEVLH-RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
A E L + ++ ++D+WS GV+ + ++ G+ P+ I +
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 51/242 (21%), Positives = 92/242 (38%), Gaps = 38/242 (15%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG 209
LGK +G G FG K+ + +VAVK + K ++ IE+ E +K S
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFS- 94
Query: 210 HKHLVKFCDAC-----EDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKAIVV 259
H ++++ C + + +++ + G+L R+ + +V
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAY 319
I + + + +HRDL N + + + DFGLS + I Y
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDM---TVCVADFGLS---K------KIYSGDY 202
Query: 320 YV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
Y A E L R Y+ ++D+W+ GV + I G P+ ++ +
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262
Query: 366 LR 367
L
Sbjct: 263 LH 264
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-22
Identities = 49/238 (20%), Positives = 87/238 (36%), Gaps = 34/238 (14%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
L + +G G FG + G + QVAVK + + + D E I+
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKF 131
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD------RILARGGRYTEEDAKAIVVQI 261
+ H+++V+ +I++EL GG+L ++ D + I
Sbjct: 132 N-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
+ +HRD+ N L T ++ DFG++ R DI + YY
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRAGYYR 241
Query: 322 ------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
PE ++ + D WS GV+ + I G P+ +++ + V
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 56/224 (25%), Positives = 86/224 (38%), Gaps = 46/224 (20%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
GK +G G FG +A G VAVK++ + E + E+K+L L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYL 83
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD-----------------RILARGGRYT 250
H ++V AC ++ E C G+LL+ +
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
ED + Q+ +AF + +HRDL N L T ++ DFGL+ R
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA---R---- 193
Query: 311 LNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGV 341
DI + YV APE + + Y+ E+D+WS G+
Sbjct: 194 --DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 58/264 (21%), Positives = 102/264 (38%), Gaps = 56/264 (21%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK-ALS 208
+L + +GRG +G KG L ++ VAVK+ S A + ++ E I + L
Sbjct: 16 KLLELIGRGRYGAVY-----KGSLDERPVAVKVFSFA------NRQNFINEKNIYRVPLM 64
Query: 209 GHKHLVKFCDACEDVN-----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
H ++ +F E V +VME G L + + + +
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTR 122
Query: 264 VVAFCHLQ---------GVVHRDLKPENFLFTSGRDDADMRLI--DFGLSDFIRPDERL- 311
+A+ H + + HRDL N L D + DFGLS + + +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLV-----KNDGTCVISDFGLSMRLTGNRLVR 177
Query: 312 --------NDIVGSAYYVAPEVL--------HRSYSLEADIWSIGVISYILL---CGSRP 352
VG+ Y+APEVL S + D++++G+I + + P
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 353 FWARTESGI-FRAVLRSDPNFDDL 375
+ E + F+ + + P F+D+
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDM 261
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 49/239 (20%), Positives = 87/239 (36%), Gaps = 46/239 (19%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+E+G FG + G + Q VA+K + E+ R E + L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--EEFRHEAMLRARL 69
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD--RILARGGRYTEEDAKAIVVQILSVV 265
H ++V + ++ C G+L + + + D V L
Sbjct: 70 Q-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 266 AFCHL-------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
F HL VVH+DL N L ++++ D GL R
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL---NVKISDLGLF---R------ 176
Query: 313 DIVGSAYYV------------APE-VLHRSYSLEADIWSIGVISY-ILLCGSRPFWART 357
++ + YY APE +++ +S+++DIWS GV+ + + G +P+ +
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 58/244 (23%), Positives = 101/244 (41%), Gaps = 47/244 (19%)
Query: 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH 210
+G G+FG AR KK L+ A+K + K + + D E+++L L H
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLR-MDAAIKRM-K-EYASKDDHRDFAGELEVLCKLGHH 85
Query: 211 KHLVKFCDACEDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKAIVVQILSVV 265
+++ ACE +Y+ +E G LLD R+L + ++ A + ++
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 266 AFC--------HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIV 315
F +L + +HRDL N L ++ ++ DFGLS R +
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-------RGQE-- 193
Query: 316 GSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGI 361
YV A E L + Y+ +D+WS GV+ + I+ G P+ T + +
Sbjct: 194 ---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250
Query: 362 FRAV 365
+ +
Sbjct: 251 YEKL 254
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 58/243 (23%), Positives = 93/243 (38%), Gaps = 33/243 (13%)
Query: 150 ELGKEVGRGHFGHTCSAR-GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ +++G GHFG + + VAVK + KA ++E+ IL+ L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQ-HRSGWKQEIDILRTLY 91
Query: 209 GHKHLVKFCDACED--VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
H+H++K+ CED ++ +VME G L D + QI +A
Sbjct: 92 -HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMA 148
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV----- 321
+ H Q +HRDL N L + R +++ DFGL+ + YY
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHE--------YYRVREDG 197
Query: 322 -------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNF 372
APE L + +D+WS GV Y +L T+ + +
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
Query: 373 DDL 375
L
Sbjct: 258 LRL 260
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-21
Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 38/233 (16%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQ-QVAVKIISKAKMTTAISIEDVRREVKILKALS 208
L ++G+G FG G +VA+K + M+ E +E +++K L
Sbjct: 270 RLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR 320
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVVAF 267
H+ LV+ + +YIV E G LLD + G+Y + QI S +A+
Sbjct: 321 -HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV------ 321
VHRDL+ N L ++ ++ DFGL+ I +E Y
Sbjct: 379 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE---------YTARQGAKF 426
Query: 322 -----APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLR 367
APE + +++++D+WS G++ + G P+ + V R
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-21
Identities = 64/331 (19%), Positives = 120/331 (36%), Gaps = 47/331 (14%)
Query: 53 GRSSHPSPWPSPYPHGVSASPLPAGVSPSPARASTPRRFFRRPFPPPSPAKHIKASLAKR 112
+ S + P P R P K
Sbjct: 251 KEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPR---- 306
Query: 113 LGGGKPKESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGE 172
P ++++ E ++PE+ DK ++ + E+G G+FG + +
Sbjct: 307 ---PMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIAD--IELGCGNFGSVRQGVYRMRK 361
Query: 173 LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232
K VA+K++ + T E++ RE +I+ L + ++V+ C+ + +VME+
Sbjct: 362 -KQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EALMLVMEM 416
Query: 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292
GG L ++ + + ++ Q+ + + + VHR+L N L +
Sbjct: 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN----- 471
Query: 293 DMRLI----DFGLSDFIRPDERLNDIVGSAYYV------------APEVL-HRSYSLEAD 335
R DFGLS + D+ +YY APE + R +S +D
Sbjct: 472 --RHYAKISDFGLSKALGADD--------SYYTARSAGKWPLKWYAPECINFRKFSSRSD 521
Query: 336 IWSIGVISY-ILLCGSRPFWARTESGIFRAV 365
+WS GV + L G +P+ + +
Sbjct: 522 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 49/243 (20%), Positives = 96/243 (39%), Gaps = 40/243 (16%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ +E+G+G FG + A+G + + +VA+K +++A + E ++K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMKEF 85
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKA---------IV 258
H+V+ ++MEL G+L + + A +
Sbjct: 86 -NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
+I +A+ + VHRDL N + +++ DFG++ R DI +
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDF---TVKIGDFGMT---R------DIYETD 192
Query: 319 YYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRA 364
YY +PE L ++ +D+WS GV+ + I +P+ + + R
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252
Query: 365 VLR 367
V+
Sbjct: 253 VME 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 58/239 (24%), Positives = 94/239 (39%), Gaps = 47/239 (19%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
L +E+G G FG VAVK + + +D +RE ++L L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA---RKDFQREAELLTNL 74
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD--RILARGGRYTEEDAKAIVVQILSVV 265
H+H+VKF C D + + +V E + G+L R + L +
Sbjct: 75 Q-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 266 AFCHL-------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLN 312
H+ Q VHRDL N L + +++ DFG+S R
Sbjct: 134 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---R------ 181
Query: 313 DIVGSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWART 357
D+ + YY PE + +R ++ E+D+WS GVI + I G +P++ +
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 45/223 (20%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+LGK +GRG FG A G + VAVK++ + T + E+KIL +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHI 87
Query: 208 SGHKHLVKFCDACEDVNN-VYIVMELCEGGELLD-----RILARGGRYTEEDAKAIVVQI 261
H ++V AC + +++E C+ G L R + ED + +
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 262 LSVVAFC--------HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL 311
++ + L + +HRDL N L + + +++ DFGL+ R
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA---R----- 196
Query: 312 NDIVGSAYYV------------APEVL-HRSYSLEADIWSIGV 341
DI YV APE + R Y++++D+WS GV
Sbjct: 197 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 9e-21
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 33/226 (14%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI-ISKAKMTTAISIEDVRREVKI 203
G +Y LG+++G G FG ++VA+K+ K K + E KI
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAA---GEEVAIKLECVKTKHPQ------LHIESKI 57
Query: 204 LKALSGHKHL--VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
K + G + +++C A D N +VMEL G L D +++ + + Q+
Sbjct: 58 YKMMQGGVGIPTIRWCGAEGDYN--VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQM 114
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF---------IRPDERLN 312
+S + + H + +HRD+KP+NFL G+ + +IDFGL+ I E
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN-K 173
Query: 313 DIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYIL---LCGSRPFW 354
++ G+A Y + L S D+ S+G Y+L GS P W
Sbjct: 174 NLTGTARYASINTHLGIEQSRRDDLESLG---YVLMYFNLGSLP-W 215
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 46/238 (19%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
L E+G G FG E VAVK + +A + +D +RE ++L L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA---RQDFQREAELLTML 100
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD--------------RILARGGRYTEED 253
H+H+V+F C + + +V E G+L G
Sbjct: 101 Q-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
A+ Q+ + + + VHRDL N L G +++ DFG+S R D
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---R------D 207
Query: 314 IVGSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWART 357
I + YY PE + +R ++ E+D+WS GV+ + I G +P++ +
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 35/228 (15%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI-ISKAKMTTAISIEDVRREVKI 203
G + +GK++G G+FG + ++ VA+K+ K++ + E +
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKSRAPQ------LHLEYRF 57
Query: 204 LKALSGHKHL--VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
K L + V + C N +V+EL G L D ++ + I +Q+
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYN--AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQL 114
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR--LIDFGLS----DF-----IRPDER 310
+S + + H + +++RD+KPENFL + +IDF L+ D I E
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174
Query: 311 LNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYIL---LCGSRPFW 354
+ + G+A Y++ L + S D+ ++G ++ L GS P W
Sbjct: 175 KS-LTGTARYMSINTHLGKEQSRRDDLEALG---HMFMYFLRGSLP-W 217
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 51/229 (22%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
E GK +G G FG +A G QVAVK++ + + E + E+K++ L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE--KADSSEREALMSELKMMTQL 105
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD--------------RILARGGRYTEED 253
H+++V AC +Y++ E C G+LL+ + EED
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 254 AKAIVVQILSVVAFC------HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305
+ + L A+ L + VHRDL N L T +++ DFGL+
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLA--- 219
Query: 306 RPDERLNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGV 341
R DI+ + YV APE L Y++++D+WS G+
Sbjct: 220 R------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 58/251 (23%), Positives = 101/251 (40%), Gaps = 47/251 (18%)
Query: 150 ELGKEVGRGHFGH----TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
LGK +G G FG K + +VAVK++ + D+ E++++K
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--SDLISEMEMMK 129
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD---------------RILARGGRYT 250
+ HK+++ AC +Y+++E G L + + +
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
+D + Q+ + + + +HRDL N L T +D M++ DFGL+ R
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA---R---- 239
Query: 311 LNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWAR 356
DI YY APE L R Y+ ++D+WS GV+ + I G P+
Sbjct: 240 --DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297
Query: 357 TESGIFRAVLR 367
+F+ +
Sbjct: 298 PVEELFKLLKE 308
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 46/224 (20%)
Query: 150 ELGKEVGRGHFGH----TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
LGK +G G FG K + VAVK++ T + D+ E++++K
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMK 95
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKAIVVQ 260
+ HK+++ AC +Y+++E G L + R Y +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 261 ILSVVAFC--------HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
+V+ +L Q +HRDL N L T ++ M++ DFGL+ R
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R---- 205
Query: 311 LNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGV 341
DI YY APE L R Y+ ++D+WS GV
Sbjct: 206 --DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 8e-19
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 27/222 (12%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS-KAKMTTAISIEDVRREVKIL 204
G K+ LG+++G G FG + +++VA+K+ + K K + E KI
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKHPQ------LLYESKIY 56
Query: 205 KALSGHKHL--VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
+ L G + V++ D N +VM+L G L D + + + + Q++
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYN--VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF---------IRPDERLND 313
+ V F H + +HRD+KP+NFL GR + +IDFGL+ I E +
Sbjct: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN-KN 172
Query: 314 IVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFW 354
+ G+A Y + L S D+ S+G + L GS P W
Sbjct: 173 LTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 62/255 (24%), Positives = 100/255 (39%), Gaps = 54/255 (21%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
LGK +G G FG +A KG VAVK++ + + + D+ E +LK +
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE--NASPSELRDLLSEFNVLKQV 83
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD----------RILARGGRYTEEDAKAI 257
H H++K AC + +++E + G L L GG
Sbjct: 84 -NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 258 VVQILSV---VAFC--------HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304
+ L++ ++F +L +VHRDL N L + M++ DFGLS
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGLS-- 197
Query: 305 IRPDERLNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGS 350
R D+ YV A E L Y+ ++D+WS GV+ + I+ G
Sbjct: 198 -R------DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250
Query: 351 RPFWARTESGIFRAV 365
P+ +F +
Sbjct: 251 NPYPGIPPERLFNLL 265
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 46/224 (20%)
Query: 150 ELGKEVGRGHFGH----TCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
LGK +G G FG K + VAVK++ T + D+ E++++K
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMK 141
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLD-----RILARGGRYTEEDAKAIVVQ 260
+ HK+++ AC +Y+++E G L + R Y +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 261 ILSVVAFC--------HL--QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER 310
+V+ +L Q +HRDL N L T ++ M++ DFGL+ R
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R---- 251
Query: 311 LNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGV 341
DI YY APE L R Y+ ++D+WS GV
Sbjct: 252 --DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 293
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 29/225 (12%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI-ISKAKMTTAISIEDVRREVKI 203
G Y++G+ +G G FG +QQVA+K ++ +R E +
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLN---NQQVAIKFEPRRSDAPQ------LRDEYRT 58
Query: 204 LKALSGHKHL--VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
K L+G + V + N +V++L G L D + G +++ + Q+
Sbjct: 59 YKLLAGCTGIPNVYYFGQEGLHN--VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQM 115
Query: 262 LSVVAFCHLQGVVHRDLKPENFLF--TSGRDDADMRLIDFGLS----DF-----IRPDER 310
L+ V H + +V+RD+KP+NFL + ++ + ++DFG+ D I E+
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 311 LNDIVGSAYYVAPEV-LHRSYSLEADIWSIGVISYILLCGSRPFW 354
N + G+A Y++ L R S D+ ++G + L GS P W
Sbjct: 176 KN-LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 52/247 (21%), Positives = 90/247 (36%), Gaps = 54/247 (21%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
E +++G G FG A G VAVK++ + +A D +RE ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALMAEF 107
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLD----------RILARGGRYTEEDAKAI 257
+ ++VK C + ++ E G+L + L+ T +
Sbjct: 108 D-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 258 VVQILSVVAFCHL-------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304
LS + + VHRDL N L +++ DFGLS
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM---VVKIADFGLS-- 221
Query: 305 IRPDERLNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGS 350
R +I + YY PE + + Y+ E+D+W+ GV+ + I G
Sbjct: 222 -R------NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274
Query: 351 RPFWART 357
+P++
Sbjct: 275 QPYYGMA 281
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 51/242 (21%), Positives = 91/242 (37%), Gaps = 48/242 (19%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL 204
G ++ LGK++G G FG A KD + VK+ + + E+K
Sbjct: 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-------LFSELKFY 87
Query: 205 KALSGHKHLVKFCD------------------ACEDVNNVYIVMELCEGGELLDRILARG 246
+ ++ + K+ + + + ++VME G L +I +
Sbjct: 88 QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQN 145
Query: 247 GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM-RLIDFGLSDFI 305
G + + + +++L V+ + H VH D+K N L G + D L D+GLS
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL--GYKNPDQVYLADYGLSYRY 203
Query: 306 RPDERLNDI--------VGSAYYVAPEVLHRSY--SLEADIWSIGVISYIL---LCGSRP 352
P+ G+ + H+ S +D+ +G Y + LCG P
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG---YCMLRWLCGKLP 259
Query: 353 FW 354
W
Sbjct: 260 -W 260
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 42/191 (21%), Positives = 79/191 (41%), Gaps = 22/191 (11%)
Query: 404 QALTHPWLRDDSRP---VPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQ 460
H R++ V L + K +K++ K+ AL ++K L + E+ LR
Sbjct: 3 HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNI 62
Query: 461 FRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAA 517
F L+ + G++S + +G + VL ++S A ++++ +F AA
Sbjct: 63 FIALDVDNSGTLSSQEILDGLKKIGYQKI----PPDIHQVLRDIDSNASGQIHYTDFLAA 118
Query: 518 AISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR---ELNVG-PSAYSFLKDWIR 573
I E F++F+ +GN IS+EEL R ++ P + ++
Sbjct: 119 TIDKQTYLKKEVCLI----PFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQ 174
Query: 574 ----NSDGKLS 580
N DG++
Sbjct: 175 EVDLNGDGEID 185
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-17
Identities = 38/188 (20%), Positives = 78/188 (41%), Gaps = 20/188 (10%)
Query: 406 LTHPWLRDDSRP--VPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRL 463
+ H R I + + K+Y F++ A+ +++ + ++ L++ F +
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60
Query: 464 LEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ 523
L+ + G ++ E + L ++ +L ++S K+ + EF AAA+ Q
Sbjct: 61 LDEDGKGYITKEQLKKGLEKDGLKLPYN--FDLLLDQIDSDGSGKIDYTEFIAAALDRKQ 118
Query: 524 LEALEGWEQIASTAFEYFEEEGNRVISIEELAR-------ELNVGPSAYSFLKDWIR--- 573
L + AF F+ + + I+ ELA + N+ + +K IR
Sbjct: 119 LSKKLIYC-----AFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVD 173
Query: 574 -NSDGKLS 580
N+DGK+
Sbjct: 174 KNNDGKID 181
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 43/243 (17%), Positives = 83/243 (34%), Gaps = 47/243 (19%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVK 202
A +++G +G+G FG A E D VK+ + E+K
Sbjct: 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS-------DNGPLFTELK 85
Query: 203 ILKALSGHKHL----------------VKFCDACEDVNNVY--IVMELCEGGELLDRILA 244
+ + + + + Y ++M+ G +L A
Sbjct: 86 FYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA 144
Query: 245 RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM-RLIDFGLSD 303
R++ + + ++IL ++ + H VH D+K N L + D L+D+GL+
Sbjct: 145 NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL--NYKNPDQVYLVDYGLAY 202
Query: 304 FIRPDERLNDI--------VGSAYYVAPEV-LHRSYSLEADIWSIGVISYIL---LCGSR 351
P+ G+ + + + + S D+ +G Y + L G
Sbjct: 203 RYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILG---YCMIQWLTGHL 259
Query: 352 PFW 354
P W
Sbjct: 260 P-W 261
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 43/238 (18%), Positives = 75/238 (31%), Gaps = 39/238 (16%)
Query: 146 GAKYELGKEVGRGHFG-----HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRR- 199
G +++L R + G S + Q+ ++K+ +K R
Sbjct: 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100
Query: 200 ---EVKILKALSGHKHL----VKFCDACEDVNNVYIVMELCEGGELLDRILARGGR--YT 250
+V K L L +D ++V+ G L L + +
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSL--GRSLQSALDVSPKHVLS 157
Query: 251 EEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM-RLIDFGLSDFIRPD- 308
E + ++L + F H VH ++ EN +D L +G + P
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV--DPEDQSQVTLAGYGFAFRYCPSG 215
Query: 309 ------ERLND-IVGSAYYVAPEVLHRSY--SLEADIWSIGVISYIL---LCGSRPFW 354
E G + LH+ S +D+ S+G Y + L G P W
Sbjct: 216 KHVAYVEGSRSPHEGDLEF-ISMDLHKGCGPSRRSDLQSLG---YCMLKWLYGFLP-W 268
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 33/227 (14%), Positives = 71/227 (31%), Gaps = 30/227 (13%)
Query: 374 DLPWPSVSPEAKDFVKRL------LNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKL 427
D ++ + ++ +L + ++ R A + + L L+ L
Sbjct: 40 DRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASLLKDL 99
Query: 428 VKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATD 487
L+ L+E++ LR F + G S ++ + VL D
Sbjct: 100 EDD-----ASGYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVL-AKYAD 153
Query: 488 AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNR 547
+ E + + +E+ +M + A A L A F + N
Sbjct: 154 TIPEGPLKKLFVMVENDTKGRMSYITLVAVANDLAALVA----------DFRKIDTNSNG 203
Query: 548 VISIEELAREL-NVGPSAYSFLKDWIR----NSDGKLSLHGYTKFLH 589
+S +E +G S R + + +++++H
Sbjct: 204 TLSRKEFREHFVRLGFDKKSVQDALFRYADEDESDDVG---FSEYVH 247
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 21/137 (15%), Positives = 46/137 (33%), Gaps = 31/137 (22%)
Query: 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRES--RVPDVLSSMESLAYR----KMY 510
L A FR ++ N +G++S + FR + V ++ A +
Sbjct: 190 LVADFRKIDTNSNGTLSRKEFR--------EHFVRLGFDKKSVQDALFRYADEDESDDVG 241
Query: 511 FEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR---ELNVGPSAYSF 567
F E+ + L + + + + + +S EE+ + + ++ SA
Sbjct: 242 FSEYVHLGLCLLVLRI----------LYAFADFDKSGQLSKEEVQKVLEDAHIPESARKK 291
Query: 568 LKDWIR----NSDGKLS 580
+ + LS
Sbjct: 292 FEHQFSVVDVDDSKSLS 308
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 78.0 bits (191), Expect = 5e-15
Identities = 80/489 (16%), Positives = 155/489 (31%), Gaps = 161/489 (32%)
Query: 194 IEDVRREVKILKALSGH--KHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTE 251
++D+ + + LS H++ D V+ L +L++ E
Sbjct: 38 VQDMPKSI-----LSKEEIDHIIMSKD---AVSGTLR---------LFWTLLSKQ----E 76
Query: 252 EDAKAIVVQILSVVAFCHLQGVVHRDLKPE-NFLFTSGRDDADMRLIDFGLSDFIRPDER 310
E + V ++L + FL + + + + + +I +R
Sbjct: 77 EMVQKFVEEVL----------------RINYKFLMSPIKTEQRQPSMMTRM--YIEQRDR 118
Query: 311 L-NDI-VGSAYYVA-PEVLHRSYSLEADIWSIGVISYILLCG---------------SRP 352
L ND V + Y V+ + + L + + +L+ G S
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLK---LRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYK 175
Query: 353 FWARTESGIF----------RAVL--------RSDPNFDDLPWPSVSP-----EAKDFVK 389
+ + IF VL + DPN+ S + + ++
Sbjct: 176 VQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR 235
Query: 390 RLL-NKDYRKRMTAVQALTHPWLRD--DSRPV-PLD----ILI---FKLVKSYLHATPFK 438
RLL +K Y + V L + +++ + IL+ FK V +L A
Sbjct: 236 RLLKSKPY-ENCLLV-------LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT 287
Query: 439 RAALKALSKALTEDELVYLRAQFRLLEPN---------------------KDGSVSLENF 477
+L S LT DE+ L ++ P +DG + +N+
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 478 RMVLGRNATDAMRESRVPDVLSSMESLAYRKMY-----FEEFCAAAISTHQLEALEGWEQ 532
+ V T + S L+ +E YRKM+ F +A I T L + W
Sbjct: 348 KHVNCDKLTTIIESS-----LNVLEPAEYRKMFDRLSVFPP--SAHIPTILLSLI--WFD 398
Query: 533 IASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592
+ + + + +L + YS ++ + +S+ +L
Sbjct: 399 V-----IKSDVM----VVVNKLHK--------YSLVEKQ--PKESTISIPSI--YLELKV 437
Query: 593 LRSSNTRHH 601
+ H
Sbjct: 438 KLENEYALH 446
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 7e-05
Identities = 46/310 (14%), Positives = 87/310 (28%), Gaps = 117/310 (37%)
Query: 275 HRDLKP---ENFLFTSGRDDADMRLIDFGLSDFIRP---DERLNDIVGSAYYVAPEVLHR 328
++D+ + F+ D+ D + + D + E ++ I+ S + +
Sbjct: 18 YKDILSVFEDAFV-----DNFDCKDV----QDMPKSILSKEEIDHIIMS-----KDAVSG 63
Query: 329 SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFV 388
+ L FW L S + FV
Sbjct: 64 TLRL--------------------FW----------TLLSKQE----------EMVQKFV 83
Query: 389 KRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHATPFK-----RA-AL 442
+ +L +Y+ M+ ++ + + I + + Y F R
Sbjct: 84 EEVLRINYKFLMSPIKT------EQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY 137
Query: 443 KALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRM------VLGRNATDAMRESRVPD 496
L +AL E L P K+ V ++ + + A D +V
Sbjct: 138 LKLRQALLE------------LRPAKN--VLIDG--VLGSGKTWV---ALDVCLSYKV-- 176
Query: 497 VLSSMESLAYRKMYFEEF------CAAAIST-HQLEALEGWEQIASTAFEYFEEEGNRVI 549
KM F+ F C + + L+ L QI + N +
Sbjct: 177 ---------QCKMDFKIFWLNLKNCNSPETVLEMLQKL--LYQIDPNWTSRSDHSSNIKL 225
Query: 550 SIEELARELN 559
I + EL
Sbjct: 226 RIHSIQAELR 235
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 67/309 (21%), Positives = 105/309 (33%), Gaps = 89/309 (28%)
Query: 125 EERGTEPEQSLDKSFGYN------KNFGAKYELGKE--VGRGHFGHTCSARGKKGELKDQ 176
E + E + SF + NF + +G G FG KG + +
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFG-----VVYKGYVNNT 55
Query: 177 QVAVKIISKAKMTTAISIEDV------RREVKILKALSGHKHLVK---FCDACEDVNN-- 225
VAVK K+ + I +E+K++ H++LV+ F + +
Sbjct: 56 TVAVK-----KLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFS--SDGDDLCL 107
Query: 226 VYIVMELCEGGELLDRILARGG--------RYTEEDAKAIVVQILSVVAFCHLQGVVHRD 277
VY G LLDR+ G R I + + F H +HRD
Sbjct: 108 VY---VYMPNGSLLDRLSCLDGTPPLSWHMRC------KIAQGAANGINFLHENHHIHRD 158
Query: 278 LKPENFLFTSGRDDADMR--LIDFGLSDFIRPDERLND----------IVGSAYYVAPEV 325
+K N L D + DFGL+ R ++ IVG+ Y+APE
Sbjct: 159 IKSANILL-----DEAFTAKISDFGLA-------RASEKFAQTVMTSRIVGTTAYMAPEA 206
Query: 326 LHRSYSLEADIWSIGVISYILLCGSRPF-----------WAR---TESGIFRAVLRSDPN 371
L + ++DI+S GV+ ++ G E + D
Sbjct: 207 LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI--DKK 264
Query: 372 FDDLPWPSV 380
+D SV
Sbjct: 265 MNDADSTSV 273
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 9e-14
Identities = 46/341 (13%), Positives = 96/341 (28%), Gaps = 73/341 (21%)
Query: 132 EQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-----SKA 186
Q F + K + +++G G FG + VA+KII
Sbjct: 6 SQKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVF-----QTIADHTPVAIKIIAIEGPDLV 59
Query: 187 KMTTAISIEDVRREVKILKALSG--------HKHLVKFCDAC------------------ 220
+ + E++ E+ I K LS + +
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 221 ------------EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
+ ++IV+E GG L+++ + + AK+I+ Q+ + +A
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVA 177
Query: 269 HLQ-GVVHRDLKPENFLFTSG-----RDDADMRLIDFGLSDFI--------RPDERLNDI 314
HRDL N L + + ER +
Sbjct: 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIV 237
Query: 315 VGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374
V + ++ + DI+ + + + + +
Sbjct: 238 VFCDVSMDEDLFTGDGDYQFDIYRL--MKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT 295
Query: 375 LPWPSVSPEAKDFVKRLLNKDYRKRM----TAVQALTHPWL 411
+P K +++ +++ + M +A L L
Sbjct: 296 FKTKCNTPAMKQIKRKI--QEFHRTMLNFSSATDLLCQHSL 334
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 9e-13
Identities = 35/154 (22%), Positives = 80/154 (51%), Gaps = 21/154 (13%)
Query: 437 FKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESR 493
FK+ AL+ ++++L+E+E+ L+ F +++ +K G ++ E + +G N ES
Sbjct: 9 FKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLK----ESE 64
Query: 494 VPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEE 553
+ D++ + + + ++EF AA + +++E + AF YF+++G+ I+ +E
Sbjct: 65 ILDLMQAADVDNSGTIDYKEFIAATLHLNKIEREDHLFA----AFTYFDKDGSGYITPDE 120
Query: 554 L---ARELNVGPSAYSFLKDWIR----NSDGKLS 580
L E V +++ +R ++DG++
Sbjct: 121 LQQACEEFGVED---VRIEELMRDVDQDNDGRID 151
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 25/173 (14%), Positives = 65/173 (37%), Gaps = 14/173 (8%)
Query: 420 LDILIFKLVKSYLHATPFKRAALKALSKALT--EDELVYLRAQFRLLEPNKDGSVSLENF 477
+ + +KSY+ + + + ++ L+ + + Y+ F L+ N +GS+S
Sbjct: 2 ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61
Query: 478 RMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTA 537
VL +++ + +L +++ + + EF A +E+ A
Sbjct: 62 YTVLASV---GIKKWDINRILQALDINDRGNITYTEFMAGCYRWKNIESTFLKA-----A 113
Query: 538 FEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIR----NSDGKLSLHGYTK 586
F +++ + IS ++ ++ + + ++ G H K
Sbjct: 114 FNKIDKDEDGYISKSDIVSLVHDKVLDNNDIDNFFLSVHSIKKGIPREHIINK 166
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 21/164 (12%), Positives = 52/164 (31%), Gaps = 24/164 (14%)
Query: 437 FKRAALKALSKALTEDELVYLRAQ----FRLLEPNKDGSVSLENFRMVLGRNATDAMRES 492
++ A + + +A+ ++ + + F+ + N+ G + + S
Sbjct: 26 DRKEAWERIRQAIPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTS 85
Query: 493 RVPDVLSSMESLAYRKMY---------FEEFCAAAISTHQLEALEGWEQIASTAFEYFEE 543
RV D+ + F EF + + + ++ F+ +
Sbjct: 86 RVRDITKRAFDKSRTLGSKLENKGSEDFVEFLEFRLMLCY---IYDFFELTV-MFDEIDA 141
Query: 544 EGNRVISIEELAR---ELNVGPSAYSFLKDWIR----NSDGKLS 580
GN ++ EE R +L + + N G ++
Sbjct: 142 SGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDKNGTGSVT 185
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-11
Identities = 32/179 (17%), Positives = 58/179 (32%), Gaps = 23/179 (12%)
Query: 419 PLDILIFKLVKSYLHATPFKRAALKAL-SKALTEDELVYLRAQFRLLEPNKDGSVSLENF 477
+K + + +AA+ + SK T +E L FR L+ N DG + +
Sbjct: 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKEL 62
Query: 478 RMVLGRNATDAMRESRVPDVLSSMESLAYRKMY------------FEEFCAAAISTHQLE 525
+ D + + + EF + L
Sbjct: 63 IEGYRKLMQWKGDTVSDLDSSQIEAEV--DHILQSVDFDRNGYIEYSEFVTVCMDKQLLL 120
Query: 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIR----NSDGKLS 580
+ E AF+ F+ +G+ I+ EEL R V ++ N+DG++
Sbjct: 121 SRERLLA----AFQQFDSDGSGKITNEELGRLFGVTEVDDETWHQVLQECDKNNDGEVD 175
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 39/186 (20%), Positives = 68/186 (36%), Gaps = 20/186 (10%)
Query: 150 ELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+LGK +GRG FG A G + VAVK++ + T + E+KIL +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHI 82
Query: 208 SGHKHLVKFCDACEDVNN-VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
H ++V AC + +++E C+ G L + R + +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKTKGARFRQ 137
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----------LNDIVG 316
G + DLK TS + A ++ + +E L ++
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC 197
Query: 317 SAYYVA 322
++ VA
Sbjct: 198 YSFQVA 203
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 32/117 (27%), Positives = 50/117 (42%), Gaps = 26/117 (22%)
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
T E Q+ + F + +HRDL N L + +++ DFGL+ R
Sbjct: 191 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLA---R--- 241
Query: 310 RLNDIVGSAYYV------------APEVL-HRSYSLEADIWSIGVISY-ILLCGSRP 352
DI YV APE + R Y++++D+WS GV+ + I G+ P
Sbjct: 242 ---DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 67/265 (25%), Positives = 99/265 (37%), Gaps = 67/265 (25%)
Query: 123 IPEERGTEPEQSLDKSFGYN------KNFGAKYELGKEVGRGHFGHTCSARGKKGELKD- 175
+P E E K F NF K LG RG FG KG L D
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILG----RGGFGKV-----YKGRLADG 54
Query: 176 QQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN---VYIVME- 231
VAVK + K + T ++ + EV+++ H++L++ C VY M
Sbjct: 55 TLVAVKRL-KEERTQGGELQ-FQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMAN 111
Query: 232 ---------LCEGGELLD-----RIL---ARGGRYTEEDAKAIVVQILSVVAFCHLQGVV 274
E LD RI ARG Y + C + ++
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH--------------CDPK-II 156
Query: 275 HRDLKPENFLFTSGRDDADM--RLIDFGLSDFIRPDERLN---DIVGSAYYVAPEVLHRS 329
HRD+K N L D + + DFGL+ + + + + G+ ++APE L
Sbjct: 157 HRDVKAANILL-----DEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYLSTG 210
Query: 330 YSLE-ADIWSIGVISYILLCGSRPF 353
S E D++ GV+ L+ G R F
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAF 235
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 57/268 (21%), Positives = 100/268 (37%), Gaps = 73/268 (27%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKD-QQVAVKIISKAKMTTAISIEDVR--- 198
NF K+ +G G FG + KG L+D +VA+K + S + +
Sbjct: 39 NNFDHKFLIGH----GVFG-----KVYKGVLRDGAKVALKRRTPE------SSQGIEEFE 83
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED----- 253
E++ L H HLV C++ N + ++ + E G L +
Sbjct: 84 TEIETLSFCR-HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 254 ------AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM--RLIDFGLS-DF 304
A+ + + H + ++HRD+K N L D + ++ DFG+S
Sbjct: 143 EICIGAARGL--------HYLHTRAIIHRDVKSINILL-----DENFVPKITDFGISKKG 189
Query: 305 IRPDE-----RLNDIVGSAYYVAPEVLHRSYSLE-ADIWSIGVISYILLCGSRPF----- 353
D+ + G+ Y+ PE + E +D++S GV+ + +LC
Sbjct: 190 TELDQTHLSTV---VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 354 --------WART--ESGIFRAVLRSDPN 371
WA +G ++ DPN
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIV--DPN 272
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-09
Identities = 24/166 (14%), Positives = 56/166 (33%), Gaps = 24/166 (14%)
Query: 438 KRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMV--------LGRNATDAM 489
+ A+K + + + F L+ N +G ++L+ L
Sbjct: 3 SKYAVKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTK 62
Query: 490 RESRVPDVLS-SMESLAYRKMYFEEFCA--AAISTHQLEALEGWEQIAST-----AFEYF 541
R + +++ F +F ++T +L+ E F+ F
Sbjct: 63 RHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIF 122
Query: 542 EEEGNRVISIEEL---ARELNVGPSAYSFLKDWIR----NSDGKLS 580
+++G+ I+++E + + PS + R ++ G L
Sbjct: 123 DKDGSGTITLDEWKAYGKISGISPSQED-CEATFRHCDLDNAGDLD 167
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 4e-08
Identities = 23/122 (18%), Positives = 48/122 (39%), Gaps = 10/122 (8%)
Query: 438 KRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRV 494
L+ L E++ + F L + N DG + ++ LG +
Sbjct: 6 SSLQSGPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKRE----I 61
Query: 495 PDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEEL 554
D++ +S M +++F ++ + ++I AF+ F+++ ISI+ L
Sbjct: 62 LDLIDEYDSEGRHLMKYDDFYIVM--GEKILKRDPLDEI-KRAFQLFDDDHTGKISIKNL 118
Query: 555 AR 556
R
Sbjct: 119 RR 120
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 49.0 bits (118), Expect = 3e-07
Identities = 23/110 (20%), Positives = 49/110 (44%), Gaps = 10/110 (9%)
Query: 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSMESLAY 506
TE++ +R F L + + G++ ++ ++ LG + ++S ++
Sbjct: 1 TEEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEE----IKKMISEIDKEGT 56
Query: 507 RKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
KM F +F T ++ + E+I AF+ F+++ IS + L R
Sbjct: 57 GKMNFGDFLTVM--TQKMSEKDTKEEIL-KAFKLFDDDETGKISFKNLKR 103
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 21/163 (12%), Positives = 45/163 (27%), Gaps = 22/163 (13%)
Query: 440 AALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMV--------LGRNATDAMRE 491
A K S + + F L+ N +G +SL+ LG A R
Sbjct: 1 ANSKLTSDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRH 60
Query: 492 SRVPDVLS-SMESLAYRKMYFEEFCAAA-------ISTHQLEALEGWEQIASTAFEYFEE 543
+ + + + + + F+ ++
Sbjct: 61 KDAVEAFFGGAGMKYGVETDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDK 120
Query: 544 EGNRVISIEELAREL-NVG-PSAYSFLKDWIR----NSDGKLS 580
+ N I+++E G + ++ R + G+L
Sbjct: 121 DQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLD 163
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 18/154 (11%), Positives = 49/154 (31%), Gaps = 25/154 (16%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGR-NATDAMRESRVPDVLSSMESLAYR 507
L L L +F + + DG + ++ R + +V + ++
Sbjct: 30 LHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLH 89
Query: 508 -------KMYFEEFCAAA-------ISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEE 553
+ E++ A + ++++ ++ +++G+ + ++E
Sbjct: 90 KGVEPVNGLLREDWVEANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDE 149
Query: 554 LAR---ELNVGPSAYSFLKDWIR----NSDGKLS 580
L +V A + + GKL
Sbjct: 150 LKTMMKAFDVPQEA---AYTFFEKADTDKSGKLE 180
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 48.6 bits (117), Expect = 4e-07
Identities = 29/114 (25%), Positives = 57/114 (50%), Gaps = 10/114 (8%)
Query: 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSME 502
S+ LTE+++ + F L + + GS+S V LG + ++A V D+++ ++
Sbjct: 2 SQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAE----VADLMNEID 57
Query: 503 SLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
+ F EF A + QL+ + +++ AF+ F++ G+ +IS EL
Sbjct: 58 VDGNHAIEFSEFLALM--SRQLKCNDSEQEL-LEAFKVFDKNGDGLISAAELKH 108
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 5e-07
Identities = 26/145 (17%), Positives = 69/145 (47%), Gaps = 27/145 (18%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSMESLA 505
L+E+E+ L+ F++++ + G+++ + + +G ++ ++ M++
Sbjct: 4 LSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMES-------EIKDLMDAAD 56
Query: 506 Y---RKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEEL---ARELN 559
+ + EF AA + ++LE E AF YF+++G+ I+++E+ ++
Sbjct: 57 IDKSGTIDYGEFIAATVHLNKLEREENLVS----AFSYFDKDGSGYITLDEIQQACKDFG 112
Query: 560 VGPSAYSFLKDWIR----NSDGKLS 580
+ + D I+ ++DG++
Sbjct: 113 LDD---IHIDDMIKEIDQDNDGQID 134
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 5e-07
Identities = 29/122 (23%), Positives = 56/122 (45%), Gaps = 17/122 (13%)
Query: 441 ALKALSKA---LTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRV 494
A KA S L + ++ ++ F +++ ++DG VS E+ + + LGR D
Sbjct: 1 ADKAASGVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKE----- 55
Query: 495 PDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEEL 554
L++M A + F F + + +L + E I + AF F+E+ + ++IE +
Sbjct: 56 ---LTAMLKEAPGPLNFTMFLSIF--SDKLSGTDSEETIRN-AFAMFDEQETKKLNIEYI 109
Query: 555 AR 556
Sbjct: 110 KD 111
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 6e-07
Identities = 32/157 (20%), Positives = 65/157 (41%), Gaps = 18/157 (11%)
Query: 434 ATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMR 490
R K LTE++ +R F L + + G++ + ++ LG
Sbjct: 7 TVVSARRDQKKGRVGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEE- 65
Query: 491 ESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVIS 550
+ ++S ++ + FEEF T ++ + E+I AF F+++ + I+
Sbjct: 66 ---IKKMISEIDKDGSGTIDFEEFLTMM--TAKMGERDSREEIL-KAFRLFDDDNSGTIT 119
Query: 551 IEEL---ARELNVGPSAYSFLKDWIR----NSDGKLS 580
I++L A+EL + L++ I N D ++
Sbjct: 120 IKDLRRVAKELGENLTE-EELQEMIAEADRNDDNEID 155
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 7e-07
Identities = 24/111 (21%), Positives = 46/111 (41%), Gaps = 14/111 (12%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSMESLA 505
+ ++ + F +++ N+DG + E+ + +G+N TD L M S A
Sbjct: 1 FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEY--------LEGMMSEA 52
Query: 506 YRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
+ F F + +L + + I + AF F+EE + I + L
Sbjct: 53 PGPINFTMFL--TMFGEKLNGTDPEDVIRN-AFACFDEEASGFIHEDHLRE 100
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 7e-07
Identities = 27/114 (23%), Positives = 60/114 (52%), Gaps = 10/114 (8%)
Query: 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSME 502
++ LTE+++ + F L + + DG+++ + V LG+N T+A + D+++ ++
Sbjct: 1 AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAE----LQDMINEVD 56
Query: 503 SLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
+ + F EF + +++ + E++ AF+ F+ +GN +IS EL
Sbjct: 57 ADGNGTIDFPEFLSLM--ARKMKEQDSEEELIE-AFKVFDRDGNGLISAAELRH 107
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 9e-07
Identities = 12/111 (10%), Positives = 38/111 (34%), Gaps = 14/111 (12%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSMESLA 505
E+++ + E + G +S++N LG + ++ L
Sbjct: 9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSID--------EKKIKELY 60
Query: 506 YRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
+ +E++ + + + E++ F +F+ ++ ++
Sbjct: 61 GDNLTYEQYL--EYLSICVHDKDNVEELIK-MFAHFDNNCTGYLTKSQMKN 108
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 18/155 (11%), Positives = 54/155 (34%), Gaps = 19/155 (12%)
Query: 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVL-SSMES 503
++++ L ++ + + ++ DG +S E++ ++ R A A + +
Sbjct: 4 ITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLR 63
Query: 504 LAYR-------KMYFEEFCAAA---ISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEE 553
+A + ++ EE A + + E + ++ + + + +S+ E
Sbjct: 64 VADQLGLAPGVRISVEEAAVNATDSLLKMKGEEKAMAVIQSLIMYDCIDTDKDGYVSLPE 123
Query: 554 LAR---ELNVGPSAYSFLKDWIR----NSDGKLSL 581
+ + N +G++S
Sbjct: 124 FKAFLQAVGPDLTD-DKAITCFNTLDFNKNGQISR 157
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 22/125 (17%), Positives = 41/125 (32%), Gaps = 17/125 (13%)
Query: 442 LKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVL---GRNATDAMRESRVPDVL 498
L+A + + L FR L+ + S+ + FR L G A +
Sbjct: 24 LRAQCLSRGASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQA-------EAE 76
Query: 499 SSMESL---AYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELA 555
+ EEF A E + + AF + G+ V+++++L
Sbjct: 77 GVCRKWDRNGSGTLDLEEFLRALRPPMSQAR----EAVIAAAFAKLDRSGDGVVTVDDLR 132
Query: 556 RELNV 560
+
Sbjct: 133 GVYSG 137
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 22/150 (14%), Positives = 50/150 (33%), Gaps = 21/150 (14%)
Query: 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKM 509
++ + ++ F ++ +KDG+++ +F + R A ++ ++ VL + +
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNF 60
Query: 510 Y----------FEEFCAAAISTHQLEALEGW-EQIASTAFEYFEEEGNRVISIEELAR-- 556
F + + + E F + + IS +E
Sbjct: 61 LTAVAGGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFF 120
Query: 557 -ELNVGPSAYSFLKDWIR----NSDGKLSL 581
L + + N+DG LSL
Sbjct: 121 GMLGLDKTM---APASFDAIDTNNDGLLSL 147
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 2e-06
Identities = 28/114 (24%), Positives = 57/114 (50%), Gaps = 10/114 (8%)
Query: 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSME 502
+ LTE+++ + F L + + DG+++ + V LG+N T+A + D+++ ++
Sbjct: 2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAE----LQDMINEVD 57
Query: 503 SLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
+ + F EF +++ + E+I AF F+++GN IS EL
Sbjct: 58 ADGNGTIDFPEFLTMM--ARKMKDTDSEEEI-REAFRVFDKDGNGYISAAELRH 108
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 24/111 (21%), Positives = 48/111 (43%), Gaps = 7/111 (6%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSMESLA 505
L+E+ + +A F + + + G +S + V LG+N T + ++ ++
Sbjct: 14 LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEE----LDAIIEEVDEDG 69
Query: 506 YRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
+ FEEF + + +A E+ + F F++ + I IEEL
Sbjct: 70 SGTIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGE 120
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 13/125 (10%), Positives = 38/125 (30%), Gaps = 18/125 (14%)
Query: 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKM 509
T L+ +F + + +G++ +F A +++ +V + +
Sbjct: 2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFD 61
Query: 510 Y--------------FEEFCAAAISTHQLEALEGWEQIAST----AFEYFEEEGNRVISI 551
Y E+F + + + ++ ++ + I+
Sbjct: 62 YLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINA 121
Query: 552 EELAR 556
+E A
Sbjct: 122 DEFAA 126
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 17/170 (10%), Positives = 41/170 (24%), Gaps = 16/170 (9%)
Query: 417 PVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLEN 476
P+ Y + L + D+ + F ++ ++ G++ +
Sbjct: 13 LQPIQGSWMGAACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINE 72
Query: 477 FRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIAST 536
M + ++ ++ + F EF A + +E
Sbjct: 73 LMMGQ-FPGGIRLSPQTALRMMRIFDTDFNGHISFYEFMAM------YKFMELAYN---- 121
Query: 537 AFEYFEEEGNRVISIEELAREL-----NVGPSAYSFLKDWIRNSDGKLSL 581
F + + E+ L + L L
Sbjct: 122 LFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFARGMAFCDL 171
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 20/136 (14%), Positives = 42/136 (30%), Gaps = 14/136 (10%)
Query: 432 LHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDA 488
+ T L + + +E +R + + G + E + L A
Sbjct: 83 VLPTEENFLLLFRCQQLKSCEEF---MKTWRKYDTDHSGFIETEELKNFLKDLLEKANKT 139
Query: 489 MRESRVPDVLSSMESLAYR----KMYFEEFCAAAISTHQLEALEGWEQIAST----AFEY 540
+ ++++ + M L K+ E ++ AFE
Sbjct: 140 VDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLLPVQENFLLKFQGIKMCGKEFNKAFEL 199
Query: 541 FEEEGNRVISIEELAR 556
++++GN I EL
Sbjct: 200 YDQDGNGYIDENELDA 215
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 8e-06
Identities = 25/125 (20%), Positives = 46/125 (36%), Gaps = 16/125 (12%)
Query: 438 KRAALKALSKA---LTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRE 491
KR A + S E E+ + F +++ N DG + ++ R +GR
Sbjct: 5 KRRAAEGSSNVFSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKN--- 61
Query: 492 SRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISI 551
+ L +M A + F F + +L+ + + I AF+ + +G I
Sbjct: 62 ----EELDAMIKEASGPINFTVFLT--MFGEKLKGADPEDVIMG-AFKVLDPDGKGSIKK 114
Query: 552 EELAR 556
L
Sbjct: 115 SFLEE 119
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 9e-06
Identities = 22/116 (18%), Positives = 46/116 (39%), Gaps = 10/116 (8%)
Query: 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSME 502
++L +E+ LR FR + +KDG ++ + +G T+ + ++ +
Sbjct: 2 DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEME----LIELSQQIN 57
Query: 503 SLAYRKMYFEEFCAAAISTHQLEALEGW--EQIASTAFEYFEEEGNRVISIEELAR 556
+ F++F E + +++ AF F+ G+ IS EL
Sbjct: 58 MNLGGHVDFDDFVELMGPKLLAETADMIGVKELRD-AFREFDTNGDGEISTSELRE 112
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 24/138 (17%), Positives = 52/138 (37%), Gaps = 23/138 (16%)
Query: 433 HATPFKRAALKALSKA--LTEDELVYLRAQFRLLEPNKDGSVSLENFRMV--LGRNATDA 488
+T + L+ + K + ++ L ++F L+ ++G++S E+F+ + L N
Sbjct: 5 ASTLLRDEELEEIKKETGFSHSQITRLYSRFTSLDKGENGTLSREDFQRIPELAINPL-- 62
Query: 489 MRESRVPDVLSSMESLAYRKMYFEEFCAA------------AISTHQLEALEGWEQIAST 536
R+ + S ++ F F + + E L
Sbjct: 63 --GDRIINAFFSEGE---DQVNFRGFMRTLAHFRPIEDNEKSKDVNGPEPLNSRSNKLHF 117
Query: 537 AFEYFEEEGNRVISIEEL 554
AF ++ + + IS +EL
Sbjct: 118 AFRLYDLDKDDKISRDEL 135
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 28/111 (25%), Positives = 57/111 (51%), Gaps = 10/111 (9%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSMESLA 505
LTE+++ + F L + + DG+++ + V LG+N T+A + D+++ +++
Sbjct: 306 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAE----LQDMINEVDADG 361
Query: 506 YRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
+ F EF + +++ + E+I AF F+++GN IS EL
Sbjct: 362 NGTIDFPEFL--TMMARKMKDTDSEEEIRE-AFRVFDKDGNGYISAAELRH 409
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 28/113 (24%), Positives = 44/113 (38%), Gaps = 10/113 (8%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLS--SMES 503
+D+L + F L + DG + V LG+N T+A V VL +
Sbjct: 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAE----VLKVLGNPKSDE 59
Query: 504 LAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
L R++ FE F + + +E F F++EGN + EL
Sbjct: 60 LKSRRVDFETFLPMLQAVAKNRGQGTYEDYLE-GFRVFDKEGNGKVMGAELRH 111
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-05
Identities = 15/103 (14%), Positives = 40/103 (38%), Gaps = 8/103 (7%)
Query: 457 LRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSMESLAYRKMYFEE 513
A F+ ++ N DG+VS E + + + + + S+++ ++ E
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQL----LQLIFKSIDADGNGEIDQNE 57
Query: 514 FCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
F S + + + ++ + +G+ ++ EE+
Sbjct: 58 FAKFYGSIQGQDLSDDKIGLKV-LYKLMDVDGDGKLTKEEVTS 99
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142 | Back alignment and structure |
|---|
Score = 43.6 bits (104), Expect = 2e-05
Identities = 20/114 (17%), Positives = 40/114 (35%), Gaps = 20/114 (17%)
Query: 451 EDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDA-----MRESRVPDVLSSME 502
+D++ + F L + + G ++ E + V G A E+ D + +
Sbjct: 2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEA---DATGNGK 58
Query: 503 SLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
+ F EF + +++ + + AF F+ EG I L
Sbjct: 59 ------IQFPEFLSMM--GRRMKQTTSEDIL-RQAFRTFDPEGTGYIPKAALQD 103
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 3e-05
Identities = 27/118 (22%), Positives = 54/118 (45%), Gaps = 8/118 (6%)
Query: 443 KALSKALTEDELVYLRAQFRLLEPN-KDGSVSLENFRMV---LGRNATDAMRESRVPDVL 498
KA + LTE++ +A F + +DGS+S + V LG+N T + +++
Sbjct: 6 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEE----LQEMI 61
Query: 499 SSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
++ + F+EF + + + ++ E+ S F F++ + I +EEL
Sbjct: 62 DEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKI 119
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 24/109 (22%), Positives = 41/109 (37%), Gaps = 6/109 (5%)
Query: 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLA 505
KA+ E F + G +L F+ +LG + + V ++ ++
Sbjct: 13 QKAVPTQETHVWYRTFMME--YPSGLQTLHEFKTLLGLQGLNQKANKHIDQVYNTFDTNK 70
Query: 506 YRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEEL 554
+ F EF AA Q + EQ F+ ++ +GN I EL
Sbjct: 71 DGFVDFLEFIAAVNLIMQEKM----EQKLKWYFKLYDADGNGSIDKNEL 115
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 8e-05
Identities = 20/114 (17%), Positives = 45/114 (39%), Gaps = 11/114 (9%)
Query: 449 LTEDELVYLRAQFRLL-EPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSMESL 504
L+ +++ L FR P G VS + ++ LG T + + ++ +
Sbjct: 7 LSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKST----IRQLIDEFDPF 62
Query: 505 AYRKMYFEEFCAAAIS--THQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
+ F+ F ++ + +++ AF +++EGN IS + +
Sbjct: 63 GNGDIDFDSFKIIGARFLGEEVNPEQMQQEL-REAFRLYDKEGNGYISTDVMRE 115
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 25/103 (24%), Positives = 39/103 (37%), Gaps = 17/103 (16%)
Query: 198 RREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
R E + L+ L G ++MEL + EL E+ +
Sbjct: 152 RNEFRALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYR--------VRVENPDEV 198
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
+ IL VA + +G+VH DL N L + + +IDF
Sbjct: 199 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFP 237
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149 | Back alignment and structure |
|---|
Score = 41.7 bits (99), Expect = 1e-04
Identities = 21/111 (18%), Positives = 40/111 (36%), Gaps = 6/111 (5%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSMESLA 505
++ + F L + D ++ + LG+N T+A + + S E +
Sbjct: 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNP--SKEEMN 59
Query: 506 YRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
+ FEEF + +G + F++EGN + EL
Sbjct: 60 AAAITFEEFL-PMLQAAANNKDQGTFEDFVEGLRVFDKEGNGTVMGAELRH 109
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 14/128 (10%), Positives = 36/128 (28%), Gaps = 18/128 (14%)
Query: 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVL-----GRNATDAMRESRVPDVLSS 500
A + ++ + + +G + + D + + RV + S
Sbjct: 2 DSAFANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKS 61
Query: 501 MESLAYR----KMYFEEFCAA--------AISTHQLEALEGWEQIASTAFEYFEEEGNRV 548
S ++ EE + + L+ + + ++ + +
Sbjct: 62 FMSAYDATFDGRLQIEELANMILPQEENFLLIFRREAPLDNSVEF-MKIWRKYDADSSGY 120
Query: 549 ISIEELAR 556
IS EL
Sbjct: 121 ISAAELKN 128
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 30/192 (15%), Positives = 68/192 (35%), Gaps = 28/192 (14%)
Query: 419 PLDILIFKLVKSYLHATPFKRAALKALSKA--LTEDELVYLRAQFRLLEPN--KDGSVSL 474
L + L+ + L++ + E+ L F+ + DG ++
Sbjct: 10 HLCTSVLGCFDLDLYKQSGGLGDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLINK 69
Query: 475 ENFRMVLGRNATDAMRES-RVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533
E F++ L + + RV D+ + + + FEEF A H ++ ++I
Sbjct: 70 EEFQLALFKTNKKESLFADRVFDLFDTKHN---GILGFEEFARALSVFHPNAPID--DKI 124
Query: 534 ASTAFEYFEEEGNRVISIEELAR---------ELNVGPSAYSFLKDWI-----RNSDGKL 579
+F+ ++ + I +E+ + +N+ + + D DGK+
Sbjct: 125 -HFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKI 183
Query: 580 SLHGYTKFLHGV 591
++ V
Sbjct: 184 D---KEEWRSLV 192
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 18/118 (15%), Positives = 39/118 (33%), Gaps = 19/118 (16%)
Query: 457 LRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSMESLAYRKMY--- 510
+ A+F + + +G + +F + A R R + E+L ++ +
Sbjct: 6 IAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEAL-WQGLAGIA 64
Query: 511 ---------FEEFCAAA---ISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR 556
EEF A + E A + +G+ +++ + AR
Sbjct: 65 DRDGDQRITREEFVTGAVKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTAR 122
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A Length = 207 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 35/175 (20%), Positives = 59/175 (33%), Gaps = 28/175 (16%)
Query: 436 PFKRAALKALSKA--LTEDELVYLRAQFRLLEPN--KDGSVSLENFRMVLGRNATDAMRE 491
P + L+ T +E+ L F+ L + DG + E F++ L RN
Sbjct: 16 PPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFRNRNRRNLF 75
Query: 492 -SRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVIS 550
R+ DV + + F EF ++ A + AF+ ++ I
Sbjct: 76 ADRIFDVFDVKRN---GVIEFGEFV-RSLGVFHPSAPV--HEKVKFAFKLYDLRQTGFIE 129
Query: 551 IEELAR---------ELNVGPSAYSFLKDWI-----RNSDGKLSLHGYTKFLHGV 591
EEL EL + + D R +DGK+ ++ V
Sbjct: 130 REELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKID---IDEWKDFV 181
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} Length = 198 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 27/153 (17%), Positives = 49/153 (32%), Gaps = 20/153 (13%)
Query: 442 LKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSM 501
KA+ + L+ E +F G ++L F+ G V + +
Sbjct: 5 SKAVEE-LSATECHQWYKKFMTE--CPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETF 61
Query: 502 ESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG 561
+ + F E+ AA + + +Q F+ ++ +GN I EL +
Sbjct: 62 DFNKDGYIDFMEYVAALSLVLKGK----VDQKLRWYFKLYDVDGNGCIDRGELLNIIKAI 117
Query: 562 PSAYS-------------FLKDWIRNSDGKLSL 581
+ N DG+LSL
Sbjct: 118 RAINRCNEAMTAEEFTNMVFDKIDINGDGELSL 150
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E Length = 183 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 29/160 (18%), Positives = 56/160 (35%), Gaps = 26/160 (16%)
Query: 442 LKALSKA--LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLS 499
L+ L T+ EL L F+ P G V+ E F+ + + + + +
Sbjct: 6 LEQLEAQTNFTKRELQVLYRGFKNEXP--SGVVNEETFKQIYAQFFPHGDASTYAHYLFN 63
Query: 500 SMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEEL----- 554
+ ++ + FE+F A + + F ++ + I+ EE+
Sbjct: 64 AFDTTQTGSVKFEDFVTALSILLRGT----VHEKLRWTFNLYDINKDGYINKEEMMDIVK 119
Query: 555 ARELNVGPSAYSFLKDWI-------------RNSDGKLSL 581
A +G Y LK+ +N DG ++L
Sbjct: 120 AIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTL 159
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 14/88 (15%)
Query: 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE 281
D++N I+M G D I ED I +I +V H V+H DL
Sbjct: 410 DLDNKRIMMSYINGKLAKDVI---------EDNLDIAYKIGEIVGKLHKNDVIHNDLTTS 460
Query: 282 NFLFTSGRDDADMRLIDFGLSDFIRPDE 309
NF+F D D+ +IDFGL DE
Sbjct: 461 NFIF-----DKDLYIIDFGLGKISNLDE 483
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} Length = 91 | Back alignment and structure |
|---|
Score = 38.1 bits (89), Expect = 7e-04
Identities = 13/54 (24%), Positives = 20/54 (37%)
Query: 430 SYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGR 483
+ H R L +EL LR+ F + N+ G + E FR +
Sbjct: 2 HHHHHHSSGRENLYFQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTE 55
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 22/123 (17%), Positives = 47/123 (38%), Gaps = 22/123 (17%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMV--LGRNATDAMRESRVPDVLSSMESLAY 506
++ L+ L +FR L+ NK G +S + + + L N R+ + S
Sbjct: 23 FSQASLLRLHHRFRALDRNKKGYLSRMDLQQIGALAVNPL----GDRIIESFFPDGS--- 75
Query: 507 RKMYFEEFCAA-------AISTHQLEALEGWEQIAST------AFEYFEEEGNRVISIEE 553
+++ F F + + + E + S AF+ ++ + + IS E
Sbjct: 76 QRVDFPGFVRVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHE 135
Query: 554 LAR 556
+ +
Sbjct: 136 MLQ 138
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 30/178 (16%), Positives = 51/178 (28%), Gaps = 32/178 (17%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKI-------------------ISKA 186
G +G + G + A G K +AVKI
Sbjct: 46 GYITAMGGVISTGKEANVFYADGVFDG-KPVAMAVKIYRIETSEFDKMDEYLYGDERFDM 104
Query: 187 KMTTAISIED--VRREVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGEL-LDRIL 243
+ + +E + L+ + V ++ME EL ++
Sbjct: 105 RRISPKEKVFIWTEKEFRNLERA--KEAGVS-VPQPYTYMKNVLLMEFIGEDELPAPTLV 161
Query: 244 ARGGRYTEEDAKAIVVQILS-VVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300
G E D + I ++ V +VH DL N ++ + ID G
Sbjct: 162 ELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK-----VYFIDMG 214
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 601 | |||
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 99.93 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 99.89 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 99.89 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 99.88 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 99.88 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 99.87 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 99.87 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 99.87 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 99.87 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 99.86 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 99.84 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 99.84 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 99.84 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 99.84 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 99.83 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 99.83 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 99.83 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 99.82 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 99.82 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 99.82 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 99.82 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 99.81 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 99.81 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 99.81 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 99.8 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 99.8 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 99.8 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 99.8 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 99.8 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 99.8 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 99.79 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 99.79 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 99.79 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 99.79 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 99.79 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 99.79 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 99.79 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 99.79 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 99.79 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 99.78 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 99.78 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 99.78 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 99.78 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 99.78 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 99.77 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 99.76 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 99.76 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 99.76 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 99.76 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 99.76 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 99.76 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 99.76 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 99.76 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 99.75 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 99.74 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 99.74 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 99.74 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 99.74 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 99.74 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 99.74 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 99.73 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 99.73 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 99.73 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 99.73 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 99.72 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 99.72 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 99.72 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 99.71 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 99.71 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 99.71 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 99.69 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 99.68 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 99.68 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 99.68 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 99.67 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 99.67 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 99.67 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 99.66 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 99.64 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 99.61 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 99.6 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 99.58 | |
| 1sjj_A | 863 | Actinin; 3-helix bundle, calponin homology domain, | 99.54 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 99.54 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 99.53 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 99.52 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 99.5 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 99.49 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 99.49 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 99.48 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 99.48 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 99.47 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 99.47 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 99.46 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 99.46 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 99.46 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 99.45 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 99.44 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 99.44 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 99.44 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 99.39 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 99.38 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 99.38 | |
| 2zkm_X | 799 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 99.37 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 99.35 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 99.33 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 99.32 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 99.32 | |
| 1eg3_A | 261 | Dystrophin; EF-hand like domain, WW domain, struct | 99.31 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 99.31 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 99.3 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 99.29 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 99.28 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 99.27 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 99.27 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 99.25 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 99.25 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 99.25 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 99.24 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 99.23 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 99.23 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 99.23 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 99.21 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 99.19 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 99.19 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 99.18 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 99.18 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 99.18 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 99.18 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 99.18 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 99.17 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 99.17 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 99.17 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 99.17 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 99.17 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 99.16 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 99.16 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 99.16 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.15 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 99.15 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 99.15 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 99.15 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 99.14 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 99.14 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 99.14 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 99.13 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 99.13 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 99.12 | |
| 3ohm_B | 885 | 1-phosphatidylinositol-4,5-bisphosphate phosphodi | 99.11 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 99.11 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 99.1 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 99.1 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 99.09 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 99.09 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 99.09 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 99.09 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 99.08 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 99.07 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 99.07 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 99.07 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 99.07 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 99.06 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 99.05 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 99.05 | |
| 2kld_A | 123 | Polycystin-2; PC2, PKD2, calcium binding domain, E | 99.05 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 99.04 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 99.04 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 99.04 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 99.03 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 99.03 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 99.03 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 99.02 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 99.02 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 99.02 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 99.02 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 99.02 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 99.01 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 99.01 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 99.01 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 99.0 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 99.0 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 98.98 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 98.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 98.98 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 98.97 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 98.97 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 98.97 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 98.96 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 98.96 | |
| 1h8b_A | 75 | ACT-EF34, alpha-actinin 2, skeletal muscle isoform | 98.96 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 98.96 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 98.95 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 98.95 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 98.95 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 98.95 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 98.95 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 98.95 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 98.95 | |
| 3qr0_A | 816 | Phospholipase C-beta (PLC-beta); PH domain, EF han | 98.94 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 98.94 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 98.94 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.94 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 98.93 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 98.93 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 98.93 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 98.93 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 98.93 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 98.92 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 98.92 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 98.92 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 98.92 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 98.92 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 98.91 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 98.91 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 98.91 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 98.91 | |
| 2jq6_A | 139 | EH domain-containing protein 1; metal binding prot | 98.91 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 98.91 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 98.9 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 98.9 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 98.9 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 98.89 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 98.89 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 98.89 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 98.89 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 98.88 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 98.88 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.88 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 98.88 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 98.88 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 98.88 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 98.88 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 98.88 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 98.87 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 98.87 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 98.87 |
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-76 Score=638.26 Aligned_cols=440 Identities=33% Similarity=0.562 Sum_probs=382.2
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++++.||+|+||.||+|+++. ++..||||++.+...... ....+.+|+.+++.|. |||||+++++|.+.
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 108 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKV---THVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLD-HPNIMKLYDFFEDK 108 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETT---TCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECC---CCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 345679999999999999999999876 788999999987543322 3467889999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
..+|||||||++|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++....++.+||+|||++.
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999999999988765 579999999999999999999999999999999999999764456779999999998
Q ss_pred ccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.+.........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+++..+......+....|..++++
T Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 188 VFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp ECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred ECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 88766666778999999999999888999999999999999999999999999999999999988888877778899999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCCC------CCCChhHHHHHHHHhhhccCchhHHHHHHhhhhc-chHHHHH
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS------RPVPLDILIFKLVKSYLHATPFKRAALKALSKAL-TEDELVY 456 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~------~~~~~~~~~~~~~k~~~~~~~l~~~~~~~~~~~l-~~~~~~~ 456 (601)
+++||++||..||.+|||+.|+|+||||++.. ...+........++.|.....+.++++..++..+ +++++++
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~ 347 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKE 347 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHH
Confidence 99999999999999999999999999997531 1223333456778999999999999999998776 8999999
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcchh-------hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhh
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATD-------AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEG 529 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~-------~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~ 529 (601)
++++|..||.|+||.|+.+||..+++.++.. .....+++.+|+.+|.|++|.|+|+||+.++........
T Consensus 348 l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~EF~~~~~~~~~~~~--- 424 (494)
T 3lij_A 348 LTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLLS--- 424 (494)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHTC---
T ss_pred HHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhhcccc---
Confidence 9999999999999999999999999988632 345678999999999999999999999987665433333
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHhcC---Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhhccc
Q 007498 530 WEQIASTAFEYFEEEGNRVISIEELARELNV---GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVTL 593 (601)
Q Consensus 530 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~---~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~~ 593 (601)
++.++.+|+.||+|+||+|+.+||+.+|.. ..+ ++.+|+.+|.|+||.|+|+||+++|.++..
T Consensus 425 -~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~ 491 (494)
T 3lij_A 425 -KDKLESAFQKFDQDGNGKISVDELASVFGLDHLESKTWKEMISGIDSNNDGDVDFEEFCKMIQKLCS 491 (494)
T ss_dssp -HHHHHHHHHHHCTTCSSEECHHHHHHHC-CCSCCCHHHHHHHHTTCSSSSSSEEHHHHHHHHHHHSS
T ss_pred -HHHHHHHHHHHCCCCCCcCCHHHHHHHHHhcCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhhcc
Confidence 567899999999999999999999999953 222 999999999999999999999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-75 Score=635.94 Aligned_cols=440 Identities=30% Similarity=0.516 Sum_probs=382.4
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch----------hhHHHHHHHHHHHHHhcCCCCe
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA----------ISIEDVRREVKILKALSGHKHL 213 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~~h~ni 213 (601)
.+..+|+++++||+|+||.||+|+++. +++.||||++.+...... ...+.+.+|+.+|++|. ||||
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpni 108 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKN---GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNI 108 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTB
T ss_pred CcccceEEEeEecccCCeEEEEEEECC---CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCC
Confidence 456789999999999999999999876 788999999987543321 23567899999999996 9999
Q ss_pred eEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCC
Q 007498 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD 293 (601)
Q Consensus 214 v~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~ 293 (601)
|++++++.+...+|||||||+||+|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.+.....
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 109 IKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred CeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999999988765 57999999999999999999999999999999999999975333347
Q ss_pred eEEeecccccccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCC
Q 007498 294 MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373 (601)
Q Consensus 294 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 373 (601)
+||+|||++..+.........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+++..+......+.
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999999988877666677899999999999998899999999999999999999999999999999999988877776
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC-----hhHHHHHHHHhhhccCchhHHHHHHhhhh
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP-----LDILIFKLVKSYLHATPFKRAALKALSKA 448 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~-----~~~~~~~~~k~~~~~~~l~~~~~~~~~~~ 448 (601)
...|..+++++++||++||..||.+|||+.|+|+||||+....... ........+++|....++.++++..++..
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~ 347 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSK 347 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHH
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 6667789999999999999999999999999999999987654332 12235777889999999999999999877
Q ss_pred c-chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcch-------hhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 449 L-TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNAT-------DAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 449 l-~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~-------~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+ +++++++++++|..||.|+||.|+.+||..+++.++. ......+++.+|+.+|.|++|.|+|+||+.++..
T Consensus 348 ~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~ 427 (504)
T 3q5i_A 348 LTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFISVCMD 427 (504)
T ss_dssp TSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSC
T ss_pred CCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 6 9999999999999999999999999999999988742 1355678999999999999999999999987665
Q ss_pred chhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcC---Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 521 THQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNV---GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 521 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~---~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
...... ++.++.+|+.||+|+||+|+.+||+.+|.. ..+ ++.+|+.+|.|+||.|+|+||+++|.+..
T Consensus 428 ~~~~~~----~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~ 499 (504)
T 3q5i_A 428 KQILFS----EERLRRAFNLFDTDKSGKITKEELANLFGLTSISEKTWNDVLGEADQNKDNMIDFDEFVSMMHKIC 499 (504)
T ss_dssp HHHHTC----HHHHHHHHHHHCTTCCSEECHHHHHHHTTCSCCCHHHHHHHHHTTCSSCSSSEEHHHHHHHHHHHC
T ss_pred hhcccC----HHHHHHHHHHhcCCCCCcCcHHHHHHHHhhCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHhc
Confidence 432222 567899999999999999999999999853 332 99999999999999999999999998865
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-76 Score=637.20 Aligned_cols=439 Identities=33% Similarity=0.542 Sum_probs=384.1
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++.+.||+|+||.||+|+++. +++.||||++.+.........+.+.+|+.++++|. |||||++++++.+.
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDK 98 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred cccCceEEeeEEecCCCEEEEEEEECC---CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence 355689999999999999999999876 78899999998766554556788999999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+.+|+|||||.+|+|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||+.....++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999999999987654 579999999999999999999999999999999999999654567899999999998
Q ss_pred ccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.+.........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+.+..+++..+......+....|..++++
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 178 HFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp HBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred EcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 88766666778899999999999889999999999999999999999999999999999999988877777677889999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCCCC-----CCChhHHHHHHHHhhhccCchhHHHHHHhhhhc-chHHHHHH
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR-----PVPLDILIFKLVKSYLHATPFKRAALKALSKAL-TEDELVYL 457 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~-----~~~~~~~~~~~~k~~~~~~~l~~~~~~~~~~~l-~~~~~~~l 457 (601)
+++||++||..||.+|||+.|+|+||||+.... ..+........+++|.....+.++++..++..+ ++++++++
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l 337 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKEL 337 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHH
Confidence 999999999999999999999999999975432 334444566777889999999999999998765 88999999
Q ss_pred HHHHHhhCCCCCCcccHHHHHHHH----hhcchhhhh-------hccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh
Q 007498 458 RAQFRLLEPNKDGSVSLENFRMVL----GRNATDAMR-------ESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 458 ~~~F~~~D~d~~G~I~~~el~~~l----~~~~~~~~~-------~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
+++|..||.|+||.|+.+||..++ +.++. .++ ..+++.+|+.+|.|++|.|+|+||+.++........
T Consensus 338 ~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~-~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~~~~ 416 (484)
T 3nyv_A 338 TAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQ-DASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTLLS 416 (484)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHHHHHC-----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCcCCCceEeHHHHHHHHHHHhhhccc-ccccccccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHHhccccCc
Confidence 999999999999999999995555 44443 233 677999999999999999999999987654432222
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELARELN---VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
++.++.+|+.||+|+||+|+.+||+.+|. +..+ ++.+|+.+|.|+||.|+|+||+++|.+..
T Consensus 417 ----~~~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~~~~~ 482 (484)
T 3nyv_A 417 ----RERLERAFRMFDSDNSGKISSTELATIFGVSDVDSETWKSVLSEVDKNNDGEVDFDEFQQMLLKLC 482 (484)
T ss_dssp ----HHHHHHHHHHHCTTCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHTT
T ss_pred ----HHHHHHHHHHHCCCCCCcCCHHHHHHHHHhcCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHhhh
Confidence 67889999999999999999999999994 3333 99999999999999999999999998864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-75 Score=630.75 Aligned_cols=439 Identities=32% Similarity=0.571 Sum_probs=370.1
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++++.||+|+||.||+|+++. +++.||||++.+..... .....+.+|+.+|++|. |||||++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKN-KDTSTILREVELLKKLD-HPNIMKLFEILEDS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETT---TCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECC---CCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcC
Confidence 456789999999999999999999876 78899999997644322 24577899999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
..+|+|||||.+|+|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999999999988765 579999999999999999999999999999999999999765557789999999998
Q ss_pred ccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.+.........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+++..+......+....|..++++
T Consensus 173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp TBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred ECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 87766666778999999999999989999999999999999999999999999999999999888877777777889999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC------hhHHHHHHHHhhhccCchhHHHHHHhhhhc-chHHHHH
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP------LDILIFKLVKSYLHATPFKRAALKALSKAL-TEDELVY 456 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~------~~~~~~~~~k~~~~~~~l~~~~~~~~~~~l-~~~~~~~ 456 (601)
+++||.+||..||.+|||+.|+|+||||+......+ ........+++|.....+.++++..++..+ +.+++++
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~ 332 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQ 332 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHH
Confidence 999999999999999999999999999987654332 122356778889999999999999998776 8899999
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhc----chh---------hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRN----ATD---------AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ 523 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~----~~~---------~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~ 523 (601)
++++|..||.|+||.|+.+||..++..+ +.. .....++..+|+.+|.|++|.|+|+||+.++.....
T Consensus 333 l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~Ef~~~~~~~~~ 412 (486)
T 3mwu_A 333 LTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAIDRTI 412 (486)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCHHHHHHHHSCTTT
T ss_pred HHHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcHHHHHHHHHhhhc
Confidence 9999999999999999999997776544 321 112667999999999999999999999887654433
Q ss_pred hhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC-----c-cHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 524 LEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG-----P-SAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 524 ~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~-----~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
... ++.++.+|+.||+|+||+|+.+||+.+|... . +++.+|..+|.|+||.|+|+||+++|.+.-
T Consensus 413 ~~~----~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~ 483 (486)
T 3mwu_A 413 LLS----RERMERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDNNKDGEVDFNEFVEMLQNFV 483 (486)
T ss_dssp TCC----HHHHHHHHHHHCSSCSSSBCSSCC--------------------CCCCSSCSSSBCHHHHHHHHHHHC
T ss_pred cch----HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHhh
Confidence 333 5678999999999999999999999999422 2 289999999999999999999999998753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-64 Score=506.16 Aligned_cols=255 Identities=32% Similarity=0.599 Sum_probs=232.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
+|++++.||+|+||+||+|+++. +++.||||++.+.........+.+.+|+++|++|+ |||||+++++|.+.+.+|
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred ccEEEEEEecccCeEEEEEEECC---CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEE
Confidence 59999999999999999999986 88999999998766555556788999999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
||||||+||+|.+++.+. +.+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+..
T Consensus 109 ivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~---~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECCT
T ss_pred EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc---CCCCEEEEEcCCceecCC
Confidence 999999999999998765 5799999999999999999999999999999999999995 588999999999988753
Q ss_pred C---CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 308 D---ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 308 ~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
. ....+.|||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+..+++..+.+....++. .+|++
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~ 260 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPK 260 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCHH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCHH
Confidence 3 2356789999999999987 57999999999999999999999999999999999999988877653 68999
Q ss_pred HHHHHHHcccccccCCCCHHH------HHcCcccCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQ------ALTHPWLRDD 414 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~e------ll~hp~f~~~ 414 (601)
+++||.+||++||++|+|++| +++||||++.
T Consensus 261 ~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 999999999999999999887 6899999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-63 Score=506.50 Aligned_cols=260 Identities=30% Similarity=0.530 Sum_probs=230.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|+++++||+|+||+||+|+++. +++.||||++.+..... .+.+.+|+.+|++|+ |||||+++++|.+.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ 146 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQ-HENVVEMYNSYLVGDEL 146 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECC---CCCEEEEEEEecCchhH---HHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence 469999999999999999999986 88999999997654332 356789999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++.+ +.+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+.
T Consensus 147 ~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp EEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC---CCCCEEEecCcCceecC
Confidence 999999999999998765 4699999999999999999999999999999999999995 48899999999998775
Q ss_pred CC-CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
.. ....+.+||+.|||||++. ..|+.++||||||||+|||++|+.||.+.+..+++..+....+. ....+..+|+++
T Consensus 222 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~s~~~ 300 (346)
T 4fih_A 222 KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSL 300 (346)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCSCGGGSCHHH
T ss_pred CCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccccCCHHH
Confidence 44 4456789999999999987 57999999999999999999999999999988888888765432 222346799999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
++||.+||++||++|||+.|+|+||||++...+..
T Consensus 301 ~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p~~ 335 (346)
T 4fih_A 301 KGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 335 (346)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCCcc
Confidence 99999999999999999999999999998765543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-63 Score=517.15 Aligned_cols=261 Identities=30% Similarity=0.523 Sum_probs=231.2
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
...|+++++||+|+||.||+|+++. +++.||||++...... ..+.+.+|+.+|+.|+ |||||+++++|.+.+.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECC---CCCEEEEEEEeccchh---HHHHHHHHHHHHHhCC-CCCCCceEEEEEECCE
Confidence 3579999999999999999999986 8899999999765433 2356889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||+||+|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+
T Consensus 223 ~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~---~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQV 297 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC---TTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEecCccceEC
Confidence 9999999999999998754 4699999999999999999999999999999999999995 4889999999999877
Q ss_pred CCC-CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPD-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
... ....+.|||+.|||||++. ..|+.++||||||||+|||++|+.||.+.+..+.+..+....... ...+..+|++
T Consensus 298 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-~~~~~~~s~~ 376 (423)
T 4fie_A 298 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-LKNLHKVSPS 376 (423)
T ss_dssp CSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSCTTSSCHH
T ss_pred CCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-CcccccCCHH
Confidence 543 4456789999999999987 579999999999999999999999999999888888887654322 2235689999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
+++||.+||.+||++|+|+.|+|+||||++...+..
T Consensus 377 ~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p~~ 412 (423)
T 4fie_A 377 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 412 (423)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCCcc
Confidence 999999999999999999999999999998765543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-63 Score=491.93 Aligned_cols=255 Identities=33% Similarity=0.616 Sum_probs=213.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++++.||+|+||+||+|+++. +++.||||++.+...........+.+|+++|++|+ |||||++++++.+.+.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT---TCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 379999999999999999999876 78999999998876655556778999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
||||||| +|+|.+++.+. +.+++.+++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 89 ~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTCCEEECCSSCC----
T ss_pred EEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC---CCCCEEEeecCCCeecC
Confidence 9999999 67999988765 6799999999999999999999999999999999999995 48899999999998877
Q ss_pred CCCCccccccccccccchhccC-CC-CChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLHR-SY-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
......+.+||+.|||||++.+ .| +.++|||||||++|+|++|+.||.+.+...++..+......++ ..+|+++
T Consensus 164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 239 (275)
T 3hyh_A 164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGA 239 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHH
T ss_pred CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHH
Confidence 6666778899999999999874 44 6899999999999999999999999998889999988776655 3689999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
++||.+||++||++|||++|+|+||||+.+
T Consensus 240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 240 AGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 999999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-63 Score=503.87 Aligned_cols=257 Identities=26% Similarity=0.501 Sum_probs=224.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|+++++||+|+||+||+|+++. +++.||||++.+.... ....+.+.+|+++|++|+ |||||+++++|.+++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTE---DGRQYVIKEINISRMS-SKEREESRREVAVLANMK-HPNIVQYRESFEENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETT---TCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEE
Confidence 479999999999999999999986 7899999999876543 335678999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|||||||+||+|.++|... ...+++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+.+
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVL 175 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC---TTCCEEECSTTEESCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCCEEEcccccceee
Confidence 9999999999999998764 34589999999999999999999999999999999999995 4889999999999876
Q ss_pred CCCC-CccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.... ...+.+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+.+..+++..+....... .+..+|++
T Consensus 176 ~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~ 252 (350)
T 4b9d_A 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYD 252 (350)
T ss_dssp CHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHH
T ss_pred cCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHH
Confidence 5432 2356789999999999874 69999999999999999999999999999999999888775432 23579999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+++||.+||++||++|||+.|+|+||||+..
T Consensus 253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999999999999999764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-62 Score=492.06 Aligned_cols=258 Identities=28% Similarity=0.510 Sum_probs=223.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||+||+|++..+..+++.||||++++...... ....+.+|+++|++|+ |||||+++++|.+.+.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 369999999999999999999866555788999999987554332 2346788999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++.+. +.+++.+++.|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+...
T Consensus 102 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTSCEEEESSEEEEC--
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc---CCCCEEecccccceecc
Confidence 9999999999999998765 5799999999999999999999999999999999999995 58899999999998754
Q ss_pred C-CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 P-DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
. .....+.+||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+..+++..+.+....++ ..+|+++
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 253 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEA 253 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHH
Confidence 3 34456789999999999986 5799999999999999999999999999999999999998876655 3689999
Q ss_pred HHHHHHcccccccCCCC-----HHHHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRMT-----AVQALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~ 414 (601)
++||++||++||++||| ++|+++||||++.
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 99999999999999998 5899999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-61 Score=482.90 Aligned_cols=255 Identities=22% Similarity=0.383 Sum_probs=217.4
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec----CC
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED----VN 224 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~ 224 (601)
|++.++||+|+||+||+|+++. ++..||||++.+.... ....+.+.+|+++|++|+ |||||+++++|.+ ..
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEE
T ss_pred EEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCc
Confidence 4788899999999999999886 7889999999876543 335678999999999996 9999999999865 35
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
.+|||||||+||+|.+++.+. +.+++..++.|+.||+.||.|||++| ||||||||+||||+. .++.+||+|||+|
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~--~~g~vKl~DFGla 179 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS--TTSCEEECCTTGG
T ss_pred EEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC--CCCCEEEEeCcCC
Confidence 689999999999999988764 67999999999999999999999998 999999999999952 4689999999999
Q ss_pred cccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHccCCCCCCCCCCCCC
Q 007498 303 DFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s 381 (601)
+... .....+.+||+.|||||++.+.|+.++|||||||+||||++|+.||.+.... .++..+..... +......++
T Consensus 180 ~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~ 256 (290)
T 3fpq_A 180 TLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAI 256 (290)
T ss_dssp GGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred EeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCC
Confidence 7543 3455678999999999999989999999999999999999999999775544 44444443322 111224678
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+++++||.+||.+||++|||+.|+|+||||++.
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-60 Score=482.96 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=221.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++.++||+|+||.||+|+++. +++.||||++++.... .+|+.+|+.|+ |||||+++++|.+++.+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~---~g~~vAiK~i~~~~~~--------~~E~~il~~l~-HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVRLEVFR--------VEELVACAGLS-SPRIVPLYGAVREGPWV 125 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCC--------THHHHTTTTCC-CTTBCCEEEEEEETTEE
T ss_pred hheEeCcEeccCCCeEEEEEEECC---CCCEEEEEEECHHHhH--------HHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence 368999999999999999999986 7899999999765432 36999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCC-CeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA-DMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~-~vkl~DFG~a~~~ 305 (601)
|||||||+||+|.+++.+. +.|++.+++.|+.||+.||.|||++|||||||||+||||+. ++ .+||+|||+|+.+
T Consensus 126 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~---~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS---DGSRAALCDFGHALCL 201 (336)
T ss_dssp EEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECT---TSCCEEECCCTTCEEC
T ss_pred EEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeC---CCCEEEEeeCCCCeEc
Confidence 9999999999999998765 57999999999999999999999999999999999999963 55 6999999999877
Q ss_pred CCCCC------ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 306 RPDER------LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 306 ~~~~~------~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
..... ....+||+.|||||++. ..|+.++|||||||+||||++|+.||.+.+...++..+....+.+... ++
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~ 280 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREI-PP 280 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGS-CT
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhc-Cc
Confidence 54321 23468999999999987 469999999999999999999999999888888888888766544332 36
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHH-------------HcCcccCCCCCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQA-------------LTHPWLRDDSRPV 418 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~el-------------l~hp~f~~~~~~~ 418 (601)
.+++++.+||.+||.+||.+|||+.|+ |+|||+.+...|.
T Consensus 281 ~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 899999999999999999999999997 5799998876653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=483.98 Aligned_cols=262 Identities=28% Similarity=0.480 Sum_probs=222.8
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-- 222 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-- 222 (601)
++++|++++.||+|+||+||+|+++. +++.||||++++... .....+.+.+|+++|+.|+ |||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~---t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRL---TGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTV 126 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSS
T ss_pred CCCCeEEEEEEecccCeEEEEEEECC---CCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccc
Confidence 45689999999999999999999986 889999999976543 3334567889999999996 9999999998753
Q ss_pred ----CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 223 ----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 223 ----~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
.+.+|||||||+ |+|.+++.. .+.+++.+++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|
T Consensus 127 ~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~---~~~~~Ki~D 201 (398)
T 4b99_A 127 PYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIGD 201 (398)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEECC
T ss_pred ccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC---CCCCEEEee
Confidence 367999999996 588887754 46899999999999999999999999999999999999995 588999999
Q ss_pred cccccccCCC-----CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC
Q 007498 299 FGLSDFIRPD-----ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 299 FG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
||+|+.+... ....+.+||++|||||++.+ .|+.++||||+|||+|||++|++||.+.+..+++..|......
T Consensus 202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~ 281 (398)
T 4b99_A 202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 281 (398)
T ss_dssp CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999876432 23456899999999998764 5799999999999999999999999999998888887654322
Q ss_pred CCC-----------------------CC----CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 372 FDD-----------------------LP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 372 ~~~-----------------------~~----~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
.+. .+ ++.++++++|||.+||.+||++|+|+.|+|+||||++...
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 211 11 2467999999999999999999999999999999987543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=472.14 Aligned_cols=260 Identities=24% Similarity=0.435 Sum_probs=214.1
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+.++|+++++||+|+||+||+|+++....+++.||||++.+.. ...++.+|+++|+.+.+|||||+++++|.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 45678999999999999999999986433467899999986542 2356789999999997799999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+++|||||||+||+|.+++ +.+++.+++.|+.||+.||+|||++|||||||||+|||++. +.+.+||+|||+|+
T Consensus 93 ~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~--~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR--RLKKYALVDFGLAQ 166 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCE
T ss_pred CEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC--CCCeEEECcCCCCc
Confidence 9999999999999999987 35999999999999999999999999999999999999964 34789999999997
Q ss_pred ccCCCC-----------------------------CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCC
Q 007498 304 FIRPDE-----------------------------RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRP 352 (601)
Q Consensus 304 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~p 352 (601)
...... ...+.+||++|||||++.+ .|+.++||||+|||+|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 543221 2244689999999998864 589999999999999999999999
Q ss_pred CCCC-ChhHHHHHHHccC--------------------------------------C------------CCCCCCCCCCC
Q 007498 353 FWAR-TESGIFRAVLRSD--------------------------------------P------------NFDDLPWPSVS 381 (601)
Q Consensus 353 f~~~-~~~~~~~~i~~~~--------------------------------------~------------~~~~~~~~~~s 381 (601)
|... ++.+++..|.... . ......|..+|
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 9654 3444444432200 0 01112356789
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
++++|||++||++||++|+|++|+|+||||++.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=499.26 Aligned_cols=265 Identities=34% Similarity=0.622 Sum_probs=242.4
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+.++|++++.||+|+||.||+|+++. +++.||||++.+.. ....+.+.+|+.+|+.|+ |||||+++++|.+.+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~---tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN 227 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSS
T ss_pred CccccEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence 44689999999999999999999986 88999999997643 234577899999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|||||||+||+|.+++....+.|++.+++.|+.||+.||.|||++||+||||||+|||++. +..+.+||+|||+|+.
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEE
T ss_pred EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeE
Confidence 999999999999999998766678999999999999999999999999999999999999975 3458999999999999
Q ss_pred cCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
+.........+||+.|||||++. ..|+.++|||||||+||||++|..||.+.+..+++..+......++...|..+|++
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 88777777889999999999987 46999999999999999999999999999999999999998888887778899999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
+++||++||.+||.+|||+.|+|+||||+....+
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 9999999999999999999999999999976543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-56 Score=486.00 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=220.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHH---HHHHHhcCCCCeeEEeeeEecC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREV---KILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~~h~niv~l~~~~~~~ 223 (601)
++|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|. .+++.+ +|||||+++++|.+.
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~---tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP 264 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS
T ss_pred HHeEEEEEEecccCeEEEEEEECC---CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEEC
Confidence 479999999999999999999986 8899999999876554444444555554 445555 499999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+.+|||||||+||+|.++|.+. +.|++..++.|+.||+.||+|||++|||||||||+||||+ .+|++||+|||+|+
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld---~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLAC 340 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---TTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe---CCCCEEecccceee
Confidence 9999999999999999998765 6799999999999999999999999999999999999995 58999999999998
Q ss_pred ccCCCCCccccccccccccchhcc-C-CCCChhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHccCCCCCCCCCC
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH-R-SYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~ 378 (601)
.+... ...+.|||+.|||||++. + .|+.++||||||||||||++|.+||.+.+ ...+...+......++ .
T Consensus 341 ~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~ 415 (689)
T 3v5w_A 341 DFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----D 415 (689)
T ss_dssp ECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----T
T ss_pred ecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----c
Confidence 76543 456789999999999985 3 69999999999999999999999997643 3345666666665554 4
Q ss_pred CCCHHHHHHHHHcccccccCCCC-----HHHHHcCcccCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMT-----AVQALTHPWLRDD 414 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~ 414 (601)
.+|+++++||.+||++||.+|++ ++|+++||||++.
T Consensus 416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 79999999999999999999998 7999999999863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=453.26 Aligned_cols=254 Identities=33% Similarity=0.497 Sum_probs=198.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC--
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-- 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-- 224 (601)
.+|++++.||+|+||+||+|+++. +++.||||++.... .....+.+.+|+++|++|+ |||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV---DDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT---TCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC--
T ss_pred hhCEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCcc
Confidence 369999999999999999999886 78999999997543 3335578899999999996 999999999987544
Q ss_pred ----------cEEEEEeecCCCchHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCC
Q 007498 225 ----------NVYIVMELCEGGELLDRILARGG--RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292 (601)
Q Consensus 225 ----------~~~lv~e~~~~g~L~~~~~~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~ 292 (601)
.+|||||||+||+|.+++..... ..++..++.|+.||+.||+|||++|||||||||+|||++ .++
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~---~~~ 155 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDD 155 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTC
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC---CCC
Confidence 37999999999999998865422 245677899999999999999999999999999999995 478
Q ss_pred CeEEeecccccccCCCC-------------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 007498 293 DMRLIDFGLSDFIRPDE-------------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE 358 (601)
Q Consensus 293 ~vkl~DFG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~ 358 (601)
.+||+|||+|+.+.... ...+.+||+.|||||++. ..|+.++|||||||++|||++ ||.+..+
T Consensus 156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~ 232 (299)
T 4g31_A 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME 232 (299)
T ss_dssp CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH
Confidence 99999999998765332 123468999999999987 479999999999999999996 8864332
Q ss_pred h-HHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 359 S-GIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 359 ~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
. ..+..+... .++. .+...++++.+||.+||++||.+|||+.|+|+||||++..
T Consensus 233 ~~~~~~~~~~~--~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 233 RVRTLTDVRNL--KFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHHHHTT--CCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHHHHhcC--CCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 2 222223222 2221 1234678889999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-56 Score=448.16 Aligned_cols=249 Identities=23% Similarity=0.399 Sum_probs=206.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+++++++||+|+||+||+|+++. .||||+++.... .....+.+.+|+.+|++|+ |||||++++++.+ +.+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~------~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG------DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNL 106 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS------EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC------cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeE
Confidence 468899999999999999998642 599999875432 3345678999999999996 9999999998865 568
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++....+.+++.++..|+.||+.||.|||+++||||||||+||||+ +++.+||+|||+|+...
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~---~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKS 183 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---TTEEEEECCCSSCBC--
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---CCCcEEEeeccCceecc
Confidence 999999999999999987777899999999999999999999999999999999999996 47899999999998764
Q ss_pred CC---CCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC--CCC
Q 007498 307 PD---ERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD--LPW 377 (601)
Q Consensus 307 ~~---~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~ 377 (601)
.. ......+||+.|||||++. +.|+.++|||||||+||||+||+.||.+.+....+..++......+. ..+
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 263 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY 263 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence 32 2345679999999999984 35899999999999999999999999887665555555443322222 224
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..+++++.+||.+||..||++|||+.|+++
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 578999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=445.10 Aligned_cols=254 Identities=23% Similarity=0.377 Sum_probs=215.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|.+.++||+|+||+||+|++... ..++..||||+++.. .....+.+.+|+++|++|+ |||||+++++|.+.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCC
Confidence 4699999999999999999987531 225788999999653 3345678999999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHc------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCC
Q 007498 225 NVYIVMELCEGGELLDRILAR------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~------------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~ 292 (601)
.+|||||||++|+|.+++... ...+++.++..|+.||+.||.|||+++||||||||+||||+ .++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~---~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC---CCC
Confidence 999999999999999998754 24699999999999999999999999999999999999995 478
Q ss_pred CeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHc
Q 007498 293 DMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLR 367 (601)
Q Consensus 293 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~ 367 (601)
.+||+|||+|+....... ....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+.+..+++..+..
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999987644322 23357999999999886 689999999999999999998 8999999998888888877
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 368 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
+..... ...+++++.+||.+||+.||++|||+.|++ +|++
T Consensus 246 ~~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 246 GRVLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred CCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 653211 146899999999999999999999999984 4554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-55 Score=446.08 Aligned_cols=252 Identities=22% Similarity=0.382 Sum_probs=209.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeec--CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|.+.++||+|+||.||+|+++. ...+++.||||+++.. .....+.|.+|+++|++|+ |||||+++++|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 368899999999999999998753 1225789999999653 3345678999999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC
Q 007498 225 NVYIVMELCEGGELLDRILAR--------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~--------------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~ 290 (601)
.+|||||||++|+|.+++... .+.+++.++..|+.||+.||.|||+++||||||||+||||+ .
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~---~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---Q 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---T
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC---C
Confidence 999999999999999988653 24699999999999999999999999999999999999996 4
Q ss_pred CCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007498 291 DADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAV 365 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i 365 (601)
++.+||+|||+|+.+..... ....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+.+..+++..+
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 88999999999987643322 24568999999999986 579999999999999999998 89999998888888888
Q ss_pred HccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..+... + ....+++++.+||.+||..||++|||+.|++.+
T Consensus 274 ~~g~~~-~--~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 274 TQGREL-E--RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHTCCC-C--CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HcCCCC-C--CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 765421 1 114689999999999999999999999999763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-55 Score=440.29 Aligned_cols=253 Identities=19% Similarity=0.303 Sum_probs=214.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeec--CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
..+++.++||+|+||+||+|+... ...+++.||||+++... .....+.|.+|+.+|++|+ |||||+++++|.+.+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEECC
Confidence 468899999999999999998742 11256899999996542 2234578999999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC
Q 007498 225 NVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~ 289 (601)
.+|||||||++|+|.+++..+. ..+++.++..|+.||+.||.|||+++||||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~--- 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY--- 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC---
Confidence 9999999999999999986532 4589999999999999999999999999999999999995
Q ss_pred CCCCeEEeecccccccCCCC---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 007498 290 DDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRA 364 (601)
Q Consensus 290 ~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~ 364 (601)
+++.+||+|||+|+.+.... .....+||+.|||||++. +.|+.++|||||||+||||+| |..||.+.+..+++..
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 47899999999998764332 234578999999999876 689999999999999999998 8999999998888888
Q ss_pred HHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+...... +. ...+++++.+|+.+||..||++|||+.||+++
T Consensus 260 i~~~~~~-~~--p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVL-PC--PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCC-CC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCC-CC--cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7765432 11 24789999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-54 Score=441.22 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=212.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC--ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-C
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-V 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~ 223 (601)
++|++++.||+|+||.||+|++.... ..++.||||++.... .....+.+.+|+++|.+|..|||||+++++|.+ +
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 57999999999999999999987522 245789999997643 223457799999999999756999999999866 4
Q ss_pred CcEEEEEeecCCCchHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC
Q 007498 224 NNVYIVMELCEGGELLDRILAR---------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~---------------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~ 288 (601)
+.+|||||||++|+|.++|... ...+++.++..|+.||+.||.|||+++||||||||+|||++
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~-- 219 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-- 219 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC--
Confidence 6799999999999999998753 23589999999999999999999999999999999999995
Q ss_pred CCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 007498 289 RDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFR 363 (601)
Q Consensus 289 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~ 363 (601)
+++.+||+|||+|+.+..... ....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+....+.+.
T Consensus 220 -~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 220 -EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp -GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred -CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 478999999999987654432 34568999999999886 679999999999999999998 999998866544444
Q ss_pred HHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 364 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.++........ ...+++++.+||.+||..||++|||+.||++|
T Consensus 299 ~~i~~g~~~~~--p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 299 RRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCC--CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 44433222221 14689999999999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=450.65 Aligned_cols=296 Identities=34% Similarity=0.617 Sum_probs=253.9
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++++.||+|+||.||+|+++. +++.||+|++...... ....+.+.+|+.+++.|. |||||++++++.+.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~---~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKLS-ARDHQKLEREARICRLLK-HPNIVRLHDSISEE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETT---TTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECC---CCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEEC
Confidence 355689999999999999999999876 7899999999875543 334567899999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+.+|||||||.||+|.+.+... +.+++.++..++.||+.||.|||++||+||||||+|||++...+++.+||+|||++.
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred CEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999999999988765 579999999999999999999999999999999999999764457889999999998
Q ss_pred ccCCCC-CccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 304 FIRPDE-RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 304 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......+..+......++...|+.++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 241 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCC
Confidence 765443 3456789999999999874 69999999999999999999999999999999999999988888888888999
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC--CCChhHHHHHHHHhhhccCchhHHHHHHh
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR--PVPLDILIFKLVKSYLHATPFKRAALKAL 445 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~--~~~~~~~~~~~~k~~~~~~~l~~~~~~~~ 445 (601)
+++.+||.+||..||.+|||+.|+|+||||+.... ...........++.+...+++..+.+..+
T Consensus 242 ~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~ 307 (444)
T 3soa_A 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVM 307 (444)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEE
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999975421 22223455666777777666666655544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=434.37 Aligned_cols=265 Identities=36% Similarity=0.694 Sum_probs=238.1
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++.+.||+|+||.||+|+++. +++.||||++...... ....+.+.+|+.+++.|. |||||++++++.+.
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE 100 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 345679999999999999999999876 7889999999775543 335577899999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+.+|||||||+||+|.+.+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.+..++.+||+|||++.
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred CEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999999999887654 579999999999999999999999999999999999999764445679999999998
Q ss_pred ccCCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
...........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||++......+..+......++...|..+++
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp CCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred EecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 8776666667899999999999874 699999999999999999999999999998888999988888887777788999
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
++++||.+||..||.+||++.|+|+||||+..
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=431.90 Aligned_cols=266 Identities=35% Similarity=0.634 Sum_probs=236.0
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch---hhHHHHHHHHHHHHHhcCCCCeeEEeeeE
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILKALSGHKHLVKFCDAC 220 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~ 220 (601)
.+...|++++.||+|+||.||+|+++. +++.||||++.+...... ...+.+.+|+.+|++|. ||||++++++|
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~ 84 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVY 84 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECC---CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEE
Confidence 456789999999999999999999876 788999999987543321 23577899999999996 99999999999
Q ss_pred ecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC-CCCCeEEeec
Q 007498 221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR-DDADMRLIDF 299 (601)
Q Consensus 221 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~-~~~~vkl~DF 299 (601)
.+...+|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+..+. ....+||+||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999999998754 46799999999999999999999999999999999999996411 1127999999
Q ss_pred ccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
|++..+.........+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..+.+..+......++...|.
T Consensus 164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp SSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred CCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 9998877666667789999999999987 479999999999999999999999999999999999998887777666667
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.+++++++||.+||..||.+|||+.|+|+||||+..
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 899999999999999999999999999999999853
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=431.11 Aligned_cols=257 Identities=28% Similarity=0.517 Sum_probs=226.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++.+.........+.+.+|+.+++.+.+||||+++++++.+.+.+
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcC---CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 479999999999999999999876 78899999998765444556677889999999986799999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC---CCCCEEEccccceeecc
Confidence 9999999999999988765 5799999999999999999999999999999999999995 58899999999998643
Q ss_pred -CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 -PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 -~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
........+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+++..+......++. .+++++
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~ 251 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDA 251 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHH
Confidence 233455679999999999986 46999999999999999999999999999999999999988776653 589999
Q ss_pred HHHHHHcccccccCCCCH------HHHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRMTA------VQALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~------~ell~hp~f~~~ 414 (601)
.+||++||.+||.+|+++ .|+++||||++.
T Consensus 252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 252 TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 999999999999999998 999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=422.30 Aligned_cols=257 Identities=35% Similarity=0.617 Sum_probs=231.2
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||+|++.. +++.||||++.+... .....+.+.+|+++|+.++ ||||+++++++...+.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHIL---TGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKT 88 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCE
Confidence 3579999999999999999999876 789999999977554 3345677899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+|||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD---ADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTCCGGG
T ss_pred EEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc---CCCCEEEeeccCceec
Confidence 99999999999999988765 5799999999999999999999999999999999999995 4889999999999887
Q ss_pred CCCCCccccccccccccchhccC-CC-CChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPDERLNDIVGSAYYVAPEVLHR-SY-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.........+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+.+...+...+......++. .++++
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 240 (328)
T 3fe3_A 165 TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTD 240 (328)
T ss_dssp SSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred CCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence 76666778899999999999864 44 57999999999999999999999999988888888887766553 58999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
+.+||++||..||.+|||++|+|+||||+...
T Consensus 241 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999999998654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=438.21 Aligned_cols=260 Identities=34% Similarity=0.618 Sum_probs=215.4
Q ss_pred CCCeEEc-ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--
Q 007498 146 GAKYELG-KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-- 222 (601)
Q Consensus 146 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-- 222 (601)
...|.+. +.||+|+||.||+++++. +++.||||++... ..+.+|+.++.++.+||||++++++|..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~---~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECC---CCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 3467776 789999999999999876 7889999998532 3567899998777679999999999875
Q ss_pred --CCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 223 --VNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 223 --~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
...+|||||||+||+|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+|||++....++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 567999999999999999987643 36999999999999999999999999999999999999975444789999999
Q ss_pred ccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHccCCCCCC
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES----GIFRAVLRSDPNFDD 374 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~ 374 (601)
|+++...........+||+.|+|||++. +.|+.++|||||||++|+|++|..||.+.... .....+......++.
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 9998776555566789999999999986 57999999999999999999999999765432 245566666667777
Q ss_pred CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 375 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
..|..+++++.+||++||..||.+|||+.|+|+||||.....
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 677889999999999999999999999999999999986543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=425.92 Aligned_cols=263 Identities=28% Similarity=0.567 Sum_probs=236.6
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++++.||+|+||.||+|+++. +++.||+|++.... .....+.+|+.+++.+. ||||+++++++.+.
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESM 73 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEET
T ss_pred chhhceEeeeEEecCCCeEEEEEEECC---CCcEEEEEEEecCc----ccHHHHHHHHHHHHhCC-CCCCCeEeEEEecC
Confidence 355789999999999999999999876 78899999986432 23467889999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+.+|||||||+||+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++. +.++.+||+|||++.
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQAR 152 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCe
Confidence 9999999999999999988766567999999999999999999999999999999999999964 236899999999998
Q ss_pred ccCCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
.+.........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......++...|+.++.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 8876666667889999999999875 579999999999999999999999999999999999988887776666778999
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 999999999999999999999999999998753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=422.36 Aligned_cols=256 Identities=29% Similarity=0.528 Sum_probs=228.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+|+.++ ||||+++++++.+.+.+
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEE
Confidence 479999999999999999999876 78999999998754433445677899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 81 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC---CCCCEEEeeccchhhcc
Confidence 9999999999999887654 5799999999999999999999999999999999999995 48899999999998643
Q ss_pred -CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 -PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 -~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
........+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+...++..+......++. .+++++
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 232 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEA 232 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHH
Confidence 334456789999999999986 56899999999999999999999999998888888888887666553 689999
Q ss_pred HHHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
.+||.+||..||.+|+ ++.|+++||||++.
T Consensus 233 ~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999999 89999999999763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=428.88 Aligned_cols=256 Identities=27% Similarity=0.534 Sum_probs=222.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++++...........+.+|..++.++.+|||||+++++|.+.+.+
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 479999999999999999999886 78899999998766555545567889999999986699999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc-
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI- 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~- 305 (601)
|||||||+||+|..++... +.+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+..
T Consensus 129 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCC
T ss_pred EEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC---CCCCEEEeecceeeecc
Confidence 9999999999999888765 5799999999999999999999999999999999999995 5889999999999863
Q ss_pred CCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC---------ChhHHHHHHHccCCCCCCC
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR---------TESGIFRAVLRSDPNFDDL 375 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~ 375 (601)
.......+.+||+.|+|||++. ..|+.++|||||||++|||++|+.||... ....+...+......++.
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~- 283 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR- 283 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT-
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC-
Confidence 3445566789999999999987 46999999999999999999999999632 234456667776666553
Q ss_pred CCCCCCHHHHHHHHHcccccccCCCCH------HHHHcCcccCC
Q 007498 376 PWPSVSPEAKDFVKRLLNKDYRKRMTA------VQALTHPWLRD 413 (601)
Q Consensus 376 ~~~~~s~~~~~li~~~L~~dP~~R~s~------~ell~hp~f~~ 413 (601)
.+++++++||++||++||.+|+++ .|+++||||++
T Consensus 284 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 284 ---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp ---TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred ---cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 689999999999999999999985 89999999976
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=424.09 Aligned_cols=257 Identities=33% Similarity=0.564 Sum_probs=206.2
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||+|+++. +++.||||++...... .+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 90 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL---TKELVAVKYIERGAAI----DENVQREIINHRSLR-HPNIVRFKEVILTPTH 90 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT---TCCEEEEEEEESSTTS----CHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEecCccc----cHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCE
Confidence 3579999999999999999999886 7889999999764432 256789999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++..
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC---
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCccccc
Confidence 99999999999999988664 57999999999999999999999999999999999999964 22345999999999865
Q ss_pred CCCCCccccccccccccchhcc-CCCCC-hhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHccCCCCCCCCCCC
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH-RSYSL-EADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~-~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~ 379 (601)
.........+||+.|+|||++. ..++. ++|||||||++|+|++|+.||.+... ...+..+......++. ...
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 246 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIR 246 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSC
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCC
Confidence 5455556678999999999875 45554 48999999999999999999976543 3344445544444433 246
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+++++.+||.+||..||.+|||+.|+|+||||...
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 89999999999999999999999999999999765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=421.34 Aligned_cols=288 Identities=36% Similarity=0.630 Sum_probs=225.9
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+...|++.+.||+|+||.||+|+++. +++.||||++.... ..+.+.+|+.++++|. ||||+++++++.+.+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKG---TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPT 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECSS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECC---CCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEecCC
Confidence 45679999999999999999999876 67899999997542 2356789999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+||||||+++|+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++.
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred eEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999999998754 45799999999999999999999999999999999999997544578999999999987
Q ss_pred cCCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHccCCCCCCCCCCCCCH
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESG-IFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
..........+||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .+..+......+....|..++.
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 765555566789999999999874 68999999999999999999999998765444 6677777666666656678999
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCChhHHHHHHHHhhhccCchhHHHH
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHATPFKRAAL 442 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~k~~~~~~~l~~~~~ 442 (601)
++.+||.+||..||++|||+.|+|+||||+.............+.++.|....++.+...
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNARRKLKAAVK 340 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchhhhcchHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999875543333344555666655555544443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=428.14 Aligned_cols=265 Identities=34% Similarity=0.628 Sum_probs=227.7
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc--hhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT--AISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
+..+|++.+.||+|+||.||+|+++. +++.||||++....... ....+.+.+|+.+++.|+ ||||+++++++.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSS 97 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 45679999999999999999999876 78999999997543221 123577899999999996 9999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 223 VNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~---~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
.+.+|||||||+|++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999999998877643 345899999999999999999999999999999999999976444566999999
Q ss_pred ccccccCCCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCC
Q 007498 300 GLSDFIRPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 300 G~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 377 (601)
|++........ ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+. ....+..+......+....|
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccc
Confidence 99987754433 45578999999999986 46899999999999999999999999874 45566777776665554456
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
..+++++++||.+||..||++|||+.|+|+||||++.
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 6899999999999999999999999999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=419.35 Aligned_cols=266 Identities=38% Similarity=0.652 Sum_probs=233.3
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc---hhhHHHHHHHHHHHHHhcCCCCeeEEeeeE
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT---AISIEDVRREVKILKALSGHKHLVKFCDAC 220 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~l~~~~ 220 (601)
.+...|++.+.||+|+||.||+|+++. +++.||||++.+..... ....+.+.+|+.+|++|. ||||+++++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 83 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVY 83 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred CcccceEeceEEeeCCCeEEEEEEECC---CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 345679999999999999999999876 78899999997654322 124678999999999996 99999999999
Q ss_pred ecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC-CCCCeEEeec
Q 007498 221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR-DDADMRLIDF 299 (601)
Q Consensus 221 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~-~~~~vkl~DF 299 (601)
.+...+|+|||||++++|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+. ....+||+||
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999999998754 46799999999999999999999999999999999999996421 1237999999
Q ss_pred ccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
|++..+.........+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......++...+.
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 9998876666666788999999999987 579999999999999999999999999988888888888776666554456
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.++.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 789999999999999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=421.17 Aligned_cols=257 Identities=29% Similarity=0.495 Sum_probs=228.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++.+.........+.+.+|..++..+.+||||+++++++.+.+.+
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 479999999999999999999876 78999999998754433345677889999999885699999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC---CCCCEEEeEChhhhhcc
Confidence 9999999999999988764 5799999999999999999999999999999999999995 47899999999998653
Q ss_pred C-CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 P-DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
. .......+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+..+++..+....+.++. .+++++
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 245 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEA 245 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHHH
Confidence 2 33456689999999999886 46899999999999999999999999999998999888887766553 589999
Q ss_pred HHHHHHcccccccCCCCHH-HHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRMTAV-QALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~-ell~hp~f~~~ 414 (601)
++||.+||..||++||++. ++++||||++.
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 9999999999999999998 99999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=416.62 Aligned_cols=257 Identities=27% Similarity=0.523 Sum_probs=225.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++.+.........+.+.+|+.+++++.+||||+++++++.+.+.+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 479999999999999999999876 78999999998876666666778899999999985699999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 86 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCGGGCBCSC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEEecccccccc
Confidence 9999999999999988654 5799999999999999999999999999999999999995 48899999999998643
Q ss_pred -CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCC---------CChhHHHHHHHccCCCCCCC
Q 007498 307 -PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWA---------RTESGIFRAVLRSDPNFDDL 375 (601)
Q Consensus 307 -~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~ 375 (601)
........+||+.|+|||++. ..|+.++|||||||++|||++|+.||.. .....+...+......++
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p-- 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-- 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC--
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC--
Confidence 334456779999999999986 4689999999999999999999999965 233445666666665554
Q ss_pred CCCCCCHHHHHHHHHcccccccCCCCH------HHHHcCcccCCC
Q 007498 376 PWPSVSPEAKDFVKRLLNKDYRKRMTA------VQALTHPWLRDD 414 (601)
Q Consensus 376 ~~~~~s~~~~~li~~~L~~dP~~R~s~------~ell~hp~f~~~ 414 (601)
..++.++++||.+||..||.+||++ .|+++||||++.
T Consensus 240 --~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 240 --RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred --CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 3689999999999999999999995 899999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=420.54 Aligned_cols=256 Identities=26% Similarity=0.472 Sum_probs=229.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++.+.........+.+.+|..++..+.+||||+++++++.+.+.+
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETT---EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 479999999999999999999876 78899999998765434445677889999999886699999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 97 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc---CCCcEEEEeCCcccccc
Confidence 9999999999999988765 5799999999999999999999999999999999999995 58899999999998643
Q ss_pred -CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 -PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 -~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
........+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+++..+......++. .+++++
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 248 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEA 248 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHH
Confidence 333456789999999999986 57999999999999999999999999999999999999887776653 689999
Q ss_pred HHHHHHcccccccCCCC-----HHHHHcCcccCC
Q 007498 385 KDFVKRLLNKDYRKRMT-----AVQALTHPWLRD 413 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s-----~~ell~hp~f~~ 413 (601)
.+||.+||..||.+|++ ++++++||||+.
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 99999999999999994 699999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=413.85 Aligned_cols=254 Identities=24% Similarity=0.582 Sum_probs=227.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++.+.........+.+.+|+.+++.+. ||||+++++++.+...+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEE
Confidence 479999999999999999999876 78999999998754433345677889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 82 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSCEECS
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc---CCCCEEEeecCcceecC
Confidence 9999999999999987654 5799999999999999999999999999999999999995 48899999999998754
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
. .....+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+....+..+......++ +.+++++.
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 231 (318)
T 1fot_A 158 D--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVK 231 (318)
T ss_dssp S--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred C--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHH
Confidence 3 345678999999999886 5689999999999999999999999999988888888988776655 36899999
Q ss_pred HHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 386 DFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 386 ~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
+||++||..||++|+ +++|+++||||++.
T Consensus 232 ~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 232 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 999999999999999 89999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=431.46 Aligned_cols=260 Identities=28% Similarity=0.469 Sum_probs=226.2
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+++.+. |||||+++++|.+...
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRY 143 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECC---CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence 3579999999999999999999886 78899999997644333333455789999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||+||+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC---CCCCEEEeccceeEee
Confidence 9999999999999998765 3699999999999999999999999999999999999995 5889999999999876
Q ss_pred CCCC--CccccccccccccchhccC-C----CCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 306 RPDE--RLNDIVGSAYYVAPEVLHR-S----YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 306 ~~~~--~~~~~~gt~~y~aPE~~~~-~----~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
.... ...+.+||+.|+|||++.+ . |+.++|||||||++|||++|+.||.+.+..+.+..+......+....+.
T Consensus 219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 298 (410)
T 3v8s_A 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298 (410)
T ss_dssp CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTC
T ss_pred ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcc
Confidence 5443 2346799999999998853 2 7899999999999999999999999999989888888754322222345
Q ss_pred CCCHHHHHHHHHcccccccC--CCCHHHHHcCcccCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRK--RMTAVQALTHPWLRDD 414 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~--R~s~~ell~hp~f~~~ 414 (601)
.+++++++||++||..+|.+ |++++|+++||||++.
T Consensus 299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred cccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 79999999999999999998 9999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=423.40 Aligned_cols=264 Identities=34% Similarity=0.606 Sum_probs=235.6
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+...|++++.||+|+||.||+|+++. +++.||+|++.... ......+.+|+.+|+.|. ||||+++++++.+..
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKY 121 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSS
T ss_pred cccceEEEEEEecCCCEEEEEEEECC---CCCEEEEEEecccc---hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCC
Confidence 44679999999999999999999876 78899999986543 223467889999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|||||||+||+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||++..
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEeccccee
Confidence 999999999999999988766567999999999999999999999999999999999999964 2457899999999988
Q ss_pred cCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
..........+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......+....+..++++
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 77665566678999999999987 46899999999999999999999999998888888888887777766667789999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+.+||.+||..||.+|||+.|+|+||||+....
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 999999999999999999999999999987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=405.31 Aligned_cols=264 Identities=34% Similarity=0.680 Sum_probs=224.9
Q ss_pred cccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 143 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
..+.++|.+.+.||+|+||.||+|+++. ++..||+|++...... ...+.+.+|++++++++ ||||+++++++.+
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 91 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLD-HPNIIKIFEVFED 91 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred CChhhheeecceeccCCCeEEEEEEEcc---CCceEEEEEeeccccc--hhHHHHHHHHHHHHhCC-CchHHhHHHheec
Confidence 3455689999999999999999999876 7889999999765422 24578899999999996 9999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 223 VNNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
...+|+|||||++|+|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||+..++.++.+||+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence 9999999999999999998854 3467999999999999999999999999999999999999965445688999999
Q ss_pred ccccccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
|++............+||+.|+|||++.+.++.++|||||||++|+|++|..||.+.........+......+... ...
T Consensus 172 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 250 (285)
T 3is5_A 172 GLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRP 250 (285)
T ss_dssp CCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CC
T ss_pred ecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCc
Confidence 9998776665566778999999999998889999999999999999999999999888877777766655544432 235
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
+++++.+||.+||..||++|||+.|+|+||||++
T Consensus 251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 8999999999999999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=432.17 Aligned_cols=261 Identities=30% Similarity=0.479 Sum_probs=227.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+.++..+. ||||++++++|.+.+.
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNN 148 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcC---CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCE
Confidence 4579999999999999999999876 78899999997644333333345889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||+||+|.+++....+.+++..++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+..
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~---~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc---CCCCEEEcchhhhhhc
Confidence 9999999999999999877667899999999999999999999999999999999999995 5889999999999776
Q ss_pred CCCCC--ccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC--CCCCCC
Q 007498 306 RPDER--LNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--PNFDDL 375 (601)
Q Consensus 306 ~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~ 375 (601)
..... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+.+..+.+..++... ..++.
T Consensus 226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~- 304 (437)
T 4aw2_A 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT- 304 (437)
T ss_dssp CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS-
T ss_pred ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc-
Confidence 54433 23468999999999874 358999999999999999999999999999888888887543 33332
Q ss_pred CCCCCCHHHHHHHHHcccccccC--CCCHHHHHcCcccCCC
Q 007498 376 PWPSVSPEAKDFVKRLLNKDYRK--RMTAVQALTHPWLRDD 414 (601)
Q Consensus 376 ~~~~~s~~~~~li~~~L~~dP~~--R~s~~ell~hp~f~~~ 414 (601)
.+..+++++++||++||..+|++ |++++|+++||||++.
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 22568999999999999999988 9999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=416.07 Aligned_cols=253 Identities=29% Similarity=0.542 Sum_probs=228.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++.+.........+.+.+|+.+|+.+. ||||+++++++.+...+
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEE
Confidence 479999999999999999999876 78899999998765444445678899999999995 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 117 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECS
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC---CCCCEEEcccccceecc
Confidence 9999999999999988765 5799999999999999999999999999999999999995 48899999999998764
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.. ....+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+..+++..+......++ ..+++++.
T Consensus 193 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 266 (350)
T 1rdq_E 193 GR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLK 266 (350)
T ss_dssp SC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHH
T ss_pred CC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 32 35678999999999876 5689999999999999999999999999999899999988776655 36899999
Q ss_pred HHHHHcccccccCCCC-----HHHHHcCcccCC
Q 007498 386 DFVKRLLNKDYRKRMT-----AVQALTHPWLRD 413 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s-----~~ell~hp~f~~ 413 (601)
+||.+||..||.+||+ ++|+++||||+.
T Consensus 267 ~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 9999999999999998 999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=403.79 Aligned_cols=260 Identities=25% Similarity=0.448 Sum_probs=224.0
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
...+|++++.||+|+||.||+|++.. +++.||||++...... ..+.+.+|+.+++.+. ||||+++++++...+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTT---TCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hhhceeeeeeeccCCCeEEEEEEECC---CCcEEEEEEeeccccc---HHHHHHHHHHHHhcCC-CCCCCeEeEEEEECC
Confidence 44689999999999999999999876 7889999999765433 3467889999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|+|||||+||+|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQ 165 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred EEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC---CCCCEEEeeCCCcee
Confidence 999999999999999988654 699999999999999999999999999999999999995 478999999999987
Q ss_pred cCCCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 305 IRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 305 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
..... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.........+......... ....+++
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 244 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKLSA 244 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-CGGGSCH
T ss_pred cCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-CccccCH
Confidence 65433 345578999999999876 57899999999999999999999999888776666655543322111 1246899
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
.+.+||.+||..||.+|||+.|+|+||||+.....
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 279 (297)
T 3fxz_A 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPL 279 (297)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhChhhcccCcc
Confidence 99999999999999999999999999999876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=400.05 Aligned_cols=267 Identities=36% Similarity=0.691 Sum_probs=238.9
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++.+.||+|+||.||+|.++. +++.||+|++..... .....+.+.+|+.++++++ ||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcC---CCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcC
Confidence 456789999999999999999999876 788999999976554 3335577889999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+..|+||||+++++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.+...+.+||+|||++.
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 9999999999999999888765 579999999999999999999999999999999999999764445669999999998
Q ss_pred ccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+......++...+..+++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 877666666788999999999986 4689999999999999999999999999998888888888877777777778999
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
++.+||.+||..||++|||+.|+|+||||++...
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999999999999999999999999987643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=408.07 Aligned_cols=263 Identities=28% Similarity=0.440 Sum_probs=218.9
Q ss_pred cccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 143 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
+.+..+|++++.||+|+||.||+|++. +++.||||++..... .......+.+|++++++++ ||||+++++++.+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 90 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS----QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIHS 90 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET----TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECC
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC----CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEcc
Confidence 456678999999999999999999985 578999999975432 2224567889999999996 9999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
...+|||||||++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a 166 (311)
T 3niz_A 91 ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLA 166 (311)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTC
T ss_pred CCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC---CCCCEEEccCcCc
Confidence 9999999999985 88888877767799999999999999999999999999999999999995 4789999999999
Q ss_pred cccCCC-CCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC---
Q 007498 303 DFIRPD-ERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP--- 376 (601)
Q Consensus 303 ~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--- 376 (601)
...... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+...........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 876533 3345568999999999875 3589999999999999999999999988877776666644211111100
Q ss_pred -----------------------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 377 -----------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 377 -----------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
.+.+++++.+||.+||..||++|||+.|+|+||||++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 235788999999999999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=411.32 Aligned_cols=246 Identities=22% Similarity=0.282 Sum_probs=189.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC--
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-- 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-- 224 (601)
.+|.+.++||+|+||+||+|++ +++.||||++..... .......|+.++.+|+ |||||++++++.+.+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-----~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~ 72 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSREE----RSWFREAEIYQTVMLR-HENILGFIAADNKDNGT 72 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-----TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccch----hhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCC
Confidence 4699999999999999999986 467999999865421 1122345666667786 999999999998653
Q ss_pred --cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeccCCCCceEeecCCCCCCe
Q 007498 225 --NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ--------GVVHRDLKPENFLFTSGRDDADM 294 (601)
Q Consensus 225 --~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~--------~iiHrDikp~NIll~~~~~~~~v 294 (601)
.+|||||||+||+|.+++... .++++.+..++.|++.||.|||++ +||||||||+||||+ .++.+
T Consensus 73 ~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~---~~~~~ 147 (303)
T 3hmm_A 73 WTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTC 147 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC---TTSCE
T ss_pred ceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC---CCCCE
Confidence 589999999999999998654 699999999999999999999987 999999999999995 58999
Q ss_pred EEeecccccccCCCCC-----ccccccccccccchhccC-------CCCChhhHHHHHHHHHHHHhCCCCCCCC------
Q 007498 295 RLIDFGLSDFIRPDER-----LNDIVGSAYYVAPEVLHR-------SYSLEADIWSIGVISYILLCGSRPFWAR------ 356 (601)
Q Consensus 295 kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DvwSlG~il~ell~g~~pf~~~------ 356 (601)
||+|||+|+....... ....+||+.|||||++.+ .|+.++|||||||+||||+||..||...
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 9999999987654332 234689999999999864 3678999999999999999997765321
Q ss_pred ---------ChhHHHHHHHccCC--CCCCCC-CCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 357 ---------TESGIFRAVLRSDP--NFDDLP-WPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 357 ---------~~~~~~~~i~~~~~--~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
....+...+..... .++... ....+..+.+|+.+||..||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11223333332221 111110 0112357889999999999999999999885
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=419.03 Aligned_cols=256 Identities=25% Similarity=0.547 Sum_probs=225.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+|+.+. |||||+++++|.+.+.+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEE
Confidence 579999999999999999999876 78899999998765444455678899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|||||.||+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+.
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC---CCCCEEEeccceeeecc
Confidence 999999999999988754 46799999999999999999999999999999999999995 58899999999998887
Q ss_pred CCCCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHccCCCCCCCCCCC
Q 007498 307 PDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
........+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.... ....+..+......++ ..
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~ 242 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SA 242 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TT
T ss_pred CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----Cc
Confidence 666777889999999999985 248999999999999999999999997533 3444555555544444 36
Q ss_pred CCHHHHHHHHHcccccccCCCC-HHHHHcCcccCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMT-AVQALTHPWLRDD 414 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s-~~ell~hp~f~~~ 414 (601)
+++++.+||.+||..||.+||+ ++++++||||++.
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 8999999999999999999998 9999999999763
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=426.42 Aligned_cols=260 Identities=31% Similarity=0.480 Sum_probs=225.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||+|+++. +++.||||++.+.........+.+.+|+.++..+. ||||++++++|.+.+.
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~---~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENY 135 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCE
Confidence 3579999999999999999999876 78999999997654333334456889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||+||+|.+++.+.+..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld---~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec---CCCCEEEeechhheec
Confidence 9999999999999999887666899999999999999999999999999999999999995 5889999999999877
Q ss_pred CCCCC--ccccccccccccchhcc--------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC--CCCC
Q 007498 306 RPDER--LNDIVGSAYYVAPEVLH--------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--PNFD 373 (601)
Q Consensus 306 ~~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~ 373 (601)
..... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+.+..+.+..+.... ..++
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence 54433 23568999999999875 358999999999999999999999999999888888887533 2232
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCC---CCHHHHHcCcccCCC
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKR---MTAVQALTHPWLRDD 414 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R---~s~~ell~hp~f~~~ 414 (601)
.. ...+++++++||++||. +|.+| ++++|+++||||++.
T Consensus 293 ~~-~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 293 LV-DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp -----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred cc-ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 21 24689999999999999 99998 599999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=418.45 Aligned_cols=256 Identities=33% Similarity=0.605 Sum_probs=220.7
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
-++|++++.||+|+||.||+|++.. +++.||||++.+...........+.+|+.+++.++ ||||+++++++...+.
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYK---TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTD 83 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCE
Confidence 3579999999999999999999876 78899999997654333334467899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+||||||+ +|+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC---TTCCEEECCSSCTBTT
T ss_pred EEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc---CCCCEEEEEeccceec
Confidence 99999999 67999988765 5799999999999999999999999999999999999995 4789999999999887
Q ss_pred CCCCCccccccccccccchhccCC-C-CChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPDERLNDIVGSAYYVAPEVLHRS-Y-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.........+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+.........+......++ ..++++
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 234 (336)
T 3h4j_B 159 TDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPG 234 (336)
T ss_dssp TTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSCHH
T ss_pred cCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCCHH
Confidence 777667778999999999998753 3 7899999999999999999999977655443333322222222 358999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+.+||++||..||.+|||+.|+++||||+..
T Consensus 235 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 9999999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=401.45 Aligned_cols=260 Identities=27% Similarity=0.471 Sum_probs=218.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++..... .......+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC---CCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEE
Confidence 479999999999999999999876 788999999976543 2334567889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||++ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~---~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccceecC
Confidence 999999975 78888777778899999999999999999999999999999999999995 47899999999998765
Q ss_pred CC-CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCC-CCCChhHHHHHHHccCCCCCCC-------
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPF-WARTESGIFRAVLRSDPNFDDL------- 375 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~------- 375 (601)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|..|| .+....+.+..+..........
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 33 33455689999999998863 3899999999999999999888885 4555556666654422111111
Q ss_pred ------------------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 376 ------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 376 ------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
..+.+++++++||.+||..||++|||++|+|+||||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 1235789999999999999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=415.79 Aligned_cols=259 Identities=37% Similarity=0.627 Sum_probs=226.3
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++++.||+|+||.||+|+++. +++.||||++.+.... ..+|++++.++.+||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 455689999999999999999999876 7899999999765432 347999999986699999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC-CCCCeEEeecccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR-DDADMRLIDFGLS 302 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~-~~~~vkl~DFG~a 302 (601)
..+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+...+ ..+.+||+|||++
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 9999999999999999988654 5799999999999999999999999999999999999985421 1245999999999
Q ss_pred cccCCC-CCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCC---CChhHHHHHHHccCCCCCCCCC
Q 007498 303 DFIRPD-ERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWA---RTESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 303 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~ 377 (601)
...... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ ....+++..+......+....|
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 876543 33456789999999999874 589999999999999999999999976 3556777888888777777778
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
+.+++++++||++||..||++||++.++|+||||.+
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 899999999999999999999999999999999965
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=402.28 Aligned_cols=264 Identities=39% Similarity=0.746 Sum_probs=237.2
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++.+.||+|+||.||+|+++. ++..||+|++...... ..+.+.+|+++++++. ||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLD-HPNIIRLYETFEDN 78 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCC---CCcEEEEEeehhhccc---hHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 345689999999999999999999876 7789999999765432 3567899999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
..+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+..++.++.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 9999999999999999987665 569999999999999999999999999999999999999654567899999999998
Q ss_pred ccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
...........+||+.|+|||++.+.++.++|||||||++|+|++|..||......+....+......++...+..++++
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred eccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 87766666778899999999999888999999999999999999999999998888888888888777666556679999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
+.+||.+||..||.+||++.++|+||||++..
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999999999997643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=416.68 Aligned_cols=255 Identities=28% Similarity=0.525 Sum_probs=217.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHH-HHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKIL-KALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|..++ +.+ +|||||+++++|.+.+.
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADK 113 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETT---TCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCE
Confidence 479999999999999999999876 7889999999887655544556677788774 556 49999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCBCGGG
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEeeCcccccc
Confidence 99999999999999988664 5799999999999999999999999999999999999995 5889999999999864
Q ss_pred C-CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 R-PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
. ........+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+..+++..+......++ +.++.+
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~ 265 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNS 265 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHH
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHH
Confidence 3 334556789999999999986 4699999999999999999999999999999999999988766554 368999
Q ss_pred HHHHHHHcccccccCCCCH----HHHHcCcccCC
Q 007498 384 AKDFVKRLLNKDYRKRMTA----VQALTHPWLRD 413 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~----~ell~hp~f~~ 413 (601)
+++||.+||..||.+|+++ .++++||||+.
T Consensus 266 ~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 9999999999999999986 69999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=418.27 Aligned_cols=258 Identities=35% Similarity=0.620 Sum_probs=225.9
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
|...+.||+|+||.||+|++.. +++.||+|++..... ...+.+.+|+.+|++|+ ||||+++++++.+.+.+||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETA---TGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLD-HANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp EEEEEECC-----CEEEEEETT---TCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred eecceEEecCcCEEEEEEEEcC---CCcEEEEEEEccccc---ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEE
Confidence 3346789999999999999876 788999999976432 34577899999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~ 308 (601)
|||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||+++.+...
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCc
Confidence 99999999999988876667999999999999999999999999999999999999964 34678999999999888766
Q ss_pred CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHH
Q 007498 309 ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387 (601)
Q Consensus 309 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 387 (601)
......+||+.|+|||++. +.++.++|||||||++|||++|..||.+....+.+..+......+....+..+++++++|
T Consensus 243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 322 (373)
T 2x4f_A 243 EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF 322 (373)
T ss_dssp CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence 6666778999999999886 568999999999999999999999999999988888888877766666667899999999
Q ss_pred HHHcccccccCCCCHHHHHcCcccCCC
Q 007498 388 VKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 388 i~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
|.+||..||.+|||+.|+|+||||++.
T Consensus 323 i~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 323 ISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=403.76 Aligned_cols=267 Identities=34% Similarity=0.582 Sum_probs=219.2
Q ss_pred CcccCCCeEEc-ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeE
Q 007498 142 NKNFGAKYELG-KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC 220 (601)
Q Consensus 142 ~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~ 220 (601)
...+...|++. +.||+|+||.||+|++.. +++.||||++..... .....+.+|+.+++++.+||||+++++++
T Consensus 7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp CCCTTTSCEECCCCCCCCSSEEEEEEECSS---SCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcccceeEEecCceecCCceEEEEEEEEcC---CCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34567789995 789999999999999875 788999999976432 23567899999999965699999999999
Q ss_pred ecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecc
Q 007498 221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300 (601)
Q Consensus 221 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG 300 (601)
.+.+.+|||||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+.....+||+|||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 81 EEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred eeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 9999999999999999999988765 579999999999999999999999999999999999999753333459999999
Q ss_pred cccccCCCC--------Cccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh--------
Q 007498 301 LSDFIRPDE--------RLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTE-------- 358 (601)
Q Consensus 301 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-------- 358 (601)
++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 987653221 123457999999999875 3489999999999999999999999976542
Q ss_pred -------hHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 359 -------SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 359 -------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
...+..+......++...+..+++++++||.+||..||.+|||+.|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 345566666666655544567899999999999999999999999999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=404.63 Aligned_cols=259 Identities=27% Similarity=0.510 Sum_probs=216.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc-hhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-AISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+|++++.||+|+||.||+|++..+..+++.||||++.+..... ......+.+|+.+|+.++ ||||+++++++...+.
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSSC
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCCE
Confidence 47999999999999999999986444478999999997654322 223456789999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||+|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC---CCCcEEEEeCCccccc
Confidence 99999999999999988654 5799999999999999999999999999999999999995 4789999999999764
Q ss_pred CC-CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RP-DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.. .......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+....+..+......++ +.++++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~ 247 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQE 247 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSCHH
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHH
Confidence 32 23345678999999999876 5689999999999999999999999999888888888888766554 368999
Q ss_pred HHHHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 384 AKDFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
+.+||.+||..||.+|| ++.|+++||||+..
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 99999999999999999 89999999999853
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=409.98 Aligned_cols=261 Identities=38% Similarity=0.650 Sum_probs=206.6
Q ss_pred CCCeEEc---ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 146 GAKYELG---KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 146 ~~~y~~~---~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
..+|++. +.||+|+||.||+|+++. +++.||||++.+. ....+.+|+.+++.+.+||||+++++++.+
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETT---TCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhccccccCCCccccCCCeEEEEEEECC---CCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 3467775 789999999999999876 7889999998653 235678999999999779999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
...+|||||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred CCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 99999999999999999988764 67999999999999999999999999999999999999975333448999999999
Q ss_pred cccCCC-CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-------hHHHHHHHccCCCCC
Q 007498 303 DFIRPD-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE-------SGIFRAVLRSDPNFD 373 (601)
Q Consensus 303 ~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~ 373 (601)
...... ......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+... .+.+..+......+.
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 157 RLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp EECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred eecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 866543 2345678999999999986 5699999999999999999999999976432 456667776666666
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
...|..+++++++||.+||..||.+|||+.|+++||||++...
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 5556679999999999999999999999999999999987644
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=399.00 Aligned_cols=258 Identities=28% Similarity=0.463 Sum_probs=214.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|++. +++.||||++...... ......+.+|+.++++++ ||||+++++++...+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKED-EGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEcC----CCCEEEEEEEeccccc-cccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeE
Confidence 47999999999999999999883 6789999999764422 223466889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFG 151 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHHHC
T ss_pred EEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEeECccccccC
Confidence 999999976 89988877667899999999999999999999999999999999999995 47899999999998764
Q ss_pred CC-CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC---------
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD--------- 374 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--------- 374 (601)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+.+.......
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 32 23345689999999999863 5899999999999999999999999988877776666542111000
Q ss_pred ------------C----CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 375 ------------L----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 375 ------------~----~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
. ....+++++.+||.+||..||++|||+.|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 123578999999999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=407.62 Aligned_cols=270 Identities=30% Similarity=0.530 Sum_probs=232.4
Q ss_pred CcccCCCeEEc-ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeE
Q 007498 142 NKNFGAKYELG-KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC 220 (601)
Q Consensus 142 ~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~ 220 (601)
.+.+..+|.+. +.||+|+||.||+|+++. +++.||||++....... .....+.+|+.+++.+.+||||+++++++
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKS---TGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECC---CCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 34567789988 899999999999999876 78899999997654332 34577899999999998789999999999
Q ss_pred ecCCcEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 221 EDVNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 221 ~~~~~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
.+.+.+|+|||||++|+|.+++... ...+++.+++.++.||+.||.|||++||+||||||+|||++....++.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999999877532 357999999999999999999999999999999999999964334689999999
Q ss_pred ccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
|++............+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+......+....+.
T Consensus 179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 258 (327)
T 3lm5_A 179 GMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258 (327)
T ss_dssp GGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred ccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence 9998876665566778999999999986 578999999999999999999999999998888888888877777776777
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
.+++.+.+||.+||..||.+|||++++|+||||++..
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 8999999999999999999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=404.40 Aligned_cols=263 Identities=25% Similarity=0.414 Sum_probs=226.8
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
....|++++.||+|+||.||+|++.. +++.||||++...........+.+.+|++++++++ ||||+++++++...+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 127 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH 127 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hhhheeeeeEEccCCCEEEEEEEEcc---CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence 34569999999999999999999875 78899999997655444445678899999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|||||||. |+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 128 ~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 128 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASI 203 (348)
T ss_dssp EEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBS
T ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccCcee
Confidence 9999999997 588888877677899999999999999999999999999999999999996 478999999999976
Q ss_pred cCCCCCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
... ....+||+.|+|||++. +.++.++|||||||++|||++|+.||.+......+..+....... .....+
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~ 278 (348)
T 1u5q_A 204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHW 278 (348)
T ss_dssp SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCCTTS
T ss_pred cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCCCCC
Confidence 543 24568999999999873 568999999999999999999999998887777666666544322 122468
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCCh
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPL 420 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 420 (601)
++++.+||.+||..||++|||+.++|+||||.....+...
T Consensus 279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~ 318 (348)
T 1u5q_A 279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 318 (348)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHH
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcchh
Confidence 9999999999999999999999999999999887655443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=398.98 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=217.2
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc--hhhHHHHHHHHHHHHHhc--CCCCeeEEeeeE
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT--AISIEDVRREVKILKALS--GHKHLVKFCDAC 220 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~ 220 (601)
+..+|++++.||+|+||.||+|++.. +++.||||++....... ......+.+|+.+++.+. +||||+++++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTT---TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 45689999999999999999999876 78899999997543211 112245677888887774 499999999999
Q ss_pred ecCC-----cEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCe
Q 007498 221 EDVN-----NVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294 (601)
Q Consensus 221 ~~~~-----~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~v 294 (601)
.... .+|+||||+. ++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~---~~~~~ 159 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTV 159 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC---TTSCE
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCE
Confidence 8754 5899999997 59999887643 2399999999999999999999999999999999999995 47899
Q ss_pred EEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCC
Q 007498 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373 (601)
Q Consensus 295 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 373 (601)
||+|||++............+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+.......+
T Consensus 160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999999998877666667789999999999875 6799999999999999999999999999888888777765322222
Q ss_pred CCC-----------------------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 374 DLP-----------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 374 ~~~-----------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
... .+.+++++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 211 135789999999999999999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=424.55 Aligned_cols=256 Identities=28% Similarity=0.521 Sum_probs=217.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+++.++ ||||++++++|...+.+
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRL 223 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcC---CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEE
Confidence 579999999999999999999876 78999999998755444445567889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|||||||++|+|.+++... +.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+..
T Consensus 224 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~---~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC---SSSCEEECCCCCCCTT
T ss_pred EEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC---CCCCEEEccCCCceec
Confidence 9999999999999887655 579999999999999999999998 9999999999999995 4789999999999764
Q ss_pred C-CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 R-PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
. ........+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+......+..+......++. .++++
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~ 375 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPE 375 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHH
Confidence 3 333456689999999999886 57999999999999999999999999999988888888887766553 68999
Q ss_pred HHHHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 384 AKDFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
+.+||.+||..||.+|| +++|+|+||||++.
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999999999999 99999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=424.81 Aligned_cols=257 Identities=35% Similarity=0.614 Sum_probs=229.4
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|.+++.||+|+||.||+|++.. +++.||||++.+...........+.+|+.+++.+. ||||+++++++...+.
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHEL---TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSD 90 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETT---TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 3579999999999999999999876 78999999997755433345678899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 91 ~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~---~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC---TTCCEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe---cCCCeEEEeccchhhc
Confidence 9999999999999998754 46799999999999999999999999999999999999995 4789999999999887
Q ss_pred CCCCCccccccccccccchhccCC--CCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.......+.+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+......+..+.......+ ..++++
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 242 (476)
T 2y94_A 167 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPS 242 (476)
T ss_dssp CTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHH
T ss_pred cccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHH
Confidence 766666778999999999998753 47899999999999999999999998888888888887665443 358999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+.+||++||..||.+|||+.|+++||||+..
T Consensus 243 ~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 243 VISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 9999999999999999999999999999865
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=428.71 Aligned_cols=258 Identities=26% Similarity=0.480 Sum_probs=226.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++.+.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+|+.+. |||||++++++.+.+.
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDA 258 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCE
Confidence 3579999999999999999999876 78999999998765444445677889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+|||||||+||+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld---~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD---DHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe---CCCCeEEEeccccee
Confidence 999999999999999886543 3499999999999999999999999999999999999995 588999999999988
Q ss_pred cCCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHccCCCCCCCCCCC
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
+.........+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.. ...+...+......++ ..
T Consensus 336 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~ 411 (576)
T 2acx_A 336 VPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ER 411 (576)
T ss_dssp CCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TT
T ss_pred cccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----cc
Confidence 776666667799999999999874 69999999999999999999999998753 3445555655544443 46
Q ss_pred CCHHHHHHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
+++++++||.+||..||.+|+ +++|+++||||++.
T Consensus 412 ~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 412 FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 899999999999999999999 89999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=402.42 Aligned_cols=260 Identities=25% Similarity=0.422 Sum_probs=206.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++...... .....+.+|+.+++++. ||||+++++++...+.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKT---TGVYVALKEVKLDSEE--GTPSTAIREISLMKELK-HENIVRLYDVIHTENKL 78 (317)
T ss_dssp --------------CEEEEEECSS---SCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEE
T ss_pred cceeEeeEECCCCCEEEEEEEECC---CCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeE
Confidence 479999999999999999999876 7889999999765322 23466889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 227 YIVMELCEGGELLDRILARG-----GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~-----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
|||||||+ |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc---CCCCEEECcCcc
Confidence 99999998 59998886542 4599999999999999999999999999999999999995 478999999999
Q ss_pred ccccCCC-CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCC---
Q 007498 302 SDFIRPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL--- 375 (601)
Q Consensus 302 a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--- 375 (601)
+...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+..........
T Consensus 155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 155 ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp CEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred ceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence 9876533 33455689999999999864 58999999999999999999999999988887777665421111000
Q ss_pred ---------------------------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 376 ---------------------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 376 ---------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
....++.++.+||.+||..||++|||+.|+|+||||++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 01257889999999999999999999999999999987543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=440.64 Aligned_cols=258 Identities=26% Similarity=0.458 Sum_probs=231.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||+|+++. +++.||||++.+.........+.+.+|..++..+.+||||+++++++.+.+.
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESS---SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred ccceEEEEEEccCCCEEEEEEEECC---CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 3579999999999999999999886 7889999999875444444567788999999988779999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+||||||++||+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+..
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~---~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC---SSSCEEECCCTTCEEC
T ss_pred EEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc---CCCcEEEeecceeecc
Confidence 99999999999999988765 5799999999999999999999999999999999999995 5889999999999864
Q ss_pred C-CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 R-PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
. ........+||+.|+|||++. ..|+.++|||||||+||||++|+.||.+.+..+++..|......++. .++++
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 568 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKE 568 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHH
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHH
Confidence 3 334456789999999999986 57999999999999999999999999999999999999988777664 68999
Q ss_pred HHHHHHHcccccccCCCCH-----HHHHcCcccCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTA-----VQALTHPWLRDD 414 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~-----~ell~hp~f~~~ 414 (601)
+++||++||++||++|+++ +||++||||+..
T Consensus 569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 569 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 9999999999999999997 999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=404.96 Aligned_cols=269 Identities=28% Similarity=0.457 Sum_probs=227.3
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec---
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--- 222 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--- 222 (601)
..+|++++.||+|+||.||+|+++. +++.||||++....... .....+.+|+.+++.++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETT---TCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECC---CCCEEEEEEEecccccc-cchHHHHHHHHHHHhcc-CCCcccHhheeecccc
Confidence 3589999999999999999999876 78899999986654332 23456789999999996 9999999999876
Q ss_pred -----CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 223 -----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 223 -----~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
.+.+|||||||++ +|.+.+......+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~---~~~~~kl~ 166 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLA 166 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEEC
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCCEEEc
Confidence 4568999999975 88888877667899999999999999999999999999999999999995 47899999
Q ss_pred ecccccccCCC-----CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC
Q 007498 298 DFGLSDFIRPD-----ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP 370 (601)
Q Consensus 298 DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 370 (601)
|||++..+... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+.....
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99999876422 23345689999999998753 589999999999999999999999999888888777766544
Q ss_pred CCCCCCCCCC----------------------------CHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCChhH
Q 007498 371 NFDDLPWPSV----------------------------SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDI 422 (601)
Q Consensus 371 ~~~~~~~~~~----------------------------s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~ 422 (601)
.++...|+.+ ++++.+||.+||..||++|||+.|+|+||||++...+..+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~ 326 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKG 326 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCSHH
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcccccc
Confidence 4444333332 778999999999999999999999999999999887766544
Q ss_pred H
Q 007498 423 L 423 (601)
Q Consensus 423 ~ 423 (601)
.
T Consensus 327 ~ 327 (351)
T 3mi9_A 327 M 327 (351)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=401.87 Aligned_cols=262 Identities=36% Similarity=0.652 Sum_probs=230.8
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch---hhHHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
+..+|++++.||+|+||.||+|+++. +++.||||++........ ...+.+.+|+.+++++. ||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 85 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYE 85 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECC---CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEe
Confidence 45679999999999999999999876 788999999976543321 23677999999999996 999999999999
Q ss_pred cCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCC----CeEEe
Q 007498 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA----DMRLI 297 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~----~vkl~ 297 (601)
+...+|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++. ++ .+||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~---~~~~~~~~kl~ 161 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD---KNIPIPHIKLI 161 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC---TTSSSCCEEEC
T ss_pred cCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEec---CCCCcCCEEEc
Confidence 99999999999999999998764 467999999999999999999999999999999999999964 34 79999
Q ss_pred ecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 376 (601)
|||++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......++...
T Consensus 162 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (321)
T 2a2a_A 162 DFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241 (321)
T ss_dssp CCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred cCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh
Confidence 999998877665566778999999999886 5689999999999999999999999999888888888877665554433
Q ss_pred CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+..++.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 45789999999999999999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=400.47 Aligned_cols=257 Identities=25% Similarity=0.322 Sum_probs=213.3
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|+++++||+|+||+||+|+++. +++.||||++...... .........|+..+.++.+||||++++++|.+.
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKE---DGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETT---TSCEEEEEEESSSCCS-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhheeeeheeccCCCeEEEEEEECC---CCeEEEEEEecccccC-hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 345689999999999999999999876 7889999998654332 234455667777777775699999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+.+||||||| +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLV 205 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---GGGCEEECCCTTCE
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEccceeee
Confidence 9999999999 6699999888777899999999999999999999999999999999999995 47899999999998
Q ss_pred ccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
...........+||+.|+|||++.+.++.++|||||||++|||++|..||++... ...+.... .+......++++
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~ 280 (311)
T 3p1a_A 206 ELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGY--LPPEFTAGLSSE 280 (311)
T ss_dssp ECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTC--CCHHHHTTSCHH
T ss_pred ecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccC--CCcccccCCCHH
Confidence 7765555566789999999999988999999999999999999999887765322 22332221 111112468999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
+.+||.+||..||++|||+.|+|+||||++
T Consensus 281 l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=413.87 Aligned_cols=261 Identities=30% Similarity=0.483 Sum_probs=209.4
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++++.||+|+||.||+|+++. +++.||||++.+.. ........+.+|+.+++.+.+||||+++++++...
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETT---TCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECC---CCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence 345689999999999999999999876 78999999986543 33445677889999999997799999999999754
Q ss_pred --CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 224 --NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 224 --~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
..+|||||||+ ++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 82 ~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~ 155 (388)
T 3oz6_A 82 NDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN---AECHVKVADFGL 155 (388)
T ss_dssp TSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTT
T ss_pred CCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc---CCCCEEecCCcc
Confidence 47999999997 488887765 4799999999999999999999999999999999999995 478999999999
Q ss_pred ccccCC----------------------CCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 007498 302 SDFIRP----------------------DERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWART 357 (601)
Q Consensus 302 a~~~~~----------------------~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~ 357 (601)
|+.+.. .......+||++|+|||++. ..|+.++|||||||++|||++|++||.+.+
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 976532 11234468999999999875 468999999999999999999999999988
Q ss_pred hhHHHHHHHccCCCCC--------------------------C-----------------CCCCCCCHHHHHHHHHcccc
Q 007498 358 ESGIFRAVLRSDPNFD--------------------------D-----------------LPWPSVSPEAKDFVKRLLNK 394 (601)
Q Consensus 358 ~~~~~~~i~~~~~~~~--------------------------~-----------------~~~~~~s~~~~~li~~~L~~ 394 (601)
....+..+........ . .++..+++++.+||.+||..
T Consensus 236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 8777777653211100 0 01126789999999999999
Q ss_pred cccCCCCHHHHHcCcccCCC
Q 007498 395 DYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 395 dP~~R~s~~ell~hp~f~~~ 414 (601)
||++|||++|+|+||||+..
T Consensus 316 dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 316 NPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp SGGGSCCHHHHTTSTTTTTT
T ss_pred CcccCCCHHHHhCCHHHHHh
Confidence 99999999999999999764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=419.97 Aligned_cols=261 Identities=30% Similarity=0.511 Sum_probs=198.3
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-- 222 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-- 222 (601)
+..+|++++.||+|+||.||+|+++. +++.||||++.+.. ......+.+.+|+.+|+.|+ |||||++++++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKL---EKRVVAIKKILRVF-EDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKD 125 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC-----CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECC---CCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCC
Confidence 44689999999999999999999886 78899999996542 34445678899999999996 9999999999843
Q ss_pred ---CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 223 ---VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 223 ---~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
...+||||||+. ++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+||
T Consensus 126 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~---~~~~~kl~DF 200 (458)
T 3rp9_A 126 VEKFDELYVVLEIAD-SDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN---QDCSVKVCDF 200 (458)
T ss_dssp TTTCCCEEEEECCCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEECCC
T ss_pred cccCceEEEEEeccc-cchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC---CCCCEeeccc
Confidence 357999999995 588887654 46799999999999999999999999999999999999995 4789999999
Q ss_pred ccccccCCCC----------------------------Cccccccccccccchhc-c-CCCCChhhHHHHHHHHHHHHh-
Q 007498 300 GLSDFIRPDE----------------------------RLNDIVGSAYYVAPEVL-H-RSYSLEADIWSIGVISYILLC- 348 (601)
Q Consensus 300 G~a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~DvwSlG~il~ell~- 348 (601)
|+|+...... .....+||++|+|||++ . ..|+.++||||||||||||++
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 9998764221 23456899999999975 3 469999999999999999999
Q ss_pred ----------CCCCCCCCCh--------------------hHHHHHHHcc-----------------------CCCCC--
Q 007498 349 ----------GSRPFWARTE--------------------SGIFRAVLRS-----------------------DPNFD-- 373 (601)
Q Consensus 349 ----------g~~pf~~~~~--------------------~~~~~~i~~~-----------------------~~~~~-- 373 (601)
|+++|.+... .+.+..+... .+...
T Consensus 281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (458)
T 3rp9_A 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360 (458)
T ss_dssp STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence 6777765431 1222222210 01000
Q ss_pred --CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 374 --DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 374 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
...++.+++++.+||++||..||.+|||++|+|+||||++..
T Consensus 361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 112456799999999999999999999999999999998753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=391.26 Aligned_cols=265 Identities=35% Similarity=0.600 Sum_probs=233.6
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc------chhhHHHHHHHHHHHHHhcCCCCeeEEe
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT------TAISIEDVRREVKILKALSGHKHLVKFC 217 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~niv~l~ 217 (601)
.+..+|++.+.||+|+||.||+|+++. +++.||||++...... .....+.+.+|+.+++++.+||||++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcC---cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 345689999999999999999999876 7889999999764311 1123467889999999996799999999
Q ss_pred eeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 218 DACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 218 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
+++...+.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~ 166 (298)
T 1phk_A 91 DTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLT 166 (298)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEEC
T ss_pred eeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc---CCCcEEEe
Confidence 9999999999999999999999988764 5799999999999999999999999999999999999995 47899999
Q ss_pred ecccccccCCCCCccccccccccccchhcc-------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH-------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP 370 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 370 (601)
|||++............+||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.....
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 167 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 999998877666666778999999999873 3588999999999999999999999999888888888888777
Q ss_pred CCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
.+....+..++.++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 766655667999999999999999999999999999999998653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=405.88 Aligned_cols=262 Identities=35% Similarity=0.652 Sum_probs=230.8
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc-----hhhHHHHHHHHHHHHHhcCCCCeeEEee
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-----AISIEDVRREVKILKALSGHKHLVKFCD 218 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~ 218 (601)
.+..+|++.+.||+|+||.||+|+++. +++.||||++....... ....+.+.+|+.+++++.+||||+++++
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRA---TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECC---CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 345679999999999999999999875 78899999987643211 1224568899999999955999999999
Q ss_pred eEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 219 ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 219 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
++......||||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~---~~~~ikl~D 243 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---DNMQIRLSD 243 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECC
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEEe
Confidence 999999999999999999999988654 5799999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCCCccccccccccccchhcc-------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
||++..+.........+||+.|+|||++. ..++.++|||||||++|+|++|..||........+..+......
T Consensus 244 fG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 323 (365)
T 2y7j_A 244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ 323 (365)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred cCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99998887666667789999999999874 24889999999999999999999999998888888888877666
Q ss_pred CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 372 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
+....|..++.++.+||.+||..||.+|||+.|+|+||||+
T Consensus 324 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 65545668899999999999999999999999999999997
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=395.95 Aligned_cols=255 Identities=28% Similarity=0.569 Sum_probs=214.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch-----------------------hhHHHHHHHHHH
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-----------------------ISIEDVRREVKI 203 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~ 203 (601)
.+|++.+.||+|+||.||+|++.. +++.||||++.+...... ...+.+.+|+++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNEN---DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETT---TTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred cceEEEeEEeecCCEEEEEEEECC---CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 579999999999999999999876 788999999976543211 123568899999
Q ss_pred HHHhcCCCCeeEEeeeEec--CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCC
Q 007498 204 LKALSGHKHLVKFCDACED--VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE 281 (601)
Q Consensus 204 l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~ 281 (601)
+++|. ||||+++++++.+ ...+||||||+++++|.+++ ....+++.+++.++.||+.||.|||++||+||||||+
T Consensus 90 l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 99996 9999999999986 56899999999999988753 3457999999999999999999999999999999999
Q ss_pred ceEeecCCCCCCeEEeecccccccCCCC-CccccccccccccchhccCC----CCChhhHHHHHHHHHHHHhCCCCCCCC
Q 007498 282 NFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLHRS----YSLEADIWSIGVISYILLCGSRPFWAR 356 (601)
Q Consensus 282 NIll~~~~~~~~vkl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~DvwSlG~il~ell~g~~pf~~~ 356 (601)
|||++ .++.+||+|||++....... .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...
T Consensus 167 Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 167 NLLVG---EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GEEEC---TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HEEEC---CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99995 47899999999998765432 23456899999999998643 478899999999999999999999888
Q ss_pred ChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 357 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
........+......++. .+.+++++.+||.+||..||++||++.|+|+||||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 244 RIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred cHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 777777777665554443 247899999999999999999999999999999995
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=402.33 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=211.2
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||+|++.. +++.||||++..... .......+.+|+.++++++ ||||+++++++.+.+.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHR 107 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECC---CCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCE
Confidence 3579999999999999999999876 789999999976532 2223456789999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC--CCCCCeEEeeccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG--RDDADMRLIDFGLSD 303 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~--~~~~~vkl~DFG~a~ 303 (601)
+|||||||++ +|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+ +..+.+||+|||++.
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEEecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999999975 999887654 579999999999999999999999999999999999999642 234569999999998
Q ss_pred ccCCC-CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC--
Q 007498 304 FIRPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP-- 378 (601)
Q Consensus 304 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-- 378 (601)
..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+...........|+
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 76533 33455688999999998864 48999999999999999999999999988877777765432222111111
Q ss_pred ------------------------CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 379 ------------------------SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 379 ------------------------~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 168999999999999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=422.26 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=210.1
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV- 223 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~- 223 (601)
+..+|++++.||+|+||.||+|++.. +++.||||++.+.. ........+.+|+.+|+.++ |||||++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK 134 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCC
Confidence 34689999999999999999999876 78999999997653 33345677889999999996 99999999999654
Q ss_pred -----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 224 -----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..+|||||||++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 135 ~~~~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~---~~~~~kl~D 207 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 207 (464)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECC
T ss_pred ccccCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe---CCCCEEEEE
Confidence 457999999976 5666653 3599999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC-------
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP------- 370 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------- 370 (601)
||+|+...........+||++|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+++..+.+...
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 208 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp CCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred EEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99998877666667789999999999876 5799999999999999999999999999887777766654211
Q ss_pred ---------------CCCCCCCC----C------------CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 371 ---------------NFDDLPWP----S------------VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 371 ---------------~~~~~~~~----~------------~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.+....++ . .++++++||.+||..||++|||++|+|+||||+..
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 11111110 0 15679999999999999999999999999999854
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=392.94 Aligned_cols=263 Identities=39% Similarity=0.701 Sum_probs=229.8
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++.+.||+|+||.||+|+++. +++.||||++...... ..+.+.+|+.+++.+. ||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRL---TGKLFALKCIKKSPAF---RDSSLENEIAVLKKIK-HENIVTLEDIYEST 78 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred chhccceeeeeccCCCCceEEEEEECC---CCCEEEEEEEeccccc---chHHHHHHHHHHHhCC-CCCeeehhhhcccC
Confidence 345689999999999999999999876 7889999999764322 2356889999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+.+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred CEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 9999999999999999988665 579999999999999999999999999999999999999544457899999999997
Q ss_pred ccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
.... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||...........+......+....+..+++
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 158 MEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp CCCC-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred ecCC-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 5433 2344567999999999986 4689999999999999999999999999888888888888777666666678999
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
++.+||.+||..||.+||++.|+|+||||+...
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999999998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=392.73 Aligned_cols=265 Identities=40% Similarity=0.743 Sum_probs=235.0
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++++.||+|+||.||+|++.. +++.||||++...... ....+.+.+|+++++++. ||||+++++++.+.
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAK-NKDTSTILREVELLKKLD-HPNIMKLFEILEDS 93 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcC---CCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCC
Confidence 445689999999999999999999875 7889999999765432 234577899999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+.+|+||||+++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+..++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred CeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999999887665 479999999999999999999999999999999999999764445689999999998
Q ss_pred ccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
............||+.|+|||++.+.++.++|||||||++|+|++|..||.+.........+......+....+..++++
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp TBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred eecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence 77666555667899999999999888999999999999999999999999998888888888877666555555689999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+.+||.+||..||.+|||+.|+|+||||++.
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999999754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=422.03 Aligned_cols=258 Identities=28% Similarity=0.457 Sum_probs=225.5
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
...|++.+.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+|++++ ||||++++++|.+...
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTD 259 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCE
Confidence 3579999999999999999999876 78999999998765544445678899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 226 VYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~---~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
+|||||||+||+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~---~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe---CCCCEEEeeccee
Confidence 99999999999999988654 34699999999999999999999999999999999999995 5889999999999
Q ss_pred cccCCCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHccCCCCCCCC
Q 007498 303 DFIRPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAVLRSDPNFDDLP 376 (601)
Q Consensus 303 ~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~ 376 (601)
+.+..... ....+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.. ...+...+......++
T Consensus 337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--- 413 (543)
T 3c4z_A 337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--- 413 (543)
T ss_dssp EECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC---
T ss_pred eeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC---
Confidence 87755433 34569999999999987 469999999999999999999999998753 3566667776665554
Q ss_pred CCCCCHHHHHHHHHcccccccCCCC-----HHHHHcCcccCCC
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMT-----AVQALTHPWLRDD 414 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~ 414 (601)
..+++++++||++||.+||.+||+ ++++++||||++.
T Consensus 414 -~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 414 -DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred -cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 368999999999999999999995 5899999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=417.58 Aligned_cols=264 Identities=36% Similarity=0.617 Sum_probs=214.2
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch-----hhHHHHHHHHHHHHHhcCCCCeeEEee
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-----ISIEDVRREVKILKALSGHKHLVKFCD 218 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~ 218 (601)
.+..+|.+.+.||+|+||.||+|+++. +++.||||++.+...... .....+.+|+.+|++|. ||||+++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~ 207 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKN 207 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECC---CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence 345789999999999999999999876 788999999987543211 12234789999999996 999999999
Q ss_pred eEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 219 ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 219 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
++.. +.+|||||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+||+|
T Consensus 208 ~~~~-~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 208 FFDA-EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp EEES-SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred EEec-CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEee
Confidence 9864 558999999999999887654 46799999999999999999999999999999999999997644566799999
Q ss_pred cccccccCCCCCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHccCCCCC
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNFD 373 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~ 373 (601)
||+++...........+||+.|+|||++. ..|+.++|||||||++|+|++|..||...... .....+......+.
T Consensus 286 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~ 365 (419)
T 3i6u_A 286 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365 (419)
T ss_dssp SSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC
T ss_pred cccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC
Confidence 99998876665666789999999999874 46889999999999999999999999765433 34455555554444
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
...|..+++++.+||.+||..||.+||++.|+|+||||++
T Consensus 366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 4445678999999999999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=407.84 Aligned_cols=268 Identities=34% Similarity=0.625 Sum_probs=226.8
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc--chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--TAISIEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
.+..+|++++.||+|+||.||+|++.. +++.||||++.+.... .....+.+.+|+.++++++ ||||+++++++.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~ 98 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQ---TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYE 98 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred hhhhheeecceeeecCCeEEEEEEECC---CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhc
Confidence 456789999999999999999999876 7889999999765322 2235678999999999996 999999999999
Q ss_pred cCCcEEEEEeecCCCchHHHHHHc---------------------------------------CCCCCHHHHHHHHHHHH
Q 007498 222 DVNNVYIVMELCEGGELLDRILAR---------------------------------------GGRYTEEDAKAIVVQIL 262 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~---------------------------------------~~~l~~~~~~~i~~ql~ 262 (601)
+.+.+|||||||+||+|.+++... ...+++..++.++.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 999999999999999999877310 11246788999999999
Q ss_pred HHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCC-----Cccccccccccccchhcc---CCCCChh
Q 007498 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-----RLNDIVGSAYYVAPEVLH---RSYSLEA 334 (601)
Q Consensus 263 ~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~ 334 (601)
.||.|||++||+||||||+|||++. +....+||+|||++..+.... .....+||+.|+|||++. ..++.++
T Consensus 179 ~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 179 SALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999999999999999999964 223489999999998653221 234568999999999875 4689999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 335 DIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 335 DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
|||||||++|+|++|+.||.+....+....+......+....+..+++++.+||.+||..||.+||++.|+|+||||++.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 99999999999999999999999988888888887776665566789999999999999999999999999999999876
Q ss_pred CC
Q 007498 415 SR 416 (601)
Q Consensus 415 ~~ 416 (601)
..
T Consensus 338 ~~ 339 (345)
T 3hko_A 338 SD 339 (345)
T ss_dssp SS
T ss_pred hH
Confidence 54
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=401.10 Aligned_cols=258 Identities=29% Similarity=0.543 Sum_probs=215.1
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+..+|++++.||+|+||.||+|+++. +++.||||++....... ..+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN-HENVVKFYGHRREGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECC---CCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 45689999999999999999999876 78899999996543322 2356889999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
..|||||||+||+|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATV 154 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe---CCCCEEEEEeeccce
Confidence 99999999999999987643 45699999999999999999999999999999999999995 478999999999976
Q ss_pred cCCC---CCccccccccccccchhccC-C-CCChhhHHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHccCCCCCCCCCC
Q 007498 305 IRPD---ERLNDIVGSAYYVAPEVLHR-S-YSLEADIWSIGVISYILLCGSRPFWARTESGI-FRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 305 ~~~~---~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 378 (601)
+... ......+||+.|+|||++.+ . ++.++|||||||++|+|++|+.||........ +......... ...+.
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~ 232 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWK 232 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--STTGG
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--CCccc
Confidence 5422 22345789999999999864 3 47899999999999999999999987655433 3333332222 22346
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 789999999999999999999999999999999865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=407.80 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=216.3
Q ss_pred CCCeEEcceeccC--CCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 146 GAKYELGKEVGRG--HFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
..+|++++.||+| +||.||+|+++. +++.||||++..... .....+.+.+|+.+++.++ |||||++++++.+.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---CCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEEC
Confidence 3579999999999 999999999986 789999999977543 3345677889999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 224 NNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
+.+|||||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~---~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccccc
Confidence 9999999999999999988764 35699999999999999999999999999999999999995 4889999999998
Q ss_pred cccCCC--------CCccccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC
Q 007498 303 DFIRPD--------ERLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 303 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
...... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+......+..+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 654221 11233589999999999864 5899999999999999999999999876665554443322110
Q ss_pred C------------------------------------------CCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCc
Q 007498 372 F------------------------------------------DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409 (601)
Q Consensus 372 ~------------------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp 409 (601)
. ....+..+++++.+||.+||..||++|||+.|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 0 0011245789999999999999999999999999999
Q ss_pred ccCCCCC
Q 007498 410 WLRDDSR 416 (601)
Q Consensus 410 ~f~~~~~ 416 (601)
||+....
T Consensus 336 ~f~~~~~ 342 (389)
T 3gni_B 336 FFKQIKR 342 (389)
T ss_dssp GGGGC--
T ss_pred HHHHHhh
Confidence 9987654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=401.79 Aligned_cols=260 Identities=26% Similarity=0.441 Sum_probs=213.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++++.||+|+||.||+|++.. +++.||||++....... ....+.+|+.+++.++ ||||+++++++...+.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---TDNLVALKEIRLEHEEG--APCTAIREVSLLKDLK-HANIVTLHDIIHTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---CCcEEEEEEEecccccc--cchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEE
Confidence 479999999999999999999876 78899999986543211 1123457999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 76 TLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN---ERGELKLADFGLARAKS 151 (324)
T ss_dssp EEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC---TTCCEEECSSSEEECC-
T ss_pred EEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC---CCCCEEEccCccccccc
Confidence 999999975 99999888777899999999999999999999999999999999999995 47899999999997654
Q ss_pred CC-CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC-------
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP------- 376 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------- 376 (601)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+...........
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 33 23445689999999998763 589999999999999999999999999888877777655322222211
Q ss_pred -------------------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 377 -------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 377 -------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
++.+++++.+||.+||..||.+|||++|+|+||||.+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 1357899999999999999999999999999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=393.75 Aligned_cols=261 Identities=31% Similarity=0.529 Sum_probs=223.9
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|...+.||+|+||.||+|+++. +++.||||++..... ...+.+.+|+.++++++ ||||+++++++...+.+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~---~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred hhhccEEeccCCCeEEEEEEECC---CCcEEEEEEEeccch---hHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence 47888899999999999999875 788999999975432 23567889999999996 999999999999999999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
|||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 119 lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp EEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCcEEEeeeeeeeeccc
Confidence 99999999999987643 4799999999999999999999999999999999999995 478999999999987654
Q ss_pred CC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 308 DE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 308 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.. .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||........+..+......... ....+++++.
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~ 272 (321)
T 2c30_A 194 DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK-NSHKVSPVLR 272 (321)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCT-TGGGSCHHHH
T ss_pred CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcC-ccccCCHHHH
Confidence 32 345678999999999986 46899999999999999999999999988877777766654432211 1246899999
Q ss_pred HHHHHcccccccCCCCHHHHHcCcccCCCCCCCChh
Q 007498 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLD 421 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~ 421 (601)
+||.+||..||++|||+.|+|+||||.....+..+.
T Consensus 273 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~ 308 (321)
T 2c30_A 273 DFLERMLVRDPQERATAQELLDHPFLLQTGLPECLV 308 (321)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGGGGH
T ss_pred HHHHHHccCChhhCcCHHHHhcChhhccCCCcccch
Confidence 999999999999999999999999999876554433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=402.14 Aligned_cols=266 Identities=26% Similarity=0.398 Sum_probs=218.5
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch--hhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA--ISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
..+|++++.||+|+||.||+|++.. +++.||||++........ .....+.+|+.+++.++ ||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHK 84 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCT
T ss_pred hcccEEEeEEeecCCEEEEEEEECC---CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeC
Confidence 4579999999999999999999876 788999999875432211 11246789999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+.+|+||||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAK 160 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGS
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc---CCCCEEEEecccce
Confidence 999999999986 88888776666799999999999999999999999999999999999995 47899999999998
Q ss_pred ccCCC-CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC----
Q 007498 304 FIRPD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP---- 376 (601)
Q Consensus 304 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---- 376 (601)
.+... ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+.+..+...........
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 76433 33456789999999999853 489999999999999999999999999888887777765322111111
Q ss_pred --------------------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 377 --------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 377 --------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
+..+++++.+||.+||..||++|||+.|+|+||||++.+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 1456799999999999999999999999999999998765543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=388.64 Aligned_cols=257 Identities=30% Similarity=0.606 Sum_probs=223.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|++.. +++.||||++.+...........+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRV 84 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEE
Confidence 479999999999999999999876 77899999997655444445677899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC---TTSCEEECSCCEESCC-
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc---CCCCEEEEeccccccCC
Confidence 9999999999999988665 5799999999999999999999999999999999999995 48899999999986543
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.. .....+||+.|+|||++. ..++.++|||||||++|+|++|..||......+....+......++. .+++++.
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 235 (279)
T 3fdn_A 161 SS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGAR 235 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHH
T ss_pred cc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHHHH
Confidence 32 334568999999999886 46899999999999999999999999988888888888776655543 5899999
Q ss_pred HHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+||.+||..||.+|||+.|+|+||||++...
T Consensus 236 ~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 236 DLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 9999999999999999999999999987643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=396.84 Aligned_cols=263 Identities=29% Similarity=0.500 Sum_probs=231.4
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
...+|.+++.||+|+||.||++++.. +++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDND 114 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 34589999999999999999999876 78899999998766555556788999999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|+|||||++++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATK 190 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc---CCCCEEEeeccCcee
Confidence 999999999999999887654 5799999999999999999999999999999999999995 478999999999987
Q ss_pred cCCC-CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 305 IRPD-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 305 ~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
.... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||......+.+..+......++ ..+++
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~ 266 (335)
T 2owb_A 191 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINP 266 (335)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCH
T ss_pred cccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCH
Confidence 6533 3345578999999999886 4689999999999999999999999998888777777776655544 36899
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
++.+||.+||..||++||++.|+|+||||+....+..
T Consensus 267 ~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~ 303 (335)
T 2owb_A 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 303 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccCCCcccc
Confidence 9999999999999999999999999999988765443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=388.48 Aligned_cols=259 Identities=31% Similarity=0.573 Sum_probs=198.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||+|++.. +++.||||++...........+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYV 86 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEE
T ss_pred ccceeeeeecCCCceEEEEEEEcc---CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeE
Confidence 479999999999999999999875 78899999997654333334577899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEEeecceeecc
Confidence 999999999999998877667899999999999999999999999999999999999995 47899999999998765
Q ss_pred CC-CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
.. ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||........+..+.......+ ..++.++
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 239 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP----SFLSIEA 239 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC----TTSCHHH
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc----cccCHHH
Confidence 32 2334568999999999886 4689999999999999999999999987665555444433332222 3589999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
.+||.+||..||++|||+.++|+||||.....
T Consensus 240 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 271 (278)
T 3cok_A 240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271 (278)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred HHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence 99999999999999999999999999987643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=400.70 Aligned_cols=264 Identities=23% Similarity=0.382 Sum_probs=219.8
Q ss_pred cCcCcccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc----CCCCee
Q 007498 139 FGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS----GHKHLV 214 (601)
Q Consensus 139 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv 214 (601)
+.....+..+|+++++||+|+||.||+|++.. +++.||||++... ......+.+|+.+++.+. +||||+
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECC---CCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 33445567899999999999999999999876 7889999998642 223456788999999995 499999
Q ss_pred EEeeeEecCCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC-----
Q 007498 215 KFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG----- 288 (601)
Q Consensus 215 ~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~----- 288 (601)
++++++...+.+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence 9999999999999999999 889999887653 359999999999999999999999999999999999999531
Q ss_pred -----------------CCCCCeEEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCC
Q 007498 289 -----------------RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGS 350 (601)
Q Consensus 289 -----------------~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~ 350 (601)
..++.+||+|||+|..... .....+||+.|+|||++. ..++.++|||||||++|+|++|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 1267899999999976443 334578999999999876 57999999999999999999999
Q ss_pred CCCCCCChhHHHHHHHccCCCCCCC---------------------CCC---------------------CCCHHHHHHH
Q 007498 351 RPFWARTESGIFRAVLRSDPNFDDL---------------------PWP---------------------SVSPEAKDFV 388 (601)
Q Consensus 351 ~pf~~~~~~~~~~~i~~~~~~~~~~---------------------~~~---------------------~~s~~~~~li 388 (601)
.||.+....+.+..+......++.. .|+ ..++++.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 9999888777766665433222210 011 1247788999
Q ss_pred HHcccccccCCCCHHHHHcCcccC
Q 007498 389 KRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 389 ~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
.+||+.||++|||+.|+|+||||+
T Consensus 337 ~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999996
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=387.31 Aligned_cols=264 Identities=36% Similarity=0.676 Sum_probs=224.6
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch---hhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
..+|++++.||+|+||.||+|++.. +++.||+|++........ ...+.+.+|+.+++++. ||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 79 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFEN 79 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC---CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecC
Confidence 3579999999999999999999876 788999999976543321 23678999999999996 9999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC-CCCCeEEeeccc
Q 007498 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR-DDADMRLIDFGL 301 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~-~~~~vkl~DFG~ 301 (601)
...+|+||||+++++|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.+. ....+||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999999988654 5799999999999999999999999999999999999996421 123799999999
Q ss_pred ccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 302 SDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 302 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......+....+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 159 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp CEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred ceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence 98776655556678999999999886 57899999999999999999999999998888888877766655544334578
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+..+.+||.+||..||++||++.|+|+||||+..
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9999999999999999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=406.90 Aligned_cols=264 Identities=29% Similarity=0.486 Sum_probs=209.9
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++++.||+|+||.||+|+++. +++.||||++.... ........+.+|+.+|+.++ ||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRMF-EDLIDCKRILREITILNRLK-SDYIIRLYDLIIPD 97 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecC
Confidence 456789999999999999999999876 78999999997542 34445678899999999996 99999999999766
Q ss_pred -----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 224 -----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..+||||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~~kL~D 172 (432)
T 3n9x_A 98 DLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN---QDCSVKVCD 172 (432)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECC
T ss_pred CCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC---CCCCEEEcc
Confidence 57999999996 499887754 46799999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCC-----------------------Cccccccccccccchhc-c-CCCCChhhHHHHHHHHHHHHhC----
Q 007498 299 FGLSDFIRPDE-----------------------RLNDIVGSAYYVAPEVL-H-RSYSLEADIWSIGVISYILLCG---- 349 (601)
Q Consensus 299 FG~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~DvwSlG~il~ell~g---- 349 (601)
||+|+...... .....+||++|+|||++ . ..|+.++|||||||++|||++|
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 99998764332 23567899999999985 3 4699999999999999999984
Q ss_pred -------CCCCCCCC-----------------hhHHHHHHHc-----------------------cCCCCCCC----CCC
Q 007498 350 -------SRPFWART-----------------ESGIFRAVLR-----------------------SDPNFDDL----PWP 378 (601)
Q Consensus 350 -------~~pf~~~~-----------------~~~~~~~i~~-----------------------~~~~~~~~----~~~ 378 (601)
.++|.+.. ..+.+..+.. ..+..... .++
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 44443332 1122222211 11111111 135
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
.+++++.+||.+||..||.+|||++|+|+||||++...+
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 689999999999999999999999999999999876443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=391.23 Aligned_cols=262 Identities=27% Similarity=0.466 Sum_probs=213.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|++.. +++.||||++.... ......+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCC---CCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeE
Confidence 579999999999999999999876 78899999986653 23334567889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|||||++++|.+++ ...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 78 ~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 78 HLVFEYCDHTVLHELD-RYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EEEEECCSEEHHHHHH-HTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred EEEEEeCCCchHHHHH-hhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc---CCCCEEEeeCCCchhcc
Confidence 9999999998877655 4456799999999999999999999999999999999999995 47899999999998765
Q ss_pred CC-CCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC-------------
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP------------- 370 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------- 370 (601)
.. ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 154 GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred CcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 33 3345668999999999875 4689999999999999999999999998877766555432111
Q ss_pred ------CCCCC--------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 371 ------NFDDL--------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 371 ------~~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
..+.. .++.++.++.+||.+||..||.+|||++|+|+||||++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 01100 124689999999999999999999999999999999986543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=385.73 Aligned_cols=262 Identities=29% Similarity=0.503 Sum_probs=230.6
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
...+|.+++.||+|+||.||+|++.. +++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDND 88 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred cccceEEEEEEeecCCEEEEEEEECC---CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCC
Confidence 34689999999999999999999876 78899999998766555556788999999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|+||||+++++|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEE
T ss_pred EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc---CCCCEEEEeccCcee
Confidence 999999999999999877654 5799999999999999999999999999999999999995 478999999999987
Q ss_pred cCCC-CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 305 IRPD-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 305 ~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
.... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||......+.+..+......++ ..+++
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 240 (294)
T 2rku_A 165 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINP 240 (294)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCH
T ss_pred cccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCH
Confidence 6532 3344568999999999986 4689999999999999999999999998888777777776655443 36899
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPV 418 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 418 (601)
.+.+||.+||..||++|||+.|+++||||++...+.
T Consensus 241 ~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 999999999999999999999999999998876544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=399.87 Aligned_cols=260 Identities=26% Similarity=0.495 Sum_probs=213.7
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++++.||+|+||.||+|+++. +++.||||++.... ......+.+.+|+.+|+.++ ||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPD 96 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSC
T ss_pred eecceEEEeEEeeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecC
Confidence 345689999999999999999999876 78899999986543 23345677899999999996 99999999999765
Q ss_pred C------cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 224 N------NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 224 ~------~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
. .+||||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~ 170 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKIL 170 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEEC
T ss_pred CccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc---CCCCEEEE
Confidence 3 469999999 7799888765 4799999999999999999999999999999999999995 47899999
Q ss_pred ecccccccCCCCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC----
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN---- 371 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---- 371 (601)
|||+++.... .....+||++|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 171 Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 171 DFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp CCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999987543 345678999999999875 46999999999999999999999999988877776666542111
Q ss_pred -------------------CCCC----CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 372 -------------------FDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 372 -------------------~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
.... .++.+++++.+||.+||..||.+|||+.|+|+||||++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 1111 13467999999999999999999999999999999987543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=412.90 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=211.7
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
....+|++++.||+|+||.||+|++.. + ..||+|++...... ..+|+++++.++ ||||++++++|...
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~---~-~~~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVE---S-DEVAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETT---T-EEEEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEEEE
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECC---C-CeEEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEEEEec
Confidence 345689999999999999999999864 3 34888888654322 237999999996 99999999998654
Q ss_pred C------cEEEEEeecCCCchHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCe
Q 007498 224 N------NVYIVMELCEGGELLDRIL---ARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294 (601)
Q Consensus 224 ~------~~~lv~e~~~~g~L~~~~~---~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~v 294 (601)
+ .+|||||||++ +++..+. .....+++..++.++.||+.||.|||++||+||||||+|||++. .++.+
T Consensus 105 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~~ 181 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PSGVL 181 (394)
T ss_dssp SSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEE
T ss_pred CCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC--CCCcE
Confidence 3 38999999987 4544443 23567999999999999999999999999999999999999962 47899
Q ss_pred EEeecccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC---
Q 007498 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--- 369 (601)
Q Consensus 295 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--- 369 (601)
||+|||+|+.+.........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.+..+.+..+.+..
T Consensus 182 kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp EECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999988766666667889999999998753 58999999999999999999999999988777766665421
Q ss_pred --------------CCCCCC--------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 370 --------------PNFDDL--------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 370 --------------~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
..++.. ..+.+++++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 111111 1234889999999999999999999999999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=385.42 Aligned_cols=257 Identities=27% Similarity=0.600 Sum_probs=226.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||+|++.. +++.||||++.............+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRI 89 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred hhceeeheecCCCCeEEEEEEEcC---CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEE
Confidence 479999999999999999999876 77899999997654433334577899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECS
T ss_pred EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc---CCCCEEEecccccccCc
Confidence 9999999999999988765 5799999999999999999999999999999999999995 47899999999997654
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.. .....+||+.|+|||++. ..++.++|||||||++|+|++|..||......+....+......++ +.++.++.
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 240 (284)
T 2vgo_A 166 SL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSK 240 (284)
T ss_dssp SS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHH
T ss_pred cc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHH
Confidence 32 334568999999999886 4689999999999999999999999998888888888877665544 36899999
Q ss_pred HHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+||.+||..||.+||++.++++||||+....
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 9999999999999999999999999986543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=397.95 Aligned_cols=264 Identities=37% Similarity=0.618 Sum_probs=216.5
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHHhcCCCCeeEEee
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-----TAISIEDVRREVKILKALSGHKHLVKFCD 218 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~l~~ 218 (601)
.+..+|++.+.||+|+||.||+|+++. +++.||||++...... .......+.+|+.+++++. ||||+++++
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~ 82 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKN 82 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcC---CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEee
Confidence 345689999999999999999999876 7889999999764322 1122345789999999996 999999999
Q ss_pred eEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 219 ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 219 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
++.... +|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+||+|
T Consensus 83 ~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 83 FFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp EEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred EEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 987655 8999999999999987754 46799999999999999999999999999999999999997544455699999
Q ss_pred cccccccCCCCCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHccCCCCC
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNFD 373 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~ 373 (601)
||++............+||+.|+|||++. ..++.++|||||||++|+|++|..||...... .....+......+.
T Consensus 161 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 161 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp CTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred CccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 99998776544445678999999999862 46899999999999999999999999765443 34444444444333
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
...+..++.++.+||.+||..||.+||++.++|+||||++
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 3334578999999999999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=382.81 Aligned_cols=258 Identities=35% Similarity=0.602 Sum_probs=216.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||++++.. +++.||||++...........+.+.+|+.+++.++ ||||+++++++...+.
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQL---TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTD 85 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred eccEEEEeeecCCCCeEEEEEEECC---CCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCe
Confidence 3589999999999999999999875 78899999997654333345678899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC---TTSCEEECCCCGGGCC
T ss_pred EEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC---CCCCEEEeeccccccc
Confidence 99999999999999988765 5799999999999999999999999999999999999995 4789999999999877
Q ss_pred CCCCCccccccccccccchhccCC-C-CChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPDERLNDIVGSAYYVAPEVLHRS-Y-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.........+||+.|+|||++.+. + +.++|||||||++|+|++|..||........+..+......++ ..++.+
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 237 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRS 237 (276)
T ss_dssp CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHH
Confidence 665555667899999999998753 3 6899999999999999999999988887777777776654443 357899
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
+.+||.+||..||.+|||+.|+++||||++..
T Consensus 238 l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 99999999999999999999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=401.62 Aligned_cols=259 Identities=26% Similarity=0.482 Sum_probs=213.7
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcC-CCCeeEEeeeEecCC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG-HKHLVKFCDACEDVN 224 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~ 224 (601)
...|++++.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.+|++|.. |||||++++++...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEccCCCeEEEEEEcC----CCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 346999999999999999999875 477899999976543 33456789999999999973 699999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+||||| +.+++|.+++... ..+++.+++.|+.||+.||.|||++||+||||||+|||+. ++.+||+|||+++.
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQ 203 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCC
T ss_pred EEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCcccc
Confidence 9999999 5578999988765 5799999999999999999999999999999999999994 57899999999987
Q ss_pred cCCCC---CccccccccccccchhccC------------CCCChhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHcc
Q 007498 305 IRPDE---RLNDIVGSAYYVAPEVLHR------------SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRS 368 (601)
Q Consensus 305 ~~~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~ 368 (601)
+.... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||..... ...+..+...
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 65432 2345789999999998753 589999999999999999999999987543 3455555554
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 369 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
...+... ...+.++.+||.+||..||.+||++.|+|+||||+....+
T Consensus 284 ~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 284 NHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp TSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred cccCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence 3333221 2457899999999999999999999999999999876543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=396.49 Aligned_cols=263 Identities=26% Similarity=0.442 Sum_probs=219.9
Q ss_pred cccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 143 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
..+..+|++++.||+|+||.||+|++.. +++.||||++.............+.+|+.+++++. ||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 83 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEA 83 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEE
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECC---CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeec
Confidence 3456789999999999999999999876 78899999998765555556678899999999996 9999999999876
Q ss_pred CCc----EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 223 VNN----VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 223 ~~~----~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
... +|||||||+|++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~D 159 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA---TNAVKVMD 159 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TSCEEECC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcC---CCCEEEee
Confidence 543 49999999999999988655 57999999999999999999999999999999999999964 78899999
Q ss_pred cccccccCCCC----Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCC
Q 007498 299 FGLSDFIRPDE----RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373 (601)
Q Consensus 299 FG~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 373 (601)
||++..+.... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+.......+
T Consensus 160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239 (311)
T ss_dssp CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH
T ss_pred ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc
Confidence 99998764332 223467999999999886 4689999999999999999999999998888777777776655444
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
...+..+++++.+||.+||..||.+||++.++|.|+|++.
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 3334578999999999999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=406.90 Aligned_cols=266 Identities=27% Similarity=0.470 Sum_probs=200.7
Q ss_pred cCCCeEE-cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe--
Q 007498 145 FGAKYEL-GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE-- 221 (601)
Q Consensus 145 ~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-- 221 (601)
+...|++ +++||+|+||.||+|+++... +++.||||++..... ...+.+|+.+|++|+ |||||++++++.
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSH 90 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSS-CCCCEEEEECSSSSC-----CHHHHHHHHHHHHCC-CTTBCCCCEEEEET
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCC-CCeEEEEEEECCCCC-----CHHHHHHHHHHHhcC-CCCeeeEeeEEecC
Confidence 4456887 568999999999999976322 578999999865432 245789999999996 999999999995
Q ss_pred cCCcEEEEEeecCCCchHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC-CCCC
Q 007498 222 DVNNVYIVMELCEGGELLDRILAR--------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG-RDDA 292 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~--------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~-~~~~ 292 (601)
....+||||||+.+ +|.+.+... ...+++..++.|+.||+.||.|||++||+||||||+|||+... +.++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 46789999999975 888877532 1249999999999999999999999999999999999999542 3578
Q ss_pred CeEEeecccccccCCC----CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCh--------
Q 007498 293 DMRLIDFGLSDFIRPD----ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTE-------- 358 (601)
Q Consensus 293 ~vkl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~-------- 358 (601)
.+||+|||+|+.+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 9999999999876532 23345789999999998864 589999999999999999999999976554
Q ss_pred -hHHHHHHHccCCCCCCCCCC----------------------------------CCCHHHHHHHHHcccccccCCCCHH
Q 007498 359 -SGIFRAVLRSDPNFDDLPWP----------------------------------SVSPEAKDFVKRLLNKDYRKRMTAV 403 (601)
Q Consensus 359 -~~~~~~i~~~~~~~~~~~~~----------------------------------~~s~~~~~li~~~L~~dP~~R~s~~ 403 (601)
.+.+..+...........|. ..++++.+||.+||..||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 24444444332222222222 1278899999999999999999999
Q ss_pred HHHcCcccCCCCCCC
Q 007498 404 QALTHPWLRDDSRPV 418 (601)
Q Consensus 404 ell~hp~f~~~~~~~ 418 (601)
|+|+||||++.+.+.
T Consensus 330 e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 330 QAMQDPYFLEDPLPT 344 (405)
T ss_dssp HHHTSGGGTSSSCCC
T ss_pred HHhcChhhccCCCCc
Confidence 999999999876553
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=381.51 Aligned_cols=259 Identities=21% Similarity=0.361 Sum_probs=216.6
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec---
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--- 222 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--- 222 (601)
+..|++.+.||+|+||.||+|.+.. ++..||+|++...... ....+.+.+|+.++++++ ||||+++++++..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK 99 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESS
T ss_pred ceeEEeeeeccCCCCeEEEEeEecC---CceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccC
Confidence 4569999999999999999999876 7889999999765443 345678899999999996 9999999998865
Q ss_pred -CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCceEeecCCCCCCeEEeec
Q 007498 223 -VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 223 -~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
...+|+||||+++++|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~~kl~Df 176 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDL 176 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCT
T ss_pred CCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC--CCCCEEEeeC
Confidence 35689999999999999988654 57999999999999999999999999 999999999999952 4789999999
Q ss_pred ccccccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
|++..... ......+||+.|+|||++.+.++.++|||||||++|+|++|+.||.................... .....
T Consensus 177 g~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~ 254 (290)
T 1t4h_A 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-SFDKV 254 (290)
T ss_dssp TGGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG-GGGGC
T ss_pred CCcccccc-cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc-ccCCC
Confidence 99965443 33455689999999999988899999999999999999999999987554444333333222111 11235
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 77999999999999999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=403.66 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=211.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC---
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--- 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--- 223 (601)
.+|++++.||+|+||.||+|+++. +++.||||++...... ..+|+++|+.|+ |||||+++++|...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~~-------~~~E~~il~~l~-hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKRF-------KNRELQIMRKLD-HCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEEEEETT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECC---CCcEEEEEEecccchh-------HHHHHHHHHHcC-CCCccceeeEEeccCCC
Confidence 479999999999999999999876 7889999998654321 247999999996 99999999988532
Q ss_pred ---CcEEEEEeecCCCchHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 224 ---NNVYIVMELCEGGELLDRIL---ARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 224 ---~~~~lv~e~~~~g~L~~~~~---~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
..++|||||+++ +|.+.+. .....+++..++.++.||+.||.|||++||+||||||+|||++. +.+.+||+
T Consensus 123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~~kl~ 199 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLC 199 (420)
T ss_dssp TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET--TTTEEEEC
T ss_pred CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC--CCCeEEec
Confidence 237899999976 6666554 34567999999999999999999999999999999999999963 34678999
Q ss_pred ecccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc-------
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS------- 368 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~------- 368 (601)
|||+++.+.........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....+.+..+++.
T Consensus 200 DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 200 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp CCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999988766655667789999999998753 6999999999999999999999999988877766665541
Q ss_pred -----CCC-----CCCC---C-----CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 369 -----DPN-----FDDL---P-----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 369 -----~~~-----~~~~---~-----~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.+. ++.. + .+.+++++.+||.+||..||.+||++.|+|+||||++.
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 111 1111 1 13568999999999999999999999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=384.00 Aligned_cols=263 Identities=29% Similarity=0.471 Sum_probs=219.6
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
....+|++++.||+|+||.||+|++.. +++.||+|++.... ....+.+.+|+.+++.+. ||||+++++++...
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIETKS---EEELEDYIVEIEILATCD-HPYIVKLLGAYYHD 88 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETT---TCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC
T ss_pred CCccceeecceeccCCCeEEEEEEEcC---CCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeC
Confidence 455689999999999999999999876 78899999986543 224577889999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+.+|+|||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSA 165 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTSCEEECCCHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC---CCCCEEEEECCCCc
Confidence 999999999999999998877667899999999999999999999999999999999999995 47889999999975
Q ss_pred ccCCC-CCccccccccccccchhc------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC
Q 007498 304 FIRPD-ERLNDIVGSAYYVAPEVL------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376 (601)
Q Consensus 304 ~~~~~-~~~~~~~gt~~y~aPE~~------~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 376 (601)
..... ......+||+.|+|||++ ...++.++|||||||++|+|++|..||........+..+......... .
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 244 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL-T 244 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-S
T ss_pred cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccC-C
Confidence 43211 123346799999999987 246899999999999999999999999988877777666655433211 1
Q ss_pred CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
...++.++.+||.+||..||.+|||+.++++||||++....
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 24678999999999999999999999999999999986554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=395.34 Aligned_cols=255 Identities=31% Similarity=0.504 Sum_probs=216.1
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch-----hhHHHHHHHHHHHHHhcCCCCeeEEee
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-----ISIEDVRREVKILKALSGHKHLVKFCD 218 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~ 218 (601)
.+..+|++++.||+|+||.||+|+++. +++.||||++........ .....+.+|+.++++++ ||||+++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~ 96 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKE---KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLD 96 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETT---TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECC---CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence 455689999999999999999999876 789999999987543221 12345678999999996 999999999
Q ss_pred eEecCCcEEEEEeecCCC-chHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 219 ACEDVNNVYIVMELCEGG-ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 219 ~~~~~~~~~lv~e~~~~g-~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
++.+.+.+|+||||+.+| +|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~ 172 (335)
T 3dls_A 97 IFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLI 172 (335)
T ss_dssp EEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEEC
T ss_pred EEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc---CCCcEEEe
Confidence 999999999999999777 88887654 46799999999999999999999999999999999999995 47899999
Q ss_pred ecccccccCCCCCccccccccccccchhccC-CC-CChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCC
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SY-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 375 (601)
|||++............+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..... .......
T Consensus 173 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~---- 242 (335)
T 3dls_A 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIH---- 242 (335)
T ss_dssp CCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCC----
T ss_pred ecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccC----
Confidence 9999988776666677889999999999864 44 8899999999999999999999965322 1111111
Q ss_pred CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 376 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
....+++++.+||.+||..||.+|||+.++|+||||++...
T Consensus 243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 283 (335)
T 3dls_A 243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283 (335)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence 12358999999999999999999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=391.01 Aligned_cols=259 Identities=26% Similarity=0.473 Sum_probs=210.1
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCC-CCeeEEeeeEecCC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLVKFCDACEDVN 224 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~ 224 (601)
+.+|++++.||+|+||.||++.+. +++.||||++..... .....+.+.+|+.+|++|..| +||+++++++....
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT----TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC----CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 457999999999999999999874 578899999976543 334567789999999999722 99999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|||||+ .+++|.+++... +.+++.+++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC
T ss_pred EEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccc
Confidence 99999995 577999988764 6799999999999999999999999999999999999995 57899999999987
Q ss_pred cCCCCC---ccccccccccccchhcc------------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHcc
Q 007498 305 IRPDER---LNDIVGSAYYVAPEVLH------------RSYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRS 368 (601)
Q Consensus 305 ~~~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~ 368 (601)
+..... ....+||+.|+|||++. +.++.++|||||||++|+|++|+.||..... ...+..+...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 654332 34568999999999874 4588999999999999999999999976543 2334444433
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 369 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
...... ....+.++.+||.+||..||.+|||+.|+|+||||+....+
T Consensus 237 ~~~~~~--~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 283 (343)
T 3dbq_A 237 NHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283 (343)
T ss_dssp TSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred CcccCC--cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence 222211 13467899999999999999999999999999999876544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=399.66 Aligned_cols=260 Identities=31% Similarity=0.529 Sum_probs=218.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc-chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+|++++.||+|+||.||+|++..+..+++.||||++++.... .....+.+.+|+.+++.+.+||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4799999999999999999998654457899999999764321 112334567899999999669999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCcEEEeeCCCCeec
Confidence 99999999999999988765 5799999999999999999999999999999999999995 4789999999999865
Q ss_pred CCCC--CccccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHccCCCCCCCC
Q 007498 306 RPDE--RLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAVLRSDPNFDDLP 376 (601)
Q Consensus 306 ~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~ 376 (601)
.... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.... ...+...+....+.++
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 286 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--- 286 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC---
Confidence 4322 2345689999999999863 47899999999999999999999997532 3444555555544443
Q ss_pred CCCCCHHHHHHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
..++..+.+||.+||..||.+|| ++.|+++||||+..
T Consensus 287 -~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 287 -QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred -cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 46899999999999999999999 99999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=386.79 Aligned_cols=255 Identities=28% Similarity=0.550 Sum_probs=212.4
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--C
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--V 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~ 223 (601)
..+|++++.||+|+||.||+|++.. +++.||||++... ..+.+.+|+.++++|.+||||+++++++.+ .
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCceEEEEEecccCCeEEEEEEECC---CCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 3579999999999999999999876 7889999998643 236788999999999779999999999987 6
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
...++||||+.+++|.+++. .+++.+++.++.||+.||.|||++||+||||||+|||++. +...+||+|||++.
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAE 179 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCTTCE
T ss_pred CceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--CCCEEEEEeCCCce
Confidence 77999999999999987652 4999999999999999999999999999999999999964 23489999999998
Q ss_pred ccCCCCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHH-------------c
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVL-------------R 367 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~-------------~ 367 (601)
...........+||..|+|||++. ..++.++|||||||++|+|++|+.||.... ..+.+..+. .
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 180 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred EcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 877666667788999999999875 468999999999999999999999995432 322222221 1
Q ss_pred cCCCC--------------------CCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 368 SDPNF--------------------DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 368 ~~~~~--------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
....+ .......+++++.+||.+||..||.+|||++|+|+||||++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 11111 0011123799999999999999999999999999999998753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=398.80 Aligned_cols=254 Identities=27% Similarity=0.471 Sum_probs=213.3
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec---
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--- 222 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--- 222 (601)
..+|++++.||+|+||.||+|++.. +++.||||++...... ..+|+.+|+.++ |||||+++++|..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~~~-------~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRY-------KNRELDIMKVLD-HVNIIKLVDYFYTTGD 74 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETT---TCCEEEEEEEECCTTS-------CCHHHHHHTTCC-CTTBCCEEEEEEEC--
T ss_pred cceEEEEEEEEeccCEEEEEEEECC---CCCEEEEEEEecCcch-------HHHHHHHHHHcC-CCCccchhheeeecCc
Confidence 4589999999999999999999876 7899999998654322 237999999996 9999999999843
Q ss_pred -----------------------------------CCcEEEEEeecCCCchHHHHH---HcCCCCCHHHHHHHHHHHHHH
Q 007498 223 -----------------------------------VNNVYIVMELCEGGELLDRIL---ARGGRYTEEDAKAIVVQILSV 264 (601)
Q Consensus 223 -----------------------------------~~~~~lv~e~~~~g~L~~~~~---~~~~~l~~~~~~~i~~ql~~~ 264 (601)
...+|||||||++ +|.+.+. .....+++..++.++.||+.|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp -----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 3348999999985 8776665 345689999999999999999
Q ss_pred HHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHH
Q 007498 265 VAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVI 342 (601)
Q Consensus 265 L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~i 342 (601)
|.|||++||+||||||+|||++. .++.+||+|||+|+.+.........+||+.|+|||++.+ .|+.++|||||||+
T Consensus 154 L~~LH~~gi~H~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 154 VGFIHSLGICHRDIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHHHTTTEECSCCCGGGEEEET--TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHHHCcCccCccCHHHEEEcC--CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999999999999999999963 477899999999988776666677889999999998764 58999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHccC------------C-----CCCCC---C-----CCCCCHHHHHHHHHccccccc
Q 007498 343 SYILLCGSRPFWARTESGIFRAVLRSD------------P-----NFDDL---P-----WPSVSPEAKDFVKRLLNKDYR 397 (601)
Q Consensus 343 l~ell~g~~pf~~~~~~~~~~~i~~~~------------~-----~~~~~---~-----~~~~s~~~~~li~~~L~~dP~ 397 (601)
+|||++|+.||.+....+.+..++... + .++.. . ...+++++.+||.+||..||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999999988877776665421 1 11111 0 124789999999999999999
Q ss_pred CCCCHHHHHcCcccCC
Q 007498 398 KRMTAVQALTHPWLRD 413 (601)
Q Consensus 398 ~R~s~~ell~hp~f~~ 413 (601)
+|||+.|+|+||||++
T Consensus 312 ~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDH 327 (383)
T ss_dssp GSCCHHHHHTSGGGHH
T ss_pred hCCCHHHHhcCHHHHH
Confidence 9999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=397.76 Aligned_cols=258 Identities=27% Similarity=0.472 Sum_probs=205.5
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+..+|++++.||+|+||.||+|++.. +++.||||++.... ........+.+|+.+++.+. ||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK 97 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECC---CCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeecccc
Confidence 34689999999999999999999876 78899999997643 23345577889999999996 999999999997654
Q ss_pred ------cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 225 ------NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 225 ------~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
.+|||||||++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~D 170 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 170 (371)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECC
T ss_pred ccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEEE
Confidence 78999999975 7887764 3599999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC------
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN------ 371 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------ 371 (601)
||+++...........+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 171 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp CCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred eecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99998776554556678999999999886 46899999999999999999999999998887777776653221
Q ss_pred ----------------CCCCC---------CCC-------CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 372 ----------------FDDLP---------WPS-------VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 372 ----------------~~~~~---------~~~-------~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+.... ++. .+.++++||.+||..||++|||++|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 11000 000 15689999999999999999999999999999764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=377.17 Aligned_cols=260 Identities=20% Similarity=0.317 Sum_probs=213.1
Q ss_pred cccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 143 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
..+..+|++++.||+|+||.||+|++.. +++.||||++....... .....+.+|+.++..+.+||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRL---DGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAE 82 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcC---CCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 4456789999999999999999999876 78899999997654333 2456788999999999559999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC----------
Q 007498 223 VNNVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR---------- 289 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~---~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~---------- 289 (601)
.+.+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+.
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 99999999999999999988653 25799999999999999999999999999999999999996421
Q ss_pred ------CCCCeEEeecccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 007498 290 ------DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGI 361 (601)
Q Consensus 290 ------~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~ 361 (601)
....+||+|||++...... ....||+.|+|||++.+ .++.++|||||||++|+|++|.+++.... .
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~ 236 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---Q 236 (289)
T ss_dssp -------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---H
T ss_pred cccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---H
Confidence 3557999999999876543 23469999999999864 45679999999999999999998875432 2
Q ss_pred HHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 362 FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 362 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
...+..... +.. ...+++++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 237 ~~~~~~~~~--~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 237 WHEIRQGRL--PRI-PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHHTTCC--CCC-SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHHHHcCCC--CCC-CcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 334443322 111 146899999999999999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=397.47 Aligned_cols=260 Identities=29% Similarity=0.535 Sum_probs=201.8
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++++.||+|+||.||+|++.. +++.||||++.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA 100 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETT---TTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence 445789999999999999999999876 78999999986543 23345677889999999996 99999999998654
Q ss_pred ------CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 224 ------NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 224 ------~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kL~ 174 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKIL 174 (367)
T ss_dssp SSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEEC
T ss_pred CccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC---CCCCEEEe
Confidence 5689999999 6799887754 5799999999999999999999999999999999999995 47899999
Q ss_pred ecccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC-----
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP----- 370 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----- 370 (601)
|||+++.... .....+||++|+|||++.+ .|+.++|||||||++|||++|+.||.+.+..+.+..+.+...
T Consensus 175 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 175 DFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp C-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999976543 2445789999999998764 689999999999999999999999998887777666654211
Q ss_pred ------------------CCCCCC----CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 371 ------------------NFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 371 ------------------~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
..+... ++.+++++.+||.+||..||.+|||+.|+|+||||++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 111111 2457899999999999999999999999999999987644
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=402.54 Aligned_cols=260 Identities=28% Similarity=0.426 Sum_probs=215.2
Q ss_pred cccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc-----CCCCeeEEe
Q 007498 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-----GHKHLVKFC 217 (601)
Q Consensus 143 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~l~ 217 (601)
..+..+|++++.||+|+||.||+|++.. +++.||||++.... .....+.+|+.+++.++ +|+||++++
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~---~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETT---TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECC---CCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 3456789999999999999999999876 78899999996532 23466788999999884 477999999
Q ss_pred eeEecCCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCC--e
Q 007498 218 DACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD--M 294 (601)
Q Consensus 218 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~--v 294 (601)
+++.....+||||||+. ++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++. ++. +
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~---~~~~~v 241 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ---QGRSGI 241 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESS---TTSCCE
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcc---CCCcce
Confidence 99999999999999996 58999887653 45999999999999999999999999999999999999964 444 9
Q ss_pred EEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCC
Q 007498 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD 373 (601)
Q Consensus 295 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 373 (601)
||+|||+|+.... .....+||+.|+|||++. ..|+.++|||||||++|||++|..||.+....+.+..+.......+
T Consensus 242 kL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 242 KVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp EECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EEeecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999999976532 345678999999999876 4699999999999999999999999999888777666553211000
Q ss_pred C--------------------------------------------------CC-----CCCCCHHHHHHHHHcccccccC
Q 007498 374 D--------------------------------------------------LP-----WPSVSPEAKDFVKRLLNKDYRK 398 (601)
Q Consensus 374 ~--------------------------------------------------~~-----~~~~s~~~~~li~~~L~~dP~~ 398 (601)
. .. ....++++.+||++||+.||++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 0 00 0123788999999999999999
Q ss_pred CCCHHHHHcCcccCCCC
Q 007498 399 RMTAVQALTHPWLRDDS 415 (601)
Q Consensus 399 R~s~~ell~hp~f~~~~ 415 (601)
|||+.|+|+||||+...
T Consensus 400 Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 400 RMTPGQALRHPWLRRRL 416 (429)
T ss_dssp SCCHHHHHTSTTTC---
T ss_pred CCCHHHHhCChhhccCC
Confidence 99999999999999763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=391.76 Aligned_cols=255 Identities=30% Similarity=0.463 Sum_probs=205.7
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+..+|++++.||+|+||.||+|+++. +++.||||++.... .....+.+.+|+.+|++|+ |||||+++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKV---DDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETT---TCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECC
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcC---CCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEec
Confidence 34579999999999999999999876 78899999997643 2234578999999999996 999999999986543
Q ss_pred ---------------------------------------------------------cEEEEEeecCCCchHHHHHHcC-
Q 007498 225 ---------------------------------------------------------NVYIVMELCEGGELLDRILARG- 246 (601)
Q Consensus 225 ---------------------------------------------------------~~~lv~e~~~~g~L~~~~~~~~- 246 (601)
.+|+|||||++++|.+++....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 3899999999999999887542
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCC-------------Ccc
Q 007498 247 -GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-------------RLN 312 (601)
Q Consensus 247 -~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-------------~~~ 312 (601)
...++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....... ...
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEECSCC--------------CCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe---CCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 2356677999999999999999999999999999999995 47899999999998765432 224
Q ss_pred ccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHc
Q 007498 313 DIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRL 391 (601)
Q Consensus 313 ~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 391 (601)
..+||+.|+|||++. ..++.++|||||||++|+|++|..|+.. .......+.... ++. .+...++++.+||.+|
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~--~~~-~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLK--FPL-LFTQKYPQEHMMVQDM 309 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC--CCH-HHHHHCHHHHHHHHHH
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC--CCc-ccccCChhHHHHHHHH
Confidence 467999999999886 5789999999999999999998777521 122222222221 111 1234678899999999
Q ss_pred ccccccCCCCHHHHHcCcccCC
Q 007498 392 LNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 392 L~~dP~~R~s~~ell~hp~f~~ 413 (601)
|..||.+|||+.|+|+||||++
T Consensus 310 l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 310 LSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccCCCCcCCCHHHHhhchhhhc
Confidence 9999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=383.03 Aligned_cols=261 Identities=28% Similarity=0.516 Sum_probs=215.1
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED- 222 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~- 222 (601)
....+|++++.||+|+||.||+|++.. +++.||||++..... ..+.+.+|+.+++++.+||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECC---CCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 345689999999999999999999876 788999999865432 236788999999999569999999999976
Q ss_pred -----CCcEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEE
Q 007498 223 -----VNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296 (601)
Q Consensus 223 -----~~~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl 296 (601)
...+||||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~---~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc---CCCCEEE
Confidence 46899999999999999988764 35799999999999999999999999999999999999995 4789999
Q ss_pred eecccccccCCC-CCccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC
Q 007498 297 IDFGLSDFIRPD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369 (601)
Q Consensus 297 ~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 369 (601)
+|||++...... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||........+..+....
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 999999776433 2234568999999999874 458999999999999999999999998877766666555443
Q ss_pred CCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
.. ......++..+.+||.+||..||.+||++.++++||||++.+.
T Consensus 251 ~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 251 AP--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp CC--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred cc--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 22 2223568999999999999999999999999999999987643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=379.22 Aligned_cols=259 Identities=26% Similarity=0.475 Sum_probs=223.7
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
...|++++.||+|+||.||+|++.. +++.||||++...... ...+.+.+|+.+++.+. ||||+++++++.+...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 94 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTK 94 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECC---CCcEEEEEEecccccH--HHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCe
Confidence 3579999999999999999999875 7889999999765432 24678999999999995 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 95 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQL 169 (303)
T ss_dssp EEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC---CCCCEEEeecccceec
Confidence 9999999999999987743 5799999999999999999999999999999999999995 4789999999999876
Q ss_pred CCCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
.... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||...........+........ ...++..
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 246 (303)
T 3a7i_A 170 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL---EGNYSKP 246 (303)
T ss_dssp BTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---CSSCCHH
T ss_pred CccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC---ccccCHH
Confidence 5433 234568999999999986 5689999999999999999999999988877776666655443221 2468999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCCCCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPV 418 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 418 (601)
+.+||.+||..||.+|||+.++++||||.......
T Consensus 247 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 281 (303)
T 3a7i_A 247 LKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281 (303)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCG
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCcc
Confidence 99999999999999999999999999997765443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=392.71 Aligned_cols=261 Identities=29% Similarity=0.512 Sum_probs=218.0
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++++.||+|+||.||+|++.. +++.||||++.... .......+.+|+++++++. ||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAP 97 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCS
T ss_pred cccccEEEEEEeecCCCeEEEEEEECC---CCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecC
Confidence 345689999999999999999999876 78899999986532 3334577899999999996 99999999998754
Q ss_pred -----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 224 -----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..+|+||||+.+ +|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 98 ~~~~~~~~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~D 171 (364)
T 3qyz_A 98 TIEQMKDVYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICD 171 (364)
T ss_dssp STTTCCCEEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECC
T ss_pred CccccceEEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC---CCCCEEEEe
Confidence 468999999975 89988765 4699999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCCC----ccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCC
Q 007498 299 FGLSDFIRPDER----LNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF 372 (601)
Q Consensus 299 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 372 (601)
||++........ ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+.......
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999987643322 34568999999999864 358999999999999999999999999888777766664321110
Q ss_pred -----------------------CCCC----CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 373 -----------------------DDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 373 -----------------------~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
...+ ++.+++++.+||.+||..||.+|||+.|+|+||||++...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 1111 2467899999999999999999999999999999987643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=380.65 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=216.9
Q ss_pred cccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 143 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
..+..+|++++.||+|+||.||+|++.. +++.||||++...........+.+.+|+.++++++ ||||+++++++..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTI---LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEE 82 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETT---TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEEC
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECC---CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeee
Confidence 3456789999999999999999999876 78899999997765555566788999999999996 9999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
.+.+|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIA 158 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCSSS
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEEeCCCc
Confidence 99999999999999999988765 5799999999999999999999999999999999999995 4789999999999
Q ss_pred cccCCCC--Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC-CCCCCCCC
Q 007498 303 DFIRPDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP-NFDDLPWP 378 (601)
Q Consensus 303 ~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~ 378 (601)
....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+............... .......+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRK 238 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCT
T ss_pred cccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhccc
Confidence 8765432 234467999999999876 4689999999999999999999999998877666555554432 21112235
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
.+++.+.++|.+||..||.+||+..+.+.+.|..
T Consensus 239 ~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 239 DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 7899999999999999999999666666666643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=392.06 Aligned_cols=259 Identities=27% Similarity=0.468 Sum_probs=213.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|++.. +++.||||++..... .....+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRW 99 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETT---TCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred hhheeeeEEeecCCEEEEEEEECC---CCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEE
Confidence 479999999999999999999876 788999999866542 3334566889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.++ ....+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+.
T Consensus 100 ~lv~e~~~~~~l~~~-~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 100 YLVFEFVDHTILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EEEEECCSEEHHHHH-HHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCTTC----
T ss_pred EEEEecCCcchHHHH-HhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc---CCCcEEEEeCCCceeec
Confidence 999999998777665 44456799999999999999999999999999999999999995 47899999999997664
Q ss_pred CC-CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC------------
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN------------ 371 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------ 371 (601)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+......
T Consensus 176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 33 33455689999999998864 5899999999999999999999999988876666555421110
Q ss_pred -------CCCC--------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 372 -------FDDL--------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 372 -------~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.+.. .++.+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 1100 124679999999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=388.01 Aligned_cols=260 Identities=22% Similarity=0.373 Sum_probs=213.9
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+..+|++.+.||+|+||.||+|++.. +++.||||++....... ..+.+.+|++++++++ ||||+++++++....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLN-HKNIVKLFAIEEETT 80 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCC-CTTBCCEEEEEECTT
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECC---CCcEEEEEEeccccccc--hHHHHHHHHHHHHhcC-CCCcceEEEEeecCC
Confidence 45689999999999999999999876 78899999997644322 3567789999999996 999999999988655
Q ss_pred --cEEEEEeecCCCchHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec-CCCCCCeEEeec
Q 007498 225 --NVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDF 299 (601)
Q Consensus 225 --~~~lv~e~~~~g~L~~~~~~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~-~~~~~~vkl~DF 299 (601)
.+|||||||++++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+.. ++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 7899999999999999887543 23999999999999999999999999999999999999843 234567999999
Q ss_pred ccccccCCCCCccccccccccccchhcc---------CCCCChhhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHH
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH---------RSYSLEADIWSIGVISYILLCGSRPFWART----ESGIFRAVL 366 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DvwSlG~il~ell~g~~pf~~~~----~~~~~~~i~ 366 (601)
|+++...........+||+.|+|||++. ..++.++|||||||++|||++|+.||.... ..+.+..+.
T Consensus 161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 9998887666667788999999999874 568999999999999999999999996432 234455555
Q ss_pred ccCCC-------------------CCCC--CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcc
Q 007498 367 RSDPN-------------------FDDL--PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410 (601)
Q Consensus 367 ~~~~~-------------------~~~~--~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~ 410 (601)
...+. ++.. ....++..+.+||++||+.||++|||++|+|+||=
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 44331 1100 01124568899999999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=387.39 Aligned_cols=258 Identities=37% Similarity=0.637 Sum_probs=188.7
Q ss_pred cCCCeEEcc-eeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-
Q 007498 145 FGAKYELGK-EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED- 222 (601)
Q Consensus 145 ~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~- 222 (601)
+..+|++.+ .||+|+||.||+|+++. +++.||||++.... ...+|+..+.++.+||||+++++++..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRR---TGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECC---CCCEEEEEEecCcH--------HHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 456799965 69999999999999986 78899999986531 223444444344469999999999876
Q ss_pred ---CCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 223 ---VNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 223 ---~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
...+|||||||+||+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 456899999999999999887653 3699999999999999999999999999999999999997645567799999
Q ss_pred cccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHH----HHHHHccCCCCC
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGI----FRAVLRSDPNFD 373 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~ 373 (601)
||++..... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||........ ...+......++
T Consensus 175 fg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3fhr_A 175 FGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253 (336)
T ss_dssp CTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred cccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence 999976543 2345568999999999986 5689999999999999999999999976654433 223333344455
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
...|..+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 55567899999999999999999999999999999999865
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=380.00 Aligned_cols=264 Identities=27% Similarity=0.459 Sum_probs=219.0
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.....|++++.||+|+||.||+|++.. +++.||||++.... ..+.+.+|+.+++.+. ||||+++++++...
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 96 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFKN 96 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETT---TCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEET
T ss_pred cchhhhhhheeeccCCCeEEEEEEECC---CCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEeC
Confidence 345689999999999999999999875 78899999997543 2356889999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+.+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~ 173 (314)
T 3com_A 97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAG 173 (314)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCE
T ss_pred CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC---CCCCEEEeecccch
Confidence 999999999999999999876677899999999999999999999999999999999999995 47899999999997
Q ss_pred ccCCCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 304 FIRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 304 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+......... ....++
T Consensus 174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 252 (314)
T 3com_A 174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR-KPELWS 252 (314)
T ss_dssp ECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-SGGGSC
T ss_pred hhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccC-CcccCC
Confidence 765432 234568999999999986 46899999999999999999999999887766655555443322111 123578
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCCh
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPL 420 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 420 (601)
.++.+||.+||..||.+|||+.++|+||||++......+
T Consensus 253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~ 291 (314)
T 3com_A 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSIL 291 (314)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGG
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchHH
Confidence 999999999999999999999999999999987654433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=378.42 Aligned_cols=258 Identities=26% Similarity=0.369 Sum_probs=198.5
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||+|++.. +++.||||++..... .......+.++..+++.+ +||||+++++++.+.+.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVP---SGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecC---CCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCC
Confidence 3579999999999999999999876 789999999975432 222233344444456666 49999999999999999
Q ss_pred EEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 226 VYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
+|+||||+++ +|.+.+.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~ 156 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGI 156 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC---TTCCEEBCCC--
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeecCC
Confidence 9999999975 88776643 456899999999999999999999998 999999999999995 478999999999
Q ss_pred ccccCCCCCccccccccccccchhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHccCCCCCCC
Q 007498 302 SDFIRPDERLNDIVGSAYYVAPEVLH-----RSYSLEADIWSIGVISYILLCGSRPFWAR-TESGIFRAVLRSDPNFDDL 375 (601)
Q Consensus 302 a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~ 375 (601)
+.............||+.|+|||++. ..++.++|||||||++|+|++|+.||... .....+......... ..
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~ 234 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP--QL 234 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC--CC
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC--Cc
Confidence 98776655555668999999999862 35899999999999999999999999763 333444444433221 22
Q ss_pred CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 376 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+...+++++.+||.+||..||++|||+.|+++||||+..
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 234689999999999999999999999999999999754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=387.37 Aligned_cols=267 Identities=23% Similarity=0.411 Sum_probs=211.8
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc--------chhhHHHHHHHHHHHHHhcCCCCeeE
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT--------TAISIEDVRREVKILKALSGHKHLVK 215 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~niv~ 215 (601)
.+..+|++++.||+|+||.||+|++. .++.||||++...... .....+.+.+|+.++++++ ||||++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~ 93 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS----EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILG 93 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT----TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCC
T ss_pred HhccceEEeEEeccCCCEEEEEEECC----CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccc
Confidence 34568999999999999999999875 4789999998653322 1223477899999999996 999999
Q ss_pred EeeeEec-----CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC
Q 007498 216 FCDACED-----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 216 l~~~~~~-----~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~ 290 (601)
+++++.. ...+|+||||+. |+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA---D 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---T
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc---C
Confidence 9999843 346899999997 589988887667899999999999999999999999999999999999995 4
Q ss_pred CCCeEEeecccccccCCCCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc
Q 007498 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS 368 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 368 (601)
++.+||+|||++............+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+...
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 249 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249 (362)
T ss_dssp TCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 7889999999998766555556678999999999875 46899999999999999999999999988877766665431
Q ss_pred CC------------------------CCCCCC----CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 369 DP------------------------NFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 369 ~~------------------------~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
.. ..+... .+.+++.+.+||.+||..||.+|||+.|+|+||||++...+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 328 (362)
T 3pg1_A 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD 328 (362)
T ss_dssp HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence 11 111111 2356899999999999999999999999999999998755443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=399.93 Aligned_cols=258 Identities=17% Similarity=0.204 Sum_probs=197.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc-CCCCeeEEe-------e
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-GHKHLVKFC-------D 218 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~l~-------~ 218 (601)
..|++++.||+|+||.||+|++.. +++.||||++...........+.+.+|+.+++.|. +||||++++ +
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVE---RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred eeeeeeeeccCCCCEEEEEEEECC---CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence 359999999999999999999876 78899999998876555556778889977666664 499988865 3
Q ss_pred eEecC-----------------CcEEEEEeecCCCchHHHHHHcCCCCCHHHH------HHHHHHHHHHHHHHHHcCCee
Q 007498 219 ACEDV-----------------NNVYIVMELCEGGELLDRILARGGRYTEEDA------KAIVVQILSVVAFCHLQGVVH 275 (601)
Q Consensus 219 ~~~~~-----------------~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~------~~i~~ql~~~L~~LH~~~iiH 275 (601)
++... ..+|||||||+ |+|.+++...+..+++..+ ..++.||+.||.|||++||+|
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 44332 34899999998 7999998875455665555 677799999999999999999
Q ss_pred ccCCCCceEeecCCCCCCeEEeecccccccCCCCCccccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCC
Q 007498 276 RDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRP 352 (601)
Q Consensus 276 rDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~p 352 (601)
|||||+|||++ .++.+||+|||+|+.... ......||+.|+|||++.+ .|+.++|||||||++|||++|+.|
T Consensus 218 rDikp~NIll~---~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 218 GHFTPDNLFIM---PDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TTCSGGGEEEC---TTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCHHHEEEC---CCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 99999999995 478999999999986642 2224567799999999864 589999999999999999999999
Q ss_pred CCCCChhHH--HHH---HHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 353 FWARTESGI--FRA---VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 353 f~~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
|.+...... +.. .......+....++.+++++.+||.+||..||++|||+.|+|+||||++
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 976633210 000 0111112222223578999999999999999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=392.18 Aligned_cols=262 Identities=25% Similarity=0.425 Sum_probs=216.1
Q ss_pred CcccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCC-----eeEE
Q 007498 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH-----LVKF 216 (601)
Q Consensus 142 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-----iv~l 216 (601)
...+..+|++.+.||+|+||.||+|++.. +++.||||++.... .....+.+|+.+++.+..|++ |+++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcC---CCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 34556789999999999999999999876 78899999996432 235677889999999864664 9999
Q ss_pred eeeEecCCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--HcCCeeccCCCCceEeecCCCCCC
Q 007498 217 CDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCH--LQGVVHRDLKPENFLFTSGRDDAD 293 (601)
Q Consensus 217 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH--~~~iiHrDikp~NIll~~~~~~~~ 293 (601)
++++...+.+||||||+.+ +|.+++.... ..+++..++.++.||+.||.||| +.||+||||||+|||++. +.++.
T Consensus 122 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~ 199 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSA 199 (382)
T ss_dssp EEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCC
T ss_pred eeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCc
Confidence 9999999999999999965 9999887653 56999999999999999999999 579999999999999964 34678
Q ss_pred eEEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCC
Q 007498 294 MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF 372 (601)
Q Consensus 294 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 372 (601)
+||+|||+++.... .....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.+..+.+..+.......
T Consensus 200 ~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp EEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred EEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999999987643 345678999999999886 469999999999999999999999999988877776665421110
Q ss_pred C------------------CCCC-----------------CC-------------------------CCHHHHHHHHHcc
Q 007498 373 D------------------DLPW-----------------PS-------------------------VSPEAKDFVKRLL 392 (601)
Q Consensus 373 ~------------------~~~~-----------------~~-------------------------~s~~~~~li~~~L 392 (601)
+ ...| .. .++++++||.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 0 0000 00 0147899999999
Q ss_pred cccccCCCCHHHHHcCcccCCC
Q 007498 393 NKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 393 ~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+.||++|||+.|+|+||||++.
T Consensus 358 ~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CSCTTTSCCHHHHTTSGGGCC-
T ss_pred CCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=381.44 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=215.2
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++.+.||+|+||.||+++++.....+..||||++.... .....+.+.+|+.++++|+ ||||+++++++.+.+.
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCc
Confidence 457999999999999999999987543355679999997542 3334577899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||++|+|.+++....+.+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC---CCCCEEECCCCccccc
Confidence 9999999999999999877767899999999999999999999999999999999999995 4789999999999876
Q ss_pred CCCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 306 RPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 306 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
..... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+....... ....
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 278 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---APMG 278 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCTT
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---CCCC
Confidence 54322 22345678899999886 578999999999999999999 999999988888877776653221 1246
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+++++.+||.+||..||.+||++.++++
T Consensus 279 ~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 279 CPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8999999999999999999999999886
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=388.49 Aligned_cols=261 Identities=17% Similarity=0.235 Sum_probs=219.8
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeec--CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
...+|++++.||+|+||.||+|++.. ...+++.||||++.... .......+.+|+.++++++ |||||++++++.+
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGVSLQ 145 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEec
Confidence 34679999999999999999999643 12367899999986432 3334567889999999996 9999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEE
Q 007498 223 VNNVYIVMELCEGGELLDRILARG------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl 296 (601)
....|||||||++|+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.+..+..+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999999987653 45999999999999999999999999999999999999975334556999
Q ss_pred eecccccccCCC---CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCC
Q 007498 297 IDFGLSDFIRPD---ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 297 ~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
+|||+++.+... ......+||+.|+|||++. +.++.++|||||||++|||++ |..||......+.+..+......
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999754321 2234467899999999875 679999999999999999998 99999998888888777765432
Q ss_pred CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 372 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.. ...++.++.+||.+||..||.+||++.+++++.|+
T Consensus 306 ~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 306 DP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 22 24689999999999999999999999999998775
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=385.29 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=215.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC----CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG----ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
.+|++++.||+|+||.||+|++... ..++..||||++.... .....+.+.+|+.+|+.+.+||||++++++|.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 5799999999999999999997531 1245689999997542 334567899999999999559999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec
Q 007498 223 VNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS 287 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~ 287 (601)
.+.+||||||+++|+|.+++.... ..+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~- 237 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT- 237 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC-
Confidence 999999999999999999987643 3589999999999999999999999999999999999995
Q ss_pred CCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 007498 288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF 362 (601)
Q Consensus 288 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~ 362 (601)
.++.+||+|||+++.+..... .....||+.|+|||++. ..|+.++|||||||++|||++ |..||.+....+++
T Consensus 238 --~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 238 --ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp --TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred --CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 478999999999987654322 23456788999999876 569999999999999999999 99999988887777
Q ss_pred HHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..+....... ....++.++.+||.+||..||.+||++.|++++
T Consensus 316 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7666553221 114689999999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=373.20 Aligned_cols=259 Identities=29% Similarity=0.537 Sum_probs=217.8
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||+|+++. +++.||||++...... ...+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HENVVKFYGHRREGNI 79 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTE
T ss_pred ecceEEEEEeecCCCcEEEEEEECC---CCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCE
Confidence 3579999999999999999999876 7889999999765432 24577899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++..+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVF 155 (276)
T ss_dssp EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc---cCCCEEEeeCCCcccc
Confidence 9999999999999987643 35799999999999999999999999999999999999995 4789999999999765
Q ss_pred CCCC---CccccccccccccchhccC-C-CCChhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHccCCCCCCCCCCC
Q 007498 306 RPDE---RLNDIVGSAYYVAPEVLHR-S-YSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 306 ~~~~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 379 (601)
.... .....+||+.|+|||++.+ . ++.++|||||||++|+|++|..||...... ..+..+....... ..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 233 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKK 233 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS--TTGGG
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc--Cchhh
Confidence 4322 2345689999999999864 3 478999999999999999999999876543 2333333332222 23457
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+++++.+||.+||..||++|||+.|+++||||++...
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 234 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred cCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 8999999999999999999999999999999987643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=380.26 Aligned_cols=265 Identities=28% Similarity=0.421 Sum_probs=218.8
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc--CCCCeeEEeeeEe-
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACE- 221 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~- 221 (601)
...+|++++.||+|+||.||+|++.. .+++.||||++........ ....+.+|+.+++.+. +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecC--CCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 34689999999999999999999852 1678999999976443221 2234667888888773 4999999999987
Q ss_pred ----cCCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEE
Q 007498 222 ----DVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296 (601)
Q Consensus 222 ----~~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl 296 (601)
....+|+||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~---~~~~~kl 161 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKL 161 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc---CCCCEEE
Confidence 5677999999997 59999887643 3599999999999999999999999999999999999995 4789999
Q ss_pred eecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCC--
Q 007498 297 IDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFD-- 373 (601)
Q Consensus 297 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-- 373 (601)
+|||++............+||..|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+........
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 9999998765544455678999999999876 5689999999999999999999999998888777766654211000
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 374 ---------------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 374 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
...++.++.++.+||.+||..||.+||++.|+|+||||++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 0112468999999999999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=377.78 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=207.8
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++.+.||+|+||.||+|++ +++.||||++..... .....+.+.+|++++++++ ||||+++++++.+.+.
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-----HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSTTC
T ss_pred hhHceeeeEeecCCCeEEEEEEE-----CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCc
Confidence 45799999999999999999976 467899999976543 3335577899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 226 VYIVMELCEGGELLDRILARGG--RYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
+|+|||||++|+|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC---TTCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe---CCCcEEECCCCC
Confidence 9999999999999998865421 3999999999999999999999999 99999999999995 478999999999
Q ss_pred ccccCCCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 302 SDFIRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 302 a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
++...... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+....+......... ...
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~ 263 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI--PRN 263 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC--CTT
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--Ccc
Confidence 97654332 234568999999999986 46899999999999999999999999988887777666543332222 146
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHc--CcccCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALT--HPWLRDD 414 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~--hp~f~~~ 414 (601)
+++++.+||.+||..||.+|||+.++++ +++++..
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 8999999999999999999999999987 5666543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=402.70 Aligned_cols=249 Identities=16% Similarity=0.238 Sum_probs=201.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc--CCCCeeEEe------
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFC------ 217 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~------ 217 (601)
..+|++.+.||+|+||.||+|+++. +++.||||++...........+.+.+|+.+++.+. +|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CceEEEcceeecCCCEEEEEEEECC---CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 4579999999999999999999875 78899999998665555556788999995555443 499999998
Q ss_pred -eeEecCC-----------------cEEEEEeecCCCchHHHHHHcCCCCCH-------HHHHHHHHHHHHHHHHHHHcC
Q 007498 218 -DACEDVN-----------------NVYIVMELCEGGELLDRILARGGRYTE-------EDAKAIVVQILSVVAFCHLQG 272 (601)
Q Consensus 218 -~~~~~~~-----------------~~~lv~e~~~~g~L~~~~~~~~~~l~~-------~~~~~i~~ql~~~L~~LH~~~ 272 (601)
+++...+ ..||||||| +|+|.+++... +.+++ ..+..|+.||+.||.|||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 5555543 389999999 57999988764 23444 888899999999999999999
Q ss_pred CeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCccccccccccccchhcc-C-----------CCCChhhHHHHH
Q 007498 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-R-----------SYSLEADIWSIG 340 (601)
Q Consensus 273 iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----------~~~~~~DvwSlG 340 (601)
|+||||||+|||++ .++.+||+|||+|+... ......+| +.|+|||++. . .|+.++||||||
T Consensus 227 ivHrDikp~NIll~---~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLD---QRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEEC---TTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEc---CCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999995 47899999999998643 24456678 9999999876 3 599999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 341 VISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 341 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
|++|||++|+.||.+.........+.. .+..+++++.+||.+||..||.+||++.|+|+||||++
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHHSSCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHHCCCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 999999999999976554333322222 12578999999999999999999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=378.24 Aligned_cols=259 Identities=26% Similarity=0.491 Sum_probs=218.4
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc-hhhHHHHHHHHHHHHHhcCCCCeeEEeeeE--ec
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-AISIEDVRREVKILKALSGHKHLVKFCDAC--ED 222 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~--~~ 222 (601)
..+|++++.||+|+||.||+|++.. +++.||||++....... ......+.+|+.++++++ ||||+++++++ .+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSE---TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEE 79 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTT---TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC-
T ss_pred ccceeEeeEEecCCCeEEEEEEECC---CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC
Confidence 4589999999999999999999876 78899999997654321 234577899999999996 99999999998 44
Q ss_pred CCcEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 223 VNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
...+|||||||+++ |.+.+... ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~---~~~~~kl~dfg~ 155 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALGV 155 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTT
T ss_pred CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---CCCcEEeecccc
Confidence 56899999999876 76666553 45799999999999999999999999999999999999995 478999999999
Q ss_pred ccccCCC---CCccccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCC
Q 007498 302 SDFIRPD---ERLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375 (601)
Q Consensus 302 a~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 375 (601)
+...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-- 233 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP-- 233 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC--
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC--
Confidence 9876432 22345679999999999864 247899999999999999999999998888888888777655443
Q ss_pred CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 376 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
..+++++.+||.+||..||.+|||+.|+++||||++...
T Consensus 234 --~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 234 --GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp --SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred --CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 368999999999999999999999999999999987643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=393.65 Aligned_cols=262 Identities=24% Similarity=0.423 Sum_probs=209.1
Q ss_pred CcccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc-------CCCCee
Q 007498 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-------GHKHLV 214 (601)
Q Consensus 142 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-------~h~niv 214 (601)
...+..+|++++.||+|+||.||+|++.. +++.||||++... ....+.+.+|+.+++.++ +|+||+
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecC---CCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 34556789999999999999999999876 7889999998643 234567889999999995 278899
Q ss_pred EEeeeEe----cCCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecC
Q 007498 215 KFCDACE----DVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSG 288 (601)
Q Consensus 215 ~l~~~~~----~~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~ 288 (601)
++++++. ....+||||||+ +++|++.+.... ..+++..++.|+.||+.||.|||++ ||+||||||+|||++.+
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence 9999987 567899999999 567887776653 5699999999999999999999999 99999999999999641
Q ss_pred C----------------------------------------------CCCCeEEeecccccccCCCCCcccccccccccc
Q 007498 289 R----------------------------------------------DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322 (601)
Q Consensus 289 ~----------------------------------------------~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~a 322 (601)
. ....+||+|||++..... .....+||+.|+|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~a 261 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCC
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccC
Confidence 1 113799999999987643 2445689999999
Q ss_pred chhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh------hHHHHHHHccCCCCCC---------------------
Q 007498 323 PEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE------SGIFRAVLRSDPNFDD--------------------- 374 (601)
Q Consensus 323 PE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~~~--------------------- 374 (601)
||++. ..|+.++|||||||++|+|++|+.||..... ...+..+.......+.
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 99886 4699999999999999999999999976542 2223322221111000
Q ss_pred ----CC-------------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 375 ----LP-------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 375 ----~~-------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
.+ ....+.++.+||.+||..||++|||+.|+|+||||++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00 0123467899999999999999999999999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=388.01 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=214.9
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
...+|++++.||+|+||.||+|++.. +++.||+|++.... .....+.+.+|+.+++++. ||||+++++++.+.+
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 104 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDG 104 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETT
T ss_pred ccccceeeeeecCCCCeEEEEEEECC---CCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECC
Confidence 45689999999999999999999876 78899999997642 3335677899999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
.+|||||||++++|.+++... +.+++..+..++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||++.
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSG 180 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCH
T ss_pred EEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC---CCCCEEEEECCCCc
Confidence 999999999999999988665 5799999999999999999999996 999999999999995 47899999999997
Q ss_pred ccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHH------------------
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA------------------ 364 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~------------------ 364 (601)
..... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||...........
T Consensus 181 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 181 QLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred ccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 65322 234568999999999886 4689999999999999999999999987655443221
Q ss_pred ------------------------HHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 365 ------------------------VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 365 ------------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+.... .+..+...++.++.+||.+||..||++|||+.|+|+||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp --------------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 11111 1112223578999999999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=388.80 Aligned_cols=258 Identities=31% Similarity=0.558 Sum_probs=213.3
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|.+.+.||+|+||.||+|+++. +++.||||++.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 113 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPA 113 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred cccccEEEEeEEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheecc
Confidence 355689999999999999999999876 78999999997643 23345677889999999996 99999999999877
Q ss_pred CcE------EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 224 NNV------YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 224 ~~~------~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
+.. |+||||+. ++|.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kL~ 186 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKIL 186 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEEC
T ss_pred CCcccceeEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC---CCCCEEEE
Confidence 654 99999997 5887765 34599999999999999999999999999999999999995 47899999
Q ss_pred ecccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC----
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN---- 371 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---- 371 (601)
|||+++.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+......
T Consensus 187 Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 187 DFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp STTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 9999976543 3455689999999998764 6899999999999999999999999988877766666432111
Q ss_pred -------------------CCCC----CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 372 -------------------FDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 372 -------------------~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
.... .++.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 1110 0246799999999999999999999999999999998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=378.26 Aligned_cols=261 Identities=27% Similarity=0.490 Sum_probs=199.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++.+.||+|+||.||+|++.. +++.||||++...... ...+.+.+|+.+++++. ||||+++++++...+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDE 87 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC-------CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSSC
T ss_pred hhhhhhhheeccccceEEEEEEECC---CCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCC
Confidence 3579999999999999999999875 6789999998654322 23567889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 226 VYIVMELCEGGELLDRILA-------RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~-------~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
+|+||||+++++|.+++.. ..+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc---CCCCEEEEe
Confidence 9999999999999998864 245699999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCC------Cccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC
Q 007498 299 FGLSDFIRPDE------RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP 370 (601)
Q Consensus 299 FG~a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 370 (601)
||++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.................
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 99997654322 123467999999999885 4689999999999999999999999988777666655554433
Q ss_pred CCCC------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 371 NFDD------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 371 ~~~~------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
.... ..+..++.++.+||.+||..||.+||++.++++||||++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 2111 12346889999999999999999999999999999998754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=380.37 Aligned_cols=261 Identities=31% Similarity=0.502 Sum_probs=215.2
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++.+.||+|+||.||+|++.. +++.||||++... ........+.+|+.++++++ ||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPF--DKPLFALRTLREIKILKHFK-HENIITIFNIQRPD 81 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECC---CCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeeccc
Confidence 456789999999999999999999875 7889999998643 23334567889999999996 99999999987654
Q ss_pred -----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 224 -----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 224 -----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 82 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~---~~~~~kl~D 155 (353)
T 2b9h_A 82 SFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN---SNCDLKVCD 155 (353)
T ss_dssp CSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECC
T ss_pred ccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---CCCcEEEEe
Confidence 67999999997 589888765 4799999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCC-----------Cccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 007498 299 FGLSDFIRPDE-----------RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV 365 (601)
Q Consensus 299 FG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i 365 (601)
||++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+
T Consensus 156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 235 (353)
T 2b9h_A 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235 (353)
T ss_dssp CTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 99998764321 123357999999999864 56899999999999999999999999988766655544
Q ss_pred HccC------------------------CCCCCC----CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 366 LRSD------------------------PNFDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 366 ~~~~------------------------~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
.... +..+.. .++.+++++.+||.+||..||++|||+.|+|+||||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 3211 111111 12468999999999999999999999999999999987644
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=379.52 Aligned_cols=262 Identities=32% Similarity=0.515 Sum_probs=212.7
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe--
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE-- 221 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-- 221 (601)
.+..+|++++.||+|+||.||+|++.. +++.||||++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPS 80 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETT---TTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTT
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECC---CCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEecccc
Confidence 456789999999999999999999876 7889999998653 3345677899999999996 999999999873
Q ss_pred ------------cCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC
Q 007498 222 ------------DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289 (601)
Q Consensus 222 ------------~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~ 289 (601)
+...+|+||||++ |+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-- 155 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT-- 155 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--
Confidence 3467899999997 59988774 357999999999999999999999999999999999999963
Q ss_pred CCCCeEEeecccccccCCC----CCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 007498 290 DDADMRLIDFGLSDFIRPD----ERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFR 363 (601)
Q Consensus 290 ~~~~vkl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~ 363 (601)
.++.+||+|||++...... .......||..|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+.
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 235 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 3678999999999876432 2234457899999999874 468999999999999999999999999888777766
Q ss_pred HHHccCCCCC----------------------CC----CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 364 AVLRSDPNFD----------------------DL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 364 ~i~~~~~~~~----------------------~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
.+....+... .. .++.++.++.+||.+||..||.+|||+.|+|+||||+....|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 6654432211 00 124689999999999999999999999999999999976554
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=383.86 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=204.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc-
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN- 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~- 225 (601)
.+|++.+.||+|+||.||+|+++. +++.||||++...... .....+|++.+..+. ||||++++++|...+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDPRF----RNRELQIMQDLAVLH-HPNIVQLQSYFYTLGER 94 (360)
T ss_dssp TTEEEC----------CEEEEETT---TCCEEEEEEEECCTTC----CCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEecCccc----cHHHHHHHHHHHhcC-CCCcccHHHhhhccccc
Confidence 479999999999999999999876 7889999998654322 234567888888886 9999999999865433
Q ss_pred ------EEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH--HcCCeeccCCCCceEeecCCCCCCe
Q 007498 226 ------VYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCH--LQGVVHRDLKPENFLFTSGRDDADM 294 (601)
Q Consensus 226 ------~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH--~~~iiHrDikp~NIll~~~~~~~~v 294 (601)
+|+||||+++ +|...+.. ....+++..++.++.||+.||.||| ++||+||||||+|||++. .++.+
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET--TTTEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC--CCCcE
Confidence 8999999986 56554443 4567999999999999999999999 999999999999999963 37899
Q ss_pred EEeecccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCC
Q 007498 295 RLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF 372 (601)
Q Consensus 295 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 372 (601)
||+|||++..+.........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+.+.....
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 9999999988776666667789999999998753 48999999999999999999999999988877776665421110
Q ss_pred --------------------CCCC--------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 373 --------------------DDLP--------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 373 --------------------~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
...+ ....++++.+||.+||..||.+|||+.|+|+||||++...+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 0000 12357899999999999999999999999999999876443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=367.12 Aligned_cols=247 Identities=23% Similarity=0.412 Sum_probs=215.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||++++. +++.||+|++..... ..+.+.+|++++++++ ||||+++++++.+.+.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET----TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSE
T ss_pred hhceeeheecCCCccEEEEEEec----CCCeEEEEEeccccc----CHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCce
Confidence 47999999999999999999986 456799999976543 2367899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++....+.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---GGGCEEECCTTGGGGBC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc---CCCCEEecccccccccc
Confidence 999999999999999877777899999999999999999999999999999999999995 47889999999998664
Q ss_pred CCC--Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 307 PDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 307 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||......+....+......... ..+++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 234 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLAST 234 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCH
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC---CcCCH
Confidence 332 223456788999999986 679999999999999999999 99999998888888777765332222 45799
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
++.+||.+||..||.+||++.++++|
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 235 HVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=374.31 Aligned_cols=256 Identities=27% Similarity=0.482 Sum_probs=209.6
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-- 222 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-- 222 (601)
+..+|++++.||+|+||.||+|++.. +++.||||++... ....+.+.+|+.+++++. ||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNAL---DSRYYAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERR 75 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECC
T ss_pred ccccchhhheeccCCcEEEEEEEEcC---CCeEEEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhc
Confidence 34579999999999999999999875 7889999998643 234577899999999996 9999999998754
Q ss_pred -----------CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCC
Q 007498 223 -----------VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291 (601)
Q Consensus 223 -----------~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~ 291 (601)
...+|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~---~~ 152 (303)
T 1zy4_A 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ES 152 (303)
T ss_dssp CCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TT
T ss_pred chhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc---CC
Confidence 4578999999999999999987766789999999999999999999999999999999999995 47
Q ss_pred CCeEEeecccccccCCC---------------CCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCC
Q 007498 292 ADMRLIDFGLSDFIRPD---------------ERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFW 354 (601)
Q Consensus 292 ~~vkl~DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~ 354 (601)
+.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++ ||.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 89999999999765422 12345679999999999863 58999999999999999998 564
Q ss_pred CC-ChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 355 AR-TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 355 ~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.. ........+......++.......+..+.+||.+||..||.+|||+.++++||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp SHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred CchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 32 3344555555555555544445678899999999999999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=369.71 Aligned_cols=258 Identities=29% Similarity=0.496 Sum_probs=218.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe--cCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE--DVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--~~~ 224 (601)
.+|++++.||+|+||.||+|+++. +++.||+|++...... ....+.+.+|+.++++++ ||||+++++++. ...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGT
T ss_pred hheeeehhccCCCCcEEEEEEECC---CCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCc
Confidence 479999999999999999999876 7889999999765433 335677899999999996 999999999874 467
Q ss_pred cEEEEEeecCCCchHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeeccCCCCceEeecCCCCCCeEE
Q 007498 225 NVYIVMELCEGGELLDRILAR---GGRYTEEDAKAIVVQILSVVAFCHLQG-----VVHRDLKPENFLFTSGRDDADMRL 296 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~---~~~l~~~~~~~i~~ql~~~L~~LH~~~-----iiHrDikp~NIll~~~~~~~~vkl 296 (601)
.+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~---~~~~~kl 157 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKL 157 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC---SSSCEEE
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc---CCCCEEE
Confidence 899999999999999988653 345999999999999999999999999 99999999999995 4789999
Q ss_pred eecccccccCCCCC-ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC
Q 007498 297 IDFGLSDFIRPDER-LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374 (601)
Q Consensus 297 ~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 374 (601)
+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-- 235 (279)
T 2w5a_A 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-- 235 (279)
T ss_dssp CCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--
T ss_pred ecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc--
Confidence 99999977654322 23467999999999876 468999999999999999999999999888777777776654321
Q ss_pred CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 375 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
.+ ..++.++.+||.+||..||.+||++.|+|+|+|+.+..
T Consensus 236 ~~-~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 236 IP-YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp CC-TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred CC-cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 11 36899999999999999999999999999999998653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=378.01 Aligned_cols=263 Identities=28% Similarity=0.442 Sum_probs=214.9
Q ss_pred CcccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCC------CeeE
Q 007498 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK------HLVK 215 (601)
Q Consensus 142 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~------niv~ 215 (601)
...+..+|++++.||+|+||.||+|++.. .+++.||||++.... ...+.+.+|+.+++.+. |+ +|++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~ 81 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN-TTDPNSTFRCVQ 81 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHH-HHCTTCTTCBCC
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecC--CCCcEEEEEEEecCC----chhHHHHHHHHHHHHhh-hcCCCCceeeEe
Confidence 34556789999999999999999998742 267899999986432 24567889999999986 55 4999
Q ss_pred EeeeEecCCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC----
Q 007498 216 FCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD---- 290 (601)
Q Consensus 216 l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~---- 290 (601)
+++++...+.+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 789999887653 36899999999999999999999999999999999999964211
Q ss_pred ------------CCCeEEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 007498 291 ------------DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART 357 (601)
Q Consensus 291 ------------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~ 357 (601)
++.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|||++|..||....
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred CCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 56799999999976433 334568999999999886 478999999999999999999999998877
Q ss_pred hhHHHHHHHccCCCCCC----------------CCC------------------------CCCCHHHHHHHHHccccccc
Q 007498 358 ESGIFRAVLRSDPNFDD----------------LPW------------------------PSVSPEAKDFVKRLLNKDYR 397 (601)
Q Consensus 358 ~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~s~~~~~li~~~L~~dP~ 397 (601)
..+....+......++. ..| ...++++.+||.+||..||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 76655444322111110 001 12346789999999999999
Q ss_pred CCCCHHHHHcCcccCCC
Q 007498 398 KRMTAVQALTHPWLRDD 414 (601)
Q Consensus 398 ~R~s~~ell~hp~f~~~ 414 (601)
+|||+.|+|+||||+..
T Consensus 319 ~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 319 KRITLREALKHPFFDLL 335 (339)
T ss_dssp TSCCHHHHTTSGGGGGG
T ss_pred cccCHHHHhcCHHHHHH
Confidence 99999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=363.57 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=215.1
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||+++++ ++..||||++..... ..+.+.+|+.++++++ ||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK----GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYP 77 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSS
T ss_pred hhheeeeeeeccCCCceEEEEEec----CceeEEEEEeccCCC----cHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCc
Confidence 357999999999999999999875 456799999976543 2366889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYV 154 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC---TTCCEEECCTTCEEEC
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC---CCCCEEEccCccceec
Confidence 9999999999999999887766799999999999999999999999999999999999995 4789999999999876
Q ss_pred CCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
..... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||...........+......... ..++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 231 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLAS 231 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSC
T ss_pred chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcCh
Confidence 54432 23345677899999886 468999999999999999999 99999988888777777665433322 3578
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+++.+||.+||..||.+|||+.+++++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 232 DTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=366.86 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=203.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||+|++......+..||+|++.... .....+.+.+|+.+++++. ||||+++++++. .+.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-cCc
Confidence 458999999999999999999987544456789999986532 3335677899999999996 999999999985 467
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYM 166 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE---TTEEEECC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECC---CCCEEECcccccccc
Confidence 89999999999999998877667999999999999999999999999999999999999964 788999999999876
Q ss_pred CCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
..... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+....... ..+.++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~ 243 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCP 243 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTCC
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---CCCCCC
Confidence 54332 23346778999999886 678999999999999999996 999999888888777776653221 124789
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+++.+||.+||..||.+|||+.++++
T Consensus 244 ~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 244 PTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999886
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=383.85 Aligned_cols=261 Identities=23% Similarity=0.437 Sum_probs=221.0
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhh--------------HHHHHHHHHHHHHhcC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS--------------IEDVRREVKILKALSG 209 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~~~~E~~~l~~l~~ 209 (601)
.+..+|++++.||+|+||.||+|++ +++.||||++.......... .+.+.+|+.++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 101 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK- 101 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-
Confidence 3456899999999999999999987 57899999997654332211 277899999999996
Q ss_pred CCCeeEEeeeEecCCcEEEEEeecCCCchHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCC
Q 007498 210 HKHLVKFCDACEDVNNVYIVMELCEGGELLDR------ILAR-GGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPE 281 (601)
Q Consensus 210 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~------~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~ 281 (601)
||||+++++++.+.+.+|+||||+++++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 99999999999999999999999999999886 4332 4679999999999999999999999 99999999999
Q ss_pred ceEeecCCCCCCeEEeecccccccCCCCCccccccccccccchhccC--CCCC-hhhHHHHHHHHHHHHhCCCCCCCCCh
Q 007498 282 NFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSL-EADIWSIGVISYILLCGSRPFWARTE 358 (601)
Q Consensus 282 NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~-~~DvwSlG~il~ell~g~~pf~~~~~ 358 (601)
|||++ .++.+||+|||++...... ......||..|+|||++.+ .++. ++|||||||++|+|++|..||.....
T Consensus 182 Nil~~---~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMD---KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEEC---TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEc---CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99995 4789999999999876443 4455789999999999874 4555 99999999999999999999988776
Q ss_pred -hHHHHHHHccCCCCCCCC---------------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 359 -SGIFRAVLRSDPNFDDLP---------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 359 -~~~~~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.+....+......++... ...+++++.+||.+||..||.+||++.|+|+||||++.
T Consensus 258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 667777766655444211 14689999999999999999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=381.74 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=211.1
Q ss_pred CCCeEEcceeccCCCeEEEEEEeec--CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
..+|++++.||+|+||.||+|++.. ...+++.||||++.... .....+.+.+|+++++++.+|||||++++++.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 4589999999999999999998653 22367899999997542 2334567899999999996699999999998875
Q ss_pred C-cEEEEEeecCCCchHHHHHHcCC-------------------------------------------------------
Q 007498 224 N-NVYIVMELCEGGELLDRILARGG------------------------------------------------------- 247 (601)
Q Consensus 224 ~-~~~lv~e~~~~g~L~~~~~~~~~------------------------------------------------------- 247 (601)
+ .+|+|||||++|+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 4 49999999999999998875432
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCC---Ccccc
Q 007498 248 ----------RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDI 314 (601)
Q Consensus 248 ----------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~ 314 (601)
.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+.... .....
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCcEEEEeccceeeecccccchhcccc
Confidence 189999999999999999999999999999999999995 47899999999998664332 23446
Q ss_pred ccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcc
Q 007498 315 VGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLL 392 (601)
Q Consensus 315 ~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 392 (601)
.||+.|+|||++. ..++.++|||||||++|||++ |..||.+......+............ ...+++++.+||.+||
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l 333 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDCW 333 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHHHT
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHc
Confidence 7899999999875 679999999999999999998 99999887655544444443322221 1468999999999999
Q ss_pred cccccCCCCHHHHHcC
Q 007498 393 NKDYRKRMTAVQALTH 408 (601)
Q Consensus 393 ~~dP~~R~s~~ell~h 408 (601)
..||.+|||+.|+++|
T Consensus 334 ~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 334 HGEPSQRPTFSELVEH 349 (359)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCChhhCCCHHHHHHH
Confidence 9999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=374.43 Aligned_cols=262 Identities=22% Similarity=0.358 Sum_probs=198.5
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||+|++.........||||++....... ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFD-HPHVAKLVGVSLRSRA 99 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC--
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCC-CCceehhhceeecccc
Confidence 457999999999999999999987532222489999987654332 34678999999999996 9999999999987765
Q ss_pred E------EEEEeecCCCchHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCe
Q 007498 226 V------YIVMELCEGGELLDRILARG-----GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294 (601)
Q Consensus 226 ~------~lv~e~~~~g~L~~~~~~~~-----~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~v 294 (601)
. |+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~---~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc---CCCCE
Confidence 4 99999999999999886532 2599999999999999999999999999999999999995 47899
Q ss_pred EEeecccccccCCCCCc---cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccC
Q 007498 295 RLIDFGLSDFIRPDERL---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSD 369 (601)
Q Consensus 295 kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 369 (601)
||+|||+++........ ....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 99999999876543322 2345778999999876 568999999999999999999 999999888888887777654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHcccccccCCCC-------HHHHHcCcccCCCC
Q 007498 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMT-------AVQALTHPWLRDDS 415 (601)
Q Consensus 370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-------~~ell~hp~f~~~~ 415 (601)
.... .+.+++++.+||.+||..||.+||| .++++.|+|+....
T Consensus 257 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 257 RLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp CCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred CCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 3222 2468999999999999999999999 78899999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=379.99 Aligned_cols=254 Identities=24% Similarity=0.402 Sum_probs=216.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC----ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
.+|++++.||+|+||.||+|++.... ..+..||||++.... .......+.+|+++++++.+|||||++++++..
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 57999999999999999999975311 234689999987642 334567789999999999559999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec
Q 007498 223 VNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS 287 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~ 287 (601)
.+.+|||||||++|+|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+|||++
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~- 225 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT- 225 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc-
Confidence 999999999999999999987653 3599999999999999999999999999999999999995
Q ss_pred CCCCCCeEEeecccccccCCCC---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 007498 288 GRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF 362 (601)
Q Consensus 288 ~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~ 362 (601)
.++.+||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 226 --~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 226 --EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp --TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred --CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 47899999999998765432 233456789999999876 568999999999999999999 99999988888777
Q ss_pred HHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..+........ ...+++++.+||.+||..||++|||+.|++++
T Consensus 304 ~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77765533221 24689999999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=378.49 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=214.3
Q ss_pred CcccCCCeEEcceeccCCCeEEEEEEeecCCccC-cEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCC------ee
Q 007498 142 NKNFGAKYELGKEVGRGHFGHTCSARGKKGELKD-QQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH------LV 214 (601)
Q Consensus 142 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n------iv 214 (601)
...+..+|++++.||+|+||.||+|++.. ++ +.||||++.... ...+.+.+|+.+++.+. |++ |+
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-~~~~~~~~~~~ 85 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHA---RGKSQVALKIIRNVG----KYREAARLEINVLKKIK-EKDKENKFLCV 85 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETT---TTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHH-HHCTTSCSCBC
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecC---CCceEEEEEEEcccc----cchhHHHHHHHHHHHHh-hcCCCCceeEE
Confidence 34456789999999999999999999865 44 789999986432 24567889999999996 655 99
Q ss_pred EEeeeEecCCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC-----
Q 007498 215 KFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG----- 288 (601)
Q Consensus 215 ~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~----- 288 (601)
.+++++...+.+||||||+ +++|++.+.... ..+++.+++.++.||+.||.|||++||+||||||+|||+...
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999999 567888776653 569999999999999999999999999999999999999432
Q ss_pred -----------CCCCCeEEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 007498 289 -----------RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR 356 (601)
Q Consensus 289 -----------~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~ 356 (601)
+.++.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|||++|..||...
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 2478899999999976433 334568999999999886 57999999999999999999999999888
Q ss_pred ChhHHHHHHHccCCCCCC----------------CCCC------------------------CCCHHHHHHHHHcccccc
Q 007498 357 TESGIFRAVLRSDPNFDD----------------LPWP------------------------SVSPEAKDFVKRLLNKDY 396 (601)
Q Consensus 357 ~~~~~~~~i~~~~~~~~~----------------~~~~------------------------~~s~~~~~li~~~L~~dP 396 (601)
...+.+..+......++. ..|+ ..+.++.+||.+||..||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 776655544332211110 0011 124578999999999999
Q ss_pred cCCCCHHHHHcCcccCCC
Q 007498 397 RKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 397 ~~R~s~~ell~hp~f~~~ 414 (601)
++|||+.|+|+||||++.
T Consensus 323 ~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAGL 340 (355)
T ss_dssp TTSCCHHHHTTSGGGGGC
T ss_pred hhCcCHHHHhcChhhcCC
Confidence 999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=377.86 Aligned_cols=257 Identities=32% Similarity=0.575 Sum_probs=211.7
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+..+|.+.+.||+|+||.||+|+++. +++.||||++.... ........+.+|+.+++.++ ||||+++++++....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPAS 96 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred cCceEEEeeeEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccc
Confidence 34689999999999999999999876 78999999997643 23334577889999999996 999999999998765
Q ss_pred c------EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 225 N------VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 225 ~------~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
. +|+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~D 169 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILD 169 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTCCEEECS
T ss_pred ccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC---CCCcEEEee
Confidence 4 599999997 58877652 3599999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC-------
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD------- 369 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------- 369 (601)
||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+....
T Consensus 170 fg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 170 FGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred cccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999976543 2345689999999998764 68999999999999999999999999887766665554311
Q ss_pred ----------------C-----CCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 370 ----------------P-----NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 370 ----------------~-----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+ .+. ..++.+++++.+||.+||..||++|||+.|+|+||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 0 111 113468999999999999999999999999999999986543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=365.49 Aligned_cols=247 Identities=23% Similarity=0.388 Sum_probs=211.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||++++. ++..||||++..... ..+.+.+|+++++++. ||||+++++++.+.+.+
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET----TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSE
T ss_pred HHHHhHhhcCCCCCceEEEEEEc----CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCe
Confidence 47999999999999999999875 466899999976543 2366889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTSCEEECSTTGGGGBC
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc---CCCCEEEcccccccccc
Confidence 999999999999999877566799999999999999999999999999999999999995 47899999999998664
Q ss_pred CCC--Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 307 PDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 307 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
... ......+|+.|+|||++. ..++.++|||||||++|+|++ |+.||...........+......... ..+++
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 248 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASE 248 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCCH
Confidence 332 123346788899999886 679999999999999999998 99999988888887777765433222 35789
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.+.+||.+||..||.+|||+.++++|
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=367.86 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=207.1
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
|.....||+|+||.||+|++.. +++.||||++.... ....+.+.+|+.+++.+. ||||+++++++...+.+|+
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLS---NQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETT---TCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECC---CCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEE
Confidence 3344589999999999999876 78899999987643 223567899999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 229 VMELCEGGELLDRILARGG--RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~--~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
||||+++++|.+++....+ .+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTCCEEECCTTTCEESC
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC--CCCCEEEeecccccccC
Confidence 9999999999998876533 4679999999999999999999999999999999999963 36899999999998765
Q ss_pred CCC-CccccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHH--HHHH-HccCCCCCCCCCCC
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGI--FRAV-LRSDPNFDDLPWPS 379 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~--~~~i-~~~~~~~~~~~~~~ 379 (601)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ .... ....+.++ ..
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~ 250 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP----ES 250 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC----TT
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc----cc
Confidence 332 2345689999999999853 389999999999999999999999975433221 1111 12222222 46
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+++++.+||.+||..||++||++.++|+||||+....
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 8999999999999999999999999999999987643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=369.82 Aligned_cols=259 Identities=25% Similarity=0.465 Sum_probs=209.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcC-CCCeeEEeeeEecCC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG-HKHLVKFCDACEDVN 224 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~ 224 (601)
..+|++++.||+|+||.||++++. +++.||||++..... .....+.+.+|+.+++++.. |+||+++++++...+
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCCEEEEEEEcC----CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 457999999999999999999875 477899999976543 33456788999999999973 599999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|||||+ .+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 102 ~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 102 YIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEEECC-CSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC
T ss_pred EEEEEEec-CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeecccccc
Confidence 99999995 577999988764 5799999999999999999999999999999999999995 57899999999987
Q ss_pred cCCCCC---ccccccccccccchhccC------------CCCChhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHcc
Q 007498 305 IRPDER---LNDIVGSAYYVAPEVLHR------------SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRS 368 (601)
Q Consensus 305 ~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~ 368 (601)
...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+..+...
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence 654322 234679999999998753 588899999999999999999999976543 3334444433
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCC
Q 007498 369 DPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417 (601)
Q Consensus 369 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 417 (601)
...... ....+.++.+||.+||..||.+||++.|+|+||||+....+
T Consensus 256 ~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 256 NHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp TSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred ccccCC--cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 322211 13468899999999999999999999999999999876544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=376.55 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=206.2
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
++.+|++++.||+|+||.||+|++.. +++.||||++...... +.+.+|+.++++|.+||||+++++++.+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETT---TTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred EcCCeEEEEEeeccCCceEEEEEECC---CCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 45689999999999999999999875 7899999998754322 347899999999955999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCC-----eEEeec
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD-----MRLIDF 299 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~-----vkl~DF 299 (601)
..||||||+ +++|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++. ++. +||+||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~---~~~~~~~~~kl~DF 154 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR---PGNKTQQVIHIIDF 154 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECC---GGGTCTTSEEECCC
T ss_pred ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecc---CCCCCCceEEEEEc
Confidence 999999999 89999998876678999999999999999999999999999999999999964 444 999999
Q ss_pred ccccccCCCCC--------ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHc
Q 007498 300 GLSDFIRPDER--------LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE---SGIFRAVLR 367 (601)
Q Consensus 300 G~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~ 367 (601)
|+++.+..... ....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+... .+.+..+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 99987643322 24678999999999986 4689999999999999999999999987443 333444433
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 368 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.....+........+++.+||.+||..||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 TKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2221111111112339999999999999999999988776
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=375.24 Aligned_cols=245 Identities=22% Similarity=0.369 Sum_probs=206.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|++.. +++.||+|++... .....+.+.+|++++++++ ||||+++++++.+.+.+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~---~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRE---TGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred hHeeccceecCCCCEEEEEEEECC---CCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCee
Confidence 479999999999999999999876 7889999988542 3345678999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|||||++|+|.+++......+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC---TTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC---CCCCEEEeecccceecc
Confidence 999999999999999988777899999999999999999999999999999999999995 47899999999998764
Q ss_pred CCCCc---------------cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhH-----HHHHH
Q 007498 307 PDERL---------------NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESG-----IFRAV 365 (601)
Q Consensus 307 ~~~~~---------------~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-----~~~~i 365 (601)
..... ...+||+.|+|||++. ..++.++|||||||++|+|++|..||....... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 33211 2568999999999987 468999999999999999999999986532211 11111
Q ss_pred HccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.... . .+.+++++.+||.+||..||++|||+.++++
T Consensus 240 ~~~~--~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 240 LDRY--C----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHT--C----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccc--C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 1 1467889999999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=368.97 Aligned_cols=258 Identities=27% Similarity=0.389 Sum_probs=196.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++...... ....+.+..+..+++.+ +||||+++++++.+.+.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRK---TGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp GGEEEEEEC------CEEEEEETT---TCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeecCCeeEEEEEEec---CCeEEEEEEecccccc-hHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcE
Confidence 479999999999999999999876 7889999999765322 22233344455566666 499999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
||||||+ ++.+........+.+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||++...
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGRL 175 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC---TTSCEEECCCTTC---
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC---CCCCEEEEECCCchhc
Confidence 9999999 5555555555567899999999999999999999996 999999999999995 4789999999999877
Q ss_pred CCCCCccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHccCCCCCCCCCC
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWAR-TESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
..........||+.|+|||++. ..++.++|||||||++|+|++|+.||... .....+..+......... ...
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 254 (318)
T 2dyl_A 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP-GHM 254 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC-SSS
T ss_pred cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC-ccC
Confidence 6555555678999999999973 35899999999999999999999999863 455566666655433221 124
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.+++++.+||.+||..||.+||++.++++||||+..
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 689999999999999999999999999999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=362.94 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=207.1
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhh----HHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS----IEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
..+|++.+.||+|+||.||+|++.. +++.||||++.......... .+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 93 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMH 93 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETT---TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEET
T ss_pred hccceehhccccCCceeEEEEEEcC---CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeec
Confidence 3579999999999999999999876 78899999986644332211 267899999999996 999999999997
Q ss_pred cCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCceEeecCC--CCCCeEEe
Q 007498 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGR--DDADMRLI 297 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDikp~NIll~~~~--~~~~vkl~ 297 (601)
+.. ++||||+++|+|.+.+......+++..++.++.||+.||.|||++| |+||||||+|||++.+. ....+||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 655 7999999999999998877778999999999999999999999999 99999999999996421 11239999
Q ss_pred ecccccccCCCCCccccccccccccchhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHH--HHHHHccCCCC
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFWARTESGI--FRAVLRSDPNF 372 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~ 372 (601)
|||+++.... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||........ ...+.......
T Consensus 172 Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 172 DFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp CCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred CCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 9999975432 345578999999999983 3478999999999999999999999976554333 33333332221
Q ss_pred CCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 373 DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 373 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.....+++++.+||.+||..||.+|||+.|+++
T Consensus 250 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 250 --TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 122478999999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=373.34 Aligned_cols=253 Identities=20% Similarity=0.305 Sum_probs=214.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCC--ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
..+|++++.||+|+||.||+|++.... .+++.||||++.... .....+.+.+|+.+++++. ||||+++++++.+.
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAVG 122 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEccC
Confidence 357999999999999999999987421 245899999987543 2334577899999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCC
Q 007498 224 NNVYIVMELCEGGELLDRILARG-----------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKP 280 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~-----------------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp 280 (601)
+.+||||||+++|+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 99999999999999999987642 5799999999999999999999999999999999
Q ss_pred CceEeecCCCCCCeEEeecccccccCCCC---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 007498 281 ENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWA 355 (601)
Q Consensus 281 ~NIll~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~ 355 (601)
+|||++ .++.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.+
T Consensus 203 ~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 203 RNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp GGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ceEEEC---CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999995 47899999999997654322 223457899999999876 679999999999999999999 9999998
Q ss_pred CChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 356 RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 356 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
....+....+........ ...+++++.+||.+||..||.+||++.++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp SCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 888888777766543221 1468999999999999999999999999886
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=366.08 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=214.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeec--CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
..+|++++.||+|+||.||+|++.. ...+++.||||++.... .....+.+.+|+.++++|.+||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3589999999999999999998643 22367899999997543 2234577899999999995599999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEee
Q 007498 224 NNVYIVMELCEGGELLDRILARGG-----------------RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT 286 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~-----------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~ 286 (601)
+..|+|||||++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 999999999999999999876543 489999999999999999999999999999999999996
Q ss_pred cCCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 007498 287 SGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGI 361 (601)
Q Consensus 287 ~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~ 361 (601)
.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+......
T Consensus 180 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 180 ---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp ---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred ---CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 478999999999987654432 23456788999999875 679999999999999999998 9999987765555
Q ss_pred HHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 362 FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 362 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+........... ....++.++.+||.+||..||.+|||+.|++++
T Consensus 257 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 257 FYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 544444332222 124689999999999999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=372.63 Aligned_cols=256 Identities=29% Similarity=0.512 Sum_probs=214.3
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch---hhHHHHHHHHHHHHHhc-CCCCeeEEeee
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILKALS-GHKHLVKFCDA 219 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~-~h~niv~l~~~ 219 (601)
.+..+|++++.||+|+||.||+|++.. +++.||||++........ .....+.+|+.+++++. +|+||++++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETT---TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 345689999999999999999999876 788999999976543321 11244678999999996 36999999999
Q ss_pred EecCCcEEEEEeecCC-CchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 220 CEDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 220 ~~~~~~~~lv~e~~~~-g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
+...+.+++||||+.+ ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~~kL~D 193 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLID 193 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC--CCCCEEEee
Confidence 9999999999999986 8999888664 57999999999999999999999999999999999999962 468899999
Q ss_pred cccccccCCCCCccccccccccccchhcc-CC-CCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-RS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 376 (601)
||++...... ......||+.|+|||++. .. ++.++|||||||++|||++|+.||.... .+......+.
T Consensus 194 fg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~--- 263 (320)
T 3a99_A 194 FGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--- 263 (320)
T ss_dssp CTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS---
T ss_pred Cccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc---
Confidence 9999876533 344568999999999875 33 4788999999999999999999996432 2233332222
Q ss_pred CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
..+++++.+||.+||..||.+|||+.|+++||||++...
T Consensus 264 -~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 264 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp -SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred -ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 468999999999999999999999999999999987644
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=358.77 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=200.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc-hhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT-AISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+|++.+.||+|+||.||++++ +++.||||++....... ....+.+.+|+++++.++ ||||+++++++.+.+.
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-----IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPN 80 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-----TTEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--
T ss_pred hheeeeeeeccCCCeEEEEEEE-----cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCc
Confidence 4799999999999999999986 36789999987643322 234577899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CeeccCCCCceEeecCC-----CCCCeEEe
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG---VVHRDLKPENFLFTSGR-----DDADMRLI 297 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~---iiHrDikp~NIll~~~~-----~~~~vkl~ 297 (601)
+|+||||+++++|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++... .++.+||+
T Consensus 81 ~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred eEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999988763 457999999999999999999999999 99999999999996421 26789999
Q ss_pred ecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 376 (601)
|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+.........
T Consensus 159 Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 235 (271)
T 3dtc_A 159 DFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI-- 235 (271)
T ss_dssp CCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--
T ss_pred cCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--
Confidence 999997665432 23568999999999876 56899999999999999999999999988877776666655443332
Q ss_pred CCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
...+++++.+||.+||..||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 24689999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=381.34 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=211.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++. +++.||||++.... .......+.+|+++|+++. |||||++++++...+.+
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEeccCCCCeEEEEEEec---CCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCCc
Confidence 479999999999999999999875 67899999986532 2234456889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~---~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCGGGCEECT
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc---CCCcEEECcCCCceecC
Confidence 999999999999999887766799999999999999999999999999999999999995 47899999999997654
Q ss_pred CCCCc---cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 307 PDERL---NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 307 ~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
..... ....++..|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..... .+. ...++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~ 341 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR-LPC--PELCP 341 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-CCC--CTTCC
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCC--CCCCC
Confidence 32211 1234577899999886 678999999999999999998 9999988877776666654432 211 13588
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+++.+||.+||..||.+|||+.++++
T Consensus 342 ~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 342 DAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=364.49 Aligned_cols=249 Identities=18% Similarity=0.265 Sum_probs=206.8
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCC----ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGE----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
..+|++.+.||+|+||.||+|+++... ..+..||+|++.... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLS-HKHLVLNYGVCV 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSC-CTTBCCEEEEEC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEE
Confidence 458999999999999999999987521 012579999986543 234577899999999996 999999999999
Q ss_pred cCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCC--------
Q 007498 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD-------- 293 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~-------- 293 (601)
+.+..|||||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~~~~~~~~ 159 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIR---EEDRKTGNPPF 159 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEE---CCBGGGTBCCE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEec---CCcccccccce
Confidence 999999999999999999998876556999999999999999999999999999999999999975 343
Q ss_pred eEEeecccccccCCCCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC
Q 007498 294 MRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 294 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
+||+|||++..... .....||..|+|||++. ..++.++|||||||++|+|++|..|++.................
T Consensus 160 ~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (289)
T 4fvq_A 160 IKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236 (289)
T ss_dssp EEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred eeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence 99999999865532 23456899999999886 45899999999999999999966655554444444444444433
Q ss_pred CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 372 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
++ ...++++.+||.+||..||.+|||+.++++|
T Consensus 237 ~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 237 LP----APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33 2467889999999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=369.98 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=205.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCc----EEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQ----QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
.+|++++.||+|+||.||+|++.. +++ .||+|.+.... .......+.+|+.++++++ ||||+++++++..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 88 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLT 88 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC-------CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEES
T ss_pred HHcccceEEeeCCCeEEEEEEEcC---CCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEec
Confidence 579999999999999999999865 333 46788775432 2234577899999999996 9999999999987
Q ss_pred CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
.. .++||||+.+|+|.+++....+.+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a 164 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLA 164 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE---TTEEEECCTTHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECC---CCCEEEccCcce
Confidence 54 78999999999999999887788999999999999999999999999999999999999964 788999999999
Q ss_pred cccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCC
Q 007498 303 DFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 303 ~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 377 (601)
+....... .....||..|+|||++. +.++.++|||||||++|||++ |+.||.+.........+...... +. .
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~--~ 241 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQ--P 241 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-CC--C
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC-CC--C
Confidence 87654332 23346788999999876 679999999999999999999 99999888777766666554322 11 2
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..++.++.+||.+||..||.+||++.+++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 242 PICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 4689999999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=358.16 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=211.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||+|++.....++..||||++.... .....+.+.+|+.+++.++ ||||+++++++.+ +..
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECS-SSC
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-CCC
Confidence 57999999999999999999987544455679999987642 2334678899999999996 9999999999875 457
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS---PECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEE---TTEEEECCCCGGGCC-
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECC---CCcEEeCccCCCcccc
Confidence 8999999999999999877777999999999999999999999999999999999999964 7889999999998765
Q ss_pred CCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 307 PDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 307 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
.... .....+|+.|+|||++. ..++.++|||||||++|+|++ |+.||...........+........ ...+++
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 241 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PDLCPP 241 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CTTCCH
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CCCCCH
Confidence 4322 23456788999999886 678999999999999999998 9999988777777666655432211 146899
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.+.+||.+||..||.+||++.|++++
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHH
Confidence 99999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=377.88 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=203.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||+++++....++..||||++.... .....+.+.+|+.+++++. ||||+++++++.+.+.+
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSC
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCce
Confidence 47999999999999999999886433357789999986542 3335677999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||++|+|.+++......+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc---CCCCEEECcCccccccc
Confidence 999999999999999887767899999999999999999999999999999999999995 47899999999998765
Q ss_pred CCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 307 PDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 307 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
.... .....+|..|+|||++. +.++.++|||||||++|||++ |+.||+.....+....+...... + ....+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~-~--~~~~~ 275 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL-P--PPMDC 275 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-C--CCTTC
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCccc
Confidence 4321 12234577899999886 679999999999999999998 99999988888777776654221 1 12368
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.++.+||.+||..||.+||++.++++
T Consensus 276 ~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 276 PAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp BHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 899999999999999999999999885
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=372.07 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=212.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
..+|++++.||+|+||.||+|++... ..++..||||++.... .....+.+.+|+.++++|.+||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 35799999999999999999997431 1256789999997542 2223467899999999995599999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCC
Q 007498 224 NNVYIVMELCEGGELLDRILARGG----------------------RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE 281 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~----------------------~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~ 281 (601)
+.+|||||||++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 999999999999999999876532 3799999999999999999999999999999999
Q ss_pred ceEeecCCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 007498 282 NFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWAR 356 (601)
Q Consensus 282 NIll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~ 356 (601)
|||++ .++.+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++ |..||.+.
T Consensus 202 NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 202 NVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hEEEc---CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99996 478999999999987644332 23456788999999875 679999999999999999998 99999887
Q ss_pred ChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCc
Q 007498 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409 (601)
Q Consensus 357 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp 409 (601)
.....+..++........ ...+++++.+||.+||..||.+|||+.++++|-
T Consensus 279 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 665555555544333222 246899999999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=369.58 Aligned_cols=262 Identities=18% Similarity=0.233 Sum_probs=215.4
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeec--CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
...+|++++.||+|+||.||+|++.. ...+++.||||++.... .......+.+|+.+++++. ||||+++++++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGVSLQ 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCC-CCCCCeEEEEEcC
Confidence 45689999999999999999998542 12367899999986432 3334567889999999995 9999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEE
Q 007498 223 VNNVYIVMELCEGGELLDRILARG------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRL 296 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl 296 (601)
...+|||||||++++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.+..+..+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999999987653 35899999999999999999999999999999999999975334667999
Q ss_pred eecccccccCCCC---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCC
Q 007498 297 IDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 297 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++ |..||...........+......
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence 9999997653322 223457899999999875 678999999999999999998 99999888877777777655432
Q ss_pred CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 372 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
.. ...++..+.+||.+||..||.+||++.++++|.|+-
T Consensus 265 ~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 265 DP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 21 246899999999999999999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=363.15 Aligned_cols=252 Identities=22% Similarity=0.353 Sum_probs=201.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeec-CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV- 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~- 223 (601)
..+|++++.||+|+||.||+|+... ...+++.||||++... .....+.+.+|+.++++++ ||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG 84 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 4589999999999999999998431 1126889999998653 3334577899999999996 99999999998653
Q ss_pred -CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 224 -NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 224 -~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
..+|||||||++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~---~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN---ENRVKIGDFGLT 161 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE---TTEEEECCCCSC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcC---CCeEEEccCccc
Confidence 5699999999999999998877667999999999999999999999999999999999999964 788999999999
Q ss_pred cccCCCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh----------------HH
Q 007498 303 DFIRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES----------------GI 361 (601)
Q Consensus 303 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----------------~~ 361 (601)
........ .....||..|+|||++. ..++.++|||||||++|+|++|..||...... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87654322 23346788899999876 67999999999999999999999998543211 11
Q ss_pred HHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 362 FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 362 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
...+. .....+. ...+++++.+||.+||..||++|||+.|+++
T Consensus 242 ~~~~~-~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 242 IELLK-NNGRLPR--PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHH-TTCCCCC--CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHh-ccCcCCC--CcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11222 2222221 2468999999999999999999999999885
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=365.56 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=214.8
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
..+|++.+.||+|+||.||+|++... ..+++.||||++.... .....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQD 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEEEEecC
Confidence 35799999999999999999987431 2256899999987542 3345677899999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCC
Q 007498 224 NNVYIVMELCEGGELLDRILARG-----------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKP 280 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~-----------------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp 280 (601)
+.+|+||||+++++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 99999999999999999987643 2389999999999999999999999999999999
Q ss_pred CceEeecCCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 007498 281 ENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWA 355 (601)
Q Consensus 281 ~NIll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~ 355 (601)
+|||++ .++.+||+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+
T Consensus 179 ~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 179 RNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp GGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred heEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999996 478899999999987644322 23456788999999876 568999999999999999999 9999998
Q ss_pred CChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 356 RTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 356 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.........+....... ....+++++.+||.+||..||.+||++.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 256 IPPERLFNLLKTGHRME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHhhcCCcCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88877776666543221 124689999999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=363.97 Aligned_cols=255 Identities=21% Similarity=0.308 Sum_probs=210.2
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|++++.||+|+||.||+|++.. +++.||||++..... ...+.+|+.+++.+.+|+||+++++++...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred ccccceEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 345689999999999999999999865 788999999865432 234788999999997699999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC--CCCCCeEEeeccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG--RDDADMRLIDFGL 301 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~--~~~~~vkl~DFG~ 301 (601)
...|+||||+ +++|.+++......+++.++..++.||+.||.|||++||+||||||+|||++.+ .....+||+|||+
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999999999 899999988776779999999999999999999999999999999999999642 1233499999999
Q ss_pred ccccCCCCC--------ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHccC
Q 007498 302 SDFIRPDER--------LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSD 369 (601)
Q Consensus 302 a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~ 369 (601)
+........ ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.. ....+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 987654322 34568999999999986 468999999999999999999999998743 333333333221
Q ss_pred CCCC-CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 370 PNFD-DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 370 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
...+ ......+++++.+||.+||..||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1111 0112368999999999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=386.68 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=199.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|.+.+.||+|+||+||... .. +++.||||++...... .+.+|+.+|+.+.+|||||++++++.+...+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~-~~---~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRG-MF---DNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEE-ES---SSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EEEecCCeeecCcCEEEEEEE-Ee---CCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 369999999999999976433 22 6789999998654322 2468999999995599999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC--CCCCeEEeecccccc
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR--DDADMRLIDFGLSDF 304 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~--~~~~vkl~DFG~a~~ 304 (601)
|||||||. |+|.+++......+.+..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+|+.
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99999996 599999887666677778889999999999999999999999999999996422 234688999999987
Q ss_pred cCCCC----Cccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCC-
Q 007498 305 IRPDE----RLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDD- 374 (601)
Q Consensus 305 ~~~~~----~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~- 374 (601)
+.... .....+||+.|+|||++. ..++.++|||||||++|||++ |..||......... .+.. ......
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~-~~~~~~~ 250 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLG-ACSLDCL 250 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTT-CCCCTTS
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhc-cCCcccc
Confidence 65432 334578999999999985 357889999999999999999 89999655443322 2222 211111
Q ss_pred CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 375 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
.+....+..+.+||.+||..||.+|||+.|+|+||||++
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 111234667899999999999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=379.62 Aligned_cols=261 Identities=27% Similarity=0.440 Sum_probs=207.7
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc----------CCCCeeE
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS----------GHKHLVK 215 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~niv~ 215 (601)
..+|++++.||+|+||.||+|++.. +++.||||++.... ...+.+.+|+.+++++. +|+||++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC---CCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 3579999999999999999999876 78899999986432 24467889999999885 2789999
Q ss_pred EeeeEecCC----cEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecC-
Q 007498 216 FCDACEDVN----NVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSG- 288 (601)
Q Consensus 216 l~~~~~~~~----~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~- 288 (601)
+++++...+ .+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999988654 799999999 88999988764 34699999999999999999999998 99999999999999642
Q ss_pred --CCCCCeEEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC------hh
Q 007498 289 --RDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART------ES 359 (601)
Q Consensus 289 --~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~------~~ 359 (601)
+..+.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|||++|..||.+.. ..
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 2344799999999977643 234568999999999886 468999999999999999999999997543 22
Q ss_pred HHHHHHHccCCCCCC------------------------C--------------CCCCCCHHHHHHHHHcccccccCCCC
Q 007498 360 GIFRAVLRSDPNFDD------------------------L--------------PWPSVSPEAKDFVKRLLNKDYRKRMT 401 (601)
Q Consensus 360 ~~~~~i~~~~~~~~~------------------------~--------------~~~~~s~~~~~li~~~L~~dP~~R~s 401 (601)
..+..+.......+. . ....++.++.+||.+||..||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 233333221111000 0 00134578999999999999999999
Q ss_pred HHHHHcCcccCCCCC
Q 007498 402 AVQALTHPWLRDDSR 416 (601)
Q Consensus 402 ~~ell~hp~f~~~~~ 416 (601)
+.|+|+||||++...
T Consensus 328 ~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 328 AGGLVNHPWLKDTLG 342 (373)
T ss_dssp HHHHHTCGGGTTCTT
T ss_pred HHHHhhChhhhcccC
Confidence 999999999997643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=382.84 Aligned_cols=258 Identities=27% Similarity=0.413 Sum_probs=199.5
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+...|.+.+.||+|+||+||.+... +++.||||++.... .+.+.+|+.+++++.+|||||++++++.+.
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~~~----~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQGSF----QGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEEES----SSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred hhhheeeccCeEeeCCCeEEEEEEEE----CCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 44567888899999999999875432 68899999986532 345788999999875699999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC---------
Q 007498 224 NNVYIVMELCEGGELLDRILARGGR------YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG--------- 288 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~------l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~--------- 288 (601)
+.+|||||||. |+|.+++...... .++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 99999999996 5999988654211 1333567899999999999999999999999999999742
Q ss_pred -CCCCCeEEeecccccccCCCCC-----ccccccccccccchhcc--------CCCCChhhHHHHHHHHHHHHh-CCCCC
Q 007498 289 -RDDADMRLIDFGLSDFIRPDER-----LNDIVGSAYYVAPEVLH--------RSYSLEADIWSIGVISYILLC-GSRPF 353 (601)
Q Consensus 289 -~~~~~vkl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~--------~~~~~~~DvwSlG~il~ell~-g~~pf 353 (601)
+.+..+||+|||++..+..... ....+||+.|+|||++. +.++.++|||||||++|||++ |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 2356899999999987754321 23468999999999874 358999999999999999999 99999
Q ss_pred CCCChhHHHHHHHccCCCCCCCC---CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 354 WARTESGIFRAVLRSDPNFDDLP---WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 354 ~~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
....... ..+......+.... ...+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 241 ~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 241 GDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp CSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred CCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 7654433 34444443333221 12356889999999999999999999999999999753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=355.29 Aligned_cols=247 Identities=23% Similarity=0.403 Sum_probs=214.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||++++. +++.||+|++..... ..+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSC
T ss_pred hheeeeeEecCCCceeEEEEEec----CCCeEEEEEccccCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCe
Confidence 47999999999999999999985 457899999976543 2367899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++....+.+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---GGGCEEECCTTGGGGBC
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC---CCCCEEEcccccccccc
Confidence 999999999999999887767899999999999999999999999999999999999995 47889999999997664
Q ss_pred CCC--Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 307 PDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 307 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
... ......||..|+|||++. ..++.++|||||||++|+|++ |..||...........+........ ...++.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~ 232 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAST 232 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCH
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcH
Confidence 321 123456788999999986 678999999999999999999 8999998888887777766533222 135789
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
++.+||.+||..||.+||++.+++++
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 233 HVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=364.02 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=204.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||+|++.. +++.||||++...........+.+.+|+.+++++. ||||+++++++...+.+
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTV---RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcC---CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeE
Confidence 479999999999999999999876 78899999997765545555678999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~---~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSCCC-----
T ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc---CCCCEEEecCccCcccc
Confidence 9999999999999988765 5799999999999999999999999999999999999995 47899999999997664
Q ss_pred CCC--Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 307 PDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 307 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.....+.. .+...........+.++++
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA-HINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH-HHHSCCCCGGGTSTTCCTH
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH-HhccCCCCccccCCCCCHH
Confidence 432 234567999999999886 568999999999999999999999998766554333 3333333222334678999
Q ss_pred HHHHHHHcccccccCCC-CHHHHHc
Q 007498 384 AKDFVKRLLNKDYRKRM-TAVQALT 407 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~-s~~ell~ 407 (601)
+.+||.+||..||.+|| +++++++
T Consensus 265 l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 265 FDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999999 7877765
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=369.50 Aligned_cols=258 Identities=29% Similarity=0.558 Sum_probs=203.7
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch---hhHHHHHHHHHHHHHhc---CCCCeeEEee
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILKALS---GHKHLVKFCD 218 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~---~h~niv~l~~ 218 (601)
+..+|++++.||+|+||.||+|++.. +++.||||++........ .....+.+|+.+++++. +||||+++++
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLT---DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTT---TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEcc---CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 45689999999999999999999876 788999999976543221 12234567999999993 3999999999
Q ss_pred eEecCCcEEEEEee-cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 219 ACEDVNNVYIVMEL-CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 219 ~~~~~~~~~lv~e~-~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
++...+..|+|||| +.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~kl~ 182 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKLI 182 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET--TTTEEEEC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC--CCCeEEEE
Confidence 99999999999999 7899999988765 57999999999999999999999999999999999999962 47889999
Q ss_pred ecccccccCCCCCccccccccccccchhcc-CCC-CChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCC
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSY-SLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 375 (601)
|||++...... ......||..|+|||++. ..+ +.++|||||||++|+|++|+.||.... .+......++
T Consensus 183 dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~-- 253 (312)
T 2iwi_A 183 DFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP-- 253 (312)
T ss_dssp CCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC--
T ss_pred EcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc--
Confidence 99999876543 345668999999999875 344 568999999999999999999996431 2333333332
Q ss_pred CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 376 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
..++.++.+||.+||..||++||++.|+++||||+......+
T Consensus 254 --~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~ 295 (312)
T 2iwi_A 254 --AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVP 295 (312)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC------
T ss_pred --ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhccc
Confidence 468999999999999999999999999999999998765444
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=372.32 Aligned_cols=249 Identities=21% Similarity=0.338 Sum_probs=206.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcE----EEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQ----VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
.+|++++.||+|+||.||+|++.. +++. ||+|++...... .....+.+|+.++++++ ||||+++++++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~- 85 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIP---EGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLD-HAHIVRLLGLCP- 85 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECC---TTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-
T ss_pred hHceeeeeeeecCCceEEEEEEcC---CCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-
Confidence 579999999999999999999875 4443 777877543211 12345678999999996 999999999986
Q ss_pred CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
+..+|+||||+.+|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~a 162 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVA 162 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES---SSSCEEECSCSGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC---CCCeEEECCCCcc
Confidence 4678999999999999999877666899999999999999999999999999999999999995 4789999999999
Q ss_pred cccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCC
Q 007498 303 DFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 303 ~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 377 (601)
+.+..... .....||..|+|||++. +.++.++|||||||++|+|++ |..||.+.........+.........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 239 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP--- 239 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---
Confidence 87754332 24457888999999886 679999999999999999999 99999988777777666654322211
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..++.++.+||.+||..||.+||++.+++++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 240 QICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3578889999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=369.55 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=189.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHH-HHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK-ILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+|++++.||+|+||.||+|+++. +++.||||++.... .......+.+|+. +++.+ +||||+++++++...+.
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKP---SGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREGD 95 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETT---TTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSSE
T ss_pred HHhhehheeccCCCEEEEEEEEcC---CCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCCc
Confidence 579999999999999999999876 78899999997643 2223455666776 55555 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCceEeecCCCCCCeEEeecc
Q 007498 226 VYIVMELCEGGELLDRILA----RGGRYTEEDAKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTSGRDDADMRLIDFG 300 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~----~~~~l~~~~~~~i~~ql~~~L~~LH~~-~iiHrDikp~NIll~~~~~~~~vkl~DFG 300 (601)
+||||||+++ +|.+.+.. ....+++..+..++.|++.||.|||++ ||+||||||+|||++ .++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccCC
Confidence 9999999986 77776653 256799999999999999999999999 999999999999996 47899999999
Q ss_pred cccccCCCCCccccccccccccchhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHccC-CCCC
Q 007498 301 LSDFIRPDERLNDIVGSAYYVAPEVLH-----RSYSLEADIWSIGVISYILLCGSRPFWARTES-GIFRAVLRSD-PNFD 373 (601)
Q Consensus 301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~-~~~~ 373 (601)
++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||...... +.+..+.... +.+.
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251 (327)
T ss_dssp SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 998776554445568999999999972 45899999999999999999999999764321 2222222221 2222
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
...+..+++++.+||.+||..||.+||++.++++||||...
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 22335689999999999999999999999999999999754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=358.43 Aligned_cols=252 Identities=21% Similarity=0.369 Sum_probs=212.4
Q ss_pred CCeEEcc-eeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGK-EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+|.+.+ .||+|+||.||+|.++... ++..||||++.... .....+.+.+|+++++++. ||||+++++++ ..+.
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAEA 83 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESSS
T ss_pred HHhhhhhccccccCceeEEEeEeccCC-CcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCCC
Confidence 4677776 9999999999999865322 57789999997642 3345678999999999996 99999999999 4567
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN---RHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE---TTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcC---CCCEEECcccceeee
Confidence 99999999999999988766677999999999999999999999999999999999999964 789999999999876
Q ss_pred CCCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 306 RPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 306 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
..... .....||+.|+|||++. ..++.++|||||||++|+|++ |+.||......+....+....... ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~ 237 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPE 237 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCTT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC---CCCC
Confidence 54322 22345789999999886 578999999999999999998 999998888777777776643221 1247
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCc
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp 409 (601)
+++++.+||.+||..||.+||++.+++++.
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 899999999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=361.38 Aligned_cols=252 Identities=27% Similarity=0.488 Sum_probs=200.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||+|++.. +++.||||++.............+.+|+.++++++ ||||+++++++...+.+
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNEL 107 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETT---TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred cceEEEEeecCCCCceEEEEEEcC---CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcE
Confidence 479999999999999999999875 78899999998655555556778999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 227 YIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
|+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~---~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc---CCCCEEEEecccee
Confidence 999999999999988764 356799999999999999999999999999999999999995 47899999999997
Q ss_pred ccCCCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC--hhHHHHHHHccCCCCCCCCCCC
Q 007498 304 FIRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART--ESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 304 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.. .......+... .++......
T Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 262 (310)
T 2wqm_A 185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDH 262 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT--CSCCCCTTT
T ss_pred eecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc--cCCCCcccc
Confidence 764332 234567999999999876 568999999999999999999999997643 22333444332 223333457
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++.++.+||.+||..||.+||++.++++
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 8999999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=360.38 Aligned_cols=251 Identities=22% Similarity=0.422 Sum_probs=197.6
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
...+|+++++||+|+||.||++++.. .||||++..... .....+.+.+|+.++++++ ||||+++++++ ...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG------DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAP 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS------EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSS
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC------ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCC
Confidence 45689999999999999999998642 599999876542 3345678999999999996 99999999965 456
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+++|||||++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~---~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE---DNTVKIGDFGLATE 169 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET---TTEEEECCCC----
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC---CCCEEEccceeccc
Confidence 789999999999999988766678999999999999999999999999999999999999964 78999999999976
Q ss_pred cCC---CCCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc-CCCCC-CC
Q 007498 305 IRP---DERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS-DPNFD-DL 375 (601)
Q Consensus 305 ~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~-~~ 375 (601)
... ........||+.|+|||++. ..++.++|||||||++|+|++|+.||........+...... ..... ..
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 543 22234568999999999874 45888999999999999999999999876655544444332 22111 11
Q ss_pred CCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 376 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
....+++++.+||.+||..||.+|||+.++++
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 23468899999999999999999999999886
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=362.83 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=205.6
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
...+|.+++.||+|+||.||+|++.....++..||||++..... .....+.+.+|+.++++++ ||||+++++++....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMS 109 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC--
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeecc
Confidence 34689999999999999999998876544667899999876433 2334577899999999996 999999999997754
Q ss_pred -----cEEEEEeecCCCchHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCe
Q 007498 225 -----NVYIVMELCEGGELLDRILA-----RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294 (601)
Q Consensus 225 -----~~~lv~e~~~~g~L~~~~~~-----~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~v 294 (601)
..|+||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC---TTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcE
Confidence 45999999999999998853 235699999999999999999999999999999999999995 47899
Q ss_pred EEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccC
Q 007498 295 RLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSD 369 (601)
Q Consensus 295 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 369 (601)
||+|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+.........+....
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence 9999999987644321 23356788999999886 568999999999999999999 999998888888777776654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.... ...+++++.+||.+||..||.+||++.+++++
T Consensus 267 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 RLKQ---PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCCC---BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCC---CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2211 24689999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=363.76 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=210.4
Q ss_pred CCCeEEcceeccCCCeEEEEEEeec--CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
..+|++++.||+|+||.||+|++.. ...+++.||||++.... .......+.+|+.+++++.+||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 4589999999999999999998653 22367899999997643 2334567899999999996699999999998765
Q ss_pred C-cEEEEEeecCCCchHHHHHHcCCC---------------CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec
Q 007498 224 N-NVYIVMELCEGGELLDRILARGGR---------------YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS 287 (601)
Q Consensus 224 ~-~~~lv~e~~~~g~L~~~~~~~~~~---------------l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~ 287 (601)
+ .+|+|||||++|+|.+++...... +++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~- 182 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 182 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC-
Confidence 4 599999999999999988765322 89999999999999999999999999999999999995
Q ss_pred CCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 007498 288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF 362 (601)
Q Consensus 288 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~ 362 (601)
.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+......+
T Consensus 183 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 183 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp --GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred --CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 478899999999987654322 23457889999999875 678999999999999999998 99999876644443
Q ss_pred HHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
...+........ ...+++++.++|.+||..||.+|||+.|+++|
T Consensus 261 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCccCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333332222211 13589999999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=361.10 Aligned_cols=254 Identities=22% Similarity=0.342 Sum_probs=206.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|++......+..||||++...........+.+.+|+.+++++. ||||+++++++.... .
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-C
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-c
Confidence 47999999999999999999875432234479999987655444445678999999999996 999999999998765 8
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
++||||+++++|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~---~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE---TTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcC---CCCEEEcccccccccc
Confidence 9999999999999998876677999999999999999999999999999999999999964 7889999999998765
Q ss_pred CCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 307 PDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 307 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
.... .....+|..|+|||++. ..++.++|||||||++|+|++ |..||.+....+.+..+......++. ...+
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 250 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDC 250 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcCc
Confidence 4332 23356788999999886 568999999999999999999 99999998888888877766544432 2468
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.++.++|.+||..||.+||++.++++
T Consensus 251 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=356.27 Aligned_cols=248 Identities=21% Similarity=0.347 Sum_probs=214.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++.+.||+|+||.||+|+++. ++..||||++.... ...+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPP 83 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGG---GTEEEEEEEECSCS----THHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSS
T ss_pred ccceeEEeecCCCCceeEEEeEecC---CCEEEEEEecCcCH----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCC
Confidence 4579999999999999999999986 78899999986532 24577899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC---GGGCEEECCCCGGGT
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc---CCCCEEEccCcccee
Confidence 99999999999999998764 34599999999999999999999999999999999999995 478899999999987
Q ss_pred cCCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 305 IRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 305 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
...... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||...........+....... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME---RPEGC 237 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---CCTTC
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC---CCCCC
Confidence 654332 23356788999999876 679999999999999999999 999998887777766665542221 12468
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++++.+||.+||..||.+|||+.++++
T Consensus 238 ~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 238 PEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 999999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=368.50 Aligned_cols=251 Identities=21% Similarity=0.330 Sum_probs=208.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcE--EEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQ--VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|++.+.||+|+||.||+|+++. ++.. ||||++.... .....+.+.+|+.+++++.+||||+++++++.+.+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred HHccceeeeecCCCceEEEEEEcc---CCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 479999999999999999999876 5554 4999886532 22345678899999999955999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC
Q 007498 225 NVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~ 289 (601)
.+||||||+++|+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~--- 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG--- 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc---
Confidence 9999999999999999886542 4699999999999999999999999999999999999995
Q ss_pred CCCCeEEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHc
Q 007498 290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLR 367 (601)
Q Consensus 290 ~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~ 367 (601)
.++.+||+|||++.............+++.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256 (327)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence 47899999999997544333334456788999999886 568999999999999999998 9999998888777766655
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 368 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..... ....+++++.+||.+||..||.+|||+.+++++
T Consensus 257 ~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 257 GYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 42211 124689999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=364.98 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=213.8
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecC----CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKG----ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
..+|++++.||+|+||.||+|++... ..++..||||++.... .......+.+|+.+++++.+||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 35899999999999999999997531 1256789999987543 33356778999999999955999999999999
Q ss_pred cCCcEEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEee
Q 007498 222 DVNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT 286 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~ 286 (601)
..+.+|+||||+++|+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence 9999999999999999999887543 2489999999999999999999999999999999999995
Q ss_pred cCCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 007498 287 SGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGI 361 (601)
Q Consensus 287 ~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~ 361 (601)
.++.+||+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+.
T Consensus 192 ---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 192 ---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp ---TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred ---CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 478999999999987654332 23346788999999875 568999999999999999999 9999998888777
Q ss_pred HHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 362 FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 362 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
...+....... ....++.++.+||.+||..||.+||++.|++++
T Consensus 269 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 269 FKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77666553221 124689999999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=363.96 Aligned_cols=254 Identities=18% Similarity=0.310 Sum_probs=214.7
Q ss_pred CCCeEEcceeccCCCeEEEEEEeec--CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
..+|++.+.||+|+||.||+|+++. ...+++.||||++.... .......+.+|+.+++.+. ||||+++++++.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG 100 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSS
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEccC
Confidence 4589999999999999999998762 11256789999987542 2234567889999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCe
Q 007498 224 NNVYIVMELCEGGELLDRILARG---------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADM 294 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~---------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~v 294 (601)
+..|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc---CCCeE
Confidence 99999999999999999886532 4579999999999999999999999999999999999995 47899
Q ss_pred EEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccC
Q 007498 295 RLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSD 369 (601)
Q Consensus 295 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 369 (601)
||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++ |..||.+.........+....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence 9999999976543321 23346789999999876 578999999999999999999 899998888877777776654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.... ...++.++.+||.+||..||.+|||+.|+++|
T Consensus 258 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 LLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3211 24689999999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=364.27 Aligned_cols=249 Identities=20% Similarity=0.326 Sum_probs=203.8
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcE----EEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQ----VAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE 221 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 221 (601)
..+|++++.||+|+||.||+|++.. +++. ||+|.+.... .......+.+|+.++++++ ||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 87 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICL 87 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC---TTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcC---CCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEe
Confidence 3579999999999999999999875 4444 5667664432 2234577899999999996 999999999998
Q ss_pred cCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 222 DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
... .++||||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 88 ~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~---~~~~kL~DfG~ 163 (327)
T 3lzb_A 88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGL 163 (327)
T ss_dssp SSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE---TTEEEECCTTC
T ss_pred cCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcC---CCCEEEccCcc
Confidence 754 88999999999999999887788999999999999999999999999999999999999964 78899999999
Q ss_pred ccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCC
Q 007498 302 SDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLP 376 (601)
Q Consensus 302 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 376 (601)
++....... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+.........+...... +.
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~~-- 240 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQ-- 240 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-CC--
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CC--
Confidence 987643322 23345788999999876 579999999999999999999 99999988877776666554322 11
Q ss_pred CCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 377 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
...++.++.+||.+||..||.+||++.|+++
T Consensus 241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 241 PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2468999999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=358.09 Aligned_cols=252 Identities=19% Similarity=0.301 Sum_probs=208.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeE-ecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC-EDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~-~~~~~ 225 (601)
.+|++.+.||+|+||.||+|++.........||+|++... ......+.+.+|+.++++++ ||||+++++++ ..++.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS 101 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCCc
Confidence 4799999999999999999997653334557999998653 23345677899999999996 99999999985 45678
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.|+||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDM 178 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSCGGGCCC
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC---CCCCEEECcccccccc
Confidence 8999999999999999877667799999999999999999999999999999999999995 4789999999999866
Q ss_pred CCCC-----Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 306 RPDE-----RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 306 ~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
.... ......||+.|+|||++. ..++.++|||||||++|+|++ |.+||......+....+......... .
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 255 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---E 255 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---T
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---c
Confidence 4332 123456788999999886 578999999999999999999 66677776666666666665443322 4
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.++.++.+||.+||..||.+||++.|+++
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 57899999999999999999999999886
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=357.08 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=205.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeec-CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV- 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~- 223 (601)
...|++++.||+|+||.||+|+... ...+++.||||++.... .....+.+.+|+.+++.++ ||||+++++++...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence 3469999999999999999998421 12378999999997543 2234577899999999996 99999999999876
Q ss_pred -CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 224 -NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 224 -~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
..+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES---EHQVKIGDFGLT 173 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE---TTEEEECCCTTC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcC---CCCEEECccccc
Confidence 6799999999999999998777778999999999999999999999999999999999999964 788999999999
Q ss_pred cccCCCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC--------------ChhHHHH
Q 007498 303 DFIRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWAR--------------TESGIFR 363 (601)
Q Consensus 303 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~--------------~~~~~~~ 363 (601)
........ .....||..|+|||++. ..++.++|||||||++|+|++|..|+... .....+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 87754432 33467889999999876 56889999999999999999999886321 1111222
Q ss_pred HHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 364 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.........+ ....+++++.+||.+||..||.+|||+.++++
T Consensus 254 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGKRLP--CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccCCCC--CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2222222222 12478999999999999999999999999885
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=381.87 Aligned_cols=257 Identities=22% Similarity=0.372 Sum_probs=209.8
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+..+|++.+.||+|+||.||+|+++. +++.||||++....... ..+.+.+|++++++++ ||||+++++++....
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLN-HKNIVKLFAIEEETT 80 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCC-CTTBCCEEEEEECTT
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECC---CCcEEEEEEeccccccc--hHHHHHHHHHHHHhcC-CCCCCeEEEeeccCC
Confidence 45689999999999999999999876 78899999997644322 3567789999999996 999999999998754
Q ss_pred --cEEEEEeecCCCchHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec-CCCCCCeEEeec
Q 007498 225 --NVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDF 299 (601)
Q Consensus 225 --~~~lv~e~~~~g~L~~~~~~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~-~~~~~~vkl~DF 299 (601)
.+|||||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+.. ++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 7899999999999999876532 23999999999999999999999999999999999999843 134567999999
Q ss_pred ccccccCCCCCccccccccccccchhcc---------CCCCChhhHHHHHHHHHHHHhCCCCCCCC----ChhHHHHHHH
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH---------RSYSLEADIWSIGVISYILLCGSRPFWAR----TESGIFRAVL 366 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DvwSlG~il~ell~g~~pf~~~----~~~~~~~~i~ 366 (601)
|+++...........+||+.|+|||++. ..++.++|||||||++|||++|+.||... ...+.+..+.
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp GGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred CCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 9998877666666788999999999874 35788999999999999999999999642 3344555555
Q ss_pred ccCCCCC-------------------CC--CCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 367 RSDPNFD-------------------DL--PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 367 ~~~~~~~-------------------~~--~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
...+... .. ....++..+.+||.+||..||++|+++.|+++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 5443210 00 00124567899999999999999999999865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=362.46 Aligned_cols=254 Identities=20% Similarity=0.340 Sum_probs=208.7
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCC-ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
..+|.+.+.||+|+||.||+|+++... ..+..||||++.... .......+.+|+.+++++. ||||+++++++...+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYK 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCC
Confidence 357999999999999999999886421 124569999986542 2334567899999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+||||||+++|+|.+++....+.+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC---CCCcEEECCCCcchh
Confidence 99999999999999999887777899999999999999999999999999999999999995 478999999999987
Q ss_pred cCCCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 305 IRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 305 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
...... .....+|..|+|||++. ..++.++|||||||++|+|++ |..||......+....+..... .+. ..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~-~~~--~~ 273 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-LPT--PM 273 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCC--CT
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc-CCC--cc
Confidence 653321 12345688999999886 578999999999999999998 9999998888777777765432 111 24
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.++.++.+||.+||..||.+||++.+++++
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 689999999999999999999999998863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=364.50 Aligned_cols=255 Identities=22% Similarity=0.348 Sum_probs=212.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCC--ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
..+|++++.||+|+||.||+|++.... ...+.||+|++.... .....+.+.+|+.++++|.+||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 457999999999999999999986421 133589999986543 2334577899999999994599999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC
Q 007498 224 NNVYIVMELCEGGELLDRILAR-------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~-------------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~ 290 (601)
+.+|||||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~--- 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN--- 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG---
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC---
Confidence 9999999999999999988653 346899999999999999999999999999999999999964
Q ss_pred CCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007498 291 DADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAV 365 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i 365 (601)
++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+......+..+
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 78899999999986643322 23456788999999875 679999999999999999998 99999887665555555
Q ss_pred HccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
......... ...+++++.+||.+||..||.+|||+.|+++
T Consensus 280 ~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 280 VKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 544333222 2357899999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=359.64 Aligned_cols=240 Identities=33% Similarity=0.605 Sum_probs=193.8
Q ss_pred cCCCeEEc-ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-
Q 007498 145 FGAKYELG-KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED- 222 (601)
Q Consensus 145 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~- 222 (601)
+..+|.+. +.||+|+||.||+|+++. +++.||||++... ..+.+|+.++.++.+||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcC---CCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 44568877 789999999999999876 7889999998542 3567899998666569999999999877
Q ss_pred ---CCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 223 ---VNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 223 ---~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
...+|||||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++....++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 678999999999999999987753 3699999999999999999999999999999999999997544478899999
Q ss_pred cccccccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHc----cCCCCCC
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR----SDPNFDD 374 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~----~~~~~~~ 374 (601)
||++..... ..++.++|||||||++|+|++|..||.+.........+.. ....++.
T Consensus 164 fg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 164 FGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp CTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred ccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 999865431 3467899999999999999999999976554332211111 1111111
Q ss_pred CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 375 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
..+..+++++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 11246899999999999999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=356.75 Aligned_cols=254 Identities=20% Similarity=0.293 Sum_probs=205.3
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCee-EEeeeEec
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLV-KFCDACED 222 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv-~l~~~~~~ 222 (601)
.+..+|++++.||+|+||.||+|++.. +++.||||++...... +.+.+|+.+++.+. |++++ .+..++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~-~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQ-GGVGIPTIRWCGAE 76 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEESCSSC-----CHHHHHHHHHHHHT-TSTTCCCEEEEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcC---CCcEEEEEEecCCcch-----hHHHHHHHHHHHhh-cCCCCCccccccCC
Confidence 345689999999999999999999875 7899999998654322 35789999999997 66655 44445567
Q ss_pred CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
....|+||||+ +++|.+++......+++.++..++.||+.||.|||++||+||||||+|||++.++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 78889999999 88999998866778999999999999999999999999999999999999964345789999999999
Q ss_pred cccCCCCC--------ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHccCC
Q 007498 303 DFIRPDER--------LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART---ESGIFRAVLRSDP 370 (601)
Q Consensus 303 ~~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~ 370 (601)
........ ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.. ....+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 87654322 24568999999999986 468999999999999999999999997633 2233333332211
Q ss_pred CCCC-CCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 371 NFDD-LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 371 ~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..+. .....+++++.+||.+||..||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1110 011368899999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=373.65 Aligned_cols=260 Identities=17% Similarity=0.235 Sum_probs=198.3
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCC--ccCcEEEEEEeecccccchh--------hHHHHHHHHHHHHHhcCCCCee
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGE--LKDQQVAVKIISKAKMTTAI--------SIEDVRREVKILKALSGHKHLV 214 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~~h~niv 214 (601)
...+|++++.||+|+||.||+|+++.+. ..++.||||++......... ....+..|+..++.+. ||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCCC
Confidence 4458999999999999999999987532 13578999998654311000 0012234445555564 99999
Q ss_pred EEeeeEecC----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCC
Q 007498 215 KFCDACEDV----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 215 ~l~~~~~~~----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~ 290 (601)
++++++... ..+||||||| |++|.+++....+.+++..++.|+.||+.||.|||++||+||||||+|||++. +.
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-SC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-CC
Confidence 999998765 4589999999 99999998877678999999999999999999999999999999999999973 24
Q ss_pred CCCeEEeecccccccCCCCC--------ccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 007498 291 DADMRLIDFGLSDFIRPDER--------LNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGI 361 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~ 361 (601)
++.+||+|||+++.+..... ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 78999999999977643221 234569999999999874 699999999999999999999999975433222
Q ss_pred HHHHHcc--CCCCC-----CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 362 FRAVLRS--DPNFD-----DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 362 ~~~i~~~--~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+...... ..... ......+++++.+||.+||..||.+||++.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111110 00000 0011467899999999999999999999998875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=372.43 Aligned_cols=253 Identities=20% Similarity=0.288 Sum_probs=202.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe-cCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE-DVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-~~~~ 225 (601)
..|++.+.||+|+||.||++++.........||||.+... ......+.+.+|+.++++++ ||||+++++++. ..+.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCC
Confidence 3689999999999999999998653333467999998653 23335678999999999996 999999999865 4568
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
.|+||||+++|+|.+++......+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC---CCCCEEEeeccccccc
Confidence 8999999999999999877667799999999999999999999999999999999999995 4789999999999866
Q ss_pred CCCCC-----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 306 RPDER-----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 306 ~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
..... .....+|+.|+|||++. +.++.++|||||||++|||++ |.+||......+....+........ ..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p~ 319 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PE 319 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---CT
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 43321 23356788999999876 679999999999999999999 7888877766666666665543222 14
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.++..+.+||.+||..||.+||++.|++++
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 689999999999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=382.80 Aligned_cols=248 Identities=21% Similarity=0.360 Sum_probs=213.3
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++.+.||+|+||.||+++++. ++..||||++..... ..+.+.+|+.+|++|+ |||||++++++.....
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGG---GTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcC---CCeEEEEEEecCccc----chHHHHHHHHHHHhcC-CCCEeeEEEEEecCCc
Confidence 3579999999999999999999876 678999999875432 3577899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+|||||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRL 367 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGGCEEECCTTCEEC
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC---CCCcEEEeeccccee
Confidence 99999999999999998764 34699999999999999999999999999999999999995 478999999999987
Q ss_pred cCCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 305 IRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 305 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
...... .....++..|+|||++. +.++.++|||||||+||||++ |..||.+.....+...+..... .. ....+
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 444 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-ME--RPEGC 444 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-CC--CCTTC
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCCC
Confidence 653321 23345678999999886 679999999999999999999 9999998887777766654322 11 12468
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++++.+||.+||..||.+|||+.++++
T Consensus 445 ~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 445 PEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999999999999876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=354.21 Aligned_cols=252 Identities=19% Similarity=0.250 Sum_probs=208.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++.+.||+|+||.||+|++.....++..||+|++... ......+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCC
Confidence 3688899999999999999998654434558999998653 23345678899999999996 99999999999876655
Q ss_pred -EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 -YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 -~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDI 174 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECCTTSSCTT
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcEEeCcCCCcccc
Confidence 999999999999999877677899999999999999999999999999999999999995 4789999999999765
Q ss_pred CCC-----CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCC-CCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 306 RPD-----ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRP-FWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 306 ~~~-----~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
... .......||+.|+|||++. ..++.++|||||||++|+|++|..| |...........+........ ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 251 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ---PE 251 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC---CT
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC---Cc
Confidence 432 2233457899999999986 4689999999999999999995555 555555555555554432211 24
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.+++++.+||.+||..||.+|||+.++++
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 68999999999999999999999999886
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=357.39 Aligned_cols=249 Identities=24% Similarity=0.427 Sum_probs=211.2
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED- 222 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~- 222 (601)
.+..+|++++.||+|+||.||+|++.. +++.||||++.... +.+.+|+++++++. ||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 76 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGF 76 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETT---TCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEE
T ss_pred hhccccceeeeeccCCceEEEEEEEcC---CCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEecc
Confidence 455689999999999999999999875 78899999986542 24578999999996 9999999998854
Q ss_pred ---------------CCcEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEee
Q 007498 223 ---------------VNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFT 286 (601)
Q Consensus 223 ---------------~~~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~ 286 (601)
...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156 (284)
T ss_dssp EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc
Confidence 45689999999999999998754 35799999999999999999999999999999999999996
Q ss_pred cCCCCCCeEEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 007498 287 SGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV 365 (601)
Q Consensus 287 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i 365 (601)
. ++.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.. .......+
T Consensus 157 ~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~ 231 (284)
T 2a19_B 157 D---TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDL 231 (284)
T ss_dssp E---TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHH
T ss_pred C---CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHh
Confidence 4 7889999999998877665566678999999999886 5689999999999999999999999843 22233333
Q ss_pred HccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.... ++ ..++.++.+||.+||..||.+||++.|+++|.|.-..
T Consensus 232 ~~~~--~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 232 RDGI--IS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HTTC--CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred hccc--cc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 3221 11 3578999999999999999999999999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=376.28 Aligned_cols=243 Identities=23% Similarity=0.364 Sum_probs=206.2
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC-
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN- 224 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~- 224 (601)
..+|++.+.||+|+||.||++.+. ++.||||+++... ..+.+.+|+.+|++|+ |||||++++++....
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 260 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----TEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTS
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-----CCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCC
Confidence 357999999999999999999863 5689999997543 3467899999999996 999999999987654
Q ss_pred cEEEEEeecCCCchHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
.+|||||||++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTK 337 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTSCEEECCCTTCE
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC---CCCCEEEeeCCCcc
Confidence 79999999999999999887643 379999999999999999999999999999999999995 47899999999997
Q ss_pred ccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
..... .....++..|+|||++. +.++.++|||||||++|||++ |+.||.+....+....+...... . ....++
T Consensus 338 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~--~p~~~~ 412 (450)
T 1k9a_A 338 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-D--APDGCP 412 (450)
T ss_dssp ECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-C--CCTTCC
T ss_pred ccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCCcCC
Confidence 65322 23346789999999886 579999999999999999998 99999988777777776654321 1 124689
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+++.+||.+||..||.+|||+.++++
T Consensus 413 ~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 413 PAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=378.61 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=209.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++.+.||+|+||.||++++. .+..||||+++.... ..+.+.+|+.+|++|+ |||||++++++. .+.
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KEP 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET----TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSS
T ss_pred hHHeEEEEEcccCCceEEEEEEEC----CccEEEEEEecCCCc----cHHHHHHHHHHHhhCC-CCCEeeEEEEEe-CCc
Confidence 457999999999999999999885 457899999976432 3578999999999996 999999999986 567
Q ss_pred EEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+|||||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARV 333 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTCCEEECSTTGGGG
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC---CCCcEEEeeCCCceE
Confidence 99999999999999988643 23689999999999999999999999999999999999995 478999999999987
Q ss_pred cCCCC--Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 305 IRPDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 305 ~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
..... ......+|..|+|||++. +.++.++|||||||++|||++ |+.||.+....++...+..... .+. ...+
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~~--~~~~ 410 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MPR--PENC 410 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC-CCC--CTTS
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCC--CCCC
Confidence 64322 123345678999999986 679999999999999999999 9999998888887777765432 221 2468
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++++.+||.+||..||++|||+.+++.
T Consensus 411 ~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 411 PEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 999999999999999999999998875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=367.63 Aligned_cols=254 Identities=19% Similarity=0.312 Sum_probs=204.6
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
....+|++.+.||+|+||.||+++++ +++.||||++.... ....+.+.+|+.+++.++ ||||+++++++...
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR----DGAKVALKRRTPES---SQGIEEFETEIETLSFCR-HPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT----TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCT
T ss_pred HHHhccCccceeecCCCeeEEEEEEC----CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCC
Confidence 34568999999999999999999864 57899999886542 224577899999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecc
Q 007498 224 NNVYIVMELCEGGELLDRILARG---GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~---~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG 300 (601)
+.+|+||||+++|+|.+++.... ..+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD---ENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC---TTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC---CCCCEEEeecc
Confidence 99999999999999998875432 3589999999999999999999999999999999999995 58899999999
Q ss_pred cccccCCCC---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH-----HccCCC
Q 007498 301 LSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV-----LRSDPN 371 (601)
Q Consensus 301 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i-----~~~~~~ 371 (601)
++....... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.+....+....+ ......
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 997654221 234457999999999875 67999999999999999999999999765432211000 001111
Q ss_pred C--------CCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 372 F--------DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 372 ~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+ .....+.++..+.+||.+||..||++|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 111112345678999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=350.83 Aligned_cols=245 Identities=18% Similarity=0.248 Sum_probs=208.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC--C
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV--N 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~ 224 (601)
.+|++.+.||+|+||.||++++ +++.||||++..... .....+.+.+|+.++++++ ||||+++++++.+. .
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-----QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAP 82 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSS
T ss_pred HHhHHHHHhcCCCcceEEEEEE-----CCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCC
Confidence 4799999999999999999987 367899999976543 3334577999999999996 99999999999887 7
Q ss_pred cEEEEEeecCCCchHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCceEeecCCCCCCeEEeeccc
Q 007498 225 NVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGL 301 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDikp~NIll~~~~~~~~vkl~DFG~ 301 (601)
.+|+||||+++|+|.+++..... .+++.+++.++.||+.||.|||++| |+||||||+|||++ .++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---~~~~~~l~~~~~ 159 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMADV 159 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC---TTSCEEEEGGGS
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc---CCcceeEEeccc
Confidence 89999999999999998876533 5999999999999999999999999 99999999999995 478899999998
Q ss_pred ccccCCCCCccccccccccccchhccC-C---CCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCC
Q 007498 302 SDFIRPDERLNDIVGSAYYVAPEVLHR-S---YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 302 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~---~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 377 (601)
+.... .....||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.+.........+......... .
T Consensus 160 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 233 (271)
T 3kmu_A 160 KFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI--P 233 (271)
T ss_dssp CCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC--C
T ss_pred eeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC--C
Confidence 75432 234578999999999864 2 344899999999999999999999988887776666654433221 2
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..+++++.+||.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 468999999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=386.76 Aligned_cols=250 Identities=21% Similarity=0.374 Sum_probs=207.0
Q ss_pred CCeEEcc-eeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGK-EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+.+.+ .||+|+||.||++.++... ++..||||+++... .....+.+.+|+++|++|+ |||||++++++.. +.
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EA 409 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSS-CEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SS
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCC-CcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CC
Confidence 3456655 8999999999999876422 45689999997642 2235678999999999996 9999999999976 56
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||++|+|.+++......+++..+..|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN---RHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE---TTEEEECCCSTTTTC
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcC---CCcEEEeeccCcccc
Confidence 99999999999999988766677999999999999999999999999999999999999964 789999999999876
Q ss_pred CCCCCc----cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 306 RPDERL----NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 306 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
...... ....+|+.|+|||++. +.++.++|||||||+||||++ |+.||.+....+++..+........ ...
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~ 563 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPE 563 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC---CTT
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CCc
Confidence 433221 2234568999999886 679999999999999999998 9999999888888777776542211 146
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+++++.+||.+||..||.+||++.++++
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=364.68 Aligned_cols=245 Identities=22% Similarity=0.302 Sum_probs=196.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC--
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN-- 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-- 224 (601)
.+|++++.||+|+||.||+|++. ++.||||++.... .......+|+.++++++ |||||++++++....
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-----NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSV 93 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-----TEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred hhchhhheecccCceEEEEEEEC-----CCEEEEEEeecCc----hHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCC
Confidence 47999999999999999999863 5789999986542 23345667999999996 999999999998754
Q ss_pred --cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc----------CCeeccCCCCceEeecCCCCC
Q 007498 225 --NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ----------GVVHRDLKPENFLFTSGRDDA 292 (601)
Q Consensus 225 --~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~----------~iiHrDikp~NIll~~~~~~~ 292 (601)
.+|||||||++|+|.+++... .+++..++.++.||+.||.|||++ ||+||||||+|||++ .++
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~---~~~ 168 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNL 168 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC---TTC
T ss_pred CceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC---CCC
Confidence 479999999999999988653 599999999999999999999999 999999999999995 478
Q ss_pred CeEEeecccccccCCCCC---ccccccccccccchhccC------CCCChhhHHHHHHHHHHHHhCCCCCCCCCh-----
Q 007498 293 DMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLHR------SYSLEADIWSIGVISYILLCGSRPFWARTE----- 358 (601)
Q Consensus 293 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~DvwSlG~il~ell~g~~pf~~~~~----- 358 (601)
.+||+|||+++.+..... ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+...
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 999999999987654332 344689999999999864 356789999999999999999999965422
Q ss_pred -----------hHHHHHHHccCCCCCCCC--C--CCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 359 -----------SGIFRAVLRSDPNFDDLP--W--PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 359 -----------~~~~~~i~~~~~~~~~~~--~--~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
......+..... .+... | ...+.++.+||.+||..||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKK-RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCC-CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhccCCchhhhhhhhhcccC-CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 122222222211 11110 0 112456999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=354.75 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=200.1
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeE-EeeeEec
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVK-FCDACED 222 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~-l~~~~~~ 222 (601)
.+..+|++++.||+|+||.||+|++.. +++.||||++...... ..+.+|+.+++.+. |++++. +..++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~-~~~~i~~~~~~~~~ 76 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQ-GGVGIPTIRWCGAE 76 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEC---C-----CCHHHHHHHHHHHT-TSTTCCCEEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcC---CCceEEEEeecccccc-----hHHHHHHHHHHHhc-CCCCCCeeeeecCC
Confidence 345689999999999999999999876 7889999987654322 34778999999997 665554 4445577
Q ss_pred CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
....|+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+..++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 78899999999 88999998876778999999999999999999999999999999999999953345788999999999
Q ss_pred cccCCCCC--------ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHHHHccCC
Q 007498 303 DFIRPDER--------LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES---GIFRAVLRSDP 370 (601)
Q Consensus 303 ~~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~ 370 (601)
........ .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.... ..+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 87654322 23568999999999986 46899999999999999999999999764322 22222222211
Q ss_pred CCCC-CCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 371 NFDD-LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 371 ~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..+. .....+++++.+||.+||..||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1110 011357899999999999999999999999886
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=352.13 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=207.5
Q ss_pred CCeEEcc-eeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGK-EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+|++.+ .||+|+||.||++.+... ..++.||||++..... .....+.+.+|+.+++.+. ||||+++++++ ..+.
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAES 91 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECS-SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESSS
T ss_pred hhhhhccCccccccCeeeEeeeecCC-CceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCCC
Confidence 4799988 999999999999966432 2578999999976532 2234577999999999996 99999999999 5677
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT---QHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE---TTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeC---CCcEEEccCCcceee
Confidence 89999999999999988664 57999999999999999999999999999999999999964 788999999999876
Q ss_pred CCCCCc----cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 306 RPDERL----NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 306 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
...... ....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+.........+....... ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 244 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAG 244 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTT
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCC
Confidence 544321 2245678999999886 568999999999999999999 999999888877777666543211 1246
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+++++.+||.+||..||.+||++.++++
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8999999999999999999999999885
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=361.69 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=206.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeec-CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe--cC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE--DV 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--~~ 223 (601)
.+|++++.||+|+||.||+|+... ...+++.||||++... .....+.+.+|++++++++ ||||+++++++. +.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCC
Confidence 579999999999999999998432 1226889999998654 2334567899999999996 999999999886 45
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
..+|||||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~---~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES---EAHVKIADFGLAK 175 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE---TTEEEECCGGGCE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECC---CCCEEEcccccce
Confidence 6799999999999999998876667999999999999999999999999999999999999964 7889999999998
Q ss_pred ccCCCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh--------------HHHHH
Q 007498 304 FIRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES--------------GIFRA 364 (601)
Q Consensus 304 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--------------~~~~~ 364 (601)
....... .....||..|+|||++. ..++.++|||||||++|+|++|..||...... ..+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 7654332 23456888999999876 56899999999999999999999998543321 11112
Q ss_pred HHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 365 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
........+. ...+++++.+||.+||..||.+|||+.|++++
T Consensus 256 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLEEGQRLPA--PPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcccCCCC--CCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222222211 24789999999999999999999999999653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=350.11 Aligned_cols=246 Identities=23% Similarity=0.374 Sum_probs=208.6
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||++++. .+..||||++..... ..+.+.+|+++++++. ||||+++++++.+ +.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred HHhhhheeeecCCCCeEEEEEEEc----CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCC-CcCcceEEEEEcC-CC
Confidence 357999999999999999999875 456899999865432 3467899999999996 9999999999874 56
Q ss_pred EEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARL 158 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc---CCCCEEECCCccccc
Confidence 899999999999999875432 2699999999999999999999999999999999999995 478999999999987
Q ss_pred cCCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 305 IRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 305 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
...... .....+|..|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+....... ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 235 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNC 235 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTC
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---Ccccc
Confidence 654322 23456788999999986 578999999999999999999 999999888877777776543221 12468
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+.++.+||.+||..||++|||+.++++
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999999999885
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=377.45 Aligned_cols=255 Identities=21% Similarity=0.318 Sum_probs=208.9
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
.+..+|+++++||+|+||.||+|++.. +++.||||++...... ..+.+|+++++.|..|++|+.+..++...
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETT---TCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECC---CCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 355789999999999999999999875 7889999998654332 34778999999998567788888888888
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
...||||||| +++|.+++......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.++.+||+|||+++
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 9999999999 889999988767789999999999999999999999999999999999999644458899999999998
Q ss_pred ccCCCCC--------ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHccCCC
Q 007498 304 FIRPDER--------LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE---SGIFRAVLRSDPN 371 (601)
Q Consensus 304 ~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~ 371 (601)
.+..... ....+||+.|+|||++. ..++.++|||||||+||||++|+.||.+... ...+..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 7654332 22578999999999986 4789999999999999999999999977543 2333333221110
Q ss_pred CC-CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 372 FD-DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 372 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.. ......++.++.+||.+||..||.+||++.+|++
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0001357899999999999999999999987765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=361.22 Aligned_cols=248 Identities=23% Similarity=0.406 Sum_probs=186.8
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe----
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE---- 221 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~---- 221 (601)
..+|++.+.||+|+||.||+|++.. +++.||||++... .......+.+|+.+++++.+||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVG---SGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred CceEEEEEEEccCCceEEEEEEECC---CCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 3479999999999999999999876 7889999998553 23345678899999999977999999999984
Q ss_pred ----cCCcEEEEEeecCCCchHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCceEeecCCCCCC
Q 007498 222 ----DVNNVYIVMELCEGGELLDRILA--RGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDAD 293 (601)
Q Consensus 222 ----~~~~~~lv~e~~~~g~L~~~~~~--~~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDikp~NIll~~~~~~~~ 293 (601)
....+|+||||+. |+|.+++.. ..+.+++.+++.++.||+.||.|||++| |+||||||+|||++ .++.
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~---~~~~ 176 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGT 176 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC---TTSC
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC---CCCC
Confidence 3455899999996 689888765 3567999999999999999999999999 99999999999995 4789
Q ss_pred eEEeecccccccCCCCCc-------------cccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 007498 294 MRLIDFGLSDFIRPDERL-------------NDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWAR 356 (601)
Q Consensus 294 vkl~DFG~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~ 356 (601)
+||+|||++......... ...+||+.|+|||++. ..++.++|||||||++|+|++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999999876533221 2457999999999872 35889999999999999999999999765
Q ss_pred ChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCc
Q 007498 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409 (601)
Q Consensus 357 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp 409 (601)
....... .....+ .....+..+.+||.+||..||.+||++.|+++|-
T Consensus 257 ~~~~~~~----~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 257 AKLRIVN----GKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -------------CCCC--TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hHHHhhc----CcccCC--cccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 4433222 222211 2245778899999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=355.52 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=196.7
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHH--hcCCCCeeEEeeeEe
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA--LSGHKHLVKFCDACE 221 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~l~~~~~ 221 (601)
.+..+|++++.||+|+||.||++++ +++.||||++... ....+.+|.+++.. ++ ||||+++++++.
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~niv~~~~~~~ 72 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW-----QGENVAVKIFSSR------DEKSWFRETELYNTVMLR-HENILGFIASDM 72 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCC-CTTBCCEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE-----CCEEEEEEEeccc------cchhhHHHHHHHHHhhcc-CcCeeeEEEeec
Confidence 4567899999999999999999976 4678999998643 23456678888877 64 999999999865
Q ss_pred c----CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeeccCCCCceEeecCC
Q 007498 222 D----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH--------LQGVVHRDLKPENFLFTSGR 289 (601)
Q Consensus 222 ~----~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH--------~~~iiHrDikp~NIll~~~~ 289 (601)
. ...+|+||||+++|+|.+++. ...+++..+..++.||+.||.||| ++||+||||||+|||++
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~--- 147 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK--- 147 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC---
T ss_pred cccCCCceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc---
Confidence 4 356899999999999999884 357999999999999999999999 99999999999999995
Q ss_pred CCCCeEEeecccccccCCCCC-----ccccccccccccchhccCC-------CCChhhHHHHHHHHHHHHhC--------
Q 007498 290 DDADMRLIDFGLSDFIRPDER-----LNDIVGSAYYVAPEVLHRS-------YSLEADIWSIGVISYILLCG-------- 349 (601)
Q Consensus 290 ~~~~vkl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DvwSlG~il~ell~g-------- 349 (601)
.++.+||+|||+++....... ....+||+.|+|||++.+. ++.++|||||||++|||++|
T Consensus 148 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~ 227 (301)
T 3q4u_A 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227 (301)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence 478999999999976644322 2345899999999998643 45789999999999999999
Q ss_pred --CCCCCCCC----hhHHHHHHHccCCCCCCCCC----CCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 350 --SRPFWART----ESGIFRAVLRSDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 350 --~~pf~~~~----~~~~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..||.... ....+..........+..+. ..+++++.+||.+||..||.+|||+.++++
T Consensus 228 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 88986532 22333333332222222110 124578999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=374.04 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=207.7
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++.+.||+|+||.||++++.. +..||||++..... ..+.+.+|+.+|++|+ ||||+++++++.+ +.
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC----CceEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-Cc
Confidence 3579999999999999999999863 45799999876432 3467899999999996 9999999999876 67
Q ss_pred EEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+|||||||++|+|.+++... ...+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARL 329 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC-
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC---CCCCEEECCCcccee
Confidence 89999999999999988643 35699999999999999999999999999999999999995 478999999999987
Q ss_pred cCCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 305 IRPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 305 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
...... .....++..|+|||++. +.++.++|||||||++|||++ |+.||.+....+.+..+...... +. ...+
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~~--~~~~ 406 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PC--PPEC 406 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-CC--CTTS
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CC--CCCC
Confidence 653321 23345788999999875 679999999999999999999 99999988888877777654321 11 1468
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHc--CcccCC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALT--HPWLRD 413 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~--hp~f~~ 413 (601)
++++.+||.+||..||++|||+.++++ ..++..
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 999999999999999999999999886 355543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.78 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=203.3
Q ss_pred cCCCe-EEcceeccCCCeEEEEEEeec-CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 145 FGAKY-ELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 145 ~~~~y-~~~~~lG~G~~g~V~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
+..+| ++++.||+|+||.||+++... ...+++.||||++.... .....+.+.+|++++++++ ||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYKGCCED 104 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEEEEEec
Confidence 34455 999999999999999986532 22368899999997642 3335677899999999996 9999999999987
Q ss_pred C--CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecc
Q 007498 223 V--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300 (601)
Q Consensus 223 ~--~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG 300 (601)
. ..+|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg 179 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFG 179 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCGG
T ss_pred CCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc---CCCCEEECCcc
Confidence 4 6789999999999999987543 599999999999999999999999999999999999995 47899999999
Q ss_pred cccccCCCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh--------------HH
Q 007498 301 LSDFIRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES--------------GI 361 (601)
Q Consensus 301 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--------------~~ 361 (601)
++........ .....||..|+|||++. ..++.++|||||||++|+|++|..||...... ..
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 9987754432 23456888999999886 46889999999999999999999999643221 01
Q ss_pred HHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 362 FRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 362 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+..........+ ....+++++.+||++||..||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 260 LTELLERGERLP--RPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccCCC--CCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 112222222211 12468999999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=359.73 Aligned_cols=250 Identities=20% Similarity=0.342 Sum_probs=202.1
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEe----
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACE---- 221 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~---- 221 (601)
..+|++++.||+|+||.||+|++.. +++.||||++... .....+.+.+|+.+++.+. ||||+++++++.
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLH---DGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERG 100 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEET
T ss_pred CeEEEEEEEecCCCCeEEEEEEecC---CCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccC
Confidence 3579999999999999999999875 7889999998653 2345677899999999996 999999999987
Q ss_pred cCCcEEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 222 DVNNVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
....+|+||||+.+|+|.+++.. ....+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~d 177 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMD 177 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECC
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc---CCCCEEEEe
Confidence 34578999999999999998876 356799999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCCC----------ccccccccccccchhccC----CCCChhhHHHHHHHHHHHHhCCCCCCCCC--hhHHH
Q 007498 299 FGLSDFIRPDER----------LNDIVGSAYYVAPEVLHR----SYSLEADIWSIGVISYILLCGSRPFWART--ESGIF 362 (601)
Q Consensus 299 FG~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~DvwSlG~il~ell~g~~pf~~~~--~~~~~ 362 (601)
||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .....
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 999876432111 123467999999999863 26899999999999999999999995311 11112
Q ss_pred HHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
........++. .+.++.++.+||.+||..||.+||++.+++++
T Consensus 258 -~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 258 -LAVQNQLSIPQ--SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -HHHHCC--CCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -HHhhccCCCCc--cccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 22222222222 24689999999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=382.64 Aligned_cols=245 Identities=22% Similarity=0.337 Sum_probs=203.6
Q ss_pred cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEe
Q 007498 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 231 (601)
.++||+|+||.||++.+... ..++.||||+++.... .....+.+.+|+++|++|+ |||||++++++.. +.+|||||
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~lv~E 449 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVME 449 (635)
T ss_dssp EEEEEECSSEEEEEEEEECS-SCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEEEEEE
T ss_pred CCEeccCCCEEEEEEEEcCC-CcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEEEEEE
Confidence 34799999999999976532 2568899999976432 3334678999999999996 9999999999965 56899999
Q ss_pred ecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCC-
Q 007498 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER- 310 (601)
Q Consensus 232 ~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~- 310 (601)
||++|+|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+++.+.....
T Consensus 450 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~---~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 450 MAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT---QHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp CCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE---TTEEEECCTTHHHHTTC----
T ss_pred ccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeC---CCCEEEEEcCCccccccCccc
Confidence 9999999998865 467999999999999999999999999999999999999964 78899999999987654332
Q ss_pred ---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 311 ---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 311 ---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
.....||+.|+|||++. ..++.++|||||||++|||++ |+.||.+....++...+........ ...+++++.
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~ 602 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMY 602 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHH
Confidence 22345788999999986 579999999999999999998 9999999888888777776543211 146899999
Q ss_pred HHHHHcccccccCCCCHHHHHc
Q 007498 386 DFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~ 407 (601)
+||.+||..||++||++.++++
T Consensus 603 ~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 603 DLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=367.55 Aligned_cols=259 Identities=20% Similarity=0.243 Sum_probs=197.3
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch--------hhHHHHHHHHHHHHHhcCCCCeeEE
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA--------ISIEDVRREVKILKALSGHKHLVKF 216 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~niv~l 216 (601)
...+|++++.||+|+||.||+|++.....++..||||++........ .....+.+|+.+++.+. ||||+++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~ 113 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLF 113 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCccee
Confidence 34689999999999999999999875444678999999876432110 11234567888899986 9999999
Q ss_pred eeeEec----CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCC
Q 007498 217 CDACED----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDA 292 (601)
Q Consensus 217 ~~~~~~----~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~ 292 (601)
++++.. ...+||||||| +++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++. +..+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY-KNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEES-SSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEcc-CCCC
Confidence 999987 77899999999 89999887654 37999999999999999999999999999999999999975 2234
Q ss_pred CeEEeecccccccCCCC--------CccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC--hhHH
Q 007498 293 DMRLIDFGLSDFIRPDE--------RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWART--ESGI 361 (601)
Q Consensus 293 ~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~--~~~~ 361 (601)
.+||+|||+++.+.... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.. ....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 99999999997764321 1245689999999999874 58999999999999999999999996532 2222
Q ss_pred HHHHHccCCCCCC-----CCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 362 FRAVLRSDPNFDD-----LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 362 ~~~i~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..........++. .+...+++++.+||.+||..||++||++.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1111111111111 011268899999999999999999999998876
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=366.37 Aligned_cols=248 Identities=18% Similarity=0.240 Sum_probs=198.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeec--CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcC--CCCeeEEeeeEe
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKK--GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSG--HKHLVKFCDACE 221 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~niv~l~~~~~ 221 (601)
..+|.+.+.||+|+||.||+|++.. ...+++.||||++... ....+.+|+++++.|.. |+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 4579999999999999999995322 1126889999998654 23567788888888852 899999999999
Q ss_pred cCCcEEEEEeecCCCchHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec--------CC
Q 007498 222 DVNNVYIVMELCEGGELLDRILA----RGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS--------GR 289 (601)
Q Consensus 222 ~~~~~~lv~e~~~~g~L~~~~~~----~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~--------~~ 289 (601)
..+..|||||||++|+|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+|||++. ++
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999999875 3467999999999999999999999999999999999999964 12
Q ss_pred CCCCeEEeecccccccC---CCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 007498 290 DDADMRLIDFGLSDFIR---PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAV 365 (601)
Q Consensus 290 ~~~~vkl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i 365 (601)
.++.+||+|||+|+.+. ........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 26899999999997543 3334456789999999999874 68999999999999999999999996443211
Q ss_pred HccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 366 LRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 366 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
......+.. ...++.+.+++.+||..+|.+|++..+.|.
T Consensus 293 ~~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 293 CKPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp EEECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred eeechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 011111221 124678999999999999999976555444
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=350.42 Aligned_cols=240 Identities=29% Similarity=0.465 Sum_probs=192.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||++++ .++.||||++... ...+.+.+|+.++++++ ||||+++++++.+ ..
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~ 74 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-----RAKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLYGACLN--PV 74 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEECSST-----THHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TT
T ss_pred hHeeeeeEeecCCCceEEEEEE-----CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--Cc
Confidence 4799999999999999999986 3578999998543 24567899999999996 9999999998874 48
Q ss_pred EEEEeecCCCchHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHH---cCCeeccCCCCceEeecCCCCCC-eEEeecc
Q 007498 227 YIVMELCEGGELLDRILARGG--RYTEEDAKAIVVQILSVVAFCHL---QGVVHRDLKPENFLFTSGRDDAD-MRLIDFG 300 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~--~l~~~~~~~i~~ql~~~L~~LH~---~~iiHrDikp~NIll~~~~~~~~-vkl~DFG 300 (601)
||||||+++|+|.+++..... .+++..+..++.||+.||.|||+ +||+||||||+|||++. ++. +||+|||
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~~kl~Dfg 151 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA---GGTVLKICDFG 151 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET---TTTEEEECCCC
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC---CCCEEEEcccc
Confidence 999999999999998865432 47899999999999999999999 89999999999999964 454 8999999
Q ss_pred cccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHccCCCCCCCCC
Q 007498 301 LSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES--GIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~ 377 (601)
++...... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||...... .....+..... + ...
T Consensus 152 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~-~~~ 226 (307)
T 2eva_A 152 TACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR--P-PLI 226 (307)
T ss_dssp C--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC--C-CCB
T ss_pred cccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC--C-Ccc
Confidence 99765432 23457999999999987 46899999999999999999999999754332 23333333221 1 112
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..++..+.+||.+||..||.+|||+.++++
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 478999999999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.50 Aligned_cols=242 Identities=22% Similarity=0.352 Sum_probs=198.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-Cc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV-NN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-~~ 225 (601)
.+|++.+.||+|+||.||++++ +++.||||++.... ..+.+.+|+.++++++ ||||+++++++... +.
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--C
T ss_pred hhceEEeEEecCCCceEEEEEE-----cCCEEEEEEecchh-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCc
Confidence 5799999999999999999976 46789999986542 3467889999999996 99999999987554 57
Q ss_pred EEEEEeecCCCchHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~-~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+|+||||+++++|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKE 166 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC---
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe---CCCcEEEeecccccc
Confidence 9999999999999998875432 389999999999999999999999999999999999995 478999999999976
Q ss_pred cCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
.... .....++..|+|||++. ..++.++|||||||++|+|++ |..||......+....+...... .....+++
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 241 (278)
T 1byg_A 167 ASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPP 241 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCCH
T ss_pred cccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCcccCCH
Confidence 5432 23446789999999886 578999999999999999998 99999888777777666544221 12246899
Q ss_pred HHHHHHHHcccccccCCCCHHHHHc
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++.++|.+||..||.+||++.|+++
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 242 AVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCChhhCCCHHHHHH
Confidence 9999999999999999999999885
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=359.22 Aligned_cols=256 Identities=18% Similarity=0.256 Sum_probs=202.4
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
...+|++.+.||+|+||.||++++. +++.||||++....... ....+.+|+.+++.+. ||||+++++++...+
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAV-HRNLLRLRGFCMTPT 100 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS----SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEECCSS
T ss_pred HhhccccceeEecCCCcEEEEEEec----CCCEEEEEEeccccCch--HHHHHHHHHHHHHhcc-CCCccceEEEEecCC
Confidence 4468999999999999999999754 57889999987643222 2235889999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCeeccCCCCceEeecCCCCCCeEEee
Q 007498 225 NVYIVMELCEGGELLDRILARG---GRYTEEDAKAIVVQILSVVAFCHLQ---GVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~---~~l~~~~~~~i~~ql~~~L~~LH~~---~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
..|+|||||++|+|.+++.... ..+++..+..++.||+.||.|||++ ||+||||||+|||++ .++.+||+|
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~---~~~~~kl~D 177 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGD 177 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC---TTCCEEECC
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC---CCCCEEecc
Confidence 9999999999999999887542 3499999999999999999999999 999999999999995 478999999
Q ss_pred cccccccCCCC--Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCC----CChhHHHHHHHccCC-
Q 007498 299 FGLSDFIRPDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWA----RTESGIFRAVLRSDP- 370 (601)
Q Consensus 299 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~----~~~~~~~~~i~~~~~- 370 (601)
||++....... .....+||+.|+|||++. +.++.++|||||||++|+|++|+.||.. ...............
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99998764332 234456999999999885 5789999999999999999999999941 111111111111110
Q ss_pred --CCCCC--------CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcc
Q 007498 371 --NFDDL--------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPW 410 (601)
Q Consensus 371 --~~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~ 410 (601)
..... .....+..+.+||.+||..||.+|||+.|+++|-+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00000 01122467999999999999999999999998754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=391.09 Aligned_cols=261 Identities=24% Similarity=0.410 Sum_probs=208.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec----
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED---- 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---- 222 (601)
.+|++.+.||+|+||.||+|++.. +++.||||++... ......+.+.+|+.++++++ ||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~---tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTT---TTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccc
Confidence 579999999999999999998875 7889999998654 23345677899999999996 9999999998765
Q ss_pred --CCcEEEEEeecCCCchHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 223 --VNNVYIVMELCEGGELLDRILARG--GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 223 --~~~~~lv~e~~~~g~L~~~~~~~~--~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
.+..|||||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 677899999999999999887543 2699999999999999999999999999999999999997643344599999
Q ss_pred cccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHH---------HH---
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFR---------AV--- 365 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~---------~i--- 365 (601)
||++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+........ .+
T Consensus 168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 99998877666666789999999999886 579999999999999999999999997643321110 00
Q ss_pred --HccCCCCCC------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 366 --LRSDPNFDD------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 366 --~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
......+.. .....+++++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 001111111 011236789999999999999999999999999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=378.99 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=212.1
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++.++||+|+||.||++++.. +..||||++..... ..+.+.+|+++|++|+ |||||++++++.+ +.
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT----TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC----CceEEEEEeCCCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEee-cc
Confidence 3579999999999999999999863 46799999976432 3467899999999996 9999999999876 67
Q ss_pred EEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+|||||||++|+|.+++... ...+++.++..|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARL 412 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCTTSTTT
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc---CCCcEEEccccccee
Confidence 99999999999999998643 34699999999999999999999999999999999999995 478999999999987
Q ss_pred cCCCC--Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 305 IRPDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 305 ~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
+.... ......++..|+|||++. +.++.++|||||||+||||++ |+.||.+....+++..+..... .+. ...+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~~--~~~~ 489 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPC--PPEC 489 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-CCC--CTTC
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCC--CCCC
Confidence 64321 123345788999999875 679999999999999999999 9999998888887777765432 111 2468
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcC--cccCC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTH--PWLRD 413 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~h--p~f~~ 413 (601)
+.++.+||.+||..||++|||+.+|++. .+|..
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 9999999999999999999999998863 45543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=362.46 Aligned_cols=249 Identities=15% Similarity=0.202 Sum_probs=199.7
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCc-----cCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeE-----
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGEL-----KDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVK----- 215 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~----- 215 (601)
..+|++.+.||+|+||.||+|++..... .++.||||++... ..+.+|+++++++. ||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence 4689999999999999999999875211 3689999998654 24678999999996 999987
Q ss_pred ----------EeeeEec-CCcEEEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCce
Q 007498 216 ----------FCDACED-VNNVYIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENF 283 (601)
Q Consensus 216 ----------l~~~~~~-~~~~~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NI 283 (601)
+++++.. +..+||||||| +++|.+++... ...+++.+++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 5666665 67899999999 99999998764 36799999999999999999999999999999999999
Q ss_pred EeecCCCCC--CeEEeecccccccCCCC--------CccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCC
Q 007498 284 LFTSGRDDA--DMRLIDFGLSDFIRPDE--------RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRP 352 (601)
Q Consensus 284 ll~~~~~~~--~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~p 352 (601)
|++. ++ .+||+|||+++.+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.|
T Consensus 191 l~~~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 191 FVDP---EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEET---TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEcC---CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9964 55 89999999997664322 1234589999999999874 789999999999999999999999
Q ss_pred CCCCC--hhHHHHHH---HccCCCCC--CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 353 FWART--ESGIFRAV---LRSDPNFD--DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 353 f~~~~--~~~~~~~i---~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
|.... ...+.... ......+. ...|..+++++.+||.+||..||++||++.++++
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 97653 22222222 12222221 1123467999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=353.48 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=203.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccc-cchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM-TTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.|..++.||+|+||.||++++ +++.||||++..... ......+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 105 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDL 105 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES-----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSC
T ss_pred ccccCCccccCCCeEEEEEEE-----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCce
Confidence 355668999999999999986 467899999875432 22334677999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 227 YIVMELCEGGELLDRILAR--GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~--~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD---EAFTAKISDFGLARA 182 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc---CCCcEEEeecccccc
Confidence 9999999999999988643 35699999999999999999999999999999999999995 478999999999976
Q ss_pred cCCCCC---ccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhH----HHHHHHccCCC------
Q 007498 305 IRPDER---LNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESG----IFRAVLRSDPN------ 371 (601)
Q Consensus 305 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~------ 371 (601)
...... ....+||+.|+|||++.+.++.++|||||||++|+|++|..||....... +...+......
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYID 262 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSC
T ss_pred cccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcc
Confidence 643322 23467999999999998889999999999999999999999997654332 22222211110
Q ss_pred --CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 372 --FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 372 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+.. .....+..+.++|.+||..||.+|||+.+++++
T Consensus 263 ~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 263 KKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SSCSC-CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccccc-cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 110 012345678999999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=380.89 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=212.0
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++++.||+|+||.||+|++......+..||||++.... .....+.+.+|+.++++++ ||||+++++++. .+.
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP 464 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-SSS
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe-cCc
Confidence 457999999999999999999987644456789999986532 3334577899999999996 999999999985 466
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~---~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYM 541 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE---TTEEEECCCCCCCSC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeC---CCCEEEEecCCCeec
Confidence 89999999999999998877667999999999999999999999999999999999999964 789999999999876
Q ss_pred CCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
..... .....||+.|+|||++. ..++.++|||||||++|||++ |..||.+....+.+..+........ .+.++
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~ 618 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PPNCP 618 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC---CTTCC
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC---Ccccc
Confidence 54332 22346788999999886 679999999999999999997 9999998888888777766543211 24689
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+++.+||.+||..||.+||++.++++
T Consensus 619 ~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 619 PTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999885
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=372.38 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=195.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHHhc--------CCCCe
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-----TAISIEDVRREVKILKALS--------GHKHL 213 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~h~ni 213 (601)
.+|++++.||+|+||.||+|++ +++.||||++...... .....+.+.+|+.+++.|+ .||||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred ccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4799999999999999999987 4689999999875432 2234577899999999995 47777
Q ss_pred eEEeeeE-----------------ec-------------CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHH
Q 007498 214 VKFCDAC-----------------ED-------------VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263 (601)
Q Consensus 214 v~l~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~ 263 (601)
|++.+.+ .+ .+.+|||||||++|++++.+.+ +.+++.+++.|+.||+.
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHH
Confidence 7776653 22 6789999999999988777643 57999999999999999
Q ss_pred HHHHHH-HcCCeeccCCCCceEeecCC-----------------CCCCeEEeecccccccCCCCCccccccccccccchh
Q 007498 264 VVAFCH-LQGVVHRDLKPENFLFTSGR-----------------DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325 (601)
Q Consensus 264 ~L~~LH-~~~iiHrDikp~NIll~~~~-----------------~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~ 325 (601)
||.||| ++||+||||||+|||++.+. ....+||+|||+|+..... ..+||+.|+|||+
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGG
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhh
Confidence 999999 99999999999999997521 0128999999999876543 4589999999999
Q ss_pred ccCCCCChhhHHHHHHH-HHHHHhCCCCCCCCCh-hHHHHHHHccCC---CCCCCCCCCCCHHHHHHHHHcccccccCCC
Q 007498 326 LHRSYSLEADIWSIGVI-SYILLCGSRPFWARTE-SGIFRAVLRSDP---NFDDLPWPSVSPEAKDFVKRLLNKDYRKRM 400 (601)
Q Consensus 326 ~~~~~~~~~DvwSlG~i-l~ell~g~~pf~~~~~-~~~~~~i~~~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 400 (601)
+.+..+.++||||||++ .++++.|..||..... ......+..... ......++.+++++++||++||++|
T Consensus 249 ~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----- 323 (336)
T 2vuw_A 249 FTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----- 323 (336)
T ss_dssp GCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred hcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence 98777999999998777 7789999999843211 112223332111 1111112357899999999999987
Q ss_pred CHHHHH-cCcccC
Q 007498 401 TAVQAL-THPWLR 412 (601)
Q Consensus 401 s~~ell-~hp~f~ 412 (601)
|+.|+| +||||+
T Consensus 324 sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 SATDLLCQHSLFK 336 (336)
T ss_dssp SHHHHHHHCGGGC
T ss_pred CHHHHHhcCCCcC
Confidence 999999 999995
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=350.33 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=204.4
Q ss_pred CCCeEEcceeccCCCeEEEEEEeec-CCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
..+|++++.||+|+||.||+++... ...+++.||||++... .....+.+.+|+.++++++ ||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC--
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEecC
Confidence 3579999999999999999998431 1226889999998653 2234577899999999996 999999999987653
Q ss_pred --cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 225 --NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 225 --~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
.+|+||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~---~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN---ENRVKIGDFGLT 192 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE---TTEEEECCCTTC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcC---CCcEEEecCcch
Confidence 789999999999999999877677999999999999999999999999999999999999964 788999999999
Q ss_pred cccCCCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh------------H---HH
Q 007498 303 DFIRPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES------------G---IF 362 (601)
Q Consensus 303 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~------------~---~~ 362 (601)
........ .....++..|+|||++. ..++.++|||||||++|+|++|..||...... . .+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 87654432 22346788899999876 56899999999999999999999998532110 0 11
Q ss_pred HHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
...+......+. ...+++++.+||.+||..||++|||+.|+++
T Consensus 273 ~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 273 IELLKNNGRLPR--PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHTTCCCCC--CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhcCCCCCC--CCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 122222222221 2468999999999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.33 Aligned_cols=248 Identities=22% Similarity=0.393 Sum_probs=206.1
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|++.+.||+|+||.||++++.. .||+|++....... ...+.+.+|+.++++++ ||||+++++++.+...
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG------EVAIRLIDIERDNE-DQLKAFKREVMAYRQTR-HENVVLFMGACMSPPH 103 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS------SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSSC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC------eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCc
Confidence 3579999999999999999998753 49999987643222 22345678999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSIS 179 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC--
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCcccc
Confidence 9999999999999998876656799999999999999999999999999999999999994 578999999998754
Q ss_pred CC------CCCccccccccccccchhccC----------CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC
Q 007498 306 RP------DERLNDIVGSAYYVAPEVLHR----------SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD 369 (601)
Q Consensus 306 ~~------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 369 (601)
.. ........||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 31 122334579999999998753 47889999999999999999999999888877777666543
Q ss_pred CCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 370 PNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 370 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
... .....++.++.+||.+||..||.+|||+.++++
T Consensus 260 ~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 260 KPN--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCC--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCC--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 322 222368899999999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.60 Aligned_cols=249 Identities=20% Similarity=0.334 Sum_probs=193.4
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc-CCCCeeEEeeeEec
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS-GHKHLVKFCDACED 222 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~l~~~~~~ 222 (601)
.+..+|++++.||+|+||.||++++ +++.||||++.... .....+|.+++..+. +||||+++++++..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW-----RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEE-----CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 3456899999999999999999986 46789999985432 234455666665541 49999999999987
Q ss_pred C----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeccCCCCceEeecCCC
Q 007498 223 V----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ--------GVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 223 ~----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~--------~iiHrDikp~NIll~~~~~ 290 (601)
. ..+|||||||++|+|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||++ .
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~---~ 177 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK---K 177 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC---T
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC---C
Confidence 7 7899999999999999988654 699999999999999999999999 999999999999995 4
Q ss_pred CCCeEEeecccccccCCCCC-----ccccccccccccchhccC-CCCC------hhhHHHHHHHHHHHHhC---------
Q 007498 291 DADMRLIDFGLSDFIRPDER-----LNDIVGSAYYVAPEVLHR-SYSL------EADIWSIGVISYILLCG--------- 349 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~------~~DvwSlG~il~ell~g--------- 349 (601)
++.+||+|||++..+..... ....+||+.|+|||++.+ .++. ++|||||||++|||++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 78999999999976643322 135689999999999864 3333 49999999999999999
Q ss_pred -CCCCCCCC----hhHHHHHHHccCCCCCCCC----CCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 350 -SRPFWART----ESGIFRAVLRSDPNFDDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 350 -~~pf~~~~----~~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..||.... ...............+..+ ...+++++.+||.+||..||.+|||+.++++|
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 77775432 1222333332221111111 01356779999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=351.35 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=189.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHH--HHHhcCCCCeeEEeeeEec--
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI--LKALSGHKHLVKFCDACED-- 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~~h~niv~l~~~~~~-- 222 (601)
.+|++++.||+|+||.||+++. +++.||||++.... ...+..|.++ +..+. ||||+++++.+..
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSFAN------RQNFINEKNIYRVPLME-HDNIARFIVGDERVT 80 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEEC
T ss_pred HHhheeeecccCCCeEEEEEEE-----CCeEEEEEEeeccc------hhhHHHHHHHHHHHhcc-Ccchhhheecccccc
Confidence 4799999999999999999965 56899999986542 2334444444 44465 9999999985532
Q ss_pred ---CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeeccCCCCceEeecCCC
Q 007498 223 ---VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQ---------GVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 223 ---~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~---------~iiHrDikp~NIll~~~~~ 290 (601)
...+|||||||++|+|.+++... .+++..+..++.||+.||.|||++ ||+||||||+|||++ .
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~---~ 155 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK---N 155 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC---T
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc---C
Confidence 34679999999999999988654 469999999999999999999999 999999999999995 4
Q ss_pred CCCeEEeecccccccCCCC---------CccccccccccccchhccC--------CCCChhhHHHHHHHHHHHHhCCCCC
Q 007498 291 DADMRLIDFGLSDFIRPDE---------RLNDIVGSAYYVAPEVLHR--------SYSLEADIWSIGVISYILLCGSRPF 353 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~DvwSlG~il~ell~g~~pf 353 (601)
++.+||+|||++..+.... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 7899999999998764321 1234679999999999864 3567899999999999999998776
Q ss_pred CCCCh-----------------hHHHHHHHccC---CCCCCCC--CCCCCHHHHHHHHHcccccccCCCCHHHH------
Q 007498 354 WARTE-----------------SGIFRAVLRSD---PNFDDLP--WPSVSPEAKDFVKRLLNKDYRKRMTAVQA------ 405 (601)
Q Consensus 354 ~~~~~-----------------~~~~~~i~~~~---~~~~~~~--~~~~s~~~~~li~~~L~~dP~~R~s~~el------ 405 (601)
..... ........... +.++... ...+++++.+||.+||..||++|||+.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 43211 11111222111 1111110 11245689999999999999999999999
Q ss_pred HcCcccCCCCC
Q 007498 406 LTHPWLRDDSR 416 (601)
Q Consensus 406 l~hp~f~~~~~ 416 (601)
+.++|-++...
T Consensus 316 ll~~~~~~~~~ 326 (336)
T 3g2f_A 316 LMMIWERNKSV 326 (336)
T ss_dssp HHHCCCC----
T ss_pred HHHHHHhcccC
Confidence 55788777643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=369.69 Aligned_cols=248 Identities=17% Similarity=0.229 Sum_probs=194.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCC-CCeeE----------
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLVK---------- 215 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~---------- 215 (601)
..|.+.+.||+|+||.||+|++.. +++.||||++...........+.+.+|+.+++.|. | .|+..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCC
T ss_pred eeEEEecccccCCCEEEEEEEecC---CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccc
Confidence 458899999999999999999876 78899999987544444445678999999999986 5 32211
Q ss_pred -----------EeeeEec-----CCcEEEEEeecCCCchHHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 007498 216 -----------FCDACED-----VNNVYIVMELCEGGELLDRILA------RGGRYTEEDAKAIVVQILSVVAFCHLQGV 273 (601)
Q Consensus 216 -----------l~~~~~~-----~~~~~lv~e~~~~g~L~~~~~~------~~~~l~~~~~~~i~~ql~~~L~~LH~~~i 273 (601)
++.++.. ...++++|+++ +++|.+++.. ....+++..+..++.||+.||.|||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 1111121 23478888887 5699887742 23457888999999999999999999999
Q ss_pred eeccCCCCceEeecCCCCCCeEEeecccccccCCCCCccccccccccccchhc----------cC-CCCChhhHHHHHHH
Q 007498 274 VHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL----------HR-SYSLEADIWSIGVI 342 (601)
Q Consensus 274 iHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~~DvwSlG~i 342 (601)
+||||||+|||++ .++.+||+|||+++..... ....+| +.|+|||++ .+ .|+.++|||||||+
T Consensus 233 iHrDiKp~NILl~---~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLD---QRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEEC---TTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEe---cCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999995 4788999999998765432 456688 999999988 32 47889999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 343 SYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 343 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
+|||++|+.||...........++.. +..+++++.+||.+||..||.+||++.++|+||||+.
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGGGSS--------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHHHHHhh--------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999999999876654443333221 2468899999999999999999999999999999964
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=347.56 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=199.0
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHH--hcCCCCeeEEeeeEec
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA--LSGHKHLVKFCDACED 222 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~l~~~~~~ 222 (601)
+..+|++.+.||+|+||.||++++ +++.||||++... ....+.+|+++++. + +||||+++++++..
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR------EERSWFREAEIYQTVML-RHENILGFIAADNK 107 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECGG------GHHHHHHHHHHHHHSCC-CCTTBCCEEEEEEC
T ss_pred ccccEEEEeeecCCCCcEEEEEEE-----cCccEEEEEeCch------hHHHHHHHHHHHHHhhc-CCCcEEEEEeeecc
Confidence 446799999999999999999986 4678999998543 23567889999988 5 49999999999987
Q ss_pred CC----cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeeccCCCCceEeecCCC
Q 007498 223 VN----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCH--------LQGVVHRDLKPENFLFTSGRD 290 (601)
Q Consensus 223 ~~----~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH--------~~~iiHrDikp~NIll~~~~~ 290 (601)
.. .+|+||||+++|+|.+++... .+++.+++.++.||+.||.||| ++||+||||||+|||++ .
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~---~ 182 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---K 182 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC---T
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC---C
Confidence 75 899999999999999988653 6999999999999999999999 89999999999999995 4
Q ss_pred CCCeEEeecccccccCCCC-----CccccccccccccchhccCC-------CCChhhHHHHHHHHHHHHhC---------
Q 007498 291 DADMRLIDFGLSDFIRPDE-----RLNDIVGSAYYVAPEVLHRS-------YSLEADIWSIGVISYILLCG--------- 349 (601)
Q Consensus 291 ~~~vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DvwSlG~il~ell~g--------- 349 (601)
++.+||+|||++....... .....+||+.|+|||++.+. ++.++|||||||++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 7899999999998765443 23456899999999998653 23689999999999999999
Q ss_pred -CCCCCCCC-----hhHHHHHHHccCCCCCCCC--C--CCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 350 -SRPFWART-----ESGIFRAVLRSDPNFDDLP--W--PSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 350 -~~pf~~~~-----~~~~~~~i~~~~~~~~~~~--~--~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..||.... .......+...... +..+ + ..++..+.+||.+||..||++|||+.++++|
T Consensus 263 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccCccccCcCcccHHHHHHHHHHHHhC-CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 78986542 22333333322211 1111 0 1234679999999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=338.30 Aligned_cols=227 Identities=16% Similarity=0.100 Sum_probs=186.9
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+.++|++.+.||+|+||.||+|++.. +++.||||++...........+.+.+|+.++.++. ||||+++++++.+.+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~ 104 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTA---LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRA 104 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETT---TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecC---CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECC
Confidence 44689999999999999999999875 68899999998765555556678999999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|||||||+|++|.+++.. + ....++..|+.||+.||.|||++||+||||||+|||++ .++.+||+++|
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~---- 174 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA---- 174 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCC----
T ss_pred cEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEecc----
Confidence 99999999999999998732 2 46678899999999999999999999999999999996 47889998544
Q ss_pred cCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHH---HHHccCCCCCCCCCCCCC
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFR---AVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~s 381 (601)
|++ .++.++|||||||++|||++|+.||.+.+....+. ..............+.++
T Consensus 175 ---------------~~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T 3uqc_A 175 ---------------TMP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233 (286)
T ss_dssp ---------------CCT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSC
T ss_pred ---------------ccC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCC
Confidence 333 37899999999999999999999998765432111 001111111111135689
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
+++.+||.+||..||.+| |+.|+++
T Consensus 234 ~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 234 FQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred HHHHHHHHHHcccCCccC-CHHHHHH
Confidence 999999999999999999 9999886
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=380.19 Aligned_cols=245 Identities=23% Similarity=0.349 Sum_probs=201.1
Q ss_pred cccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 143 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
..+..+|++++.||+|+||.||++++.. .+++.||||++.... .......+.+|+.++++|+ |||||++++++..
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRN--VNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEH 150 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGG--GTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEE
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcC--CCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEee
Confidence 3455789999999999999999999864 257899999986532 2334567889999999996 9999999999987
Q ss_pred CCc-----EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEe
Q 007498 223 VNN-----VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLI 297 (601)
Q Consensus 223 ~~~-----~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~ 297 (601)
.+. .|||||||+|++|.+.+.. .+++.+++.|+.||+.||.|||++|||||||||+|||++. +.+||+
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~----~~~kl~ 223 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE----EQLKLI 223 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS----SCEEEC
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC----CcEEEE
Confidence 765 7999999999999886532 7999999999999999999999999999999999999953 489999
Q ss_pred ecccccccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCC
Q 007498 298 DFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 298 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 377 (601)
|||+++..... ...+||+.|+|||++.+.++.++|||||||++|+|++|..||.+..... .+ ...+.
T Consensus 224 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------~~--~~~~~ 290 (681)
T 2pzi_A 224 DLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------LP--EDDPV 290 (681)
T ss_dssp CCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------CC--TTCHH
T ss_pred ecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc--------cc--ccccc
Confidence 99999876543 4568999999999988777999999999999999999999986432110 00 01111
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
..+++.+.+||.+||..||.+||+..+++.|+|+.
T Consensus 291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 13467899999999999999999999888888763
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.78 Aligned_cols=232 Identities=19% Similarity=0.149 Sum_probs=156.8
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc-------chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-------TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..++.|++|.+..++..- .|+.||||++.+.... .....+++.+|+++|+++..|+||+++++++++++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~---fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~ 316 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYF---FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS 316 (569)
T ss_dssp CC-C--------CCEEEE---ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred hccccCCccccccccccc---ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence 356778888887776654 7889999999764321 123456799999999999779999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||+|++|.++|.. .+.+++. .|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+..
T Consensus 317 ~yLVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~---~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD---ARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEEEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC---TTSCEEECCCTTEESC
T ss_pred EEEEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC---CCCCEEEeecccCeeC
Confidence 9999999999999998865 4678765 5889999999999999999999999999995 5889999999999876
Q ss_pred CCC-CCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 306 RPD-ERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 306 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
... ....+.+||+.|||||++.+.+..++|+||+|+++++|.++..++ ...+..... ....+
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~~~---------~~~~~ 452 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQEPV---------ERWNF 452 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHTSCG---------GGCSH
T ss_pred CCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhcCCC---------CCCcH
Confidence 543 345668999999999999988889999999999998887664443 111211110 01124
Q ss_pred HHHHHHcccccccCCCCHHHHHcCccc
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.+++..++..+|..|+.......++|.
T Consensus 453 ~~l~~~l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 453 VLLLALFEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp HHHHHHHHTGGGSCCGGGSSCCHHHHH
T ss_pred HHHHHHHhCCCCCCCCChhhhccchhH
Confidence 566677777788777765554444443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=270.55 Aligned_cols=185 Identities=22% Similarity=0.225 Sum_probs=145.2
Q ss_pred EEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch-----hhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA-----ISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 150 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
...+.||+|+||.||+++. .++.+|+|+......... ...+.+.+|+++|++++ ||||+++..++...+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLD 412 (540)
T ss_dssp ---------CCEEEEEEEC-----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETT
T ss_pred CCCCEEeeCCCEEEEEEEE-----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCC
Confidence 4466899999999999944 467899998755333221 12456899999999996 999996666666777
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
..|||||||+|++|.+++.. +..|+.||+.||.|||++||+||||||+|||++ . .+||+|||+|+.
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~----~-~~kL~DFGla~~ 478 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD----K-DLYIIDFGLGKI 478 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES----S-SEEECCCTTCEE
T ss_pred ccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC----C-eEEEEECccCEE
Confidence 88999999999999987643 678999999999999999999999999999994 3 999999999988
Q ss_pred cCCCCC--------ccccccccccccchhcc---CCCCChhhHHHHHHHHHHHHhCCCCCC
Q 007498 305 IRPDER--------LNDIVGSAYYVAPEVLH---RSYSLEADIWSIGVISYILLCGSRPFW 354 (601)
Q Consensus 305 ~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~DvwSlG~il~ell~g~~pf~ 354 (601)
...... ....+||+.|||||++. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 754322 13578999999999986 358888999999999999888887773
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=213.06 Aligned_cols=180 Identities=23% Similarity=0.325 Sum_probs=144.6
Q ss_pred cCcccCCCC-CCCChhHHHHHHHHhhhccCchhHHHHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcc
Q 007498 407 THPWLRDDS-RPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNA 485 (601)
Q Consensus 407 ~hp~f~~~~-~~~~~~~~~~~~~k~~~~~~~l~~~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~ 485 (601)
.|||.+... .+++++..++..++.|...+.+.+.++..++..++++++.+++++|..+|.|++|.|+.+||..++..++
T Consensus 8 ~~~~~~~~~~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g 87 (197)
T 3pm8_A 8 SSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKKIG 87 (197)
T ss_dssp ---------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHC
T ss_pred cchHhhhccCCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhC
Confidence 589998875 6888999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred hhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC--c-
Q 007498 486 TDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG--P- 562 (601)
Q Consensus 486 ~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~--~- 562 (601)
. ..+..++..+++.+|.+++|.|+|+||+.++........ ++.++.+|+.||+|++|+|+.+||+.++... +
T Consensus 88 ~-~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~~~~----~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~ 162 (197)
T 3pm8_A 88 Y-QKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLK----KEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIEN 162 (197)
T ss_dssp -----CHHHHHHHHC-------CEEHHHHHHTTCCHHHHCS----HHHHHHHHHHHCTTCSSEECHHHHHHHHC----CC
T ss_pred C-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHhhhh----HHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC
Confidence 5 577888999999999999999999999987665443333 6688999999999999999999999999644 1
Q ss_pred -----cHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 563 -----SAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 563 -----~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+++.+|..+|.|+||.|+|+||+.+|++.
T Consensus 163 ~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~~~ 196 (197)
T 3pm8_A 163 PLIDKAIDSLLQEVDLNGDGEIDFHEFMLMMSKK 196 (197)
T ss_dssp HHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHCC
T ss_pred CCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHcC
Confidence 18999999999999999999999999863
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.9e-25 Score=205.75 Aligned_cols=175 Identities=20% Similarity=0.335 Sum_probs=149.5
Q ss_pred Ccc-cCCCCCCCChhHHHHHHHHhhhccCchhHHHHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcch
Q 007498 408 HPW-LRDDSRPVPLDILIFKLVKSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNAT 486 (601)
Q Consensus 408 hp~-f~~~~~~~~~~~~~~~~~k~~~~~~~l~~~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~ 486 (601)
||| ......+.+++..+++.+++|...+.+.+.++..++..++++++++++++|..+|.|++|.|+.+||..+++.++.
T Consensus 4 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~ 83 (191)
T 3k21_A 4 HHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKDGL 83 (191)
T ss_dssp ----------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC
T ss_pred CccccCCccccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcCC
Confidence 555 5555678889999999999999999999999999999999999999999999999999999999999999999986
Q ss_pred hhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcC------
Q 007498 487 DAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNV------ 560 (601)
Q Consensus 487 ~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~------ 560 (601)
. .+ .++..+++.+|.|++|.|+|+||+.++..... .. ++.++.+|+.||+|++|+|+.+||+.++..
T Consensus 84 ~-~~-~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~~-~~----~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~ 156 (191)
T 3k21_A 84 K-LP-YNFDLLLDQIDSDGSGKIDYTEFIAAALDRKQ-LS----KKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGN 156 (191)
T ss_dssp C-CC-TTHHHHHHHHCTTCSSSEEHHHHHHHHSCGGG-CC----HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSC
T ss_pred C-cH-HHHHHHHHHhCCCCCCeEeHHHHHHHHHhhhh-cc----HHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCC
Confidence 3 44 78999999999999999999999987654432 22 567899999999999999999999999821
Q ss_pred -Cc----cHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 561 -GP----SAYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 561 -~~----~~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
.. +++.+|..+|.|+||.|+|+||+++|.
T Consensus 157 l~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~ 190 (191)
T 3k21_A 157 ITQRDVNRVKRMIRDVDKNNDGKIDFHEFSEMMK 190 (191)
T ss_dssp CCHHHHHHHHHHHHHHCSSSSSSBCHHHHHHHHC
T ss_pred CCHhHHHHHHHHHHHhcCCCCCeECHHHHHHHHc
Confidence 21 288999999999999999999999985
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=223.93 Aligned_cols=159 Identities=26% Similarity=0.304 Sum_probs=122.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch---------------hhHHHHHHHHHHHHHhcCCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---------------ISIEDVRREVKILKALSGHK 211 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~~h~ 211 (601)
..|.+++.||+|+||.||+|++ . +++.||||+++....... .....+.+|+.+|+++. |
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~---~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~- 163 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-E---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G- 163 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-T---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T-
T ss_pred eEEEecCEeccCCCceEEEEEe-C---CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C-
Confidence 3466779999999999999998 4 788999999965322111 13567899999999996 4
Q ss_pred CeeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCC
Q 007498 212 HLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291 (601)
Q Consensus 212 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~ 291 (601)
+++++++.. +..|+|||||+|++|.+ + .......++.||+.||.|||++||+||||||+|||++ +
T Consensus 164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l-------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~ 228 (282)
T 1zar_A 164 --LAVPKVYAW-EGNAVLMELIDAKELYR-V-------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----E 228 (282)
T ss_dssp --SSSCCEEEE-ETTEEEEECCCCEEGGG-C-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----T
T ss_pred --CCcCeEEec-cceEEEEEecCCCcHHH-c-------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----C
Confidence 555554433 56799999999999987 3 1134567999999999999999999999999999995 7
Q ss_pred CCeEEeecccccccCCCCCccccccccccccchhcc-----------CCCCChhhHHH
Q 007498 292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-----------RSYSLEADIWS 338 (601)
Q Consensus 292 ~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----------~~~~~~~DvwS 338 (601)
+.+||+|||+|+. +..|+|||++. ..|+..+|+|.
T Consensus 229 ~~vkl~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 229 EGIWIIDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TEEEECCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CcEEEEECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 8899999999853 45678999874 23555666665
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=194.10 Aligned_cols=142 Identities=21% Similarity=0.364 Sum_probs=124.3
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
..|+++++++++++|..||.|++|.|+.+||..+|+.++. .++..++..++..+|.+++|.|+|.||+..+........
T Consensus 3 ~~Lt~eqi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~-~~~~~~~~~~~~~~d~d~~~~i~~~ef~~~~~~~~~~~~ 81 (176)
T 2lhi_A 3 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGL-SPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSND 81 (176)
T ss_dssp CCCCTTGGGHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTC-CCCHHHHHHHHTTTCSSCSSSBCTTHHHHHHTSSCCSSH
T ss_pred CcCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCC-ChhHHHHHHHHHHhCcCCCccchHHHHHHHHHHhcccCC
Confidence 5689999999999999999999999999999999999986 678889999999999999999999999986654322211
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcC-----Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhhccc
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELARELNV-----GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVTL 593 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~-----~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~~ 593 (601)
.++.+..+|+.||+|++|+|+.+||+.+|.. ..+ ++.+|+.+| |+||+|+|+||+++|++.++
T Consensus 82 ---~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d-d~dG~I~~~EF~~~m~k~~~ 150 (176)
T 2lhi_A 82 ---SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLSKGSS 150 (176)
T ss_dssp ---HHHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH-TTSSCBCTTHHHHHHTCCSS
T ss_pred ---cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc-CCCCeEeHHHHHHHHHhcCC
Confidence 2678999999999999999999999999932 222 999999999 99999999999999987653
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.3e-23 Score=185.77 Aligned_cols=139 Identities=17% Similarity=0.314 Sum_probs=121.2
Q ss_pred hcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhh
Q 007498 448 ALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEAL 527 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~ 527 (601)
.|+++++++|+++|..||.|++|.|+.+||..+++.++. .++..++..++..+|.+++|.|++.||+..+........
T Consensus 3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~- 80 (148)
T 2lmt_A 3 ELTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQ-NPTEAELQDLIAEAENNNNGQLNFTEFCGIMAKQMRETD- 80 (148)
T ss_dssp SCCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTC-CCCHHHHHHHHHHHHTTSTTEEEHHHHHHHHHHTTTTTT-
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCC-CchHHHHHHHHHhcccCCCCcccHHHHHHHHHHHhcccC-
Confidence 478999999999999999999999999999999999986 577888999999999999999999999876543222111
Q ss_pred hhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 528 EGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 528 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
.++.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|+.+|.|+||.|+|+||+++|.+
T Consensus 81 --~~~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~m~~ 147 (148)
T 2lmt_A 81 --TEEEMREAFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREADFDGDGMINYEEFVWMISQ 147 (148)
T ss_dssp --THHHHHHHHHHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSCCSSEEHHHHHHHHTT
T ss_pred --cHHHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 156789999999999999999999999982 2222 999999999999999999999999975
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-22 Score=188.92 Aligned_cols=169 Identities=20% Similarity=0.291 Sum_probs=150.1
Q ss_pred ChhHHHHHHHHhhhccCchhHHHHHHhhhhc-chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhc-----------ch
Q 007498 419 PLDILIFKLVKSYLHATPFKRAALKALSKAL-TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRN-----------AT 486 (601)
Q Consensus 419 ~~~~~~~~~~k~~~~~~~l~~~~~~~~~~~l-~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~-----------~~ 486 (601)
|++..++..++.|...+.+.+..+..++..+ +++++.+++++|..+|.|++|.|+.+||..++..+ +.
T Consensus 3 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~ 82 (191)
T 3khe_A 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDS 82 (191)
T ss_dssp CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccc
Confidence 5677889999999999999999999999888 89999999999999999999999999999999987 53
Q ss_pred hhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---CCcc
Q 007498 487 DAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN---VGPS 563 (601)
Q Consensus 487 ~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---~~~~ 563 (601)
.....++..+++.+|.|++|.|+++||+.++........ ++.+..+|+.+|.|++|+|+.+||+.++. +..+
T Consensus 83 -~~~~~~~~~~~~~~D~d~~g~i~~~ef~~~~~~~~~~~~----~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~ 157 (191)
T 3khe_A 83 -SQIEAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLS----RERLLAAFQQFDSDGSGKITNEELGRLFGVTEVDDE 157 (191)
T ss_dssp -HHHHHHHHHHHHHTCTTCSSSEEHHHHHHHHSCHHHHCC----HHHHHHHHHHHCTTCSSEECHHHHHHHTTSSCCCHH
T ss_pred -hhhHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhcccch----HHHHHHHHHHHCCCCcCcCCHHHHHHHHccCCCCHH
Confidence 466778999999999999999999999987654433333 56789999999999999999999999996 2222
Q ss_pred -HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 564 -AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 564 -~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
++.+|..+|.|+||.|+|+||+++|.+..
T Consensus 158 ~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~ 187 (191)
T 3khe_A 158 TWHQVLQECDKNNDGEVDFEEFVEMMQKIC 187 (191)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999999999999999999998764
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=99.88 E-value=6.4e-22 Score=184.26 Aligned_cols=162 Identities=15% Similarity=0.312 Sum_probs=141.2
Q ss_pred hHHHHHHHHhhhccCchhHHHHHHhhhhcc--hHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHH
Q 007498 421 DILIFKLVKSYLHATPFKRAALKALSKALT--EDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVL 498 (601)
Q Consensus 421 ~~~~~~~~k~~~~~~~l~~~~~~~~~~~l~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~ 498 (601)
+..++..++.|...+.+.+..+..++..++ ++++.+++++|..+|.|++|.|+.+||..+++.++.. ..++..++
T Consensus 3 ~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~~---~~~~~~~~ 79 (180)
T 3mse_B 3 SPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASVGIK---KWDINRIL 79 (180)
T ss_dssp CHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCC---HHHHHHHH
T ss_pred CHHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCC---HHHHHHHH
Confidence 456788999999999999999999999887 9999999999999999999999999999999998752 46799999
Q ss_pred hhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---CCcc-HHHHHHHHhcC
Q 007498 499 SSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN---VGPS-AYSFLKDWIRN 574 (601)
Q Consensus 499 ~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---~~~~-~~~~~~~~d~~ 574 (601)
+.+|.+++|.|+|+||+.++...... . ++.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|
T Consensus 80 ~~~D~d~~g~i~~~Ef~~~~~~~~~~-~----~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~d~~ 154 (180)
T 3mse_B 80 QALDINDRGNITYTEFMAGCYRWKNI-E----STFLKAAFNKIDKDEDGYISKSDIVSLVHDKVLDNNDIDNFFLSVHSI 154 (180)
T ss_dssp HHHCTTCCSEECHHHHHHHHSCCTTC-------CHHHHHHHHHCTTCSSCBCHHHHHHHTTTSSCCHHHHHHHHHHHHTC
T ss_pred HHhCCCCCCcCcHHHHHHHHHhcccC-C----HHHHHHHHHHHCCCCCCCCCHHHHHHHHcCCCCCHHHHHHHHHHhhhc
Confidence 99999999999999999876543321 1 35689999999999999999999999995 3333 99999999999
Q ss_pred CC--------CceeHHHHHHHHhh
Q 007498 575 SD--------GKLSLHGYTKFLHG 590 (601)
Q Consensus 575 ~d--------G~is~~EF~~~~~~ 590 (601)
+| |.|+|+||+.+|..
T Consensus 155 ~d~~~~~~~~G~i~~~eF~~~l~~ 178 (180)
T 3mse_B 155 KKGIPREHIINKISFQEFKDYMLS 178 (180)
T ss_dssp ---------CCCBCHHHHHHHHHT
T ss_pred cCcccccccCCeeeHHHHHHHHHh
Confidence 99 99999999999975
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.9e-22 Score=178.33 Aligned_cols=136 Identities=16% Similarity=0.340 Sum_probs=117.4
Q ss_pred chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhh
Q 007498 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEG 529 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~ 529 (601)
+++++.+++++|..||.|++|.|+.+||..+|+.++. .++..++..+++.+|.+++|.|+|+||+.++...... ..
T Consensus 1 ~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~---~~ 76 (143)
T 2obh_A 1 TEEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGF-EPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSE---KD 76 (143)
T ss_dssp CHHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHH---HH
T ss_pred CHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeeeHHHHHHHHHHHhcc---cc
Confidence 3578899999999999999999999999999999986 5778889999999999999999999998865432111 11
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 530 WEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 530 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
..+.++.+|+.||+|++|+|+.+||+.++. +..+ ++.+|..+|.|+||.|+|+||+.+|.
T Consensus 77 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~eF~~~~~ 142 (143)
T 2obh_A 77 TKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIMK 142 (143)
T ss_dssp HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHC
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence 256789999999999999999999999982 2222 99999999999999999999999986
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=203.45 Aligned_cols=146 Identities=17% Similarity=0.336 Sum_probs=124.8
Q ss_pred HHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 441 ALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 441 ~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
.+......++++|+++|+++|+.||.|++|.|+.+||..+|+.++. .+++.+++.+++.+|.|++|.|+|+||+.++..
T Consensus 288 ~wePs~E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~-~~TeeEI~~Lf~~~D~DgDG~IdFeEFl~lms~ 366 (440)
T 3u0k_A 288 GWEPTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGDGTIDFPEFLIMMAR 366 (440)
T ss_dssp EECCBCBCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSSCSSSEEHHHHHHHHHT
T ss_pred hhHhhHhhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 3455566799999999999999999999999999999999999986 578889999999999999999999999987654
Q ss_pred chhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh-----cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 521 THQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL-----NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 521 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l-----~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
...... .++.++.+|+.||+|++|+|+.+||+++| .+..+ ++.+|+.+|.|+||.|+|+||+++|..
T Consensus 367 ~lk~~d---~eeeLreAFk~fDkDgdG~IS~eELr~vL~~lGe~LSdeEIdeLfke~D~DgDGkIsyeEFvkmMtS 439 (440)
T 3u0k_A 367 KMKDTD---SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA 439 (440)
T ss_dssp C---------CHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHC-
T ss_pred HhcCCC---hHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHhCC
Confidence 322111 25678999999999999999999999998 23333 999999999999999999999999964
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=183.35 Aligned_cols=144 Identities=19% Similarity=0.211 Sum_probs=118.4
Q ss_pred hcchHHHHHHHHHHHhhCC--CCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 448 ALTEDELVYLRAQFRLLEP--NKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~--d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
.|+++++++++++|..||. |++|+|+..||..+|+.+|. .++..++..++. .|.+++|.|+|+||+.++.......
T Consensus 2 qLt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~-~~t~~el~~~~~-~d~~~~g~i~f~eFl~~~~~~~~~~ 79 (159)
T 3i5g_C 2 QLTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGM-NPTEAQVHQHGG-TKKMGEKAYKLEEILPIYEEMSSKD 79 (159)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTC-CCCHHHHHTTTC-CSSTTSCEECHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCC-CCCHHHHHHHHc-ccccCCCcccHHHHHHHHHHhhccc
Confidence 5899999999999999995 89999999999999999996 577778887765 4777899999999998654322111
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhc--CCCCceeHHHHHHHHhhcccC
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIR--NSDGKLSLHGYTKFLHGVTLR 594 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~--~~dG~is~~EF~~~~~~~~~~ 594 (601)
. ...++.++.+|++||+|++|+|+.+||+++|. ++.+ ++.+++.+|. |+||+|+|+||+++|+..+.+
T Consensus 80 ~-~~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~D~~~d~dG~I~~~EF~~~m~~~p~p 155 (159)
T 3i5g_C 80 T-GTAADEFMEAFKTFDREGQGLISSAEIRNVLKMLGERITEDQCNDIFTFCDIREDIDGNIKYEDLMKKVMAGPFP 155 (159)
T ss_dssp T-TCCHHHHHHHHHHHCTTSSSEECHHHHHHHHHHSSSCCCHHHHHHHHHHTTCCCCSSCCEEHHHHHHHHHHCSCC
T ss_pred c-cchHHHHHHHHHHHhcCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCCCeEeHHHHHHHHHCCCCC
Confidence 1 11156789999999999999999999999992 3332 9999999995 889999999999999876543
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.87 E-value=7e-22 Score=181.04 Aligned_cols=158 Identities=22% Similarity=0.477 Sum_probs=131.7
Q ss_pred hhhccCchhHHHHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcc
Q 007498 430 SYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKM 509 (601)
Q Consensus 430 ~~~~~~~l~~~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i 509 (601)
+|...+.+.+..+..++..++++++.+++++|..+|.|++|.|+.+||..++..++. ..+..++..+++.+|.+++|.|
T Consensus 2 ~f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i 80 (166)
T 2aao_A 2 QFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGA-NLKESEILDLMQAADVDNSGTI 80 (166)
T ss_dssp ----CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTC-CCCHHHHHHHHHHHCTTCCSSB
T ss_pred chhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCeE
Confidence 566677778888999999999999999999999999999999999999999999875 4667789999999999999999
Q ss_pred cHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---CCcc-HHHHHHHHhcCCCCceeHHHHH
Q 007498 510 YFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN---VGPS-AYSFLKDWIRNSDGKLSLHGYT 585 (601)
Q Consensus 510 ~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---~~~~-~~~~~~~~d~~~dG~is~~EF~ 585 (601)
+++||+..+........ ++.+..+|+.+|.|++|+|+.+||+.++. +..+ ++.+|..+|.|+||.|+|+||+
T Consensus 81 ~~~ef~~~~~~~~~~~~----~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~ 156 (166)
T 2aao_A 81 DYKEFIAATLHLNKIER----EDHLFAAFTYFDKDGSGYITPDELQQACEEFGVEDVRIEELMRDVDQDNDGRIDYNEFV 156 (166)
T ss_dssp CHHHHHHHHTTCHHHHT----THHHHHHHHHHCTTCSSSBCHHHHHHHTCC--------CCHHHHHCTTCSSSBCHHHHH
T ss_pred cHHHHHHHHHHHhhccc----HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 99999987654433222 45789999999999999999999999984 3332 8889999999999999999999
Q ss_pred HHHhhcc
Q 007498 586 KFLHGVT 592 (601)
Q Consensus 586 ~~~~~~~ 592 (601)
.+|.+.+
T Consensus 157 ~~~~~~~ 163 (166)
T 2aao_A 157 AMMQKGS 163 (166)
T ss_dssp HHHC---
T ss_pred HHHHhcc
Confidence 9998764
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-21 Score=174.67 Aligned_cols=140 Identities=18% Similarity=0.367 Sum_probs=120.6
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
..++++++.+++++|..||.|++|.|+.+||..+++.++. .++..++..+++.+|.+++|.|+|+||+.++.......
T Consensus 2 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~- 79 (148)
T 1exr_A 2 EQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQ- 79 (148)
T ss_dssp CCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHH-
T ss_pred CcCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHhcccCC-
Confidence 3578899999999999999999999999999999999885 56777899999999999999999999988654322111
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
..++.+..+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||.|+|+||+.+|..
T Consensus 80 --~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~~ 147 (148)
T 1exr_A 80 --DSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMVS 147 (148)
T ss_dssp --HHHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHHC
T ss_pred --CcHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHcc
Confidence 1256788999999999999999999999982 2222 999999999999999999999999864
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-21 Score=175.54 Aligned_cols=137 Identities=15% Similarity=0.229 Sum_probs=114.3
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
..|+++++++|+++|..||.|++|.|+.+||..+|+.++. .++..++..++. +.+|.|+|++|+.++........
T Consensus 8 ~~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~-~~~~~~~~~~~~----~~~~~i~f~ef~~~~~~~~~~~~ 82 (153)
T 3i5g_B 8 VKLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGR-VPPDDELNAMLK----ECPGQLNFTAFLTLFGEKVSGTD 82 (153)
T ss_dssp TTCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTS-CCCHHHHHHHHH----TSSSCCCSHHHHHTTTTTTTTCC
T ss_pred cCCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCC-CccHHHHHHHHH----hccCCccHHHHHHHHHhhhcccc
Confidence 3589999999999999999999999999999999999986 566665665554 46788999999986544322211
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.++.++.+|+.||+|++|+|+.+||+.+|. ++.+ ++.+|+.+|.| ||+|+|+||+++|++..
T Consensus 83 ---~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~ei~~~~~~~D~~-dG~I~y~EF~~~m~~~~ 150 (153)
T 3i5g_B 83 ---PEDALRNAFSMFDEDGQGFIPEDYLKDLLENMGDNFSKEEIKNVWKDAPLK-NKQFNYNKMVDIKGKAE 150 (153)
T ss_dssp ---CHHHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSSCCCHHHHHHHHTTCCEE-TTEECHHHHHHHHHCSC
T ss_pred ---cHHHHHHHHhccccCCCCeEeHHHHHHHHHHcCCcCCHHHHHHHHHHhCCC-cCEEcHHHHHHHhcCCC
Confidence 166899999999999999999999999993 2332 99999999988 99999999999998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=193.44 Aligned_cols=141 Identities=18% Similarity=0.183 Sum_probs=108.0
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcE--EEEEEeecccccc---------------------hhhHHHHHHHHHHH
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQ--VAVKIISKAKMTT---------------------AISIEDVRREVKIL 204 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l 204 (601)
-|++.+.||+|+||.||+|++.. +++. ||||+++...... ......+.+|+.+|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~---~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVF---DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEE---TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcC---CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 48899999999999999999854 6778 9999975432110 01124688999999
Q ss_pred HHhcCCCCe--eEEeeeEecCCcEEEEEeecCC-C----chHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeec
Q 007498 205 KALSGHKHL--VKFCDACEDVNNVYIVMELCEG-G----ELLDRILARGGRYTEEDAKAIVVQILSVVAFCH-LQGVVHR 276 (601)
Q Consensus 205 ~~l~~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH-~~~iiHr 276 (601)
+.|. |++| +.++.. ...||||||+.+ | +|.+... .+++..+..++.||+.||.||| ++||+||
T Consensus 125 ~~l~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 125 ERAK-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HHHH-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred HHHH-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 9997 7754 444432 357899999942 3 5655432 1345678899999999999999 9999999
Q ss_pred cCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 277 DLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 277 Dikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
||||+|||++ . .++|+|||+|...
T Consensus 196 Dlkp~NILl~----~-~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYI----D-KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEES----S-SEEECCCTTCEET
T ss_pred CCCHHHEEEc----C-cEEEEECcccccC
Confidence 9999999994 3 8999999999754
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=172.09 Aligned_cols=147 Identities=21% Similarity=0.344 Sum_probs=123.3
Q ss_pred HhhhhcchHHHHHHHHHHHhhCCCC-CCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcch
Q 007498 444 ALSKALTEDELVYLRAQFRLLEPNK-DGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTH 522 (601)
Q Consensus 444 ~~~~~l~~~~~~~l~~~F~~~D~d~-~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~ 522 (601)
.....+++.++.+++++|..+|.|+ +|.|+.+||..+++.++. .++..++..+++.+|.+++|.|+++||+.++....
T Consensus 7 ~~~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 85 (161)
T 1dtl_A 7 AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQ-NPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSM 85 (161)
T ss_dssp TGGGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHh
Confidence 3456789999999999999999999 999999999999999885 56778899999999999999999999988665432
Q ss_pred hhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCc-----c-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 523 QLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGP-----S-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 523 ~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~-----~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.........+.+..+|+.||+|++|+|+.+||+.++...+ + ++.+|..+|.|+||.|+|+||+.+|.++
T Consensus 86 ~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~ 160 (161)
T 1dtl_A 86 KDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV 160 (161)
T ss_dssp C-----CHHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC-
T ss_pred cccccchHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHcC
Confidence 1000111256789999999999999999999999994322 2 9999999999999999999999999765
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-20 Score=167.58 Aligned_cols=141 Identities=22% Similarity=0.393 Sum_probs=120.1
Q ss_pred hhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh
Q 007498 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL 524 (601)
Q Consensus 445 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~ 524 (601)
++..++++++.+++++|..+|.|++|.|+.+||..++..++. ..+..++..+++.+|.+++|.|+++||+.++......
T Consensus 1 m~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~d~~~~g~i~~~ef~~~~~~~~~~ 79 (147)
T 4ds7_A 1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGL-SPSEAEVADLMNEIDVDGNHAIEFSEFLALMSRQLKC 79 (147)
T ss_dssp ---CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHHHHHT
T ss_pred CCCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCC-CCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHhccC
Confidence 356789999999999999999999999999999999999885 5677889999999999999999999999876533221
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
.. .++.+..+|+.+|+|++|+|+.+||+.++. +..+ ++.++..+| |+||.|+|+||+++|.+
T Consensus 80 ~~---~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~l~k 147 (147)
T 4ds7_A 80 ND---SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREVS-DGSGEINIKQFAALLSK 147 (147)
T ss_dssp HH---HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHS-SSCSSEEHHHHHHHTTC
T ss_pred CC---cHHHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHhC
Confidence 11 256789999999999999999999999993 2332 899999999 99999999999999864
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2.4e-20 Score=171.28 Aligned_cols=142 Identities=15% Similarity=0.317 Sum_probs=121.4
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
..++++++++++++|..+|.|++|.|+.+||..++..++. ..+..++..+++.+|.+++|.|+++||+.++.......
T Consensus 20 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~- 97 (169)
T 3qrx_A 20 VGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGF-EPKKEEIKKMISEIDKDGSGTIDFEEFLTMMTAKMGER- 97 (169)
T ss_dssp CCCCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHTSC-CCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHHHHHHHH-
T ss_pred CCCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHhccc-
Confidence 4578899999999999999999999999999999999885 56778899999999999999999999998765332211
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
...+.+..+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||.|+|+||+.+|.+.+
T Consensus 98 --~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~ 167 (169)
T 3qrx_A 98 --DSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTS 167 (169)
T ss_dssp --HHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCCSSSSCBCHHHHHHHHC---
T ss_pred --CcHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHhcc
Confidence 1256788999999999999999999999983 2222 99999999999999999999999998754
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=99.84 E-value=2.7e-20 Score=169.52 Aligned_cols=149 Identities=20% Similarity=0.360 Sum_probs=126.1
Q ss_pred HHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 442 LKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 442 ~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
...+...++++++.+++++|..+|.|++|.|+.+||..++..++. ..+..++..+++.+|.+++|.|+++||+.++...
T Consensus 7 ~~~~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 85 (162)
T 1top_A 7 QAEARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQ 85 (162)
T ss_dssp HHHHHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHH
T ss_pred HHHhhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHHcCCCCCcEeHHHHHHHHHHH
Confidence 445566799999999999999999999999999999999999885 5677889999999999999999999998866533
Q ss_pred hhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 522 HQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 522 ~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
..........+.++.+|+.||.|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||.|+|+||+.+|.++
T Consensus 86 ~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~ 161 (162)
T 1top_A 86 MKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGV 161 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHSC
T ss_pred hccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhhc
Confidence 21111111256789999999999999999999999993 2222 8999999999999999999999999875
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3e-20 Score=172.43 Aligned_cols=144 Identities=17% Similarity=0.334 Sum_probs=119.8
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
+..++++++.+++++|..+|.|++|.|+.+||..++..++. .++..++..+++.+|.+++|.|+++||+.++.......
T Consensus 2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~D~~~~g~i~~~EF~~~~~~~~~~~ 80 (179)
T 2f2o_A 2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDT 80 (179)
T ss_dssp ----CCSHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhccCCCCCCcHHHHHHHHHHHccCc
Confidence 45678899999999999999999999999999999999885 56777899999999999999999999988664332111
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhccc
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVTL 593 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~~ 593 (601)
..++.+..+|+.||+|++|+|+.+||+.++. +..+ ++.+|..+|.|+||.|+|+||+.+|.....
T Consensus 81 ---~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~~ 151 (179)
T 2f2o_A 81 ---DSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAKGG 151 (179)
T ss_dssp ---HHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHSCC---
T ss_pred ---ccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCC
Confidence 1256789999999999999999999999983 2222 999999999999999999999999987653
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-20 Score=168.92 Aligned_cols=144 Identities=19% Similarity=0.276 Sum_probs=121.4
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
+..++++++++++++|..+|.|++|.|+.+||..+++.++. ..+..++..+++.+|.+++|.|+|+||+.++.......
T Consensus 2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~ 80 (153)
T 3ox6_A 2 DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGY-MPTEMELIELSQQINMNLGGHVDFDDFVELMGPKLLAE 80 (153)
T ss_dssp CSCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTC-CCCHHHHHHHHHHHHTTSTTCCCHHHHHHHHHHHHTTC
T ss_pred cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCccCcHHHHHHHHHHHhhcc
Confidence 45689999999999999999999999999999999999886 57788899999999999999999999988654321111
Q ss_pred h-hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc------CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 526 A-LEGWEQIASTAFEYFEEEGNRVISIEELARELN------VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 526 ~-~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~------~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
. .....+.+..+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||.|+|+||+.+|.+
T Consensus 81 ~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~k 153 (153)
T 3ox6_A 81 TADMIGVKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMSR 153 (153)
T ss_dssp CHHHHCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHTCC
T ss_pred ccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhC
Confidence 1 011146788999999999999999999999883 2222 999999999999999999999999864
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3.5e-20 Score=168.60 Aligned_cols=142 Identities=15% Similarity=0.280 Sum_probs=123.0
Q ss_pred hhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh
Q 007498 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL 524 (601)
Q Consensus 445 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~ 524 (601)
....++++++.+++++|..+|.|++|.|+.+||..+++.++. ..+..++..+++.+|.+++|.|+|+||+.++......
T Consensus 13 ~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~ 91 (161)
T 3fwb_A 13 LNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGF-ELPKREILDLIDEYDSEGRHLMKYDDFYIVMGEKILK 91 (161)
T ss_dssp TTTTSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTSSSCEEHHHHHHHHHHHHHT
T ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCcCCCCeEeHHHHHHHHHHHHhc
Confidence 345689999999999999999999999999999999999885 5677889999999999999999999998866532211
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
. ...+.+..+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||.|+|+||+++|.+
T Consensus 92 ~---~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 160 (161)
T 3fwb_A 92 R---DPLDEIKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEFDLDGDGEINENEFIAICTD 160 (161)
T ss_dssp C---CHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCSSSSSSEEHHHHHHHHHH
T ss_pred C---CcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhc
Confidence 1 1256789999999999999999999999993 2332 999999999999999999999999875
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=169.52 Aligned_cols=144 Identities=18% Similarity=0.326 Sum_probs=121.1
Q ss_pred hhcchHHHHHHHHHHHhhC-CCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 447 KALTEDELVYLRAQFRLLE-PNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D-~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
..++++++.+++++|..+| .|++|.|+.+||..+++.++. .++..++..+++.+|.+++|.|+|+||+.++.......
T Consensus 5 ~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 83 (158)
T 2jnf_A 5 SKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGI-QQTKSTIRQLIDEFDPFGNGDIDFDSFKIIGARFLGEE 83 (158)
T ss_dssp TTSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTC-SCSHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHCCCC
T ss_pred hhCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccc
Confidence 3578899999999999999 999999999999999999885 56778899999999999999999999988664322110
Q ss_pred -hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 526 -ALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 526 -~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
......+.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||.|+|+||+++|.+.
T Consensus 84 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~ 156 (158)
T 2jnf_A 84 VNPEQMQQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEIDADGSGTVDFEEFMGVMTGG 156 (158)
T ss_dssp CCTTTTSSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCSSCCSEECSHHHHHHTSSC
T ss_pred cchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCcCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhcc
Confidence 0001144688999999999999999999999982 3333 9999999999999999999999999764
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.5e-20 Score=165.94 Aligned_cols=135 Identities=19% Similarity=0.320 Sum_probs=115.8
Q ss_pred chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhh
Q 007498 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEG 529 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~ 529 (601)
+++++.+++++|..+|.|++|.|+.+||..+++.++. .++..++..+++.+|.+++|.|+++||+.++........
T Consensus 1 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~--- 76 (142)
T 2bl0_C 1 GDDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGV-RVEPAAFNEMFNEADATGNGKIQFPEFLSMMGRRMKQTT--- 76 (142)
T ss_dssp CCHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHTTCC---
T ss_pred CHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCcCCCCeeeHHHHHHHHHHHhcCCC---
Confidence 3578899999999999999999999999999999885 567778999999999999999999999886653211111
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 530 WEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 530 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
..+.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+| |+||.|+|+||+.+|.
T Consensus 77 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~~ 141 (142)
T 2bl0_C 77 SEDILRQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGITE-TEKGQIRYDNFINTMF 141 (142)
T ss_dssp CHHHHHHHHHHTCCSSCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC-CSSSEECSHHHHTTTC
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCcEeHHHHHHHHc
Confidence 156789999999999999999999999993 2222 999999999 9999999999998875
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.82 E-value=4.9e-21 Score=179.59 Aligned_cols=141 Identities=20% Similarity=0.448 Sum_probs=121.6
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
..++++++++++++|..+|.|++|.|+.+||..+|..++. ..+..++..+|+.+|.+++|.|+|+||+.++........
T Consensus 2 ~~ls~~~~~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~-~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~ 80 (188)
T 1s6i_A 2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-ELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLER 80 (188)
T ss_dssp CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTC-CCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCC
T ss_pred CCCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHhccCH
Confidence 3577788999999999999999999999999999999885 567778999999999999999999999987654332222
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELARELN---VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
++.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||.|+|+||+.+|.+..
T Consensus 81 ----~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~~~~ 146 (188)
T 1s6i_A 81 ----EENLVSAFSYFDKDGSGYITLDEIQQACKDFGLDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRKRK 146 (188)
T ss_dssp ----CCSTHHHHHHTTTTCSSEEEHHHHHHTTTTTTCCTTHHHHHHHHHCSSSSSEEETTHHHHTTSCCC
T ss_pred ----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHcC
Confidence 34578899999999999999999999983 3333 99999999999999999999999997654
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=99.82 E-value=5.5e-20 Score=176.89 Aligned_cols=152 Identities=10% Similarity=0.094 Sum_probs=128.7
Q ss_pred HhhhccCchhHHHHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCc
Q 007498 429 KSYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRK 508 (601)
Q Consensus 429 k~~~~~~~l~~~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~ 508 (601)
..+.....+.+..+..+...++++++++++++|..+|.|++|.|+.+||..+++.++. ..+..+++.+++.+|.|++|.
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~-~~~~~~~~~l~~~~D~d~dg~ 103 (220)
T 3sjs_A 25 CIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFPGGI-RLSPQTALRMMRIFDTDFNGH 103 (220)
T ss_dssp HHHHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBGGGB-CCCHHHHHHHHHHHCTTCSSC
T ss_pred hccCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCc
Confidence 3444455555555666778899999999999999999999999999999999999885 577888999999999999999
Q ss_pred ccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHH
Q 007498 509 MYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLH 582 (601)
Q Consensus 509 i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~ 582 (601)
|+|+||+.++.. .+.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+++.+| |+||.|+|+
T Consensus 104 I~~~EF~~~~~~----------~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~d-d~dg~I~~~ 172 (220)
T 3sjs_A 104 ISFYEFMAMYKF----------MELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFA-RGMAFCDLN 172 (220)
T ss_dssp BCHHHHHHHHHH----------HHHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC---CCSEEHH
T ss_pred CCHHHHHHHHHH----------HHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc-CCCCcCcHH
Confidence 999999886543 23578899999999999999999999992 3332 999999999 999999999
Q ss_pred HHHHHHhhcc
Q 007498 583 GYTKFLHGVT 592 (601)
Q Consensus 583 EF~~~~~~~~ 592 (601)
||+++|..+.
T Consensus 173 eF~~~~~~l~ 182 (220)
T 3sjs_A 173 CWIAICAFAA 182 (220)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998764
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=99.81 E-value=4.3e-20 Score=167.27 Aligned_cols=141 Identities=23% Similarity=0.269 Sum_probs=120.3
Q ss_pred hcchHHHHHHHHHHHhhCC--CCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 448 ALTEDELVYLRAQFRLLEP--NKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~--d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
.++++++.+++++|..+|. |++|.|+.+||..+++.++. .++..++..+ +.+|.+++|.|+|+||+.++.......
T Consensus 2 ~ls~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l-~~~D~~~~g~i~~~eF~~~~~~~~~~~ 79 (156)
T 1wdc_C 2 KLSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGI-NPRNEDVFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCE 79 (156)
T ss_dssp -CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTC-CCCHHHHHHT-TCCSSTTSCEECHHHHHHHHHHHTTSC
T ss_pred CCCHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCC-CCCHHHHHHH-HhhCCCCCCeeeHHHHHHHHHHHhhcc
Confidence 4788999999999999999 99999999999999999886 5677789999 999999999999999998665432210
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHH--HhcCCCCceeHHHHHHHHhhcc
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKD--WIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~--~d~~~dG~is~~EF~~~~~~~~ 592 (601)
. ...+.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|.. +|.|+||.|+|+||+.+|.+.+
T Consensus 80 ~--~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~ 152 (156)
T 1wdc_C 80 Q--GTFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMAGP 152 (156)
T ss_dssp C--CCHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHHCS
T ss_pred C--ChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCCcEeHHHHHHHHhcCC
Confidence 1 1156789999999999999999999999983 2222 9999999 9999999999999999998864
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-19 Score=171.20 Aligned_cols=150 Identities=13% Similarity=0.159 Sum_probs=115.3
Q ss_pred HHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHH-----HHHhhcchhhhhhc-----cHHHHHhhcccCCCCcccH
Q 007498 442 LKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFR-----MVLGRNATDAMRES-----RVPDVLSSMESLAYRKMYF 511 (601)
Q Consensus 442 ~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~-----~~l~~~~~~~~~~~-----~~~~~~~~~D~~~~g~i~~ 511 (601)
+..+...++++++++++++|..+|.|++|.|+.+||. .+++.++. .++.. .+..+++.+|.|++|.|+|
T Consensus 7 ~~~~~~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~-~~~~~~~~~~~~~~l~~~~D~d~~g~i~~ 85 (195)
T 1qv0_A 7 VKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEA-TPEQTKRHQVCVEAFFRGCGMEYGKEIAF 85 (195)
T ss_dssp CCCSCCTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTC-CHHHHHHHHHHHHHHHHHTTCCTTCCBCH
T ss_pred hhcCcccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCC-CccHHHHHHHHHHHHHHHcCCCCCceEcH
Confidence 3344455699999999999999999999999999999 67777775 34443 5889999999999999999
Q ss_pred HHHHHHhhcchhhh-------hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCc
Q 007498 512 EEFCAAAISTHQLE-------ALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGK 578 (601)
Q Consensus 512 ~ef~~~~~~~~~~~-------~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~ 578 (601)
+||+.++....... ..+.+...+..+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||.
T Consensus 86 ~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~ 165 (195)
T 1qv0_A 86 PQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGD 165 (195)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSC
T ss_pred HHHHHHHHHHHhhhhhcccccHHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCc
Confidence 99987654322110 0011122334899999999999999999999982 2232 999999999999999
Q ss_pred eeHHHHHHHHhhcc
Q 007498 579 LSLHGYTKFLHGVT 592 (601)
Q Consensus 579 is~~EF~~~~~~~~ 592 (601)
|+|+||+.+|...-
T Consensus 166 i~~~eF~~~~~~~~ 179 (195)
T 1qv0_A 166 LDVDEMTRQHLGFW 179 (195)
T ss_dssp EEHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHc
Confidence 99999999998763
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.8e-19 Score=160.19 Aligned_cols=138 Identities=16% Similarity=0.243 Sum_probs=117.8
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhc---ccCCCCcccHHHHHHHhhcchhhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSM---ESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~---D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
++++++.+++++|..+|.|++|.|+.+||..++..++. .++..++..+++.+ |.++ |.|+|+||+.++.......
T Consensus 2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~-~~~~~~~~~l~~~~~~~d~~~-g~i~~~eF~~~~~~~~~~~ 79 (149)
T 2mys_C 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQ-NPTNAEINKILGNPSKEEMNA-AAITFEEFLPMLQAAANNK 79 (149)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhhhccccC-CcCcHHHHHHHHHHHhccC
Confidence 67889999999999999999999999999999999885 56778899999999 9999 9999999988665431111
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
. ....+.+..+|+.||+|++|+|+.+||+.+|. +..+ ++.+|.. |.|+||.|+|+||+.+|.+
T Consensus 80 ~-~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-d~~~dg~i~~~eF~~~~~~ 148 (149)
T 2mys_C 80 D-QGTFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHIMS 148 (149)
T ss_pred C-cchHHHHHHHHHHhCCCCCceEcHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCcEeHHHHHHHHhc
Confidence 1 11256789999999999999999999999993 2332 8999999 9999999999999999875
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.2e-20 Score=176.17 Aligned_cols=142 Identities=11% Similarity=0.191 Sum_probs=118.8
Q ss_pred hhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHH-HHhhcchhhhhhccHHHHHhhc---------ccCCCCcccHHHH
Q 007498 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRM-VLGRNATDAMRESRVPDVLSSM---------ESLAYRKMYFEEF 514 (601)
Q Consensus 445 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~-~l~~~~~~~~~~~~~~~~~~~~---------D~~~~g~i~~~ef 514 (601)
+...++++++.+++++|..||.|++|.|+.+||.. +++.++. .+...++..++..+ |.+++|.|+|+||
T Consensus 41 l~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~-~~~~~~~~~~~~~~f~~~~~~~~D~d~~G~I~~~EF 119 (226)
T 2lvv_A 41 IPRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKL-DEFTTHLPDIVQRAFDKAKDLGNKVKGVGEEDLVEF 119 (226)
T ss_dssp SCSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCC-TTTSSSCHHHHHHHHHHHHHHHHHHSCCCCCSCBCH
T ss_pred hchhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCC-CCCHHHHHHHHHHHHHHhcccCCCCCCCCcCCHHHH
Confidence 34467899999999999999999999999999999 5555564 45666777788777 9999999999999
Q ss_pred HHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh------cCCcc-HHHHHHHHhcCCCCceeHHHHHHH
Q 007498 515 CAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL------NVGPS-AYSFLKDWIRNSDGKLSLHGYTKF 587 (601)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l------~~~~~-~~~~~~~~d~~~dG~is~~EF~~~ 587 (601)
+.++........ ++.++.+|+.||+|++|+|+.+||+.+| ++..+ ++.+|..+|.|+||.|+|+||+.+
T Consensus 120 ~~~~~~~~~~~~----~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~~e~~~~~~~~D~d~dG~Is~~EF~~~ 195 (226)
T 2lvv_A 120 LEFRLMLCYIYD----IFELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDITDATTVFNEIDTNGSGVVTFDEFSCW 195 (226)
T ss_dssp HHHHHHHHHHHH----HHHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCCCSCHHHHHHHCCSCSSCEEHHHHHHH
T ss_pred HHHHHHHHhccC----HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCHHHHHHHHHHhCCCCCCcEeHHHHHHH
Confidence 986443333322 5678999999999999999999999998 23322 999999999999999999999999
Q ss_pred Hhhc
Q 007498 588 LHGV 591 (601)
Q Consensus 588 ~~~~ 591 (601)
|.+.
T Consensus 196 ~~~~ 199 (226)
T 2lvv_A 196 AVTK 199 (226)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 9765
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.80 E-value=2.5e-19 Score=165.47 Aligned_cols=144 Identities=13% Similarity=0.102 Sum_probs=118.0
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHH----HHhhcchhhhhhccHH-----------HHHhhcccCCCCcccHHH
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRM----VLGRNATDAMRESRVP-----------DVLSSMESLAYRKMYFEE 513 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~----~l~~~~~~~~~~~~~~-----------~~~~~~D~~~~g~i~~~e 513 (601)
++++++++++++|..+|.|++|.|+.+||.. +++.++. .++..++. .+|+.+|.+++|.|+++|
T Consensus 1 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~~~~~l~~~g~-~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~E 79 (176)
T 1nya_A 1 TTAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGK-DAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQ 79 (176)
T ss_dssp CCSHHHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSS-CSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHH
T ss_pred CcHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHcCC-CCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHH
Confidence 4678899999999999999999999999999 6777775 45555555 789999999999999999
Q ss_pred HHHHhhcchhhhh----hhhHHHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHH
Q 007498 514 FCAAAISTHQLEA----LEGWEQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYT 585 (601)
Q Consensus 514 f~~~~~~~~~~~~----~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~ 585 (601)
|+.++........ .+..++.++.+|+.||+|++|+|+.+||+.++ ++..+ ++.+|..+|.|+||.|+|+||+
T Consensus 80 f~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~D~d~dg~i~~~ef~ 159 (176)
T 1nya_A 80 FIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALGMSKAEAAEAFNQVDTNGNGELSLDELL 159 (176)
T ss_dssp HHHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred HHHHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhCCCHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 9876543321111 11124568999999999999999999999998 33333 9999999999999999999999
Q ss_pred HHHhhccc
Q 007498 586 KFLHGVTL 593 (601)
Q Consensus 586 ~~~~~~~~ 593 (601)
++|.....
T Consensus 160 ~~~~~~~~ 167 (176)
T 1nya_A 160 TAVRDFHF 167 (176)
T ss_dssp HHHSCCSS
T ss_pred HHHHHHhc
Confidence 99987653
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.7e-19 Score=166.20 Aligned_cols=144 Identities=10% Similarity=0.121 Sum_probs=119.6
Q ss_pred hhcchHHHHHHHHHHHhh-CCCCCCcccHHHHHHHHhhc----chhhhhhccHHHHH-----------hhcccCCCCccc
Q 007498 447 KALTEDELVYLRAQFRLL-EPNKDGSVSLENFRMVLGRN----ATDAMRESRVPDVL-----------SSMESLAYRKMY 510 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~-D~d~~G~I~~~el~~~l~~~----~~~~~~~~~~~~~~-----------~~~D~~~~g~i~ 510 (601)
..+++.++++++++|..+ |.|++|.|+.+||..++..+ +. ..+..++..++ +.+|.|++|.|+
T Consensus 4 ~~ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~-~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i~ 82 (191)
T 2ccm_A 4 HQLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSW-PTDGKKHNEARATLKLIWDGLRKYADENEDEQVT 82 (191)
T ss_dssp CCCCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTC-CTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCEE
T ss_pred hhccHHHHHHHHHhccccccCCCCCeeeHHHHHHHHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeEC
Confidence 457888999999999999 99999999999999999887 53 45566777787 999999999999
Q ss_pred HHHHHHHhhcchhh---h--hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeH
Q 007498 511 FEEFCAAAISTHQL---E--ALEGWEQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSL 581 (601)
Q Consensus 511 ~~ef~~~~~~~~~~---~--~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~ 581 (601)
++||+..+...... . .....++.+..+|+.+|+|++|+|+.+||+.++ ++..+ ++.+|..+|.|+||.|++
T Consensus 83 ~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~~~~D~d~dG~i~~ 162 (191)
T 2ccm_A 83 KEEWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYGIPKSDCDAAFDTLSDGGKTMVTR 162 (191)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHCTTCSSBCCHHHHHHHHHTTTCCHHHHHHHHHHHTTTTTSCCBH
T ss_pred HHHHHHHHHHHhccccchhhchHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCHHHHHHHHHHhCCCCCCCcCH
Confidence 99998765432110 0 011225678999999999999999999999998 33333 999999999999999999
Q ss_pred HHHHHHHhhc
Q 007498 582 HGYTKFLHGV 591 (601)
Q Consensus 582 ~EF~~~~~~~ 591 (601)
+||+.+|...
T Consensus 163 ~Ef~~~~~~~ 172 (191)
T 2ccm_A 163 EIFARLWTEY 172 (191)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999999876
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-20 Score=168.47 Aligned_cols=137 Identities=12% Similarity=0.159 Sum_probs=111.2
Q ss_pred HHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhc-ccCCCCcccHHHHHHHhhcchhhh--hhhh
Q 007498 453 ELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSM-ESLAYRKMYFEEFCAAAISTHQLE--ALEG 529 (601)
Q Consensus 453 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~-D~~~~g~i~~~ef~~~~~~~~~~~--~~~~ 529 (601)
++++++++|..+|.|++|.|+.+||..+++.++. .++..++..+++.+ |.+++|.|+|+||+.++....... ....
T Consensus 2 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~ 80 (148)
T 1m45_A 2 ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGY-NPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKA 80 (148)
T ss_dssp -CCCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCC
T ss_pred hHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCC-CCCHHHHHHHHHHhhCCCCCCeEcHHHHHHHHHHHHhhccccccc
Confidence 4456788999999999999999999999999985 56778899999999 999999999999998765441110 0011
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 530 WEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 530 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
..+.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||.|+|+||+.+|.+
T Consensus 81 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~~ 147 (148)
T 1m45_A 81 KTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVLR 147 (148)
T ss_dssp CTHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHC
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 146789999999999999999999999983 2222 999999999999999999999999864
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=170.51 Aligned_cols=138 Identities=19% Similarity=0.329 Sum_probs=114.6
Q ss_pred chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhh
Q 007498 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEG 529 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~ 529 (601)
...++.+++++|..+|.|++|.|+.+||..+++.++. ..+..++..+++.+|.+++|.|+++||+.++........
T Consensus 32 ~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~~~~--- 107 (204)
T 3e3r_A 32 GASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGL-VLDQAEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAR--- 107 (204)
T ss_dssp --------CHHHHHHCTTCCSSBCHHHHHHHHHTTTC-CCCHHHHHHHHHHHCTTCSSSBCHHHHHHHTSCCCCHHH---
T ss_pred CchhHHHHHHHHHHHccCCCCCcCHHHHHHHHHHcCC-CCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHhhcCchH---
Confidence 4567889999999999999999999999999999985 567788999999999999999999999987654332222
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHhcCC-------c-----c-HHHHHHHHhc-CCCCceeHHHHHHHHhhcc
Q 007498 530 WEQIASTAFEYFEEEGNRVISIEELARELNVG-------P-----S-AYSFLKDWIR-NSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 530 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~-------~-----~-~~~~~~~~d~-~~dG~is~~EF~~~~~~~~ 592 (601)
++.++.+|+.||.|++|+|+.+||+.++... + + ++.+|+.+|. |+||.|+|+||+.+|..++
T Consensus 108 -~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~~d~dg~Is~~EF~~~~~~~~ 183 (204)
T 3e3r_A 108 -EAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDSSEKDGQVTLAEFQDYYSGVS 183 (204)
T ss_dssp -HHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSCSSCCSCEEHHHHHHHHHHHH
T ss_pred -HHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHcC
Confidence 6678999999999999999999999999521 1 1 8899999998 9999999999999998875
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.8e-20 Score=163.29 Aligned_cols=135 Identities=16% Similarity=0.267 Sum_probs=113.4
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALE 528 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~ 528 (601)
++++++++++++|..+|.|++|.|+.+||..+++.++. .++..++..++.. ++|.|+|+||+.++........
T Consensus 1 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~----~~g~i~~~eF~~~~~~~~~~~~-- 73 (143)
T 3j04_B 1 FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGK-NPTDEYLEGMMSE----APGPINFTMFLTMFGEKLNGTD-- 73 (143)
T ss_dssp CCHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSC-CCCHHHHHTTTTT----SSSCCCHHHHHHHHHHTTTSSC--
T ss_pred CCHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCC-CCCHHHHHHHHHh----CCCCcCHHHHHHHHHHHhccCC--
Confidence 57889999999999999999999999999999999886 4666666666655 8999999999987653322111
Q ss_pred hHHHHHHHHHHHHcccCCCcccHHHHHHHhcC-----Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 529 GWEQIASTAFEYFEEEGNRVISIEELARELNV-----GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 529 ~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~-----~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.++.+..+|+.||+|++|+|+.+||+.+|.. ..+ ++.+|..+|.|+||.|+|+||+++|.+.
T Consensus 74 -~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~ 141 (143)
T 3j04_B 74 -PEDVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFNYVEFTRILKHG 141 (143)
T ss_dssp -CHHHHHHHHTTSCSSSCCCCCTTTHHHHHHTSSSCCCHHHHHHHHHHTTCCSSSCCCSTHHHHHHHSS
T ss_pred -cHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHhcc
Confidence 1567899999999999999999999999932 222 9999999999999999999999999874
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-19 Score=171.39 Aligned_cols=142 Identities=15% Similarity=0.180 Sum_probs=117.6
Q ss_pred hhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhh-cchhhhhhccHHHHHhhc---------ccCCCCcccHHHH
Q 007498 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGR-NATDAMRESRVPDVLSSM---------ESLAYRKMYFEEF 514 (601)
Q Consensus 445 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~~~~~~~~~~~~~~~~~~---------D~~~~g~i~~~ef 514 (601)
+...++++++.+++++|..||.|++|.|+.+||..+|.. ++. .++..++..++..+ |.+++|.|+|+||
T Consensus 38 ~~~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~g~I~~~EF 116 (219)
T 3cs1_A 38 IPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKL-DEFTSRVRDITKRAFDKSRTLGSKLENKGSEDFVEF 116 (219)
T ss_dssp SCCSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCG-GGTCSCHHHHHHHHHHHHHHHHHHHHTSCCCSSBCH
T ss_pred hcccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCC-CccHHHHHHHHHHHHHHHHhhhhccCCCCcCCHHHH
Confidence 345678899999999999999999999999999999987 665 46667777666533 3478999999999
Q ss_pred HHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh------cCCcc-HHHHHHHHhcCCCCceeHHHHHHH
Q 007498 515 CAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL------NVGPS-AYSFLKDWIRNSDGKLSLHGYTKF 587 (601)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l------~~~~~-~~~~~~~~d~~~dG~is~~EF~~~ 587 (601)
+.++........ ++.++.+|+.||+|++|+|+.+||+.+| .+..+ ++.+|..+|.|+||.|+|+||+.+
T Consensus 117 ~~~~~~~~~~~~----~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~ 192 (219)
T 3cs1_A 117 LEFRLMLCYIYD----FFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDKNGTGSVTFDEFAAW 192 (219)
T ss_dssp HHHHHHHHHHHH----HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHCTTSSSEEEHHHHHHH
T ss_pred HHHHHHHhccch----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhCCCCCCcEeHHHHHHH
Confidence 986543332222 5678999999999999999999999998 24443 999999999999999999999999
Q ss_pred Hhhc
Q 007498 588 LHGV 591 (601)
Q Consensus 588 ~~~~ 591 (601)
|.+.
T Consensus 193 ~~~~ 196 (219)
T 3cs1_A 193 ASAV 196 (219)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 9764
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.6e-19 Score=166.06 Aligned_cols=142 Identities=12% Similarity=0.128 Sum_probs=115.7
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHH-----HHHhhcchhhhhhc-----cHHHHHhhcccCCCCcccHHHHHHHh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFR-----MVLGRNATDAMRES-----RVPDVLSSMESLAYRKMYFEEFCAAA 518 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~-----~~l~~~~~~~~~~~-----~~~~~~~~~D~~~~g~i~~~ef~~~~ 518 (601)
++++++++++++|..+|.|++|.|+.+||. .+++.++. .++.. .+..+++.+|.+++|.|+|+||+..+
T Consensus 10 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~-~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~~ 88 (191)
T 1uhk_A 10 DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGA-TPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGW 88 (191)
T ss_dssp TCHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCC-CHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHH
T ss_pred CCHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCC-CchhHHHHHHHHHHHHHHhCcCCCCcCcHHHHHHHH
Confidence 578899999999999999999999999999 78888875 34444 68999999999999999999998765
Q ss_pred hcchhhh-------hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh---c--CCcc-HHHHHHHHhcCCCCceeHHHHH
Q 007498 519 ISTHQLE-------ALEGWEQIASTAFEYFEEEGNRVISIEELAREL---N--VGPS-AYSFLKDWIRNSDGKLSLHGYT 585 (601)
Q Consensus 519 ~~~~~~~-------~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l---~--~~~~-~~~~~~~~d~~~dG~is~~EF~ 585 (601)
....... ..+.....++.+|+.||+|++|+|+.+||+.++ + +..+ ++.+|..+|.|+||.|+|+||+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~eF~ 168 (191)
T 1uhk_A 89 KKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMT 168 (191)
T ss_dssp HHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHH
T ss_pred HHHhcchhhhhhhhhHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 4322111 001111223489999999999999999999998 2 2333 9999999999999999999999
Q ss_pred HHHhhc
Q 007498 586 KFLHGV 591 (601)
Q Consensus 586 ~~~~~~ 591 (601)
.+|...
T Consensus 169 ~~~~~~ 174 (191)
T 1uhk_A 169 RQHLGF 174 (191)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=171.72 Aligned_cols=146 Identities=14% Similarity=0.232 Sum_probs=114.1
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchh-hhhhccHHHHH-------hhcccCCCCcccHHHHHHHh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATD-AMRESRVPDVL-------SSMESLAYRKMYFEEFCAAA 518 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~-~~~~~~~~~~~-------~~~D~~~~g~i~~~ef~~~~ 518 (601)
..++++++.+++++|..+|.|++|.|+.+||..+++.++.. .++..++..++ +.+|.|++|.|+++||+.++
T Consensus 28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i~~~EF~~~~ 107 (208)
T 2hpk_A 28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGLLREDWVEAN 107 (208)
T ss_dssp --------CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBEEGGGHHHHH
T ss_pred HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 55788889999999999999999999999999999988741 35677788888 99999999999999998865
Q ss_pred hc---c-h--hh-hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHH
Q 007498 519 IS---T-H--QL-EALEGWEQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKF 587 (601)
Q Consensus 519 ~~---~-~--~~-~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~ 587 (601)
.. . . .. ......++.++.+|+.||+|++|+|+.+||+.++ ++..+ ++.+|..+|.|+||.|+|+||+.+
T Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~D~d~dG~I~~~EF~~~ 187 (208)
T 2hpk_A 108 RVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAFDVPQEAAYTFFEKADTDKSGKLERTELVHL 187 (208)
T ss_dssp HHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTSCTTHHHHHHHHHCTTCCSSBCHHHHHHH
T ss_pred HHHhhhhhhhhccCChHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCcCHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence 41 0 0 11 1111123447899999999999999999999998 43333 999999999999999999999999
Q ss_pred Hhhcc
Q 007498 588 LHGVT 592 (601)
Q Consensus 588 ~~~~~ 592 (601)
|...-
T Consensus 188 ~~~~~ 192 (208)
T 2hpk_A 188 FRKFW 192 (208)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 98763
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.79 E-value=9.8e-19 Score=162.76 Aligned_cols=143 Identities=13% Similarity=0.176 Sum_probs=117.4
Q ss_pred cchHHHHHHHHHHHhh-CCCCCCcccHHHHHHHHhhcc----hhhhhhccHHHH-----------HhhcccCCCCcccHH
Q 007498 449 LTEDELVYLRAQFRLL-EPNKDGSVSLENFRMVLGRNA----TDAMRESRVPDV-----------LSSMESLAYRKMYFE 512 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~-D~d~~G~I~~~el~~~l~~~~----~~~~~~~~~~~~-----------~~~~D~~~~g~i~~~ 512 (601)
+++.++++++++|..| |.|++|.|+.+||..++..++ . .++..++..+ |+.+|.|++|.|+++
T Consensus 2 ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~ 80 (185)
T 2sas_A 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKG-SLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWE 80 (185)
T ss_dssp CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHH
T ss_pred cCHHHHHHHHHHHHHheeCCCCCeEcHHHHHHHHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHH
Confidence 5678899999999999 999999999999999998877 3 3455556544 999999999999999
Q ss_pred HHHHHhhcchhh-----hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---CCcc-HHHHHHHHhcCCCCceeHHH
Q 007498 513 EFCAAAISTHQL-----EALEGWEQIASTAFEYFEEEGNRVISIEELARELN---VGPS-AYSFLKDWIRNSDGKLSLHG 583 (601)
Q Consensus 513 ef~~~~~~~~~~-----~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---~~~~-~~~~~~~~d~~~dG~is~~E 583 (601)
||+.++...... ......++.++.+|+.+|+|++|+|+.+||+.++. +..+ ++.+|..+|.|+||.|+++|
T Consensus 81 Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g~~~~~~~~~~~~~D~d~dG~i~~~e 160 (185)
T 2sas_A 81 EYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQLQCADVPAVYNVITDGGKVTFDLNR 160 (185)
T ss_dssp HHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSCCCCSSHHHHHHHHHTTTTSCCSHHH
T ss_pred HHHHHHHHHhccccchhhhhHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhCCCHHHHHHHHHHhcCCCCCcCcHHH
Confidence 998765433211 00112357789999999999999999999999993 2233 99999999999999999999
Q ss_pred HHHHHhhcc
Q 007498 584 YTKFLHGVT 592 (601)
Q Consensus 584 F~~~~~~~~ 592 (601)
|+.+|...-
T Consensus 161 f~~~~~~~~ 169 (185)
T 2sas_A 161 YKELYYRLL 169 (185)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999998763
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=99.79 E-value=7.8e-19 Score=158.50 Aligned_cols=135 Identities=22% Similarity=0.329 Sum_probs=112.2
Q ss_pred chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhh
Q 007498 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEG 529 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~ 529 (601)
+++++++++++|..+|.|++|.|+.+|| ..+..++. ...+..+++.+|.+++|.|+|+||+.++........
T Consensus 1 s~~~~~~l~~~F~~~D~d~~G~i~~~el-~~l~~~~~----~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~--- 72 (155)
T 3ll8_B 1 DADEIKRLGKRFKKLDLDNSGSLSVEEF-MSLPELQQ----NPLVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGD--- 72 (155)
T ss_dssp CCHHHHHHHHHHHHHCTTCSSSBCHHHH-TTSGGGTT----CTTHHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCC---
T ss_pred CHHHHHHHHHHHHHhCcCCCCeEcHHHH-HHhhcccc----chHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCC---
Confidence 4678999999999999999999999999 66665553 237999999999999999999999987654322111
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHhcC------Ccc-HHHHHHH----HhcCCCCceeHHHHHHHHhhcc
Q 007498 530 WEQIASTAFEYFEEEGNRVISIEELARELNV------GPS-AYSFLKD----WIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 530 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~------~~~-~~~~~~~----~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.++.++.+|+.||+|++|+|+.+||+.++.. ..+ ++.++.. +|.|+||.|+|+||+.+|.+..
T Consensus 73 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~ 146 (155)
T 3ll8_B 73 KEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLD 146 (155)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHCTTSSSSBCHHHHHHHHGGGC
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHhccC
Confidence 2567899999999999999999999998832 222 6667776 9999999999999999998875
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=99.79 E-value=5.2e-19 Score=161.96 Aligned_cols=140 Identities=13% Similarity=0.206 Sum_probs=116.4
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
...++++++.+++.+|..||.|++|.|+.+||..+++.++...++..++..++... +|.|+|+||+.++.......
T Consensus 16 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~~----dg~i~~~eF~~~~~~~~~~~ 91 (166)
T 2mys_B 16 FSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEA----SGPINFTVFLTMFGEKLKGA 91 (166)
T ss_pred hhhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHC----CCCcCHHHHHHHHHHHhccC
Confidence 34688999999999999999999999999999999999874135667788888764 79999999998665332111
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
. ..+.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||.|+|+||+.+|.+..
T Consensus 92 ~---~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~I~~~eF~~~~~~~~ 161 (166)
T 2mys_B 92 D---PEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITHGE 161 (166)
T ss_pred C---cHHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCCCCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHHhcc
Confidence 1 156789999999999999999999999993 2222 99999999999999999999999998754
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=99.79 E-value=2.9e-20 Score=167.33 Aligned_cols=140 Identities=20% Similarity=0.273 Sum_probs=109.7
Q ss_pred hcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccC--CCCcccHHHHHHHhhcchhhh
Q 007498 448 ALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESL--AYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~--~~g~i~~~ef~~~~~~~~~~~ 525 (601)
.++++++.+++++|..+|.|++|.|+.+||..+++.++. .++..++..+++.+|.+ ++|.|+|+||+.++.......
T Consensus 3 ~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~~~~~~g~i~~~eF~~~~~~~~~~~ 81 (151)
T 1w7j_B 3 EFNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQ-NPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNR 81 (151)
T ss_dssp --------CHHHHHHHHCCSSSSEEESTTHHHHHHHTTC-CCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCcCcCCCCcCcHHHHHHHHHHHhccC
Confidence 367889999999999999999999999999999999885 56778899999999999 999999999988665432111
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
. ....+.+..+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+| |+||.|+|+||+.+|.+
T Consensus 82 ~-~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~~~ 150 (151)
T 1w7j_B 82 G-QGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHE-DSNGCINYEAFLKHILS 150 (151)
T ss_dssp -------CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC-CTTSEEEHHHHHHHTC-
T ss_pred C-CCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHhcc-CCCCeEeHHHHHHHHhc
Confidence 1 11145678899999999999999999999993 2332 999999999 99999999999999864
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=5e-19 Score=167.80 Aligned_cols=140 Identities=20% Similarity=0.275 Sum_probs=115.3
Q ss_pred hcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh--
Q 007498 448 ALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE-- 525 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~-- 525 (601)
.++++++++|+++|..+|.|++|.|+.+||..+ ..++. .+ .+..+++.+|.+++|.|+|+||+.++.......
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~-~~---~~~~l~~~~D~d~dg~i~~~EF~~~~~~~~~~~~~ 96 (202)
T 2bec_A 22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAV-NP---LGDRIIESFFPDGSQRVDFPGFVRVLAHFRPVEDE 96 (202)
T ss_dssp CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHH-ST---THHHHHHTTSCSSCCCCCHHHHHHHHGGGSCCCHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCC-Cc---cHHHHHHHhCCCCCCcCcHHHHHHHHHHhcccchh
Confidence 578999999999999999999999999999999 76664 22 299999999999999999999998765443200
Q ss_pred -----------hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-C-----Ccc-HHHHHHH----HhcCCCCceeHHH
Q 007498 526 -----------ALEGWEQIASTAFEYFEEEGNRVISIEELARELN-V-----GPS-AYSFLKD----WIRNSDGKLSLHG 583 (601)
Q Consensus 526 -----------~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-~-----~~~-~~~~~~~----~d~~~dG~is~~E 583 (601)
......+.++.+|+.||+|++|+|+.+||+.+|. + ..+ ++.++.. +|.|+||.|+|+|
T Consensus 97 ~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~D~d~dG~Is~~E 176 (202)
T 2bec_A 97 DTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGVQVTEEQLENIADRTVQEADEDGDGAVSFVE 176 (202)
T ss_dssp HHC-----CCCCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHSCCSCCCHHHHHHHHHHHHHHHCSSCSSSEEHHH
T ss_pred cccccccccccccccHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHcCCCCCCcCcHHH
Confidence 0112267789999999999999999999999993 2 222 6667776 9999999999999
Q ss_pred HHHHHhhcc
Q 007498 584 YTKFLHGVT 592 (601)
Q Consensus 584 F~~~~~~~~ 592 (601)
|+.+|.+..
T Consensus 177 F~~~~~~~~ 185 (202)
T 2bec_A 177 FTKSLEKMD 185 (202)
T ss_dssp HHHTTTTSC
T ss_pred HHHHHHHhC
Confidence 999998763
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.1e-19 Score=154.31 Aligned_cols=128 Identities=16% Similarity=0.213 Sum_probs=111.3
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh---cchhhhhhhhHHHH
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI---STHQLEALEGWEQI 533 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~---~~~~~~~~~~~~~~ 533 (601)
++++|..+|.|++|.|+.+||..++..++. ..+..++..+++.+|.+++|.|+++||..++. ....... .+.
T Consensus 2 l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~----~~~ 76 (134)
T 1jfj_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRA-IKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDD----KIG 76 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCC-SSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHH----HHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCC----HHH
Confidence 688999999999999999999999999875 56777899999999999999999999998764 2211112 445
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhcCCcc--HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELNVGPS--AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~~~~~--~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
++.+|+.+|.|++|+|+.+||+.++...+. ++.+|..+|.|+||.|+|+||+++|.
T Consensus 77 ~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~ll 134 (134)
T 1jfj_A 77 LKVLYKLMDVDGDGKLTKEEVTSFFKKHGIEKVAEQVMKADANGDGYITLEEFLEFSL 134 (134)
T ss_dssp HHHHHHHHCCSSSSEEEHHHHHHHHTTTTCHHHHHHHHHHHCSSSSEEEHHHHHHHHC
T ss_pred HHHHHHHHCCCCCCccCHHHHHHHHHHhCHHHHHHHHHHhCCCCCCcEeHHHHHHHhC
Confidence 899999999999999999999999965444 89999999999999999999999873
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.9e-19 Score=161.47 Aligned_cols=140 Identities=16% Similarity=0.152 Sum_probs=114.5
Q ss_pred chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcc----hhhhhhcc-H--------HHHHhhcccCCCCcccHHHHHH
Q 007498 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNA----TDAMRESR-V--------PDVLSSMESLAYRKMYFEEFCA 516 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~----~~~~~~~~-~--------~~~~~~~D~~~~g~i~~~ef~~ 516 (601)
+++++++++++|..+|.|++|.|+.+||..+++.++ . .++..+ + +.+++.+| ++|.|+++||+.
T Consensus 1 s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~g~-~~~~~~~~~~~~~~~~~~l~~~~D--~~g~i~~~EF~~ 77 (174)
T 1q80_A 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEM-KAEHAKVLMDSLTGVWDNFLTAVA--GGKGIDETTFIN 77 (174)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEESHHHHHHHHHHHHHHSSC-CTTHHHHHHHHHHHHHHHTGGGTT--TTSCEEHHHHHH
T ss_pred CHHHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHhcC--CCCeEcHHHHHH
Confidence 467889999999999999999999999999999887 3 344444 4 46788899 899999999988
Q ss_pred Hhhcchhhh-hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 517 AAISTHQLE-ALEGWEQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 517 ~~~~~~~~~-~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
++....... ......+.++.+|+.||+|++|+|+.+||+.++ ++..+ ++.+|..+|.|+||.|+|+||+.+|...
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~ 157 (174)
T 1q80_A 78 SMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGLDKTMAPASFDAIDTNNDGLLSLEEFVIAGSDF 157 (174)
T ss_dssp HHHHHTTSTTCHHHHHTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHTCCGGGHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHcCcccHHHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHcCCCHHHHHHHHHHhCCCCCceEeHHHHHHHHHHH
Confidence 655432210 001125678999999999999999999999998 55554 9999999999999999999999999775
Q ss_pred c
Q 007498 592 T 592 (601)
Q Consensus 592 ~ 592 (601)
.
T Consensus 158 ~ 158 (174)
T 1q80_A 158 F 158 (174)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=99.78 E-value=8.3e-19 Score=158.80 Aligned_cols=140 Identities=18% Similarity=0.279 Sum_probs=113.6
Q ss_pred HhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh
Q 007498 444 ALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ 523 (601)
Q Consensus 444 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~ 523 (601)
.....++++++.+|+++|..||.|++|.|+.+||..+|+.++. .++..++..+++ +.+|.|+|+||+.++.....
T Consensus 7 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~ 81 (156)
T 1wdc_B 7 GVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGR-APDDKELTAMLK----EAPGPLNFTMFLSIFSDKLS 81 (156)
T ss_dssp -----CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSS-CCCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTC
T ss_pred chhccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHH----hCCCcCcHHHHHHHHHHHhc
Confidence 4456688999999999999999999999999999999999885 466667777775 46899999999886653211
Q ss_pred hhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 524 LEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 524 ~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
... .++.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.| ||.|+|+||+++|.+..
T Consensus 82 ~~~---~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~-dg~i~~~eF~~~~~~~~ 152 (156)
T 1wdc_B 82 GTD---SEETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGSG 152 (156)
T ss_dssp SCC---CHHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHTSC
T ss_pred CCC---hHHHHHHHHHHHCcCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcCCC-CCEEeHHHHHHHHhcCc
Confidence 111 156789999999999999999999999993 2222 99999999999 99999999999998754
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=99.78 E-value=3e-19 Score=168.58 Aligned_cols=138 Identities=14% Similarity=0.200 Sum_probs=118.5
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh-h
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ-L 524 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~ 524 (601)
...++.+++.+|+++|..||.|++|.|+.+||..+|+.++. .++..++..++..+ +|.|+|+||+.++..... .
T Consensus 48 ~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~-~~~~~~~~~l~~~~----~g~i~~~eF~~~~~~~~~~~ 122 (196)
T 3dtp_E 48 FAMFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGR-LCTEQELDSMVAEA----PGPINFTMFLTIFGDRIAGT 122 (196)
T ss_dssp SCSSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSC-CCCHHHHHHHHTTS----SSCCBHHHHHHHHHHCCCSS
T ss_pred hhhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHc----cCCCcHHHHHHHHHHHhcCC
Confidence 34578899999999999999999999999999999999985 57777888888887 899999999987653221 1
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCcc------HHHHHHHHhcCCCCceeHHHHHHHHhhccc
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPS------AYSFLKDWIRNSDGKLSLHGYTKFLHGVTL 593 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~------~~~~~~~~d~~~dG~is~~EF~~~~~~~~~ 593 (601)
.. .+.+..+|+.||.|++|+|+.+||+.+| ..+. ++.+|..+|.|+||.|+|+||+++|.+.+.
T Consensus 123 ~~----~~~l~~~F~~~D~d~~G~Is~~El~~~l-~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~l~~~~~ 192 (196)
T 3dtp_E 123 DE----EDVIVNAFNLFDEGDGKCKEETLKRSLT-TWGEKFSQDEVDQALSEAPIDGNGLIDIKKFAQILTKGAK 192 (196)
T ss_dssp CC----HHHHHHHHHTTCSSSSCCBHHHHHHHHH-HSSSCCCHHHHHHHHHSSCEETTEECHHHHHHHHHSSCCB
T ss_pred Cc----HHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCCHHHHHHHHHHcCCCCCCEEeHHHHHHHHHcCCc
Confidence 12 5678999999999999999999999999 3321 899999999999999999999999988653
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=99.77 E-value=9.4e-19 Score=156.08 Aligned_cols=127 Identities=19% Similarity=0.292 Sum_probs=109.5
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcch--hhhhhhhHHHHH
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTH--QLEALEGWEQIA 534 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~--~~~~~~~~~~~~ 534 (601)
++++|..+|.|++|.|+.+||..+++.++. .++..++..+++. +++|.|+|+||+.++.... .... .+.+
T Consensus 7 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~---~~~g~i~~~eF~~~~~~~~~~~~~~----~~~l 78 (145)
T 2bl0_B 7 IQECFQIFDKDNDGKVSIEELGSALRSLGK-NPTNAELNTIKGQ---LNAKEFDLATFKTVYRKPIKTPTEQ----SKEM 78 (145)
T ss_dssp HHHHHHHHCTTCSSCEEGGGHHHHHHHTTC-CCCHHHHHHHHHH---HTSSEECHHHHHHHHTSCCCCGGGG----HHHH
T ss_pred HHHHHHHhCCCCcCccCHHHHHHHHHHhCC-CCCHHHHHHHHHh---cCCCeEcHHHHHHHHHHHhhcCccc----HHHH
Confidence 999999999999999999999999999885 5667778888887 7899999999998765432 1112 5678
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 535 STAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||.|+|+||+.+|...
T Consensus 79 ~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~ 141 (145)
T 2bl0_B 79 LDAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVSVSGDGAINYESFVDMLVTG 141 (145)
T ss_dssp HHHHHHHCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHHS
T ss_pred HHHHHHhCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHHHhc
Confidence 9999999999999999999999992 2222 9999999999999999999999999864
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.8e-18 Score=155.73 Aligned_cols=139 Identities=16% Similarity=0.179 Sum_probs=110.2
Q ss_pred HHHHHHHHHHhhCCCCCCcccHHHHHHHHh----hcchhhhhhccHH-----------HHHhhcccCCCCcccHHHHHHH
Q 007498 453 ELVYLRAQFRLLEPNKDGSVSLENFRMVLG----RNATDAMRESRVP-----------DVLSSMESLAYRKMYFEEFCAA 517 (601)
Q Consensus 453 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~----~~~~~~~~~~~~~-----------~~~~~~D~~~~g~i~~~ef~~~ 517 (601)
++++++++|..+|.|++|.|+.+||..++. .++. .++..++. .+|+.+|.+++|.|+++||+.+
T Consensus 2 ~~~~l~~~F~~~D~d~dG~i~~~E~~~~l~~~~~~~g~-~~~~~~~~~l~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~ 80 (166)
T 3akb_A 2 YERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGV-AARSDRGQALYGGAEALWQGLAGIADRDGDQRITREEFVTG 80 (166)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHHTC-CTTSHHHHHHHHHHHHHHHHHHHHHCTTSSSCEEHHHHHHT
T ss_pred HHHHHHHHHhHHcCCCCCCcCHHHHHHHHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence 467899999999999999999999999864 3343 34455555 4479999999999999999876
Q ss_pred hhcchhhhh---hhhHHHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 518 AISTHQLEA---LEGWEQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 518 ~~~~~~~~~---~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
+........ .+..++.++.+|+.||+|++|+|+.+||+.++ ++..+ ++.+|..+|.|+||.|+|+||+.+|.+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~ 160 (166)
T 3akb_A 81 AVKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAFGVPEDLARQAAAALDTDGDGKVGETEIVPAFAR 160 (166)
T ss_dssp HHHHHHHSHHHHHHHHHHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSBCCHHHHHHHHHH
T ss_pred HHHHhccCccchHHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 543321110 11124458999999999999999999999998 33333 999999999999999999999999977
Q ss_pred cc
Q 007498 591 VT 592 (601)
Q Consensus 591 ~~ 592 (601)
.-
T Consensus 161 ~~ 162 (166)
T 3akb_A 161 YF 162 (166)
T ss_dssp HT
T ss_pred Hh
Confidence 53
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.8e-18 Score=161.59 Aligned_cols=140 Identities=20% Similarity=0.262 Sum_probs=115.6
Q ss_pred hcchHHHHHHHHHHHhhCCC--CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 448 ALTEDELVYLRAQFRLLEPN--KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~d--~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
.++.+++.+++++|..+|.| ++|.|+.+||..++.... ......+..+|+.+|.+++|.|+++||+.++.......
T Consensus 30 ~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~~~--~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~ 107 (207)
T 2ehb_A 30 PFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFRNR--NRRNLFADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSA 107 (207)
T ss_dssp SCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHSCT--TCCCHHHHHHHHHHCTTCSSEECHHHHHHHHGGGSTTS
T ss_pred CCCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhccc--cccHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHccCC
Confidence 57899999999999999999 999999999999998622 22334567899999999999999999998765443211
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---------CCcc-----HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELN---------VGPS-----AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---------~~~~-----~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
. .++.++.+|+.||.|++|+|+.+||+.++. +..+ +..+|..+|.|+||.|+|+||+.+|.+.
T Consensus 108 ~---~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~ 184 (207)
T 2ehb_A 108 P---VHEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKIDIDEWKDFVSLN 184 (207)
T ss_dssp C---HHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC
T ss_pred C---HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhC
Confidence 1 266789999999999999999999999882 2222 4566779999999999999999999876
Q ss_pred c
Q 007498 592 T 592 (601)
Q Consensus 592 ~ 592 (601)
+
T Consensus 185 ~ 185 (207)
T 2ehb_A 185 P 185 (207)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-18 Score=178.91 Aligned_cols=140 Identities=18% Similarity=0.357 Sum_probs=119.4
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
..++++++++++++|..||.|++|.|+.+||..+|+.++. ..+.++++.+++.+|.|++|.|+|+||+.++........
T Consensus 304 ~~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~-~~s~eel~~Lf~~~D~DgdG~IsfeEFl~ll~~~~~~~~ 382 (450)
T 3sg6_A 304 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTD 382 (450)
T ss_dssp -CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHTTCTTSSSSEEHHHHHHHHHC------
T ss_pred ccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhccCCCCcccHHHHHHHHHhhccccc
Confidence 4578889999999999999999999999999999999885 577888999999999999999999999987654322111
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
.++.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||.|+|+||+.+|..
T Consensus 383 ---~~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ls~eei~~Lf~~~D~D~DG~IsfdEFv~~L~~ 449 (450)
T 3sg6_A 383 ---SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA 449 (450)
T ss_dssp ---CHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTSSSSEEHHHHHHHHC-
T ss_pred ---hhhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhc
Confidence 156789999999999999999999999982 3333 999999999999999999999999864
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.8e-18 Score=164.77 Aligned_cols=148 Identities=15% Similarity=0.215 Sum_probs=118.3
Q ss_pred HHHHHhhh--hcchHHHHHHHHHHHhhCCC--CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHH
Q 007498 440 AALKALSK--ALTEDELVYLRAQFRLLEPN--KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFC 515 (601)
Q Consensus 440 ~~~~~~~~--~l~~~~~~~l~~~F~~~D~d--~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~ 515 (601)
..+..+.. .++.+++++++++|..+|.| ++|.|+.+||..+|.... ......+..+|+.+|.|++|.|+++||+
T Consensus 31 ~~~~~l~~~~~ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~~~~--~~~~~~~~~~f~~~D~d~dG~I~~~Ef~ 108 (226)
T 2zfd_A 31 GDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTN--KKESLFADRVFDLFDTKHNGILGFEEFA 108 (226)
T ss_dssp -CTHHHHHHSSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHSCS--SCCCHHHHHHHHHHCSSCSSSBCHHHHH
T ss_pred HHHHHHHHhCCCCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHhccC--cccHHHHHHHHHHHcCCCCCcCcHHHHH
Confidence 44444443 57999999999999999999 999999999999998621 2223346779999999999999999998
Q ss_pred HHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---------CCcc-----HHHHHHHHhcCCCCceeH
Q 007498 516 AAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN---------VGPS-----AYSFLKDWIRNSDGKLSL 581 (601)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---------~~~~-----~~~~~~~~d~~~dG~is~ 581 (601)
.++....... ..++.++.+|+.||.|++|+|+.+||+.++. +..+ ++.+|+.+|.|+||.|+|
T Consensus 109 ~~~~~~~~~~---~~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~ 185 (226)
T 2zfd_A 109 RALSVFHPNA---PIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDK 185 (226)
T ss_dssp HHHHHTSTTS---CHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECH
T ss_pred HHHHHHccCC---CHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcH
Confidence 8665432211 1266789999999999999999999999882 2222 456667999999999999
Q ss_pred HHHHHHHhhcc
Q 007498 582 HGYTKFLHGVT 592 (601)
Q Consensus 582 ~EF~~~~~~~~ 592 (601)
+||+.+|.+.+
T Consensus 186 ~EF~~~~~~~~ 196 (226)
T 2zfd_A 186 EEWRSLVLRHP 196 (226)
T ss_dssp HHHHHHHHHSG
T ss_pred HHHHHHHHhCh
Confidence 99999998764
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-18 Score=160.73 Aligned_cols=139 Identities=16% Similarity=0.221 Sum_probs=116.4
Q ss_pred hcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhh
Q 007498 448 ALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEAL 527 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~ 527 (601)
.++.+++.++.+.|+.+ |++|.|+.+||..++..++....+...+..+|+.+|.+++|.|+++||+.++........
T Consensus 14 ~~s~~~i~~l~~~fd~~--d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~- 90 (183)
T 1s6c_A 14 NFTKRELQVLYRGFKNE--XPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTV- 90 (183)
T ss_dssp SCCHHHHHHHHHHHHHH--CTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCH-
T ss_pred CCCHHHHHHHHHHHHHh--CCCCcCCHHHHHHHHHHHcCCCChHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCCH-
Confidence 47888888888777776 688999999999999998754466778999999999999999999999987654332222
Q ss_pred hhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-------------CC-----ccHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 528 EGWEQIASTAFEYFEEEGNRVISIEELARELN-------------VG-----PSAYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 528 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-------------~~-----~~~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
++.++.+|+.||.|++|+|+.+||+.++. +. .+++.+|+.+|.|+||.|+|+||+.+|.
T Consensus 91 ---~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~ 167 (183)
T 1s6c_A 91 ---HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESXQ 167 (183)
T ss_dssp ---HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHTT
T ss_pred ---HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 66789999999999999999999999882 11 2289999999999999999999999998
Q ss_pred hcc
Q 007498 590 GVT 592 (601)
Q Consensus 590 ~~~ 592 (601)
+.+
T Consensus 168 ~~~ 170 (183)
T 1s6c_A 168 EDD 170 (183)
T ss_dssp SCC
T ss_pred cCh
Confidence 754
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=99.76 E-value=6.4e-18 Score=163.52 Aligned_cols=140 Identities=15% Similarity=0.204 Sum_probs=117.1
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
..++.++++.+++.|.. .|++|.|+.+||..++..+.........++.+|+.+|.|++|.|+|+||+.++.......
T Consensus 59 ~~~s~~ei~~l~~~F~~--~d~~G~Is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~~~- 135 (229)
T 3dd4_A 59 SKFTKKELQILYRGFKN--ECPSGVVNEETFKEIYSQFFPQGDSTTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGT- 135 (229)
T ss_dssp HHHHHHHHHHHHHHHHT--TCCSCCCCHHHHHHHHHHHSCSSSHHHHHHHHHHTTCSSCCSSCCHHHHHHHHHHHHHSC-
T ss_pred cCCCHHHHHHHHHHHHh--hCCCCCcCHHHHHHHHHHHCCCCCcHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHcCCC-
Confidence 35788899999998876 567899999999999998654445667789999999999999999999998765433222
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcC-----------------Cc-cHHHHHHHHhcCCCCceeHHHHHHHH
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELARELNV-----------------GP-SAYSFLKDWIRNSDGKLSLHGYTKFL 588 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~-----------------~~-~~~~~~~~~d~~~dG~is~~EF~~~~ 588 (601)
.++.++.+|+.||+|++|+|+.+||+.++.. .. .++.+|+.+|.|+||.|+|+||++++
T Consensus 136 ---~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~ 212 (229)
T 3dd4_A 136 ---VQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFIESC 212 (229)
T ss_dssp ---HHHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC-----------CCTHHHHHHHHHCSSCSSBCCHHHHHHHH
T ss_pred ---hHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchhhHHHHHHHHHHHhcCCCCCcEeHHHHHHHH
Confidence 2678899999999999999999999998831 11 19999999999999999999999999
Q ss_pred hhcc
Q 007498 589 HGVT 592 (601)
Q Consensus 589 ~~~~ 592 (601)
.+.+
T Consensus 213 ~~~~ 216 (229)
T 3dd4_A 213 QKDE 216 (229)
T ss_dssp HTCH
T ss_pred HhCH
Confidence 8754
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.76 E-value=2.4e-18 Score=163.28 Aligned_cols=137 Identities=15% Similarity=0.198 Sum_probs=116.8
Q ss_pred chHHHHHHHHHHHhhCCC-CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhh
Q 007498 450 TEDELVYLRAQFRLLEPN-KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALE 528 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D~d-~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~ 528 (601)
+.-..++++++|..||.| ++|.|+.+||..+++.++. ......++.+|+.+|.|++|.|+++||+.++........
T Consensus 17 t~~~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~-- 93 (204)
T 1jba_A 17 GAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDN-EEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTL-- 93 (204)
T ss_dssp CHHHHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSS-STTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCC--
T ss_pred cCCCHHHHHHHHHHHHhhCCCCCcCHHHHHHHHHHhcC-CCcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCH--
Confidence 345677889999999999 8999999999999999886 566778999999999999999999999887654332222
Q ss_pred hHHHHHHHHHHHHcccCCCcccHHHHHHHhcC---------------------Cc-c-HHHHHHHHhcCCCCceeHHHHH
Q 007498 529 GWEQIASTAFEYFEEEGNRVISIEELARELNV---------------------GP-S-AYSFLKDWIRNSDGKLSLHGYT 585 (601)
Q Consensus 529 ~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~---------------------~~-~-~~~~~~~~d~~~dG~is~~EF~ 585 (601)
++.++.+|+.||.|++|+|+.+||+.++.. .. + ++.+|..+|.|+||.|+++||+
T Consensus 94 --~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~g~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~ 171 (204)
T 1jba_A 94 --EHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFV 171 (204)
T ss_dssp --THHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHH
T ss_pred --HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccccccCchhhHHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 557899999999999999999999998821 11 2 8999999999999999999999
Q ss_pred HHHhhc
Q 007498 586 KFLHGV 591 (601)
Q Consensus 586 ~~~~~~ 591 (601)
++|.+.
T Consensus 172 ~~~~~~ 177 (204)
T 1jba_A 172 EGARRD 177 (204)
T ss_dssp HHHTTT
T ss_pred HHHHcC
Confidence 999764
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.9e-18 Score=158.03 Aligned_cols=130 Identities=13% Similarity=0.250 Sum_probs=112.1
Q ss_pred HHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHH
Q 007498 452 DELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWE 531 (601)
Q Consensus 452 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~ 531 (601)
.+.++++++|..+|.|++|.|+.+||..+++.++....+..++..+++.+|.+++|.|+++||+.++.. .
T Consensus 4 ~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~ef~~~~~~----------~ 73 (172)
T 2znd_A 4 PDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKY----------I 73 (172)
T ss_dssp --CHHHHHHHHHHCTTCSSCEEHHHHHHHCCCSSSSCCCHHHHHHHHHHHCSSSSSEECHHHHHHHHHH----------H
T ss_pred cchhHHHHHHHHhCCCCCCcCcHHHHHHHHHhcCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH----------H
Confidence 356689999999999999999999999999988743567778999999999999999999999886432 2
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 532 QIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.++..+|.|+||.|+|+||+.+|...
T Consensus 74 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~ 139 (172)
T 2znd_A 74 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVL 139 (172)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 4578899999999999999999999983 2222 9999999999999999999999988754
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.8e-18 Score=162.14 Aligned_cols=133 Identities=17% Similarity=0.193 Sum_probs=112.6
Q ss_pred HHHHHHHhhCCC-CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 456 YLRAQFRLLEPN-KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 456 ~l~~~F~~~D~d-~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
+++++|..||.| ++|.|+.+||..+++.++........+..+|+.+|.+++|.|+++||..++........ ++.+
T Consensus 26 el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~----~~~~ 101 (190)
T 2l2e_A 26 ELQQWYKGFFKDCPSGHLNKSEFQKIYKQFFPFGDPSAFAEYVFNVFDADKNGYIDFKEFICALSVTSRGEL----NDKL 101 (190)
T ss_dssp HHHHHHHHHHHHSCCCEECHHHHHHHHHHHCCCSCHHHHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCS----HHHH
T ss_pred HHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCCccHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCH----HHHH
Confidence 467778999999 89999999999999988643345667999999999999999999999987654433222 5678
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhcC-----------------Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 535 STAFEYFEEEGNRVISIEELARELNV-----------------GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~~-----------------~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
..+|+.||.|++|+|+.+||+.++.. ..+ ++.+|..+|.|+||.|+++||+.++...+
T Consensus 102 ~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~ 177 (190)
T 2l2e_A 102 IWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNKDGQLTLEEFCEGSKRDP 177 (190)
T ss_dssp HHHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCCCTHHHHHHHHHHHTCCSSCCBCHHHHHHHHHTCT
T ss_pred HHHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccccHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhCc
Confidence 99999999999999999999998732 111 89999999999999999999999998754
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.75 E-value=5e-18 Score=159.45 Aligned_cols=127 Identities=15% Similarity=0.216 Sum_probs=110.5
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHH
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 533 (601)
.++++++|..+|.|++|.|+.+||..++..++. ..+..++..+++.+|.|++|.|+++||+..+.. .+.
T Consensus 26 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~-~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~----------~~~ 94 (191)
T 1y1x_A 26 NQELMEWFRAVDTDGSGAISVPELNAALSSAGV-PFSLATTEKLLHMYDKNHSGEITFDEFKDLHHF----------ILS 94 (191)
T ss_dssp TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTB-CCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH----------HHH
T ss_pred HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH----------HHH
Confidence 457899999999999999999999999976654 467788999999999999999999999886542 245
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhcC-----Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELNV-----GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~~-----~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
++.+|+.||+|++|+|+.+||+.++.. ..+ ++.+|..+|.|+||.|+|+||+.+|...
T Consensus 95 ~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~ 158 (191)
T 1y1x_A 95 MREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFV 158 (191)
T ss_dssp HHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHH
Confidence 788999999999999999999999932 222 8999999999999999999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=7.7e-19 Score=180.25 Aligned_cols=143 Identities=18% Similarity=0.244 Sum_probs=99.9
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc-----------chh--------hHHHHHHHHHHHHHhc
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-----------TAI--------SIEDVRREVKILKALS 208 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~--------~~~~~~~E~~~l~~l~ 208 (601)
-|++++.||+|+||.||+|++. +|+.||||+++..... ... ..-...+|...|.+|.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 4999999999999999999875 6789999997642211 000 0111346777788874
Q ss_pred CCCCeeEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC
Q 007498 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288 (601)
Q Consensus 209 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~ 288 (601)
+.++.. ...+.. ...+|||||++|++|... ........++.||+.+|.|||++|||||||||.|||++.+
T Consensus 172 -~~gv~v-p~p~~~-~~~~LVME~i~G~~L~~l-------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 172 -EEGFPV-PEPIAQ-SRHTIVMSLVDALPMRQV-------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp -HTTCSC-CCEEEE-ETTEEEEECCSCEEGGGC-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred -hcCCCC-Ceeeec-cCceEEEEecCCccHhhh-------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 444321 111111 123799999999887542 2223567889999999999999999999999999999752
Q ss_pred CCC-------CCeEEeecccccc
Q 007498 289 RDD-------ADMRLIDFGLSDF 304 (601)
Q Consensus 289 ~~~-------~~vkl~DFG~a~~ 304 (601)
.+. ..+.|+||+-+..
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcccccccccceEEEEeCCccc
Confidence 110 1388999997743
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.74 E-value=6.9e-18 Score=162.70 Aligned_cols=139 Identities=16% Similarity=0.215 Sum_probs=115.9
Q ss_pred hcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhh
Q 007498 448 ALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEAL 527 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~ 527 (601)
.++.++++++.+.|+.. |++|.|+.+||..++..++....+..++..+|+.+|.|++|.|+++||+.++........
T Consensus 47 ~~s~~ei~~l~~~Fd~~--d~~G~I~~~E~~~~l~~l~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~~~~- 123 (224)
T 1s1e_A 47 NFTKRELQVLYRGFKNE--CPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTV- 123 (224)
T ss_dssp SCCHHHHHHHHHHHHHH--CTTSCBCHHHHHHHHHTTCTTSCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHCCH-
T ss_pred CCCHHHHHHHHHHHHhh--CCCCCCCHHHHHHHHHHhcCCCCcHHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHccCCH-
Confidence 37888877777777665 479999999999999998754456778999999999999999999999987654332222
Q ss_pred hhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-------------CC-----ccHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 528 EGWEQIASTAFEYFEEEGNRVISIEELARELN-------------VG-----PSAYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 528 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-------------~~-----~~~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
++.++.+|+.||.|++|+|+.+||+.++. +. .+++.+|+.+|.|+||.|+|+||+.+|.
T Consensus 124 ---~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~ 200 (224)
T 1s1e_A 124 ---HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQ 200 (224)
T ss_dssp ---HHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHCTTCSSCEEHHHHHHHHH
T ss_pred ---HHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 66789999999999999999999999882 11 1289999999999999999999999998
Q ss_pred hcc
Q 007498 590 GVT 592 (601)
Q Consensus 590 ~~~ 592 (601)
+.+
T Consensus 201 ~~~ 203 (224)
T 1s1e_A 201 EDD 203 (224)
T ss_dssp TCH
T ss_pred hCH
Confidence 753
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.7e-18 Score=159.32 Aligned_cols=146 Identities=11% Similarity=0.178 Sum_probs=114.2
Q ss_pred hHHHHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcc---cCCCCcccHHHH
Q 007498 438 KRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSME---SLAYRKMYFEEF 514 (601)
Q Consensus 438 ~~~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D---~~~~g~i~~~ef 514 (601)
....+..++..++..++.+++++|..|| ++|.|+.+||..++ +. .++...+..+++.+| .+++|.|+++||
T Consensus 11 ~~~~l~~~~~~~~~~~~~~~~~~F~~~D--~dG~I~~~el~~~l---g~-~~~~~~~~~i~~~~d~~~~~~~~~i~~~ef 84 (179)
T 3a8r_A 11 ALKGLQFVTAKVGNDGWAAVEKRFNQLQ--VDGVLLRSRFGKCI---GM-DGSDEFAVQMFDSLARKRGIVKQVLTKDEL 84 (179)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHHHHHHC--BTTBEEGGGHHHHH---TC-CSCHHHHHHHHHHHHHHHTCCSSEECHHHH
T ss_pred hHHHHHHHHhccchhhHHHHHHHHhccC--CCCCCcHHHHHHHH---CC-CCcHHHHHHHHHHHHHhccCCCCCcCHHHH
Confidence 3445666777666677889999999999 79999999999976 32 345566788888887 467889999999
Q ss_pred HHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc----C---------Cc-cHHHHHHHHhcCCCCcee
Q 007498 515 CAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN----V---------GP-SAYSFLKDWIRNSDGKLS 580 (601)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~----~---------~~-~~~~~~~~~d~~~dG~is 580 (601)
..++..... ...++.++.+|++||+|+||+|+.+||+.+|. . .. +++.+|..+|.|+||.|+
T Consensus 85 ~~~~~~~~~----~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~ 160 (179)
T 3a8r_A 85 KDFYEQLTD----QGFDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELDPTNLGYIE 160 (179)
T ss_dssp HHHHHHHHC----CCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHSTTCCSEEC
T ss_pred HHHHHHHcC----CCHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhCCCCCCcCc
Confidence 876543211 11267899999999999999999999999884 1 12 289999999999999999
Q ss_pred HHHHHHHHhhccc
Q 007498 581 LHGYTKFLHGVTL 593 (601)
Q Consensus 581 ~~EF~~~~~~~~~ 593 (601)
|+||+.+|...++
T Consensus 161 ~~EF~~~~~~~p~ 173 (179)
T 3a8r_A 161 MEDLEALLLQSPS 173 (179)
T ss_dssp HHHHHHHHC----
T ss_pred HHHHHHHHHhCcc
Confidence 9999999988754
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=99.74 E-value=6.1e-18 Score=161.11 Aligned_cols=149 Identities=17% Similarity=0.273 Sum_probs=116.2
Q ss_pred HHHHHHhh--hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHH
Q 007498 439 RAALKALS--KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCA 516 (601)
Q Consensus 439 ~~~~~~~~--~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~ 516 (601)
...+..+. ..++++++++++++|..+|.|++|+|+.+||..++ .++. .+ ..+.+++.+|.+++|.|+|+||+.
T Consensus 11 ~~~~~~l~~~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~~-~lg~-~~---~~~~l~~~~d~~~~g~i~~~EF~~ 85 (208)
T 2ct9_A 11 DEELEEIKKETGFSHSQITRLYSRFTSLDKGENGTLSREDFQRIP-ELAI-NP---LGDRIINAFFSEGEDQVNFRGFMR 85 (208)
T ss_dssp HHHHHHHHHHHCCCHHHHHHHHHHHHHHCTTCSSEECTGGGGGCH-HHHT-ST---THHHHHHTTSCTTCSCEEHHHHHH
T ss_pred HHHHHHHHHcCCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCC-CC---cHHHHHHHHcCCCCCcCcHHHHHH
Confidence 34444443 35799999999999999999999999999999965 4543 22 246789999999999999999998
Q ss_pred Hhhcchhhhhh------------hhHHHHHHHHHHHHcccCCCcccHHHHHHHhcC------Ccc-HHHH----HHHHhc
Q 007498 517 AAISTHQLEAL------------EGWEQIASTAFEYFEEEGNRVISIEELARELNV------GPS-AYSF----LKDWIR 573 (601)
Q Consensus 517 ~~~~~~~~~~~------------~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~------~~~-~~~~----~~~~d~ 573 (601)
++......... ....+.++.+|+.||+|++|+|+.+||+.+|.. ..+ ++.+ |..+|.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~~~D~ 165 (208)
T 2ct9_A 86 TLAHFRPIEDNEKSKDVNGPEPLNSRSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQ 165 (208)
T ss_dssp HHHTTSCCC-----------CCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHHHCS
T ss_pred HHHhhccccchhhhcccccccccccHHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCC
Confidence 76543211000 013678899999999999999999999999831 222 5555 999999
Q ss_pred CCCCceeHHHHHHHHhhcc
Q 007498 574 NSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 574 ~~dG~is~~EF~~~~~~~~ 592 (601)
|+||.|+|+||+.+|.+..
T Consensus 166 d~dG~Is~~EF~~~~~~~~ 184 (208)
T 2ct9_A 166 DGDSAISFTEFVKVLEKVD 184 (208)
T ss_dssp SSSSSEEHHHHHHTTTTSC
T ss_pred CCCCcCcHHHHHHHHhccC
Confidence 9999999999999998754
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.3e-18 Score=162.57 Aligned_cols=135 Identities=16% Similarity=0.218 Sum_probs=112.3
Q ss_pred HHHHHHHHHHhhCCC-CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHH
Q 007498 453 ELVYLRAQFRLLEPN-KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWE 531 (601)
Q Consensus 453 ~~~~l~~~F~~~D~d-~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~ 531 (601)
..++++++|..||.+ ++|.|+.+||..+++.++........+..+|+.+|.+++|.|+++||+.++........ +
T Consensus 12 ~~~el~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~----~ 87 (198)
T 2r2i_A 12 SATECHQWYKKFMTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKV----D 87 (198)
T ss_dssp HTSCHHHHHHHHHHHCTTSEECHHHHHHHHTCCSCCHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCH----H
T ss_pred CHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCch----H
Confidence 344578889999988 89999999999999998864333456999999999999999999999887654332222 5
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhc-CC----------c-c-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 532 QIASTAFEYFEEEGNRVISIEELARELN-VG----------P-S-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l~-~~----------~-~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+.++.+|+.||.|++|+|+.+||+.++. +. . + ++.+|..+|.|+||.|+++||+.+|...
T Consensus 88 ~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~ 160 (198)
T 2r2i_A 88 QKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKIDINGDGELSLEEFMEGVQKD 160 (198)
T ss_dssp HHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHTTC
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcC
Confidence 6789999999999999999999999983 21 1 2 8889999999999999999999999753
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.3e-17 Score=156.22 Aligned_cols=151 Identities=18% Similarity=0.211 Sum_probs=117.2
Q ss_pred chhHHHHHHhhh--hcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHH
Q 007498 436 PFKRAALKALSK--ALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEE 513 (601)
Q Consensus 436 ~l~~~~~~~~~~--~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~e 513 (601)
.+.+..+..+.. .++.++++++.+.|+.. +++|.|+.+||..+++.++........+..+|+.+|.+++|.|+++|
T Consensus 7 ~l~~~~l~~l~~~~~~~~~~i~~~~~~fd~~--~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e 84 (190)
T 1fpw_A 7 KLSKDDLTCLKQSTYFDRREIQQWHKGFLRD--CPSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEE 84 (190)
T ss_dssp CSTTHHHHHHTTTCCSTHHHHHHHHHHHHHH--CTTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHH
T ss_pred CCCHHHHHHHHHhcCCCHHHHHHHHHHHHHH--CCCCcCcHHHHHHHHHHHcCCCCcHHHHHHHHHHHCCCCCCcEeHHH
Confidence 345555666654 46777755555544433 38999999999999998864334456689999999999999999999
Q ss_pred HHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcC-----C-----------c--cHHHHHHHHhcCC
Q 007498 514 FCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNV-----G-----------P--SAYSFLKDWIRNS 575 (601)
Q Consensus 514 f~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~-----~-----------~--~~~~~~~~~d~~~ 575 (601)
|..++........ ++.++.+|+.||.|++|+|+.+||+.++.. . . +++.+|+.+|.|+
T Consensus 85 f~~~~~~~~~~~~----~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~ 160 (190)
T 1fpw_A 85 FITVLSTTSRGTL----EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNE 160 (190)
T ss_dssp HHHHHHHHSCCCS----THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTC
T ss_pred HHHHHHHHccCCc----HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCCCC
Confidence 9886654332222 567889999999999999999999998832 1 1 1889999999999
Q ss_pred CCceeHHHHHHHHhhcc
Q 007498 576 DGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 576 dG~is~~EF~~~~~~~~ 592 (601)
||.|+++||+.++...+
T Consensus 161 dG~I~~~Ef~~~~~~~~ 177 (190)
T 1fpw_A 161 DGYITLDEFREGSKVDP 177 (190)
T ss_dssp SSEEEHHHHHHHHHSST
T ss_pred CCcCcHHHHHHHHHhCh
Confidence 99999999999998754
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=99.74 E-value=7.5e-19 Score=178.62 Aligned_cols=198 Identities=13% Similarity=0.165 Sum_probs=145.4
Q ss_pred CCCCHHHHHHHHHcc---cccccCCCCHHHHHcC------cccCCCCC---------------------CCCh-hHH---
Q 007498 378 PSVSPEAKDFVKRLL---NKDYRKRMTAVQALTH------PWLRDDSR---------------------PVPL-DIL--- 423 (601)
Q Consensus 378 ~~~s~~~~~li~~~L---~~dP~~R~s~~ell~h------p~f~~~~~---------------------~~~~-~~~--- 423 (601)
..++.++.+|.++++ ..+|..|...++.+.| +|+...+. .... ...
T Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~ 94 (323)
T 1ij5_A 15 KKVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLAS 94 (323)
T ss_dssp HHHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHH
Confidence 346778899999988 7899999999999988 88754411 1111 111
Q ss_pred HHHHHH-hhhccCchhHHHHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcc
Q 007498 424 IFKLVK-SYLHATPFKRAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSME 502 (601)
Q Consensus 424 ~~~~~k-~~~~~~~l~~~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D 502 (601)
++..++ .|...+.+.+ ++..++++++.+++.+|..||.|++|.|+.+||..+|..++. .++..++..++..+|
T Consensus 95 vl~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~-~~~~~~i~~l~~~~D 168 (323)
T 1ij5_A 95 LLKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYAD-TIPEGPLKKLFVMVE 168 (323)
T ss_dssp HHHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHT-TSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhc
Confidence 222222 3333333333 456789999999999999999999999999999999999885 577888999999999
Q ss_pred cCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh-c--CCcc-HHH-HHHHHhcCCCC
Q 007498 503 SLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL-N--VGPS-AYS-FLKDWIRNSDG 577 (601)
Q Consensus 503 ~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l-~--~~~~-~~~-~~~~~d~~~dG 577 (601)
.+++|.|+|.+|+.+. . ....+..+|..||.|++|+|+.+||+.+| + +... ++. +|..+|.|+||
T Consensus 169 ~d~~G~I~f~ef~~l~------~----~~~~l~~~F~~~D~d~dG~Is~~El~~~l~g~~~~~~ei~~~l~~~~D~d~dG 238 (323)
T 1ij5_A 169 NDTKGRMSYITLVAVA------N----DLAALVADFRKIDTNSNGTLSRKEFREHFVRLGFDKKSVQDALFRYADEDESD 238 (323)
T ss_dssp HCCSSTHHHHHHTTSH------H----HHHTSCCCHHHHCTTCCSEECHHHHHHHHHHTTCCCHHHHHHHHHHHCTTCSS
T ss_pred CCCCCcCcHHHHHhhh------h----HHHHHHHHHHHHCCCCCCcCcHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCCC
Confidence 9999999999997632 1 14456779999999999999999999987 2 2222 888 99999999999
Q ss_pred ceeHHHHHHHHhhc
Q 007498 578 KLSLHGYTKFLHGV 591 (601)
Q Consensus 578 ~is~~EF~~~~~~~ 591 (601)
.|+|+||+.+|...
T Consensus 239 ~Is~~EF~~~l~~~ 252 (323)
T 1ij5_A 239 DVGFSEYVHLGLCL 252 (323)
T ss_dssp CEEHHHHHHHHHHH
T ss_pred EEeHHHHHHHHHHH
Confidence 99999999988653
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=99.73 E-value=4.6e-18 Score=158.61 Aligned_cols=143 Identities=10% Similarity=0.162 Sum_probs=114.9
Q ss_pred HhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhc------chhhhhhccHHHH---------HhhcccCCCCc
Q 007498 444 ALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRN------ATDAMRESRVPDV---------LSSMESLAYRK 508 (601)
Q Consensus 444 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~------~~~~~~~~~~~~~---------~~~~D~~~~g~ 508 (601)
.+...++++++++++++|..||.|++|.|+.+||..+++.+ +. .++..++..+ |+.+|.+++|.
T Consensus 3 ~~~~~l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~-~~~~~~~~~l~~~~~~~~~f~~~D~d~dg~ 81 (186)
T 2hps_A 3 EITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSA-EKAEETRQEFLRVADQLGLAPGVRISVEEA 81 (186)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCH-HHHHHHHHHHHHHHHHHTCCTTCEEEHHHH
T ss_pred cccccccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCC-CCCcHHHHHHHHHHHHHHHHHhcCCCCCCc
Confidence 34556788999999999999999999999999999999876 54 5667778877 49999999999
Q ss_pred ccHHHHHHHhhcchhhhhhhhHHHHHHHHH--HHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCcee
Q 007498 509 MYFEEFCAAAISTHQLEALEGWEQIASTAF--EYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLS 580 (601)
Q Consensus 509 i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F--~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is 580 (601)
|+++| .++........ ..+.+..+| +.||+|++|+|+.+||+.++. +..+ ++.+|..+|.|+||.|+
T Consensus 82 I~~~E--~~~~~~~~~~~---~~~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~ 156 (186)
T 2hps_A 82 AVNAT--DSLLKMKGEEK---AMAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFNKNGQIS 156 (186)
T ss_dssp HHHHH--HHHHHCCTHHH---HHTTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCTTCSSEEE
T ss_pred ccHHH--HHHHHhcCChH---HHHHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHcCCCCCcCc
Confidence 99999 32222211111 123455666 888999999999999999982 3333 99999999999999999
Q ss_pred HHHHHHHHhhcc
Q 007498 581 LHGYTKFLHGVT 592 (601)
Q Consensus 581 ~~EF~~~~~~~~ 592 (601)
|+||+.+|....
T Consensus 157 ~~ef~~~~~~~~ 168 (186)
T 2hps_A 157 RDEFLVTVNDFL 168 (186)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999998764
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.73 E-value=2.6e-18 Score=152.43 Aligned_cols=130 Identities=15% Similarity=0.229 Sum_probs=107.7
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHH
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 533 (601)
+++++++|..+|.|++|.|+.+||..+++.++. .++..++..+++ +++|.|+|+||+.++......... ...+.
T Consensus 4 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~~~~~-~~~~~ 77 (140)
T 1ggw_A 4 DSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQ-NPTLAEITEIES----TLPAEVDMEQFLQVLNRPNGFDMP-GDPEE 77 (140)
T ss_dssp CTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSC-CCCHHHHHHHHT----TSCSSEEHHHHHHHHCTTSSSSSS-CCHHH
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHh----CCCCcCcHHHHHHHHHHHhcccCc-ccHHH
Confidence 456899999999999999999999999999885 466667777776 789999999999876543221110 11467
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|. +||.|+|+||+.+|.+
T Consensus 78 ~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~-~dg~i~~~eF~~~~~~ 139 (140)
T 1ggw_A 78 FVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPV-KDGMVNYHDFVQMILA 139 (140)
T ss_dssp HHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTC-SSCCSTTTHHHHHHHC
T ss_pred HHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCCCHHHHHHHHHhccC-CCCcEeHHHHHHHHhc
Confidence 89999999999999999999999982 3333 9999999999 9999999999999864
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.73 E-value=7.6e-18 Score=158.16 Aligned_cols=149 Identities=21% Similarity=0.294 Sum_probs=117.7
Q ss_pred chhHHHHHHhhhh--cchHHHHHHHHHHHhhCCC-CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHH
Q 007498 436 PFKRAALKALSKA--LTEDELVYLRAQFRLLEPN-KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFE 512 (601)
Q Consensus 436 ~l~~~~~~~~~~~--l~~~~~~~l~~~F~~~D~d-~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ 512 (601)
.+.+..+..+... ++.++ ++++|..||.+ ++|.|+.+||..++..++........+..+|+.+|.+++|.|+++
T Consensus 7 ~l~~~~l~~l~~~~~~~~~~---i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~ 83 (193)
T 1bjf_A 7 KLRPEVMQDLLESTDFTEHE---IQEWYKGFLRDCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFR 83 (193)
T ss_dssp CCCHHHHHHHHHHSSCCHHH---HHHHHHHHHHHSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHH
T ss_pred cCCHHHHHHHHHHcCCCHHH---HHHHHHHHHHHCCCCCcCHHHHHHHHHHhcCcCChHHHHHHHHHHhCCCCCCcCcHH
Confidence 3445555555443 56555 56677788887 899999999999999887533345568999999999999999999
Q ss_pred HHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----------CCc-------cHHHHHHHHhcC
Q 007498 513 EFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----------VGP-------SAYSFLKDWIRN 574 (601)
Q Consensus 513 ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----------~~~-------~~~~~~~~~d~~ 574 (601)
||..++........ ++.++.+|+.||.|++|+|+.+||+.++. +.. .+..+|..+|.|
T Consensus 84 Ef~~~~~~~~~~~~----~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d 159 (193)
T 1bjf_A 84 EFIIALSVTSRGKL----EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTN 159 (193)
T ss_dssp HHHHHHHHHTSSCH----HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTT
T ss_pred HHHHHHHHHcCCCH----HHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcccccHHHHHHHHHHHhCCC
Confidence 99886654332222 56789999999999999999999999882 111 188999999999
Q ss_pred CCCceeHHHHHHHHhhc
Q 007498 575 SDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 575 ~dG~is~~EF~~~~~~~ 591 (601)
+||.|+++||+.+|...
T Consensus 160 ~dG~I~~~Ef~~~~~~~ 176 (193)
T 1bjf_A 160 RDGKLSLEEFIRGAKSD 176 (193)
T ss_dssp CSSEECHHHHHHHHHHC
T ss_pred CCCeEeHHHHHHHHhcC
Confidence 99999999999998753
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=154.41 Aligned_cols=128 Identities=17% Similarity=0.261 Sum_probs=110.3
Q ss_pred HHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhc-ch------hhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh
Q 007498 452 DELVYLRAQFRLLEPNKDGSVSLENFRMVLGRN-AT------DAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL 524 (601)
Q Consensus 452 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~-~~------~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~ 524 (601)
+++++++++|..+| |++|.|+.+||..+++.+ +. ...+..++..+++.+|.+++|.|+++||+.++..
T Consensus 1 e~~~~l~~~F~~~D-d~~G~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~---- 75 (173)
T 1alv_A 1 EEVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNN---- 75 (173)
T ss_dssp CHHHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH----
T ss_pred CchhHHHHHHHHHh-CCCCCcCHHHHHHHHHHhhhcccccccCCCCHHHHHHHHHHHcCCCCCccCHHHHHHHHHH----
Confidence 36789999999999 999999999999999987 41 2456778999999999999999999999876542
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.++..+| |+||.|+|+||+.+|...
T Consensus 76 ------~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dg~i~~~eF~~~~~~~ 141 (173)
T 1alv_A 76 ------IKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS-DEGGNMDFDNFISCLVRL 141 (173)
T ss_dssp ------HHHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHT-CSSSCBCHHHHHHHHHHH
T ss_pred ------HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHHHH
Confidence 24578899999999999999999999982 2222 899999999 999999999999998754
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=99.72 E-value=2.6e-17 Score=154.05 Aligned_cols=150 Identities=16% Similarity=0.224 Sum_probs=117.7
Q ss_pred chhHHHHHHhhh--hcchHHHHHHHHHHHhhCCC-CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHH
Q 007498 436 PFKRAALKALSK--ALTEDELVYLRAQFRLLEPN-KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFE 512 (601)
Q Consensus 436 ~l~~~~~~~~~~--~l~~~~~~~l~~~F~~~D~d-~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ 512 (601)
.+.+..+..+.. .++.++ ++++|..||.+ ++|.|+.+||..+++.+.........+..+|+.+|.+++|.|+++
T Consensus 7 ~l~~~~l~~l~~~~~~~~~~---i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~ 83 (190)
T 1g8i_A 7 KLKPEVVEELTRKTYFTEKE---VQQWYKGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFS 83 (190)
T ss_dssp SCCHHHHHHHHHTSSSCHHH---HHHHHHHHHHHCTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEHH
T ss_pred cCCHHHHHHHHHccCCCHHH---HHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCChHHHHHHHHHHHhcCCCCeEeHH
Confidence 345555666654 455555 55666667776 899999999999999873222345569999999999999999999
Q ss_pred HHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcC----------------Cc-c-HHHHHHHHhcC
Q 007498 513 EFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNV----------------GP-S-AYSFLKDWIRN 574 (601)
Q Consensus 513 ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~----------------~~-~-~~~~~~~~d~~ 574 (601)
||..++........ ++.++.+|+.||.|++|+|+.+||+.++.. .. + ++.+|..+|.|
T Consensus 84 ef~~~~~~~~~~~~----~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d 159 (190)
T 1g8i_A 84 EFIQALSVTSRGTL----DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKN 159 (190)
T ss_dssp HHHHHHHHHHHCCH----HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSS
T ss_pred HHHHHHHHhcCCCH----HHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcCC
Confidence 99887654332222 667899999999999999999999998832 11 1 89999999999
Q ss_pred CCCceeHHHHHHHHhhcc
Q 007498 575 SDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 575 ~dG~is~~EF~~~~~~~~ 592 (601)
+||.|+++||+.+|...+
T Consensus 160 ~dG~i~~~ef~~~~~~~~ 177 (190)
T 1g8i_A 160 ADGKLTLQEFQEGSKADP 177 (190)
T ss_dssp CSSEEEHHHHHHHHHHCH
T ss_pred CCCcEeHHHHHHHHHhCh
Confidence 999999999999998754
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-17 Score=160.18 Aligned_cols=148 Identities=17% Similarity=0.241 Sum_probs=118.2
Q ss_pred hhHHHHHHhh--hhcchHHHHHHHHHHHhhCC-----CC-C--CcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCC
Q 007498 437 FKRAALKALS--KALTEDELVYLRAQFRLLEP-----NK-D--GSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAY 506 (601)
Q Consensus 437 l~~~~~~~~~--~~l~~~~~~~l~~~F~~~D~-----d~-~--G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~ 506 (601)
+....+..+. ..++..++++++++|..+|. |+ + |.|+.+||.. +..++. .+ ....+++.+|.|++
T Consensus 31 l~~e~l~~l~~~t~~s~~ei~~l~~~F~~~D~~~~~~d~~~~dG~I~~~E~~~-l~~lg~-~~---~~~~lf~~~D~d~d 105 (214)
T 2l4h_A 31 LSKELLAEYQDLTFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKA-NP---FKERICRVFSTSPA 105 (214)
T ss_dssp CCHHHHHHHHSCCSCCHHHHHHHHHHHHHHSCGGGCCHHHHTTSEECHHHHTT-CHHHHT-ST---THHHHHHHHCCSSS
T ss_pred CCHHHHHHHHHhCCCCHHHHHHHHHHHHHhCcccccccccccCCcCCHHHHHH-hhccCC-Ch---HHHHHHHHhCcCCC
Confidence 4445555553 35899999999999999999 66 6 9999999999 777664 22 35678999999999
Q ss_pred Cc-ccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc----------CCcc-HH----HHHHH
Q 007498 507 RK-MYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN----------VGPS-AY----SFLKD 570 (601)
Q Consensus 507 g~-i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~----------~~~~-~~----~~~~~ 570 (601)
|. |+|+||+.++....... ..++.++.+|+.||+|++|+|+.+||+.+|. +..+ ++ .+|..
T Consensus 106 G~~I~f~EF~~~~~~~~~~~---~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~ 182 (214)
T 2l4h_A 106 KDSLSFEDFLDLLSVFSDTA---TPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEE 182 (214)
T ss_dssp CCSEEHHHHHHHHHHTSSCS---CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHH
T ss_pred CCEecHHHHHHHHHHHcCCC---CHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHH
Confidence 99 99999998765432211 1256789999999999999999999999882 2222 44 59999
Q ss_pred HhcCCCCceeHHHHHHHHhhcc
Q 007498 571 WIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 571 ~d~~~dG~is~~EF~~~~~~~~ 592 (601)
+|.|+||.|+|+||+.+|.+.+
T Consensus 183 ~D~d~dG~Is~~EF~~~~~~~p 204 (214)
T 2l4h_A 183 SDIDRDGTINLSEFQHVISRSP 204 (214)
T ss_dssp HCCSCCSSBCSHHHHHHHHTCH
T ss_pred hCCCCCCcCCHHHHHHHHHhCh
Confidence 9999999999999999998753
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.2e-18 Score=163.50 Aligned_cols=135 Identities=20% Similarity=0.246 Sum_probs=108.1
Q ss_pred HHHHHHHHHHhhCCC-CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHH
Q 007498 453 ELVYLRAQFRLLEPN-KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWE 531 (601)
Q Consensus 453 ~~~~l~~~F~~~D~d-~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~ 531 (601)
..++++++|..||.+ ++|.|+.+||..+++.++........++.+|+.+|.|++|.|+++||+.++........ +
T Consensus 17 s~~ei~~~f~~fD~~~~~G~is~~El~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~----~ 92 (211)
T 2ggz_A 17 PTQETHVWYRTFMMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKM----E 92 (211)
T ss_dssp -------CCCSHHHHCTTSEEEHHHHHHHTTCCSCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSH----H
T ss_pred CHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCch----H
Confidence 344578889999988 89999999999999988764334556999999999999999999999887654322222 6
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhcC----------Cc-c-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 532 QIASTAFEYFEEEGNRVISIEELARELNV----------GP-S-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l~~----------~~-~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+.++.+|+.||.|++|+|+.+||+.++.. .. + ++.+|..+|.|+||.|+|+||+.+|...
T Consensus 93 ~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~ 164 (211)
T 2ggz_A 93 QKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFINLVFHKIDINNDGELTLEEFINGMAKD 164 (211)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHTT
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC
Confidence 67899999999999999999999998821 11 2 7889999999999999999999999864
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.6e-17 Score=153.19 Aligned_cols=137 Identities=18% Similarity=0.240 Sum_probs=112.8
Q ss_pred hcchHHHHHHHHHHHhhCC-----CC-C--CcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCc-ccHHHHHHHh
Q 007498 448 ALTEDELVYLRAQFRLLEP-----NK-D--GSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRK-MYFEEFCAAA 518 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~-----d~-~--G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~-i~~~ef~~~~ 518 (601)
.++.+++.+++++|..+|. |+ + |.|+.+||.. +..++.. +. ...+++.+|.+++|. |+|+||+.++
T Consensus 13 ~ls~~~~~~l~~~F~~~D~~~~~~~~~~~~G~i~~~el~~-l~~~g~~-~~---~~~l~~~~D~d~~G~~I~~~EF~~~~ 87 (183)
T 1dgu_A 13 FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKAN-PF---KERICRVFSTSPAKDSLSFEDFLDLL 87 (183)
T ss_dssp SCCHHHHHHHHHHHHHHSCSTTCSSCCCTTTCSCHHHHHT-STTSSSC-TT---HHHHHHHHSCSSSSCCCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhCccccccccccccCcCcHHHHHH-HHhhhcC-cH---HHHHHHHhCCCCCCCEecHHHHHHHH
Confidence 5789999999999999999 68 8 9999999999 8887752 22 457889999999999 9999999876
Q ss_pred hcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---C-------Ccc-HH----HHHHHHhcCCCCceeHHH
Q 007498 519 ISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN---V-------GPS-AY----SFLKDWIRNSDGKLSLHG 583 (601)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---~-------~~~-~~----~~~~~~d~~~dG~is~~E 583 (601)
........ .++.++.+|+.||+|++|+|+.+||+.+|. . ..+ ++ .+|..+|.|+||.|+|+|
T Consensus 88 ~~~~~~~~---~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~E 164 (183)
T 1dgu_A 88 SVFSDTAT---PDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSE 164 (183)
T ss_dssp HHHSTTCC---HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHCTTSSSEEEHHH
T ss_pred HHhcCCCC---HHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhCCCCCCeEcHHH
Confidence 53322111 256789999999999999999999999982 2 111 44 499999999999999999
Q ss_pred HHHHHhhcc
Q 007498 584 YTKFLHGVT 592 (601)
Q Consensus 584 F~~~~~~~~ 592 (601)
|+.+|.+.+
T Consensus 165 F~~~~~~~~ 173 (183)
T 1dgu_A 165 FQHVISRSP 173 (183)
T ss_dssp HHHHHCSSC
T ss_pred HHHHHHhCh
Confidence 999998754
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=99.71 E-value=8e-18 Score=160.05 Aligned_cols=137 Identities=20% Similarity=0.249 Sum_probs=112.3
Q ss_pred cchHHHHHHHHHHHhhCCC-CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhh
Q 007498 449 LTEDELVYLRAQFRLLEPN-KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEAL 527 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d-~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~ 527 (601)
++.++ ++++|..||.+ ++|.|+.+||..++..++.......++..+|+.+|.+++|.|+++||+.++........
T Consensus 30 ~~~~~---i~~~f~~~d~~~~~G~i~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~- 105 (207)
T 2d8n_A 30 FSEEE---LCSWYQSFLKDCPTGRITQQQFQSIYAKFFPDTDPKAYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKT- 105 (207)
T ss_dssp CCHHH---HHHHHHHHHHHCTTSEEEHHHHHHHHHHTCTTSCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSS-
T ss_pred CCHHH---HHHHHHHHHhhCCCCCCCHHHHHHHHHHhccCCCcHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCH-
Confidence 45554 56677777777 79999999999999988753356677999999999999999999999987654332222
Q ss_pred hhHHHHHHHHHHHHcccCCCcccHHHHHHHhcC-----C---------------ccHHHHHHHHhcCCCCceeHHHHHHH
Q 007498 528 EGWEQIASTAFEYFEEEGNRVISIEELARELNV-----G---------------PSAYSFLKDWIRNSDGKLSLHGYTKF 587 (601)
Q Consensus 528 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~-----~---------------~~~~~~~~~~d~~~dG~is~~EF~~~ 587 (601)
++.++.+|+.||+|++|+|+.+||+.++.. . ..++.+|..+|.|+||.|+|+||+.+
T Consensus 106 ---~~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~l~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~ 182 (207)
T 2d8n_A 106 ---NQKLEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKNDDDKLTEKEFIEG 182 (207)
T ss_dssp ---STTHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCHHHHHTSCTTTSSHHHHHHHHHHHTTCCTTCCEEHHHHHHH
T ss_pred ---HHHHHHHHHHhcCCCCCeEcHHHHHHHHHHHHHHhccccCCCcccccccHHHHHHHHHHHcCCCCCCcCcHHHHHHH
Confidence 456788999999999999999999998832 2 12899999999999999999999999
Q ss_pred Hhhcc
Q 007498 588 LHGVT 592 (601)
Q Consensus 588 ~~~~~ 592 (601)
|...+
T Consensus 183 ~~~~~ 187 (207)
T 2d8n_A 183 TLANK 187 (207)
T ss_dssp HHHCH
T ss_pred HHhCh
Confidence 98753
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-17 Score=149.66 Aligned_cols=130 Identities=10% Similarity=0.079 Sum_probs=109.0
Q ss_pred hHHHHHHHHHHHhhCCCC-CCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhh
Q 007498 451 EDELVYLRAQFRLLEPNK-DGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEG 529 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~d~-~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~ 529 (601)
-+++.+++++|..+|.|+ +|.|+.+||..+++.++. .++..++..+++.+|.+ |+|+||+.++........
T Consensus 10 ~~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~~----i~~~eF~~~~~~~~~~~~--- 81 (146)
T 2qac_A 10 LEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGL-APSSIDEKKIKELYGDN----LTYEQYLEYLSICVHDKD--- 81 (146)
T ss_dssp HHHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSE----ECHHHHHHHHHHTCCTTC---
T ss_pred HHHHHHHHHHHHHhCccCCCCcccHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC----CCHHHHHHHHHHHhcCcc---
Confidence 356778999999999999 999999999999999986 56778899999999987 999999986653211111
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 530 WEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 530 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
..+.++.+|+.||+|++|+|+.+||+.++. +..+ ++.+|..+ |+||.|+|+||+.+|.+
T Consensus 82 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~l~~ 146 (146)
T 2qac_A 82 NVEELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAF--SSEDNIDYKLFCEDILQ 146 (146)
T ss_dssp CHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHH--CSSSEEEHHHHHHHHTC
T ss_pred hHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHc--CCCCcCcHHHHHHHHhC
Confidence 156789999999999999999999999982 2222 89999999 99999999999999863
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=99.69 E-value=2.1e-17 Score=156.00 Aligned_cols=130 Identities=15% Similarity=0.230 Sum_probs=111.3
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchh----hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATD----AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL 524 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~ 524 (601)
.+..+++++++ |..+|.|++|.|+.+||..+++.++.. ..+..+++.+++.+|.|++|.|+|+||+.++..
T Consensus 27 ~~~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~eF~~~~~~---- 101 (198)
T 1juo_A 27 FPGQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAV---- 101 (198)
T ss_dssp CTTCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHH----
T ss_pred CCccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCCCCCeECHHHHHHHHHH----
Confidence 44457778899 999999999999999999999998742 356778999999999999999999999886542
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.++..+ |+||.|+|+||+.++...
T Consensus 102 ------~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~--d~dg~i~~~eF~~~~~~~ 166 (198)
T 1juo_A 102 ------LNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRY--STNGKITFDDYIACCVKL 166 (198)
T ss_dssp ------HHHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHT--CSSSSEEHHHHHHHHHHH
T ss_pred ------HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHHH
Confidence 24578899999999999999999999983 2222 88999998 999999999999988764
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.68 E-value=1.5e-16 Score=145.83 Aligned_cols=121 Identities=16% Similarity=0.224 Sum_probs=104.0
Q ss_pred HHHHhhCCCCCCcccHHHHHHHHhhcchh----hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 459 AQFRLLEPNKDGSVSLENFRMVLGRNATD----AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 459 ~~F~~~D~d~~G~I~~~el~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
+.|..+|.|++|.|+.+||..+++.++.. ..+..++..+++.+|.+++|.|+++||+.++.. .+.+
T Consensus 5 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~----------~~~~ 74 (167)
T 1gjy_A 5 YGYFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAV----------LNGW 74 (167)
T ss_dssp HHHHHHHCCTTSCBCHHHHHHHHHHHTCSTTSCCCCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHH----------HHHH
T ss_pred HHHHHHHcCCCCcCCHHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH----------HHHH
Confidence 45899999999999999999999998742 356778999999999999999999999886542 2457
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhcCC-----cc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 535 STAFEYFEEEGNRVISIEELARELNVG-----PS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~~~-----~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+.+|+.||+|++|+|+.+||+.+|... .+ ++.++..+ |+||.|+|+||+.+|...
T Consensus 75 ~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~~ 135 (167)
T 1gjy_A 75 RQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRY--STSGKITFDDYIACCVKL 135 (167)
T ss_dssp HHHHHHHCTTCCSEECHHHHHHHHHTTTCCCCHHHHHHHHHHT--CBTTBEEHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHh--CcCCcCcHHHHHHHHHHH
Confidence 889999999999999999999999322 22 88899998 999999999999988654
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=99.68 E-value=7.5e-17 Score=159.07 Aligned_cols=143 Identities=13% Similarity=0.102 Sum_probs=115.3
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhh------ccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRE------SRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~------~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
..+++.++++++++|..||.|++|.|+.+||..+++.++. .++. ..+..+++.+|.+++|.|+|+||+..+..
T Consensus 8 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~l~~-~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~Ef~~~~~~ 86 (263)
T 2f33_A 8 LQSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQ-ARKKAGLELSPEMKTFVDQYGQRDDGKIGIVELAHVLPT 86 (263)
T ss_dssp TTTSCCCHHHHHHHHHHHCTTCSSSBCSHHHHHHHHHHHH-HHHHHTCCCCHHHHHHHHHHTTGGGCCBCHHHHHHHTTS
T ss_pred hhcCcccHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHHHh-hcCCCccchHHHHHHHHHHhCCCCCCcCcHHHHHHHHhh
Confidence 3577778889999999999999999999999999998875 2332 56889999999999999999999987543
Q ss_pred chhhh-----hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-------C--Ccc-HHH----HHHHHhcCCCCceeH
Q 007498 521 THQLE-----ALEGWEQIASTAFEYFEEEGNRVISIEELARELN-------V--GPS-AYS----FLKDWIRNSDGKLSL 581 (601)
Q Consensus 521 ~~~~~-----~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-------~--~~~-~~~----~~~~~d~~~dG~is~ 581 (601)
..... ......+.++.+|+.||+|++|+|+.+||+.+|. . ... +.. ++..+|.|+||.|+|
T Consensus 87 ~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d~~~dg~i~~ 166 (263)
T 2f33_A 87 EENFLLLFRCQQLKSCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKLEL 166 (263)
T ss_dssp CTTHHHHHGGGTSSCHHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTCSSSSSCBCH
T ss_pred hhhHHHHHHHhhccHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcCCCCCCeEcH
Confidence 21000 0011256789999999999999999999999883 1 111 444 999999999999999
Q ss_pred HHHHHHHhh
Q 007498 582 HGYTKFLHG 590 (601)
Q Consensus 582 ~EF~~~~~~ 590 (601)
+||+.+|..
T Consensus 167 ~ef~~~~~~ 175 (263)
T 2f33_A 167 TEMARLLPV 175 (263)
T ss_dssp HHHHHHSCT
T ss_pred HHHHHHHHH
Confidence 999998864
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.68 E-value=9.7e-17 Score=157.98 Aligned_cols=139 Identities=17% Similarity=0.249 Sum_probs=114.1
Q ss_pred hcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhh
Q 007498 448 ALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEAL 527 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~ 527 (601)
.++.+++..+.+.|+.. +++|.|+.+||..++..++........+..+|+.+|.|++|.|+++||..++........
T Consensus 87 ~~s~~ei~~l~~~fd~~--~~~G~I~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~- 163 (256)
T 2jul_A 87 KFTKKELQSLYRGFKNE--CPTGLVDEDTFKLIYSQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTV- 163 (256)
T ss_dssp TSCHHHHHHHHHHHHHH--CTTSSEEHHHHHHHHHHHCCSSCCHHHHHHHHHHSSCSCCSEECSHHHHHHHHHHHSCCH-
T ss_pred CCCHHHHHHHHHHHHhh--CCCCcCCHHHHHHHHHHHcccCCcHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHhccCh-
Confidence 47888877776666642 479999999999999988643456677999999999999999999999987654332222
Q ss_pred hhHHHHHHHHHHHHcccCCCcccHHHHHHHhcC-----C-----------c--cHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 528 EGWEQIASTAFEYFEEEGNRVISIEELARELNV-----G-----------P--SAYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 528 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~-----~-----------~--~~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
++.++.+|+.||.|++|+|+.+||+.++.. . . +++.+|..+|.|+||.|+++||+.+|.
T Consensus 164 ---~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~ 240 (256)
T 2jul_A 164 ---HEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQDGVVTIDEFLETCQ 240 (256)
T ss_dssp ---HHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCCSTTCSBCHHHHHHHHH
T ss_pred ---HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCCCCCCcEeHHHHHHHHH
Confidence 677899999999999999999999998821 1 1 189999999999999999999999998
Q ss_pred hcc
Q 007498 590 GVT 592 (601)
Q Consensus 590 ~~~ 592 (601)
+..
T Consensus 241 ~~~ 243 (256)
T 2jul_A 241 KDE 243 (256)
T ss_dssp HCS
T ss_pred hCH
Confidence 753
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=9.8e-17 Score=147.88 Aligned_cols=115 Identities=13% Similarity=0.124 Sum_probs=95.5
Q ss_pred CCCCCCcccHHHHHHHHhhcc-----hhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHH
Q 007498 465 EPNKDGSVSLENFRMVLGRNA-----TDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFE 539 (601)
Q Consensus 465 D~d~~G~I~~~el~~~l~~~~-----~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~ 539 (601)
+.|++|+|+.+||..+|+.++ ...++.++++.+++.+|.+++|.|+|+||+.++.. .+.++.+|+
T Consensus 14 ~~~~dG~I~~~EL~~~l~~l~~~~~~g~~~~~~~~~~l~~~~D~d~~G~I~f~EF~~~~~~----------~~~l~~aF~ 83 (174)
T 2i7a_A 14 LVPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKVNGRLDQEEFARLWKR----------LVHYQHVFQ 83 (174)
T ss_dssp SCC-CCCEEHHHHHHHHHHHHC-----CCCCHHHHHHHHHHHCSSCSSEECHHHHHHHHHH----------HHHHHHHHH
T ss_pred cCCCCCcCCHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH----------HHHHHHHHH
Confidence 578999999999999999872 12456778999999999999999999999886532 235788999
Q ss_pred HHcccCCCcccHHHHHHHhcCC----cc------HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 540 YFEEEGNRVISIEELARELNVG----PS------AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 540 ~~D~d~~G~I~~~El~~~l~~~----~~------~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.|| |++|+|+.+||+.+|... +. ++.++..+| |+||.|+|+||+.+|.+.
T Consensus 84 ~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~~l~~~~d-d~dG~I~~~EF~~~~~~~ 143 (174)
T 2i7a_A 84 KVQ-TSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYS-DSVGRVSFPSLVCFLMRL 143 (174)
T ss_dssp HHC-SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHHHHHHHHS-CTTSEECHHHHHHHHHHH
T ss_pred Hhc-CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHHHHHHHHc-CCCCeEcHHHHHHHHHHH
Confidence 999 999999999999998433 21 888999999 999999999999998764
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-16 Score=145.18 Aligned_cols=121 Identities=14% Similarity=0.255 Sum_probs=104.4
Q ss_pred HHHHhhCCCCCCcccHHHHHHHHhhcchh----hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 459 AQFRLLEPNKDGSVSLENFRMVLGRNATD----AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 459 ~~F~~~D~d~~G~I~~~el~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
..|..+|.|++|.|+.+||..+++.++.. .++..++..+++.+|.+++|.|+++||+.++.. .+.+
T Consensus 3 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~----------~~~~ 72 (165)
T 1k94_A 3 YTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAA----------LNAW 72 (165)
T ss_dssp HHHHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHH----------HHHH
T ss_pred HHHHHHhCCCCCcCCHHHHHHHHHHhccccCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH----------HHHH
Confidence 46999999999999999999999998752 356778999999999999999999999886542 2457
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 535 STAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+.+|+.||+|++|+|+.+||+.+|. +..+ ++.++..+ |+||.|+|+||+.+|...
T Consensus 73 ~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~~ 133 (165)
T 1k94_A 73 KENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY--SKNGRIFFDDYVACCVKL 133 (165)
T ss_dssp HHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHH--CBTTBCBHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCceECHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHHH
Confidence 8899999999999999999999983 2222 88899998 999999999999998754
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.7e-16 Score=156.43 Aligned_cols=138 Identities=16% Similarity=0.247 Sum_probs=110.5
Q ss_pred HHHHHHHHHHhhCCCCCCcccHHHHHHHHhhc----chhhhhhccHHH----HHhhcccCCCCcccHHHHHHHhhcch--
Q 007498 453 ELVYLRAQFRLLEPNKDGSVSLENFRMVLGRN----ATDAMRESRVPD----VLSSMESLAYRKMYFEEFCAAAISTH-- 522 (601)
Q Consensus 453 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~----~~~~~~~~~~~~----~~~~~D~~~~g~i~~~ef~~~~~~~~-- 522 (601)
..++++.+|..||.|++|+|+.+||..++..+ +. ..+..++.. +++.+|.+++|.|+++||+.++....
T Consensus 101 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~-~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~ 179 (263)
T 2f33_A 101 SCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANK-TVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLLPVQENF 179 (263)
T ss_dssp CHHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTS-CCCHHHHHHHHHHHHHHTCSSSSSCBCHHHHHHHSCTTTCS
T ss_pred HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCC-CCCHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHHHHHHHH
Confidence 34568999999999999999999999999887 43 345555655 99999999999999999988654310
Q ss_pred --hhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh---------cCCcc-HHHHHHH-HhcCCCCceeHHHHHHHHh
Q 007498 523 --QLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL---------NVGPS-AYSFLKD-WIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 523 --~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l---------~~~~~-~~~~~~~-~d~~~dG~is~~EF~~~~~ 589 (601)
.........+.++.+|+.||+|++|+|+.+||+.+| .+..+ ++.++.. +|.|+||.|+|+||+.+|.
T Consensus 180 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~is~~El~~~l~~~~~~~~~~~~~~e~~~~~~~~~D~d~dG~i~~~EF~~~~~ 259 (263)
T 2f33_A 180 LLKFQGIKMCGKEFNKAFELYDQDGNGYIDENELDALLKDLCEKNKQELDINNISTYKKNIMALSDGGKLYRTDLALILS 259 (263)
T ss_dssp HHHHHHTCCCHHHHHHHHHHHCCSSSSCEEHHHHHHHHHHHHHHCTTTCCTTTHHHHHHHHHTTSBTTEECGGGTHHHHC
T ss_pred HHHhcCcchHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhhccCCCCeEcHHHHHHHHh
Confidence 000011125678999999999999999999999988 23333 8888887 7999999999999999997
Q ss_pred hc
Q 007498 590 GV 591 (601)
Q Consensus 590 ~~ 591 (601)
+.
T Consensus 260 ~~ 261 (263)
T 2f33_A 260 AG 261 (263)
T ss_dssp CS
T ss_pred cc
Confidence 63
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.6e-16 Score=157.41 Aligned_cols=138 Identities=9% Similarity=0.097 Sum_probs=109.0
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhc----chhhhhhccH----HHHHhhcccCCCCcccHHHHHHHhhcc----
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRN----ATDAMRESRV----PDVLSSMESLAYRKMYFEEFCAAAIST---- 521 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~----~~~~~~~~~~----~~~~~~~D~~~~g~i~~~ef~~~~~~~---- 521 (601)
..+++.+|..||.|++|.|+.+||..++..+ +. ..+..++ ..+++.+|.+++|.|+++||+..+...
T Consensus 103 ~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~-~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~~~~~ 181 (272)
T 2be4_A 103 SVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKK-KIPPNKLDEYTDAMMKIFDKNKDGRLDLNDLARILALQENFL 181 (272)
T ss_dssp HHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTC-CCCHHHHHHHHHHHHHHHCSSCSSEEEHHHHGGGSCCSSCSS
T ss_pred HHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCC-CCCHHHHHHHHHHHHHHhccCCCCcCcHHHHHHHHhhhHHHH
Confidence 4568999999999999999999999999887 42 3444444 459999999999999999998765321
Q ss_pred -hhh---hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---------CCcc-HHH----HHHHHhcCCCCceeHHH
Q 007498 522 -HQL---EALEGWEQIASTAFEYFEEEGNRVISIEELARELN---------VGPS-AYS----FLKDWIRNSDGKLSLHG 583 (601)
Q Consensus 522 -~~~---~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---------~~~~-~~~----~~~~~d~~~dG~is~~E 583 (601)
... .......+.++.+|+.||+|++|+|+.+||+.++. +..+ ++. +|..+|.|+||.|+|+|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~~D~d~dG~is~~E 261 (272)
T 2be4_A 182 LQFKMDASSQVERKRDFEKIFAHYDVSRTGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDMNKDGKIQKSE 261 (272)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHCTTCCSEEETHHHHHHHHHHHHHHSSSCCHHHHHHHHHHHHHHHCCSTTCEEEHHH
T ss_pred hhhhhhhccccccHHHHHHHHHHhCCCCCCeecHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHH
Confidence 000 01111256789999999999999999999999882 3332 444 99999999999999999
Q ss_pred HHHHHhhcc
Q 007498 584 YTKFLHGVT 592 (601)
Q Consensus 584 F~~~~~~~~ 592 (601)
|+.+|...+
T Consensus 262 F~~~~~~~p 270 (272)
T 2be4_A 262 LALCLGLKH 270 (272)
T ss_dssp HHHHTTCCC
T ss_pred HHHHHccCC
Confidence 999998654
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2e-16 Score=160.68 Aligned_cols=128 Identities=16% Similarity=0.225 Sum_probs=111.3
Q ss_pred HHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHH-HHhhcccCCCCcccHHHHHHHhhcchhhhhhhhH
Q 007498 452 DELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPD-VLSSMESLAYRKMYFEEFCAAAISTHQLEALEGW 530 (601)
Q Consensus 452 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~-~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~ 530 (601)
.....++.+|..||.|++|+|+.+||..++ ++. ..+..++.. +++.+|.+++|.|+|+||+.++....
T Consensus 185 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l--~g~-~~~~~ei~~~l~~~~D~d~dG~Is~~EF~~~l~~~~-------- 253 (323)
T 1ij5_A 185 NDLAALVADFRKIDTNSNGTLSRKEFREHF--VRL-GFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLL-------- 253 (323)
T ss_dssp HHHHTSCCCHHHHCTTCCSEECHHHHHHHH--HHT-TCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH--------
T ss_pred hHHHHHHHHHHHHCCCCCCcCcHHHHHHHH--cCC-CCCHHHHHHHHHHHhcCCCCCEEeHHHHHHHHHHHH--------
Confidence 456778899999999999999999999999 553 466778999 99999999999999999988654322
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh-cCCc------cHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL-NVGP------SAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l-~~~~------~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+..+|+.||.|++|+|+.+||+.+| ...+ +++.+|..+|.|+||.|+|+||+.+|.+..
T Consensus 254 --~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~ls~~e~~~l~~~~D~d~dG~Is~~EF~~~~~~~~ 320 (323)
T 1ij5_A 254 --VLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLVLLMF 320 (323)
T ss_dssp --HHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHHHHC
T ss_pred --HHHHHHHHhCCCCCCCccHHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHhc
Confidence 46889999999999999999999999 4322 299999999999999999999999998753
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=99.61 E-value=1.2e-15 Score=171.02 Aligned_cols=130 Identities=12% Similarity=0.183 Sum_probs=114.4
Q ss_pred cchHH-HHHHHHHHHhhCCCCCCcccHHHHHHHHhhc--------chhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 449 LTEDE-LVYLRAQFRLLEPNKDGSVSLENFRMVLGRN--------ATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 449 l~~~~-~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~--------~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
+++++ +++++++|..|| |++|.|+.+||..+|..+ + ..++.++++.+++.+|.|++|.|+|+||+.++.
T Consensus 525 ls~~e~~~~l~~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g-~~~s~~~~~~l~~~~D~d~~G~I~f~EF~~l~~ 602 (714)
T 3bow_A 525 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKS-DGFSIETCKIMVDMLDEDGSGKLGLKEFYILWT 602 (714)
T ss_dssp CSGGGCCHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCC-SCCCHHHHHHHHHHHCCSSCSSBCHHHHHHHHH
T ss_pred CChhhHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccC-CCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 67778 899999999999 999999999999999986 3 356778899999999999999999999998654
Q ss_pred cchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 520 STHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.. +.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.++..+| |+||.|+|+||+.+|.+.
T Consensus 603 ~~----------~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls~~~~~~l~~~~D-d~dG~Isf~EF~~~l~~~ 669 (714)
T 3bow_A 603 KI----------QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRL 669 (714)
T ss_dssp HH----------HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECCHHHHHHHHHHHS-CTTCEECHHHHHHHHHHH
T ss_pred HH----------HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHH
Confidence 22 4578899999999999999999999993 2222 999999999 999999999999999754
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.7e-16 Score=155.84 Aligned_cols=141 Identities=13% Similarity=0.228 Sum_probs=110.0
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHh----hcchh-hhhhccHHH----HHhhcccCCCCcccHHHHHHHhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLG----RNATD-AMRESRVPD----VLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~----~~~~~-~~~~~~~~~----~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
+++.+.++++++|..||.|++|.|+.+||..+++ .++.. .++..++.. +|+.+|.|++|.|+|+||+.++.
T Consensus 5 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~lg~~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~ 84 (272)
T 2be4_A 5 FANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFMSAYDATFDGRLQIEELANMIL 84 (272)
T ss_dssp CCCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHHSTTSCCCHHHHHHHHHHHSCHHHHTCCSEEEHHHHHHHHS
T ss_pred HHhcCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhcCCCCCcEeHHHHHHHHh
Confidence 4556678899999999999999999999999998 66641 344555554 45889999999999999998743
Q ss_pred cc--------hhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcC---------Ccc-----HHHHHHHHhcCCCC
Q 007498 520 ST--------HQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNV---------GPS-----AYSFLKDWIRNSDG 577 (601)
Q Consensus 520 ~~--------~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~---------~~~-----~~~~~~~~d~~~dG 577 (601)
.. ..... ....+.++.+|+.||+|++|+|+.+||+.++.. ... ++.+|..+|.|+||
T Consensus 85 ~~~~~~~~~~~~~~~-~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~D~~~dg 163 (272)
T 2be4_A 85 PQEENFLLIFRREAP-LDNSVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDG 163 (272)
T ss_dssp CHHHHHHHHHHHHSC-CCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSS
T ss_pred hhhHHHHHHHhhccC-cccHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHhccCCCC
Confidence 21 01000 111567899999999999999999999998831 111 34599999999999
Q ss_pred ceeHHHHHHHHhh
Q 007498 578 KLSLHGYTKFLHG 590 (601)
Q Consensus 578 ~is~~EF~~~~~~ 590 (601)
.|+|+||+.+|..
T Consensus 164 ~i~~~ef~~~~~~ 176 (272)
T 2be4_A 164 RLDLNDLARILAL 176 (272)
T ss_dssp EEEHHHHGGGSCC
T ss_pred cCcHHHHHHHHhh
Confidence 9999999998864
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.58 E-value=6.8e-15 Score=137.90 Aligned_cols=125 Identities=10% Similarity=0.124 Sum_probs=106.9
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
+++..+|..+|.|++|.|+.+||..++... ..+..+|+.+|.|++|.|+.+||..++........ ++.+
T Consensus 63 ~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~----~~~~ 131 (191)
T 1y1x_A 63 ATTEKLLHMYDKNHSGEITFDEFKDLHHFI-------LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVS----EQTF 131 (191)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCC----HHHH
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHHHH-------HHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCC----HHHH
Confidence 346778999999999999999999998753 35788999999999999999999887654433223 5678
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCc--eeHHHHHHHHhh
Q 007498 535 STAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGK--LSLHGYTKFLHG 590 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~--is~~EF~~~~~~ 590 (601)
..+|+.+|.|++|.|+.+||..++.....+..+|+.+|.|+||. |+++||+.+|..
T Consensus 132 ~~~~~~~D~d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~dG~i~~~~~eF~~~~~~ 189 (191)
T 1y1x_A 132 QALMRKFDRQRRGSLGFDDYVELSIFVCRVRNVFAFYDRERTGQVTFTFDTFIGGSVS 189 (191)
T ss_dssp HHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHCTTCCSEEEEEHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCeEeHHHHHHHHHHHHHHHHHHHHhCcCCCceEEeeHHHHHHHHHh
Confidence 99999999999999999999999864455889999999999999 789999999864
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 | Back alignment and structure |
|---|
Probab=99.54 E-value=2.6e-15 Score=173.34 Aligned_cols=142 Identities=19% Similarity=0.270 Sum_probs=120.6
Q ss_pred hhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh
Q 007498 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL 524 (601)
Q Consensus 445 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~ 524 (601)
....++..++.+++++|..||.|++|+|+.+||..++..+|. ..+..++..+|+.+|.|++|.|+|+||+.++......
T Consensus 715 ~~~~l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~-~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~~ 793 (863)
T 1sjj_A 715 DAKGISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGY-NMGEAEFARIMSIVDPNRMGVVTFQAFIDFMSRETAD 793 (863)
T ss_dssp CCCCSSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHHHTC-CCCTHHHHHHHHHHCTTSCSEEETTHHHHTHHHHSTT
T ss_pred hccCCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcC
Confidence 345577889999999999999999999999999999999885 5677889999999999999999999998765432211
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcC-----CCCceeHHHHHHHHhhcc
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRN-----SDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~-----~dG~is~~EF~~~~~~~~ 592 (601)
.. ..+.+..+|+.| .|++|+|+.+||+.+|. ..+++.+|..+|.| +||.|+|+||+.+|.+.+
T Consensus 794 ~~---~~~~l~~aF~~~-~d~~G~Is~~El~~~l~-~~~~~~l~~~~d~~~~~~~~dg~I~~~eF~~~~~~~~ 861 (863)
T 1sjj_A 794 TD---TADQVMASFKIL-AGDKNYITVDELRRELP-PDQAEYCIARMAPYNGRDAVPGALDYMSFSTALYGES 861 (863)
T ss_dssp CS---SSHHHHHHHHGG-GTSSSEEEHHHHHHHSC-HHHHHHHHHHSEECCSSCCCTTEEESHHHHHHHSCCS
T ss_pred CC---CHHHHHHHHHHH-hCCCCcCcHHHHHHHCC-HHHHHHHHHHcchhcCCCCCCCceeHHHHHHHHhcCC
Confidence 11 145689999999 89999999999999996 22399999999987 799999999999998754
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.8e-14 Score=132.36 Aligned_cols=125 Identities=13% Similarity=0.189 Sum_probs=105.3
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
.++..+|..+|.|++|.|+.+||..++... ..+..+|+.+|.+++|.|+.+||..++........ ++.+
T Consensus 44 ~~~~~l~~~~D~~~~g~i~~~ef~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~ 112 (172)
T 2znd_A 44 VTVRSIISMFDRENKAGVNFSEFTGVWKYI-------TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLS----DQFH 112 (172)
T ss_dssp HHHHHHHHHHCSSSSSEECHHHHHHHHHHH-------HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCC----HHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCC----HHHH
Confidence 346678889999999999999999988643 34788999999999999999999887654432222 5678
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCcee--HHHHHHHHhh
Q 007498 535 STAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLS--LHGYTKFLHG 590 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~is--~~EF~~~~~~ 590 (601)
..+|+.+|.|++|.|+.+||..++.....+..+|+.+|.|+||.|+ ++||+.++..
T Consensus 113 ~~~~~~~d~~~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~dG~i~~~~~ef~~~~~~ 170 (172)
T 2znd_A 113 DILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQVSYEQYLSMVFS 170 (172)
T ss_dssp HHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHHCTTSSSCCCCCHHHHHHHHHT
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEeeeHHHHHHHHHh
Confidence 9999999999999999999999885444588999999999999995 8999998865
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=99.53 E-value=2.1e-15 Score=165.19 Aligned_cols=128 Identities=16% Similarity=0.251 Sum_probs=57.7
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
.+++++|..||.|++|.|+.+||..+|+.++. ..+.++++.+|+.+|.|++|.|+|+||+.++.... . ++++
T Consensus 11 ~~l~~~F~~fD~d~dG~Is~~El~~~l~~lg~-~~s~~el~~lf~~~D~d~~G~I~f~EF~~~~~~l~---~----~~el 82 (624)
T 1djx_A 11 HWIHSCLRKADKNKDNKMNFKELKDFLKELNI-QVDDGYARKIFRECDHSQTDSLEDEEIETFYKMLT---Q----RAEI 82 (624)
T ss_dssp ----------------------------------------------------------CTTHHHHHHT---C----CHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhc---c----HHHH
Confidence 47899999999999999999999999999985 57788899999999999999999999988664321 1 3468
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhc-------CCcc-HHHHHHHHhcC----CCCceeHHHHHHHHhhc
Q 007498 535 STAFEYFEEEGNRVISIEELARELN-------VGPS-AYSFLKDWIRN----SDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~-------~~~~-~~~~~~~~d~~----~dG~is~~EF~~~~~~~ 591 (601)
+.+|+.||++ +|+|+.+||+++|. +..+ ++.+|+.+|.| +||.|+|+||+.+|...
T Consensus 83 ~~aF~~fD~~-~G~Is~~EL~~fL~~~qge~~ls~ee~~~ii~~~d~d~~~~~dG~Is~deF~~~L~s~ 150 (624)
T 1djx_A 83 DRAFEEAAGS-AETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSA 150 (624)
T ss_dssp HHHHHHHHTT-SSSEEHHHHHHHHHHTSCCSSCSHHHHHHHHHHHCCCHHHHHTTEECHHHHHHHHHST
T ss_pred HHHHHHhcCC-CCeecHHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCChhhccCCCCCHHHHHHHhcCc
Confidence 9999999985 99999999999993 2222 89999999998 79999999999999763
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.7e-14 Score=131.45 Aligned_cols=122 Identities=12% Similarity=0.121 Sum_probs=102.0
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc----hhhhhhhhH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST----HQLEALEGW 530 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~----~~~~~~~~~ 530 (601)
++++.+|..+|.|++|.|+++||..++... ..++.+|+.+| |++|.|+.+|+..++... .....
T Consensus 46 ~~~~~l~~~~D~d~~G~I~f~EF~~~~~~~-------~~l~~aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~---- 113 (174)
T 2i7a_A 46 DECRSLVALMELKVNGRLDQEEFARLWKRL-------VHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFIS---- 113 (174)
T ss_dssp HHHHHHHHHHCSSCSSEECHHHHHHHHHHH-------HHHHHHHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCC----
T ss_pred HHHHHHHHHHCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCC----
Confidence 457788899999999999999999987653 34888999999 999999999998876554 32223
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCC-ceeHHHHHHHHh
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDG-KLSLHGYTKFLH 589 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG-~is~~EF~~~~~ 589 (601)
++.+..+++.+| |++|.|+.+||..++.....+..+|+.+|.|+|| .++++||+.++.
T Consensus 114 ~~~~~~l~~~~d-d~dG~I~~~EF~~~~~~~~~~~~~F~~~D~d~~GI~~~~~Ef~~~~~ 172 (174)
T 2i7a_A 114 RELLHLVTLRYS-DSVGRVSFPSLVCFLMRLEAMAKTFRNLSKDGKGLYLTEMEWMSLVM 172 (174)
T ss_dssp HHHHHHHHHHHS-CTTSEECHHHHHHHHHHHHHHHHHHHHHCSSSSCCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHc-CCCCeEcHHHHHHHHHHHHHHHHHHHHhCCCCCCceecHHHHHHHHH
Confidence 567888999999 9999999999999885434488999999999999 349999999864
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=99.50 E-value=3.8e-14 Score=135.93 Aligned_cols=125 Identities=8% Similarity=0.044 Sum_probs=104.5
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
.++..+|..+|.|++|.|+.+||..++..+ ..+..+|+.+|.|++|.|+.+||..++........ ++.+
T Consensus 87 ~~~~~l~~~~D~d~dg~I~~~EF~~~~~~~-------~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~----~~~~ 155 (220)
T 3sjs_A 87 QTALRMMRIFDTDFNGHISFYEFMAMYKFM-------ELAYNLFVMNARARSGTLEPHEILPALQQLGFYIN----QRTS 155 (220)
T ss_dssp HHHHHHHHHHCTTCSSCBCHHHHHHHHHHH-------HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCC----HHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCC----HHHH
Confidence 346778888999999999999999998764 34888999999999999999999887654433333 5578
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHH-hcCCCC------ceeHHHHHHHHhhc
Q 007498 535 STAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDW-IRNSDG------KLSLHGYTKFLHGV 591 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~-d~~~dG------~is~~EF~~~~~~~ 591 (601)
..+|+.+| |+||.|+.+||..++.....+..+|+.+ |.+++| .|+|+||+.++..+
T Consensus 156 ~~l~~~~d-d~dg~I~~~eF~~~~~~l~~~~~~F~~~~D~~~~G~i~~~~~i~~~ef~~~~~~~ 218 (220)
T 3sjs_A 156 LLLHRLFA-RGMAFCDLNCWIAICAFAAQTRSAYQMIFMNPYYGPMKPFNPMEFGKFLDVVTSL 218 (220)
T ss_dssp HHHHHHHC---CCSEEHHHHHHHHHHHHHHHHHHHHHHTSGGGCSCCCCCHHHHHHHHHHHHHT
T ss_pred HHHHHHhc-CCCCcCcHHHHHHHHHHHHHHHHHHHHhcccCCCCCcccccceeHHHHHHHHHHh
Confidence 89999999 9999999999999885444588999999 999999 89999999998764
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=99.49 E-value=6.7e-14 Score=118.20 Aligned_cols=94 Identities=17% Similarity=0.268 Sum_probs=79.8
Q ss_pred hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC---c--
Q 007498 488 AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG---P-- 562 (601)
Q Consensus 488 ~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~---~-- 562 (601)
.++.+++..+++.+| ++|.|+|+||+.++.... .. .+.++.+|+.||+|++|+|+.+||+.+|... +
T Consensus 6 ~~~~~ei~~~~~~~D--~~g~i~~~eF~~~~~~~~--~~----~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~ 77 (109)
T 3fs7_A 6 ILSAKDIESALSSCQ--AADSFNYKSFFSTVGLSS--KT----PDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARV 77 (109)
T ss_dssp TSCHHHHHHHHHHTC--STTCCCHHHHHHHHTCTT--CC----HHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCC
T ss_pred cCCHHHHHHHHHhcC--CCCcCcHHHHHHHHhcCC--Cc----HHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhccccc
Confidence 467788999999998 799999999998754321 12 5678999999999999999999999998432 1
Q ss_pred ---c-HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 563 ---S-AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 563 ---~-~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
+ ++.+|..+|.|+||.|+|+||+++|+
T Consensus 78 ~~~~~~~~~~~~~D~~~dg~i~~~EF~~~~~ 108 (109)
T 3fs7_A 78 LTSAETKAFLAAGDTDGDGKIGVEEFQSLVK 108 (109)
T ss_dssp CCHHHHHHHHHHHCTTCSSSBCHHHHHHHHT
T ss_pred CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 1 99999999999999999999999986
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.49 E-value=2.3e-14 Score=134.17 Aligned_cols=123 Identities=17% Similarity=0.241 Sum_probs=94.7
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcch-------hhhh-
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTH-------QLEA- 526 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-------~~~~- 526 (601)
..+..+|..+|.|++|.|+.+||..++..++. ......+..+|+.+|.|++|.|+++||..++.... ....
T Consensus 63 ~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~ 141 (193)
T 1bjf_A 63 KFAEHVFRTFDANGDGTIDFREFIIALSVTSR-GKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPED 141 (193)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTS-SCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGG
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcC-CCHHHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcc
Confidence 45789999999999999999999999988764 45567799999999999999999999987664321 0111
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCce
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKL 579 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~i 579 (601)
....++.+..+|+.+|+|++|.|+.+||..++....++..+| .+|.|+||.|
T Consensus 142 ~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~-~~D~~~dG~i 193 (193)
T 1bjf_A 142 ESTPEKRTEKIFRQMDTNRDGKLSLEEFIRGAKSDPSIVRLL-QCDPSSAGQF 193 (193)
T ss_dssp GSSHHHHHHHHHHHSCTTCSSEECHHHHHHHHHHCTHHHHTT-CC--------
T ss_pred cccHHHHHHHHHHHhCCCCCCeEeHHHHHHHHhcCHHHHHHh-ccCCCCCCCC
Confidence 112356789999999999999999999999997666688999 9999999986
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.3e-13 Score=131.32 Aligned_cols=134 Identities=10% Similarity=0.132 Sum_probs=107.7
Q ss_pred hHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh--hhh
Q 007498 451 EDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE--ALE 528 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~--~~~ 528 (601)
....++++++|..+|.|++|.|+++||..++..+.. ......+..+|+.+|.|++|.|+++||..++....... ...
T Consensus 53 ~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~-~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~ 131 (211)
T 2ggz_A 53 QKANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQ-EKMEQKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTL 131 (211)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSC-SSHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSC
T ss_pred cchHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhcc-CchHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccc
Confidence 345567899999999999999999999999987764 35567799999999999999999999988765432100 011
Q ss_pred hHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 529 GWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 529 ~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
..++.+..+|+.+|.|+||.|+.+||..++....++..+|.. .++|+||+.+|.+..
T Consensus 132 ~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~-------~~d~~~f~~~~~~~~ 188 (211)
T 2ggz_A 132 SPEEFINLVFHKIDINNDGELTLEEFINGMAKDQDLLEIVYK-------SFDFSNVLRVICNGK 188 (211)
T ss_dssp THHHHHHHHHHHHCTTCSSSBCHHHHHHHHHTTTTTHHHHHH-------HSCTTHHHHHHHHHC
T ss_pred cHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCHHHHHHHhc-------cCCHHHHHHHHhcCC
Confidence 124568999999999999999999999999766667777774 355999999998764
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=116.67 Aligned_cols=93 Identities=18% Similarity=0.264 Sum_probs=78.6
Q ss_pred hhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC---c---
Q 007498 489 MRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG---P--- 562 (601)
Q Consensus 489 ~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~---~--- 562 (601)
++..+++.+++.+| ++|.|+|+||+.++... ... .+.++.+|+.||+|++|+|+.+||+.+|... +
T Consensus 6 ~~~~e~~~l~~~~d--~~g~i~~~eF~~~~~~~--~~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~ 77 (108)
T 2pvb_A 6 LKDADVAAALAACS--AADSFKHKEFFAKVGLA--SKS----LDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARAL 77 (108)
T ss_dssp SCHHHHHHHHHHTC--STTCCCHHHHHHHHTGG--GSC----HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCC
T ss_pred CCHHHHHHHHHHhC--CCCcCcHHHHHHHHhCC--hhH----HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCC
Confidence 67788999999998 78999999999865321 111 5678999999999999999999999999432 1
Q ss_pred --c-HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 563 --S-AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 563 --~-~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
+ ++.+|..+|.|+||.|+|+||+.+|.
T Consensus 78 ~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 107 (108)
T 2pvb_A 78 TDAETKAFLADGDKDGDGMIGVDEFAAMIK 107 (108)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred CHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 1 99999999999999999999999886
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.47 E-value=8.1e-14 Score=117.66 Aligned_cols=96 Identities=16% Similarity=0.279 Sum_probs=80.3
Q ss_pred hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcC----C--
Q 007498 488 AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNV----G-- 561 (601)
Q Consensus 488 ~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~----~-- 561 (601)
.++.++++.+++.+|. +|.|+|+||+.++.... .. .+.++.+|+.||+|++|+|+.+||+.+|.. .
T Consensus 5 ~~s~~ei~~~~~~~d~--~g~i~~~eF~~~~~~~~--~~----~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~ 76 (109)
T 5pal_A 5 VLKADDINKAISAFKD--PGTFDYKRFFHLVGLKG--KT----DAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRD 76 (109)
T ss_dssp TSCHHHHHHHHHHTCS--TTCCCHHHHHHHHTCTT--CC----HHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCC
T ss_pred cCCHHHHHHHHHHhCC--CCcCcHHHHHHHHhhcc--Cc----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCC
Confidence 4667789999999997 89999999998664321 12 567899999999999999999999998832 1
Q ss_pred --cc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 562 --PS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 562 --~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+ ++.+|..+|.|+||.|+|+||+.+|.++
T Consensus 77 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~ 109 (109)
T 5pal_A 77 LNDTETKALLAAGDSDHDGKIGADEFAKMVAQA 109 (109)
T ss_dssp CCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhC
Confidence 11 8999999999999999999999999763
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-13 Score=116.81 Aligned_cols=99 Identities=17% Similarity=0.263 Sum_probs=82.1
Q ss_pred hcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC-
Q 007498 483 RNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG- 561 (601)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~- 561 (601)
++|. .++..+++.+++.+| ++|.|+|+||+.++.. .. .. .+.++.+|+.||+|++|+|+.+||+.+|...
T Consensus 2 alG~-~~t~~e~~~~~~~~d--~~g~i~~~ef~~~~~~-~~-~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~ 72 (110)
T 1pva_A 2 AAKD-LLKADDIKKALDAVK--AEGSFNHKKFFALVGL-KA-MS----ANDVKKVFKAIDADASGFIEEEELKFVLKSFA 72 (110)
T ss_dssp CHHH-HSCHHHHHHHHHHTC--STTCCCHHHHHHHHTC-TT-SC----HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTC
T ss_pred cccc-cCCHHHHHHHHHhcC--CCCcCcHHHHHHHHcc-Cc-ch----HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHh
Confidence 3454 577888999999998 8899999999986532 11 11 5678999999999999999999999998422
Q ss_pred --c-----c-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 562 --P-----S-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 562 --~-----~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
+ + ++.+|..+|.|+||.|+|+||+.+|.+
T Consensus 73 ~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~ 109 (110)
T 1pva_A 73 ADGRDLTDAETKAFLKAADKDGDGKIGIDEFETLVHE 109 (110)
T ss_dssp TTCCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred hcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHh
Confidence 1 1 999999999999999999999999875
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.46 E-value=6.1e-14 Score=123.49 Aligned_cols=97 Identities=13% Similarity=0.210 Sum_probs=59.6
Q ss_pred cHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCc------c-HH
Q 007498 493 RVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGP------S-AY 565 (601)
Q Consensus 493 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~------~-~~ 565 (601)
.++.+++.+|.|++|.|+|+||+.++....... ...+.++.+|+.||+|++|+|+.+||+.+|...+ + ++
T Consensus 4 ~~~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~---~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~ 80 (135)
T 3h4s_E 4 TEKSMLLETTSTTKMETKYEDMLPVMAEKMDVE---EFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQ 80 (135)
T ss_dssp ---------------CCCC-----------CHH---HHHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHH
T ss_pred hHHHHHHHHcCCCCCcEeHHHHHHHHHHHcccc---chHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHH
Confidence 356799999999999999999988654322111 1256789999999999999999999999993211 1 99
Q ss_pred HHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 566 SFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 566 ~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+|..+|.|+||.|+|+||+.+|.+..
T Consensus 81 ~~~~~~D~d~dG~I~~~EF~~~~~~~~ 107 (135)
T 3h4s_E 81 GMVREGDLDGDGALNQTEFCVLMVRLS 107 (135)
T ss_dssp HHHHHHCSSCSSSBCHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCcHHHHHHHHHHhC
Confidence 999999999999999999999998753
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-13 Score=129.76 Aligned_cols=122 Identities=11% Similarity=0.105 Sum_probs=103.2
Q ss_pred hhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccC-CCCcccHHHHHHHhhcchhh-hhhhhHHHHHHHHHHH
Q 007498 463 LLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESL-AYRKMYFEEFCAAAISTHQL-EALEGWEQIASTAFEY 540 (601)
Q Consensus 463 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~-~~g~i~~~ef~~~~~~~~~~-~~~~~~~~~~~~~F~~ 540 (601)
.++.+++|.|+.+|+..+++.++ .+..++..+|+.+|.+ ++|.|+++||..++...... .. ++.+..+|+.
T Consensus 7 ~mg~~~~g~l~~~el~~~~~~~~---~~~~~i~~~f~~~d~~~~~G~i~~~ef~~~l~~~~~~~~~----~~~~~~~f~~ 79 (207)
T 2d8n_A 7 GMGNSKSGALSKEILEELQLNTK---FSEEELCSWYQSFLKDCPTGRITQQQFQSIYAKFFPDTDP----KAYAQHVFRS 79 (207)
T ss_dssp -CTTCCTTCCCHHHHHHHHHHSS---CCHHHHHHHHHHHHHHCTTSEEEHHHHHHHHHHTCTTSCC----HHHHHHHHHH
T ss_pred hhccccCCCCCHHHHHHHHHHcC---CCHHHHHHHHHHHHhhCCCCCCCHHHHHHHHHHhccCCCc----HHHHHHHHHH
Confidence 37889999999999999999876 3567899999999999 69999999998876544221 12 5678999999
Q ss_pred HcccCCCcccHHHHHHHhc-----CCc-cHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 541 FEEEGNRVISIEELARELN-----VGP-SAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 541 ~D~d~~G~I~~~El~~~l~-----~~~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+|.|++|.|+.+||..++. ... ++..+|..+|.|+||.|+++||..+|...
T Consensus 80 ~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~ 136 (207)
T 2d8n_A 80 FDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTISKNEVLEIVMAI 136 (207)
T ss_dssp HCTTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred hcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHHHhcCCCCCeEcHHHHHHHHHHH
Confidence 9999999999999999882 222 29999999999999999999999999764
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.7e-13 Score=126.07 Aligned_cols=122 Identities=10% Similarity=0.175 Sum_probs=100.8
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
.++..+|..+|.|++|.|+.+||..++... ..+..+|+.+|.+++|.|+.+||..++........ ++.+
T Consensus 47 ~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~ 115 (173)
T 1alv_A 47 DTCRSMVAVMDSDTTGKLGFEEFKYLWNNI-------KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLN----EHLY 115 (173)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCC----HHHH
T ss_pred HHHHHHHHHHcCCCCCccCHHHHHHHHHHH-------HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCC----HHHH
Confidence 457788899999999999999999988753 35888999999999999999999887654432223 5678
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 535 STAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
..+|+.+| |++|.|+.+||..++.....+..+|+.+|.|+||.|+.+ |.++|.
T Consensus 116 ~~~~~~~d-d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~~G~i~~~-~~~~l~ 168 (173)
T 1alv_A 116 SMIIRRYS-DEGGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVN-IQEWLQ 168 (173)
T ss_dssp HHHHHHHT-CSSSCBCHHHHHHHHHHHHHHHHHHHHHSSSCCSEEEEE-HHHHHH
T ss_pred HHHHHHhc-CCCCcCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeecHh-HHHHHH
Confidence 89999999 999999999999988544458899999999999999866 555543
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.3e-13 Score=116.41 Aligned_cols=95 Identities=11% Similarity=0.226 Sum_probs=79.8
Q ss_pred hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcC-------
Q 007498 488 AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNV------- 560 (601)
Q Consensus 488 ~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~------- 560 (601)
.++..+++.+++.+| ++|.|+|+||+.++.. . ... .+.++.+|+.||+|++|+|+.+||+.+|..
T Consensus 5 ~~t~~e~~~~~~~~d--~~g~i~~~eF~~~~~~-~-~~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~ 76 (109)
T 1rwy_A 5 LLSAEDIKKAIGAFT--AADSFDHKKFFQMVGL-K-KKS----ADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARD 76 (109)
T ss_dssp HSCHHHHHHHHHTTC--STTCCCHHHHHHHHTG-G-GSC----HHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCC
T ss_pred cCCHHHHHHHHHHcC--CCCcEeHHHHHHHHhc-C-cch----HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCC
Confidence 567788999999999 8999999999986532 1 111 567899999999999999999999998831
Q ss_pred -Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 561 -GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 561 -~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
..+ ++.++..+|.|+||.|+|+||+.+|.+
T Consensus 77 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~ 108 (109)
T 1rwy_A 77 LSAKETKTLMAAGDKDGDGKIGVEEFSTLVAE 108 (109)
T ss_dssp CCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHc
Confidence 112 899999999999999999999999875
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.44 E-value=1.7e-13 Score=115.65 Aligned_cols=97 Identities=19% Similarity=0.258 Sum_probs=80.3
Q ss_pred cchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-C--
Q 007498 484 NATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-V-- 560 (601)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-~-- 560 (601)
++. .++..+++.+++.+| ++|.|+|+||+.++... ... .+.++.+|+.||+|++|+|+.+||+.+|. +
T Consensus 3 lg~-~~~~~e~~~~~~~~d--~~g~i~~~eF~~~~~~~--~~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~ 73 (109)
T 1bu3_A 3 FSG-ILADADVAAALKACE--AADSFNYKAFFAKVGLT--AKS----ADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSA 73 (109)
T ss_dssp CSC-SSCHHHHHHHHHHTC--STTCCCHHHHHHHHTGG--GSC----HHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHST
T ss_pred ccc-cCCHHHHHHHHHHhC--CCCcCcHHHHHHHHHcC--hhh----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcc
Confidence 443 567888999999999 88999999998865321 111 56789999999999999999999999883 2
Q ss_pred -----Ccc-HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 561 -----GPS-AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 561 -----~~~-~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
..+ ++.+|+.+|.|+||.|+|+||+.+|.
T Consensus 74 ~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 108 (109)
T 1bu3_A 74 GARALTDAETKAFLKAGDSDGDGAIGVDEWAALVK 108 (109)
T ss_dssp TCCCCCHHHHHHHHHHHCTTCSSEECHHHHHHHHT
T ss_pred cCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 112 99999999999999999999999885
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=99.44 E-value=2.8e-13 Score=114.13 Aligned_cols=94 Identities=13% Similarity=0.193 Sum_probs=78.7
Q ss_pred hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC------
Q 007498 488 AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG------ 561 (601)
Q Consensus 488 ~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~------ 561 (601)
.++..+++.+++.+| ++|.|+|+||+.++. .. ... .+.++.+|+.||+|++|+|+.+||+.+|...
T Consensus 5 ~~t~~e~~~~~~~~d--~~g~i~~~eF~~~~~-~~-~~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~ 76 (108)
T 1rro_A 5 ILSAEDIAAALQECQ--DPDTFEPQKFFQTSG-LS-KMS----ASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARE 76 (108)
T ss_dssp TSCHHHHHHHHHHTC--STTCCCHHHHHHHHS-GG-GSC----HHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCC
T ss_pred cCCHHHHHHHHHHcc--CCCCcCHHHHHHHHh-cC-ccc----HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCC
Confidence 467788999999998 889999999988653 21 111 5678999999999999999999999999432
Q ss_pred --cc-HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 562 --PS-AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 562 --~~-~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
.+ ++.+|..+|.|+||.|+|+||+.+|.
T Consensus 77 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 107 (108)
T 1rro_A 77 LTESETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp CCHHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHc
Confidence 11 89999999999999999999999885
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=99.44 E-value=2.3e-14 Score=165.50 Aligned_cols=131 Identities=15% Similarity=0.198 Sum_probs=99.2
Q ss_pred cchHH-HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchh-------hhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 449 LTEDE-LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATD-------AMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 449 l~~~~-~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~-------~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+++++ +++++++|..+| |++|.|+.+||..+|..++.. ..+.++++.+++.+|.|++|.|+|+||+.++..
T Consensus 527 l~~~e~~~~l~~~F~~~D-~~dG~Is~~El~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~ 605 (900)
T 1qxp_A 527 LSEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNR 605 (900)
T ss_dssp --------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHHH
T ss_pred CCcchHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHhhcccccccCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence 44444 889999999999 999999999999999987641 467788999999999999999999999986542
Q ss_pred chhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 521 THQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 521 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.++..+| |+||.|+|+||+.+|...
T Consensus 606 ----------~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~l~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~~ 671 (900)
T 1qxp_A 606 ----------IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRL 671 (900)
T ss_dssp ----------HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTS-CSSSBCCHHHHHHHHHHH
T ss_pred ----------HHHHHHHHHhhCCCCCCeECHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHH
Confidence 24678899999999999999999999993 2222 999999999 999999999999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-12 Score=128.95 Aligned_cols=139 Identities=18% Similarity=0.184 Sum_probs=110.4
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++...+|.|+++.||++.. .+..+++|+....... ....+.+|+.+++.|..+..++++++++...+..|
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~-----~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC-----SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred cceeEeeccCCCCCeEEEEEC-----CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 488888999999999999974 3568999998653211 12358899999999976778899999999889999
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL------------------------------------- 270 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~------------------------------------- 270 (601)
+||||++|.+|.+.+ .+......++.+++.+|..||+
T Consensus 87 lv~e~i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 87 LLMSEADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEecCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999998887642 1223345788999999999998
Q ss_pred ----------------------cCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 271 ----------------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 271 ----------------------~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
..++|+|+++.|||++. ...+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~---~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD---GKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET---TEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC---CcEEEEEEchhcc
Confidence 45899999999999952 3445699999874
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.39 E-value=7e-13 Score=121.07 Aligned_cols=122 Identities=9% Similarity=0.070 Sum_probs=100.0
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
.++..+|..+|.|++|.|+.+||..++... ..+..+|+.+|.+++|.|+.+||..++........ ++.+
T Consensus 42 ~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~ 110 (167)
T 1gjy_A 42 ETCRLMVSMLDRDMSGTMGFNEFKELWAVL-------NGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLN----PQTV 110 (167)
T ss_dssp HHHHHHHHHHCTTCCSCBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSEECHHHHHHHHHTTTCCCC----HHHH
T ss_pred HHHHHHHHHHCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCC----HHHH
Confidence 456788899999999999999999988653 35888999999999999999999887654433223 5678
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCceeH--HHHHHHHh
Q 007498 535 STAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSL--HGYTKFLH 589 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~is~--~EF~~~~~ 589 (601)
..+|+.+ |++|.|+.+||..++.....+..+|+.+|.|+||.|+. .+|+.++.
T Consensus 111 ~~~~~~~--d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~~G~i~~~~~~~l~~~~ 165 (167)
T 1gjy_A 111 NSIAKRY--STSGKITFDDYIACCVKLRALTDSFRRRDSAQQGMVNFSYDDFIQCVM 165 (167)
T ss_dssp HHHHHHT--CBTTBEEHHHHHHHHHHHHHHHHHHHHHCTTCCSEEEEEHHHHHHHHH
T ss_pred HHHHHHh--CcCCcCcHHHHHHHHHHHHHHHHHHHHhCCCCCeeEEeeHHHHHHHHH
Confidence 8889988 89999999999998854455889999999999999986 56655543
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=99.38 E-value=8.4e-13 Score=124.27 Aligned_cols=122 Identities=9% Similarity=0.078 Sum_probs=100.9
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
.++..+|..+|.|++|.|+++||..++... ..+..+|+.+|.|++|.|+.+||..++........ ++.+
T Consensus 73 ~~~~~l~~~~D~d~~g~i~~~eF~~~~~~~-------~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~----~~~~ 141 (198)
T 1juo_A 73 ETCRLMVSMLDRDMSGTMGFNEFKELWAVL-------NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLS----PQAV 141 (198)
T ss_dssp HHHHHHHHHHCTTCSSCEEHHHHHHHHHHH-------HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCC----HHHH
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHHHHHHH-------HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCC----HHHH
Confidence 346788899999999999999999988753 35888999999999999999999887654432223 5678
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCceeH--HHHHHHHh
Q 007498 535 STAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSL--HGYTKFLH 589 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~is~--~EF~~~~~ 589 (601)
..+|+.+ |++|.|+.+||..++.....+..+|+.+|.|+||.|+. ++|+.++.
T Consensus 142 ~~l~~~~--d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~~G~is~~~~~~l~~~~ 196 (198)
T 1juo_A 142 NSIAKRY--STNGKITFDDYIACCVKLRALTDSFRRRDTAQQGVVNFPYDDFIQCVM 196 (198)
T ss_dssp HHHHHHT--CSSSSEEHHHHHHHHHHHHHHHHHHHHTCTTCCSEEEEEHHHHHHHHT
T ss_pred HHHHHHh--CCCCeEcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEeecHHHHHHHHh
Confidence 8899988 89999999999998854455889999999999999987 77776654
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=99.38 E-value=7.4e-13 Score=120.62 Aligned_cols=122 Identities=13% Similarity=0.147 Sum_probs=99.6
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
.++..+|..+|.|++|.|+.+||..++... ..+..+|+.+|.+++|.|+.+||..++........ ++.+
T Consensus 40 ~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~ 108 (165)
T 1k94_A 40 ETCRIMIAMLDRDHTGKMGFNAFKELWAAL-------NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLS----PQTL 108 (165)
T ss_dssp HHHHHHHHHHCTTCSSCBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCC----HHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHhCCCCCceECHHHHHHHHHHhCCCCC----HHHH
Confidence 356778889999999999999999988653 35888999999999999999999887654432223 5667
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 535 STAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
..+|+.+ |++|.|+.+||..++.....+..+|+.+|.|+||.|+.+ |.++|..
T Consensus 109 ~~~~~~~--d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~~G~i~~~-~~~~l~~ 161 (165)
T 1k94_A 109 TTIVKRY--SKNGRIFFDDYVACCVKLRALTDFFRKRDHLQQGSANFI-YDDFLQG 161 (165)
T ss_dssp HHHHHHH--CBTTBCBHHHHHHHHHHHHHHHHHHHTTCTTCCSEEEEE-HHHHHHH
T ss_pred HHHHHHh--CCCCeEcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEeee-HHHHHHH
Confidence 8888888 899999999999988544558899999999999999776 6666543
|
| >2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B | Back alignment and structure |
|---|
Probab=99.37 E-value=4.2e-13 Score=150.54 Aligned_cols=126 Identities=17% Similarity=0.284 Sum_probs=93.5
Q ss_pred HHHHHHHHHH--hhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhccc-------CCCCcccHHHHHHHhhcchh
Q 007498 453 ELVYLRAQFR--LLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMES-------LAYRKMYFEEFCAAAISTHQ 523 (601)
Q Consensus 453 ~~~~l~~~F~--~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~-------~~~g~i~~~ef~~~~~~~~~ 523 (601)
...+|+++|. .||.|++|.|+.+||..+|+.. ..+++.+++.+|. +++|.|+|+||+.++....
T Consensus 144 ~~~~Lk~~F~~~~fD~d~dG~Is~~EL~~~l~~~------~~ev~~li~~~d~~~~~~D~d~~g~idf~EF~~~~~~l~- 216 (799)
T 2zkm_X 144 RSTFLDKILVKLKMQLNSEGKIPVKNFFQMFPAD------RKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLC- 216 (799)
T ss_dssp HHHHHHHHHHHHHHSCCTTSCEEHHHHHHHSCSC------HHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHS-
T ss_pred HHHHHHHHhHHhccCCCCCCeECHHHHHHHHhhh------HHHHHHHHHHhCcCccccccCCCCcCCHHHHHHHHHHcc-
Confidence 3557889999 8999999999999999999752 3568889998884 7889999999998765332
Q ss_pred hhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-C--------------Ccc-HHHHHHHHhcC----CCCceeHHH
Q 007498 524 LEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-V--------------GPS-AYSFLKDWIRN----SDGKLSLHG 583 (601)
Q Consensus 524 ~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-~--------------~~~-~~~~~~~~d~~----~dG~is~~E 583 (601)
. .++++.+|+.||+|++|+|+.+||+++|. + ..+ ++.||+.+|.| +||.|+|+|
T Consensus 217 --~----r~el~~aF~~fD~d~~g~Is~~eL~~fL~~~Qge~~~~~~~~~~~t~ee~~~iI~~~d~d~~~~~dg~is~ee 290 (799)
T 2zkm_X 217 --P----RPEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEG 290 (799)
T ss_dssp --C----CHHHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHH
T ss_pred --C----HHHHHHHHHHhccCCCCeEcHHHHHHHHHHhcCCcccccccccCCCHHHHHHHHHHhhcccccccCCccchhh
Confidence 1 35689999999999999999999999992 1 122 89999999999 899999999
Q ss_pred HHHHHhhc
Q 007498 584 YTKFLHGV 591 (601)
Q Consensus 584 F~~~~~~~ 591 (601)
|+.+|...
T Consensus 291 F~~~L~S~ 298 (799)
T 2zkm_X 291 MVWFLCGP 298 (799)
T ss_dssp HHHHHHST
T ss_pred hhhcccCc
Confidence 99999753
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.1e-11 Score=116.53 Aligned_cols=118 Identities=13% Similarity=0.167 Sum_probs=93.9
Q ss_pred hHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh---hh
Q 007498 451 EDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE---AL 527 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~---~~ 527 (601)
....++++.+|..+|.|++|.|+++||..++..++. ......+..+|+.+|.|++|.|+++||..++....... ..
T Consensus 48 ~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~ 126 (198)
T 2r2i_A 48 PSANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLK-GKVDQKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEA 126 (198)
T ss_dssp HHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSS-CCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSC
T ss_pred cchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHcc-CchHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCch
Confidence 345567999999999999999999999999988774 45667799999999999999999999988765442111 01
Q ss_pred hhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHH
Q 007498 528 EGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLK 569 (601)
Q Consensus 528 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~ 569 (601)
...++.+..+|+.+|.|++|.|+.+||..++....++..++.
T Consensus 127 ~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~ 168 (198)
T 2r2i_A 127 MTAEEFTNMVFDKIDINGDGELSLEEFMEGVQKDEVLLDILT 168 (198)
T ss_dssp CCHHHHHHHHHHHHCTTCSSEECHHHHHHHHTTCHHHHHHHH
T ss_pred hhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcCHHHHHHHh
Confidence 112456899999999999999999999999976555555444
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=99.33 E-value=2.3e-12 Score=148.83 Aligned_cols=136 Identities=16% Similarity=0.173 Sum_probs=101.8
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh--------
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE-------- 525 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~-------- 525 (601)
+++++.+|..||.|++|+|+.+||..+|+.++. ..+.++++.+++.+| +++|.|+|+||+..+.......
T Consensus 606 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~-~l~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~~~~l~~~F~~~D~ 683 (900)
T 1qxp_A 606 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGF-KLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRLEILFKIFKQLDP 683 (900)
T ss_dssp HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTE-ECCHHHHHHHHHHTS-CSSSBCCHHHHHHHHHHHHHHHHHHHHSCS
T ss_pred HHHHHHHHHhhCCCCCCeECHHHHHHHHHHhCC-CCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHHHHHHHHHHhhCC
Confidence 478999999999999999999999999999885 567788999999999 9999999999987654211000
Q ss_pred -----------------------------------------hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCc--
Q 007498 526 -----------------------------------------ALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGP-- 562 (601)
Q Consensus 526 -----------------------------------------~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~-- 562 (601)
......+.++.+|+.+|.+ +|.|+.+||+.+|....
T Consensus 684 d~~G~It~~~~efl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~~-~G~Is~~El~~~L~~~~~~ 762 (900)
T 1qxp_A 684 ENTGTIQLDLISWLSFSVLGKLAAAIEHHHHHHMHYSNIEANESEEERQFRKLFVQLAGD-DMEVSATELMNILNKVVTR 762 (900)
T ss_dssp SCCSCEEEEHHHHHHHTCC--------------CCCCCC--------------CCCCTTC-SSCBCHHHHTTTSCC----
T ss_pred CCCceEEecHHHHHHHhhhccccccccccccccccccCCCCCChHHHHHHHHHHHHhcCC-CCccCHHHHHHHHHHhccc
Confidence 0000123455566666665 67779999999884311
Q ss_pred -----------c-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 563 -----------S-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 563 -----------~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
+ ++.+++.+|.|+||.|+|+||+.++..+.
T Consensus 763 ~~~~~~~~~s~~~~~~l~~~~D~d~dG~Is~~EF~~l~~~~~ 804 (900)
T 1qxp_A 763 HPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNIK 804 (900)
T ss_dssp CCSCC--CCCHHHHHHHHHHHCCSSSSSBCSHHHHHHHHHHH
T ss_pred ccccccCCCCHHHHHHHHHHHCCCCCCeECHHHHHHHHHHHH
Confidence 1 88999999999999999999999986643
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.32 E-value=4.5e-12 Score=118.15 Aligned_cols=118 Identities=11% Similarity=0.140 Sum_probs=98.4
Q ss_pred CCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccC-CCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccC
Q 007498 467 NKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESL-AYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEG 545 (601)
Q Consensus 467 d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~-~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~ 545 (601)
+.+|.|+.+|+..+.+.++ .+..+++.+|+.+|.+ ++|.|+++||..++........ .++.+..+|+.+|.|+
T Consensus 3 ~~~~~l~~~el~~~~~~~~---~~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~---~~~~~~~~f~~~D~d~ 76 (190)
T 2l2e_A 3 KSQSKLSQDQLQDLVRSTR---FDKKELQQWYKGFFKDCPSGHLNKSEFQKIYKQFFPFGD---PSAFAEYVFNVFDADK 76 (190)
T ss_dssp CSSCCSCHHHHHHHHHHHC---SCSHHHHHHHHHHHHHSCCCEECHHHHHHHHHHHCCCSC---HHHHHHHHHHHHCSSS
T ss_pred cccccCCHHHHHHHHHhcC---CCHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCC---ccHHHHHHHHHhcCCC
Confidence 3578999999999998864 4677899999999999 7999999999887654322111 1567889999999999
Q ss_pred CCcccHHHHHHHhcCCc------cHHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 546 NRVISIEELARELNVGP------SAYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 546 ~G~I~~~El~~~l~~~~------~~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
+|.|+.+||..++.... ++..+|+.+|.|+||.|+++||..++..
T Consensus 77 ~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~ 127 (190)
T 2l2e_A 77 NGYIDFKEFICALSVTSRGELNDKLIWAFQLYDLDNNGLISYDEMLRIVDA 127 (190)
T ss_dssp TTCEEHHHHHHHHTTSSCSCSHHHHHHHHHHHCTTSCSCBCHHHHHHHHHH
T ss_pred CCeEeHHHHHHHHHHHcCCCHHHHHHHHHhHccCCCCCcCcHHHHHHHHHH
Confidence 99999999999984321 2889999999999999999999999876
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=99.32 E-value=5.9e-12 Score=121.39 Aligned_cols=120 Identities=13% Similarity=0.147 Sum_probs=96.0
Q ss_pred HHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh--------
Q 007498 453 ELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL-------- 524 (601)
Q Consensus 453 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~-------- 524 (601)
....+.++|..+|.|++|.|+++||..++..+.. ....+.+..+|+.+|.|++|.|+++||..++......
T Consensus 100 ~~~~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~-~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~ 178 (229)
T 3dd4_A 100 STTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLR-GTVQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPV 178 (229)
T ss_dssp HHHHHHHHHHTTCSSCCSSCCHHHHHHHHHHHHH-SCHHHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC------
T ss_pred cHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHcC-CChHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCC
Confidence 3445789999999999999999999999987763 4556779999999999999999999998766543110
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhc
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIR 573 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~ 573 (601)
......++.+..+|+.+|.|+||.|+.+||..++.-.+.+..+|..+|.
T Consensus 179 ~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~~~~~~~~~~~~D~ 227 (229)
T 3dd4_A 179 LKEDAPRQHVETFFQKMDKNKDGVVTIDEFIESCQKDENIMRSMQLFEN 227 (229)
T ss_dssp -----CCTHHHHHHHHHCSSCSSBCCHHHHHHHHHTCHHHHHHHHHHTT
T ss_pred cchhhHHHHHHHHHHHhcCCCCCcEeHHHHHHHHHhCHHHHHHHHhccc
Confidence 0111114578999999999999999999999999877777788887763
|
| >1eg3_A Dystrophin; EF-hand like domain, WW domain, structural protein; 2.00A {Homo sapiens} SCOP: a.39.1.7 a.39.1.7 b.72.1.1 PDB: 1eg4_A | Back alignment and structure |
|---|
Probab=99.31 E-value=1e-11 Score=119.51 Aligned_cols=133 Identities=10% Similarity=0.003 Sum_probs=100.9
Q ss_pred HHHHHHHHHHhhCCC-CCCcccHHHHHHHHhhcchh----hh--------hhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 453 ELVYLRAQFRLLEPN-KDGSVSLENFRMVLGRNATD----AM--------RESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 453 ~~~~l~~~F~~~D~d-~~G~I~~~el~~~l~~~~~~----~~--------~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
.+..+.++|+...-+ ++..|+..|+..+|..+... .+ .+..++.+|+.||.|++|.|+|.||+.++.
T Consensus 80 ~l~~~~~~f~~~~l~~~~~~l~~~~l~~~L~~lY~~l~~~~p~~v~~~~~~~~~a~~lf~~FD~~~~G~I~f~ef~~aLs 159 (261)
T 1eg3_A 80 SLSAACDALDQHNLKQNDQPMDILQIINCLTTIYDRLEQEHNNLVNVPLCVDMCLNWLLNVYDTGRTGRIRVLSFKTGII 159 (261)
T ss_dssp CHHHHHHHHHHTTCCCTTSEEEHHHHHHHHHHHHHHHHHHSTTTCCHHHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHH
T ss_pred eHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHHHHHHHhhCcCcCCchhhHHHHHHHHHHHccCCCCceEeHHHHHHHHH
Confidence 455566777766543 56688998888877554321 11 133467799999999999999999988766
Q ss_pred cchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc----------C----C---cc--HHHHHHHHhcCCCCcee
Q 007498 520 STHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN----------V----G---PS--AYSFLKDWIRNSDGKLS 580 (601)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~----------~----~---~~--~~~~~~~~d~~~dG~is 580 (601)
....... +++++++|++|| |+||+|+.+||..+|. . . .+ ++.+|+.+| +||+|+
T Consensus 160 ~l~rG~l----eeKL~w~F~lyD-D~~G~I~~~El~~il~~i~~i~~~vge~~~~~~~~~e~~v~~~F~~~d--~dg~It 232 (261)
T 1eg3_A 160 SLCKAHL----EDKYRYLFKQVA-SSTGFCDQRRLGLLLHDSIQIPRQLGEVASFGGSNIEPSVRSCFQFAN--NKPEIE 232 (261)
T ss_dssp HTSSSCH----HHHHHHHHHHHS-CTTSCBCHHHHHHHHHHHHHHHHHTTCGGGGTCSCCHHHHHHHHHHTT--TCSCBC
T ss_pred HHcCCCH----HHHHHHHHheee-CCCCCCcHHHHHHHHHHHHHHHHhcCCcccCCCCCHHHHHHHHHHhCC--CCCcCC
Confidence 5544333 779999999999 9999999999999881 1 1 11 888999985 899999
Q ss_pred HHHHHHHHhhcc
Q 007498 581 LHGYTKFLHGVT 592 (601)
Q Consensus 581 ~~EF~~~~~~~~ 592 (601)
++||++-+++.+
T Consensus 233 ~~EFl~~~~~dp 244 (261)
T 1eg3_A 233 AALFLDWMRLEP 244 (261)
T ss_dssp HHHHHHHHHTCC
T ss_pred HHHHHHHHHhCc
Confidence 999999888754
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=99.31 E-value=5.7e-12 Score=117.43 Aligned_cols=117 Identities=16% Similarity=0.252 Sum_probs=95.5
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh--------hhh
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL--------EAL 527 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~--------~~~ 527 (601)
.++.+|..+|.|++|.|+.+||..++..++. ....+++..+|+.+|.|++|.|+++||..++...... ...
T Consensus 64 ~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~-~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~ 142 (190)
T 1fpw_A 64 FANHLFTVFDKDNNGFIHFEEFITVLSTTSR-GTLEEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDE 142 (190)
T ss_dssp HHHHHHHTCCSSCSSEECHHHHHHHHHHHSC-CCSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCC
T ss_pred HHHHHHHHHCCCCCCcEeHHHHHHHHHHHcc-CCcHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCccccc
Confidence 5889999999999999999999999988774 4567789999999999999999999998766542110 000
Q ss_pred hhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhc
Q 007498 528 EGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIR 573 (601)
Q Consensus 528 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~ 573 (601)
...++.+..+|+.+|.|++|.|+.+||..++.....+..+|..+|.
T Consensus 143 ~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~~d~ 188 (190)
T 1fpw_A 143 ATPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDPSIIGALNLYDG 188 (190)
T ss_dssp CCHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSSTTHHHHHHHHHC
T ss_pred chHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhChHHHHHHhhccc
Confidence 1226678999999999999999999999999766667777777763
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=99.30 E-value=6.3e-12 Score=116.40 Aligned_cols=118 Identities=12% Similarity=0.133 Sum_probs=93.8
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh----h----h
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ----L----E 525 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~----~----~ 525 (601)
..+++.+|..+|.|++|.|+.+||..++..++. ......+..+|+.+|.|++|.|+++||..++..... . .
T Consensus 55 ~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~ 133 (183)
T 1s6c_A 55 STYAHYLFNAFDTTQTGSVKFEDFVTALSILLR-GTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVL 133 (183)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-------
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcC-CCHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCc
Confidence 345788999999999999999999999987764 456677999999999999999999999887654311 0 1
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHh
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWI 572 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d 572 (601)
.....++.+..+|+.+|.|++|.|+.+||..++.....+...|..+|
T Consensus 134 ~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~~~~~~~~l~~~d 180 (183)
T 1s6c_A 134 KEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESXQEDDNIMRSLQLFQ 180 (183)
T ss_dssp ----CHHHHHHHHHHHCTTCSSEECHHHHHHHTTSCCHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHhcChHHHHHHHHhh
Confidence 11112467899999999999999999999999976666666666665
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=99.29 E-value=1.5e-12 Score=115.58 Aligned_cols=93 Identities=17% Similarity=0.107 Sum_probs=45.2
Q ss_pred HHHhhcccCCCCcccHHHHHHHhhcchhhh-hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC-------------
Q 007498 496 DVLSSMESLAYRKMYFEEFCAAAISTHQLE-ALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG------------- 561 (601)
Q Consensus 496 ~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~-~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~------------- 561 (601)
.+|+.+|.|++|.|+++||...+....... .....++.++.+|+.||+|++|+|+.+||+.++...
T Consensus 31 ~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~s 110 (143)
T 3a4u_B 31 SQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMS 110 (143)
T ss_dssp --------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------CC
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCCC
Confidence 355556666666666666654432211100 000124567888999999999999999999888321
Q ss_pred cc-H----HHHHHHHhcCCCCceeHHHHHHHH
Q 007498 562 PS-A----YSFLKDWIRNSDGKLSLHGYTKFL 588 (601)
Q Consensus 562 ~~-~----~~~~~~~d~~~dG~is~~EF~~~~ 588 (601)
.+ + +.+|+.+|.|+||.|+|+||+.+|
T Consensus 111 ~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~~ 142 (143)
T 3a4u_B 111 EDELINIIDGVLRDDDKNNDGYIDYAEFAKSL 142 (143)
T ss_dssp HHHHHHHHHHHHHHHCTTCSSEECHHHHHC--
T ss_pred HHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence 11 3 556699999999999999999876
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=5.2e-12 Score=104.46 Aligned_cols=72 Identities=18% Similarity=0.311 Sum_probs=66.6
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHh
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAA 518 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 518 (601)
...++++++++++++|..||.|++|+|+.+||..+|+.+|. ..++.+++.+++.+|.|++|.|+|+||+.++
T Consensus 27 ~~~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~-~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m 98 (100)
T 2lv7_A 27 PVDIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGY-MPNEVELEVIIQRLDMDGDGQVDFEEFVTLL 98 (100)
T ss_dssp CCCCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTC-CCCTTTHHHHHHHHCSSCSSSBCHHHHHHHT
T ss_pred cccCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHHCCCCCCeEeHHHHHHHh
Confidence 34578999999999999999999999999999999999986 6788899999999999999999999999854
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.2e-11 Score=121.27 Aligned_cols=118 Identities=12% Similarity=0.137 Sum_probs=95.2
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh-h-------
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL-E------- 525 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~-~------- 525 (601)
..++..+|..+|.|++|.|+++||..++..++. ....+++..+|+.+|.|++|.|+++||..++...... .
T Consensus 128 ~~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~-~~~~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~ 206 (256)
T 2jul_A 128 TTYAHFLFNAFDADGNGAIHFEDFVVGLSILLR-GTVHEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPIL 206 (256)
T ss_dssp HHHHHHHHHHSSCSCCSEECSHHHHHHHHHHHS-CCHHHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCS
T ss_pred HHHHHHHHHHhccCCCCcCcHHHHHHHHHHHhc-cChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCccc
Confidence 346888999999999999999999999988764 4567789999999999999999999998876543211 0
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHh
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWI 572 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d 572 (601)
.....++.+..+|+.+|.|+||.|+.+||..++.....+...|..+|
T Consensus 207 ~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~~~~l~~~l~~~d 253 (256)
T 2jul_A 207 REDAPLEHVERFFQKMDRNQDGVVTIDEFLETCQKDENIMNSMQLFE 253 (256)
T ss_dssp CCCCHHHHHHHHHHHSCCSTTCSBCHHHHHHHHHHCSSHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhCHHHHHHHHhhc
Confidence 01113678899999999999999999999999965555666676665
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=99.27 E-value=2.1e-13 Score=114.93 Aligned_cols=95 Identities=16% Similarity=0.255 Sum_probs=77.5
Q ss_pred hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc--------
Q 007498 488 AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-------- 559 (601)
Q Consensus 488 ~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-------- 559 (601)
.++..+++.+++.+| ++|.|+|+||+.++... . .. .+.++.+|+.||+|++|+|+.+||+.+|.
T Consensus 5 ~~~~~e~~~l~~~~d--~~g~i~~~eF~~~~~~~-~-~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~ 76 (108)
T 2kyc_A 5 ILSPSDIAAALRDCQ--APDSFSPKKFFQISGMS-K-KS----SSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGARV 76 (108)
T ss_dssp SSCHHHHHHHHTTSC--STTTCCHHHHHHHHTCT-T-CC----SSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCCC
T ss_pred cCCHHHHHHHHHHcC--CCCcCCHHHHHHHHhhC-c-cc----HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccCC
Confidence 466778888999998 88999999998865321 1 11 34678999999999999999999999883
Q ss_pred CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 560 VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 560 ~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
+..+ ++.++..+|.|+||.|+|+||+.+|++
T Consensus 77 ~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~ 108 (108)
T 2kyc_A 77 LTASETKTFLAAADHDGDGKIGAEEFQEMVQS 108 (108)
T ss_dssp CCTTTTHHHHTTTCCSSSSCCCSSHHHHHHHC
T ss_pred CCHHHHHHHHHHhCCCCCCcCCHHHHHHHHhC
Confidence 1122 899999999999999999999999863
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.8e-11 Score=112.23 Aligned_cols=109 Identities=19% Similarity=0.197 Sum_probs=87.1
Q ss_pred hhhhcchHHHHH--------HHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhh-------hccHHHHHhhcccCCCCcc
Q 007498 445 LSKALTEDELVY--------LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMR-------ESRVPDVLSSMESLAYRKM 509 (601)
Q Consensus 445 ~~~~l~~~~~~~--------l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~-------~~~~~~~~~~~D~~~~g~i 509 (601)
++...+..++.. +..+|..+|.|++|.|+++||..++......... ...+..+|+.+|.+++|.|
T Consensus 40 ~g~~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I 119 (176)
T 1nya_A 40 FGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQI 119 (176)
T ss_dssp TSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEE
T ss_pred cCCCCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 344445555544 4489999999999999999999999876532211 3558899999999999999
Q ss_pred cHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 510 YFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 510 ~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
+++||..++.... .. ++.+..+|+.+|.|++|.|+.+||..++.
T Consensus 120 ~~~e~~~~l~~~g--~~----~~~~~~~~~~~D~d~dg~i~~~ef~~~~~ 163 (176)
T 1nya_A 120 NADEFAAWLTALG--MS----KAEAAEAFNQVDTNGNGELSLDELLTAVR 163 (176)
T ss_dssp EHHHHHHHHHHTT--CC----HHHHHHHHHHHCTTCSSEEEHHHHHHHHS
T ss_pred CHHHHHHHHHHhC--CC----HHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 9999988765443 22 56789999999999999999999999883
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.25 E-value=4.8e-11 Score=112.62 Aligned_cols=116 Identities=16% Similarity=0.204 Sum_probs=93.6
Q ss_pred HHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh------
Q 007498 453 ELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA------ 526 (601)
Q Consensus 453 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~------ 526 (601)
....++.+|..+|.|++|.|+++||..++..++. ....+.+..+|+.+|.|++|.|+++||..++........
T Consensus 57 ~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~ 135 (204)
T 1jba_A 57 ATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLR-GTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEV 135 (204)
T ss_dssp THHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSS-CCCTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCT
T ss_pred cHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHcc-CCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccc
Confidence 3456788999999999999999999999988764 456677999999999999999999999887654321100
Q ss_pred -------hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHH
Q 007498 527 -------LEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLK 569 (601)
Q Consensus 527 -------~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~ 569 (601)
....++.+..+|+.+|.|+||.|+.+||..++...+++..+|.
T Consensus 136 ~~~~~g~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~ 185 (204)
T 1jba_A 136 EAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRDKWVMKMLQ 185 (204)
T ss_dssp TSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTTTTTHHHHHH
T ss_pred cccccCchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHcChHHHHHHH
Confidence 0022567899999999999999999999999976666666665
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=99.25 E-value=2.6e-11 Score=107.58 Aligned_cols=110 Identities=12% Similarity=0.232 Sum_probs=86.4
Q ss_pred HHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 442 LKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 442 ~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
+..++...+..+ +..+|..+|.|++|.|+++||..++............+..+|+.+|.+++|.|+.+||..++...
T Consensus 32 l~~~g~~~~~~~---~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~ 108 (143)
T 2obh_A 32 MRALGFEPKKEE---IKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAKEL 108 (143)
T ss_dssp HHHTTCCCCHHH---HHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHT
T ss_pred HHHcCCCCCHHH---HHHHHHHhCCCCCCeeeHHHHHHHHHHHhccccHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHh
Confidence 344454555554 56778889999999999999999886543222345678999999999999999999998876544
Q ss_pred hhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 522 HQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 522 ~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
..... ++.+..+|+.+|.|+||.|+.+||..++
T Consensus 109 g~~~~----~~~~~~~~~~~D~d~dG~I~~~eF~~~~ 141 (143)
T 2obh_A 109 GENLT----DEELQEMIDEADRDGDGEVSEQEFLRIM 141 (143)
T ss_dssp TCCCC----HHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred CCCCC----HHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 33333 5678999999999999999999999876
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.24 E-value=5.4e-11 Score=114.20 Aligned_cols=118 Identities=12% Similarity=0.138 Sum_probs=93.4
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh--------h
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL--------E 525 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~--------~ 525 (601)
..+++.+|..+|.|++|.|+++||..++..++. ....+++..+|+.+|.|++|.|+++||..++...... .
T Consensus 88 ~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~-~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~ 166 (224)
T 1s1e_A 88 STYAHYLFNAFDTTQTGSVKFEDFVTALSILLR-GTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVL 166 (224)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGG
T ss_pred HHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHcc-CCHHHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCC
Confidence 346788999999999999999999999988764 4566779999999999999999999998866443110 1
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHh
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWI 572 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d 572 (601)
.....++.+..+|+.+|.|+||.|+.+||..++.....+-..|..++
T Consensus 167 ~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~~~~l~~~l~~~~ 213 (224)
T 1s1e_A 167 KEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDDNIMRSLQLFQ 213 (224)
T ss_dssp CSSSHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHTCHHHHHHHHHHH
T ss_pred CHhHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCHHHHHHhcCCC
Confidence 11223577899999999999999999999999976655555555443
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-11 Score=138.69 Aligned_cols=126 Identities=13% Similarity=0.159 Sum_probs=106.2
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHH
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 533 (601)
.++++.+|..+|.|++|.|+++||..++..+ ..+..+|+.+|.|++|.|+.+||..++........ ++.
T Consensus 574 ~~~~~~l~~~~D~d~~G~I~f~EF~~l~~~~-------~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls----~~~ 642 (714)
T 3bow_A 574 IETCKIMVDMLDEDGSGKLGLKEFYILWTKI-------QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLP----CQL 642 (714)
T ss_dssp HHHHHHHHHHHCCSSCSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECC----HHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH-------HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCC----HHH
Confidence 3457788899999999999999999998754 45889999999999999999999887654433233 567
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+..+|+.+| |+||.|+.+||..++.....+..+|+.+|.|+||.|+++|+..++...
T Consensus 643 ~~~l~~~~D-d~dG~Isf~EF~~~l~~~~~l~~~F~~~D~d~dG~Is~~el~~l~~~~ 699 (714)
T 3bow_A 643 HQVIVARFA-DDELIIDFDNFVRCLVRLEILFKIFKQLDPENTGTIQLDLISWLSFSV 699 (714)
T ss_dssp HHHHHHHHS-CTTCEECHHHHHHHHHHHHHHHHHHSSSCSSCCSEEEEEHHHHHHHHH
T ss_pred HHHHHHHhC-CCCCeEcHHHHHHHHHHHHHHHHHHHHhCCCCCCcEEHHHHHHHHHHH
Confidence 899999999 999999999999988544458889999999999999999988876554
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=99.23 E-value=1.7e-11 Score=115.94 Aligned_cols=119 Identities=16% Similarity=0.136 Sum_probs=87.9
Q ss_pred CCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccC--CCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcc
Q 007498 466 PNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESL--AYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEE 543 (601)
Q Consensus 466 ~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~--~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~ 543 (601)
+|++|.|+.+|+..+....+........+..+|+.+|.| ++|.|+++||..++.. ..... +..+..+|+.+|.
T Consensus 11 ~~~~g~l~~~el~~l~~~~~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~-~~~~~----~~~~~~~f~~~D~ 85 (207)
T 2ehb_A 11 KNAMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFR-NRNRR----NLFADRIFDVFDV 85 (207)
T ss_dssp ----------CHHHHHHHSSCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHS-CTTCC----CHHHHHHHHHHCT
T ss_pred hccccccCHHHHHHHHHhCCCCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhc-ccccc----HHHHHHHHHHhcC
Confidence 477899999999999987664444455678899999999 9999999999886643 11111 3456789999999
Q ss_pred cCCCcccHHHHHHHhcCC-----cc--HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 544 EGNRVISIEELARELNVG-----PS--AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 544 d~~G~I~~~El~~~l~~~-----~~--~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
|++|.|+.+||..++... .+ +..+|+.+|.|+||.|+++||..++.
T Consensus 86 d~~g~i~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~ 138 (207)
T 2ehb_A 86 KRNGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYDLRQTGFIEREELKEMVV 138 (207)
T ss_dssp TCSSEECHHHHHHHHGGGSTTSCHHHHHHHHHHHHCTTCCSSEEHHHHHHHHH
T ss_pred CCCCeEeHHHHHHHHHHHccCCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 999999999999988321 11 88999999999999999999999985
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-11 Score=115.14 Aligned_cols=113 Identities=14% Similarity=0.201 Sum_probs=89.5
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh--------hh
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL--------EA 526 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~--------~~ 526 (601)
..+..+|..+|.|++|.|+.+||..++..++. ....+.+..+|+.+|.|++|.|+++||..++...... ..
T Consensus 63 ~~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~ 141 (190)
T 1g8i_A 63 KFATFVFNVFDENKDGRIEFSEFIQALSVTSR-GTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEE 141 (190)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGG
T ss_pred HHHHHHHHHHhcCCCCeEeHHHHHHHHHHhcC-CCHHHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccc
Confidence 45889999999999999999999999988764 4566779999999999999999999998866542110 01
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHH
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFL 568 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~ 568 (601)
....++.+..+|+.+|.|++|.|+.+||..++...+.+...+
T Consensus 142 ~~~~~~~~~~~f~~~D~d~dG~i~~~ef~~~~~~~~~~~~~~ 183 (190)
T 1g8i_A 142 ENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSKADPSIVQAL 183 (190)
T ss_dssp GSSHHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHCHHHHHHH
T ss_pred cccHHHHHHHHHHHhcCCCCCcEeHHHHHHHHHhChHHHHHH
Confidence 112367789999999999999999999999985444333333
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-11 Score=104.34 Aligned_cols=68 Identities=13% Similarity=0.272 Sum_probs=59.5
Q ss_pred hHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhh-----cchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLLEPNKDGSVSLENFRMVLGR-----NATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-----~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..++.|+++|+.||.| +|+|+.+||..+|+. ++ ...+..+++.+++.+|.|+||.|+|+||+.++..
T Consensus 11 E~~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~-~~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm~~ 83 (121)
T 4drw_A 11 EHAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLE-NQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAG 83 (121)
T ss_dssp HHHHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHT-TSSCTTHHHHHHHHHCTTCSSCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcc-cCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH
Confidence 45688999999999988 899999999999987 34 2456788999999999999999999999986654
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.2e-11 Score=108.65 Aligned_cols=98 Identities=8% Similarity=-0.042 Sum_probs=61.4
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh-hhhhhhHHHHHH
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ-LEALEGWEQIAS 535 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~~~ 535 (601)
.+++|..+|.|++|.|+++||..++............+..+|+.+|.+++|.|+.+||..++..... ... ++.+.
T Consensus 5 ~~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~----~~e~~ 80 (135)
T 3h4s_E 5 EKSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMS----KEDAQ 80 (135)
T ss_dssp --------------CCCC-----------CHHHHHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCC----HHHHH
T ss_pred HHHHHHHHcCCCCCcEeHHHHHHHHHHHccccchHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCC----HHHHH
Confidence 4678999999999999999999998764333345667999999999999999999999987765541 333 56789
Q ss_pred HHHHHHcccCCCcccHHHHHHHh
Q 007498 536 TAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 536 ~~F~~~D~d~~G~I~~~El~~~l 558 (601)
.+|+.+|.|+||.|+.+||..++
T Consensus 81 ~~~~~~D~d~dG~I~~~EF~~~~ 103 (135)
T 3h4s_E 81 GMVREGDLDGDGALNQTEFCVLM 103 (135)
T ss_dssp HHHHHHCSSCSSSBCHHHHHHHH
T ss_pred HHHHHhCCCCCCCCcHHHHHHHH
Confidence 99999999999999999999988
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=3.7e-11 Score=117.84 Aligned_cols=135 Identities=14% Similarity=0.134 Sum_probs=97.0
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCC-CeeEEeeeEecCCcE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK-HLVKFCDACEDVNNV 226 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~ 226 (601)
.|.+....+.|..+.||++... ++..+++|+..... ...+.+|+.+++.|..+. .+++++.++...+..
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~----~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT----TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred CCceEecccCCCCceEEEEecC----CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 4555444445666999999653 45679999975431 134778999999997442 256789988888889
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC----------------------------------
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG---------------------------------- 272 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~---------------------------------- 272 (601)
|+||||++|.+|. + .... ...++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l~--~----~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--S----SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEEECCSSEETT--T----SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEEEEecCCcccC--c----CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 9999999998773 1 1122 2356677777777777643
Q ss_pred ------------------------CeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 273 ------------------------VVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 273 ------------------------iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
++|+|++|.|||++. +..+.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~---~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN---GRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET---TEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC---CcEEEEEcchhccc
Confidence 999999999999952 34456999998743
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=99.19 E-value=6.2e-11 Score=108.01 Aligned_cols=101 Identities=8% Similarity=0.142 Sum_probs=84.3
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
.++..+|..+|.|++|.|+.+||..++............+..+|+.+|.+++|.|+.+||..++........ ++.+
T Consensus 64 ~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~ 139 (169)
T 3qrx_A 64 EEIKKMISEIDKDGSGTIDFEEFLTMMTAKMGERDSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLT----EEEL 139 (169)
T ss_dssp HHHHHHHHHHCSSSSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCC----HHHH
T ss_pred HHHHHHHHHhcCCCCCcCCHHHHHHHHHHHhcccCcHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCC----HHHH
Confidence 346778899999999999999999999765433445667889999999999999999999887654433333 5678
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhc
Q 007498 535 STAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
..+|+.+|.|+||.|+.+||..++.
T Consensus 140 ~~~~~~~D~~~dg~i~~~eF~~~~~ 164 (169)
T 3qrx_A 140 QEMIAEADRNDDNEIDEDEFIRIMK 164 (169)
T ss_dssp HHHHHHHCCSSSSCBCHHHHHHHHC
T ss_pred HHHHHHhCCCCCCCEeHHHHHHHHH
Confidence 9999999999999999999999884
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=99.19 E-value=7.8e-11 Score=104.96 Aligned_cols=107 Identities=13% Similarity=0.212 Sum_probs=85.3
Q ss_pred hhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh
Q 007498 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL 524 (601)
Q Consensus 445 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~ 524 (601)
++...+.. ++..+|..+|.|++|.|+++||..++............+..+|+.+|.+++|.|+.+||..++......
T Consensus 39 ~g~~~~~~---~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~ 115 (148)
T 1exr_A 39 LGQNPTEA---ELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEK 115 (148)
T ss_dssp HTCCCCHH---HHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCC
T ss_pred cCCCCCHH---HHHHHHHHHCCCCCCcCcHHHHHHHHHhcccCCCcHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCC
Confidence 34444444 467788899999999999999999887543223445678899999999999999999998876544332
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
.. ++.+..+|+.+|.|++|.|+.+||..++
T Consensus 116 ~~----~~~~~~~~~~~d~d~dg~i~~~eF~~~~ 145 (148)
T 1exr_A 116 LT----DDEVDEMIREADIDGDGHINYEEFVRMM 145 (148)
T ss_dssp CC----HHHHHHHHHHHCSSSSSSBCHHHHHHHH
T ss_pred CC----HHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 33 5678999999999999999999999876
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=99.18 E-value=7.7e-11 Score=106.79 Aligned_cols=96 Identities=11% Similarity=0.121 Sum_probs=79.5
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhh------hccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhH
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMR------ESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGW 530 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~------~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~ 530 (601)
+..+|..+|.|++|.|+.+||..++......... ...+..+|+.+|.+++|.|+++||..++.... ..
T Consensus 57 ~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~--~~---- 130 (166)
T 3akb_A 57 WQGLAGIADRDGDQRITREEFVTGAVKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAFG--VP---- 130 (166)
T ss_dssp HHHHHHHHCTTSSSCEEHHHHHHTHHHHHHHSHHHHHHHHHHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTT--CC----
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCccchHHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC--CC----
Confidence 3588999999999999999999998776432111 23488999999999999999999988765443 22
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
++.+..+|+.+|.|++|.|+.+||..++
T Consensus 131 ~~~~~~~~~~~D~d~dg~i~~~ef~~~~ 158 (166)
T 3akb_A 131 EDLARQAAAALDTDGDGKVGETEIVPAF 158 (166)
T ss_dssp HHHHHHHHHHHCTTCSSBCCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 5678999999999999999999999877
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.18 E-value=5.3e-11 Score=109.97 Aligned_cols=105 Identities=15% Similarity=0.201 Sum_probs=83.6
Q ss_pred hcchHHHHHH--------HHHHHhhCCCCCCcccHHHHHHHHhhcchh--------hhhhccHHHHHhhcccCCCCcccH
Q 007498 448 ALTEDELVYL--------RAQFRLLEPNKDGSVSLENFRMVLGRNATD--------AMRESRVPDVLSSMESLAYRKMYF 511 (601)
Q Consensus 448 ~l~~~~~~~l--------~~~F~~~D~d~~G~I~~~el~~~l~~~~~~--------~~~~~~~~~~~~~~D~~~~g~i~~ 511 (601)
.++..++..+ ..+|..+|.|++|.|+.+||..++...... ......+..+|+.+|.|++|.|++
T Consensus 45 ~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~ 124 (185)
T 2sas_A 45 SLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDL 124 (185)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHHHHHhccccchhhhhHHHHHHHHHHHHHHcCCCCCeEcH
Confidence 4455555554 466999999999999999999999765321 113356899999999999999999
Q ss_pred HHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 512 EEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 512 ~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
+||..++.... .. ++.+..+|+.+|.|+||.|+.+||..++
T Consensus 125 ~E~~~~l~~~g--~~----~~~~~~~~~~~D~d~dG~i~~~ef~~~~ 165 (185)
T 2sas_A 125 EEFQNYCKNFQ--LQ----CADVPAVYNVITDGGKVTFDLNRYKELY 165 (185)
T ss_dssp HHHHHHTTSSC--CC----CSSHHHHHHHHHTTTTSCCSHHHHHHHH
T ss_pred HHHHHHHHHhC--CC----HHHHHHHHHHhcCCCCCcCcHHHHHHHH
Confidence 99998765443 12 3467889999999999999999999876
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=99.18 E-value=6.9e-11 Score=99.44 Aligned_cols=103 Identities=11% Similarity=0.155 Sum_probs=81.8
Q ss_pred hhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc---
Q 007498 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST--- 521 (601)
Q Consensus 445 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~--- 521 (601)
++..+++++ +.++|..+| ++|.|+++||..++... ......+..+|+.+|.|++|.|+.+||..++...
T Consensus 3 l~~~~~~~e---i~~~~~~~D--~~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~ 74 (109)
T 3fs7_A 3 ITDILSAKD---IESALSSCQ--AADSFNYKSFFSTVGLS---SKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSS 74 (109)
T ss_dssp GGGTSCHHH---HHHHHHHTC--STTCCCHHHHHHHHTCT---TCCHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTT
T ss_pred ccCcCCHHH---HHHHHHhcC--CCCcCcHHHHHHHHhcC---CCcHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcc
Confidence 445566555 666777777 79999999999998752 2345678999999999999999999998766544
Q ss_pred hhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 522 HQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 522 ~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
..... ++.+..+|+.+|.|++|.|+.+||..++.
T Consensus 75 ~~~~~----~~~~~~~~~~~D~~~dg~i~~~EF~~~~~ 108 (109)
T 3fs7_A 75 ARVLT----SAETKAFLAAGDTDGDGKIGVEEFQSLVK 108 (109)
T ss_dssp SCCCC----HHHHHHHHHHHCTTCSSSBCHHHHHHHHT
T ss_pred cccCC----HHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 22223 56789999999999999999999998863
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=99.18 E-value=7.4e-11 Score=102.61 Aligned_cols=96 Identities=19% Similarity=0.217 Sum_probs=80.6
Q ss_pred cHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc----CCc-----c
Q 007498 493 RVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN----VGP-----S 563 (601)
Q Consensus 493 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~----~~~-----~ 563 (601)
+++.+|+.+|.+++|.|+++||..++........ ++.+..+|+.+|.|++|.|+.+||..++. ... +
T Consensus 1 ~l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~----~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~ 76 (134)
T 1jfj_A 1 MAEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKN----EQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIG 76 (134)
T ss_dssp CHHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSH----HHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHH
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCC----HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCCHHH
Confidence 3678999999999999999999887654433222 56789999999999999999999999984 111 1
Q ss_pred HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 564 AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 564 ~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
+..+|+.+|.|+||.|+++||..++....
T Consensus 77 ~~~~f~~~D~d~~G~i~~~e~~~~l~~~~ 105 (134)
T 1jfj_A 77 LKVLYKLMDVDGDGKLTKEEVTSFFKKHG 105 (134)
T ss_dssp HHHHHHHHCCSSSSEEEHHHHHHHHTTTT
T ss_pred HHHHHHHHCCCCCCccCHHHHHHHHHHhC
Confidence 88999999999999999999999998653
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=99.18 E-value=9.8e-11 Score=109.10 Aligned_cols=97 Identities=12% Similarity=0.132 Sum_probs=80.1
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcch--------hhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhh
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNAT--------DAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEAL 527 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~--------~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~ 527 (601)
.+..+|..+|.|++|.|+++||..++..... .......+..+|+.+|.|++|.|+++||..++.... ..
T Consensus 65 ~~~~~~~~~D~d~dG~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g--~~- 141 (191)
T 2ccm_A 65 IWDGLRKYADENEDEQVTKEEWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IP- 141 (191)
T ss_dssp HHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHCTTCSSBCCHHHHHHHHHTTT--CC-
T ss_pred HHHHHHHhcCCCCCCeECHHHHHHHHHHHhccccchhhchHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhC--CC-
Confidence 4456779999999999999999999877532 122345688999999999999999999998765443 22
Q ss_pred hhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 528 EGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 528 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
++.+..+|+.+|.|+||.|+.+||..++
T Consensus 142 ---~~~~~~~~~~~D~d~dG~i~~~Ef~~~~ 169 (191)
T 2ccm_A 142 ---KSDCDAAFDTLSDGGKTMVTREIFARLW 169 (191)
T ss_dssp ---HHHHHHHHHHHTTTTTSCCBHHHHHHHH
T ss_pred ---HHHHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence 5678999999999999999999999877
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=99.17 E-value=1.7e-11 Score=109.80 Aligned_cols=89 Identities=10% Similarity=0.256 Sum_probs=70.1
Q ss_pred hHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhH
Q 007498 451 EDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGW 530 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~ 530 (601)
.+++++++++|..||.|++|+|+.+||..+|+.++. ..+..+++.+++.+|.|++|.|+|+||+.++...
T Consensus 46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~e~~~l~~~~D~d~dg~I~~~eF~~~~~~~--------- 115 (150)
T 2jjz_A 46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGV-PKTHLEMKKMISEVTGGVSDTISYRDFVNMMLGK--------- 115 (150)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHHTTSCSSBCHHHHHHHHHSS---------
T ss_pred HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHh---------
Confidence 577889999999999999999999999999999885 5677889999999999999999999999876543
Q ss_pred HHHHHHHHHHHcccCCCcc
Q 007498 531 EQIASTAFEYFEEEGNRVI 549 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I 549 (601)
...+..+|+.||.|++|+-
T Consensus 116 ~~~i~~aF~~~D~d~~G~~ 134 (150)
T 2jjz_A 116 RSAVLKLVMMFEGKANESS 134 (150)
T ss_dssp SCCHHHHHHC---------
T ss_pred HHHHHHHHHHHcCCCCCCC
Confidence 1246889999999999984
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=99.17 E-value=9.4e-11 Score=104.96 Aligned_cols=104 Identities=12% Similarity=0.132 Sum_probs=82.1
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc-chhhhhhhhHHHHH
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS-THQLEALEGWEQIA 534 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~-~~~~~~~~~~~~~~ 534 (601)
.+..+|..+|.|++|.|+.+||..++............+..+|+.+|.+++|.|+.+||..++.. ..........++.+
T Consensus 39 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~ 118 (155)
T 3ll8_B 39 LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIV 118 (155)
T ss_dssp THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHH
Confidence 56779999999999999999999999876543345667999999999999999999999887654 23333322233444
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhc
Q 007498 535 STAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
..+|..+|.|++|.|+.+||..++.
T Consensus 119 ~~~~~~~D~~~dg~i~~~eF~~~~~ 143 (155)
T 3ll8_B 119 DKTIINADKDGDGRISFEEFCAVVG 143 (155)
T ss_dssp HHHHHHHCTTSSSSBCHHHHHHHHG
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 5555559999999999999999883
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=99.17 E-value=6.1e-11 Score=120.74 Aligned_cols=111 Identities=14% Similarity=0.270 Sum_probs=87.2
Q ss_pred HHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 441 ALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 441 ~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
++..++..+++++ +.++|..+|.|++|.|+++||..++..........+++..+|+.+|.|++|.|+.+||..++..
T Consensus 327 aLrsLG~~~TeeE---I~~Lf~~~D~DgDG~IdFeEFl~lms~~lk~~d~eeeLreAFk~fDkDgdG~IS~eELr~vL~~ 403 (440)
T 3u0k_A 327 VMRSLGQNPTEAE---LQDMINEVDADGDGTIDFPEFLIMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN 403 (440)
T ss_dssp HHHHTTCCCCHHH---HHHHHHHHCSSCSSSEEHHHHHHHHHTC------CHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred HHHHcCCCCCHHH---HHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCChHHHHHHHHHHHCCCCcCcCCHHHHHHHHHH
Confidence 3445555666655 6678889999999999999999998665433345667899999999999999999999887655
Q ss_pred chhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 521 THQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 521 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
...... ++++..+|+.+|.|+||.|+.+||.++|
T Consensus 404 lGe~LS----deEIdeLfke~D~DgDGkIsyeEFvkmM 437 (440)
T 3u0k_A 404 LGEKLT----DEEVDEMIREADIDGDGQVNYEEFVQMM 437 (440)
T ss_dssp HTCCCC----HHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred hCCCCC----HHHHHHHHHHhCCCCCCcEeHHHHHHHh
Confidence 443333 5678999999999999999999999987
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=3.8e-11 Score=99.20 Aligned_cols=59 Identities=20% Similarity=0.369 Sum_probs=52.6
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCc-cHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELN-----VGP-SAYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~-~~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
.++++.+|+.||+|++|+|+.+||+.+|. +.. +++.+|+.+|.|+||.|+|+||+.+|.
T Consensus 35 ~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m~ 99 (100)
T 2lv7_A 35 LEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFEEFVTLLG 99 (100)
T ss_dssp HHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHHHHHHHTC
T ss_pred HHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHHHHHHHhC
Confidence 56789999999999999999999999982 233 299999999999999999999999874
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=99.17 E-value=1.1e-10 Score=105.07 Aligned_cols=101 Identities=8% Similarity=0.186 Sum_probs=84.0
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchhh----hhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHH
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATDA----MRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWE 531 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~----~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~ 531 (601)
++..+|..+|.|++|.|+.+||..++....... .....+..+|+.+|.+++|.|+.+||..++........ +
T Consensus 51 ~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~----~ 126 (158)
T 2jnf_A 51 TIRQLIDEFDPFGNGDIDFDSFKIIGARFLGEEVNPEQMQQELREAFRLYDKEGNGYISTDVMREILAELDETLS----S 126 (158)
T ss_dssp HHHHHHHHHCTTCCSEECHHHHHHHHHHHCCCCCCTTTTSSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHCTTCC----H
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccccchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCcCC----H
Confidence 467888999999999999999999997654322 45667999999999999999999999887654432223 5
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhcC
Q 007498 532 QIASTAFEYFEEEGNRVISIEELARELNV 560 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l~~ 560 (601)
+.+..+|+.+|.|++|.|+.+||..++.-
T Consensus 127 ~~~~~~~~~~D~d~dg~i~~~eF~~~~~~ 155 (158)
T 2jnf_A 127 EDLDAMIDEIDADGSGTVDFEEFMGVMTG 155 (158)
T ss_dssp HHHHHHHHHHCSSCCSEECSHHHHHHTSS
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHhc
Confidence 67899999999999999999999998843
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=99.16 E-value=8e-11 Score=105.07 Aligned_cols=112 Identities=14% Similarity=0.212 Sum_probs=89.4
Q ss_pred HHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 441 ALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 441 ~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
.+..++...++.+ +..+|..+|.+++|.|+..||..++..........+.+..+|+.+|.|++|.|+.+||..++..
T Consensus 35 ~l~~~~~~~~~~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~El~~~l~~ 111 (148)
T 2lmt_A 35 LMRTLGQNPTEAE---LQDLIAEAENNNNGQLNFTEFCGIMAKQMRETDTEEEMREAFKIFDRDGDGFISPAELRFVMIN 111 (148)
T ss_dssp HHHHHTCCCCHHH---HHHHHHHHHTTSTTEEEHHHHHHHHHHTTTTTTTHHHHHHHHHHHHSSCSSEECHHHHHHHHHH
T ss_pred HHHhcCCCchHHH---HHHHHHhcccCCCCcccHHHHHHHHHHHhcccCcHHHHHHHHHHHCCCCcCcCcHHHHHHHHHH
Confidence 3444454555544 6678888999999999999999988765544455667999999999999999999999887655
Q ss_pred chhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 521 THQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 521 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
...... .+.+..+|+.+|.|+||.|+.+||.++|.
T Consensus 112 ~g~~~~----~~e~~~l~~~~D~d~dG~I~~~EF~~~m~ 146 (148)
T 2lmt_A 112 LGEKVT----DEEIDEMIREADFDGDGMINYEEFVWMIS 146 (148)
T ss_dssp HTCCCC----HHHHHHHHHHHCCSCCSSEEHHHHHHHHT
T ss_pred cCcccc----HHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 443333 56789999999999999999999999873
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=99.16 E-value=1.5e-11 Score=109.10 Aligned_cols=103 Identities=13% Similarity=0.020 Sum_probs=50.8
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchh----hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh--------
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATD----AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ-------- 523 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-------- 523 (601)
.-...|..+|.|+||.|+++||..++..+... ....+.+..+|+.+|.|++|.|+++||..++.....
T Consensus 28 ~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~ 107 (143)
T 3a4u_B 28 ASFSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAP 107 (143)
T ss_dssp -----------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTCC------------
T ss_pred CCHHHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCC
Confidence 34468999999999999999999998765321 123456888999999999999999999886654321
Q ss_pred hhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 524 LEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 524 ~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
....+...+.+..+|+.+|.|+||.|+.+||..++
T Consensus 108 ~~s~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~~ 142 (143)
T 3a4u_B 108 LMSEDELINIIDGVLRDDDKNNDGYIDYAEFAKSL 142 (143)
T ss_dssp -CCHHHHHHHHHHHHHHHCTTCSSEECHHHHHC--
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence 12222234456778899999999999999998765
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=99.16 E-value=7.1e-11 Score=106.60 Aligned_cols=99 Identities=14% Similarity=0.198 Sum_probs=80.8
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcch---hhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHH
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNAT---DAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQ 532 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~---~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~ 532 (601)
++..+|..+|.|++|.|+++||..++..... .......+..+|+.+|.+++|.|+.+||..++........ ++
T Consensus 56 ~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~----~~ 131 (161)
T 1dtl_A 56 ELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATGETIT----ED 131 (161)
T ss_dssp HHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-----CHHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCC----HH
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHHHHHHHhcccccchHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCC----HH
Confidence 4677899999999999999999999876542 2234566899999999999999999999886654432223 56
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 533 IASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 533 ~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
.+..+|+.+|.|++|.|+.+||..++
T Consensus 132 ~~~~~~~~~D~d~dg~i~~~eF~~~~ 157 (161)
T 1dtl_A 132 DIEELMKDGDKNNDGRIDYDEFLEFM 157 (161)
T ss_dssp HHHHHHHHHCTTSSSEEEHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 78999999999999999999999877
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=99.16 E-value=1.1e-10 Score=107.40 Aligned_cols=100 Identities=10% Similarity=0.210 Sum_probs=83.1
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHH
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIAS 535 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~ 535 (601)
++..+|..+|.|++|.|+++||..++............+..+|+.+|.+++|.|+.+||..++........ ++.+.
T Consensus 48 ~~~~l~~~~D~~~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~----~~~~~ 123 (179)
T 2f2o_A 48 ELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLT----DEEVD 123 (179)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCC----HHHHH
T ss_pred HHHHHHHHhccCCCCCCcHHHHHHHHHHHccCcccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCC----HHHHH
Confidence 46788999999999999999999998765433345567899999999999999999999887654433223 56789
Q ss_pred HHHHHHcccCCCcccHHHHHHHhc
Q 007498 536 TAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 536 ~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
.+|+.+|.|++|.|+.+||..++.
T Consensus 124 ~~~~~~D~~~dg~i~~~eF~~~~~ 147 (179)
T 2f2o_A 124 EMIREADIDGDGQVNYEEFVQMMT 147 (179)
T ss_dssp HHHHHHCTTCSSSEEHHHHHHHSC
T ss_pred HHHHHcCCCCCCcCcHHHHHHHHH
Confidence 999999999999999999999984
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.1e-10 Score=120.40 Aligned_cols=142 Identities=23% Similarity=0.375 Sum_probs=104.4
Q ss_pred cceeccCCCeEEEEEEeecCCccCcEEEEEEee--cccccchhhHHHHHHHHHHHHHhcC-CCCeeEEeeeEecC---Cc
Q 007498 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIIS--KAKMTTAISIEDVRREVKILKALSG-HKHLVKFCDACEDV---NN 225 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~---~~ 225 (601)
++.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+++.|.. +..+++++.++.+. +.
T Consensus 43 ~~~l~~G~sn~~y~v~~~-----~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-----GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp EEECCC-CCSCEEEEECS-----SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred EEEcCCcccceEEEEEEC-----CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 467899999999998753 3578899875 32211 123567899999999973 34588899888776 45
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL----------------------------------- 270 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~----------------------------------- 270 (601)
.|+||||++|..+.+.. ...++..+...++.+++..|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp CEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred eEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 89999999987764321 2347888999999999999999997
Q ss_pred -----------------------cCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 271 -----------------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 271 -----------------------~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
..++|+|+++.|||++.+ ....+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~-~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPT-EPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSS-SSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCC-CCcEEEEECcccccc
Confidence 358999999999999631 112368999998853
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=99.15 E-value=2.1e-11 Score=108.79 Aligned_cols=89 Identities=9% Similarity=0.214 Sum_probs=74.3
Q ss_pred hHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhH
Q 007498 451 EDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGW 530 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~ 530 (601)
++++++++.+|..||.|++|+|+.+||..+++.++. ..+..++..+++.+|.+++|.|+|+||+.++...
T Consensus 44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~-~~~~~~~~~l~~~~D~d~dg~I~~~eF~~~~~~~--------- 113 (147)
T 1wy9_A 44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGV-PKTHLELKRLIREVSSGSEETFSYSDFLRMMLGK--------- 113 (147)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSSCTTEECHHHHHHHHCSS---------
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHh---------
Confidence 678899999999999999999999999999999885 5677889999999999999999999999876543
Q ss_pred HHHHHHHHHHHcccCCCcc
Q 007498 531 EQIASTAFEYFEEEGNRVI 549 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I 549 (601)
.+.+..+|+.||.|++|..
T Consensus 114 ~~~~~~aF~~~D~d~~g~~ 132 (147)
T 1wy9_A 114 RSAILRMILMYEEKNKEHK 132 (147)
T ss_dssp GGGGGGGGGGCCCC-----
T ss_pred HHHHHHHHHHHccCCCCCC
Confidence 1235779999999999984
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=99.15 E-value=9.3e-11 Score=105.75 Aligned_cols=106 Identities=11% Similarity=0.141 Sum_probs=86.0
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
+..++..+ +..+|..+|.|++|.|+.+||..++............+..+|+.+|.+++|.|+.+||..++.......
T Consensus 53 ~~~~~~~~---~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~ 129 (161)
T 3fwb_A 53 GFELPKRE---ILDLIDEYDSEGRHLMKYDDFYIVMGEKILKRDPLDEIKRAFQLFDDDHTGKISIKNLRRVAKELGETL 129 (161)
T ss_dssp TCCCCHHH---HHHHHHHHCTTSSSCEEHHHHHHHHHHHHHTCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCC
T ss_pred CCCCCHHH---HHHHHHHhCcCCCCeEeHHHHHHHHHHHHhcCCcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCCCC
Confidence 33445444 777888999999999999999999976543334466789999999999999999999998766443333
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
. ++.+..+|+.+|.|++|.|+.+||..++
T Consensus 130 ~----~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 158 (161)
T 3fwb_A 130 T----DEELRAMIEEFDLDGDGEINENEFIAIC 158 (161)
T ss_dssp C----HHHHHHHHHTTCSSSSSSEEHHHHHHHH
T ss_pred C----HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3 5678999999999999999999999876
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.2e-10 Score=103.18 Aligned_cols=98 Identities=10% Similarity=0.135 Sum_probs=82.2
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHH
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIAS 535 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~ 535 (601)
++..+|..+|.|++|.|+.+||..++............+..+|+.+|.+++|.|+.+||..++........ ++.+.
T Consensus 48 ~~~~l~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~----~~~~~ 123 (147)
T 4ds7_A 48 EVADLMNEIDVDGNHAIEFSEFLALMSRQLKCNDSEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLT----DAEVD 123 (147)
T ss_dssp HHHHHHHHHCTTSSSEEEHHHHHHHHHHHHHTHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCC----HHHHH
T ss_pred HHHHHHHHhccCCCCcCcHHHHHHHHHHhccCCCcHHHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCC----HHHHH
Confidence 36778888999999999999999999765433445677899999999999999999999987754433233 56789
Q ss_pred HHHHHHcccCCCcccHHHHHHHh
Q 007498 536 TAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 536 ~~F~~~D~d~~G~I~~~El~~~l 558 (601)
.+|+.+| |++|.|+.+||..++
T Consensus 124 ~~~~~~d-~~dg~i~~~eF~~~l 145 (147)
T 4ds7_A 124 EMLREVS-DGSGEINIKQFAALL 145 (147)
T ss_dssp HHHHHHS-SSCSSEEHHHHHHHT
T ss_pred HHHHHhc-CCCCcCcHHHHHHHH
Confidence 9999999 999999999999876
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1e-10 Score=112.36 Aligned_cols=106 Identities=14% Similarity=0.113 Sum_probs=84.9
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc----chhhhhhhhHH
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS----THQLEALEGWE 531 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~----~~~~~~~~~~~ 531 (601)
.+.++|..+|.|++|.|+++||..++............+..+|+.+|.|++|.|+++||..++.. .......+..+
T Consensus 86 ~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~ 165 (226)
T 2zfd_A 86 FADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIE 165 (226)
T ss_dssp HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHH
T ss_pred HHHHHHHHHcCCCCCcCcHHHHHHHHHHHccCCCHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHH
Confidence 46779999999999999999999999877643345667999999999999999999999876632 11112223345
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhcCC
Q 007498 532 QIASTAFEYFEEEGNRVISIEELARELNVG 561 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l~~~ 561 (601)
+.+..+|+.+|.|+||.|+.+||..++...
T Consensus 166 ~~~~~~f~~~D~d~dG~I~~~EF~~~~~~~ 195 (226)
T 2zfd_A 166 DIIDKTFEEADTKHDGKIDKEEWRSLVLRH 195 (226)
T ss_dssp HHHHHHHHHHCSSCSSEECHHHHHHHHHHS
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHhC
Confidence 567889999999999999999999998433
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=99.14 E-value=7e-11 Score=94.75 Aligned_cols=74 Identities=16% Similarity=0.242 Sum_probs=64.5
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
+..++++++++++.+|..+|.|++|+|+.+||..+++.++ ..+..++..+++.+|.+++|.|+|+||+.++...
T Consensus 2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g--~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~ 75 (86)
T 2opo_A 2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG--SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARAN 75 (86)
T ss_dssp ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT--TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC
T ss_pred CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC--CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHC
Confidence 4567889999999999999999999999999999999988 5677889999999999999999999999876543
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=99.14 E-value=8.4e-11 Score=103.74 Aligned_cols=106 Identities=8% Similarity=0.134 Sum_probs=84.6
Q ss_pred hhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh
Q 007498 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL 524 (601)
Q Consensus 445 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~ 524 (601)
++..++.. ++..+|..+|.|++|.|+.+||..++............+..+|+.+|.+++|.|+.+||..++......
T Consensus 35 ~~~~~~~~---~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~ 111 (142)
T 2bl0_C 35 FGVRVEPA---AFNEMFNEADATGNGKIQFPEFLSMMGRRMKQTTSEDILRQAFRTFDPEGTGYIPKAALQDALLNLGDR 111 (142)
T ss_dssp HTCCCCHH---HHHHHHHHHCTTCSSEEEHHHHHHHHHHHHTTCCCHHHHHHHHHHTCCSSCSCEEHHHHHHHHHHSSSC
T ss_pred hCCCCCHH---HHHHHHHHhCcCCCCeeeHHHHHHHHHHHhcCCChHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCC
Confidence 34445544 467789999999999999999999997633223456678999999999999999999998876544322
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
.. ++.+..+|+.+| |++|.|+.+||..++
T Consensus 112 ~~----~~~~~~~~~~~d-~~dg~i~~~eF~~~~ 140 (142)
T 2bl0_C 112 LK----PHEFAEFLGITE-TEKGQIRYDNFINTM 140 (142)
T ss_dssp CC----HHHHHHHHHHHC-CSSSEECSHHHHTTT
T ss_pred CC----HHHHHHHHHHhC-CCCCcEeHHHHHHHH
Confidence 23 567899999999 999999999998876
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.13 E-value=1.3e-10 Score=97.66 Aligned_cols=101 Identities=13% Similarity=0.188 Sum_probs=80.6
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc---h
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST---H 522 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~---~ 522 (601)
+..+++++ ++++|..+|. +|.|+++||..++... .....++..+|+.+|.|++|.|+.+||..++... .
T Consensus 3 ~~~~s~~e---i~~~~~~~d~--~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g 74 (109)
T 5pal_A 3 TKVLKADD---INKAISAFKD--PGTFDYKRFFHLVGLK---GKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHG 74 (109)
T ss_dssp GGTSCHHH---HHHHHHHTCS--TTCCCHHHHHHHHTCT---TCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTC
T ss_pred CCcCCHHH---HHHHHHHhCC--CCcCcHHHHHHHHhhc---cCcHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcC
Confidence 44566555 6667777787 8999999999988653 2345678999999999999999999998766543 2
Q ss_pred hhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 523 QLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 523 ~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
.... ++.+..+|+.+|.|++|.|+.+||..++
T Consensus 75 ~~~~----~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (109)
T 5pal_A 75 RDLN----DTETKALLAAGDSDHDGKIGADEFAKMV 106 (109)
T ss_dssp CCCC----HHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred CCCC----HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 2223 5678999999999999999999999876
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=99.13 E-value=2e-10 Score=103.66 Aligned_cols=107 Identities=15% Similarity=0.233 Sum_probs=85.3
Q ss_pred hhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhh---hhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAM---RESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 445 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~---~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
++..++.. ++..+|..+|.|++|.|+.+||..++........ ....+..+|+.+|.+++|.|+.+||..++...
T Consensus 49 ~~~~~~~~---~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~ 125 (162)
T 1top_A 49 LGQNPTKE---ELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRAT 125 (162)
T ss_dssp TTCCCCHH---HHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTT
T ss_pred cCCCCCHH---HHHHHHHHHcCCCCCcEeHHHHHHHHHHHhccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHh
Confidence 33344444 4667899999999999999999999876542222 45668999999999999999999998876544
Q ss_pred hhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 522 HQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 522 ~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
..... ++.+..+|+.+|.|++|.|+.+||..++
T Consensus 126 g~~~~----~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 158 (162)
T 1top_A 126 GEHVT----EEDIEDLMKDSDKNNDGRIDFDEFLKMM 158 (162)
T ss_dssp TCCCC----HHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred CCCCC----HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 32223 5678999999999999999999999887
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.12 E-value=2.1e-10 Score=108.04 Aligned_cols=103 Identities=12% Similarity=0.176 Sum_probs=83.4
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh---hhhhhHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL---EALEGWE 531 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~---~~~~~~~ 531 (601)
.++..+|..+|.|++|.|+.+||..++..... ......+..+|+.+|.|++|.|+++||..++...... ......+
T Consensus 73 ~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~ 151 (204)
T 3e3r_A 73 AEAEGVCRKWDRNGSGTLDLEEFLRALRPPMS-QAREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTED 151 (204)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHTSCCCC-HHHHHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHH
T ss_pred HHHHHHHHHhccCCCCcCcHHHHHHHHHhhcC-chHHHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChH
Confidence 34778899999999999999999999987653 3456678999999999999999999999876532110 0111225
Q ss_pred HHHHHHHHHHcc-cCCCcccHHHHHHHh
Q 007498 532 QIASTAFEYFEE-EGNRVISIEELAREL 558 (601)
Q Consensus 532 ~~~~~~F~~~D~-d~~G~I~~~El~~~l 558 (601)
+.+..+|+.+|. |+||.|+.+||..++
T Consensus 152 ~~~~~~~~~~D~~d~dg~Is~~EF~~~~ 179 (204)
T 3e3r_A 152 EVLRRFLDNFDSSEKDGQVTLAEFQDYY 179 (204)
T ss_dssp HHHHHHHHHHSCSSCCSCEEHHHHHHHH
T ss_pred HHHHHHHHHhhccCCCCcCcHHHHHHHH
Confidence 678999999999 999999999999987
|
| >3ohm_B 1-phosphatidylinositol-4,5-bisphosphate phosphodi beta-3; PH domain, EF hand, TIM barrel, C2 domain, GTPase, lipase, C binding, GTP binding; HET: GDP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.4e-10 Score=130.01 Aligned_cols=124 Identities=20% Similarity=0.319 Sum_probs=103.3
Q ss_pred HHHHHHHHHh--hCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccC-------CCCcccHHHHHHHhhcchhh
Q 007498 454 LVYLRAQFRL--LEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESL-------AYRKMYFEEFCAAAISTHQL 524 (601)
Q Consensus 454 ~~~l~~~F~~--~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~-------~~g~i~~~ef~~~~~~~~~~ 524 (601)
..+|+++|.. +|.|+||.|+.+|+..+|+. ...++..++..+|.+ ++|.|+|+||..++.....
T Consensus 149 ~~~L~kaf~~~~~D~n~dGkIs~kel~~~l~~------~~~~v~~l~~~~d~~~~~~d~~~~g~i~feEF~~f~~~l~~- 221 (885)
T 3ohm_B 149 NTFLRKAYTKLKLQVNQDGRIPVKNILKMFSA------DKKRVETALESCGLKFNRSESIRPDEFSLEIFERFLNKLCL- 221 (885)
T ss_dssp HHHHHHHHHHHHHSCCTTSCEEHHHHHHTTGG------GHHHHHHHHHTTTCCCSTTCEECGGGCCHHHHHHHHHHHSC-
T ss_pred HHHHHHHHHHhcCccCCCCccCHHHHHHHHhc------CHHHHHHHHHHhCCCccccccCCCCcCCHHHHHHHHHhcCC-
Confidence 3578888988 89999999999999998874 234688899998876 7789999999987653321
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc----C-----------Ccc-HHHHHHHHhcC----CCCceeHHHH
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELARELN----V-----------GPS-AYSFLKDWIRN----SDGKLSLHGY 584 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~----~-----------~~~-~~~~~~~~d~~----~dG~is~~EF 584 (601)
..+++.+|+.||.+++|+||.+||+.+|. . ..+ ++.+|+.++.+ ++|.|++++|
T Consensus 222 ------R~EI~eiF~~ydsd~~g~mT~~EL~~FL~~~Q~e~~~~e~~~~~~t~e~~~~iI~k~e~~~~~~~~g~LsldgF 295 (885)
T 3ohm_B 222 ------RPDIDKILLEIGAKGKPYLTLEQLMDFINQKQRDPRLNEVLYPPLRPSQARLLIEKYEPNQQFLERDQMSMEGF 295 (885)
T ss_dssp ------CHHHHHHHHHTTCCSTTCEEHHHHHHHHHHHSSCTTSCTTTSCCCCHHHHHHHHHHHCCCHHHHHTTEECHHHH
T ss_pred ------HHHHHHHHHHHhcCCCCccCHHHHHHHHHHhcCcccccccccccCCHHHHHHHHHHhcCChhhhccCccchhhh
Confidence 34689999999999999999999999991 2 112 89999999998 7999999999
Q ss_pred HHHHhh
Q 007498 585 TKFLHG 590 (601)
Q Consensus 585 ~~~~~~ 590 (601)
..+|..
T Consensus 296 ~~yL~S 301 (885)
T 3ohm_B 296 SRYLGG 301 (885)
T ss_dssp HHHHTS
T ss_pred hhhccC
Confidence 999975
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=99.11 E-value=1.4e-10 Score=103.16 Aligned_cols=109 Identities=9% Similarity=0.109 Sum_probs=84.1
Q ss_pred HHhhhhcchHHHHHHHHHHHhh-CCCCCCcccHHHHHHHHhhcc-----hhhhhhccHHHHHhhcccCCCCcccHHHHHH
Q 007498 443 KALSKALTEDELVYLRAQFRLL-EPNKDGSVSLENFRMVLGRNA-----TDAMRESRVPDVLSSMESLAYRKMYFEEFCA 516 (601)
Q Consensus 443 ~~~~~~l~~~~~~~l~~~F~~~-D~d~~G~I~~~el~~~l~~~~-----~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~ 516 (601)
..++..++.. ++..+|..+ |.|++|.|+.+||..++.... ........+..+|+.+|.+++|.|+.+||..
T Consensus 31 ~~~g~~~~~~---~~~~l~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~ 107 (148)
T 1m45_A 31 RAIGYNPTNQ---LVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDLRY 107 (148)
T ss_dssp HHTTCCCCHH---HHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHHHHHHHHTTCSSSSSEEEHHHHHH
T ss_pred HHhCCCCCHH---HHHHHHHHhhCCCCCCeEcHHHHHHHHHHHHhhccccccccHHHHHHHHHHhCCCCCCcCCHHHHHH
Confidence 3344445544 467789999 999999999999999998762 1233456789999999999999999999988
Q ss_pred HhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 517 AAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
++........ ++.+..+|+.+|.|++|.|+.+||..++
T Consensus 108 ~l~~~g~~~~----~~~~~~~~~~~d~d~dg~i~~~eF~~~~ 145 (148)
T 1m45_A 108 MLTGLGEKLT----DAEVDELLKGVEVDSNGEIDYKKFIEDV 145 (148)
T ss_dssp HHHHSTTCCC----HHHHHHHHTTCCCCTTSEEEHHHHHHHH
T ss_pred HHHHcCCCCC----HHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 7654433333 5678999999999999999999999876
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1.4e-10 Score=95.47 Aligned_cols=62 Identities=16% Similarity=0.207 Sum_probs=53.7
Q ss_pred HHHHHHHHHHHc-ccCC-CcccHHHHHHHhc--C----C----c-cHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFE-EEGN-RVISIEELARELN--V----G----P-SAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D-~d~~-G~I~~~El~~~l~--~----~----~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+.+..+|+.|| +||+ |+|+.+||+.+|. + . . +++.+|+.+|.|+||.|+|+||+.+|.++.
T Consensus 9 i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~~~~~ 83 (101)
T 3nso_A 9 VAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACLC 83 (101)
T ss_dssp HHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHH
Confidence 467899999998 8998 9999999999984 2 2 1 199999999999999999999999997653
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.8e-10 Score=106.10 Aligned_cols=110 Identities=12% Similarity=0.190 Sum_probs=89.4
Q ss_pred HHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 441 ALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 441 ~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
++..++..+++.+ +..+|..+|.|++|.|++.||..++..........+++...|+.+|.|++|.|+.+||..++..
T Consensus 36 ~l~~lg~~~~~~~---~~~~~~~~d~d~~~~i~~~ef~~~~~~~~~~~~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~ 112 (176)
T 2lhi_A 36 VMRSLGLSPSEAE---VNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVLTS 112 (176)
T ss_dssp HHHHHTCCCCHHH---HHHHHTTTCSSCSSSBCTTHHHHHHTSSCCSSHHHHHHHHHHHHHCSSCSSSBCHHHHHHHHHT
T ss_pred HHHHcCCChhHHH---HHHHHHHhCcCCCccchHHHHHHHHHHhcccCCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 3445555666555 6677889999999999999999998765543445667899999999999999999999887765
Q ss_pred chhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 521 THQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 521 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
...... ++++..+|+.+| |+||.|+.+||.++|
T Consensus 113 ~g~~~~----~~ei~~l~~~~d-d~dG~I~~~EF~~~m 145 (176)
T 2lhi_A 113 IGEKLT----DAEVDDMLREVS-DGSGEINIQQFAALL 145 (176)
T ss_dssp TTCCCC----HHHHHHHHHHHH-TTSSCBCTTHHHHHH
T ss_pred cCcccc----hHHHHHHHHhhc-CCCCeEeHHHHHHHH
Confidence 544444 567889999999 999999999999999
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.2e-10 Score=109.26 Aligned_cols=100 Identities=11% Similarity=0.109 Sum_probs=75.7
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc--hhhhhhhhHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST--HQLEALEGWEQ 532 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~--~~~~~~~~~~~ 532 (601)
.++..+|..+|.|++|.|+++||..++..... ....+.+..+|+.+|.|++|.|+.+||..++... ..... ++
T Consensus 93 ~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~-~~~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~----~~ 167 (197)
T 3pm8_A 93 PDIHQVLRDIDSNASGQIHYTDFLAATIDKQT-YLKKEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLI----DK 167 (197)
T ss_dssp HHHHHHHHC-------CEEHHHHHHTTCCHHH-HCSHHHHHHHHHHHCTTCSSEECHHHHHHHHC----CCHHH----HH
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHh-hhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCC----HH
Confidence 34778899999999999999999998866543 3456679999999999999999999999876544 22222 56
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 533 IASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 533 ~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
.+..+|+.+|.|+||.|+.+||..+|.
T Consensus 168 ~~~~l~~~~D~d~dG~Is~~EF~~~l~ 194 (197)
T 3pm8_A 168 AIDSLLQEVDLNGDGEIDFHEFMLMMS 194 (197)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCcCcHHHHHHHHH
Confidence 789999999999999999999999873
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=99.09 E-value=2.8e-10 Score=95.47 Aligned_cols=98 Identities=11% Similarity=0.114 Sum_probs=78.2
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc---hhhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST---HQLE 525 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~---~~~~ 525 (601)
+++++ +..+|..+| ++|.|+++||..++... ......+..+|+.+|.+++|.|+.+||..++... ....
T Consensus 6 ~~~~e---~~~l~~~~d--~~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~ 77 (108)
T 2pvb_A 6 LKDAD---VAAALAACS--AADSFKHKEFFAKVGLA---SKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARAL 77 (108)
T ss_dssp SCHHH---HHHHHHHTC--STTCCCHHHHHHHHTGG---GSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCC
T ss_pred CCHHH---HHHHHHHhC--CCCcCcHHHHHHHHhCC---hhHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCC
Confidence 45444 666777788 79999999999998542 2345678999999999999999999998866544 2222
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
. ++.+..+|+.+|.|++|.|+.+||..++
T Consensus 78 ~----~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (108)
T 2pvb_A 78 T----DAETKAFLADGDKDGDGMIGVDEFAAMI 106 (108)
T ss_dssp C----HHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred C----HHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 2 5678999999999999999999999876
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=99.09 E-value=2.7e-10 Score=95.67 Aligned_cols=101 Identities=12% Similarity=0.159 Sum_probs=80.2
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc---h
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST---H 522 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~---~ 522 (601)
+..+++++ +.++|..+| ++|.|+++||..++... ......+..+|+.+|.+++|.|+.+||..++... .
T Consensus 3 g~~~t~~e---~~~~~~~~d--~~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g 74 (109)
T 1rwy_A 3 TDLLSAED---IKKAIGAFT--AADSFDHKKFFQMVGLK---KKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDA 74 (109)
T ss_dssp HHHSCHHH---HHHHHHTTC--STTCCCHHHHHHHHTGG---GSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTC
T ss_pred CCcCCHHH---HHHHHHHcC--CCCcEeHHHHHHHHhcC---cchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccC
Confidence 44566655 666777788 89999999999998532 2345678999999999999999999998766543 2
Q ss_pred hhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 523 QLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 523 ~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
.... ++.+..+|+.+|.|++|.|+.+||..++
T Consensus 75 ~~~~----~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (109)
T 1rwy_A 75 RDLS----AKETKTLMAAGDKDGDGKIGVEEFSTLV 106 (109)
T ss_dssp CCCC----HHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred CCCC----HHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 2222 5678999999999999999999999876
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.2e-10 Score=107.85 Aligned_cols=103 Identities=17% Similarity=0.133 Sum_probs=80.3
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcch----------------hhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNAT----------------DAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~----------------~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..+|..+|.|++|.|+++||..++..... .......+..+|+.+|.|++|.|+.+||..++..
T Consensus 63 ~~~l~~~~D~d~dg~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~ 142 (202)
T 2bec_A 63 GDRIIESFFPDGSQRVDFPGFVRVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRL 142 (202)
T ss_dssp HHHHHHTTSCSSCCCCCHHHHHHHHGGGSCCCHHHHC-----CCCCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHhcccchhcccccccccccccccHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence 778899999999999999999999977642 2334566899999999999999999999887654
Q ss_pred c-hhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 521 T-HQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 521 ~-~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
. ......+..++.+..+|+.+|.|+||.|+.+||..++.
T Consensus 143 ~~g~~~~~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~ 182 (202)
T 2bec_A 143 MVGVQVTEEQLENIADRTVQEADEDGDGAVSFVEFTKSLE 182 (202)
T ss_dssp SCCSCCCHHHHHHHHHHHHHHHCSSCSSSEEHHHHHHTTT
T ss_pred hcCCCCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHH
Confidence 4 32233222233344455559999999999999999883
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=99.08 E-value=2.2e-10 Score=109.08 Aligned_cols=104 Identities=12% Similarity=0.123 Sum_probs=82.9
Q ss_pred HHHHhhCCCCCCc-ccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh-----hhhhhhHHH
Q 007498 459 AQFRLLEPNKDGS-VSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ-----LEALEGWEQ 532 (601)
Q Consensus 459 ~~F~~~D~d~~G~-I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-----~~~~~~~~~ 532 (601)
++|..+|.|++|. |+++||..++..+.......+.+..+|+.+|.|++|.|+.+||..++..... ....+..++
T Consensus 95 ~lf~~~D~d~dG~~I~f~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~ 174 (214)
T 2l4h_A 95 RICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQ 174 (214)
T ss_dssp HHHHHHCCSSSCCSEEHHHHHHHHHHTSSCSCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHH
T ss_pred HHHHHhCcCCCCCEecHHHHHHHHHHHcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHH
Confidence 5788899999999 9999999999876532334567999999999999999999999887654432 223233345
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHhcCCc
Q 007498 533 IASTAFEYFEEEGNRVISIEELARELNVGP 562 (601)
Q Consensus 533 ~~~~~F~~~D~d~~G~I~~~El~~~l~~~~ 562 (601)
.+..+|+.+|.|+||.|+.+||..++...+
T Consensus 175 ~~~~~~~~~D~d~dG~Is~~EF~~~~~~~p 204 (214)
T 2l4h_A 175 LIDNILEESDIDRDGTINLSEFQHVISRSP 204 (214)
T ss_dssp HHHHHHHHHCCSCCSSBCSHHHHHHHHTCH
T ss_pred HHHHHHHHhCCCCCCcCCHHHHHHHHHhCh
Confidence 566799999999999999999999886544
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=99.08 E-value=3.4e-10 Score=95.29 Aligned_cols=102 Identities=18% Similarity=0.244 Sum_probs=80.6
Q ss_pred hhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc---
Q 007498 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST--- 521 (601)
Q Consensus 445 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~--- 521 (601)
++..+++++ +..+|..+| ++|.|+++||..++... ......+..+|+.+|.+++|.|+.+||..++...
T Consensus 3 lG~~~t~~e---~~~~~~~~d--~~g~i~~~ef~~~~~~~---~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~ 74 (110)
T 1pva_A 3 AKDLLKADD---IKKALDAVK--AEGSFNHKKFFALVGLK---AMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAAD 74 (110)
T ss_dssp HHHHSCHHH---HHHHHHHTC--STTCCCHHHHHHHHTCT---TSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTT
T ss_pred ccccCCHHH---HHHHHHhcC--CCCcCcHHHHHHHHccC---cchHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhc
Confidence 455566655 556667777 89999999999998532 2345678999999999999999999998866544
Q ss_pred hhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 522 HQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 522 ~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
..... ++.+..+|+.+|.|++|.|+.+||..++
T Consensus 75 g~~~~----~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 107 (110)
T 1pva_A 75 GRDLT----DAETKAFLKAADKDGDGKIGIDEFETLV 107 (110)
T ss_dssp CCCCC----HHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred CCCCC----HHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 22222 5678999999999999999999999876
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=1.5e-10 Score=116.65 Aligned_cols=184 Identities=16% Similarity=0.232 Sum_probs=123.4
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCC--eeEEeeeEecCC---cEE
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH--LVKFCDACEDVN---NVY 227 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n--iv~l~~~~~~~~---~~~ 227 (601)
+.++.|....||.+. ..+++|+.... .....+.+|..+|+.|..+.. +.+++....... ..|
T Consensus 26 ~~~~~G~~n~v~~v~--------~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~ 92 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN--------RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF 92 (304)
T ss_dssp CEEEECSSEEEEEST--------TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred EecCCCCcceEEEEC--------CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence 458999999999763 35899986432 235678999999999853433 445555544333 358
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL------------------------------------- 270 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~------------------------------------- 270 (601)
+|||+++|.+|.+.... .++..+...++.+++..|..||+
T Consensus 93 ~vm~~i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 93 AGFTKIKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EEEECCCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EEEcccCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 99999999888754332 47888888999999999999996
Q ss_pred ---------------------cCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCCccccccccccccchhcc--
Q 007498 271 ---------------------QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-- 327 (601)
Q Consensus 271 ---------------------~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-- 327 (601)
..++|+|+++.||+++.+ ....+.|+||+.+.................-..|+...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHH
Confidence 136999999999999631 13457899999986543221111110000002232211
Q ss_pred -CCC------------CChhhHHHHHHHHHHHHhCCCCC
Q 007498 328 -RSY------------SLEADIWSIGVISYILLCGSRPF 353 (601)
Q Consensus 328 -~~~------------~~~~DvwSlG~il~ell~g~~pf 353 (601)
..| ....+.|++|.++|.+.+|..+|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12258999999999999999887
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.07 E-value=3.2e-10 Score=95.29 Aligned_cols=102 Identities=13% Similarity=0.131 Sum_probs=79.7
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc---h
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST---H 522 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~---~ 522 (601)
+..+++++ +.++|..+| ++|.|+++||..++... ......+..+|+.+|.+++|.|+.+||..++... .
T Consensus 4 g~~~~~~e---~~~~~~~~d--~~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g 75 (109)
T 1bu3_A 4 SGILADAD---VAAALKACE--AADSFNYKAFFAKVGLT---AKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGA 75 (109)
T ss_dssp SCSSCHHH---HHHHHHHTC--STTCCCHHHHHHHHTGG---GSCHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTC
T ss_pred cccCCHHH---HHHHHHHhC--CCCcCcHHHHHHHHHcC---hhhHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccC
Confidence 33455555 666777778 89999999999988542 2345668999999999999999999998766544 2
Q ss_pred hhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 523 QLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 523 ~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
.... ++.+..+|+.+|.|++|.|+.+||..++.
T Consensus 76 ~~~~----~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 108 (109)
T 1bu3_A 76 RALT----DAETKAFLKAGDSDGDGAIGVDEWAALVK 108 (109)
T ss_dssp CCCC----HHHHHHHHHHHCTTCSSEECHHHHHHHHT
T ss_pred CCCC----HHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 2222 56789999999999999999999998763
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.07 E-value=2.3e-10 Score=106.43 Aligned_cols=98 Identities=10% Similarity=0.118 Sum_probs=83.2
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHH
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 533 (601)
..++..+|..+|.|++|.|+.+||..++..... ....+.+..+|+.+|.|++|.|+.+||..++. ..... ++.
T Consensus 86 ~~~~~~~~~~~D~d~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~--~~~~~----~~~ 158 (191)
T 3khe_A 86 EAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQL-LLSRERLLAAFQQFDSDGSGKITNEELGRLFG--VTEVD----DET 158 (191)
T ss_dssp HHHHHHHHHHTCTTCSSSEEHHHHHHHHSCHHH-HCCHHHHHHHHHHHCTTCSSEECHHHHHHHTT--SSCCC----HHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhcc-cchHHHHHHHHHHHCCCCcCcCCHHHHHHHHc--cCCCC----HHH
Confidence 446888999999999999999999999876543 44566799999999999999999999998765 22222 567
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHh
Q 007498 534 ASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
+..+|+.+|.|++|.|+.+||..++
T Consensus 159 ~~~~~~~~D~~~dg~i~~~eF~~~~ 183 (191)
T 3khe_A 159 WHQVLQECDKNNDGEVDFEEFVEMM 183 (191)
T ss_dssp HHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 8999999999999999999999977
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=99.07 E-value=3.4e-10 Score=94.93 Aligned_cols=102 Identities=13% Similarity=0.181 Sum_probs=79.7
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcch---
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTH--- 522 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~--- 522 (601)
...+++++ +.++|..+| ++|.|+++||..++... ......+..+|+.+|.+++|.|+.+||..++....
T Consensus 3 ~~~~t~~e---~~~~~~~~d--~~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g 74 (108)
T 1rro_A 3 TDILSAED---IAAALQECQ--DPDTFEPQKFFQTSGLS---KMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDA 74 (108)
T ss_dssp GGTSCHHH---HHHHHHHTC--STTCCCHHHHHHHHSGG---GSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTS
T ss_pred cccCCHHH---HHHHHHHcc--CCCCcCHHHHHHHHhcC---cccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcc
Confidence 34556555 556677777 89999999999988532 23456689999999999999999999988665442
Q ss_pred hhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 523 QLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 523 ~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
.... ++.+..+|+.+|.|++|.|+.+||..++.
T Consensus 75 ~~~~----~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 107 (108)
T 1rro_A 75 RELT----ESETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp CCCC----HHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred CCCC----HHHHHHHHHHhCCCCCCcCcHHHHHHHHc
Confidence 1122 56789999999999999999999998763
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=99.07 E-value=4.5e-10 Score=100.09 Aligned_cols=106 Identities=15% Similarity=0.186 Sum_probs=82.9
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhh----hhhccHHHHHhhcccCCCCcccHHHHHHHhhc-
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDA----MRESRVPDVLSSMESLAYRKMYFEEFCAAAIS- 520 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~----~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~- 520 (601)
+..++..+ +..+|..+|.|++|.|+.+||..++....... .....+..+|+.+|.+++|.|+.+||..++..
T Consensus 41 ~~~~~~~~---~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~ 117 (153)
T 3ox6_A 41 GYMPTEME---LIELSQQINMNLGGHVDFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRAL 117 (153)
T ss_dssp TCCCCHHH---HHHHHHHHHTTSTTCCCHHHHHHHHHHHHTTCCHHHHCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred CCCCCHHH---HHHHHHHhCCCCCccCcHHHHHHHHHHHhhccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 33445444 66788889999999999999999986543211 12456889999999999999999999887654
Q ss_pred chhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 521 THQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 521 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
...... ++.+..+|+.+|.|++|.|+.+||..++
T Consensus 118 ~~~~~~----~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 151 (153)
T 3ox6_A 118 LGHQVG----HRDIEEIIRDVDLNGDGRVDFEEFVRMM 151 (153)
T ss_dssp HSSCCC----HHHHHHHHHHHCSSSSSSBCHHHHHHHT
T ss_pred hcCCCC----HHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 222223 5678999999999999999999999876
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=4.1e-10 Score=105.07 Aligned_cols=99 Identities=12% Similarity=0.130 Sum_probs=75.3
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchh------hhhhccHH----HHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATD------AMRESRVP----DVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~------~~~~~~~~----~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
++..+|..+|.|++|.|+++||..++...... ....+.++ .+|+.+|.|++|.|+.+||..++.......
T Consensus 67 ~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~ 146 (195)
T 1qv0_A 67 CVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISP 146 (195)
T ss_dssp HHHHHHHHTTCCTTCCBCHHHHHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCC
T ss_pred HHHHHHHHcCCCCCceEcHHHHHHHHHHHHhhhhhcccccHHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHhCCCC
Confidence 58889999999999999999999998765321 11112244 899999999999999999988765443222
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
. ++.+..+|+.+|.|++|.|+.+||..++
T Consensus 147 ~----~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 175 (195)
T 1qv0_A 147 S----QEDCEATFRHCDLDNAGDLDVDEMTRQH 175 (195)
T ss_dssp C----HHHHHHHHHHSCCCTTSCEEHHHHHHHH
T ss_pred C----HHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence 2 5678999999999999999999998866
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=99.05 E-value=4e-10 Score=104.76 Aligned_cols=99 Identities=10% Similarity=0.115 Sum_probs=79.3
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchhh------hhhccHH----HHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATDA------MRESRVP----DVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~------~~~~~~~----~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
.+..+|..+|.|++|.|+++||..++....... ...+.++ .+|+.+|.|++|.|+.+||..++.......
T Consensus 63 ~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~ 142 (191)
T 1uhk_A 63 AVEAFFGGAGMKYGVETDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQ 142 (191)
T ss_dssp HHHHHHHHTTCCTTCEEEHHHHHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCC
T ss_pred HHHHHHHHhCcCCCCcCcHHHHHHHHHHHhcchhhhhhhhhHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHhCCCC
Confidence 588899999999999999999999987653211 1122244 899999999999999999988765433222
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
. ++.+..+|+.+|.|++|.|+.+||..++
T Consensus 143 ~----~~~~~~~~~~~D~d~dG~i~~~eF~~~~ 171 (191)
T 1uhk_A 143 S----SEDCEETFRVCDIDESGQLDVDEMTRQH 171 (191)
T ss_dssp S----HHHHHHHHHHSCCCTTSCEEHHHHHHHH
T ss_pred C----HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 2 5678999999999999999999999876
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=99.05 E-value=4.9e-10 Score=104.56 Aligned_cols=102 Identities=5% Similarity=0.039 Sum_probs=81.5
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc--hhhhhhhhHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST--HQLEALEGWEQ 532 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~--~~~~~~~~~~~ 532 (601)
.++..+|..+|.|++|.|+++||..++.... ....+.+..+|+.+|.|++|.|+.+||..++... ......+ ..+
T Consensus 87 ~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~--~~~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~l~~~-~~~ 163 (191)
T 3k21_A 87 YNFDLLLDQIDSDGSGKIDYTEFIAAALDRK--QLSKKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQR-DVN 163 (191)
T ss_dssp TTHHHHHHHHCTTCSSSEEHHHHHHHHSCGG--GCCHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSCCCHH-HHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHhhh--hccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCCCCHh-HHH
Confidence 4577889999999999999999999986543 2445678899999999999999999998876431 1111111 134
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 533 IASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 533 ~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
.+..+|+.+|.|+||.|+.+||..++.
T Consensus 164 ~~~~~~~~~D~d~dG~Is~~EF~~~~~ 190 (191)
T 3k21_A 164 RVKRMIRDVDKNNDGKIDFHEFSEMMK 190 (191)
T ss_dssp HHHHHHHHHCSSSSSSBCHHHHHHHHC
T ss_pred HHHHHHHHhcCCCCCeECHHHHHHHHc
Confidence 689999999999999999999999874
|
| >2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.3e-11 Score=106.36 Aligned_cols=100 Identities=13% Similarity=0.099 Sum_probs=48.9
Q ss_pred HhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHH-----HhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHH
Q 007498 481 LGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCA-----AAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELA 555 (601)
Q Consensus 481 l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~-----~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~ 555 (601)
|+.+|. .++..++..++..+ +|.|+|+||+. ++.... .... ..+.++.+|++|| |+|+.+||+
T Consensus 2 lr~lG~-~~t~~ei~~~~~~~----~g~i~f~EF~~~~~~~~~~~~~-~~~~--~~~~l~~aF~~fD----G~I~~~El~ 69 (123)
T 2kld_A 2 STAIGI-NDTYSEVKSDLAQQ----KAEMELSDLIRKGYHKALVKLK-LKKN--TVDDISESLRQGG----GKLNFDELR 69 (123)
T ss_dssp ---------------------------------------------------------CCSCSSTTTT----TCEEHHHHH
T ss_pred hhhcCC-CCCHHHHHHHHHHc----CCCccHHHHHhHhHHHHHHHhh-cChh--HHHHHHHHHHHhC----CCCCHHHHH
Confidence 566665 57788899888876 79999999988 433221 1111 1355788999999 999999999
Q ss_pred HHhcCC---c-cHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 556 RELNVG---P-SAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 556 ~~l~~~---~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+|... . +++.++..+|.|+||.|+|+||+.+|....
T Consensus 70 ~~l~~lG~t~~ei~~~~~~~D~d~dG~I~~~EF~~~~~~~~ 110 (123)
T 2kld_A 70 QDLKGKGHTDAEIEAIFTKYDQDGDQELTEHEHQQMRDDLE 110 (123)
T ss_dssp HHTTTCCSSHHHHHHHHHHHSSSSCCEECSHHHHHCSCTTT
T ss_pred HHHHHhCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHH
Confidence 999322 2 299999999999999999999999997764
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=5.8e-10 Score=103.10 Aligned_cols=104 Identities=12% Similarity=0.123 Sum_probs=80.6
Q ss_pred HHHHhhCCCCCCc-ccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh-----hhhhhhHHH
Q 007498 459 AQFRLLEPNKDGS-VSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ-----LEALEGWEQ 532 (601)
Q Consensus 459 ~~F~~~D~d~~G~-I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-----~~~~~~~~~ 532 (601)
++|..+|.|++|. |+++||..++............+..+|+.+|.|++|.|+.+||..++..... ....+..++
T Consensus 64 ~l~~~~D~d~~G~~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~ 143 (183)
T 1dgu_A 64 RICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQ 143 (183)
T ss_dssp HHHHHHSCSSSSCCCCHHHHHHHHHHHSTTCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHH
T ss_pred HHHHHhCCCCCCCEecHHHHHHHHHHhcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHH
Confidence 4677789999999 9999999999876532333557999999999999999999999887654432 223222233
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHhcCCc
Q 007498 533 IASTAFEYFEEEGNRVISIEELARELNVGP 562 (601)
Q Consensus 533 ~~~~~F~~~D~d~~G~I~~~El~~~l~~~~ 562 (601)
.+..+|+.+|.|++|.|+.+||..++...+
T Consensus 144 ~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~ 173 (183)
T 1dgu_A 144 LIDNILEESDIDRDGTINLSEFQHVISRSP 173 (183)
T ss_dssp HHHHHHHHHCTTSSSEEEHHHHHHHHCSSC
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHHHHHhCh
Confidence 344699999999999999999999885443
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.2e-09 Score=100.71 Aligned_cols=94 Identities=9% Similarity=0.064 Sum_probs=79.9
Q ss_pred hccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC-----ccHH
Q 007498 491 ESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG-----PSAY 565 (601)
Q Consensus 491 ~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~-----~~~~ 565 (601)
..++..+|+.+|.|++|.|+++||..++..... . ...+..+|+.+|.|++|.|+.+||..++... ..+.
T Consensus 38 ~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~--~----~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~ 111 (180)
T 3mse_B 38 IKYINELFYKLDTNHNGSLSHREIYTVLASVGI--K----KWDINRILQALDINDRGNITYTEFMAGCYRWKNIESTFLK 111 (180)
T ss_dssp HHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--C----HHHHHHHHHHHCTTCCSEECHHHHHHHHSCCTTC--CHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCC--C----HHHHHHHHHHhCCCCCCcCcHHHHHHHHHhcccCCHHHHH
Confidence 456889999999999999999999887654332 1 3568899999999999999999999988322 1289
Q ss_pred HHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 566 SFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 566 ~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
.+|+.+|.|+||.|+.+||..++.+
T Consensus 112 ~~F~~~D~d~~G~I~~~El~~~l~~ 136 (180)
T 3mse_B 112 AAFNKIDKDEDGYISKSDIVSLVHD 136 (180)
T ss_dssp HHHHHHCTTCSSCBCHHHHHHHTTT
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHcC
Confidence 9999999999999999999999984
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=99.03 E-value=3.9e-10 Score=101.20 Aligned_cols=108 Identities=7% Similarity=0.037 Sum_probs=85.1
Q ss_pred HHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchh-hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 443 KALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATD-AMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 443 ~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
..++..++..+ +..+ ..+|.|++|.|+++||..++...... ......+..+|+.+|.+++|.|+.+||..++...
T Consensus 38 ~~~g~~~~~~~---~~~l-~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~ 113 (156)
T 1wdc_C 38 RCLGINPRNED---VFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHVLTAL 113 (156)
T ss_dssp HHTTCCCCHHH---HHHT-TCCSSTTSCEECHHHHHHHHHHHTTSCCCCHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHS
T ss_pred HHcCCCCCHHH---HHHH-HhhCCCCCCeeeHHHHHHHHHHHhhccCChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHc
Confidence 33444556555 4445 77899999999999999999876431 2345668999999999999999999998876544
Q ss_pred hhhhhhhhHHHHHHHHHHH--HcccCCCcccHHHHHHHh
Q 007498 522 HQLEALEGWEQIASTAFEY--FEEEGNRVISIEELAREL 558 (601)
Q Consensus 522 ~~~~~~~~~~~~~~~~F~~--~D~d~~G~I~~~El~~~l 558 (601)
..... ++.+..+|+. +|.|++|.|+.+||..++
T Consensus 114 g~~~~----~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 148 (156)
T 1wdc_C 114 GERLS----DEDVDEIIKLTDLQEDLEGNVKYEDFVKKV 148 (156)
T ss_dssp SSCCC----HHHHHHHHHHHTCCCCTTSEEEHHHHHHHH
T ss_pred CCCCC----HHHHHHHHHHhCCCCCCCCcEeHHHHHHHH
Confidence 33233 5678999999 999999999999999987
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.03 E-value=3.3e-10 Score=95.19 Aligned_cols=62 Identities=13% Similarity=0.113 Sum_probs=55.1
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhc---CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELN---VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~---~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.++++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+++.+|.|+||.|+|+||+.+|+...
T Consensus 21 ~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~gl~~~el~~i~~~~D~d~dG~I~~~EF~~~m~~~~ 86 (110)
T 1iq3_A 21 REYYVNQFRSLQPDPSSFISGSVAKNFFTKSKLSIPELSYIWELSDADCDGALTLPEFCAAFHLIV 86 (110)
T ss_dssp HHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSSCSSCCHHHHHHHHCSSSCSEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHH
Confidence 56789999999999999999999999993 3332 99999999999999999999999997764
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=3e-10 Score=92.37 Aligned_cols=62 Identities=18% Similarity=0.345 Sum_probs=53.3
Q ss_pred HHHHHHHHHHHc-ccCC-CcccHHHHHHHhc--CC--------c-cHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFE-EEGN-RVISIEELARELN--VG--------P-SAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D-~d~~-G~I~~~El~~~l~--~~--------~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+.++.+|+.|| +||+ |+|+.+||+.+|. +. . +++.+|+.+|.|+||.|+|+||+.+|.++.
T Consensus 9 ~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~~~~~~ 83 (93)
T 4eto_A 9 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIA 83 (93)
T ss_dssp HHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHH
Confidence 567899999998 6885 8999999999984 21 1 299999999999999999999999998753
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.02 E-value=3e-10 Score=94.17 Aligned_cols=61 Identities=20% Similarity=0.406 Sum_probs=52.9
Q ss_pred HHHHHHHHHHHc-ccCC-CcccHHHHHHHhc--C----C----c-cHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFE-EEGN-RVISIEELARELN--V----G----P-SAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D-~d~~-G~I~~~El~~~l~--~----~----~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.|| +||+ |+|+.+||+.+|. + . . +++.+|+.+|.|+||.|+|+||+.+|.++
T Consensus 12 ~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~m~~~ 85 (104)
T 3zwh_A 12 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSSI 85 (104)
T ss_dssp HHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 567899999998 7886 8999999999984 2 1 2 29999999999999999999999999765
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=99.02 E-value=4.3e-10 Score=90.97 Aligned_cols=75 Identities=15% Similarity=0.306 Sum_probs=67.8
Q ss_pred HhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 444 ALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 444 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
.+...++++++.+++++|..||.|++|+|+.+||..+++.++. ..+..++..+++.+|.+++|.|+|+||+.++.
T Consensus 9 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~D~~~dg~i~~~eF~~~~~ 83 (90)
T 1avs_A 9 EARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDEDGSGTIDFEEFLVMMV 83 (90)
T ss_dssp SHHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHH
T ss_pred HHHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 4556789999999999999999999999999999999999885 56778899999999999999999999988654
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.02 E-value=5e-10 Score=104.26 Aligned_cols=97 Identities=8% Similarity=0.057 Sum_probs=81.8
Q ss_pred hccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC------ccH
Q 007498 491 ESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG------PSA 564 (601)
Q Consensus 491 ~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~------~~~ 564 (601)
..++..+|+.+|.|++|.|+++||..++........ ++.+..+|+.+|.|++|.|+.+||..++... ..+
T Consensus 9 ~~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~----~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~~l 84 (188)
T 1s6i_A 9 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELM----ESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLEREENL 84 (188)
T ss_dssp TCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCC----HHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCCCST
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCC----HHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHhccCHHHHH
Confidence 456889999999999999999999887655433223 5678899999999999999999999987321 128
Q ss_pred HHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 565 YSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 565 ~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
..+|..+|.|+||.|+.+||..++...
T Consensus 85 ~~~F~~~D~d~dG~Is~~El~~~l~~~ 111 (188)
T 1s6i_A 85 VSAFSYFDKDGSGYITLDEIQQACKDF 111 (188)
T ss_dssp HHHHHHTTTTCSSEEEHHHHHHTTTTT
T ss_pred HHHHHHHCCCCCCcCcHHHHHHHHHHc
Confidence 999999999999999999999998764
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=99.02 E-value=6.3e-10 Score=105.22 Aligned_cols=93 Identities=10% Similarity=0.008 Sum_probs=74.5
Q ss_pred HHHhhCCCCCCcccHHHHHHHHh---------hcchhhh-hhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhh
Q 007498 460 QFRLLEPNKDGSVSLENFRMVLG---------RNATDAM-RESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEG 529 (601)
Q Consensus 460 ~F~~~D~d~~G~I~~~el~~~l~---------~~~~~~~-~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~ 529 (601)
+|..+|.|++|.|+++||..++. .+..... ..+.+..+|+.+|.|++|.|+.+||..++.... ..
T Consensus 86 lf~~~D~d~dg~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g--~~--- 160 (208)
T 2hpk_A 86 FFLHKGVEPVNGLLREDWVEANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAFD--VP--- 160 (208)
T ss_dssp HHHHTTCBTTTBEEGGGHHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTT--SC---
T ss_pred HHHHhCCCCCCeEcHHHHHHHHHHHhhhhhhhhccCChHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC--cC---
Confidence 44999999999999999999986 2221111 122278899999999999999999988765443 22
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 530 WEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 530 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
++.+..+|+.+|.|+||.|+.+||..++
T Consensus 161 -~~~~~~~~~~~D~d~dG~I~~~EF~~~~ 188 (208)
T 2hpk_A 161 -QEAAYTFFEKADTDKSGKLERTELVHLF 188 (208)
T ss_dssp -TTHHHHHHHHHCTTCCSSBCHHHHHHHH
T ss_pred -HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 4567899999999999999999999977
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=99.01 E-value=5.1e-10 Score=90.86 Aligned_cols=89 Identities=13% Similarity=0.221 Sum_probs=70.7
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALE 528 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~ 528 (601)
.+.++.++++++|..||.|++|+|+.+||..++..++. ..+..++..+++.+|.+++|.|+|+||+.++..........
T Consensus 3 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~~~dg~i~~~eF~~~~~~~~~~~~~~ 81 (92)
T 2kn2_A 3 MDTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGE-KLTDEEVEQMIKEADLDGDGQVNYEEFVKMMMTVRGGGGGN 81 (92)
T ss_dssp CCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSSCCSSEEHHHHHHHHHHHTTTCCCH
T ss_pred CCccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhccCCCCCc
Confidence 45677889999999999999999999999999999885 56778899999999999999999999998765433221100
Q ss_pred hHHHHHHHHHH
Q 007498 529 GWEQIASTAFE 539 (601)
Q Consensus 529 ~~~~~~~~~F~ 539 (601)
..++++.+|+
T Consensus 82 -~~~~l~~aF~ 91 (92)
T 2kn2_A 82 -GWSRLRRKFS 91 (92)
T ss_dssp -HHHHHHHHHT
T ss_pred -hHHHHHHHhc
Confidence 1345666664
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.01 E-value=5.8e-11 Score=95.42 Aligned_cols=80 Identities=11% Similarity=0.081 Sum_probs=60.5
Q ss_pred CCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC-----cc-HHHHHHHHhcCCCC
Q 007498 504 LAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG-----PS-AYSFLKDWIRNSDG 577 (601)
Q Consensus 504 ~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~-----~~-~~~~~~~~d~~~dG 577 (601)
|++|.|+|+|++. ... ..... .+.++.+|+.||+|++|+|+.+||+.+|... .+ ++.+|..+|.|+||
T Consensus 1 ~~~G~i~~~e~~~--~~~--l~~~~--~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g 74 (87)
T 1s6j_A 1 HSSGHIDDDDKHM--AER--LSEEE--IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSG 74 (87)
T ss_dssp CCSSSSSSHHHHS--SSS--SCSSS--TTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSS
T ss_pred CCCCccCccHHHH--HHH--CCHHH--HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCC
Confidence 4689999999432 111 11111 2347889999999999999999999998322 22 89999999999999
Q ss_pred ceeHHHHHHHHh
Q 007498 578 KLSLHGYTKFLH 589 (601)
Q Consensus 578 ~is~~EF~~~~~ 589 (601)
.|+|+||+.++.
T Consensus 75 ~i~~~eF~~~~~ 86 (87)
T 1s6j_A 75 TIDYGEFIAATV 86 (87)
T ss_dssp EECHHHHTTCCC
T ss_pred cCcHHHHHHHHh
Confidence 999999987653
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.01 E-value=3.5e-10 Score=91.95 Aligned_cols=62 Identities=16% Similarity=0.097 Sum_probs=54.9
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+.++.+|+.||+|++|+|+.+||+.+| ++..+ ++.++..+|.|+||.|+|+||+.+|+...
T Consensus 8 ~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~~~ 73 (92)
T 1fi6_A 8 RQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSKLPILELSHIWELSDFDKDGALTLDEFCAAFHLVV 73 (92)
T ss_dssp HHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHSSCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
Confidence 4568899999999999999999999998 44433 99999999999999999999999997653
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=99.00 E-value=4.6e-10 Score=87.70 Aligned_cols=70 Identities=14% Similarity=0.365 Sum_probs=63.7
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
++++++++++++|..||.|++|.|+.+||..+++.++. ..+..++..+++.+|.+++|.|+|+||+.++.
T Consensus 1 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 70 (77)
T 2joj_A 1 LSEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGF-DVKKPEILELMNEYDREGNGYIGFDDFLDIMT 70 (77)
T ss_dssp CCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTC-CCHHHHHHHHHHHHCCSSSSEEEHHHHHHHHT
T ss_pred CCHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCC-CCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHH
Confidence 46788999999999999999999999999999999875 56778899999999999999999999988654
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=3.6e-10 Score=92.52 Aligned_cols=62 Identities=13% Similarity=0.079 Sum_probs=54.8
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+.++.+|+.||+|++|+|+.+||+.+| ++..+ ++.+++.+|.|+||.|+|+||+.+|+...
T Consensus 9 ~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~~~ 74 (95)
T 1c07_A 9 KAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLIS 74 (95)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHCTTCSSSEETTTHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHH
Confidence 5678999999999999999999999998 33333 99999999999999999999999997654
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.98 E-value=3e-10 Score=93.58 Aligned_cols=61 Identities=13% Similarity=0.013 Sum_probs=54.1
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.||+|++|+|+.+|++.+| ++..+ ++.+++.+|.|+||.|+|+||+.+|+..
T Consensus 10 ~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~l~~~~l~~i~~~~D~d~dG~i~~~EF~~~~~~~ 74 (99)
T 1qjt_A 10 NPVYEKYYRQVEAGNTGRVLALDAAAFLKKSGLPDLILGKIWDLADTDGKGVLSKQEFFVALRLV 74 (99)
T ss_dssp CTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSSSCHHHHHHHHHHHCCSSSSSCCSHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH
Confidence 3568899999999999999999999999 33333 9999999999999999999999999765
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.4e-09 Score=98.66 Aligned_cols=97 Identities=8% Similarity=0.066 Sum_probs=80.5
Q ss_pred hccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCc------cH
Q 007498 491 ESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGP------SA 564 (601)
Q Consensus 491 ~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~------~~ 564 (601)
...+..+|..+|.+++|.|+++||..++........ +..+..+|+.+|.|++|.|+.+||..++.... .+
T Consensus 26 ~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~----~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~ 101 (166)
T 2aao_A 26 IAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLK----ESEILDLMQAADVDNSGTIDYKEFIAATLHLNKIEREDHL 101 (166)
T ss_dssp HHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCC----HHHHHHHHHHHCTTCCSSBCHHHHHHHHTTCHHHHTTHHH
T ss_pred HHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCC----HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhcccHHHH
Confidence 345778999999999999999999887655433223 45688999999999999999999999884321 28
Q ss_pred HHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 565 YSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 565 ~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
..+|..+|.|++|.|+.+||..++...
T Consensus 102 ~~~F~~~D~d~~G~i~~~e~~~~l~~~ 128 (166)
T 2aao_A 102 FAAFTYFDKDGSGYITPDELQQACEEF 128 (166)
T ss_dssp HHHHHHHCTTCSSSBCHHHHHHHTCC-
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHHHHc
Confidence 899999999999999999999998764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=98.98 E-value=2.2e-09 Score=116.05 Aligned_cols=167 Identities=11% Similarity=0.085 Sum_probs=109.7
Q ss_pred hHHHHHHHHhhhccCchhHHHHHHhhhh---------cc---hHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhh
Q 007498 421 DILIFKLVKSYLHATPFKRAALKALSKA---------LT---EDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDA 488 (601)
Q Consensus 421 ~~~~~~~~k~~~~~~~l~~~~~~~~~~~---------l~---~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~ 488 (601)
...+..+++.++..++..|....++-.. .. ...+......+..|. ...++....+..+...+.. .
T Consensus 275 s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~kl~~a~l~~i~~~~~~-~ 351 (504)
T 3q5i_A 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFE--GSQKLAQAAILFIGSKLTT-L 351 (504)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCC--CCSHHHHHHHHHHHHHTSC-H
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHH--HHHHHHHHHHHHhhccCCc-H
Confidence 3445666777777777666665554321 11 111122222223332 2344444444444433322 2
Q ss_pred hhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh----hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC---
Q 007498 489 MRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE----ALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG--- 561 (601)
Q Consensus 489 ~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~----~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~--- 561 (601)
....+++.+|+.+|.|++|.|+++||..++....... .....++.+..+|+.+|.|+||.|+.+||..++...
T Consensus 352 ~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~~ 431 (504)
T 3q5i_A 352 EERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFISVCMDKQIL 431 (504)
T ss_dssp HHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHH
T ss_pred HHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhhhcc
Confidence 3345688999999999999999999987654432210 001126778999999999999999999999988422
Q ss_pred --c-cHHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 562 --P-SAYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 562 --~-~~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
. .+..+|+.+|.|+||.|+.+||..++..
T Consensus 432 ~~~~~~~~~F~~~D~d~dG~Is~~El~~~l~~ 463 (504)
T 3q5i_A 432 FSEERLRRAFNLFDTDKSGKITKEELANLFGL 463 (504)
T ss_dssp TCHHHHHHHHHHHCTTCCSEECHHHHHHHTTC
T ss_pred cCHHHHHHHHHHhcCCCCCcCcHHHHHHHHhh
Confidence 2 2899999999999999999999999865
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.97 E-value=5.3e-10 Score=90.90 Aligned_cols=68 Identities=16% Similarity=0.313 Sum_probs=61.3
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
++++++++++++|..||.|++|+|+.+|+..+++.++ .+.+++..+++.+|.|++|.|+|+||+.++.
T Consensus 3 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g---~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~ 70 (92)
T 1fi6_A 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK---LPILELSHIWELSDFDKDGALTLDEFCAAFH 70 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS---SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC---CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 5678899999999999999999999999999999876 3466799999999999999999999988654
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=98.97 E-value=4.4e-10 Score=92.56 Aligned_cols=70 Identities=14% Similarity=0.204 Sum_probs=59.9
Q ss_pred hHHHHHHHHHHHhhC-CCCC-CcccHHHHHHHHhh-cc---hhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLLE-PNKD-GSVSLENFRMVLGR-NA---TDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D-~d~~-G~I~~~el~~~l~~-~~---~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..+.+|+++|..|| .|++ |+|+.+||..+++. ++ ....++++++.+++.+|.|+||.|+|+||+.++..
T Consensus 6 e~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~~~ 81 (101)
T 3nso_A 6 EQAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLAC 81 (101)
T ss_dssp HHHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 467889999999997 8887 99999999999986 42 13566788999999999999999999999876543
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=98.97 E-value=7.4e-10 Score=93.15 Aligned_cols=61 Identities=18% Similarity=0.389 Sum_probs=53.6
Q ss_pred HHHHHHHHHHHc-ccCCC-cccHHHHHHHhc------C----Cc-cHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFE-EEGNR-VISIEELARELN------V----GP-SAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D-~d~~G-~I~~~El~~~l~------~----~~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|++|| +|++| +|+.+||+.+|. + .. +++.+|+.+|.|+||.|+|+||+.+|.+.
T Consensus 21 ~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~Idf~EF~~~m~~~ 94 (113)
T 2lnk_A 21 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCI 94 (113)
T ss_dssp HHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHH
Confidence 567899999999 89997 999999999983 1 22 29999999999999999999999998764
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=98.96 E-value=2.8e-10 Score=105.47 Aligned_cols=94 Identities=12% Similarity=0.038 Sum_probs=73.4
Q ss_pred HHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHH--hhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHH
Q 007498 459 AQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVL--SSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIAST 536 (601)
Q Consensus 459 ~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~--~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~ 536 (601)
++|..+|.|++|.|+++| .++...........++...+ ..+|.+++|.|+++||..++........ ++.+..
T Consensus 69 ~~f~~~D~d~dg~I~~~E--~~~~~~~~~~~~~~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~----~~~~~~ 142 (186)
T 2hps_A 69 GLAPGVRISVEEAAVNAT--DSLLKMKGEEKAMAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLT----DDKAIT 142 (186)
T ss_dssp TCCTTCEEEHHHHHHHHH--HHHHHCCTHHHHHTTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCC----HHHHHH
T ss_pred HHHHhcCCCCCCcccHHH--HHHHHhcCChHHHHHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCC----HHHHHH
Confidence 568999999999999999 66665543223334444444 7779999999999999987654432223 667899
Q ss_pred HHHHHcccCCCcccHHHHHHHh
Q 007498 537 AFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 537 ~F~~~D~d~~G~I~~~El~~~l 558 (601)
+|+.+|.|++|.|+.+||..++
T Consensus 143 ~~~~~D~d~dG~i~~~ef~~~~ 164 (186)
T 2hps_A 143 CFNTLDFNKNGQISRDEFLVTV 164 (186)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHH
T ss_pred HHHHHcCCCCCcCcHHHHHHHH
Confidence 9999999999999999999977
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.3e-09 Score=96.21 Aligned_cols=106 Identities=14% Similarity=0.155 Sum_probs=82.1
Q ss_pred HHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcc-hhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 443 KALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNA-TDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 443 ~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~-~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
..++..++..+ +..+|.. |++|.|+.+||..++.... ........+..+|+.+|.+++|.|+.+||..++...
T Consensus 32 ~~~~~~~~~~~---~~~~~~~---~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~ 105 (145)
T 2bl0_B 32 RSLGKNPTNAE---LNTIKGQ---LNAKEFDLATFKTVYRKPIKTPTEQSKEMLDAFRALDKEGNGTIQEAELRQLLLNL 105 (145)
T ss_dssp HHTTCCCCHHH---HHHHHHH---HTSSEECHHHHHHHHTSCCCCGGGGHHHHHHHHHHHCSSSSSEEEHHHHHHHHHHS
T ss_pred HHhCCCCCHHH---HHHHHHh---cCCCeEcHHHHHHHHHHHhhcCcccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHc
Confidence 33444455555 4445554 8899999999999998753 233456678999999999999999999998876544
Q ss_pred hhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 522 HQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 522 ~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
..... ++.+..+|+.+|.|++|.|+.+||..++
T Consensus 106 g~~~~----~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 138 (145)
T 2bl0_B 106 GDALT----SSEVEELMKEVSVSGDGAINYESFVDML 138 (145)
T ss_dssp SSCCC----HHHHHHHHTTCCCCTTSEEEHHHHHHHH
T ss_pred CCCCC----HHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence 32223 5678999999999999999999999987
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.96 E-value=6.6e-10 Score=90.15 Aligned_cols=75 Identities=21% Similarity=0.316 Sum_probs=63.4
Q ss_pred HHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 442 LKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 442 ~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
.......++++++++++++|..||.|++|+|+.+||..+++.++ .+..+++.+++.+|.+++|.|+|+||+.++.
T Consensus 14 ~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g---~~~~~~~~~~~~~D~d~dg~I~~~EF~~~~~ 88 (91)
T 2pmy_A 14 LYFQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR---VRPADAEAVFQRLDADRDGAITFQEFARGFL 88 (91)
T ss_dssp -----CHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT---CCHHHHHHHHHHHCTTCSSEECHHHHTHHHH
T ss_pred HHHHhccCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC---cCHHHHHHHHHHhCCCCCCCEeHHHHHHHHH
Confidence 33445667889999999999999999999999999999999887 3566799999999999999999999987653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=1.2e-09 Score=117.50 Aligned_cols=98 Identities=11% Similarity=0.123 Sum_probs=84.2
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHH
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 533 (601)
..++.++|..+|.|++|.|+++||..++..... ....+++..+|+.+|.|++|.|+++||..++.. .... +++
T Consensus 381 ~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~--~~~~----~~~ 453 (484)
T 3nyv_A 381 EHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKT-LLSRERLERAFRMFDSDNSGKISSTELATIFGV--SDVD----SET 453 (484)
T ss_dssp HHHHHHHHHHHTCCTTSEEEHHHHHHHHHHHHH-HHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH--TTCC----HHH
T ss_pred HHHHHHHHHHhCCCCCCeEeHHHHHHHHHhccc-cCcHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCC----HHH
Confidence 467889999999999999999999999877653 456678999999999999999999999886643 1112 567
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHh
Q 007498 534 ASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
+..+|+.+|.|+||.|+.+||..++
T Consensus 454 ~~~~~~~~D~d~dG~i~~~Ef~~~~ 478 (484)
T 3nyv_A 454 WKSVLSEVDKNNDGEVDFDEFQQML 478 (484)
T ss_dssp HHHHHHHHCTTCCSEEEHHHHHHHH
T ss_pred HHHHHHHhcCCCCCcCCHHHHHHHH
Confidence 8999999999999999999999987
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=7e-10 Score=94.29 Aligned_cols=61 Identities=20% Similarity=0.376 Sum_probs=52.9
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhcC----------Cc-cHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELNV----------GP-SAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~----------~~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
-+.+..+|..||.| +|+|+.+||+.+|.- .. +++.+|+.+|.|+||.|+|+||+.+|.++.
T Consensus 14 ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm~~l~ 85 (121)
T 4drw_A 14 METMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLT 85 (121)
T ss_dssp HHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHH
Confidence 45688999999988 899999999999842 11 299999999999999999999999998763
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=98.95 E-value=1e-09 Score=91.41 Aligned_cols=70 Identities=11% Similarity=0.172 Sum_probs=58.7
Q ss_pred hHHHHHHHHHHHhhC-CCCC-CcccHHHHHHHHhh-cchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLLE-PNKD-GSVSLENFRMVLGR-NATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D-~d~~-G~I~~~el~~~l~~-~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
++++++++++|..|| .|++ |+|+.+||..+++. ++....+..+++.+++.+|.|+||.|+|+||+.++..
T Consensus 18 e~~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d~dG~Idf~EF~~~~~~ 90 (106)
T 2h2k_A 18 EESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGE 90 (106)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH
Confidence 356789999999999 7986 79999999999986 5532233578999999999999999999999987653
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=98.95 E-value=7.3e-10 Score=88.73 Aligned_cols=72 Identities=10% Similarity=0.032 Sum_probs=64.9
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhcc---HHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESR---VPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~---~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
...++++++.+++++|..||.|++|+|+.+||..+++.++. ..+..+ +..+++.+|.+++|.|+| ||+.++.
T Consensus 5 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~~~~d~~~~g~i~~-eF~~~~~ 79 (86)
T 1j7q_A 5 ARALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQ-TYTKRETEAIMKEARGPKGDKKNIGPE-EWLTLCS 79 (86)
T ss_dssp CCCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSC-CCSHHHHHHHHHHHHCSSCSSCCBCTT-HHHHHHH
T ss_pred cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcC-CCCHHHHHHHHHHHHHhCCCCCCcCCH-HHHHHHH
Confidence 45578889999999999999999999999999999999985 567778 999999999999999999 9988654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=3.5e-09 Score=114.13 Aligned_cols=101 Identities=12% Similarity=0.103 Sum_probs=79.9
Q ss_pred hhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh----hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC----
Q 007498 490 RESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE----ALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG---- 561 (601)
Q Consensus 490 ~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~----~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~---- 561 (601)
...+++.+|+.+|.|++|.|+++||..++....... .....++.+..+|+.+|.|++|.|+.+||..++...
T Consensus 344 ~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~EF~~~~~~~~~~~ 423 (494)
T 3lij_A 344 ETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLL 423 (494)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHT
T ss_pred HHHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhhccc
Confidence 345689999999999999999999987554332100 001126678999999999999999999999987321
Q ss_pred -cc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 562 -PS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 562 -~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
.+ +..+|+.+|.|+||.|+++||..++..
T Consensus 424 ~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~ 454 (494)
T 3lij_A 424 SKDKLESAFQKFDQDGNGKISVDELASVFGL 454 (494)
T ss_dssp CHHHHHHHHHHHCTTCSSEECHHHHHHHC-C
T ss_pred cHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh
Confidence 22 889999999999999999999998864
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.95 E-value=5.6e-10 Score=91.34 Aligned_cols=68 Identities=16% Similarity=0.170 Sum_probs=61.3
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
++++++++++++|..||.|++|+|+.+|+..+++.++ .+.++++.+++.+|.|++|.|+|+||+.++.
T Consensus 4 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g---~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~ 71 (95)
T 1c07_A 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG---LPSTLLAHIWSLCDTKDCGKLSKDQFALAFH 71 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT---CCHHHHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC---CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHH
Confidence 5678899999999999999999999999999999875 3467799999999999999999999987654
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=98.95 E-value=1.1e-09 Score=91.18 Aligned_cols=61 Identities=21% Similarity=0.309 Sum_probs=53.2
Q ss_pred HHHHHHHHHHHc-ccCC-CcccHHHHHHHhc--C----C--ccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFE-EEGN-RVISIEELARELN--V----G--PSAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D-~d~~-G~I~~~El~~~l~--~----~--~~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.|| +|++ |+|+.+||+.+|. + . .+++.+|+.+|.|+||.|+|+||+.+|...
T Consensus 21 ~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d~dG~Idf~EF~~~~~~~ 91 (106)
T 2h2k_A 21 IETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGEL 91 (106)
T ss_dssp HHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHH
Confidence 567899999999 7997 7999999999982 1 1 239999999999999999999999998764
|
| >3qr0_A Phospholipase C-beta (PLC-beta); PH domain, EF hand, C2 domain, TIM barrel domain, hydrolase, calcium binding, phospholipid binding; 2.00A {Sepia officinalis} PDB: 3qr1_A | Back alignment and structure |
|---|
Probab=98.94 E-value=1.5e-09 Score=121.13 Aligned_cols=118 Identities=13% Similarity=0.274 Sum_probs=95.2
Q ss_pred hhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhc-------ccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHH
Q 007498 463 LLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSM-------ESLAYRKMYFEEFCAAAISTHQLEALEGWEQIAS 535 (601)
Q Consensus 463 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~-------D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~ 535 (601)
.||.|+||.|+.+|+..+++..+. ...++..+++.. |.+++|.|+|+||..++..... ..+++
T Consensus 163 ~fd~n~dG~Is~kEl~~~l~~~~~---~~~el~~~~~~~~~~~~k~D~~~~g~L~FeEF~~f~~~L~~-------R~EI~ 232 (816)
T 3qr0_A 163 TTVEMEKNKIPVKAIQKCLSKDKD---DRARISKALEKIGWPSGKNDAIDLKAFDFDTFFKFYLALLE-------RSEIE 232 (816)
T ss_dssp HHTSCCSSEEEHHHHHHHHCSCHH---HHHHHHHHHHHHTSCCSTTCEEETTTCCHHHHHHHHHHHCC-------CTHHH
T ss_pred hccCCCCCCCCHHHHHHHHHhcCC---hHHHHHHHHHHhcccccccccCCCCcCCHHHHHHHHHhcCC-------HHHHH
Confidence 379999999999999999986542 134577888877 6778899999999987654321 34689
Q ss_pred HHHHHHcccCCCcccHHHHHHHhc----C-----------Ccc-HHHHHHHHhc--C----CCCceeHHHHHHHHhhc
Q 007498 536 TAFEYFEEEGNRVISIEELARELN----V-----------GPS-AYSFLKDWIR--N----SDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 536 ~~F~~~D~d~~G~I~~~El~~~l~----~-----------~~~-~~~~~~~~d~--~----~dG~is~~EF~~~~~~~ 591 (601)
.+|+.||.|++|+|+. ||+.+|. . ..+ ++.+++.++. | ++|.|++++|..+|...
T Consensus 233 eiF~~y~~dg~~~mT~-eL~~FL~~~Q~E~~~~~~~~~~~t~e~~~~iI~kye~~~~~~~~~~g~LsldgF~~yL~S~ 309 (816)
T 3qr0_A 233 GIFKELSKNKGNITTV-MFRDFLNDMQRHPSLHKTLFPLYTDAQCEALINDYESAVNKKGKKKGQLTKEGLLYFLMCE 309 (816)
T ss_dssp HHHHHHTTTSSSEEHH-HHHHHHHHTSSCTTSCTTTSCCCCHHHHHHHHHHHHHHHHGGGCBTTEECHHHHHHHHHSG
T ss_pred HHHHHHccCCCCcccH-HHHHHHHHhCCccccccccccccCHHHHHHHHHHhccccchhhhccCCccHHHHHHHhhcc
Confidence 9999999999999999 9999991 1 122 8889998887 5 78999999999999753
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=98.94 E-value=1.7e-09 Score=112.74 Aligned_cols=101 Identities=10% Similarity=0.208 Sum_probs=81.6
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
++++.+|..+|.|++|.|+++||..++..........+.+..+|+.+|.|++|.|+.+||..++........ ++.+
T Consensus 348 eel~~Lf~~~D~DgdG~IsfeEFl~ll~~~~~~~~~~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ls----~eei 423 (450)
T 3sg6_A 348 AELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLT----DEEV 423 (450)
T ss_dssp HHHHHHHHTTCTTSSSSEEHHHHHHHHHC------CHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCC----HHHH
T ss_pred HHHHHHHHHhccCCCCcccHHHHHHHHHhhccccchhhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCC----HHHH
Confidence 346778999999999999999999999875533445567899999999999999999999887654433333 5678
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhc
Q 007498 535 STAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
..+|+.+|.|+||.|+.+||..+|.
T Consensus 424 ~~Lf~~~D~D~DG~IsfdEFv~~L~ 448 (450)
T 3sg6_A 424 DEMIREADIDGDGQVNYEEFVQMMT 448 (450)
T ss_dssp HHHHHHHCTTSSSSEEHHHHHHHHC
T ss_pred HHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 9999999999999999999998873
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=98.94 E-value=3.4e-09 Score=93.92 Aligned_cols=104 Identities=14% Similarity=0.143 Sum_probs=81.6
Q ss_pred hhhcchHHHHHHHHHHHhh---CCCCCCcccHHHHHHHHhhc--chhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 446 SKALTEDELVYLRAQFRLL---EPNKDGSVSLENFRMVLGRN--ATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~---D~d~~G~I~~~el~~~l~~~--~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..++..+ +..+|..+ |.|+ |.|+.+||..++... .........+..+|+.+|.+++|.|+.+||..++..
T Consensus 38 ~~~~~~~~---~~~l~~~~~~~d~~~-g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~ 113 (149)
T 2mys_C 38 GQNPTNAE---INKILGNPSKEEMNA-AAITFEEFLPMLQAAANNKDQGTFEDFVEGLRVFDKEGNGTVMGAELRHVLAT 113 (149)
T ss_pred CCCCCHHH---HHHHHHHhhhccccC-CcCcHHHHHHHHHHHhccCCcchHHHHHHHHHHhCCCCCceEcHHHHHHHHHH
Confidence 33445444 56677777 9999 999999999999775 222234566889999999999999999999887654
Q ss_pred chhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 521 THQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 521 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
...... ++.+..+|+. |.|++|.|+.+||..++
T Consensus 114 ~g~~~~----~~~~~~~~~~-d~~~dg~i~~~eF~~~~ 146 (149)
T 2mys_C 114 LGEKMT----EEEVEELMKG-QEDSNGCINYEAFVKHI 146 (149)
T ss_pred hCCCCC----HHHHHHHHhh-CCCCCCcEeHHHHHHHH
Confidence 433223 5678999999 99999999999999876
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=98.93 E-value=7.3e-10 Score=98.74 Aligned_cols=108 Identities=16% Similarity=0.131 Sum_probs=83.1
Q ss_pred HHhhhhcchHHHHHHHHHHHhhCCC--CCCcccHHHHHHHHhhcchh--hhhhccHHHHHhhcccCCCCcccHHHHHHHh
Q 007498 443 KALSKALTEDELVYLRAQFRLLEPN--KDGSVSLENFRMVLGRNATD--AMRESRVPDVLSSMESLAYRKMYFEEFCAAA 518 (601)
Q Consensus 443 ~~~~~~l~~~~~~~l~~~F~~~D~d--~~G~I~~~el~~~l~~~~~~--~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 518 (601)
..++..++.. ++..+|..+|.| ++|.|+++||..++...... ......+..+|+.+|.+++|.|+.+||..++
T Consensus 37 ~~~g~~~~~~---~~~~l~~~~d~~~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l 113 (151)
T 1w7j_B 37 RALGQNPTNA---EVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELRHVL 113 (151)
T ss_dssp HHTTCCCCHH---HHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CCHHHHHTTCTTSSSEEEHHHHHHHH
T ss_pred HHcCCCCCHH---HHHHHHHHhCcCcCCCCcCcHHHHHHHHHHHhccCCCCcHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3344445543 477889999999 99999999999999775421 1234567889999999999999999998876
Q ss_pred hcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 519 ISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
........ ++.+..+|+.+| |++|.|+.+||..++
T Consensus 114 ~~~g~~~~----~~~~~~~~~~~d-~~dg~i~~~eF~~~~ 148 (151)
T 1w7j_B 114 TTLGEKMT----EEEVETVLAGHE-DSNGCINYEAFLKHI 148 (151)
T ss_dssp HHSSSCCC----HHHHHHHHTTCC-CTTSEEEHHHHHHHT
T ss_pred HHcCCCCC----HHHHHHHHHhcc-CCCCeEeHHHHHHHH
Confidence 54433223 567899999999 999999999999876
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.6e-09 Score=102.41 Aligned_cols=102 Identities=14% Similarity=0.113 Sum_probs=78.3
Q ss_pred HHHHHhhCCCCCCcccHHHHHHHHhhcchhh---------------hhhccHHHHHhhcccCCCCcccHHHHHHHhhcc-
Q 007498 458 RAQFRLLEPNKDGSVSLENFRMVLGRNATDA---------------MRESRVPDVLSSMESLAYRKMYFEEFCAAAIST- 521 (601)
Q Consensus 458 ~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~---------------~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~- 521 (601)
.++|..+|.|++|.|+++||..++....... .....+..+|+.+|.|++|.|+.+||..++...
T Consensus 64 ~~l~~~~d~~~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~ 143 (208)
T 2ct9_A 64 DRIINAFFSEGEDQVNFRGFMRTLAHFRPIEDNEKSKDVNGPEPLNSRSNKLHFAFRLYDLDKDDKISRDELLQVLRMMV 143 (208)
T ss_dssp HHHHHTTSCTTCSCEEHHHHHHHHHTTSCCC-----------CCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHS
T ss_pred HHHHHHHcCCCCCcCcHHHHHHHHHhhccccchhhhcccccccccccHHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHh
Confidence 3578889999999999999999997653110 145668899999999999999999998876543
Q ss_pred hhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 522 HQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 522 ~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
......+..++.+..+|+.+|.|+||.|+.+||..++.
T Consensus 144 g~~~s~~~~~~l~~~~~~~~D~d~dG~Is~~EF~~~~~ 181 (208)
T 2ct9_A 144 GVNISDEQLGSIADRTIQEADQDGDSAISFTEFVKVLE 181 (208)
T ss_dssp CTTCCHHHHHHHHHHHHHHHCSSSSSSEEHHHHHHTTT
T ss_pred CCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 32233222233344559999999999999999999884
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=1.5e-09 Score=91.86 Aligned_cols=88 Identities=13% Similarity=0.158 Sum_probs=61.8
Q ss_pred hHHHHHHHHHHHhhCC-CCCC-cccHHHHHHHHh-hcchh--h--hhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh
Q 007498 451 EDELVYLRAQFRLLEP-NKDG-SVSLENFRMVLG-RNATD--A--MRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ 523 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~-d~~G-~I~~~el~~~l~-~~~~~--~--~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~ 523 (601)
++++.+|+++|..||. |++| +|+.+||..+|+ .++.. . .+..+++.+++.+|.|++|.|+|+||+.++....
T Consensus 8 ~~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~- 86 (113)
T 1xk4_C 8 ERNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMARLT- 86 (113)
T ss_dssp HHHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH-
T ss_pred HHHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHHHH-
Confidence 3567889999999995 9999 999999999998 66531 1 4677899999999999999999999998664321
Q ss_pred hhhhhhHHHHHHHHHHHHcccCCCc
Q 007498 524 LEALEGWEQIASTAFEYFEEEGNRV 548 (601)
Q Consensus 524 ~~~~~~~~~~~~~~F~~~D~d~~G~ 548 (601)
......|...| +++|.
T Consensus 87 --------~~~~~~f~~~~-~~~g~ 102 (113)
T 1xk4_C 87 --------WASHEKMHEGD-EGPGH 102 (113)
T ss_dssp --------HHHHC------------
T ss_pred --------HHHHHHHhhCC-CCCcc
Confidence 12345688888 88875
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.9e-09 Score=90.60 Aligned_cols=69 Identities=17% Similarity=0.295 Sum_probs=59.8
Q ss_pred chHHHHHHHHHHHhhC-CCCCC-cccHHHHHHHHhh-----cchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 450 TEDELVYLRAQFRLLE-PNKDG-SVSLENFRMVLGR-----NATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D-~d~~G-~I~~~el~~~l~~-----~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
.++++++|+++|..|| .|++| +|+.+||..+|+. ++. ..++.+++.+++.+|.|+||.|+|+||+.++.
T Consensus 17 ~~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~-~~t~~ev~~li~~~D~dgdG~Idf~EF~~~m~ 92 (113)
T 2lnk_A 17 LEKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGK-RTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLS 92 (113)
T ss_dssp HHHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTT-CCCTTHHHHHHHHHCSSSSSCBCHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 3567889999999999 89997 9999999999986 332 45678899999999999999999999988654
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=1.7e-09 Score=87.90 Aligned_cols=70 Identities=17% Similarity=0.286 Sum_probs=58.5
Q ss_pred hHHHHHHHHHHHhhC-CCCC-CcccHHHHHHHHhh-cch---hhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLLE-PNKD-GSVSLENFRMVLGR-NAT---DAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D-~d~~-G~I~~~el~~~l~~-~~~---~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..+++++++|..|| .|++ |+|+.+||..+++. ++. ...+..+++.+++.+|.|+||.|+|+||+.++..
T Consensus 6 e~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~~~~ 81 (93)
T 4eto_A 6 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSC 81 (93)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH
Confidence 467889999999998 6775 89999999999986 552 1235778999999999999999999999886553
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.92 E-value=1.3e-09 Score=91.91 Aligned_cols=62 Identities=13% Similarity=0.063 Sum_probs=54.5
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhc---CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELN---VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~---~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+++.+|.|+||.|+|+||+.+|....
T Consensus 13 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~i~~~~D~d~dG~I~~~EF~~~~~~~~ 78 (111)
T 2kgr_A 13 RLKYRQLFNSHDKTMSGHLTGPQARTILMQSSLPQAQLASIWNLSDIDQDGKLTAEEFILAMHLID 78 (111)
T ss_dssp HHHHHHHHHTTSCSSCCEEEHHHHHHHHHTTCCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHhCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHH
Confidence 56788999999999999999999999994 3322 89999999999999999999999987653
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.92 E-value=2e-09 Score=87.83 Aligned_cols=60 Identities=18% Similarity=0.347 Sum_probs=53.2
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
++.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|+.+|.|+||.|+|+||+.+|..
T Consensus 28 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~~~ 93 (94)
T 2kz2_A 28 EEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA 93 (94)
T ss_dssp HHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred HHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhc
Confidence 56789999999999999999999999982 2222 999999999999999999999999864
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.8e-09 Score=88.97 Aligned_cols=62 Identities=19% Similarity=0.313 Sum_probs=53.4
Q ss_pred HHHHHHHHHHHcccC---CCcccHHHHHHHhc------CC-----ccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEG---NRVISIEELARELN------VG-----PSAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~---~G~I~~~El~~~l~------~~-----~~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+.++.+|+.||+|+ +|+|+.+||+.+|. +. .+++.+|+.+|.|+||.|+|+||+.+|.++.
T Consensus 10 i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~m~~~~ 85 (100)
T 3nxa_A 10 VIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYWTLIGGIT 85 (100)
T ss_dssp HHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHH
Confidence 567899999999964 79999999999883 22 1299999999999999999999999998754
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.92 E-value=6.3e-10 Score=93.48 Aligned_cols=68 Identities=21% Similarity=0.302 Sum_probs=61.7
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
++++++++++++|..||.|++|+|+.+|+..+|+.++ .+.+++..+++.+|.|++|.|+|+||+.++.
T Consensus 16 ls~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~g---l~~~el~~i~~~~D~d~dG~I~~~EF~~~m~ 83 (110)
T 1iq3_A 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK---LSIPELSYIWELSDADCDGALTLPEFCAAFH 83 (110)
T ss_dssp CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS---CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcC---CCHHHHHHHHHHHcCCCCCcCcHHHHHHHHH
Confidence 5677889999999999999999999999999998875 4577899999999999999999999988654
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=98.92 E-value=3.5e-09 Score=96.69 Aligned_cols=96 Identities=9% Similarity=0.135 Sum_probs=78.4
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchh----hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHH
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATD----AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWE 531 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~ 531 (601)
.+..+|..+| ++|.|+++||..++...... ......+..+|+.+|.|++|.|+.+||..++.... .. +
T Consensus 56 ~~~~l~~~~D--~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g--~~----~ 127 (174)
T 1q80_A 56 VWDNFLTAVA--GGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LD----K 127 (174)
T ss_dssp HHHHTGGGTT--TTSCEEHHHHHHHHHHHTTSTTCHHHHHTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHT--CC----G
T ss_pred HHHHHHHhcC--CCCeEcHHHHHHHHHHHcCcccHHHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHcC--CC----H
Confidence 3467899999 89999999999998765421 12356789999999999999999999988765442 22 3
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 532 QIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
+.+..+|+.+|.|++|.|+.+||..++.
T Consensus 128 ~~~~~~~~~~D~d~dg~i~~~ef~~~~~ 155 (174)
T 1q80_A 128 TMAPASFDAIDTNNDGLLSLEEFVIAGS 155 (174)
T ss_dssp GGHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCceEeHHHHHHHHH
Confidence 4678999999999999999999998773
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.91 E-value=1.3e-09 Score=82.42 Aligned_cols=58 Identities=17% Similarity=0.326 Sum_probs=50.4
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 533 IASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 533 ~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
.++.+|+.||+|++|+|+.+||+.++. +..+ ++.+|..+|.|+||.|+|+||+.++.+
T Consensus 2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~ 65 (67)
T 1tiz_A 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEK 65 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 367899999999999999999999983 2222 899999999999999999999999875
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.91 E-value=1.5e-09 Score=89.95 Aligned_cols=70 Identities=19% Similarity=0.296 Sum_probs=59.0
Q ss_pred hHHHHHHHHHHHhhC-CCCC-CcccHHHHHHHHhh-cch---hhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLLE-PNKD-GSVSLENFRMVLGR-NAT---DAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D-~d~~-G~I~~~el~~~l~~-~~~---~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..+.+|+++|..|| .|++ |+|+.+||..+|+. ++. ...+..+++.+++.+|.|+||.|+|+||+.++..
T Consensus 9 e~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~m~~ 84 (104)
T 3zwh_A 9 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSS 84 (104)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHH
Confidence 467889999999997 6775 89999999999986 552 1245778999999999999999999999886553
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=98.91 E-value=5.1e-09 Score=86.21 Aligned_cols=70 Identities=13% Similarity=0.238 Sum_probs=58.6
Q ss_pred hHHHHHHHHHHHhhCCCC---CCcccHHHHHHHHhhcchhh----hhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLLEPNK---DGSVSLENFRMVLGRNATDA----MRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~d~---~G~I~~~el~~~l~~~~~~~----~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..+++|+++|..||.++ +|+|+.+||..+++..+... .+..+++.+++.+|.|+||.|+|+||+.++..
T Consensus 7 e~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~m~~ 83 (100)
T 3nxa_A 7 EKAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYWTLIGG 83 (100)
T ss_dssp HHHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 467889999999999964 79999999999998754322 23567999999999999999999999986653
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.6e-09 Score=94.25 Aligned_cols=61 Identities=15% Similarity=0.059 Sum_probs=54.7
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.++++.+|+.|| |+||+|+.+|++.+| ++..+ ++.++..+|.|+||.|+|+||+.+|+...
T Consensus 50 ~~~l~~~F~~fD-d~dG~Is~~El~~~l~~~gl~~~el~~I~~~~D~d~dG~Ld~~EF~~am~li~ 114 (139)
T 2jq6_A 50 KPTYDEIFYTLS-PVNGKITGANAKKEMVKSKLPNTVLGKIWKLADVDKDGLLDDEEFALANHLIK 114 (139)
T ss_dssp HHHHHHHHHHSC-CSSSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhC-CCCCeECHHHHHHHHHHhCcCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 567899999999 999999999999999 44443 99999999999999999999999997764
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=98.91 E-value=5.8e-10 Score=84.26 Aligned_cols=57 Identities=16% Similarity=0.291 Sum_probs=46.9
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhcCCc------cHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 535 STAFEYFEEEGNRVISIEELARELNVGP------SAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~~~~------~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+.+|+.||.|++|+|+.+||+.++...+ +++.+|..+|.|+||.|+|+||+.+|.++
T Consensus 3 ~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 65 (66)
T 3li6_A 3 EALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSI 65 (66)
T ss_dssp CHHHHHHCTTCSSSCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHTCC
T ss_pred HHHHHHHCCCCCCcccHHHHHHHHHHccCCCcHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 4678999999999999999998883221 18889999999999999999999988765
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.90 E-value=2.5e-09 Score=86.68 Aligned_cols=61 Identities=15% Similarity=0.234 Sum_probs=54.1
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.||+|++|+|+.+||+.+| ++... ++.+|..+|.|+||.|+|+||+.++.+.
T Consensus 26 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~D~d~dg~I~~~EF~~~~~~~ 90 (91)
T 2pmy_A 26 LARLRSVFAACDANRSGRLEREEFRALCTELRVRPADAEAVFQRLDADRDGAITFQEFARGFLGS 90 (91)
T ss_dssp HHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSEECHHHHTHHHHHT
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcCcCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHHH
Confidence 5678999999999999999999999988 43333 9999999999999999999999998753
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.90 E-value=9.6e-10 Score=84.31 Aligned_cols=60 Identities=18% Similarity=0.378 Sum_probs=52.9
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhcCC-----cc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELNVG-----PS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~-----~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
++.++.+|+.||+|++|+|+.+||+.++... .. ++.++..+|.|+||.|+|+||+.+|.+
T Consensus 5 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 70 (71)
T 2b1u_A 5 LEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVNYEEFARMLAQ 70 (71)
T ss_dssp HHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCSSSSSEEETTHHHHHHTC
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhh
Confidence 5678999999999999999999999999322 22 899999999999999999999999865
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=3.9e-09 Score=113.50 Aligned_cols=102 Identities=11% Similarity=0.132 Sum_probs=74.6
Q ss_pred hhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh----h------hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 490 RESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE----A------LEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 490 ~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~----~------~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
...+++.+|+.+|.|+||.|+++||..++....... . ....++.+..+|+.+|.|+||.|+.+||...+.
T Consensus 329 ~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~Ef~~~~~ 408 (486)
T 3mwu_A 329 ETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAI 408 (486)
T ss_dssp HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCHHHHHHHHS
T ss_pred HHHHHHHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcHHHHHHHHH
Confidence 345689999999999999999999965443221110 0 012266789999999999999999999988772
Q ss_pred CC-----cc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 560 VG-----PS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 560 ~~-----~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.. .+ +..+|+.+|.|+||.|+.+||..+|...
T Consensus 409 ~~~~~~~~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~ 446 (486)
T 3mwu_A 409 DRTILLSRERMERAFKMFDKDGSGKISTKELFKLFSQA 446 (486)
T ss_dssp CTTTTCCHHHHHHHHHHHCSSCSSSBCSSCC-------
T ss_pred hhhccchHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHc
Confidence 21 12 8899999999999999999999998765
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.1e-09 Score=88.53 Aligned_cols=61 Identities=21% Similarity=0.386 Sum_probs=53.0
Q ss_pred HHHHHHHHHHHc-ccCCC-cccHHHHHHHhc------C----Cc-cHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFE-EEGNR-VISIEELARELN------V----GP-SAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D-~d~~G-~I~~~El~~~l~------~----~~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.|| +||+| +|+.+||+.+|. + .. +++.+|+.+|.|+||.|+|+||+.+|.+.
T Consensus 9 ~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~ 82 (99)
T 2y5i_A 9 MDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDSNKDNEVDFNEFVVLVAAL 82 (99)
T ss_dssp HHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHH
Confidence 567899999998 89998 999999999983 1 11 29999999999999999999999998764
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=98.89 E-value=2.3e-09 Score=96.85 Aligned_cols=112 Identities=11% Similarity=0.083 Sum_probs=86.3
Q ss_pred HHHHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchh--hhhhccHHHHHhhcccCCCCcccHHHHHH
Q 007498 439 RAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATD--AMRESRVPDVLSSMESLAYRKMYFEEFCA 516 (601)
Q Consensus 439 ~~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~--~~~~~~~~~~~~~~D~~~~g~i~~~ef~~ 516 (601)
+.++..++...++.++.++ + ..|.+++|.|+++||..++...... ....+++...|+.+|.+++|.|+.+|+..
T Consensus 34 ~~~lr~lG~~~t~~el~~~---~-~~d~~~~g~i~f~eFl~~~~~~~~~~~~~~~~~l~~aF~~fD~d~~G~I~~~el~~ 109 (159)
T 3i5g_C 34 GDLLRCLGMNPTEAQVHQH---G-GTKKMGEKAYKLEEILPIYEEMSSKDTGTAADEFMEAFKTFDREGQGLISSAEIRN 109 (159)
T ss_dssp HHHHHHTTCCCCHHHHHTT---T-CCSSTTSCEECHHHHHHHHHHHTTCCTTCCHHHHHHHHHHHCTTSSSEECHHHHHH
T ss_pred HHHHHHcCCCCCHHHHHHH---H-cccccCCCcccHHHHHHHHHHhhcccccchHHHHHHHHHHHhcCCCCcCcHHHHHH
Confidence 3455667777787776553 3 3578889999999999998765421 22345688899999999999999999988
Q ss_pred HhhcchhhhhhhhHHHHHHHHHHHHcc--cCCCcccHHHHHHHh
Q 007498 517 AAISTHQLEALEGWEQIASTAFEYFEE--EGNRVISIEELAREL 558 (601)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~F~~~D~--d~~G~I~~~El~~~l 558 (601)
++.......+ ++++..+++.+|. |++|.|+.+||.++|
T Consensus 110 ~l~~~g~~ls----~~e~~~l~~~~D~~~d~dG~I~~~EF~~~m 149 (159)
T 3i5g_C 110 VLKMLGERIT----EDQCNDIFTFCDIREDIDGNIKYEDLMKKV 149 (159)
T ss_dssp HHHHSSSCCC----HHHHHHHHHHTTCCCCSSCCEEHHHHHHHH
T ss_pred HHHHhCCCCC----HHHHHHHHHHhCcCCCCCCeEeHHHHHHHH
Confidence 7765544444 6678999999994 899999999998876
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=98.89 E-value=2.4e-09 Score=89.17 Aligned_cols=67 Identities=18% Similarity=0.164 Sum_probs=61.0
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
++.+++.+++++|..||+ +||+|+.+|+..+|+.++ .+.+++..+++.+|.|++|.|+|+||+.++.
T Consensus 9 ls~~e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~g---l~~~el~~i~~~~D~d~dG~id~~EF~~~m~ 75 (106)
T 1eh2_A 9 VKPEDKAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSK---LPVDILGRVWELSDIDHDGMLDRDEFAVAMF 75 (106)
T ss_dssp SCHHHHHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTT---CCHHHHHHHHHHHCSSCSSBCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcC---CCHHHHHHHHHHHcCCCCCcCcHHHHHHHHH
Confidence 578899999999999999 999999999999999876 3567799999999999999999999987654
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=98.89 E-value=1.7e-09 Score=90.04 Aligned_cols=61 Identities=13% Similarity=0.056 Sum_probs=53.8
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.++++.+|+.||+ +||+|+.+|++.+| ++..+ ++.+++.+|.|+||.|+|+||+.+|+...
T Consensus 14 ~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~gl~~~el~~i~~~~D~d~dG~id~~EF~~~m~~~~ 78 (106)
T 1eh2_A 14 KAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMFLVY 78 (106)
T ss_dssp HHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTTCCHHHHHHHHHHHCSSCSSBCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHH
Confidence 5668899999999 99999999999999 33333 99999999999999999999999997653
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=2e-09 Score=90.75 Aligned_cols=68 Identities=15% Similarity=0.192 Sum_probs=60.8
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
+++++.++++++|..||.|++|+|+.+||..+++.. ..+..++..+++.+|.|++|.|+|+||+.++.
T Consensus 8 ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~---~~~~~~~~~i~~~~D~d~dG~I~~~EF~~~~~ 75 (111)
T 2kgr_A 8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILMQS---SLPQAQLASIWNLSDIDQDGKLTAEEFILAMH 75 (111)
T ss_dssp SCHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHHHTT---CCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHhC---CCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 577889999999999999999999999999999832 35667899999999999999999999988654
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=98.88 E-value=5.2e-09 Score=94.84 Aligned_cols=87 Identities=7% Similarity=0.073 Sum_probs=70.6
Q ss_pred CCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCc
Q 007498 469 DGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRV 548 (601)
Q Consensus 469 ~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~ 548 (601)
+|.|+++||..++............+..+|+.+|.|++|.|+.+||..++........ ++.+..+|+.+|.|++|.
T Consensus 72 dg~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~----~~~~~~~~~~~D~d~dg~ 147 (166)
T 2mys_B 72 SGPINFTVFLTMFGEKLKGADPEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFT----PEEIKNMWAAFPPDVAGN 147 (166)
T ss_pred CCCcCHHHHHHHHHHHhccCCcHHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCCCCC----HHHHHHHHHhcCCCCCCe
Confidence 7999999999998765322334567889999999999999999999887654433223 567889999999999999
Q ss_pred ccHHHHHHHhc
Q 007498 549 ISIEELARELN 559 (601)
Q Consensus 549 I~~~El~~~l~ 559 (601)
|+.+||..++.
T Consensus 148 I~~~eF~~~~~ 158 (166)
T 2mys_B 148 VDYKNICYVIT 158 (166)
T ss_pred EeHHHHHHHHH
Confidence 99999999883
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=98.88 E-value=2.7e-09 Score=87.15 Aligned_cols=61 Identities=18% Similarity=0.349 Sum_probs=52.2
Q ss_pred HHHHHHHHHHHc-ccC-CCcccHHHHHHHhc------CC----c-cHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFE-EEG-NRVISIEELARELN------VG----P-SAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D-~d~-~G~I~~~El~~~l~------~~----~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.|| +|+ +|+|+.+||+.+|. +. . +++.+|+.+|.|+||.|+|+||+.+|.+.
T Consensus 8 ~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~ 81 (95)
T 1j55_A 8 MGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAI 81 (95)
T ss_dssp HHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH
Confidence 567899999999 798 58999999999983 11 1 29999999999999999999999998764
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.2e-09 Score=96.31 Aligned_cols=88 Identities=9% Similarity=0.118 Sum_probs=73.3
Q ss_pred CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCC
Q 007498 468 KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNR 547 (601)
Q Consensus 468 ~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G 547 (601)
++|.|+.+||..++............+..+|+.+|.|++|.|+.+||..++........ ++.+..+|+.+|.|++|
T Consensus 52 ~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~----~~~~~~~~~~~D~d~dg 127 (143)
T 3j04_B 52 APGPINFTMFLTMFGEKLNGTDPEDVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFT----DEEVDEMYREAPIDKKG 127 (143)
T ss_dssp SSSCCCHHHHHHHHHHTTTSSCCHHHHHHHHTTSCSSSCCCCCTTTHHHHHHTSSSCCC----HHHHHHHHHHTTCCSSS
T ss_pred CCCCcCHHHHHHHHHHHhccCCcHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCCC----HHHHHHHHHHcCCCCCC
Confidence 89999999999999865433344567899999999999999999999887765443333 56789999999999999
Q ss_pred cccHHHHHHHhc
Q 007498 548 VISIEELARELN 559 (601)
Q Consensus 548 ~I~~~El~~~l~ 559 (601)
.|+.+||..++.
T Consensus 128 ~i~~~eF~~~~~ 139 (143)
T 3j04_B 128 NFNYVEFTRILK 139 (143)
T ss_dssp CCCSTHHHHHHH
T ss_pred cCcHHHHHHHHh
Confidence 999999999874
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=98.88 E-value=6.6e-09 Score=95.75 Aligned_cols=109 Identities=11% Similarity=0.055 Sum_probs=80.2
Q ss_pred chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh-cchhh-h--
Q 007498 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI-STHQL-E-- 525 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~-~~~~~-~-- 525 (601)
++..+.++.+.|...+.+++|.|+.+||..++..+.. ......+..+|+.+|.|++|.|+.+|+..++. ..... .
T Consensus 57 ~~~~~~~i~~~~d~~~~~~~~~i~~~ef~~~~~~~~~-~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~ 135 (179)
T 3a8r_A 57 SDEFAVQMFDSLARKRGIVKQVLTKDELKDFYEQLTD-QGFDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSK 135 (179)
T ss_dssp CHHHHHHHHHHHHHHHTCCSSEECHHHHHHHHHHHHC-CCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHH
T ss_pred cHHHHHHHHHHHHHhccCCCCCcCHHHHHHHHHHHcC-CCHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccc
Confidence 4444444444444444678899999999998876542 23456789999999999999999999987664 33211 1
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
.....++.+..+|+.+|.|+||.|+.+||..++.
T Consensus 136 ~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~ 169 (179)
T 3a8r_A 136 IKERADEYTALIMEELDPTNLGYIEMEDLEALLL 169 (179)
T ss_dssp HHHHHHHHHHHHHHHHSTTCCSEECHHHHHHHHC
T ss_pred cccchHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 0011267789999999999999999999999884
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=98.88 E-value=3.7e-09 Score=82.17 Aligned_cols=61 Identities=28% Similarity=0.454 Sum_probs=54.2
Q ss_pred HHHHHHHHHHH-cccCC-CcccHHHHHHHh-----cC--Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYF-EEEGN-RVISIEELAREL-----NV--GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~-D~d~~-G~I~~~El~~~l-----~~--~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.| |+|++ |+|+.+||+.+| .+ ..+ ++.++..+|.|+||.|+|+||+.++.++
T Consensus 4 ~~~l~~~F~~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~ 74 (76)
T 1qx2_A 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKKI 74 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCcCeECHHHHHHHHHHhCCCcCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHh
Confidence 45789999999 99999 999999999988 23 333 9999999999999999999999999765
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.4e-09 Score=88.98 Aligned_cols=61 Identities=13% Similarity=0.178 Sum_probs=53.2
Q ss_pred HHHHHHHHHHHc-ccCCC-cccHHHHHHHhcC----------Cc-cHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFE-EEGNR-VISIEELARELNV----------GP-SAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D-~d~~G-~I~~~El~~~l~~----------~~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.|| +|++| +|+.+||+.+|.. .. +++.+|+.+|.|+||.|+|+||+.+|.+.
T Consensus 11 ~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~~ 84 (95)
T 2wcb_A 11 LEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIA 84 (95)
T ss_dssp HHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSSSSTTSEEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence 567899999999 89998 9999999999841 22 28999999999999999999999998764
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=98.87 E-value=1.9e-09 Score=84.47 Aligned_cols=65 Identities=17% Similarity=0.269 Sum_probs=58.3
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
++++.+|..+|.|++|+|+.+||..+++.++ ..+..++..+++.+|.+++|.|+++||+.++...
T Consensus 3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~g--~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~ 67 (78)
T 1k9u_A 3 DDMERIFKRFDTNGDGKISLSELTDALRTLG--STSADEVQRMMAEIDTDGDGFIDFNEFISFCNAN 67 (78)
T ss_dssp CHHHHHHHHHCTTCSSEECHHHHHHHHHHHH--TCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHC
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhC--CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHC
Confidence 4688999999999999999999999999987 5677889999999999999999999999866543
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=98.87 E-value=3.5e-09 Score=86.52 Aligned_cols=68 Identities=10% Similarity=0.216 Sum_probs=55.6
Q ss_pred hHHHHHHHHHHHhhC-CCC-CCcccHHHHHHHHhh-----cchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 451 EDELVYLRAQFRLLE-PNK-DGSVSLENFRMVLGR-----NATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D-~d~-~G~I~~~el~~~l~~-----~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
++++++++++|..|| .|+ +|+|+.+||..+++. ++. ..+..+++.+++.+|.|++|.|+|+||+.++.
T Consensus 5 ~~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~-~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~ 79 (95)
T 1j55_A 5 ETAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQS-GKDKDAVDKLLKDLDANGDAQVDFSEFIVFVA 79 (95)
T ss_dssp HHHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC-------CHHHHHHHHHCSSSSSSEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhccc-ccCHHHHHHHHHHhCCCCCCcCCHHHHHHHHH
Confidence 356889999999999 788 589999999999986 332 45778899999999999999999999998654
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=98.87 E-value=2.9e-09 Score=86.43 Aligned_cols=61 Identities=15% Similarity=0.206 Sum_probs=52.5
Q ss_pred HHHHHHHHHHHcccCCC---cccHHHHHHHhcC------Cc-----cHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNR---VISIEELARELNV------GP-----SAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G---~I~~~El~~~l~~------~~-----~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+.++.+|+.|| ++|| +|+.+||+.+|.. .. +++.+|+.+|.|+||.|+|+||+.+|.++.
T Consensus 8 ~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~l~ 82 (92)
T 3rm1_A 8 VVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGECDFQEFMAFVAMIT 82 (92)
T ss_dssp HHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence 457889999999 7777 9999999998832 21 199999999999999999999999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 601 | ||||
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-84 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-82 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-82 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-81 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-80 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-79 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-79 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-75 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-75 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-74 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-73 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-73 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-70 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-69 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-69 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-69 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-68 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-67 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-66 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-63 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-62 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-61 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-61 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-61 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-61 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-61 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-60 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-60 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-59 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-59 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-57 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-56 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-55 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-55 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-53 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-53 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-52 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-51 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-43 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-42 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-21 | |
| d1lkja_ | 146 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 2e-10 | |
| d1topa_ | 162 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 2e-10 | |
| d1dtla_ | 156 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 6e-08 | |
| d1s6ia_ | 182 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 7e-07 | |
| d1exra_ | 146 | a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr | 1e-06 | |
| d1s6ja_ | 87 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 4e-06 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 3e-05 | |
| d2pq3a1 | 73 | a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T | 6e-05 | |
| d2obha1 | 141 | a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien | 6e-05 | |
| d1f54a_ | 77 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 1e-04 | |
| d2scpa_ | 174 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 3e-04 | |
| d1nyaa_ | 176 | a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth | 4e-04 | |
| d1ij5a_ | 321 | a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind | 6e-04 | |
| d1uhka1 | 187 | a.39.1.5 (A:3-189) Calcium-regulated photoprotein | 7e-04 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 0.001 | |
| d1w7jb1 | 139 | a.39.1.5 (B:11-149) Myosin Essential Chain {Human | 0.002 | |
| d1avsa_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 0.002 | |
| d1auib_ | 165 | a.39.1.5 (B:) Calcineurin regulatory subunit (B-ch | 0.003 | |
| d1wrka1 | 82 | a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens) | 0.003 |
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 264 bits (676), Expect = 5e-84
Identities = 92/276 (33%), Positives = 141/276 (51%), Gaps = 9/276 (3%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
Y++ +E+G G FG K + K I+ + V+ E+ I+ L
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYP---LDKYTVKNEISIMNQL 83
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H L+ DA ED + +++E GGEL DRI A + +E + + Q +
Sbjct: 84 H-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 327
H +VH D+KPEN + + + + +++IDFGL+ + PDE + +A + APE++
Sbjct: 143 MHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 201
Query: 328 RS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
R D+W+IGV+ Y+LL G PF + + V R D FD+ + SVSPEAKD
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261
Query: 387 FVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDI 422
F+K LL K+ RKR+T AL HPWL+ D + I
Sbjct: 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 261 bits (667), Expect = 1e-82
Identities = 91/271 (33%), Positives = 139/271 (51%), Gaps = 9/271 (3%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
Y++ +E+G G FG + A K + + E VR+E++ + L
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHES---DKETVRKEIQTMSVL 80
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H LV DA ED N + ++ E GGEL +++ + +E++A + Q+ +
Sbjct: 81 R-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH 327
H VH DLKPEN +FT+ R + +++LIDFGL+ + P + + G+A + APEV
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198
Query: 328 -RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
+ D+WS+GV+SYILL G PF + R V D N DD + +S + KD
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258
Query: 387 FVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417
F+++LL D RMT QAL HPWL + P
Sbjct: 259 FIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 257 bits (658), Expect = 6e-82
Identities = 108/300 (36%), Positives = 165/300 (55%), Gaps = 9/300 (3%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
++ Y+ +G G F A K+ + VA+K I+K + + E+
Sbjct: 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRT---QKLVAIKCIAKKALEGKE--GSMENEIA 59
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
+L + H ++V D E ++Y++M+L GGEL DRI+ +G YTE DA ++ Q+L
Sbjct: 60 VLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVL 117
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
V + H G+VHRDLKPEN L+ S +D+ + + DFGLS P L+ G+ YVA
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 177
Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
PEVL + YS D WSIGVI+YILLCG PF+ ++ +F +L+++ FD W +S
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLR-DDSRPVPLDILIFKLVKSYLHATPFKRA 440
AKDF++ L+ KD KR T QAL HPW+ D + + + + +K + +K+A
Sbjct: 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQA 297
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 254 bits (649), Expect = 5e-81
Identities = 93/281 (33%), Positives = 140/281 (49%), Gaps = 20/281 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS------IEDVR 198
F YE + +GRG K ++ AVKII + + E
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELREATL 57
Query: 199 REVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
+EV IL+ +SGH ++++ D E ++V +L + GEL D + +E++ + I+
Sbjct: 58 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 116
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
+L V+ H +VHRDLKPEN L DD +++L DFG S + P E+L ++ G+
Sbjct: 117 RALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTP 173
Query: 319 YYVAPEVL-------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371
Y+APE++ H Y E D+WS GVI Y LL GS PFW R + + R ++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
F W S KD V R L +KR TA +AL HP+ +
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (645), Expect = 9e-80
Identities = 80/307 (26%), Positives = 145/307 (47%), Gaps = 12/307 (3%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
K KY + +++GRG FG + K + V++E+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSS---KKTYMAKFVKVKGT----DQVLVKKEIS 53
Query: 203 ILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQIL 262
IL H++++ ++ E + + ++ E G ++ +RI E + + V Q+
Sbjct: 54 ILNIAR-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 263 SVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVA 322
+ F H + H D++PEN ++ + R + +++I+FG + ++P + + + Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 323 PEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
PEV H S D+WS+G + Y+LL G PF A T I ++ ++ FD+ + +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHATPFKRAA 441
EA DFV RLL K+ + RMTA +AL HPWL+ V ++ + +K + +
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI--RTLKHRRYYHTLIKKD 289
Query: 442 LKALSKA 448
L + A
Sbjct: 290 LNMVVSA 296
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (638), Expect = 4e-79
Identities = 87/283 (30%), Positives = 135/283 (47%), Gaps = 19/283 (6%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E+ E+G G FG A+ K+ A K+I +ED E+ IL +
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKET---SVLAAAKVIDTKSEE---ELEDYMVEIDILASCD 67
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H ++VK DA NN++I++E C GG + +L TE + + Q L + +
Sbjct: 68 -HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVLH 327
H ++HRDLK N LFT D D++L DFG+S R +R + +G+ Y++APEV+
Sbjct: 127 HDNKIIHRDLKAGNILFTL---DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 328 ------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
R Y +AD+WS+G+ + P + + +S+P P S
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWS 242
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
KDF+K+ L K+ R T Q L HP++ DS P+ LI
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK-PIRELI 284
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (635), Expect = 4e-79
Identities = 79/269 (29%), Positives = 142/269 (52%), Gaps = 14/269 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+E+G+ +G+G FG+ AR K+ +A+K++ KA++ A +RREV+I L
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQS---KFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H ++++ D VY+++E G + R L + ++ E+ + ++ + +++
Sbjct: 64 R-HPNILRLYGYFHDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSY 121
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
CH + V+HRD+KPEN L S ++++ DFG S P R + G+ Y+ PE++
Sbjct: 122 CHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIE 177
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
R + + D+WS+GV+ Y L G PF A T ++ + R + F D V+ A+D
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 233
Query: 387 FVKRLLNKDYRKRMTAVQALTHPWLRDDS 415
+ RLL + +R + L HPW+ +S
Sbjct: 234 LISRLLKHNPSQRPMLREVLEHPWITANS 262
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 240 bits (614), Expect = 2e-75
Identities = 68/309 (22%), Positives = 131/309 (42%), Gaps = 17/309 (5%)
Query: 141 YNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE 200
+ + + +E+G G FG AR + + VA+K +S + + +D+ +E
Sbjct: 9 FKDDPEKLFSDLREIGHGSFGAVYFARDVRN---SEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 201 VKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
V+ L+ L H + +++ + ++VME C G D + E + A+
Sbjct: 66 VRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHG 123
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
L +A+ H ++HRD+K N L + + ++L DFG + + P N VG+ Y+
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA---NSFVGTPYW 177
Query: 321 VAPEVL----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
+APEV+ Y + D+WS+G+ L P + + +++ L
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQ 235
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKSYLHATP 436
S ++FV L K + R T+ L H ++ + P + LI + +
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDN 295
Query: 437 FKRAALKAL 445
+ +K +
Sbjct: 296 LQYRKMKKI 304
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (609), Expect = 6e-75
Identities = 101/276 (36%), Positives = 151/276 (54%), Gaps = 10/276 (3%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRR 199
+N Y+ G+E+G G F R K Q A K I K + ++ +S ED+ R
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 200 EVKILKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
EV ILK + H +++ + E+ +V +++EL GGEL D + A TEE+A +
Sbjct: 63 EVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLK 120
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTS-GRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
QIL+ V + H + H DLKPEN + +++IDFGL+ I +I G+
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 180
Query: 319 YYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377
+VAPE++ + LEAD+WSIGVI+YILL G+ PF T+ V + F+D +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
+ S AKDF++RLL KD +KRMT +L HPW++
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 1e-74
Identities = 90/294 (30%), Positives = 140/294 (47%), Gaps = 22/294 (7%)
Query: 148 KYE-LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKA 206
Y+ + +G G G K+ ++ A+K++ RREV++
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDCPK--------ARREVELHWR 60
Query: 207 LSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQI 261
S H+V+ D E++ + IVME +GGEL RI RG +TE +A I+ I
Sbjct: 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
+ + H + HRD+KPEN L+TS R +A ++L DFG + L + YYV
Sbjct: 121 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 180
Query: 322 APEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTE----SGIFRAVLRSDPNFDDLP 376
APEVL Y D+WS+GVI YILLCG PF++ G+ + F +
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKS 430
W VS E K ++ LL + +RMT + + HPW+ ++ + +++K
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKE 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 1e-73
Identities = 81/276 (29%), Positives = 135/276 (48%), Gaps = 22/276 (7%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
++ GK +G G F AR ++ A+KI+ K + + V RE ++ L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERDVMSRL 65
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H VK +D +Y + + GELL I + G + E + +I+S + +
Sbjct: 66 D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 123
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
H +G++HRDLKPEN L +D +++ DFG + + P+ R N VG+A YV+PE
Sbjct: 124 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
+L +S +D+W++G I Y L+ G PF A E IF+ +++ + +F P+
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPK 236
Query: 384 AKDFVKRLLNKDYRKRMTAVQA------LTHPWLRD 413
A+D V++LL D KR+ + HP+
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (594), Expect = 7e-73
Identities = 75/272 (27%), Positives = 133/272 (48%), Gaps = 16/272 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
++L + +G G +G A + ++ VAVKI+ + E++++E+ I K L
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVT---EEAVAVKIVDMKRAVDCP--ENIKKEICINKML 60
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ H+++VKF + N Y+ +E C GGEL DRI E DA+ Q+++ V +
Sbjct: 61 N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPE 324
H G+ HRD+KPEN L ++++ DFGL+ R + R LN + G+ YVAPE
Sbjct: 119 LHGIGITHRDIKPENLLLDE---RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 325 VLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
+L R ++ D+WS G++ +L G P+ ++S + + + + PW +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKKIDS 234
Query: 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414
+ ++L ++ R+T W
Sbjct: 235 APLALLHKILVENPSARITIPDIKKDRWYNKP 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 1e-70
Identities = 69/279 (24%), Positives = 133/279 (47%), Gaps = 15/279 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
KY +++G+G G +A Q+VA++ ++ + E + E+ +++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMREN 74
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ ++V + D+ + +++VME GG L D + E A+ + L + F
Sbjct: 75 K-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEF 131
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVGSAYYVAPEVL 326
H V+HRD+K +N L D ++L DFG I P++ + + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 327 -HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
++Y + DIWS+G+++ ++ G P+ + + + +S +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFR 247
Query: 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILI 424
DF+ R L+ D KR +A + L H +L+ L LI
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 3e-69
Identities = 60/276 (21%), Positives = 114/276 (41%), Gaps = 18/276 (6%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
N G + E+GRG F + +VA + K+T + + + E ++
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKS-ERQRFKEEAEM 61
Query: 204 LKALSGHKHLVKFCDACEDV----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
LK L H ++V+F D+ E + +V EL G L L R + ++
Sbjct: 62 LKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSG-TLKTYLKRFKVMKIKVLRSWCR 119
Query: 260 QILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
QIL + F H + ++HRDLK +N T +++ D GL+ R ++G+
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKRAS-FAKAVIGT 176
Query: 318 AYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNFDDLP 376
++APE+ Y D+++ G+ + P+ + + I+R V
Sbjct: 177 PEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVKPASF 234
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
PE K+ ++ + ++ +R + L H + +
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 3e-69
Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 14/268 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ L K +G+G FG A KK +Q A+K + K + +E E ++L
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H L + N++ VME GG+L+ I ++ A +I+ + F
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFL 119
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL- 326
H +G+V+RDLK +N L D +++ DFG+ + + D + N G+ Y+APE+L
Sbjct: 120 HSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
+ Y+ D WS GV+ Y +L G PF + E +F ++ +P + + EAKD
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKD 232
Query: 387 FVKRLLNKDYRKRMTAVQA-LTHPWLRD 413
+ +L ++ KR+ HP R+
Sbjct: 233 LLVKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 9e-69
Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 22/279 (7%)
Query: 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIED---VRREV 201
++Y++G +G G FG S + VA+K + K +++ + + V EV
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSD---NLPVAIKHVEKDRISDWGELPNGTRVPMEV 58
Query: 202 KILKALS-GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
+LK +S G +++ D E ++ +++E E + L + G EE A++ Q
Sbjct: 59 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
+L V CH GV+HRD+K EN L + +++LIDFG + D D G+ Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL-KDTVYTDFDGTRVY 175
Query: 321 VAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378
PE + HR + A +WS+G++ Y ++CG PF E ++R F
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----Q 225
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417
VS E + ++ L R T + HPW++D P
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 221 bits (565), Expect = 1e-68
Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 11/276 (3%)
Query: 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVK 202
+ +YELG+ +G G AR + + VAVK++ RRE +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 203 ILKALSGHKHLVKFCDACEDVNN----VYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
AL+ H +V D E YIVME +G L D I+ G T + A ++
Sbjct: 60 NAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVI 117
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG-LSDFIRPDERLNDIVGS 317
+ F H G++HRD+KP N + ++ M ++D + ++G+
Sbjct: 118 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
A Y++PE S +D++S+G + Y +L G PF + + +R DP
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 377 WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412
+S + V + L K+ R + +R
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 7e-68
Identities = 77/276 (27%), Positives = 125/276 (45%), Gaps = 23/276 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
YE+ +G G +G R K + + K + MT A + + EV +L+ L
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLREL 60
Query: 208 SGHKHLVKFCDACEDVNN--VYIVMELCEGGELLDRI---LARGGRYTEEDAKAIVVQIL 262
H ++V++ D D N +YIVME CEGG+L I EE ++ Q+
Sbjct: 61 K-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 263 SVVAFCHLQG-----VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-RLNDIVG 316
+ CH + V+HRDLKP N +++L DFGL+ + D VG
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKAFVG 176
Query: 317 SAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
+ YY++PE ++R SY+ ++DIWS+G + Y L PF A ++ + +
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--- 233
Query: 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411
S E + + R+LN R + + L +P +
Sbjct: 234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 1e-67
Identities = 72/316 (22%), Positives = 124/316 (39%), Gaps = 54/316 (17%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+E E+G G+ G K +A K+I + RE+++L
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLEIKPAIR--NQIIRELQVLHEC 61
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ ++V F A + I ME +GG L D++L + GR E+ + + ++ + +
Sbjct: 62 N-SPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 268 CH-LQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
++HRD+KP N L S +++L DFG+S + D N VG+ Y++PE L
Sbjct: 120 LREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERL 175
Query: 327 H-RSYSLEADIWSIGVISYILLCGSRPFWARTES---GIFRAVLRSDPNF---------- 372
YS+++DIWS+G+ + G P +F + D
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 373 ---------------------------DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
LP S E +DFV + L K+ +R Q
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 406 LTHPWLRD-DSRPVPL 420
+ H +++ D+ V
Sbjct: 296 MVHAFIKRSDAEEVDF 311
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (550), Expect = 2e-66
Identities = 61/281 (21%), Positives = 113/281 (40%), Gaps = 23/281 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ +G+ +G G FG KG+ VAVK+++ T ++ + EV +L+
Sbjct: 9 QITVGQRIGSGSFGTVY-----KGKWHGD-VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKT 61
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H +++ F + IV + CEG L + ++ I Q + +
Sbjct: 62 R-HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPE 324
H + ++HRDLK N D +++ DFGL+ + + GS ++APE
Sbjct: 120 LHAKSIIHRDLKSNNIFLHE---DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 325 VL----HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP--WP 378
V+ YS ++D+++ G++ Y L+ G P+ ++ DL
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419
+ K + L K +R Q L + +R +P
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILAS--IELLARSLP 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 211 bits (539), Expect = 1e-63
Identities = 67/274 (24%), Positives = 119/274 (43%), Gaps = 18/274 (6%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ + + +GRG FG R + A+K + K ++ E +L +S
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 209 --GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
+V A + + +++L GG+L L++ G ++E D + +I+ +
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL 326
H + VV+RDLKP N L + +R+ D GL+ ++ + VG+ Y+APEVL
Sbjct: 122 HMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVL 177
Query: 327 HR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
+ +Y AD +S+G + + LL G PF + R S SPE
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPEL 236
Query: 385 KDFVKRLLNKDYRKRMT-----AVQALTHPWLRD 413
+ ++ LL +D +R+ A + P+ R
Sbjct: 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 207 bits (527), Expect = 2e-62
Identities = 63/271 (23%), Positives = 129/271 (47%), Gaps = 20/271 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+++ + +G G FG R + + A+K++ K + +E E +L ++
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H +++ +D ++++M+ EGGEL +L + R+ AK ++ + +
Sbjct: 63 -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-H 327
H + +++RDLKPEN L + +++ DFG + ++ + + G+ Y+APEV+
Sbjct: 121 HSKDIIYRDLKPENILLDK---NGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVST 175
Query: 328 RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKDF 387
+ Y+ D WS G++ Y +L G PF+ + +L ++ F P + + KD
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDL 231
Query: 388 VKRLLNKDYRKRM-----TAVQALTHPWLRD 413
+ RL+ +D +R+ HPW ++
Sbjct: 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-61
Identities = 75/273 (27%), Positives = 127/273 (46%), Gaps = 19/273 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
++ K +G+G FG R K + A+KI+ K + + E ++L+
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H L A + + + VME GGEL + +R +TEE A+ +I+S + +
Sbjct: 63 R-HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEY 120
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAPEVL 326
H + VV+RD+K EN + D +++ DFGL + G+ Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 327 HRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385
+ Y D W +GV+ Y ++CG PF+ + +F +L + F ++SPEAK
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAK 233
Query: 386 DFVKRLLNKDYRKRM-----TAVQALTHPWLRD 413
+ LL KD ++R+ A + + H +
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-61
Identities = 77/277 (27%), Positives = 130/277 (46%), Gaps = 15/277 (5%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKA 206
+EL K +G G +G R G + A+K++ KA + A + E R E ++L+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 207 LSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
+ LV A + ++++++ GGEL L++ R+TE + + V +I+ +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP--DERLNDIVGSAYYVAPE 324
H G+++RD+K EN L + + L DFGLS ER D G+ Y+AP+
Sbjct: 144 HLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 325 VL---HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
++ + D WS+GV+ Y LL G+ PF E + R + +S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 382 PEAKDFVKRLLNKDYRKRM-----TAVQALTHPWLRD 413
AKD ++RLL KD +KR+ A + H + +
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 202 bits (515), Expect = 3e-61
Identities = 77/294 (26%), Positives = 130/294 (44%), Gaps = 38/294 (12%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
KY +++G G +G A+ G + A+K I K I RE+ ILK L
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYG----ETFALKKIRLEKEDEGI-PSTTIREISILKEL 57
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H ++VK D + +V E + +L + G AK+ ++Q+L+ +A+
Sbjct: 58 K-HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR-PDERLNDIVGSAYYVAPEVL 326
CH + V+HRDLKP+N L + ++++ DFGL+ P + + + +Y AP+VL
Sbjct: 116 CHDRRVLHRDLKPQNLLINR---EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 327 HRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP------ 378
S YS DIWS+G I ++ G+ F +E+ + R + WP
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 379 -------------------SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
+ D + ++L D +R+TA QAL H + ++
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 204 bits (519), Expect = 3e-61
Identities = 78/304 (25%), Positives = 136/304 (44%), Gaps = 53/304 (17%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
Y+L +++GRG + A +++V VKI+ K + ++RE+KIL+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKK------KKIKREIKILENL 86
Query: 208 SGHKHLVKFCDACEDV--NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
G +++ D +D +V E + T+ D + + +IL +
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKAL 142
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
+CH G++HRD+KP N + + +RLID+GL++F P + N V S Y+ PE+
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200
Query: 326 L--HRSYSLEADIWSIGVISYILLCGSRPFWA------------------RTESGIFRAV 365
L ++ Y D+WS+G + ++ PF+ I +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 366 LRSDPNFDDL----------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHP 409
+ DP F+D+ VSPEA DF+ +LL D++ R+TA +A+ HP
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320
Query: 410 WLRD 413
+
Sbjct: 321 YFYT 324
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 4e-61
Identities = 76/297 (25%), Positives = 121/297 (40%), Gaps = 37/297 (12%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+YE E+G G +G AR K + VA+K + + REV +L+ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMP-LSTIREVAVLRHL 64
Query: 208 SG--HKHLVKFCDAC-----EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQ 260
H ++V+ D C + + +V E + E K ++ Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 261 ILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYY 320
+L + F H VVHRDLKP+N L TS ++L DFGL+ L +V + +Y
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWY 181
Query: 321 VAPEVLHRS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP- 378
APEVL +S Y+ D+WS+G I + F ++ +L + WP
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 379 ----------------------SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413
+ KD + + L + KR++A AL+HP+ +D
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-60
Identities = 83/317 (26%), Positives = 134/317 (42%), Gaps = 50/317 (15%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
+ G +Y +G G +G CSA +VA+K IS + T + RE+KI
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVN---KVRVAIKKISPFEHQTYC--QRTLREIKI 59
Query: 204 LKALSGHKHLVKFCDAC-----EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
L H++++ D E + +VY+V L G +L + + + + +
Sbjct: 60 LLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL--KTQHLSNDHICYFL 115
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE----RLNDI 314
QIL + + H V+HRDLKP N L + D+++ DFGL+ PD L +
Sbjct: 116 YQILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEY 172
Query: 315 VGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR----- 367
V + +Y APE++ S Y+ DIWS+G I +L F + +L
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232
Query: 368 ------------------SDPNFDDLPW----PSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
S P+ + +PW P+ +A D + ++L + KR+ QA
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
Query: 406 LTHPWLRDDSRPVPLDI 422
L HP+L P I
Sbjct: 293 LAHPYLEQYYDPSDEPI 309
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 5e-60
Identities = 72/299 (24%), Positives = 119/299 (39%), Gaps = 37/299 (12%)
Query: 150 ELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAIS--IEDVRREVKILKAL 207
E +G G F AR K +Q VA+K I + A RE+K+L+ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNT---NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
S H +++ DA +N+ +V + E + I T KA ++ L + +
Sbjct: 58 S-HPNIIGLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL 326
H ++HRDLKP N L ++ ++L DFGL+ F P+ V + +Y APE+L
Sbjct: 116 LHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172
Query: 327 --HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP------ 378
R Y + D+W++G I LL ++ + + + WP
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 379 ------------------SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419
+ + D ++ L + R+TA QAL + + P P
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-59
Identities = 78/318 (24%), Positives = 130/318 (40%), Gaps = 54/318 (16%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
KYE ++G+G FG AR +K Q+VA+K + I RE+KIL+ L
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPIT-ALREIKILQLL 66
Query: 208 SGHKHLVKFCDACEDV--------NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVV 259
H+++V + C ++Y+V + CE L + ++T + K ++
Sbjct: 67 K-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQ 124
Query: 260 QILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-----RLNDI 314
+L+ + + H ++HRD+K N L T D ++L DFGL+ + R +
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 315 VGSAYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF 372
V + +Y PE+L R Y D+W G I + S TE + + +
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 373 DDLPWPSV----------------------------SPEAKDFVKRLLNKDYRKRMTAVQ 404
WP+V P A D + +LL D +R+ +
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 405 ALTHPWLRDDSRPVPLDI 422
AL H + D P+P D+
Sbjct: 302 ALNHDFFWSD--PMPSDL 317
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-59
Identities = 70/334 (20%), Positives = 123/334 (36%), Gaps = 58/334 (17%)
Query: 119 KESTIPEERGTEPEQSLDKSFGYNKNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQV 178
K +T+ G P++ + S Y K +G G FG A+ + V
Sbjct: 2 KVTTVVATPGQGPDRPQEVS----------YTDTKVIGNGSFGVVYQAKLCD---SGELV 48
Query: 179 AVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDAC------EDVNNVYIVMEL 232
A+K + + K RE++I++ L H ++V+ +D + +V++
Sbjct: 49 AIKKVLQDK-------RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100
Query: 233 CEGG--ELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRD 290
+ K + Q+ +A+ H G+ HRD+KP+N L D
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--D 158
Query: 291 DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRS--YSLEADIWSIGVISYILLC 348
A ++L DFG + + E + S YY APE++ + Y+ D+WS G + LL
Sbjct: 159 TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 218
Query: 349 GSRPFWARTESGIFRAVLR-------------------------SDPNFDDLPWPSVSPE 383
G F + +++ + + P PE
Sbjct: 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE 278
Query: 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417
A RLL R+T ++A H + + P
Sbjct: 279 AIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 5e-59
Identities = 79/300 (26%), Positives = 130/300 (43%), Gaps = 36/300 (12%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
++ +++G G +G AR K + VA+K I T + RE+ +LK L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGV-PSTAIREISLLKEL 58
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ H ++VK D N +Y+V E + K+ + Q+L +AF
Sbjct: 59 N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI-RPDERLNDIVGSAYYVAPEVL 326
CH V+HRDLKP+N L + ++L DFGL+ P V + +Y APE+L
Sbjct: 118 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 327 HRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS----- 379
YS DIWS+G I ++ F +E + R+ D++ WP
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 380 --------------------VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419
+ + + + ++L+ D KR++A AL HP+ +D ++PVP
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-58
Identities = 55/264 (20%), Positives = 98/264 (37%), Gaps = 13/264 (4%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
L +++G G FG K VAVK + ++ +++D REV + +L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H++L++ + +V EL G LLDR+ G + VQ+ + +
Sbjct: 70 -HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE----RLNDIVGSAYYVAPE 324
+ +HRDL N L +++ DFGL + ++ + APE
Sbjct: 128 ESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 325 VL-HRSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
L R++S +D W GV + + G P+ S I + +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCPQ 242
Query: 383 EAKDFVKRLLNKDYRKRMTAVQAL 406
+ + + + R T V
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-57
Identities = 59/264 (22%), Positives = 108/264 (40%), Gaps = 19/264 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
KE+G G FG + + VA+K+I + M S ++ E K++ LS
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQ----YDVAIKMIKEGSM----SEDEFIEEAKVMMNLS 57
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H+ LV+ C ++I+ E G LL+ + R+ + + + + +
Sbjct: 58 -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPEVL 326
+ +HRDL N L D +++ DFGLS ++ DE + PEVL
Sbjct: 117 ESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 327 -HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
+ +S ++DIW+ GV+ + I G P+ T S + + + S +
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKV 230
Query: 385 KDFVKRLLNKDYRKRMTAVQALTH 408
+ ++ +R T L++
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSN 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-57
Identities = 65/290 (22%), Positives = 117/290 (40%), Gaps = 36/290 (12%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD--QQVAVKIISKAKMTTAISIEDVRREVKILK 205
E GK +G G FG +A QVAVK++ + ++ E + E+K++
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EALMSELKMMT 95
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY---------------- 249
L H+++V AC +Y++ E C G+LL+ + ++ ++
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 250 ------TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303
T ED Q+ + F + VHRDL N L T +++ DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLAR 212
Query: 304 FIRPDERL---NDIVGSAYYVAPEVLHRS-YSLEADIWSIGVISY-ILLCGSRPFWARTE 358
I D + ++APE L Y++++D+WS G++ + I G P+
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 359 SGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
F ++++ D + E ++ D RKR + +
Sbjct: 273 DANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (491), Expect = 6e-57
Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 20/272 (7%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+++ K +G G FG + K+ A+KI+ K K+ IE E +IL+A+
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ LVK + +D +N+Y+VME GGE+ L R GR++E A+ QI+ +
Sbjct: 99 N-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS-HLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL- 326
H +++RDLKPEN L +++ DFG + R R + G+ +APE++
Sbjct: 157 LHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIIL 211
Query: 327 HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
+ Y+ D W++GV+ Y + G PF+A I+ ++ F S + KD
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKD 267
Query: 387 FVKRLLNKDYRKRM-----TAVQALTHPWLRD 413
++ LL D KR H W
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-56
Identities = 55/265 (20%), Positives = 103/265 (38%), Gaps = 23/265 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ +L + +G+G FG G+ + +VAVK I + E ++ L
Sbjct: 8 ELKLLQTIGKGEFGDVM-----LGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQL 57
Query: 208 SGHKHLVKFCDAC-EDVNNVYIVMELCEGGELLDRILARGGRY-TEEDAKAIVVQILSVV 265
H +LV+ E+ +YIV E G L+D + +RG + + + +
Sbjct: 58 R-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEV 325
+ VHRDL N L + +D ++ DFGL+ + + APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEA 171
Query: 326 L-HRSYSLEADIWSIGVISYILL-CGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
L + +S ++D+WS G++ + + G P+ + V + + P
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPA 228
Query: 384 AKDFVKRLLNKDYRKRMTAVQALTH 408
+ +K + D R + +Q
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-56
Identities = 57/274 (20%), Positives = 109/274 (39%), Gaps = 20/274 (7%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
E+G G+FG + + K VA+K++ + T E++ RE +I+ L + +
Sbjct: 15 IELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPY 70
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+V+ C+ + +VME+ GG L ++ + + ++ Q+ + + +
Sbjct: 71 IVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 129
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND----IVGSAYYVAPEVL-H 327
VHRDL N L + ++ DFGLS + D+ + APE +
Sbjct: 130 FVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186
Query: 328 RSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386
R +S +D+WS GV + L G +P+ + + + + P P PE
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--MECP-PECPPELYA 243
Query: 387 FVKRLLNKDYRKRMTA---VQALTHPWLRDDSRP 417
+ + R Q + + S+
Sbjct: 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (477), Expect = 1e-55
Identities = 55/284 (19%), Positives = 103/284 (36%), Gaps = 25/284 (8%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
G +Y LG+++G G FG ++VA+K+ + E KI K
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTK-----HPQLHIESKIYK 57
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
+ G + + + +VMEL L D +++ + + Q++S +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPS-LEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--------RLNDIVGS 317
+ H + +HRD+KP+NFL G+ + +IDFGL+ R ++ G+
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 318 AYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP 376
A Y + S D+ S+G + GS P+ + + R P
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 377 ----WPSVSPEAKDFVKRLLNKDYRKRMTA---VQALTHPWLRD 413
E ++ + + + Q + + R
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-55
Identities = 57/264 (21%), Positives = 104/264 (39%), Gaps = 19/264 (7%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+E+G G FG +VA+K I + M S ED E +++ LS
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREGAM----SEEDFIEEAEVMMKLS 58
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H LV+ C + + +V E E G L D + + G + E + + + +A+
Sbjct: 59 -HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND--IVGSAYYVAPEVL 326
V+HRDL N L ++ +++ DFG++ F+ D+ + + +PEV
Sbjct: 118 EEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 327 -HRSYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384
YS ++D+WS GV+ + + + + R+ S + + F S
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLASTHV 231
Query: 385 KDFVKRLLNKDYRKRMTAVQALTH 408
+ + R + L
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-55
Identities = 76/299 (25%), Positives = 128/299 (42%), Gaps = 38/299 (12%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
KYE +++G G +G A+ ++ + VA+K + + RE+ +LK L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRVRLDDDDEGV-PSSALREICLLKEL 58
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
HK++V+ D + +V E C+ G E K+ + Q+L + F
Sbjct: 59 K-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGF 116
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS-DFIRPDERLNDIVGSAYYVAPEVL 326
CH + V+HRDLKP+N L + +++L +FGL+ F P + V + +Y P+VL
Sbjct: 117 CHSRNVLHRDLKPQNLLINR---NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 327 HRS--YSLEADIWSIGVISYILLCGSRP-FWARTESGIFRAVLRSDPNFDDLPWPS---- 379
+ YS D+WS G I L RP F + + R + WPS
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 380 ---------------------VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRP 417
++ +D ++ LL + +R++A +AL HP+ D P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-54
Identities = 69/309 (22%), Positives = 128/309 (41%), Gaps = 48/309 (15%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
A Y + VG G +G CSA + +VA+K + + + + RE+++
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELF-AKRAYRELRL 70
Query: 204 LKALSGHKHLVKFCDAC------EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
LK + H++++ D +D + Y+VM L + + E+ + +
Sbjct: 71 LKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---DLGKLMKHEKLGEDRIQFL 126
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
V Q+L + + H G++HRDLKP N +D +++++DFGL+ D + V +
Sbjct: 127 VYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ--ADSEMTGYVVT 181
Query: 318 AYYVAPEVL--HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
+Y APEV+ Y+ DIWS+G I ++ G F + +++
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 376 PW---------------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
+ SP A + ++++L D +R+TA +AL H
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301
Query: 409 PWLRDDSRP 417
P+
Sbjct: 302 PYFESLHDT 310
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-54
Identities = 59/268 (22%), Positives = 114/268 (42%), Gaps = 22/268 (8%)
Query: 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKH 212
KE+G G+FG + ++ + VAVKI+ A+ +++ E +++ L + +
Sbjct: 13 KELGSGNFGTVKKGYYQMKKV-VKTVAVKILKNEANDPAL-KDELLAEANVMQQLD-NPY 69
Query: 213 LVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG 272
+V+ CE + +VME+ E G L ++ L + +++ +V Q+ + +
Sbjct: 70 IVRMIGICEA-ESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 273 VVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND----IVGSAYYVAPEVL-H 327
VHRDL N L + ++ DFGLS +R DE + APE + +
Sbjct: 128 FVHRDLAARNVLLVT---QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 328 RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSPEAK 385
+S ++D+WS GV+ + G +P+ S + + + + + P+ E
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----MGCPAGCPREMY 240
Query: 386 DFVKRLLNKDYRKRMTA---VQALTHPW 410
D + D R L + +
Sbjct: 241 DLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 7e-54
Identities = 62/266 (23%), Positives = 106/266 (39%), Gaps = 16/266 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ ELG+ +G G FG E VA+K + E +E ++
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 65
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
H H+VK + N V+I+MELC GEL + R Q+ + +A+
Sbjct: 66 D-HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPEV 325
+ VHRD+ N L +S ++L DFGLS ++ + + ++APE
Sbjct: 124 LESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 326 L-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS-VSP 382
+ R ++ +D+W GV + IL+ G +PF + + + + LP P P
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----LPMPPNCPP 236
Query: 383 EAKDFVKRLLNKDYRKRMTAVQALTH 408
+ + D +R +
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-53
Identities = 62/271 (22%), Positives = 107/271 (39%), Gaps = 23/271 (8%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
L ++G+G FG +VA+K + M S E +E +++K L
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTM----SPEAFLQEAQVMKKL 69
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYT-EEDAKAIVVQILSVVA 266
H+ LV+ + +YIV E G LLD + G+Y + QI S +A
Sbjct: 70 R-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPE 324
+ VHRDL+ N L ++ ++ DFGL+ I +E + APE
Sbjct: 128 YVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNFDDLPWPSVSP 382
+ +++++D+WS G++ L R + + V R + P
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPE 241
Query: 383 EAKDFVKRLLNKDYRKRMTA--VQALTHPWL 411
D + + K+ +R T +QA +
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (461), Expect = 3e-53
Identities = 58/268 (21%), Positives = 103/268 (38%), Gaps = 17/268 (6%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
++ + +G G FG CS K ++ VA+K + T D E I+
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD 85
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFC 268
H +++ V I+ E E G L + G++T ++ I + + +
Sbjct: 86 -HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 269 HLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND------IVGSAYYVA 322
VHRDL N L S + ++ DFGLS F+ D + A
Sbjct: 145 ADMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 323 PEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380
PE + +R ++ +D+WS G++ + ++ G RP+W T + A+ + ++ P
Sbjct: 202 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDC 258
Query: 381 SPEAKDFVKRLLNKDYRKRMTAVQALTH 408
+ KD R Q +
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-53
Identities = 76/343 (22%), Positives = 135/343 (39%), Gaps = 57/343 (16%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+Y+ K +G G G C+A D+ VA+K +S+ + RE+ ++K +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQT-HAKRAYRELVLMKCV 73
Query: 208 SGHKHLVKFCDAC------EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQI 261
+ HK+++ + E+ +VY+VMEL + E ++ Q+
Sbjct: 74 N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQM 128
Query: 262 LSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSAYYV 321
L + H G++HRDLKP N + S D ++++DFGL+ + V + YY
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 322 APE-VLHRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLR------------- 367
APE +L Y DIWS+G I ++ F R + V+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 368 ---------SDPNFDDLPWPS----------------VSPEAKDFVKRLLNKDYRKRMTA 402
+ P + L +P + +A+D + ++L D KR++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 403 VQALTHPWLRDDSRPVPLDILIFKLVKSYLHATPFKRAALKAL 445
AL HP++ P ++ ++ L K L
Sbjct: 306 DDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 348
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 5e-53
Identities = 64/283 (22%), Positives = 105/283 (37%), Gaps = 31/283 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD--QQVAVKIISKAKMTTAISIEDVRREVKILK 205
+ GK +G G FG A D VAVK++ + T E + E+K+L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLS 81
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-----------------GR 248
L H ++V AC ++ E C G+LL+ + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
ED + Q+ +AF + +HRDL N L ++ DFGL+ I+ D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKND 198
Query: 309 ERL---NDIVGSAYYVAPEVLHRSY-SLEADIWSIGVISYILLCGSRP-FWARTESGIFR 363
+ ++APE + + E+D+WS G+ + L + F
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
+++ F L E D +K + D KR T Q +
Sbjct: 259 KMIK--EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 9e-53
Identities = 56/294 (19%), Positives = 111/294 (37%), Gaps = 28/294 (9%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS 208
+ +G G+FG AR KK L+ A+K + + D E+++L L
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLR-MDAAIKRMKEYASKD--DHRDFAGELEVLCKLG 68
Query: 209 GHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILAR---------------GGRYTEED 253
H +++ ACE +Y+ +E G LLD + + +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 254 AKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLND 313
+ + + + +HRDL N L ++ ++ DFGLS +
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTM 185
Query: 314 IVGSAYYVAPEVLHRS-YSLEADIWSIGVISYILL-CGSRPFWARTESGIFRAVLRSDPN 371
++A E L+ S Y+ +D+WS GV+ + ++ G P+ T + ++ + +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---G 242
Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH--PWLRDDSRPVPLDIL 423
+ + E D +++ + +R + Q L L + V +
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 296
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-52
Identities = 57/264 (21%), Positives = 106/264 (40%), Gaps = 21/264 (7%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+L + +G G FG +VAVK + + M S + E ++K L
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGH----TKVAVKSLKQGSM----SPDAFLAEANLMKQL 65
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGG-RYTEEDAKAIVVQILSVVA 266
H+ LV+ +YI+ E E G L+D + G + T + QI +A
Sbjct: 66 Q-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPE 324
F + +HRDL+ N L D ++ DFGL+ I +E + APE
Sbjct: 124 FIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 325 VL-HRSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382
+ + ++++++D+WS G++ ++ G P+ T + + + R + + +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GYRMVRPDNCPE 237
Query: 383 EAKDFVKRLLNKDYRKRMTAVQAL 406
E ++ + R T
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLR 261
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 177 bits (450), Expect = 1e-51
Identities = 55/269 (20%), Positives = 103/269 (38%), Gaps = 24/269 (8%)
Query: 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
G Y++G+ +G G FG +QQVA+K + +R E + K
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSD-----APQLRDEYRTYK 55
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVV 265
L+G + ++ + +V++L G L D + G +++ + Q+L+ V
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 266 AFCHLQGVVHRDLKPENFLFTSGRDDAD--MRLIDFGLSDFIRPDE--------RLNDIV 315
H + +V+RD+KP+NFL + ++DFG+ F R ++
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 316 GSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374
G+A Y++ R S D+ ++G + L GS P+ + + R
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 375 LP----WPSVSPEAKDFVKRLLNKDYRKR 399
P E ++ N +
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-51
Identities = 54/280 (19%), Positives = 109/280 (38%), Gaps = 16/280 (5%)
Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
++ K +G G FG GE VA+K + +A A +++ E ++ ++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASV 68
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
+ H+ + C + V ++ +L G LLD + + VQI + +
Sbjct: 69 D-NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPE 324
+ +VHRDL N L + +++ DFGL+ + +E+ ++A E
Sbjct: 127 LEDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
+ HR Y+ ++D+WS GV + L+ + + ++L P + +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ--PPICTID 241
Query: 384 AKDFVKRLLNKDYRKRMTAVQALTH--PWLRDDSRPVPLD 421
+ + D R + + RD R + +
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 281
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 7e-51
Identities = 58/281 (20%), Positives = 111/281 (39%), Gaps = 28/281 (9%)
Query: 148 KYELGKEVGRGHFGHTCSAR----GKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
+ LGK +G G FG A K + +VAVK++ T + D+ E+++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEM 71
Query: 204 LKALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG---------------GR 248
+K + HK+++ AC +Y+++E G L + + AR +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 249 YTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308
+ +D + Q+ + + + +HRDL N L T I
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 309 ERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISY-ILLCGSRPFWARTESGIFRAVL 366
++ + ++APE L R Y+ ++D+WS GV+ + I G P+ +F+ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 367 RSDPNFDDLPWPS-VSPEAKDFVKRLLNKDYRKRMTAVQAL 406
+ PS + E ++ + +R T Q +
Sbjct: 252 EGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 4e-50
Identities = 75/314 (23%), Positives = 132/314 (42%), Gaps = 48/314 (15%)
Query: 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKI 203
+Y+ VG G +G C+A K +VAVK +S+ + I + RE+++
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSI-IHAKRTYRELRL 70
Query: 204 LKALSGHKHLVKFCDACE------DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAI 257
LK + H++++ D + N+VY+V L + + + T++ + +
Sbjct: 71 LKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQFL 126
Query: 258 VVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGS 317
+ QIL + + H ++HRDLKP N +D +++++DFGL+ D+ + V +
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHT--DDEMTGYVAT 181
Query: 318 AYYVAPEVLHRS--YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375
+Y APE++ Y+ DIWS+G I LL G F + +LR
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 376 PW---------------------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
+P A D ++++L D KR+TA QAL H
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 409 PWLRDDSRPVPLDI 422
+ P +
Sbjct: 302 AYFAQYHDPDDEPV 315
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 6e-50
Identities = 52/274 (18%), Positives = 104/274 (37%), Gaps = 19/274 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ ++G G +G KK VAVK + + M +E+ +E ++K +
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKTLKEDTM----EVEEFLKEAAVMKEI 70
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVA 266
H +LV+ C YI+ E G LLD + + + QI S +
Sbjct: 71 K-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE--RLNDIVGSAYYVAPE 324
+ + +HRDL N L ++ +++ DFGLS + D + APE
Sbjct: 130 YLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 325 VL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383
L + +S+++D+W+ GV+ + + + + +L D + +
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME--RPEGCPEK 244
Query: 384 AKDFVKRLLNKDYRKRMTAVQALT--HPWLRDDS 415
+ ++ + R + + ++ S
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 1e-47
Identities = 52/289 (17%), Positives = 106/289 (36%), Gaps = 39/289 (13%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD--QQVAVKIISKAKMTTAISIEDVRREVKILK 205
E +++G G FG AR + VAVK++ + D +RE ++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMA 71
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRY---------------- 249
+ ++VK C + ++ E G+L + + +
Sbjct: 72 EFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 250 -------TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302
+ + I Q+ + +A+ + VHRDL N L ++ +++ DFGLS
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS 187
Query: 303 DFIRPDERL---NDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSR-PFWART 357
I + + ++ PE + + Y+ E+D+W+ GV+ + + P++
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 358 ESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406
+ V D N P + E + ++ +K R +
Sbjct: 248 HEEVIYYVR--DGNILACP-ENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-47
Identities = 48/269 (17%), Positives = 99/269 (36%), Gaps = 17/269 (6%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+ +GRGHFG + K AVK +++ + E I+K
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV--SQFLTEGIIMKDF 85
Query: 208 SGHKHLVKFCDAC-EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVA 266
S H +++ C + +V+ + G+L + I T +D +Q+ +
Sbjct: 86 S-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 267 FCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-----RLNDIVGSAYYV 321
F + VHRDL N + + +++ DFGL+ + E ++
Sbjct: 145 FLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 322 APEVLH-RSYSLEADIWSIGVISYILLCGSRPFWA-RTESGIFRAVLRSDPNFDDLPWPS 379
A E L + ++ ++D+WS GV+ + L+ P + I +L+
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EY 258
Query: 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
+ + + + R + + ++
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 7e-45
Identities = 51/265 (19%), Positives = 100/265 (37%), Gaps = 16/265 (6%)
Query: 149 YELGKEVGRGHFGHTCSARGKK-GELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
K +G G FG K K+ VA+K + T D E I+
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF 66
Query: 208 SGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAF 267
S H ++++ + I+ E E G L + + G ++ ++ I + + +
Sbjct: 67 S-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 268 CHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER----LNDIVGSAYYVAP 323
VHRDL N L + ++ DFGLS + D + + AP
Sbjct: 126 LANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 324 EVL-HRSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381
E + +R ++ +D+WS G++ + ++ G RP+W + + +A+ + F
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---NDGFRLPTPMDCP 239
Query: 382 PEAKDFVKRLLNKDYRKRMTAVQAL 406
+ + ++ +R +
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIV 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-44
Identities = 51/290 (17%), Positives = 118/290 (40%), Gaps = 31/290 (10%)
Query: 148 KYELGKEVGRGHFG--HTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILK 205
K + +E+G+G FG + A+G + + +VA+K +++A + E ++K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMK 78
Query: 206 ALSGHKHLVKFCDACEDVNNVYIVMELCEGGELLDRILARGGR---------YTEEDAKA 256
+ H+V+ ++MEL G+L + + +
Sbjct: 79 EFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 257 IVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERL---ND 313
+ +I +A+ + VHRDL N + +D +++ DFG++ I +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 314 IVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRAVLRSDPN 371
+ +++PE L ++ +D+WS GV+ + + + P+ + + R V+ +
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--EGG 252
Query: 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT------HPWLRDDS 415
D P + + ++ + + R + ++ ++ P R+ S
Sbjct: 253 LLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 7e-44
Identities = 58/301 (19%), Positives = 112/301 (37%), Gaps = 57/301 (18%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
L + +G+G FG +G+ + ++VAVKI S + + E+ L
Sbjct: 4 TIVLQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWFR----EAEIYQTVML 54
Query: 208 SGHKHLVKFCDACEDVNN----VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILS 263
H++++ F A N +++V + E G L D + T E + + S
Sbjct: 55 R-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTAS 111
Query: 264 VVAFCHLQ--------GVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE-----R 310
+A H++ + HRDLK +N L + + D GL+
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIA 168
Query: 311 LNDIVGSAYYVAPEVL-------HRSYSLEADIWSIGVISYILLCGSRPFWARTESGI-F 362
N VG+ Y+APEVL H ADI+++G++ + + + + +
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228
Query: 363 RAVLRSDPNFDDL-----------------PWPSVSPEAKDFVKRLLNKDYRKRMTAVQA 405
++ SDP+ +++ ++ + R+TA++
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
Query: 406 L 406
Sbjct: 289 K 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-43
Identities = 61/284 (21%), Positives = 116/284 (40%), Gaps = 30/284 (10%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKD--QQVAVKIISKAKMTTAISIEDVRREVKILK 205
+ +LGK +GRG FG A + + VAVK++ + + + E+KIL
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILI 71
Query: 206 ALSGHKHLVKFCDAC-EDVNNVYIVMELCEGGELLDRILARGGRY--------------- 249
+ H ++V AC + + +++E C+ G L + ++ +
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 250 TEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDE 309
T E Q+ + F + +HRDL N L + + +++ DFGL+ I D
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 188
Query: 310 ---RLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSR-PFWARTESGIFRA 364
R D ++APE + R Y++++D+WS GV+ + + P+ F
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 365 VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408
L+ + +PE + + + +R T + + H
Sbjct: 249 RLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (384), Expect = 9e-42
Identities = 75/344 (21%), Positives = 125/344 (36%), Gaps = 68/344 (19%)
Query: 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKAL 207
+Y L +++G GHF A+ + VA+KI+ K+ T E E+K+L+ +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVN---NTHVAMKIVRGDKVYT----EAAEDEIKLLQRV 66
Query: 208 S----------GHKHLVK----FCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEED 253
+ G H++K F + +V +V E+ L
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 254 AKAIVVQILSVVAFCHLQ-GVVHRDLKPENFLFTS-GRDDADMRLIDFGLSDFIRPDERL 311
K I Q+L + + H + G++H D+KPEN L + +++ L + DE
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 312 NDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYILLCGSRPFWARTESGIF-------- 362
+ + + Y +PEVL + ADIWS + + L+ G F
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 363 -------------------------RAVLRSDPNFDDLPWPSV-----------SPEAKD 386
R +LR+ P V + E D
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 387 FVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVPLDILIFKLVKS 430
F+ +L D RKR A + HPWL+D + + +L S
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGS 350
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 90.2 bits (223), Expect = 2e-21
Identities = 45/208 (21%), Positives = 72/208 (34%), Gaps = 29/208 (13%)
Query: 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKII-----SKAKMTTAISIEDVR-REVK 202
+GK +G G + +K + VK S K+ D+ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA 57
Query: 203 ILKALSGHKHLVKFCDACE----DVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIV 258
I A + + L K ++MEL + R E+ ++
Sbjct: 58 IRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVL 109
Query: 259 VQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDERLNDIVGSA 318
IL VA + +G+VH DL N L + + +IDF S + +E +I+
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVG-EEGWREILERD 164
Query: 319 YYVAPEVLHRSYSLEADIWSIGVISYIL 346
R+Y E DI S I IL
Sbjct: 165 VRNIITYFSRTYRTEKDINS--AIDRIL 190
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 57.2 bits (137), Expect = 2e-10
Identities = 33/148 (22%), Positives = 67/148 (45%), Gaps = 9/148 (6%)
Query: 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLA 505
S LTE+++ + F L + + +GS+S V+ E+ V D+++ ++
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLS-PSEAEVNDLMNEIDVDG 59
Query: 506 YRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL-NVGPSA 564
++ F EF A + EQ AF+ F++ G+ +IS EL L ++G
Sbjct: 60 NHQIEFSEFLALMSRQLK---SNDSEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKL 116
Query: 565 Y-SFLKDWIR---NSDGKLSLHGYTKFL 588
+ + D +R + G++++ + L
Sbjct: 117 TDAEVDDMLREVSDGSGEINIQQFAALL 144
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 57.6 bits (138), Expect = 2e-10
Identities = 30/149 (20%), Positives = 64/149 (42%), Gaps = 7/149 (4%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRK 508
L+E+ + +A F + + + G +S + V+ + +E + ++ ++
Sbjct: 14 LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE-ELDAIIEEVDEDGSGT 72
Query: 509 MYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYS-- 566
+ FEEF + + +A E+ + F F++ + I IEEL L +
Sbjct: 73 IDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEE 132
Query: 567 ----FLKDWIRNSDGKLSLHGYTKFLHGV 591
+KD +N+DG++ + K + GV
Sbjct: 133 DIEDLMKDSDKNNDGRIDFDEFLKMMEGV 161
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 50.3 bits (119), Expect = 6e-08
Identities = 33/156 (21%), Positives = 69/156 (44%), Gaps = 8/156 (5%)
Query: 443 KALSKALTEDELVYLRAQFRLLEPN-KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSM 501
KA + LTE++ +A F + +DGS+S + V+ R + +++ +
Sbjct: 2 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVM-RMLGQNPTPEELQEMIDEV 60
Query: 502 ESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG 561
+ + F+EF + + + ++ E+ S F F++ + I +EEL L
Sbjct: 61 DEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQAT 120
Query: 562 PSAYS------FLKDWIRNSDGKLSLHGYTKFLHGV 591
+ +KD +N+DG++ + +F+ GV
Sbjct: 121 GETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV 156
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 47.7 bits (112), Expect = 7e-07
Identities = 27/145 (18%), Positives = 73/145 (50%), Gaps = 9/145 (6%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRK 508
L+E+E+ L+ F++++ + G+++ + + L + + ES + D++ + +
Sbjct: 4 LSEEEIGGLKELFKMIDTDNSGTITFDELKDGL-KRVGSELMESEIKDLMDAADIDKSGT 62
Query: 509 MYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEEL---ARELNVGPS-A 564
+ + EF AA + ++LE E AF YF+++G+ I+++E+ ++ +
Sbjct: 63 IDYGEFIAATVHLNKLEREENLVS----AFSYFDKDGSGYITLDEIQQACKDFGLDDIHI 118
Query: 565 YSFLKDWIRNSDGKLSLHGYTKFLH 589
+K+ +++DG++ + +
Sbjct: 119 DDMIKEIDQDNDGQIDYGEFAAMMR 143
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Score = 46.4 bits (109), Expect = 1e-06
Identities = 25/146 (17%), Positives = 65/146 (44%), Gaps = 10/146 (6%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRK 508
LTE+++ + F L + + DG+++ + V+ + E+ + D+++ +++
Sbjct: 3 LTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQN-PTEAELQDMINEVDADGNGT 61
Query: 509 MYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYS-- 566
+ F EF + + + E+ AF+ F+ +GN +IS EL + +
Sbjct: 62 IDFPEFLSLMARKMK---EQDSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDD 118
Query: 567 ----FLKDWIRNSDGKLSLHGYTKFL 588
+++ + DG ++ + + +
Sbjct: 119 EVDEMIREADIDGDGHINYEEFVRMM 144
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 43.0 bits (101), Expect = 4e-06
Identities = 15/77 (19%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 443 KALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSME 502
K +++ L+E+E+ L+ F++++ + G+++ + + L + + ES + D++ + +
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGL-KRVGSELMESEIKDLMDAAD 69
Query: 503 SLAYRKMYFEEFCAAAI 519
+ + EF AA +
Sbjct: 70 IDKSGTIDYGEFIAATV 86
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 43.8 bits (102), Expect = 3e-05
Identities = 22/176 (12%), Positives = 50/176 (28%), Gaps = 4/176 (2%)
Query: 172 ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVME 231
+++ + +K+ T DV RE ++ L G + K ++M
Sbjct: 34 VGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90
Query: 232 LCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDD 291
+G + + A +++ + D + + D
Sbjct: 91 EADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150
Query: 292 ADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVL-HRSYSLEADIWSIGVISYIL 346
AD+ ++ + L D + + V H G +S +
Sbjct: 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFI 206
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Score = 39.6 bits (92), Expect = 6e-05
Identities = 17/71 (23%), Positives = 37/71 (52%), Gaps = 7/71 (9%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSMESLA 505
LTE+++ + F L + + DG+++ + V LG+N T+A + D+++ +++
Sbjct: 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAE----LQDMINEVDADG 57
Query: 506 YRKMYFEEFCA 516
+ F EF
Sbjct: 58 NGTIDFPEFLT 68
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (95), Expect = 6e-05
Identities = 21/145 (14%), Positives = 57/145 (39%), Gaps = 10/145 (6%)
Query: 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKM 509
TE++ +R F L + + G++ ++ ++ + + +E + + +
Sbjct: 1 TEEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMN 60
Query: 510 YFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR---ELNVGPS--- 563
+ + + + E + AF+ F+++ IS + L R EL +
Sbjct: 61 FGDFLTVMTQKMSEKDTKEEILK----AFKLFDDDETGKISFKNLKRVAKELGENLTDEE 116
Query: 564 AYSFLKDWIRNSDGKLSLHGYTKFL 588
+ + R+ DG++S + + +
Sbjct: 117 LQEMIDEADRDGDGEVSEQEFLRIM 141
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 38.8 bits (90), Expect = 1e-04
Identities = 18/74 (24%), Positives = 36/74 (48%), Gaps = 7/74 (9%)
Query: 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMV---LGRNATDAMRESRVPDVLSSME 502
S LTE+++ + F L + + +GS+S V LG + ++A D+++ ++
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVN----DLMNEID 56
Query: 503 SLAYRKMYFEEFCA 516
++ F EF A
Sbjct: 57 VDGNHQIEFSEFLA 70
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Score = 39.7 bits (91), Expect = 3e-04
Identities = 22/155 (14%), Positives = 50/155 (32%), Gaps = 15/155 (9%)
Query: 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKM 509
++ + ++ F ++ +KDG+++ +F + R A ++ ++ VL + +
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNF 60
Query: 510 Y----------FEEFCAAAISTHQLE-ALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558
F + + A E F + + IS +E
Sbjct: 61 LTAVAGGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFF 120
Query: 559 NVGPSAYSFLKDWIR----NSDGKLSLHGYTKFLH 589
+ + N+DG LSL +
Sbjct: 121 GMLGLDKTMAPASFDAIDTNNDGLLSLEEFVIAGS 155
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Score = 39.2 bits (90), Expect = 4e-04
Identities = 19/166 (11%), Positives = 51/166 (30%), Gaps = 25/166 (15%)
Query: 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLA 505
+ A+ D L + +F + + +G++ +F A +++ +V + +
Sbjct: 1 TTAIASDRL---KKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFG 57
Query: 506 YR--------------KMYFEEFCAAAIS----THQLEALEGWEQIASTAFEYFEEEGNR 547
+ E+F + + + ++ +
Sbjct: 58 GLFDYLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADG 117
Query: 548 VISIEELARELNVGPSAYSFLKDWIR----NSDGKLSLHGYTKFLH 589
I+ +E A L + + + N +G+LSL +
Sbjct: 118 QINADEFAAWLTALGMSKAEAAEAFNQVDTNGNGELSLDELLTAVR 163
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Score = 39.6 bits (91), Expect = 6e-04
Identities = 14/74 (18%), Positives = 29/74 (39%), Gaps = 1/74 (1%)
Query: 442 LKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSM 501
L+ L+E++ LR F + G S ++ + VL D + E + + +
Sbjct: 109 LRPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVL-AKYADTIPEGPLKKLFVMV 167
Query: 502 ESLAYRKMYFEEFC 515
E+ +M +
Sbjct: 168 ENDTKGRMSYITLV 181
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Score = 38.8 bits (89), Expect = 7e-04
Identities = 16/156 (10%), Positives = 43/156 (27%), Gaps = 22/156 (14%)
Query: 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMR---------ESRVPDVLSSMESLAYR 507
+ F L+ N +G +SL+ + + + V
Sbjct: 14 HKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGV 73
Query: 508 KMYFEEFC-------AAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNV 560
+ + + + + F+ +++ N I+++E
Sbjct: 74 ETDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKA 133
Query: 561 --GPSAYSFLKDWIR----NSDGKLSLHGYTKFLHG 590
+ ++ R + G+L + T+ G
Sbjct: 134 AGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQHLG 169
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 35.2 bits (81), Expect = 0.001
Identities = 10/66 (15%), Positives = 29/66 (43%), Gaps = 3/66 (4%)
Query: 451 EDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMY 510
E+E+ F++ + N DG + + F+ ++ + + + ++ V + + + +
Sbjct: 1 EEEI---LRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVID 57
Query: 511 FEEFCA 516
EF
Sbjct: 58 IPEFMD 63
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.002
Identities = 17/137 (12%), Positives = 40/137 (29%), Gaps = 5/137 (3%)
Query: 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCA 516
+ F L + DG + V+ + + + + + E
Sbjct: 2 FKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFL 61
Query: 517 AAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAR-----ELNVGPSAYSFLKDW 571
+ +G + F F++EGN + EL + +
Sbjct: 62 PMLQAVAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG 121
Query: 572 IRNSDGKLSLHGYTKFL 588
+S+G ++ + K +
Sbjct: 122 HEDSNGCINYEAFLKHI 138
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 35.3 bits (81), Expect = 0.002
Identities = 12/68 (17%), Positives = 28/68 (41%), Gaps = 1/68 (1%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRK 508
L+E+ + +A F + + + G +S + V R + + ++ ++
Sbjct: 8 LSEEMIAEFKAAFDMFDADGGGDISTKELGTV-MRMLGQNPTKEELDAIIEEVDEDGSGT 66
Query: 509 MYFEEFCA 516
+ FEEF
Sbjct: 67 IDFEEFLV 74
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} Length = 165 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.6 bits (83), Expect = 0.003
Identities = 20/154 (12%), Positives = 51/154 (33%), Gaps = 5/154 (3%)
Query: 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRK 508
DE+ L +F+ L+ + GS+S+E F + ++ + + K
Sbjct: 10 FDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNPLVQR-VIDIFDTDGNGEVDFK 68
Query: 509 MYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFL 568
+ E ++ + + L +I + + G ++ + +
Sbjct: 69 EFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIV 128
Query: 569 KDWIR----NSDGKLSLHGYTKFLHGVTLRSSNT 598
I + DG++S + + G+ +
Sbjct: 129 DKTIINADKDGDGRISFEEFCAVVGGLDIHKKMV 162
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Score = 34.6 bits (79), Expect = 0.003
Identities = 18/78 (23%), Positives = 36/78 (46%), Gaps = 8/78 (10%)
Query: 443 KALSKALTEDELVYLRAQFRLLEPN-KDGSVSLENFRMVL---GRNATDAMRESRVPDVL 498
KA + LTE++ +A F + +DGS+S + V+ G+N T + +++
Sbjct: 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQ----EMI 58
Query: 499 SSMESLAYRKMYFEEFCA 516
++ + F+EF
Sbjct: 59 DEVDEDGSGTVDFDEFLV 76
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 601 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.86 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 99.86 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.84 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.84 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 99.83 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 99.82 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 99.82 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 99.81 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 99.81 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.81 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 99.8 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 99.8 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 99.78 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 99.77 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 99.76 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 99.76 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 99.76 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 99.75 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 99.75 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 99.75 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 99.75 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 99.74 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 99.72 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 99.71 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 99.71 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 99.7 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 99.69 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 99.68 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 99.68 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 99.67 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 99.66 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 99.66 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 99.64 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 99.62 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 99.61 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 99.59 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 99.58 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 99.58 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 99.49 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 99.45 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 99.43 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 99.43 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 99.41 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 99.38 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 99.37 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 99.36 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 99.35 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 99.33 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.32 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 99.32 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 99.3 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 99.3 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.3 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.29 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 99.28 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 99.28 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 99.27 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 99.26 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 99.26 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.23 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.23 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 99.21 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 99.2 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 99.17 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.15 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.15 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 99.15 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 99.14 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 99.14 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 99.14 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.13 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 99.13 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 99.13 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.13 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 99.13 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.13 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 99.12 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 99.11 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 99.11 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.1 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 99.09 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 99.09 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 99.08 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 99.07 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 99.07 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 99.05 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.01 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 98.98 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 98.98 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 98.98 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 98.97 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 98.95 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.94 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 98.94 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 98.94 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 98.93 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.93 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 98.91 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.91 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 98.91 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 98.88 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 98.88 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 98.88 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 98.88 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.86 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 98.84 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 98.84 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.83 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 98.83 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.82 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 98.81 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 98.81 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.81 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 98.81 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 98.79 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 98.78 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.77 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.77 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 98.75 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 98.75 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 98.75 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 98.74 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 98.72 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 98.71 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.7 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 98.7 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 98.69 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 98.69 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 98.69 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 98.68 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 98.67 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 98.67 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.67 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 98.67 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 98.66 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 98.64 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.62 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.6 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 98.55 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 98.51 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 98.5 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 98.49 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 98.49 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 98.46 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.46 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 98.43 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.28 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 98.24 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.21 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 98.17 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 98.11 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.1 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 98.1 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 98.09 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 98.04 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.04 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 97.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.9 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 97.86 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 97.8 | |
| d1tuza_ | 118 | Diacylglycerol kinase alpha, N-terminal domain {Hu | 97.51 | |
| d1tuza_ | 118 | Diacylglycerol kinase alpha, N-terminal domain {Hu | 97.47 | |
| d1sraa_ | 151 | C-terminal (EC) domain of BM-40/SPARC/osteonectin | 97.13 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.04 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.83 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.21 | |
| d1sraa_ | 151 | C-terminal (EC) domain of BM-40/SPARC/osteonectin | 95.16 | |
| d2cclb1 | 59 | Endo-1,4-beta-xylanase Y {Clostridium thermocellum | 91.65 | |
| d1qasa1 | 94 | Phosphoinositide-specific phospholipase C, isozyme | 91.59 | |
| d1qasa1 | 94 | Phosphoinositide-specific phospholipase C, isozyme | 91.36 | |
| d1pula1 | 103 | Hypothetical protein c32e8.3 {Caenorhabditis elega | 90.14 | |
| d1j7qa_ | 86 | Calcium vector protein {Amphioxus (Branchiostoma l | 89.82 | |
| d1h8ba_ | 73 | alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | 89.06 | |
| d2cclb1 | 59 | Endo-1,4-beta-xylanase Y {Clostridium thermocellum | 86.08 | |
| d2b59b1 | 60 | Cellulosomal scaffolding protein A {Clostridium th | 84.7 | |
| d1dava_ | 71 | Cellulosome endoglucanase SS {Clostridium thermoce | 80.81 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-61 Score=489.16 Aligned_cols=288 Identities=37% Similarity=0.686 Sum_probs=232.3
Q ss_pred cccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 143 KNFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 143 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
+++.+.|++++.||+|+||+||+|+++. +++.||||++.+..... ....+.+|+.+|++|+ |||||++++++.+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKR---TQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIK-HPNIVALDDIYES 78 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETT---TCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence 3456679999999999999999999876 78899999998765433 2356889999999996 9999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 223 VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
++.+|||||||+||+|.+++.. .+.+++.+++.|+.||+.||.|||++||+||||||+|||+...++++.+||+|||+|
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred CCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecccee
Confidence 9999999999999999998865 467999999999999999999999999999999999999976556889999999999
Q ss_pred cccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 303 DFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 303 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
+.........+.+||+.|||||++. +.|+.++|||||||++|||++|+.||.+....++...+.+....++...++.+|
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCC
Confidence 8877666677789999999999987 469999999999999999999999999999999999999888877776677899
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC-CCChhHHHHHHHHhhhccCch
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR-PVPLDILIFKLVKSYLHATPF 437 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~-~~~~~~~~~~~~k~~~~~~~l 437 (601)
+++++||.+||.+||++|||++|+|+||||++... ...+...+...++......++
T Consensus 238 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKW 294 (307)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCCCCCHHHHHHHHHHHSCCCTT
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCccccccchhHHHHHHHHHHHhhh
Confidence 99999999999999999999999999999986543 344555555556655555443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-61 Score=473.55 Aligned_cols=255 Identities=29% Similarity=0.594 Sum_probs=230.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++++.||+|+||.||+|+++. +++.||||++.+.........+.+.+|++++++++ |||||++++++.+.+.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRV 81 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECC---CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEE
Confidence 369999999999999999999986 78899999998765555556678999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++... +.+++.+++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 82 ~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAP 157 (263)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCSCSCCC
T ss_pred EEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec---CCCCEeecccceeeecC
Confidence 9999999999999988755 5799999999999999999999999999999999999995 47899999999997765
Q ss_pred CCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
. ......+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+..+++..+.+....++. .++++++
T Consensus 158 ~-~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~ 232 (263)
T d2j4za1 158 S-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGAR 232 (263)
T ss_dssp C-CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHH
T ss_pred C-CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHH
Confidence 3 34456789999999999874 6899999999999999999999999999999999998887766553 6899999
Q ss_pred HHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 386 DFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 386 ~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+||.+||.+||++|||++|+|+||||+.+
T Consensus 233 ~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 233 DLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 99999999999999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-59 Score=470.25 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=224.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..+|+++++||+|+||+||+|+++. +++.||||++...... ..+.+.+|+.+|++++ |||||+++++|.+.+.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT---TCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEecccCh---HHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCE
Confidence 4579999999999999999999876 7899999999765433 3467899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||+||+|.+++.+ +.+++.+++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 92 ~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQI 166 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC---CCCcEeeccchhheee
Confidence 9999999999999987654 4699999999999999999999999999999999999995 4789999999999877
Q ss_pred CCC-CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 306 RPD-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 306 ~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
... ......+||+.|+|||++. +.|+.++|||||||++|+|++|+.||.+.+....+..+........ ..+..++++
T Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~ 245 (293)
T d1yhwa1 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAI 245 (293)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SSGGGSCHH
T ss_pred ccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CCcccCCHH
Confidence 544 3456678999999999987 4689999999999999999999999998887777766665433211 123578999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
+++||.+||.+||.+|||+.|+|+||||+...
T Consensus 246 ~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 99999999999999999999999999998643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.5e-60 Score=484.87 Aligned_cols=264 Identities=34% Similarity=0.615 Sum_probs=239.4
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+-++|++++.||+|+||.||+|+++. +++.||||++.+.. ....+.+.+|+.+|++|+ |||||+++++|.+.+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~---~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETT
T ss_pred CccCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 34579999999999999999999876 78999999997643 234577899999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|||||||+||+|.+++....+.+++.+++.|+.||+.||.|||++|||||||||+|||++. +.++.+||+|||+|+.
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchhee
Confidence 999999999999999988766678999999999999999999999999999999999999964 3468899999999998
Q ss_pred cCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHH
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPE 383 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 383 (601)
+.......+.+||+.|||||++. ..|+.++|||||||++|+|++|+.||.+.+..+++..+......++...++.+|++
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 87777777789999999999987 46899999999999999999999999999999999999988877776666789999
Q ss_pred HHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 384 AKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 384 ~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+++||.+||..||++|||++|+|+||||+....
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 999999999999999999999999999987643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-59 Score=482.65 Aligned_cols=262 Identities=34% Similarity=0.607 Sum_probs=239.1
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+.|++++.||+|+||.||+|+++. +++.||||++.+... .....+.+|+.+|++|+ |||||+++++|.+++.
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYP---LDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYE 100 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSE
T ss_pred ccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECCcch---hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 3579999999999999999999876 789999999976432 24567889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||+||+|.+.+......+++.+++.|+.||+.||.|||++|||||||||+||||+. ..++.+||+|||+|..+
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceec
Confidence 99999999999999987766668999999999999999999999999999999999999964 24689999999999988
Q ss_pred CCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 306 RPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 306 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
.........+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+.+..+.+..+......++...++.+++++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 8777777789999999999987 469999999999999999999999999999999999999988888777778999999
Q ss_pred HHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 385 KDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
++||.+||++||.+|||+.|+|+||||+...
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9999999999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-60 Score=470.16 Aligned_cols=258 Identities=29% Similarity=0.536 Sum_probs=217.4
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
-++|++++.||+|+||+||+|+++. +++.||||++.+..... ..+.+.+|+++|++|+ |||||++++++.+++.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN-HENVVKFYGHRREGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCC-CCCEeeEeeeeccCce
Confidence 3579999999999999999999986 78999999997654322 3456899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||+||+|.+++.. .+.+++.+++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 78 ~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~---~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVF 153 (271)
T ss_dssp EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred eEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC---CCCCEEEccchhheee
Confidence 9999999999999988743 46799999999999999999999999999999999999995 4789999999999876
Q ss_pred CCCC---CccccccccccccchhccC-C-CCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 306 RPDE---RLNDIVGSAYYVAPEVLHR-S-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 306 ~~~~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
.... .....+||+.|||||++.+ . ++.++|||||||++|||++|+.||................... ..++..+
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~ 232 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKI 232 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-STTGGGS
T ss_pred ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCccccC
Confidence 4332 2456789999999999864 4 4688999999999999999999998765544433333333322 2345679
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
++++++||.+||..||++|||++|+|+||||++.
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 233 DSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 9999999999999999999999999999999853
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-60 Score=471.14 Aligned_cols=256 Identities=32% Similarity=0.592 Sum_probs=227.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++++.||+|+||+||+|+++. +++.||||++.+.........+.+.+|+++|++|+ |||||+++++|.+.+.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEE
Confidence 369999999999999999999976 78899999998765544456678999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||++ +++.+||+|||+|+.+.
T Consensus 84 ~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~---~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred EEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC---CCceEEecccccceecc
Confidence 9999999999999987655 6799999999999999999999999999999999999995 57899999999998775
Q ss_pred CCC---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 307 PDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 307 ~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
... ...+.+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+++..+.+....++ ..+++
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 235 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFP 235 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCH
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCH
Confidence 332 345678999999999986 5799999999999999999999999999999999999988876665 36899
Q ss_pred HHHHHHHHcccccccCCCCHHH------HHcCcccCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQ------ALTHPWLRDD 414 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~e------ll~hp~f~~~ 414 (601)
++++||.+||++||++|||++| +++||||++.
T Consensus 236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 9999999999999999999987 6889999764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-59 Score=470.64 Aligned_cols=266 Identities=38% Similarity=0.658 Sum_probs=237.2
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch---hhHHHHHHHHHHHHHhcCCCCeeEEeeeE
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA---ISIEDVRREVKILKALSGHKHLVKFCDAC 220 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~ 220 (601)
++.++|++++.||+|+||+||+|+++. +++.||||++.+...... ...+.+.+|+.+|++|+ |||||+++++|
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~ 82 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVY 82 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 456689999999999999999999976 789999999986544322 24678999999999996 99999999999
Q ss_pred ecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC-CCCCeEEeec
Q 007498 221 EDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR-DDADMRLIDF 299 (601)
Q Consensus 221 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~-~~~~vkl~DF 299 (601)
.+.+.+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+||
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999999988665 5799999999999999999999999999999999999996521 2236999999
Q ss_pred ccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
|+|..........+.+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+.+..+.+..+......++...++
T Consensus 162 G~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp TTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 9999887777777889999999999987 469999999999999999999999999999999999998887776655556
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.+|+++++||++||..||++|||++|+|+||||+..
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 899999999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=469.87 Aligned_cols=258 Identities=32% Similarity=0.509 Sum_probs=226.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
+.|++++.||+|+||.||+|+++. +++.||||++.+... ...+.+.+|+++|++|+ |||||++++++.+.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE---TSVLAAAKVIDTKSE---EELEDYMVEIDILASCD-HPNIVKLLDAFYYENNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC---CCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeE
Confidence 469999999999999999999986 788999999976432 23467889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++.+..+.+++.+++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~---~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNT 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECH
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC---CCCCEEEEechhhhccC
Confidence 999999999999998877777899999999999999999999999999999999999995 47899999999997654
Q ss_pred CC-CCccccccccccccchhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLH------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
.. ....+.+||+.|||||++. +.|+.++|||||||++|||++|+.||.+.+..+.+..+....+..... ...
T Consensus 162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~ 240 (288)
T d2jfla1 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ-PSR 240 (288)
T ss_dssp HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSS-GGG
T ss_pred CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc-ccc
Confidence 32 2334678999999999873 358999999999999999999999999998888888888765433221 247
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
+|+++++||++||++||++|||++|+|+||||+.+.
T Consensus 241 ~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 899999999999999999999999999999998653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-59 Score=471.59 Aligned_cols=261 Identities=24% Similarity=0.388 Sum_probs=228.4
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
....|++++.||+|+||+||+|+++. +++.||||++.+.........+.+.+|+++|++|+ |||||++++++.+.+
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH 88 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETT
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECC---CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECC
Confidence 34569999999999999999999876 78999999998776655556778999999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|||||||.+|+|..++ ...+.+++.+++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|||+|..
T Consensus 89 ~~~iv~E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASI 164 (309)
T ss_dssp EEEEEEECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBS
T ss_pred EEEEEEEecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeecccccc
Confidence 999999999998876544 4456899999999999999999999999999999999999996 478999999999986
Q ss_pred cCCCCCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
... ....+||+.|||||++. +.|+.++|||||||++|||++|..||.+....+.+..+........ ....+
T Consensus 165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~ 239 (309)
T d1u5ra_ 165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHW 239 (309)
T ss_dssp SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTS
T ss_pred cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCC
Confidence 543 34568999999999874 3589999999999999999999999999888888777776654322 23468
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPV 418 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 418 (601)
|+++++||.+||..||.+|||++|+|+||||+....+.
T Consensus 240 s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~ 277 (309)
T d1u5ra_ 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCch
Confidence 99999999999999999999999999999998765543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-58 Score=459.76 Aligned_cols=262 Identities=35% Similarity=0.613 Sum_probs=236.2
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccc------hhhHHHHHHHHHHHHHhcCCCCeeEEee
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTT------AISIEDVRREVKILKALSGHKHLVKFCD 218 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~niv~l~~ 218 (601)
|.++|++++.||+|+||+||+|+++. +++.||||++.+..... ....+.+.+|+.+|++|..|||||++++
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 77 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECC---CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence 45689999999999999999999876 78999999998754332 1234568899999999977999999999
Q ss_pred eEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 219 ACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 219 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
++.+++.+|||||||+||+|.+++... +.+++.+++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 78 ~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~~kl~D 153 (277)
T d1phka_ 78 TYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTD 153 (277)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECC
T ss_pred ecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc---CCCCeEEcc
Confidence 999999999999999999999998765 5799999999999999999999999999999999999995 588999999
Q ss_pred cccccccCCCCCccccccccccccchhcc-------CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH-------RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
||+++.+.........+||+.|+|||++. ..++.++||||+||++|||++|+.||.+.+....+..+......
T Consensus 154 FG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~ 233 (277)
T d1phka_ 154 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233 (277)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred chheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999887766667789999999999874 24789999999999999999999999999999999999988877
Q ss_pred CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 372 FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 372 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
++...++++|+++++||++||++||++|||++|+|+||||++
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 776667789999999999999999999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-59 Score=473.34 Aligned_cols=256 Identities=29% Similarity=0.527 Sum_probs=232.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++++.||+|+||.||+|+++. +++.||||++++.........+.+.+|+.+|++++ |||||+++++|.+.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeecccccc
Confidence 369999999999999999999886 88999999998766555556788999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+...
T Consensus 81 ~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~---~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSC
T ss_pred ccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec---CCCCEEEeecccccccc
Confidence 9999999999999987665 5799999999999999999999999999999999999995 57899999999998764
Q ss_pred C-CCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 P-DERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
. .......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+++..+......++ ..+|+++
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 232 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEA 232 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHH
Confidence 4 44556789999999999986 5799999999999999999999999999999999999998877665 3699999
Q ss_pred HHHHHHcccccccCCCC-----HHHHHcCcccCCC
Q 007498 385 KDFVKRLLNKDYRKRMT-----AVQALTHPWLRDD 414 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~ 414 (601)
++||++||++||.+|++ ++|+++||||++.
T Consensus 233 ~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 99999999999999994 9999999999763
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=457.98 Aligned_cols=253 Identities=22% Similarity=0.377 Sum_probs=216.3
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec----CC
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED----VN 224 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~ 224 (601)
|++.++||+|+||+||+|+++. +++.||+|++...... ....+.+.+|+++|++|+ |||||+++++|.+ ..
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~---~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred EEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCC
Confidence 5788899999999999999876 7889999999776543 335678999999999996 9999999999865 35
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCceEeecCCCCCCeEEeecccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQG--VVHRDLKPENFLFTSGRDDADMRLIDFGLS 302 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~--iiHrDikp~NIll~~~~~~~~vkl~DFG~a 302 (601)
.+|||||||++|+|.+++.+. +.+++..++.++.||+.||+|||+++ |+||||||+|||++ ++++.+||+|||+|
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred EEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcc
Confidence 689999999999999988665 57999999999999999999999998 99999999999995 24688999999999
Q ss_pred cccCCCCCccccccccccccchhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHccCCCCCCCCCCCCC
Q 007498 303 DFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
+... .....+.+||+.|||||++.+.|+.++|||||||++|||++|+.||.+... ..++..+...... ......++
T Consensus 163 ~~~~-~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~ 239 (270)
T d1t4ha_ 163 TLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAI 239 (270)
T ss_dssp GGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCC
T ss_pred eecc-CCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC--cccCccCC
Confidence 7644 334557799999999999998999999999999999999999999976554 4444555443221 11224689
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcCcccC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTHPWLR 412 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~hp~f~ 412 (601)
+++++||.+||.+||++|||++|+|+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-59 Score=472.69 Aligned_cols=262 Identities=28% Similarity=0.570 Sum_probs=237.5
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
++.++|++++.||+|+||+||+|+++. +++.||||++++... ....+.+|+++|+.++ |||||+++++|.+.
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~---~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKGT----DQVLVKKEISILNIAR-HRNILHLHESFESM 73 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCTH----HHHHHHHHHHHHHHSC-CTTBCCEEEEEEET
T ss_pred CCccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC
Confidence 345689999999999999999999986 788999999976432 3356889999999996 99999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+.+|||||||+||+|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||++. +....+||+|||+++
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQAR 152 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhh
Confidence 9999999999999999988766668999999999999999999999999999999999999964 345689999999998
Q ss_pred ccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
...........+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..+.+..+.+....++...|+.+|+
T Consensus 153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 877666667789999999999876 4689999999999999999999999999999999999999888777766778999
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
++++||++||.+||.+|||+.|+|+||||+..
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999999999999999764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-58 Score=456.65 Aligned_cols=254 Identities=29% Similarity=0.481 Sum_probs=212.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--CC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--VN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~ 224 (601)
++|++++.||+|+||+||+|+++. +++.||||++...... ....+.+.+|+++|++|+ |||||++++++.+ ++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----
T ss_pred hhCEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCC
Confidence 469999999999999999999886 7899999999876543 335677899999999996 9999999999865 46
Q ss_pred cEEEEEeecCCCchHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeeccCCCCceEeecCCCCCCeEE
Q 007498 225 NVYIVMELCEGGELLDRILA---RGGRYTEEDAKAIVVQILSVVAFCHLQG-----VVHRDLKPENFLFTSGRDDADMRL 296 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~---~~~~l~~~~~~~i~~ql~~~L~~LH~~~-----iiHrDikp~NIll~~~~~~~~vkl 296 (601)
.+|||||||+||+|.+++.+ ..+.+++..++.++.||+.||.|||++| ||||||||+|||++ .++.+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~---~~~~vkl 155 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKL 155 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC---TTSCEEE
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC---CCCcEEE
Confidence 79999999999999998764 3567999999999999999999999976 99999999999995 4789999
Q ss_pred eecccccccCCCC-Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC
Q 007498 297 IDFGLSDFIRPDE-RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD 374 (601)
Q Consensus 297 ~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 374 (601)
+|||+|+.+.... .....+||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+..+++..+........
T Consensus 156 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~- 234 (269)
T d2java1 156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI- 234 (269)
T ss_dssp CCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-
T ss_pred eeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence 9999998876443 345679999999999986 5699999999999999999999999999888888888877654321
Q ss_pred CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 375 LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 375 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
...+|+++.+||.+||..||.+|||++|+|+|||+
T Consensus 235 --~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 235 --PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 24689999999999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9e-58 Score=462.86 Aligned_cols=254 Identities=24% Similarity=0.579 Sum_probs=228.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||+||+|+++. +++.||||++.+.........+.+.+|+.+|++++ |||||++++++.+.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCee
Confidence 369999999999999999999876 78999999998765544455678999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|||||+||+|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+...
T Consensus 80 ~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~---~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVP 155 (316)
T ss_dssp EEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSCEECS
T ss_pred eeEeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc---CCCCEEEecCccceEec
Confidence 999999999998887654 46799999999999999999999999999999999999995 48899999999998765
Q ss_pred CCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
. ...+.+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+..+++..+......++ +.++++++
T Consensus 156 ~--~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 229 (316)
T d1fota_ 156 D--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVK 229 (316)
T ss_dssp S--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred c--ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 3 3456799999999999875 699999999999999999999999999999999999988776554 36899999
Q ss_pred HHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 386 DFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 386 ~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
++|.+||.+||.+|+ |++++|+||||++.
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 999999999999996 89999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-57 Score=465.60 Aligned_cols=254 Identities=29% Similarity=0.546 Sum_probs=229.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++++.||+|+||.||+|+++. +++.||||++.+.........+.+.+|+++|+.++ |||||++++++.+...+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeeccccccccccc
Confidence 479999999999999999999976 78999999998765544455678999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+.||+|..++... +.+++.+++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+.+.
T Consensus 117 ~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~---~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECS
T ss_pred ccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC---CCCCEEeeeceeeeecc
Confidence 9999999999999988765 5799999999999999999999999999999999999995 47899999999998775
Q ss_pred CCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHH
Q 007498 307 PDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAK 385 (601)
Q Consensus 307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 385 (601)
. ...+.+||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+...++..+......++ ..+++++.
T Consensus 193 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 266 (350)
T d1rdqe_ 193 G--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLK 266 (350)
T ss_dssp S--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHH
T ss_pred c--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHH
Confidence 3 345678999999999987 4699999999999999999999999999999999999988776554 47999999
Q ss_pred HHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 386 DFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 386 ~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
+||++||.+||.+|+ |++|+|+||||++.
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 999999999999995 89999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-58 Score=465.21 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=213.9
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.++|+++++||+|+||+||+|+++. +++.||+|++++.. .......+.+|+.+|++|+ |||||+++++|.+.++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETT---TTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 3579999999999999999999876 78999999997643 2234578899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+|||||||+||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+.
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCHH
T ss_pred EEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC---CCCCEEEeeCCCccc
Confidence 99999999999999988765 579999999999999999999997 5999999999999995 488999999999987
Q ss_pred cCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHH-------------------
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRA------------------- 364 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~------------------- 364 (601)
+... ...+.+||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+.......
T Consensus 155 ~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 155 LIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HHHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred cCCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 6432 345679999999999987 4799999999999999999999999977554321110
Q ss_pred -----------------------HHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 365 -----------------------VLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 365 -----------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
+... ..+..+...+|.++++||.+||..||.+|||++|+|+||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ------------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000 01111123468999999999999999999999999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-57 Score=456.48 Aligned_cols=256 Identities=29% Similarity=0.495 Sum_probs=227.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++++.||+|+||+||+|+++. +++.||||++++.........+.+.+|+.++.+..+|||||++++++.+++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence 369999999999999999999986 88999999998765444445667778888876433599999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 79 yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~---~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENM 154 (320)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCC
T ss_pred eEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec---CCCceeccccchhhhcc
Confidence 9999999999999988654 5799999999999999999999999999999999999995 58899999999998765
Q ss_pred CC-CCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHH
Q 007498 307 PD-ERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEA 384 (601)
Q Consensus 307 ~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 384 (601)
.. ......+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+.+...++..+....+.++ ..+|+++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 230 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEA 230 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHH
Confidence 43 3345578999999999987 5799999999999999999999999999999999999888776655 3689999
Q ss_pred HHHHHHcccccccCCCCHH-HHHcCcccCC
Q 007498 385 KDFVKRLLNKDYRKRMTAV-QALTHPWLRD 413 (601)
Q Consensus 385 ~~li~~~L~~dP~~R~s~~-ell~hp~f~~ 413 (601)
++||++||.+||.+||++. |+++||||++
T Consensus 231 ~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 9999999999999999995 8999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=466.11 Aligned_cols=260 Identities=34% Similarity=0.606 Sum_probs=219.7
Q ss_pred cCCCeEEcc-eeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-
Q 007498 145 FGAKYELGK-EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED- 222 (601)
Q Consensus 145 ~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~- 222 (601)
+-++|++.. .||+|+||.||+|+++. +++.||||++++. ..+.+|+.++.++.+|||||+++++|.+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECC---CCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 345799875 59999999999999876 7899999998643 3567899998777569999999999875
Q ss_pred ---CCcEEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 223 ---VNNVYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 223 ---~~~~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
...+|||||||+||+|.+++..++ ..|++.+++.|+.||+.||+|||++||+||||||+|||++..+..+.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 467999999999999999987653 4699999999999999999999999999999999999997655577899999
Q ss_pred cccccccCCCCCccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH----ccCCCCC
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL----RSDPNFD 373 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~~~~ 373 (601)
||+|+...........+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.........+. .....++
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 999998877777778899999999999874 69999999999999999999999998766554443332 2333444
Q ss_pred CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 374 DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 374 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
...+..+|+++++||++||+.||++|||+.|+|+||||++..
T Consensus 238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 444557899999999999999999999999999999997654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=452.08 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=216.5
Q ss_pred EcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccch--hhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 151 LGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTA--ISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 151 ~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
.+++||+|+||+||+|+++. +++.||||+++....... ...+.+.+|+.+|++++ |||||++++++.+++.+||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~i 77 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISL 77 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEE
T ss_pred cceEeccCcCeEEEEEEECC---CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceee
Confidence 45789999999999999876 789999999976543221 12346889999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCC
Q 007498 229 VMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPD 308 (601)
Q Consensus 229 v~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~ 308 (601)
|||||.++++. .+......+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.....
T Consensus 78 vmE~~~~~~~~-~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~---~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 78 VFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp EEECCSEEHHH-HHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGSTTTSC
T ss_pred hhhhhcchHHh-hhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec---CCCccccccCccccccCCC
Confidence 99999887655 4455567899999999999999999999999999999999999995 5889999999999876543
Q ss_pred -CCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC---------
Q 007498 309 -ERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP--------- 376 (601)
Q Consensus 309 -~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 376 (601)
......+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+..+++..+.+.........
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 3345678999999999875 3589999999999999999999999999998888877764321111100
Q ss_pred ---------------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 377 ---------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 377 ---------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
++.+++++++||.+||+.||++|||++|+|+||||++.+.|.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~ 291 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCC
Confidence 2357899999999999999999999999999999999877665
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-56 Score=460.07 Aligned_cols=258 Identities=24% Similarity=0.395 Sum_probs=215.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHH---HHHHHHhcCCCCeeEEeeeEecC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRRE---VKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
++|++++.||+|+||.||+|+++. +++.||||++.+...........+.+| +.+++.+ +|||||+++++|.+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS
T ss_pred HhCeeeeEEecCCCeEEEEEEECC---CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEEC
Confidence 369999999999999999999886 789999999987554443344445555 5555555 499999999999999
Q ss_pred CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 224 NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
+.+|||||||+||+|.+++... +.+++.+++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~---~~g~iKl~DFGla~ 155 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLAC 155 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---SSSCEEECCCTTCE
T ss_pred CEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc---CCCcEEEeeeceee
Confidence 9999999999999999988765 5799999999999999999999999999999999999995 57899999999998
Q ss_pred ccCCCCCccccccccccccchhcc-C-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 304 FIRPDERLNDIVGSAYYVAPEVLH-R-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 304 ~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
.+... .....+||+.|+|||++. + .|+.++|||||||+||||++|+.||.+............ ........+..+|
T Consensus 156 ~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s 233 (364)
T d1omwa3 156 DFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVELPDSFS 233 (364)
T ss_dssp ECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-SSSCCCCCCSSSC
T ss_pred ecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cccCCCCCCCCCC
Confidence 76543 345678999999999985 3 589999999999999999999999987654433322222 1122222235799
Q ss_pred HHHHHHHHHcccccccCCCC-----HHHHHcCcccCCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMT-----AVQALTHPWLRDD 414 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~ 414 (601)
+++++||.+||.+||++||| ++|+++||||++.
T Consensus 234 ~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 99999999999999999999 7999999999863
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-56 Score=448.40 Aligned_cols=264 Identities=30% Similarity=0.482 Sum_probs=220.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|+++++||+|+||+||+|+++. +++.||||+++..... ....+.+.+|+++|++++ |||||+++++|.+++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTET-EGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCC-CCcEEEeccccccccce
Confidence 479999999999999999999976 7889999999765432 224567889999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRIL-ARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~-~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|||||||.++ +.+.+. ...+.+++.+++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+..
T Consensus 77 ~iv~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~---~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTHHHHH
T ss_pred eEEEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec---ccCcceeccCCcceec
Confidence 9999999764 454444 3456799999999999999999999999999999999999995 4789999999999877
Q ss_pred CCC-CCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCC------
Q 007498 306 RPD-ERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLP------ 376 (601)
Q Consensus 306 ~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 376 (601)
... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.........
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 543 3455678999999999865 3468999999999999999999999998887777766654222111111
Q ss_pred -------------------CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 377 -------------------WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 377 -------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
++.+++++++||++||.+||++|||++|+|+||||++..+|+|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 2357899999999999999999999999999999999888876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=437.07 Aligned_cols=255 Identities=29% Similarity=0.513 Sum_probs=214.5
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchh---hHHHHHHHHHHHHHhc-CCCCeeEEeeeE
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAI---SIEDVRREVKILKALS-GHKHLVKFCDAC 220 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~-~h~niv~l~~~~ 220 (601)
+..+|++++.||+|+||.||+|+++. +++.||||++.+....... ...++.+|+.+|++++ .|||||++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 34689999999999999999999986 7899999999865443221 1234668999999995 489999999999
Q ss_pred ecCCcEEEEEeecCC-CchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 221 EDVNNVYIVMELCEG-GELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 221 ~~~~~~~lv~e~~~~-g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
.+.+.+|+||||+.+ +++.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++. +++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--~~~~vkl~DF 155 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDF 155 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--CCCeEEECcc
Confidence 999999999999986 5666666544 67999999999999999999999999999999999999963 3578999999
Q ss_pred ccccccCCCCCccccccccccccchhcc-CC-CCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCC
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RS-YSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPW 377 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 377 (601)
|+|+.... ....+.+||+.|+|||++. .. ++.++|||||||++|||++|+.||.+. ..+.+....++
T Consensus 156 G~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~---- 224 (273)
T d1xwsa_ 156 GSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR---- 224 (273)
T ss_dssp TTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----
T ss_pred ccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----
Confidence 99976543 3456678999999999986 33 577899999999999999999999653 23444444433
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
..+|+++++||++||.+||++|||++|+|+||||++...
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 468999999999999999999999999999999987643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=441.63 Aligned_cols=263 Identities=28% Similarity=0.398 Sum_probs=218.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc--CCCCeeEEeeeEec--
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS--GHKHLVKFCDACED-- 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~-- 222 (601)
.+|+++++||+|+||+||+|++.. .+++.||||+++....... ....+.+|+.+|+.|. +|||||+++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~--~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEEC--CCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 589999999999999999999865 1467899999976443222 2234667888888773 49999999999853
Q ss_pred ---CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 223 ---VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 223 ---~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
...+|++||||.++.+..........+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~---~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc---CCCCeeecch
Confidence 3578999999998766555555567799999999999999999999999999999999999995 4789999999
Q ss_pred ccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC----
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD---- 374 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---- 374 (601)
|++............+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+.+..+.........
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 9998776666667789999999999876 57999999999999999999999999999888877776542111100
Q ss_pred -------------------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 375 -------------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 375 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
..+..+++++++||++||++||++|||+.|+|+||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 11246789999999999999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-54 Score=433.07 Aligned_cols=259 Identities=26% Similarity=0.438 Sum_probs=218.5
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+.++|++.+.||+|+||.||+|+++. +++.||||++++...........+.+|+++|+.++ |||||++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAET 80 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEC
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeecc
Confidence 45689999999999999999999876 78999999998776666666778999999999996 999999999987653
Q ss_pred ----cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecc
Q 007498 225 ----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300 (601)
Q Consensus 225 ----~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG 300 (601)
.+|||||||+|++|.+++... +.+++.+++.|+.||+.||.|||++||+||||||+|||++. ++.++|+|||
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~---~~~~~l~d~~ 156 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA---TNAVKVMDFG 156 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TSCEEECCCT
T ss_pred CCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc---cccceeehhh
Confidence 489999999999999877655 57999999999999999999999999999999999999964 7889999999
Q ss_pred cccccCCCC----CccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCC
Q 007498 301 LSDFIRPDE----RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDL 375 (601)
Q Consensus 301 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 375 (601)
++....... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.+..+.+..++...+..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 236 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGG
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCch
Confidence 987653322 3445789999999999874 69999999999999999999999999998888888888887776666
Q ss_pred CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCccc
Q 007498 376 PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWL 411 (601)
Q Consensus 376 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f 411 (601)
.++.+|+++.+||.+||.+||.+||+..+.|.|+|.
T Consensus 237 ~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 677899999999999999999999954444456665
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=428.04 Aligned_cols=250 Identities=22% Similarity=0.403 Sum_probs=207.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+.+ ..||||+++..... ....+.+.+|+.+|++++ |||||++++++.+ +.+
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~------~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR-HVNILLFMGYSTA-PQL 78 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS------SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC------CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCC-CCCEeeeeEEEec-cEE
Confidence 47999999999999999999754 25999999765433 335678999999999996 9999999998754 568
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||+||+|.+++......+++.++..|+.||+.||+|||+++||||||||+|||++ .++.+||+|||+|+...
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTSSEEECCCCCSCC--
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---CCCCEEEccccceeecc
Confidence 999999999999999887777899999999999999999999999999999999999996 47899999999998764
Q ss_pred CC---CCccccccccccccchhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC--CCC
Q 007498 307 PD---ERLNDIVGSAYYVAPEVLH----RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD--LPW 377 (601)
Q Consensus 307 ~~---~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~ 377 (601)
.. ......+||+.|||||++. +.|+.++|||||||+||||++|+.||.+......+..+.......+. ...
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence 32 2345678999999999985 24899999999999999999999999887665555444443322221 123
Q ss_pred CCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 378 PSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 378 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
..+++++.+||.+||..||++|||+.|++++
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 5789999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.4e-54 Score=429.13 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=214.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|+++++||+|+||+||+|+++ +++.||||++...... ....+.+.+|+.+|++|+ |||||+++++|.+.+..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKED-EGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC----CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCce
Confidence 47999999999999999999885 6789999999765432 234577899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+||||+.++ ++..+....+.+++..++.|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+|....
T Consensus 76 ~i~~e~~~~~-~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~---~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 76 VLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFG 151 (286)
T ss_dssp EEEEECCSEE-HHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHHHC
T ss_pred eEEEEeehhh-hHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc---CCCCEEecccccceecc
Confidence 9999999775 4555566668899999999999999999999999999999999999995 58899999999998765
Q ss_pred CCC-Cccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCC---------
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDD--------- 374 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--------- 374 (601)
... .....+|++.|+|||++. ..++.++|||||||++|||++|+.||.+.+..+.+..+.........
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 432 344567999999999875 35799999999999999999999999988887777766532111100
Q ss_pred ----------------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCC
Q 007498 375 ----------------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRD 413 (601)
Q Consensus 375 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~ 413 (601)
...+.+++++.|||++||++||++|||++|+|+||||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 012457899999999999999999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-53 Score=425.53 Aligned_cols=248 Identities=21% Similarity=0.344 Sum_probs=210.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.++||+|+||+||+|+++. +++.||||+++.... ..+++.+|+++|++|+ |||||+++++|.+++.+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPF 88 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGG---GTEEEEEEECCTTCS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECC---CCeEEEEEEECCccc----hHHHHHHHHHHHHhCC-CCCEecCCccEeeCCee
Confidence 479999999999999999999986 788999999876432 3467899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|||||||++|+|.+++... ...+++..+..|+.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+..
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCCTTTC
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC---CCCcEEEccccceeec
Confidence 9999999999999988754 45799999999999999999999999999999999999995 4789999999999876
Q ss_pred CCCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 306 RPDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 306 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
..... .....||+.|+|||++. +.|+.++|||||||++|||++|..||........+..++....... ....+++
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~--~~~~~~~ 243 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME--RPEGCPE 243 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC--CCTTCCH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC--CCccchH
Confidence 54432 23356899999999876 6899999999999999999997777655444333333433332222 2247899
Q ss_pred HHHHHHHHcccccccCCCCHHHHHc
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++.+||.+||..||++|||++|+++
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=420.87 Aligned_cols=247 Identities=23% Similarity=0.404 Sum_probs=204.2
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++ +++.||||+++.... ..+.+.+|++++++++ |||||+++++|...+.+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET----TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC----CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcC-CCCcccccceeccCCce
Confidence 36999999999999999999976 456899999876432 3467899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||++|+|.+++......+++..+..|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||+|+...
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC---GGGCEEECSCC------
T ss_pred EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec---CCCCeEecccchheecc
Confidence 999999999999999887777899999999999999999999999999999999999995 47899999999998765
Q ss_pred CCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 307 PDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 307 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
.... .....||+.|+|||++. +.|+.++|||||||++|||++ |.+||...+..+++..+........ ...+++
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~ 229 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAST 229 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCH
T ss_pred CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCH
Confidence 4432 23467999999999987 579999999999999999999 5666766777777777766533221 146799
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
++.+||.+||..||++|||++|+++|
T Consensus 230 ~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 230 HVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=431.91 Aligned_cols=264 Identities=28% Similarity=0.455 Sum_probs=215.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec----
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED---- 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---- 222 (601)
.+|+++++||+|+||+||+|+++. +++.||||++.+..... .....+.+|+.+|++|+ ||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKASP 84 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC----
T ss_pred CCEEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeccccc
Confidence 589999999999999999999876 78999999987654332 34567889999999996 9999999998855
Q ss_pred ----CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 223 ----VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 223 ----~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
...+|+|||||.++. ...+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 85 ~~~~~~~~~iv~e~~~~~~-~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~---~~~~~kl~d 160 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDL-AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLAD 160 (318)
T ss_dssp ------CEEEEEECCCEEH-HHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECC
T ss_pred ccccCceEEEEEeccCCCc-cchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec---CCCcEEeee
Confidence 356899999998754 444555567899999999999999999999999999999999999995 488999999
Q ss_pred cccccccCCCC-----Cccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCC
Q 007498 299 FGLSDFIRPDE-----RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPN 371 (601)
Q Consensus 299 FG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 371 (601)
||+++.+.... .....+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.........+......
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99997664322 234468999999999875 36899999999999999999999999988887777666554333
Q ss_pred CCCCCCCC----------------------------CCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCCCCC
Q 007498 372 FDDLPWPS----------------------------VSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSRPVP 419 (601)
Q Consensus 372 ~~~~~~~~----------------------------~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 419 (601)
+....+.. .+++++|||.+||++||++|+|++|+|+||||++++.|..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~ 316 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 316 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCC
Confidence 32222111 2678899999999999999999999999999998766654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-53 Score=426.88 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=205.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
..|++.+.||+|+||+||+|+++........||||++.... .....+.+.+|+++|++|+ |||||++++++.+.+.+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSC
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCEE
Confidence 47999999999999999999987532233468999876542 2335577999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||++|+|.+++....+.+++.++..|+.||+.||.|||+++|+||||||+||||+ .++.+||+|||+|+.+.
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC-------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC---CCCcEEECCcccceEcc
Confidence 999999999999998877677899999999999999999999999999999999999995 58899999999998765
Q ss_pred CCCCc------cccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCC
Q 007498 307 PDERL------NDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWP 378 (601)
Q Consensus 307 ~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 378 (601)
..... ....||+.|||||++. +.|+.++|||||||++|||++ |+.||.+....+++..+...... + ...
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-~--~~~ 256 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL-P--PPM 256 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-C--CCT
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCc
Confidence 43221 2246799999999886 679999999999999999998 89999998888888777664321 1 124
Q ss_pred CCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 379 SVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 379 ~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.+++++.+||.+||..||++|||+.|++++
T Consensus 257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 689999999999999999999999998864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=422.50 Aligned_cols=254 Identities=21% Similarity=0.376 Sum_probs=214.2
Q ss_pred CCeEEcc-eeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGK-EVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
.+|.+.+ +||+|+||.||+|.++... ++..||||+++... .....+.+.+|+++|++|+ |||||++++++.+ +.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EA 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SS
T ss_pred cCeEECCcEEecccCeEEEEEEEecCC-CcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-Ce
Confidence 3577877 4999999999999875422 45689999997542 3345678999999999996 9999999999875 46
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|||||||++|+|.+++......+++.++..|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.+
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~---~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN---RHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE---TTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeecc---CCceeeccchhhhcc
Confidence 89999999999999987766678999999999999999999999999999999999999964 789999999999877
Q ss_pred CCCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 306 RPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 306 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
..... ....+||+.|+|||++. +.|+.++|||||||++|||++ |+.||.+....+++..+.++.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~ 236 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPE 236 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCTT
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCc
Confidence 54332 23457899999999986 679999999999999999998 999999888888877776654321 1257
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHH---HcCccc
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQA---LTHPWL 411 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~el---l~hp~f 411 (601)
+++++.+||.+||..||++|||+.++ |+|+|+
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 89999999999999999999999877 566665
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=431.82 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=213.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCc--cCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGEL--KDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
++|++++.||+|+||+||+|+++.... ....||+|++..... ......+.+|+.+|.++.+|||||++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 479999999999999999999875221 234799999865432 2234678899999999955999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCc
Q 007498 225 NVYIVMELCEGGELLDRILARG----------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPEN 282 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~----------------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~N 282 (601)
.+|||||||++|+|.+++.... ..+++..++.|+.||+.||.|||+++||||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 9999999999999999986543 348999999999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 007498 283 FLFTSGRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWART 357 (601)
Q Consensus 283 Ill~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~ 357 (601)
||++ .++.+||+|||+|+....... ..+.+||+.|||||++. +.|+.++|||||||++|||++ |+.||.+..
T Consensus 195 ill~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 195 VLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp EEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cccc---cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9996 478999999999987654432 23567899999999875 689999999999999999997 899998877
Q ss_pred hhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 358 ESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 358 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
....+..++.....++. ...+++++++||.+||+.||++|||++||++|
T Consensus 272 ~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 272 VDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66666666665544332 24689999999999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-53 Score=414.48 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=217.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|+++++||+|+||+||+++++ +++.||||++++... ..+.+.+|+.++++++ |||||+++++|.+.+.+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCce
Confidence 36899999999999999999975 567899999987543 3467899999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|+|||||++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~---~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC---TTCCEEECCCSSCCBCS
T ss_pred EEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc---CCCcEEECcchhheecc
Confidence 999999999999998877777899999999999999999999999999999999999995 47899999999998765
Q ss_pred CCCC--ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 307 PDER--LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 307 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
.... .....||+.|+|||++. +.|+.++|||||||++|||++ |+.||.+.+..++...+........ ...+++
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~ 228 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASE 228 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCH
T ss_pred CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC---cccccH
Confidence 4432 23467999999999886 679999999999999999998 8999999998888888876543222 246889
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
++.+||++||+.||++|||++++|+|
T Consensus 229 ~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 229 KVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-53 Score=434.18 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=212.9
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC----
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV---- 223 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---- 223 (601)
+|+.+++||+|+||+||+|+++. +++.||||++.+.... ..+|+++|++|+ |||||+++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~ 89 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKRF-------KNRELQIMRKLD-HCNIVRLRYFFYSSGEKK 89 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSSS-------CCHHHHHHHHCC-CTTBCCEEEEEEEC--CC
T ss_pred CcEeeeEEeeCcCeEEEEEEECC---CCCEEEEEEECccchH-------HHHHHHHHHhcC-CCCCCcEEEEEEecCccC
Confidence 69999999999999999999986 7899999999765422 247999999996 99999999998542
Q ss_pred --CcEEEEEeecCCCchHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 224 --NNVYIVMELCEGGELLDRIL---ARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 224 --~~~~lv~e~~~~g~L~~~~~---~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
.++|||||||+++ +...+. .....+++.+++.|+.||+.||+|||++||+||||||+|||++. +...+||+|
T Consensus 90 ~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~--~~~~~kl~D 166 (350)
T d1q5ka_ 90 DEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCD 166 (350)
T ss_dssp SCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TTCCEEECC
T ss_pred CceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec--CCCceeEec
Confidence 3589999999875 333332 34567999999999999999999999999999999999999963 235899999
Q ss_pred cccccccCCCCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC-------
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD------- 369 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------- 369 (601)
||+++.+.......+.+||+.|+|||++. ..|+.++|||||||++|||++|+.||...+..+.+..+.+..
T Consensus 167 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 99999887777777789999999999764 468999999999999999999999999888877776665311
Q ss_pred ----------CCCCC--------CCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 370 ----------PNFDD--------LPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 370 ----------~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
..++. ...+.+++++.+||.+||++||++|||+.|+|+||||++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 11111 11346799999999999999999999999999999998653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.7e-53 Score=430.22 Aligned_cols=253 Identities=29% Similarity=0.554 Sum_probs=211.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec--CC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED--VN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~ 224 (601)
++|+++++||+|+||+||+|+++. +++.||||++++.. .+++.+|+.+|+++.+||||++++++|.. ..
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred cCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 579999999999999999999876 78999999986532 35788999999999779999999999874 45
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
.+|+|||||.+++|... .+.+++.+++.++.||+.||.|||++||+||||||+|||++. +++.+||+|||+|+.
T Consensus 106 ~~~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEF 179 (328)
T ss_dssp SEEEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCGGGCEE
T ss_pred ceeEEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--CCCeeeeccccccee
Confidence 69999999999998754 246999999999999999999999999999999999999974 345699999999998
Q ss_pred cCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHc-------------c
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTE-SGIFRAVLR-------------S 368 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~-------------~ 368 (601)
..........+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||..... ......+.. .
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 877777778899999999998753 589999999999999999999999976543 222222211 0
Q ss_pred CC-----------C---------CCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 369 DP-----------N---------FDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 369 ~~-----------~---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
.. . +....+..++++++|||++||.+||++|||++|+|+||||++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 00 0 0111123478999999999999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-53 Score=419.75 Aligned_cols=250 Identities=22% Similarity=0.376 Sum_probs=210.8
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++++.||+|+||.||+|+++ +++.||||+++.... ..+.+.+|+++|++|+ |||||++++++.+ +.+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~ 82 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPI 82 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred HHeEEeEEEecCCCcEEEEEEEC----CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CCe
Confidence 47999999999999999999975 467899999975432 3467899999999996 9999999998765 567
Q ss_pred EEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|||||||++|+|.+++... ...+++.++..|+.||+.||.|||+++|+||||||+||||+ +++.+||+|||+|+.+
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~---~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee---cccceeeccccceEEc
Confidence 9999999999998876433 23599999999999999999999999999999999999995 5889999999999887
Q ss_pred CCCC--Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCG-SRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
.... ......||+.|||||++. +.|+.++|||||||++|||+|| .+||......+++..+........ ...++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~ 236 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNCP 236 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCC
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---cccCh
Confidence 5443 234567999999999886 6799999999999999999995 455556666677777665432221 24689
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc--CcccC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT--HPWLR 412 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~--hp~f~ 412 (601)
+++.+||.+||..||++|||++|+++ |+||.
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999999999999998 78875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-53 Score=418.95 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=205.2
Q ss_pred ceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEEEEee
Q 007498 153 KEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYIVMEL 232 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 232 (601)
++||+|+||.||+|.++... +++.||||+++.... .....+.+.+|+++|++|+ |||||+++++|.. +.+||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~-~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS-SEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES-SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCC-cCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc-CCEEEEEEc
Confidence 47999999999999875422 567899999975433 3334578999999999996 9999999999965 467999999
Q ss_pred cCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCCCCC--
Q 007498 233 CEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRPDER-- 310 (601)
Q Consensus 233 ~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~-- 310 (601)
|++|+|.+++... ..+++.++..|+.||+.||.|||+++||||||||+|||++. ++.+||+|||+|+.+.....
T Consensus 89 ~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~---~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 89 AELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT---QHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp CTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE---TTEEEECCCTTCEECCTTCSEE
T ss_pred CCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccc---cCcccccchhhhhhcccccccc
Confidence 9999999987654 67999999999999999999999999999999999999964 78999999999987654332
Q ss_pred --ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCHHHHH
Q 007498 311 --LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSPEAKD 386 (601)
Q Consensus 311 --~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 386 (601)
.....||+.|||||++. +.|+.++|||||||++|||++ |+.||.+.+..++...+.++.... . ...+++++.+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~--~-p~~~~~~~~~ 241 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--C-PAGCPREMYD 241 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--C-CTTCCHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC--C-CcccCHHHHH
Confidence 23357999999999886 679999999999999999997 899999988888777776643211 1 2468999999
Q ss_pred HHHHcccccccCCCCHHHH---HcCccc
Q 007498 387 FVKRLLNKDYRKRMTAVQA---LTHPWL 411 (601)
Q Consensus 387 li~~~L~~dP~~R~s~~el---l~hp~f 411 (601)
||.+||..||++|||++++ |+|+|+
T Consensus 242 li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 242 LMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999998 455554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=429.98 Aligned_cols=258 Identities=26% Similarity=0.497 Sum_probs=211.3
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
+..+|+++++||+|+||+||+|+++. +++.||||++++... .....+.+.+|+++|++|+ |||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE 90 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCc
Confidence 56789999999999999999999876 789999999976443 3445678899999999996 999999999997654
Q ss_pred ------cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 225 ------NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 225 ------~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
.+||||||| +++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~---~~~~~kl~D 164 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILD 164 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECC
T ss_pred cccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc---ccccccccc
Confidence 579999999 5577665543 4799999999999999999999999999999999999995 588999999
Q ss_pred cccccccCCCCCccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCC------
Q 007498 299 FGLSDFIRPDERLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDP------ 370 (601)
Q Consensus 299 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------ 370 (601)
||+|+.... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 165 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 165 FGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 999987643 345678999999999875 3579999999999999999999999988877666555433211
Q ss_pred -----------------CCCCC----CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCC
Q 007498 371 -----------------NFDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDS 415 (601)
Q Consensus 371 -----------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 415 (601)
..... ....+++++.+||++||..||++|||+.|+|+||||++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 11111 1246799999999999999999999999999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=414.56 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=206.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++++.||+|+||.||+|++......+..||||+++.. ......+.+.+|+.+|++++ |||||++++++. .+.+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSSC
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCeE
Confidence 4799999999999999999998754334567899987543 23345678999999999996 999999999996 4678
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||++|+|.+++....+.+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~---~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE---TTEEEECC--------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecC---CCcEEEccchhheecc
Confidence 9999999999999988877778999999999999999999999999999999999999964 7889999999998765
Q ss_pred CCC--Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 307 PDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 307 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
... ......||+.|+|||++. +.|+.++|||||||++|||++ |.+||.+....+++..+...... ..++.+++
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~ 236 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPP 236 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCCH
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence 432 234467899999999986 689999999999999999998 89999998888888888765432 12357999
Q ss_pred HHHHHHHHcccccccCCCCHHHHHcC
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
++.+||.+||..||++|||+.|+++|
T Consensus 237 ~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-53 Score=428.65 Aligned_cols=264 Identities=30% Similarity=0.464 Sum_probs=218.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc-chhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT-TAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
++|++++.||+|+||+||+|++.....+++.||||++++.... .....+.+.+|+++|+++++||||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4699999999999999999998765567899999999765432 222345678999999999745899999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+|||||.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec---CCCCEEEeeccchhhh
Confidence 99999999999999987665 5789999999999999999999999999999999999995 4789999999999876
Q ss_pred CCC--CCccccccccccccchhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 306 RPD--ERLNDIVGSAYYVAPEVLHR---SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 306 ~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
... ....+..||+.|+|||.+.+ .++.++|||||||+||+|++|+.||.+.........+.+............+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 433 23456789999999998753 4788999999999999999999999876554444343332211111112468
Q ss_pred CHHHHHHHHHcccccccCCC-----CHHHHHcCcccCCC
Q 007498 381 SPEAKDFVKRLLNKDYRKRM-----TAVQALTHPWLRDD 414 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 414 (601)
++++.+||++||.+||.+|+ +++|+|+||||++.
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 99999999999999999999 58999999999763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=426.13 Aligned_cols=261 Identities=28% Similarity=0.503 Sum_probs=211.5
Q ss_pred ccCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC
Q 007498 144 NFGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV 223 (601)
Q Consensus 144 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 223 (601)
+++.+|+++++||+|+||+||+|+++. +++.||||++.+.. .....+.+.+|+.+|++|+ |||||++++++...
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~ 78 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNV---NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAP 78 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETT---TCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCS
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECC---CCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeec
Confidence 345689999999999999999999876 78999999997543 3334567899999999996 99999999998765
Q ss_pred C-----cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEee
Q 007498 224 N-----NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLID 298 (601)
Q Consensus 224 ~-----~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~D 298 (601)
. .+||+ +|+.+|+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|
T Consensus 79 ~~~~~~~~~l~-~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~---~~~~~kl~D 152 (345)
T d1pmea_ 79 TIEQMKDVYLV-THLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICD 152 (345)
T ss_dssp STTTCCCEEEE-EECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECC
T ss_pred cccccceEEEE-EeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC---CCCCEEEcc
Confidence 3 34555 556689999988653 699999999999999999999999999999999999995 478999999
Q ss_pred cccccccCCCC----Cccccccccccccchhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccC---
Q 007498 299 FGLSDFIRPDE----RLNDIVGSAYYVAPEVLH--RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSD--- 369 (601)
Q Consensus 299 FG~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--- 369 (601)
||+|....... .....+||+.|+|||++. ..|+.++||||+||++|+|++|+.||.+....+.........
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 99998764332 235578999999999875 358999999999999999999999998877655544432211
Q ss_pred --------------------CCCCCC----CCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 370 --------------------PNFDDL----PWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 370 --------------------~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+..... .++.+++++++||.+||+.||.+|||+.|+|+||||+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 111111 13578899999999999999999999999999999986644
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=412.75 Aligned_cols=261 Identities=27% Similarity=0.447 Sum_probs=217.6
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|+++++||+|+||+||+|+++. +++.||||+++.... .......+.+|+.+|+.++ |||||+++++|.+...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---CCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccce
Confidence 479999999999999999999986 788999999976543 3345678999999999996 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
++|||++.+++|... ....+.+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||.|+...
T Consensus 77 ~iv~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~---~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 77 TLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEECCSEEHHHHH-HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred eEEeeeccccccccc-cccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc---cCCceeeeecchhhccc
Confidence 999999988877655 45567899999999999999999999999999999999999995 47889999999998775
Q ss_pred CCC-CccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCC-CCChhHHHHHHHccCCCCC---------
Q 007498 307 PDE-RLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFW-ARTESGIFRAVLRSDPNFD--------- 373 (601)
Q Consensus 307 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~--------- 373 (601)
... ......++..|+|||++.+ .++.++|||||||++|||++|+.||. +.+..+.+..+........
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 443 3344577899999998763 47999999999999999999999865 4455555555432111110
Q ss_pred ----------------CCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 374 ----------------DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 374 ----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
......+++++.+||++||+.||.+|||++|+|+||||++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 0112457899999999999999999999999999999987543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=411.20 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=208.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
.+|++.+.||+|+||.||+|+..........||||++.+.........+.+.+|+.+|++|+ |||||++++++.+ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cch
Confidence 46999999999999999999876533344579999998766555556778999999999996 9999999999976 578
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
|||||||++|+|.+.+..+.+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~---~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE---TTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc---ccceeeccchhhhhcc
Confidence 9999999999999988887778999999999999999999999999999999999999975 7789999999998775
Q ss_pred CCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCC
Q 007498 307 PDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 307 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
.... .....|+..|+|||++. ..++.++|||||||++|||++ |+.||.+.+..+.+..+.+....++. ...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~ 240 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDC 240 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--cccc
Confidence 4432 23356888999999886 578999999999999999998 89999999999988888876554432 3578
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++++.+||.+||..||++|||+.||++
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999863
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=409.61 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=207.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
++|++++.||+|+||.||+|+++ +++.||||+++.... ..+.+.+|+.+|++++ |||||++++++.+ +.+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~----~~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET----TTEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC----CCCEEEEEEECcccC----CHHHHHHHHHHHHhcc-cCCEeEEEEEEec-CCe
Confidence 47999999999999999999986 345799999975432 3467999999999996 9999999999865 568
Q ss_pred EEEEeecCCCchHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 227 YIVMELCEGGELLDRILAR-GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~-~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
|+|||||++|+|...+... .+.+++.++..|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+.+
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~---~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLI 163 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC--
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC---CCCcEEEcccchhhhc
Confidence 9999999999998877543 35699999999999999999999999999999999999995 4789999999999876
Q ss_pred CCCC--Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCC-CCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 306 RPDE--RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRP-FWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 306 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
.... .....+||+.|+|||++. +.++.++|||||||++|||++|..| |......+++..+..... .+ ..+.++
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~-~~--~~~~~~ 240 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP--CPPECP 240 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CC--CCTTSC
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-CC--CCcccC
Confidence 5433 234467999999999876 6799999999999999999996555 555666667766665432 11 225789
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHc--CcccCCCC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALT--HPWLRDDS 415 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~--hp~f~~~~ 415 (601)
+++++||.+||+.||++||+++++++ ++||....
T Consensus 241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 99999999999999999999999988 89997653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-51 Score=406.92 Aligned_cols=252 Identities=19% Similarity=0.317 Sum_probs=204.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC-ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 225 (601)
..|++.+.||+|+||.||+|.++... .....||||++.... .......+.+|+++|++|+ |||||++++++.+.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence 36999999999999999999887521 123579999986543 2334567899999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeeccccccc
Q 007498 226 VYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFI 305 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~ 305 (601)
+|+|||||.+|+|.+.+....+.+++.++..++.||+.||+|||+++|+||||||+||||+ .++.+||+|||+|+.+
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~---~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC---CCCeEEEcccchhhcc
Confidence 9999999999999998887778899999999999999999999999999999999999995 4889999999999876
Q ss_pred CCCCC----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCC-CCCCChhHHHHHHHccCCCCCCCCCCC
Q 007498 306 RPDER----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRP-FWARTESGIFRAVLRSDPNFDDLPWPS 379 (601)
Q Consensus 306 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~ 379 (601)
..... .....||+.|||||++. +.|+.++|||||||++|||++|..| |......+++..+..... .+. ...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~~~--~~~ 237 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-LPT--PMD 237 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCC--CTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-CCC--chh
Confidence 54322 23357899999999886 5799999999999999999996555 555566666666654422 211 246
Q ss_pred CCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 380 VSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 380 ~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++.++.+||.+||..||++|||+.|+++
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 8999999999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=412.18 Aligned_cols=251 Identities=20% Similarity=0.304 Sum_probs=208.5
Q ss_pred CeEEcceeccCCCeEEEEEEeecCC-ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGE-LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNV 226 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 226 (601)
+|++++.||+|+||+||+|++.... .....||+|.+.... .....+.+.+|+++|++|+ |||||+++++|.++ ..
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-Ce
Confidence 6999999999999999999986511 112368888876432 2234678999999999996 99999999999864 57
Q ss_pred EEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccC
Q 007498 227 YIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIR 306 (601)
Q Consensus 227 ~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~ 306 (601)
++||||+.+|+|.+.+......+++..+..|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+.+.
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~---~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE---TTEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCC---CCCeEeeccccceecc
Confidence 8889999999999998888888999999999999999999999999999999999999964 7899999999998775
Q ss_pred CCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCC
Q 007498 307 PDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVS 381 (601)
Q Consensus 307 ~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 381 (601)
.... .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+.+..++...+..+... +. .+.++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~~--p~~~~ 239 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQ--PPICT 239 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-CC--CTTBC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CC--CcccC
Confidence 4332 23457899999999875 679999999999999999998 79999888877777666654321 11 14689
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 382 PEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 382 ~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+++.+||.+||..||.+|||+.|++.|
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=422.11 Aligned_cols=260 Identities=27% Similarity=0.485 Sum_probs=213.2
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecC-
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDV- 223 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~- 223 (601)
+.++|+++++||+|+||+||+|+++. +++.||||++.+... .....+.+.+|+++|++|+ |||||++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 90 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETT---TTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeecc
Confidence 34689999999999999999999886 789999999976543 3335567899999999996 99999999998643
Q ss_pred ----CcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeec
Q 007498 224 ----NNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDF 299 (601)
Q Consensus 224 ----~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DF 299 (601)
...++||+|+.||+|.+++. .+.+++.+++.|+.||+.||.|||++||+||||||+|||++ .++.+|++||
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~---~~~~~kl~df 165 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDF 165 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCC
T ss_pred ccccCceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc---cccccccccc
Confidence 33466677778999998774 35799999999999999999999999999999999999995 4889999999
Q ss_pred ccccccCCCCCccccccccccccchhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHccCCCC-----
Q 007498 300 GLSDFIRPDERLNDIVGSAYYVAPEVLHR--SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRSDPNF----- 372 (601)
Q Consensus 300 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----- 372 (601)
|+|.... ....+.+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 166 g~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 166 GLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp ----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred chhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 9997643 33456789999999998653 47899999999999999999999999888777666665432211
Q ss_pred ------------------CCCC----CCCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCCCC
Q 007498 373 ------------------DDLP----WPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDDSR 416 (601)
Q Consensus 373 ------------------~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 416 (601)
+... +..+++++++||++||..||++|||+.|+|+||||++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 1111 2468999999999999999999999999999999987543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=408.06 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=201.9
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-C
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-V 223 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~ 223 (601)
++|+++++||+|+||.||+|++... ..+++.||||+++... .....+.+.+|+.++.++.+|+|||.+++++.. +
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 4799999999999999999998642 2256789999986543 233456788899999998779999999998765 4
Q ss_pred CcEEEEEeecCCCchHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC
Q 007498 224 NNVYIVMELCEGGELLDRILAR---------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG 288 (601)
Q Consensus 224 ~~~~lv~e~~~~g~L~~~~~~~---------------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~ 288 (601)
..+|+|||||++|+|.+++... ...+++.++..|+.||+.||.|||++|||||||||+||||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~-- 168 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-- 168 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC--
Confidence 5699999999999999998653 23589999999999999999999999999999999999995
Q ss_pred CCCCCeEEeecccccccCCCC---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhC-CCCCCCCChhHHHH
Q 007498 289 RDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCG-SRPFWARTESGIFR 363 (601)
Q Consensus 289 ~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~ 363 (601)
.++.+||+|||+|+...... .....+||+.|+|||++. +.|+.++|||||||++|||++| .+||.+......+.
T Consensus 169 -~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 169 -EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp -GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred -CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 47899999999998764332 234568999999999876 6799999999999999999987 56787766555554
Q ss_pred HHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 364 AVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 364 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
.++.....+.. ...+++++.+||.+||..||++|||+.|+++|
T Consensus 248 ~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 248 RRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCC--CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 54443332221 24689999999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-51 Score=419.25 Aligned_cols=256 Identities=28% Similarity=0.481 Sum_probs=202.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec----
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED---- 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---- 222 (601)
.+|+++++||+|+||+||+|+++. +++.||||++.+... .......+.+|+.+|++++ |||||+++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~---t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~ 91 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL 91 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETT---TTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred CCeEEEEEeecCcCeEEEEEEECC---CCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccccc
Confidence 579999999999999999999986 789999999977543 3345567899999999996 9999999999963
Q ss_pred --CCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecc
Q 007498 223 --VNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFG 300 (601)
Q Consensus 223 --~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG 300 (601)
...+|+|||||.+ ++++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|++|||
T Consensus 92 ~~~~~~~iv~Ey~~~-~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~---~~~~~kl~df~ 164 (355)
T d2b1pa1 92 EEFQDVYLVMELMDA-NLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG 164 (355)
T ss_dssp TTCCEEEEEEECCSE-EHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCC
T ss_pred ccCceeEEEEeccch-HHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc---cccceeeechh
Confidence 4679999999976 555544 24699999999999999999999999999999999999995 47889999999
Q ss_pred cccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHcc-----------
Q 007498 301 LSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVLRS----------- 368 (601)
Q Consensus 301 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~----------- 368 (601)
+++...........+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp C---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 998877666667789999999999986 46899999999999999999999999888776665554321
Q ss_pred -----------CCCCCCCCC----------------CCCCHHHHHHHHHcccccccCCCCHHHHHcCcccCCC
Q 007498 369 -----------DPNFDDLPW----------------PSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLRDD 414 (601)
Q Consensus 369 -----------~~~~~~~~~----------------~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 414 (601)
........+ ..+++++.+||++||.+||++|||++|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 111111110 1136789999999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=409.64 Aligned_cols=251 Identities=20% Similarity=0.332 Sum_probs=209.3
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCc--EEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQ--QVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
++|++.+.||+|+||.||+|+++. ++. .||||++.... .....+.+.+|+++|+++.+|||||+++++|.+.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~---~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC---CCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 479999999999999999999876 444 57778775432 22345678999999999955999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCC
Q 007498 225 NVYIVMELCEGGELLDRILAR---------------GGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGR 289 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~---------------~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~ 289 (601)
.+|||||||+||+|.+++... ...+++.++..++.||+.||.|||+++|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~--- 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG--- 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc---
Confidence 999999999999999988643 35799999999999999999999999999999999999995
Q ss_pred CCCCeEEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCC-CCCCCCChhHHHHHHHc
Q 007498 290 DDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGS-RPFWARTESGIFRAVLR 367 (601)
Q Consensus 290 ~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~ 367 (601)
.++.+||+|||+|+...........+||..|+|||.+. +.|+.++|||||||++|||++|. +||.+.+..+++..+.+
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 47899999999998765555555678999999999886 67999999999999999999975 57877788887777765
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 368 SDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 368 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
+.. +. .+..+++++.+||.+||..||++|||+.|+++|
T Consensus 242 ~~~-~~--~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GYR-LE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCC-CC--CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC-CC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 422 11 225789999999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=401.67 Aligned_cols=253 Identities=24% Similarity=0.420 Sum_probs=209.7
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCC----ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGE----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED 222 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 222 (601)
++|++++.||+|+||.||+|+..... .++..||||++++.. .......+.+|+.++.++.+|||||+++++|.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 47999999999999999999876421 133579999987643 233457788999999999669999999999999
Q ss_pred CCcEEEEEeecCCCchHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec
Q 007498 223 VNNVYIVMELCEGGELLDRILARG---------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS 287 (601)
Q Consensus 223 ~~~~~lv~e~~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~ 287 (601)
++.+|+|||||++|+|.+++..+. ..+++.++..++.||+.||+|||+++||||||||+|||++
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~- 169 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT- 169 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec-
Confidence 999999999999999999986542 4589999999999999999999999999999999999995
Q ss_pred CCCCCCeEEeecccccccCCCC---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 007498 288 GRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF 362 (601)
Q Consensus 288 ~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~ 362 (601)
.++.+||+|||+++...... .....+||+.|+|||++. +.|+.++|||||||++|||++ |.+||.+.....++
T Consensus 170 --~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 170 --EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp --TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred --CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 58899999999998765432 234468999999999875 789999999999999999998 78899888887777
Q ss_pred HHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..+..... +.. ...+++++.+||.+||..||++|||+.|+++
T Consensus 248 ~~i~~~~~-~~~--p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGHR-MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTCC-CCC--CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCC-CCC--CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 66655422 221 2468999999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-50 Score=401.96 Aligned_cols=252 Identities=20% Similarity=0.302 Sum_probs=213.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
++|++++.||+|+||+||+|+++.. ..+++.||||++.... .....+.+.+|+++|++|+ ||||++++++|...+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeeeccCC
Confidence 4799999999999999999998641 2356789999986543 2334678999999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCC
Q 007498 225 NVYIVMELCEGGELLDRILARG-----------------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPE 281 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~-----------------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~ 281 (601)
.+++|||||++|+|.+++.... ..+++.++..|+.||+.||+|||+++||||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999886432 24899999999999999999999999999999999
Q ss_pred ceEeecCCCCCCeEEeecccccccCCCC---Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCC-CCCCCC
Q 007498 282 NFLFTSGRDDADMRLIDFGLSDFIRPDE---RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGS-RPFWAR 356 (601)
Q Consensus 282 NIll~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~-~pf~~~ 356 (601)
|||++ .++.+||+|||+|+.+.... ...+.+||+.|+|||++. ..|+.++|||||||++|||++|. +||.+.
T Consensus 170 NILld---~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 170 NCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp GEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ceEEC---CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 99995 47899999999998664332 234567999999999876 57999999999999999999995 688888
Q ss_pred ChhHHHHHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 357 TESGIFRAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 357 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
...+++..+...... .. ...+++++.+||.+||+.||++|||+.||++
T Consensus 247 ~~~e~~~~v~~~~~~--~~-p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 247 AHEEVIYYVRDGNIL--AC-PENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CHHHHHHHHHTTCCC--CC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCCCC--CC-CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888887765432 11 2478999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=395.28 Aligned_cols=242 Identities=22% Similarity=0.364 Sum_probs=199.4
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-CCc
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-VNN 225 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~~ 225 (601)
.+|++++.||+|+||.||+|+++ ++.||||++++.. ..+.+.+|++++++++ |||||+++++|.+ .+.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~ 75 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGG 75 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-----TEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--C
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-----CeEEEEEEECcHH-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCc
Confidence 36999999999999999999873 5689999996543 3467899999999996 9999999999854 467
Q ss_pred EEEEEeecCCCchHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 226 VYIVMELCEGGELLDRILARG-GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 226 ~~lv~e~~~~g~L~~~~~~~~-~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
+|||||||++|+|.+++.... ..+++..+..|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++.
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKE 152 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC---
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec---CCCCEeeccccccee
Confidence 899999999999999986542 3589999999999999999999999999999999999995 588999999999986
Q ss_pred cCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHccCCCCCCCCCCCCCH
Q 007498 305 IRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIFRAVLRSDPNFDDLPWPSVSP 382 (601)
Q Consensus 305 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 382 (601)
... ......+|..|+|||++. +.++.++|||||||++|||++ |++||......+++..+.+.... .. ...+++
T Consensus 153 ~~~--~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~--~~-~~~~~~ 227 (262)
T d1byga_ 153 ASS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--DA-PDGCPP 227 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC--CC-CTTCCH
T ss_pred cCC--CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--CC-CccCCH
Confidence 543 234567899999999875 689999999999999999998 78889888888888777654221 11 246899
Q ss_pred HHHHHHHHcccccccCCCCHHHHHc
Q 007498 383 EAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 383 ~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
++.+||.+||..||.+|||+.++++
T Consensus 228 ~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 228 AVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHH
Confidence 9999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=397.81 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=213.5
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|++++.||+|+||.||+|+++.. ..+++.||||+++... .......+.+|+.+++++.+|||||++++++.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 4799999999999999999987532 2367899999997653 23355678999999999966999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeec
Q 007498 225 NVYIVMELCEGGELLDRILARG-----------------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTS 287 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~-----------------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~ 287 (601)
.+|||||||++|+|.+++.... ..+++..+..|+.||+.||.|||+++|+||||||+|||++
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~- 179 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT- 179 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc-
Confidence 9999999999999999886542 2589999999999999999999999999999999999996
Q ss_pred CCCCCCeEEeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 007498 288 GRDDADMRLIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLC-GSRPFWARTESGIF 362 (601)
Q Consensus 288 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~ 362 (601)
.++.+||+|||+++....... ....+||+.|+|||++. +.++.++|||||||++|||++ |.+||......+.+
T Consensus 180 --~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 180 --HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp --TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred --ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 478999999999987654332 23468999999999876 679999999999999999998 56666666665666
Q ss_pred HHHHccCCCCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 363 RAVLRSDPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 363 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
..++........ ...+++++.+||.+||..||++|||++|+++
T Consensus 258 ~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 555554332222 2468999999999999999999999999885
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-49 Score=396.05 Aligned_cols=252 Identities=18% Similarity=0.301 Sum_probs=214.0
Q ss_pred CCeEEcceeccCCCeEEEEEEeecC--CccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKG--ELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
.+|+++++||+|+||.||+|.++.. ..+++.||||++++.. .......+.+|+.+++++. |||||++++++....
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecCC
Confidence 5799999999999999999988531 1245789999987543 3335567899999999996 999999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeE
Q 007498 225 NVYIVMELCEGGELLDRILARG---------GRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMR 295 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~---------~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vk 295 (601)
.++||||||++|+|.+++.... ..+++..+..|+.|++.||.|||+++|+||||||+|||++ .++.+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld---~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec---CCceEE
Confidence 9999999999999999876431 3478999999999999999999999999999999999995 588999
Q ss_pred EeecccccccCCCCC---ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHccCC
Q 007498 296 LIDFGLSDFIRPDER---LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCG-SRPFWARTESGIFRAVLRSDP 370 (601)
Q Consensus 296 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~ 370 (601)
|+|||+|+.+..... ....+||+.|+|||.+. +.++.++|||||||++|||++| .+||.+.+..+.+..+.+...
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence 999999987643322 23457899999999876 6789999999999999999998 578888888888887776543
Q ss_pred CCCCCCCCCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 371 NFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 371 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
.. . .+.+++.+.+||.+||..||++|||+.++++
T Consensus 254 ~~--~-p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 254 LD--K-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CC--C-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC--C-cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 21 1 2478999999999999999999999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-49 Score=398.17 Aligned_cols=261 Identities=21% Similarity=0.307 Sum_probs=207.7
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
++++|++++.||+|+||.||+|+++. +++.||||++...... ..+.+|+++++.+..|++|+.+..++.+.+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECC---CCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 45689999999999999999999876 7889999998764322 347789999999974555666777778888
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDF 304 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~ 304 (601)
..++||||| +++|.+.+....+.+++..+..++.|++.||+|||++|||||||||+|||++..+.+..+||+|||+|+.
T Consensus 77 ~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 999999999 5578887777778899999999999999999999999999999999999997655567899999999987
Q ss_pred cCCCC--------CccccccccccccchhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH---ccCCCC
Q 007498 305 IRPDE--------RLNDIVGSAYYVAPEVLHR-SYSLEADIWSIGVISYILLCGSRPFWARTESGIFRAVL---RSDPNF 372 (601)
Q Consensus 305 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~ 372 (601)
+.... .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||...........+. ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 65432 2345689999999999874 69999999999999999999999997765443322221 110001
Q ss_pred -CCCCCCCCCHHHHHHHHHcccccccCCCCHH---HHHcCcccCCC
Q 007498 373 -DDLPWPSVSPEAKDFVKRLLNKDYRKRMTAV---QALTHPWLRDD 414 (601)
Q Consensus 373 -~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~---ell~hp~f~~~ 414 (601)
.....+.+++++.+||.+||..||++||++. ++|+|+|.+..
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 0111246899999999999999999999986 56788876543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=391.94 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=204.5
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEec-CCcEE
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACED-VNNVY 227 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~~~~ 227 (601)
+.+.++||+|+||+||+|++.....+...||||++++. ......+.+.+|+++|++|+ |||||++++++.+ ++.+|
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceE
Confidence 34467899999999999998653323457999998643 34445688999999999996 9999999999865 56899
Q ss_pred EEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCCeEEeecccccccCC
Q 007498 228 IVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDADMRLIDFGLSDFIRP 307 (601)
Q Consensus 228 lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~~~~~ 307 (601)
+|||||++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++ +++.+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~---~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC---CCCCEEEecccchhhccc
Confidence 99999999999998877777789999999999999999999999999999999999995 578999999999987653
Q ss_pred CCC-----ccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHccCCCCCCCCCCCC
Q 007498 308 DER-----LNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWART-ESGIFRAVLRSDPNFDDLPWPSV 380 (601)
Q Consensus 308 ~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 380 (601)
... .....||..|+|||++. +.++.++|||||||++|||++|..||.... ..+....+..+..... ...+
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~---p~~~ 259 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYC 259 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC---CTTC
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---cccC
Confidence 322 23357899999999876 689999999999999999999888876543 3344555555432211 1468
Q ss_pred CHHHHHHHHHcccccccCCCCHHHHHcC
Q 007498 381 SPEAKDFVKRLLNKDYRKRMTAVQALTH 408 (601)
Q Consensus 381 s~~~~~li~~~L~~dP~~R~s~~ell~h 408 (601)
++++.+||.+||..||++||++.|+++|
T Consensus 260 ~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 260 PDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.7e-47 Score=380.66 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=207.3
Q ss_pred cCCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC
Q 007498 145 FGAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN 224 (601)
Q Consensus 145 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 224 (601)
++.+|++++.||+|+||+||+|++.. +++.||||++..... ...+.+|+++++.|.+|+||+.+++++..+.
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CCCceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 35689999999999999999999876 789999999865432 2346789999999986699999999999999
Q ss_pred cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecC--CCCCCeEEeecccc
Q 007498 225 NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSG--RDDADMRLIDFGLS 302 (601)
Q Consensus 225 ~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~--~~~~~vkl~DFG~a 302 (601)
..|+||||| +++|.+.+......+++.++..++.|++.||+|||++|||||||||+|||++.. ...+.+||+|||+|
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 999999999 679999888777789999999999999999999999999999999999999642 23578999999999
Q ss_pred cccCCCC--------Cccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHccCC
Q 007498 303 DFIRPDE--------RLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTE---SGIFRAVLRSDP 370 (601)
Q Consensus 303 ~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~ 370 (601)
+.+.... .....+||+.|||||++. ..++.++|||||||++|||++|..||.+... ...+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 8764321 234568999999999886 4699999999999999999999999975433 233333322111
Q ss_pred CCC-CCCCCCCCHHHHHHHHHcccccccCCCCHHHHH
Q 007498 371 NFD-DLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQAL 406 (601)
Q Consensus 371 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell 406 (601)
..+ ....+.+++++.+++..|+..+|++||+++.+.
T Consensus 234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 111 111246889999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=380.27 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=188.5
Q ss_pred CCCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCC-
Q 007498 146 GAKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVN- 224 (601)
Q Consensus 146 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~- 224 (601)
...|.+.++||+|+||.||+|+. +++.||||++..... .......|+..+..++ |||||++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-----~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSREE----RSWFREAEIYQTVMLR-HENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccch----hHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCC
Confidence 35799999999999999999985 568999999864321 1122334555556775 999999999997653
Q ss_pred ---cEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeeccCCCCceEeecCCCCCC
Q 007498 225 ---NVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHL--------QGVVHRDLKPENFLFTSGRDDAD 293 (601)
Q Consensus 225 ---~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~--------~~iiHrDikp~NIll~~~~~~~~ 293 (601)
.+|||||||++|+|.+++.+. .+++.++..++.|++.||.|||+ +|||||||||+||||+ .++.
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~---~~~~ 146 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGT 146 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC---TTSC
T ss_pred cceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc---CCCC
Confidence 589999999999999998764 69999999999999999999996 5999999999999995 5889
Q ss_pred eEEeecccccccCCCC-----CccccccccccccchhccCC-------CCChhhHHHHHHHHHHHHhCCCCCCCCC----
Q 007498 294 MRLIDFGLSDFIRPDE-----RLNDIVGSAYYVAPEVLHRS-------YSLEADIWSIGVISYILLCGSRPFWART---- 357 (601)
Q Consensus 294 vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DvwSlG~il~ell~g~~pf~~~~---- 357 (601)
+||+|||+++...... .....+||+.|+|||++.+. ++.++|||||||+||||++|..||....
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 9999999998765432 23457899999999998642 5778999999999999999988773211
Q ss_pred ----------hhHHHHHHHccCCCCCCCC--C--CCCCHHHHHHHHHcccccccCCCCHHHHHc
Q 007498 358 ----------ESGIFRAVLRSDPNFDDLP--W--PSVSPEAKDFVKRLLNKDYRKRMTAVQALT 407 (601)
Q Consensus 358 ----------~~~~~~~i~~~~~~~~~~~--~--~~~s~~~~~li~~~L~~dP~~R~s~~ell~ 407 (601)
....+.........-+..+ + .....++.+|+.+||..||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1122222222211111111 0 112346899999999999999999999876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-44 Score=372.39 Aligned_cols=261 Identities=28% Similarity=0.410 Sum_probs=197.1
Q ss_pred CCeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhc----------CCCCeeEE
Q 007498 147 AKYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALS----------GHKHLVKF 216 (601)
Q Consensus 147 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~niv~l 216 (601)
.+|+++++||+|+||+||+|+++. +++.||||++++... ..+.+.+|+++++.+. +|+|||++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~---~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 469999999999999999999876 789999999976432 3456788999998885 25789999
Q ss_pred eeeEecC--CcEEEEEeecCCCchHHHH--HHcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCceEeecCCC-
Q 007498 217 CDACEDV--NNVYIVMELCEGGELLDRI--LARGGRYTEEDAKAIVVQILSVVAFCHL-QGVVHRDLKPENFLFTSGRD- 290 (601)
Q Consensus 217 ~~~~~~~--~~~~lv~e~~~~g~L~~~~--~~~~~~l~~~~~~~i~~ql~~~L~~LH~-~~iiHrDikp~NIll~~~~~- 290 (601)
++++... ...++||+++..+...... ......+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 9988643 5567777776655433332 2345679999999999999999999998 89999999999999975211
Q ss_pred --CCCeEEeecccccccCCCCCccccccccccccchhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChh------HH
Q 007498 291 --DADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLH-RSYSLEADIWSIGVISYILLCGSRPFWARTES------GI 361 (601)
Q Consensus 291 --~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~------~~ 361 (601)
...+|++|||.|..... .....+||+.|+|||++. ..|+.++||||+||++++|++|+.||...... ..
T Consensus 166 ~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 12489999999976532 345678999999999875 57999999999999999999999999654321 11
Q ss_pred HHHHHccCC------------------------CCCCC--------------CCCCCCHHHHHHHHHcccccccCCCCHH
Q 007498 362 FRAVLRSDP------------------------NFDDL--------------PWPSVSPEAKDFVKRLLNKDYRKRMTAV 403 (601)
Q Consensus 362 ~~~i~~~~~------------------------~~~~~--------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ 403 (601)
+........ ..... .+...+++++|||.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 111110000 00000 0112467899999999999999999999
Q ss_pred HHHcCcccCCCCC
Q 007498 404 QALTHPWLRDDSR 416 (601)
Q Consensus 404 ell~hp~f~~~~~ 416 (601)
|+|+||||++...
T Consensus 324 e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 324 GLVNHPWLKDTLG 336 (362)
T ss_dssp HHHTCGGGTTCTT
T ss_pred HHhcCcccCCCCC
Confidence 9999999996543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.5e-26 Score=215.70 Aligned_cols=167 Identities=25% Similarity=0.275 Sum_probs=123.9
Q ss_pred eEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeeccccc---------------chhhHHHHHHHHHHHHHhcCCCCe
Q 007498 149 YELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMT---------------TAISIEDVRREVKILKALSGHKHL 213 (601)
Q Consensus 149 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~~h~ni 213 (601)
|.++++||+|+||+||+|++. +++.||||+++..... .........+|...+.++. |.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~----~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v 76 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAV 76 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSS
T ss_pred chhCCEeeeCcceEEEEEECC----CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCc
Confidence 467899999999999999874 6789999987532111 0111234567899999996 9999
Q ss_pred eEEeeeEecCCcEEEEEeecCCCchHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCceEeecCCCCCC
Q 007498 214 VKFCDACEDVNNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVAFCHLQGVVHRDLKPENFLFTSGRDDAD 293 (601)
Q Consensus 214 v~l~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~l~~~~~~~i~~ql~~~L~~LH~~~iiHrDikp~NIll~~~~~~~~ 293 (601)
+..+++.. .+|||||++++.+. .++...+..++.|++.+|.|||++||+||||||+|||++ +..
T Consensus 77 ~~~~~~~~----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~ 140 (191)
T d1zara2 77 PKVYAWEG----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEG 140 (191)
T ss_dssp CCEEEEET----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTE
T ss_pred ceEEEecC----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCC
Confidence 99887542 37999999886542 256667789999999999999999999999999999996 345
Q ss_pred eEEeecccccccCCCCCcccccccccccc------chhccCCCCChhhHHHHHHHH
Q 007498 294 MRLIDFGLSDFIRPDERLNDIVGSAYYVA------PEVLHRSYSLEADIWSIGVIS 343 (601)
Q Consensus 294 vkl~DFG~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DvwSlG~il 343 (601)
++|+|||+|........ ..|.. .+.+.+.|+.++|+||+.--+
T Consensus 141 ~~liDFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 141 IWIIDFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EEECCCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EEEEECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99999999976542211 11211 123446789999999975433
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.86 E-value=1.1e-21 Score=177.18 Aligned_cols=149 Identities=19% Similarity=0.356 Sum_probs=126.1
Q ss_pred HHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcch
Q 007498 443 KALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTH 522 (601)
Q Consensus 443 ~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~ 522 (601)
......|+++++.+++++|..+|.|++|+|+.+||..++...+. ......+..++..+|.+++|.+++.||+..+....
T Consensus 8 ~~~~~~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~~~~-~~~~~~~~~~~~~~d~~~~~~~~~~e~~~~~~~~~ 86 (162)
T d1topa_ 8 AEARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQM 86 (162)
T ss_dssp HHHHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHH
T ss_pred HHHHccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhccCC-chhHHHHHhhhheeccCCCCCeeeehhhhhhhhhh
Confidence 33455689999999999999999999999999999999998875 56778899999999999999999999987654332
Q ss_pred hhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC-----cc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 523 QLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG-----PS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 523 ~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~-----~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
........++.++.+|+.||.|++|+|+.+||+++|... .+ ++.+|+.+|.|+||+|+|+||+++|++++
T Consensus 87 ~~~~~~~~~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~~~~ 162 (162)
T d1topa_ 87 KEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGVQ 162 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHSCC
T ss_pred hhhcccCcHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhhCCCCCHHHHHHHHHHhCCCCCCcEEHHHHHHHHHcCC
Confidence 222222336678899999999999999999999999322 22 89999999999999999999999999874
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=99.86 E-value=1.5e-21 Score=173.08 Aligned_cols=138 Identities=18% Similarity=0.368 Sum_probs=120.6
Q ss_pred hcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhh
Q 007498 448 ALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEAL 527 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~ 527 (601)
.|+++++++|+++|+.+|.|++|.|+.+||..++...+. ..+...+..+++.+|.+++|.|+|+||+..+........
T Consensus 2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~- 79 (146)
T d1exra_ 2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQD- 79 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHH-
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCC-CCCHHHHHHHHHhcCCCCCCcccHHHHHHHHHHHhhccC-
Confidence 478999999999999999999999999999999998885 567788999999999999999999999986543322111
Q ss_pred hhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 528 EGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 528 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
..+.++.+|+.||+|++|+|+.+||+.++. +..+ ++.+|+.+|.|+||+|+|+||+++|+
T Consensus 80 --~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~i~~~~D~d~dG~i~~~eF~~~l~ 145 (146)
T d1exra_ 80 --SEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMV 145 (146)
T ss_dssp --HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHH
T ss_pred --hHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhc
Confidence 256789999999999999999999999992 3333 99999999999999999999999986
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.84 E-value=5.4e-21 Score=171.42 Aligned_cols=144 Identities=21% Similarity=0.353 Sum_probs=121.0
Q ss_pred hhcchHHHHHHHHHHHhhCCCC-CCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNK-DGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~-~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
..|+++++++|+++|..||.|+ ||.|+..||..+|+.++. ..+..++..++..++.+++|.+++++|...........
T Consensus 6 ~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (156)
T d1dtla_ 6 EQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQ-NPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDD 84 (156)
T ss_dssp GGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC--
T ss_pred HHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHHcCC-CCCHHHHHHHHHHhhccCCCccchhhhhhhhhhccccc
Confidence 4689999999999999999995 899999999999999986 67788899999999999999999999976543322111
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC-----cc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG-----PS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~-----~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.....++.++.+|+.||.|++|+|+.+||++++... .+ ++.+|+.+|.|+||+|+|+||+++|+++
T Consensus 85 ~~~~~~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D~d~dG~I~~~eF~~~l~g~ 156 (156)
T d1dtla_ 85 SKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV 156 (156)
T ss_dssp ---CHHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC-
T ss_pred ccccHHHHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHcCC
Confidence 112236778999999999999999999999999432 22 9999999999999999999999999874
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.84 E-value=4e-21 Score=170.22 Aligned_cols=139 Identities=22% Similarity=0.388 Sum_probs=120.4
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
..++++++.+++++|+.||.|++|+|+.+||..++...+. .++...+..++..++.+..+.+++++|...+........
T Consensus 2 ~~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (146)
T d1lkja_ 2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGL-SPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSND 80 (146)
T ss_dssp CCCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTC-CCCHHHHHHHHHHHCSSSCCEEEHHHHHHHHHHHTCCCC
T ss_pred CCCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCC-CCCHHHHHHHHHHhccCCcccccHHHHHHHHHHhhcccc
Confidence 4689999999999999999999999999999999999885 577888999999999999999999999876543322211
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHh-----cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELAREL-----NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l-----~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
.++.++.+|+.||+|++|+|+.+||+.+| .+..+ ++.+|+.+| |+||+|+|+||+++|.+
T Consensus 81 ---~~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dG~I~~~eF~~~m~k 146 (146)
T d1lkja_ 81 ---SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLSK 146 (146)
T ss_dssp ---HHHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTCSCCHHHHHHHHHHHC-CSSSEEEHHHHHHHHCC
T ss_pred ---HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCcccHHHHHHHHHhcc-CCCCeEeHHHHHHHhCC
Confidence 26678999999999999999999999998 23333 999999999 99999999999999975
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=99.83 E-value=8.4e-21 Score=167.21 Aligned_cols=134 Identities=19% Similarity=0.294 Sum_probs=112.8
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALE 528 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~ 528 (601)
|+++++++++++|..||.|++|.|+.+||..+|+.++. .++..++..+++ +.+|.|+|+||+.++........
T Consensus 1 L~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~-~~~~~el~~~~~----~~~~~i~~~eF~~~~~~~~~~~~-- 73 (142)
T d1wdcb_ 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGR-APDDKELTAMLK----EAPGPLNFTMFLSIFSDKLSGTD-- 73 (142)
T ss_dssp CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSS-CCCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTCSCC--
T ss_pred CCHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHHhhc-CCCHHHHHHHHH----hccCccccccccccccccccccc--
Confidence 57899999999999999999999999999999999986 567777777775 56799999999986543211111
Q ss_pred hHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 529 GWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 529 ~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.++.++.+|+.||+|++|+|+.+||+.+|. ++.+ ++.+|+.+|.| +|+|+|+||+++|++.
T Consensus 74 -~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-~G~I~y~eF~~~l~~~ 140 (142)
T d1wdcb_ 74 -SEETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGS 140 (142)
T ss_dssp -CHHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHTS
T ss_pred -hhhhHHHhhhhhcccCCCcccHHHHHHHHHHccccCCHHHHHHHHHHhCCC-CCEEcHHHHHHHHhcC
Confidence 156789999999999999999999999982 3333 99999999998 6999999999999873
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=99.82 E-value=2.2e-20 Score=162.73 Aligned_cols=131 Identities=17% Similarity=0.214 Sum_probs=112.2
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHH
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIAST 536 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~ 536 (601)
...+|+.+|.|+||.|+.+||..++..++. ..+..+++.++..+|.+++|.|+++||+.++....... ....+..++.
T Consensus 2 ae~~F~~~D~d~dG~is~~E~~~~l~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~-~~~~~~~~~~ 79 (134)
T d1jfja_ 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRA-IKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQD-LSDDKIGLKV 79 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCC-SSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCS-SHHHHHHHHH
T ss_pred HHHHHHHHcCCCcCCCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhhhcccccccccccccccccccccc-cccccccccc
Confidence 357999999999999999999999999985 56777899999999999999999999998765432221 1122567899
Q ss_pred HHHHHcccCCCcccHHHHHHHhcCCcc--HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 537 AFEYFEEEGNRVISIEELARELNVGPS--AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 537 ~F~~~D~d~~G~I~~~El~~~l~~~~~--~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
+|+.+|.|++|+|+.+||+.++..... +..+|..+|.|+||+|+|+||+++|+
T Consensus 80 ~F~~~D~~~~g~i~~~el~~~~~~~~~~~~~~~~~~~D~d~dG~is~~EF~~~~l 134 (134)
T d1jfja_ 80 LYKLMDVDGDGKLTKEEVTSFFKKHGIEKVAEQVMKADANGDGYITLEEFLEFSL 134 (134)
T ss_dssp HHHHHCCSSSSEEEHHHHHHHHTTTTCHHHHHHHHHHHCSSSSEEEHHHHHHHHC
T ss_pred cccccccccCCcccHHHHHHHHHhcCcHHHHHHHHHHCCCCCCCCCHHHHHHHhC
Confidence 999999999999999999999954333 88899999999999999999999984
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=3.9e-20 Score=162.68 Aligned_cols=135 Identities=16% Similarity=0.340 Sum_probs=117.3
Q ss_pred chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhh
Q 007498 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEG 529 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~ 529 (601)
|+++.++++++|..||.|++|+|+.+||..+++..+. ..+...+..++..+|.+++|.|+++||...+........
T Consensus 1 t~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~--- 76 (141)
T d2obha1 1 TEEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGF-EPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKD--- 76 (141)
T ss_dssp CHHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHH---
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCC-chhHHHHHHHHHhhccCCCCeechHHHHHHHHHHHhhhc---
Confidence 5788999999999999999999999999999999875 577888999999999999999999999876543322111
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHH
Q 007498 530 WEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFL 588 (601)
Q Consensus 530 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~ 588 (601)
..+.+..+|+.+|.+++|+|+.+||+.++. +... ++.+|+.+|.|+||+|+|+||+++|
T Consensus 77 ~~~~l~~~f~~~d~~~~G~i~~~el~~~l~~~g~~l~~~e~~~l~~~~D~d~dG~i~~~EF~~~m 141 (141)
T d2obha1 77 TKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIM 141 (141)
T ss_dssp HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred cHHHHHHHHHHhcccCCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCCEeHHHHHHhC
Confidence 256789999999999999999999999982 3332 9999999999999999999999987
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=99.81 E-value=2.7e-20 Score=165.98 Aligned_cols=140 Identities=23% Similarity=0.213 Sum_probs=114.5
Q ss_pred cchHHHHHHHHHHHhhCC--CCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh
Q 007498 449 LTEDELVYLRAQFRLLEP--NKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~--d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
|+++++++++++|..||. |++|.|+.+||..+|+.+|. .++..++..+. ..|.+++|.|+|+||+.++........
T Consensus 1 Ls~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~-~~t~~e~~~~~-~~~~~~~~~i~~~eFl~~~~~~~~~~~ 78 (152)
T d1wdcc_ 1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGI-NPRNEDVFAVG-GTHKMGEKSLPFEEFLPAYEGLMDCEQ 78 (152)
T ss_dssp CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTC-CCCHHHHHHTT-CCSSTTSCEECHHHHHHHHHHHTTSCC
T ss_pred CCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHhcc-CccHhhhhhhh-hhhccccccccccccccccccccccch
Confidence 578999999999999994 88999999999999999996 56777777654 457788999999999986543322111
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHh-----cCCcc-HHHHHHHHhcC--CCCceeHHHHHHHHhhcc
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELAREL-----NVGPS-AYSFLKDWIRN--SDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l-----~~~~~-~~~~~~~~d~~--~dG~is~~EF~~~~~~~~ 592 (601)
. ..+.+..+|+.||+|++|+|+.+||+.+| .++.+ ++.+++.+|.+ ++|+|+|+||+++|+..+
T Consensus 79 ~--~~~~l~~aF~~~D~~~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~d~~~d~~G~I~y~eF~~~~~~~p 150 (152)
T d1wdcc_ 79 G--TFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMAGP 150 (152)
T ss_dssp C--CHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHHCS
T ss_pred h--HHHhhhhhhhccccccCccchHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCEEEHHHHHHHHhcCC
Confidence 1 15678999999999999999999999999 23333 99999999975 468999999999998654
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=5.2e-20 Score=166.49 Aligned_cols=141 Identities=20% Similarity=0.301 Sum_probs=118.2
Q ss_pred HhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh
Q 007498 444 ALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ 523 (601)
Q Consensus 444 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~ 523 (601)
.+.+.++++++++|+++|..+|.|++|.|+.+||..++... ....++.+++.+|.+++|.|+|+||+..+.....
T Consensus 5 ~~~t~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~~~-----~~~~~~~l~~~~d~~~~g~i~~~EFl~~~~~~~~ 79 (165)
T d1auib_ 5 EMCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQ-----QNPLVQRVIDIFDTDGNGEVDFKEFIEGVSQFSV 79 (165)
T ss_dssp CCCCSCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHHHH-----TCTTHHHHHHHHCTTCSSSEEHHHHHHHHGGGCT
T ss_pred HHcCCCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhhcc-----CCHHHHHHHHHHccccchhhhhhhhhhhcccccc
Confidence 35677999999999999999999999999999998765432 2345788999999999999999999987665432
Q ss_pred hhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc------CCcc-----HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 524 LEALEGWEQIASTAFEYFEEEGNRVISIEELARELN------VGPS-----AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 524 ~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~------~~~~-----~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
... ..+.++.+|+.||.|++|+|+.+||++++. +... ++.+|..+|.|+||+|+++||+++|.+..
T Consensus 80 ~~~---~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dG~Is~~EF~~i~~~~~ 156 (165)
T d1auib_ 80 KGD---KEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLD 156 (165)
T ss_dssp TCC---HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHCTTSSSSEEHHHHHHHHGGGC
T ss_pred chh---hHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHHhcCC
Confidence 221 256789999999999999999999999882 2222 78899999999999999999999998764
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.81 E-value=4.6e-21 Score=176.38 Aligned_cols=141 Identities=20% Similarity=0.448 Sum_probs=123.9
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
..|+++++.+|+++|..+|.|++|+|+.+||..++..++. .++...++.++..+|.+++|.|+|++|+.++........
T Consensus 2 ~~Lt~~ei~~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~ 80 (182)
T d1s6ia_ 2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-ELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLER 80 (182)
T ss_dssp CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTC-CCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCC
T ss_pred CCCCHHHHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCC-ccccccchhhhhhhhccccccchHHHHHHHHHhhccccc
Confidence 4688899999999999999999999999999999999985 577888999999999999999999999886654433333
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELARELN---VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
++.++.+|+.+|.+++|+|+.+||++++. +..+ ++.+|+.+|.|+||+|+|+||+++|++..
T Consensus 81 ----~e~l~~aF~~~D~d~~G~i~~~el~~~l~~~gl~~~ev~~~f~~~D~d~DG~Is~~EF~~~m~~~~ 146 (182)
T d1s6ia_ 81 ----EENLVSAFSYFDKDGSGYITLDEIQQACKDFGLDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRKRK 146 (182)
T ss_dssp ----CCSTHHHHHHTTTTCSSEEEHHHHHHTTTTTTCCTTHHHHHHHHHCSSSSSEEETTHHHHTTSCCC
T ss_pred ----HHHHHHHHHHHhhcCCCccchhhhhhhhhhcCccHHHHHHHHHHhhcCCCCeEeHHHHHHHHHhCc
Confidence 34578899999999999999999999993 3333 99999999999999999999999998764
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.80 E-value=6e-20 Score=162.28 Aligned_cols=136 Identities=15% Similarity=0.226 Sum_probs=112.9
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALE 528 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~ 528 (601)
++++++.+++++|..||.|++|.|+.+||..+|+.++...+.. .++..++.+.+|.|+|++|+..+........
T Consensus 1 f~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~----~~~~~~~~~~~g~i~~~eF~~~~~~~~~~~~-- 74 (145)
T d2mysb_ 1 FDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKN----EELDAMIKEASGPINFTVFLTMFGEKLKGAD-- 74 (145)
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchH----HHHHHHHHhccCceeechhhhhhhhcccccc--
Confidence 4788999999999999999999999999999999988533333 3455666678899999999986654322211
Q ss_pred hHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 529 GWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 529 ~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.++.++.+|+.||++++|+|+.+||+++|. ++.+ ++.++..+|.|+||+|+|+||+++|++.
T Consensus 75 -~~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d~d~dg~I~y~eF~~~l~~~ 142 (145)
T d2mysb_ 75 -PEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITHG 142 (145)
T ss_pred -hHHHHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhccC
Confidence 156789999999999999999999999993 2332 9999999999999999999999999764
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.80 E-value=9.1e-20 Score=161.13 Aligned_cols=134 Identities=15% Similarity=0.223 Sum_probs=110.1
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccC--CCCcccHHHHHHHhhcchhhhhhhhHH
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESL--AYRKMYFEEFCAAAISTHQLEALEGWE 531 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~--~~g~i~~~ef~~~~~~~~~~~~~~~~~ 531 (601)
.++++++|..||.|++|.|+.+||..+|+.+|. .++..++..++..++.+ ++|.|+|+||+.++........ ....
T Consensus 3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~-~~~~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~-~~~~ 80 (145)
T d2mysc_ 3 ADDFKEAFLLFDRTGDAKITASQVGDIARALGQ-NPTNAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKD-QGTF 80 (145)
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhh-cchhhhhHHHHHHHhhcccccCccchhHHHHHHhhhhhccc-cchH
Confidence 568999999999999999999999999999986 57888899999988665 5789999999876543221111 1125
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 532 QIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
+.+..+|+.||+|++|+|+.+||+++|. +..+ ++.+++. |.|+||+|+|+||+++|+.
T Consensus 81 ~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~d~dG~I~y~eF~~~ll~ 144 (145)
T d2mysc_ 81 EDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHIMS 144 (145)
T ss_pred HHHHHHHHHhhcCCCCEEcHHHHHHHHHHhCCCCCHHHHHHHHhh-cCCCCCeEEHHHHHHHHhc
Confidence 5689999999999999999999999993 2222 8888874 8899999999999998864
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.78 E-value=1.1e-18 Score=160.52 Aligned_cols=142 Identities=15% Similarity=0.218 Sum_probs=118.1
Q ss_pred hhhcchHHHHHHHHHHHhhCCC--CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh
Q 007498 446 SKALTEDELVYLRAQFRLLEPN--KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ 523 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d--~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~ 523 (601)
.+.++.++++.|++.|..+|.+ ++|.|+.+||..++...+. .....++.+++.+|.+++|.|+|+||+.++.....
T Consensus 8 ~t~Fs~~ei~~L~~~F~~~d~~~~~~G~i~~~ef~~~l~~~~~--~~~~~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~ 85 (183)
T d2zfda1 8 DTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNK--KESLFADRVFDLFDTKHNGILGFEEFARALSVFHP 85 (183)
T ss_dssp HSSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHSCSS--CCCHHHHHHHHHHCSSCSSSBCHHHHHHHHHHTST
T ss_pred hCCCCHHHHHHHHHHHHHHCcCCCCCCcCcHHHHHHHHHhcCC--CCCHHHHHHHHHHccCCCCcCcHHHHHHHHHhhhc
Confidence 5568999999999999999976 6999999999999977663 23345789999999999999999999886543322
Q ss_pred hhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---------CCcc-----HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 524 LEALEGWEQIASTAFEYFEEEGNRVISIEELARELN---------VGPS-----AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 524 ~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---------~~~~-----~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
... .++.++.+|++||.|++|+|+.+|++.++. +..+ ++.+|..+|.|+||+|+|+||+++|.
T Consensus 86 ~~~---~~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~ 162 (183)
T d2zfda1 86 NAP---IDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLVL 162 (183)
T ss_dssp TSC---HHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHHHHH
T ss_pred cCc---HHHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 211 266789999999999999999999999871 1221 67789999999999999999999998
Q ss_pred hcc
Q 007498 590 GVT 592 (601)
Q Consensus 590 ~~~ 592 (601)
+.+
T Consensus 163 ~~p 165 (183)
T d2zfda1 163 RHP 165 (183)
T ss_dssp HSG
T ss_pred HCH
Confidence 764
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.4e-18 Score=160.34 Aligned_cols=153 Identities=16% Similarity=0.180 Sum_probs=123.9
Q ss_pred cCchhHHHHHHhhhh--cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccH
Q 007498 434 ATPFKRAALKALSKA--LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYF 511 (601)
Q Consensus 434 ~~~l~~~~~~~~~~~--l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~ 511 (601)
.+++....+..+.+. ++..|++.|.+.|...| .+|.|+..+|..++..++........++.+|+.+|.+++|.|+|
T Consensus 2 nskl~~e~i~~l~~~t~fs~~Ei~~l~~~F~~~~--~~g~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~d~~~dg~I~~ 79 (187)
T d1g8ia_ 2 NSKLKPEVVEELTRKTYFTEKEVQQWYKGFIKDC--PSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEF 79 (187)
T ss_dssp CCSCCHHHHHHHHHTSSSCHHHHHHHHHHHHHHC--TTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEH
T ss_pred CccCCHHHHHHHHHhcCCCHHHHHHHHHHHHHHC--CCCCcCHHHHHHHHHHhcCCCCHHHHHHHHHHHhCcCCCCCCcH
Confidence 345666677777654 79999999999997665 57999999999999887753333445688999999999999999
Q ss_pred HHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----------CCc------c-HHHHHHHHhc
Q 007498 512 EEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----------VGP------S-AYSFLKDWIR 573 (601)
Q Consensus 512 ~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----------~~~------~-~~~~~~~~d~ 573 (601)
+||+..+........ ++.++.+|++||.|++|+|+.+||+.++. ... + ++.+|+.+|.
T Consensus 80 ~EF~~~l~~~~~~~~----~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~ 155 (187)
T d1g8ia_ 80 SEFIQALSVTSRGTL----DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDK 155 (187)
T ss_dssp HHHHHHHHHHHHCCH----HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHhccCch----hhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCC
Confidence 999987654433222 67899999999999999999999999872 111 1 8889999999
Q ss_pred CCCCceeHHHHHHHHhhcc
Q 007498 574 NSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 574 ~~dG~is~~EF~~~~~~~~ 592 (601)
|+||.|+++||++++.+.+
T Consensus 156 d~dG~Is~~EF~~~~~~~p 174 (187)
T d1g8ia_ 156 NADGKLTLQEFQEGSKADP 174 (187)
T ss_dssp SCSSEEEHHHHHHHHHHCH
T ss_pred CCCCcEeHHHHHHHHHHCH
Confidence 9999999999999998754
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.76 E-value=1.2e-18 Score=160.00 Aligned_cols=151 Identities=21% Similarity=0.260 Sum_probs=122.8
Q ss_pred chhHHHHHHhhhh--cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHH
Q 007498 436 PFKRAALKALSKA--LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEE 513 (601)
Q Consensus 436 ~l~~~~~~~~~~~--l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~e 513 (601)
++....+..+.+. +++++++.+++.|... +++|.|+.+||..++..++........++++++.+|.+++|.|+|+|
T Consensus 3 ~l~~~~~~~L~~~t~fs~~ei~~l~~~F~~~--~~~g~i~~~ef~~~l~~~~~~~~~~~~~~~lf~~~d~~~~g~i~~~e 80 (181)
T d1bjfa_ 3 KLRPEVMQDLLESTDFTEHEIQEWYKGFLRD--CPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFRE 80 (181)
T ss_dssp CCCHHHHHHHHHHSSCCHHHHHHHHHHHHHH--STTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHH
T ss_pred CCCHHHHHHHHHhcCCCHHHHHHHHHHHHhh--CCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhcCCCCCCcEeHHH
Confidence 4555666666544 8999999999999655 46899999999999998774333345578999999999999999999
Q ss_pred HHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----------CCc-c------HHHHHHHHhcCC
Q 007498 514 FCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----------VGP-S------AYSFLKDWIRNS 575 (601)
Q Consensus 514 f~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----------~~~-~------~~~~~~~~d~~~ 575 (601)
|+..+........ ++.++.+|++||.|++|+|+.+|++.++. +.. + ++.+|+.+|.|+
T Consensus 81 Fl~~~~~~~~~~~----~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~ 156 (181)
T d1bjfa_ 81 FIIALSVTSRGKL----EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNR 156 (181)
T ss_dssp HHHHHHHHTSSCH----HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTC
T ss_pred HHHHHHHHhhhch----HHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCCCC
Confidence 9987665443333 67889999999999999999999999882 111 1 888999999999
Q ss_pred CCceeHHHHHHHHhhcc
Q 007498 576 DGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 576 dG~is~~EF~~~~~~~~ 592 (601)
||.|||+||++++.+.+
T Consensus 157 dG~Is~~EF~~~~~~~p 173 (181)
T d1bjfa_ 157 DGKLSLEEFIRGAKSDP 173 (181)
T ss_dssp SSEECHHHHHHHHHHCT
T ss_pred CCcEeHHHHHHHHHhCH
Confidence 99999999999998765
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.76 E-value=3.2e-19 Score=156.42 Aligned_cols=129 Identities=16% Similarity=0.257 Sum_probs=105.7
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
.+++++|..||.|++|.|+.+||..+|+.+|. .++..++. .++.+.+|.|+|+||+.++........ ....+.+
T Consensus 5 ~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~-~~t~~ei~----~~~~~~~~~i~~~eF~~~~~~~~~~~~-~~~~~~l 78 (140)
T d1ggwa_ 5 SPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQ-NPTLAEIT----EIESTLPAEVDMEQFLQVLNRPNGFDM-PGDPEEF 78 (140)
T ss_dssp TTTHHHHHHTCSSSSSEECHHHHHHHHHHTSC-CCCHHHHH----HHHTTSCSSEEHHHHHHHHCTTSSSSS-SCCHHHH
T ss_pred HHHHHHHHHHCCCCCCeECHHHHHHHHHHHHh-hhHHHhhh----hhhccccccccchhhhhhhhhhhhcch-hhHHHHH
Confidence 56899999999999999999999999999986 45555444 457788999999999987643221111 1125678
Q ss_pred HHHHHHHcccCCCcccHHHHHHHh-----cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 535 STAFEYFEEEGNRVISIEELAREL-----NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l-----~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
+.+|+.||+|++|+|+.+||+.+| .+..+ ++.+++.+|.| ||+|+|+||+++|+.
T Consensus 79 ~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-dG~I~y~eF~~~m~s 139 (140)
T d1ggwa_ 79 VKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVK-DGMVNYHDFVQMILA 139 (140)
T ss_dssp HHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTCS-SCCSTTTHHHHHHHC
T ss_pred HHHHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhCCC-CCEEeHHHHHHHHhc
Confidence 999999999999999999999999 24443 99999999988 999999999999864
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.76 E-value=2.4e-18 Score=159.14 Aligned_cols=151 Identities=17% Similarity=0.184 Sum_probs=122.1
Q ss_pred chhHHHHHHhhhh--cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHH
Q 007498 436 PFKRAALKALSKA--LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEE 513 (601)
Q Consensus 436 ~l~~~~~~~~~~~--l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~e 513 (601)
.+.+..+..+.+. +++.|+++|++.|...+ ++|.|+..||..++..++........++++|+.+|.+++|.|+++|
T Consensus 7 ~l~~e~l~~l~~~t~fs~~Ei~~l~~~F~~~~--~~G~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~D~~~~G~I~~~E 84 (190)
T d1fpwa_ 7 KLSKDDLTCLKQSTYFDRREIQQWHKGFLRDC--PSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEE 84 (190)
T ss_dssp CSTTHHHHHHTTTCCSTHHHHHHHHHHHHHHC--TTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHH
T ss_pred CCCHHHHHHHHHHcCCCHHHHHHHHHHHHHHC--CCCCccHHHHHHHHHHHCCCCChHHHHHHHHHHhCcCCCCcccHHH
Confidence 3555566666544 79999999999997655 4899999999999998874333344578999999999999999999
Q ss_pred HHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc----C-----C----c----c-HHHHHHHHhcCC
Q 007498 514 FCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN----V-----G----P----S-AYSFLKDWIRNS 575 (601)
Q Consensus 514 f~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~----~-----~----~----~-~~~~~~~~d~~~ 575 (601)
|+..+........ ++.++.+|++||.|++|+|+.+||..++. . . . . ++.+|+.+|.|+
T Consensus 85 f~~~~~~~~~~~~----~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~ 160 (190)
T d1fpwa_ 85 FITVLSTTSRGTL----EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNE 160 (190)
T ss_dssp HHHHHHHHSCCCS----THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTC
T ss_pred HHHHHHHHccCch----HHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCCCC
Confidence 9887654433333 66789999999999999999999999881 0 0 0 1 888999999999
Q ss_pred CCceeHHHHHHHHhhcc
Q 007498 576 DGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 576 dG~is~~EF~~~~~~~~ 592 (601)
||.|+++||++++.+.+
T Consensus 161 dG~Is~~EF~~~~~~~p 177 (190)
T d1fpwa_ 161 DGYITLDEFREGSKVDP 177 (190)
T ss_dssp SSEEEHHHHHHHHHSST
T ss_pred CCcCcHHHHHHHHHHCH
Confidence 99999999999998764
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.75 E-value=1.6e-18 Score=161.97 Aligned_cols=149 Identities=19% Similarity=0.231 Sum_probs=118.6
Q ss_pred hhHHHHHHhhh--hcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHH
Q 007498 437 FKRAALKALSK--ALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEF 514 (601)
Q Consensus 437 l~~~~~~~~~~--~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef 514 (601)
+.+..+..+.. .++..++.+|++.|...+ ++|.|+.+||..++..++........++.+|+.+|.+++|.|+|.||
T Consensus 8 l~~e~l~~l~~~t~f~~~ei~~l~~~F~~~~--~~G~is~~EF~~~l~~~~~~~~~~~~~~~if~~~D~~~~G~I~f~EF 85 (201)
T d1omra_ 8 LSKEILEELQLNTKFTEEELSSWYQSFLKEC--PSGRITRQEFQTIYSKFFPEADPKAYAQHVFRSFDANSDGTLDFKEY 85 (201)
T ss_dssp HHHHHHHHHGGGCSSCHHHHHHHHHHHHHHC--TTSEEEHHHHHHHHHHHCTTSCCHHHHHHHHHTTTSCSSSEEEHHHH
T ss_pred CCHHHHHHHHHhCCCCHHHHHHHHHHHHHHC--cCCCccHHHHHHHHHHhcCCCCHHHHHHHHHHHhccCCCCeEeehhH
Confidence 44444555543 479999999999996554 58999999999999988754444556789999999999999999999
Q ss_pred HHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc----C-C--------c-----c--HHHHHHHHhcC
Q 007498 515 CAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN----V-G--------P-----S--AYSFLKDWIRN 574 (601)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~----~-~--------~-----~--~~~~~~~~d~~ 574 (601)
+.++........ ++.++.+|++||.|++|+|+.+|+..++. . . . + ++.+|+.+|.|
T Consensus 86 ~~~~~~~~~~~~----~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d 161 (201)
T d1omra_ 86 VIALHMTSAGKT----NQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKK 161 (201)
T ss_dssp HHHHHHHHSSCG----GGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTTCC
T ss_pred HHHHHhhcccch----HHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhCCC
Confidence 876654433222 45689999999999999999999998871 1 1 0 0 67899999999
Q ss_pred CCCceeHHHHHHHHhhc
Q 007498 575 SDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 575 ~dG~is~~EF~~~~~~~ 591 (601)
+||+|+|+||++.+.+.
T Consensus 162 ~dG~Is~~EF~~~~~~~ 178 (201)
T d1omra_ 162 DDDKLTEKEFIEGTLAN 178 (201)
T ss_dssp TTCCBCHHHHHHHHHHC
T ss_pred CCCCCcHHHHHHHHHHC
Confidence 99999999999987654
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.75 E-value=2e-18 Score=159.56 Aligned_cols=139 Identities=15% Similarity=0.206 Sum_probs=112.3
Q ss_pred cchHHHHHHHHHHHhhCCC-CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhh
Q 007498 449 LTEDELVYLRAQFRLLEPN-KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEAL 527 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d-~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~ 527 (601)
+++-...+|+++|..|+.+ ++|+|+.+||..+|...+. ......++.+|+.+|.|++|.|+|.||+..+........
T Consensus 15 ~~~~~~~ei~~~~~~F~~~~~~G~i~~~Ef~~~l~~~~~-~~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~- 92 (189)
T d1jbaa_ 15 VGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDN-EEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTL- 92 (189)
T ss_dssp CCHHHHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSS-STTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCC-
T ss_pred cCccCHHHHHHHHHHhcccCCCCeeeHHHHHHHHHHcCC-CccHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccch-
Confidence 4455556666666666555 5899999999999987775 456677999999999999999999999887654433322
Q ss_pred hhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---------------------CCcc--HHHHHHHHhcCCCCceeHHHH
Q 007498 528 EGWEQIASTAFEYFEEEGNRVISIEELARELN---------------------VGPS--AYSFLKDWIRNSDGKLSLHGY 584 (601)
Q Consensus 528 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---------------------~~~~--~~~~~~~~d~~~dG~is~~EF 584 (601)
++.++.+|++||.|++|+|+.+|+..++. ...+ ++.+|..+|.|+||.|+|+||
T Consensus 93 ---~~~~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~if~~~D~d~dG~Is~~EF 169 (189)
T d1jbaa_ 93 ---EHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEF 169 (189)
T ss_dssp ---THHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHH
T ss_pred ---HHHHHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhhhccccchHHHHHHHHHHhCCCCCCcEeHHHH
Confidence 56789999999999999999999998761 0001 788999999999999999999
Q ss_pred HHHHhhcc
Q 007498 585 TKFLHGVT 592 (601)
Q Consensus 585 ~~~~~~~~ 592 (601)
+++|++.+
T Consensus 170 ~~~~~~~p 177 (189)
T d1jbaa_ 170 VEGARRDK 177 (189)
T ss_dssp HHHHTTTT
T ss_pred HHHHHhCH
Confidence 99998764
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=99.75 E-value=2.6e-18 Score=157.64 Aligned_cols=127 Identities=15% Similarity=0.216 Sum_probs=111.5
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHH
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 533 (601)
.++|+++|..+|.|++|+|+.+||..+|+.++. ..+..+++.+++.+|.+++|.|+++||...+.. ...
T Consensus 17 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~-~~s~~~~~~l~~~~d~d~~~~i~~~ef~~~~~~----------~~~ 85 (182)
T d1y1xa_ 17 NQELMEWFRAVDTDGSGAISVPELNAALSSAGV-PFSLATTEKLLHMYDKNHSGEITFDEFKDLHHF----------ILS 85 (182)
T ss_dssp TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTB-CCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH----------HHH
T ss_pred HHHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcc-cCchhhhhhhhcccccccccccccccccccccc----------ccc
Confidence 357999999999999999999999999999885 577888999999999999999999999875432 234
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhcC-----Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELNV-----GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~~-----~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+..+|+.+|.+++|+|+.+||+++|.. ..+ ++.+|+.+|.|+||.|+|+||+++|..+
T Consensus 86 ~~~~F~~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d~~~dg~I~~~eF~~~~~~l 149 (182)
T d1y1xa_ 86 MREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFV 149 (182)
T ss_dssp HHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred cccchhccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhcccCCCCCcCHHHHHHHHHHH
Confidence 677899999999999999999999832 222 9999999999999999999999998654
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.75 E-value=2.9e-18 Score=157.21 Aligned_cols=130 Identities=13% Similarity=0.251 Sum_probs=112.5
Q ss_pred HHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHH
Q 007498 452 DELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWE 531 (601)
Q Consensus 452 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~ 531 (601)
.+.++|..+|+.+|.|++|+|+.+||..+|+.++....+...++.+++.+|.+++|.|+|+||+.++.. .
T Consensus 16 ~~~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EFl~~~~~----------~ 85 (181)
T d1hqva_ 16 PDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKY----------I 85 (181)
T ss_dssp SCHHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCSSSSSBCHHHHHHHHHH----------H
T ss_pred ccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccccccchhhhHHHhhhhh----------c
Confidence 355779999999999999999999999999988764456778999999999999999999999986432 2
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHh-----cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 532 QIASTAFEYFEEEGNRVISIEELAREL-----NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l-----~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
..++.+|+.||++++|+|+.+||+++| .+..+ ++.++..+|.++||+|+|+||+.++..+
T Consensus 86 ~~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~~~d~~~dg~Is~~eF~~~~~~l 151 (181)
T d1hqva_ 86 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVL 151 (181)
T ss_dssp HHHHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHHHHCSSCSSCBCHHHHHHHHHHH
T ss_pred cccccccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 346789999999999999999999998 23333 8999999999999999999999988654
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.74 E-value=5.2e-19 Score=156.39 Aligned_cols=133 Identities=13% Similarity=0.178 Sum_probs=107.2
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhc-ccCCCCcccHHHHHHHhhcchhhh--hhhhHHHH
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSM-ESLAYRKMYFEEFCAAAISTHQLE--ALEGWEQI 533 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~-D~~~~g~i~~~ef~~~~~~~~~~~--~~~~~~~~ 533 (601)
++++|..||.|++|.|+.+||..+|+.+|. .++.+++..++... +.+.+|.|+|++|..++....... ......+.
T Consensus 4 ~k~~F~~~D~d~~G~I~~~el~~~l~~lg~-~~s~~ei~~l~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~~~~ 82 (146)
T d1m45a_ 4 NKDIFTLFDKKGQGAIAKDSLGDYLRAIGY-NPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTED 82 (146)
T ss_dssp CTTCHHHHCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHH
T ss_pred HHHHHHHHcCCCcCCCCHHHHHHHHHHcCC-chhHHHHhhhhccccccccccccccchhhhhhhhhcccccccccchHHH
Confidence 578999999999999999999999999986 57888899999754 455678999999987654322111 11112467
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
+..+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||+|+|+||+++|.+
T Consensus 83 l~~~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D~d~dG~I~y~eF~~~i~~ 145 (146)
T d1m45a_ 83 FVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVLR 145 (146)
T ss_dssp HHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHC
T ss_pred HHHHHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhCCCCCCcEEHHHHHHHHHc
Confidence 89999999999999999999999992 3333 999999999999999999999998865
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=8.5e-19 Score=153.60 Aligned_cols=131 Identities=21% Similarity=0.284 Sum_probs=104.3
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhccc--CCCCcccHHHHHHHhhcchhhhhhhhHHHH
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMES--LAYRKMYFEEFCAAAISTHQLEALEGWEQI 533 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~--~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 533 (601)
+++++|..||.|++|.|+.+||..+|+.++. .++..++..++..++. +++|.|+|.+|...+........ ....+.
T Consensus 1 e~ke~F~~~D~d~~G~I~~~el~~~l~~lg~-~~t~~e~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~-~~~~~~ 78 (139)
T d1w7jb1 1 EFKEAFELFDRVGDGKILYSQCGDVMRALGQ-NPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRG-QGTYED 78 (139)
T ss_dssp CHHHHHHHHCCSSSSEEESTTHHHHHHHTTC-CCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC---------C
T ss_pred CHHHHHHHHhCCCCCeECHHHHHHHHHHhcc-CCCHHHHHHHHHHHhcccccCCceeeeccchhhHhhhhhcc-ccHHHH
Confidence 4789999999999999999999999999986 5778889999888774 57899999999876543222111 111455
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
+..+|+.||+|++|+|+.+||+++|. +..+ ++.++.. |.|+||+|+|+||+++|+
T Consensus 79 l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~d~dg~I~~~eF~~~ll 139 (139)
T d1w7jb1 79 YLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG-HEDSNGCINYEAFLKHIL 139 (139)
T ss_dssp CHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTT-CCCTTSEEEHHHHHHHTC
T ss_pred HHHhhhhccCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCeEeHHHHHHHhC
Confidence 78899999999999999999999992 2222 7777764 889999999999999874
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=99.71 E-value=3e-17 Score=150.82 Aligned_cols=143 Identities=15% Similarity=0.170 Sum_probs=111.8
Q ss_pred cchHHHHHHHHHHHh-hCCCCCCcccHHHHHHHHhhcchhh--------------hhhccHHHHHhhcccCCCCcccHHH
Q 007498 449 LTEDELVYLRAQFRL-LEPNKDGSVSLENFRMVLGRNATDA--------------MRESRVPDVLSSMESLAYRKMYFEE 513 (601)
Q Consensus 449 l~~~~~~~l~~~F~~-~D~d~~G~I~~~el~~~l~~~~~~~--------------~~~~~~~~~~~~~D~~~~g~i~~~e 513 (601)
||+.+.++++++|+. ||.|+||.|+.+||..++..+.... ........++...|.+++|.|++++
T Consensus 2 lt~~q~~~i~~~F~~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~i~~~~ 81 (185)
T d2sasa_ 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEE 81 (185)
T ss_dssp CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHH
T ss_pred cCHHHHHHHHHHHHHhhcCCCCCcCCHHHHHHHHHHhccccCCCcccHHHHHHHHHHHHHHHHHHHHhCcCCCCcEeeeH
Confidence 688899999999997 5999999999999999997754210 0111234567778999999999999
Q ss_pred HHHHhhcchhh-----hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHH
Q 007498 514 FCAAAISTHQL-----EALEGWEQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGY 584 (601)
Q Consensus 514 f~~~~~~~~~~-----~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF 584 (601)
|...+...... .........+..+|+.+|.|++|+|+.+||+.+| ++..+ ++.+|..+|.|+||.|+|+||
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~l~~~~~~~~f~~~D~d~dG~i~~~EF 161 (185)
T d2sasa_ 82 YLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQLQCADVPAVYNVITDGGKVTFDLNRY 161 (185)
T ss_dssp HHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSCCCCSSHHHHHHHHHTTTTSCCSHHHH
T ss_pred hhHHHHHHhhhhhhhhhhhHHHHHHHHHHHHHHccCCCccCCHHHHHHHHHHcCCCHHHHHHHHHHcCCCCCCCCcHHHH
Confidence 98665322111 0111224568899999999999999999999999 44433 999999999999999999999
Q ss_pred HHHHhhc
Q 007498 585 TKFLHGV 591 (601)
Q Consensus 585 ~~~~~~~ 591 (601)
++++++.
T Consensus 162 ~~~~~~f 168 (185)
T d2sasa_ 162 KELYYRL 168 (185)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998764
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.71 E-value=2.3e-17 Score=150.77 Aligned_cols=140 Identities=16% Similarity=0.210 Sum_probs=113.2
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
+.++..|++.+++.|...| ++|.|+.+||..++..++........++++|+.+|.+++|.|+++||+.++........
T Consensus 8 t~ft~~ei~~l~~~F~~~~--~~G~is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~ 85 (178)
T d1s6ca_ 8 TNFTKRELQVLYRGFKNEC--PSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTV 85 (178)
T ss_dssp SSCCHHHHHHHHHHHHHHC--TTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCH
T ss_pred CCCCHHHHHHHHHHHHHHC--cCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHHhccch
Confidence 4579999999988886554 57999999999999887653334455689999999999999999999876643332222
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-------------CCc---c--HHHHHHHHhcCCCCceeHHHHHHHH
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELARELN-------------VGP---S--AYSFLKDWIRNSDGKLSLHGYTKFL 588 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-------------~~~---~--~~~~~~~~d~~~dG~is~~EF~~~~ 588 (601)
++.++.+|+.||.|++|+|+.+|+..++. +.. + ++.+|+.+|.|+||.||++||.+++
T Consensus 86 ----~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~DG~Is~~EF~~~i 161 (178)
T d1s6ca_ 86 ----HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESC 161 (178)
T ss_dssp ----HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHT
T ss_pred ----HHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 66789999999999999999999988761 111 1 7889999999999999999999998
Q ss_pred hhcc
Q 007498 589 HGVT 592 (601)
Q Consensus 589 ~~~~ 592 (601)
.+.+
T Consensus 162 ~~~~ 165 (178)
T d1s6ca_ 162 QEDD 165 (178)
T ss_dssp TSCC
T ss_pred HHCH
Confidence 8754
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=4e-17 Score=149.10 Aligned_cols=138 Identities=18% Similarity=0.248 Sum_probs=107.6
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCc--------ccHHHHHHHHhhcchhhhhhccHHHHHhhcccC-CCCcccHHHHHHH
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGS--------VSLENFRMVLGRNATDAMRESRVPDVLSSMESL-AYRKMYFEEFCAA 517 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~--------I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~-~~g~i~~~ef~~~ 517 (601)
+.++++|+..|++.|..+|++++|. |++++|..+.. .......+++++.+|.+ ++|.|+|+||+.+
T Consensus 9 T~ft~~EI~~l~~~F~~l~~~~~~~~~~~~~~~i~~~e~~~~~~-----l~~~~~~~rif~~fd~~~~~g~I~f~EFv~~ 83 (180)
T d1xo5a_ 9 TFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLPE-----LKANPFKERICRVFSTSPAKDSLSFEDFLDL 83 (180)
T ss_dssp CCSCHHHHHHHHHHHHTTSCGGGCSHHHHHHCCEEHHHHHTSHH-----HHTCTTHHHHHHHHCCSTTCCEECHHHHHHH
T ss_pred cCCCHHHHHHHHHHHHHHCcCccccccccccceEcHHHHhcCcc-----cccChHHHHHHHhccCCCCCCcCcHHHHHHH
Confidence 4679999999999999999988765 55555544321 11233578899999987 6899999999987
Q ss_pred hhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc----------CCcc-----HHHHHHHHhcCCCCceeHH
Q 007498 518 AISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN----------VGPS-----AYSFLKDWIRNSDGKLSLH 582 (601)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~----------~~~~-----~~~~~~~~d~~~dG~is~~ 582 (601)
+........ .++.++.+|++||+|++|+|+.+||+.++. +..+ ++.+|+.+|.|+||+|||+
T Consensus 84 l~~~~~~~~---~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~dG~Is~~ 160 (180)
T d1xo5a_ 84 LSVFSDTAT---PDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLS 160 (180)
T ss_dssp HHHHSTTSC---HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHCTTCSSSBCHH
T ss_pred HHHHhhcCC---HHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhCCCCCCcCcHH
Confidence 644322211 267899999999999999999999999872 1121 6778999999999999999
Q ss_pred HHHHHHhhcc
Q 007498 583 GYTKFLHGVT 592 (601)
Q Consensus 583 EF~~~~~~~~ 592 (601)
||.++|.+.+
T Consensus 161 EF~~~~~~~P 170 (180)
T d1xo5a_ 161 EFQHVISRSP 170 (180)
T ss_dssp HHHHHHHHCH
T ss_pred HHHHHHHhCH
Confidence 9999998764
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=99.69 E-value=2.2e-17 Score=151.92 Aligned_cols=132 Identities=11% Similarity=0.164 Sum_probs=108.9
Q ss_pred cchHHH-HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhh-------hhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 449 LTEDEL-VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDA-------MRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 449 l~~~~~-~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~-------~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
++++++ +.++++|..+| |+||.|+..||..+|..++... ...+.+..++..+|.|++|.|+|+||..++..
T Consensus 11 ~~~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~ 89 (186)
T d1df0a1 11 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTK 89 (186)
T ss_dssp CCCSCSCHHHHHHHHHHH-GGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHc-CCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcCCCCCcccHHHHHHHHHh
Confidence 344444 46899999998 9999999999999998876421 23456899999999999999999999876432
Q ss_pred chhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 521 THQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 521 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.||+|++|+|+.+||+.+|. +..++..++..+|.|+||.|+|+||+.+|.++
T Consensus 90 ----------~~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~~~~~~~~~~~d~d~dg~I~f~eFi~~~~~l 155 (186)
T d1df0a1 90 ----------IQKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFADDELIIDFDNFVRCLVRL 155 (186)
T ss_dssp ----------HHHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECCHHHHHHHHHHHCCSTTEECHHHHHHHHHHH
T ss_pred ----------HHHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhcccHHHHHHHHHHHcCCCCeEeHHHHHHHHHHH
Confidence 34578899999999999999999999993 33336677778999999999999999998765
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=99.68 E-value=3.9e-17 Score=148.46 Aligned_cols=129 Identities=19% Similarity=0.257 Sum_probs=106.1
Q ss_pred HHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhh-------hhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh
Q 007498 452 DELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDA-------MRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL 524 (601)
Q Consensus 452 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~-------~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~ 524 (601)
+++++++++|..+|. +||.|+..||..+|..++... ...+.++.++..+|.+++|.|+|+||+.++..
T Consensus 1 ee~~~~r~~F~~~d~-~dg~I~~~EL~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~~d~d~~g~i~~~ef~~~~~~---- 75 (173)
T d1alva_ 1 EEVRQFRRLFAQLAG-DDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNN---- 75 (173)
T ss_dssp CHHHHHHHHHHHHHG-GGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH----
T ss_pred ChHHHHHHHHHHHcC-CCCcCCHHHHHHHHHHhCCCcchhhhccCCHHHHHHHHHHhccCCCCcccchhhhhhhhh----
Confidence 478899999999994 589999999999999876421 23456899999999999999999999875432
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh-----cCCccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELAREL-----NVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l-----~~~~~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
...+..+|+.||+|++|.|+..||+.+| .+..+....|..+|.|+||.|+|+||+++|.++
T Consensus 76 ------~~~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~~~~~~~~~~d~d~~G~i~~~EF~~~~~~~ 141 (173)
T d1alva_ 76 ------IKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYSDEGGNMDFDNFISCLVRL 141 (173)
T ss_dssp ------HHHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHTCSSSCBCHHHHHHHHHHH
T ss_pred ------hhHHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhHHHHHHHhhccccCCCCeEeHHHHHHHHHHH
Confidence 2346789999999999999999999999 233334555667788999999999999998664
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=99.68 E-value=2.1e-16 Score=143.68 Aligned_cols=142 Identities=17% Similarity=0.161 Sum_probs=106.7
Q ss_pred chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchh-hhhhc-------cHHHHHhh--cccCCCCcccHHHHHHHhh
Q 007498 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATD-AMRES-------RVPDVLSS--MESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~-~~~~~-------~~~~~~~~--~D~~~~g~i~~~ef~~~~~ 519 (601)
++-+.++|+.+|..+|.|+||.|+.+||..++..+... ..... .....+.. .+.+++|.|+++||+..+.
T Consensus 1 s~~~~~~l~~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~ 80 (174)
T d2scpa_ 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFINSMK 80 (174)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCCCTTHHHHHHHHHHHHHHHTGGGTTTTSCEEHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHccCCCCcEeHHHHHHHHHHHhccccchhHHHHHhHHhhhhhccccccccCCCCcCcHHHHHHHHH
Confidence 35678899999999999999999999999998765421 11111 12222332 2567789999999987654
Q ss_pred cchhh-hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 520 STHQL-EALEGWEQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 520 ~~~~~-~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
..... .......+.+..+|+.+|+|++|+|+.+||+.++ ++..+ ++.+|+.+|.|+||.|+++||++++...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~f 157 (174)
T d2scpa_ 81 EMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGLDKTMAPASFDAIDTNNDGLLSLEEFVIAGSDF 157 (174)
T ss_dssp HHTSCGGGTHHHHTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCCGGGHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred hhhcchhhHHHHHHHHHHHHHHHCCCccccCCHHHHHHHHHHHhhhhHHHHHHHhhcCCCCCCcEeHHHHHHHHHHH
Confidence 32111 1122235568899999999999999999999988 44444 9999999999999999999999988654
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=99.67 E-value=7e-18 Score=154.85 Aligned_cols=133 Identities=14% Similarity=0.197 Sum_probs=93.0
Q ss_pred cchHHHH-HHHHHHHhhCCCCCCcccHHHHHHHHhhcchhh-------hhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 449 LTEDELV-YLRAQFRLLEPNKDGSVSLENFRMVLGRNATDA-------MRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 449 l~~~~~~-~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~-------~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
++++++. +++++|..+| +++|.|+..||..+|...+... ...+.++.++..+|.|++|.|+|+||..++..
T Consensus 13 ls~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~d~~G~i~~~EF~~l~~~ 91 (188)
T d1qxpa2 13 LSEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNR 91 (188)
T ss_dssp --------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHc-CCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcCCCCCcccHHHHHHHHhh
Confidence 5666664 5999999999 5589999999999997765321 23456899999999999999999999885432
Q ss_pred chhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 521 THQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 521 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+.++.+|+.||+|++|+|+..||+.+|. +..++..++-..|.|+||.|+|+||+.+|.++.
T Consensus 92 ----------~~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~~~~~~dg~i~f~eFi~~~~~l~ 158 (188)
T d1qxpa2 92 ----------IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFADDELIIDFDNFVRCLVRLE 158 (188)
T ss_dssp ----------HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTSCSSSBCCHHHHHHHHHHHH
T ss_pred ----------hHHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHHHhcCCCCcCCHHHHHHHHHHHH
Confidence 23568899999999999999999999993 233344555555789999999999999987653
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=1.5e-16 Score=142.51 Aligned_cols=122 Identities=15% Similarity=0.279 Sum_probs=100.2
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcchhhh----hhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHH
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAM----RESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQ 532 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~----~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~ 532 (601)
+..+|+++ .+.||.|+.+||..+|+..+.... +.+.++.+++.+|.+++|.|+|+||+.++.. .+
T Consensus 2 ~~~~F~~~-a~~dG~I~~~EL~~~L~~~g~~~~~~~~s~~~~~~li~~~D~~~~G~i~~~EF~~l~~~----------~~ 70 (165)
T d1k94a_ 2 VYTYFSAV-AGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAA----------LN 70 (165)
T ss_dssp HHHHHHHH-HGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHH----------HH
T ss_pred hHHHHHHh-cCCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHhhc----------cc
Confidence 45677777 678999999999999999875321 2356899999999999999999999875432 34
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 533 IASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 533 ~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.++.+|+.||+|++|+|+.+||+.+|. +... ++.++..+|. ||.|+|+||+.+|.++
T Consensus 71 ~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~~~d~--~g~i~~~eFi~~~~~l 133 (165)
T d1k94a_ 71 AWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYSK--NGRIFFDDYVACCVKL 133 (165)
T ss_dssp HHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHCB--TTBCBHHHHHHHHHHH
T ss_pred hhHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHHHcCC--CCcCcHHHHHHHHHHH
Confidence 578899999999999999999999992 2222 8999999864 6899999999988765
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=99.66 E-value=1.3e-16 Score=159.99 Aligned_cols=144 Identities=15% Similarity=0.172 Sum_probs=115.7
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcch---
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTH--- 522 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~--- 522 (601)
...+++++...++++|..+|.|++|.|+.+||..+|..++. .++..++..++..+|.|++|.|+|.||+..+....
T Consensus 113 ~~~l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~ 191 (321)
T d1ij5a_ 113 KPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYAD-TIPEGPLKKLFVMVENDTKGRMSYITLVAVANDLAALV 191 (321)
T ss_dssp CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHT-TSCSSHHHHHHHHHHHCCSSTHHHHHHTTSHHHHHTSC
T ss_pred cccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHcCC-cccHHHHHHHHHHHhhcCCccccchhhhhhhhhhhhhh
Confidence 34578889999999999999999999999999999999885 67888999999999999999999999963221000
Q ss_pred ------------------------------hh----------------------hhhhhHHHHHHHHHHHHcccCCCccc
Q 007498 523 ------------------------------QL----------------------EALEGWEQIASTAFEYFEEEGNRVIS 550 (601)
Q Consensus 523 ------------------------------~~----------------------~~~~~~~~~~~~~F~~~D~d~~G~I~ 550 (601)
.. .........+..+|..+|.|++|+|+
T Consensus 192 ~~F~~~d~d~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~F~~~D~d~~G~Is 271 (321)
T d1ij5a_ 192 ADFRKIDTNSNGTLSRKEFREHFVRLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLLVLRILYAFADFDKSGQLS 271 (321)
T ss_dssp CCHHHHCTTCCSEECHHHHHHHHHHTTCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHHHHHHHTCSSSCSSEE
T ss_pred HHHHHHhhcccccchhHHHhhhhhcccccchHHHHHHHHhhhcccccccccccccchhhhhhHHHHHHHHHhcCCCCCCc
Confidence 00 00000122345689999999999999
Q ss_pred HHHHHHHh---cC---Cc-cHHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 551 IEELAREL---NV---GP-SAYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 551 ~~El~~~l---~~---~~-~~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
.+||+.+| ++ .. ++..+|..+|.|+||.|+|+||+++|.-
T Consensus 272 ~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~ml~ 318 (321)
T d1ij5a_ 272 KEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLVLL 318 (321)
T ss_dssp HHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCcCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 99999998 22 11 2999999999999999999999999864
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=99.64 E-value=9.2e-16 Score=141.36 Aligned_cols=142 Identities=12% Similarity=0.157 Sum_probs=102.9
Q ss_pred chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhh-----cchhhhhhccHH-----HHHhhcccCCCCcccHHHHHHHhh
Q 007498 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGR-----NATDAMRESRVP-----DVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-----~~~~~~~~~~~~-----~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
.++++++++++|..||.|++|.|+.+||..++.. ++. .++..+.. ..+...+....+.|+++||...+.
T Consensus 9 ~~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~e~~~~~~ 87 (189)
T d1qv0a_ 9 NPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEA-TPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFLDGWK 87 (189)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTC-CHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCC-CchhHHHHHHHHHHHhhhccccCCCceehHHHHHHHH
Confidence 5578899999999999999999999999886643 332 22323322 234445667788999999987654
Q ss_pred cchhhh-------hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHH
Q 007498 520 STHQLE-------ALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTK 586 (601)
Q Consensus 520 ~~~~~~-------~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~ 586 (601)
...... ......+.+..+|+.||+|++|+|+.+||+.++. +..+ ++.+|+.+|.|+||.|+|+||++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~ 167 (189)
T d1qv0a_ 88 QLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTR 167 (189)
T ss_dssp HHHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHH
T ss_pred HHHHHhhhccccccHHHHHHHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHH
Confidence 321111 1122345677899999999999999999999992 3333 99999999999999999999999
Q ss_pred HHhhcc
Q 007498 587 FLHGVT 592 (601)
Q Consensus 587 ~~~~~~ 592 (601)
++.+..
T Consensus 168 ~~~~~~ 173 (189)
T d1qv0a_ 168 QHLGFW 173 (189)
T ss_dssp HHHHHH
T ss_pred HHHHhC
Confidence 998754
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=99.62 E-value=2e-15 Score=137.00 Aligned_cols=140 Identities=12% Similarity=0.079 Sum_probs=107.5
Q ss_pred HHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchh---hhhh-----------ccHHHHHhhcccCCCCcccHHHHHHH
Q 007498 452 DELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATD---AMRE-----------SRVPDVLSSMESLAYRKMYFEEFCAA 517 (601)
Q Consensus 452 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~---~~~~-----------~~~~~~~~~~D~~~~g~i~~~ef~~~ 517 (601)
-..++|+++|..+|.|++|.|+.+||..++..+... .... .....++...|.+.+|.|++.++...
T Consensus 4 ~~~~~l~~~F~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 83 (176)
T d1nyaa_ 4 IASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRV 83 (176)
T ss_dssp HHHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHcCCcccHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccHHHHHHH
Confidence 355679999999999999999999999999765421 1111 11245667778899999999999765
Q ss_pred hhcch----hhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 518 AISTH----QLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 518 ~~~~~----~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
..... .........+.++.+|..||.|++|+|+.+||+.++ ++... ++.+|+.+|.|+||.|+++||+++|+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~ 163 (176)
T d1nyaa_ 84 TENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALGMSKAEAAEAFNQVDTNGNGELSLDELLTAVR 163 (176)
T ss_dssp HHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHS
T ss_pred HhhhhhhhhhhhhHHHHHHHHHHHHHHHccCCChhhhHHHHHHHHHhcCCcHHHHHHHHHHHCCCCCCcEeHHHHHHHHH
Confidence 43221 111112234568889999999999999999999987 44443 99999999999999999999999997
Q ss_pred hc
Q 007498 590 GV 591 (601)
Q Consensus 590 ~~ 591 (601)
..
T Consensus 164 ~~ 165 (176)
T d1nyaa_ 164 DF 165 (176)
T ss_dssp CC
T ss_pred HH
Confidence 64
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=4.5e-16 Score=141.13 Aligned_cols=128 Identities=16% Similarity=0.240 Sum_probs=98.2
Q ss_pred hHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhh----hhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhh
Q 007498 451 EDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDA----MRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEA 526 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~----~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~ 526 (601)
.++...++..|..++ ++||.|+..||..+|+.++... .+.+.++.+++.+|.|++|.|+|+||+.++..
T Consensus 3 ~~~~~~~~~~F~~~~-~~dG~Is~~EL~~~L~~~g~~~~~~~~~~~~v~~l~~~~D~d~~G~I~f~EF~~~~~~------ 75 (172)
T d1juoa_ 3 GQTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAV------ 75 (172)
T ss_dssp TCCCCTTHHHHHHHH-TTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHH------
T ss_pred cchHHHHHHHHHHhC-CCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHHCCCCCCceehHHHHHHHHh------
Confidence 344556889999997 7899999999999999987431 23566899999999999999999999875432
Q ss_pred hhhHHHHHHHHHHHHcccCCCcccHHHHHHHh-----cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 527 LEGWEQIASTAFEYFEEEGNRVISIEELAREL-----NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 527 ~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l-----~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
...+..+|+.||.|++|+|+.+||+.+| .+..+ ++.+++.+| .+|.|+|+||+.+|.++
T Consensus 76 ----~~~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~~~d--~~g~i~~~eF~~~~~~~ 140 (172)
T d1juoa_ 76 ----LNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYS--TNGKITFDDYIACCVKL 140 (172)
T ss_dssp ----HHHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTC--SSSSEEHHHHHHHHHHH
T ss_pred ----hhhhhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHHHHH--hcCCcCHHHHHHHHHHH
Confidence 2345778999999999999999999998 22322 666666664 44667777777666543
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=99.59 E-value=1.7e-15 Score=125.12 Aligned_cols=94 Identities=18% Similarity=0.306 Sum_probs=76.2
Q ss_pred hhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-C-------
Q 007498 489 MRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-V------- 560 (601)
Q Consensus 489 ~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-~------- 560 (601)
.+.+++..++..+| .+|.|+|+||+.++..... . ++.++.+|+.||+|++|+|+.+||+.+|. +
T Consensus 6 l~~eeI~~~~~~~d--~dG~idf~EF~~~~~~~~~--~----~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~l 77 (109)
T d1pvaa_ 6 LKADDIKKALDAVK--AEGSFNHKKFFALVGLKAM--S----ANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDL 77 (109)
T ss_dssp SCHHHHHHHHHHTC--STTCCCHHHHHHHHTCTTS--C----HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCC
T ss_pred CCHHHHHHHHHhcC--CCCCCcHHHHHHHHHHccC--C----HHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCC
Confidence 34566778888775 5788999999886543221 2 45688999999999999999999999983 1
Q ss_pred Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 561 GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 561 ~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
+.+ ++.+|+.+|.|+||+|+|+||+++|++
T Consensus 78 s~~ev~~~~~~~D~d~dG~I~~~EF~~~m~~ 108 (109)
T d1pvaa_ 78 TDAETKAFLKAADKDGDGKIGIDEFETLVHE 108 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred CHHHHHHHHHHHCCCCcCcEeHHHHHHHHHh
Confidence 122 899999999999999999999999975
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=99.58 E-value=1.9e-15 Score=124.87 Aligned_cols=93 Identities=15% Similarity=0.270 Sum_probs=75.7
Q ss_pred hhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc--------CC
Q 007498 490 RESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN--------VG 561 (601)
Q Consensus 490 ~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~--------~~ 561 (601)
+.+++.+++..+| .+|.|+|+||+.++.... .. ++.++.+|+.||+|++|+|+.+||+.+|. +.
T Consensus 7 ~~~di~~~~~~~~--~~G~idf~eF~~~~~~~~--~~----~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~ 78 (109)
T d5pala_ 7 KADDINKAISAFK--DPGTFDYKRFFHLVGLKG--KT----DAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLN 78 (109)
T ss_dssp CHHHHHHHHHHTC--STTCCCHHHHHHHHTCTT--CC----HHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCC
T ss_pred cHHHHHHHHHhcC--CCCcCcHHHHHHHHHhcC--CC----HHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCC
Confidence 4556788888776 468899999987653221 12 56789999999999999999999999872 22
Q ss_pred cc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 562 PS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 562 ~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
.+ ++.+|+.+|.|+||+|+|+||+++|.+
T Consensus 79 ~~e~~~~~~~~D~d~dG~I~~~EF~~~m~~ 108 (109)
T d5pala_ 79 DTETKALLAAGDSDHDGKIGADEFAKMVAQ 108 (109)
T ss_dssp HHHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCEeHHHHHHHHHh
Confidence 22 999999999999999999999999976
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=99.58 E-value=3.3e-15 Score=137.26 Aligned_cols=140 Identities=11% Similarity=0.102 Sum_probs=102.8
Q ss_pred hHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhc-----chhhhhhccHHH-----HHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRN-----ATDAMRESRVPD-----VLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~-----~~~~~~~~~~~~-----~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
..++++++++|..||.|+||+|+.+||..++... +. .++...+.. .+.......++.+++.+|+.....
T Consensus 8 p~~~~~~k~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (187)
T d1uhka1 8 PRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGA-TPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWKK 86 (187)
T ss_dssp HHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCC-CHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHhcc-CccHHHHHHHHHHhhhhcccccccccccHHHHHHHHHH
Confidence 4568899999999999999999999998877542 22 223332222 223344456678999999765433
Q ss_pred chhhhh-------hhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHH
Q 007498 521 THQLEA-------LEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKF 587 (601)
Q Consensus 521 ~~~~~~-------~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~ 587 (601)
...... .......+..+|+.||+|++|+|+.+||+.+|. +..+ ++.+|+.+|.|+||+|+|+||+++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~ 166 (187)
T d1uhka1 87 LATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQ 166 (187)
T ss_dssp HHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHHH
T ss_pred HHHHHHHhhhhhhHHHHHHHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCCCCCCCEeHHHHHHH
Confidence 211110 112345578899999999999999999999982 3333 999999999999999999999998
Q ss_pred Hhhc
Q 007498 588 LHGV 591 (601)
Q Consensus 588 ~~~~ 591 (601)
+.+.
T Consensus 167 ~~~~ 170 (187)
T d1uhka1 167 HLGF 170 (187)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 8764
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=99.49 E-value=4.2e-14 Score=116.97 Aligned_cols=94 Identities=10% Similarity=0.255 Sum_probs=76.1
Q ss_pred hhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc--------C
Q 007498 489 MRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN--------V 560 (601)
Q Consensus 489 ~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~--------~ 560 (601)
.+.+++..++..++. +|.|+|+||+.++..... . ++.++.+|+.||+|++|+|+.+||+.+|. +
T Consensus 6 ~~~~~i~~~~~~~~~--~~~i~f~eF~~~~~~~~~--~----~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~ 77 (109)
T d1rwya_ 6 LSAEDIKKAIGAFTA--ADSFDHKKFFQMVGLKKK--S----ADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDL 77 (109)
T ss_dssp SCHHHHHHHHHTTCS--TTCCCHHHHHHHHTGGGS--C----HHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCC
T ss_pred cCHHHHHHHHHhccc--CCCcCHHHHHHHHccccC--C----HHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccC
Confidence 345667888887754 588999999886542221 2 56789999999999999999999999982 1
Q ss_pred Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 561 GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 561 ~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
... ++.+|+.+|.|+||+|+|+||+++|++
T Consensus 78 ~~~e~~~~~~~~D~d~dG~i~~~EF~~~m~~ 108 (109)
T d1rwya_ 78 SAKETKTLMAAGDKDGDGKIGVEEFSTLVAE 108 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred CHHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 222 999999999999999999999999975
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=99.45 E-value=1.1e-13 Score=113.78 Aligned_cols=93 Identities=17% Similarity=0.285 Sum_probs=75.6
Q ss_pred hhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-C-------
Q 007498 489 MRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-V------- 560 (601)
Q Consensus 489 ~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-~------- 560 (601)
.++.++..+++.++. +|.|+|.||+..+.... .. +++++.+|++||+|++|+|+.+||+.+|. +
T Consensus 5 ls~~di~~~~~~~~~--~gsi~~~eF~~~~~l~~--~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~ 76 (107)
T d2pvba_ 5 LKDADVAAALAACSA--ADSFKHKEFFAKVGLAS--KS----LDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARAL 76 (107)
T ss_dssp SCHHHHHHHHHHTCS--TTCCCHHHHHHHHTGGG--SC----HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCC
T ss_pred CCHHHHHHHHHhccC--CCCcCHHHHHHHHhccc--CC----HHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccC
Confidence 456678888888865 56799999987654221 12 56789999999999999999999999872 1
Q ss_pred Ccc-HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 561 GPS-AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 561 ~~~-~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
..+ ++.+|+.+|.|+||+|+|+||+.+|+
T Consensus 77 ~~~~~~~l~~~~D~d~dG~I~~~EF~~~m~ 106 (107)
T d2pvba_ 77 TDAETKAFLADGDKDGDGMIGVDEFAAMIK 106 (107)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred CHHHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence 222 99999999999999999999999986
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=2.6e-13 Score=121.09 Aligned_cols=123 Identities=10% Similarity=0.068 Sum_probs=98.4
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
+.++.++..+|.|++|.|+.+||..++..+ ..++.+|+.+|.|++|.|+.+|+..++........ .+.+
T Consensus 40 ~~~~~li~~~D~~~~G~i~~~EF~~l~~~~-------~~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~----~~~~ 108 (165)
T d1k94a_ 40 ETCRIMIAMLDRDHTGKMGFNAFKELWAAL-------NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLS----PQTL 108 (165)
T ss_dssp HHHHHHHHHHCTTCSSCBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCC----HHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHhhcc-------chhHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCC----HHHH
Confidence 446677778899999999999999887654 24778999999999999999999887665543333 5568
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCce--eHHHHHHHHhh
Q 007498 535 STAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKL--SLHGYTKFLHG 590 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~i--s~~EF~~~~~~ 590 (601)
..+++.||+ +|.|+.+||...+-....+..+|+.+|.|++|.| +++||+++++.
T Consensus 109 ~~l~~~~d~--~g~i~~~eFi~~~~~l~~~~~~F~~~D~d~~G~i~l~~~ef~~~~~~ 164 (165)
T d1k94a_ 109 TTIVKRYSK--NGRIFFDDYVACCVKLRALTDFFRKRDHLQQGSANFIYDDFLQGTMA 164 (165)
T ss_dssp HHHHHHHCB--TTBCBHHHHHHHHHHHHHHHHHHHTTCTTCCSEEEEEHHHHHHHHHT
T ss_pred HHHHHHcCC--CCcCcHHHHHHHHHHHHHHHHHHHHhCCCCCCcEEecHHHHHHHHHc
Confidence 888999975 5889999998877322336778999999999977 78999998875
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.43 E-value=3.3e-13 Score=122.93 Aligned_cols=124 Identities=14% Similarity=0.187 Sum_probs=102.8
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHH
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 533 (601)
.+.++.+|..+|.|++|.|+.+||..++.... .+..+++.+|.+++|.|+.+||..++........ ++.
T Consensus 55 ~~~~~~l~~~~D~d~~g~i~~~EFl~~~~~~~-------~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~----~e~ 123 (181)
T d1hqva_ 55 PVTVRSIISMFDRENKAGVNFSEFTGVWKYIT-------DWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLS----DQF 123 (181)
T ss_dssp HHHHHHHHHHHCCSSSSSBCHHHHHHHHHHHH-------HHHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCC----HHH
T ss_pred HHHHHHHhhccccccccchhhhHHHhhhhhcc-------ccccccccccccccchhhhHHHHHHHHHcCCcch----hHH
Confidence 34577788889999999999999999886532 3678999999999999999999887655433333 567
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCce--eHHHHHHHH
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKL--SLHGYTKFL 588 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~i--s~~EF~~~~ 588 (601)
+..+++.+|.+++|.|+.+||...+.....+..+|+.+|+++||.| +++||+.+|
T Consensus 124 ~~~~~~~~d~~~dg~Is~~eF~~~~~~l~~l~~~F~~~D~~~dG~i~~~~~ef~~~~ 180 (181)
T d1hqva_ 124 HDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQVSYEQYLSMV 180 (181)
T ss_dssp HHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHHHHHCTTCSSCCCCCHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHHHHHHHhCCCCCCCEEecHHHHHHHh
Confidence 8899999999999999999999887433347889999999999966 799999987
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.41 E-value=2.3e-13 Score=112.03 Aligned_cols=93 Identities=13% Similarity=0.249 Sum_probs=73.8
Q ss_pred hhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-C-------
Q 007498 489 MRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-V------- 560 (601)
Q Consensus 489 ~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-~------- 560 (601)
.+.+++..+++.++ .+|.|+|++|+..+.... . . .+.++.+|+.||+|++|+|+.+||+.+|. +
T Consensus 6 ls~~dI~~~l~~~~--~~~s~~~~~F~~~~~~~~-~-~----~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l 77 (108)
T d1rroa_ 6 LSAEDIAAALQECQ--DPDTFEPQKFFQTSGLSK-M-S----ASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDAREL 77 (108)
T ss_dssp SCHHHHHHHHHHTC--STTCCCHHHHHHHHSGGG-S-C----HHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCC
T ss_pred CCHHHHHHHHHhcc--cCCCccHHHHHHHHccCc-C-C----HHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCC
Confidence 34556777777665 467799999977543221 1 1 45789999999999999999999999982 1
Q ss_pred Ccc-HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 561 GPS-AYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 561 ~~~-~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
..+ ++.+|+.+|.|+||.|+|+||+++|+
T Consensus 78 ~~~~~~~~~~~~D~d~dG~I~~~EF~~~m~ 107 (108)
T d1rroa_ 78 TESETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp CHHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred CHHHHHHHHHHhCCCCCCeEeHHHHHHHHc
Confidence 222 99999999999999999999999986
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=7.4e-13 Score=119.48 Aligned_cols=124 Identities=10% Similarity=0.079 Sum_probs=101.7
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHH
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 533 (601)
.+.++.++..+|.|++|.|+.+||..++.... .+...++.+|.+++|.|+.+|+..++........ ++.
T Consensus 46 ~~~v~~l~~~~D~d~~G~I~f~EF~~~~~~~~-------~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls----~~~ 114 (172)
T d1juoa_ 46 LETCRLMVSMLDRDMSGTMGFNEFKELWAVLN-------GWRQHFISFDTDRSGTVDPQELQKALTTMGFRLS----PQA 114 (172)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH-------HHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCC----HHH
T ss_pred HHHHHHHHHHHCCCCCCceehHHHHHHHHhhh-------hhhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhh----HHH
Confidence 45577889999999999999999998886543 2567899999999999999999887655443333 567
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCce--eHHHHHHHHhh
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKL--SLHGYTKFLHG 590 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~i--s~~EF~~~~~~ 590 (601)
+..+|+.+| ++|.|+.+||..++.-...+..+|+.+|+|+||.| +|+||+.+++.
T Consensus 115 ~~~l~~~~d--~~g~i~~~eF~~~~~~~~~~~~~f~~~D~d~~G~Itl~~~eFl~~~l~ 171 (172)
T d1juoa_ 115 VNSIAKRYS--TNGKITFDDYIACCVKLRALTDSFRRRDTAQQGVVNFPYDDFIQCVMS 171 (172)
T ss_dssp HHHHHHHTC--SSSSEEHHHHHHHHHHHHHHHHHHHHTCTTCCSEEEEEHHHHHHHHTT
T ss_pred HHHHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHhCCCCCCcEEecHHHHHHHHHc
Confidence 889999997 45889999999988433347889999999999998 88999999875
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=99.37 E-value=1.5e-12 Score=118.49 Aligned_cols=129 Identities=10% Similarity=0.127 Sum_probs=102.2
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
+..++..+ ++.+|..+|.|++|.|+.+||...+... ..+...|..+|.+++|.|+.+||..++.......
T Consensus 48 ~~~~s~~~---~~~l~~~~d~d~~~~i~~~ef~~~~~~~-------~~~~~~F~~~D~~~~g~I~~~el~~~l~~~g~~l 117 (182)
T d1y1xa_ 48 GVPFSLAT---TEKLLHMYDKNHSGEITFDEFKDLHHFI-------LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQV 117 (182)
T ss_dssp TBCCCHHH---HHHHHHHHCTTCSSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCC
T ss_pred cccCchhh---hhhhhccccccccccccccccccccccc-------cccccchhccccccchhhhhHHHHHHHHHhCCch
Confidence 33455554 5667788899999999999998877543 2366788999999999999999988766544333
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCce--eHHHHHHHH
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKL--SLHGYTKFL 588 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~i--s~~EF~~~~ 588 (601)
. ++.+..+|+.+|.|++|.|+.+||.+++.....+..+|+.+|.++||.| +|+||+.-.
T Consensus 118 s----~~e~~~i~~~~d~~~dg~I~~~eF~~~~~~l~~~~~~F~~~D~~~~G~is~~~~~f~~~~ 178 (182)
T d1y1xa_ 118 S----EQTFQALMRKFDRQRRGSLGFDDYVELSIFVCRVRNVFAFYDRERTGQVTFTFDTFIGGS 178 (182)
T ss_dssp C----HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHCTTCCSEEEEEHHHHHHHH
T ss_pred h----HHHHHHHHhhcccCCCCCcCHHHHHHHHHHHHHHHHHHHHhCCCCCCcEEeeHHHHHHHH
Confidence 3 5678899999999999999999999988433347889999999999995 689998753
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=99.36 E-value=6.3e-13 Score=121.59 Aligned_cols=124 Identities=11% Similarity=0.121 Sum_probs=99.7
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHH
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 533 (601)
.+.+..++..+|.|++|.|+.+||..++... ..+..+|+.+|.|++|.|+.+|+..++........ ..
T Consensus 60 ~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~~-------~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~-----~~ 127 (186)
T d1df0a1 60 IETCKIMVDMLDEDGSGKLGLKEFYILWTKI-------QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLP-----CQ 127 (186)
T ss_dssp HHHHHHHHHHHCCSSSSEECHHHHHHHHHHH-------HHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECC-----HH
T ss_pred HHHHHHHHHHHcCCCCCcccHHHHHHHHHhH-------HHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhccc-----HH
Confidence 3457788889999999999999999887653 23778999999999999999999887654433332 23
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCce--eHHHHHHHHh
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKL--SLHGYTKFLH 589 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~i--s~~EF~~~~~ 589 (601)
+..+|..+|.|++|.|+.+||..++--...+..+|+.+|.|++|.| ++.||+.+..
T Consensus 128 ~~~~~~~~d~d~dg~I~f~eFi~~~~~l~~~~~~F~~~D~~~~G~i~l~~~ef~~~~~ 185 (186)
T d1df0a1 128 LHQVIVARFADDELIIDFDNFVRCLVRLEILFKIFKQLDPENTGTIQLDLISWLSFSV 185 (186)
T ss_dssp HHHHHHHHHCCSTTEECHHHHHHHHHHHHHHHHHHHHHCTTCCSEEEEEHHHHHHHHT
T ss_pred HHHHHHHHHcCCCCeEeHHHHHHHHHHHHHHHHHHHHhCCCCCCcEEecHHHHHHHhh
Confidence 4567778999999999999998877333347889999999999987 8999998764
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=99.35 E-value=1.4e-12 Score=117.79 Aligned_cols=123 Identities=8% Similarity=0.102 Sum_probs=98.5
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIA 534 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~ 534 (601)
+.++.++..+|.|++|.|+.+||..++.... .+..+|+.+|.+++|.|+..|+..++.......+ + ..
T Consensus 47 ~~~~~l~~~~d~d~~g~i~~~ef~~~~~~~~-------~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~----~-~~ 114 (173)
T d1alva_ 47 DTCRSMVAVMDSDTTGKLGFEEFKYLWNNIK-------KWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLN----E-HL 114 (173)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH-------HHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCC----H-HH
T ss_pred HHHHHHHHHhccCCCCcccchhhhhhhhhhh-------HHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhH----H-HH
Confidence 4567788999999999999999998876543 2567899999999999999999887654433222 2 33
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCce--eHHHHHHHHh
Q 007498 535 STAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKL--SLHGYTKFLH 589 (601)
Q Consensus 535 ~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~i--s~~EF~~~~~ 589 (601)
...|..+|.|++|.|+.+||.+++.....+..+|+.+|.|+||.| +|+||+.+..
T Consensus 115 ~~~~~~~d~d~~G~i~~~EF~~~~~~~~~~~~~f~~~D~d~~G~it~~~~efl~~~~ 171 (173)
T d1alva_ 115 YSMIIRRYSDEGGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVNIQEWLQLTM 171 (173)
T ss_dssp HHHHHHHHTCSSSCBCHHHHHHHHHHHHHHHHHHHHHSSSCCSEEEEEHHHHHHHHH
T ss_pred HHHhhccccCCCCeEeHHHHHHHHHHHHHHHHHHHHhCCCCCCcEEecHHHHHHHHH
Confidence 456667788999999999999988433347789999999999988 6899999874
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=1.7e-13 Score=123.23 Aligned_cols=129 Identities=15% Similarity=0.215 Sum_probs=89.0
Q ss_pred HHHHHHHh--hCCCCCCcccHHHHHHHHhhcchh-hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHH
Q 007498 456 YLRAQFRL--LEPNKDGSVSLENFRMVLGRNATD-AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQ 532 (601)
Q Consensus 456 ~l~~~F~~--~D~d~~G~I~~~el~~~l~~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~ 532 (601)
.|+++|.+ +|.|++|.|+.+||.+++...... ......+..++...|.+++|.|+|+||..++.... . ..
T Consensus 6 ~l~k~~~k~~~d~n~dG~Is~~el~k~l~~~~~~~~~~~~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l~---~----r~ 78 (170)
T d2zkmx1 6 FLDKILVKLKMQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLC---P----RP 78 (170)
T ss_dssp HHHHHHHHHHHSCCTTSCEEHHHHHHHSCSCHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHS---C----CH
T ss_pred HHHHHHHHHhcccCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhhccccccCCCccCHHHHHHHHhccC---C----HH
Confidence 35555555 799999999999999999765431 12334567778889999999999999998765332 1 34
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHhcC---------------Ccc-HHHHHHHHhcCCC----CceeHHHHHHHHhhc
Q 007498 533 IASTAFEYFEEEGNRVISIEELARELNV---------------GPS-AYSFLKDWIRNSD----GKLSLHGYTKFLHGV 591 (601)
Q Consensus 533 ~~~~~F~~~D~d~~G~I~~~El~~~l~~---------------~~~-~~~~~~~~d~~~d----G~is~~EF~~~~~~~ 591 (601)
++..+|..||.|++|+||.+||+.+|.. ..+ +..++..+..+.+ |.|++++|+.+|..-
T Consensus 79 ei~~~F~~~d~d~~~~it~~el~~fL~~~Q~~~~~~e~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ls~d~F~~fL~S~ 157 (170)
T d2zkmx1 79 EIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWFLCGP 157 (170)
T ss_dssp HHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHHHHHHHHST
T ss_pred HHHHHHHHHcCCCCCcccHHHHHHHHHHHhcchhhhhhccccCCHHHHHHHHHHHccccccccCCeECHHHHHHHHcCc
Confidence 5788999999999999999999999921 111 7888888877654 899999999988653
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.32 E-value=8.5e-13 Score=101.70 Aligned_cols=72 Identities=22% Similarity=0.402 Sum_probs=67.3
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
..|+++++++++++|..||.|++|+|+.+||..+|+.++. .++..++..+++.+|.+++|.|+|+||+.++.
T Consensus 2 ~~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m~ 73 (77)
T d1f54a_ 2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGL-SPSEAEVNDLMNEIDVDGNHQIEFSEFLALMS 73 (77)
T ss_dssp CCCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTC-CCCHHHHHHHHHTTCCSSCCEEEHHHHHHHHT
T ss_pred CCCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 5689999999999999999999999999999999999986 67888999999999999999999999998653
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=99.32 E-value=1.3e-12 Score=101.55 Aligned_cols=68 Identities=18% Similarity=0.272 Sum_probs=63.0
Q ss_pred chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
|++++++++++|..||.|++|+|+..||..+|+.++ .++..++..+++.+|.|++|.|+|+||+.++.
T Consensus 1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg--~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~~ 68 (81)
T d2opoa1 1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG--SVTPDEVRRMMAEIDTDGDGFISFDEFTDFAR 68 (81)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT--TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh--cCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 578999999999999999999999999999999997 36778899999999999999999999998654
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=99.30 E-value=2.1e-12 Score=117.72 Aligned_cols=123 Identities=15% Similarity=0.201 Sum_probs=93.0
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHH
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQI 533 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 533 (601)
.+.++.++..+|.|++|.|+.+||..++..+. .++.+|+.+|.|++|.|+..|+..++........ ++.
T Consensus 62 ~e~~~~li~~~D~d~~G~i~~~EF~~l~~~~~-------~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~----~~~ 130 (188)
T d1qxpa2 62 LESCRSMVNLMDRDGNGKLGLVEFNILWNRIR-------NYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLP----CQL 130 (188)
T ss_dssp HHHHHHHHHHHCC--CCCCCSSSHHHHHHHHH-------HHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECC----HHH
T ss_pred HHHHHHHHHHhcCCCCCcccHHHHHHHHhhhH-------HHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCC----HHH
Confidence 34577888889999999999999998876542 3677999999999999999999877654443333 344
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCce--eHHHHHHHH
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKL--SLHGYTKFL 588 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~i--s~~EF~~~~ 588 (601)
+..++..+ .|++|.|+.+||..++.....+..+|+.+|.+++|.| +++||+.+.
T Consensus 131 ~~~l~~~~-~~~dg~i~f~eFi~~~~~l~~~~~~F~~~D~~~~G~i~l~~~efl~~~ 186 (188)
T d1qxpa2 131 HQVIVARF-ADDELIIDFDNFVRCLVRLEILFKIFKQLDPENTGTIQLDLISWLSFS 186 (188)
T ss_dssp HHHHHHHT-SCSSSBCCHHHHHHHHHHHHHHHHHHHHSCSSCCSCEEEEHHHHHHHT
T ss_pred HHHHHHHh-cCCCCcCCHHHHHHHHHHHHHHHHHHHHhCCCCCCeEEeeHHHHHHHH
Confidence 55666664 5899999999998877333336678899999999976 899998865
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=99.30 E-value=2.7e-12 Score=99.73 Aligned_cols=75 Identities=19% Similarity=0.301 Sum_probs=68.4
Q ss_pred HhhhhcchHHHHHHHHHHHhhCCCC-CCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 444 ALSKALTEDELVYLRAQFRLLEPNK-DGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 444 ~~~~~l~~~~~~~l~~~F~~~D~d~-~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
.....++++++++++++|+.||.|+ +|.|+..||..+|+.+|. .+++.+++.+++.+|.|++|.|+|+||+.++.
T Consensus 4 ~~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~-~~t~~el~~~i~~~D~d~~G~I~f~eFl~im~ 79 (82)
T d1wrka1 4 AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQ-NPTPEELQEMIDEVDEDGSGTVDFDEFLVMMV 79 (82)
T ss_dssp HHHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTC-CCCHHHHHHHHHTTCTTCCSSBCHHHHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 4455799999999999999999995 899999999999999996 68889999999999999999999999988654
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.30 E-value=2.2e-12 Score=98.58 Aligned_cols=62 Identities=29% Similarity=0.513 Sum_probs=55.3
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
+++++.+|+.||+|++|+|+..||+.+|. +... ++.+|..+|.|+||.|+|+||+++|++++
T Consensus 8 eeel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m~~~~ 75 (75)
T d1jc2a_ 8 EEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGVQ 75 (75)
T ss_dssp HHHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCc
Confidence 67899999999999999999999999982 2222 99999999999999999999999998753
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.29 E-value=1.9e-12 Score=100.51 Aligned_cols=72 Identities=15% Similarity=0.325 Sum_probs=66.9
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
..|+++++++++++|..||.|++|+|+.+||..+|+.++. ..++.++..+++.+|.+++|.|+|+||+.++.
T Consensus 6 ~~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m~ 77 (81)
T d1avsa_ 6 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDEDGSGTIDFEEFLVMMV 77 (81)
T ss_dssp HHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 3589999999999999999999999999999999999986 67888899999999999999999999998654
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=99.28 E-value=1.2e-12 Score=97.98 Aligned_cols=59 Identities=15% Similarity=0.318 Sum_probs=52.8
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhcC------Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 532 QIASTAFEYFEEEGNRVISIEELARELNV------GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l~~------~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
++++.+|+.||+|++|+|+.+||+.+|.. +.+ ++.+|+.+|.|+||.|+|+||+.+|.+
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m~r 67 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIKK 67 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 56899999999999999999999999832 222 999999999999999999999999976
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=99.28 E-value=1.3e-12 Score=99.39 Aligned_cols=71 Identities=18% Similarity=0.393 Sum_probs=65.9
Q ss_pred hcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 448 ALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
.|+++++.+++++|..||.|++|+|+..||..+++.++. ..+.+++..+++.+|.+++|.|+|+||+.++.
T Consensus 1 qLs~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m~ 71 (73)
T d2pq3a1 1 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLTMMA 71 (73)
T ss_dssp CCCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 378999999999999999999999999999999999986 57888999999999999999999999988643
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.27 E-value=1.3e-11 Score=112.97 Aligned_cols=113 Identities=17% Similarity=0.209 Sum_probs=89.2
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh---------
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE--------- 525 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~--------- 525 (601)
..+..+|..+|.|++|.|++.||..++..+.. ......++.+|+.+|.|++|.|+++||..++.......
T Consensus 58 ~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~-~~~~~~~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~ 136 (189)
T d1jbaa_ 58 QYVEAMFRAFDTNGDNTIDFLEYVAALNLVLR-GTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEA 136 (189)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHHSS-CCCTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTS
T ss_pred HHHHHHHHHhccCCCCeEeehhHHHHHHhhcc-cchHHHHHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchh
Confidence 45778999999999999999999999988764 45567789999999999999999999976543221110
Q ss_pred ----hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHH
Q 007498 526 ----ALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFL 568 (601)
Q Consensus 526 ----~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~ 568 (601)
.....++.+..+|+.+|+|+||.|+.+||++++.-.+++..+|
T Consensus 137 ~~~~~~~~~e~~~~~if~~~D~d~dG~Is~~EF~~~~~~~p~i~~~l 183 (189)
T d1jbaa_ 137 EQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRDKWVMKML 183 (189)
T ss_dssp STTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTTTTTHHHHH
T ss_pred hhhccccchHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCHHHHHHh
Confidence 0112256678899999999999999999999997766544443
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.26 E-value=5.9e-12 Score=115.39 Aligned_cols=115 Identities=17% Similarity=0.244 Sum_probs=93.3
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh--------hhhh
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL--------EALE 528 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~--------~~~~ 528 (601)
+.++|+.+|.|++|.|++.||..++..+.. ...++.++.+|+.+|.|++|.|+++||..++...... ....
T Consensus 65 ~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~-~~~~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~ 143 (190)
T d1fpwa_ 65 ANHLFTVFDKDNNGFIHFEEFITVLSTTSR-GTLEEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEA 143 (190)
T ss_dssp HHHHHHTCCSSCSSEECHHHHHHHHHHHSC-CCSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCC
T ss_pred HHHHHHHhCcCCCCcccHHHHHHHHHHHcc-CchHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhh
Confidence 467999999999999999999999988774 4567789999999999999999999998765322110 1123
Q ss_pred hHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHHHHh
Q 007498 529 GWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLKDWI 572 (601)
Q Consensus 529 ~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d 572 (601)
..++.+..+|+.+|.|+||.|+.+||++++...+.+-..|.-+|
T Consensus 144 ~~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~p~i~~~l~~~d 187 (190)
T d1fpwa_ 144 TPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDPSIIGALNLYD 187 (190)
T ss_dssp CHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSSTTHHHHHHHHH
T ss_pred hHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCHHHHHHhhhhc
Confidence 34677899999999999999999999999976666666666655
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=99.26 E-value=4.3e-12 Score=98.50 Aligned_cols=61 Identities=28% Similarity=0.513 Sum_probs=54.7
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
++.++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|..+|.|+||+|+|+||+++|.+.
T Consensus 14 ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m~~~ 80 (81)
T d1fi5a_ 14 EEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV 80 (81)
T ss_dssp HHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHSCC
T ss_pred HHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhc
Confidence 66799999999999999999999999993 2222 9999999999999999999999999875
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.23 E-value=3.2e-12 Score=94.72 Aligned_cols=58 Identities=21% Similarity=0.420 Sum_probs=51.5
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHH
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFL 588 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~ 588 (601)
+++++.+|+.||+|++|+|+.+||+.++. +... ++.++..+|.|+||.|+|+||+++|
T Consensus 2 eeel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~eF~~~m 65 (65)
T d1fw4a_ 2 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM 65 (65)
T ss_dssp CHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred HHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence 45789999999999999999999999992 2222 9999999999999999999999976
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.23 E-value=4.8e-13 Score=105.44 Aligned_cols=75 Identities=21% Similarity=0.451 Sum_probs=69.0
Q ss_pred HHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHh
Q 007498 443 KALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAA 518 (601)
Q Consensus 443 ~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 518 (601)
..++..++++++.+++++|+.||.|++|+|+..||..+|+.++. .+++.+++.+++.+|.|++|.|+|+||+.++
T Consensus 11 ~~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~-~~s~~e~~~l~~~~D~d~~g~I~~~EFl~am 85 (87)
T d1s6ja_ 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-ELMESEIKDLMDAADIDKSGTIDYGEFIAAT 85 (87)
T ss_dssp HHSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTS-SCCHHHHHHHHHHHCTTCSSEECHHHHTTCC
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHcCCCCCCeEeHHHHHHHH
Confidence 45677889999999999999999999999999999999999986 6888899999999999999999999998754
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.21 E-value=1.2e-11 Score=95.16 Aligned_cols=62 Identities=18% Similarity=0.369 Sum_probs=55.5
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh-----cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL-----NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l-----~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
+++++.+|+.||+|++|+|+.+||+.+| .+..+ ++.+|+.+|.|+||.|+|+||+++|++.+
T Consensus 8 ~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m~k~~ 75 (77)
T d1oqpa_ 8 REEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTS 75 (77)
T ss_dssp HHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHccC
Confidence 6789999999999999999999999999 23332 99999999999999999999999998754
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.20 E-value=1.1e-11 Score=92.32 Aligned_cols=58 Identities=17% Similarity=0.346 Sum_probs=51.8
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
++++|+.||+|++|+|+..||+.++. +..+ ++.+|..+|.|+||.|+|+||+.+|.+.
T Consensus 3 ~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m~~~ 66 (67)
T d1tiza_ 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEKM 66 (67)
T ss_dssp HHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHTC
T ss_pred HHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 68899999999999999999999992 2222 9999999999999999999999999863
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=2.8e-11 Score=109.63 Aligned_cols=107 Identities=12% Similarity=0.133 Sum_probs=84.9
Q ss_pred HHHHHHhhCCC-CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc-----hhhhhhhhH
Q 007498 457 LRAQFRLLEPN-KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST-----HQLEALEGW 530 (601)
Q Consensus 457 l~~~F~~~D~d-~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~-----~~~~~~~~~ 530 (601)
..++|+.||.| ++|.|+++||..++..+......++.++.+|+.+|.|++|.|+.+|+..++... .....++.+
T Consensus 59 ~~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~ 138 (180)
T d1xo5a_ 59 KERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEM 138 (180)
T ss_dssp HHHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTH
T ss_pred HHHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHH
Confidence 45789999987 699999999999997765333456679999999999999999999997754332 111223445
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhcCCcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELNVGPS 563 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~ 563 (601)
++.+..+|+.+|.|+||.|+.+||++++.-.++
T Consensus 139 ~~~v~~~~~~~D~d~dG~Is~~EF~~~~~~~P~ 171 (180)
T d1xo5a_ 139 KQLIDNILEESDIDRDGTINLSEFQHVISRSPD 171 (180)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHCHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHhCHH
Confidence 667888999999999999999999999865554
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.15 E-value=1.9e-11 Score=90.47 Aligned_cols=62 Identities=18% Similarity=0.377 Sum_probs=57.8
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAA 517 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~ 517 (601)
++|+++|..||.|++|+|+.+||..+++.++. ..+..++..+++.+|.|++|.|+|+||+.+
T Consensus 3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~-~~~~~e~~~l~~~~D~d~~g~I~~~eF~~~ 64 (65)
T d1fw4a_ 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGE-KLTDEEVDEMIREADIDGDGQVNYEEFVQM 64 (65)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHTTCTTCSSSEEHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHcCCCCCCcEeHHHHHHH
Confidence 46899999999999999999999999999986 578888999999999999999999999875
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.15 E-value=3.1e-11 Score=93.53 Aligned_cols=59 Identities=15% Similarity=0.298 Sum_probs=52.6
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 532 QIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
++++.+|+.||+||+|+|+.+||+.+|. +... ++.+|..+|.|+||.|+|+||+.+|.+
T Consensus 14 ~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m~~ 78 (81)
T d1avsa_ 14 AEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVR 78 (81)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 4688999999999999999999999992 2222 999999999999999999999999975
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.15 E-value=5.8e-11 Score=107.39 Aligned_cols=112 Identities=12% Similarity=0.135 Sum_probs=86.5
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh--------hhhh
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL--------EALE 528 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~--------~~~~ 528 (601)
+..+|+.||.|++|.|+.+||..++..+.. ......++.+++.+|.+++|.|+.+|+...+...... ....
T Consensus 53 ~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~-~~~~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~ 131 (178)
T d1s6ca_ 53 AHYLFNAFDTTQTGSVKFEDFVTALSILLR-GTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKED 131 (178)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC----------
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHHhc-cchHHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHH
Confidence 567999999999999999999999976653 4556779999999999999999999997654322111 1111
Q ss_pred hHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHHH
Q 007498 529 GWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFLK 569 (601)
Q Consensus 529 ~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~ 569 (601)
..++.+..+|+.+|+|+||.||.+||.+++.-.+++-+++.
T Consensus 132 ~~~~~~~~if~~~D~d~DG~Is~~EF~~~i~~~~~~~~~l~ 172 (178)
T d1s6ca_ 132 TPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDDNIMRSLQ 172 (178)
T ss_dssp -CHHHHHHHHHHHCTTCSSEECHHHHHHHTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHCHHHHHHhh
Confidence 22556788999999999999999999999976666444443
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.14 E-value=4.5e-11 Score=109.06 Aligned_cols=111 Identities=14% Similarity=0.179 Sum_probs=87.2
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh--------hhhhh
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ--------LEALE 528 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~--------~~~~~ 528 (601)
...+|+.+|.+++|.|+++||..++..+.. ...++.++.+|+.+|.|++|.|+.+|+..++..... .....
T Consensus 62 ~~~if~~~d~~~dg~I~~~EF~~~l~~~~~-~~~~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~ 140 (187)
T d1g8ia_ 62 ATFVFNVFDENKDGRIEFSEFIQALSVTSR-GTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEEN 140 (187)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGS
T ss_pred HHHHHHHhCcCCCCCCcHHHHHHHHHHhcc-CchhhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhc
Confidence 466899999999999999999999987653 345667999999999999999999999765432211 11123
Q ss_pred hHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCccHHHHH
Q 007498 529 GWEQIASTAFEYFEEEGNRVISIEELARELNVGPSAYSFL 568 (601)
Q Consensus 529 ~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~ 568 (601)
..++.+..+|+.+|.|+||.|+.+||++++.-.+.+-.+|
T Consensus 141 ~~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~p~~~~~l 180 (187)
T d1g8ia_ 141 TPEKRVDRIFAMMDKNADGKLTLQEFQEGSKADPSIVQAL 180 (187)
T ss_dssp SHHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHCHHHHHHH
T ss_pred cHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHCHHHHHHH
Confidence 3467789999999999999999999999886555444433
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=99.14 E-value=7.3e-11 Score=101.12 Aligned_cols=95 Identities=19% Similarity=0.212 Sum_probs=79.7
Q ss_pred HHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC-cc--------H
Q 007498 494 VPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG-PS--------A 564 (601)
Q Consensus 494 ~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~-~~--------~ 564 (601)
.+.+|+.+|.|++|.|+++||..++........ ++.+..+|+.+|.+++|.|+.+||..++... .. +
T Consensus 2 ae~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~----~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~ 77 (134)
T d1jfja_ 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKN----EQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGL 77 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSH----HHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHH
T ss_pred HHHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCC----HHHHHHHHHHhhhcccccccccccccccccccccccccccccc
Confidence 468999999999999999999876654433333 5678999999999999999999999988321 11 7
Q ss_pred HHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 565 YSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 565 ~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
..+|+.+|.|++|.|+.+||..++....
T Consensus 78 ~~~F~~~D~~~~g~i~~~el~~~~~~~~ 105 (134)
T d1jfja_ 78 KVLYKLMDVDGDGKLTKEEVTSFFKKHG 105 (134)
T ss_dssp HHHHHHHCCSSSSEEEHHHHHHHHTTTT
T ss_pred cccccccccccCCcccHHHHHHHHHhcC
Confidence 7899999999999999999999988764
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.14 E-value=1e-10 Score=106.21 Aligned_cols=104 Identities=15% Similarity=0.128 Sum_probs=84.0
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcch----hhhhhhhHH
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTH----QLEALEGWE 531 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~----~~~~~~~~~ 531 (601)
....+|..+|.|++|.|+++||..++..+......++.++.+|+.+|.|++|.|+.+|+..++.... ....+...+
T Consensus 55 ~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~ 134 (183)
T d2zfda1 55 FADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIE 134 (183)
T ss_dssp HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHH
T ss_pred HHHHHHHHHccCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHH
Confidence 3568999999999999999999999876653334566799999999999999999999987543221 111234456
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 532 QIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
+.+..+|+.+|.|+||.|+.+||++++.
T Consensus 135 ~~~~~if~~~D~d~dG~Is~~EF~~~~~ 162 (183)
T d2zfda1 135 DIIDKTFEEADTKHDGKIDKEEWRSLVL 162 (183)
T ss_dssp HHHHHHHHHHCSSCSSEECHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 7788899999999999999999999884
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.13 E-value=2e-11 Score=89.00 Aligned_cols=55 Identities=20% Similarity=0.337 Sum_probs=48.9
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHH
Q 007498 532 QIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTK 586 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~ 586 (601)
++++.+|+.||+|++|+|+.+||+.+|. ++.. ++.+|+.+|.|+||.|+|+||++
T Consensus 1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~eFl~ 61 (61)
T d2fcea1 1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIE 61 (61)
T ss_dssp HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence 3678999999999999999999999992 2322 99999999999999999999985
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=99.13 E-value=1.1e-11 Score=92.42 Aligned_cols=64 Identities=13% Similarity=0.375 Sum_probs=58.9
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHh
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAA 518 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 518 (601)
++|+++|..||.|++|+|+.+||..+|+.++....+..+++.+++.+|.|++|.|+|+||+.++
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m 65 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLI 65 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHH
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 4689999999999999999999999999998644688899999999999999999999999854
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=99.13 E-value=3.8e-11 Score=93.04 Aligned_cols=62 Identities=23% Similarity=0.309 Sum_probs=54.3
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhcCCcc-----HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELNVGPS-----AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~-----~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.++++++|+.||+|++|+|+..||+.+|...+. +..+|+.+|.|+||.|+|+||+.+|....
T Consensus 5 ~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~~~~~ 71 (81)
T d2opoa1 5 IADRERIFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANR 71 (81)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTTTCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHCc
Confidence 457899999999999999999999999932221 99999999999999999999999987654
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.13 E-value=2.8e-11 Score=92.27 Aligned_cols=64 Identities=20% Similarity=0.357 Sum_probs=59.4
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
++|+++|..||.|++|+|+..||..+|+.++. .++..+++.+++.+|.+++|.|+|+||+.++.
T Consensus 9 eel~~~F~~fD~~~~G~I~~~el~~~l~~lg~-~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m~ 72 (75)
T d1jc2a_ 9 EELANCFRIFDKNADGFIDIEELGEILRATGE-HVIEEDIEDLMKDSDKNNDGRIDFDEFLKMME 72 (75)
T ss_dssp HHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSS-CCCHHHHHHHHHHHCSSSCSEECHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCC-CccHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 46899999999999999999999999999996 67888999999999999999999999998654
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.13 E-value=6.3e-11 Score=109.43 Aligned_cols=105 Identities=12% Similarity=0.213 Sum_probs=83.7
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh----------
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE---------- 525 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~---------- 525 (601)
.+..+|..+|.|++|.|++.||..++..+.. ...++.++.+|+.+|.|++|.|+++||..++.......
T Consensus 64 ~~~~if~~~D~~~~G~I~f~EF~~~~~~~~~-~~~~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~ 142 (201)
T d1omra_ 64 YAQHVFRSFDANSDGTLDFKEYVIALHMTSA-GKTNQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPE 142 (201)
T ss_dssp HHHHHHHTTTSCSSSEEEHHHHHHHHHHHHS-SCGGGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCG
T ss_pred HHHHHHHHhccCCCCeEeehhHHHHHHhhcc-cchHHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhh
Confidence 4568999999999999999999999987764 45677899999999999999999999976543221110
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCC
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELNVG 561 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~ 561 (601)
.....++.+..+|+.+|+|+||.|+.+||.+++.-.
T Consensus 143 ~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~~~ 178 (201)
T d1omra_ 143 DENTPEKRAEKIWGFFGKKDDDKLTEKEFIEGTLAN 178 (201)
T ss_dssp GGSSHHHHHHHHHHHTTCCTTCCBCHHHHHHHHHHC
T ss_pred hhccHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHC
Confidence 112235667889999999999999999999877433
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.13 E-value=2.9e-11 Score=88.13 Aligned_cols=61 Identities=16% Similarity=0.353 Sum_probs=57.1
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCA 516 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~ 516 (601)
++|+++|..||++++|+|+.+||..+|+.++. ..++.++..+++.+|.+++|.|+|+||+.
T Consensus 1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~-~~~~~ei~~l~~~~D~d~dg~I~~~eFl~ 61 (61)
T d2fcea1 1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGE-KLTDAEVDELLKGVEVDSNGEIDYKKFIE 61 (61)
T ss_dssp HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTC-CCCHHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCC-CCCHHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence 47899999999999999999999999999986 57888999999999999999999999974
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=99.12 E-value=1.3e-10 Score=101.19 Aligned_cols=107 Identities=13% Similarity=0.213 Sum_probs=86.4
Q ss_pred hhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh
Q 007498 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL 524 (601)
Q Consensus 445 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~ 524 (601)
++..++. ..+..+|..+|.+++|.|+.+||..++..........+.+..+|+.+|.+++|.|+..||..++......
T Consensus 38 ~~~~~~~---~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~ 114 (146)
T d1exra_ 38 LGQNPTE---AELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEK 114 (146)
T ss_dssp HTCCCCH---HHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCC
T ss_pred cCCCCCH---HHHHHHHHhcCCCCCCcccHHHHHHHHHHHhhccChHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhc
Confidence 3444444 4467788889999999999999999987655433346678999999999999999999998876544433
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
.. ++.+..+|+.+|.|+||.|+.+||.++|
T Consensus 115 ~~----~~~~~~i~~~~D~d~dG~i~~~eF~~~l 144 (146)
T d1exra_ 115 LT----DDEVDEMIREADIDGDGHINYEEFVRMM 144 (146)
T ss_dssp CC----HHHHHHHHHHHCSSSSSSBCHHHHHHHH
T ss_pred CC----HHHHHHHHHHhCCCCCCeEeHHHHHHHh
Confidence 33 5678999999999999999999999876
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=99.11 E-value=3e-11 Score=91.65 Aligned_cols=59 Identities=14% Similarity=0.333 Sum_probs=52.8
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 532 QIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
++++.+|+.||+|++|+|+.+||+.+|. ++.+ +..++..+|.|+||.|+|+||+.+|.+
T Consensus 8 ~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m~~ 72 (73)
T d2pq3a1 8 AEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR 72 (73)
T ss_dssp HHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 5688999999999999999999999992 2333 999999999999999999999999875
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.11 E-value=5.8e-11 Score=90.81 Aligned_cols=62 Identities=21% Similarity=0.330 Sum_probs=53.2
Q ss_pred HHHHHHHHHHHccc--CCCcccHHHHHHHhc-----CCc---cHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEE--GNRVISIEELARELN-----VGP---SAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d--~~G~I~~~El~~~l~-----~~~---~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
+++++.+|+.||.+ ++|+|+.+||+.+|. +.. +++.+|..+|.|+||.|+|+||+.+|.+.+
T Consensus 4 ~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~~~~ 75 (76)
T d1qx2a_ 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKKIS 75 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHHHHc
Confidence 56789999999765 469999999999992 221 299999999999999999999999998865
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.10 E-value=4.3e-11 Score=91.88 Aligned_cols=61 Identities=15% Similarity=0.259 Sum_probs=53.7
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh-----cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL-----NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l-----~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.++++.+|+.||.|++|+|+.+||+.+| .+..+ +..++..+|.|+||.|+|+||+.+|.+.
T Consensus 9 i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m~~~ 75 (77)
T d1f54a_ 9 IAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQ 75 (77)
T ss_dssp HHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHHHHHHHHTTS
T ss_pred HHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 3568899999999999999999999999 23332 9999999999999999999999999763
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.09 E-value=5.4e-11 Score=88.52 Aligned_cols=62 Identities=19% Similarity=0.315 Sum_probs=57.4
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
++++|+.||.|++|+|+..||..+++.++. ..+.++++.+++.+|.|++|.|+|+||+.++.
T Consensus 3 ~r~~F~~~D~d~~G~I~~~El~~~l~~lg~-~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m~ 64 (67)
T d1tiza_ 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSP-YFTQEDIVKFFEEIDVDGNGELNADEFTSCIE 64 (67)
T ss_dssp HHHHHHHHCTTSSSCEEHHHHHHHHHHTCT-TSCHHHHHHHHHHHCCSSSSEECHHHHHHHHH
T ss_pred HHHHHHHHCCCCcCcCcHHHHHHHHHHhcc-ccchHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 689999999999999999999999999986 67888999999999999999999999988653
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=99.09 E-value=5.4e-11 Score=92.16 Aligned_cols=64 Identities=19% Similarity=0.400 Sum_probs=59.2
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
++|+++|..||.|++|+|+..||..+++.++. .++..+++.+++.+|.|++|.|+|+||+.++.
T Consensus 15 e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m~ 78 (81)
T d1fi5a_ 15 EELSDLFRMFDKNADGYIDLEELKIMLQATGE-TITEDDIEELMKDGDKNNDGRIDYDEFLEFMK 78 (81)
T ss_dssp HHHHHHHHHHCSSCSSEECHHHHHHHHHTSSS-CCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHS
T ss_pred HHHHHHHHHHcCCCCCcccHHHHHHHHHhcCC-CCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHH
Confidence 56899999999999999999999999999986 67888899999999999999999999998654
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.08 E-value=6.1e-11 Score=91.01 Aligned_cols=67 Identities=15% Similarity=0.308 Sum_probs=60.6
Q ss_pred HHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 452 DELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 452 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
+..++|+++|..||.|++|+|+.+||..+|+.++. ..+..++..+++.+|.|++|.|+|+||+.++.
T Consensus 6 d~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m~ 72 (77)
T d1oqpa_ 6 DSREEILKAFRLFDDDNSGTITIKDLRRVAKELGE-NLTEEELQEMIAEADRNDDNEIDEDEFIRIMK 72 (77)
T ss_dssp SHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTC-CCCHHHHHHHHHHHCCSSSSEECHHHHHHHHH
T ss_pred cHHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 34568999999999999999999999999999986 57788899999999999999999999998653
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=99.07 E-value=1.7e-10 Score=94.52 Aligned_cols=99 Identities=18% Similarity=0.258 Sum_probs=74.7
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh---hh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ---LE 525 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~---~~ 525 (601)
++.++ |.+++..+| ++|.|++.||..++... ....+.++.+|+.+|.|++|.|+.+|+..++..... ..
T Consensus 6 l~~ee---I~~~~~~~d--~dG~idf~EF~~~~~~~---~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~l 77 (109)
T d1pvaa_ 6 LKADD---IKKALDAVK--AEGSFNHKKFFALVGLK---AMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDL 77 (109)
T ss_dssp SCHHH---HHHHHHHTC--STTCCCHHHHHHHHTCT---TSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCC
T ss_pred CCHHH---HHHHHHhcC--CCCCCcHHHHHHHHHHc---cCCHHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCC
Confidence 45555 444444454 56889999998877532 234566899999999999999999999776543321 12
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
+ ++++..+|+.+|.|+||.|+.+||..++.
T Consensus 78 s----~~ev~~~~~~~D~d~dG~I~~~EF~~~m~ 107 (109)
T d1pvaa_ 78 T----DAETKAFLKAADKDGDGKIGIDEFETLVH 107 (109)
T ss_dssp C----HHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred C----HHHHHHHHHHHCCCCcCcEeHHHHHHHHH
Confidence 2 56788999999999999999999999873
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=99.07 E-value=8.3e-11 Score=91.10 Aligned_cols=60 Identities=15% Similarity=0.285 Sum_probs=52.8
Q ss_pred HHHHHHHHHHHcccC-CCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 531 EQIASTAFEYFEEEG-NRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~-~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
.+.++.+|+.||+|| +|+|+..||+.+|. ...+ ++.+++.+|.|+||.|+|+||+.+|.+
T Consensus 14 ~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G~I~f~eFl~im~~ 80 (82)
T d1wrka1 14 KNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVR 80 (82)
T ss_dssp HHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 457889999999996 79999999999992 2222 999999999999999999999999986
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=99.05 E-value=2.4e-10 Score=93.70 Aligned_cols=100 Identities=13% Similarity=0.189 Sum_probs=75.1
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcch---h
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTH---Q 523 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~---~ 523 (601)
..++.+++ .+++..+|. +|.|++.||..++... ..+.++++.+|+.+|.|++|.|+.+|+..++.... .
T Consensus 4 ~~l~~~di---~~~~~~~~~--~G~idf~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~ 75 (109)
T d5pala_ 4 KVLKADDI---NKAISAFKD--PGTFDYKRFFHLVGLK---GKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGR 75 (109)
T ss_dssp GTSCHHHH---HHHHHHTCS--TTCCCHHHHHHHHTCT---TCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCC
T ss_pred hHccHHHH---HHHHHhcCC--CCcCcHHHHHHHHHhc---CCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccC
Confidence 34565664 455555554 6899999998776422 23456799999999999999999999976554321 1
Q ss_pred hhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 524 LEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 524 ~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
... ++++..+|+.+|.|+||.|+.+||..++
T Consensus 76 ~~~----~~e~~~~~~~~D~d~dG~I~~~EF~~~m 106 (109)
T d5pala_ 76 DLN----DTETKALLAAGDSDHDGKIGADEFAKMV 106 (109)
T ss_dssp CCC----HHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred cCC----HHHHHHHHHHhCCCCCCCEeHHHHHHHH
Confidence 122 5678999999999999999999999876
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.01 E-value=3e-11 Score=94.89 Aligned_cols=78 Identities=13% Similarity=0.144 Sum_probs=59.5
Q ss_pred CCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc-----CCcc-HHHHHHHHhcCCCCc
Q 007498 505 AYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN-----VGPS-AYSFLKDWIRNSDGK 578 (601)
Q Consensus 505 ~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~~-~~~~~~~~d~~~dG~ 578 (601)
.+|.|+.++...+ . .... +. ...++.+|+.||+|++|+|+.+||+.+|. +..+ ++.+|+.+|.|+||.
T Consensus 2 ~~g~id~~~~~ma--~--~l~~-~~-i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g~ 75 (87)
T d1s6ja_ 2 SSGHIDDDDKHMA--E--RLSE-EE-IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGT 75 (87)
T ss_dssp CSSSSSSHHHHSS--S--SSCS-SS-TTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSE
T ss_pred CCCccCchHHHHH--h--hCCH-HH-HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCe
Confidence 5788888875421 1 1111 11 22468899999999999999999999993 2222 999999999999999
Q ss_pred eeHHHHHHHH
Q 007498 579 LSLHGYTKFL 588 (601)
Q Consensus 579 is~~EF~~~~ 588 (601)
|+|+||+.+|
T Consensus 76 I~~~EFl~am 85 (87)
T d1s6ja_ 76 IDYGEFIAAT 85 (87)
T ss_dssp ECHHHHTTCC
T ss_pred EeHHHHHHHH
Confidence 9999999765
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.98 E-value=9.4e-10 Score=94.94 Aligned_cols=110 Identities=12% Similarity=0.232 Sum_probs=87.5
Q ss_pred HHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 442 LKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 442 ~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
+..++..++..+ +...+..+|.+++|.|+..||..++............+..+|..+|.+++|.|+.++|..++...
T Consensus 32 l~~~~~~~~~~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~l~~~f~~~d~~~~G~i~~~el~~~l~~~ 108 (141)
T d2obha1 32 MRALGFEPKKEE---IKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAKEL 108 (141)
T ss_dssp HHHTTCCCCHHH---HHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHT
T ss_pred HHhcCCchhHHH---HHHHHHhhccCCCCeechHHHHHHHHHHHhhhccHHHHHHHHHHhcccCCCCccHHHHHHHHHHh
Confidence 334444555544 55667778999999999999999987655434456678999999999999999999998876654
Q ss_pred hhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 522 HQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 522 ~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
..... .+.+..+|+.+|.|+||.|+.+||.++|
T Consensus 109 g~~l~----~~e~~~l~~~~D~d~dG~i~~~EF~~~m 141 (141)
T d2obha1 109 GENLT----DEELQEMIDEADRDGDGEVSEQEFLRIM 141 (141)
T ss_dssp TCCCC----HHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred CCCCC----HHHHHHHHHHHCCCCCCCEeHHHHHHhC
Confidence 43333 5678999999999999999999999875
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.98 E-value=6.4e-10 Score=98.99 Aligned_cols=103 Identities=12% Similarity=0.131 Sum_probs=82.5
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc-hhhhhhhhHHHHHH
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST-HQLEALEGWEQIAS 535 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~-~~~~~~~~~~~~~~ 535 (601)
+.++|..+|.+++|.|+.+||..++............+..+++.+|.+++|.|+.+|+..++... .........++.+.
T Consensus 50 ~~~l~~~~d~~~~g~i~~~EFl~~~~~~~~~~~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~ 129 (165)
T d1auib_ 50 VQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVD 129 (165)
T ss_dssp HHHHHHHHCTTCSSSEEHHHHHHHHGGGCTTCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHH
T ss_pred HHHHHHHHccccchhhhhhhhhhhccccccchhhHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHH
Confidence 45689999999999999999999998765433445668999999999999999999998765332 11112233466788
Q ss_pred HHHHHHcccCCCcccHHHHHHHhc
Q 007498 536 TAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 536 ~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
.+|..+|.|+||.|+.+||.+++.
T Consensus 130 ~~~~~~D~~~dG~Is~~EF~~i~~ 153 (165)
T d1auib_ 130 KTIINADKDGDGRISFEEFCAVVG 153 (165)
T ss_dssp HHHHHHCTTSSSSEEHHHHHHHHG
T ss_pred HHHHHcCCCCCCcEeHHHHHHHHh
Confidence 999999999999999999999883
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=98.98 E-value=6.3e-10 Score=91.31 Aligned_cols=106 Identities=11% Similarity=0.128 Sum_probs=77.0
Q ss_pred hhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh
Q 007498 445 LSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL 524 (601)
Q Consensus 445 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~ 524 (601)
++..++++++.+ ++..++. +|.|++.||..++... ..+...++.+|+.+|.|++|.|+.+||..++......
T Consensus 2 ~~~~~~~~~i~~---~~~~~~~--~~~i~f~eF~~~~~~~---~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~ 73 (109)
T d1rwya_ 2 MTDLLSAEDIKK---AIGAFTA--ADSFDHKKFFQMVGLK---KKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSD 73 (109)
T ss_dssp HHHHSCHHHHHH---HHHTTCS--TTCCCHHHHHHHHTGG---GSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTT
T ss_pred hhhhcCHHHHHH---HHHhccc--CCCcCHHHHHHHHccc---cCCHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccc
Confidence 344566666544 4445544 5889999998887532 2345678899999999999999999998765433221
Q ss_pred hhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 525 EALEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 525 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
.. .-.++++..+|+.+|.|+||.|+.+||.+++.
T Consensus 74 ~~-~~~~~e~~~~~~~~D~d~dG~i~~~EF~~~m~ 107 (109)
T d1rwya_ 74 AR-DLSAKETKTLMAAGDKDGDGKIGVEEFSTLVA 107 (109)
T ss_dssp CC-CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred cc-cCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 10 00156788999999999999999999998873
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.97 E-value=6e-10 Score=100.77 Aligned_cols=106 Identities=17% Similarity=0.252 Sum_probs=84.3
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhh--------hhh
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQL--------EAL 527 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~--------~~~ 527 (601)
.+.++|+.+|.+++|.|+++||..++..... ....+.++.+|+.+|.|++|.|+.+||..++...... ...
T Consensus 60 ~~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~-~~~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~ 138 (181)
T d1bjfa_ 60 FAEHVFRTFDANGDGTIDFREFIIALSVTSR-GKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDE 138 (181)
T ss_dssp HHHHHHHHHCSSCSSEEEHHHHHHHHHHHTS-SCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGG
T ss_pred HHHHHHHhcCCCCCCcEeHHHHHHHHHHHhh-hchHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCccc
Confidence 4578999999999999999999999877653 3456678999999999999999999998765432110 011
Q ss_pred hhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCc
Q 007498 528 EGWEQIASTAFEYFEEEGNRVISIEELARELNVGP 562 (601)
Q Consensus 528 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~ 562 (601)
...++.+..+|+.+|.|+||.|+.+||++++.-.+
T Consensus 139 ~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~~~p 173 (181)
T d1bjfa_ 139 STPEKRTEKIFRQMDTNRDGKLSLEEFIRGAKSDP 173 (181)
T ss_dssp SSHHHHHHHHHHHSCTTCSSEECHHHHHHHHHHCT
T ss_pred ccHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCH
Confidence 22366788999999999999999999999885443
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.95 E-value=9.5e-10 Score=89.96 Aligned_cols=104 Identities=12% Similarity=0.103 Sum_probs=70.5
Q ss_pred hhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhh
Q 007498 446 SKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLE 525 (601)
Q Consensus 446 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 525 (601)
+..++.+++..+. ..+ +.+|.|++.+|...+.. ...+.+.++.+|+.+|.|++|+|+++||..++.......
T Consensus 3 ~d~ls~~dI~~~l---~~~--~~~~s~~~~~F~~~~~~---~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~ 74 (108)
T d1rroa_ 3 TDILSAEDIAAAL---QEC--QDPDTFEPQKFFQTSGL---SKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDA 74 (108)
T ss_dssp GGTSCHHHHHHHH---HHT--CSTTCCCHHHHHHHHSG---GGSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTS
T ss_pred hhhCCHHHHHHHH---Hhc--ccCCCccHHHHHHHHcc---CcCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhcc
Confidence 4456666655543 333 34677888888655432 234556688899999999999999999887654332111
Q ss_pred hhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 526 ALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 526 ~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
.. -.++.++.+|+.+|.|+||.|+.+||..++
T Consensus 75 ~~-l~~~~~~~~~~~~D~d~dG~I~~~EF~~~m 106 (108)
T d1rroa_ 75 RE-LTESETKSLMDAADNDGDGKIGADEFQEMV 106 (108)
T ss_dssp CC-CCHHHHHHHHHHHCCSSSSSEEHHHHHHHH
T ss_pred CC-CCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 00 015667888999999999999999998876
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.94 E-value=8.1e-10 Score=90.16 Aligned_cols=94 Identities=11% Similarity=0.056 Sum_probs=54.7
Q ss_pred HHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHH
Q 007498 459 AQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAF 538 (601)
Q Consensus 459 ~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F 538 (601)
.++...|. +|.|++.||..++... ....++++.+|+.+|.+++|.|+.+||..++........ .-.++.++.+|
T Consensus 12 ~~~~~~~~--~gsi~~~eF~~~~~l~---~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~-~~~~~~~~~l~ 85 (107)
T d2pvba_ 12 AALAACSA--ADSFKHKEFFAKVGLA---SKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSAR-ALTDAETKAFL 85 (107)
T ss_dssp HHHHHTCS--TTCCCHHHHHHHHTGG---GSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSC-CCCHHHHHHHH
T ss_pred HHHHhccC--CCCcCHHHHHHHHhcc---cCCHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccc-cCCHHHHHHHH
Confidence 33444443 3557777776655422 223445777777777777777777777665433321100 00145667777
Q ss_pred HHHcccCCCcccHHHHHHHh
Q 007498 539 EYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 539 ~~~D~d~~G~I~~~El~~~l 558 (601)
+.+|.|+||.|+.+||..++
T Consensus 86 ~~~D~d~dG~I~~~EF~~~m 105 (107)
T d2pvba_ 86 ADGDKDGDGMIGVDEFAAMI 105 (107)
T ss_dssp HHHCTTCSSSBCHHHHHHHH
T ss_pred HHhCCCCCCcEeHHHHHHHH
Confidence 77777777777777777665
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.94 E-value=5e-10 Score=90.27 Aligned_cols=57 Identities=18% Similarity=0.161 Sum_probs=47.6
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhc-----CCc-----------------cHHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 534 ASTAFEYFEEEGNRVISIEELARELN-----VGP-----------------SAYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l~-----~~~-----------------~~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
++.+|++||.||||+|+.+||+.+|. +.. .++.+|..+|.|+||.||++||++++.+
T Consensus 18 ~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG~Is~~EF~~~~~~ 96 (99)
T d1snla_ 18 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLASTQR 96 (99)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence 46789999999999999999988872 100 0778999999999999999999999876
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=98.94 E-value=8e-10 Score=87.27 Aligned_cols=61 Identities=20% Similarity=0.358 Sum_probs=52.1
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhc----------CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELN----------VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~----------~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+.+..+|..||.| +|+|+.+||+++|. .... ++.+|+.+|.|+||+|+|+||+.+|.++.
T Consensus 8 ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~ 79 (92)
T d1a4pa_ 8 METMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLT 79 (92)
T ss_dssp HHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHH
Confidence 45688899999987 89999999999982 1112 99999999999999999999999997753
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=98.93 E-value=7e-10 Score=88.12 Aligned_cols=62 Identities=19% Similarity=0.318 Sum_probs=52.0
Q ss_pred HHHHHHHHHHH-cccCC-CcccHHHHHHHhc----------CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYF-EEEGN-RVISIEELARELN----------VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~-D~d~~-G~I~~~El~~~l~----------~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
-+.+..+|..| |+||+ |+|+.+||+++|. ...+ ++.+|+.+|.|+||.|+|+||+.+|.++.
T Consensus 8 i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l~ 82 (93)
T d1zfsa1 8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALT 82 (93)
T ss_dssp HHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence 35678889888 89985 9999999999991 1111 99999999999999999999999997653
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.93 E-value=4.9e-10 Score=89.42 Aligned_cols=61 Identities=13% Similarity=0.072 Sum_probs=53.6
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.+|+|++|+|+.+|++.+| ++..+ +..+++.+|.|+||.|+++||+.+|+-+
T Consensus 9 ~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~l~~~~l~~i~~~~D~d~dG~l~~~EF~~am~Li 73 (95)
T d1c07a_ 9 KAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLI 73 (95)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHCTTCSSSEETTTHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHH
Confidence 4568899999999999999999999999 34333 9999999999999999999999887654
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=98.91 E-value=6e-10 Score=85.20 Aligned_cols=62 Identities=19% Similarity=0.380 Sum_probs=52.2
Q ss_pred HHHHHHHHHHHcc-c-CCCcccHHHHHHHh-----cCC--c-cHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEE-E-GNRVISIEELAREL-----NVG--P-SAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~-d-~~G~I~~~El~~~l-----~~~--~-~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+.++.+|..||. | ++|+|+.+||+.+| +.. . +++.++..+|.|+||.|+|+||+.+|.++.
T Consensus 6 ~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~~~la 77 (78)
T d1cb1a_ 6 PAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKKIS 77 (78)
T ss_dssp HHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHh
Confidence 4678999999975 4 45899999999999 111 1 299999999999999999999999998864
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.91 E-value=4.3e-10 Score=89.81 Aligned_cols=67 Identities=16% Similarity=0.163 Sum_probs=61.0
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAA 518 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 518 (601)
++.++.++++++|+.+|.|++|+|+.+|+..++...+. ..+.++.+++.+|.|++|.|+++||+.++
T Consensus 4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~l---~~~~l~~i~~~~D~d~dG~l~~~EF~~am 70 (95)
T d1c07a_ 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGL---PSTLLAHIWSLCDTKDCGKLSKDQFALAF 70 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTTC---CHHHHHHHHHHHCTTCSSSEETTTHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcCC---CHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 67889999999999999999999999999999988753 46679999999999999999999998754
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=98.91 E-value=1.2e-09 Score=87.32 Aligned_cols=60 Identities=20% Similarity=0.307 Sum_probs=50.8
Q ss_pred HHHHHHHHHH-cccCC-CcccHHHHHHHhc-------CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 532 QIASTAFEYF-EEEGN-RVISIEELARELN-------VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 532 ~~~~~~F~~~-D~d~~-G~I~~~El~~~l~-------~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+.+..+|..| |+||+ |+|+..||+++|. ...+ ++.+|..+|.|+||.|+|+||+.+|.++
T Consensus 14 ~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l 83 (98)
T d1yuta1 14 ETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGEL 83 (98)
T ss_dssp HHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 4677788887 78885 9999999999992 1222 9999999999999999999999999765
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.88 E-value=8.6e-10 Score=87.45 Aligned_cols=67 Identities=16% Similarity=0.329 Sum_probs=61.0
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAA 518 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 518 (601)
+++++.++++++|..+|.|++|+|+.+|+..++...+ ....++..+++.+|.|++|.|+++||+.++
T Consensus 3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~---l~~~~l~~i~~~~D~d~dG~l~~~EF~~a~ 69 (92)
T d1fi6a_ 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK---LPILELSHIWELSDFDKDGALTLDEFCAAF 69 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS---SCHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHcc---CCHHHHHHHHHHhCCCCCCeecHHHHHHHH
Confidence 6789999999999999999999999999999999865 345679999999999999999999998654
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.88 E-value=1.8e-09 Score=83.94 Aligned_cols=65 Identities=15% Similarity=0.305 Sum_probs=59.6
Q ss_pred HHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHh
Q 007498 453 ELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAA 518 (601)
Q Consensus 453 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 518 (601)
....++++|..||.+++|+|+.+||..+|..++. ..++.++..++..+|.+++|.|+|.||+..+
T Consensus 18 ~~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~-~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~f 82 (83)
T d1wlza1 18 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQ-ILTDEQFDRLWNEMPVNAKGRLKYPDFLSRF 82 (83)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTC-CCCHHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCceEChhHHHHHHHHhCC-CCChhHHHHHhhccccCCCCcEeHHHHHHHh
Confidence 3567899999999999999999999999999986 5888999999999999999999999998753
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=98.88 E-value=1.6e-09 Score=85.39 Aligned_cols=62 Identities=16% Similarity=0.222 Sum_probs=51.9
Q ss_pred HHHHHHHHHHH-cccCCCc-ccHHHHHHHhc------C----Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYF-EEEGNRV-ISIEELARELN------V----GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~-D~d~~G~-I~~~El~~~l~------~----~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
-+.+..+|..| |+||+|. |+.+||+++|. + ... ++.+++.+|.|+||.|+|+||+.+|.++.
T Consensus 8 i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l~ 82 (93)
T d1ksoa_ 8 VAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACLC 82 (93)
T ss_dssp HHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence 34567788887 9999995 99999999982 1 111 99999999999999999999999998764
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.88 E-value=1.5e-09 Score=82.69 Aligned_cols=66 Identities=14% Similarity=0.255 Sum_probs=55.1
Q ss_pred HHHHHHHHHhhCCC--CCCcccHHHHHHHHhhcchhh-hhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 454 LVYLRAQFRLLEPN--KDGSVSLENFRMVLGRNATDA-MRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 454 ~~~l~~~F~~~D~d--~~G~I~~~el~~~l~~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
.++|+++|+.||.+ ++|+|+.+||..+|+.++... ....+++.+++.+|.|++|.|+|+||+.++.
T Consensus 4 ~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~ 72 (76)
T d1qx2a_ 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMK 72 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHH
Confidence 45688999999654 479999999999999988532 2355799999999999999999999998653
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.86 E-value=4.7e-09 Score=92.84 Aligned_cols=110 Identities=15% Similarity=0.235 Sum_probs=83.9
Q ss_pred HHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcch---hhhhhccHHHHHhhcccCCCCcccHHHHHHHh
Q 007498 442 LKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNAT---DAMRESRVPDVLSSMESLAYRKMYFEEFCAAA 518 (601)
Q Consensus 442 ~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~---~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 518 (601)
+..+...+++. .+..+|..+|.+++|.|+..|+...+..... .....+.+...|+.+|.+++|.|+..||..++
T Consensus 46 l~~~~~~~~~~---~~~~~~~~~d~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~aF~~~D~d~~G~Is~~e~~~~l 122 (162)
T d1topa_ 46 MRMLGQNPTKE---ELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEIL 122 (162)
T ss_dssp HHHTTCCCCHH---HHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHH
T ss_pred HhccCCchhHH---HHHhhhheeccCCCCCeeeehhhhhhhhhhhhhcccCcHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 33334444444 4667888899999999999998877644321 12345567889999999999999999998876
Q ss_pred hcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 519 ISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
........ .+.+..+|+.+|+|+||.|+.+||.++|
T Consensus 123 ~~~~~~~~----~~~~~~l~~~~D~d~dG~Is~~EF~~~l 158 (162)
T d1topa_ 123 RATGEHVT----EEDIEDLMKDSDKNNDGRIDFDEFLKMM 158 (162)
T ss_dssp HTTTCCCC----HHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HhhCCCCC----HHHHHHHHHHhCCCCCCcEEHHHHHHHH
Confidence 65433333 5678999999999999999999999987
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=98.84 E-value=2.9e-09 Score=84.20 Aligned_cols=62 Identities=18% Similarity=0.371 Sum_probs=51.2
Q ss_pred HHHHHHHHHHH-cccCCC-cccHHHHHHHhc----------CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYF-EEEGNR-VISIEELARELN----------VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~-D~d~~G-~I~~~El~~~l~----------~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
-+.+..+|..| |.||+| +|+.+||+++|. ...+ ++.+|+.+|.|+||.|+|+||+.+|.++.
T Consensus 8 i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l~ 82 (93)
T d3c1va1 8 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIA 82 (93)
T ss_dssp HHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Confidence 35678899998 677765 699999999982 1112 99999999999999999999999998764
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=98.84 E-value=1.8e-09 Score=85.25 Aligned_cols=70 Identities=13% Similarity=0.256 Sum_probs=58.6
Q ss_pred hHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchh----hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 451 EDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATD----AMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
+..++.+.++|+.||.| +|+|+.+||..++...... ......++.+++.+|.|+||.|+|+||+.++..+
T Consensus 5 E~~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l 78 (92)
T d1a4pa_ 5 EHAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGL 78 (92)
T ss_dssp HHHHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHH
Confidence 45788999999999987 8999999999999875421 2346679999999999999999999998866543
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.83 E-value=4.7e-09 Score=91.10 Aligned_cols=108 Identities=11% Similarity=0.166 Sum_probs=83.2
Q ss_pred HHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcch
Q 007498 443 KALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTH 522 (601)
Q Consensus 443 ~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~ 522 (601)
...+...++. .+..++..++.++++.++.+++..++..........+.+..+|+.+|.+++|.|+.+||..++....
T Consensus 37 ~~~g~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g 113 (146)
T d1lkja_ 37 RSLGLSPSEA---EVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVLTSIG 113 (146)
T ss_dssp HHHTCCCCHH---HHHHHHHHHCSSSCCEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHT
T ss_pred HhcCCCCCHH---HHHHHHHHhccCCcccccHHHHHHHHHHhhccccHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence 3344444543 4566778889999999999999998876554333455688899999999999999999988765554
Q ss_pred hhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 523 QLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 523 ~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
.... ++.+..+|+.+| |++|.|+.+||.++|
T Consensus 114 ~~~~----~~~~~~~~~~~d-d~dG~I~~~eF~~~m 144 (146)
T d1lkja_ 114 EKLT----DAEVDDMLREVS-DGSGEINIQQFAALL 144 (146)
T ss_dssp CSCC----HHHHHHHHHHHC-CSSSEEEHHHHHHHH
T ss_pred Cccc----HHHHHHHHHhcc-CCCCeEeHHHHHHHh
Confidence 4333 567888999999 999999999999887
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=98.83 E-value=4.5e-09 Score=83.94 Aligned_cols=71 Identities=11% Similarity=0.199 Sum_probs=59.4
Q ss_pred hHHHHHHHHHHHhh-CCCCC-CcccHHHHHHHHhhcchh-hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 451 EDELVYLRAQFRLL-EPNKD-GSVSLENFRMVLGRNATD-AMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 451 ~~~~~~l~~~F~~~-D~d~~-G~I~~~el~~~l~~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
+.+++.+.++|++| |.|++ |+|+.+||..+++..+.. ..+...++.+++.+|.|+||.|+|+||+.++..+
T Consensus 10 E~~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l 83 (98)
T d1yuta1 10 EESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGEL 83 (98)
T ss_dssp HHHHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 35678999999998 77775 999999999999886532 3456679999999999999999999999876543
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.82 E-value=4.7e-09 Score=92.22 Aligned_cols=110 Identities=15% Similarity=0.236 Sum_probs=83.2
Q ss_pred HHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcch---hhhhhccHHHHHhhcccCCCCcccHHHHHHHh
Q 007498 442 LKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNAT---DAMRESRVPDVLSSMESLAYRKMYFEEFCAAA 518 (601)
Q Consensus 442 ~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~---~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 518 (601)
+..++...++.+ +..++..++.+++|.|+..++...+..... .....+.+..+|+.+|.+++|.|+.+||..++
T Consensus 41 l~~lg~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~e~~~~~ 117 (156)
T d1dtla_ 41 MRMLGQNPTPEE---LQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIML 117 (156)
T ss_dssp HHHTTCCCCHHH---HHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-----CHHHHHHHHHHHHCTTCSSEEEHHHHGGGG
T ss_pred HHHcCCCCCHHH---HHHHHHHhhccCCCccchhhhhhhhhhcccccccccHHHHHHHHHHHhCcCCCCcCcHHHHHHHH
Confidence 344455555544 556777889999999999999887654321 12345568889999999999999999998766
Q ss_pred hcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 519 ISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
.......+ ++++..+|+.+|.|+||.|+.+||.++|
T Consensus 118 ~~~~~~ls----~~e~~~i~~~~D~d~dG~I~~~eF~~~l 153 (156)
T d1dtla_ 118 QATGETIT----EDDIEELMKDGDKNNDGRIDYDEFLEFM 153 (156)
T ss_dssp TTC--CCC----HHHHHHHHHHHCTTSSSEEEHHHHHHHH
T ss_pred hhcCCCCC----HHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 55444333 6678999999999999999999999987
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.81 E-value=2.5e-09 Score=84.68 Aligned_cols=62 Identities=16% Similarity=0.097 Sum_probs=53.9
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+.++.+|+.+|+|++|+|+.+|++.+| ++... +..+++.+|.|+||.|+|+||+.+|+-+.
T Consensus 8 ~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~l~~~~l~~i~~~~D~d~dG~l~~~EF~~a~~li~ 73 (92)
T d1fi6a_ 8 RQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSKLPILELSHIWELSDFDKDGALTLDEFCAAFHLVV 73 (92)
T ss_dssp HHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHSSCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCcccchhHHHHHHHHHHccCCHHHHHHHHHHhCCCCCCeecHHHHHHHHHHHH
Confidence 3567889999999999999999999999 45444 89999999999999999999997776543
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.81 E-value=4e-09 Score=91.44 Aligned_cols=98 Identities=11% Similarity=0.065 Sum_probs=77.4
Q ss_pred hccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHccc--CCCcccHHHHHHHhcCC------c
Q 007498 491 ESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEE--GNRVISIEELARELNVG------P 562 (601)
Q Consensus 491 ~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d--~~G~I~~~El~~~l~~~------~ 562 (601)
.++++.+|..+|.+++|.|+.+||..++.......+ .+++..++..+|.+ ++|.|+.+||..++... .
T Consensus 3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~----~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 78 (145)
T d2mysc_ 3 ADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPT----NAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKDQG 78 (145)
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcch----hhhhHHHHHHHhhcccccCccchhHHHHHHhhhhhccccc
Confidence 356888999999999999999999886654433333 45567777777655 68999999999988211 1
Q ss_pred ---cHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 563 ---SAYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 563 ---~~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+..+|+.+|.|++|.|+.+||.++|..+.
T Consensus 79 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g 111 (145)
T d2mysc_ 79 TFEDFVEGLRVFDKEGNGTVMGAELRHVLATLG 111 (145)
T ss_pred hHHHHHHHHHHhhcCCCCEEcHHHHHHHHHHhC
Confidence 178899999999999999999999998753
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=98.81 E-value=3e-09 Score=82.79 Aligned_cols=60 Identities=15% Similarity=0.226 Sum_probs=50.5
Q ss_pred HHHHHHHHHH-cccCCCcc-cHHHHHHHhc--CCc-----cHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 532 QIASTAFEYF-EEEGNRVI-SIEELARELN--VGP-----SAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 532 ~~~~~~F~~~-D~d~~G~I-~~~El~~~l~--~~~-----~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+.+..+|..| |+||+|.+ +.+||+.+|. +.. .++.+|+.+|.|+||+|+|+||+.+|.++
T Consensus 10 ~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~~~l 78 (87)
T d1xk4a1 10 NSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKM 78 (87)
T ss_dssp HHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 4567778777 99999975 9999999983 222 19999999999999999999999999875
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.81 E-value=2.5e-09 Score=83.00 Aligned_cols=58 Identities=17% Similarity=0.199 Sum_probs=51.1
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh-----cCCcc-HHHHHHHHhcCCCCceeHHHHHHHH
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL-----NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFL 588 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l-----~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~ 588 (601)
...+..+|+.||.|++|+|+.+||+.+| .++.+ ++.++..+|.|+||.|+|.||+..+
T Consensus 19 ~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~f 82 (83)
T d1wlza1 19 YHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSRF 82 (83)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCCcEeHHHHHHHh
Confidence 4568889999999999999999999998 23333 9999999999999999999999875
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.79 E-value=8e-09 Score=89.14 Aligned_cols=107 Identities=10% Similarity=0.128 Sum_probs=80.7
Q ss_pred HHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 441 ALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 441 ~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
++..++..+++.++.. ++ .+++|.|+..||..++..........+.+...|+.+|.+++|.|+.+||..++..
T Consensus 32 ~l~~lg~~~~~~el~~---~~----~~~~~~i~~~eF~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~ 104 (142)
T d1wdcb_ 32 ISEQLGRAPDDKELTA---ML----KEAPGPLNFTMFLSIFSDKLSGTDSEETIRNAFAMFDEQETKKLNIEYIKDLLEN 104 (142)
T ss_dssp HHHHHSSCCCHHHHHH---HH----TTSSSCCCHHHHHHHHHHHTCSCCCHHHHHHHHHTTCTTCCSCEEHHHHHHHHHH
T ss_pred HHHHhhcCCCHHHHHH---HH----HhccCccccccccccccccccccchhhhHHHhhhhhcccCCCcccHHHHHHHHHH
Confidence 3445566666665443 33 4678999999999988654332344567889999999999999999999887765
Q ss_pred chhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 521 THQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 521 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
.....+ ++++..+|+.+|.| +|.|+.+||.++|.
T Consensus 105 ~g~~lt----~~e~~~l~~~~d~~-~G~I~y~eF~~~l~ 138 (142)
T d1wdcb_ 105 MGDNFN----KDEMRMTFKEAPVE-GGKFDYVKFTAMIK 138 (142)
T ss_dssp SSSCCC----HHHHHHHHHHCCEE-TTEECHHHHHHHHH
T ss_pred ccccCC----HHHHHHHHHHhCCC-CCEEcHHHHHHHHh
Confidence 543333 56788899999998 59999999999884
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=98.78 E-value=5.7e-09 Score=81.46 Aligned_cols=61 Identities=21% Similarity=0.439 Sum_probs=51.6
Q ss_pred HHHHHHHHHH-cccCCC-cccHHHHHHHhc--------CCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 532 QIASTAFEYF-EEEGNR-VISIEELARELN--------VGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 532 ~~~~~~F~~~-D~d~~G-~I~~~El~~~l~--------~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
+.+..+|..| |+||+| .|+..||++++. ...+ ++.+++.+|.|+||.|+|+||+.+|.++.
T Consensus 9 ~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~la 80 (89)
T d1k8ua_ 9 GLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGALA 80 (89)
T ss_dssp HHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHHH
Confidence 4567788887 999999 599999999982 1222 99999999999999999999999998763
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.77 E-value=3.7e-09 Score=84.07 Aligned_cols=67 Identities=16% Similarity=0.102 Sum_probs=60.1
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
++.++..+++++|+.+| +++|+|+.+|+..+|...+. +.++++.|++.+|.|++|.|+++||+.++.
T Consensus 4 ls~ee~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~gl---~~~~L~~Iw~~~D~~~dG~l~~~EF~~a~~ 70 (95)
T d2jxca1 4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSKL---PVDILGRVWELSDIDHDGMLDRDEFAVAMF 70 (95)
T ss_dssp SCHHHHHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSSC---CHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhC-CCCCceeHHHHHHHHHHcCC---CHHHHHHHHHHhcCCCCCeEcHHHHHHHHH
Confidence 68899999999999999 89999999999999998764 456799999999999999999999976543
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=98.77 E-value=8.2e-09 Score=80.27 Aligned_cols=70 Identities=13% Similarity=0.152 Sum_probs=59.7
Q ss_pred hHHHHHHHHHHHhh-CCCCCCc-ccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLL-EPNKDGS-VSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~-D~d~~G~-I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..++.+.++|++| |+|++|. ++.+||..++........+...++.+++.+|.|+||.|+|+||+.++..
T Consensus 6 E~ai~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~~~ 77 (87)
T d1xk4a1 6 EKALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIK 77 (87)
T ss_dssp HHHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 46778899999999 8999986 5999999999864334677888999999999999999999999986553
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=98.75 E-value=3.4e-09 Score=84.06 Aligned_cols=70 Identities=14% Similarity=0.209 Sum_probs=58.9
Q ss_pred hHHHHHHHHHHHhh-CCCCC-CcccHHHHHHHHhhcchh----hhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLL-EPNKD-GSVSLENFRMVLGRNATD----AMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~-D~d~~-G~I~~~el~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..++.+.++|.+| |.|++ |+|+.+||..+|...... ......++.+++.+|.|+||.|+|+||+.++..
T Consensus 5 E~~i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~ 80 (93)
T d1zfsa1 5 ETAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAA 80 (93)
T ss_dssp HHHHHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHH
Confidence 45688999999998 88875 999999999999886531 235677999999999999999999999886643
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.75 E-value=6.8e-09 Score=84.83 Aligned_cols=61 Identities=13% Similarity=0.116 Sum_probs=53.5
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++.+|+.+|+|++|+|+.+|++.+| ++..+ +..+++.+|.|+||.|+++||+.+|+-+
T Consensus 21 ~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~L~~~~L~~Iw~l~D~d~dG~l~~~EF~~am~Li 85 (110)
T d1iq3a_ 21 REYYVNQFRSLQPDPSSFISGSVAKNFFTKSKLSIPELSYIWELSDADCDGALTLPEFCAAFHLI 85 (110)
T ss_dssp HHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSSCSSCCHHHHHHHHCSSSCSEEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCcccchhHHHHHHHHHhhccchHHHHHHHHHhccCCCCeECHHHHHHHHHHH
Confidence 4567889999999999999999999999 34443 9999999999999999999999877544
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=98.75 E-value=4.5e-09 Score=84.40 Aligned_cols=61 Identities=15% Similarity=0.251 Sum_probs=48.1
Q ss_pred HHHHHHHHHHHcc--cCCCcccHHHHHHHhcC------------Ccc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFEE--EGNRVISIEELARELNV------------GPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D~--d~~G~I~~~El~~~l~~------------~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
|+.+..+|++|++ +++|.|+..||+++|.. ... ++.+|..+|.|+||+|+|+||+.+|.++
T Consensus 6 E~~i~~l~~~F~~y~~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l 81 (100)
T d1psra_ 6 ERSIIGMIDMFHKYTRRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDI 81 (100)
T ss_dssp HHHHHHHHHHHHHTCCTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHH
Confidence 4444555555544 88999999999999931 112 8999999999999999999999999775
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=98.74 E-value=2.1e-09 Score=82.07 Aligned_cols=69 Identities=13% Similarity=0.193 Sum_probs=57.2
Q ss_pred hHHHHHHHHHHHhhCC-C-CCCcccHHHHHHHHhhcch-hhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 451 EDELVYLRAQFRLLEP-N-KDGSVSLENFRMVLGRNAT-DAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~-d-~~G~I~~~el~~~l~~~~~-~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
+..+++|+.+|..||. + +.|+|+.+||..+++.... ...+..+++.+++.+|.|+||.|+|+||+.++.
T Consensus 3 e~~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~~ 74 (78)
T d1cb1a_ 3 QKSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVK 74 (78)
T ss_dssp SCCHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHH
Confidence 4567889999999975 3 4589999999999988742 234566799999999999999999999988654
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.72 E-value=1.3e-08 Score=88.99 Aligned_cols=112 Identities=5% Similarity=0.023 Sum_probs=85.8
Q ss_pred HHHHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcch-hhhhhccHHHHHhhcccCCCCcccHHHHHHH
Q 007498 439 RAALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNAT-DAMRESRVPDVLSSMESLAYRKMYFEEFCAA 517 (601)
Q Consensus 439 ~~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~ 517 (601)
+.++..++...++.++..+ ...|.+++|.|+++||..++..... ......++...|+.+|.+++|.|+.+||..+
T Consensus 32 ~~~l~~lG~~~t~~e~~~~----~~~~~~~~~~i~~~eFl~~~~~~~~~~~~~~~~l~~aF~~~D~~~~G~I~~~el~~~ 107 (152)
T d1wdcc_ 32 GDVCRCLGINPRNEDVFAV----GGTHKMGEKSLPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHV 107 (152)
T ss_dssp HHHHHHTTCCCCHHHHHHT----TCCSSTTSCEECHHHHHHHHHHHTTSCCCCHHHHHHHHHTTCSSSSSEEEHHHHHHH
T ss_pred HHHHHHhccCccHhhhhhh----hhhhccccccccccccccccccccccchhHHHhhhhhhhccccccCccchHHHHHHH
Confidence 4445666777777776543 3468889999999999998865432 2234456889999999999999999999887
Q ss_pred hhcchhhhhhhhHHHHHHHHHHHHcc--cCCCcccHHHHHHHh
Q 007498 518 AISTHQLEALEGWEQIASTAFEYFEE--EGNRVISIEELAREL 558 (601)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~F~~~D~--d~~G~I~~~El~~~l 558 (601)
+.......+ ++++..+++.+|. |++|.|+.+||.+.|
T Consensus 108 l~~~g~~ls----~~e~~~l~~~~d~~~d~~G~I~y~eF~~~~ 146 (152)
T d1wdcc_ 108 LTALGERLS----DEDVDEIIKLTDLQEDLEGNVKYEDFVKKV 146 (152)
T ss_dssp HHHSSSCCC----HHHHHHHHHHHTCCCCTTSEEEHHHHHHHH
T ss_pred HHHcCCCCC----HHHHHHHHHHhccCCCCCCEEEHHHHHHHH
Confidence 765544444 5678899999986 456899999998876
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.71 E-value=1.4e-08 Score=87.98 Aligned_cols=113 Identities=9% Similarity=0.084 Sum_probs=81.8
Q ss_pred HHHHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchh-----hhhhccHHHHHhhcccCCCCcccHHHH
Q 007498 440 AALKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATD-----AMRESRVPDVLSSMESLAYRKMYFEEF 514 (601)
Q Consensus 440 ~~~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~-----~~~~~~~~~~~~~~D~~~~g~i~~~ef 514 (601)
.++..++..++.++++.+.. ...+.+.+|.|+..||..++...... ....+.+...|+.+|.+++|.|+.+||
T Consensus 26 ~~l~~lg~~~s~~ei~~l~~--~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~~~~G~I~~~el 103 (146)
T d1m45a_ 26 DYLRAIGYNPTNQLVQDIIN--ADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDL 103 (146)
T ss_dssp HHHHHTTCCCCHHHHHHHHH--C--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHHHHHHHHTTCSSSSSEEEHHHH
T ss_pred HHHHHcCCchhHHHHhhhhc--cccccccccccccchhhhhhhhhcccccccccchHHHHHHHHHhhccccccccchhhh
Confidence 34556666777777555432 23556678999999999998654321 122345888899999999999999999
Q ss_pred HHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 515 CAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
..++.......+ ++++..+|..+|.|++|.|+.+||.+.+
T Consensus 104 ~~~l~~~g~~l~----~~ei~~l~~~~D~d~dG~I~y~eF~~~i 143 (146)
T d1m45a_ 104 RYMLTGLGEKLT----DAEVDELLKGVEVDSNGEIDYKKFIEDV 143 (146)
T ss_dssp HHHHHHSTTCCC----HHHHHHHHTTCCCCTTSEEEHHHHHHHH
T ss_pred hhhhcccCCcch----HHHHHHHHHHhCCCCCCcEEHHHHHHHH
Confidence 988765544333 5678999999999999999999997654
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.70 E-value=1.1e-08 Score=81.34 Aligned_cols=60 Identities=13% Similarity=0.067 Sum_probs=52.1
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.+.++++|+.+| |++|+|+.+|++.+| ++..+ +..+++.+|.|+||.|+++||+.+|+-+
T Consensus 9 ~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~gl~~~~L~~Iw~~~D~~~dG~l~~~EF~~a~~Li 72 (95)
T d2jxca1 9 KAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMFLV 72 (95)
T ss_dssp HHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSSCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHhC-CCCCceeHHHHHHHHHHcCCCHHHHHHHHHHhcCCCCCeEcHHHHHHHHHHH
Confidence 456889999999 899999999999999 34333 9999999999999999999998777644
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=98.70 E-value=7.9e-09 Score=81.35 Aligned_cols=69 Identities=13% Similarity=0.220 Sum_probs=58.5
Q ss_pred hHHHHHHHHHHHhh-CCCCCC-cccHHHHHHHHhhcchh----hhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 451 EDELVYLRAQFRLL-EPNKDG-SVSLENFRMVLGRNATD----AMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 451 ~~~~~~l~~~F~~~-D~d~~G-~I~~~el~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
++.++.+..+|++| |+||+| +|+.+||+++|+..... ..+...++.+++.+|.|+||.|+|+||+.++.
T Consensus 5 E~~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~ 79 (93)
T d1ksoa_ 5 EQAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLA 79 (93)
T ss_dssp HHHHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHH
Confidence 46788999999998 999999 59999999999875421 23566799999999999999999999987654
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.69 E-value=4.7e-09 Score=85.82 Aligned_cols=69 Identities=20% Similarity=0.295 Sum_probs=61.8
Q ss_pred hcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 448 ALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 448 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
.++.++.++++++|..+|+|++|+|+.+|+..+|.+.+ .....+..+++.+|.|++|.|+++||+.++.
T Consensus 15 ~lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~---L~~~~L~~Iw~l~D~d~dG~l~~~EF~~am~ 83 (110)
T d1iq3a_ 15 RITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK---LSIPELSYIWELSDADCDGALTLPEFCAAFH 83 (110)
T ss_dssp CCSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS---CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred ccCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc---cchHHHHHHHHHhccCCCCeECHHHHHHHHH
Confidence 47788999999999999999999999999999998765 3567799999999999999999999986543
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=98.69 E-value=9.4e-09 Score=82.48 Aligned_cols=70 Identities=14% Similarity=0.230 Sum_probs=58.7
Q ss_pred chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchh------hhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATD------AMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~------~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
.+..+..+.++|++|| +++|.|+.+||..+|+..... ..+...++.+|+.+|.|+||.|+|+||+.++..
T Consensus 5 ~E~~i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~ 80 (100)
T d1psra_ 5 AERSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGD 80 (100)
T ss_dssp HHHHHHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHH
Confidence 4667889999999997 779999999999999886532 234567899999999999999999999986543
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=98.69 E-value=7.8e-08 Score=86.51 Aligned_cols=97 Identities=16% Similarity=0.191 Sum_probs=76.9
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchh--------hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhh
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATD--------AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEAL 527 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~--------~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~ 527 (601)
.+..++...|.+++|.|+.+++..++...... ......+..+|+.+|.|++|.|+.+||..++.... . +
T Consensus 61 ~~~~~~~~~d~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~-l-~- 137 (185)
T d2sasa_ 61 EWRDLKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ-L-Q- 137 (185)
T ss_dssp HHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC-C-C-
T ss_pred HHHHHHHHhCcCCCCcEeeeHhhHHHHHHhhhhhhhhhhhHHHHHHHHHHHHHHccCCCccCCHHHHHHHHHHcC-C-C-
Confidence 44567888899999999999999998654321 11122378899999999999999999998765432 1 2
Q ss_pred hhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 528 EGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 528 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
.+.+..+|..+|+|++|.|+.+||..++
T Consensus 138 ---~~~~~~~f~~~D~d~dG~i~~~EF~~~~ 165 (185)
T d2sasa_ 138 ---CADVPAVYNVITDGGKVTFDLNRYKELY 165 (185)
T ss_dssp ---CSSHHHHHHHHHTTTTSCCSHHHHHHHH
T ss_pred ---HHHHHHHHHHcCCCCCCCCcHHHHHHHH
Confidence 3457889999999999999999999876
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.68 E-value=1.7e-08 Score=86.73 Aligned_cols=105 Identities=13% Similarity=0.105 Sum_probs=79.0
Q ss_pred HHHhhhhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchh--hhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 442 LKALSKALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATD--AMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 442 ~~~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~--~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
+..++...+++++.. ++.+++|.|+.+||..++...... .....++...|+.+|.+++|.|+.+||..++.
T Consensus 31 l~~lg~~~t~~ei~~-------~~~~~~~~i~~~eF~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~ 103 (140)
T d1ggwa_ 31 LRACGQNPTLAEITE-------IESTLPAEVDMEQFLQVLNRPNGFDMPGDPEEFVKGFQVFDKDATGMIGVGELRYVLT 103 (140)
T ss_dssp HHHTSCCCCHHHHHH-------HHTTSCSSEEHHHHHHHHCTTSSSSSSCCHHHHHHHHHTTCSSCSSCCCHHHHHHHHH
T ss_pred HHHHHhhhHHHhhhh-------hhccccccccchhhhhhhhhhhhcchhhHHHHHHHHHHHHhccCCCcchHHHHHHHHH
Confidence 445566666666433 467889999999999998654321 12234588889999999999999999988776
Q ss_pred cchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 520 STHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
......+ ++++..+|+.+|.| ||.|+.+||.++|
T Consensus 104 ~~g~~lt----~~e~~~l~~~~d~~-dG~I~y~eF~~~m 137 (140)
T d1ggwa_ 104 SLGEKLS----NEEMDELLKGVPVK-DGMVNYHDFVQMI 137 (140)
T ss_dssp HHHSCSC----HHHHHHHHHHTTCS-SCCSTTTHHHHHH
T ss_pred HcCCCCC----HHHHHHHHHhhCCC-CCEEeHHHHHHHH
Confidence 5443333 56788899999988 9999999998875
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=98.67 E-value=1.5e-08 Score=80.02 Aligned_cols=70 Identities=17% Similarity=0.305 Sum_probs=57.3
Q ss_pred hHHHHHHHHHHHhh-CCCCCC-cccHHHHHHHHhhcch----hhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLL-EPNKDG-SVSLENFRMVLGRNAT----DAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~-D~d~~G-~I~~~el~~~l~~~~~----~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..++.+.++|.+| |.|++| +|+.+||+.+|..... .....+.++.+++.+|.|+||.|+|+||+.++..
T Consensus 5 E~~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~ 80 (93)
T d3c1va1 5 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSC 80 (93)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Confidence 45678999999998 667655 7999999999987542 2345677999999999999999999999886543
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.67 E-value=1.3e-08 Score=88.07 Aligned_cols=93 Identities=6% Similarity=0.064 Sum_probs=71.8
Q ss_pred hhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHc
Q 007498 463 LLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFE 542 (601)
Q Consensus 463 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D 542 (601)
.++.+++|.|+..||..++..........+.+...|+.+|.+++|.|+.+||..++.......+ ++++..+|+.+|
T Consensus 48 ~~~~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls----~~e~~~~~~~~d 123 (145)
T d2mysb_ 48 AMIKEASGPINFTVFLTMFGEKLKGADPEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFT----PEEIKNMWAAFP 123 (145)
T ss_pred HHHHhccCceeechhhhhhhhcccccchHHHHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCC----HHHHHHHHHHhC
Confidence 3456778899999999888665433444566888899999999999999999887655443333 566788899999
Q ss_pred ccCCCcccHHHHHHHhc
Q 007498 543 EEGNRVISIEELARELN 559 (601)
Q Consensus 543 ~d~~G~I~~~El~~~l~ 559 (601)
.|++|.|+..||.++|.
T Consensus 124 ~d~dg~I~y~eF~~~l~ 140 (145)
T d2mysb_ 124 PDVAGNVDYKNICYVIT 140 (145)
T ss_pred CCCCCeEeHHHHHHHhc
Confidence 99999999999988873
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.67 E-value=2.1e-08 Score=90.33 Aligned_cols=97 Identities=8% Similarity=0.061 Sum_probs=81.4
Q ss_pred ccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhcCCc------cHH
Q 007498 492 SRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELNVGP------SAY 565 (601)
Q Consensus 492 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~------~~~ 565 (601)
.+++.+|+.+|.+++|.|+++||..++........ ...+..+|..+|.+++|.|+.+|+..+..... .+.
T Consensus 10 ~~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~----~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~e~l~ 85 (182)
T d1s6ia_ 10 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSELM----ESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLEREENLV 85 (182)
T ss_dssp CSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCC----HHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCCCSTH
T ss_pred HHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCccc----cccchhhhhhhhccccccchHHHHHHHHHhhcccccHHHHH
Confidence 46888999999999999999999887765533333 56789999999999999999999988762211 188
Q ss_pred HHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007498 566 SFLKDWIRNSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 566 ~~~~~~d~~~dG~is~~EF~~~~~~~~ 592 (601)
.+|..+|.+++|.|+.+||.++++...
T Consensus 86 ~aF~~~D~d~~G~i~~~el~~~l~~~g 112 (182)
T d1s6ia_ 86 SAFSYFDKDGSGYITLDEIQQACKDFG 112 (182)
T ss_dssp HHHHHTTTTCSSEEEHHHHHHTTTTTT
T ss_pred HHHHHHhhcCCCccchhhhhhhhhhcC
Confidence 999999999999999999999987654
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=98.67 E-value=1.3e-08 Score=79.37 Aligned_cols=68 Identities=10% Similarity=0.271 Sum_probs=58.6
Q ss_pred hHHHHHHHHHHHhh-CCCCCC-cccHHHHHHHHhh---cchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 451 EDELVYLRAQFRLL-EPNKDG-SVSLENFRMVLGR---NATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 451 ~~~~~~l~~~F~~~-D~d~~G-~I~~~el~~~l~~---~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
+..+..+.++|++| |+|++| +|+..||..+++. ++. ..+...++.+++.+|.|+||.|+|+||+.++.
T Consensus 5 E~ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~-~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~ 77 (89)
T d1k8ua_ 5 DQAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGS-KLQDAEIARLMEDLDRNKDQEVNFQEYVTFLG 77 (89)
T ss_dssp HHHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGG-GTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhc-cCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHH
Confidence 46788999999999 999999 6999999999987 333 45567799999999999999999999987654
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.66 E-value=9.5e-09 Score=82.30 Aligned_cols=59 Identities=14% Similarity=0.010 Sum_probs=52.1
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHh---cCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 533 IASTAFEYFEEEGNRVISIEELAREL---NVGPS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 533 ~~~~~F~~~D~d~~G~I~~~El~~~l---~~~~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
.++++|+.+|+|++|+|+.+|++.++ ++..+ +..+++.+|.|+||.|+++||+.+|+-+
T Consensus 12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~L~~~~L~~i~~~~D~d~dG~L~~~EF~~am~Li 74 (99)
T d1qjta_ 12 VYEKYYRQVEAGNTGRVLALDAAAFLKKSGLPDLILGKIWDLADTDGKGVLSKQEFFVALRLV 74 (99)
T ss_dssp HHHHHHHHHCCTTSSCCCSHHHHHHHHTSSSCHHHHHHHHHHHCCSSSSSCCSHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcccHHHHHHHHHHcCCcHHHHHHHHHHHcCCCCCccCHHHHHHHHHHH
Confidence 46789999999999999999999999 44444 9999999999999999999999888644
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.64 E-value=1.3e-08 Score=81.64 Aligned_cols=29 Identities=17% Similarity=0.327 Sum_probs=26.4
Q ss_pred HHHHHHhhCCCCCCcccHHHHHHHHhhcc
Q 007498 457 LRAQFRLLEPNKDGSVSLENFRMVLGRNA 485 (601)
Q Consensus 457 l~~~F~~~D~d~~G~I~~~el~~~l~~~~ 485 (601)
++.+|..+|.|+||+|+++||..+++.++
T Consensus 18 ~r~~F~~~D~DgdG~i~~~El~~~l~~~~ 46 (99)
T d1snla_ 18 PKTFFILHDINSDGVLDEQELEALFTKEL 46 (99)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHHH
Confidence 67899999999999999999999997654
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.62 E-value=1.6e-08 Score=61.67 Aligned_cols=30 Identities=33% Similarity=0.493 Sum_probs=27.4
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhcC
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELNV 560 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~ 560 (601)
+++++.+|++||+||||+|+..||+.+|..
T Consensus 2 eeel~eAF~~FDkDg~G~Is~~EL~~vm~~ 31 (33)
T d2hf5a1 2 EEEIREAFRVFDKDGNGYISAAELRHVMTN 31 (33)
T ss_dssp HHHHHHHHHHHSSSCCSCBCHHHHHHHTTS
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 568999999999999999999999999853
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=98.60 E-value=5.2e-08 Score=75.31 Aligned_cols=60 Identities=13% Similarity=0.180 Sum_probs=48.9
Q ss_pred HHHHHHHHHH-cccCCC-cccHHHHHHHhc-----CC-----cc-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 532 QIASTAFEYF-EEEGNR-VISIEELARELN-----VG-----PS-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 532 ~~~~~~F~~~-D~d~~G-~I~~~El~~~l~-----~~-----~~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+.+..+|..| +++|++ .|+.+||+++|. .. ++ ++.+|+.+|.|+||.|+|+||+.+|.++
T Consensus 8 ~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l 80 (87)
T d1e8aa_ 8 EGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIA 80 (87)
T ss_dssp HHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHH
Confidence 4566788877 666665 699999999992 11 11 9999999999999999999999999875
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=98.55 E-value=1.2e-07 Score=84.53 Aligned_cols=88 Identities=10% Similarity=0.151 Sum_probs=69.1
Q ss_pred CCCCCCcccHHHHHHHHhhcchh----hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHH
Q 007498 465 EPNKDGSVSLENFRMVLGRNATD----AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEY 540 (601)
Q Consensus 465 D~d~~G~I~~~el~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~ 540 (601)
|.+++|.|+.+||...+...... ......+..+|+.+|.+++|.|+.+||..++..... . .+.+..+|+.
T Consensus 63 ~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~~--~----~~~~~~~f~~ 136 (174)
T d2scpa_ 63 AVAGGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGL--D----KTMAPASFDA 136 (174)
T ss_dssp GTTTTSCEEHHHHHHHHHHHTSCGGGTHHHHTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--C----GGGHHHHHHH
T ss_pred ccCCCCcCcHHHHHHHHHhhhcchhhHHHHHHHHHHHHHHHCCCccccCCHHHHHHHHHHHhh--h----hHHHHHHHhh
Confidence 67788999999999988765421 122445788999999999999999999876543221 1 3357889999
Q ss_pred HcccCCCcccHHHHHHHh
Q 007498 541 FEEEGNRVISIEELAREL 558 (601)
Q Consensus 541 ~D~d~~G~I~~~El~~~l 558 (601)
+|.|+||.|+.+||..++
T Consensus 137 ~D~d~dG~Is~~Ef~~~~ 154 (174)
T d2scpa_ 137 IDTNNDGLLSLEEFVIAG 154 (174)
T ss_dssp HCTTCSSEECHHHHHHHH
T ss_pred cCCCCCCcEeHHHHHHHH
Confidence 999999999999999876
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=2.5e-07 Score=88.11 Aligned_cols=85 Identities=16% Similarity=0.139 Sum_probs=62.2
Q ss_pred CeEEcceeccCCCeEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEE
Q 007498 148 KYELGKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVY 227 (601)
Q Consensus 148 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 227 (601)
.|++.+..+-|+.+.||.+.. .++.++||+....... ....+.+|..++..|..+--+.+++.++..++..|
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~-----~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC-----SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred ceEEEEcCCCCCCCcEEEEEe-----CCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 577766655455578998863 4567888987544322 22346789999999876655788888888889999
Q ss_pred EEEeecCCCchHH
Q 007498 228 IVMELCEGGELLD 240 (601)
Q Consensus 228 lv~e~~~~g~L~~ 240 (601)
+||++++|.++.+
T Consensus 87 lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 87 LLMSEADGVLCSE 99 (263)
T ss_dssp EEEECCSSEEHHH
T ss_pred EEEEecccccccc
Confidence 9999999877654
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=98.51 E-value=1.5e-07 Score=85.13 Aligned_cols=95 Identities=12% Similarity=0.110 Sum_probs=68.7
Q ss_pred HHHhhCCCCCCcccHHHHHHHHhhcchhh----------hhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhhh
Q 007498 460 QFRLLEPNKDGSVSLENFRMVLGRNATDA----------MRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALEG 529 (601)
Q Consensus 460 ~F~~~D~d~~G~I~~~el~~~l~~~~~~~----------~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~ 529 (601)
.+...|.+.++.|+.+|+..++....... .....+..+|+.+|.+++|.|+.+||..++.......+
T Consensus 65 ~~~~~~~~~~~~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~--- 141 (189)
T d1qv0a_ 65 FFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPS--- 141 (189)
T ss_dssp HHHHTTCCTTCCBCHHHHHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCC---
T ss_pred HhhhccccCCCceehHHHHHHHHHHHHHhhhccccccHHHHHHHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCC---
Confidence 45677888899999999988876533110 11223556899999999999999999887665433333
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 530 WEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 530 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
++.+..+|+.+|.|+||.|+.+||.+++
T Consensus 142 -~~~~~~lf~~~D~d~dG~Is~~EF~~~~ 169 (189)
T d1qv0a_ 142 -QEDCEATFRHCDLDNAGDLDVDEMTRQH 169 (189)
T ss_dssp -HHHHHHHHHHSCCCTTSCEEHHHHHHHH
T ss_pred -HHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 5678999999999999999999998765
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=98.50 E-value=2.1e-07 Score=82.75 Aligned_cols=97 Identities=20% Similarity=0.211 Sum_probs=77.3
Q ss_pred HHHHHHHhhCCCCCCcccHHHHHHHHhhcchh-------hhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchhhhhhh
Q 007498 456 YLRAQFRLLEPNKDGSVSLENFRMVLGRNATD-------AMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQLEALE 528 (601)
Q Consensus 456 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~-------~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~ 528 (601)
.+...+...|.+++|.|+..++...+...... ......+..+|..+|.+++|.|+.+||..++.... ..
T Consensus 59 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~--~~-- 134 (176)
T d1nyaa_ 59 LFDYLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MS-- 134 (176)
T ss_dssp HHHHHHHHHTSCTTCCBCHHHHHHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CC--
T ss_pred HHHHHHHHhcCCCCCcccHHHHHHHHhhhhhhhhhhhhHHHHHHHHHHHHHHHccCCChhhhHHHHHHHHHhcC--Cc--
Confidence 44567888899999999999998887654311 12234578899999999999999999987654332 12
Q ss_pred hHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 529 GWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 529 ~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
++.+..+|..||.|+||.|+.+||..++
T Consensus 135 --~~~~~~~f~~~D~d~dG~i~~~Ef~~~~ 162 (176)
T d1nyaa_ 135 --KAEAAEAFNQVDTNGNGELSLDELLTAV 162 (176)
T ss_dssp --HHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred --HHHHHHHHHHHCCCCCCcEeHHHHHHHH
Confidence 5678999999999999999999999987
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=98.49 E-value=9.6e-08 Score=86.16 Aligned_cols=70 Identities=7% Similarity=0.175 Sum_probs=61.4
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 449 LTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 449 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
..+.....++.+|..+|.|++|+|+.+||..+|..++. ..+.++++.+|+.+|.|++|+|+++||+.++.
T Consensus 99 ~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~-~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~~ 168 (187)
T d1uhka1 99 EPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGI-IQSSEDCEETFRVCDIDESGQLDVDEMTRQHL 168 (187)
T ss_dssp CCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTS-CCSHHHHHHHHHHSCCCTTSCEEHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHccCCCcccchHHHHHHHHHhCC-CccHHHHHHHHHHhCCCCCCCEeHHHHHHHHH
Confidence 34445567889999999999999999999999999885 56788899999999999999999999987654
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=6.1e-08 Score=82.99 Aligned_cols=111 Identities=16% Similarity=0.152 Sum_probs=79.0
Q ss_pred HHHHHhhhhcchHHHHHHHHHHHhhCC--CCCCcccHHHHHHHHhhcchh--hhhhccHHHHHhhcccCCCCcccHHHHH
Q 007498 440 AALKALSKALTEDELVYLRAQFRLLEP--NKDGSVSLENFRMVLGRNATD--AMRESRVPDVLSSMESLAYRKMYFEEFC 515 (601)
Q Consensus 440 ~~~~~~~~~l~~~~~~~l~~~F~~~D~--d~~G~I~~~el~~~l~~~~~~--~~~~~~~~~~~~~~D~~~~g~i~~~ef~ 515 (601)
.++..++...++.++. +++..++. +++|.|++.||..++...... .....++...|+.+|.+++|.|+.+||.
T Consensus 24 ~~l~~lg~~~t~~e~~---~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~ 100 (139)
T d1w7jb1 24 DVMRALGQNPTNAEVL---KVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELR 100 (139)
T ss_dssp HHHHHTTCCCCHHHHH---HHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CCHHHHHTTCTTSSSEEEHHHHH
T ss_pred HHHHHhccCCCHHHHH---HHHHHHhcccccCCceeeeccchhhHhhhhhccccHHHHHHHhhhhccCCCCCeEeHHHHH
Confidence 4556667777776644 44555553 578999999999988654321 2234557889999999999999999998
Q ss_pred HHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 516 AAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
.++........ ++++..+++. |.|+||.|+.+||.+.|
T Consensus 101 ~~l~~~g~~~~----~~e~~~l~~~-~~d~dg~I~~~eF~~~l 138 (139)
T d1w7jb1 101 HVLTTLGEKMT----EEEVETVLAG-HEDSNGCINYEAFLKHI 138 (139)
T ss_dssp HHHHHSSSCCC----HHHHHHHHTT-CCCTTSEEEHHHHHHHT
T ss_pred HHHHHhCCCCC----HHHHHHHHhh-CCCCCCeEeHHHHHHHh
Confidence 87765543333 4567777875 88999999999998865
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.46 E-value=7.3e-08 Score=76.99 Aligned_cols=62 Identities=13% Similarity=0.113 Sum_probs=54.7
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
..++++|+.+|.|++|+|+.+|+..++...+. ..+++..+|+.+|.|++|.|+++||+.++.
T Consensus 11 ~~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~L---~~~~L~~i~~~~D~d~dG~L~~~EF~~am~ 72 (99)
T d1qjta_ 11 PVYEKYYRQVEAGNTGRVLALDAAAFLKKSGL---PDLILGKIWDLADTDGKGVLSKQEFFVALR 72 (99)
T ss_dssp THHHHHHHHHCCTTSSCCCSHHHHHHHHTSSS---CHHHHHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcccHHHHHHHHHHcCC---cHHHHHHHHHHHcCCCCCccCHHHHHHHHH
Confidence 35778999999999999999999999998763 466799999999999999999999986543
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=98.46 E-value=1.5e-07 Score=72.61 Aligned_cols=69 Identities=12% Similarity=0.224 Sum_probs=55.9
Q ss_pred hHHHHHHHHHHHhh-CCCCCC-cccHHHHHHHHhhcch----hhhhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 451 EDELVYLRAQFRLL-EPNKDG-SVSLENFRMVLGRNAT----DAMRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 451 ~~~~~~l~~~F~~~-D~d~~G-~I~~~el~~~l~~~~~----~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
+..+..+.++|.+| +.++++ +|+.+||+++++.... ...+...++.+++.+|.|+||.|+|+||+.++.
T Consensus 4 E~ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~ 78 (87)
T d1e8aa_ 4 EEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVA 78 (87)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHHH
Confidence 46788999999999 456665 6999999999987432 123456799999999999999999999987654
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=2.5e-08 Score=88.70 Aligned_cols=99 Identities=10% Similarity=0.023 Sum_probs=69.4
Q ss_pred HHHHHhh--cccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHhc---CCccHHHHH
Q 007498 494 VPDVLSS--MESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELARELN---VGPSAYSFL 568 (601)
Q Consensus 494 ~~~~~~~--~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~---~~~~~~~~~ 568 (601)
+++++.. +|.|++|+|+++|+..++....... +...+.+...|...|.+++|.|+.+||..++. ...++..+|
T Consensus 7 l~k~~~k~~~d~n~dG~Is~~el~k~l~~~~~~~--~~~~~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l~~r~ei~~~F 84 (170)
T d2zkmx1 7 LDKILVKLKMQLNSEGKIPVKNFFQMFPADRKRV--EAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLCPRPEIDEIF 84 (170)
T ss_dssp HHHHHHHHHHSCCTTSCEEHHHHHHHSCSCHHHH--HHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHSCCHHHHTTC
T ss_pred HHHHHHHHhcccCCCCCCcHHHHHHHHHHhhhhH--HHHHHHHhhhhccccccCCCccCHHHHHHHHhccCCHHHHHHHH
Confidence 4444444 7999999999999988764332221 11245667789999999999999999999883 333489999
Q ss_pred HHHhcCCCCceeHHHHHHHHhhcccC
Q 007498 569 KDWIRNSDGKLSLHGYTKFLHGVTLR 594 (601)
Q Consensus 569 ~~~d~~~dG~is~~EF~~~~~~~~~~ 594 (601)
..+|.|++|.|+.+||.++|...+.-
T Consensus 85 ~~~d~d~~~~it~~el~~fL~~~Q~~ 110 (170)
T d2zkmx1 85 TSYHAKAKPYMTKEHLTKFINQKQRD 110 (170)
T ss_dssp C--------CCCHHHHHHHHHHTCC-
T ss_pred HHHcCCCCCcccHHHHHHHHHHHhcc
Confidence 99999999999999999999887643
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.28 E-value=2.6e-07 Score=56.13 Aligned_cols=31 Identities=23% Similarity=0.448 Sum_probs=28.6
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcc
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNA 485 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~ 485 (601)
++|+++|+.||+|+||+|+..||..+|+.+|
T Consensus 3 eel~eAF~~FDkDg~G~Is~~EL~~vm~~lG 33 (33)
T d2hf5a1 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLG 33 (33)
T ss_dssp HHHHHHHHHHSSSCCSCBCHHHHHHHTTSCC
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence 4799999999999999999999999998764
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=98.24 E-value=1.3e-06 Score=67.39 Aligned_cols=60 Identities=15% Similarity=0.275 Sum_probs=48.3
Q ss_pred HHHHHHHHHH-cccCC-CcccHHHHHHHhc-----CCc-----c-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 532 QIASTAFEYF-EEEGN-RVISIEELARELN-----VGP-----S-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 532 ~~~~~~F~~~-D~d~~-G~I~~~El~~~l~-----~~~-----~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+.+..+|..| .++|+ +.|+..||+++|. ... . ++.+|+.+|.|+||.|+|+||+.+|-++
T Consensus 9 ~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~l 81 (90)
T d3cr5x1 9 VALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMI 81 (90)
T ss_dssp HHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 3466678877 56665 5799999999992 121 1 9999999999999999999999998765
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.21 E-value=4.8e-07 Score=52.33 Aligned_cols=29 Identities=34% Similarity=0.537 Sum_probs=26.7
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELN 559 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~ 559 (601)
|+++..+|+.||+|+||||+.+||..+|.
T Consensus 3 EeELae~FRifDkNaDGyiD~eEl~~ilr 31 (34)
T d1ctda_ 3 EEELANAFRIFDKNADGYIDIEELGEILR 31 (34)
T ss_dssp HHHHHHHHHTTCCSSSSCBCHHHHHHHHH
T ss_pred HHHHHHHHHHHccCCcccccHHHHHHHHH
Confidence 67889999999999999999999999874
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=98.17 E-value=2.3e-06 Score=66.58 Aligned_cols=60 Identities=22% Similarity=0.329 Sum_probs=47.7
Q ss_pred HHHHHHHHHH-cccCC-CcccHHHHHHHhcC---------Cc-c-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 532 QIASTAFEYF-EEEGN-RVISIEELARELNV---------GP-S-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 532 ~~~~~~F~~~-D~d~~-G~I~~~El~~~l~~---------~~-~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
..+..+|..| .++|+ +.++..||+.+|.- .+ + ++.+|+.+|.|+||.|+|+||+.+|-++
T Consensus 9 ~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~l 81 (95)
T d1qlsa_ 9 ESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGL 81 (95)
T ss_dssp HHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHH
Confidence 3456677666 55665 67999999999931 11 1 9999999999999999999999998765
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=98.11 E-value=2.8e-06 Score=65.56 Aligned_cols=70 Identities=17% Similarity=0.240 Sum_probs=54.5
Q ss_pred hHHHHHHHHHHHhhC-CCCC-CcccHHHHHHHHhhcc----hhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLLE-PNKD-GSVSLENFRMVLGRNA----TDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D-~d~~-G~I~~~el~~~l~~~~----~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..+..+..+|.+|. .+++ ++|+..||+.++..-. ........++.+++.+|.|+||.|+|+||+.++..
T Consensus 5 E~ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~ 80 (90)
T d3cr5x1 5 EKAVVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAM 80 (90)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence 456788999999984 5555 4799999999997621 11223445899999999999999999999876543
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.10 E-value=1.5e-06 Score=50.25 Aligned_cols=32 Identities=25% Similarity=0.452 Sum_probs=28.4
Q ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHhhcc
Q 007498 454 LVYLRAQFRLLEPNKDGSVSLENFRMVLGRNA 485 (601)
Q Consensus 454 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~ 485 (601)
.+++-++|+.||+|.||+|+.+||..+++..|
T Consensus 3 EeELae~FRifDkNaDGyiD~eEl~~ilr~tG 34 (34)
T d1ctda_ 3 EEELANAFRIFDKNADGYIDIEELGEILRATG 34 (34)
T ss_dssp HHHHHHHHHTTCCSSSSCBCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHccCCcccccHHHHHHHHHhcC
Confidence 35788999999999999999999999998643
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=98.10 E-value=1.9e-06 Score=84.29 Aligned_cols=93 Identities=12% Similarity=0.073 Sum_probs=71.4
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcchh-hhhhhhHHHH
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTHQ-LEALEGWEQI 533 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~ 533 (601)
......+..+|.+.+|.|...++........ .+..+|..+|.+++|.|+..||..++....- ... .+.
T Consensus 223 ~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~-------~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~----~~~ 291 (321)
T d1ij5a_ 223 SVQDALFRYADEDESDDVGFSEYVHLGLCLL-------VLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESA----RKK 291 (321)
T ss_dssp HHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH-------HHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGG----CST
T ss_pred HHHHHHHHhhhcccccccccccccchhhhhh-------HHHHHHHHHhcCCCCCCcHHHHHHHHHHcCCCcCc----HHH
Confidence 3445677788999999999999887765443 2556888899999999999999877654432 122 345
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHh
Q 007498 534 ASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 534 ~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
+..+|+.+|.|+||+|+.+||..+|
T Consensus 292 ~~~l~~~~D~d~dG~Is~~EF~~~m 316 (321)
T d1ij5a_ 292 FEHQFSVVDVDDSKSLSYQEFVMLV 316 (321)
T ss_dssp HHHHHHHHTTTTCSEECHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 7888999999999999999999876
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=98.09 E-value=4.4e-06 Score=64.92 Aligned_cols=60 Identities=18% Similarity=0.334 Sum_probs=47.5
Q ss_pred HHHHHHHHHH-cccCC-CcccHHHHHHHhc-----CCc-----c-HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 532 QIASTAFEYF-EEEGN-RVISIEELARELN-----VGP-----S-AYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 532 ~~~~~~F~~~-D~d~~-G~I~~~El~~~l~-----~~~-----~-~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
+.+..+|..| .++|+ +.++..||+.+|. ... . ++.+|+.+|.|+||.|+|+||+.+|-++
T Consensus 9 ~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~l 81 (94)
T d1j55a_ 9 GMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAI 81 (94)
T ss_dssp HHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 3466678777 44554 5899999999992 111 1 9999999999999999999999998765
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=98.04 E-value=4.3e-06 Score=65.02 Aligned_cols=70 Identities=13% Similarity=0.155 Sum_probs=54.9
Q ss_pred hHHHHHHHHHHHhhC-CCCC-CcccHHHHHHHHhh-----cchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 451 EDELVYLRAQFRLLE-PNKD-GSVSLENFRMVLGR-----NATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D-~d~~-G~I~~~el~~~l~~-----~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
+..+..|..+|.+|. .+|+ ++|+..||+.++.. ++. ......++.+++.+|.|+||.|+|+||+.++..+
T Consensus 5 E~ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~-~~d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~l 81 (95)
T d1qlsa_ 5 ERCIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQN-QKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGL 81 (95)
T ss_dssp HHHHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHH-CCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcC-CCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHH
Confidence 356788999999985 4555 57999999999976 221 2334569999999999999999999998765543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.04 E-value=6e-06 Score=83.28 Aligned_cols=82 Identities=17% Similarity=0.201 Sum_probs=52.6
Q ss_pred cceeccCCCeEEEEEEeecCCccCcEEEEEEeecccc----cchhhHHHHHHHHHHHHHhcCC--CCeeEEeeeEecCCc
Q 007498 152 GKEVGRGHFGHTCSARGKKGELKDQQVAVKIISKAKM----TTAISIEDVRREVKILKALSGH--KHLVKFCDACEDVNN 225 (601)
Q Consensus 152 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~ 225 (601)
.+.||.|....||.+.+.. .++.|+||.-..... .......+...|.+.|+.+..+ ..+++++.+ +...
T Consensus 31 ~~eig~G~~N~vfrV~~~~---~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred EEEeCCCceEeEEEEEeCC---CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC
Confidence 3468999999999998754 567899997543111 1112344567799999887544 346666654 3445
Q ss_pred EEEEEeecCCCch
Q 007498 226 VYIVMELCEGGEL 238 (601)
Q Consensus 226 ~~lv~e~~~~g~L 238 (601)
.++|||++.+..+
T Consensus 106 ~~lvmE~L~~~~~ 118 (392)
T d2pula1 106 AVTVMEDLSHLKI 118 (392)
T ss_dssp TEEEECCCTTSEE
T ss_pred CEEEEeccCCccc
Confidence 6789999987554
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=97.98 E-value=1e-05 Score=61.11 Aligned_cols=59 Identities=14% Similarity=0.264 Sum_probs=46.5
Q ss_pred HHHHHHHHHHc-ccC-CCcccHHHHHHHhc------CC---cc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007498 532 QIASTAFEYFE-EEG-NRVISIEELARELN------VG---PS---AYSFLKDWIRNSDGKLSLHGYTKFLHG 590 (601)
Q Consensus 532 ~~~~~~F~~~D-~d~-~G~I~~~El~~~l~------~~---~~---~~~~~~~~d~~~dG~is~~EF~~~~~~ 590 (601)
..+..+|..|- ++| .+.++..||+.+|. +. .+ ++.+|..+|.|+||.|+|+||+.++-+
T Consensus 10 ~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~ 82 (83)
T d1xk4c1 10 ETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMAR 82 (83)
T ss_dssp HHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHhh
Confidence 34566787774 444 36899999999992 11 11 899999999999999999999999865
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.90 E-value=2e-05 Score=74.05 Aligned_cols=75 Identities=12% Similarity=0.130 Sum_probs=53.3
Q ss_pred eeccCCC-eEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCC-CCeeEEeeeEecCCcEEEEEe
Q 007498 154 EVGRGHF-GHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGH-KHLVKFCDACEDVNNVYIVME 231 (601)
Q Consensus 154 ~lG~G~~-g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~lv~e 231 (601)
.+..|.. +.||.+... .+..+++|....... ..+..|...++.|..+ -.+.+++.+..+.+..++||+
T Consensus 17 ~~~~G~s~~~v~r~~~~----~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~ 86 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 86 (255)
T ss_dssp ECSCTTSSCEEEEEECT----TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred EcCCcccCCeEEEEEeC----CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEE
Confidence 4455553 578988764 455688898654322 2467899999888643 236778888888889999999
Q ss_pred ecCCCch
Q 007498 232 LCEGGEL 238 (601)
Q Consensus 232 ~~~~g~L 238 (601)
+++|.++
T Consensus 87 ~i~G~~~ 93 (255)
T d1nd4a_ 87 EVPGQDL 93 (255)
T ss_dssp CCSSEET
T ss_pred eeecccc
Confidence 9988654
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=97.86 E-value=1.5e-05 Score=61.87 Aligned_cols=69 Identities=10% Similarity=0.206 Sum_probs=52.7
Q ss_pred hHHHHHHHHHHHhhCC-CCC-CcccHHHHHHHHhh-----cchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhc
Q 007498 451 EDELVYLRAQFRLLEP-NKD-GSVSLENFRMVLGR-----NATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIS 520 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~-d~~-G~I~~~el~~~l~~-----~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~ 520 (601)
+..+..+..+|.+|.. +++ ++|+.+||+.++.. +. .......++.+++.+|.|+||.|+|+||+.++..
T Consensus 5 E~ai~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~-~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~ 80 (94)
T d1j55a_ 5 ETAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQ-SGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAA 80 (94)
T ss_dssp HHHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC-------CHHHHHHHHHCSSSSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhc-CCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence 4567789999999853 444 48999999999976 22 1234566999999999999999999999876543
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=97.80 E-value=2.6e-05 Score=58.89 Aligned_cols=69 Identities=13% Similarity=0.277 Sum_probs=52.5
Q ss_pred hHHHHHHHHHHHhhCC-CC-CCcccHHHHHHHHhhcchh---h--hhhccHHHHHhhcccCCCCcccHHHHHHHhh
Q 007498 451 EDELVYLRAQFRLLEP-NK-DGSVSLENFRMVLGRNATD---A--MRESRVPDVLSSMESLAYRKMYFEEFCAAAI 519 (601)
Q Consensus 451 ~~~~~~l~~~F~~~D~-d~-~G~I~~~el~~~l~~~~~~---~--~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 519 (601)
+..+..+..+|++|.. ++ .++++..||..++..-... . .....++.+++.+|.|+||.|+|+||+.++.
T Consensus 6 E~ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~ 81 (83)
T d1xk4c1 6 ERNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMA 81 (83)
T ss_dssp HHHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHh
Confidence 3567788999999964 33 3589999999999762111 1 1233489999999999999999999987643
|
| >d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Diacylglycerol kinase alpha, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.51 E-value=9.1e-05 Score=60.29 Aligned_cols=95 Identities=15% Similarity=0.204 Sum_probs=62.7
Q ss_pred CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhccc------CCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHH
Q 007498 468 KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMES------LAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYF 541 (601)
Q Consensus 468 ~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~------~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~ 541 (601)
.++.|+.+++.++.+... .+..+++.+++.+.. ..+|.|++++|..++.........+ +.-+..+|+.|
T Consensus 4 ~~s~l~p~~l~~L~~~T~---fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~--~~l~~rlF~~F 78 (118)
T d1tuza_ 4 ERGLISPSDFAQLQKYME---YSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVP--RHLSLALFQSF 78 (118)
T ss_dssp CCSCSCHHHHHHHHHHHH---HCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCC--HHHHHHHHHHS
T ss_pred ccCCCCHHHHHHHHHHcC---CCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCch--HHHHHHHHHHH
Confidence 467799999999888654 567778888887732 3578899999987654322211111 44678899999
Q ss_pred cccCCCcccHHHHHHHhcCCccHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007498 542 EEEGNRVISIEELARELNVGPSAYSFLKDWIRNSDGKLSLHGYTKFLH 589 (601)
Q Consensus 542 D~d~~G~I~~~El~~~l~~~~~~~~~~~~~d~~~dG~is~~EF~~~~~ 589 (601)
|+|+++.+. ..++|.|+|.||+..|.
T Consensus 79 D~~~d~~~~----------------------~~~~g~I~f~efv~~LS 104 (118)
T d1tuza_ 79 ETGHCLNET----------------------NVTKDVVCLNDVSCYFS 104 (118)
T ss_dssp CCCCCTTCC----------------------CCCSCCEEHHHHHHHHH
T ss_pred ccccccccc----------------------cCCCceeeHHHHHHHHH
Confidence 998774322 34556666666666554
|
| >d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Diacylglycerol kinase alpha, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.47 E-value=4.2e-05 Score=62.35 Aligned_cols=84 Identities=10% Similarity=0.054 Sum_probs=63.2
Q ss_pred hhHHHHHHhh--hhcchHHHHHHHHHHHhhC---CCCCCcccHHHHHHHHhhcchh-hhhhccHHHHHhhcccCCC----
Q 007498 437 FKRAALKALS--KALTEDELVYLRAQFRLLE---PNKDGSVSLENFRMVLGRNATD-AMRESRVPDVLSSMESLAY---- 506 (601)
Q Consensus 437 l~~~~~~~~~--~~l~~~~~~~l~~~F~~~D---~d~~G~I~~~el~~~l~~~~~~-~~~~~~~~~~~~~~D~~~~---- 506 (601)
+....+.++. +.+++.+++.|++.|.... .+.+|.|+.++|..++..+... ..+...++++|+.+|.+++
T Consensus 8 l~p~~l~~L~~~T~fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~~~d~~~~ 87 (118)
T d1tuza_ 8 ISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNET 87 (118)
T ss_dssp SCHHHHHHHHHHHHHCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCCCCCTTCC
T ss_pred CCHHHHHHHHHHcCCCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHccccccccc
Confidence 4444444443 4579999999999997543 2457999999999999877632 2235678999999999976
Q ss_pred ----CcccHHHHHHHhhc
Q 007498 507 ----RKMYFEEFCAAAIS 520 (601)
Q Consensus 507 ----g~i~~~ef~~~~~~ 520 (601)
|.|+|.||+..+..
T Consensus 88 ~~~~g~I~f~efv~~LS~ 105 (118)
T d1tuza_ 88 NVTKDVVCLNDVSCYFSL 105 (118)
T ss_dssp CCCSCCEEHHHHHHHHHH
T ss_pred cCCCceeeHHHHHHHHHH
Confidence 88999999876543
|
| >d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Osteonectin domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.13 E-value=0.00013 Score=61.05 Aligned_cols=56 Identities=14% Similarity=0.125 Sum_probs=48.6
Q ss_pred HHHHHHHHHccc-CCCcccHHHHHHHhc-CC-cc--HHHHHHHHhcCCCCceeHHHHHHHH
Q 007498 533 IASTAFEYFEEE-GNRVISIEELARELN-VG-PS--AYSFLKDWIRNSDGKLSLHGYTKFL 588 (601)
Q Consensus 533 ~~~~~F~~~D~d-~~G~I~~~El~~~l~-~~-~~--~~~~~~~~d~~~dG~is~~EF~~~~ 588 (601)
.+.+.|..+|.| .||+|+..||+.+.. +. .+ +..+++..|.|+||.||+.|+...+
T Consensus 78 ~v~W~F~~LD~n~~D~~L~~~EL~~l~~~L~~~e~C~~~F~~~CD~n~D~~Is~~EW~~Cf 138 (151)
T d1sraa_ 78 PVHWQFGQLDQHPIDGYLSHTELAPLRAPLIPMEHCTTRFFETCDLDNDKYIALDEWAGCF 138 (151)
T ss_dssp HHHHHHHHHCCTTCSSEECTTTTGGGGSTTSTTGGGHHHHHHHHCTTCSSSEEHHHHHHHT
T ss_pred cceeehhhcCCCCCCCccCHHHHHHHHHhhcCCchHHHHHHHHhcCCCCCcCCHHHHHHHc
Confidence 467789999999 599999999999875 22 23 9999999999999999999999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.04 E-value=0.00071 Score=65.67 Aligned_cols=68 Identities=9% Similarity=0.123 Sum_probs=44.8
Q ss_pred eEEEEEEeecCCccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCC-CeeEEee-----eEecCCcEEEEEeecC
Q 007498 161 GHTCSARGKKGELKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHK-HLVKFCD-----ACEDVNNVYIVMELCE 234 (601)
Q Consensus 161 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~-----~~~~~~~~~lv~e~~~ 234 (601)
-.||.++.. +|..|++|+.+.... ..+++..|+..+..|..+. -++..+. .+...+..+.|++++.
T Consensus 36 N~vy~v~~~----dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 36 NRVYQFQDE----DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SEEEEECCT----TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred ceeEEEEcC----CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 479998764 577899999765422 3467888999999986331 1222111 2334567889999997
Q ss_pred CC
Q 007498 235 GG 236 (601)
Q Consensus 235 ~g 236 (601)
|.
T Consensus 108 G~ 109 (325)
T d1zyla1 108 GR 109 (325)
T ss_dssp CE
T ss_pred Cc
Confidence 64
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.83 E-value=0.0016 Score=65.00 Aligned_cols=77 Identities=14% Similarity=0.036 Sum_probs=52.2
Q ss_pred ceeccCCCeEEEEEEeecCC----ccCcEEEEEEeecccccchhhHHHHHHHHHHHHHhcCCCCeeEEeeeEecCCcEEE
Q 007498 153 KEVGRGHFGHTCSARGKKGE----LKDQQVAVKIISKAKMTTAISIEDVRREVKILKALSGHKHLVKFCDACEDVNNVYI 228 (601)
Q Consensus 153 ~~lG~G~~g~V~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l 228 (601)
+.|+-|-.=.+|++....+. ...+.|.+++.-.. .. .-...+|..+++.+..+.-..++++++.+ .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 56776777789999875432 13456777776421 11 23456899999999866555688888764 58
Q ss_pred EEeecCCCch
Q 007498 229 VMELCEGGEL 238 (601)
Q Consensus 229 v~e~~~~g~L 238 (601)
||||++|..|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.21 E-value=0.011 Score=56.56 Aligned_cols=30 Identities=40% Similarity=0.579 Sum_probs=24.7
Q ss_pred cCCeeccCCCCceEeecCCCCCCeEEeeccccc
Q 007498 271 QGVVHRDLKPENFLFTSGRDDADMRLIDFGLSD 303 (601)
Q Consensus 271 ~~iiHrDikp~NIll~~~~~~~~vkl~DFG~a~ 303 (601)
.|+||+|+.++||+++. +...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~---~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLG---DELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEET---TEEEEECCCTTCE
T ss_pred cccccCCcchhhhhccc---ccceeEecccccc
Confidence 36999999999999963 4455799999874
|
| >d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Osteonectin domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.16 E-value=0.0035 Score=52.17 Aligned_cols=55 Identities=15% Similarity=0.166 Sum_probs=41.1
Q ss_pred HHHhhCCC-CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHH
Q 007498 460 QFRLLEPN-KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAA 517 (601)
Q Consensus 460 ~F~~~D~d-~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~ 517 (601)
.|..+|.| +||.|+..|+..+...+- +.+.=++.+++..|.|+||.|++.|+..-
T Consensus 82 ~F~~LD~n~~D~~L~~~EL~~l~~~L~---~~e~C~~~F~~~CD~n~D~~Is~~EW~~C 137 (151)
T d1sraa_ 82 QFGQLDQHPIDGYLSHTELAPLRAPLI---PMEHCTTRFFETCDLDNDKYIALDEWAGC 137 (151)
T ss_dssp HHHHHCCTTCSSEECTTTTGGGGSTTS---TTGGGHHHHHHHHCTTCSSSEEHHHHHHH
T ss_pred ehhhcCCCCCCCccCHHHHHHHHHhhc---CCchHHHHHHHHhcCCCCCcCCHHHHHHH
Confidence 48888888 588888888877644331 23444777888888888888888888773
|
| >d2cclb1 a.139.1.1 (B:1-59) Endo-1,4-beta-xylanase Y {Clostridium thermocellum [TaxId: 1515]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Type I dockerin domain superfamily: Type I dockerin domain family: Type I dockerin domain domain: Endo-1,4-beta-xylanase Y species: Clostridium thermocellum [TaxId: 1515]
Probab=91.65 E-value=0.12 Score=35.26 Aligned_cols=21 Identities=5% Similarity=-0.058 Sum_probs=10.3
Q ss_pred HHHHhcCCCCceeHHHHHHHH
Q 007498 568 LKDWIRNSDGKLSLHGYTKFL 588 (601)
Q Consensus 568 ~~~~d~~~dG~is~~EF~~~~ 588 (601)
+..+|.|+||.|+..+++.++
T Consensus 32 ~~aaDvn~Dg~i~i~D~~~l~ 52 (59)
T d2cclb1 32 KARADVDKNGSINAADVLLLS 52 (59)
T ss_dssp HHHHCTTCSSCCSHHHHHHHH
T ss_pred hhccccCCCCCCCHHHHHHHH
Confidence 344455555555555544443
|
| >d1qasa1 a.39.1.7 (A:205-298) Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=91.59 E-value=0.1 Score=39.57 Aligned_cols=66 Identities=14% Similarity=0.163 Sum_probs=48.2
Q ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHhhcchh-hhhhccHHHHHhhcccCC----CCcccHHHHHHHhhcc
Q 007498 455 VYLRAQFRLLEPNKDGSVSLENFRMVLGRNATD-AMRESRVPDVLSSMESLA----YRKMYFEEFCAAAIST 521 (601)
Q Consensus 455 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~-~~~~~~~~~~~~~~D~~~----~g~i~~~ef~~~~~~~ 521 (601)
.+|..+|..+-.+ .+.|+.++|..+|+.-... ..+.+.+..++..+..+. .+.+++++|...+...
T Consensus 8 ~ei~~if~~ys~~-~~~mt~~~f~~FL~~eQ~~~~~~~~~~~~ii~~~e~~~~~~~~~~ls~~gF~~fL~S~ 78 (94)
T d1qasa1 8 AEIDRAFEEAAGS-AETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSA 78 (94)
T ss_dssp HHHHHHHHHHHTT-SSSCBHHHHHHHHHHTSCCTTCSHHHHHHHHHHHCCCHHHHHTTBCCHHHHHHHHHSS
T ss_pred HHHHHHHHHHhCC-CCccCHHHHHHHHHHHcCCccCCHHHHHHHHHHHcccHhhhhcCCcCHHHHHHHHcCc
Confidence 3567788888554 4689999999999876532 345566788888887653 4679999998876654
|
| >d1qasa1 a.39.1.7 (A:205-298) Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=91.36 E-value=0.15 Score=38.57 Aligned_cols=59 Identities=22% Similarity=0.380 Sum_probs=42.9
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhc----C---Ccc-HHHHHHHHhcCC----CCceeHHHHHHHHhhc
Q 007498 532 QIASTAFEYFEEEGNRVISIEELARELN----V---GPS-AYSFLKDWIRNS----DGKLSLHGYTKFLHGV 591 (601)
Q Consensus 532 ~~~~~~F~~~D~d~~G~I~~~El~~~l~----~---~~~-~~~~~~~~d~~~----dG~is~~EF~~~~~~~ 591 (601)
.++..+|..|= ++.+.+|.++|..+|. . ..+ +..+|..+..+. .|.+++++|..+|..-
T Consensus 8 ~ei~~if~~ys-~~~~~mt~~~f~~FL~~eQ~~~~~~~~~~~~ii~~~e~~~~~~~~~~ls~~gF~~fL~S~ 78 (94)
T d1qasa1 8 AEIDRAFEEAA-GSAETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSA 78 (94)
T ss_dssp HHHHHHHHHHH-TTSSSCBHHHHHHHHHHTSCCTTCSHHHHHHHHHHHCCCHHHHHTTBCCHHHHHHHHHSS
T ss_pred HHHHHHHHHHh-CCCCccCHHHHHHHHHHHcCCccCCHHHHHHHHHHHcccHhhhhcCCcCHHHHHHHHcCc
Confidence 35678888884 4457899999999992 1 111 677888886553 4779999999998653
|
| >d1pula1 a.39.1.11 (A:18-120) Hypothetical protein c32e8.3 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: p25-alpha domain: Hypothetical protein c32e8.3 species: Caenorhabditis elegans [TaxId: 6239]
Probab=90.14 E-value=1 Score=34.22 Aligned_cols=71 Identities=13% Similarity=0.106 Sum_probs=54.3
Q ss_pred chHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcc---hhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcc
Q 007498 450 TEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNA---TDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAIST 521 (601)
Q Consensus 450 ~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~---~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 521 (601)
+..+++..-+.|..|-.-..-.++-..|..+++..+ ....+..+++-+|..+-... .+|+|++|..++-.+
T Consensus 3 ~~~~l~~~F~aF~~FG~~~~~em~~~~f~Kl~kdc~lid~K~~T~tdvDIiF~K~k~k~-~ri~f~~F~~aL~~l 76 (103)
T d1pula1 3 DDADVKKRWDAFTKFGAATATEMTGKNFDKWLKDAGVLDNKAITGTMTGIAFSKVTGPK-KKATFDETKKVLAFV 76 (103)
T ss_dssp CHHHHHHHHHHHHHHTCSSSSCCCHHHHHHHHHHHTSCCSSSSCHHHHHHHHHHHTCSS-SCCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHhcCCCCcCCCHHHHHHHHHHcCCCcCCCCCccchhhhhHhhcCCC-CCcCHHHHHHHHHHH
Confidence 456788888899999854445799999999998744 23477788999999986544 569999998776443
|
| >d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=89.82 E-value=0.31 Score=32.87 Aligned_cols=72 Identities=11% Similarity=0.138 Sum_probs=56.2
Q ss_pred hhcchHHHHHHHHHHHhhCCCCCCcccHHHHHHHHhhcchhhhhhccHHHHHhhccc-CCC-CcccHHHHHHHhh
Q 007498 447 KALTEDELVYLRAQFRLLEPNKDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMES-LAY-RKMYFEEFCAAAI 519 (601)
Q Consensus 447 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~-~~~-g~i~~~ef~~~~~ 519 (601)
..+..++..+-.++|+.||.|...---..+-...|..+|. ..+..+.+.+++..-. .+| ..|.-+|++.++.
T Consensus 6 ralgpeekdecmkifdifdrnaeniapvsdtmdmltklgq-tytkreteaimkeargpkgdkknigpeewltlcs 79 (86)
T d1j7qa_ 6 RALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQ-TYTKRETEAIMKEARGPKGDKKNIGPEEWLTLCS 79 (86)
T ss_dssp CCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSC-CCSHHHHHHHHHHHHCSSCSSCCBCTTHHHHHHH
T ss_pred cccCchhHHHHHHHHHHHhccccccCCcchHHHHHHHhhh-HHhHHHHHHHHHHhcCCCCccccCCHHHHHHHHH
Confidence 3466778889999999999998888888888899999985 4566678888887643 223 3688899988765
|
| >d1h8ba_ a.39.1.7 (A:) alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: alpha-Actinin species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.06 E-value=0.55 Score=33.07 Aligned_cols=59 Identities=25% Similarity=0.342 Sum_probs=45.6
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhcCCcc-HHHHHHHHhc-----CCCCceeHHHHHHHHhhcc
Q 007498 531 EQIASTAFEYFEEEGNRVISIEELARELNVGPS-AYSFLKDWIR-----NSDGKLSLHGYTKFLHGVT 592 (601)
Q Consensus 531 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~-~~~~~~~~d~-----~~dG~is~~EF~~~~~~~~ 592 (601)
.+.+..+|+.. -++..|||.+||++.|. .+ ++.++..+-. -..|..+|..|++.|-+.+
T Consensus 7 aEqv~~aFr~l-A~~KpyVT~~dL~~~L~--peqaeyc~~~M~~y~~~~~~~~ayDY~sF~~~l~ges 71 (73)
T d1h8ba_ 7 AEQVIASFRIL-ASDKPYILAEELRRELP--PDQAQYCIKRMPAYSGPGSVPGALDYAAFSSALYGES 71 (73)
T ss_dssp HHHHHHHHHHH-TTSCSSBCHHHHHHHSC--HHHHHHHHHHSCSCCCSSCCTTCBCHHHHHHHHTCCS
T ss_pred HHHHHHHHHHH-hCCCCeeCHHHHHhhcC--HHHHHHHHHHCcccCCCCCCCCcccHHHHHHHHhccc
Confidence 46688899999 47799999999999753 43 7777777743 2467899999999886644
|
| >d2cclb1 a.139.1.1 (B:1-59) Endo-1,4-beta-xylanase Y {Clostridium thermocellum [TaxId: 1515]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Type I dockerin domain superfamily: Type I dockerin domain family: Type I dockerin domain domain: Endo-1,4-beta-xylanase Y species: Clostridium thermocellum [TaxId: 1515]
Probab=86.08 E-value=0.48 Score=32.11 Aligned_cols=51 Identities=10% Similarity=-0.026 Sum_probs=29.5
Q ss_pred ccCCCCcccHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 007498 502 ESLAYRKMYFEEFCAAAISTHQLEALEGWEQIASTAFEYFEEEGNRVISIEELAREL 558 (601)
Q Consensus 502 D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l 558 (601)
|.|.||.|+..++..+........... ...|...|.|+||.|+..++..+.
T Consensus 2 DvN~Dg~vni~D~~~l~~~il~~~~~~------~~~~~aaDvn~Dg~i~i~D~~~l~ 52 (59)
T d2cclb1 2 DVNGDGTINSTDLTMLKRSVLRAITLT------DDAKARADVDKNGSINAADVLLLS 52 (59)
T ss_dssp CTTCSSSCCHHHHHHHHHHHTTSSCCC------HHHHHHHCTTCSSCCSHHHHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHHhCCCCCC------hhhhhccccCCCCCCCHHHHHHHH
Confidence 567777777777765432211111100 224666788888888887776654
|
| >d2b59b1 a.139.1.1 (B:104-163) Cellulosomal scaffolding protein A {Clostridium thermocellum [TaxId: 1515]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Type I dockerin domain superfamily: Type I dockerin domain family: Type I dockerin domain domain: Cellulosomal scaffolding protein A species: Clostridium thermocellum [TaxId: 1515]
Probab=84.70 E-value=0.62 Score=30.41 Aligned_cols=51 Identities=10% Similarity=0.080 Sum_probs=38.3
Q ss_pred CCCcccHHHHHHHHhhcchhhhhhccHHHHHhhcccCCCCcccHHHHHHHhhcch
Q 007498 468 KDGSVSLENFRMVLGRNATDAMRESRVPDVLSSMESLAYRKMYFEEFCAAAISTH 522 (601)
Q Consensus 468 ~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~ 522 (601)
.||.|+..++-++.+.++...... .....+|-|.||.|++.+.+-+..++.
T Consensus 2 qD~~INm~DVmei~k~F~~~~g~~----~y~~~lDlN~dGaInm~Di~Iv~khF~ 52 (60)
T d2b59b1 2 KDNSINLLDVAEVIRCFNATKGSA----NYVEELDINRNGAINMQDIMIVHKHFG 52 (60)
T ss_dssp SSSCCCHHHHHHHHHTTTCBTTST----TCCGGGSTTCSSBCSHHHHHHHHTTTT
T ss_pred CcccccHHHHHHHHHHhccccCCc----chhhhccccccccccHHHHHHHHHHhC
Confidence 479999999999999888543222 245678999999999999876544443
|
| >d1dava_ a.139.1.1 (A:) Cellulosome endoglucanase SS {Clostridium thermocellum [TaxId: 1515]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Type I dockerin domain superfamily: Type I dockerin domain family: Type I dockerin domain domain: Cellulosome endoglucanase SS species: Clostridium thermocellum [TaxId: 1515]
Probab=80.81 E-value=0.047 Score=39.09 Aligned_cols=48 Identities=10% Similarity=0.068 Sum_probs=26.2
Q ss_pred cccCCCcccHHHHHHHh----cCCccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007498 542 EEEGNRVISIEELAREL----NVGPSAYSFLKDWIRNSDGKLSLHGYTKFLHGV 591 (601)
Q Consensus 542 D~d~~G~I~~~El~~~l----~~~~~~~~~~~~~d~~~dG~is~~EF~~~~~~~ 591 (601)
|.|+||.|+..++..++ +.....+ +..+|.|+||.|+..++..+.+.+
T Consensus 8 DvN~DG~Vd~~D~~~~~~~i~~~~~~~~--~~~aDvn~DG~Id~~D~~~l~~~i 59 (71)
T d1dava_ 8 DVNDDGKVNSTDAVALKRYVLRSGISIN--TDNADLNEDGRVNSTDLGILKRYI 59 (71)
T ss_dssp CSSSSSBSSGGGHHHHHHHHHCSCSCCC--GGGTCSSSSSSCSSHHHHHHHHHT
T ss_pred ccCCCCCCcHHHHHHHHHHHcCCCCcCC--CcceecCCCCCcCHHHHHHHHHHH
Confidence 55666666666665544 2111111 123577777777777776665543
|